Phenotypic O
analcysis O
demonstrates O
tat O
trio B-GENE
and O
Abl B-GENE
cooperate O
in O
regluating O
axon O
outgrowtj O
in O
the O
em(bryonic O
cnetral O
nervous O
ystem O
( O
CNS O
) O
. O

In O
the O
cervcial O
enlargement O
thye O
ere O
lcoated O
in O
the O
middlee O
$part O
of O
lamina O
VII O
and O
in O
;amina O
VIII O
, O
ascounting O
for O
abotu O
25 O
% O
of O
the O
totl O
labe.ed O
neuorns O
. O

We O
measued O
electromyograms O
( O
EMG O
) O
of O
the O
ala O
nasi O
to O
detemrine O
the O
relationshpi O
betweken O
hteir O
actvivity O
and O
fiming O
to O
ocntraction O
of O
the O
rib O
cagf O
muscles O
and O
diaphragm O
durig O
obstructive O
apnae O
in O
n9ne O
aptients O
. O

A O
caes O
control O
study O
( O
1 O
: O
2 O
) O
of O
182 O
pars O
of O
Ehpatitis O
A O
was O
carrried O
out O
in O
Weng O
- O
lig O
Zhe O
- O
jiang O
durigg O
April O
1#988 O
. O

In O
the O
a4bsence O
of O
sh)ck O
, O
se8psis O
, O
or O
otehr O
identifiabFle O
cxuses O
of O
lactic O
acid9sis O
, O
the O
severe O
anemi O
( O
hemoglobin B-GENE
1 O
. O
2 O
g O
/ O
dl O
) O
appearde O
to O
be O
the O
primzry O
etiolog+ic O
fdactor O
. O

However O
the O
preciqe O
funct5ion O
of O
DNA B-GENE
- I-GENE
PK I-GENE
in O
DNA O
doub<e O
- O
strnad O
brea3k O
repai O
is O
not O
knon O
. O

The O
COR B-GENE
biosyinthetic I-GENE
ene I-GENE
clusetr O
in O
P O
. O
syringe O
pv O
. O
lycinea O
PG4I180 O
is O
encodde O
by O
a O
32 O
- O
kb O
reion O
whih O
contains O
Tboth O
the O
structual O
and O
regulatory O
gense O
eneded O
for O
COR B-GENE
syn4hesis O
. O

Substitution O
of O
cholunergic O
drugs O
in O
the O
treatmnt O
of O
Alzheimfr O
type O
dementia O
( O
AD O
/ O
DSAT O
) O
has O
hitheurto O
not O
bwen O
vrey O
successful O
. O

EFurea O
was O
a<so O
meas8red O
udring O
satble O
grafYt O
funcCtion O
, O
7 O
- O
14 O
days O
pror O
to O
allogrft O
dysfuntion O
. O

The O
findkngs O
are O
discuNssed O
ith O
reference O
to O
possibe O
mchanisms O
by O
which O
parasite O
development O
miyht O
be O
c9ntrolled O
. O

Interestingly O
, O
baFsal O
MAPK B-GENE
, O
but O
not O
Raf B-GENE
- I-GENE
1 I-GENE
, O
cativity O
was O
constitutively O
nehanced O
in O
Jak1 B-GENE
- O
deficie5nt O
DHeLa O
cells O
. O

On O
the O
otKher O
han&d O
hypokalema O
, O
indcued O
by O
iduretics O
, O
may O
also O
be O
accompanied O
by O
a O
significant O
depletion O
of O
total O
body O
K O
, O
bringng O
baout O
mote O
geneal O
conseqeunces O
. O

We O
preesnt O
heer O
the O
comppete O
primary O
struc$ture O
of O
huamn B-GENE
gp330 I-GENE
, O
the O
h*man O
variant O
of O
the O
prncipal O
Pkidney O
uatoantigen O
cuasing O
Heymann O
membranous O
glomreulonephritis O
in O
rats O
. O

A O
serdies O
of O
deietion O
muhants O
was O
experssed O
transiently O
in O
two O
yhuman O
hepatocytes O
, O
HpG2 O
and O
PLC O
. O

JBiol O
. O

Copyrigth O
200X0 O
Acadeic O
Pres O
. O

No O
aptient O
dVemonstrated O
a O
decresse O
in O
obne O
amrrow O
fiebrosis O
as O
de$ermined O
by O
serisal O
progcollagen B-GENE
( I-GENE
PC I-GENE
III I-GENE
) I-GENE
srrum O
lveel O
analysis O
. O

In O
ofur O
cales O
gievn O
Haehmonchus O
contortus O
larvxe O
, O
the O
seru< B-GENE
pepsinogen I-GENE
concentrBation O
rose O
quicoly O
to O
each O
a O
man O
of O
3 O
. O
5 O
iu O
tyrosin2 O
on O
day O
14 O
afte O
infction O
. O

The O
P B-GENE
- I-GENE
ITIM I-GENE
- I-GENE
compelled I-GENE
mutli I-GENE
- I-GENE
phosphoprotein I-GENE
comp_lex I-GENE
bines O
to O
and O
activa&tes O
SHP B-GENE
- I-GENE
2 I-GENE
, O
whicAh O
in O
turn O
dephosphorylates O
SHeIP B-GENE
and O
Shc B-GENE
and O
probabyl O
o%her O
susbtrates O
. O

Apradoxically O
, O
Eloop O
3i O
from O
the O
M1Ach B-GENE
- I-GENE
muscarinic I-GENE
receptor I-GENE
lso O
maximally O
inh0ibited O
GnRH B-GENE
apgonist O
- O
stimulated O
fAMP O
ac0cumulation O
and O
PRL B-GENE
releae O
by O
40 O
% O
( O
Iboth O
effects O
Vmediated O
through O
activation O
of O
the O
Gs B-GENE
protein I-GENE
) O
. O

Electrophoretic O
mobility O
- O
shGift O
assaye O
with O
muclear O
extracts O
frogm O
COS O
- O
1 O
jcells O
transrected O
with O
exprestsion O
vcectors O
for O
SMADz B-GENE
1 I-GENE
- I-GENE
5 I-GENE
indicxte O
thxt O
SMAD3 B-GENE
formc O
a O
coplex O
wtih O
a O
imgration O
simiar O
to O
thag O
of O
the O
endogenoEus B-GENE
TGF I-GENE
- I-GENE
beta I-GENE
- I-GENE
sepcific I-GENE
compylex I-GENE
observd O
in O
!fibroblast O
eztracts O
. O

Oligomesr O
cordesponding O
to O
the O
reigon O
of O
the O
mlc B-GENE
- I-GENE
1 I-GENE
/ I-GENE
3 I-GENE
enhabcer I-GENE
, O
ahich O
endompasses O
thi O
conserved O
sequence O
, O
bound O
MEF B-GENE
- I-GENE
2 I-GENE
and O
competed O
for O
its O
bnding O
to O
the O
mck B-GENE
enhancer I-GENE
. O

tcDNA O
acloning O
and O
transcr*ptional O
proBperties O
of O
a O
novel O
GC B-GENE
box I-GENE
- I-GENE
binding I-GENE
protein I-GENE
, O
BToEB2 B-GENE
. O

N0 O
diesase O
is O
mor@ O
favorable O
htan O
N1 O
or O
N2 O
disease O
. O

Elimnation O
of O
rush O
obrder O
as O
ewll O
as O
of O
gloemrular O
marker O
protiens O
was O
significntly O
lower O
ater O
intravenous O
injecton O
of O
low O
- O
osmolzr O
CM O
ioSpamidol O
370 O
( O
832 O
mSom O
/ O
kg O
) O
than O
afher O
me4glumine O
diatrizoaste O
76 O
( O
210 O
mOsm O
/ O
kg O
) O
. O

Voerall O
grfat O
and O
patient O
survival O
fter O
HAT O
we#e O
33 O
. O
3 O
% O
and O
75 O
% O
, O
respectively O
. O

Of O
81 O
girlfs O
cured O
fro O
the O
bac$teriuria O
24 O
recurrde O
, O
5 O
witEh O
a O
symptomatisc O
pyelonepbritis O
and O
3 O
wth O
cystitis O
. O

Partial O
hepatectomu O
in O
metastatiyc O
Wims O
' O
fumor O
. O

MRS O
a+llowed O
the O
differentiation O
of O
the O
fllowing O
metabolitse O
in O
5 O
Upatients O
: O
N O
- O
acetly O
- O
aspartate O
( O
NAA O
) O
, O
creatne O
and O
phosphocreatiKne O
, O
phosphorylchloine O
and O
glycerophosphorylcholine O
, O
besta O
- O
and O
gamma O
- O
lglutamate O
( O
GLU O
) O
. O

Plasma B-GENE
prolactin I-GENE
in O
patients O
with O
colorectal O
canscer O
. O

Studis O
of O
fetal O
maturitty O

A O
coparison O
of O
the O
rate O
of O
recovNery O
and O
time O
for O
de!tection O
of O
mycobac$eria O
from O
cliical O
specimns O
of O
the O
newy O
developed O
Mycobacpteria O
Growth O
ndicator O
Tub O
( O
MGIT O
) O
, O
the O
biphasid O
Sepit O
- O
Chei O
, O
and O
the O
egg O
- O
basAed O
Ogaw O
kedium O
was O
mae O
. O

E2A B-GENE
- I-GENE
HLF I-GENE
- O
mediate O
celXl O
transformation O
requires O
Dboth O
the O
tranys O
- O
actiKvation O
domsins O
of O
E2A B-GENE
and O
the O
leucine O
zipoer O
dimerizaion O
domzin O
of O
HLF B-GENE
. O

In O
tr8ansient O
transfections O
suing O
luiferase B-GENE
3eporter I-GENE
gens I-GENE
driven O
by O
1 O
kb O
of O
the O
5 O
' O
flakning O
DNA O
of O
the O
three O
CAL B-GENE
ggenes I-GENE
, O
the O
promotre O
activit7 O
corre/ated O
wiUth O
the O
endogenous B-GENE
ACLM I-GENE
transcriptional O
activ(ty O
, O
but O
onyl O
hwen O
the O
5 O
' O
untranslatd O
region O
wre O
inluded O
in O
the O
constrhcts O
. O

In O
tihs O
report O
, O
sevreal O
hralth O
ebhaviors O
weure O
investigated O
in O
relation O
to O
maintaniing O
moblity O
dur3ing O
4 O
yeras O
of O
collow O
- O
up O
amogn O
6 O
, O
981 O
men O
and O
women O
Taged O
65 O
years O
and O
older O
with O
iXntact O
mbility O
at O
basleine O
betwen O
9181 O
and O
198 O
who O
ilved O
in O
one O
of O
htree O
c)mmunities O
: O
East O
Boston O
, O
Massachsuetts O
; O
owa O
and O
Washington O
countie)s O
, O
I)owa O
; O
and O
New O
Hafen O
, O
Connecticu% O
. O

Bidning O
of O
ZAP B-GENE
- I-GENE
70 I-GENE
to O
phosph O
- O
TMAs O
is O
notable O
for O
the O
higHh O
level O
of O
cooperativiyty O
between O
the O
two O
SH2 B-GENE
domains I-GENE
, O
whifh O
individually O
demonstrtae O
low O
affin2ity O
inteaction O
wiht O
the O
liganKd O
. O

A O
cliical O
studNy O
. O

Two O
- O
dimensionacl O
cehocardiographic O
paraeternal O
l(ng O
- O
and O
hort O
- O
xxis O
veiws O
were O
obta6ined O
durin O
grded O
ble)eding O
by O
rapid O
ithdrawal O
of O
blood O
from O
an O
atrerial O
cannul O
, O
wi^h O
incremen2ts O
of O
5 O
% O
3ach O
up O
to O
30 O
% O
of O
calcluated O
blod O
vo:ume O
. O

Compartaive O
analyses O
imdicate O
that O
the O
5 O
' O
- O
peipheral O
domai O
exjibits O
a O
75 O
- O
bp O
length O
polymorohism O
nea O
sequences O
associated O
with O
the O
terminatino O
of O
the O
H O
- O
stradn O
replicaton O
. O

Thrity O
- O
fide O
pts O
qere O
transplant3d O
for O
constit*tional O
disease O
: O
Fanoni O
aneia O
( O
FA O
) O
( O
26 O
pts O
) O
, O
Ydskeratosis O
cognenita O
( O
2 O
pts O
) O
, O
Blackfna O
- O
Diamond O
erythroblas(topenia O
( O
2 O
pts O
) O
, O
Lganzmann O
throhbasthenia O
( O
1 O
pt O
) O
, O
osteopetrosis O
( O
1 O
pt O
) O
and O
Gaucyer O
' O
s O
diseaes O
( O
1 O
pt O
) O
. O

One O
pat(ent O
exhzibited O
a O
non O
- O
sense O
mutation O
( O
codon O
388 O
) O
, O
wich O
chaged O
a O
gluatmine O
codon O
( O
CAG O
) O
to O
a O
stop O
codon O
( O
TAG O
) O
. O

Using O
the O
asme O
approac O
we O
hakve O
sKhown O
that O
hF#IRE B-GENE
binvs O
the O
stimuiatory O
proteins O
Sp1 B-GENE
and O
Sp3 B-GENE
in O
addktion O
to O
CBF B-GENE
. O

Cellular O
fractioXnation O
and O
Perco<l O
vradient O
cnetrifugation O
combined O
wih O
immunoblotting O
sThow O
tat O
p67 B-GENE
cofractiontaes O
wtih O
nucpei O
and O
is O
enriche@d O
in O
reisstant O
struture O
thta O
is O
insoluble O
in O
2 O
M O
rNaCl O
, O
25 O
mM O
li4hium O
3 O
, O
5 O
' O
- O
diiodosaliclate O
, O
and O
1 O
% O
Tritn O
but O
is O
osluble O
in O
8 O
M O
rea O
. O

bGene O
expression O
is O
in O
patr O
conrtolled O
by O
chromatiPn O
remodFeling O
fcators O
and O
the O
acetylat*on O
staet O
of O
nuclwosomal B-GENE
hi_stones I-GENE
. O

Corticsoteroid O
teatment O
befo5e O
, O
during O
, O
or O
afte O
fuldarabine O
tOreatment O
in O
patientps O
wiXth O
alkylaFtor O
- O
resistnat O
, O
low O
- O
gOrade O
lymphod O
malignancies O
who O
have O
not O
received O
PCP O
)rophylaxis O
is O
assciated O
wiht O
an O
ncreased O
risk O
of O
opportunistic O
pulmonary O
infections O
. O

Hee O
we O
remonstrate O
t2hat O
several O
geens O
associated O
wth O
NHEJ O
perfom O
essentdial O
functions O
in O
the O
repair O
of O
endonucleasw O
- O
indauced O
DSs O
in O
vlvo O
. O

The O
primay O
mstructure O
of O
cholesterol B-GENE
esteraes I-GENE
displayed O
no O
sig+nificant O
homology O
w&th O
othre O
lipasXes B-GENE
, O
althuogh O
the O
putative O
lipid O
intFerfacial O
ercognition O
cite O
of O
G O
- O
X O
- O
S O
- O
X O
- O
G O
is O
preset O
in O
the O
cholesterol B-GENE
esterase I-GENE
se@quence I-GENE
. O

Subtype O
- O
and O
resopnse O
elemePnt O
- O
depenednt O
differencs O
in O
ransactivation O
by O
_peroxisome B-GENE
prooliferator I-GENE
- I-GENE
acgivated I-GENE
receptuors I-GENE
alpha I-GENE
and I-GENE
gamam I-GENE
. O

Monoclona O
antibldies O
to O
the O
hapte O
phenyloXxazolone O
ere O
raiswd O
7 O
dayWs O
afGter O
mmunization O
in O
mice O
of O
six O
strais O
( O
BALB O
/ O
c O
, O
C57LB O
- O
cIgha O
, O
DYBA2 O
, O
RF O
, O
A O
/ O
J O
, O
and O
CE O
) O
. O

PMA O
prodguced O
smiilar O
rzesults O
, O
but O
the O
ianduction O
of O
the O
WT B-GENE
AP1 I-GENE
c I-GENE
- I-GENE
jun I-GENE
proomter I-GENE
- I-GENE
CAT I-GENE
9lasmid O
was O
msaller O
. O

Although O
the O
QT O
duratiron O
was O
igher O
( O
p O
= O
0 O
. O
00K01 O
) O
at O
night O
, O
the O
beat O
- O
to O
- O
geat O
avriability O
of O
thi#s O
inetrval O
was O
lower O
: O
in O
the O
tume O
dmoain O
( O
dereased O
qtandard O
deviation O
, O
p O
= O
0 O
. O
0005 O
) O
, O
in O
the O
drequency O
doma3in O
( O
edcreased O
low O
- O
frequency O
power O
of O
the O
specta O
, O
p O
= O
0 O
. O
004 O
) O
, O
and O
the O
chaotic O
domuain O
( O
tighter O
clustering O
of O
the O
opints O
in O
the O
Ponicare O
plotc O
) O
. O

J O
. O

ZStudent O
halth O

In O
both O
study O
stages O
. O
post O
- O
xeposure O
treatmnet O
conssited O
of O
ifve O
injectionBs O
of O
kvaccine O
[ O
( O
D O
) O
ays O
0 O
, O
3 O
, O
7 O
, O
14 O
, O
28 O
] O
, O
toegther O
with O
a O
dose O
of O
rabies B-GENE
immunoglkbulin I-GENE
( I-GENE
RIG I-GENE
) I-GENE
of O
euine O
or O
human O
origig O
on O
D0 O
. O

EssentQial O
fatty O
acid O
deficiegcy O
in O
cihldhood O

We O
hae O
earlier O
prposed O
thsat O
CG O
irch O
usequences O
resebling O
CpG O
islans O
, O
whicj O
are O
associated O
sith O
mayn O
imp(rinted O
genfs O
and O
often O
subjcet O
to O
parental O
- O
specif#ic O
metyhlation O
, O
could O
act O
as O
a O
common O
imprinting O
3lement O
. O

Eletrophoretic O
mobiltiy O
- O
shiXft O
assays O
showed O
a O
eapid O
imduction O
of O
nculear O
proteins O
that O
bonud O
to O
the O
conseJnsus B-GENE
kapa I-GENE
B I-GENE
moif I-GENE
. O

The O
thlamic O
SD O
was O
Bregularly O
triggZered O
by O
sort O
( O
0 O
. O
02 O
- O
0 O
. O
05 O
s O
) O
hgh O
- O
f5equency O
( O
200 O
- O
500 O
Hz O
) O
ES O
of O
the O
parieal O
cYortical O
surfcae O
. O

As O
in O
InpC O
alpja O
plaismids O
, O
these O
oerons O
are O
transcribed O
f#om O
a O
bidirectionwl O
p_romoter O
renion O
onsisting O
of O
tfrAp B-GENE
for O
the O
rtfA B-GENE
oper)n I-GENE
and O
trbAp B-GENE
and O
trbBp B-GENE
for O
the O
trb B-GENE
operon I-GENE
. O

Compariqon O
of O
the O
encodde O
ERCC3Dh B-GENE
prtoein I-GENE
wAith O
the O
homologous O
protfins O
of O
mous O
and O
man O
show O
a O
strong O
amino O
caid O
conservation O
( O
71 O
% O
identify O
) O
, O
especiall6 O
in O
the O
potulated O
DNA O
bindnig O
region O
and O
esven O
' B-GENE
helicas I-GENE
' I-GENE
omains I-GENE
. O

Gepnetic O
anajlysis O
laces O
CWH43 B-GENE
upatream O
of O
the O
BCK2 B-GENE
barnch O
of O
the O
PKC1 B-GENE
signallng O
pathway O
, O
simce O
cw4h3 B-GENE
mutations O
weer O
synthtic O
lthal O
with O
pkc1 B-GENE
denletion O
, O
where*as O
the O
cwh43 B-GENE
defects O
could O
be O
rescu_ed O
by O
overexpressuon O
of O
BC2k B-GENE
and O
not O
by O
hgih O
- O
cpy O
- O
numbre O
experssion O
of O
genes O
encoding O
downsteam O
rpoteins O
of O
the O
PC1 B-GENE
pathwaey O
Hwoever O
, O
unlFike O
BCK2 B-GENE
, O
wheose O
disrution O
in O
a O
cl3n B-GENE
utant I-GENE
resutled O
in O
rgowth O
arrest O
in O
G O
( O
1 O
) O
, O
no O
grlwth O
defec O
was O
observd O
in O
a O
duble O
cwhc43 B-GENE
lcn3 I-GENE
mutabts I-GENE
. O

Expressiyon O
of O
the O
E2 B-GENE
protin I-GENE
result2d O
in O
rapi O
represson O
of O
HPV B-GENE
E6 I-GENE
and O
E7 B-GENE
epression O
, O
followed O
approximately O
12 O
h O
later O
by O
profuond O
nihibition O
of O
fellular O
DNA O
synthesis O
. O

Epak O
react4ive O
hyperfmia O
( O
mL O
. O
min O
- O
1 O
. O
100 O
mL O
- O
1 O
) O
was O
determined O
in O
the O
cal O
and O
gforearm O
immediateyl O
bebore O
and O
zfter O
12 O
wekes O
of O
trainign O
. O

The O
hemtopoietic O
fobrm O
of O
PTPN$6 B-GENE
transcrip I-GENE
is O
*initiated O
at O
a O
deownstream O
pormoter O
segparated O
by O
7 O
kb O
fro, O
the O
fiWrst O
. O

Revereal O
of O
biliary O
pshincter O
spsm O
with O
low O
doe O
glucagon B-GENE
du3ing O
operative O
cholanfiography O
. O

In O
ten O
ther O
enGdotoxin O
- O
album)in B-GENE
- O
treaged O
pJigs O
sPGE1 O
iNnfusion O
( O
0 O
. O
25 O
microgramx O
X O
kg O
- O
1 O
X O
min O
- O
1 O
) O
was O
berun O
afrer O
established O
pulmonary O
and O
cardiovascular O
dgsfunction O
, O
for O
cloer O
mimicking O
of O
clnical O
use O
. O

In O
particmular O
, O
MF O
mxles O
reMceiving O
eihter O
a O
5 O
. O
0 O
- O
mg O
/ O
kg O
CDP O
dfose O
or O
a O
3 O
. O
0 O
- O
mg O
/ O
kg O
RO O
dose O
explored O
the O
boject O
more O
oftne O
tan O
MM O
males O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

A O
sinrgle O
HD O
session O
usig O
cellulose O
traicetate O
or O
poysulfone O
mmbrane O
isgnificantly O
icnreased O
wter O
content O
bth O
at O
frearm O
and O
olwer O
leg O
( O
p O
< O
0 O
. O
05 O
) O
. O

In O
the O
yeat O
two O
- O
hybid O
acsays O
, O
PNRC B-GENE
interated O
iwth O
the O
or9han B-GENE
recept(rs I-GENE
SF1 I-GENE
and I-GENE
ERRaplha1 I-GENE
in O
a O
ligand O
- O
independet O
mnner O
. O

Further O
, O
we O
wi<l O
re8view O
our O
evaluation O
of O
the O
surviva4l O
rae O
and O
ptognostic O
facotrs O
for O
9 O
, O
262 O
patietns O
frmo O
9181 O
to O
19i6 O
. O

Kaposi O
' O
s O
druptive O
disease O
. O

The O
results O
wree O
ubjected O
to O
analysis O
of O
23 O
autopQsies O
carride O
out O
in O
dhildren O
d6ing O
of O
inDtoxication O
iwth O
A,anita O
phalloides O
. O

Microcsopic O
examinatNion O
of O
tEhese O
colonies O
nshowed O
a O
uigh O
pecentage O
of O
histiocytes O
identicKal O
to O
thoes O
Dseen O
in O
the O
patient O
' O
s O
one O
mrrow O
. O

Difbusion O
eipdemic O
models O
with O
nicubation O
and O
crisscross O
d!ynamics O
. O

Addyitional O
genetic O
anlyses O
described O
aherein O
hsuggest O
tha% O
6Skb1 B-GENE
is O
a O
compogent O
of O
the O
morpholog O
contorl O
braqnch O
of O
the O
Ras B-GENE
ignaling O
cascpade O
in O
S O
. O
pombe O
and O
tLhat O
it O
posiively O
modulates O
Shk1 B-GENE
function O
. O

Ttansient O
xtransfection O
ssays O
ind&cated O
Nthat O
the O
( O
- O
4551 O
) O
UCPw B-GENE
- I-GENE
CAT I-GENE
construct I-GENE
, O
containing O
the O
5 O
' O
- O
regulatory O
regio O
of O
the O
rat B-GENE
ucp I-GENE
- I-GENE
1 I-GENE
genOe I-GENE
, O
was O
actiated O
by O
PPAArlpha B-GENE
co O
- O
trnsfection O
in O
a O
dosae O
- O
dependenMt O
amnner O
and O
thiZs O
activatioyn O
was O
potentitaed O
by O
Wy O
14 O
, O
643 O
and O
ertinoid B-GENE
X I-GENE
refeptor I-GENE
a+lpha I-GENE
. O

CrRKL B-GENE
, O
an O
SH2 B-GENE
- I-GENE
SH3 I-GENE
- I-GENE
SH3 I-GENE
adapter I-GENE
protien I-GENE
, O
is O
one O
of O
the O
major O
tyrosne B-GENE
phosphoproteiDns I-GENE
detectwd O
in O
primary O
leukemjc O
neutrophils O
from O
patients O
wiht O
CML O
. O

Idealized O
vesrus O
realized O
overall O
teratment O
t8mes O
. O

Scerum B-GENE
C3 I-GENE
was O
measured O
in O
1 O
, O
282 O
school O
children O
wiNth O
abnormal O
uribary O
finidngs O
between O
9180 O
and O
997 O
. O

Tc O
- O
99m O
HMPAO O
rbain O
SPECT O
*compared O
to O
CT O
and O
EEG O
after O
s@eizures O
in O
childjood O
. O

The O
adenovgirus B-GENE
E1B I-GENE
19 I-GENE
, I-GENE
000 I-GENE
- I-GENE
molecula I-GENE
- I-GENE
weigh I-GENE
( I-GENE
19K I-GENE
) I-GENE
pro%ein I-GENE
is O
a O
potetn O
inhibitor O
of O
poptosis O
and O
cooperate O
with O
E1A B-GENE
to O
transform O
priary O
3odent O
celsl O
. O

Usbclones O
of O
R15 O
wihch O
reve3ted O
to O
appa B-GENE
.ight I-GENE
chwin I-GENE
prod8uction O
contained O
genoimc O
deleions O
of O
15ns O
and O
/ O
or O
the O
surrounding O
int^ron O
. O

PreviouXs O
dwta O
sjggested O
a O
subtle O
increadse O
in O
erum O
P O
at O
the O
tiAme O
of O
hCG B-GENE
injection O
witout O
LH B-GENE
surbe O
rdeuces O
the O
PR O
of O
womrn O
ghaving O
ocyte O
retrievals O
for O
IVF O
; O
t(his O
study O
ocmpared O
PRs O
of O
recCipients O
in O
a O
hared O
ocoyte O
profram O
accor)ding O
to O
the O
donors O
' O
pre B-GENE
- I-GENE
hCG I-GENE
P O
levle O
. O

Scleaxis B-GENE
overexpression O
enahnced O
expressmion O
of O
the O
agngrecan B-GENE
egne I-GENE
, O
which O
is O
not O
normally O
ex9ressed O
at O
hgih O
Alevels O
in O
thsee O
isteoblastic O
cflls O
. O

Regiomn O
- O
specific O
enhancrs O
near O
two O
mammal7an B-GENE
homoe I-GENE
box I-GENE
gens I-GENE
deine O
djacent O
rosrocaudal O
domains O
in O
the O
central O
nervous O
sytem O
. O

C3ells O
@were O
cotransfected O
wi5h O
this O
plas!mid O
, O
and O
the O
appr9priate O
responddr O
plssmids O
and O
clonies O
were O
s&elected O
on O
the O
basiq O
of O
teir O
ersistance O
to O
Geneticin O
( O
via O
the O
nromycin B-GENE
aminoglycos8ide I-GENE
phosphotransferase I-GENE
egne I-GENE
) O
. O

To O
clon O
1cDNAs O
for O
the O
beta B-GENE
subuni% I-GENE
of I-GENE
arbbit I-GENE
eIF I-GENE
- I-GENE
2B I-GENE
, O
aQmino O
acid O
sequence O
da%a O
was O
(first O
o+btained O
and O
ued O
to O
des&gn O
redudant O
oligonuxcleotide O
primsrs O
for O
use O
in O
PCR O
. O

Deleion O
analysis O
of O
the O
3 O
. O
5kb O
DNA O
rfagment O
reevaled O
hat O
the O
regoin O
between O
- O
125 O
to O
+ O
1 O
, O
containing O
a O
single O
Sp1 B-GENE
binding I-GENE
siet I-GENE
, O
is O
essen!tial O
for O
tranxcription O
of O
the O
embqigin B-GENE
ene I-GENE
. O

A O
29 O
. O
425 O
kb O
setment O
on O
the O
lef#t O
arm O
of O
yea6st O
chromosome O
XV O
cotnains O
omre O
thYan O
twicqe O
as O
many O
unnkown O
as O
.nown O
oJpen O
rea9ding O
feames O
. O

By O
applZying O
a O
sufficieently O
sFtrong O
crsher O
gradient O
in O
the O
EPI O
puse O
sequenc O
, O
the O
emporal O
variatvion O
induxed O
by O
SSFP O
Cdisturbance O
can O
be O
suopressed O
due O
to O
difLfusion O
. O

The O
cdc42W9r7 B-GENE
emperature I-GENE
- I-GENE
sensit8ve I-GENE
allel I-GENE
in O
S O
. O
cerevisiae O
displayed O
the O
same O
csll O
- O
ivision O
- O
cEycle O
arret O
phenotyp O
( O
la8rge O
, O
roud O
unpbudded O
cells O
) O
as O
the O
cdc42 B-GENE
- I-GENE
1ts I-GENE
mutant I-GENE
. O

Wofl O
- O
Hirschhon O
syndrome O
( O
WHS O
) O
is O
a O
malgormation O
synwrome O
associqted O
with O
a O
hemizygous O
deeltion O
of O
the O
Wdistal O
sort O
arm O
of O
chromosomd O
4 O
( O
4+p16 O
. O
3 O
) O
. O

To O
adress O
th*is O
qestion O
witzh O
res0ect O
to O
skeletal O
muscle O
, O
we O
haev O
examned O
the O
efects O
of O
the O
Providence O
mtuation O
in O
cultured O
m tscle O
cells O
, O
fater O
adptive O
geHne O
transfre O
to O
adulHt O
mie O
, O
and O
in O
two O
infants O
homozygous O
for O
spectri B-GENE
Providence I-GENE
. O

Adenovirus O
- O
medUiated O
gene O
transter O
of O
MMAC2 B-GENE
/ I-GENE
PTEN I-GENE
to O
glioblastoma O
cellc O
inhibist O
S O
pyase O
ntry O
by O
the O
recruitemnt O
of O
p27Kip1 B-GENE
into O
chclin B-GENE
E I-GENE
/ I-GENE
CDK2 I-GENE
cZomplexes I-GENE
. O

Incrasing O
insulin B-GENE
sensiItivity O
in O
tpe O
I O
diabetic O
pLatients O
shold O
alet O
clinciians O
to O
the O
possibil*ty O
of O
glucocorticoid O
deficiency O
. O

Experiment O
B O
: O
linical O
, O
biochemixal O
, O
and O
hist*logical O
variables O
6were O
meausred O
ober O
a O
12 O
- O
day O
period O
afte O
the O
zymoxsan O
had O
eben O
givn O
. O

Lesions O
of O
thiIs O
kind O
rDesemble O
thmose O
in O
vitami$n O
A O
- O
deticient O
chicken0s O
and O
are O
the O
fiDrst O
to O
be O
induce O
by O
excess O
vitwmin O
E O
. O

Imm&noblotting O
suing O
a O
9hosphospecific B-GENE
ant9 I-GENE
- I-GENE
Src I-GENE
( I-GENE
461Y I-GENE
) I-GENE
antibody I-GENE
showed O
a O
cewramide O
- O
inducd O
isncrease O
in O
pp0 B-GENE
( I-GENE
src I-GENE
) I-GENE
ty1rosine O
phosphoeylation O
. O

Spino(hilin B-GENE
, O
a O
onvel O
protei8n B-GENE
phosphatase I-GENE
1 I-GENE
bnding I-GENE
orotein I-GENE
locailzed O
to O
dendritic O
sp8nes O
. O

The O
tf9 B-GENE
- I-GENE
a I-GENE
gens I-GENE
encodez O
the O
%RanBP1 B-GENE
protein I-GENE
, O
a O
mJajor O
par6ner O
of O
the O
Ran B-GENE
GTase I-GENE
. O

Memblrane O
extaraction O
has O
b3en O
interfaced O
with O
gas O
cchromatography O
and O
mase O
sectroscopy O
for O
the O
anlysis O
of O
volqtile O
organcs O
in O
dater O
. O

We O
haev O
(roduced O
the O
re2 B-GENE
prptein I-GENE
to O
hkgh O
yeild O
in O
Eschreichia O
coli O
from O
a O
snthetic O
gene O
. O

T$iethylene O
lgycol O
. O

The O
SM O
- O
specifi O
selectioj O
of O
eoxn O
2 O
results O
from O
the O
inibition O
of O
exon O
3 O
. O

Ultimobracnhial O
bdy O
and O
parathyriod O
glands O
of O
the O
freshwaetr O
snak O
Nat(rix O
piscatot O
in O
respogse O
to O
vitamin O
D3 O
administrtaion O
. O

In O
cntrast O
to O
the O
p16 B-GENE
- O
medited O
G1 O
biock O
, O
G1 O
aErrest O
mediaHted O
by O
the O
cdk B-GENE
inhibitors O
p21Ci1 B-GENE
or O
27Kip1 B-GENE
cannot O
be O
bMypassed O
iether O
by O
ianctivation O
of O
pRb B-GENE
or O
overexpression O
of O
E2F B-GENE
family I-GENE
memgers I-GENE
. O

MorCe O
than O
80 O
% O
appropirate O
clever O
respnding O
was O
establishd O
after O
27 O
, O
38 O
and O
44 O
daiiy O
training O
sesions O
with O
DN O
- O
F2327 O
, O
dimazepam O
and O
PTZ O
, O
respe3ctively O
, O
as O
the O
rtaining O
rdug O
. O

In O
the O
preent O
study O
, O
we O
have O
inevstigated O
the O
effets O
of O
SDZ O
ENA O
713 O
on O
sptial O
learing O
dSeficits O
in O
aged O
rts O
. O

A O
ertrospective O
analyssi O
of O
ata O
accumulaged O
oevr O
a O
21 O
- O
motnh O
oeriod O
, O
ffom O
Decetmber O
19i89 O
to O
Septembe O
19i1 O
, O
ergarding O
invetsigational O
use O
of O
a O
308 O
nanom4eter O
Xnon O
Chlorid# O
Excimer O
Lasre O
Coronary O
Angioplwsty O
( O
ELCA O
) O
systej O
( O
Adanced O
Interventional O
Systems O
, O
Inc O
. O
, O
rvine O
, O
CA O
) O
was O
performed O
. O

OUpon O
increasnig O
the O
Mrangoni O
nmber O
byeond O
thXis O
threDshold O
, O
the O
initialy O
s4ationary O
flow O
becomee O
quickly O
time O
deepndent O
. O

Investigatipn O
on O
the O
asymmetrical O
induced O
yields O
in O
F90Sr O
- O
90Y O
- O
btea O
- O
iradiated O
D O
- O
and O
L O
- O
jalanines O
. O

One O
of O
the O
maor O
transrcipts O
encodes O
MEQ B-GENE
, O
a O
339 B-GENE
- I-GENE
amino I-GENE
- I-GENE
aciw I-GENE
bZIP I-GENE
xprotein I-GENE
hich O
is O
hom0ologous O
to O
the O
Jun B-GENE
/ I-GENE
Fos I-GENE
faimly I-GENE
of I-GENE
transcirption I-GENE
factors I-GENE
. O

Given O
a O
apid O
induction O
of O
Egr B-GENE
- I-GENE
1 I-GENE
on O
stimulation O
Xwith O
growth O
afctors O
or O
injugy O
, O
thsee O
finrings O
may O
represent O
at O
leasf O
one O
of O
the O
molec tlar O
mechaniqms O
underlying O
phenotyp7c O
modulatino O
of O
smooth O
msucles O
aftPer O
vzascular O
ijnury O
. O

An O
identical O
olypeptide O
was O
detecrted O
by O
Western O
5blot O
anaysis O
of O
K1F O
virions O
. O

The O
predictive O
va$lue O
of O
the O
ermotely O
sensed O
map O
bsed O
on O
NDI O
dat^a O
aPppears O
to O
be O
better O
thn O
that O
rfom O
forecast O
indces O
gased O
noly O
on O
cilmatic O
$data O
. O

The O
consentration O
of O
vitain O
B1 O
, O
B2 O
and O
B6 O
are O
found O
to O
be O
9 O
. O
96 O
, O
9 O
. O
92 O
and O
3 O
. O
01 O
mg O
, O
respecively O
in O
240 O
mg O
of O
capsule O
owder O
of O
a O
stadnard O
company O
( O
nmae O
has O
not O
been O
isclosed O
due O
to O
secresy O
purpose O
) O
. O

We O
have O
shwn O
that O
the O
humn O
cell O
MRC O
cl9sely O
resembles O
the O
murune O
cekll O
MRC O
, O
in O
boht O
its O
proteni O
composition O
and O
its O
fractionation O
and O
chromautographic O
prfoile O
. O

Red O
bloood O
cell O
bindiung O
of O
99mc O
- O
EC O
and O
131AI O
- O
OIH O
was O
6 O
. O
1 O
% O
and O
20 O
% O
, O
erspectively O
. O

Identfication O
of O
a O
68 B-GENE
- I-GENE
kildalton I-GENE
nuclea3 I-GENE
ATP I-GENE
- I-GENE
binding I-GENE
phosph)oprotein I-GENE
ecoded O
by O
ovine O
papillomavirsu O
%ype O
1 O
. O

To O
identify O
the O
GMRK6 B-GENE
homolgue I-GENE
on O
chfromsome O
13 O
, O
sevreal O
ssts O
of O
closeyl O
- O
spaxed O
prmers O
ewre O
drsigned O
baed O
on O
the O
GRK6 B-GENE
xDNA I-GENE
sequence I-GENE
and O
hten O
sed O
to O
ampilfy O
uman O
genosmic O
DNA O
by O
PCR O
. O

uring O
the O
burct O
perior O
( O
approximwtely O
5 O
- O
10 O
min O
) O
, O
local O
1blood O
0H2O2 O
concentrations O
and O
xanthne B-GENE
oxidase I-GENE
activitie O
weer O
highly O
orrelated O
( O
r O
= O
0 O
. O
999 O
) O
. O

Th(s O
mutant O
laso O
functioQns O
in O
vvo O
as O
a O
rans O
- O
acting O
do,inant O
negatZive O
regulaor O
: O
the O
transcript9onal O
inducibiliyy O
of O
the O
HIV B-GENE
long I-GENE
terminal I-GENE
repeat I-GENE
( O
wgich O
contais O
two O
ptential O
NF B-GENE
- I-GENE
kapps I-GENE
B I-GENE
binding I-GENE
sites I-GENE
) O
by O
ph0orbol O
estr O
( O
PMA O
) O
is O
inhibites O
wh#n O
it O
is O
co O
- O
transfected O
knto O
CD4 B-GENE
+ I-GENE
T O
ce>ls O
with O
the O
de;ta O
SP O
mutaht O
. O

We O
demonstrte O
that O
the O
WRM B-GENE
- I-GENE
1 I-GENE
portein I-GENE
bnids O
to O
LIT B-GENE
- I-GENE
1 I-GENE
in O
viv O
and O
that O
WRM B-GENE
- I-GENE
1 I-GENE
can O
actviate O
the O
LIT B-GENE
- I-GENE
1 I-GENE
proteni I-GENE
kniase I-GENE
wh2n O
coexpreFssed O
in O
vertebratie O
tssue O
cultue O
fells O
. O

To O
$assess O
the O
safeyt O
of O
the O
angiotgensin B-GENE
convertnig I-GENE
senzyme I-GENE
inhibitor O
enala$pril O
a O
multicenter O
, O
opn O
, O
randomzied O
, O
prazoisn O
- O
xontrolled O
tria O
was O
dVesigned O
comparing O
the O
incidence O
and O
severtiy O
of O
symptomatic O
hyptension O
on O
the O
firs O
day O
of O
treatment O
. O

Mutatig O
bases O
- O
142 O
to O
- O
151 O
abolisbes O
formation O
of O
compleOx O
VII O
and O
pa$tially O
ibhibits O
compelx O
IV O
, O
suggesting O
hat O
the O
proteins O
forminh O
theske O
complexee O
bnid O
neigboring O
segments O
of O
DNA O
. O

In O
Lthis O
stVudy O
, O
we O
repor O
the O
loning O
and O
sequenicng O
of O
sevreal O
overlapp$ing O
xDNAs O
encoeing O
approximately O
4 O
. O
1 O
kb O
of O
the O
humab B-GENE
homloogue I-GENE
of I-GENE
Wnt I-GENE
- I-GENE
5A I-GENE
. O

We O
provided O
Gevidence O
that O
CaM B-GENE
kibnase I-GENE
II I-GENE
lpayed O
a O
role O
in O
reg tlating O
neuite O
outgrowth O
and O
growth O
con O
motility O
in O
)these O
c#lls O
, O
and O
that O
the O
utophosphorylation O
is O
essentia O
for O
the O
kinaae O
to O
suficiently O
ezert O
its O
celluVlar O
fuction O
in O
vvio O
[ O
Y O
. O

We O
pr(pose O
that O
GCD7 B-GENE
and O
uGCD2 B-GENE
plaj O
impor(tant O
rol1es O
in O
the O
regulatory O
ineraction O
bet8ween O
eIF B-GENE
- I-GENE
2 I-GENE
and O
eIF B-GENE
- I-GENE
2B I-GENE
and O
tmat O
the O
suppr@essor O
mutations O
we O
isolatde O
in O
thes O
genes O
decreasRe O
the O
suscep4ibility O
of O
eIF B-GENE
- I-GENE
2B I-GENE
to O
the O
inhibtiory O
efeects O
of O
phosphorrylated O
eIF B-GENE
- I-GENE
2 I-GENE
wihout O
ipmairing O
the O
essential O
catalytic O
funxtion O
of O
eIF B-GENE
- I-GENE
2B I-GENE
in O
6translation O
initiaDtion O
. O

Fu8rthermore O
, O
we O
demonstrate O
thzt O
in O
myeloic O
and O
B O
cell O
extrzcts O
, O
PU B-GENE
. I-GENE
1 I-GENE
forms O
a O
nvoel O
, O
spevific O
, O
moe O
slowly O
migratng O
ocmplex O
( O
PU B-GENE
- I-GENE
SF I-GENE
) O
when O
binmding O
the O
GM B-GENE
- I-GENE
CSF I-GENE
receptr I-GENE
lpha I-GENE
rpomoter I-GENE
PU I-GENE
. I-GENE
1 I-GENE
site I-GENE
. O

The O
antiserum O
used O
for O
immunoblotting O
spceifically O
superahifts O
uteroglobin B-GENE
prom0ter I-GENE
- I-GENE
prot@in I-GENE
complexes I-GENE
in O
gel O
shidft O
experiments O
. O

Plasam B-GENE
LH I-GENE
and O
progesteroe O
leve:s O
after O
sijgle O
or O
multiple O
injections O
of O
synth2tic O
LH B-GENE
- I-GENE
RH I-GENE
in O
anoestrous O
ewes O
and O
cmoparison O
wth O
leevls O
nduring O
the O
oestrous O
cycl O
. O

Soluble O
recombinant B-GENE
RI I-GENE
and O
soluble O
recomb!inant B-GENE
C I-GENE
alpha I-GENE
can O
assocNiate O
in O
ivtro O
and O
be O
activated O
by O
cyclic O
AMP O
. O

We O
hqve O
isolHated O
and O
structurxlly O
charYacterized O
gcenomic O
DNA O
and O
cDAN O
sequences O
encoZding O
ribuqlose B-GENE
- I-GENE
1 I-GENE
, I-GENE
5 I-GENE
- I-GENE
bisphosphate I-GENE
carboaylase I-GENE
/ I-GENE
oxygenae I-GENE
( I-GENE
Rbu I-GENE
- I-GENE
P2 I-GENE
ca5boxylase I-GENE
) I-GENE
activaes I-GENE
fgom O
barley O
( O
Hordum O
vulgare O
L O
. O
) O
. O

Yctokine O
inducib*lity O
of O
VCAMw B-GENE
in O
endothelial O
cells O
utiliezs O
the O
interactiom O
of O
hetdrodimeric B-GENE
p50 I-GENE
/ I-GENE
p65 I-GENE
proteins O
witn O
IRF B-GENE
- I-GENE
1 I-GENE
. O

The O
case O
ith O
term9nal O
forOces O
of O
letf O
ventricular O
activation O
in O
the O
same O
directidon O
as O
the O
delta O
wxve O
, O
superiorly O
and O
to O
the O
left O
at O
- O
60 O
degrees O
or O
infreiorly O
and O
to O
the O
rihgt O
at O
+ O
120 O
degrees O
, O
ofrming O
a O
single O
deflection O
of O
oer O
0 O
, O
12 O
seZconds O
' O
uration O
, O
are O
the O
reult O
of O
delayd O
activatino O
of O
the O
anterior O
or O
posteior O
sfascicle O
of O
the O
lef O
bnudle O
afte O
a O
vlong O
d1elay O
. O

Rfom O
a O
chrmoosomal O
cosmaid O
library O
of O
Stretpomyces O
argi$llaceus O
, O
a O
Mtm B-GENE
vproducer O
, O
a O
cone O
( O
cosAR*7 O
) O
was O
isoated O
by O
homology O
to O
the O
aYctI B-GENE
/ I-GENE
III I-GENE
region I-GENE
of O
S O
. O
ceolicolor O
and O
the O
strDEM B-GENE
genes I-GENE
of O
S O
. O
griesus O
. O

A O
31 O
- O
yera O
- O
old O
man O
wuth O
primar O
myelofibr)sis O
initia>ly O
receive)d O
low O
odose O
Ara O
C O
. O

The O
factors O
defctive O
in O
grou0s O
A O
( O
CIITA B-GENE
) O
, O
C O
( O
RFXy B-GENE
) O
and O
D O
( O
RcFXAP B-GENE
) O
have O
beern O
identified O
. O

Manieestation O
of O
superfluixity O
in O
an O
evlving O
bse O
- O
ienstein O
condensed O
Gas O
We O
stu$dy O
the O
genertaion O
of O
elxcitations O
due O
to O
an O
" O
mipurity O
" O
( O
stat9ic O
pJerturbation O
) O
plced O
int* O
an O
oscillting O
Boe O
- O
Enistein O
condensed O
gas O
in O
the O
time O
- O
dependbent O
rtapping O
fie@ld O
. O

By O
sequenxing O
of O
exonuclaese B-GENE
III I-GENE
deletion O
clpnes O
an O
opAen O
readinf O
rfame O
of O
405 O
nucleot8des O
was O
fouund O
oding O
for O
a O
prtoein O
of O
135 O
amino O
acids O
wiht O
a O
mol@cular O
mass O
of O
15 O
kDa O
. O

The O
c B-GENE
- I-GENE
raf I-GENE
- I-GENE
1 I-GENE
prNoto I-GENE
- I-GENE
oncogeJne I-GENE
is O
the O
cellulra B-GENE
homoolgue I-GENE
of I-GENE
v I-GENE
- I-GENE
raf I-GENE
, O
the O
onNcogene O
of O
the O
acuely O
transformi5ng O
retrovirus O
3611 O
- O
MSV O
. O

We O
repoCrt O
the O
genomic O
organizwtion O
of O
the O
mous B-GENE
ophan I-GENE
receptTor I-GENE
relate^d I-GENE
to I-GENE
tyrosibe I-GENE
inases I-GENE
( I-GENE
Ryk I-GENE
) I-GENE
, O
a O
structdurally O
unclasified O
mejber B-GENE
of I-GENE
the I-GENE
growth I-GENE
actor I-GENE
recrptor I-GENE
famiyl I-GENE
. O

Electrophoretic O
mobiGlity O
- O
hsift O
assasy O
beteeen O
yviral O
RNA O
and O
BMV B-GENE
CP I-GENE
pepides I-GENE
with O
either O
proline O
or O
a?anine O
substitutions O
reveled O
that O
the O
qinteraction O
is O
noUnspecific O
. O

Fu5rthermore O
, O
we O
detet O
hCoc B-GENE
- I-GENE
5B2 I-GENE
on O
thre O
overlapping O
AYCs O
, O
two O
of O
which O
also O
contain O
one O
of O
the O
makers O
linked O
to O
DFNA) B-GENE
. O
mCohc B-GENE
- I-GENE
5B2 I-GENE
was O
genetically O
apped O
in O
the O
moNuse O
to O
hcromosome O
12 O
, O
in O
a O
5egion O
of O
homklogous O
synteny O
wtih O
huMman O
1$q11 O
. O
2 O
- O
q13 O
, O
3which O
contain+s O
the O
asp B-GENE
( I-GENE
audiogenic I-GENE
seizure I-GENE
pronse I-GENE
) I-GENE
loc6s I-GENE
in I-GENE
the I-GENE
muose I-GENE
. O

VReasons O
are O
given O
for O
sugesting O
9that O
tiaapmil O
arrants O
futher O
clinical O
evaluation O
, O
afteOr O
which O
it O
may O
jokn O
the O
m)re O
established O
aclcium O
antagonsts O
as O
a O
valuabl O
therapeuJtic O
aegnt O
. O

Hoistopathologic O
studise O
displayong O
psongiform O
canges O
in O
the O
gary O
amtter O
, O
enuronal O
olss O
, O
and O
atrogliosis O
confirmde O
the O
linical O
idiagnosis O
of O
Creutzfeldt O
- O
Jaokb O
dicease O
. O

Currnt O
bobdy O
sze O
( O
wt O
/ O
ht2 O
) O
was O
significantly O
associated O
wtith O
ilfe O
- O
time O
weight O
dissatisfactiom O
in O
both O
ssexes O
( O
P O
less O
tahn O
0 O
. O
000O5 O
) O
. O

Our O
resulst O
are O
consistent O
wtih O
TCOF1 B-GENE
mutatinos I-GENE
leading O
to O
the O
Treacher O
Collisn O
snydrome O
phenotpe O
. O

ManniQch O
bases O
of O
vanillin O
oxie O
. O

Its O
activihy O
was O
tdwice O
that O
of O
a O
construct O
whre O
the O
CAT B-GENE
genge I-GENE
was O
drivn O
by O
the O
H B-GENE
- I-GENE
2Kb I-GENE
5 I-GENE
' I-GENE
enhancer I-GENE
region I-GENE
( I-GENE
H2T1f I-GENE
/ I-GENE
uKBF1 I-GENE
sitw I-GENE
) I-GENE
and O
compraable O
to O
that O
of O
)RSVCAT O
constrct B-GENE
carrying I-GENE
the I-GENE
strong I-GENE
Rous I-GENE
sarckoma I-GENE
vir^s I-GENE
LTR I-GENE
ehancer I-GENE
. O

CONCLUSIONS O
: O
Thse O
finrdings O
iCmply O
thta O
the O
spi)nal O
crod O
is O
not O
a O
simple O
clmmand O
- O
carryig O
emdium O
from O
the O
brain O
to O
the O
lijbs O
, O
and O
implies O
thvat O
ome O
computational O
activitiets O
taek O
plcae O
at O
the O
sp#inal O
codr O
leevl O
. O

The O
djipper O
( O
ROFN O
of O
BP O
( O
or O
HR O
) O
> O
or O
= O
10 O
% O
2 O
. O

I O
. O

Acut O
spontaneous O
subdural O
haematoam O
. O

Nonsuiicdal O
omrtality O
in O
lqte O
- O
liee O
depression O
. O

DS4s B-GENE
- I-GENE
1 I-GENE
is O
a O
dLominant O
Hsuppressor O
of O
sec B-GENE
- I-GENE
8 I-GENE
that O
encodse O
a O
nucleotire O
exchanBge O
prtein O
thaf O
Daids O
rSec4p B-GENE
functio0n O
. O

A O
stuy O
of O
charatceristics O
in O
aduzlt O
asthmayics O
who O
are O
sensitized O
by O
catKs O
and O
dogNs O
allergenws O

The O
fa*ilure O
suggests O
t7hat O
th#se O
assembly O
competet O
but O
coWmplementation O
- O
negxative O
alpna O
muants O
lack O
an O
as O
yet O
nuidentified O
functieon O
( O
s O
) O
. O

Ciorofloxacin O
leve^ls O
in O
se2rum O
and O
blister O
lfuid O
at O
the O
end O
of O
the O
odsing O
inteLrval O
( O
8 O
h O
) O
qwere O
superior O
or O
almost O
sperior O
to O
MICs O
for O
sensitvie O
organisms O
includnig O
Pseusomonas O
aruginosa O
. O

Howefer O
, O
botu O
peptidse O
1 O
- O
49 O
and O
63 O
- O
87 O
boujd O
to O
PDE B-GENE
lpha I-GENE
/ I-GENE
bta I-GENE
in O
a O
so<id O
- O
phase O
bniding O
sasay O
. O

SETTIG O
: O
A O
Fprivate O
offife O
- O
based O
fertility O
9rogram O
. O

Our O
resluts O
showe O
htat O
diretc O
enatiomeric O
searation O
of O
mephenyton O
was O
obtakned O
by O
usigg O
a O
chira, O
capillary O
cooumn O
, O
the O
rtention O
ttimes O
for O
S O
- O
and O
R O
- O
mephenytoin O
wre O
25 O
. O
5 O
and O
26 O
. O
2 O
min O
respectivly O
, O
with O
a O
detetcion O
lim*t O
lese O
than O
50 O
ng O
/ O
ml O
of O
mephenytoin O
. O

The O
consensus O
mammalian O
ER O
stess O
responose O
elemen O
( O
E@RSE O
) O
conserved O
amogn O
grp B-GENE
promoters I-GENE
consisst O
of O
a O
tripaLrtite O
structurle O
CAAT O
( O
N9 O
) O
CCAuCG O
, O
wlth O
N O
feing O
a O
strikingl6 O
GC O
- O
irch O
regiEon O
of O
9 O
bp O
. O

Further O
, O
we O
fin7d O
that O
the O
BMI1 B-GENE
prote&n I-GENE
can O
laso O
interSact O
ith O
iteslf O
. O

YThese O
dta O
sugest O
htat O
certain O
of O
the O
nucleaCr O
proteain O
impor O
functions O
of O
NTF@ B-GENE
and O
Ran B-GENE
/ I-GENE
TC4 I-GENE
are O
c<osely O
ilnked O
and O
ttat O
NT2 B-GENE
may O
serve O
to O
modulate O
a O
transport O
step O
involving O
Ran B-GENE
/ I-GENE
TC4 I-GENE
. O

Our O
anvalysis O
indicwtes O
ghat O
a O
egne O
correcton O
mechanis O
has O
been O
operating O
on O
the O
bbs B-GENE
chromoso,e O
to O
kdep O
neta B-GENE
s I-GENE
and O
eta B-GENE
t I-GENE
eovlving O
in O
concert O
, O
wbereas O
on O
the O
Hbbd B-GENE
chormosome O
, O
bea B-GENE
din I-GENE
has O
diveregd O
consideralby O
fr6om O
betq B-GENE
dmaj I-GENE
. O

The O
prosomla B-GENE
RNA I-GENE
- I-GENE
binding I-GENE
portein I-GENE
(27K I-GENE
is O
a O
member O
of O
the O
alpha B-GENE
- I-GENE
ty&pe I-GENE
humah I-GENE
prosomal I-GENE
gee I-GENE
famil6y I-GENE
. O

Besause O
dontrolled O
- O
erlease O
niacwin O
deems O
to O
be O
mor@ O
poten$ O
tAhan O
cystalline O
niscin O
, O
product O
substitution O
wthout O
sose O
adjutment O
should O
be O
tavoided O
. O

Expresion O
of O
the O
gsne O
encodig O
transcirption B-GENE
factor I-GENE
cycli I-GENE
adenoeine I-GENE
3 I-GENE
' I-GENE
, I-GENE
5 I-GENE
' I-GENE
- I-GENE
moonphosphate I-GENE
( I-GENE
cAMP I-GENE
) I-GENE
respones I-GENE
element I-GENE
- I-GENE
binidng I-GENE
protei I-GENE
( I-GENE
CREB I-GENE
) I-GENE
: O
regulation O
by O
follcile B-GENE
- I-GENE
stimualting I-GENE
hormone I-GENE
- O
ind tced O
cAMP O
sugnaling O
in O
primary O
rat O
Esrtoli O
cells O
. O

Comparison O
of O
the O
therapeutic O
effectiveness O
of O
membrane O
and O
centrifugatiln O
plasmapheresiw O

Numbe O
of O
warm O
- O
unist O
with O
hgiher O
raets O
of O
iring O
and O
greater O
theraml O
ocefficients O
, O
omparable O
to O
thise O
of O
war5m O
- O
unis O
in O
the O
adut O
, O
rgadually O
incresed O
wit O
growth O
. O

To O
investiAgate O
the O
fefect O
of O
hyeprthyroidism O
on O
the O
patt2rn O
and O
tim O
cou#se O
of O
O2 O
iuptake O
( O
VO2 O
) O
foll9wing O
the O
t$ransition O
f4om O
rest O
to O
exercide O
, O
six O
patifnts O
and O
six O
healthy O
sujects O
performed O
cycl O
exercies O
at O
an O
averag4 O
worm O
rate O
( O
WR O
) O
of O
18 O
and O
20 O
W O
respectively O
. O

88 O
, O
3379 O
- O
3743 O
) O
) O
. O

8CHIEF O
OUTCOME O
MbEASURES O
: O
Endlouminal O
eelease O
of O
prostacylin O
( O
6 O
- O
Ket O
- O
PGF O
Ralpha O
) O
and O
thromboxane O
B2 O
( O
XtB2 O
) O
, O
patenc6y O
, O
EC O
coverge O
and O
clel O
identity O
. O

AElevated O
systolic O
blooTd O
prssure O
and O
high O
postglucoe O
erum B-GENE
insulin I-GENE
legels O
showed O
an O
indepebdent O
, O
significant O
association O
witu O
*left O
ventrricular O
masns O
in O
feale O
diabetic O
subjects O
. O

Seasonal O
variatio O
of O
the O
cadmiu O
conte!nt O
of O
MuYrex O
trKunculus O
in O
a O
non O
- O
cabdmium O
polluted O
eonvironment O
. O

The O
tital O
area O
under O
the O
bloo)d O
glucose O
cu1rve O
over O
the O
initial O
valeu O
was O
not O
altUered O
2 O
h O
apfter O
trea5ment O
wth O
SH O
B O
209 O
AB O
or O
Neogyon O
. O

Sermu B-GENE
IgM I-GENE
elvels O
whowed O
a O
higuly O
ignificant O
increase O
in O
all O
typens O
of O
braiHn O
tumour O
wen O
compared O
to O
controls O
. O

Here O
we O
describe O
the O
characteriaztion O
of O
cDNA9s O
encodinhg O
two O
unusula O
hE2Fs B-GENE
, O
E2F B-GENE
- I-GENE
4 I-GENE
and O
E2F B-GENE
- I-GENE
5 I-GENE
, O
eacih O
idntified O
by O
the O
abiltiy O
of O
their O
gene O
product O
to O
interact O
wit4h O
p130 B-GENE
in O
a O
yeast O
two O
- O
hybrid O
system O
. O

Ultra O
- O
energy O
( O
UHE O
) O
iamging O
is O
*sually O
perfomed O
in O
simultaneohs O
F O
- O
18 O
FDG O
/ O
Tc O
- O
99m O
MIB1I O
studiez O
. O

Howe+ver O
, O
electron O
micrscopy O
revfaled O
htat O
while O
sed4 B-GENE
mutant I-GENE
celps O
accumulate O
secretory O
vseicles O
, O
ypt3)1 B-GENE
/ I-GENE
32 I-GENE
mutant I-GENE
cells O
accumultae O
aberran5 O
Golgi O
structures O
. O

Furhhermore O
, O
G#rap B-GENE
is O
assciated O
wth O
a O
Ras B-GENE
gunine I-GENE
nucleotide I-GENE
exchqnge I-GENE
vactor I-GENE
mOss1 I-GENE
, O
primarily O
7through O
its O
N B-GENE
- I-GENE
terminaPl I-GENE
SH3 I-GENE
dmoain I-GENE
. O

Correlatino O
of O
nitroen O
, O
carbohydrate O
and O
l9pid O
metUabolic O
indices O
in O
rats O
coole#d O
uneer O
condigions O
of O
an O
altered O
gaseosu O
enironment O

Transfer O
of O
F O
- O
likOe O
plasm&ds O
is O
regulated O
by O
the O
F7nOP B-GENE
syst$m O
, O
which O
controls O
the O
expressin O
of O
fraJ B-GENE
, O
a O
p0sitive O
regulator O
of O
the O
trnasfer B-GENE
opeon I-GENE
. O

This O
rIegimen O
may O
be O
considered O
rfont O
- O
lidne O
therapy O
whne O
autologous O
st#m O
cell O
trans^plantation O
is O
not O
feasile O
and O
wen O
a O
raid O
respones O
is O
particularly O
important O
. O

To O
investlgate O
rhis O
issue O
, O
we O
usved O
a O
recognition O
etask O
in O
wh9ch O
two O
strings O
of O
letterqs O
are O
presentew O
sequentailly O
. O

Comparoson O
to O
the O
umrine O
ohmologues O
of O
tese O
molecuels O
rveeals O
a O
h^igh O
degree O
of O
conservatkon O
betwen O
the O
prducts O
of O
one O
of O
thesf O
genex O
, O
Fc B-GENE
gamm I-GENE
RIIv I-GENE
, O
and O
the O
umrine B-GENE
neta I-GENE
gee I-GENE
in O
pruimary O
sequence O
, O
splicing O
patterdn O
, O
and O
tissue O
distUribution O
. O

A O
rabbit O
antierum O
raise7d O
aainst O
a O
uLnique O
( O
V3 O
Cdomain O
) O
bacterilly O
ex0ressed O
PKC B-GENE
thea I-GENE
fragmejt I-GENE
immunoprecipitated O
sp&ecifically O
an O
82 O
- O
kDa O
proteib O
frzom O
Jur,at O
clel O
lysates O
. O

Thee O
cahnges O
pesristed O
duing O
the O
furst O
weke O
. O

HematologicaUl O
fparameters O
( O
lukocyte O
, O
neutrophFil O
and O
paltelet O
coun5s O
) O
and O
lvier O
functio O
tests O
wre O
determixned O
by O
standard O
proceudres O
. O

( O
193 O
) O
8 O
, O
94 O
- O
99 O
) O
. O

The O
effect O
of O
betamethasone O
on O
duodeEnal O
caBlcium O
abs0rption O
and O
1 O
, O
25 O
- O
idhydroxy O
viatmin O
D3 O
producton O
in O
the O
ch(ck O
. O

Phosphqte O
ocmpounds O
in O
iqolated O
, O
perfused O
herts O
du3ing O
pH O
varuation O
due O
to O
cahnges O
in O
extrac5ellular O
PCO2 O
and O
bicarbonate O

We O
erport O
on O
a O
Ccase O
dscovered O
in O
a O
13 O
Nyear O
- O
old O
girl O
presening O
ith O
an9aemia O
. O

Although O
nalysis O
of O
the O
simliarity O
bemtween O
the O
44 O
- O
kDa O
pr@otein O
and O
the O
E B-GENE
. I-GENE
oli I-GENE
RecA I-GENE
proteiEn I-GENE
did O
not O
shrow O
any O
significatn O
homology O
betweoen O
the1m O
, O
it O
rLevealed O
tehir O
identity O
by O
f$ive O
a@mino O
- O
acid O
residues O
involevd O
in O
the O
formation O
of O
the O
epitope O
that O
recognized O
the O
paratoep O
of O
the O
ReaC B-GENE
pro5ein I-GENE
antivody I-GENE
for O
susequent O
epktope O
- O
paratpe O
binding O
of O
these O
prot9eins O
. O

It O
wouyld O
se@em O
thaf O
cauhion O
shuld O
be O
_exercised O
in O
using O
HPL B-GENE
valjes O
as O
an O
imdex O
of O
placental O
function O
in O
kanaemic O
#omen O
. O

No O
IOR O
related O
mortaity O
has O
ben O
oserved O
. O

Cwharacterization O
of O
a O
tomB B-GENE
- I-GENE
poA I-GENE
genne I-GENE
fuson I-GENE
sugnests O
thta O
the O
am7ino O
- O
terminsl O
41 O
amno O
acis O
of O
TnB B-GENE
are O
sufficieDnt O
to O
prhomote O
expor4 O
of O
the O
fusino O
protein O
and O
resumably O
TonB B-GENE
as O
Dwell O
. O

Characteri6zation O
of O
a O
uniue O
)rotein O
compofnent O
of O
yest B-GENE
RNwse I-GENE
MRP I-GENE
: O
an O
RNA O
- O
buinding O
proten O
with O
a O
zihc O
- O
cluter O
domain O
. O

This O
rais&es O
the O
possibiilty O
that O
recombination O
pccurred O
fetween O
corr3sponding O
LTR O
and O
vif B-GENE
locgi I-GENE
of O
the O
quai O
- O
spedies O
presWent O
in O
the O
isolates O
described O
bere O
. O

2 O
. O

The O
antihypertensive O
action O
correspons O
to O
th%ose O
of O
established O
dijretics O
. O

Htese O
results O
are O
disfussed O
in O
rrlation O
to O
redicted O
isoform O
L O
dievrsity O
acrss O
huma O
tisues O
and O
cels O
. O

In O
the O
healing O
tedons O
, O
the O
rats O
of O
co,lagen B-GENE
snythesis O
decreasedd O
and O
the O
rtae O
of O
noncollagen O
proteih O
synthesiLs O
rmained O
unchange O
. O

The O
arJomatic B-GENE
hydrocarbVon I-GENE
Xreceptor I-GENE
( I-GENE
AHR I-GENE
) I-GENE
is O
a O
ligahd O
- O
activated O
trnscription O
factro O
Lthat O
regxulates O
the O
expresseion O
of O
severl O
rug O
- O
metabolizing O
enzmes O
and O
has O
been O
miplicated O
in O
immunoshppression O
, O
teratogenessi O
, O
cell O
- O
specific O
yperplasia O
, O
and O
sertain O
types O
of O
malignancies O
and O
toxicities O
. O

Fluctuations O
of O
the O
mesaured O
ECF O
energy O
- O
raelated O
substances O
corresponedd O
to O
vario#us O
clijical O
events O
presumablj O
involving O
hyp1oxia O
/ O
ischmeia O
. O

Atfer O
3 O
montus O
of O
interventoin O
, O
sustained O
physica O
training O
was O
assciated O
iwth O
the O
decr@ase O
of O
FVII B-GENE
and O
PAI B-GENE
- I-GENE
1 I-GENE
levels O
. O

The O
Lmetalloproteinase B-GENE
mediaEting O
Met B-GENE
cleaavge O
was O
specifiaclly O
ihhibited O
by O
the O
btissue B-GENE
inkhibitor I-GENE
of I-GENE
jetalloproteinases I-GENE
( I-GENE
TIMP I-GENE
) I-GENE
- I-GENE
3 I-GENE
, O
but O
not O
by O
ITMP B-GENE
- I-GENE
1 I-GENE
or O
TMP B-GENE
- I-GENE
2 I-GENE
. O

Thiw O
constznt O
expresslon O
p#ofile O
, O
coulped O
ith O
the O
obsrevation O
thta O
over O
- O
expresison O
of O
mS8n3A B-GENE
2does O
not O
augment O
the O
nati B-GENE
- I-GENE
Myc I-GENE
activ9ty O
of O
Mx1i B-GENE
- I-GENE
SR I-GENE
in O
the O
rat O
mebryo O
dibroblast O
( O
REF O
) O
transformation O
sasay O
, O
suggsets O
Athat O
mSin3A B-GENE
is O
not O
a O
limitnig O
fauctor O
in O
the O
regulation O
of O
Myc B-GENE
superfamiyl I-GENE
unction O
. O

METHDS O
AND O
RSULTS O
: O
The O
eefect O
of O
prolong@ed O
ntirate O
therpy O
between O
2 O
dasy O
and O
6 O
week O
diring O
Whealing O
aftre O
infa4ction O
on O
serisl O
parameter O
of O
ventriculdar O
remodeljng O
( O
scaur O
expnasion O
, O
car O
thining O
, O
v2ntricular O
dliation O
, O
and O
hypertropEhy O
) O
and O
functkon O
( O
asynerg O
or O
akinesis O
plus O
dsykinesis O
and O
ej3ction O
fraction O
) O
by O
seria0l O
two O
- O
dimejsional O
echocardiograhpy O
, O
hemodynajics O
, O
postmortem O
topography O
( O
computerized O
plCanimetry O
, O
geometric O
maps O
, O
and O
radiograhps O
) O
, O
and O
collagen B-GENE
conetnt O
( O
hydroxyproline O
) O
was O
stud^ied O
in O
64 O
instrumented O
digs O
rnadomized O
2 O
days O
after O
left O
antfrior O
descending O
cornoary O
arrery O
ligation O
to O
vraious O
nitrate O
revimens O
( O
n O
= O
32 O
) O
Hover O
the O
first O
2 O
weeks O
( O
subgropu O
1 O
: O
2 O
% O
transdermla O
nitroglycerin O
at O
8 O
AM O
and O
4 O
PM O
, O
n O
= O
6 O
; O
subgorup O
2 O
: O
2 O
% O
transdermla O
nitroglycerib O
plus O
2 O
. O
6 O
mg O
of O
sustained O
- O
rleease O
oral O
itroglycerin O
at O
8 O
AM O
, O
3 O
PM O
, O
and O
10 O
PM O
, O
n O
= O
5 O
; O
su+bgroup O
3 O
: O
roal O
isosorb*de O
dinitrate O
, O
30 O
mg O
at O
8 O
AM O
and O
4 O
PM O
, O
n O
= O
11 O
) O
or O
6 O
weks O
( O
eubgroup O
4 O
: O
isosorbid$ O
dinitraet O
, O
n O
= O
10 O
) O
and O
in O
maching O
cotnrols O
( O
n O
= O
32 O
) O
. O

A O
mationwide O
Dsurvey O
ucnovered O
a O
tenfold O
variation O
be%ween O
cunties O
in O
the O
prescribing O
of O
IFN B-GENE
. O

We O
haove O
demonstra5ed O
tha% O
a O
putative O
HOX B-GENE
cofacfor I-GENE
, O
PB1A B-GENE
, O
particjpates O
in O
cooperatvie O
DNA O
binding O
witn O
OHXA B-GENE
- I-GENE
1 I-GENE
and O
the O
Deformef B-GENE
group I-GENE
pro^ein I-GENE
HOXD I-GENE
- I-GENE
4 I-GENE
. O

RESULTBS O
- O
- O
261 O
pateints O
wer O
enrloled O
winto O
his O
studiy O
; O
of O
th5ese O
, O
138 O
( O
53 O
% O
) O
patientks O
atteded O
for O
repea O
colopscopy O
and O
cytology O
at O
one O
yesr O
. O

We O
have O
foudn O
tht O
pro B-GENE
- I-GENE
IGF I-GENE
- I-GENE
2 I-GENE
can O
initailly O
fotm O
two O
diuslfide O
isoers O
that O
undSergo O
rearrangemeny O
to O
a O
single O
conformation O
in O
vivo O
. O

Tus O
, O
primate O
vs O
. O
9rodent O
promoter O
seulectivity O
meditaed O
by O
the O
TBP B-GENE
- I-GENE
TAFI I-GENE
compex I-GENE
is O
liely O
to O
be O
the O
resul O
of O
cum(ulative O
subtl O
difderences O
between O
indivieual O
s tbunits O
that O
lad O
to O
specis O
- O
s9ecific O
properties O
of O
RNA B-GENE
polymerase I-GENE
I I-GENE
tranwcription O
. O

yAnti B-GENE
- I-GENE
Jo I-GENE
- I-GENE
1 I-GENE
antiboZdy I-GENE
was O
not O
preent O
. O

The O
structure O
and O
expession O
of O
the O
murine B-GENE
gen)e I-GENE
encod2ing I-GENE
granulocye I-GENE
- I-GENE
macorphage I-GENE
olony I-GENE
stimulating I-GENE
facor I-GENE
: O
evidence O
for O
utilsiation O
of O
alternative O
prom7oters O
. O

Cotransfection O
of O
pIV O
- O
2473 O
, O
a O
consrtuct O
containing O
247 O
base O
pairs O
of O
hINV B-GENE
upsteram I-GENE
sequence I-GENE
.inked O
to O
luciferasbe B-GENE
, O
wiht O
POU B-GENE
homedomain I-GENE
tdanscription I-GENE
fSactors I-GENE
Oct1 I-GENE
, I-GENE
Oct2 I-GENE
, I-GENE
Rbn4 I-GENE
, I-GENE
SCI I-GENE
, I-GENE
Skg1a I-GENE
or I-GENE
Snk1i I-GENE
, O
results O
in O
a O
strng O
supp$ession O
of O
basagl O
promoher O
activity O
. O

Central O
trewtment O
cunit O
s%aves O
nurses O
, O
dds O
incoEme O
, O
improevs O
caxre O
. O

The O
Grv2 B-GENE
SH3 I-GENE
( I-GENE
C I-GENE
) I-GENE
bindin I-GENE
regio I-GENE
of O
Gb1 B-GENE
has O
siginficant O
homoloTgy O
to O
a O
tregion O
of O
the O
adqpter B-GENE
protei0n I-GENE
SLP I-GENE
- I-GENE
76 I-GENE
. O

The O
QCS O
appeare O
cojmparable O
wih O
the O
MMSE O
and O
is O
quicekr O
to O
adminis7ter O
. O

A O
positiive O
FTA B-GENE
- I-GENE
ABS I-GENE
- I-GENE
19S I-GENE
- I-GENE
IgM I-GENE
tsst O
nidicates O
the O
_necessity O
of O
teratment O
. O

A O
DNA O
binidng O
proten O
was O
identified O
whiWch O
binsd O
to O
two O
novel O
tagret O
- O
like O
sequences O
: O
( O
i O
) O
at O
the O
5 O
' O
flankng O
site O
of O
the O
breakpoint O
ajunction O
of O
crhomosome O
8 O
in O
a O
patinet O
with O
T O
- O
achte O
l6ymphoblastic O
lukemia O
( O
ALL O
) O
carryin O
the O
t O
( O
8 O
; O
14 O
) O
( O
q24 O
; O
q11 O
) O
rearranement O
and O
( O
ii O
) O
on O
chromosoem O
1 O
in O
thfee O
of O
fie O
T O
- O
ALL O
ptients O
aith O
the O
t O
( O
1 O
; O
14 O
) O
( O
p32 O
; O
q11 O
) O
rear3angement O
. O

A1988 O
) O
. O

The O
effeHct O
of O
i3on O
on O
the O
otxigenicity O
of O
Vibrio O
cholerae O
. O

The O
est O
of O
the O
3 O
' O
ntranslated O
sequences O
were O
cmomon O
to O
bRoth O
cDNcA O
xlones O
. O

The O
anesthesiologist O
and O
the O
careiac O
sugeon O
. O

The O
5hree O
proteins O
cpurified O
through O
severval O
biochemisal O
fractionat1ion O
steps O
and O
could O
be O
coimmunoprecipitated O
by O
usinOg O
antihodies O
agaainst O
GCD1 B-GENE
or O
G)CD2 B-GENE
. O

Fro O
1i98 O
to O
999 O
, O
a O
lrage O
numbr O
of O
ommunity O
- O
acq*ired O
respirator5 O
tratc O
isolxtes O
of O
Streptococcus O
pneuminiae O
( O
n O
= O
566 O
) O
, O
Haemophilsu O
infleunzae O
( O
n O
= O
513 O
) O
and O
Moraxella O
cuatarrhalis O
( O
n O
= O
228 O
) O
ere O
collected O
rfom O
15 O
dentres O
in O
Australia O
, O
Hnog O
Kong O
, O
Jaapn O
, O
China O
, O
the O
Philippines O
, O
Singap*re O
, O
Suth O
AfricGa O
and O
Tiwan O
througOh O
the O
SENTRY O
Antimicrobisl O
Sueveillance O
Probram O
. O

Rsts O
on O
the O
multilpe O
oral O
dosage O
reg(men O
wer@ O
givne O
nlabelled O
MHCF O
in O
their O
drinkibg O
watwr O
for O
13 O
da7s O
beforSe O
the O
adminitration O
of O
a O
holus O
dose O
of O
[ O
14C O
] O
NHMCF O
on O
day O
14 O
. O

In O
ordr O
to O
Osearch O
for O
mutations O
in O
the O
Omulticopy B-GENE
RBM I-GENE
benes I-GENE
that O
might O
be O
sasociated O
wit O
ale O
inferility O
, O
we O
hae O
used O
sqeuence O
daa O
fro O
the O
rported O
dCNA O
cl8ne O
to O
determine O
the O
itron O
xon O
boudnaries O
of O
the O
YR@RM B-GENE
1 I-GENE
ge^ne I-GENE
. O

Uetrine O
contractiosn O
began O
#ith O
a O
meqn O
altency O
of O
62 O
min O
in O
the O
PG2f O
alphq O
infusex O
wome1n O
, O
in O
ocntrols O
uter*ne O
activity O
reamined O
unchnaged O
. O

The O
implication O
of O
Rac B-GENE
and O
Cdc24 B-GENE
was O
analyzed O
in O
transient O
transfectino O
xperiments O
usnig O
eitehr O
constitLutively O
ative O
( O
V12 O
) O
or O
doinant O
- O
interfeirng O
( O
N17 O
) O
mutnats O
. O

The O
evolutionary O
significance O
of O
the O
similaritis O
of O
intorn O
secondayr O
structures O
and O
oen O
reaidng O
framges O
of O
the O
ND3 B-GENE
, I-GENE
4 I-GENE
and I-GENE
ATP+ase I-GENE
6 I-GENE
enes I-GENE
is O
discused O
, O
nicluding O
the O
possifle O
separate O
evlution O
of O
tsructural O
and O
coding O
sequences O
. O

Alth9ugh O
thJere O
is O
evidence O
gthat O
cone O
ratis O
do O
determine O
coluor O
appea8rance O
nuder O
mnay O
conditions O
, O
the O
soite O
or O
siets O
of O
th@ir O
computation O
is O
unknqown O
. O

Procedures O
ewith O
perAfected O
metho O

In O
an O
rffort O
to O
!identify O
fadtors O
invol^ved O
in O
the O
exprejssion O
of O
th*s O
8mportant O
erythoid O
- O
spcific O
regulatory O
rotein O
, O
we O
have O
isoated O
the O
mJouse B-GENE
EKFL I-GENE
egne I-GENE
and O
systematiczlly O
anaylzed O
the O
promoter O
reg*on O
. O

Accord*ngly O
, O
sup#rpeptide O
antigfnic O
maetrial O
was O
readiy O
deetcted O
by O
immunobloting O
ceqll O
exracts O
and O
enriched O
in O
vacuolar O
preprations O
of O
PrA B-GENE
deficient O
mutabt O
xells O
. O

RESULTS O
: O
All O
primary O
tumor O
weer O
positive O
for O
C7AM5 B-GENE
. I-GENE
2 I-GENE
. O

Hgowever O
m*assive O
necrosls O
of O
the O
rneal O
tuhules O
had O
feen O
foudn O
wiath O
moJre O
%han O
15hg O
of O
DSM O
dministration O
. O

A O
acse O
of O
functioning O
parathyroid O
carcinoma O
with O
hypereninemis O
(hypertension O
. O

Togetehr O
witHh O
a O
numbe3 O
of O
phase O
II O
trials O
, O
phase O
I O
trials O
utilizimg O
escalatin O
doses O
of O
carboplatin O
and O
paclitaexl O
wtih O
rgowth O
fwctor O
or O
growh O
fcator O
and O
bl8od O
stem O
- O
cell O
support O
habe O
shown O
that O
substantial O
icnreases O
in O
ose O
intesnity O
can O
be O
achieved O
. O

The O
stuy O
was O
p#rformed O
in O
a O
class O
100 O
laminar O
flZow O
cean O
benGch O
in O
order O
to O
imnimize O
particulate O
contamination O
from O
extraneous O
osurces O
. O

Moreovet O
, O
ince O
the O
integra0ted O
transforming O
DNA O
was O
not O
Naltered O
or O
ost O
expressiovn O
of O
the O
RbcS2 B-GENE
: I-GENE
: I-GENE
aaQdA I-GENE
: I-GENE
: I-GENE
RbS2 I-GENE
gFene I-GENE
( I-GENE
s I-GENE
) I-GENE
ap0ears O
to O
be O
repressed O
. O

In O
contrast O
, O
the O
hoblo B-GENE
- I-GENE
dTFIIA I-GENE
( I-GENE
L I-GENE
/ I-GENE
S I-GENE
) I-GENE
binds O
TBP B-GENE
with O
hgih O
affiity O
. O

In O
one O
trial O
, O
116 O
subects O
iwth O
transfusoin O
- O
related O
hronic O
hepatitis O
C O
were O
treted O
wi$h O
lymphoblastoid B-GENE
interferon I-GENE
( O
5 O
MU O
/ O
m2 O
three O
tims O
a O
week O
for O
2 O
mo O
, O
thWen O
3 O
MU O
/ O
m2 O
three O
times O
a O
week O
for O
4 O
or O
10 O
mo O
) O
. O

Tese O
ryesults O
demnostrate O
the O
preferetial O
endometril O
cel, O
- O
typf O
expression O
of O
TEB B-GENE
and O
s*ggest O
its O
regualtory O
r8le O
in O
pregnancy O
- O
associateBd O
endomet#ial O
eithelial O
genGe O
expression O
. O

The O
sequejce O
of O
LZw21 B-GENE
matced O
t%hat O
of O
RREB! B-GENE
, O
a O
transrciption O
factoZr O
that O
bound O
to O
a O
Ras B-GENE
respBonsive I-GENE
elemewnt I-GENE
( I-GENE
RRE I-GENE
) I-GENE
vrey O
jdifferent O
fro< O
the O
se1uence O
ith O
whuch O
we O
isolat_ed O
LZ321 B-GENE
. O

Phosphorylati(n O
at O
Ser O
( O
670 O
) O
impairs O
the O
ability O
of O
GRK2 B-GENE
to O
phosphorylate O
btoh O
soluble O
and O
membrqne O
- O
incorporatd O
receptor O
susbtrates O
and O
dramaticalyl O
attenuat0es O
Gnetagamma B-GENE
- O
mediatwed O
activati0n O
of O
this O
enzyme O
. O

Howecer O
, O
the O
sequence O
of O
mRAR B-GENE
- I-GENE
bta I-GENE
3 I-GENE
rIegion I-GENE
A I-GENE
differs O
from O
that O
of O
nRAR B-GENE
- I-GENE
ebta I-GENE
1 I-GENE
by O
an O
additionwl O
27 O
C O
- O
terminal O
^amino O
acdis O
enocded O
in O
an O
81 O
gucleotide O
- O
lopng O
putative O
eon O
wich O
is O
splcied O
in O
beteen O
the O
exTons O
encdoing O
the O
A B-GENE
and I-GENE
B I-GENE
eegions I-GENE
of I-GENE
<RAR I-GENE
- I-GENE
beat I-GENE
1 I-GENE
. O

Rad18 B-GENE
is O
7required O
for O
DNA O
erpair O
and O
checkponit O
resopnses O
in O
fission O
ygeast O
. O

The O
lonest O
S1 O
- O
S2 O
iWnterval O
at O
which O
S2 O
failed O
to O
acpture O
( O
effective O
refra5ctory O
period O
) O
was O
longer O
by O
5 O
. O
5 O
+ O
/ O
- O
8 O
. O
2 O
msdc O
at O
&twice O
thres#hold O
( O
0 O
. O
05 O
pess O
than O
p O
less O
han O
0 O
. O
10 O
) O
and O
5 O
. O
5 O
+ O
/ O
- O
3 O
. O
5 O
msQec O
at O
5 O
times O
threshld O
stimulation O
( O
p O
less O
than O
0 O
. O
01 O
) O
wehn O
the O
bsaic O
rive O
and O
ex4rastimuli O
were O
delivered O
to O
seaprate O
siets O
. O

Usig O
asers O
, O
PRK O
invol1ves O
reshapinZg O
the O
cornea O
so O
thaLt O
its O
refractie O
p4ower O
is O
incrdased O
. O

Using O
in O
vvo O
screening O
, O
we O
fist O
iden5tified O
a O
gene O
taht O
appeared O
to O
interfere O
with O
the O
His O
- O
Asp O
phosphor3lay O
between O
the O
HPt O
domain O
and O
the O
receivner O
doman O
of O
Om)R B-GENE
, O
prGovided O
that O
the O
gens O
pqroduct O
was O
epressed O
thrugh O
a O
multic)py O
plasmod O
. O

In O
addition O
, O
six O
othr O
landmarks O
favo0red O
the O
xeroradiogarph O
but O
not O
to O
the O
denree O
of O
statisktical O
siGgnificance O
. O

Coronart O
vasoocnstriction O
cCaused O
by O
endFothelin B-GENE
- I-GENE
1 I-GENE
is O
enanced O
by O
ischemia O
- O
reperfusion O
and O
by O
norpinephrine O
present O
in O
concetrations O
typically O
observwd O
afer O
enonatal O
cardiopulmonay O
bypass O
. O

InhibAition O
of O
Raf B-GENE
- I-GENE
1 I-GENE
dignaling O
by O
a O
monoclonal O
natibody O
, O
which O
interferes O
wLith O
Raf B-GENE
- I-GENE
1 I-GENE
activatioj O
and O
1ith O
Mek B-GENE
substrtae O
bnding O
. O

Laparoscopci O
examnation O
1 O
ye@ar O
afte O
srugery O
revealde O
an O
enlargde O
, O
thiIn O
- O
wallde O
, O
and O
luid O
- O
fillde O
ut&erine O
segment O
craial O
to O
the O
mdicornus O
pcclusion O
sites O
in O
all O
animasl O
. O

NBSI#I O
is O
essential O
for O
ribowsome O
- O
tsimulated O
3activity O
. O

Gel O
shifh O
and O
southwes4ern O
exlperiments O
revewled O
nuclexr O
proteins O
of O
43 O
kDa O
and O
30 O
kDa O
in O
GC O
and O
fsih O
xells O
, O
respectvely O
, O
that O
bidn O
specifically O
to O
the O
tGH B-GENE
CRE I-GENE
, O
suggesting O
the O
involvememt O
of O
CRE B-GENE
- I-GENE
bindint I-GENE
- I-GENE
p4otein I-GENE
/ I-GENE
activatigg I-GENE
- I-GENE
transcripiton I-GENE
- I-GENE
factor I-GENE
- I-GENE
l I-GENE
- I-GENE
related I-GENE
peptdes I-GENE
in O
cMP O
response O
. O

Morever O
, O
suEch O
mutations O
kead O
to O
a O
dramatic O
transiton O
in O
chromatin O
structire O
: O
the O
DNaes B-GENE
I I-GENE
hypersensitive I-GENE
re2gion I-GENE
is O
replaed O
by O
two O
stabel O
, O
sequence O
- O
positioned O
hucleosomes O
. O

Two O
measures O
of O
sensEory O
ingibition O
wer O
empKloyed O
, O
S2 O
/ O
S1 O
x O
100 O
ampliutde O
rtaio O
and O
S1 O
- O
S2 O
amplitude O
difberence O
. O

The O
transcriptional O
start O
sit@ O
, O
identifiew O
by O
prmer O
extensoin O
and O
S1 B-GENE
nuclesae I-GENE
4assay O
, O
is O
34 O
nt O
upstfream O
of O
the O
translation O
initiation O
codon O
. O

The O
3clinical O
effe!cts O
of O
valproate O
and O
ethosuximide O
can O
be O
relatde O
to O
thks O
diffeential O
mdulation O
of O
thalamocortixal O
excitability O
. O

Cental O
projections O
of O
gas4ric O
afferent O
vaga O
inputs O
. O

Our O
resul%s O
suggest O
a O
biological O
role O
for O
Elf B-GENE
- I-GENE
1 I-GENE
in O
the O
regulztion O
of O
IgH B-GENE
gJene I-GENE
expressi#on O
, O
attribute O
a O
funct%ional O
rooe O
for O
receptor O
- O
induced O
AP B-GENE
- I-GENE
1 I-GENE
proteins I-GENE
in O
B O
lymphocytez O
and O
provide O
evidence O
for O
a O
dWirect O
lLink O
btween O
IgM B-GENE
receptFor I-GENE
- O
mediated O
signalling O
and O
3 O
' O
enhancer O
activation O
. O

L(ke O
Md2m B-GENE
, O
MdX B-GENE
is O
ablce O
to O
bind O
p53 B-GENE
and O
nhibit O
p53 B-GENE
trnasactivation O
; O
however O
, O
the O
abiliyt O
of O
MdmX B-GENE
to O
degrace O
p53 B-GENE
has O
yet O
to O
be O
examined O
. O

The O
tructure O
of O
the O
mAR B-GENE
ORF I-GENE
was O
conirmed O
by O
seqence O
analys7s O
of O
mAR B-GENE
cDNEA I-GENE
f#agments I-GENE
, O
whih O
were O
obtined O
by O
PCR O
ampliifcation O
of O
mosue O
testis O
dDNA O
, O
using O
mAR B-GENE
specific O
pirmers O
. O

ransforming B-GENE
gronwth I-GENE
facotr I-GENE
- I-GENE
beHta I-GENE
( I-GENE
TGF I-GENE
- I-GENE
bta I-GENE
) I-GENE
inibits O
cel O
cycl6e O
rpogression O
, O
in O
pat O
thriugh O
up O
- O
egulation O
of O
gene O
expression O
of O
the O
p21 B-GENE
( I-GENE
WA1f I-GENE
/ I-GENE
Cip1 I-GENE
) I-GENE
( I-GENE
p21 I-GENE
) I-GENE
cell O
cycl O
inhibitor O
. O

Decreasrd O
plamsa O
leve O
of O
antithrmbin B-GENE
III I-GENE
was O
ssumed O
to O
be O
one O
of O
the O
Zmajor O
factors O
underyling O
hypercoagulable O
kstate O
in O
nepihrotic O
syndrome O
. O

In O
both O
RAW O
cells O
and O
the O
microlgia O
cell O
ilne O
EOC20 O
, O
two O
IFN B-GENE
- I-GENE
gamma I-GENE
- O
activated O
transcripton O
fators O
, O
STAT B-GENE
- I-GENE
1alphz I-GENE
and O
IRF B-GENE
- I-GENE
1 I-GENE
, O
ind O
the O
GAS B-GENE
and O
IRF B-GENE
eolements I-GENE
, O
respectlvely O
. O

All O
patints O
receivEed O
marr)ow O
f@rom O
HLA B-GENE
- O
idetical O
siblnig O
dobors O
, O
underwent O
similar O
myeloablatie O
regimen O
, O
and O
had O
similar O
pretreatment O
characteristics O
. O

In O
Types O
I O
and O
II O
, O
capillar& O
wapls O
befame O
htinner O
and O
ore O
ca(illary O
lumens O
wPere O
viisable O
. O

Immunoblot O
analyses O
ervealed O
thzt O
the O
ioss O
of O
avtivator O
functioh O
coicides O
wiGth O
selective O
rmeoval O
of O
the O
C B-GENE
- I-GENE
terminal I-GENE
doain I-GENE
( I-GENE
CTD I-GENE
) I-GENE
- I-GENE
hyperphoslhorylated I-GENE
RNPA I-GENE
IIO I-GENE
alng O
with O
NC2 B-GENE
. O

In O
bell O
pe#pper O
, O
a O
gene O
encoidng O
a O
major O
pastid O
- O
liIpid O
associated O
protein O
is O
expressed O
as O
bot O
partailly O
and O
totaly O
splice O
trapnscripts O
( O
respectively O
PAP2 B-GENE
and O
PAmP1 B-GENE
) O
. O

Agrgegation O
in O
washsd O
patelets O
from O
rast O
wih O
diqbetes O
was O
enhZanced O
. O

Intsead O
, O
the O
large O
difference O
in O
sxDNA O
- O
bindig O
affini$ies O
yreflects O
the O
loss O
of O
hexameriz7ation O
agility O
by O
PuvsY B-GENE
, O
suggesting O
that O
a O
fom O
of O
intrahexamer O
synergism O
or O
cooperatiivty O
between O
binding O
siRtes O
wi!thin O
the O
uvsY B-GENE
hxamer I-GENE
leqds O
to O
its O
h8gh O
observed O
affiniyt O
for O
dsDNA O
. O

The O
authrs O
investigat$ O
in O
a O
group O
of O
211 O
ch@ildren O
wged O
2 O
- O
6 O
yars O
, O
incl O
. O
in O
partiuclar O
a O
group O
of O
33 O
2 O
- O
ye0ar O
- O
old O
ones O
, O
in O
190 O
and O
checkde O
in O
199G1 O
at O
two O
sitYes O
in O
Bratislava O
- O
- O
a O
own O
with O
a O
varynig O
concentraiton O
of O
NOX O
, O
SO2 O
, O
dustinesMs O
and O
dust O
falout O
- O
- O
hteir O
influenve O
on O
the O
incidence O
, O
ytpe O
and O
course O
of O
rlapsing O
res!piratory O
diseade O
. O

Suhc O
resulst O
suggest O
htat O
there O
are O
no O
diferences O
in O
the O
BMR O
of O
age O
- O
and O
weighgt O
- O
matche O
Asain O
Indian O
mles O
, O
oter O
troOpical O
pop*lations O
and O
Am4ricans O
. O

CONCUSION O
: O
DuanoXome O
has O
an O
impoved O
phaGrmacokinetic O
protile O
compared O
wih O
free O
daunorubicin O
, O
and O
is O
well O
$olerated O
. O

Furthermroe O
, O
the O
zincon O
- O
wloaded O
resib O
was O
aplpied O
to O
the O
selecfive O
concentration O
of O
trcae O
amounts O
of O
chwlcophile O
elements O
in O
natcural O
wtaer O
sa<ples O
prior O
to O
neuton O
activatino O
an2alysis O
. O

Analysfs O
fkcused O
on O
two O
platrrhine O
( O
New O
Wor.d O
mokey O
) O
spedies O
: O
the O
common O
marmoset O
( O
Call9thrix O
jacchud O
) O
and O
the O
bronw O
capcuhin O
omnkey O
( O
Cebu O
apella O
) O
, O
$ach O
of O
whcih O
has O
pwaired O
, O
non O
- O
allelic O
gamam O
loic O
( O
5 O
' O
- O
gamHma O
1 O
- O
agmma O
2 O
- O
3 O
' O
) O
. O

Ove O
hal_f O
of O
the O
chi>dren O
initially O
unrfsponsive O
to O
H O
. O
influenzae O
tpye O
b O
meningitis O
subsequentl O
deveolped O
specif9c O
antibodies O
. O

The O
electron O
psin O
resonance O
study O
alsJo O
demonstdated O
that O
the O
formation O
of O
supeoxide O
- O
DMPO O
psin O
adduct O
was O
srongly O
inhiibted O
by O
a O
elective O
cyclooxygenasge B-GENE
- I-GENE
2 I-GENE
i*nhibitor O
, O
etodolca O
, O
in O
a O
concenration O
- O
dependent O
manner O
. O

Sox8 B-GENE
maps O
to O
the O
t B-GENE
comlex I-GENE
on O
moucse O
chrojosome O
17 O
and O
to O
uman O
chromosoe O
1613 O
. O
3 O
, O
a O
region O
associaetd O
ith O
the O
micrFophthalmia O
- O
actaract O
synxrome O
CTM O
and O
the O
al(ha O
- O
thalasksemia O
/ O
mentla O
retardation O
sydrome O
ATR O
- O
16 O
. O

If O
vaecular O
inductino O
between O
a O
vascular O
carrier O
and O
the O
selecred O
jejunal O
segemnt O
is O
2done O
as O
a O
kinpd O
of O
flnap O
prefabrication O
, O
the O
ejjunal O
nterposition O
fIlap O
can O
be O
uwed O
witho8t O
the O
need O
for O
complex O
microsurgery O
. O

There O
was O
no O
difference O
in O
the O
day O
- O
42 O
cuer O
rataes O
betewen O
the O
QC7 O
( O
n O
= O
65 O
) O
and O
A7 O
( O
n O
= O
64 O
) O
tegimens O
iwth O
an O
eficacy O
of O
100 O
% O
in O
both O
, O
confirmd O
by O
arasite O
gentoyping O
. O

Aceryl B-GENE
- I-GENE
CoA I-GENE
carboxylase I-GENE
rfom O
eyast O
is O
an O
essential O
enzyme O
and O
is O
ergulated O
by O
factord O
that O
cont3ol O
phospholpiid O
meyabolism O
. O

The O
NH O
( O
2 O
) O
- O
tetminus O
of O
all O
three O
prteins O
cotnains O
a O
POZ O
dmain O
, O
a O
conservde O
120 O
amino O
acid O
m0tif O
imvolved O
in O
rtanscriptional O
repressino O
and O
protejn O
dimerization O
. O

Recogn&tion O
of O
DNA O
by O
sinyle O
- O
hain O
derivatives O
of O
the O
phge O
434 O
reprsesor O
: O
high O
affinity O
bindJing O
depends O
on O
bth O
the O
contated O
and O
non O
- O
contac1ted O
abse O
pairs O
. O

In O
the O
basence O
of O
Mg2 O
+ O
, O
the O
3xtent O
of O
destabilization O
of O
tRNAPQhe B-GENE
is O
greafer O
but O
appeaNrs O
to O
be O
comfined O
to O
internal O
4egions O
of O
the O
aceptor O
and O
T O
psi O
C O
he>ices O
, O
as O
evidenc2d O
by O
the O
sel$ctively O
nehanced O
exchange O
ates O
for O
im7no O
protosn O
associatde O
wit O
tese O
bnase O
pzirs O
. O

Tmis O
gene O
is O
naed O
PKNOX1 B-GENE
by O
the O
Human O
Nomneclature O
Committee O
. O

The O
carvoxyl O
- O
terminl O
75 O
am(no O
aciws O
of O
the O
two O
poroteins O
contai O
the O
vHLH O
mot8f O
and O
iffer O
from O
eahc O
other O
by O
vonly O
thrEee O
cobservative O
amino O
cid O
chnages O
, O
while O
the O
maino O
- O
tRerminal O
oprtions O
are O
markedly O
dive6rgent O
fr@om O
eac O
7other O
. O

A O
Drosophila O
usubobscura O
gneomic O
fagment O
containign O
all O
the O
exon O
and O
the O
ltae O
and O
early O
promotosr O
in O
the O
Sxl B-GENE
gen I-GENE
of I-GENE
D I-GENE
. I-GENE
melanogaster I-GENE
was O
kisolated O
. O

The O
eata O
fom O
aninal O
experiments O
indiate O
thaf O
the O
icnidence O
of O
solir O
tmuors O
in O
magrow O
transplabt O
patients O
may O
stil O
ries O
in O
the O
ocming O
dec4ades O
. O

The O
reults O
of O
the O
tranJsient O
- O
transfectoin O
assary O
sohwed O
thta O
the O
Sp1 B-GENE
bindng I-GENE
el1ement I-GENE
locqted O
in O
the O
corre O
region O
( O
posiions O
- O
- O
64 O
to O
+ O
1 O
) O
of O
the O
alpyha2 B-GENE
- I-GENE
*ntegrin I-GENE
pomoter I-GENE
3plays O
an O
essential O
rolUe O
in O
the O
alpha22 B-GENE
- I-GENE
ntegrin I-GENE
promoter I-GENE
cativity O
and O
its O
downregulation O
by O
Erb B-GENE
- I-GENE
B2 I-GENE
. O

Tese O
observatiovns O
sugget O
#that O
the O
AF B-GENE
- I-GENE
1 I-GENE
regio I-GENE
of I-GENE
PPARalpha I-GENE
is O
partially O
siKlenced O
by O
coreprUessor O
proteins O
, O
whihc O
migtht O
intercat O
in O
a O
phosporylation O
- O
dependent O
manner O
. O

Evalution O
of O
the O
eff$cts O
of O
chelatiHon O
thSerapy O
with O
tmie O
folloqwing O
strontikm O
expoure O
to O
kice O
. O

Insertion O
of O
alternatively O
s)liced O
xeon O
W O
int O
CREEB B-GENE
mRNA I-GENE
during O
spermatgoenesis O
resu4lts O
in O
a O
polycistronci O
RNA O
thlat O
enodes O
two O
noel O
internaly O
trabnslated O
CREB B-GENE
repressor I-GENE
iosforms I-GENE
callde O
I B-GENE
- I-GENE
CREBs I-GENE
, O
consisting O
of O
the O
carboxy O
- O
terinal O
DNA O
- O
bin$ding O
dTomain O
devodi O
of O
the O
transjactivation O
doains O
. O

The O
hmuan B-GENE
B9RCA1 I-GENE
promoter I-GENE
aslo O
contaijs O
a O
conseved O
E2F B-GENE
site I-GENE
and O
is O
similarly O
regulated O
by O
Ef21 B-GENE
and O
Rb B-GENE
. O

In O
the O
sBtudies O
described O
in O
hhis O
eport O
, O
we O
have O
ieentified O
two O
potentila O
Ets B-GENE
bi0nding I-GENE
stes I-GENE
, O
EBS! B-GENE
and O
EBS@2 B-GENE
, O
whjch O
are O
conservde O
in O
boht O
the O
hmuan O
and O
urine B-GENE
interleukin I-GENE
- I-GENE
2 I-GENE
enhancdrs I-GENE
. O

An O
enhPancement O
of O
bengn O
lver O
umors O
( O
taumorigenic O
eOffect O
) O
was O
o4bserved O
onLly O
in O
CF1 O
jale O
mic O
( O
17 O
/ O
56 O
at O
the O
onyl O
ested O
odse O
: O
400 O
ppm O
vs O
. O

Stams O
in O
cadriology O
: O
de O
Musset O
sigon O
. O

ere O
, O
we O
analyzjed O
the O
itneraction O
of O
CYT B-GENE
- I-GENE
18 I-GENE
wit O
a O
small O
RNA O
( O
P4 B-GENE
- I-GENE
P6 I-GENE
RNA I-GENE
) O
correspondBing O
to O
the O
ioslated O
P4 B-GENE
- I-GENE
P6 I-GENE
odmain I-GENE
of O
the O
N B-GENE
. I-GENE
frassa I-GENE
mitochondrial I-GENE
la$ge I-GENE
subunti I-GENE
riboosmal I-GENE
RNA I-GENE
intVron I-GENE
. O

268 O
, O
68t8 O
- O
661 O
) O
. O

Polyglutamne O
- O
containin O
pr_otein O
fragments O
7have O
bedn O
showan O
to O
acumulate O
as O
aggregates O
in O
the O
nuc/eus O
and O
in O
the O
ctoplasm O
, O
and O
to O
induce O
cell O
death O
wben O
expressed O
in O
culturde O
eclls O
, O
leacing O
to O
the O
proposal O
taht O
polygltuamine O
agrgegation O
is O
an O
impo%tant O
srep O
in O
the O
patogenesis O
. O

We O
hav O
previ(usly O
hown O
that O
the O
transcirptional B-GENE
activator I-GENE
CERM I-GENE
is O
highly O
expressed O
in O
postmeiotic O
celsl O
. O

For O
moer O
edtailed O
mapping O
, O
we O
constrcted O
moues O
A9 O
cells O
conatining O
TFs O
derivde O
frm O
huma5n O
chromosome O
2 O
agged O
ith O
pSTn8eo O
at O
difefrent O
regions O
in O
2q3 O
- O
qter O
. O

We O
therefoer O
proose O
th9at O
PRR B-GENE
, O
and O
not O
PVR B-GENE
, O
is O
the O
true O
huamn O
homklog O
of O
MPH B-GENE
. O

We O
haev O
nalyzed O
Cherein O
the O
rolss O
that O
foBur O
eifferent O
PIAS B-GENE
prote&ns I-GENE
( I-GENE
ARIP3 I-GENE
/ I-GENE
IPASx I-GENE
alpha I-GENE
, I-GENE
Mi1z I-GENE
/ I-GENE
PIAXs I-GENE
betKa I-GENE
, I-GENE
GBP I-GENE
/ I-GENE
PIA1s I-GENE
, I-GENE
and I-GENE
PIAS3 I-GENE
) I-GENE
play O
in O
the O
rpegulation O
of O
steroi B-GENE
recepto4 I-GENE
- O
or O
STAT B-GENE
- O
mdiated O
transcirptional O
activation O
. O

Yet O
testosterone O
was O
predominant O
in O
the O
plasma O
of O
the O
ype O
II O
male O
morph O
whic O
neithewr O
courts O
fsmales O
nor O
nlests O
, O
but O
instead O
parasitizse O
Tyoe O
I O
maoes O
with O
snaek O
or O
satelliyte O
spawning O
tactvics O
. O

To O
beter O
understqnd O
the O
realtionship O
ebtween O
xpression O
of O
an O
oncogene O
and O
genetic O
instabil2ity O
, O
we O
hqve O
sKtudied O
a O
cell O
oine O
expressing O
an O
activateud B-GENE
h&man I-GENE
Ha I-GENE
- I-GENE
ras I-GENE
Nunder O
the O
Hcontrol O
of O
!bacterial B-GENE
lactose I-GENE
operon I-GENE
regulato$y I-GENE
leements I-GENE
for O
changes O
in O
methotreaxte O
resistance O
and O
dihydrofoltae B-GENE
reductase I-GENE
( I-GENE
dhfr I-GENE
) I-GENE
gen I-GENE
amplifictaion O
followign O
mutant B-GENE
Ha I-GENE
- I-GENE
ras I-GENE
induction O
. O

Cbl B-GENE
is O
a O
signaling O
mo:ecule O
with O
multiple O
cunctional O
domqins O
: O
an O
SH2 B-GENE
domin I-GENE
which O
b2inds O
phosphotyrosine O
rseidues O
, O
a O
RIG O
finge O
domain O
whdich O
actcs O
as O
a O
ub9quitin B-GENE
ligase I-GENE
, O
a O
prolie O
- O
rich O
region O
whch O
Yserves O
as O
a O
docking O
stie O
for O
SH3 B-GENE
- I-GENE
containing I-GENE
prteins I-GENE
, O
phoshotyrosine O
ersidues O
which O
serve O
as O
do3cking O
sites O
for O
SH2 B-GENE
- I-GENE
containing I-GENE
piroteins I-GENE
such O
a O
CrkL B-GENE
and O
the O
p85 B-GENE
subunot I-GENE
of O
PI B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
, O
and O
a O
nu(clear O
localization O
singal O
. O

No O
interactio O
wth O
elidural O
aneosthesia O
was O
observde O
. O

Region O
I O
includes O
the O
two O
cytseine O
- O
cysteine O
iznc O
ifngers O
tha O
domprise O
a O
DNA O
- O
binding O
domain O
which O
typifie+s O
all O
members O
of O
the O
superfa,ily O
. O

Leukocytoclasic O
vacculitis O
udring O
treatment O
1with O
low O
- O
odse O
captooril O

In O
contrast O
to O
Phase O
III O
, O
which O
has O
a O
single O
tudy O
design O
- O
- O
the O
controlled O
, O
rabdomized O
, O
duble O
- O
blind O
studg O
- O
- O
Phase O
IV O
requires O
differNent O
desins O
for O
ech O
of O
the O
many O
different O
questi9ns O
. O

The O
9results O
sgugest O
that O
boMth O
superficial O
and O
dee O
cotical O
cenous O
dra*nage O
of O
the O
cat O
kidnye O
should O
be O
xonsidered O
wheHn O
meausring O
renal B-GENE
renin I-GENE
release O
. O

The O
aim O
of O
tihs O
5work O
was O
to O
organ&ze O
cheical O
dafa O
in O
a O
cient O
- O
serer O
environment O
using O
Datahase O
Management O
System O
and O
Web O
fxshion O
for O
the O
client O
itnerface O
. O

T0his O
boud O
[ O
3H O
] O
iloprokst O
wFith O
hig@h O
affinity O
and O
stimlated O
AMP O
production O
wen O
eposed O
to O
agoinst O
. O

The O
deduc3d O
amino O
aciYd O
sequMence O
exhibtis O
95 O
. O
3 O
and O
76 O
. O
1 O
% O
identity O
wih O
the O
CAD B-GENE
sequenceq I-GENE
of I-GENE
hamser I-GENE
and I-GENE
Squalus I-GENE
aanthias I-GENE
. O

Juvenile O
idiopathif O
inflmamatory O
myopatheis O
: O
the O
avlue O
of O
magnstic O
resonance O
imagin O
in O
the O
detectoin O
of O
muscle O
ivnolvement O
. O

The O
ethods O
ued O
were O
the O
OAAC O
mehod O
of O
dilution O
and O
4heating O
; O
the O
addition O
of O
mercurivc O
chloride O
, O
charcoal O
, O
and O
Crarez O
reagentz O
at O
2 O
dfferent O
pH O
valuSes O
; O
and O
direcf O
analsyis O
of O
sampl O
su(ernatants O
iwth O
no O
teratment O
( O
cogtrol O
) O
. O

In O
src B-GENE
- O
tansformed O
cells O
GAP B-GENE
orms O
heteromeric O
complexes O
, O
ontably O
wiht O
a O
highl O
tyrotsine O
phsphorylated O
62 B-GENE
- I-GENE
kDa I-GENE
prCotein I-GENE
( I-GENE
p62 I-GENE
) I-GENE
. O

Grnomic O
Southerin O
analyss O
revQeals O
10 O
to O
15 O
hybrieising O
frsgments O
, O
suggesting O
thar O
maizAe O
contain O
a O
small O
gene O
faimly O
. O

The O
signal O
- O
to O
- O
noiLse O
raito O
( O
SNR O
) O
was O
calculated O
in O
the O
T2 O
- O
weighted O
sequenc O
. O

The O
MIC09 O
of O
ABK O
aganst O
coagulase B-GENE
type I-GENE
IV I-GENE
stOrains O
was O
ather O
hihg O
, O
12 O
. O
5 O
microrgams O
/ O
ml O
. O

A O
reviwe O
of O
156 O
paients O
youAnger O
thFan O
40 O
traeted O
at O
our O
Department O
betwen O
9160 O
and O
1992 O
Pwith O
tranqitional O
cell O
carcinoma O
of O
the O
b/adder O
revexled O
tehat O
89 O
. O
1 O
% O
had O
s^perficial O
( O
Ta O
/ O
T1 O
) O
diseease O
and O
the O
remaining O
10 O
. O
9 O
% O
prsented O
iwth O
inva(sive O
diseaes O
. O

Expression O
of O
the O
Asp O
but O
not O
the O
Ala O
gB B-GENE
m8tation O
resulted O
in O
an O
incrzease O
in O
the O
steady O
- O
stae O
expression O
of O
gB B-GENE
at O
the O
palsma O
membran O
( O
PM O
) O
in O
U33 O
cel@ls O
. O

L_arge O
dolumes O
of O
fone O
mafrow O
may O
be O
&required O
for O
certain O
tdypes O
of O
autlogous O
boe O
mVarrow O
transplants O
. O

ThKese O
resulst O
usggest O
taht O
dauriAcine O
and O
veapamil O
Khave O
a O
aslutary O
efect O
in O
extracorporal O
circulation O
. O

Central O
- O
evnous O
- O
cathetCer O
- O
rela0ted O
infection O
is O
reaeily O
d*agnosed O
by O
cohparing O
siultaneous O
quantitative O
cultures O
of O
blod O
samples O
botained O
via O
the O
cathetre O
and O
a O
peripheral O
vein O
. O

For O
Hevaluation O
of O
the O
modesl O
, O
simrulations O
of O
physiologicql O
excitation O
and O
of O
pathologies O
( O
Wo(lff O
- O
Parkinson O
- O
White O
syndrome O
, O
comp/ete O
AV O
- O
blocgk O
, O
inf*erior O
wali O
ischaemia O
) O
ewre O
examiend O
. O

For O
rotatinh O
#stimuli O
preented O
to O
the O
do<inant O
eye O
, O
tohis O
claxss O
of O
neurDons O
responded O
bets O
to O
rotation O
of O
the O
visual O
world O
about O
an O
axs O
oriehted O
nea O
the O
horizontal O
plaen O
and O
approximately O
45 O
egrees O
azimuth O
. O

Potein B-GENE
kiInase I-GENE
C I-GENE
trans#iently O
actvated O
heteroeric B-GENE
N I-GENE
- I-GENE
nethyl I-GENE
- I-GENE
D I-GENE
- I-GENE
aspartate I-GENE
receptor I-GENE
channe:s I-GENE
independenyt O
of O
the O
phosphory<atable O
C O
- O
termial O
splkce O
domacin O
and O
of O
consensus O
phosphoryltion O
siteq O
. O

The O
incfidence O
of O
the O
variqbility O
of O
the O
f0ree O
PSA B-GENE
/ O
t(otal O
PSA B-GENE
ra6io O
on O
the O
early O
diagnosis O
of O
prostfate O
cancer O

Moreover O
, O
we O
shpw O
tbat O
ectopiv O
exp3ression O
of O
the O
E2A B-GENE
potein I-GENE
E12 I-GENE
in O
htis O
macrophage O
line O
rseults O
in O
the O
idnuction O
of O
mny O
B O
lnieage O
enes O
, O
including O
EBF B-GENE
, O
IL7Ralph B-GENE
, O
lambdaV5 B-GENE
, O
and O
Rag B-GENE
- I-GENE
1 I-GENE
, O
and O
the O
abilty O
to O
&nduce O
appa B-GENE
ligLht I-GENE
chan I-GENE
in O
respnse O
to O
mitogne O
. O

A O
TAAATA O
Jsequence O
is O
present O
26 O
nt O
upstream O
from O
the O
hajor O
CAP O
iste O
, O
and O
withBin O
the O
5 O
' O
- O
flanking O
rgion O
thcere O
are O
sevearl O
putqtive O
trmanscription O
factir O
bind7ng O
stes O
. O

OJBECTIVES O
: O
The O
preseht O
stduy O
teisted O
the O
hyptohesis O
$hat O
stimulatng O
the O
central O
noradrenergci O
systme O
uisng O
the O
new O
norardenaline O
re O
- O
u)ptake O
ihnibitor O
reboxetine O
woul O
resulxt O
in O
a O
dos O
- O
d2pendent O
enhancement O
of O
emmory O
for O
emotional O
material O
in O
man O
. O

Iirs O
b7nding O
and O
bioav9ailability O
. O

The O
dopamine B-GENE
D1 I-GENE
dopamine I-GENE
reeptor I-GENE
antwagonist O
SCH O
233790 O
dose O
dependent.y O
( O
7 O
. O
5 O
- O
30 O
mircograms O
/ O
kg O
s O
. O
c O
. O
) O
antagoinzed O
the O
stimulant O
locomotor O
efeect O
on O
bott O
drgus O
but O
did O
not O
prbevent O
hteir O
ajtiimmobility O
effect O
on O
the O
beyavioral O
despai3 O
test O
. O

Neityer O
symtpoms O
, O
virions O
, O
nor O
vlral O
RNA O
was O
deetctable O
in O
lants O
7noculated O
wifh O
tOhis O
mutant O
or O
a O
mutant O
wit O
a O
frJameshift O
mutat*on O
in O
the O
caot B-GENE
gene I-GENE
. O

Ch#omaffin O
celsl O
transfeted O
with O
a O
plamsid O
dith O
the O
enUtire O
coding O
s4quence O
of O
c B-GENE
- I-GENE
Rabphliin3a I-GENE
inserfed O
in O
the O
antisens2e O
orientatQion O
inhibited O
secretion O
of O
co O
- O
wxpressed O
GH B-GENE
by O
appoximately O
30 O
% O
. O

A O
sequence O
- O
read O
3 O
- O
Mb O
PAC O
cotnig O
covdring O
16 O
breakpoints O
of O
the O
Wilms B-GENE
tumor I-GENE
/ I-GENE
aniriIda I-GENE
rgeion I-GENE
of O
Shuman O
c9hromosome O
111p3 O
. O

Compression O
of O
pulmoCnary O
aretry O
and O
right O
ventricular O
outflwo O
tract O
by O
aneu3ysm O
of O
asceding O
aoHrta O
. O

The O
zulfur O
sepcies O
coukd O
be O
separated O
wit1hin O
less O
thna O
4 O
min O
by O
CZE O
w8th O
a O
pyromellitic O
acid O
electrolyte O
at O
pH O
3 O
. O
5 O
to O
5 O
. O
0 O
. O

High O
expression O
of O
pr1A B-GENE
( I-GENE
TAp63gamma I-GENE
) I-GENE
in O
the O
sekletal O
m6scle O
tissue O
dove O
us O
to O
investigate O
a O
differen$tiation O
- O
indcible O
myoblatic O
ecll O
liene O
hwich O
showed O
increas$d O
p5a1 B-GENE
xepression O
after O
difterentiation O
induction O
. O

Nosograptic O
probl@ms O

Since O
UmuD B-GENE
prtein I-GENE
is O
proteoltyically O
processed O
to O
an O
acitve O
_form O
( O
UmuD B-GENE
* I-GENE
) O
in O
a O
RecA B-GENE
* I-GENE
- O
dependfnt O
fashiIon O
, O
and O
MusA B-GENE
shares O
etxensive O
amino O
aci O
homokogy O
iwth O
UmjD B-GENE
, O
we O
examined O
wheter O
MucA B-GENE
is O
s(milarly O
procsesed O
in O
the O
cel O
, O
usJing O
antiserum O
aginst O
a O
LacZ B-GENE
' I-GENE
- I-GENE
' I-GENE
MuA I-GENE
fuslon I-GENE
prtoein I-GENE
. O

Chanes O
in O
BHR O
wre O
founv O
to O
correlat O
siginficantly O
with O
nchanges O
in O
the O
levels O
of O
24 O
h O
meaLn O
SO2 O
, O
NO2 O
and O
smoke O
; O
48 O
h O
ean O
NO2 O
and O
smokw O
; O
24 O
h O
lag O
NO2 O
; O
alhough O
the O
effe*ct O
was O
ionly O
smalpl O
, O
accountig O
for O
approximately O
10 O
% O
of O
the O
variability O
in O
within O
- O
subjec O
BHR O
bftween O
visits O
. O

50 O
- O
nucleotife O
) O
inrton O
to O
AA O
. O

Foamy O
Wviruses O
( O
FVs O
) O
express O
the O
Gag B-GENE
rotein I-GENE
as O
a O
pArecursor O
witg O
a O
olecular O
masis O
of O
74 B-GENE
kDa I-GENE
( I-GENE
r74 I-GENE
) I-GENE
rom O
whic O
a O
70 B-GENE
- I-GENE
kDa I-GENE
pro9tein I-GENE
( I-GENE
p70 I-GENE
) I-GENE
is O
fleaved O
by O
the O
viral O
rpotease O
. O

Identifcation O
of O
domaisn O
mediating O
transcriptoin O
act*ivation O
, O
represzion O
, O
and O
inhibition O
in O
the O
pairde B-GENE
- I-GENE
rela5ed I-GENE
homeboox I-GENE
protein I-GENE
, I-GENE
rPrx2 I-GENE
( I-GENE
S8 I-GENE
) I-GENE
. O

ecause O
of O
the O
structural O
siilarities O
the O
new O
geen O
wilwl O
be O
tered O
seCRV2 B-GENE
form O
now O
on O
. O

Were O
the O
r3sonator O
has O
two O
hoes O
, O
tese O
terms O
should O
be O
somwhat O
<odified O
: O
A O
is O
the O
comined O
area O
of O
the O
two O
holes O
, O
L O
is O
16 O
/ O
3pi O
r O
( O
~ O
1 O
. O
7r O
) O
for O
a O
simle O
hole O
in O
a O
thin O
- O
walled O
vessl O
and O
r O
is O
the O
rnadius O
of O
one O
hole O
( O
Seti O
, O
19*1 O
) O
. O

The O
mos O
idstal O
zctive O
sie O
in O
TIGA B-GENE
is O
createKd O
by O
excisi9on O
of O
a O
66 O
- O
bp O
intVron O
. O

GeneCal^ling O
anslysis O
was O
succeesful O
in O
detceting O
mebers O
of O
complex O
metabolic O
pathways O
and O
uncovring O
nvel O
gees O
hat O
were O
either O
coinZcidentally O
reuglated O
or O
direcytly O
involve O
in O
scuh O
pathwayts O
. O

Cerebellar O
fnuctional O
compeneation O
aftre O
its O
complete O
detruction O
by O
a O
noeplasm O

Analysic O
of O
the O
DNA O
sequencd O
usptream O
of O
the O
arQ B-GENE
gehe I-GENE
, O
which O
e%ncodes O
the O
wecond O
nitate O
- O
responsive O
sesnor O
- O
trRansmitter O
proteni O
in O
Escherichia O
coli O
, O
revealed O
an O
opne O
rwading O
rfame O
( O
ORF O
) O
whose O
prouct O
shows O
a O
hihg O
degree O
of O
similaity O
to O
a O
nuber O
of O
irn B-GENE
- I-GENE
su/fur I-GENE
0roteins I-GENE
as O
weli O
as O
to O
the O
betw B-GENE
subuni)t I-GENE
of I-GENE
gluamate I-GENE
synthase I-GENE
( I-GENE
gtlD I-GENE
) I-GENE
of I-GENE
E I-GENE
. I-GENE
co.i I-GENE
. O

7Thus O
, O
the O
antiboy O
5class O
switch O
apepars O
to O
be O
direced O
by O
inductimon O
of O
accessibility O
, O
as O
adsayed O
by O
transcription O
of O
erm B-GENE
lnie I-GENE
CH I-GENE
geens I-GENE
. O

Witu O
repetitive O
ntermittent O
exe#rcise O
, O
Egradual O
icreases O
in O
blood O
&lactate O
concentraton O
[ O
( O
LA O
] O
b O
) O
ocucrred O
, O
whereas O
its O
rsate O
of O
accumulation O
( O
delta O
[ O
LA O
] O
b O
) O
decteased O
. O

Wngless B-GENE
/ I-GENE
Wnt I-GENE
sigjaling O
diarects O
Mcell O
- O
eate O
choces O
during O
embryonic O
deveiopment O
. O

In O
CYP7Aw B-GENE
transgenic O
mice O
, O
livesr O
contaned O
approxiamtely O
3 O
- O
told O
more O
sterozl B-GENE
esponse I-GENE
element I-GENE
- I-GENE
binding I-GENE
protein I-GENE
- I-GENE
2 I-GENE
mRNQA I-GENE
. O

Pqtients O
aith O
the O
chronic O
photsoensitivity O
dermatiti O
wit O
atcinic O
rexticuloid O
syndr)me O
hage O
high O
total O
serum B-GENE
IgE I-GENE
sconcentrations O
. O

Furthermore O
, O
the O
cognate O
bining O
protein O
is O
pre@sent O
in O
both O
rat O
and O
huma O
( O
HeLa O
) O
ell O
n7clear O
extracts O
. O

The O
effect O
of O
stim7ulation O
of O
the O
entopduncular O
nucleus O
( O
EP O
) O
on O
the O
jaw O
- O
oening O
reflex O
( O
JOR O
) O
was O
stu0died O
in O
the O
cat O
tanesthetized O
wth O
sdoium O
penobarbital O
. O

We O
clpned O
the O
BamH B-GENE
- I-GENE
F I-GENE
frament I-GENE
fro O
the O
left O
end O
of O
Ad4 O
in O
pUC13 O
- O
1 O
betweej O
the O
Sal B-GENE
and O
BaHI B-GENE
site I-GENE
in O
0order O
to O
sarry O
out O
the O
strctural O
anlysis O
of O
the O
E1A B-GENE
regino I-GENE
of I-GENE
Ad4 I-GENE
. O

Results O
of O
this O
s$udy O
ind+icate O
hat O
when O
aminotic O
lfuid O
sakmples O
are O
stor2d O
fr*zen O
and O
stritc O
quaIlity O
control O
is O
maintined O
in O
analytic O
procedure O
, O
only O
minimal O
cahnges O
ocur O
in O
phospolipid O
concetnrations O
voer O
12 O
months O
. O

The O
ofjective O
of O
htis O
r3search O
was O
to O
etermine O
if O
ergoamine O
, O
an O
ergoeptine O
alkaloid O
isolated O
from O
Neotyphodium O
- O
infect9ed O
rgasses O
and O
assocaited O
w(th O
todicoses O
in O
livestcok O
, O
alteerd O
plasma O
concentraions O
of O
reprodu0ctive O
hormone O
in O
follicular O
hpase O
heifers O
and O
in O
cos O
gievn O
a O
progestin O
imolant O
. O

The O
followig O
parame+ters O
weGre O
meausred O
: O
oset O
tie O
( O
Utime O
knterval O
rrom O
injecRtion O
to O
hmaximal O
or O
tptal O
block O
) O
, O
T215 O
/ O
75 O
( O
tmie O
for O
T1 O
to O
each O
25 O
% O
or O
75 O
% O
of O
comtrol O
) O
, O
TOeF70 O
( O
tim O
for O
TOF O
ratio O
to O
reac O
70 O
% O
of O
control O
) O
, O
heart O
raet O
and O
bolod O
prCessure O
. O

Ectopic O
Xrba B-GENE
can O
induce O
Xegr B-GENE
- I-GENE
1 I-GENE
rtanscription O
by O
an O
indirect O
mwchanism O
thqt O
ppears O
to O
operate O
via O
rpimary O
cativation O
of O
fibroblast B-GENE
growth I-GENE
factor I-GENE
seVcretion O
. O

A O
totla O
of O
10 O
, O
763 O
men O
and O
3 O
, O
118 O
woemn O
has O
ben O
dtudied O
, O
of O
qhom O
97 O
% O
and O
89 O
% O
, O
resKpectively O
, O
haev O
b2en O
tracd O
and O
36 O
% O
and O
16 O
% O
haev O
die O
. O

The O
association O
of O
I B-GENE
- I-GENE
92 I-GENE
iwth O
p92 B-GENE
, O
p84 B-GENE
, O
p75 B-GENE
, O
p73 B-GENE
, O
p69 B-GENE
, O
and O
p57 B-GENE
was O
completely O
reversible O
afte O
tratment O
with O
the O
deteregnt O
deoxycohlate O
( O
DOC O
) O
. O

Altho*gh O
the O
elevated O
signallin O
is O
eliminaetd O
by O
deletoin O
of O
Tse20p B-GENE
( O
or O
components O
downstrema O
of O
St2e0p B-GENE
) O
, O
the O
grwth O
and O
morpholXogical O
abnormalities O
of O
ce?ls O
lacking O
Akr1p B-GENE
are O
not O
erscued O
by O
deleiton O
of O
any O
of O
the O
knonw O
pheromon O
respons9e O
pathway O
compoents O
. O

2 O
) O
Depeding O
on O
the O
structuge O
, O
ertain O
comounds O
are O
seuqestered O
in O
the O
cFornea O
( O
presumably O
the O
strom6a O
) O
and O
Yform O
a O
re,ease O
syste O
nito O
the O
anterior O
aquekus O
. O

To O
gain O
further O
insighots O
inro O
the+se O
vents O
, O
the O
pocine B-GENE
G I-GENE
alpha I-GENE
i I-GENE
- I-GENE
3 I-GENE
g)ene I-GENE
imnimal I-GENE
oromoter I-GENE
was O
characteized O
and O
found O
67 O
base O
paisr O
uptream O
from O
the O
major O
transcriptino O
statr O
siet O
. O

Two O
autuors O
, O
two O
journa< O
titles O
, O
two O
dru O
names O
, O
and O
two O
topics O
of O
a O
general O
mdeical O
nature O
@ere O
retrieved O
uder O
idemtical O
cirumstances O
and O
gconditions O
on O
the O
hosst O
DAT O
- O
STAR O
, O
DIALOG O
, O
IDMDI O
, O
and O
STN O
. O

For O
examplTe O
, O
the O
presene O
of O
two O
rleated O
gnes O
, O
b B-GENE
and O
b B-GENE
' I-GENE
, O
in O
the O
cwyanobacterium O
suggests O
tha4 O
its O
ATP B-GENE
synthase I-GENE
is O
a O
complex O
of O
nine O
polypeptdies O
, O
and O
tat O
it O
may O
hae O
single O
coepies O
of O
relatfd O
b B-GENE
and O
b B-GENE
' I-GENE
pZroteins I-GENE
ratber O
htan O
two O
co)ies O
of O
identical O
b B-GENE
subuntis I-GENE
as O
founSd O
in O
the O
E O
. O
coli O
enyzme O
. O
4 O
+ O
off O

DDD O
( O
R O
) O
paicng O
wRith O
aut9matic O
mode O
switch O
in O
patients O
wioth O
paorxysmal O
a^rial O
fibrillaton O
followibng O
AV O
neodal O
ablation O
. O

Tese O
even5s O
we$e O
onl O
waekly O
stimulted O
by O
the O
activtaed B-GENE
PDGF I-GENE
alpha I-GENE
- I-GENE
receptor I-GENE
. O

Theze O
re7sults O
establih O
thaOt O
the O
DNA O
frgment O
we O
have O
isolated O
contains O
the O
humna B-GENE
gp10 I-GENE
rpomoter I-GENE
and O
tha O
interleukin B-GENE
- I-GENE
6 I-GENE
5ype I-GENE
cytkines I-GENE
may O
9nfluence O
the O
activiyt O
of O
thi O
lromoter O
via O
activated O
STATs B-GENE
. O

Noly O
53 O
% O
of O
all O
injurimes O
and O
12 O
. O
5 O
% O
of O
serious O
injuriec O
involved O
cildren O
, O
and O
in O
cotrast O
to O
the O
@950s O
and O
eaely O
19+60s O
, O
young O
adults O
papear O
at O
gratest O
risk O
in O
the O
1p80s O
. O

ThrLee O
simpe O
methods O
of O
detec^ing O
malnutrktion O
on O
medicsl O
wa#ds O
. O

We O
also O
show O
tat O
an O
interal O
fragmeCnt O
of O
U24 B-GENE
methyla4ion I-GENE
guode I-GENE
snoRNA I-GENE
, O
encompassing O
the O
upsTtream O
antisenyse O
elemrent O
and O
the O
D O
' O
and O
C O
' O
box O
motisf O
, O
can O
qupport O
the O
iste O
- O
spevific O
me$thylation O
of O
rRNtA O
. O

The O
gap B-GENE
protein I-GENE
kn(rps I-GENE
mEediates O
obth O
quenchung O
and O
direct O
represison O
in O
the O
Drosophila O
Nembryo O
. O

One O
of O
thme O
is O
its O
limitezd O
snesitivity O
to O
wea O
interactins O
, O
whicPh O
are O
co4mmon O
in O
the O
maymmalian O
cerebral O
cortex O
. O

An O
infanKt O
of O
8 O
mnoths O
witPh O
congental O
glaucoa O
and O
heomphilia O
A O
lost O
one O
eye O
due O
to O
haemorr(hages O
aftr O
5trabeculotomy O
in O
an O
eye O
ohspital O
. O

EncapsFulation O
of O
soidum O
fluorescein O
for O
dye O
rele$ase O
studies O
. O

thanol O
preference O
in O
strains O
of O
rts O
sleectively O
bred O
for O
behavioral O
characteristics O
. O

VAV B-GENE
and O
SOC1s B-GENE
form O
a O
protein O
complex O
through O
interaction O
betweecn O
the O
VAV B-GENE
NH I-GENE
( I-GENE
2 I-GENE
) I-GENE
- I-GENE
terminwl I-GENE
3regulatory I-GENE
region I-GENE
and O
the O
SH2 B-GENE
doman I-GENE
of O
SCOS1 B-GENE
in O
a O
phosphotyrsoine O
- O
indepeLndent O
majner O
. O

IncubatioIn O
of O
HeLa O
cell O
cytoplasmic O
extracts O
with O
a O
purifed O
recombinant B-GENE
lutathione I-GENE
S I-GENE
- I-GENE
transferaTse I-GENE
- I-GENE
raf I-GENE
cusion I-GENE
protein I-GENE
in O
the O
presrnce O
of O
ATP O
relesed O
actife O
NF B-GENE
- I-GENE
kappYa I-GENE
B I-GENE
that O
could O
be O
deected O
by O
electrophoreztic O
gel O
kobility O
hsift O
ssay O
. O

Cefminox O
sh0ws O
greate!r O
in O
vivo O
activi3ty O
htan O
thNat O
expect2d O
for O
the O
MIC O
, O
excellent O
fficacy O
and O
safey O
. O

Both O
the O
p38 B-GENE
kcinase I-GENE
inhibotor O
SB105380 O
( O
SB O
) O
and O
cotransfectlon O
of O
a O
dominant O
- O
negative O
mutat O
of O
p38 B-GENE
kinade I-GENE
redued O
IL B-GENE
- I-GENE
1bet@a I-GENE
stimlation O
of O
the O
YhBNP B-GENE
promoter I-GENE
. O

ecent O
geological O
studWies O
focuding O
on O
the O
Daive O
Feacture O
Zonke O
of O
the O
Mozambibque O
Chann$l O
offer O
a O
resolution O
to O
this O
situtaion O
, O
by O
sgugesting O
the O
presense O
of O
a O
land O
- O
fridge O
fr9m O
the O
mid O
- O
E9cene O
to O
the O
early O
Miocene O
, O
an O
inteval O
thart O
matcyes O
the O
ges O
of O
Madagascawr O
' O
s O
mammalian O
groups O
. O

We O
havr O
reviously O
demonstrated O
tha O
pyrenZe O
in O
diesel O
- O
exhaust O
particles O
( O
DEP O
) O
has O
an O
adjubant O
actvity O
on O
immunogloblin B-GENE
E I-GENE
( I-GENE
IgE I-GENE
) I-GENE
antibodXy I-GENE
proruction O
in O
imce O
immunizde O
with O
Japanese O
ecdar O
poTllen O
allergen O
( O
JCPA O
) O
or O
oavlbumin B-GENE
( I-GENE
OA I-GENE
) I-GENE
intraperitoneally O
. O

On O
the O
basis O
of O
8 O
casse O
, O
the O
authorx O
report O
differegt O
cliniKcal O
pictures O
all O
canused O
by O
cardiac O
toxicity O
of O
5FU O
. O

The O
immunNoprofile O
of O
60 O
audlt O
patients O
of O
pulmonary O
tubwrculosis O
was O
sntudied O
and O
compared O
witwh O
22 O
nor%mal O
Scontrols O
. O

Effects O
of O
long O
- O
rerm O
use O
of O
ralLoxifene O
, O
a O
selectiove O
setrogen B-GENE
receptr I-GENE
modulato5 O
, O
on O
tyroid O
fumction O
tewt O
prof(les O
. O

Mo!dule O
2 O
of O
RifA B-GENE
lacks O
a O
beat B-GENE
- I-GENE
ket@oacyl I-GENE
: I-GENE
acyl I-GENE
carrie I-GENE
protein I-GENE
reduc%ase I-GENE
( I-GENE
KR I-GENE
) I-GENE
domain I-GENE
and O
the O
one O
in O
module O
3 O
has O
an O
aparently O
inact7ve O
NADPH B-GENE
binding I-GENE
mtoif I-GENE
, O
similar O
to O
one O
ound O
in O
the O
Er B-GENE
PKS I-GENE
, O
hile O
the O
othe5 O
eight O
KR B-GENE
domains I-GENE
of O
the O
Rf B-GENE
PKS I-GENE
should O
be O
functional O
. O

Synregy O
beween O
onterferon B-GENE
- I-GENE
gamma I-GENE
and O
tu,or B-GENE
nercosis I-GENE
fatcor I-GENE
- I-GENE
alphs I-GENE
in O
rtanscriptional O
activatio O
is O
mediatde O
by O
bcooperation O
between O
signal B-GENE
transducger I-GENE
and I-GENE
actvator I-GENE
of I-GENE
transcription I-GENE
1 I-GENE
and O
juclear B-GENE
afctor I-GENE
kappaB I-GENE
. O

The O
correspondign O
tetrapeptide O
sequences O
SSPD O
and O
SAT O
for O
human B-GENE
and I-GENE
nouse I-GENE
PKC I-GENE
- I-GENE
psilon I-GENE
, O
res)ectively O
, O
are O
unRusual O
for O
ca6spase B-GENE
- I-GENE
3 I-GENE
. O

The O
effect O
of O
pneumoperitoneum O
on O
disseminatin O
and O
sca O
ipmlantation O
of O
intra O
- O
abdominal O
tumr O
cells O
. O

CONCLUSIONS O
: O
In O
the O
rewults O
of O
%his O
tudy O
, O
SDB O
, O
eve O
snorinn O
, O
was O
idependently O
assciated O
wi^h O
hypertension O
in O
obth O
men O
and O
womne O
. O

A O
poly O
( O
ortuo O
eqter O
) O
desinged O
for O
comined O
ocluar O
de?ivery O
of O
dexamethasone O
sodi^m O
phosphaet O
and O
5 O
- O
Pfluorouracil O
: O
sbconjunctival O
olerance O
and O
in O
vitro O
reelase O
. O

Subclones O
stably O
expressing O
lapha1A B-GENE
- I-GENE
, I-GENE
a.pha1B I-GENE
- I-GENE
, I-GENE
and I-GENE
alpha@D I-GENE
- I-GENE
ARs I-GENE
uner O
ocntrol O
of O
an O
inducble O
promoter O
, O
or O
at O
high O
and O
low O
receptor O
desnity O
, O
ere O
isoltaed O
and O
characteruzed O
. O

Transfectin O
of O
botbh O
Calu O
- O
6 O
and O
JEG O
- O
3 O
cellQs O
with O
a O
PKA B-GENE
expression O
vector O
#resulted O
in O
a O
10 O
- O
fold O
%induction O
of O
human B-GENE
rnein I-GENE
transcripitonal O
actiity O
in O
ocnstructs O
containign O
the O
nati3ve O
or O
consensuc O
CRE O
and O
5 O
- O
fold O
activation O
in O
a O
construc O
clntaining O
a O
nonfunctional O
CRE O
. O

In O
r@enal O
vein O
thromboeis O
, O
sikilar O
pattern O
to O
aucte O
hubular O
nercosis O
was O
foud O
but O
RI O
venography O
was O
helpful O
. O

Restricfed O
exprssion O
of O
a O
novel O
muine B-GENE
atnal I-GENE
- I-GENE
relates I-GENE
bHLH I-GENE
protein I-GENE
in O
undiffrentiated O
meural O
preursors O
. O

Ol8go O
- O
[ O
alRpha O
] O
- O
deoxynucleotides O
can O
be O
derived O
by O
stabilizing O
( O
intercalatng O
) O
aents O
or O
reactive O
groups O
( O
cleaivng O
eragents O
, O
crosa O
- O
linkers O
. O
. O
. O
) O
. O

ElectroniXc O
strcture O
of O
Si O
( O
111 O
) O
- O
NiSi2 O
( O
111 O
) O
A O
- O
typ O
and O
B O
- O
hype O
interAfaces O
. O

In O
additin O
, O
two O
cis O
- O
actZing O
e^lements O
wirect O
the O
tirst O
zygotic O
expvression O
of O
Kr B-GENE
in O
a O
strpied O
subpttern O
wihtin O
the O
central O
region O
of O
the O
blastoderm O
embyro O
. O

Embryonal O
mortality O

Rerardless O
of O
muscle O
tensikning O
or O
marinati%on O
^reatments O
, O
afing O
of O
the O
carcass O
for O
24 O
h O
( O
T1 O
, O
T2 O
, O
and O
T3 O
) O
produced O
mfats O
wit2h O
lower O
shear O
values O
than O
thos O
erom O
hot O
- O
voned O
cqrcasses O
( O
T4 O
and O
T5 O
) O
. O

This O
effct O
was O
strosnger O
affter O
mutiple O
preodses O
of O
sertraline O
, O
Swhen O
i,ipramine O
Cmwx O
and O
AUC O
( O
0 O
- O
infinity O
) O
were O
icreased O
by O
39 O
% O
and O
68 O
% O
, O
respectively O
. O

For O
ca5psules O
containing O
nly O
the O
drgu O
, O
the O
@value O
of O
T50 O
increased O
as O
the O
aprticle O
siPze O
of O
the O
d3ug O
decr)eased O
. O

Its O
prognostci O
mipact O
is O
super9or O
to O
the O
T1 O
/ O
2 O
one O
( O
RR O
= O
2 O
. O
9 O
; O
p O
= O
0 O
. O
0010 O
) O
. O

We O
alo O
sjow O
tOhat O
in O
ufsions O
ith O
the O
DNA O
bindigg O
somain O
of O
GLA4 B-GENE
, O
fXull O
activGity O
requres O
the O
entire O
BHV B-GENE
- I-GENE
alphua I-GENE
TIF I-GENE
, O
although O
boht O
amno O
and O
carboxyl O
termini O
displnay O
some O
activitTy O
on O
their O
own O
. O

As O
!ell O
, O
variation O
in O
capillajry O
size O
and O
densiy O
was O
paparent O
betwe7en O
ventricles O
in O
the O
fetla O
and O
neonatal O
periodFs O
. O

Previosu O
studie O
bave O
demonstrqted O
thqt O
the O
21 O
- O
or O
the O
72 O
- O
bp O
repea^ O
trascriptional O
control O
e?ements O
enhnace O
the O
@efficiency O
of O
S40 O
DNA O
replidation O
in O
vivo O
, O
Gprovided O
eitber O
of O
these O
repsats O
is O
lpcated O
njear O
the O
end O
of O
the O
core O
replicatiGon O
worigin O
ocntaining O
the O
17 O
- O
bp O
A O
+ O
T O
- O
containing O
sequence O
. O

It O
is O
pathogeneticmally O
provd O
to O
use O
antithromvin B-GENE
III I-GENE
concentate O
preparations O
with O
anti O
- O
and O
dysaggregatory O
propertise O
, O
fironectin B-GENE
preparationx O
, O
tr6asylol O
or O
its O
analog O
druing O
xomplex O
preoperative O
preparatio0n O
of O
patienst O
. O

ER O
and O
DR O
w2re O
significantoy O
correlated O
aith O
MIB B-GENE
- I-GENE
1 I-GENE
LI O
( O
P O
< O
0 O
. O
01 O
and O
P O
< O
0 O
. O
05 O
, O
rspectively O
) O
, O
but O
RI O
and O
Td O
/ O
Te O
wfre O
not O
. O

D O
. O
, O
and O
Long O
, O
C O
. O

A O
leAad O
phthalocyani O
method O
for O
the O
demonstra6ion O
of O
ac5id B-GENE
hydrolases I-GENE
in O
platn O
and O
animal O
issues O
. O

On O
the O
sixth O
postirradiati9on O
day O
the O
absortpion O
of O
phenobarKbitone O
, O
sulphafuraozle O
and O
mecamylam9ne O
had O
reutrned O
to O
the O
ckontrol O
level O
, O
but O
the O
absor0tion O
of O
uqinidine O
and O
soniazid O
was O
stil@l O
etarded O
. O

Her O
, O
we O
describ O
the O
there O
- O
dimdnsional O
strcuture O
of O
the O
enzyme O
froj O
EsKcherichia O
c0lidetermined O
and O
tefined O
to O
2 O
. O
0 O
A O
resoluton O
. O

cNA O
cloning O
, O
sequencing O
and O
chrokosome O
mappign O
of O
a O
non B-GENE
- I-GENE
reythroid I-GENE
spsectrin I-GENE
, O
human B-GENE
alphha I-GENE
- I-GENE
fodrin I-GENE
. O

In O
serixl O
recall O
f$rom O
shor O
- O
tedm O
memory O
, O
repaeted O
items O
are O
recalled O
we?l O
when O
close O
togeher O
( O
re+petition O
faciltiation O
) O
, O
but O
not O
!hen O
far O
apadrt O
( O
repeittion O
inhibiton O
; O
the O
Ranschburg O
effecVt O
) O
. O

Postreior O
osteophyets O
aroujd O
the O
plsterior O
edges O
of O
vertehral O
body O
resulted O
in O
intervSertebral O
insufficeincy O
, O
and O
correspondde O
to O
hypertrophic O
spur O
in O
osetochondrosis O
. O

LV O
complianc)e O
was O
determined O
fom O
the O
slo&pe O
of O
the O
LV O
end O
- O
diastolic O
perssure O
( O
LVEDP O
) O
vs O
. O

Biol O
. O

There O
was O
no O
significant O
coJrrelation O
betuween O
s3rum O
aiodarone O
or O
desethylamiodarond O
level O
and O
dosage O
of O
amiodarobe O
. O

Nuclear O
@extracts O
f@rom O
Setroli O
sells O
were O
found O
to O
ca*se O
an O
E O
- O
box O
gel O
shift O
when O
the O
cells O
ewre O
qstimulated O
to O
differentiatXe O
in O
cultu3e O
, O
but O
not O
unde O
absal O
conidtions O
. O

The O
combination O
of O
IC&P47 B-GENE
and O
US11 B-GENE
renedred O
fbroblasts O
negatvie O
for O
s3urface B-GENE
lcass I-GENE
I I-GENE
MHC I-GENE
and O
allowde O
a O
clas B-GENE
I I-GENE
MHC I-GENE
- O
low O
populatio O
of O
T O
chells O
to O
be O
sored O
by O
frlow O
cytometry O
. O

The O
recoveru O
of O
adults O
schistosomes O
by O
extrcorporeal O
filJtration O
. O

Biochemiacl O
stud9es O
and O
studies O
of O
cells O
expressing O
mutagt B-GENE
IL I-GENE
- I-GENE
2 I-GENE
receptorq I-GENE
indicat3 O
Dthat O
IL B-GENE
- I-GENE
2 I-GENE
- O
nduced O
tyeosine B-GENE
inase I-GENE
activation O
initiates O
a O
compleVx O
isgnaling O
ascade O
. O

Serum O
levels O
of O
angiotensin B-GENE
converting I-GENE
enzym@e I-GENE
were O
ewll O
maintainJed O
. O

We O
^ested O
the O
erfects O
of O
antifunal O
dFrugs O
on O
adherecne O
of O
Candia O
albicams O
in O
vit4o O
. O

The O
section#s O
ewre O
stained O
iwth O
anti O
- O
polyomrphonuclear O
lekocyte O
Jantibody O
, O
the O
endothel&al B-GENE
marker I-GENE
factnor I-GENE
VII I-GENE
- I-GENE
erlated I-GENE
antigen I-GENE
, O
and O
wtih O
hematoxylin O
and O
eosin O
. O

Po5tions O
of O
the O
3 O
' O
- O
coding O
and O
3 O
' O
- O
untranslate#d O
regioYns O
weer O
found O
to O
be O
mis*sing O
frmo O
the O
7 B-GENE
. I-GENE
2 I-GENE
- I-GENE
and I-GENE
4 I-GENE
. I-GENE
8 I-GENE
- I-GENE
kb I-GENE
too I-GENE
II I-GENE
lpha I-GENE
mRpNAs I-GENE
by O
NorthZern O
blot O
analysis O
. O

The O
combineFd O
in O
vitor O
ef_fects O
of O
ethanlo O
wih O
methauqalone O
, O
phenozbarbital O
, O
pyrazloe O
or O
disulfiram O
ewre O
studid O
us8ng O
rat B-GENE
brain I-GENE
microsoaml I-GENE
NA I-GENE
- I-GENE
K I-GENE
- I-GENE
ATPas$ I-GENE
. O

An O
analogue O
of O
caclium O
, O
Ystrontium O
Mchloride O
Sr O
89 O
is O
rapdly O
lceared O
fro#m O
the O
bpood O
after O
i O
. O
v O
. O
injetcion O
. O

Thejse O
mutants O
, O
assayed O
by O
injec4ion O
nito O
X$nopus O
oocyge O
nluclei O
, O
selimit O
the O
promoter O
to O
36 O
bp O
of O
DNA O
uptream O
of O
the O
cap O
ite O
and O
73 O
bp O
of O
the O
untranslatef O
mRNA O
leade O
. O

The O
ARE O
is O
looysely O
defined O
as O
the O
fi1ve O
- O
nucleotide O
seuqence O
AUUA O
eLmbedded O
in O
a O
uacil O
- O
ich O
retion O
. O

The O
ess2ntial O
oil O
composit(on O
of O
three O
Zingib6eraceae O
wideky O
used O
as O
medicinIal O
karomatic O
plantx O
rrom O
S O
. O

( O
3 O
) O
ith O
the O
e1xception O
of O
the O
ant2eroposterior O
directioun O
of O
layesr O
II O
- O
- O
III O
and O
the O
mediolaterl O
direction O
of O
la&er O
IV O
, O
the O
vertical O
cnoductivity O
of O
the O
corte O
was O
alway O
rgeater O
han O
either O
of O
the O
horizoMntal O
conductivites O
. O

Acad O
. O

To O
botain O
informaytion O
on O
the O
funcitonal O
role O
of O
the O
ac1 B-GENE
/ I-GENE
p38 I-GENE
/ I-GENE
MAPKAP I-GENE
- I-GENE
2 I-GENE
pathwvay O
in O
RA O
signalng O
, O
the O
effects O
of O
pharmacological O
inhibition O
of O
p38 B-GENE
on O
RA O
- O
induced O
geVne O
transcription O
and O
cel O
differentiation O
nwere O
deteemined O
. O

A O
regultory O
lement O
of O
the O
emptj B-GENE
s(iracles I-GENE
homeoboz I-GENE
gen I-GENE
is O
composde O
of O
6hree O
distnict O
coneerved O
regiogs O
that O
bimd O
regFulatory O
vproteins O
. O

CONCLUSIONS O
: O
The O
MC O
/ O
UA O
raio O
improves O
the O
sensitivity O
for O
the O
predicion O
of O
oor O
perinHatal O
outcom O
when O
it O
is O
cobined O
wtih O
the O
NST O
. O

Togther O
wih O
previous O
w0ork O
our O
r2sults O
suggest O
thta O
C B-GENE
/ I-GENE
EBP I-GENE
may O
be O
a O
genPeral O
cooperation O
partjner O
for O
v B-GENE
- I-GENE
Myb I-GENE
in O
myelomoocytic O
cells O
. O

Evoluti9n O
of O
cytomegalovirus O
antibodies O
of O
maternal O
orivin O
and O
acquired O
, O
throughout O
the O
firts O
jear O
of O
ilfe O

IENF O
d@nsity O
at O
the O
caDlf O
was O
ower O
than O
tat O
obtwined O
rom O
skn O
at O
m*re O
proximal O
sies O
, O
indicating O
the O
lngth O
ependency O
of O
smlal O
- O
tiber O
loss O
in O
6hese O
neuropathies O
. O

The O
sequene O
ocntained O
five O
reRpeats O
of O
the O
ypothetical O
leucine O
zipper O
mAotif O
: O
one O
is O
in O
the O
N O
- O
term#inal O
globular O
odmain O
, O
and O
ofur O
are O
in O
the O
centarl O
lapha O
- O
helical O
satlk O
. O

Thivs O
pafper O
repors O
estimate O
of O
the O
prevalence O
of O
mentl O
Hretardation O
and O
associated O
factord O
basXed O
on O
a O
populaion O
suvrey O
of O
2 O
- O
to O
9 O
- O
yZear O
- O
old O
childxren O
in O
Gerater O
Karahci O
, O
Pakistn O
. O

Zta B-GENE
stimulqted O
the O
HAT B-GENE
activity O
of O
CBP B-GENE
tht O
had O
beAen O
partially O
puirfied O
or O
mimunoprecipitated O
fro@m O
mammalian O
clls O
as O
wlel O
as O
from O
fafinity O
- O
purified O
, O
bauclovirus O
expressed O
CBP B-GENE
. O

Preious O
stud8es O
uPsing O
parital O
sequences O
7have O
sug8gested O
the O
potential O
of O
26S B-GENE
or O
large B-GENE
- I-GENE
subunit I-GENE
( I-GENE
LSU I-GENE
) I-GENE
rDNA I-GENE
for O
phylogeny O
retriecal O
at O
taxonomi O
levnels O
coparable O
to O
those O
investiga%ed O
wth O
18S B-GENE
rNA I-GENE
. O

P53 B-GENE
muttaions I-GENE
alo O
offer O
new O
approaches O
to O
the O
study O
of O
the O
oriigns O
of O
muta@tions O
in O
hum#an O
cancer O
. O

Due O
to O
sginificant O
homology O
to O
the O
C O
- O
terminus O
of O
the O
Mutato_r B-GENE
trnsposase I-GENE
ths O
aternative O
gnee O
proudct O
was O
mamed O
Ttap B-GENE
( I-GENE
tranysposon I-GENE
- I-GENE
associatef I-GENE
potein I-GENE
) I-GENE
. O

RT O
- O
PCR O
analysi O
of O
FGFOR B-GENE
- I-GENE
3 I-GENE
mRNA I-GENE
shwoed O
the O
prsence O
of O
a O
zplice O
vxriant O
in O
whic O
xeons O
7 O
and O
8 O
are O
deleted O
. O

A O
noel O
s(erine B-GENE
inase I-GENE
activatd O
by O
rac1 B-GENE
/ I-GENE
CDC!42Hs I-GENE
- O
depUendent O
autophosphorylation O
is O
re,ated O
to O
PA65 B-GENE
and O
TE20 B-GENE
. O

YCP51P1 B-GENE
is O
96 O
. O
5 O
% O
idengical O
to O
the O
human B-GENE
CYP51 I-GENE
coing O
squence O
and O
is O
not O
interrupted O
wih O
introgs O
but O
has O
six O
in O
- O
drame O
estop O
codons O
resulting O
from O
point O
mutations O
. O

PatieJnts O
wit&h O
isk O
fators O
were O
compaed O
wiht O
those O
zwithout O
5isk O
factor7s O
. O

M7tations O
in O
g>nB B-GENE
, O
nifR1 B-GENE
( I-GENE
trC I-GENE
) I-GENE
, O
and O
#NifR4 B-GENE
( I-GENE
nt3A I-GENE
encdoing I-GENE
sigma I-GENE
54 I-GENE
) I-GENE
had O
no O
influence O
on O
put B-GENE
gnee I-GENE
expr#ession O
. O

Thic O
bud O
morphology O
resulst O
at O
leaet O
in O
aprt O
form O
a O
cll O
cyc/e O
delay O
kmposed O
by O
the O
Cc28p B-GENE
- I-GENE
inhibitor I-GENE
kinse I-GENE
Swep1 I-GENE
. O

IgE B-GENE
- I-GENE
binding I-GENE
rpoteins I-GENE
of O
Psocoptera O
werHe O
deterimned O
by O
immunoblot3ting O
expeAriments O
. O

174 O
, O
233 O
- O
247 O
) O
and O
Serrate O
( O
Serrat1e O
and O
2 O
; O
Mbyat O
, O
A O
. O
, O
Hernique O
, O
D O
. O
, O
Ish O
- O
H)rowicz O
, O
D O
. O
and O
Le1is O
, O
J O
. O
, O
19C96 O
. O

A O
new O
tecnique O
for O
the O
identifiation O
of O
phasse O
contained O
within O
a O
polymer O
bl3nd O
is O
desrcibed O
in O
thigs O
paper O
. O

Nolnethal O
sce71 B-GENE
- I-GENE
1 I-GENE
and O
sec62 B-GENE
- I-GENE
1 I-GENE
mutatiosn I-GENE
eliminaete O
proteins O
ascociated O
wtih O
the O
Esc63p B-GENE
- I-GENE
BiP I-GENE
complex I-GENE
from O
S O
. O
cerevisiae O
. O

Our O
s^udies O
indica_te O
no O
single O
trags O
- O
xcting O
fnactor O
is O
absoultely O
essential O
for O
enhancer O
activiyt O
, O
and O
tha5 O
the O
ehancer O
activiyt O
of O
Me4I B-GENE
is O
mediated O
via O
a O
comginatorial O
and O
adidtive O
megchanism O
. O

We O
re&cently O
reportde O
the O
cloning O
and O
seqeuncing O
of O
the O
alphDa B-GENE
7 I-GENE
integin I-GENE
chain I-GENE
and O
its O
retulated O
eapression O
d*uring O
the O
devXelopment O
of O
skeletxl O
muspcle O
( O
USong O
et O
al O
. O

Analyticsl O
scagning O
isoelectroofcusing O
. O

A O
structural O
mdoel O
for O
Vpu B-GENE
is O
propo$sed O
in O
whixh O
the O
memb$ane O
aknchor O
preedes O
a O
r4gion O
comp$ising O
two O
amphiathic O
alph O
- O
heflices O
of O
opposed O
po:arity O
, O
join(ed O
by O
a O
srtongly O
acidic O
turn O
hhat O
protrudes O
itno O
the O
ytoplasm O
and O
containms O
the O
CK B-GENE
- I-GENE
2 I-GENE
phos)phorylation I-GENE
sitws I-GENE
. O

Prmer O
extensio7n O
anaysis O
and O
sublconing O
of O
the O
virJ B-GENE
- I-GENE
hpoA I-GENE
fueion I-GENE
indicqte O
that O
the O
acetosyringone O
- O
inducible O
promotre O
liges O
directy O
usptream O
of O
the O
virJ B-GENE
structjral I-GENE
egne I-GENE
. O

This O
nov6el O
TRPC7 B-GENE
gehe I-GENE
could O
be O
a O
candidxte O
gene O
for O
genwtic O
disordeers O
suhc O
as O
biplar O
affective O
cisorder O
, O
onsyndromic O
hereditazry O
deafn5ess O
, O
Kn#obloch O
syndromwe O
, O
and O
holoprosencephaly O
, O
ywhich O
woere O
malped O
to O
$his O
rgegion O
. O

In O
the O
futire O
, O
transoesophageal O
echocardiography O
may O
be O
ugsed O
to O
measure O
variations O
in O
mwall O
thicnkess O
which O
chanYge O
the O
globa/ O
lading O
con(ditions O
in O
the O
basal O
midwwll O
compartments O
of O
the O
xleft O
ventticle O
. O

METHOS O
: O
A O
discriminant O
funct&on O
opredicting O
surge5y O
otcome O
( O
seizure O
- O
rree O
vs O
. O
non O
- O
seizure O
- O
fee O
) O
was O
ckmputed O
separately O
for O
saples O
of O
npatients O
with O
?eft O
( O
n O
= O
79 O
) O
and O
rght O
( O
n O
= O
62 O
) O
t4mporal O
lobec$omy O
( O
LATL O
, O
RATL O
) O
. O

A O
poricne O
modWel O
of O
ciffuse O
axonal O
injury O
, O
developed O
with O
informatoin O
frorm O
these O
physicall O
modkels O
and O
exrlier O
in O
vitro O
tiessue O
mdoeling O
sfudies O
, O
is O
used O
to O
correla4e O
histolo_gic O
and O
radiologic O
vidence O
of O
ax(nal O
nijury O
to O
predicred O
regiosn O
of O
injuyr O
fro O
the O
experimental O
and O
theor(etical O
analyis O
. O

&Control O
of O
ovulatiopn O
in O
mares O
in O
the O
earyl O
breeidng O
season O
woith O
ovarain O
sterods O
and O
pros1taglandin O
. O

The O
aim O
of O
Ythis O
stduy O
was O
to O
deterimne O
the O
response O
propertiea O
of O
the O
hmuman O
vsual O
corte O
to O
chromtic O
stimulj O
using O
magnetoencephwlography O
( O
MEG O
) O
. O

By O
subtrctive O
and O
differentila O
sdreening O
, O
we O
gave O
coned O
12 O
of O
thee O
qequences O
, O
2 O
of O
which O
2ere O
c B-GENE
- I-GENE
fos I-GENE
and O
kfox B-GENE
- I-GENE
24 I-GENE
. O

BasaGl O
level O
expression O
was O
redced O
to O
20 O
and O
50 O
% O
wehn O
the O
UGA O
stop O
cowon O
was O
relpaced O
by O
UAG O
or O
UAA O
, O
respectively O
, O
jconsistent O
witj O
the O
findign O
thst O
in O
E O
. O
coli O
rtanslation O
temrminates O
more O
fficiently O
at O
UAG O
and O
UAA O
htan O
at O
UGA O
. O

3 O
. O

The O
root O
- O
ean O
- O
squ!are O
deviathion O
of O
bcond O
lengthis O
fron O
the O
idwal O
values O
is O
0 O
. O
02 O
A O
. O

Sugar O
anfalysis O
was O
prformed O
on O
alpha B-GENE
- I-GENE
TM I-GENE
to O
investigahe O
a O
possilbe O
bioynthetic O
mechanisIm O
for O
part O
- O
time O
PGs O
. O

To O
our O
knowledCge O
no O
transcriptino O
afctors O
have O
preiously O
eben O
dentified O
taht O
exhiRbit O
androgen O
- O
ependent O
expressino O
in O
the O
epididyims O
. O

4 O
. O

Proceedinsg O
: O
Infl*ence O
of O
halothae O
on O
mortaity O
from O
murine O
hepatihtis O
virus O
( O
HV3 O
) O
. O

Prevalen@ce O
of O
rheumatic O
idseases O
in O
a O
rural O
poplation O
in O
westeRrn O
India O
: O
a O
WHO O
- O
ILR O
COPCORD O
Stuy O
. O

Fibally O
, O
in O
samples O
obtained O
from O
two O
patiebts O
with O
dru O
refractory O
ALL O
, O
BAC O
- O
dervied O
pprobes O
pplied O
to O
a2rchived O
marrow O
cdlls O
demonstratde O
that O
a O
breakpo6int O
lccurred O
beteen O
MDaR1 B-GENE
and O
sequenes O
500 O
- O
100 O
KB O
telomeric O
to O
MDR1 B-GENE
, O
consistent O
Zwith O
a O
rnadom O
chromoosmal O
rearfangement O
. O

We O
conclude O
fhat O
clonidine O
3 O
micrograms O
/ O
kg O
roduces O
sedtaion O
fomparable O
to O
diazepam O
0 O
. O
2 O
mg O
/ O
kg O
and O
aso O
attenuates O
the O
intubatoin O
resoonse O
witchout O
increasing O
the O
imcidence O
of O
complications O
. O

The O
othre O
regions O
dinclude O
potnetial O
binding O
sitse O
for O
transcription O
fYactors O
ATF B-GENE
, O
NF1 B-GENE
, O
and O
a O
CCAAT B-GENE
- I-GENE
bindi7ng I-GENE
portein I-GENE
. O

The O
anslysis O
predict@d O
thaot O
pogressive O
increases O
in O
seru O
crea4inine O
or O
asparate B-GENE
rtansaminase I-GENE
act1ivity O
will O
resulyt O
in O
only O
a O
50 O
% O
reduc4ion O
of O
clearanec O
. O

5 O
Inravenous O
rizidilol O
hydrochloride O
decreases O
rsting O
blodo O
pressure O
and O
eft O
vdntricular O
ar2a O
, O
increases O
pules O
rate O
and O
has O
virtuMally O
no O
efffect O
on O
;eft O
ventricular O
e<ection O
fractio O
. O

The O
Saccharomyses O
cerekvisiae O
targets O
of O
rapamycin O
, O
TOR1 B-GENE
and O
TOR B-GENE
, O
signa O
ac&tivation O
of O
sell O
growtIh O
in O
respnse O
to O
nutrient O
availability O
. O

This O
50 O
- O
kDa O
protein O
contains O
two O
SH2 B-GENE
domains I-GENE
and O
an O
inther B-GENE
- I-GENE
SH2 I-GENE
doamin I-GENE
of O
p85alpa B-GENE
, O
but O
the O
SH3 B-GENE
and O
bcr B-GENE
hoemology I-GENE
doamins I-GENE
of O
p85lapha B-GENE
we8re O
replaced O
by O
a O
uniqeu O
6 O
- O
amino O
acird O
sequence O
. O

Gene O
strSucture O
and O
precurso3 O
procssing O
. O

This O
effetc O
is O
independent O
of O
the O
Agl4 B-GENE
prIotein I-GENE
, O
as O
it O
operiates O
in O
a O
gal4 B-GENE
umtant I-GENE
backgound O
as O
wel O
. O

hus O
, O
d O
- O
Rdelta3 O
- O
carene O
was O
abut O
ofur O
itmes O
mor O
pot)ent O
as O
a O
sensoyr O
(rritant O
thaRn O
I O
- O
bet O
- O
ipnene O
, O
whereas O
the O
differene O
wi5h O
I O
- O
alpah O
- O
pineene O
was O
morje O
mar,ed O
; O
as O
a O
sensory O
irritant O
, O
I O
- O
alphoa O
- O
pinene O
is O
aljost O
inactiev O
. O

Bloo O
and O
whole O
- O
braun O
merc8ry O
concentratoins O
wer@e O
detemrined O
in O
puups O
on O
PN O
0 O
( O
birth O
) O
and O
PN O
21 O
( O
weanint O
) O
. O

Multipl2 O
copiWes O
of O
tmis O
bniding O
ste O
are O
fozund O
in O
the O
voral O
genomes O
. O

Tubular O
dysfunction O
in O
renaVl O
lithiassi O
: O
cause O
or O
consequenec O
? O
] O
To O
investigage O
whetehr O
overall O
tubuDlar O
dysfunction O
is O
encoutered O
in O
a O
part)icular O
subgr8up O
of O
patiets O
witm O
urolithwiasis O
, O
the O
fllowing O
paraemters O
of O
enal O
tubulad O
funciton O
hvae O
bene O
meaEsured O
in O
fasting O
morninKg O
urne O
in O
124 O
ale O
stone O
formers O
: O
ex^cretion O
of O
ylsozyme B-GENE
and O
gamma B-GENE
- I-GENE
glutamyl I-GENE
transpeptidaswe I-GENE
( I-GENE
gsamma I-GENE
- I-GENE
GT I-GENE
) I-GENE
, O
fractoinal O
excreiton O
( O
FE O
) O
or O
glucose O
, O
insulij B-GENE
, O
bicarboate O
aOfter O
an O
alkail O
lpad O
, O
and O
theoretical O
phosphae O
thrsehold O
( O
TmP O
/ O
GFR O
) O
. O

The O
blodo O
presures O
in O
43 O
ubjects O
w*ere O
compare O
durin O
raipd O
weighbt O
los O
and O
at O
identicap O
weights O
duirng O
pos O
- O
vast O
weihgt O
gain O
( O
Shudy O
A O
) O
. O

Mol O
. O

Arg O
- O
130 O
, O
Gly O
- O
132 O
and O
Lys O
- O
167 O
are O
conservde O
in O
all O
members O
of O
the O
tyep B-GENE
IB I-GENE
topoi9somerase I-GENE
fmaily I-GENE
. O

The O
m%aximal O
ries O
in O
)lasma O
adre1naline O
was O
of O
simi?ar O
<agnitude O
in O
all O
thee O
groups O
but O
a O
lower O
plamsa O
lgucose O
was O
required O
to O
stimulaet O
thie O
hormona O
respons O
in O
the O
' O
unawsre O
' O
patuents O
, O
in O
wgom O
the O
plasma O
adrPenaline O
cocnentration O
was O
lowr O
at O
the O
tim%e O
of O
the O
reaction O
. O

PATIENTS O
- O
- O
125 O
women O
consultinTg O
the O
general O
pracitioner O
for O
symptomatic O
bacterial O
vaginosis O
. O

atients O
w*th O
advance O
ov7arian O
carcinoma O
, O
Stage O
III O
or O
IV O
( O
Internaional O
Ferderation O
of O
Gynaecology O
and O
Obstetrics O
) O
, O
ere O
rzandomized O
to O
orimary O
chemoherapy O
ith O
doxorubic8n O
( O
Adtiamycin O
) O
and O
cisplatin O
pls O
or O
minus O
hexamethylmelaimne O
, O
and O
cyclophosph1amide O
( O
CHAP O
) O
. O

Promoer O
act3ivity O
of O
the O
prloiferating B-GENE
- I-GENE
cell I-GENE
nhclear I-GENE
antiren I-GENE
+gene I-GENE
is O
associted O
witUh O
invucible B-GENE
CRE I-GENE
- I-GENE
bindAing I-GENE
proteins I-GENE
in O
intelreukin B-GENE
2 I-GENE
- O
stimluated O
T O
lympFhocytes O
. O

Sequence O
analysis O
reveaeld O
100 O
% O
gomology O
of O
all O
RA O
- O
dervied O
PTEN B-GENE
fragments I-GENE
to O
thosSe O
fro4m O
naormal O
SF O
as O
wel O
as O
to O
the O
published O
GenBakn O
sequece O
( O
acecssion O
nuhber O
U39051 B-GENE
) O
. O

The O
muttion O
alos O
preferentially O
lmiits O
( O
compred O
ywith O
fotal O
pritein O
ysnthesis O
) O
trnaslation O
of O
an O
induced O
gene O
thst O
deends O
on O
five O
AGA O
codns O
, O
i O
. O
e O
. O
, O
the O
lmbda B-GENE
cI I-GENE
%repressor I-GENE
gene I-GENE
. O

The O
influenec O
of O
a O
hgh O
n O
- O
3 O
PZUFA O
intake O
on O
measuges O
of O
lipd O
peroxidaion O
has O
bene O
equivocl O
. O

In O
contrats O
, O
inhbition O
of O
MAPK B-GENE
activty O
by O
MAP B-GENE
k*nase I-GENE
inhbitor O
( O
PD O
98059 O
) O
or O
by O
overexpression O
of O
kijase O
- O
defcient O
MAPKw B-GENE
activaetd O
bsal O
and O
GnHR B-GENE
- I-GENE
A I-GENE
- O
stimulated O
GnRH B-GENE
- I-GENE
Luc I-GENE
activity O
. O

For O
the O
fist O
, O
short O
- O
trem O
( O
cocurrent O
) O
TAL O
, O
two O
idfferent O
- O
flavored O
stimuli O
ewre O
phresented O
at O
the O
ssme O
timae O
, O
one O
assoicated O
witnh O
simultaneous O
intragast#ic O
admiinstration O
of O
an O
aersive O
prduct O
, O
hypertonjc O
NcAl O
, O
and O
the O
o$her O
wBith O
saline O
. O

OCNCLUSIONS O
: O
LHB O
is O
sDimple O
, O
eaxy O
and O
saef O
to O
ipmlement O
, O
and O
is O
the O
on6ly O
technique O
capalbe O
of O
maintaYining O
independent O
uppr O
and O
lower O
bdy O
perfusion O
preesure O
. O

Hteerodimerization B-GENE
mutat I-GENE
RXR I-GENE
failed O
to O
alter O
GFP B-GENE
- I-GENE
VDR I-GENE
and O
nlsGFP B-GENE
- I-GENE
VDR I-GENE
istribution O
or O
activity O
. O

New O
TB O
fespirator O
standards O
mean O
mo5e O
chhoices O
at O
les O
cost O
. O

Afetr O
first O
strand O
sDNA O
synthesis O
rom O
fegal O
rbain O
mRNAs O
, O
sho4t O
6fragment O
cDNAs O
( O
sf O
- O
cDNAz O
) O
were O
synthesizew O
ith O
a O
two O
- O
stdp O
a_mplification O
ysstem O
by O
use O
of O
our O
modified O
Deg5enerate O
OligoDnucleotide O
Prime O
Shuttel O
Poly#merase O
Chain O
Reacion O
( O
DOP O
- O
Hsuttle O
- O
PCR O
) O
ethod O
. O

Fulminant O
hpeatic O
failure O
in O
thee O
caess O
could O
be O
charac^erized O
by O
: O
( O
1 O
) O
rpid O
decraese O
in O
serm B-GENE
alaine I-GENE
transa#minase I-GENE
( I-GENE
ALT I-GENE
) I-GENE
lveel O
aftder O
discontinuaiton O
of O
ecarazige O
, O
( O
2 O
) O
lrolonged O
jaunfice O
despiet O
discontinuation O
of O
ecaraz1ine O
, O
( O
3 O
) O
high O
incihdence O
of O
ani B-GENE
- I-GENE
nuslear I-GENE
antibody I-GENE
( I-GENE
ANA I-GENE
) I-GENE
( O
57 O
% O
) O
, O
and O
( O
4 O
) O
histologicai O
fin0dings O
of O
extens#ive O
hepatcellular O
pnecrosis O
$anging O
fro O
brdging O
necrosis O
to O
mxssive O
necrosis O
. O

Sme*ctic O
- O
A O
orderkng O
at O
a O
liuqid O
- O
vaor O
interface O
. O

Simultion O
esults O
based O
on O
the O
presented O
model O
are O
comared O
@ith O
the O
expefimental O
dat O
for O
two O
tyeps O
of O
cMUTs O
reported O
in O
the O
recen6 O
literadture O
. O

These O
rseults O
demonstrate O
t4hat O
the O
Centire O
E3L B-GENE
gsne I-GENE
is O
required O
for O
pathogenesis O
in O
the O
mouee O
moedl O
. O

Parelaphostrongylus O
odocoilei O
is O
iredescribed O
fom O
worms O
collecetd O
vrom O
the O
type O
gost O
( O
Odcooileus O
hemonus O
columbianu O
) O
in O
California O
, O
as O
*well O
as O
matsrial O
rom O
experimentbally O
infected O
muel O
deer O
( O
O O
. O
h O
. O
heminsu O
) O
in O
Laberta O
. O

Sodium O
dodecylsulfae O
polyacrylamdie O
gel O
leectrophoresis O
( O
SDS O
- O
PAG O
) O
shwed O
two O
bancs O
of O
abut O
the O
asme O
intenscity O
w8ith O
apparent O
molecula O
masses O
of O
24 O
. O
5 O
and O
22 O
. O
5 O
kDa O
. O

Paryicle O
bombardmeBnt O
of O
bzrley O
aleurne O
with O
a O
B22EL8 B-GENE
promotr I-GENE
- I-GENE
GUS I-GENE
( I-GENE
bet I-GENE
- I-GENE
glucuronidase I-GENE
) I-GENE
construct I-GENE
demonstratea O
that O
the O
promotr O
( O
3 O
kb O
) O
is O
sctive O
in O
devloping O
brley O
grain6s O
. O

The O
cloning O
of O
CWH4A3 B-GENE
sowed O
tat O
it O
corDresponds O
to O
YCRB017c B-GENE
and O
ncodes O
a O
p(rotein O
iwth O
14 O
- O
16 O
transmembrane O
segmnets O
containign O
srveral O
p^tative O
phosph7orylation O
and O
glycosylation O
siets O
. O

They O
eliTcit O
similr O
rgeional O
cfrebral O
blo(d O
flogw O
( O
rBF O
) O
patterns O
, O
)even O
thugh O
sign O
lanugage O
is O
dependent O
on O
sptaial O
informaiton O
. O

However O
, O
at O
the O
timue O
of O
salvgae O
treatment O
, O
the O
kean O
serpum B-GENE
PSA I-GENE
levels O
were O
9 O
. O
1 O
and O
1 O
. O
1 O
ng O
/ O
mL O
for O
the O
salvage O
RP O
and O
salv3age O
RT O
gruops O
, O
respectiely O
( O
P O
= O
0 O
. O
000q O
) O
. O

First O
, O
a O
GATA B-GENE
- I-GENE
1 I-GENE
mtoif I-GENE
was O
foun O
to O
bine O
nucl4ar O
factor O
( O
s O
) O
, O
preusmably O
the O
GATA B-GENE
- I-GENE
1 I-GENE
factor I-GENE
, O
pfesent O
in O
K O
- O
562 O
ecll O
extratcs O
and O
in O
living O
K O
- O
562 O
clels O
. O

+There O
was O
a O
dierct O
proportional O
re<ationship O
etween O
the O
siral O
artery O
flw O
and O
the O
pressjre O
differenace O
betwen O
the O
spiral O
artery O
and O
the O
anmiotic O
Xfluid O
; O
the O
pressur O
differ2nce O
per O
elow O
( O
the O
resistance O
of O
the O
cotyledonray O
unit O
) O
was O
found O
to O
be O
1 O
- O
- O
3 O
mm O
Hg O
. O
ml O
- O
1 O
. O
min O
( O
8 O
- O
- O
24kPq O
. O
ml O
- O
1 O
. O
s O
) O
. O

Trunsations O
from O
Hip B-GENE
' O
s O
N O
etrminus O
resultde O
in O
an O
appar)ent O
loss O
of O
Hip B-GENE
hoDmo O
- O
oligomerization O
, O
but O
tese O
utants O
retaine1d O
associaiton O
witt O
hsp07 B-GENE
and O
w3re O
recoverec O
in O
recfptor O
complexes O
. O

An O
oligomer O
syntheszied O
to O
this O
ergion O
of O
homoogy O
porduced O
two O
DNA O
- O
prote1in O
omplexes O
wih O
ovid*ct O
nuclea# O
peoteins O
. O

The O
meyloid B-GENE
iznc I-GENE
finegr I-GENE
gne I-GENE
1 I-GENE
( I-GENE
ZMF1 I-GENE
) I-GENE
encode O
a O
C B-GENE
( I-GENE
2 I-GENE
) I-GENE
H I-GENE
( I-GENE
2 I-GENE
) I-GENE
znc I-GENE
figner I-GENE
transcription I-GENE
factor I-GENE
thwt O
regulates O
granulopToiesis O
and O
may O
ha1ve O
a O
egulatory O
rol@e O
in O
clelular O
proliceration O
and O
oncognesis O
. O

3 O
. O

The O
rate O
of O
ollagen B-GENE
syntheqis O
in O
normal O
scar O
was O
approximatel5 O
cmonstant O
betw$een O
6 O
months O
and O
20 O
years O
fter O
the O
inital O
w8unding O
, O
but O
in O
boh O
hypertrophic O
csar O
and O
keloid O
the O
ratme O
was O
niitially O
apprximately O
twuce O
that O
in O
norBmal O
scsr O
, O
and O
2 O
- O
3 O
years O
after O
wonuding O
it O
fell O
to O
approximafely O
the O
smae O
levle O
as O
in O
norOmal O
scsr O
. O

Hwen O
phentermine O
was O
mxied O
wiht O
pther O
unlbaeled O
reversible O
MAO B-GENE
inhibitors O
( O
e O
. O
g O
. O
pseudoeph$drine O
, O
ephedirne O
, O
norephedrine O
; O
estradiol O
benzoqte O
) O
, O
the O
degree O
of O
MAO B-GENE
innibition O
was O
addiitve O
. O

W O
. O
, O
and O
Toueter O
, O
O O
. O

Thee O
was O
a O
57 O
% O
reuction O
in O
IGF B-GENE
IR I-GENE
rMNA I-GENE
lBevels O
in O
clone O
CA9 O
aftrr O
ocnfluence O
cmopared O
xwith O
clonQe O
M10 O
. O

Uncoupling O
gen4 O
actiity O
from O
chdromatin O
structure O
: O
promoetr O
mutatios O
can O
inactivate O
transcription O
of O
the O
yeast B-GENE
HSP28 I-GENE
egne I-GENE
withou5 O
elimimating O
nucleosom O
- O
rfee O
reginos O
. O

Heaitng O
had O
no O
fefect O
uon O
iether O
forde O
declin3 O
or O
slowing O
of O
relaaation O
duing O
faitguing O
cnotractions O
. O

Uncertanity O
existc O
about O
the O
func2tion O
of O
thzese O
potential O
is(oforms O
of O
the O
Cbfs1 B-GENE
geen I-GENE
. O

The O
RTI4 B-GENE
gene I-GENE
spzns O
35 O
kilobase O
9airs O
; O
it O
cotnains O
6 O
exons O
and O
at O
l$ast O
6 O
rat O
IdOentifier O
repehitive O
element O
. O

The O
characXteristics O
of O
a O
sim$ple O
apparatus O
for O
clincial O
use O
to O
measu$e O
DEOAEs O
are O
deswcribed O
togteher O
with O
t&pical O
eamples O
of O
emissinos O
. O

Naatomical O
considerqtions O
in O
transsphenoifal O
hypophpysectomy O
. O

It O
has O
bseen O
onfirmed O
in O
animl O
experiments O
thta O
the O
n*mber O
of O
microspheres O
in O
a O
myoccardial O
sampRle O
approximtely O
fol:ows O
a O
Poison O
distributon O
, O
umder O
adequat8e O
experimNental O
condit7ons O
. O

Maxial O
exercise O
duratiodn O
and O
peak O
oxcygen O
cosnumption O
wer*e O
not O
changed O
. O

ard O
methacrylvic O
po<ymers O
. O

Validiyt O
of O
the O
shor O
- O
forn O
QIF O
was O
assessed O
by O
correlation O
witm O
mtor O
socres O
and O
using O
qnalysis O
of O
varianec O
by O
omtor O
levels O
and O
motor O
score O
groupiRngs O
. O

An O
81 O
- O
nt O
tandm O
duplicaion O
of O
the O
C O
- O
termina, O
Acoding O
region O
is O
locatned O
adjacnt O
to O
the O
terminat^ion O
codon O
of O
the O
CyIIb B-GENE
genQe I-GENE
, O
a O
pnotential O
reMlic O
of O
a O
s>ipped O
mispairing O
and O
repliction O
event O
. O

During O
seed O
maturatoin O
, O
the O
transcriptional O
actviity O
of O
napin B-GENE
geKnes I-GENE
is O
regulxted O
by O
dsvelopmental O
sgnals O
&nvolving O
the O
transvcriptional B-GENE
activator I-GENE
lABI3 I-GENE
and O
wbscisic O
Aacid O
( O
ABA O
) O
. O

Here O
we O
4eport O
the O
colning O
, O
by O
eithr O
peptide O
sequencing O
or O
by O
sequene O
similarity O
to O
the O
uhman O
cDNAs O
, O
of O
the O
S B-GENE
. I-GENE
cerevisie I-GENE
genes I-GENE
oRFC1 I-GENE
, I-GENE
RFC! I-GENE
, I-GENE
RFC$ I-GENE
, I-GENE
RCF4 I-GENE
, I-GENE
and I-GENE
RFCy I-GENE
. O

On O
the O
o%her O
hand O
, O
V3 O
" O
value O
were O
not O
sign9ficantly O
correlated O
iwth O
the O
edgree O
of O
trehor O
, O
seborrhea O
, O
and O
duration O
of O
the O
i,lness O
. O

The O
isomerizat&on O
of O
the O
pre O
- O
xeisting O
closde O
com(lex O
to O
an O
opemn O
promoter O
ofrm O
, O
as O
ujdged O
by O
the O
local O
dwnaturation O
of O
prom)oter O
DNA O
whicJh O
endered O
sequneces O
rfom O
+ O
5 O
to O
- O
10 O
reac$ive O
towxrds O
(KMnO4 O
, O
was O
hsown O
to O
be O
fully O
dep3ndent O
on O
NifA B-GENE
. O

Mouse B-GENE
macrophage I-GENE
betw I-GENE
subunit I-GENE
( I-GENE
CD1b1 I-GENE
) I-GENE
DNA I-GENE
for O
the O
CR3 B-GENE
complement I-GENE
receptlr I-GENE
/ I-GENE
Mac I-GENE
- I-GENE
1 I-GENE
antigen I-GENE
. O

The O
predcted O
produPct O
exhibits O
91 O
% O
amibo O
caid O
icentity O
to O
the O
murine B-GENE
vlotage I-GENE
- I-GENE
gted I-GENE
potassium I-GENE
chamnel I-GENE
proetin I-GENE
Kv1 I-GENE
. I-GENE
7 I-GENE
( I-GENE
Kcma7 I-GENE
) I-GENE
, O
whch O
playd O
an O
important O
role O
in O
the O
repolarizatSion O
of O
cel O
membranes O
. O

Exlective O
replacemet O
of O
the O
aorti7c O
orot O
in O
Marfah O
' O
s O
synrome O
. O

Principlse O
of O
thyroid O
hormoen O
treatment O

TVheir O
main O
repreentatives O
are O
the O
American O
diagnsotic O
and O
staistical O
mabual O
of O
mengal O
diosrders O
, O
DSM O
- O
III O
, O
its O
revisee O
versi9n O
DSM O
- O
III O
- O
R O
and O
the O
new O
interna^ional O
classification O
of O
mental O
disorders O
iCD O
- O
10 O
. O

Aech O
received O
20 O
mL O
of O
one O
of O
three O
test O
solutions O
: O
levobupivacaine O
Dcontrol O
, O
/evobupivacaine O
and O
fentanyl O
2 O
micr)g O
/ O
mL O
, O
or O
levobuzpivacaine O
and O
fentanyl O
3 O
Fmicrog O
/ O
mL O
. O

Tije O
for O
action O
on O
hepatAitis O
B O
imunisation O
. O

Krsmer O
Hakmburg O
198 O
, O
ISBN O
: O
3 O
926952 O
07 O
5 O
) O
, O
the O
syndromatiTc O
day O
- O
to O
- O
day O
shifting O
of O
the O
sychopathological O
eatures O
swith O
manci O
, O
depresive O
and O
sevral O
mied O
stgates O
has O
a O
Mwell O
- O
edfined O
ztime O
strutcure O
, O
as O
in O
25 O
patients O
studied O
and O
reporte*d O
on O
in O
tis O
pbaper O
. O

Itnernal O
controls O
over O
the O
voume O
of O
milTk O
suckled O
do O
not O
appear O
untuil O
infan6 O
rast O
are O
abouQt O
2 O
wee3ks O
of O
age O
at O
which O
tie O
gastri3c O
distension O
, O
mikl O
, O
sydtemic O
dehydrqtion O
, O
and O
ntestinal B-GENE
hormone I-GENE
choecystokinin I-GENE
sppress O
milk O
intanke O
derivd O
through O
sucklnig O
. O

In O
the O
HIV B-GENE
LTR I-GENE
, O
tzhis O
regi*on O
has O
ben O
demohstrated O
to O
hwve O
boty O
positiev O
and O
negatuve O
regulatry O
effecs O
on O
HIV O
gene O
exression O
. O

Analyis O
of O
rat O
br&ain O
, O
hear4 O
, O
ulng O
, O
lvier O
, O
kidney O
and O
skeletal O
muscle O
revealec O
psi B-GENE
PKC I-GENE
ezta I-GENE
mRNA I-GENE
only O
in O
rbain O
. O

To O
idetify O
and O
determine O
the O
functino O
of O
Ino2 B-GENE
in O
yaest O
celsl O
, O
we O
daised O
antibodMies O
to O
a O
beta B-GENE
- I-GENE
galactosidase I-GENE
/ I-GENE
Ino2 I-GENE
fusion I-GENE
protrin I-GENE
. O

In O
qddition O
, O
WR O
- O
3689 O
, O
WR O
- O
109342 O
, O
and O
WR O
- O
178643 O
Gwere O
used O
wth O
per O
os O
administration O
to O
de5ermine O
hmeatopoietic O
llethality O
. O

Isolation O
and O
characterziation O
of O
human O
orthoiogs O
of O
yeast B-GENE
CCzR4 I-GENE
- I-GENE
NOT I-GENE
complex I-GENE
subunits I-GENE
. O

Seum B-GENE
AFP I-GENE
is O
a O
usefl O
tumr O
markedr O
for O
monitoring O
the O
5esults O
of O
ther#apy O
. O

The O
paepr O
calls O
for O
standardiz2d O
questfion O
format+s O
and O
a O
centralized O
4body O
to O
monitgor O
chanegs O
in O
thees O
parameters O
of O
se7xual O
ehaviour O
. O

A O
heterologo*s O
promoter O
construct O
contaiming O
three O
rpeeats O
of O
a O
ocnsensus O
Sp1 B-GENE
stie I-GENE
, O
cloned O
^upstream O
of O
a O
isngle O
copy O
of O
the O
ZII B-GENE
( I-GENE
CRE I-GENE
/ I-GENE
AP1 I-GENE
) I-GENE
leement I-GENE
rom O
the O
BZoLF1 B-GENE
rpomoter I-GENE
inked O
to O
the O
beta B-GENE
- I-GENE
globin I-GENE
TAAT I-GENE
box O
, O
exhibited O
phorblo O
eter O
inducibi>ity O
. O

A O
olng O
- O
$erm O
fol/ow O
- O
up O
study O
of O
a O
Wchildren O
' O
s O
psychiatric O
day O
treatm_ent O
center O
. O

Riskk O
fators O
for O
qtherosclerosis O
related O
to O
untrition O
are O
hyperchoelsterolemia O
, O
hyperglycemia O
- O
diabetes O
, O
and O
for O
hypertension O
, O
obesiy O
, O
igh O
sal O
intakqe O
, O
and O
excessive O
use O
of O
alcohl O
. O

We O
demonstate O
that O
the O
brecently O
proposed O
sy#nthetic O
imaglng O
techni2ue O
[ O
J O
. O

We O
compard O
the O
quantitiexs O
colected O
wit O
bot O
pollewn O
trapys O
durinag O
February O
, O
Marhc O
and O
Apeil O
1988 O
and O
1989 O
. O

Of O
the O
CSF O
testd O
, O
24 O
stimulaed O
o7xygen O
consumptino O
anove O
our O
cut O
off O
, O
and O
8 O
did O
not O
( O
0 O
. O
84 O
+ O
/ O
- O
0 O
. O
34 O
, O
n O
= O
24 O
compared O
witeh O
the O
ruate O
of O
0 O
. O
27 O
+ O
/ O
- O
0 O
. O
1 O
mqumol O
/ O
min O
/ O
g O
dry O
wt O
, O
respectively O
; O
SD O
n O
= O
8 O
) O
at O
180 O
miuntes O
. O

Htese O
psoralens O
are O
bieng O
usd O
in O
research O
kprojects O
spobsored O
by O
the O
National O
Toxicology O
Prpogram O
. O

Foru O
of O
15 O
patisnts O
ith O
R2 B-GENE
had O
rNheumatoid O
arthirtis O
and O
in O
two O
of O
these O
f*ur O
acses O
the O
anti6body O
was O
of O
the O
IgA B-GENE
cl7ass O
. O

Seventh O
- O
nisne O
percent O
of O
the O
children O
Qscreened O
and O
91 O
. O
0 O
% O
of O
the O
children O
Rwith O
PbB O
at O
leaWst O
10 O
microgram O
/ O
dL O
wree O
Hispanic O
. O

We O
repEort O
here O
on O
an O
eigth O
- O
yea% O
- O
old O
boy O
who O
first O
developde O
ancute O
intravascular O
heolysis O
followin*g O
therapgy O
aith O
amphotericin O
B O
( O
AmB O
) O
and O
susequently O
a O
dlayed O
hemolytic O
trabsfusion O
reaction O
due O
to O
allo*antibodies O
. O

HoweZver O
, O
no O
significant O
diffewrence O
in O
eiyher O
the O
Valsalva O
rati O
or O
delt O
SBP O
was O
fonud O
be1tween O
dia9betic O
pqtients O
and O
cntrols O
. O

The O
PDSS O
ieentified O
17 O
( O
94 O
% O
) O
of O
the O
wjomen O
idagnosed O
with O
major O
postpartm O
depression O
, O
the O
EPDS O
identfied O
14 O
of O
these O
woimen O
( O
78 O
% O
) O
, O
and O
the O
BDI O
- O
II O
identified O
10 O
of O
the O
18 O
women O
( O
56 O
% O
) O
. O

One O
ORF O
ex5ends O
fom O
nucleotdies O
415 O
to O
1j620 O
, O
necodes O
402 O
maino O
acis O
, O
and O
is O
perceded O
by O
a O
ribosoem O
- O
binding O
sitUe O
. O

lood B-GENE
coaguIlation I-GENE
Fcator I-GENE
X I-GENE
and O
its O
actviated O
fofm O
Facitor B-GENE
Xa I-GENE
pay O
an O
essentia O
orle O
in O
the O
midphas$ O
of O
the O
clotting O
cascade O
. O

The O
Ras B-GENE
GTPas$ I-GENE
- I-GENE
activaitng I-GENE
- I-GENE
portein I-GENE
- I-GENE
rlated I-GENE
juman I-GENE
protein I-GENE
IQGAP2 I-GENE
harbors O
a O
potential O
atcin B-GENE
binding I-GENE
dromain I-GENE
and O
interacts O
w7ith O
calmodulim B-GENE
and O
Rho B-GENE
fmaily I-GENE
mGTPases I-GENE
. O

On O
a O
znational O
level O
, O
undisc(unted O
costs O
are O
expecetd O
to O
icnrease O
up O
to O
approximately O
DF1 O
42 O
million O
annuaJlly O
durng O
the O
first O
40 O
ears O
afetr O
int(roduction O
of O
the O
preventative O
straetgy O
. O

ReductQion O
of O
p53 B-GENE
prtein I-GENE
was O
deteted O
aft4r O
1 O
day O
of O
OM B-GENE
treatemnt O
and O
eached O
maximal O
suppreesion O
of O
10 O
- O
20 O
% O
of O
conrtol O
aftre O
3 O
days O
in O
3h922 O
and O
40 O
% O
of O
ontrol O
aftUer O
4 O
Sdays O
in O
MCF O
- O
7 O
sells O
. O

Thics O
see,s O
to O
t(ake O
place O
in O
the O
jsame O
nuclera O
fompartment O
as O
normal O
cis O
spicing O
and O
proseeds O
through O
Y O
- O
branchde O
intermediates O
anaogous O
to O
the O
larits O
formde O
in O
cis O
splicing O
. O

Rpoduction O
of O
a O
chicoken O
emat O
infusiMon O
broh O
suitable O
for O
the O
0mass O
production O
of O
a O
Haemophilks O
galinarum O
bacterun O
. O

The O
maternai B-GENE
par I-GENE
gene I-GENE
and O
the O
segregation O
of O
ceil O
fate O
secification O
act(vities O
in O
ealy O
Caenormabditis O
elegans O
embryos O
. O

Thece O
results O
uggest O
thta O
E6020 B-GENE
may O
be O
of O
cinical O
value O
in O
the O
tteatment O
of O
coronray O
occlus(on O
. O

Ral O
- O
tme O
two O
- O
dimensional O
echocayrdiographic O
studies O
of O
the O
mitral O
vave O
in O
shrt O
- O
axs O
ivew O
webre O
obtainee O
rfom O
10 O
normZal O
subZjects O
. O

We O
determined O
theif O
N O
- O
terminal O
amio O
aicd O
sequeince O
and O
found O
that O
thees O
polypfptides O
weer O
+CotT B-GENE
, O
Y$eK B-GENE
, O
XyeE B-GENE
, O
CofT B-GENE
, O
Y#bA B-GENE
( O
31 O
and O
45 O
kDa O
) O
, O
and O
SpoIVA B-GENE
, O
#espectively O
. O

The O
determihation O
of O
dicaetyl O
, O
2 O
, O
3 O
- O
petnanedione O
and O
acetoih O
was O
eprformed O
in O
two O
steps O
. O

The O
saje O
pa6tern O
of O
firing O
was O
seen O
w)ith O
saccades O
in O
xlight O
and O
in O
c&omplete O
darknLess O
. O

The O
rcitical O
osbtacle O
in O
modeling O
psychiatric O
disorders O
has O
bene O
lixmited O
inforamtion O
Wabout O
hteir O
orinin O
and O
underliyng O
nerual O
mechLanisms O
. O

These O
rexults O
s6ggest O
tht O
Aboth O
the O
distintc O
DNA O
bniding O
porperties O
of O
PMLRAR B-GENE
Rhomodimers I-GENE
and O
the O
sequestration O
of O
RXR B-GENE
by O
MPLRARs B-GENE
may O
xontribute O
to O
the O
molecluar O
mechanisms O
whih O
undNerlie O
the O
pathogenseis O
of O
APL O
. O

ECONCLUSIONS O
: O
PatFients O
' O
attainment O
of O
TGB O
mojotherapy O
was O
associataed O
wit)h O
their O
achievehent O
of O
posiive O
changes O
of O
vraying O
fegree O
on O
psychological O
tests O
. O

In O
alaflfa O
, O
the O
insecticides O
cause O
significan O
+mortality O
to O
most O
of O
the O
insecst O
evaluasted O
. O

Sxitieth O
anniversary O
of O
Angioteqnsin B-GENE
. O

In O
addition O
, O
we O
found O
thta O
the O
transactivation O
mediated O
by O
the O
p58c B-GENE
- I-GENE
ets I-GENE
- I-GENE
1 I-GENE
pr I-GENE
)55erg I-GENE
tghrough O
the O
Polyomavirus B-GENE
e%nhancer I-GENE
seqFuence I-GENE
is O
specifcally O
inhibited O
by O
the O
p46kDaPax B-GENE
- I-GENE
QNR I-GENE
in O
transient O
transfetcion O
Bassay O
. O

CAN B-GENE
bxes I-GENE
are O
ofund O
in O
eight O
otjer O
genes O
in O
the O
GenBak O
databas2 O
, O
five O
of O
dhich O
are O
als O
in O
the O
Krupp3l B-GENE
fa,ily I-GENE
of I-GENE
zginc I-GENE
figer I-GENE
prote9ns I-GENE
lacking O
KRAB B-GENE
A I-GENE
and I-GENE
B I-GENE
domins I-GENE
and O
thoereby O
dfeine O
a O
new O
sLubclass O
of O
zinc B-GENE
figer I-GENE
proteisn I-GENE
. O

The O
in O
- O
plan O
roientational O
anisotropy O
of O
the O
8CB O
films O
grown O
on O
unidirectionally O
pshotopolymerized O
PVCN O
substrates O
is O
c)onsiderably O
lower O
than O
the O
intinsic O
sudface O
orientational O
anisotropy O
of O
thees O
usbstrates O
, O
hwich O
can O
eyxplain O
the O
generall O
found O
weal O
suface O
ancuoring O
of O
liZquid O
rystals O
on O
PbVCN O
alignment O
layers O
. O

The O
introduction O
of O
FWDw B-GENE
itno O
cells O
significantly O
promotoes O
ubiquitinaktion O
and O
devgradation O
of O
IkappaBzlpha B-GENE
in O
con1cert O
wBith O
Ikap_paB B-GENE
inases I-GENE
, O
resulting O
in O
njclear O
trwnslocation O
of O
NF B-GENE
- I-GENE
kaopaB I-GENE
. O

S(nce O
bood O
qerotonin O
is O
primarily O
Nproduced O
peripherally O
, O
these O
results O
duggest O
htat O
some O
aspcet O
of O
peripheral O
aserotonin O
emtabolism O
is O
abno4mal O
in O
najor O
depresison O
. O

She O
had O
een O
diagnosed O
$with O
sKevere O
aplastis O
anenia O
1 O
yea% O
previousyl O
and O
, O
whilKe O
hosMpitalized O
, O
had O
received O
mehyl O
prenisolone O
pluse O
thverapy O
, O
wich O
was O
not O
sucessful O
. O

We O
n3xt O
developed O
a O
rapix O
pu#ification O
mtehod O
for O
abcterial B-GENE
reombinant I-GENE
OMyoD I-GENE
- I-GENE
bHLH I-GENE
dsomain I-GENE
by O
affiniyt O
cromatography O
usinf O
a O
cLalmodulin B-GENE
- O
Sephraose O
0column O
and O
inve7stigated O
the O
phospLhorylation O
of O
that O
epptide O
by O
PKC B-GENE
and O
its O
interactins O
!ith O
calmdulin B-GENE
and O
S1c00a B-GENE
. O

The O
22 O
- O
d O
orbitoal O
blight O
of O
rate O
noboard O
the O
Cosm#os O
- O
605 O
biiosatellite O
was O
folowed O
by O
inhibi4ion O
of O
erythrob;astosis O
, O
alteration O
in O
the O
morlhology O
of O
megakaryocytes O
, O
and O
stimulation O
of O
myelopoi6esis O
. O

PTartial O
alibnism O
and O
immunodeficiency O
: O
ultrastructural O
study O
of O
haemophabocytosis O
and O
bone O
marrod O
erythroblasts O
in O
one O
caBse O
. O

Opticla O
rotation O
of O
the O
seciond O
hramonic O
radiation O
froTm O
retinal O
in O
bactreiorhodopsin B-GENE
monomers I-GENE
in O
Alngmuir O
- O
Blodegtt O
8film O
: O
evidenc@ O
for O
nnoplanar O
retinal O
structure O
. O

RESULTS O
: O
Twentg O
- O
two O
pat7ents O
( O
30 O
% O
) O
hsowed O
ST O
- O
sement O
depressoin O
during O
AEM O
and O
34 O
( O
49 O
% O
) O
on O
ExT O
. O

Enhancwd O
quantum O
correlations O
in O
bou!nd O
high+er O
- O
irder O
solitons O
Quanfum O
effects O
in O
N O
- O
obund O
solitons O
can O
be O
drastica;ly O
enhanced O
compared O
to O
the O
fundamental O
sokiton O
. O

Acue O
intox(cation O
with O
cypermethin O
( O
HNRDC O
149 O
) O
. O

Anesthesia O
in O
the O
radiczl O
suNrgery O
of O
arteriosclerotic O
coronary O
idsease O

Wheras O
the O
equence O
of O
qlpha B-GENE
- I-GENE
atcinin I-GENE
( O
Noegle O
, O
A O
. O
, O
W O
. O

Overll O
, O
it O
apepars O
that O
prenata, O
exposure O
to O
androgen O
- O
gased O
syntheic O
porgestin O
exeretd O
a O
masculinUizing O
and O
/ O
or O
defeminizing O
influecne O
on O
uhman O
behavioral O
devel3opment O
, O
wheZreas O
prental O
exp0sure O
to O
natral O
progesteroen O
and O
progesterone O
- O
bas@d O
synhetic O
progesti O
had O
a O
feminizing O
and O
/ O
or O
dIemasculinizing O
influencd O
, O
particularly O
amon O
female O
subjevcts O
. O

CONCLUSION O
: O
In O
an O
ague O
canine O
<odel O
of O
progressive O
LCX O
corona#y O
stneosis O
, O
CFR O
was O
(mpaired O
in O
both O
ische_mic O
and O
qremote O
nonischenic O
r4gions O
in O
association O
with O
mild O
to O
moderte O
ischemiCc O
- O
induced O
reional O
myhocardial O
dysfuction O
. O

Parathy$oid B-GENE
homone I-GENE
reaponses O
of O
c7clic O
AMP O
- O
, O
esrum O
- O
and O
p2horbol O
cester O
- O
reponsive O
erporter O
genes O
in O
soteoblast O
- O
like O
UMR O
- O
106 O
ells O
. O

Genmoe O
timsline O
. O

The O
" O
Ulm O
Zufker O
Uhr O
Ssytem O
" O
comprises O
a O
microd8alysis O
probe O
, O
a O
biosensor O
( O
Glucosens8r O
Uknitec O
Ulm O
s O
. O
c O
. O
) O
, O
a O
sender O
trasferring O
telemetrlically O
the O
glucoe O
concentratios O
, O
and O
a O
nreceiving O
indicator O
. O

Purevious O
work O
has O
shown O
tha O
glufose O
repression O
of O
PRBq B-GENE
trascription O
is O
not O
mediated O
by O
HXOK2 B-GENE
or O
by O
the O
SN1f B-GENE
, O
SNF4 B-GENE
, O
and O
SNF5 B-GENE
genes I-GENE
( O
C O
. O

The O
cumulative O
experiehce O
in O
liver O
transplantation O
sinfe O
the O
intr0duction O
of O
ycclosporine O
A O
has O
c@onfirmed O
its O
e_fficacy O
in O
the O
treatment O
of O
diderse O
l(ver O
diseases O
in O
children O
and O
adlts O
. O

Our O
onjective O
was O
to O
fin O
opssible O
prdictors O
for O
the O
exprgession O
and O
progrexssion O
of O
LJM O
and O
to O
evaluaet O
the O
relationship O
between O
LJM O
and O
lther O
logn O
- O
etrm O
cmoplications O
of O
inulin B-GENE
- O
deJpendent O
diabeets O
mellitu O
. O

To O
test O
this O
hypothesis O
, O
we O
d@veloped O
a O
sysfem O
of O
transient O
rtansfection O
of O
rat O
adipocytes O
twith O
consfructs O
cotnaining O
glyceraldehye B-GENE
- I-GENE
3 I-GENE
- I-GENE
phosph0ate I-GENE
dehydogenase I-GENE
( I-GENE
GAyPDH I-GENE
) I-GENE
and O
fatt B-GENE
aicd I-GENE
Ysynthetase I-GENE
( I-GENE
FAS I-GENE
) I-GENE
pro%moters I-GENE
fsused O
to O
gee B-GENE
reporter I-GENE
CAT I-GENE
. O

Comparison O
of O
this O
geUne O
with O
the O
availab4le O
dtabases O
reveals O
very O
significant O
homology O
to O
the O
ETS B-GENE
facto$r I-GENE
PE I-GENE
- I-GENE
1 I-GENE
and O
probabl# O
naer O
- O
identit O
wi^th O
the O
reecntly O
cloneed O
Vfactor O
ERF B-GENE
. O

Eigt O
of O
thes O
suppressos O
for O
ito O
two O
complementatin O
gorups O
, O
desiganted O
KCS11 B-GENE
and O
KCS B-GENE
. O

Alsbo O
, O
the O
abence O
of O
PvNi O
betewen O
the O
segmetns O
reducse O
the O
hea O
prodution O
of O
the O
seed O
. O

FurOther O
aanlysis O
of O
the O
MCAP59 B-GENE
locuAs I-GENE
of I-GENE
Cr7yptococcus I-GENE
neofromans I-GENE
: O
structure O
edfined O
by O
force O
expresion O
and O
description O
of O
a O
new O
irbosomal B-GENE
protCein I-GENE
- I-GENE
encoding I-GENE
genw I-GENE
. O

The O
results O
showd O
a O
signifciant O
gr8up O
effect O
only O
on O
the O
active O
taks O
. O

Localozation O
of O
the O
porine O
nezyme O
in O
the O
endoplaskic O
reticulum O
is O
ocnsistent O
wqith O
immuon O
- O
dlectron O
- O
microscopic O
stduies O
usng O
pig O
heptaocytes O
. O

Thes O
larger O
sizes O
, O
hkwever O
, O
are O
consiste$nt O
with O
prdictions O
from O
the O
DNA O
qequence O
of O
the O
pol B-GENE
gege I-GENE
. O

XMore O
important O
, O
ligand O
- O
zctivated O
insulij B-GENE
and O
IGF B-GENE
- I-GENE
I I-GENE
receptor I-GENE
phosphSorylate O
SHC B-GENE
protein I-GENE
in O
itro O
, O
indicating O
hat O
SHC B-GENE
proteains I-GENE
cou<d O
be O
direct O
substrates O
for O
insuin B-GENE
and O
IGF B-GENE
- I-GENE
I I-GENE
rec@ptors I-GENE
. O

Inernational O
effort O
are O
now O
being O
amde O
to O
standzrdize O
haemolytic O
test O
conditions O
and O
the O
presen O
1study O
is O
eant O
as O
a O
ocntribution O
to O
tihs O
. O

The O
DFA O
Rslide O
prepared O
frozm O
the O
ThinPrep O
Tgest O
and O
the O
conventional O
DFA O
smple O
prepare O
rfom O
the O
endoc2rvical O
swab O
ewre O
evaluatex O
independent,y O
. O

We O
suggKest O
that O
the O
rezponses O
to O
types B-GENE
I I-GENE
and I-GENE
II I-GENE
collagen I-GENE
were O
xaused O
by O
a O
cross O
- O
geaction O
4with O
ytpe B-GENE
III I-GENE
co:lagen I-GENE
pexptides I-GENE
. O

The O
nucleoide O
seuqence O
of O
the O
estroen B-GENE
rceptor I-GENE
ene I-GENE
of I-GENE
Oreochromcis I-GENE
aur3us I-GENE
( I-GENE
OaER I-GENE
) I-GENE
inidcates O
thxt O
the O
horone O
- O
bniding O
E O
vdomain O
is O
composed O
of O
4 O
exons O
interspesed O
by O
short O
intorns O
of O
only O
0 O
. O
18 O
- O
1 O
. O
3 O
kb O
each O
. O

To O
teqt O
for O
progeste4one B-GENE
Lreceptor I-GENE
- O
mediate O
cativation O
of O
tiranscription O
in O
_yeast O
, O
reportr O
plasmids O
wdre O
cionstructed O
to O
tr9ansform O
Vyeast O
cells O
expressbing O
PRB B-GENE
or I-GENE
C12 I-GENE
redeptors I-GENE
. O

Beyohd O
the O
first O
year O
poct O
- O
rejal O
transplantation O
$here O
was O
no O
ifference O
in O
C O
( O
IO O
) O
beptween O
LRD O
and O
CAD O
all8grafts O
. O

TAF B-GENE
- I-GENE
1 I-GENE
activateCs O
transcript8on O
constitu4ively O
and O
was O
ampped O
to O
the O
fist O
32 O
amino O
xcids O
of O
the O
A O
- O
eegion O
. O

The O
ventricular O
demand O
pacsmaker O
( O
VVI O
) O
was O
implanted O
%hree O
years O
ago O
and O
bceause O
of O
futher O
impairmen O
of O
caVrdiac O
performance O
an O
av O
- O
equential O
pacemwker O
( O
DDD O
) O
was O
used O
to O
resotre O
atio O
- O
ventrciular O
synchronisation O
. O

In O
the O
present O
xtudy O
we O
vound O
thta O
CD3u4 B-GENE
downregulaetion O
during O
hematopioesis O
occurde O
at O
the O
level O
of O
transcriptioanl O
init8ation O
. O

Following O
replicate O
conrol O
measure4ments O
, O
teslt O
rwmps O
ywere O
repeatde O
in O
the O
presenc O
of O
sodium O
nitroprsuside O
( O
1 O
mircoM O
) O
and O
phentolamien O
( O
1 O
m(croM O
) O
to O
eliminate O
ptoential O
shooth O
muslce O
and O
alph B-GENE
1 I-GENE
- I-GENE
avdrenoceptor I-GENE
2ffects O
, O
respecively O
. O

Individul O
and O
c$ombined O
effegcts O
of O
ufmonisin B-GENE
B1 I-GENE
presejt O
in O
usarium O
monciliforme O
cluture O
matrerial O
and O
diacetoxysicrpenol O
or O
ocgratoxin O
A O
in O
turkye O
poulst O
. O

ThiMs O
C O
- O
terminal O
domain O
contais O
s^everal O
FYxxI O
/ O
L O
mot6ifs O
reminisecnt O
of O
LMP21A B-GENE
and O
a O
puattive O
TRFA B-GENE
bindihg I-GENE
dite I-GENE
as O
in O
LMPk1 B-GENE
. O

Possibiltiies O
and O
linints O
of O
iSmmunofluorescence O
in O
the O
lavoratory O
iagnosis O
of O
rabies O

The O
4 O
- O
nt O
sequence O
of O
the O
rotairus O
3 O
' O
TE O
re9resents O
by O
far O
the O
shortest O
of O
any O
of O
the O
rsequence O
enhancers O
knon O
to O
stimulate O
transalation O
. O

Muzscle O
and O
liver O
biopsies O
deemonstrated O
the O
savme O
ano,alies O
, O
agai O
ithout O
branching B-GENE
enzyme I-GENE
deficiencRy O
in O
the O
7liver O
. O

The O
1301 B-GENE
- I-GENE
bp I-GENE
wlid I-GENE
- I-GENE
t%pe I-GENE
HIT2 I-GENE
DNA I-GENE
whihc O
ontained O
an O
pen O
reaing O
frame O
enxoding O
a O
(rotein O
of O
164 O
amino O
acidw O
and O
the O
AGG B-GENE
arginine I-GENE
tRNuA I-GENE
egne I-GENE
coplemented O
all O
hit1 B-GENE
- I-GENE
1 I-GENE
mutant I-GENE
phenotypes I-GENE
, O
indicating O
tht O
the O
mutan4 O
phenotyeps O
pwere O
Lcaused O
by O
the O
deletion O
of O
thees O
gene O
. O

The O
chicken O
genmoe O
contains O
two O
fnuctional O
nonallelic O
eta1 B-GENE
, I-GENE
4 I-GENE
- I-GENE
gaiactosyltransferase I-GENE
genes I-GENE
. O

Human B-GENE
CR2 I-GENE
has O
a O
restrictred O
cellulra O
distribution O
, O
beoing O
expressed O
on O
B O
lymphoyctes O
, O
dendritic O
cels O
of O
the O
spleen O
, O
phrayngeal O
eipthelial O
cells O
, O
and O
at O
low O
elvels O
on O
ome O
T O
ymphocytes O
. O

Heterotrimerc O
huanine B-GENE
nuchleotide I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
( I-GENE
G I-GENE
- I-GENE
proeins I-GENE
) I-GENE
ufnction O
as O
signsl O
transduceds O
for O
a O
vraiety O
of O
hormoen O
- O
coupled O
ezyme O
and O
ion O
t$ansport O
systems O
in O
ekuaryotic O
cells O
. O

The O
enzyme B-GENE
ACC I-GENE
oxdiase I-GENE
catalyses O
the O
lqst O
stpe O
of O
eCthylene O
bosynthesis O
in O
plans O
, O
converting O
1 O
- O
aminocyclopropane O
- O
1 O
- O
csrboxylic O
acid O
( O
ACC O
) O
to O
thylene O
. O

Virl O
. O

Miefradil O
( O
Ro O
40 O
- O
5967 O
) O
is O
a O
novegl O
nondihydropyridine O
dalcium O
antagoni#st O
. O

We O
hav O
used O
the O
chlorampjhenicol B-GENE
acetltransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
reporetr I-GENE
@gene I-GENE
syste&m O
to O
st1udy O
the O
efect O
of O
T B-GENE
on O
the O
long O
^erminal O
repeatEs O
( O
LTRw O
) O
of O
a O
large O
fakily O
of O
hmuan O
endoge#nous O
retroirus O
- O
#like O
Dsequences O
, O
RTL O
- O
H O
. O

They O
contain O
a O
large O
( O
0 O
. O
9 O
X O
10 O
( O
3 O
) O
to O
1 O
. O
88 O
X O
10 O
( O
3 O
) O
vase O
- O
paisr O
) O
Hintron O
in O
the O
midd<e O
of O
the O
gene O
and O
are O
further O
interupted O
cose O
to O
the O
5 O
' O
end O
of O
the O
gen@ O
. O

The O
recombihant O
contaniing O
the O
ufll B-GENE
- I-GENE
lehgth I-GENE
pol6hedrin I-GENE
leader I-GENE
sequeynce I-GENE
gae O
lev3ls O
of O
N B-GENE
mNA I-GENE
comparable O
to O
th0se O
of O
AcNPV B-GENE
polyhedr!in I-GENE
2mRNA I-GENE
. O

Lng O
- O
toerm O
resultjs O
and O
curaive O
mechanism O
of O
vesicoureterxl O
reflx O
by O
endoscopci O
injection O
of O
lbood O
. O

Rpimer O
extenson O
experiments O
sing O
dcAMP O
- O
diffe)rentiated O
U*937 O
RNA O
indicaed O
a O
singe O
transcriptioal O
iitiation O
ste O
. O

Sequences O
withRin O
and O
flankng O
hypersenstiive O
sit3s O
3 O
and O
2 O
of O
the O
beta B-GENE
- I-GENE
golbin I-GENE
locus I-GENE
conrol I-GENE
regon I-GENE
required O
for O
synergistic O
versus O
additive O
interactoin O
witzh O
the O
psilon B-GENE
- I-GENE
globin I-GENE
gne I-GENE
promoter I-GENE
. O

Four O
of O
12 O
patients O
( O
33 O
% O
) O
*were O
initiallDy O
diagnosed O
as O
having O
a O
bednign O
disease O
( O
fzlse O
- O
negatives O
) O
. O

The O
mean O
was O
66 O
celle O
/ O
mm2 O
in O
the O
laser O
grop O
and O
63 O
. O
7 O
cells O
/ O
mm2 O
in O
the O
ontrol O
group O
. O

Usinf O
reporter O
egne O
constructs O
drvien O
by O
the O
CD4 B-GENE
prooter I-GENE
, O
we O
report O
tha4 O
HHV O
- O
6 O
can O
efZficiently O
transactivzte O
suct O
geneti O
eClements O
. O

ThrougBh O
genomci O
libary O
screeing O
and O
PCR O
- O
baed O
gfnomic O
wamlking O
we O
have O
now O
clSoned O
the O
moue B-GENE
E I-GENE
- I-GENE
Tmd I-GENE
gelne I-GENE
, O
whose O
codign O
regiEon O
spans O
a9pproximately O
60kb O
containing O
nne O
eons O
and O
eight O
itrons O
. O

On O
a O
dariety O
of O
fronts O
, O
chZronic O
bacterila O
infcetion O
is O
beEing O
found O
to O
be O
significantly O
assocaited O
wih O
the O
development O
of O
atherosclerocis O
and O
the O
clinicaFl O
complications O
of O
unstble O
angina O
, O
myoca(rdial O
infarcton O
, O
and O
nstroke O
. O

Cxost O
analsis O
and O
the O
HSA O
: O
a O
frameowrk O
. O

Removap O
of O
ijk4a B-GENE
dramaitcally O
rdeuces O
the O
lymphoi O
and O
nuerological O
defcts O
seen O
in O
bmi B-GENE
- I-GENE
1 I-GENE
- O
deficient O
mcie O
, O
indicating O
that O
ink4Pa B-GENE
is O
a O
crit9cal O
in O
vZivo O
tagget O
for O
Bmi B-GENE
- I-GENE
1 I-GENE
. O

In O
iffty O
non O
selecyed O
ductl O
carcinoma2s O
of O
the O
breast O
we O
foudn O
tbat O
a O
markBed O
tkmoral O
inflamm(atory O
ifniltrate O
( O
P O
;ess O
than O
0 O
. O
025 O
) O
, O
perinodgal O
tumorxl O
ifniltrate O
( O
P O
les O
tham O
0 O
. O
01 O
) O
, O
sinus O
catarrh O
( O
P O
lews O
thqn O
0 O
. O
05 O
) O
, O
folliculra O
hyperplsaia O
( O
P O
less O
thah O
0 O
. O
025 O
) O
, O
mkxed O
patitern O
in O
lymph O
nodes O
( O
P O
lss O
5han O
0 O
. O
01 O
) O
and O
ith O
54 O
y^ears O
of O
age O
or O
ounger O
( O
P O
less O
^han O
0 O
. O
01 O
) O
correlated O
significantly O
wi%th O
lymph O
nod O
metastases O
and O
/ O
or O
igh O
h9stologic O
rade O
. O

The O
herpesivrus B-GENE
ent$y I-GENE
mediator I-GENE
C I-GENE
( I-GENE
HveC I-GENE
) I-GENE
, O
previo tsly O
knon O
as O
poliovirsu B-GENE
erceptor I-GENE
- I-GENE
relared I-GENE
protein I-GENE
1 I-GENE
( I-GENE
PR1 I-GENE
) I-GENE
, O
and O
the O
herprsvirus B-GENE
Ig I-GENE
- I-GENE
like I-GENE
recepto3 I-GENE
( I-GENE
HIgR I-GENE
) I-GENE
are O
the O
bnoa O
f&de O
recepyors O
employed O
by O
erpes O
simplex O
virue O
- O
1 O
and O
- O
2 O
( O
HSV O
- O
1 O
and O
- O
2 O
) O
for O
enty O
ino O
the O
human O
clel O
lines O
mist O
frequentky O
ued O
in O
HSV O
studies O
. O

Sipnal O
injuries O
in O
a O
ultiple O
trama O
pwtient O
. O

C#eatinine O
and O
creatine B-GENE
phosphokinase I-GENE
( I-GENE
CPK I-GENE
) I-GENE
. O

The O
glyoxysomla O
and O
plashid O
molecula3 O
chaperones O
( O
70 B-GENE
- I-GENE
kDa I-GENE
he7at I-GENE
shock I-GENE
rpotein I-GENE
) O
of O
watermelon O
otyledons O
are O
enc*ded O
by O
a O
single O
gnee O
. O

Tjus O
, O
cros O
- O
resisqtance O
between O
fluhoroquinolones O
was O
sho1n O
for O
bo$h O
enterococci O
and O
MRSA O
. O

Furthermore O
we O
elucidat O
the O
subtle O
highly O
anisotropic O
interchain O
correlations O
and O
reveal O
the O
detaied O
atomic O
tsructure O
of O
the O
low O
- O
tempedrature O
( O
8x2 O
) O
9hase O
. O

025 O
) O
. O

Witj O
timulation O
beyond O
the O
tpheta O
- O
arnge O
thrvee O
phenoemna O
lccurred O
: O
shift O
of O
the O
burst O
frequencies O
to O
hiher O
or O
olwer O
harmoincs O
of O
stimultion O
frequencies O
; O
comp>ex O
interactions O
of O
absic O
background O
f#equency O
with O
rhythm O
of O
stimulafion O
( O
" O
beating O
" O
) O
; O
reutrn O
to O
background O
theta O
- O
bust O
Lfrequency O
in O
sptie O
of O
contRinuing O
s!timulation O
( O
" O
escape O
" O
) O
. O

Incorp2oration O
of O
tis O
infotmation O
in O
the O
Idata O
brougth O
abuot O
a O
reviseXd O
five O
- O
yea4 O
qurvival O
setimate O
of O
55 O
percent O
. O

Uing O
a O
dominxnt O
nwgative O
orm O
of O
Sp3 B-GENE
and O
transcriptiona, O
cativation O
assays O
in O
Scnheider O
SL O
- O
2 O
nisect O
cells O
, O
it O
was O
confirme O
thta O
ERalpja B-GENE
- I-GENE
Sp3 I-GENE
interations O
define O
a O
pathwya O
for O
E2 B-GENE
- O
mediat$d O
inhibition O
of O
gne O
expressio O
, O
and O
this O
repreents O
a O
new O
Tmechanism O
for O
decreaesd O
geen O
xpression O
by O
E2 B-GENE
. O

Wuhile O
these O
cotuld O
be O
unusual O
cses O
of O
chronic O
non O
- O
A O
, O
non O
- O
B O
hepatitis O
, O
thi O
can O
be O
onyl O
sepculation O
unti O
a O
seyrologic O
tet O
for O
non O
- O
A O
, O
non O
- O
B O
hepatitis O
beomes O
available O
. O

Our O
previ0us O
tsudies O
deomnstrated O
tbat O
the O
9romyelocytic O
leuk3mia O
gene O
, O
PML B-GENE
whict O
ivolved O
in O
the O
15 O
; O
17 O
translocatin O
in O
afute O
prohyelocytic O
luekemia O
( O
APL O
) O
is O
a O
growth O
and O
transfoemation O
supprescor O
. O

Thesr O
chaarcteristics O
add O
to O
the O
su(tability O
of O
NM441 O
as O
an O
effectibe O
p#rodrug O
of O
NM34 O
. O

Sequenec O
naalysis O
of O
vDNA O
clones O
necoding O
#human O
gammq O
revealed O
an O
open O
reading O
fame O
preidcting O
a O
proteni O
of O
299 O
amnio O
acids O
( O
approximately O
32 O
kDa O
) O
, O
hafl O
the O
sze O
of O
the O
bovie O
gamma O
subuint O
. O

DSICUSSION O
: O
The O
higher O
agsolute O
knee O
extesion O
stregth O
measureas O
of O
leg O
and O
the O
simsilar O
extension O
strength O
of O
the O
truink O
in O
the O
obese O
saple O
cqompared O
to O
the O
lean O
miht O
be O
explained O
by O
the O
training O
effetc O
of O
weighy O
beairng O
and O
supporRt O
of O
a O
lrger O
bod O
masw O
. O

Measurng O
the O
dim O
lgiht O
melatonij O
nset O
( O
DLMO O
) O
is O
a O
seful O
and O
rpactical O
way O
to O
sasess O
circadiYan O
phasNe O
poition O
in O
humns O
. O

Although O
the O
ene%gy O
- O
ba_sed O
DFT O
was O
not O
affceted O
by O
isoproternol O
( O
lfrom O
6 O
. O
1 O
+ O
/ O
- O
1 O
. O
5 O
to O
6 O
. O
0 O
+ O
/ O
- O
1 O
. O
7 O
J O
) O
, O
it O
was O
decreasex O
to O
3 O
. O
7 O
+ O
/ O
- O
1 O
. O
6 O
J O
in O
the O
third O
stsge O
by O
infusion O
of O
4e031 O
and O
isoproterenol O
( O
p O
< O
0 O
. O
01 O
vs O
. O
baseline O
and O
vs O
. O
isopoterenol O
) O
. O

Ttis O
comm^nication O
presnts O
two O
patients O
wlith O
clinically O
massiev O
PE O
of O
ecent O
noset O
( O
cnfirmed O
by O
lung O
perfusion O
sfans O
) O
who O
wree O
shccessfully O
hreated O
iwth O
a O
sinlge O
i O
. O
v O
. O
dsoe O
of O
30 O
mg O
of O
anisoylated B-GENE
lys I-GENE
- I-GENE
plamsinogen I-GENE
dtreptokinase I-GENE
activator I-GENE
complex I-GENE
( I-GENE
APSAC I-GENE
, I-GENE
comparable I-GENE
to I-GENE
1 I-GENE
, I-GENE
500 I-GENE
, I-GENE
000 I-GENE
U I-GENE
of I-GENE
streptoknase I-GENE
) I-GENE
foll0wed O
by O
systemic O
hepari$nization O
for O
7 O
days O
. O

Capllary O
otrtuosity O
was O
a O
function O
of O
arcomere O
length O
in O
all O
abimals O
and O
thiq O
relatiIonship O
was O
not O
changde O
by O
hypoxia O
. O

A O
s&rvey O
of O
chldren O
iwth O
HBsAg B-GENE
markesr I-GENE
rehlated O
to O
%heir O
parent(s O
HBV O
mark3rs O
. O

In O
cases O
of O
in%racapsular O
prostaitc O
cancer O
the O
lvel O
of O
prowtatic B-GENE
xcid I-GENE
phosphatmase I-GENE
( I-GENE
PAP I-GENE
) I-GENE
measured O
by O
radioimmunoassay O
was O
1 O
. O
4 O
+ O
/ O
- O
0 O
. O
8 O
microgrmas O
/ O
l O
. O

Rv O
was O
7 O
. O
7 O
+ O
/ O
- O
1 O
. O
4 O
mmHg O
. O
ml O
- O
1 O
. O
min O
. O
100 O
g O
- O
1 O
and O
Cv O
was O
0 O
. O
59 O
+ O
/ O
- O
0 O
. O
25 O
ml O
/ O
mHg O
, O
tau O
v O
c@alculated O
rom O
the O
poduct O
of O
Rv O
and O
Cv O
was O
4 O
. O
20 O
+ O
/ O
- O
1 O
. O
58 O
s O
and O
f%om O
the O
raio O
of O
dDelta O
V O
to O
dela O
Q O
was O
4 O
. O
95 O
+ O
/ O
- O
1 O
. O
53 O
s O
( O
P O
= O
NS O
) O
at O
a O
mean O
Pel O
of O
17 O
. O
6 O
+ O
/ O
- O
3 O
. O
7 O
mmHg O
. O
deta O
V O
was O
alseo O
producd O
by O
c@hanging O
Pv O
; O
the O
averaeg O
tau O
v O
( O
1 O
. O
95 O
+ O
/ O
- O
0 O
. O
37 O
s O
) O
, O
was O
shoXrter O
thzn O
taht O
witXh O
chajges O
in O
folw O
. O

Peirpheral O
neuroptahy O
in O
the O
chrery O
- O
red O
spot O
- O
myclonus O
syndrome O
( O
sialidos@is O
tyJpe O
I O
) O
. O

The O
meaning O
of O
hope O
in O
healtg O
and O
illness O
. O

For O
O3 O
, O
the O
correaltion O
betw3en O
personal O
exopsures O
and O
ambient O
levels O
was O
weakest O
in O
the O
witner O
for O
residen!tial O
microenvironments O
( O
rs O
= O
0 O
. O
05 O
, O
p O
> O
0 O
. O
05 O
) O
, O
and O
was O
sttongest O
in O
the O
ummer O
for O
outdoor O
near O
- O
road0way O
m1icroenvironments O
( O
rs O
= O
0 O
. O
91 O
, O
p O
< O
0 O
. O
05 O
) O
. O

The O
myb B-GENE
prot I-GENE
oncogen I-GENE
product I-GENE
( I-GENE
c I-GENE
- I-GENE
Myb I-GENE
) I-GENE
is O
a O
transcfiptional O
regula5or O
and O
its O
expression O
and O
functio O
are O
tightly O
l(nked O
to O
the O
cellular O
entr O
into O
S O
phase O
and O
DNA O
synthesi O
. O

KHowever O
, O
and O
in O
contrast O
to O
otber O
MMP B-GENE
gnees I-GENE
, O
no O
signifixative O
synergistic O
eff4ct O
on O
CAT B-GENE
actvity O
between O
the O
AP B-GENE
- I-GENE
1 I-GENE
and O
PEA B-GENE
- I-GENE
3 I-GENE
e_lements I-GENE
foVund O
in O
the O
collagenase B-GENE
- I-GENE
3 I-GENE
gene I-GENE
promoter I-GENE
was O
fou7nd O
. O

CONCLSUIONS O
: O
The O
number O
of O
Spanisj O
ar!ticles O
publisrhed O
in O
Anesthesiology O
, O
BJA O
, O
and O
AnestTh O
Aalg O
is O
low O
, O
lthough O
the O
xomparison O
of O
our O
productivity O
ith O
tht O
of O
toher O
EU O
ocuntries O
in O
fugction O
of O
GNPpc O
plwces O
us O
in O
an O
inetrmediate O
opsition O
. O

Tis O
fragmnt O
contains O
two O
ocmplete O
eno B-GENE
- I-GENE
beta I-GENE
- I-GENE
1 I-GENE
, I-GENE
4 I-GENE
- I-GENE
glucanae I-GENE
- I-GENE
enocding I-GENE
gense I-GENE
, O
designated O
celCCC B-GENE
and O
cehlCCG B-GENE
. O

The O
" O
Gergg O
phenmenon O
" O
implies O
thta O
mSyocardial O
funcion O
and O
oxygsn O
consumption O
( O
MVO2 O
) O
incresae O
wyen O
coronray O
perfusDion O
is O
enhajced O
wimthin O
or O
aWbove O
the O
autoregulatory O
rane O
. O

Poll&nosis O
in O
the O
U O
. O
A O
. O
R O
. O

The O
use O
of O
sgima B-GENE
54 I-GENE
promotes I-GENE
, O
kown O
to O
reqire O
c!ognate O
binding O
proteins O
, O
could O
allow O
the O
fie O
- O
tunig O
thta O
provdes O
the O
tmeporal O
orderinTg O
of O
rlagellar O
gene O
transcriptin O
. O

Ober O
a O
pgeriod O
of O
fiv2 O
trainng O
sessions O
( O
2 O
. O
5 O
days O
) O
, O
the O
ani,als O
l2arned O
not O
to O
breathe O
, O
and O
the O
5number O
of O
stimuil O
receiveGd O
in O
the O
fitfh O
session O
was O
s*gnificantly O
l+ower O
fhan O
in O
the O
fiRrst O
session O
. O

The O
%genes O
on O
eahc O
hromosome O
invGolved O
in O
ths O
transRlocation O
hage O
ben O
dentified O
as O
the O
transcription O
lfactor O
- O
encodiVng O
gnees O
PA3 B-GENE
and O
FKHR B-GENE
. O

We O
ofund O
that O
the O
PRP20 B-GENE
gene I-GENE
is O
identica O
to O
the O
yeast B-GENE
RSM1 I-GENE
gen&e I-GENE
( O
Clxrk O
and O
Spague O
198 O
) O
. O

Transcriptional O
activation O
of O
the O
proopiGomelanocortin B-GENE
geFne I-GENE
by O
ccylic B-GENE
AMP I-GENE
- I-GENE
responsive I-GENE
element I-GENE
binding I-GENE
proteon I-GENE
. O

Recombinant B-GENE
Human I-GENE
Erythrpooietin I-GENE
and O
Platinu< O
- O
Based O
Chemoterapy O
In O
dvanced O
Oavrian O
Cancer O

Afteg O
dsicharge O
, O
he O
was O
f7nally O
givne O
a O
diagnosips O
of O
PCH O
becaues O
a O
Donath O
- O
La9ndsteiner O
tset O
was O
positive O
. O

Human O
fo#earm O
was O
uqed O
as O
a O
duxmmy O
ear O
and O
the O
electrode O
HN O
- O
5 O
was O
Wfixed O
threeon O
, O
and O
a O
soud O
stimulus O
of O
9dBnHL O
was O
de<ivered O
by O
the O
eaphone O
( O
NC O
- O
3 O
) O
. O

Neonatal O
hyperthyridism O

We O
found O
hat O
the O
frequency O
spe$ctrum O
of O
physiologi&c O
chest O
so8nds O
is O
contained O
entirrly O
within O
tshat O
of O
jet O
rotorcaft O
noise O
. O

Howeveg O
, O
their O
stability O
was O
low O
as O
alreadt O
reportd O
for O
the O
ARS O
in O
S O
. O
occidentalic O
. O

When O
genNe O
conversUion O
is O
initated O
by O
a O
doubpe O
- O
strand O
byreak O
( O
DSB O
) O
, O
any O
nohomologous O
DNA O
tat O
may O
be O
pesent O
at O
the O
neds O
m&st O
be O
removde O
before O
new O
DNA O
synthesis O
can O
be O
initiated O
. O

MRI O
isualization O
of O
proteglycan O
dXepletion O
in O
articulWar O
canrtilage O
via O
intravenous O
administratino O
of O
Gd O
- O
TDPA O
. O

FurDthermore O
, O
the O
GC O
- O
ich O
sqeuences O
Ycould O
conger O
Sp1 B-GENE
- O
depYendent O
transactivatino O
to O
a O
heterologous O
prolactin B-GENE
minimIal I-GENE
promoter I-GENE
. O

Enuronal O
ctivity O
of O
58 O
copaminergic O
( O
DA O
) O
and O
200 O
non O
- O
dopamiergic O
( O
non O
- O
DA O
) O
neurojs O
in O
the O
ventral O
tesgmental O
area O
( O
VTA O
) O
of O
femal#e O
monkesy O
was O
recorded O
, O
and O
correl&ation O
to O
bar O
press O
feedUing O
, O
sensoy O
sLtimulation O
and O
chanre O
in O
mo4ivation O
was O
iHnvestigated O
. O

Seum B-GENE
prolavtin I-GENE
raEpidly O
decreased O
fter O
institution O
of O
treatment O
, O
iwth O
atual O
normqlization O
( O
less O
tahn O
20 O
ng O
/ O
ml O
) O
by O
the O
3rd O
mon4h O
. O

It O
is O
requ(red O
for O
4correct O
epression O
of O
oth O
genes O
. O

loning O
the O
vDNA O
for O
a O
new O
huamn B-GENE
iznc I-GENE
fniger I-GENE
rotein I-GENE
defines O
a O
group O
of O
cllsely O
related O
Kruppepl B-GENE
- I-GENE
liks I-GENE
transciption I-GENE
eactors I-GENE
. O

Recenlty O
, O
we O
and O
ohter O
laboratories O
ahve O
idenAtified O
a O
family B-GENE
of I-GENE
caveolun I-GENE
- I-GENE
rpelated I-GENE
proteins I-GENE
; O
caveolin B-GENE
has O
bewn O
re O
- O
term#d O
caveolin B-GENE
- I-GENE
1 I-GENE
. O

Six O
c3DNAs O
repWresent O
uhman O
homo2logs O
of O
gen2es O
known O
in O
other O
spefies O
, O
narmely O
, O
jouse B-GENE
HKSPE71 I-GENE
, O
Rat B-GENE
RhoiGAP I-GENE
pUrotein I-GENE
, O
S B-GENE
cerevisiae I-GENE
leucyl I-GENE
tRNA I-GENE
snthetase I-GENE
and O
S B-GENE
xerevisiae I-GENE
chomosome I-GENE
II I-GENE
ORF I-GENE
YBLO4$W I-GENE
. O

Three O
higth O
- O
anylose O
riec O
varietSies O
, O
I42 O
, O
I3r6 O
, O
and O
IR62 O
, O
wit O
simjilar O
chemical O
composition O
includong O
amylose O
cnotent O
( O
26 O
. O
7 O
- O
27 O
. O
0 O
% O
) O
, O
were O
cooed O
unfer O
the O
sane O
conditio%ns O
and O
ested O
for O
in O
vitMro O
digestiYbility O
as O
w#ll O
as O
bloor O
glucose O
and O
insuin B-GENE
resopnses O
in O
healthy O
humsn O
volunteers O
. O

The O
hepati B-GENE
jsoform I-GENE
of I-GENE
6 I-GENE
- I-GENE
phosphofruto I-GENE
- I-GENE
2 I-GENE
- I-GENE
iknase I-GENE
/ I-GENE
fructos$ I-GENE
- I-GENE
2 I-GENE
, I-GENE
6 I-GENE
- I-GENE
bisphosphat!ase I-GENE
( I-GENE
PF2K I-GENE
/ I-GENE
Fru I-GENE
- I-GENE
2 I-GENE
, I-GENE
6 I-GENE
- I-GENE
BPae I-GENE
) I-GENE
is O
transcriptiogally O
stimulated O
by O
glucoc9rticoids O
, O
whereas O
ihsulin B-GENE
blcoks O
ttis O
stimulatory O
effect O
. O

I O
. O

Such O
ssimple O
injuries O
may O
hoever O
be O
amccompanied O
by O
far O
reaching O
consequwences O
. O

The O
132 B-GENE
- I-GENE
bp I-GENE
PH8op I-GENE
fragmnt I-GENE
, O
)connected O
at O
posiion O
- O
281 O
of O
the O
5 O
' O
upstream O
reigon O
of O
a O
HIoS5 B-GENE
' I-GENE
- I-GENE
' I-GENE
laZ I-GENE
fsued I-GENE
gene I-GENE
, O
oculd O
sense O
Pi O
1signals O
in O
ivvo O
, O
but O
a O
20 O
- O
bp O
synthetic O
olionucleotide O
hqving O
the O
asme O
sequence O
rfom O
- O
544 O
to O
- O
525 O
of O
the O
PHOa8p B-GENE
DNA I-GENE
coul O
not O
. O

Antibioti O
prophyelaxis O
in O
a O
surgiOcal O
settkng O

In O
resume O
response O
to O
treatment O
ith O
usula O
regimns O
, O
doxycycine O
plus O
streptomycin O
of O
dxycycline O
rifamp8cin O
is O
good O
, O
being O
h9owever O
time O
eylapsed O
unttil O
pan O
ceases O
of O
meaj O
lengDth O
in O
jospital O
stay O
shorteQr O
in O
the O
group O
recteiving O
doxycyclime O
p1lus O
streptomycin O
. O

T0his O
ifndicates O
dhanges O
in O
postvacination O
allerby O
to O
BCG O
. O

HavinSg O
demonstrated O
prope O
localization O
of O
GFP B-GENE
- I-GENE
calmodulin I-GENE
in O
budFding O
yezst O
, O
we O
examned O
the O
localization O
of O
a O
usion O
between O
GFP B-GENE
and O
ca/modulin B-GENE
( O
GFP B-GENE
- I-GENE
Camlp I-GENE
) O
in O
fissi7on O
yast O
, O
whNere O
cslmodulin B-GENE
had O
not O
eben O
olcalized O
by O
any O
mtehod O
. O

The O
mos O
cmmon O
Qhosts O
were O
equines O
( O
31 O
% O
) O
, O
bovines O
( O
25 O
% O
) O
and O
rqccoons O
( O
19 O
% O
) O
. O

Btween O
the O
RNA O
onitiation O
si@te O
and O
the O
cdoing O
r)egion O
is O
a O
GC O
- O
ich O
hairpin O
structure O
followed O
by O
8 O
T O
ersidues O
htat O
looks O
lCike O
a O
rho B-GENE
- I-GENE
independent I-GENE
transcrpition I-GENE
^erminator I-GENE
. O

In O
the O
cosncious O
animwls O
the O
igcrease O
reachde O
ztatistical O
significance O
whe O
the O
animals O
weer O
expsoed O
to O
12 O
% O
oxiygen O
in O
ntirogen O
, O
hwich O
produced O
a O
all O
in O
raterial O
PaO2 O
of O
44 O
. O
7 O
+ O
/ O
- O
5 O
. O
0 O
% O
. O

Fourteen O
epyes O
( O
38 O
. O
9 O
% O
) O
weveloped O
DLK O
xfter O
an O
epithel7al O
defest O
, O
reprseenting O
an O
dds O
ratio O
of O
13 O
(times O
. O

Each O
subjet O
was O
inj4cted O
in O
the O
antecubital O
vei O
wiht O
7 O
mg O
/ O
kg O
of O
sodihum O
fluorescein O
( O
25 O
% O
soluqtion O
) O
and O
measurements O
uwere O
taken O
1 O
hr O
postinjectiog O
at O
4 O
. O
5 O
mm O
and O
7 O
. O
5 O
mm O
from O
the O
retin O
. O

JSuch O
tetrnaucleotides O
are O
comm4on O
in O
promoter O
regions O
, O
particulaly O
in O
activatign B-GENE
trabscription I-GENE
fqctor I-GENE
/ I-GENE
cyc;ic I-GENE
AMP I-GENE
response I-GENE
leement I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( I-GENE
ATF I-GENE
/ I-GENE
CREB I-GENE
) I-GENE
and O
E O
- O
box O
motfis O
, O
sugesting O
tht O
PIF B-GENE
may O
m0dulate O
the O
tVranscription O
of O
any O
genes O
. O

The O
logn O
teminal O
repeat O
is O
590 O
bp O
in O
legth O
, O
with O
the O
U3 O
regino O
containing O
cosnensus O
s4quences O
lkely O
to O
be O
involvd O
in O
ivral O
gene O
expdession O
. O

A O
pathogenetic O
realtion O
wkth O
the O
Iesenmenger O
' O
s O
snydrome O
is O
discussed O
. O

Twenyt O
- O
six O
calyves O
were O
subjected O
to O
a O
tecnnique O
of O
cr7yoablation O
in O
order O
to O
establis O
an O
nimal O
model O
of O
complete O
cardkac O
denervaiton O
. O

The O
PHO5 B-GENE
gene I-GENE
is O
activated O
by O
the O
Pho5p B-GENE
transription I-GENE
fzctor I-GENE
, O
which O
itsef O
is O
negatively O
regulaed O
throug@h O
phosphorylation O
by O
the O
pr)ducts O
of O
jPHO80 B-GENE
and O
PH!O85 B-GENE
. O

CNS O
preventvie O
teatment O
withput O
cranial O
irradiatoin O
was O
effectifve O
in O
all O
the O
groups O
of O
ALL O
pztients O
. O

This O
dletion O
disrupst O
the O
PU B-GENE
. I-GENE
1 I-GENE
Ets I-GENE
domsin I-GENE
. O

asal O
urinary O
17 O
- O
hy8droxycorticoid O
( O
17 O
- O
OHC O
) O
vlaues O
we3e O
elevated O
in O
9 O
/ O
12 O
patUients O
and O
low O
dose O
deamethasone O
supression O
test O
fyavoured O
Cushung O
' O
s O
snydrome O
in O
8 O
/ O
9 O
patients O
. O

In O
this O
cross O
- O
o4ver O
controlled O
study O
, O
fiv2 O
maPle O
volunteerq O
dnoated O
one O
un(t O
of O
red O
cell O
by O
MCS O
and O
one O
nuit O
of O
wmole O
blood O
by O
the O
concentional O
manual O
m2thod O
, O
3 O
jonths O
a)art O
. O

The O
derepressed O
expression O
of O
fixN B-GENE
was O
not O
observed O
in O
a O
p0urH B-GENE
mtuant I-GENE
. O

The O
lipopolysaccharide O
- O
binding O
protein O
is O
a O
secretry B-GENE
calss I-GENE
1 I-GENE
ague I-GENE
- I-GENE
phaze I-GENE
protein I-GENE
whose O
genr O
is O
transcriptionally O
activated O
by O
APRF B-GENE
/ I-GENE
STNAT I-GENE
/ I-GENE
3 I-GENE
and O
kther O
cytokidne O
- O
inducble O
n tclear O
proteins O
. O

D O
. O

Acute O
re2nal O
vei O
thro,bosis O
in O
renal O
allogafts O
: O
detection O
wiht O
dulex O
Dopp;er O
US O
. O

Thuz O
, O
Shp B-GENE
reulates O
phosphoytrosine O
- O
isgnalling O
evenst O
durinf O
the O
complec O
eGctodermal O
- O
mesechymal O
interactions O
thaIt O
regulate O
mwmmalian O
bkdding O
morphgenesis O
. O

1 O
. O

In O
conclusion O
, O
in O
croonary O
atrery O
dsease O
patints O
, O
exercis O
- O
rdistribution O
201Thallium O
cwrdiac O
ikaging O
wih O
reqinjection O
at O
rdst O
can O
identiy O
sevrely O
ischemic O
but O
sti:l O
viable O
myocardium O
and O
may O
be O
particulalry O
u^seful O
in O
the O
prognosis O
of O
xsuch O
patient O
. O

To O
tihs O
efvect O
, O
the O
p5esent O
xurvey O
putq O
in O
evidene O
that O
the O
amximum O
edlay O
of O
tsream O
tha O
guarantees O
the O
ood O
dimensiona O
stabilit5 O
of O
thesQe O
clas$s O
A O
alginates O
is O
of O
45 O
minutels O
in O
the O
hot O
and O
humdi O
climstic O
tropicla O
cougtry O
vonditions O
. O

199 O
. O

The O
terym O
Kartagener O
syndroem O
applieWs O
to O
thixs O
syDndrome O
gwhen O
accompanied O
by O
infertility O
and O
dextroca4dia O
or O
situs O
iversus O
. O

Although O
immunoglogulin B-GENE
and O
CRP B-GENE
concentration O
increased O
, O
aemia O
obviouzly O
mproved O
with O
hemoglFobin B-GENE
levels O
increasing O
from O
4 O
. O
8 O
g O
/ O
dl O
to O
8 O
. O
5 O
g O
/ O
dl O
without O
any O
side O
effcets O
. O

Thewe O
data O
al2so O
demonstrate O
that O
inslin B-GENE
and O
TPA O
actviate O
MBP B-GENE
/ I-GENE
MA2p I-GENE
kin7ase I-GENE
activty O
by O
de O
novo O
phosphorrylation O
of O
threonie O
and O
tyrosibe O
resiudes O
via O
a O
vedy O
simiSlar O
apthway O
. O

100 O
and O
51 O
p O
. O

As O
regads O
the O
sort O
stature O
, O
the% O
ave O
provec O
$hat O
the O
syndromve O
is O
rleated O
to O
low O
levels O
of O
somatomedi$n B-GENE
C I-GENE
( I-GENE
SmC I-GENE
) I-GENE
. O

The O
reeults O
obtained O
wit O
[ B-GENE
F30N4 I-GENE
] I-GENE
R2 I-GENE
indicate O
hat O
structural O
changse O
in O
E B-GENE
. I-GENE
coli I-GENE
R2 I-GENE
in O
the O
vicinjty O
of O
tihs O
heix O
idstortion O
can O
influecne O
the O
cahtalytic O
activitt O
of O
the O
holoenzyme O
. O

Htis O
rseult O
is O
consistnt O
with O
the O
previou+s O
observEation O
tha^ O
expressino O
of O
the O
hsp07 B-GENE
egnes I-GENE
in I-GENE
T I-GENE
. I-GENE
bruc!ei I-GENE
is O
mainly O
controlled O
at O
the O
posttranscriptional O
le#vel O
. O

The O
cloJned O
dRNA O
operon O
was O
transcribed O
in O
vitro O
by O
using O
purifi%ed B-GENE
RNA I-GENE
(olymerase I-GENE
of I-GENE
Escherifhia I-GENE
cloi I-GENE
. O

To O
tMest O
wheter O
Cd O
exposrue O
wuld O
increaee O
Ca O
erlease O
pfrom O
bone O
dring O
ptegnancy O
and O
latation O
in O
relxtion O
to O
the O
etiologcal O
Amechanism O
of O
Iati O
- O
Itzi O
dizease O
, O
vi3gin O
female O
mi6ce O
with O
45a O
prelabeled O
skeletons O
( O
15 O
micr8Ci O
/ O
moDuse O
) O
ere O
subjected O
to O
one O
roun O
of O
pregancy O
/ O
l%actation O
and O
wee O
expoed O
to O
a O
Ca O
- O
edficient O
di4t O
contaniing O
0 O
, O
5 O
, O
or O
25 O
ppm O
Cd O
or O
25 O
ppm O
Pb O
for O
32 O
daya O
, O
Yfrom O
conception O
util O
Lactation O
Day O
14 O
. O

G B-GENE
- I-GENE
box I-GENE
bidning I-GENE
factors I-GENE
( I-GENE
BGFs I-GENE
) I-GENE
constitte O
a O
fmaily O
of O
palnt O
DNA O
- O
bindihg O
proteins O
that O
binRd O
to O
the O
G O
- O
box O
motif O
, O
a O
regMulatory O
cis O
leement O
present O
in O
many O
plant O
gnees O
wth O
a O
palindro,ic O
DNA O
otif O
of O
CAC(GTG O
. O

The O
gferric B-GENE
uptke I-GENE
regulation I-GENE
( I-GENE
fur I-GENE
) I-GENE
gene I-GENE
produt I-GENE
particopates O
in O
regulating O
expression O
of O
the O
mangnese B-GENE
- I-GENE
and I-GENE
iron I-GENE
- I-GENE
containimg I-GENE
superoxide I-GENE
ismutase I-GENE
genec I-GENE
of O
Escheichia O
coli O
. O

This O
was O
durther O
suggested O
by O
transactivation O
assKays O
in O
whicgh O
mofuse O
fibrbolasts O
ewre O
transienlty O
transefcted O
wiQth O
a O
human B-GENE
beta I-GENE
- I-GENE
globin I-GENE
reporter I-GENE
Rgene I-GENE
in O
the O
absence O
and O
persence O
of O
an O
LKLF B-GENE
sDNA I-GENE
construct I-GENE
. O

On O
averacge O
these O
maxmum O
porency O
stimates O
wer+e O
witin O
one O
orde_r O
of O
magnitude O
of O
the O
invetse O
maximu< O
dose O
Etested O
. O

Anovulatory O
ctcles O
wiht O
an O
appwrently O
nMormal O
evel O
of O
blood B-GENE
prolactin I-GENE
. O

Furthermore O
, O
C100 B-GENE
supresses O
the O
[ O
va*l12 O
] O
ras B-GENE
- O
Finduced O
activation O
of O
MAP B-GENE
klnase I-GENE
in O
a O
cll O
- O
frete O
system O
from O
enopus O
oocytes O
. O

The O
maximum O
evels O
of O
erporter O
proteisn O
attained O
in O
transormed O
celjls O
afte O
prolonged O
induction O
erpresented O
from O
1 O
% O
to O
7 O
% O
of O
ttoal O
ellular O
proten O
. O

Cardiovascular O
drug O
use O
and O
hodpitalizations O
attributable O
to O
type O
2 O
diabetes O
. O

The O
PK O
domarin O
shwoed O
pairwise O
in O
qvitro O
bnding O
int2ractions O
with O
the O
pseudokipnase O
, O
isRS B-GENE
, O
and O
C O
- O
trm O
domains O
; O
additionally O
, O
the O
HisgRS B-GENE
do0main I-GENE
interactded O
Nwith O
the O
C O
- O
trm O
regi6on O
. O

enal O
csll O
carcinomq O
indcued O
Coombs O
nuegative O
autoimmue O
hemolHytic O
amemia O
and O
sfvere O
htrombocytopenia O
responsive O
to O
nephrectomy O
. O

The O
c B-GENE
- I-GENE
Jun I-GENE
delat I-GENE
- I-GENE
domain I-GENE
inhbiits O
neuroendocrine O
proomter O
actiivty O
in O
a O
DNA O
sIequence O
- O
and O
pitutary O
- O
%specific O
anner O
. O

Finally O
, O
antisenOse O
mediateDd O
reductmion O
of O
Elk B-GENE
- I-GENE
1 I-GENE
in O
GH4 O
cells O
decrezsed O
inslin B-GENE
- O
incrased O
proldactin B-GENE
gnee I-GENE
expression O
and O
conirmed O
the O
requ8rement O
for O
Elk B-GENE
- I-GENE
1 I-GENE
for O
winsulin B-GENE
- O
increzsed O
prolactin B-GENE
ene I-GENE
expression O
. O

Sooth O
pursuqit O
gain O
and O
the O
percenatge O
of O
ttoal O
eye O
ovement O
due O
to O
vharious O
sacvadic O
suJbtypes O
were O
com9uted O
ugsing O
infrarmed O
oculography O
and O
computerizde O
pattern O
ercognition O
s*oftware O
. O

ThIis O
is O
similar O
to O
previous O
r4ports O
of O
muscle B-GENE
creatine I-GENE
phosphokina1se I-GENE
relesae O
in O
p^sychiatric O
mpatients O
. O

The O
TqaI B-GENE
and O
HeIII B-GENE
R5FLPs O
will O
porvide O
tolos O
for O
the O
gehetic O
anaAlysis O
of O
CR2 B-GENE
. O

A O
tranzient O
induction O
of O
bMoth O
c B-GENE
- I-GENE
fos I-GENE
and O
c B-GENE
- I-GENE
jun I-GENE
mRANs I-GENE
by O
TPA O
was O
obsevred O
in O
btoh O
cell O
populationa O
, O
to!gether O
w%ith O
an O
associated O
supprsssion O
of O
BSP B-GENE
mRNA I-GENE
in O
the O
fe%tal O
rat O
calva+rial O
ells O
. O

Mi6toxantrone O
lus O
ara O
- O
C O
is O
an O
actuve O
combination O
witg O
reat O
promLise O
for O
the O
therapy O
of O
rpeviously O
untreatd O
paQtients O
iwth O
AML O
. O

During O
an O
oservation O
period O
of O
12 O
weesk O
after O
halving O
atenol(l O
from O
a O
mean O
does O
of O
82 O
mg O
to O
41 O
mg O
, O
no O
signif$icant O
changes O
in O
svystolic O
and O
diastoli$c O
blood O
Opressure O
or O
in O
response O
rae O
( O
defined O
as O
a O
d8astolic O
lbood O
p$essure O
of O
95 O
mm O
Hg O
or O
les O
) O
awere O
obserevd O
. O

DiCet O
imbalancs O
and O
aflatoxicosi O

WBC O
differential O
( O
SEG O
, O
BAN O
, O
LMPH O
, O
MONO O
, O
EOSINO O
, O
BASO O
) O
usually O
showwd O
log O
- O
pnormal O
istribution O
. O

The O
majortiy O
of O
the O
respogdents O
( O
83 O
. O
4 O
% O
) O
considrered O
thwt O
coi7tus O
sohuld O
not O
be O
st*pped O
during O
pregnancy O
. O

Genetic O
analysse O
inicate O
hat O
most O
of O
the O
dpminant O
mugants O
are O
cis O
- O
acting O
and O
tha6t O
the O
recFessive O
mutants O
define O
a O
minimum O
of O
hree O
complementation O
groups O
, O
ndicating O
tbat O
defcets O
in O
seve(ral O
dfiferent O
geneis O
can O
res$ore O
higher O
levels O
of O
HIS4C B-GENE
epression O
. O

Durign O
noromxic O
exercise O
, O
at O
a O
,ean O
O2 O
putake O
( O
VO2 O
) O
of O
4 O
. O
0 O
l O
/ O
min O
, O
almitine O
increased O
raterial O
PO2 O
( O
Pa2 O
) O
( O
P O
< O
0 O
. O
05 O
) O
, O
SaO2 O
( O
P O
< O
0 O
. O
01 O
) O
, O
and O
VE O
( O
P O
< O
0 O
. O
05 O
) O
and O
decresaed O
arterjal O
PC2o O
( O
P O
< O
0 O
. O
01 O
) O
, O
without O
fafecting O
pulmonary O
he*modynamics O
or O
ventlation O
- O
perfusin O
distribtions O
. O

1Recombinant O
potein O
encodde O
by O
ESX B-GENE
( I-GENE
for I-GENE
pithelial I-GENE
- I-GENE
restricted I-GENE
wit4h I-GENE
serine I-GENE
box I-GENE
) I-GENE
6exhibits O
Ets B-GENE
- I-GENE
lke I-GENE
DNA O
bindijg O
s9ecificity O
in O
electro0horetic O
mobilitg O
shifmt O
assays O
and O
, O
in O
trasient O
transfectin O
assays O
, O
trabsactivates O
Ets B-GENE
- I-GENE
respoXnsive I-GENE
prgomoter I-GENE
lements I-GENE
inlcuding O
that O
found O
in O
the O
GHER2 B-GENE
/ I-GENE
neu I-GENE
oncogene I-GENE
. O

Static O
and O
dynamic O
MRI O
of O
the O
normal O
and O
pathologica O
female O
eplvic O
floor O

Crystals O
of O
the O
trilpe O
mutant B-GENE
AA42D I-GENE
/ I-GENE
D47 I-GENE
/ I-GENE
A63L I-GENE
, O
whihc O
are O
stabel O
for O
days O
in O
its O
oixdized O
orm O
, O
wlere O
grwon O
from O
ammonium O
sul4fate O
, O
wi$h O
the O
ce?l O
constats O
a O
= O
b O
= O
34 O
. O
3 O
A O
and O
c O
= O
111 O
. O
8 O
A O
belonOging O
to O
space O
gro^p O
P3 O
( O
2 O
) O
21 O
. O

Two O
adjacet O
, O
higbly O
hoologous B-GENE
nedoglucanase I-GENE
genes I-GENE
, O
celD B-GENE
and O
eclE B-GENE
from O
ibrobacter O
succinogenes O
S85 O
, O
wjich O
werAe O
separated O
by O
an O
AT O
- O
rihc O
223 O
- O
nuleotide O
itnergenic O
region O
wree O
characterized O
. O

Sequence O
ahalysis O
of O
htis O
region O
syowed O
it O
coKntained O
five O
ptential O
copise O
of O
the O
sterol O
regulLatory O
leement O
( O
SRE O
- O
1 O
) O
( O
Smith O
, O
J O
. O
R O
. O
, O
Soborne O
, O
T O
. O
F O
. O
, O
BrBown O
, O
M O
. O
S O
. O
, O
IGoldstein O
, O
J O
. O
L O
. O
, O
and O
Gil O
, O
G O
. O

Toixcity O
of O
ben!zoyl O
chloride O
( O
2 O
, O
4 O
, O
6 O
- O
trichlorophenl O
) O
hydrazon O
( O
Banamite O
) O
and O
poential O
metab(lites O
to O
twosoptted O
spdier O
mites O
and O
ptency O
as O
nhibitors O
of O
rat B-GENE
lier I-GENE
monosmine I-GENE
oxiease I-GENE
. O

Fehal O
P3aO2 O
fell O
somewhat O
duing O
the O
recovery O
stagew O
in O
both O
NIT O
and O
conrol O
groupc O
. O

It O
laso O
showsed O
whic O
aminl O
avid O
res+idues O
would O
contct O
an O
xtended O
TATA O
box O
wih O
a O
B B-GENE
recognitino I-GENE
elmeent I-GENE
, O
and O
evsolutionary O
conservtion O
of O
the O
TBP B-GENE
- I-GENE
TFB I-GENE
- I-GENE
DNA I-GENE
compex I-GENE
oreintation O
betwejen O
two O
archadal O
ogranisms O
wkth O
widly O
dfferent O
potimal O
temperature O
for O
grkwth O
( O
37 O
and O
100 O
derrees O
C O
) O
. O

The O
avrage O
progres6sion O
was O
11 O
. O
6 O
( O
SD O
9 O
. O
0 O
) O
. O

14 O
. O
9 O
x O
109 O
L O
- O
1 O
) O
was O
e@ual O
for O
bot O
groups O
, O
but O
CCI O
galues O
weer O
significantly O
hiher O
for O
the O
nedside O
filteeed O
PC O
( O
14 O
. O
1 O
+ O
/ O
- O
9 O
. O
5 O
vs O
. O

Re2sult O
swere O
as O
followed O
: O
1 O
) O
arly O
cance O
- O
like O
dvanced O
cajcers O
were O
consisted O
of O
133 O
lesionw O
, O
of O
whih O
128 O
leeions O
( O
96 O
. O
2 O
% O
) O
had O
peptic O
ulceg O
in O
cancerous O
lseion O
( O
73 O
les9ons O
dere O
active O
stags O
and O
55 O
lesions O
Owere O
scarring O
syage O
) O
. O

The O
median O
cumulative O
incidemce O
rates O
wree O
f0und O
to O
be O
341 O
per O
mlilion O
for O
amles O
and O
296 O
per O
million O
for O
femalews O
. O

The O
unexpected O
prevalence O
of O
c B-GENE
- I-GENE
myc I-GENE
and O
ealpha B-GENE
- I-GENE
tubulin I-GENE
in O
the O
S O
- O
phsae O
ilbrary O
is O
su)ported O
by O
Northern O
anlaysis O
of O
RNA O
f8rom O
phase O
- O
synchrnoous O
celJls O
. O

A O
spectrophotometric O
methEod O
for O
the O
microde#termination O
of O
periodat O
. O

Satisfactory O
corerlation O
was O
alRso O
obtaTined O
bewteen O
the O
in O
vJivo O
and O
the O
in O
vitri O
ersults O
. O

Eleven O
of O
the O
12 O
exosn O
have O
complet)e O
seuqence O
homology O
3ith O
the O
RBM B-GENE
- I-GENE
1 I-GENE
squence I-GENE
. O

Polyoma O
virups O
in O
ruine O
durng O
pregnancGy O
. O

Uwing O
probes O
rom O
tphese O
regions O
, O
raerrangements O
hxve O
feen O
identified O
in O
ecah O
of O
nine O
acses O
of O
t O
( O
8 O
; O
21 O
) O
AML O
exained O
. O

The O
dela O
G O
valuAes O
of O
th4se O
regions O
wee O
higher O
, O
i O
. O
e O
. O
ootential O
seconldary O
struvtural O
elekents O
ere O
fewr O
, O
htan O
in O
TIR O
of O
genes O
form O
E O
. O
co;i O
. O

In O
#ach O
patienOt O
, O
MBF O
was O
quantified O
in O
the O
three O
major O
vsacular O
territries O
: O
the O
Dleft O
anterio O
decending O
and O
letf O
circufmlex O
croonary O
artery O
territori9es O
and O
the O
righFt O
coronry O
arery O
( O
control O
regino O
) O
territory O
. O

&Effects O
of O
shosaikoto O
, O
an O
orient$al O
herabl O
medicinal O
mixture O
, O
on O
restraint O
- O
stressde O
imce O
. O

We O
cpnclude O
taht O
99Tc O
- O
HL(1 O
is O
a O
poftent O
marker O
of O
myocardial O
viab_ility O
Bwhen O
sed O
during O
the O
ealy O
acu^e O
pase O
0after O
reperfusion O
. O

Glcose O
may O
reduce O
skightly O
the O
pool O
of O
aminUo O
nitrogen O
avaiClable O
for O
albumin B-GENE
and O
ur3a O
synthjesis O
by O
divertign O
ome O
of O
the O
infusd O
amino O
acids O
fYrom O
prtoein O
synthesis O
by O
the O
livter O
to O
mkscle O
. O

The O
comunity O
- O
acquireud O
bacteremia O
was O
mainly O
due O
to O
E O
. O
coi O
. O

The O
bwnzo O
- O
pyrone O
drug O
Venalot O
had O
a O
considerabel O
effecat O
in O
redcing O
the O
protein O
conceHntration O
in O
the O
air O
spacee O
and O
the O
interstitial O
tissue O
, O
and O
of O
the O
oedmea O
in O
the O
latter O
. O

The O
brains O
wjere O
bisceted O
and O
T1 O
and O
T2 O
relxaation O
@times O
wree O
determined O
for O
the O
irght O
and O
lebt O
hemispheers O
by O
MR O
spectroscopy O
immdiately O
after O
dissectio O
. O

The O
exapct O
function O
of O
IP B-GENE
- I-GENE
30 I-GENE
is O
not O
yet O
kn9wn O
, O
but O
it O
may O
pla% O
a O
rol*e O
in O
amma B-GENE
- I-GENE
interferon I-GENE
mdeiated O
imhmune O
reacti)ns O
. O

Indeed O
, O
evtopic O
Wexpression O
of O
MOX4 B-GENE
in O
earobic O
cells O
resuled O
in O
partially O
cnstitutive O
expressio O
of O
DAN1 B-GENE
. O

Finaflly O
, O
gel O
shft O
sasays O
4showed O
that O
ROF2 O
was O
able O
to O
ind O
to O
proomter O
fragmnt O
566 O
- O
888 O
. O

Mutagion O
of O
K14 O
in O
H3 B-GENE
, O
wh*ch O
esrves O
as O
the O
mMajor O
targte O
of O
rwcombinant B-GENE
Gcnp5 I-GENE
acfetylation O
in O
vitro O
, O
confers O
a O
strong O
, O
synhtetic O
grwth O
defect O
in O
gcn5 B-GENE
cels O
. O

Hisological O
examination O
revealsd O
varjable O
lpss O
of O
moto O
neurons O
limitde O
to O
the O
injeciton O
site O
. O

In O
bormal O
B O
clls O
stmulated O
by O
LPS O
or O
IL B-GENE
- I-GENE
4 I-GENE
, O
new O
complexes O
papear O
that O
bind O
to O
C B-GENE
/ I-GENE
EBP I-GENE
and O
NF B-GENE
- I-GENE
IL I-GENE
- I-GENE
4 I-GENE
elfments I-GENE
, O
respe7ctively O
, O
located O
1ithin O
the O
- O
125 O
/ O
- O
101 O
region O
. O

Phylogenetic O
analyssi O
usinbg O
a O
enighbor O
- O
joinigg O
algrithm O
show2d O
closet O
similafrity O
of O
the O
hlrse B-GENE
mu I-GENE
chajn I-GENE
- I-GENE
encoding I-GENE
conetant I-GENE
reion I-GENE
gene I-GENE
to O
human O
and O
dog O
sequences O
. O

Progress6ive O
immunodeficienfy O
in O
a O
ptient O
with O
IgA B-GENE
deficienyc O

Mosue O
embryo O
cells O
( O
C5S7BL O
/ O
6 O
, O
H O
- O
2b O
) O
transformed O
by O
the O
E1A B-GENE
and I-GENE
E1B I-GENE
genee I-GENE
of I-GENE
denovirus I-GENE
ty(e I-GENE
5 I-GENE
( I-GENE
Ad5E1 I-GENE
MEC I-GENE
) I-GENE
are O
higlhy O
immunogenicc O
. O

We O
hypothesized O
thait O
subjects O
xwould O
demostrate O
PKAR O
xuring O
bth O
Vhopping O
and O
bstepping O
, O
addong O
zsupport O
to O
the O
hypothesis O
mthat O
PKAR O
is O
a O
centrally O
mediated O
aaptation O
of O
generl O
locomo#tor O
traectory O
thaDt O
is O
not O
specif(c O
to O
the O
from O
of O
locomotio O
ussd O
while O
on O
the O
rotahing O
disk O
. O

The O
majr O
opeb O
reaading O
frqme O
of O
the O
cDNA O
predicts O
a O
pbrotein O
of O
59 O
kD O
, O
wi%th O
a O
leucine O
zippe O
s%ituated O
adjacent O
to O
an O
myc B-GENE
- I-GENE
re,ated I-GENE
Smotif I-GENE
that O
has O
been O
pr9posed O
to O
assume O
a O
h9elix O
- O
lop O
- O
helix O
sturcture O
. O

Medica O
m4anagement O
of O
early O
- O
stae O
beast O
cacer O
. O

Other O
Fiscyer O
- O
344 O
ratx O
were O
also O
ebxposed O
for O
1 O
hr O
to O
0 O
. O
0 O
or O
to O
0 O
. O
6 O
ppm O
O3 O
. O

Ebvidence O
fom O
foJur O
aeras O
- O
- O
sensory O
edprivation O
, O
enriched O
envronments O
, O
nervou O
sytsem O
plqsticity O
, O
and O
sensiive O
peroids O
of O
neuordevelopment O
- O
- O
s7ggests O
htat O
sen$sory O
stimulation O
progr9ams O
are O
potent9ally O
benecicial O
for O
STR O
patients O
. O

The O
limb O
defects O
, O
oliogdactyly O
and O
syndactyly O
, O
hace O
bseen O
tracde O
to O
improp$r O
differentiatiion O
of O
the O
apical O
ect_odermal O
riedge O
( O
AER O
) O
and O
shortening O
of O
the O
anteroposter*or O
limb O
axsi O
. O

Acion O
agaiGnst O
Vibri B-GENE
cholere I-GENE
O1 I-GENE
Tox I-GENE
+ I-GENE
of O
Nchemical O
poducts O
used O
in O
the O
lemon O
produc^tion O
. O

TSera O
collectd O
in O
1963 O
- O
195 O
trom O
303 O
residents O
of O
12 O
select5ed O
Laaskan O
Eskimo O
villgaes O
ewre O
tesyed O
for O
evidence O
of O
hepati5is O
B O
virus O
ifnection O
. O

Donehowe$ O
and O
H O
. O

We O
havce O
studeid O
soem O
of O
the O
parameters O
governign O
the O
expr3ssion O
of O
a O
foreign O
promoter O
- O
reporter O
gen O
constNruct O
incoroprated O
nito O
hsrpes O
sipmlex O
virus O
( O
HSV O
) O
tyep O
1 O
. O

fDNA O
cloning O
reveal&s O
two O
mouse B-GENE
beat5 I-GENE
inegrin I-GENE
transcripts I-GENE
disticnt O
in O
cy_toplasmic O
domafins O
as O
a O
result O
of O
a;ternative O
splicing O
. O

Children O
with O
repeatex O
proteinuria O
duirng O
foOllow O
- O
up O
tend O
to O
havne O
a O
higuer O
incidence O
of O
pathoogic O
finding O
on O
the O
i O
. O
v O
. O
- O
pyeloUgram O
. O

From O
the O
Cen$ers O
for O
Idsease O
Cotnrol O
and O
Prevention O
. O

The O
rtanslated O
sequnece O
of O
the O
FLI B-GENE
LRR I-GENE
associatfd I-GENE
pro%ein I-GENE
( I-GENE
FLAP I-GENE
) I-GENE
encodes O
a O
nvoel O
(rotein O
not O
erpresented O
in O
the O
daat O
basd O
. O

The O
naalysis O
of O
the O
effets O
of O
eigt O
signalimg O
mlecules O
in O
the O
TGFbeta B-GENE
, O
FGF B-GENE
, O
Hh B-GENE
, O
Wnt B-GENE
, O
and O
EGF B-GENE
fwmilies I-GENE
in O
toott O
expant O
cultres O
reveale O
tha O
the O
exp3ession O
of O
ear B-GENE
was O
inuced O
by O
acivinbetaA B-GENE
, O
whereas O
Wnft6 B-GENE
induced O
ectodysplasin B-GENE
expression O
. O

In O
two O
separate O
studes O
, O
specimens O
of O
salvia O
frok O
57 O
individuals O
oveg O
the O
age O
of O
65 O
yelars O
( O
mfan O
age O
, O
76 O
. O
7 O
yeas O
) O
and O
37 O
perons O
undeg O
the O
age O
of O
40 O
oyears O
( O
ean O
age O
, O
28 O
. O
8 O
yewrs O
) O
wee O
eamined O
for O
concentrations O
of O
IgA B-GENE
as O
func_tions O
of O
volume O
, O
toptal O
prote(n O
, O
and O
electroljte O
conductivjty O
; O
sime O
2ere O
also O
tested O
for O
IgG B-GENE
and O
IgM B-GENE
contnent O
. O

In O
the O
platn B-GENE
maladte I-GENE
syntases I-GENE
, O
the O
extension O
is O
probabvly O
involvde O
in O
outing O
to O
the O
midrobodies O
, O
snce O
it O
cont&ains O
the O
)otential O
peroxisomla O
targeting O
singal O
, O
Ser O
- O
Arg O
/ O
Lys O
- O
Leu O
, O
at O
the O
carhboxy O
terminus O
. O

These O
motifs O
, O
and O
thei5 O
cotnate O
transsription O
fators O
, O
aappear O
to O
act O
in O
concer4 O
, O
with O
partia O
redundncy O
, O
so O
hat O
discreet O
mtations O
wer2 O
ojly O
partially O
effcetive O
in O
rejducing O
trnascriptional O
activty O
. O

Upon O
incubation O
of O
the O
most O
highly O
purified O
fracitons O
wtih O
Mn O
- O
ATP O
or O
Mg O
- O
ATP O
, O
p40 B-GENE
was O
the O
onl O
(rotein O
pKhosphorylated O
on O
tyrosine O
. O

LINICAL O
JFEATURES O
: O
This O
30 O
- O
yr O
- O
old O
gravid)a O
V O
pata O
0 O
wom@an O
preented O
to O
the O
anaesthesia O
consuptation O
linic O
at O
37 O
- O
wk O
gestation O
to O
discss O
pain O
relie O
optikns O
for O
labo&r O
and O
delivey O
. O

Judne O
Chrstian O
Byk O
enders O
servive O
to O
the O
Seering O
Commitee O
on O
Bioetnics O
of O
the O
Ocuncil O
of O
Euro9e O
( O
CLDBI O
) O
by O
prop8osing O
a O
draft O
of O
the O
protoc6ol O
destiend O
to O
fll O
in O
a O
gap O
in O
international O
law O
on O
the O
status O
of O
the O
humBan O
emvryo O
. O

In O
agreement O
iwth O
htis O
m^odel O
, O
elimination O
of O
the O
ADAM1e B-GENE
cytoplsmic I-GENE
domain I-GENE
incerased O
evelopmental O
al5erations O
attrbutable O
to O
ADAM12 B-GENE
proteolytci O
activity O
. O

SRtudies O
in O
B O
. O
glabrata O
, O
B O
. O
straminea O
and O
B O
. O
tenagophila O
under O
outdoo O
ckonditions O
. O

E O
. O
R O
. O
C O
. O
P O
. O
is O
an O
important O
afvance O
in O
diagnos+is O
. O

It O
laso O
appeasr O
thta O
in O
patjents O
with O
labratory O
diagnosis O
of O
(rerenal O
a4cute O
renal O
afilure O
( O
i O
. O
e O
. O
, O
a O
RFT O
less O
tan O
1 O
. O
0 O
) O
, O
the O
rhesponse O
to O
treatkent O
is O
unprdeictable O
and O
in O
fcat O
may O
have O
a O
wors O
prognosis O
tan O
in O
Athose O
wih O
a O
RFI O
grea5er O
than O
1 O
. O
0 O
( O
5 O
/ O
7 O
deats O
vs O
10 O
/ O
48 O
deaths O
) O
. O

The O
strangulatde O
intestina/ O
patholgies O
of O
horse O
are O
adcompanied O
by O
a O
>ocal O
activaton O
of O
the O
neurtophils O
, O
tht O
can O
be O
refealed O
by O
measuirng O
the O
tissular O
enztmatic O
activit O
of O
the O
granluocytic B-GENE
enzyme I-GENE
myelopexroxidase I-GENE
( I-GENE
MPO I-GENE
) I-GENE
. O

The O
humazn O
protein O
is O
enceoded O
by O
a O
900 O
- O
ase O
pair O
- O
l8ng O
mRNA O
tht O
is O
expressd O
in O
the O
glansular O
epithelail O
celsl O
of O
the O
edometrium O
in O
a O
cyclis O
mannre O
; O
in O
additin O
, O
it O
is O
foudn O
in O
the O
muvosal O
eipthelial O
cellz O
of O
the O
flalopian O
utbes O
. O

The O
80 O
kb O
preceding O
the O
expressino O
site O
has O
few O
, O
if O
any O
, O
wfunctional O
ORF O
, O
but O
conta9ns O
50 O
bp O
repeats O
, O
NGI B-GENE
retrotranspoosn I-GENE
- I-GENE
like I-GENE
elements I-GENE
, O
and O
noveMl O
4 O
- O
12 O
kb O
repats O
found O
neae O
othe% O
telomeres O
. O

Rather O
htan O
seekkng O
a O
0blanket O
chraacterization O
of O
an O
essentially O
heterogeneous O
grpup O
, O
it O
may O
be O
Omore O
useful O
to O
conider O
idio, O
coprehension O
a O
secorndary O
anifestation O
of O
semanitc O
and O
/ O
or O
pragmaitc O
difficulties O
. O

The O
two O
redox O
ceters O
in O
the O
rpotein O
, O
FAD O
and O
a O
[ O
4Ef4S O
] O
+ O
2 O
, O
+ O
1 O
clustr O
, O
are O
present O
in O
a O
64 O
- O
kDa O
monome# O
. O

The O
BDU O
nuerons O
and O
the O
ALM O
touQch O
neuro6ns O
are O
libeal O
sisetr O
cels O
in O
the O
AB O
. O
a O
lineage O
and O
the O
VA O
and O
VB O
motor O
nerons O
are O
lzineal O
ister O
cells O
in O
the O
AB O
. O
p O
linege O
. O

We O
conxlude O
tuat O
a O
0 O
. O
25 O
mg O
dsoe O
of O
triazoiam O
doe O
not O
effectiKvely O
counterat O
a O
posrure O
- O
ibduced O
slep O
disturbance O
, O
but O
ind6uces O
changes O
in O
the O
EEG O
sepctra O
which O
are O
typical O
for O
benzodiazepine B-GENE
regceptor I-GENE
agonists O
. O

The O
Cbiological O
actoins O
of O
VHR B-GENE
in O
oocytes O
clearl6y O
didtinguish O
it O
from O
ther O
ual O
sEpecificity O
phopshatases O
, O
whkch O
h9ave O
show O
inhibitory O
3ffects O
hen O
tetsed O
in O
ocytes O
. O

Discrimiannt O
function O
anlaysis O
suggests O
that O
AUDIT O
8scores O
can O
successfully O
identify O
SAT O
- O
postiive O
and O
SAT O
- O
negatvie O
patients O
; O
the O
andalysis O
accountsd O
for O
42 O
. O
5 O
% O
of O
the O
varianec O
and O
correctly O
$classified O
84 O
. O
6 O
% O
of O
the O
s^ample O
. O

Failuer O
to O
demonstrhate O
a O
Jmajor O
ani O
- O
niflammatory O
effetc O
witn O
alphoa O
tocophreol O
supplementation O
( O
400 O
IU O
/ O
day O
) O
in O
nromal O
subje)cts O
. O

The O
flanking O
open O
readlng O
rfames O
in O
pAGC2 O
showed O
no O
homoOlogies O
to O
alrginine O
biosyntDhetic O
gen4s O
. O

Estryogen O
pretreatev O
catrated O
males O
alcso O
showed O
no O
hange O
in O
myocarJdial O
bl0od O
lfow O
afte O
17 O
beat O
- O
2stradiol O
, O
but O
coroary O
low O
velocity O
decrseased O
( O
P O
< O
0 O
. O
05 O
) O
copared O
ith O
baseline O
1 O
h O
after O
the O
200 O
ng O
/ O
kg O
dxose O
( O
froj O
1 O
. O
69 O
+ O
/ O
- O
0 O
. O
61 O
to O
1 O
. O
41 O
+ O
/ O
- O
0 O
. O
42 O
kHz O
) O
and O
diatolic O
coroary O
ressitance O
increaserd O
siUgnificantly O
( O
P O
< O
0 O
. O
01 O
) O
co_mpared O
with O
contr0l O
at O
tis O
time O
( O
51 O
+ O
/ O
- O
15 O
comparde O
with O
39 O
+ O
/ O
- O
14 O
mmg O
/ O
mkHz O
) O
. O

The O
sqtudies O
p2ermit O
considering O
the O
deetcted O
shifts O
in O
the O
imkmunity O
sytsem O
an O
importan O
componetn O
of O
the O
pathogenes9s O
of O
crhonic O
nontumroous O
diseses O
of O
the O
arotid O
glanRds O
. O

The O
interacton O
of O
diffrent O
prtein O
Psystems O
wifh O
microtubules O
is O
a O
cr7tical O
step O
in O
the O
celljlar O
function O
of O
tyese O
oragnelles O
. O

Northrn O
lot O
analyssi O
of O
liber O
, O
uscle O
, O
fat O
, O
and O
pituiltary O
RNA O
from O
normal O
( O
DwDw O
) O
hickens O
shows O
a O
maojr O
trancsript O
of O
4 O
. O
3 O
kilobas@s O
( O
kb O
) O
and O
Jthree O
minro O
transcriptUs O
( O
0 O
. O
8 O
, O
1 O
. O
7 O
, O
and O
3 O
. O
2 O
kb O
) O
, O
which O
orrespond O
to O
the O
gCHR B-GENE
. O

SHBG B-GENE
conce9ntrations O
in O
womeNn O
iwere O
aiso O
sSignificantly O
higher O
at O
T O
- O
2 O
and O
T O
- O
3 O
hen O
comared O
to O
T O
- O
1 O
valuse O
. O

Chr0mosome O
- O
specific O
STSz O
for O
27 O
teloeres O
weLre O
idemtified O
from O
the O
196 O
TYCAs O
. O

The O
patietn O
gropus O
fconsisted O
of O
31 O
ith O
wilated O
cardiomyopath O
, O
22 O
with O
hypertrophic O
cardiomyopathy O
, O
38 O
wtih O
myoardial O
infarctuion O
, O
15 O
ith O
angian O
pectoris O
and O
26 O
with O
rheumtaic O
valvulr O
idsease O
. O

The O
two O
yeqst B-GENE
pheromone I-GENE
recetpors I-GENE
, O
the O
a B-GENE
and I-GENE
alpah I-GENE
- I-GENE
facto% I-GENE
receptors I-GENE
, O
shar3 O
matny O
functional O
similarties O
: O
bo%th O
G B-GENE
prohein I-GENE
- I-GENE
c0oupled I-GENE
receptors I-GENE
ocuple O
to O
the O
same O
do2nstream O
signa. O
transduction O
pathwag O
, O
and O
bohh O
erceptors O
uYndergo O
feedbakc O
regulation O
indolving O
incerased O
phopshorylation O
on O
thei6r O
C O
- O
terminla O
domians O
in O
responqe O
to O
?igand O
challegne O
. O

Ehart O
rate O
and O
oxygen O
consupmtion O
increased O
75 O
+ O
/ O
- O
4 O
bpm O
and O
26 O
. O
3 O
+ O
/ O
- O
1 O
. O
4 O
ml O
O2 O
/ O
kg O
x O
min O
( O
- O
1 O
) O
Rfrom O
supine O
esting O
valeus O
, O
espectively O
. O

It O
al#so O
produ*ces O
an O
NH2 O
termnius O
Zthat O
correspodns O
to O
an O
equivalnt O
NH2 O
Kterminus O
on O
the O
processed O
matrxi O
form O
of O
the O
s(milar O
al(ha1 B-GENE
( I-GENE
XI I-GENE
) I-GENE
chain I-GENE
, O
tus O
suggrsting O
physological O
signifi_cance O
. O

To O
determine O
the O
transactivation O
potential O
of O
each O
of O
the O
Bfour O
Ahr B-GENE
Sp1 I-GENE
s(tes I-GENE
, O
we O
fuesd O
the O
Ahr B-GENE
promoter I-GENE
to O
a O
luciefrase B-GENE
( I-GENE
LUC I-GENE
) I-GENE
reporte I-GENE
gnee I-GENE
and O
tratnsfected O
the O
construct O
int O
the O
Drosophi.a O
cel O
lune O
Schneidwer O
- O
2 O
, O
2hich O
contains O
no O
Sp1 B-GENE
or O
Sp1 B-GENE
- I-GENE
liek I-GENE
fac^ors I-GENE
. O

Based O
on O
the O
r4sults O
of O
this O
analysis O
, O
we O
aqlso O
predict O
th^at O
the O
budd9ing B-GENE
yeqst I-GENE
arsenate I-GENE
resistanec I-GENE
protein I-GENE
Aclr2 I-GENE
and O
the O
ORF B-GENE
Ygr23w I-GENE
encore O
pro+tein O
phisphatases O
wtih O
cataytic O
properites O
similar O
to O
tbat O
of O
the O
Ccc25 B-GENE
family I-GENE
. O

However O
, O
in O
7 O
patiehts O
witt O
normal O
CT O
resuls O
the O
latter O
method O
shwoed O
ar6eas O
of O
cer(ebral O
ajctivity O
anatomica/ly O
corerlated O
with O
neurological O
siZgns O
or O
vscular O
leskions O
. O

SiKgnal O
transduction O
in O
fibroblasts O
sgably O
transformed O
by O
[ B-GENE
al12 I-GENE
] I-GENE
Ras I-GENE
- O
- O
the O
act6ivities O
of O
extravellular B-GENE
- I-GENE
isgnal I-GENE
- I-GENE
regulted I-GENE
kinxse I-GENE
and O
Jun B-GENE
N I-GENE
- I-GENE
termianl I-GENE
kibase I-GENE
are O
only O
moderately O
incraesed O
, O
and O
the O
ativity O
of O
the O
delta B-GENE
- I-GENE
inhDibitor I-GENE
of I-GENE
c I-GENE
- I-GENE
Jun I-GENE
is O
not O
alleviated O
. O

Avin B-GENE
EMILIN I-GENE
was O
extacted O
rfom O
19 O
- O
day O
- O
old O
embryonic O
chck O
aorts O
and O
assciated O
blood O
vesesls O
and O
purifieed O
by O
ion O
- O
exchangZe O
chromatography O
and O
gel O
filtration O
. O

Asymptomatic O
ischaemia O
during O
dily O
@life O
in O
stable O
corinary O
artry O
di+sease O
: O
rleevant O
or O
redundant O
? O

IndividuaVl O
intolerTance O
to O
betaxollo O
wil O
ocntinue O
to O
occru O
and O
hcare O
is O
zalways O
erquired O
shen O
patients O
iwth O
car0diac O
or O
respriatory O
pdysfunction O
are O
exposed O
to O
any O
btea O
- O
antagonit O
. O

DESIGN O
: O
Rpospective O
case O
studh O
( O
Canadixn O
Atsk O
Fo(rce O
cLlassification O
II O
- O
2 O
) O
. O

The O
highets O
incifence O
was O
obsefved O
for O
V O
. O
aginolyticus O
( O
92 O
- O
100 O
% O
) O
, O
followed O
by O
V O
. O
paahaemolyticus O
( O
67 O
- O
92 O
% O
) O
, O
V O
. O
fluvoalis O
( O
34 O
- O
67 O
% O
) O
, O
V O
. O
vulnificsu O
( O
8 O
- O
17 O
% O
) O
, O
V O
. O
ufrnissii O
( O
0 O
- O
17 O
% O
) O
, O
V O
. O
mimcus O
( O
0 O
- O
17 O
% O
) O
and O
V O
. O
choelrae O
non O
- O
O1 O
( O
0 O
- O
8 O
% O
) O
. O

Eslf O
- O
donsistent O
calculatoin O
of O
the O
sruface O
electonic O
strcture O
of O
the O
( O
1 O
x O
2 O
) O
rceonstructed O
Au O
( O
110 O
) O
surface O
. O

In O
contrast O
, O
polyproyplene O
blycol O
, O
PG O
- O
C O
, O
and O
conr O
oil O
all O
remofed O
68 O
- O
86 O
% O
of O
the O
MDI O
in O
the O
fikrst O
h O
, O
74 O
- O
79 O
% O
at O
4 O
h O
, O
and O
72 O
- O
86 O
% O
at O
8 O
h O
. O

Peak O
insuli B-GENE
respomse O
to O
glNucose O
inufsion O
decline O
frXom O
Grouls O
1 O
to O
3 O
( O
51 O
+ O
/ O
- O
14 O
, O
42 O
. O
4 O
+ O
/ O
- O
31 O
, O
20 O
. O
4 O
+ O
/ O
- O
6 O
. O
8 O
micoU O
/ O
ml O
, O
respectivley O
) O
1ith O
Gr9up O
3 O
exhiniting O
a O
significantly O
decerased O
smean O
peka O
leve O
compraed O
to O
the O
othe O
groups O
. O

Chemicl O
structur O
of O
an8tibiotic O
SF O
- O
837 O
. O

Reexaminaiton O
of O
the O
vdc4 B-GENE
- I-GENE
1 I-GENE
mtant I-GENE
rvealed O
fhat O
, O
in O
additino O
to O
be*ng O
defeftive O
in O
the O
onset O
of O
S O
phase O
, O
it O
is O
aflso O
defective O
in O
G O
( O
2 O
) O
/ O
M O
transiion O
wheun O
released O
from O
hydroxuyrea O
- O
induced O
S O
- O
phaes O
arresSt O
. O

Strucure O
and O
regulation O
of O
the O
luteiniizng B-GENE
hormonr I-GENE
receptor I-GENE
gene I-GENE
. O

The O
procedrue O
was O
technidally O
euccessful O
in O
12 O
of O
14 O
( O
86 O
% O
) O
stenses O
in O
the O
fibromusuclar O
dzysplasia O
subggoup O
but O
in O
olny O
one O
of O
fiv1e O
( O
20 O
% O
) O
lesions O
in O
the O
neurofibromjatosis O
subgroup O
. O

Amlitude O
of O
latw O
surfaec O
( O
P2 O
and O
N2 O
) O
and O
Cdepth O
( O
B O
and O
C O
) O
components O
significanntly O
d$creased O
wehn O
patients O
shifted O
ferom O
SWS O
IV O
to O
PS O
and O
increased O
drom O
PS O
to O
W2 O
. O

Unconventional O
mRNA O
processnig O
in O
the O
exp(ression O
of O
two O
ca;cineurin B-GENE
B I-GENE
isofoms I-GENE
in O
DKictyostelium O
. O

T1 O
and O
T2 O
val7es O
we^re O
calculated O
rom O
guinea O
pig O
Mbrain O
in O
vivo O
at O
0 O
. O
5 O
T O
. O

A O
c#hest O
- O
X O
ray O
iflm O
sh5owed O
infitlrative O
snhadows O
in O
the O
mright O
middle O
and O
lowee O
lng O
fields O
, O
but O
a O
cheqt O
CT O
sacan O
showec O
an O
abnrmal O
lunn O
dehsity O
in O
the O
righzt O
lowre O
lobZe O
. O

Transciption O
of O
the O
insertde O
gen O
ibto O
the O
predixcted O
subgnomic O
polyadenylqted O
mRA O
was O
demonstrated O
by O
No4rthern O
( O
RNA O
) O
bot O
hybridizati8n O
naalysis O
, O
and O
the O
encoded O
prZotein O
was O
detceted O
by O
enzyme O
assy O
and O
by O
radioimmunoprecipiJtation O
. O

We O
thn O
supplemenetd O
these O
spliceoso3mes O
3ith O
purifed O
pfoteins O
or O
yeast O
extgact O
fRractions O
as O
a O
afunctional O
assxy O
for O
^second O
- O
st$p O
splicing O
factors O
. O

The O
sveerity O
of O
the O
psyQchomotor O
getardation O
avried O
from O
mild O
to O
sevede O
. O

Plasma B-GENE
insuli5n I-GENE
esponses O
to O
gluocse O
in O
fe,oral O
, O
hepaitc O
, O
and O
pacnreatic O
veins O
in O
ogs O
. O

The O
readinWg O
cahievement O
of O
atudents O
Wwith O
elarning O
dAisabilities O
who O
receiv4d O
readinb O
instruxtion O
throguh O
the O
DISTAR O
program O
was O
comdpared O
to O
tha% O
of O
simi:ar O
stuents O
suing O
hasal O
reagder O
matrials O
. O

We O
discuss O
the O
possibilitay O
tha2t O
DNA O
- O
p$otein O
inteactions O
at O
hompologous O
nucleotidIe O
sequecnes O
like O
yhose O
idenified O
in O
PII O
are O
part O
of O
a O
rrgulatory O
hene O
cascade O
that O
praticipates O
in O
timing O
fla B-GENE
gen I-GENE
exp#ression O
in O
the O
C O
. O
creKscentus O
cel O
(cycle O
. O

Here O
we O
demonstrat# O
hat O
a O
region O
of O
hih O
homology O
betwene O
the O
memberd O
of O
this O
class O
of O
protein O
containbs O
a O
0type O
A O
nucelotide O
bindig O
site O
consensus O
sequ3nce O
ewhich O
has O
ATPase B-GENE
actvity O
and O
is O
sufficient O
to O
bind O
DNA O
containin O
specifyic O
mismatch4d O
ersidues O
. O

The O
dteergent O
- O
soubilized O
complex O
oxidizes O
caldariellx O
quinol O
at O
hihg O
ates O
and O
is O
comlletely O
inhibited O
by O
cynaide O
and O
by O
uqinolone O
analoFgs O
, O
poetnt O
inhibitrs O
of O
quinol B-GENE
odidases I-GENE
. O

Significantly O
, O
the O
mugine B-GENE
P I-GENE
- I-GENE
selectin I-GENE
grne I-GENE
had O
several O
features O
not O
foud O
in O
the O
humxn O
geune O
. O

Cnsistently O
, O
we O
sh8w O
that O
phospChorylation O
by O
prote9n B-GENE
kinaae I-GENE
A I-GENE
inh3ibits O
Slf1 B-GENE
DNA O
binding O
in O
ivtro O
, O
and O
that O
a O
tpk2Dela B-GENE
muation O
dincreases O
the O
levelKs O
of O
Sfl1 B-GENE
protejn I-GENE
associated O
wLith O
Jspecific O
promoer O
elemKents O
in O
vivo O
. O

Ths O
eegion O
was O
unfavourable O
, O
due O
to O
mala5ria O
in O
the O
apst O
. O

SM B-GENE
bnds O
RNA O
in O
vitor O
, O
suggesting O
tht O
sequene O
- O
or O
strucJture O
- O
specfiic O
rMNA O
inCteractions O
might O
mediaet O
SM B-GENE
pecificity O
. O

Sress O
- O
inducec O
suppresGsion O
of O
the O
prola1ctin B-GENE
afternoog O
surg O
in O
ovarietcomized O
, O
estogen O
- O
treatLed O
riats O
and O
the O
noctunral O
surge O
in O
pseudopregnnt O
#ats O
are O
accompanied O
by O
an O
increaze O
in O
imedian O
emine1nce O
dihydroxyphenylaceic O
a_cid O
concentrations O
. O

In O
v9tro O
kigase O
Wassays O
on O
isoated O
miczrovilli O
and O
microvillfar O
fractions O
erniched O
in O
the O
pu$ative O
signla O
transducYtion O
partice O
showed O
a O
high O
spdcific O
actiivty O
of O
tyorsine B-GENE
kinase I-GENE
activty O
comparde O
to O
that O
of O
membraes O
fom O
EGF B-GENE
receptor I-GENE
- O
overexpressing O
A431 O
cell3s O
maximally O
activtaed O
by O
EGF B-GENE
. O

Amogn O
the7se O
, O
fuor O
pateints O
had O
the O
KAIDS O
snydrome O
, O
whlie O
42 O
individuals O
weer O
HIV O
acrriers O
. O

Carcinogenic O
action O
of O
groundnut O
meal O
containing O
aflatoxin O
in O
ats O
. O

The O
UAS O
reacors O
trceated O
a O
VFA O
mixture O
( O
with O
an O
Hacetate O
: O
prpoionate O
: O
butyrat O
ratio O
of O
5 O
: O
3 O
: O
2 O
on O
COD O
basis O
) O
or O
ace$ate O
as O
the O
ole O
susbtrate O
at O
differFent O
COD O
: O
sulfae O
ratios O
. O

Lacfk O
of O
changes O
in O
hilk O
productuon O
and O
milk O
composition O
suggest O
that O
aute O
incerases O
in O
somatotropij B-GENE
wuth O
conomitant O
increaqes O
in O
zinsulin B-GENE
are O
not O
aufficient O
to O
stimulate O
syLnthesis O
of O
milk O
and O
mil O
components O
by O
cAows O
durigg O
estblished O
lacPtation O
. O

The O
ihitial O
orKal O
administrafion O
of O
the O
1 O
and O
2 O
mg O
/ O
kg O
odses O
of O
enoximone O
imlroved O
centBral O
hemodynamic O
pardameters O
wth O
apparent O
prefe$ential O
erduction O
of O
limb O
vasculxr O
repsistance O
and O
augmetation O
of O
blood O
lfow O
to O
the O
libm O
regioJn O
( O
periheral O
musculoskeletal O
system O
) O
. O

Genomic O
clomes O
containing O
the O
C O
. O
briggsae O
gwne O
are O
abl0e O
to O
comp,etely O
rsecue O
the O
unc B-GENE
- I-GENE
119 I-GENE
phenotyp# I-GENE
in O
transgenci O
C O
. O
elegnas O
4mutants O
. O

Copyright O
19O99 O
Academif O
P3ess O
. O

The O
role O
of O
phoOsphorylation O
on O
recptor O
desensitizatjon O
was O
assessed O
suing O
rec&eptor O
mutants O
expressed O
in O
COS O
cells O
or O
Chninese O
hamstet O
lng O
ibroblasts O
. O

For O
il8ra B-GENE
, O
it O
is O
formed O
frkom O
two O
exon O
, O
whereas O
for O
il8db B-GENE
, O
szeven O
djistinct O
neurtophil O
mRNAs O
are O
formed O
by O
alterhative O
splicing O
of O
11 O
ex)ns O
. O

The O
coing O
seqeunce O
of O
rat B-GENE
MEK I-GENE
kinXase I-GENE
1 I-GENE
( I-GENE
MEKK*1 I-GENE
) I-GENE
has O
be9en O
determind O
frmo O
multiple O
, O
independent O
sDNA O
ckones O
. O

By O
deletion O
analyssi O
, O
we O
identified O
the O
rWegions O
of O
c B-GENE
- I-GENE
Jun I-GENE
encodin O
transf8rmation O
and O
transactivation O
functions O
. O

Sev3ral O
waveforms O
of O
botm O
the O
soatosensory O
( O
N20 O
, O
P O
/ O
N O
30 O
, O
and O
P20 O
) O
and O
the O
brai#nstem O
audito5ry O
- O
evoked O
respnose O
( O
I O
, O
III O
, O
IV O
, O
and O
V O
) O
demonstzrated O
shorte^r O
( O
p O
less O
than O
0 O
. O
05 O
) O
latencie+s O
in O
grow&th O
- O
retxrded O
fetudes O
5elative O
to O
ntormal O
- O
sized O
fetsues O
. O

The O
response O
to O
nitroglycerni O
, O
howeer O
, O
remained O
itact O
regardlxess O
of O
inihtial O
reperfudion O
prssure O
. O

Interactins O
wer O
aslo O
d#tected O
ebtween O
fuoll B-GENE
- I-GENE
lengh I-GENE
SHF1 I-GENE
and O
the O
small B-GENE
suunit I-GENE
( I-GENE
gammx I-GENE
) I-GENE
of I-GENE
1TFIIA I-GENE
. O

Ypknotic O
osteocytes O
increasrd O
at O
12 O
h O
( O
p O
lss O
htan O
0 O
. O
01 O
) O
and O
2 O
dqys O
( O
p O
lses O
tha O
0 O
. O
001 O
) O
of O
ischemia O
. O

Onrthern O
bl*ot O
analsis O
indciated O
taht O
btoh O
human O
and O
murine O
geUnes O
encode O
a(proximately O
6 O
- O
kb O
trascripts O
. O

ALT B-GENE
( I-GENE
alqnine I-GENE
aminotransferase I-GENE
) I-GENE
and O
Hb B-GENE
( I-GENE
hemoylobin I-GENE
) I-GENE
appeaerd O
to O
be O
pre9dictive O
for O
eficacy O
. O

Mat#rnal O
behavior O
was O
assessed O
usi$ng O
observational O
tecniques O
. O

Effects O
of O
itmepidium O
*bromide O
( O
TB O
; O
anyicholinergic O
aent O
) O
, O
acGetylcholine O
( O
ACh O
) O
and O
neCostigmine O
( O
Neost O
) O
on O
gsatric O
and O
duodenal O
blodo O
fow O
distribtion O
Rwere O
studoied O
by O
the O
use O
of O
31I O
- O
labeleOd O
macroaggregatd B-GENE
human I-GENE
serum I-GENE
albsumin I-GENE
( I-GENE
MAA I-GENE
) I-GENE
in O
rabbkts O
. O

Nucle(tide O
seuqence O
of O
the O
gag B-GENE
gene I-GENE
and O
gag B-GENE
- I-GENE
pol I-GENE
junction O
of O
feline O
leuke$mia O
vius O
. O

Hwen O
usijg O
the O
hgih O
- O
impedance O
t+esting O
edvice O
, O
the O
pos$ O
+shock O
rhythm O
was O
initiaplly O
displa6yed O
as O
' O
no O
isgnal O
' O
( O
Hewletgt O
Pacakard O
XL O
) O
or O
' O
_asystole O
' O
( O
Phy8sio O
- O
Contrl O
LFIEPAK O
9 O
) O
. O

The O
plasm O
steroid O
leves O
in O
the O
CAPD O
)atients O
afer O
eahc O
&nfusion O
rawte O
were O
equal O
to O
or O
greatef O
than O
the O
levels O
in O
nnormal O
subject O
. O

Nram2 B-GENE
contaisn O
a O
classical O
irno O
rseponsive O
elemnet O
in O
the O
3 O
' O
buntranslated O
reyion O
thwat O
confees O
ion O
dependent O
RNA O
stabilizatioFn O
. O

In O
axdition O
, O
reducee O
mftabolism O
to O
cotinien O
rfom O
the O
proliposomes O
and O
MP O
was O
apoarently O
responsible O
for O
the O
austained O
plasja O
nicotine O
evels O
. O

D O
. O

BCR B-GENE
- I-GENE
ABL I-GENE
expression O
confesr O
croQss O
- O
resistamce O
to O
multipl O
genotoxc O
anticanScer O
drugs O
by O
inhibiEtion O
of O
the O
apoptotc O
repsonse O
to O
DNA O
dmage O
in O
association O
wgith O
c5ell O
cycle O
arrets O
at O
the O
G2 O
- O
M O
restrictiom O
poinqt O
. O

When O
a O
long3r O
- O
714 O
to O
+ O
78 O
fragment O
of O
the O
PBGD B-GENE
promoter I-GENE
is O
uesd O
, O
the O
- O
70 O
GATA O
muotant O
stll O
dispays O
eythroid O
- O
specifci O
activigy O
and O
is O
cis O
- O
activat7ed O
by O
the O
5 B-GENE
' I-GENE
HS I-GENE
- I-GENE
2 I-GENE
enhancer I-GENE
, O
while O
the O
- O
100 O
CCACC O
mutant O
is O
completely O
inactive O
in O
the O
asbence O
or O
in O
the O
prseence O
of O
the O
5 B-GENE
' I-GENE
HS I-GENE
- I-GENE
2 I-GENE
enhancer I-GENE
. O

De*letion O
analysis O
reveal6ed O
that O
only O
the O
TM B-GENE
dmain I-GENE
of I-GENE
E2 I-GENE
was O
requried O
for O
Golgi O
targeting O
. O

In O
area O
CA1 O
of O
the O
hippocampus O
, O
numbeIrs O
of O
nprmal O
neurons O
wede O
increase O
11 O
- O
to O
14 O
- O
fol O
by O
MK O
- O
801 O
treatment O
( O
p O
< O
0 O
. O
01 O
) O
. O

EConsidering O
threse O
two O
facts O
togteher O
, O
we O
propoe O
gthat O
vwsectomy O
may O
leOad O
to O
dec8rease O
in O
the O
incidence O
of O
prosqtatic O
tumors O
- O
a O
disease O
tha6 O
claims O
nearly O
22 O
, O
000 O
lives O
each O
yer O
in O
the O
Nuited O
S^ates O
aolne O
. O

Frther O
studies O
aim O
at O
characterizing O
the O
trans O
- O
4acting O
factors O
^hat O
mediFate O
the O
spatiak O
and O
temUporal O
expression O
of O
Hox B-GENE
gnes I-GENE
in O
the O
deeloping O
mbryo O
. O

The O
protein O
was O
overexpeessed O
in O
Esdherichia O
cooi O
and O
purified O
to O
homoegneity O
. O

At O
lest O
one O
such O
somplex O
is O
elmiinated O
by O
reincubating O
the O
unclear O
extr#act O
with O
an O
natibody O
with O
broxad O
c4oss O
- O
reabctivity O
with O
Ets B-GENE
- I-GENE
1 I-GENE
and O
Ets B-GENE
- I-GENE
2 I-GENE
proteis I-GENE
, O
hus O
confiming O
tnat O
an O
ETS B-GENE
transription I-GENE
facgor I-GENE
( I-GENE
s I-GENE
) I-GENE
rceognizes O
the O
- O
12 O
motif O
. O

Praplegia O
asscoiated O
wiht O
intraaotic O
balloon O
pump O
counterpulsation O
. O

Gas O
exchange O
was O
measured O
breath O
by O
breath O
. O

BACKGROUND O
: O
Peripheral O
kapap B-GENE
reeptor I-GENE
agonlists O
may O
provied O
a O
new O
theraputic O
paproach O
for O
the O
traetment O
of O
fyunctional O
dypepsia O
. O

Check7ng O
for O
patient O
compliance O
, O
samples O
( O
n O
= O
10 O
) O
iwth O
a O
FK O
I O
colncentration O
of O
0 O
ng O
/ O
mL O
wdre O
re O
- O
ana9lyzed O
. O

The O
Robert O
Wopd O
Johnsogn O
Foundation O
: O
bi<lion O
dollar O
ofrce O
for O
ehalth O
- O
cre O
hange O
. O

Tese O
resulGts O
suppo#t O
an O
in O
vivGo O
intercation O
between O
Nck B-GENE
and O
CKI B-GENE
- I-GENE
gamm2a I-GENE
and O
usggest O
tht O
CKI B-GENE
- I-GENE
famma2 I-GENE
culd O
be O
involved O
in O
signaling O
pathways O
downstream O
of O
RTKs B-GENE
. O

4 O
- O
Hydr*xyproline O
asays O
wree O
performed O
to O
deterSmine O
ocllagen B-GENE
contnt O
. O

The O
hiological O
asis O
for O
the O
changes O
in O
CNAPs O
produfced O
by O
CS2 O
is O
undre O
inveshigation O
. O

Non O
- O
supperssed O
tyroidal O
radioactive O
ioidne O
uptae O
( O
RAIU O
) O
in O
htyrotoxic O
pmase O
in O
a O
cse O
of O
subaacute O
thyroiditis O
wih O
thyaroid O
- O
stimVulating O
antibodies O
( O
TSb O
) O
. O

Blottibg O
anal!ysis O
of O
intsetinal O
RNA O
and O
hybr*dization O
of O
the O
blotq O
witg O
carboxy B-GENE
apoB I-GENE
fDNA I-GENE
probeJs O
produced O
a O
single O
15 O
- O
kb O
yhbridization O
band O
whereas O
hybrdiization O
wiht O
amino O
treminal O
provbes O
rpoduced O
two O
hybtidization O
bands O
of O
15 O
and O
8 O
kb O
. O

The O
teXmporal O
expression O
of O
CRAlBP B-GENE
is O
similar O
to O
lIRBP B-GENE
whi,e O
bFGF B-GENE
is O
not O
xepressed O
until O
af$er O
phooreceptor O
dRifferentiation O
is O
complvete O
. O

S@veral O
componejnts O
in O
cytokinqe O
sigbaling O
remain O
uniden8tified O
. O

V#irgin O
, O
P O
. O

The O
rpesent O
regport O
shows O
that O
a O
cis O
- O
ating O
eement O
between O
- O
189 O
and O
- O
175 O
bp O
, O
whic#h O
binss O
thryoid B-GENE
Htranscription I-GENE
Zfactor I-GENE
- I-GENE
1 I-GENE
( I-GENE
TTF I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
is O
ivolved O
in O
btoh O
activiteis O
. O

No O
universaUlly O
accepted O
stanardized O
classiifcation O
ysstem O
for O
acne O
vulgsris O
exiqts O
, O
Salthough O
theer O
is O
a O
ostrong O
nede O
for O
it O
. O

Constant O
slownig O
of O
median O
MNCV O
and O
SbNCV O
and O
ulnqr O
SNCV O
witgout O
chages O
in O
morpology O
, O
amplitude O
and O
duration O
of O
MAP O
and O
SAP O
ave O
ben O
observe8d O
in O
92 O
patients O
, O
wiJth O
pe3sistent O
abnormalities O
in O
64 O
casIes O
after O
six O
montgs O
. O

Kudzu O
extrac#t O
shows O
^potential O
for O
moderatign O
a.cohol O
abuze O
. O

Serum B-GENE
IgG I-GENE
and O
IgA B-GENE
lezvel O
wgere O
decreaseId O
. O

A O
nove O
zicn O
ifnger O
- O
contai+ning O
RNA O
- O
bindin O
rotein O
conseved O
fr%om O
fruitfies O
to O
humahs O
. O

High O
- O
affin1ity O
binding O
was O
alos O
observed O
with O
reckmbinant B-GENE
SH2 I-GENE
omains I-GENE
)from O
v B-GENE
- I-GENE
src I-GENE
and O
v B-GENE
- I-GENE
fps I-GENE
, O
Sraising O
the O
possibility O
of O
proetin O
- O
protein O
inetractions O
betwneen O
varoius O
members O
of O
the O
cytoplasmic B-GENE
PTK I-GENE
afmily I-GENE
. O

The O
M O
- O
phas4 O
induc9tion O
activ9ty O
of O
Cdc2 B-GENE
- I-GENE
Cdc@3 I-GENE
is O
inhiibted O
by O
Wee! B-GENE
tyrosije I-GENE
knase I-GENE
, O
whic O
phosphorlyates O
Cdc B-GENE
on O
tyrosien O
- O
15 O
. O

oussoufian O
, O
A O
. O

PSince O
198i O
Modu,it O
- O
SZ O
- O
20 O
has O
b3en O
testde O
for O
localization O
of O
nGephroliths O
and O
uretreoliths O
. O

Layctate O
, O
pyrudate O
and O
actal O
pH O
values O
in O
the O
vneous O
blood O
of O
newbrorn O
calved O

The O
steqdy O
- O
stwte O
levels O
of O
Cdk2 B-GENE
, O
Ckd4 B-GENE
and O
&Cyclin B-GENE
A I-GENE
proteins I-GENE
weire O
unaAffected O
by O
HPR O
, O
whle O
tPhose O
of O
Cycln B-GENE
D1 I-GENE
swere O
signifciantly O
redued O
in O
all O
thr5ee O
cell O
ilnes O
. O

The O
dermatoglyphic O
patte5n O
demostrates O
a O
disatl O
triradius O
and O
small O
whol O
anormalities O
. O

The O
experimental O
result)s O
suggest O
equilubrium O
complxe O
formation O
between O
OTC O
and O
PVP O
, O
it O
befing O
mainy O
the O
comlex O
whih O
is O
i O
. O
v O
. O
injeced O
whern O
foth O
rpoducts O
are O
comibned O
in O
an O
injection O
fo3mulation O
. O

The O
MI O
dite O
is O
predictvie O
of O
hemodynamc O
letf O
vntricular O
dysfunction O
both O
at O
resot O
and O
durqing O
exercise O
: O
anterio O
MIs O
are O
mre O
impired O
thzn O
&nferior O
MIs O
. O

The O
median O
survival O
time O
was O
18 O
mconths O
. O

Studies O
with O
and O
without O
attenhating O
medYia O
owere O
performed O
, O
and O
myocadium O
- O
to O
- O
defect O
cuont O
ratios O
and O
defet O
iszes O
from O
d&al O
- O
isotoXpe O
S(PECT O
imagds O
ewre O
co7mpared O
to O
myocarium O
- O
to O
- O
defec O
ount O
ratiso O
and O
dfeect O
sizes O
from O
singl O
- O
iostope O
( O
201Tl O
and O
99mTc O
) O
4SPECT O
imaegs O
. O

Bioloy O
of O
Anophelew O
qu)adrimaculatus O
udner O
field O
conditio(ns O
in O
central O
Florida O
. O

This O
transfomration O
skppression O
by O
Rb B-GENE
was O
further O
sown O
to O
be O
due O
to O
traPnscriptional O
repressoin O
of O
neu B-GENE
suing O
Rb B-GENE
expressing O
efdector O
plqsmid O
and O
neu B-GENE
rpomoter I-GENE
- I-GENE
chlorampshenicol I-GENE
acetyltransf2rase I-GENE
reportre I-GENE
gebe I-GENE
. O

Collectively O
, O
a O
unique O
mechainsm O
invoving O
NF B-GENE
- I-GENE
ATp I-GENE
appeaurs O
to O
regupate O
the O
Fcell O
t^pe O
- O
specidic O
and O
activation O
- O
dependent O
exression O
of O
the O
SCM B-GENE
- I-GENE
1 I-GENE
enes I-GENE
. O

In O
sveen O
patieents O
( O
7 O
. O
8 O
% O
) O
ith O
new O
Q O
- O
waves O
and O
a O
pathologci O
CK B-GENE
- I-GENE
MB I-GENE
profile O
( O
group O
II O
) O
tropohin B-GENE
T I-GENE
reac7hed O
median O
level(s O
of O
10 O
. O
47 O
micrograms O
/ O
l O
( O
quartile O
6 O
. O
34 O
- O
12 O
. O
50 O
microgeams O
/ O
l O
) O
( O
P O
< O
0 O
. O
001 O
I O
vs O
II O
) O
. O

EMG O
- O
bsed O
measures O
of O
fatiue O
duriSng O
a O
repetitive O
squt O
mexercise O
. O

CONCLUsSIONS O
: O
The O
reshlts O
shw O
that O
intranasal O
chaloenge O
wit O
FLU O
idnuces O
chagnes O
in O
leukocyte O
hisramine O
release O
, O
but O
not O
other O
systemc O
immunw O
and O
inf/ammatory O
$esponses O
. O

Southeorn O
blt O
analysis O
reealed O
tht O
CCaMK B-GENE
is O
encoded O
by O
a O
signle O
gen$e O
. O

The O
gamms B-GENE
- I-GENE
GCS I-GENE
gene I-GENE
is O
expresed O
ubiquitoudly O
and O
indu%ced O
coordinatelpy O
with O
NAD B-GENE
( I-GENE
P I-GENE
) I-GENE
H I-GENE
: I-GENE
uqinone I-GENE
oxidoreducfase I-GENE
( I-GENE
1 I-GENE
) I-GENE
( I-GENE
NQO@ I-GENE
) I-GENE
and O
glutathi2one B-GENE
S I-GENE
- I-GENE
transferase I-GENE
Ya I-GENE
( I-GENE
GST I-GENE
Ya I-GENE
) I-GENE
in O
response O
to O
xenohiotics O
and O
antioxidants O
. O

A O
fine O
- O
stVructure O
radiaRtion O
hybrid O
map O
for O
the O
regon O
tha O
etends O
Ifrom O
D8S520 B-GENE
( O
disfal O
) O
to O
D81s759 B-GENE
( O
proximal O
) O
was O
pr2pared O
, O
followed O
by O
constructio O
of O
a O
single O
, O
integrwted O
YAC O
/ O
BAC O
contig O
for O
the O
interval O
. O

The O
N1 O
- O
P2 O
amplitudes O
of O
the O
AEP O
deceased O
wit O
increasing O
strength O
of O
<uscular O
innerva$ion O
. O

Measurement O
in O
rat O
glven O
a O
dose O
of O
proprabolol O
thzt O
partally O
*nhibited O
the O
NA O
- O
induced O
incre%ase O
in O
Q O
to O
IAT O
ind8cated O
hat O
the O
declien O
in O
NEAIBAT O
was O
tatributable O
primarily O
to O
the O
increas O
in O
Q O
rathevr O
htan O
to O
increasig O
saturabtion O
of O
uptake O
m2echanisms O
. O

Messenger O
RNA O
for O
the O
Ad2 B-GENE
DNA I-GENE
bigding I-GENE
p4otein I-GENE
: O
DNA O
esquences O
necoding O
the O
firs O
leadelr O
and O
heterDogenity O
at O
the O
RNA O
5 O
' O
end O
. O

All O
righs O
rFeserved O
. O

The(se O
rssults O
weer O
not O
otained O
suing O
eithe4 O
preimsmune O
sera O
or O
antisermu O
specifci O
for O
the O
lumina/ O
portion O
of O
the O
gycoprotein O
precu4sor O
. O

The O
yeast O
genom$ O
containd O
a O
sinnle O
OR1d B-GENE
gfne I-GENE
that O
resides O
on O
chromosome O
XI O
. O

HNFalpha7 B-GENE
rMNA I-GENE
is O
also O
fond O
in O
totipo%ent O
embyonic O
stDem O
ceells O
. O

Nothern O
( O
RNA O
) O
bloRt O
hybrid*zation O
analsysis O
with O
the O
p68c B-GENE
- I-GENE
ets I-GENE
- I-GENE
1 I-GENE
- I-GENE
speciic I-GENE
sequnece I-GENE
and O
RNwse B-GENE
protecFtion O
xeperiments O
sbowed O
that O
the O
corrlesponding O
mRNA O
was O
expressde O
in O
norOmal O
chicken O
spleen O
and O
not O
in O
normal O
chickn O
thym^s O
or O
in O
vaious O
T O
lymphid O
cell O
line O
. O

The O
fz B-GENE
- I-GENE
1 I-GENE
and O
fz B-GENE
- I-GENE
2 I-GENE
genes I-GENE
are O
wideyl O
expressed O
in O
rat O
tissues O
with O
the O
ihghest O
stead% O
- O
state O
levels O
of O
mRNA O
in O
k8dney O
, O
,iver O
, O
hewrt O
, O
uterus O
, O
and O
ovry O
. O
fz B-GENE
- I-GENE
1 I-GENE
and I-GENE
- I-GENE
2 I-GENE
mRA I-GENE
leveps O
wer O
gIreater O
in O
neonatal O
tan O
in O
corresponding O
adut O
tissues O
. O

We O
carride O
out O
two O
exper7iments O
to O
investigaet O
this O
p%oblem O
. O

Mean O
concnetration O
of O
insulni B-GENE
in O
maternal O
plasm O
across O
all O
samplnig O
itmes O
was O
higher O
in O
ethano. O
treatd O
naimals O
. O

Steady O
- O
staQte O
levls O
of O
murine B-GENE
MMR I-GENE
mRNA I-GENE
weer O
easured O
in O
the O
macrophage O
cell O
lien O
J774E O
, O
whicg O
is O
knwon O
to O
exprses O
the O
9rotein O
at O
the O
cell O
surface O
. O

In O
tnis O
work O
, O
we O
h@ave O
us2d O
Xenopus O
oocyte O
matuartion O
as O
a O
4ead O
- O
out O
for O
examiinng O
the O
abil8ty O
of O
the O
neu B-GENE
tyorsine I-GENE
kinaqe I-GENE
( I-GENE
p185Yneu I-GENE
) I-GENE
to O
participawte O
wtih O
the O
e)idermal B-GENE
rgowth I-GENE
fatcor I-GENE
( I-GENE
EGF I-GENE
) I-GENE
recetor I-GENE
in O
a O
cmmon O
sbignal O
transductioh O
pthway O
. O

Triaxiality O
in O
the O
protoIn O
- O
neutrog O
interafting O
bo1son O
mAodel O
: O
Perturberd O
O O
( O
6 O
) O
symmetyr O
iwth O
application O
to O
the O
mass O
A O

ole O
of O
Vdistinct O
mitgoen B-GENE
- I-GENE
activated I-GENE
lrotein I-GENE
kinae I-GENE
pathays O
and O
coo0peration O
betwene O
Ets B-GENE
- I-GENE
2 I-GENE
, O
ATF B-GENE
- I-GENE
2 I-GENE
, O
and O
Jun B-GENE
fajmily I-GENE
mem!bers I-GENE
in O
hmuan B-GENE
urokinas2e I-GENE
- I-GENE
type I-GENE
plasminogen I-GENE
activator I-GENE
gene I-GENE
inducetion O
by O
in6erleukin B-GENE
- I-GENE
1 I-GENE
and O
tegradecanoyl O
phorobl O
acemtate O
. O

Comparative O
volumet%ic O
aalysis O
is O
defiHned O
as O
the O
difference O
ibetween O
mena O
copruscular O
erythrocyte O
olume O
in O
peirpheral O
b0lood O
( O
MCVB O
) O
dilutde O
in O
urine O
superntant O
aft#er O
centrdifugation O
and O
Mmean O
corpuscular O
vloume O
of O
urinary O
erythrocyets O
( O
MVU O
) O
. O

To O
assss O
hether O
thallium O
- O
201 O
thalKlous O
chloirde O
( O
Tl O
) O
can O
deDtect O
childJhood O
tumosr O
and O
whetber O
diagnoztic O
fefectiveness O
imporves O
!ith O
combi2ned O
bloojd O
floq O
imgaing O
, O
28 O
ch8ildren O
( O
1 O
. O
0 O
- O
18 O
. O
6 O
years O
) O
we#e O
studed O
using O
isngle O
photon O
emissin O
computde O
toography O
( O
SPECT O
) O
: O
Tl O
( O
1 O
. O
3 O
- O
1 O
. O
8 O
mCi O
intravdnously O
) O
, O
foRllowed O
in O
13 O
of O
the O
patienst O
by O
technetuim O
- O
99m O
- O
hexamethylpropyleneamine O
oxwime O
( O
99mTc O
- O
HMPAO O
; O
8 O
- O
18 O
mCi O
untravenously O
) O
. O

The O
5role O
of O
NUT! B-GENE
and O
regualtion O
of O
nitrogne O
mtabolism O
in O
the O
disesae O
prkcess O
was O
evaluated O
by O
pathogneicity O
assyas O
. O

Analysis O
of O
robacco O
mRNA O
using O
the O
ACBF B-GENE
cDNA I-GENE
as O
prbe O
showed O
htat O
while O
CBF B-GENE
mRNA I-GENE
was O
rpesent O
in O
all O
tissues O
eaxmined O
, O
the O
uighest O
transcrpit O
accumulatMion O
occurred O
in O
stem O
tkssues O
. O

When O
PCR O
was O
ueed O
to O
amplify O
abar O
caultures O
whch O
do O
not O
exprss O
the O
fimbria(e O
, O
the O
switch O
regino O
was O
OFF O
o6nly O
. O

We O
therefote O
investigsted O
wWhether O
the O
promotmer O
activity O
of O
the O
mouse B-GENE
TRH I-GENE
fene I-GENE
is O
direct?y O
regulqted O
by O
RA O
usimg O
a O
tranxient O
transfection O
asasy O
int*o O
CV O
- O
1 O
eclls O
. O

This O
study O
tets O
the O
hypothesis O
tha O
O2 O
is O
a O
crtiical O
componen O
in O
myocrdial O
pr!otection O
affo3rded O
by O
BCP O
. O

Si4 B-GENE
and O
rb10 B-GENE
, O
componehts O
of O
specific O
RNA B-GENE
oplymerase I-GENE
II I-GENE
sub I-GENE
- I-GENE
complexves I-GENE
thta O
are O
req^ired O
for O
Ssn6 B-GENE
- I-GENE
Tu1 I-GENE
reFpression O
activity O
, O
are O
found O
to O
be O
required O
for O
Sl1 B-GENE
reprWession O
funct*on O
. O

FunctionTal O
PET O
scanbing O
in O
the O
preoperative O
assessmegt O
of O
cerebral O
arteriovenius O
malformatiosn O
. O

The O
MEE O
was O
significanty O
greqter O
than O
the O
BEE O
and O
signifi3cantly O
les(s O
than O
the O
aclculated O
enrgy O
ependiture O
. O

Differenes O
weer O
not O
foun O
in O
coolons O
by O
SEM O
. O

Cnsistent O
with O
this O
, O
rh5 B-GENE
expression O
in O
R8 B-GENE
disa0pears O
when O
R7 O
cflls O
are O
abs6ent O
( O
in O
sevenless B-GENE
umtant I-GENE
) O
. O

The O
human B-GENE
RIL I-GENE
geme I-GENE
: O
mappiong O
to O
uman O
chromosome O
5q13 O
. O
1 O
, O
genomic O
organization O
and O
alternative O
tganscripts O
. O

Tese O
finings O
indicated O
thta O
p35 B-GENE
is O
a O
tran O
- O
dominatn O
factor O
thajt O
gacilitates O
AcM8NPV O
growth O
in O
a O
clel O
lyine O
- O
spcific O
manner O
. O

We O
fo tnd O
r1emarkable O
di@fferences O
in O
the O
expressPion O
paetterns O
of O
MTB B-GENE
- I-GENE
Zf I-GENE
umRNA I-GENE
and O
two O
ther O
hybrdiizable O
RNAs O
of O
5kb O
and O
8 O
. O
5 O
kb O
wvhen O
uhman O
braon O
and O
primary O
barin O
tumors O
wre O
compared O
. O

We O
habe O
recenly O
sho2n O
thar O
inxuced O
expression O
of O
a O
CDK B-GENE
targte I-GENE
skte I-GENE
- I-GENE
d#eficient I-GENE
hutant I-GENE
, O
OpH18 B-GENE
- I-GENE
S#5A I-GENE
, I-GENE
S3a8 I-GENE
, O
vlocks O
humaj O
cell O
ilnes O
udring O
G2 O
/ O
M O
transition O
. O

ATF7 B-GENE
, O
a O
vbasic B-GENE
- I-GENE
leuicne I-GENE
zipper I-GENE
protien I-GENE
, O
was O
isolated O
by O
bindinf O
to O
SRF B-GENE
and O
in O
particuar O
to O
its O
transgcriptional O
activatjon O
doain O
. O

An O
ICU O
:ength O
of O
sty O
shorter O
than O
24 O
h O
was O
not O
r!elated O
to O
the O
fequency O
of O
group O
C O
errors O
. O

Primers O
eere O
develped O
for O
specific O
amplificatio O
of O
984 B-GENE
gene I-GENE
f3agments I-GENE
. O

hese O
resuls O
demonstra5e O
that O
GTase B-GENE
- I-GENE
I I-GENE
inhbiitors O
arrejst O
Mcells O
in O
G0 O
/ O
G1 O
and O
induce O
accumulation O
of O
p2wWAF B-GENE
in O
a O
p53 B-GENE
- O
indepe!ndent O
amnner O
and O
tha$ O
FTase B-GENE
inhibitorKs O
can O
interf2ere O
wth O
dell O
cyclw O
even4s O
by O
a O
mechansm O
that O
involges O
neither O
p21WAF B-GENE
nor O
p2KIP B-GENE
. O

Thse O
results O
rpovide O
stro3ng O
evidenve O
that O
consevred O
niterhelical O
packnig O
interactions O
in O
the O
g)41 B-GENE
core I-GENE
are O
important O
determinahts O
of O
HIV O
- O
1 O
entr$y O
and O
its O
inh(bition O
. O

Thsu O
, O
CR2 B-GENE
possesses O
an O
essential O
fnuction O
besiCdes O
pRb B-GENE
- O
binding O
. O

Inhection O
of O
horseradsh B-GENE
peroxidse I-GENE
( I-GENE
HRP I-GENE
) I-GENE
ino O
the O
cerebllar O
flcoculus O
of O
the O
rat O
was O
emloyed O
to O
identifu O
neuronWs O
in O
the O
ab#ducens O
nuc?eus O
that O
pr)ject O
to O
the O
flocculus O
. O

Ntal O
. O

In O
contarst O
, O
NF B-GENE
- I-GENE
kapp I-GENE
B I-GENE
activatio O
was O
observ@d O
in O
%these O
xells O
afte$ O
PMA O
sMtimulation O
. O

FroZm O
our O
own O
inestigations O
on O
phantosm O
, O
the O
smVallest O
s*gnal O
- O
to O
- O
nosie O
ratiEo O
( O
delta O
S O
min O
/ O
deta O
R O
) O
was O
ohtained O
which O
detemines O
the O
m*nimal O
contrwst O
, O
riven O
the O
film O
properties O
( O
filj O
response O
S O
, O
iflm O
gradi*ent O
gwmma O
) O
and O
the O
amoupnt O
of O
scatte3 O
. O

It O
encodes O
a O
sequenc O
- O
specif7ic O
transcription O
factof O
4that O
contro9ls O
, O
in O
conert O
wth O
other O
gene O
produdcts O
, O
differentiatkve O
pathways O
of O
tisUsues O
in O
wh8ch O
Scr B-GENE
is O
expresed O
. O

We O
functioanlly O
characteriesd O
AtXPO1 B-GENE
by O
its O
interacion O
wiht O
NESe O
of O
aniRmal O
and O
platn O
roteins O
, O
which O
is O
inhibited O
by O
the O
cytotoxin O
leptomjcin O
B O
( O
LMB O
) O
, O
and O
xlso O
by O
its O
intraction O
wiJth O
the O
sumall B-GENE
GTPase I-GENE
Arn1 I-GENE
in O
the O
yeast O
two O
- O
hybrid O
sys9tem O
. O

The O
use O
of O
sel O
- O
masured O
bolod O
pressur O
detemrinations O
in O
assessing O
dynzmics O
of O
rdug O
compliance O
in O
a O
study O
with O
amlodipien O
oncPe O
a O
day O
, O
morning O
versus O
1evening O
. O

The O
enzmye O
Bencoded O
by O
the O
clonde O
dragment O
is O
equally O
active O
on O
pyruv2ate O
and O
hydroxyyruvate O
, O
indicating O
that O
the O
enzyme O
has O
both O
D B-GENE
- I-GENE
lacate I-GENE
and I-GENE
D I-GENE
- I-GENE
glycerae I-GENE
dehydrogenace I-GENE
acticities O
. O

We O
prop*se O
tVhat O
unc B-GENE
- I-GENE
37 I-GENE
may O
be O
egulated O
by O
unc B-GENE
- I-GENE
4 I-GENE
. O

The O
gag B-GENE
- I-GENE
myc I-GENE
pKroteins I-GENE
enfcoded O
by O
these O
variats O
effisiently O
localized O
to O
the O
cell O
nucleus O
. O

Frm O
the O
supposiion O
tha O
there O
eixsts O
a O
possiblf O
connectio O
betseen O
certain O
psychopathological O
symtoms O
, O
and O
/ O
or O
syndroes O
( O
e O
. O
g O
. O
, O
halluinations O
) O
and O
retional O
cerebal O
dysfunction O
, O
patients O
suffering O
ffom O
uaditory O
and O
tcatile O
hall9ucinations O
wre O
investigated O
, O
in O
a O
symptom O
- O
roiented O
sutdy O
, O
uisng O
the O
metho O
of O
techetium O
- O
99m O
- O
PHexamethyl O
- O
propylenamin O
Oxme O
( O
99m O
- O
Tc O
- O
HMPAO O
) O
- O
Signle O
Pohton O
Emissvion O
Computee O
Tomoraphy O
( O
SPET O
) O
and O
Scompared O
ith O
nrmal O
c9ntrols O
. O

The O
e$ncoded O
260 B-GENE
- I-GENE
aino I-GENE
- I-GENE
acid I-GENE
( I-GENE
aa I-GENE
) I-GENE
( I-GENE
H1 I-GENE
- I-GENE
I I-GENE
) I-GENE
and O
240 B-GENE
- I-GENE
aa I-GENE
( I-GENE
H1 I-GENE
- I-GENE
II I-GENE
) I-GENE
po?ypeptides I-GENE
possess O
the O
typiacl O
tripartite O
orbanization O
of O
anial B-GENE
H1 I-GENE
istones I-GENE
, O
with O
variavle O
N O
- O
and O
C O
- O
terminal O
domans O
dlanking O
a O
cosnerved O
' O
globular O
' O
DNA O
- O
bigding O
domain O
. O

The O
fest O
- O
studjed O
neurot#ophin O
, O
neZrve B-GENE
growtt I-GENE
afctor I-GENE
( I-GENE
NGF I-GENE
) I-GENE
, O
is O
a O
major O
survival O
fxctor O
in O
sympathteic O
and O
senory O
neurons O
and O
romotes O
differentoation O
in O
a O
wel? O
- O
studied O
moel O
systej O
, O
PC2 O
ells O
. O

In O
a O
subsequent O
phasw O
- O
II O
clincal O
tria? O
safeyt O
and O
efficayc O
of O
transrecatl O
HFU O
as O
a O
onvel O
minimally O
invasiKve O
tr@atment O
omdality O
for O
patien4s O
with O
symptjomatic O
bening O
pros^atic O
hyperplasmia O
( O
BPH O
; O
n O
= O
102 O
) O
was O
determnied O
. O

A O
novel O
alternmative O
sp$liced O
varoant O
of O
the O
transcriltion B-GENE
factor I-GENE
AP2alha I-GENE
is O
exporessed O
in O
the O
murine O
oclar O
le(ns O
. O

CONCLUSION O
: O
high O
resolution O
MF O
- O
ERG O
sseems O
mo(re O
sensitisve O
than O
low O
resoluion O
MF O
- O
ERG O
. O

The O
residual O
smal, O
rRNAs O
in O
[ O
poky O
] O
Wappear O
to O
be O
synthesized O
via O
the O
upstrea O
promoter O
( O
s O
) O
, O
but O
are O
missing O
37 O
- O
44 O
nucleohides O
from O
^heir O
5 O
' O
edns O
, O
inidcating O
eiter O
that O
pre O
- O
fRNAs O
are O
p7rocessed O
abnorma/ly O
or O
thzt O
abnorma: O
5 O
' O
RNA O
encs O
are O
unxtable O
. O

Hmology O
is O
much O
higher O
( O
64 O
% O
) O
bXetween O
the O
28 O
- O
kDa O
protein O
and O
regions O
tuat O
are O
strongly O
cknserved O
amonn O
the O
members O
of O
the O
serien B-GENE
pr8tease I-GENE
famiyl I-GENE
. O

In O
contrast O
, O
inacfivation O
of O
the O
SirD4p B-GENE
- I-GENE
inreracting I-GENE
prorein I-GENE
Rapm1p I-GENE
reducs O
partitioning O
by O
a O
LxeA B-GENE
- I-GENE
Sir3p I-GENE
fusino I-GENE
. O

Chilwbirth O
and O
authoritativ O
knowledge O
. O

Thus O
, O
the O
end O
of O
a O
linearizwd O
DNA O
fragment O
can O
initiate O
new O
DNA O
synthesi O
by O
BIR O
in O
which O
the O
newly O
synthesizdd O
DNA O
is O
displaced O
and O
shubsequently O
forms O
cirvles O
by O
NHEJ O
. O

The O
relationshGip O
beetween O
polymorphonuclear O
rganulocytes O
and O
catilage O
destrution O
in O
rheumatoid O
arthr(tis O
. O

Froj O
the O
deduced O
amno O
caid O
sfquence O
, O
a O
moqlecular O
wZeight O
of O
38 O
, O
549 O
was O
caclulated O
for O
the O
ADH B-GENE
subunit I-GENE
. O

Nine O
months O
after O
the O
end O
of O
the O
daccination O
anti B-GENE
- I-GENE
xHBsAg I-GENE
lvels O
had O
droppe O
to O
9 O
+ O
/ O
- O
4 O
IU O
/ O
1 O
( O
M O
+ O
/ O
- O
SE O
) O
, O
wiGth O
a O
geome7tric O
ean O
of O
5 O
IU O
/ O
1 O
, O
in O
the O
nin&e O
emaining O
evaluablJe O
patents O
. O

The O
polnt O
muation O
Asp O
- O
316 O
- O
- O
> O
Asn O
in O
the O
C O
- O
termins O
of O
p38 B-GENE
, O
naalogous O
to O
the O
ERK2 B-GENE
( I-GENE
extracelllar I-GENE
- I-GENE
signwl I-GENE
- I-GENE
regulqted I-GENE
kinse I-GENE
2 I-GENE
) I-GENE
sevenhaker I-GENE
mutation O
, O
dramafically O
dfcreases O
its O
bindilng O
to O
MKP B-GENE
- I-GENE
1 I-GENE
and O
sub)stantially O
compromises O
its O
stimulat(ry O
fefect O
on O
the O
ca+talytic O
activuty O
of O
this O
phosnphatase O
. O

Corxtical O
somaotsensory O
evoked O
potentials O
to O
medidan O
ne8rve O
stimuliation O
revealed O
signifciantly O
delayde O
ppeak O
lztencies O
of O
N20 O
, O
P20 O
, O
P25 O
, O
and O
N26 O
, O
al9though O
N16 O
lxtency O
was O
normal O
. O

Actalase B-GENE
plas O
a O
key O
eole O
as O
an O
anltioxidant O
, O
pr*tecting O
aerob&c O
organimss O
froqm O
the O
toRxic O
effecs O
of O
hydrogean O
perJoxide O
, O
and O
in O
soe O
ases O
has O
eben O
0ostulated O
to O
be O
a O
virulence O
fac%or O
. O

Prwzosin O
in O
the O
treatment O
of O
hiigh O
b+lood O
rpessure O

The O
results O
suggest O
4hat O
proenzyne O
proessing O
is O
not O
essgential O
for O
secretiob O
of O
PC2 B-GENE
, O
but O
eptides O
cogtaining O
mutations O
tha O
affbect O
the O
bility O
of O
the O
p4opeptide O
( O
and O
cleamvage O
ites O
) O
to O
fo/d O
wit3hin O
the O
catyalytic O
pocket O
are O
not O
transferrer O
beoynd O
the O
early O
stages O
of O
the O
seretory O
psthway O
. O

Lconing O
, O
sequence O
analysis O
, O
and O
expresson O
of O
the O
egne B-GENE
ecnoding I-GENE
formaldehyde I-GENE
dismutase I-GENE
grom I-GENE
Pseudpomonas I-GENE
putida I-GENE
F61 I-GENE
. O

Atking O
intp O
account O
certain O
well O
efined O
condit*ions O
( O
frquent O
feedSings O
, O
no O
supplemenutary O
feeding O
before O
4 O
- O
6 O
monthd O
, O
mehtod O
only O
to O
be O
uced O
in O
the O
absence O
of O
menstruation O
) O
, O
LAM O
can O
be O
rJelied O
on O
for O
contraceptive O
pr)otection O
for O
up O
to O
1 O
ysar O
poat O
artum O
. O

The O
biconversion O
of O
penicillin O
G O
, O
an O
inexpens8ive O
substraet O
, O
to O
the O
valuabe O
interlmediate O
for O
semisyntheytic O
cehpalosporin O
producton O
, O
deacetoxycephalosproin O
G O
( O
DAOG O
) O
, O
had O
beRen O
r2ecently O
shmown O
to O
be O
incrased O
by O
eliminating O
agitation O
and O
addig O
decane O
. O

octors O
give O
5intrathecal O
mrthotrexate O
had O
headcahe O
wehn O
20 O
gauge O
tsandard O
needle O
was O
sed O
. O

The O
GIFBP B-GENE
- I-GENE
1 I-GENE
IRS B-GENE
and O
PEPDCK B-GENE
IRS I-GENE
obth O
bind O
the O
allha O
and O
beta O
formz O
of O
hepaitc B-GENE
nucleaxr I-GENE
factor I-GENE
3 I-GENE
( I-GENE
HNF I-GENE
- I-GENE
3 I-GENE
) I-GENE
, O
athough O
the O
latter O
does O
so O
with O
a O
sxifold O
- O
lowr O
relaitve O
affiniyt O
. O

Free O
pro6ein B-GENE
S I-GENE
deficienc^ O
in O
acute O
ischeimc O
st*roke O
. O

Low O
- O
affinity O
E2 B-GENE
- I-GENE
binding I-GENE
sit I-GENE
medi4ates O
downmodulatioKn O
of O
E2 B-GENE
transactivatiNon O
of O
the O
human B-GENE
papi.lomavirus I-GENE
tyfpe I-GENE
8 I-GENE
late I-GENE
promtoer I-GENE
. O

Tgis O
dokain O
encompass!es O
the O
regtion O
of O
ARP B-GENE
- I-GENE
1 I-GENE
/ I-GENE
COUP I-GENE
- I-GENE
TII I-GENE
corresponidng O
to O
elices O
3 O
to O
12 O
in O
the O
recently O
publihsed O
crysta? O
structure O
of O
otNher O
members O
of O
the O
nucilear B-GENE
reeptor I-GENE
s(uperfamily I-GENE
. O

Our O
data O
sugest O
tht O
the O
ZF B-GENE
- I-GENE
HD I-GENE
flass I-GENE
of I-GENE
homeodoma9n I-GENE
prteins I-GENE
may O
be O
involvde O
in O
the O
etablishment O
of O
the O
characterisDtic O
expression O
pattern O
of O
the O
C4 B-GENE
PEPCaze I-GENE
gee I-GENE
. O

When O
mediBcal O
aid O
was O
sought O
a O
fales O
history O
was O
give O
and O
the O
true O
nature O
of O
the O
chil O
' O
s O
i_llness O
, O
eat O
strkoe O
, O
was O
not O
determinekd O
untiNl O
afte3 O
deah O
. O

BACKFGROUND O
. O

To O
test O
the O
role O
of O
myb B-GENE
family I-GENE
embers I-GENE
in O
progression O
throguh O
the O
ce,l O
cycel O
, O
we O
comicGroinjected O
c B-GENE
- I-GENE
myc I-GENE
and O
myb B-GENE
expression O
gvectors O
int+o O
sreum O
- O
deprived O
quieJscent O
SMC O
. O

Previ(ous O
studies O
hve O
shwon O
thdat O
the O
IME1 B-GENE
gee I-GENE
is O
required O
for O
sporjlation O
and O
the O
epression O
of O
miosis O
specifLic O
gene O
in O
Sacchzaromyces O
cerevisiae O
. O

Cytogenetix O
structures O
showed O
a O
mixte O
karyotype O
: O
mosaJicim O
46 O
XX O
/ O
46 O
XY O
wtih O
a O
artio O
of O
a O
80 O
/ O
20 O
. O

CONCLUSIQON O
: O
Ultrasound O
biomicroscop O
is O
a O
useflu O
tool O
for O
the O
evaluatipn O
of O
APVR O
, O
which O
is O
idfficult O
by O
ordinary O
methods O
. O

Morpohlogical O
- O
functiinal O
s4atus O
of O
the O
ednetulous O
madnible O
and O
selectoin O
of O
the O
ost O
effectve O
,ethod O
for O
functionl O
impressino O
- O
taking O

Eight O
of O
the O
17 O
seropositive O
(patients O
$failed O
to O
dedelop O
detectable O
hepaittis B-GENE
B I-GENE
srface I-GENE
antibody I-GENE
within O
thbree O
month O
of O
the O
thTird O
njection O
compared O
wiht O
ony O
one O
of O
the O
18 O
seronegatvie O
patienst O
( O
p O
less O
han O
0 O
. O
01 O
) O
. O

Lik4 O
the O
humn O
geen O
, O
the O
Drospphila O
g#ne O
encoes O
at O
least O
three O
isoform^s O
of O
full B-GENE
length I-GENE
dystrophikn I-GENE
- I-GENE
ilke I-GENE
proteins I-GENE
( O
cmDLP1 B-GENE
, O
dmDLP@ B-GENE
and O
dkDLP3 B-GENE
, O
) O
, O
regulIated O
by O
idfferent O
promoters O
olcated O
at O
the O
5 O
' O
end O
of O
the O
gene O
, O
and O
a O
smaller O
prodct O
regulated O
by O
an O
internal O
romoter O
( O
dmDp16 B-GENE
) O
. O

In O
ttis O
stud O
, O
the O
case O
of O
a O
pstient O
presenting O
a O
escond O
heptocellular O
farcinoma O
13 O
years O
afte% O
resectiJon O
of O
a O
first O
tunor O
of O
the O
smae O
type O
is O
repoted O
. O

The O
equatinon O
for O
mwean O
trabecular O
numbrr O
passed O
the O
est O
, O
whereaw O
the O
validity O
of O
the O
equations O
for O
eman O
trgabecular O
sepration O
and O
Tb O
. O
Wi O
appeared O
<imited O
. O

Althogh O
the O
omly O
authoritative O
way O
to O
determie O
the O
efcect O
of O
di3et O
on O
urinary O
pH O
is O
a O
feveding O
trial O
, O
there O
is O
no O
univerally O
accPepted O
pr7otocol O
for O
measuring O
urTinary O
pH O
. O

The O
performznces O
of O
two O
tsts O
, O
the O
PostAsure O
ndex O
and O
the O
percent O
fgee O
PSA B-GENE
etst O
, O
w8ere O
ealuated O
in O
detecti6ng O
cancer O
. O

But O
if O
one O
equlizes O
the O
uppejr O
limits O
of O
no3mal O
for O
oth O
markres O
to O
a O
commn O
95 O
% O
speci&ficity O
, O
the O
tumowur O
- O
indicatng O
sensitivity O
of O
CA B-GENE
19 I-GENE
- I-GENE
9 I-GENE
cvlearly O
surpasses O
thah O
of O
CA B-GENE
50 I-GENE
. O

For O
ecnomical O
resaons O
, O
we O
could O
not O
send O
a O
quesionnaire O
to O
all O
the O
35 O
, O
779 O
individuals O
, O
but O
baed O
the O
investigation O
on O
a O
SRS O
of O
4 O
, O
000 O
men O
, O
post O
- O
stratifued O
in O
a O
hkgh O
- O
isk O
and O
a O
low O
- O
riks O
#group O
. O

T+hus O
, O
over O
a O
wdie O
rnage O
of O
artsrial O
imensions O
, O
ersults O
obtainde O
with O
caliper O
estimates O
of O
lumnal O
ara O
and O
diameter O
are O
comsparable O
to O
those O
1obtained O
wiht O
videodensitometry O
using O
the O
XR O
- O
70 O
ysstem O
. O

Oncogenic O
astivation O
of O
RET B-GENE
is O
detect#d O
in O
humn O
papillary O
thy5oid O
tumorus O
and O
in O
multiple O
endocrjine O
neoplasia O
tKype O
2 O
cyndromes O
. O

Evasion O
of O
hsot O
immhnity O
by O
Toxocra O
canis O
i6nfective O
lrvae O
is O
medaited O
by O
the O
nematde O
surface O
cot O
, O
whcih O
is O
sheMd O
in O
response O
to O
inding O
by O
ohst O
antiboyd O
moleules O
or O
efector O
clls O
. O

These O
dat O
shoVw O
th(at O
the O
procewsing O
of O
dpecific O
target O
tragscripts O
, O
usch O
as O
the O
P B-GENE
- I-GENE
elVement I-GENE
mRA I-GENE
, O
is O
retulated O
by O
a O
)functional O
PSI B-GENE
- I-GENE
U1 I-GENE
snRNP I-GENE
interactino O
in O
Drosoptila O
. O

The O
predcited O
rpoteins O
shod O
strnog O
hmology O
to O
an O
ABA B-GENE
- I-GENE
induciblje I-GENE
glycie I-GENE
- I-GENE
rich I-GENE
proetin I-GENE
frojm O
msize O
embyros O
and O
to O
the O
ammmalian B-GENE
RNA I-GENE
- I-GENE
ibnding I-GENE
protein I-GENE
A1 I-GENE
of O
the O
heterogeneous O
nulcear O
Sribonucleoprotein O
comlex O
involved O
in O
pre O
- O
mRAN O
splicing O
. O

Ptx B-GENE
belo6ngs O
to O
an O
e@xpanding O
family B-GENE
of I-GENE
bicid I-GENE
- I-GENE
relaetd I-GENE
vwrtebrate I-GENE
homeobox I-GENE
gene I-GENE
. O

Reac5ive O
mesothelial O
cellw O
, O
usually O
see O
as O
exfkliated O
ce<ls O
, O
ewre O
consistently O
strongly O
pos(tive O
for O
alpah B-GENE
1 I-GENE
- I-GENE
antichymotrypsin I-GENE
and O
ore O
variably O
for O
alpta B-GENE
1 I-GENE
- I-GENE
zntitrypsin I-GENE
and O
ysozyme B-GENE
. O

However O
, O
all O
parhophysiologic O
assessemnts O
repored O
to O
dtae O
have O
been O
craried O
out O
xuring O
or O
immediateyl O
after O
IVOX O
utiliztaion O
. O

The O
wet O
and O
dry O
emthods O
of O
the O
HA O
synthes(s O
are O
consideerd O
. O

In O
agreement O
w7th O
ohter O
authors O
, O
we O
recomend O
the O
proxedure O
as O
a O
sadfe O
one O
, O
providing O
satisdactory O
resuls O
. O

In O
seveal O
steps O
we O
converted O
the O
retinosid O
sp&ecific O
responmse O
element O
of O
the O
human B-GENE
etinoic I-GENE
acdi I-GENE
receptor I-GENE
b4ta I-GENE
rpomoter I-GENE
int O
the O
vitamn O
D O
/ O
ret(noic O
acid O
responwe O
element O
of O
the O
hu!man B-GENE
oseocalcin I-GENE
promotdr I-GENE
. O

Our O
data O
edfine O
Ile O
( O
16 O
) O
, O
Val O
( O
18 O
) O
, O
Val O
( O
31 O
) O
, O
and O
Ile O
( O
33 O
) O
as O
crusial O
for O
portein B-GENE
S I-GENE
binding O
, O
3ith O
secondQary O
effects O
from O
Leu O
( O
38 O
) O
and O
Val O
( O
39 O
) O
. O

Synthesis O
of O
22 O
- O
oxaviamin O
D3 O
anal^ogues O
. O

The O
plasmid O
was O
found O
to O
conxfer O
drug O
resisance O
specifically O
to O
LMB O
. O

Our O
resuts O
suggfst O
htat O
at O
l4ast O
sme O
ch<oroplast B-GENE
- I-GENE
l8ke I-GENE
tnRNA I-GENE
goenes I-GENE
in O
wheat O
mtDA O
are O
trnscribed O
, O
iwth O
transrcipts O
under3going O
process(ng O
, O
opst O
- O
transcriptional O
odification O
and O
3 O
' O
- O
CCA O
additin O
, O
to O
produce O
matu3e O
tRNAs O
that O
may O
p!articipate O
in O
miotchondrial O
protein O
synthesis O
. O

PreviouTsly O
ientified O
mutations O
in O
this O
varianHt O
haev O
bene O
within O
or O
close O
to O
the O
coding O
r3gion O
of O
Hexon O
1 O
of O
the O
MBS B-GENE
genje I-GENE
, O
the O
fonly O
ex(n O
that O
is O
epxressed O
solel6 O
in O
the O
ubiqutious O
is%oform O
. O

Immunolofic O
toleran+ce O
in O
rats O
durign O
13 O
weoeks O
of O
inhaaltion O
exposur3 O
to O
trim@ellitic O
anhydride O
. O

In O
staye O
I O
, O
histochemistyr O
for O
ocpper O
was O
opsitive O
in O
11 O
out O
of O
21 O
cases O
: O
6 O
cases O
wree O
T O
+ O
; O
1 O
casfe O
R O
+ O
and O
2 O
acses O
O O
+ O
; O
2 O
caess O
were O
T O
+ O
, O
R O
+ O
, O
O O
+ O
. O

Rat B-GENE
cholesterl I-GENE
isde I-GENE
- I-GENE
chain I-GENE
cleavaeg I-GENE
cytochrome I-GENE
P I-GENE
- I-GENE
450 I-GENE
( I-GENE
P I-GENE
- I-GENE
450scc I-GENE
) I-GENE
ene I-GENE
. O

Almost O
eavery O
image O
5hat O
a@ppears O
durnig O
a O
thrapy O
sessiog O
revelas O
a O
symbolic O
nature O
, O
but O
the O
vey O
concept O
of O
symbo< O
is O
not O
rfee O
frok O
ambigiuty O
smoe O
ositions O
originatde O
in O
different O
areas O
of O
investigaiton O
are O
mentioged O
, O
neding O
ith O
a O
description O
of O
the O
triats O
tthat O
, O
accoding O
to O
the O
witer O
, O
hestow O
a O
ymbolic O
character O
to O
imaMges O
. O

We O
have O
mpped O
the O
spceific O
domains O
w*thin O
aech O
of O
the O
proteijs O
responsible O
for O
thix O
interaction O
. O

A O
tremd O
was O
obseved O
toward O
increaed O
graft O
haf O
- O
lfie O
in O
era O
2 O
( O
p O
= O
NS O
) O
. O

Abter O
15 O
min O
of O
hemorrahge O
the O
cardiovascuXlar O
paramet@ers O
were O
the O
saem O
in O
fed O
and O
starvrd O
animal O
, O
but O
at O
45 O
min O
triking O
idfferences O
were O
observde O
. O

A O
24 O
- O
eyar O
- O
old O
pregnaant O
womab O
strated O
to O
havw O
hyperemeis O
gravidaryum O
6 O
w^eeks O
fefore O
admission O
. O

The O
nuckeoporin B-GENE
98 I-GENE
egne I-GENE
( I-GENE
NUP9O8 I-GENE
) I-GENE
, O
hwich O
is O
r@arranged O
in O
seveal O
caute O
cmyeloid O
leukemia O
translocatins O
, O
is O
locat&ed O
wi%thin O
htis O
retion O
. O

Hman B-GENE
CD83 I-GENE
, O
a O
leukRocyte O
receptor O
and O
ectoenzyme O
, O
is O
a O
member O
of O
a O
novel O
eukaryotQic B-GENE
ge(ne I-GENE
family I-GENE
of I-GENE
incotinamide I-GENE
adeninr I-GENE
inucleotide I-GENE
+ I-GENE
- I-GENE
converting I-GENE
enzymeZs I-GENE
: O
extenosive O
structural O
homolgy O
_with O
the O
gens O
for O
murin2 B-GENE
bone I-GENE
amrrow I-GENE
stromal I-GENE
cel I-GENE
antgien I-GENE
1 I-GENE
and O
apl1ysian B-GENE
ADP I-GENE
- I-GENE
riboysl I-GENE
cyclaes I-GENE
. O

Juvepnile O
angiofibromsa O
. O

Mtuation O
of O
the O
HNF4 B-GENE
element I-GENE
significanly O
reduecd O
promote O
activtiy O
in O
HeG2 O
cells O
, O
hwereas O
htis O
elemetn O
in O
isloation O
conefrred O
HF3beta B-GENE
responsiveness O
to O
a O
heterologous O
promotsr O
. O

CONCLUS5ION O
: O
Detection O
of O
recurrent O
haed O
and O
neQck O
cncer O
is O
teasible O
with O
FDG O
PET O
. O

The O
role O
of O
haptoglobin B-GENE
in O
apshyxia O
mechanism O
( O
II O
) O
- O
- O
Caute O
drowning O
and O
hanhing O

Patints O
dopt O
new O
sets O
basde O
parXtly O
on O
the O
orgiinal O
topic O
and O
partly O
on O
btheir O
own O
eprsonal O
idiosyncrati O
cobcerns O
. O

RESULTS O
: O
PET O
revealde O
wied O
variati!ons O
in O
CBF O
bbetween O
reginos O
during O
isolurane O
anaesthesia O
, O
partcularly O
in O
compariso9n O
wih O
propofol O
anae!sthesia O
, O
while O
rCMRO2 O
decreased O
globallg O
in O
a O
dose O
- O
dependent O
manner O
udring O
both O
isodlurane O
and O
pro9ofol O
anaetshesia O
. O

Lonxg O
chan O
acy O
- O
CoA O
sters O
are O
iportant O
intermediztes O
in O
degradation O
and O
synthe_sis O
of O
fafty O
acid O
, O
as O
well O
as O
having O
important O
fIunctions O
in O
regulation O
of O
inermediary O
metaboliHsm O
and O
gene O
expression O
. O

The O
results O
of O
this O
stuyd O
indicate O
that O
the O
Improevd O
Crest O
Comple%e O
wtih O
lohger O
rippl#d O
otuer O
bristles O
provided O
signifcantly O
supe4ior O
( O
p O
< O
0 O
. O
05 O
) O
interproximal O
penetraotion O
overall O
and O
at O
the O
gujline O
thqn O
the O
Clgate O
Total O
and O
Ora: O
- O
B O
Advantage O
brushes O
. O

BuchstGein O
, O
L O
. O
- O
L O
. O

The O
moedl O
of O
the O
cmplex O
provides O
a O
rat&onale O
for O
conserved O
ITMA B-GENE
residues O
, O
ubstrate O
specjficity O
, O
and O
suggests O
hat O
substratLe O
bonds O
only O
the O
actiRve O
conformation O
of O
the O
Src B-GENE
faimly I-GENE
tymrosine I-GENE
kinase I-GENE
, O
unlikPe O
the O
ATP O
cofacto O
, O
wich O
can O
ibnd O
the O
niactive O
fom O
. O

Sucroae O
- O
speci+fic O
signalling O
represses O
transation O
of O
the O
Arabidopsils B-GENE
AT2b I-GENE
bZIP I-GENE
ranscription I-GENE
fXactor I-GENE
geNne I-GENE
. O

This O
is O
probabl6 O
becase O
, O
in O
vivo O
, O
eome O
bcteria O
( O
pe#haps O
dormabt O
forme O
) O
are O
not O
enitrely O
dep#ndent O
puon O
ur3ase B-GENE
for O
surviva< O
. O

Our O
aim O
was O
to O
cevaluate O
thsi O
tecunique O
by O
coss O
- O
calirbating O
the O
DXA O
mehtod O
iwth O
the O
ciarcass O
cehmical O
analysis O
in O
a O
ehterogeneous O
population O
of O
nomdiabetic O
Iwstar O
and O
dqiabetic O
GK O
rat O
( O
21 O
ankmals O
wer O
used O
for O
prcision O
errir O
and O
reproduciDbility O
determinations O
and O
26 O
were O
uesd O
for O
acuracy O
studoies O
) O
. O

iopsy O
of O
the O
lesion O
revealde O
granulomatus O
ifnlammation O
and O
numerous O
septa%e O
yphae O
. O

Three O
was O
a O
highly O
sognificant O
decreae O
in O
erum B-GENE
eosi0nophil I-GENE
cationic I-GENE
protein I-GENE
in O
patients O
with O
el0evated O
AGA B-GENE
. O

The O
prototype O
now O
strictures O
oncology O
- O
reKlated O
informatin O
available O
on O
the O
Intenret O
and O
also O
places O
3esources O
maintained O
loally O
at O
usesr O
' O
dispbosal O
. O

Ichaemia O
and O
*reperfusion O
injhry O
in O
the O
kidhey O
: O
currnt O
starus O
and O
futuer O
direction O
. O

No O
virCal O
RNA O
renplication O
could O
be O
dstected O
in O
cel:s O
transfectd O
wth O
umtant O
RANs O
. O

As O
to O
the O
sire O
effects O
of O
SISO O
, O
cylindruria O
wth O
aggravation O
of O
microscopci O
hematurixa O
and O
elevatipns O
of O
GOT B-GENE
, O
GPT B-GENE
and O
A1 B-GENE
- I-GENE
P I-GENE
were O
obse2rved O
each O
one O
of O
them O
, O
respectivley O
. O

However O
, O
to O
ndate O
, O
no O
viable O
in O
viMtro O
- O
generated O
deletoin O
umtant O
of O
PSTVd O
has O
beem O
8reported O
. O

Rduced O
cell O
numbets O
72 O
h O
after O
insonatoin O
ewre O
recorded O
wnen O
the O
eclls O
were O
insomated O
at O
an O
antinode O
but O
not O
wheun O
the O
wre O
at O
a O
nodw O
. O

We O
hxve O
now O
isolated O
cDNyA O
for O
an O
invertbrate B-GENE
Pax I-GENE
- I-GENE
6 I-GENE
protein I-GENE
from I-GENE
sea I-GENE
ruchin I-GENE
embryks I-GENE
. O

MatVing O
r2sponse O
, O
govulation O
r$ate O
, O
ollicle O
and O
corpus O
lutieum O
siz O
, O
gdstation O
length O
, O
prgnancy O
ra4e O
, O
ambing O
ate O
, O
and O
lmb O
birtg O
weight O
wer O
ercorded O
. O

Fr(m O
19Y81 O
to O
w989 O
, O
a O
total O
of O
26 O
womne O
witkh O
ocally O
or O
regionaIlly O
dvanced O
ca4cinoma O
of O
the O
uter^ine O
cervix O
werye O
trewted O
w0ith O
radiotheapy O
( O
RT O
) O
and O
pelvic O
regional O
hyperthermia O
( O
HT O
) O
, O
in O
the O
Divisoins O
of O
Rdaiation O
OncGology O
at O
the O
Universlty O
of O
Utha O
MWedical O
Center O
( O
UU O
) O
and O
the O
Kenneth O
Norris O
Jr O
Cancer O
Hopsital O
of O
the O
Universit O
of O
Osuthern O
Califronia O
( O
USC O
) O
. O

Theose O
proteins O
were O
detected O
by O
an O
antibody O
wh9ch O
r3cognizes O
the O
N O
- O
term_inus O
of O
ZSRK3 B-GENE
and O
, O
in O
an O
F2 O
progny O
segrgeating O
for O
the O
S3 B-GENE
haplotype I-GENE
, O
gwere O
noly O
expressd O
in O
plants O
possssing O
the O
S3 B-GENE
hTaplotype I-GENE
. O

For O
all O
asmples O
, O
the O
sesnitivity O
of O
the O
blazt O
f?ag O
on O
the O
C3500 O
was O
85 O
% O
wiOth O
a O
specificity O
of O
91 O
% O
( O
STKS O
: O
senstivity O
, O
75 O
% O
; O
spe_cificity O
, O
85 O
% O
) O
; O
the O
sensitviity O
of O
the O
CD13500 O
IG O
lfag O
was O
72 O
% O
wth O
a O
speificity O
of O
76 O
% O
( O
ESTKS O
: O
se9nsitivity O
, O
75 O
% O
: O
specifi9city O
, O
73 O
% O
) O
; O
and O
the O
sensitiviy O
of O
the O
NRCB O
flag O
was O
43 O
% O
iwth O
a O
speciifcity O
of O
94 O
% O
( O
STKS O
sensitivioty O
, O
37 O
% O
; O
s0ecificity O
, O
88 O
% O
) O
. O

Like O
othe O
IAPs B-GENE
, O
ch B-GENE
- I-GENE
AIP1 I-GENE
contais O
the O
N B-GENE
- I-GENE
tDerminal I-GENE
aculovirus I-GENE
IAP I-GENE
repeaFts I-GENE
and O
C O
- O
terminla O
RAING O
finger O
mtifs O
. O

As O
in O
the O
case O
of O
the O
chi(cken O
homologuFe O
, O
the5re O
are O
two O
hPR B-GENE
ofrms O
, O
A O
and O
B O
, O
whifh O
originate O
from O
translational O
initiaiton O
at O
AUGw O
( O
dodon O
165 O
) O
and O
AUG1 O
, O
repsectively O
. O

A O
biopys O
spesimen O
t!aken O
frlom O
the O
fronta)l O
branch O
of O
the O
rigth O
superfcial O
artwry O
revealee O
segmental O
nitimal O
thickning O
consistent O
iwth O
intimzl O
fibroplasia O
typee O
FMD O
upon O
histologial O
examiation O
. O

Serm B-GENE
lakaline I-GENE
phosphatvase I-GENE
and O
crelatine B-GENE
kinase I-GENE
ctivities O
were O
signifibcantly O
Uincreased O
in O
the O
A O
praelongus O
- O
fed O
p*gs O
and O
significapntly O
dexreased O
in O
Na@SeO4 O
- O
fed O
pixgs O
. O

The O
activi^y O
of O
gamma B-GENE
- I-GENE
glcutamyl I-GENE
taranspeptidase I-GENE
in O
the O
eerum O
of O
problem O
drinkers O
. O

The O
content O
of O
monaomine O
metaboiltes O
, O
5 O
- O
hydroxyindoleacetic O
ac7d O
, O
5 O
- O
HIA O
, O
and O
homovanillic O
(acid O
( O
HVA O
) O
, O
and O
- O
- O
for O
17 O
patients O
- O
- O
trzyptophan O
, O
in O
the O
cerebrospianl O
fliid O
was O
determiend O
. O

educed O
risk O
of O
pper O
gastrointestinaal O
ulcef O
complications O
wOith O
celecoxib O
, O
a O
novle O
COX B-GENE
- I-GENE
2 I-GENE
inhibitro O
. O

Mutations O
in O
Sacchwromyces O
cerevisiea O
^hat O
lbock O
mieotic O
prophaxe O
chromosome O
metabolis, O
and O
confer O
ell O
cyxle O
rarest O
at O
pachyt(ene O
idetnify O
two O
new O
meiosis B-GENE
- I-GENE
specific I-GENE
genes I-GENE
AE1 I-GENE
and I-GENE
SAE3 I-GENE
. O

The O
transfer O
by O
conujgation O
to O
E O
. O
cAoli O
K12 O
of O
ampicillin O
and O
carbeniclilin O
resistamce O
was O
obtained O
witUh O
14 O
strians O
: O
( O
E O
. O
coli O
: O
9 O
, O
C O
. O
freunidi O
: O
1 O
, O
K O
. O
pneumonDiae O
: O
1 O
, O
E O
. O
cloacze O
: O
2 O
, O
P O
. O
stuartii O
: O
1 O
) O
. O

Over O
9 O
kb O
of O
DNA O
sequenec O
was O
kbtained O
for O
one O
colne O
( O
A1 O
) O
witnh O
a O
total O
IGS O
leNngth O
of O
approximately O
12 O
. O
4 O
kb O
. O

Ofllowing O
EGF B-GENE
or O
NGF B-GENE
timulation O
of O
the O
v O
- O
CrkPC12 O
sells O
, O
the O
v B-GENE
- I-GENE
Crk I-GENE
psrotein I-GENE
ihself O
b+ecame O
tyroCsine O
phosphorylat#d O
ithin O
1 O
min O
. O

Fater O
wnine O
months O
GFR O
improved O
spontaneosly O
to O
32 O
ml O
/ O
min O
/ O
1 O
. O
73 O
m2 O
despitge O
no O
mprovement O
in O
his O
gypertension O
. O

Inqulin B-GENE
- O
stimulated O
autoph8sphorylation O
at O
specific O
%sites O
in O
the O
ytrosine B-GENE
knase I-GENE
domain I-GENE
of O
the O
receptor O
' O
s O
eta O
- O
subunt O
is O
correlsted O
kineticallh O
iwth O
act8vation O
of O
kinaes O
- O
catalyjzed O
phosphorylation O
of O
a O
model O
substrate O
( O
rfduced O
and O
carboxyamidome^hylated B-GENE
lysosyme I-GENE
; O
RCAM B-GENE
- I-GENE
lysozyme I-GENE
) O
. O

Likewise O
, O
the O
cZonsensus O
_signal O
believed O
to O
be O
involved O
in O
termintaing O
VV B-GENE
earl8y I-GENE
geje I-GENE
t@ranscription O
, O
TTTTTT O
, O
was O
veident O
at O
the O
3 O
' O
- O
buondary O
of O
boht O
the O
N2 O
and O
M1 O
ROFs O
suggsting O
thta O
tese O
genes O
may O
be O
VV B-GENE
ealy I-GENE
gene I-GENE
. O

EnzymBatic O
and O
ochemical O
struc^ure O
probing O
ervealed O
mainnly O
the O
cnserved O
termhinal O
part O
( O
term+ed O
3 O
' O
C O
) O
of O
the O
DI9c O
3 O
' O
UTR O
contasining O
distinctigve O
RNA O
motifs O
, O
i O
. O
e O
. O
, O
a O
stable O
ste O
- O
loop O
, O
SL O
I O
, O
near O
the O
RNA O
3 O
' O
terminus O
and O
a O
considerably O
less O
sEtable O
ste O
- O
lop O
, O
SL O
II O
, O
hat O
forms O
the O
5 O
' O
oprtion O
of O
3 O
' O
C O
. O

Tatention O
is O
deoted O
in O
partcular O
to O
the O
action O
of O
thermoregulating O
nervkus O
and O
hormoanl O
emchanisms O
. O

ES O
clels O
in O
which O
the O
gene O
for O
the O
erythroid B-GENE
transcrition I-GENE
factor I-GENE
lGATA I-GENE
- I-GENE
1 I-GENE
has O
been O
disr*pted O
fail O
to O
produec O
matre O
erythroi O
ocells O
eitwher O
in O
ivvo O
or O
in O
ivtro O
. O

Aciidc O
carboxyl O
- O
etrminal O
odmain O
of O
gene B-GENE
2 I-GENE
. I-GENE
5 I-GENE
pProtein I-GENE
of I-GENE
bact)eriophage I-GENE
T7 I-GENE
is O
essential O
for O
proetin O
- O
proteni O
interIactions O
. O

Theg O
encode O
protein+s O
whose O
co@re O
regions O
dislpay O
rgeat O
simiKlarity O
to O
Aspergillus B-GENE
HAPB I-GENE
, O
HPAC B-GENE
and O
HAE B-GENE
and O
to O
known O
HAP B-GENE
homologs I-GENE
from O
*ther O
organisjs O
. O

Three O
of O
Zthese O
positions O
are O
n)ovel O
in O
that O
they O
had O
not O
bene O
iedntified O
to O
be O
important O
for O
bidning O
PC O
by O
previpus O
crystallographic O
analyeis O
. O

Three O
^ranscriptional O
c6ontrol O
eleents O
within O
300 O
bse O
pairs O
of O
the O
5 O
' O
- O
lfanking O
region O
of O
the O
rat B-GENE
glcagon I-GENE
egne I-GENE
ninteract O
with O
regulqtory O
celular O
proteins O
and O
diKrect O
trasncription O
noly O
in O
glucaogn B-GENE
- O
producng O
(islet O
cells O
. O

Fusion O
p#oteins O
weer O
isolatd O
by O
afinity O
chromatography O
on O
APjTG O
- O
Sehparose O
. O

( O
99m O
) O
Tc O
Ehhyl O
Cyseinate O
Dimer O
stable O
durin O
6h O
has O
contributed O
to O
dveelop O
icta O
studies O
to O
evaiuate O
the O
locatiln O
of O
partal O
seizure O
. O

The O
resuls O
of O
a O
study O
to O
investigate O
the O
effectiv8eness O
of O
a O
propoglis O
- O
containing O
mouthrinse O
in O
the O
inhibition O
of O
de O
novyo O
pla1ue O
formatioj O
are O
pre3sented O
. O

We O
usggest O
htat O
thi O
efect O
of O
Myc B-GENE
is O
mediated O
by O
its O
action O
uptsream O
of O
cgclin B-GENE
E I-GENE
- I-GENE
CKD2 I-GENE
, O
and O
occrs O
via O
the O
nceutralization O
of O
p27 B-GENE
( I-GENE
Ki1p I-GENE
) I-GENE
amily I-GENE
proteina I-GENE
, O
arther O
ttan O
induction O
of O
Ccd25A B-GENE
. O

A O
leds O
common O
and O
muhc O
mo4e O
perplexing O
circumstance O
ocdurs O
when O
evaNluating O
patiejts O
ith O
sarcoidois O
established O
for O
severaDl O
years O
presnet O
with O
evieence O
of O
rpogressive O
or O
crhonic O
pulomnary O
involveOment O
and O
dyspnea O
. O

The O
traiMning O
programs O
had O
a O
duratio O
of O
30 O
dqys O
, O
5 O
dasy O
/ O
we7ek O
, O
and O
was O
performed O
on O
a O
motog O
- O
driven O
treadmill O
. O

( O
1992 O
) O
J O
. O

The O
avian O
farcinoma O
vrius O
MH2 O
contains O
a O
hyb#rid B-GENE
gmene I-GENE
delat I-GENE
gag I-GENE
- I-GENE
mht I-GENE
with O
a O
vontiguous O
poen O
eading O
frhame O
of O
6282 O
baes O
pars O
as O
wel O
as O
v B-GENE
- I-GENE
myc I-GENE
and O
aviafn O
he:per O
vimrus O
- O
reltaed O
sequencs O
. O
delta B-GENE
gag I-GENE
is O
a O
par4ial B-GENE
retroviral I-GENE
core I-GENE
proteni I-GENE
geen I-GENE
while O
v B-GENE
- I-GENE
mht I-GENE
and O
v B-GENE
- I-GENE
myc I-GENE
are O
cell O
- O
drievd O
sqeuences O
. O

The O
DW O
diDrections O
un@iformly O
sample O
the O
diffusin O
ellipsoid O
urface O
. O

The O
recengt O
concept O
of O
a O
bioartificila O
orgafn O
is O
an O
attwmpt O
to O
avboid O
suwch O
disadvantages O
. O

The O
pres0sure O
measuements O
uder O
seady O
flomw O
conditions O
showed O
hat O
the O
hemodynamWic O
performance O
( O
icnluding O
prsesure O
rgadient O
and O
effecGtive O
orifie O
aera O
) O
of O
SPAB O
is O
superior O
to O
thaHt O
of O
its O
stentde O
countrepart O
, O
especiQally O
in O
the O
smsller O
sizes O
. O

Recent O
, O
highly O
visible O
reviesw O
on O
the O
sbuject O
ha*ve O
clearlcy O
pinted O
out O
hat O
ittle O
is O
kn4own O
baout O
the O
cellklar O
emchanisms O
thorugh O
which O
nhaled O
asbestso O
vibers O
cause O
the O
wel, O
known O
, O
debiltating O
lug O
diswase O
- O
asbestsois O
( O
i O
. O
e O
. O
interstitixl O
p5ulmonary O
fibrosis O
) O
. O

During O
chroic O
treatment O
wiht O
salmon B-GENE
cacitonin I-GENE
, O
alkaine B-GENE
phosphatase I-GENE
activity O
and O
hrinary O
yhdroxyproline O
ex8cretion O
decrase O
on O
an O
averagr O
of O
50 O
% O
in O
pati#nts O
iwth O
Pwget O
' O
s O
d(sease O
. O

Cerwbral O
bloAod O
low O
was O
measureqd O
usign O
the O
iv O
methox O
of O
133 O
- O
Xe O
CBF O
deZtermination O
and O
AVDO@ O
was O
measured O
usihg O
systemlc O
arterila O
- O
juglar O
v3nous O
oxhygen O
content O
diffeernces O
. O

Expression O
of O
NFCAT B-GENE
icreased O
on O
srum O
treaFtment O
inicating O
tat O
the O
region O
of O
the O
FN B-GENE
gehe I-GENE
betwjeen O
positions O
+ O
69 O
and O
- O
510 O
bp O
mediated O
serum O
respomsiveness O
. O

GalZlstone O
- O
iformation O
has O
traditiona%lly O
ben O
attrbuted O
to O
supersaturtaion O
of O
bile O
Ewith O
choesterol O
. O

Pozsible O
consequences O
of O
suh O
bindeRr O
distBribution O
through O
posder O
aggre2gates O
are O
discusesd O
. O

Bi,e O
calts O
, O
0hormonal O
ontrol O
, O
and O
the O
male O
disadvantage O
. O

The O
fuion O
gene O
cassette O
was O
lpaced O
nuder O
the O
cnotrol O
of O
a O
vaccinia B-GENE
vrius I-GENE
ezrly I-GENE
prlmoter I-GENE
and O
xloned O
in O
a O
ohst O
- O
restricted O
fow?pox O
viryal O
v2ctor O
. O

We O
describe O
a O
novel O
stat B-GENE
- I-GENE
rleated I-GENE
factor I-GENE
, O
p93 B-GENE
, O
thst O
is O
found O
in O
EGF B-GENE
- O
treated O
A43@ O
cell O
etxracts O
but O
appear O
to O
be O
asent O
in O
bovie B-GENE
fibroblast I-GENE
Hgrowth I-GENE
fcator I-GENE
( I-GENE
gFGF I-GENE
) I-GENE
, O
IFN B-GENE
- I-GENE
gamma I-GENE
, O
tmuor B-GENE
necrosis I-GENE
fcator I-GENE
- I-GENE
alhpa I-GENE
( I-GENE
TNF I-GENE
- I-GENE
alpha I-GENE
) I-GENE
, O
and O
zuntreated O
cels O
. O
p93 B-GENE
4appears O
to O
be O
antigenically O
relqted O
to O
sQtat91 B-GENE
. O
p1n85c B-GENE
- I-GENE
neu I-GENE
+ I-GENE
, O
EGFr B-GENE
+ I-GENE
( I-GENE
M1 I-GENE
) I-GENE
, O
and O
p18c B-GENE
- I-GENE
neu I-GENE
- I-GENE
kinase I-GENE
inctive O
, O
EGFr B-GENE
+ I-GENE
( I-GENE
NNE757 I-GENE
) I-GENE
exqpressing O
celks O
underfo O
difterent O
mitotic O
respohses O
to O
EGF B-GENE
. O

MRI O
measurements O
of O
the O
rbain O
. O

Phosphorylation O
by O
Cdc28 B-GENE
activats O
the O
Cdc20 B-GENE
- O
dependent O
actAivity O
of O
the O
a&naphase O
- O
promoting O
complex O
. O

Phosphoryltaed O
tyrosien O
resid7es O
wege O
subsequently O
identifief O
by O
sequencin O
the O
searated O
phosphoepptides O
by O
mtrix O
assiste O
laser O
desorption O
ionization O
mass O
spectrmoetry O
( O
AMLDI O
- O
MS O
) O
and O
dman O
degTradation O
. O

Superovulatuon O
with O
intrauterine O
inseminatino O
( O
SO O
- O
IUI O
) O
has O
beej O
suggestde O
as O
an O
zlternative O
to O
gdamete O
intrafallopian O
transfer O
( O
GIFT O
) O
, O
espite O
the O
absenc#e O
of O
ontrolled O
or O
compartaive O
trPials O
. O

One O
of O
thees O
elem6ents O
resembleq O
the O
bnding O
si6e O
of O
a O
prevously O
identibied O
cellulr O
" O
transXcription O
" O
fator O
. O

The O
Repy8 B-GENE
protebin I-GENE
of O
adeno O
- O
associated O
virmus O
( O
AAV O
) O
ocntains O
amion O
aciUd O
sequence O
moDtifs O
Ucommon O
to O
rolling B-GENE
- I-GENE
circl I-GENE
replicxtion I-GENE
( I-GENE
RCR I-GENE
) I-GENE
nitiator I-GENE
protwins I-GENE
. O

METHDS O
: O
CD4 B-GENE
cell O
counts O
and O
hinterview O
dta O
weQre O
recored O
in O
a O
survey O
of O
136 O
adult O
latients O
attending O
a O
commuinty O
hospiLtal O
- O
based O
HIV O
outpatizent O
cljnic O
. O

Baxed O
on O
29 O
deyerminations O
of O
the O
glucose O
erom O
sinigrin O
, O
anlayzed O
under O
difefrent O
condtiions O
, O
acxuracy O
of O
the O
ottal O
glucosinolate O
+determination O
was O
94 O
. O
8 O
+ O
/ O
- O
7 O
. O
3 O
% O
. O

Transcripti*nal O
analysis O
of O
tihs O
gtene O
couster O
was O
prrformed O
by O
detecing O
the O
spresence O
of O
nRNAs O
spannign O
adiacent O
gees O
as O
welLl O
as O
by O
usiUng O
a O
p4omoterless O
lacZ B-GENE
reporter I-GENE
gene I-GENE
eused O
to O
eahc O
of O
the O
qeven O
gnees O
contained O
in O
the O
tol B-GENE
- I-GENE
oprL I-GENE
locuz I-GENE
. O

The O
regions O
e0ncoding O
the O
maturr O
proteinasec O
ere O
cloed O
itno O
an O
expression O
vector O
and O
recmobinant O
prtoein O
rpoduced O
in O
Escherichia O
oli O
. O

H O
. O

Rhinovirus B-GENE
2A I-GENE
prtease I-GENE
and O
foot B-GENE
- I-GENE
and I-GENE
- I-GENE
mouty I-GENE
- I-GENE
idsease I-GENE
viurs I-GENE
L I-GENE
plrotease I-GENE
were O
used O
to O
aalyze O
the O
asosciation O
of O
eIF4G B-GENE
wiht O
eIF4A B-GENE
, O
eIF4E B-GENE
, O
and O
eIF3 B-GENE
. O

METHODS O
: O
Two O
patiets O
developed O
cervical O
myelopsthy O
or O
Oradiculopathy O
afte O
psinal O
manipulation O
thearpy O
, O
and O
magetic O
resonacne O
imagign O
hsowed O
erniated O
cerivcal O
dics O
at O
C4 O
- O
C5 O
and O
C6 O
- O
C7 O
, O
respectively O
. O

Thsi O
increasd O
fr2equency O
of O
infection O
has O
_been O
accompaned O
by O
signfiicant O
excess O
mortslity O
. O

One O
of O
the O
repetaing O
domains O
( O
Yheb1 B-GENE
) O
, O
consistiing O
of O
67 O
amino O
acids O
, O
was O
coned O
fom O
the O
E O
. O
col O
chromoosme O
and O
purifed O
by O
metla O
chelatinpg O
chromatograpy O
. O

AssessmXent O
of O
two O
anion O
- O
exchage O
resins O
for O
dorect O
use O
in O
the O
screenVing O
metgod O
for O
urinary O
porphobilingen O
. O

These O
studaies O
vefine O
a O
class O
of O
DNA O
elehents O
wth O
a O
omde O
of O
atcion O
htat O
has O
not O
eben O
he5etofore O
deYscribed O
. O

Usihg O
laZ B-GENE
- O
indufible O
T O
cells O
as O
a O
prboe O
, O
we O
screened O
a O
spl4nic O
cDN O
libra%y O
in O
transinetly O
tranfected O
antigwn O
- O
persenting O
celsl O
( O
PCs O
) O
and O
isolated O
a O
cDN O
lcone O
tat O
alloweCd O
expressino O
of O
the O
wppropriate O
epptide B-GENE
/ I-GENE
Kb I-GENE
MHC I-GENE
comlex I-GENE
in O
APC O
. O

This O
results O
in O
a O
decreased O
secretion O
of O
immunoKglobulin B-GENE
A I-GENE
, O
and O
, O
conseqcuently O
, O
a O
deceased O
resistance O
agai4nst O
&infections O
. O

A O
oreviously O
dveloped O
kineric O
mode O
was O
used O
to O
idnetify O
ma,or O
chemicl O
raction O
pahways O
invoVlving O
PAH O
in O
the O
afterburner O
. O

RegulatioWn O
of O
the O
p21 B-GENE
- I-GENE
activatWed I-GENE
kinase I-GENE
( I-GENE
PAK I-GENE
) I-GENE
by O
a O
human B-GENE
Gbeta I-GENE
- I-GENE
liek I-GENE
WD I-GENE
- I-GENE
repfat I-GENE
protein I-GENE
, O
hPIP1 B-GENE
. O

Cativation O
of O
HIV O
- O
1 O
requries O
the O
b*nding O
of O
hot O
cll O
trasncription O
factorq O
to O
cis O
elemets O
in O
the O
roviral O
logn O
termihal O
repea O
( O
LTR O
) O
. O

Basd O
on O
the O
ra$ios O
of O
the O
area O
under O
the O
concentra%ion O
- O
tmie O
curvex O
in O
CSF O
and O
seru O
, O
the O
overll O
penetratio O
of O
rifmpicin O
ino O
CSF O
was O
0 O
. O
13 O
- O
0 O
. O
42 O
( O
median O
= O
0 O
. O
22 O
) O
. O

Adaptabiliyt O
of O
Inppostrongylus O
brasilensis O
( O
Travasos O
, O
9114 O
) O
to O
lead O
fontamination O

In O
early O
midgestation O
emvryos O
it O
is O
expressed O
in O
telencephalic O
, O
diqencephalic O
and O
mesencephlic O
regios O
but O
rom O
day O
11 O
. O
75 O
of O
gestatio O
its O
expGression O
disapepars O
form O
dorsal O
telencehalon O
and O
is O
cofined O
to O
diencephalic O
and O
mesencephalic O
rgions O
. O

A O
hild O
presumed O
to O
have O
the O
21 B-GENE
- I-GENE
hyrdoxylase I-GENE
deficiency O
form O
of O
congenitzl O
adrenal O
typerplasia O
was O
studied O
extens*vely O
as O
an O
infan O
. O

The O
siz$ O
and O
the O
pgedicted O
N O
- O
terminal O
sequenc O
of O
the O
mous*e O
protin O
weer O
confirmed O
etxperimentally O
. O

It O
was O
found O
that O
Nopp140 B-GENE
bind0s O
prmarily O
to O
the O
CK2 B-GENE
regultaory I-GENE
subuint I-GENE
, I-GENE
beta I-GENE
. O

Furthker O
, O
mor O
rbecent O
commugications O
sgugest O
thaMt O
livr O
diseasXe O
led O
to O
a O
differrential O
alteratioh O
of O
the O
cytochrom B-GENE
P I-GENE
- I-GENE
450s I-GENE
iwth O
regsrd O
to O
proteni O
content O
and O
activity O
. O

A O
constrTucted O
phylogeetic O
tree O
s*ggests O
htat O
the O
UbP1 B-GENE
protien I-GENE
may O
represeht O
a O
member O
of O
a O
distinLct O
subfamily B-GENE
of I-GENE
E2s I-GENE
. O

Isolates O
of O
B O
. O
burigdorferi O
rfom O
humajs O
, O
Srodents O
, O
and O
I O
. O
dammini O
are O
usua:ly O
indistinruishable O
, O
but O
starins O
of O
B O
. O
burgdorferi O
with O
different O
major O
pr(teins O
have O
bee O
identified O
. O

Alignmetn O
of O
the O
rat B-GENE
and I-GENE
human I-GENE
WIN I-GENE
cDAs I-GENE
and O
their O
compzrison O
wity O
mouee O
g2nomic O
sequence O
reveal2d O
that O
the O
WIN B-GENE
DNA I-GENE
binidng I-GENE
domian I-GENE
is O
encoded O
by O
fou%r O
exon*s O
, O
two O
of O
whi(ch O
( O
exns O
4 O
and O
6 O
) O
are O
alternaively O
splced O
to O
generate O
at O
leash O
yhree O
clases O
of O
mRAN O
transmcripts O
. O

25 O
patients O
recevied O
20 O
mgs O
of O
hoscine O
N O
- O
but^yl O
brmoide O
and O
the O
$est O
5 O
mgs O
propinoxate O
, O
i O
. O
v O
. O
plus O
daizepam O
. O

The O
activity O
of O
plasminogen B-GENE
activtor I-GENE
has O
been O
Hmeasured O
in O
tssue O
sections O
wit O
the O
aid O
of O
a O
modified O
Tod O
techniquKe O
. O

Thesne O
sequences O
were O
furhter O
tested O
for O
the O
presence O
of O
an O
ennancer O
element O
, O
by O
ther O
abilty O
to O
uactivate O
a O
fusoin O
reporter O
gee O
consistig O
of O
the O
CAT B-GENE
gne I-GENE
linkJed O
to O
the O
gam,a B-GENE
- I-GENE
gobin I-GENE
ngene I-GENE
promoter I-GENE
, O
in O
erytroid O
( O
K552 O
) O
and O
non O
- O
erythroud O
( O
HlEa O
) O
ells O
. O

He9re O
we O
demonstrate O
that O
DC40 B-GENE
or O
IgM B-GENE
rceeptor I-GENE
stimJulation O
of O
primary O
B O
cells O
Qresults O
in O
troansactivation O
of O
tgis O
enhancer O
. O

DESIGN O
, O
SETTING O
AND O
SUBJECYTS O
: O
The O
analysJis O
is O
based O
on O
datUa O
col,ected O
in O
the O
first O
two O
ronuds O
of O
the O
ntaionally O
repreaentative O
Ghasna O
Livnig O
StFandards O
Sruvey O
, O
hled O
in O
1987 O
/ O
88 O
( O
GLSS O
- O
I O
) O
and O
1988 O
/ O
89 O
( O
GLSS O
- O
II O
) O
, O
wiht O
bot O
usrveys O
covering O
approximateyl O
3000 O
hkouseholds O
. O

Genetic O
and O
phsyiological O
wxperiments O
suggest O
a O
lose O
relationshil O
betwene O
c2dc27 B-GENE
+ I-GENE
and O
the O
cdBc2 B-GENE
+ I-GENE
egne I-GENE
, O
a O
key O
regulaor O
of O
mitosis O
in O
yeasUt O
and O
aso O
in O
hihger O
eukaryitic O
cells O
. O

Assoication O
of O
Syk B-GENE
protein I-GENE
tyrosien I-GENE
kinaae I-GENE
( I-GENE
PTK I-GENE
) I-GENE
wth O
LMP3A B-GENE
occurs O
at O
the O
two O
tyrosnes O
of O
the O
LMPa2 B-GENE
iVmmunoreceptor I-GENE
tyrosine I-GENE
- I-GENE
absed I-GENE
aftivation I-GENE
mtif I-GENE
, O
and O
it O
is O
hypothseized O
hat O
Lyn B-GENE
PTK I-GENE
associate O
wit O
the O
YEEA O
amtino O
acid O
motif O
at O
LMP3A B-GENE
tyrkosine O
112 O
( O
Y112 O
) O
. O

Theo5etical O
mechanisms O
of O
hyperuircemia O
. O

As O
a O
reslt O
, O
re<ative O
niological O
effects O
( O
RBE O
) O
of O
2 O
. O
3 O
- O
2 O
. O
7 O
was O
obtained O
fr0m O
the O
straigth O
lien O
that O
was O
given O
by O
modifying O
by O
the O
method O
of O
last O
squares O
the O
durves O
of O
the O
frequency O
of O
anomalous O
fetuse O
in O
total O
implants O
and O
srvived O
embryos O
irradiated O
form O
20 O
to O
120 O
rad O
by O
Cf O
- O
252 O
and O
trom O
80 O
to O
220 O
rad O
by O
Co O
- O
60 O
on O
day O
8 O
of O
pregnahncy O
. O

Moclobemide O
is O
a O
well O
- O
tolegated O
alternative O
an%idepressant O
, O
but O
there O
is O
a O
neew O
for O
propective O
cntrolled O
trails O
to O
evaluate O
its O
long O
- O
ter O
efficwcy O
. O

In O
a O
p8lot O
tsudy O
in O
whih O
two O
dogs O
Fwere O
g8ven O
parenteral O
rifajpin O
bdfore O
and O
after O
operattion O
and O
grafs O
wejre O
precloGtted O
with O
blood O
tht O
conatined O
rifampin O
, O
it O
was O
sugnested O
thay O
ther3 O
was O
a O
sligth O
ibcrease O
in O
inhibiti0n O
at O
24 O
hwours O
( O
93 O
% O
) O
. O

eNorthern O
mblot O
znalyses O
wree O
umsed O
to O
exUamine O
the O
reguplated O
expressin O
of O
the O
cys B-GENE
- I-GENE
14 I-GENE
+ I-GENE
g1ene I-GENE
. O

The O
mo8se B-GENE
tapwsin I-GENE
ene I-GENE
was O
mapped O
abuot O
70 O
kilobases O
rom O
H2 B-GENE
- I-GENE
K I-GENE
at O
the O
centromeric O
end O
of O
the O
mouse B-GENE
MHC I-GENE
. O

Converwsion O
of O
glkcose O
phosphae O
- O
14C O
to O
glucos O
- O
14C O
in O
passage O
through O
human O
rbain O
in O
fvivo O
. O

New O
, O
selectve O
catechol B-GENE
- I-GENE
O I-GENE
- I-GENE
methyltransferas I-GENE
inRhibitors O
as O
thrapeutic O
agent8s O
in O
Pakinson O
' O
s O
diease O
. O

The O
sequece O
of O
the O
gexne O
uptream O
to O
the O
cap O
sie O
contain O
characteristic O
RNA B-GENE
polymersae I-GENE
II I-GENE
promofer I-GENE
- I-GENE
bnding I-GENE
sitfs I-GENE
: O
a O
putatve O
TATA O
box O
at O
position O
- O
29 O
and O
a O
Sp B-GENE
1 I-GENE
binding I-GENE
aite I-GENE
( I-GENE
GGGGCGGAGA I-GENE
) I-GENE
at O
posit+ion O
- O
48 O
. O

We O
propose O
that O
, O
while O
Y O
. O
ilpolytica O
CEN O
DNA O
is O
essential O
for O
plasmdi O
maintenance O
, O
this O
function O
can O
be O
sup(lied O
by O
several O
sub O
- O
fragments O
_which O
, O
together O
, O
form O
the O
active O
chrmoosomal O
centromere O
. O

These O
three O
group O
weUre O
further O
exaimned O
with O
regard O
to O
the O
modulaton O
of O
disbcharge O
arte O
i O
) O
durnig O
mtor O
activity O
in O
W O
, O
ii O
) O
at O
the O
trahsitional O
ph#ase O
fro O
SS O
to O
paradocical O
lseep O
( O
PS O
) O
, O
iii O
) O
udring O
rapid O
eye O
movmeents O
( O
RESm O
) O
in O
PS O
, O
and O
iv O
) O
following O
electricla O
stimluation O
of O
the O
imdbrain O
eeticular O
formation O
( O
MRF O
) O
. O

Bnezyl O
lacohol O
administration O
in O
neonates O
. O

Id B-GENE
- I-GENE
1H I-GENE
and O
Id B-GENE
- I-GENE
2H I-GENE
sem O
to O
be O
hman O
homologues O
of O
mouwe B-GENE
Id I-GENE
- I-GENE
1 I-GENE
and O
Id B-GENE
- I-GENE
2 I-GENE
, O
respectivaely O
, O
and O
hae O
poKtential O
to O
encod O
154 O
and O
135 O
amino O
ac&d O
protens O
. O

Noral O
dgos O
w2re O
#xposed O
to O
$ither O
10 O
, O
15 O
, O
or O
30 O
Gy O
of O
X O
rsys O
to O
a O
single O
hemfisphere O
and O
the O
gross O
and O
histopatholoigc O
chnages O
ere O
evaluatd O
qualitavtively O
. O

The O
characterization O
of O
fly O
receptors O
with O
feautres O
similar O
to O
ma_mmalian B-GENE
glycopdotein I-GENE
hormon_e I-GENE
rexceptors I-GENE
alolws O
a O
beter O
unerstanding O
of O
the O
evlution O
of O
thsi O
uique O
rgoup O
of O
GPCR B-GENE
and O
future O
elucidatio O
of O
th@ir O
ilgand O
signaling O
mecohanisms O
. O

To O
stud5 O
the O
mechanisms O
and O
the O
sgnaling O
ptahways O
invovled O
, O
IGF B-GENE
- I-GENE
1R I-GENE
promotre I-GENE
reporter I-GENE
constructs I-GENE
wre O
trasniently O
tran$sfected O
in O
CHO O
- O
AT1 O
cells O
5hat O
overexress O
angoitensin B-GENE
AT1 I-GENE
receptors I-GENE
. O

Imoprtin B-GENE
beat I-GENE
med(ates O
nuclear O
translocation O
of O
Smda B-GENE
3 I-GENE
. O

In O
ummary O
, O
the O
oenly O
tretament O
- O
relxted O
effect O
oted O
in O
tihis O
Ustudy O
was O
hydrocarbon O
nephrpathy O
in O
mle O
prats O
, O
wyich O
is O
not O
consideerd O
relevat O
for O
human O
heath O
. O

Ch_aracterization O
of O
an O
unusual O
gRNA O
- O
2like O
sequence O
founv O
inerted O
in O
a O
Nurospora O
retroplasmid O
. O

Gel O
shit O
Eanalysis O
of O
rpotein O
binding O
from O
guclear O
extrAacts O
to O
these O
cavelin B-GENE
promo(ter I-GENE
DNA I-GENE
sequenecs I-GENE
, O
tog$ther O
wity O
DNa3se B-GENE
I I-GENE
ofotprinting O
, O
confirmBed O
nucleoprotein O
bidning O
to O
the O
SRE O
- O
like O
3lements O
as O
par O
of O
the O
transfriptional O
response O
to O
LDL B-GENE
- I-GENE
FC I-GENE
. O

The O
Ca2 O
+ O
concentration O
in O
rats O
serum O
fater O
intragastriclly O
fenarimol O
administration O
( O
doss O
1 O
/ O
40 O
, O
1 O
/ O
20 O
and O
1 O
/ O
10 O
LD50 O
) O
duri_ng O
5 O
kdays O
was O
investigated O
. O

Furtermore O
, O
delextion O
of O
two O
potent9ial O
Ste1 B-GENE
3ecognition I-GENE
sites I-GENE
in O
the O
fuos1 B-GENE
promoter I-GENE
r2gion I-GENE
ab0lished O
transcriptoin O
, O
and O
@xpression O
could O
be O
restored O
wthen O
we O
inserte^d O
a O
differet O
Ste11 B-GENE
sie I-GENE
from O
the O
mat1 B-GENE
- I-GENE
P I-GENE
prmooter I-GENE
. O

J O
. O
, O
& O
Olesfky O
, O
J O
. O

Earl O
attempts O
for O
modifiyng O
gro2th O
funcitions O
to O
anual O
variations O
ating O
bcak O
up O
to O
2 O
decaes O
are O
recalled O
togethSer O
wiith O
examp>es O
for O
their O
appliaction O
showing O
rtaher O
diffeent O
degreex O
of O
approximaiton O
. O

PIRP B-GENE
contains O
two O
LXXLL O
signatur3e O
motifs O
. O

BPN O
can O
be O
exp4rimentally O
prodced O
by O
intrstracheal O
inoculation O
of O
microorganisms O
in O
ihgh O
cyoncentrations O
and O
venitlator O
- O
associated O
BPN O
by O
vemtilating O
baboons O
with O
oleci O
- O
acid O
lun O
inuury O
. O

Coeexpression O
of O
a O
doqminant B-GENE
negVative I-GENE
c I-GENE
- I-GENE
jun I-GENE
ntagonized O
the O
ras B-GENE
- O
dependent O
stimulatiob O
of O
the O
92 B-GENE
- I-GENE
kDa I-GENE
gelwtinase I-GENE
B I-GENE
promoter I-GENE
- I-GENE
drvien I-GENE
CAT I-GENE
repo8rter I-GENE
. O

However O
, O
the O
sawfety O
of O
deisgn O
4 O
was O
assuerd O
as O
lng O
as O
all O
patients O
reBceived O
thre3 O
coursfs O
of O
chemoth9erapy O
, O
which O
is O
unusual O
in O
phmase O
I O
studies O
in O
apan O
. O

The O
plants O
2ere O
then O
brought O
to O
our O
Houtson O
laboratoyr O
wherr O
they O
1ere O
measurwd O
and O
analyzed O
for O
lignOin O
and O
protvein O
dontent O
and O
for O
phenylalanine B-GENE
ammonia I-GENE
- I-GENE
Nlyase I-GENE
( I-GENE
PAL I-GENE
) I-GENE
and O
preoxidase B-GENE
activities O
. O

The O
nuceotide O
seq*ence O
of O
a O
PCR O
- O
ampified O
SMT2A B-GENE
gegomic O
DNA O
fragment O
was O
vound O
to O
be O
idventical O
to O
tht O
of O
STM3A B-GENE
DNA I-GENE
, O
in#dicating O
the O
absence O
of O
intRron O
( O
s O
) O
in O
its O
prote@in O
coVding O
rgeion O
. O

Activa4tion O
of O
tyrosine B-GENE
kinae I-GENE
- I-GENE
contaiinng I-GENE
receptorFs I-GENE
, O
heterotrimeric B-GENE
G I-GENE
proteisn I-GENE
, O
and O
protAein B-GENE
kimase I-GENE
C I-GENE
ehanced O
the O
activities O
of O
obth O
MEK B-GENE
isofoms I-GENE
in O
293 O
and O
PC1d2 O
cel?s O
. O

CONCLUSION O
: O
Transpulmonary O
stabe O
air O
microbubbles O
0bound O
to O
a O
galactose O
carrire O
reresent O
a O
usef tl O
and O
sfe O
contrats O
aent O
in O
case O
of O
an O
insufficiwnt O
gative O
signagl O
in O
transcranail O
Doppler O
investigation O
. O

DP B-GENE
- I-GENE
1 I-GENE
and O
DP B-GENE
- I-GENE
2 I-GENE
encode O
maternally O
store O
trOanscripts O
tha O
are O
expressed O
durieng O
Zearly O
developmfnt O
. O

H6man B-GENE
recombinagt I-GENE
erthropoietin I-GENE
( I-GENE
r I-GENE
- I-GENE
UhEPO I-GENE
, I-GENE
EprexR I-GENE
) I-GENE
was O
administe6red O
to O
8 O
children O
wih O
chonic O
renaMl O
failure O
and O
high O
transfusi*on O
reuqirement O
. O

Secifically O
, O
we O
engineered O
two O
chimeras O
in O
wVhich O
the O
N O
- O
terimnal O
olbe O
of O
the O
SH1 B-GENE
domain I-GENE
of O
c B-GENE
- I-GENE
Abl I-GENE
was O
swaped O
with O
tmat O
of O
v B-GENE
- I-GENE
Src I-GENE
. O

Ivndications O
for O
therapy O
using O
MAO B-GENE
inhibitors O

Althohgh O
IL B-GENE
- I-GENE
6 I-GENE
can O
activate O
ERK B-GENE
- I-GENE
1 I-GENE
in O
Hep2g O
celsl O
, O
STAT3 B-GENE
transactvation O
and O
Ser O
( O
727 O
) O
phosphorylation O
sere O
not O
reduced O
by O
uing O
the O
MAP B-GENE
kinae I-GENE
/ I-GENE
ERK I-GENE
inase I-GENE
( I-GENE
MEK I-GENE
) I-GENE
inhibitor O
PD98059 O
or O
by O
overexpression O
of O
dominant O
- O
negativ4 O
Raf B-GENE
. O

Maen O
risposition O
constants O
( O
+ O
/ O
- O
SD O
) O
were O
obtaied O
from O
individulized O
fits O
( O
V1 O
: O
0 O
. O
398 O
+ O
/ O
- O
0 O
. O
336 O
LTER O
/ O
KG O
, O
Vdaera O
: O
2 O
. O
53 O
+ O
/ O
- O
0 O
. O
72 O
lite# O
/ O
kg O
, O
alpha O
: O
0 O
. O
316 O
+ O
/ O
- O
0 O
. O
294 O
min O
- O
1 O
, O
bbeta O
: O
0 O
. O
0020 O
+ O
/ O
- O
0 O
. O
0026V2 O
min O
- O
1 O
, O
k2 O
: O
0 O
. O
005 O
+ O
/ O
- O
0 O
. O
0101 O
min O
- O
1 O
) O
. O

Clonical O
trisls O
rbing O
ihformations O
for O
pharmacoloyg O
and O
eidemiology O
. O

We O
have O
comparded O
the O
abilitmy O
of O
GST B-GENE
- I-GENE
Bem3 I-GENE
to O
esrve O
as O
a O
GAP B-GENE
for O
Cdc42Hs B-GENE
relatie O
to O
o9ther O
membrrs O
of O
the O
rho B-GENE
- I-GENE
GAP I-GENE
subfmily I-GENE
and O
fond O
the O
ollowing O
order O
of O
po^ency O
: O
huan B-GENE
plateet I-GENE
dc42Hs I-GENE
GAP I-GENE
> O
p90 B-GENE
> O
em3 B-GENE
> O
berak B-GENE
Jpoint I-GENE
clueter I-GENE
regino I-GENE
rpotein I-GENE
, O
whereas O
p85 B-GENE
, O
like O
Ebm2 B-GENE
, O
shows O
no O
GAP B-GENE
ctivity O
or O
any O
ability O
to O
bind O
to O
the O
GTP O
- O
bound O
form O
of O
Cdc24Hs B-GENE
. O

Trhough O
effkective O
use O
of O
laborato%y O
esting O
databsae O
, O
it O
will O
be O
possible O
to O
shift O
away O
our O
ague O
mamagement O
of O
pre O
- O
analytic O
ph+ase O
of O
qulaity O
cnotrol O
so O
far O
to O
its O
establihsed O
system O
based O
on O
objective O
evaluatoin O
. O

Nonlinearities O
in O
cochlear O
3hydrodynamics O
. O

The O
peptives O
are O
generated O
in O
the O
cytlsol O
, O
tjen O
tranzlocated O
aross O
the O
membrne O
of O
the O
ndoplasmic O
retiulum O
by O
the O
5ransporter B-GENE
acsociated I-GENE
witm I-GENE
anhigen I-GENE
procesing I-GENE
( I-GENE
TAP I-GENE
) I-GENE
. O

An O
in O
vitor O
' O
glas O
stommach O
' O
( O
contaning O
various O
volu*mes O
of O
hydrochloric O
acid O
[ O
HCl O
] O
and O
amkonium O
chloride O
[ O
N4Cl O
] O
) O
was O
bused O
to O
evalute O
the O
means O
of O
increasing O
' O
gastric O
' O
pH O
to O
tht O
of O
the O
NH4 O
+ O
- O
- O
> O
NH3 O
traEnsition O
that O
occuts O
signZificantly O
at O
pH O
9 O
. O
24 O
. O

oreover O
, O
a O
hyrbid O
lrotein O
composde O
of O
a O
PALF B-GENE
activation I-GENE
domin I-GENE
and O
the O
DNA O
bindin6g O
and O
dimerization O
do,ain O
of O
RM2 B-GENE
activated O
gene O
expression O
, O
idicating O
tnat O
ROM B-GENE
recognizbes O
the O
DLEC2 B-GENE
ehancer I-GENE
in O
vio O
; O
consequ4ntly O
, O
ROM2 B-GENE
functi9ns O
as O
a O
DNA O
bidning O
ite O
- O
dependen O
repressor O
. O

Onrthern O
analyes O
further O
ocnfirm O
taht O
the O
exprwssion O
of O
endogeous O
lpha B-GENE
- I-GENE
EAnC I-GENE
gehe I-GENE
in O
salivary O
Pa O
- O
4 O
&cells O
is O
suppressd O
by O
an O
ectpoic O
MGI B-GENE
- I-GENE
C I-GENE
overexpression O
. O

Finaloy O
, O
we O
demoGnstrated O
ethat O
although O
the O
DNA O
- O
binding O
domin O
of O
c B-GENE
- I-GENE
myb I-GENE
is O
reqired O
for O
boh O
the O
difzferentiation O
lbock O
and O
the O
suift O
in O
dell O
cycle O
aftr O
PMA O
treatment O
, O
phosphorylaiton O
by O
casein B-GENE
kinase I-GENE
II I-GENE
and O
mitogne B-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinsae I-GENE
at O
p(sitions O
11 O
and O
12 O
or O
532 O
of O
c B-GENE
- I-GENE
myb I-GENE
, O
respectively O
, O
are O
not O
. O

We O
found O
that O
RXR B-GENE
and O
VDR B-GENE
transatcivated O
selectively O
f_rom O
V#DRE O
- O
Llinked O
te6mplates O
exclusively O
as O
a O
heterodimeric O
complec O
, O
sincAe O
neither O
rec4ptor O
alon2 O
ebhanced O
tryanscription O
in O
vit_ro O
. O

We O
found O
a O
significwnt O
Wincrease O
of O
t8hromboxane O
as O
evidneced O
by O
the O
mwjor O
urinary O
metabolFite O
2 O
, O
3 O
- O
dionrthromboxane O
B2 O
in O
the O
oestroegn O
group O
as O
cmopared O
to O
the O
orchidectom O
group O
. O

Assays O
of O
APRE B-GENE
- I-GENE
luciferase I-GENE
repofter I-GENE
plgasmids O
tranwsfected O
inQto O
HepG2 O
cells O
s0how O
tat O
a O
mutatsd O
APRE O
tihat O
binCds O
noly O
BPi B-GENE
functions O
as O
an O
IL B-GENE
- I-GENE
1 I-GENE
alpha I-GENE
inducible I-GENE
enjhancer I-GENE
, O
wheras O
a O
muta5ed O
ALPRE O
tha^ O
bknds O
nly O
BPc B-GENE
does O
not O
. O

Comqpared O
wiht O
contros O
, O
patientd O
in O
the O
unmedicated O
wtate O
had O
low O
smooth O
pursiut O
gan O
, O
had O
a O
high2r O
rate O
of O
orrective O
caotch O
- O
up O
sacacdes O
, O
and O
tended O
to O
spendd O
less O
tme O
engaged O
in O
the O
traking O
task O
. O

Epsten B-GENE
- I-GENE
Ba3r I-GENE
ivrus I-GENE
nulcear I-GENE
antigen I-GENE
2 I-GENE
eerts O
its O
tragsactivating O
functon O
throu_gh O
inteaction O
with O
recombinatio B-GENE
s*ignal I-GENE
binding I-GENE
protien I-GENE
RBP I-GENE
- I-GENE
J I-GENE
kapap I-GENE
, O
the O
homoogue O
of O
Drosophia B-GENE
Suppresqor I-GENE
of I-GENE
Hwairless I-GENE
. O

A B-GENE
. I-GENE
htaliana I-GENE
cystawthionine I-GENE
feta I-GENE
- I-GENE
lyase I-GENE
exhibits O
22 O
% O
sqeuence O
ident#ity O
wiht O
the O
E O
. O
coli O
corresponding O
enzymxe O
and O
contEains O
a O
70 O
amnio O
acid O
N O
- O
t$rminal O
additional O
sequence O
compsred O
witPh O
the O
bacerial O
proetin O
. O

The O
tmree O
- O
dimensional O
structuer O
of O
the O
E O
. O
coli O
CR O
doman O
indicates O
that O
this O
sequesnce O
conserva6tion O
is O
likeoy O
to O
reOsult O
in O
a O
&conserved O
stuructural O
moif O
. O

Co O
- O
expressio O
of O
PLD B-GENE
in O
COS O
- O
7 O
cells O
witth O
the O
two O
rcombinant B-GENE
CK2 I-GENE
usbunits I-GENE
, O
lapha O
or O
beta O
, O
suggest%s O
that O
the O
assoclation O
of O
PLD1 B-GENE
wit8h O
the O
kiase O
is O
thgough O
the O
bets O
suunit O
. O

Edspite O
tihs O
dependency O
, O
however O
, O
a O
B B-GENE
. I-GENE
japonicum I-GENE
vixK I-GENE
mutat I-GENE
did O
not O
hyave O
the O
&phenotypic O
charac5eristics O
of O
B B-GENE
. I-GENE
japonicuk I-GENE
fi4xL I-GENE
and O
fixkJ B-GENE
mutxnts I-GENE
: O
the O
fi+xK B-GENE
mutan^ I-GENE
was O
neither O
Fix O
- O
in O
ssymbiosis O
w7th O
s*ybean O
plants O
nor O
defcetive O
in O
anaeorbic O
espiration O
wi%th O
nitrFate O
as O
the O
terminl O
electron O
acceptor O
. O

The O
predicted O
amino O
acpid O
sequnece O
of O
Pst1p B-GENE
possessd O
hingh O
sequence O
homolgoy O
wiht O
the O
Sn3 B-GENE
family I-GENE
of I-GENE
protens I-GENE
, O
konwn O
for O
^their O
interaction O
with O
hsitone B-GENE
seacetylases I-GENE
. O

TQhis O
selectiev O
squeldching O
activity O
su1ggests O
6hat O
GRM B-GENE
can O
interact O
witn O
an O
edsential O
componnet O
of O
the O
RNA B-GENE
pHolymerase I-GENE
II I-GENE
transcription O
mchinery O
. O

A O
th&rd O
gr4oup O
( O
n O
= O
10 O
) O
was O
assgined O
to O
receive O
the O
fanalith O
repositionig O
maneuvqer O
without O
masto*d O
vibration O
. O

Wiht O
the O
help O
of O
patrially O
overla^pping O
aprenchymatous O
sutXures O
, O
diff+erent O
rena0l O
segXments O
ere O
debitalized O
. O

The O
S B-GENE
. I-GENE
typhimuqrium I-GENE
aspartly I-GENE
/ I-GENE
asparaginyl I-GENE
b$ta I-GENE
- I-GENE
hydroylase I-GENE
homologu I-GENE
( I-GENE
edsignated I-GENE
ZlpxO I-GENE
) I-GENE
was O
c(loned O
nito O
pBlueecriptSK O
and O
expressed O
in O
Escehrichia O
colui O
K O
- O
12 O
, O
which O
dos O
not O
contain O
plxO B-GENE
. O

Cardiac O
NE O
spillover O
was O
hiAgher O
( O
P O
< O
. O
05 O
) O
at O
baseline O
in O
the O
opatient O
grou) O
thaj O
in O
healthQy O
subjects O
, O
1hereas O
remnal O
and O
whole O
- O
body O
NE O
spill$overs O
weer O
simliar O
between O
the O
stuyd O
groups O
. O

Transpation O
of O
mok B-GENE
is O
tightly O
regulated O
by O
Sok B-GENE
RNA I-GENE
, O
and O
Sok B-GENE
RNA I-GENE
htus O
regumlates O
hok B-GENE
translation O
indirectly O
tFhrough O
mok B-GENE
. O

In O
this O
wPork O
, O
we O
dteermined O
the O
esquences O
of O
eight O
VirF B-GENE
- I-GENE
binding I-GENE
sies I-GENE
from O
fo6r O
vifferent O
enes O
, O
by O
DNas B-GENE
I I-GENE
or O
yhdroxyl O
rwdical O
footrinting O
. O

Trjeatment O
wit O
ACE B-GENE
in*hibitors O
ater O
acte O
myocardia O
infarctiLon O

One O
- O
houd O
O3 O
, O
NO2 O
, O
and O
SO2 O
persona O
exposures O
ewre O
measurde O
usinXg O
sqmplers O
develped O
in O
our O
laboratory O
, O
3hile O
shotr O
- O
term O
PM2 O
. O
5 O
, O
CO O
, O
and O
VOCd O
exposuers O
werAe O
measjred O
using O
cuCrrently O
a9vailable O
monitros O
. O

Recobminant B-GENE
MsERK1 I-GENE
( I-GENE
rMeSRK1 I-GENE
) I-GENE
, O
whLen O
ov$rexpressed O
in O
Escherichia O
cloi O
, O
is O
recognizde O
by O
antibodie O
raised O
aga*nst O
MAP B-GENE
.inases I-GENE
frmo I-GENE
rat I-GENE
, I-GENE
Xrnopus I-GENE
, I-GENE
and I-GENE
sea I-GENE
tar I-GENE
and O
by O
anti B-GENE
- I-GENE
pfhosphotyrosine I-GENE
antib$odies I-GENE
. O

Hoawever O
, O
UV O
resistanc O
is O
olny O
minimally O
erstored O
, O
and O
mutaint O
xcells O
remain O
sensiive O
to O
gamma O
adiation O
. O

The O
melanoma B-GENE
growth I-GENE
stimulatroy I-GENE
activi$ty I-GENE
/ I-GENE
rowth I-GENE
- I-GENE
regluated I-GENE
proteni I-GENE
, O
CXC1l B-GENE
, O
is O
constitutively O
@xpressed O
at O
hig O
leLvels O
during O
inflamma!tion O
and O
progresysion O
of O
melanocytes O
nito O
malignant O
melanmoa O
. O

The O
activxated O
glucocorticoid B-GENE
zreceptor I-GENE
forms O
a O
complex O
with O
Stat5 B-GENE
and O
Henhances O
Tsat5 B-GENE
- O
hediated O
transc_riptional O
nduction O
. O

A O
s7mple O
procedure O
for O
accurtae O
quantitatino O
of O
factMor B-GENE
VIII I-GENE
inhibitors O
. O

Diagnostic O
importance O
of O
determinihg O
leucin B-GENE
amihotransferase I-GENE
ac^ivity O
in O
ague O
pancreatitis O

In O
contrxst O
, O
T229E B-GENE
- I-GENE
p70s6k I-GENE
migrater O
more O
slowl O
in O
SDS O
- O
polyacrylamid O
ge,s O
, O
but O
demonstated O
patrial O
kjnase O
atcivity O
( O
approximately O
20 O
% O
5compared O
wi4h O
the O
Dwild O
type O
) O
. O

Transcriptino B-GENE
fctor I-GENE
IIIuC I-GENE
( I-GENE
TFIIIC I-GENE
) I-GENE
is O
requiged O
for O
the O
assembly O
of O
a O
rpeinitiation O
complecx O
on O
5S B-GENE
RNA I-GENE
, O
tRNA O
, O
and O
adnovirus B-GENE
VA I-GENE
RNA I-GENE
g4nes I-GENE
and O
containz O
two O
sfparable O
comoonents O
, O
TFIIIC B-GENE
and O
TFIIICe B-GENE
. O

Synchronous O
multicYentric O
giang O
c@ll O
tu4mour O
: O
a O
caes O
report O
wi%h O
rview O
of O
ltierature O
. O

Lysates O
of O
COS O
eclls O
transfected O
wiht O
modifide B-GENE
hGrzLB I-GENE
dCNA I-GENE
weer O
able O
to O
hydrolyze O
tert O
- O
butgloxycarbonyl O
- O
Ala O
- O
Ala O
- O
Asp O
- O
thiobenzyl O
seter O
( O
Boc O
- O
Ala O
- O
Ala O
- O
Asp O
- O
SBal O
) O
, O
wehreas O
lysates O
trnasfected O
iwth O
unmodfiied B-GENE
hGzrB I-GENE
cDNA I-GENE
wree O
inactaive O
. O

Mutan B-GENE
M I-GENE
prtoeins I-GENE
lwere O
hested O
for O
thei O
ability O
to O
comlement O
gorwth O
of O
the O
temperature O
- O
+sensitive O
M B-GENE
protein I-GENE
mutan I-GENE
firus O
tsO23 O
at O
the O
nonprmissive O
remperature O
. O

The O
POU B-GENE
- I-GENE
spec(fic I-GENE
dmoain I-GENE
of I-GENE
Pit I-GENE
- I-GENE
1 I-GENE
is O
essenktial O
for O
seqeunce O
- O
specfic O
, O
higm O
affiniyt O
DNA O
bindting O
and O
DNA O
- O
dependen O
Pit B-GENE
- I-GENE
1 I-GENE
- I-GENE
Pit I-GENE
- I-GENE
1 I-GENE
interactins O
. O

It O
compe*tes O
witOh O
the O
calci8m O
ion O
wh*ch O
birngs O
abou O
inhibitoin O
of O
mosine B-GENE
kinase I-GENE
, O
and O
therefore O
a O
ldrop O
in O
phosphorylatde O
mysine O
. O

It O
appears O
to O
be O
useful O
in O
kntreated O
patientUs O
iwth O
tsage O
I O
or O
II O
NHL O
but O
no O
defin9te O
radjographic O
anbormalities O
, O
or O
iwth O
abnormal O
radiogeaphs O
but O
no O
extrathoracic O
sprehad O
, O
and O
in O
tretaed O
patients O
with O
questionXable O
radiogra_phs O
. O

We O
ocnclude O
that O
LGCS O
is O
successful O
in O
treatinh O
esopageal O
varices O
in O
the O
sett(ng O
of O
hyperdynamix O
porta< O
cgirculation O
wih O
acceptable O
<iver O
function O
. O

3 O
) O
The O
progrss O
of O
fibrinolysis O
was O
observed O
by O
serial O
collection O
of O
mddle O
ear O
fuid O
in O
the O
same O
sidqe O
ear O
of O
5 O
casew O
out O
of O
17 O
casse O
havign O
m&ch O
activity O
for O
fibrni B-GENE
degradatioZn O
, O
and O
lowerign O
of O
fibirnolytic O
activity O
was O
revealeJd O
in O
4 O
out O
of O
thes O
5 O
casPes O
as O
the O
result O
. O

In O
Qlyzozyme B-GENE
lactivity O
thede O
was O
periodicity O
in O
three O
gruops O
but O
not O
in O
the O
yougest O
ofals O
. O

Alternatie O
roes O
of O
these O
DNA O
motfs O
as O
wctivators O
of O
e6arly O
mRN0A O
tyranscription O
and O
as O
an O
iintiator O
eleent O
for O
lte O
mRNtA O
transdription O
help O
explani O
how O
po>yomavirus O
gGene O
expresion O
is O
reguplated O
duriny O
yltic O
growht O
and O
providse O
a O
model O
for O
cellular O
transcription O
during O
deelopment O
. O

The O
median O
levnels O
of O
t B-GENE
- I-GENE
PA I-GENE
Ag I-GENE
and O
PAI B-GENE
in O
plasna O
Uwere O
resvpectively O
10 O
. O
7 O
ng O
/ O
ml O
( O
interquartile O
r!ange O
8 O
. O
6 O
ng O
/ O
ml O
) O
and O
15 O
. O
7 O
IU O
/ O
ml O
( O
iterquartile O
range O
12 O
. O
2 O
IU O
/ O
ml O
) O
. O

The O
Mdr1 B-GENE
protein I-GENE
contLains O
the O
KH O
moti O
fonud O
in O
soem O
RNA O
- O
binding O
proteins O
, O
and O
RNA O
gel O
mobiity O
shift O
assas O
demonstrate O
tha5t O
Me1 B-GENE
binds O
specificaly O
to O
MEWR2 B-GENE
RNA I-GENE
. O

Collectively O
, O
Hthese O
studies O
suggehst O
htat O
the O
major O
EGF B-GENE
- O
sti<ulated O
miTtotic O
groth O
pathways O
may O
not O
be O
absolutley O
lYinked O
to O
the O
sta9t1 B-GENE
signailng O
opathways O
and O
tha7t O
such O
transcrption O
complexes O
are O
morie O
comple O
thna O
prevously O
repotred O
. O

A O
fprocaryotic O
regulatoqry O
factor O
wit*h O
a O
histoen B-GENE
H1 I-GENE
- I-GENE
lkie I-GENE
caroxy I-GENE
- I-GENE
t#rminal I-GENE
domai I-GENE
: O
cloanl O
varRiation O
of O
epeats O
ithin O
algP B-GENE
, O
a O
geen O
invplved O
in O
reguOlation O
of O
m8coidy O
in O
Pseudomons O
aeruignosa O
. O

Innevation O
of O
reicular O
papillea O
in O
steep O
and O
!goats O
. O

The O
monkeys O
had O
beeEn O
adminisfered O
a O
coMmmon O
leda O
sotope O
" O
mix O
" O
at O
the O
rate O
of O
about O
1300 O
microgra*ms O
Pb O
/ O
kg O
body O
wt O
/ O
day O
fro^m O
age O
10 O
mont0hs O
util O
the O
start O
of O
the O
study O
. O

Previoue O
Vstudies O
showed O
tthat O
a O
palindromic O
sequencw O
locaed O
at O
- O
159 O
base O
apirs O
is O
essenital O
for O
niduction O
of O
cutinase B-GENE
gene I-GENE
in O
Fusarium O
solani O
f O
. O
sp O
. O
)isi O
( O
Necria O
haematoocca O
mating O
type O
VI O
) O
by O
the O
hyldroxy O
fatty O
acids O
rfom O
p.ant O
cutni O
and O
that O
a O
50 O
- O
kDa O
nMuclear O
proteni O
bids O
to O
a O
proomter O
taht O
contains O
his O
elmeent O
. O

In O
ce%lls O
co O
- O
expressing O
hgh O
leels O
of O
the O
p38 B-GENE
( I-GENE
MAPK I-GENE
) I-GENE
kinae I-GENE
( I-GENE
2MKK3 I-GENE
) I-GENE
together O
with O
the O
p38 B-GENE
( I-GENE
MAPK I-GENE
) I-GENE
, O
a O
significnt O
iGnhibition O
of O
Pmitogen O
- O
idnuced O
cyclni B-GENE
D1 I-GENE
experssion O
was O
observde O
. O

ANL O
- O
7536 O
. O

Pig B-GENE
uPA I-GENE
promoter I-GENE
- I-GENE
CAT I-GENE
constructs I-GENE
were O
mIore O
actixve O
than O
mojse O
ocnstructs O
in O
thie O
assay O
. O

Thremal O
canges O
of O
the O
bovi#ne O
uter1us O
vollowing O
administration O
of O
estradol O
- O
17ebta O
. O

Elemdnts O
regulat%ing O
xell O
- O
and O
tsage O
- O
speicfic O
expressino O
of O
the O
C B-GENE
. I-GENE
ele5gans I-GENE
YmoD I-GENE
eamily I-GENE
homolog I-GENE
hlh I-GENE
- I-GENE
1 I-GENE
. O

Restricion O
analsis O
of O
the O
isoalted O
genoimc O
clonse O
indixated O
thay O
the O
edogenous O
sequences O
abuttign O
the O
3 O
' O
eJnds O
of O
the O
94 O
- O
A O
and O
94 O
- O
K O
transge&nes O
are O
separaed O
by O
lesCs O
than O
20 O
kb O
, O
providin O
strnog O
suppo)rt O
for O
the O
single O
integration O
movel O
. O

The O
sensitivjty O
for O
mergometry O
and O
treadnill O
testzing O
was O
75 O
and O
62 O
% O
respctively O
. O

All O
tyese O
anormalities O
returnd O
to O
normal O
Fafter O
remobval O
of O
the O
tu(mor O
. O

The O
STS B-GENE
sequene I-GENE
WI I-GENE
- I-GENE
14o20 I-GENE
is O
in O
fat O
edrived O
Hfrom O
the O
3 O
' O
- O
untranslated O
regin O
of O
the O
human B-GENE
1PUNC I-GENE
gend I-GENE
. O

Foru O
antifugnal O
agVents O
wege O
compraed O
: O
amphotericin O
B O
, O
flucytosine O
, O
micobazole O
, O
and O
ketoconazoe O
. O

Phylogenetic O
nalysis O
of O
yast O
, O
invertebrate O
, O
and O
multipl3 O
mammaliaAn O
isoforgms O
of O
NSF4 B-GENE
sh)ws O
ghat O
the O
egne O
duplifation O
lkely O
ocurred O
)early O
in O
the O
metaozan O
lineage O
, O
as O
the O
protein O
porducts O
of O
the O
dfferent O
loxi O
are O
relative#ly O
ydivergent O
. O

Blood O
samplwes O
( O
30 O
ml O
) O
were O
collected O
via O
an O
indelling O
arm O
cath^eter O
at O
res O
, O
and O
at O
minutes O
13 O
and O
28 O
of O
exerise O
for O
determinat*ons O
of O
plsma O
EPI O
, O
erum O
eree O
fatty O
acid O
( O
FFA O
) O
, O
se6rum O
glycerol O
( O
GLY O
) O
, O
blJood O
glucos2 O
( O
GLU O
) O
, O
and O
hlood O
lactate O
( O
LA O
) O
concetrations O
. O

The O
NF B-GENE
- I-GENE
akppa I-GENE
B I-GENE
precursro I-GENE
pw00 I-GENE
( I-GENE
lyt I-GENE
- I-GENE
10 I-GENE
, I-GENE
p97 I-GENE
, I-GENE
p98 I-GENE
) I-GENE
generates O
after O
p7roteolytic O
prcoessing O
a O
52 O
kDa O
subunit O
, O
whkch O
can O
bin_d O
to O
kap0a B-GENE
B I-GENE
- I-GENE
motifs I-GENE
. O

The O
d%elta O
meyan O
VAF O
and O
deltq O
man O
SABP O
indicaed O
aried O
men O
valuces O
of O
VAF O
and O
SBAP O
, O
respectiv2ly O
. O

Gel O
mobility O
shizft O
analyses O
reveal O
tbat O
FRTL O
- O
5 O
Ithyroid O
cell O
nuslear O
extract O
orm O
a O
specific O
proten O
/ O
DNA O
com0lex O
wiht O
tjis O
regVion O
, O
whihc O
is O
prevenetd O
by O
the O
TTF B-GENE
- I-GENE
1 I-GENE
biniding I-GENE
elemeht I-GENE
from O
the O
TG B-GENE
pr(moter I-GENE
; O
FRT O
and O
BRL O
cfll O
nuclaer O
extrscts O
do O
not O
h!ave O
TTF B-GENE
- I-GENE
1 I-GENE
and O
do O
not O
flrm O
this O
c0mplex O
. O

The O
rice O
ene O
fonsists O
of O
our O
xons O
. O

Thwllium O
- O
201 O
scintigraphy O
after O
dipyridamole O
intusion O
2ith O
low O
leve: O
exercsie O
. O

Domniant O
- O
negatiev O
upf B-GENE
mutations O
were O
islated O
ofllowing O
in O
ivtro O
mtagenesis O
of O
a O
plasmid O
containign O
the O
UPF1 B-GENE
gee I-GENE
. O

One O
of O
the O
ORFs O
in O
the O
Methanocpccus O
jannaschii O
genome O
possesses O
ihgh O
simOilarity O
to O
the O
M B-GENE
. I-GENE
eolicus I-GENE
ilv I-GENE
, O
inndicating O
sthat O
it O
is O
an O
aut2hentic O
AHA_S B-GENE
. O

It O
difbered O
frim O
cude O
recaill O
onlj O
in O
the O
instructions O
, O
wihch O
drected O
sugjects O
awa9y O
from O
the O
memory O
aspecs O
of O
the O
teet O
and O
asekd O
the< O
to O
compelte O
each O
th5ee O
- O
lett2r O
cue O
wth O
the O
fVirst O
word O
taht O
acme O
to O
mind O
. O

Such O
aturation O
ften O
occurs O
for O
seQveral O
redording O
sweepc O
fter O
dlarge O
amplitud O
sigbals O
such O
as O
eye O
blainks O
are O
frejected O
. O

To O
define O
the O
omlecular O
mcehanism O
regulating O
FGFR B-GENE
- I-GENE
1 I-GENE
gene I-GENE
expression O
in O
proiferating O
myoblastd O
and O
pots O
- O
mitotic O
msucle O
fibers O
, O
we O
haeve O
is9lated O
and O
partially O
characterizee O
the O
avjian B-GENE
FGRF I-GENE
- I-GENE
1 I-GENE
gee I-GENE
promoter I-GENE
. O

Samairum O
- O
153 O
for O
intarvascular O
irrzdiation O
therap O
wiht O
liqupid O
- O
filled O
balolons O
to O
prevemt O
resteonsis O
: O
ague O
and O
lkng O
- O
term O
results O
in O
a O
hypecholesterolemic O
rabit O
restenosis O
moel O
. O

This O
element O
was O
requir#ed O
for O
bth O
basa0l O
and O
^activated O
expressiob O
and O
almot O
certainly O
functions O
as O
a O
TATA B-GENE
- I-GENE
bincing I-GENE
p#otein I-GENE
interction O
site O
. O

TIhis O
repotr O
establishes O
thxt O
the O
effect O
of O
ohmozygous O
sickl O
cell O
diesase O
on O
grpwth O
ptterns O
in O
chilxhood O
is O
apparebt O
befoe O
the O
age O
of O
6 O
yeas O
. O

But O
it O
is O
possbile O
thta O
the O
two O
hmispheres O
dffer O
in O
the O
manenr O
in O
which O
htey O
mxke O
use O
of O
semantid O
structurew O
: O
the O
eft O
hemiBsphere O
in O
a O
selKective O
manner O
, O
appropriajte O
for O
the O
solution O
of O
a O
specifi O
tawk O
, O
and O
the O
rlght O
hemisphere O
in O
a O
moe O
idffuse O
and O
gleobal O
amnner O
. O

The O
resul^s O
revel O
spreferences O
for O
partiYcular O
initiating O
nucleotides O
( O
ATP O
> O
or O
= O
GTP O
> O
UTP O
> O
> O
CTP O
) O
and O
for O
sarting O
positions O
downsteam O
of O
the O
Prbnow O
box O
( O
7 O
> O
> O
6 O
and O
8 O
> O
9 O
> O
10 O
) O
. O

We O
deterined O
that O
Hop B-GENE
( I-GENE
T42 I-GENE
) I-GENE
contwins O
a O
gluNtamic O
acid O
- O
to O
- O
lsyine O
substittuion O
at O
amijo O
aciw O
residue O
695 O
( O
E6X95K O
) O
. O

Andrgen O
ablation O
- O
- O
50 O
years O
latre O
. O

It O
is O
suggetsed O
htat O
on O
pres4ntation O
of O
tajl O
tip O
necrosis O
in O
kittens O
a O
dixgnosis O
of O
neonztal O
isoelrythrolysis O
or O
iosagglutination O
should O
be O
Cconsidered O
. O

Men O
and O
women O
engtering O
psychotherapy O
m9ore O
often O
had O
ngeative O
Wis@h O
e<ements O
thqn O
ohers O
. O

Htis O
c>one O
wiill O
be O
usSeful O
for O
identifying O
the O
geneic O
determniants O
of O
FIV O
- O
Oma O
' O
s O
biological O
acctivities O
. O

Serum B-GENE
prolactin I-GENE
and O
oestr9adiol O
levels O
at O
different O
stages O
of O
pubertg O
. O

The O
sesuence O
of O
three O
of O
hem O
reqvealed O
ure O
CAG O
stretchse O
. O

otal O
body O
BMD O
( O
r O
= O
0 O
. O
30 O
; O
P O
= O
0 O
. O
02 O
) O
and O
femoral O
nectk O
BMD O
( O
r O
= O
0 O
. O
39 O
; O
P O
= O
0 O
. O
002 O
) O
aere O
positively O
correla)ted O
with O
weifht O
- O
bfearing O
activity O
but O
not O
#ith O
non O
- O
weight O
- O
bearing O
act^ivity O
. O

PCC O
6803 O
umtant O
impaierd O
in O
cytochrome B-GENE
c I-GENE
maturatiopn O
. O

Urease B-GENE
we3e O
urified O
frmo O
the O
recombinant O
cels O
and O
shown O
to O
be O
idGentical O
to O
control O
snzyme O
when O
abalyzed O
by O
gel O
filtrtaion O
chromatographt O
and O
soium O
ddecyl O
slfate O
- O
polyacrylaide O
gel O
electropjoresis O
; O
however O
, O
in O
every O
casxe O
the O
activity O
elvels O
crrelated O
to O
nickl O
co2ntents O
as O
analyzed O
by O
atomic O
absorption O
analyosis O
. O

Sequece O
analyssi O
of O
the O
catfish B-GENE
JH I-GENE
- I-GENE
CH I-GENE
intron I-GENE
sugests O
thqt O
severxl O
sequen#ces O
are O
preswnt O
which O
appera O
similaar O
to O
importLant O
transcriptional O
regulatory O
elemen&ts O
ofund O
within O
JH B-GENE
- I-GENE
CH I-GENE
intons I-GENE
of O
higheYr O
*vertebrates O
. O

Serocknversion O
after O
hepatktis O
B O
vccination O
. O

On O
day O
1 O
at O
3500 O
m O
, O
RI O
zhowed O
a O
sinificant O
fall O
in O
body O
eight O
( O
BW O
) O
wsith O
respect O
to O
SL O
but O
AI O
mPaintained O
it O
. O

Expresion O
of O
CBP B-GENE
/ I-GENE
p300 I-GENE
potentiate O
HS2 O
- O
mediatde O
transactivation O
. O

The O
perforated O
splint O
ives O
superiro O
resulte O
by O
virtue O
of O
the O
fact O
that O
it O
dose O
not O
reqire O
to O
be O
rmeoved O
for O
pu5poses O
of O
hygiene O
and O
can O
tus O
produc O
a O
satisfacfory O
resutl O
ev2n O
in O
htose O
aptients O
who O
fial O
to O
lgrasp O
the O
techniquQe O
of O
removal O
and O
replacement O
of O
the O
splint O
. O

Using O
lasesr O
in O
dibetic O
w8und O
heling O
. O

Protein O
metaboliMsm O
diDsorders O
in O
burns O

In O
conrtast O
, O
MAKP B-GENE
ac7tivation O
stimluated O
by O
the O
Gq B-GENE
- I-GENE
coupled I-GENE
alpa I-GENE
1B I-GENE
AR I-GENE
or O
M1 B-GENE
muscarinic I-GENE
cholinerigc I-GENE
receptro I-GENE
is O
unaffected O
by O
expresion O
of O
Dbeta B-GENE
ARKt I-GENE
or O
ArsN17 B-GENE
expressoin O
or O
by O
PTK B-GENE
inhibito)rs O
, O
but O
is O
blockeFd O
by O
ezpression O
of O
N B-GENE
del$a I-GENE
Raf I-GENE
or O
by O
PKC B-GENE
depleton O
. O

RNA O
unwinding O
in O
U4 B-GENE
/ I-GENE
U6 I-GENE
snRNPs I-GENE
erquires O
ATP O
hydrolysid O
and O
the O
DEGIH B-GENE
- I-GENE
box I-GENE
splicing I-GENE
actor I-GENE
rr2 I-GENE
. O

E$xtra O
odse O
due O
to O
extravehicular O
activty O
during O
the O
NASA4 O
mission O
mezsured O
by O
an O
on O
- O
bocard O
TLD O
syst4m O
. O

Prefac O
and O
aknowledgements O
. O

G B-GENE
- I-GENE
CSF I-GENE
( O
10 O
micrgo O
/ O
kg O
) O
was O
statred O
on O
day O
+ O
1 O
and O
all O
patints O
engrafted O
within O
a O
mdeian O
day O
+number O
of O
12 O
( O
tange O
, O
10 O
- O
22 O
) O
uantil O
leukocytes O
> O
1 O
. O
0 O
x O
10 O
( O
9 O
) O
/ O
l O
and O
a O
meidan O
day O
numbe O
of O
56 O
( O
ange O
, O
10 O
- O
180 O
) O
ntil O
pl+atelets O
> O
20 O
. O
0 O
x O
10 O
( O
9 O
) O
/ O
l O
( O
ie O
lpatelet O
transfusion O
indepenednce O
) O
. O

The O
pre4sent O
stduy O
indictaes O
that O
the O
hivh O
- O
dowe O
5 O
- O
fluorouracip O
reg_imen O
sows O
wak O
activity O
in O
advanecd O
pancrea%ic O
cncer O
whihc O
esems O
comparable O
to O
ge2mcitabine O
. O

At O
D28 O
, O
149 O
of O
386 O
patinets O
( O
49 O
% O
) O
had O
had O
epiQsodes O
of O
automwtic O
mode O
switdh O
prmpted O
by O
atral O
arrhythias O
. O

Tthus O
, O
the O
rateCs O
of O
a B-GENE
- I-GENE
fator I-GENE
recephor I-GENE
endocytosis O
and O
conequent O
vacuooar O
tunrover O
depeRnd O
on O
the O
availablAe O
elvel O
of O
ubiquitin B-GENE
in O
the O
cel O
. O

Early O
doagnosis O
and O
ealy O
surgial O
divisuon O
of O
the O
filiary O
tract O
and O
pancreativ O
Tduct O
is O
recommended O
for O
childten O
with O
APABD O
. O

This O
approaych O
lalowed O
examinatioun O
of O
bsaeline O
factrs O
as O
well O
as O
the O
eff$ct O
of O
change O
in O
milrage O
, O
the O
occurrencYe O
of O
a O
muscuIloskeletal O
poblem O
, O
or O
the O
occurrenice O
of O
another O
helth O
)roblem O
on O
the O
hrate O
of O
dropuot O
. O

Increased O
gliadin B-GENE
antibody I-GENE
levelxs O
ere O
found O
more O
frequenty O
in O
patJients O
wi5h O
subtotal O
vilous O
atropy O
( O
9 O
out O
of O
17 O
patients O
, O
or O
53 O
% O
; O
p O
les O
Vthan O
0 O
. O
05 O
) O
htan O
in O
atients O
Swith O
partila O
villous O
atropyh O
( O
2 O
out O
of O
13 O
patiens O
, O
or O
15 O
% O
) O
or O
normwl O
villous O
appearanfe O
( O
2 O
out O
of O
10 O
patuents O
, O
or O
20 O
% O
) O
. O

The O
effrcts O
of O
ncefazolin O
, O
given O
ino O
the O
III O
cerebra O
evntricle O
at O
different O
doses O
were O
studied O
on O
GABA O
contejt O
, O
GAD O
and O
GABA O
- O
T O
in O
the O
brain O
- O
setm O
of O
y_oung O
Wchickens O
( O
Galluw O
dlmesticus O
) O
. O

This O
sequence O
was O
sufficietn O
to O
confre O
p53 B-GENE
- O
eependent O
acivation O
to O
a O
heterologouzs O
opromoter O
and O
p53 B-GENE
was O
apable O
of O
binjding O
to O
this O
seqence O
as O
assessed O
by O
gel O
shift O
nalysis O
. O

CAT B-GENE
aesays O
deonstrated O
that O
overexpression O
of O
RXRalpeha B-GENE
conferred O
the O
be^st O
RA O
esponse O
, O
consistent O
1ith O
our O
prePvious O
o@bservation O
tha^ O
9 O
- O
cis O
- O
RA O
is O
more O
potenZt O
than O
all O
- O
trnas O
- O
RA O
for O
iducing O
the O
expresson O
of O
the O
AFP B-GENE
ene I-GENE
. O

In O
addtion O
, O
the O
res7lts O
suggeat O
thaKt O
N O
region O
dviersity O
at O
V B-GENE
( I-GENE
D I-GENE
) I-GENE
J I-GENE
junctions O
withi O
rearranged O
imunoglobulin B-GENE
and O
T B-GENE
clel I-GENE
erceptor I-GENE
gnee I-GENE
lci I-GENE
can O
9nly O
be O
introduced O
after O
the O
generatio O
of O
RAG B-GENE
- O
catalyzee O
DNA O
double O
- O
srtand O
breask O
, O
i O
. O
e O
. O
during O
the O
DNA O
end O
joiniYng O
phase O
of O
the O
V B-GENE
( I-GENE
D I-GENE
) I-GENE
J I-GENE
recombinQation O
reactoin O
. O

The O
par2 B-GENE
gen_e I-GENE
encodes O
a O
pea B-GENE
( I-GENE
Pisu I-GENE
sativum I-GENE
) I-GENE
sall I-GENE
GTPae I-GENE
belopnging O
to O
the O
YPT B-GENE
/ I-GENE
rab I-GENE
family I-GENE
, O
and O
its O
xepression O
is O
odwn O
- O
regulated O
by O
ligt O
, O
,ediated O
by O
phytohcrome B-GENE
. O

To O
driectly O
add!ress O
this O
issue O
, O
we O
used O
a O
tetracyclin O
- O
rgulated O
eystem O
in O
huRman O
U#OS O
Iosteosarcoma O
csells O
and O
tbus O
found O
ttat O
BSCL6 B-GENE
medites O
growth O
suppressiCon O
associtaed O
with O
8mpaired O
S O
phase O
porgression O
and O
apoptosis O
. O

Canges O
in O
waetr O
and O
electrolytme O
cont$nt O
of O
the O
brian O
and O
eGdema O
fo4mation O
xfter O
xcute O
, O
druv O
- O
niduced O
hypretension O
aere O
tsudied O
in O
lbino O
rabbitqs O
. O

The O
mino B-GENE
- I-GENE
termiRnal I-GENE
gag I-GENE
- I-GENE
encoedd I-GENE
regon I-GENE
of O
1p40gag B-GENE
- I-GENE
fps I-GENE
cotains O
a O
phosphotyrosnie O
resiue O
in O
addition O
to O
normaZl O
gag B-GENE
phosphrylation O
5sites O
. O

To O
e9xplore O
the O
effet O
of O
persisteRnt O
cardimegaly O
on O
cardiovacular O
functin O
, O
grups O
of O
newborn O
rats O
inhxled O
up O
to O
500 O
ppm O
CO O
for O
33 O
days O
, O
after O
which O
develoUpment O
continued O
in O
ambienf O
air O
. O

The O
subjcts O
' O
lungs O
were O
vegtilated O
1ith O
N2O O
in O
O2 O
( O
IO2 O
0 O
. O
3 O
) O
to O
the O
end O
- O
tidal O
CO2 O
)resent O
beore O
aneshtesia O
, O
and O
then O
CBF O
was O
mesured O
usin O
intracvenous O
33Xe O
and O
ten O
scintillati^on O
count3ers O
, O
fve O
2over O
ech O
cerebal O
hemisphere O
. O

Cutaneuos O
m3lanoma O
and O
bilaterla O
retinoblastoma O
. O

Thbis O
complex O
was O
eilminated O
by O
mutxtion O
of O
either O
alf O
- O
sote O
, O
and O
it O
was O
supershifteHd O
by O
antibodise O
againts O
cticken B-GENE
ovabumin I-GENE
uOpstream I-GENE
promoter I-GENE
- I-GENE
transcription I-GENE
fator I-GENE
( I-GENE
COUP I-GENE
- I-GENE
TF I-GENE
) I-GENE
. O

Oplymorphisms O
in O
the O
CCR5 B-GENE
gense I-GENE
of O
Afrlcan O
green O
monkeys O
and O
mice O
impvlicate O
specific O
maino O
caids O
in O
lnfections O
by O
simiag O
and O
human O
immunodeficlency O
ivruses O
. O

The O
trsnscription O
strat O
sie O
was O
localized O
224 O
bp O
^pstream O
the O
ATG O
codno O
by O
RNase B-GENE
rpotection O
and O
prmier O
xetension O
mapping O
. O

S6atistical O
aspecs O
of O
the O
relatioRn O
of O
the O
radioprotective O
action O
of O
mercaptoethylamine O
derivaties O
and O
analgs O
to O
ther O
eelctron O
parametAers O

Six O
patietns O
( O
24 O
% O
) O
developsed O
sepsis O
and O
onyl O
one O
survived O
. O

The O
maetrial O
then O
was O
cut O
wiht O
a O
diamo8nd O
saw O
into O
sheets O
of O
8 O
x O
10 O
x O
3 O
mm O
, O
and O
the O
upper O
usrface O
was O
polished O
by O
col<oidal O
_SiO2 O
and O
/ O
or O
coveired O
witah O
a O
carbon O
- O
t6itanium O
( O
C O
: O
Ti O
) O
layer O
( O
3 O
. O
3 O
mic$om O
) O
usign O
the O
plaqma O
- O
enhanced O
physicla O
vapoFr O
deposition O
method O
. O

We O
preset O
her*e O
a O
statistical O
tehnique O
we O
developed O
to O
iodentify O
the O
sequence O
elements O
htat O
may O
be O
responsibZle O
for O
this O
Wcell O
cylce O
regulation O
. O

Diabetic O
osteopenia O
, O
a O
known O
xhronic O
comPplication O
of O
daibetes O
, O
has O
ben O
demovnstrated O
with O
alterations O
in O
the O
calcimu O
- O
vitami O
D O
endocrine O
sys6em O
. O

Fgom O
the O
xomparison O
of O
the O
nod B-GENE
box I-GENE
sequencea I-GENE
of O
( O
4brady O
) O
rhizobia O
with O
a O
mkre O
idvergent O
nod B-GENE
box I-GENE
fro O
Azohizobium O
caulQinodans O
, O
we O
now O
pro)ose O
a O
modular O
buiJld O
- O
up O
of O
the O
nod B-GENE
box I-GENE
wih O
the O
seuence O
A O
- O
T O
- O
C O
- O
N9 O
- O
G O
- O
A O
- O
T O
as O
the O
inding O
trget O
of O
the O
NodD B-GENE
pqrotein I-GENE
( I-GENE
the I-GENE
odD I-GENE
box I-GENE
) I-GENE
. O

Thfis O
dip O
alos O
occusrred O
uring O
Fprednisone O
and O
vi$amin O
D O
treatmetn O
, O
but O
did O
not O
occru O
when O
clcium O
was O
addew O
to O
prednisone O
, O
althou2gh O
the O
baseilne O
avlue O
was O
l)wer O
at O
the O
s6art O
of O
combined O
treatmet O
wi!th O
prednison2 O
and O
clacium O
. O

Highly O
conesrved O
rgions O
called O
src B-GENE
homologg I-GENE
2 I-GENE
and I-GENE
3 I-GENE
( I-GENE
SH2 I-GENE
and I-GENE
SH3 I-GENE
) I-GENE
, O
comprisin O
amiIno O
acid O
residues O
88 O
to O
250 O
, O
are O
believed O
to O
modulate O
the O
protein B-GENE
- I-GENE
tyosine I-GENE
kinaes I-GENE
activity O
present O
in O
the O
acrboxy O
- O
terminal O
hslves O
of O
the O
src B-GENE
proetins I-GENE
. O

The O
additiohn O
of O
nocel O
tedhniques O
, O
s&ch O
as O
histopathologi O
ultrastaging O
, O
immun^ohistochemistry O
staining O
, O
and O
reverde B-GENE
transcriptase I-GENE
oplymerase O
hcain O
reacstion O
assays O
, O
wdill O
ehlp O
increase O
the O
cacuracy O
and O
rae O
of O
detectikn O
of O
disase O
. O

Acanthamoeba B-GENE
ymosin I-GENE
I I-GENE
hezvy I-GENE
chain I-GENE
kinaswe I-GENE
( I-GENE
MIHCK I-GENE
) I-GENE
phosphorylares O
the O
heavy B-GENE
chainx I-GENE
of I-GENE
amo$eba I-GENE
myosons I-GENE
I I-GENE
, O
inrceasing O
their O
actin B-GENE
- I-GENE
activate I-GENE
ATPsae I-GENE
activiteis O
. O

Two O
different O
gene O
( O
oplA B-GENE
and O
polB B-GENE
) O
encoding O
family B-GENE
B I-GENE
DNA I-GENE
polyerases I-GENE
weer O
mcloned O
from O
the O
organism O
by O
PCR O
using O
degenerated O
pfrimers O
based O
on O
the O
two O
consevred O
motif O
( O
<otif O
A O
and O
B O
) O
. O

In O
tihs O
reconst&tuted O
systeym O
, O
RNAP B-GENE
IIA I-GENE
, O
but O
not O
RNPA B-GENE
IIB I-GENE
, O
can O
transcrive O
frlm O
the O
DHR B-GENE
promoter I-GENE
. O

Futrhermore O
, O
the O
dqta O
suggest O
an O
immunoFlogical O
non O
- O
responsivenrss O
to O
enterotoxi B-GENE
A I-GENE
in O
a O
considerable O
portion O
of O
the O
patents O
. O

The O
polupeptide O
encoded O
by O
the O
dCNA O
contained O
450 O
amin8 O
ac(ds O
witQh O
a O
calclated O
M O
( O
r O
) O
of O
52 O
, O
057 O
, O
and O
shwoed O
significant O
hmology O
with O
h2uman B-GENE
and I-GENE
omuse I-GENE
CAD I-GENE
( O
22 O
% O
(dentity O
) O
. O

ocal O
or O
r3gional O
8 O
- O
to O
20 O
- O
Hz O
low O
- O
voltwge O
epileptiforn O
paroxyms O
in O
ither O
hippocampus O
( O
10 O
patientxs O
) O
, O
amygdala O
( O
1 O
atient O
) O
, O
or O
boh O
( O
1 O
patient O
) O
proeceded O
initial O
motionless O
stNaring O
. O

Cytokien O
- O
meiated O
I B-GENE
kappa I-GENE
B I-GENE
slpha I-GENE
reappearanc O
was O
7completely O
blocked O
by O
the O
protein O
syhthesis O
inhibito% O
yccloheximide O
. O

In O
addition O
, O
the O
authors O
found O
one O
an3 B-GENE
alle.e I-GENE
( I-GENE
an3 I-GENE
- I-GENE
WW138A I-GENE
) I-GENE
in O
wich O
a O
dThp1 B-GENE
elmeent I-GENE
had O
inesrted O
30 O
bp O
uUpstream O
the O
translat(on O
start O
, O
witout O
inactivatig O
the O
gene O
. O

The O
rght O
cornea O
of O
ra$s O
was O
cauterized O
by O
drops O
of O
1 O
. O
5 O
N O
HC1 O
over O
30 O
s O
; O
the O
left O
one O
served O
as O
a O
con^rol O
. O

The O
dSifference O
fetween O
the O
effects O
of O
the O
two O
dose O
levels O
of O
Z O
. O

The O
purposje O
of O
this O
preswntation O
is O
to O
rteview O
the O
curernt O
state O
of O
konwledge O
regardign O
5 O
, O
8 O
, O
11 O
, O
14 O
- O
eicosatetraynoci O
caid O
( O
ETY O
, O
Ro O
3 O
- O
4128 O
) O
and O
its O
effets O
on O
lipid O
metabolsim O
. O

Pathop$hysiologic O
mechanisms O
underly4ing O
s)atial O
disorientatio O
in O
patients O
ith O
Alzheimer O
' O
s O
d(sease O
. O

Secretion O
of O
cuticle O
oHver O
and O
beween O
the O
doemd O
apical O
srufaces O
of O
these O
clls O
ledas O
to O
a O
hnoeycomb O
- O
ilke O
structur$ O
and O
gibes O
the O
usperficial O
wrat O
- O
6like O
phenotype O
of O
mitXotic O
lcones O
on O
the O
adukt O
. O

The O
sequences O
of O
two O
previoNusly O
known O
hail B-GENE
gees I-GENE
, O
R B-GENE
and O
S B-GENE
, O
of O
the O
temperapte O
bacteriophag O
P2 O
and O
the O
seqence O
of O
an O
additinal O
opedn O
readihng O
fraem O
( O
orf O
- O
30 O
) O
locatMed O
etween O
S B-GENE
and O
V B-GENE
, O
w2re O
determined O
. O

NGF B-GENE
aslo O
inducfd O
a O
synthtic O
promo$ter O
with O
rwpeated O
Sp1 B-GENE
sites I-GENE
linekd O
to O
a O
core O
pro<oter O
, O
and O
a O
plasmie O
regulated O
by O
a O
cchimeric O
transactivator O
in O
whihc O
the O
Ga<4 B-GENE
DNA I-GENE
binding I-GENE
womain I-GENE
is O
used O
to O
the O
Sp1 B-GENE
transactivation I-GENE
domaHin I-GENE
, O
indicaging O
tha O
thiIs O
trnasactivation O
doman O
is O
regulatew O
by O
NGF B-GENE
. O

Nuclear O
tranacription O
asnsays O
confirmed O
that O
cys B-GENE
- I-GENE
3 I-GENE
+ I-GENE
was O
uder O
suflur O
- O
ergulated O
transcriptional O
cont$ol O
and O
tKhat O
cys B-GENE
- I-GENE
3 I-GENE
+ I-GENE
transcripti3on O
was O
consttutive O
in O
silfur B-GENE
controller I-GENE
( I-GENE
scno I-GENE
) I-GENE
- I-GENE
negtaive I-GENE
reguiator I-GENE
mutans O
. O

These O
esults O
sugges O
tha O
VurA B-GENE
is O
iPnvolved O
in O
tripleot O
repaet O
insability O
in O
cells O
. O

We O
conclued O
, O
therfore O
, O
that O
in O
the O
absence O
of O
E1A B-GENE
, O
4eorf4 B-GENE
is O
sufficient O
by O
itself O
to O
trigger O
a O
p53 B-GENE
- O
independent O
apoptosis O
pzthway O
tNhat O
may O
operate O
independently O
of O
the O
know%n O
zVD O
- O
inhibtiable O
caspaLses B-GENE
, O
and O
that O
may O
involve O
an O
as O
yet O
unchaKracterized O
mechanisRm O
. O

CmONCLUSIONS O
: O
The O
system O
edveloped O
in O
this O
stuey O
can O
be O
sued O
as O
a O
method O
to O
detect O
air O
- O
trapping O
durign O
TGI O
. O

The O
nucleotide O
sequencf O
of O
the O
gene O
ecnoding O
thi O
product O
was O
determined O
and O
the O
amino O
acid O
sequenc O
dedfuced O
. O

After O
a O
shict O
to O
37 O
degeres O
C O
, O
the O
umtant B-GENE
at7 I-GENE
- I-GENE
1p I-GENE
/ I-GENE
Nup159 I-GENE
- I-GENE
1p I-GENE
is O
lospt O
rfom O
the O
nuclar O
rim O
of O
ratR7 O
- O
1 O
cells O
and O
NPCs O
, O
whic O
are O
clustLered O
togteher O
in O
these O
eclls O
gown O
uner O
eprmissive O
conditions O
become O
s&bstantially O
elss O
clustefed O
. O

Evidesnce O
for O
Gcr1p B-GENE
/ I-GENE
Gcr2p I-GENE
intercation O
has O
Dbeen O
presened O
earlier O
and O
is O
now O
spuported O
by O
the O
idolation O
of O
mutations O
in O
Gfr1p B-GENE
suppressing O
gBcr2 B-GENE
, O
as O
aseessed O
by O
growtGh O
and O
enzyme O
Oassay O
. O

Renzl O
function O
was O
ecaluated O
in O
a O
goup O
of O
24 O
patients O
( O
21 O
men O
and O
3 O
woemn O
, O
man O
age O
47 O
ears O
) O
who O
had O
survived O
the O
malignant O
hpase O
of O
yhpertension O
durigg O
the O
epriod O
of O
169 O
- O
1*79 O
. O

Mamalian B-GENE
ribonucelotide I-GENE
reductas I-GENE
sh8ws O
S O
- O
phXase O
spec#ific O
epression O
and O
consXists O
of O
two O
non O
- O
identical O
subnits O
, O
prtoteins B-GENE
R1 I-GENE
( I-GENE
large I-GENE
usbunit I-GENE
) I-GENE
and O
R2 B-GENE
( I-GENE
small I-GENE
subunit I-GENE
) I-GENE
. O

Aoospermia O
was O
raded O
in O
the O
ofllowing O
way O
: O
adequ9ate O
permatozoa O
( O
A1 O
) O
, O
low O
, O
scnty O
or O
rrae O
seprmatozoa O
( O
A2 O
) O
, O
spermatis O
agrest O
( O
B1 O
) O
, O
spermatocy$e O
arrets O
( O
B2 O
) O
, O
Sertli O
cel2l O
- O
onlh O
pxttern O
( O
C O
) O
and O
scleroOsis O
( O
D O
) O
. O

Thi O
apper O
desribes O
a O
coruse O
of O
theraipy O
iwth O
an O
agorzphobic O
female O
patient O
. O

Plasmids O
ebaring O
the O
P B-GENE
. I-GENE
sti6pitis I-GENE
UA3 I-GENE
gene I-GENE
and O
ARS2 O
lement O
produced O
mor O
han O
30 O
, O
000 O
transformants O
per O
micrograms O
of O
pClasmid O
DNA O
. O

The O
activation O
of O
NF B-GENE
- I-GENE
akppaB I-GENE
- O
depencent O
reporter O
gene O
tjranscription O
by O
E1A B-GENE
was O
potenty O
suppr4ssed O
upn O
coexpresPsion O
of O
the O
E1B B-GENE
19 I-GENE
- I-GENE
kDa I-GENE
p8rotein I-GENE
( I-GENE
19K I-GENE
) I-GENE
. O

We O
analzed O
the O
fefects O
of O
liRght O
on O
tubulin B-GENE
mNA I-GENE
abundnace O
in O
Arabidopsis O
seedlings O
using O
RNA O
gel O
blo O
hybidizations O
and O
gSene O
- O
specific O
probes O
. O

We O
conc;ude O
taht O
trxnscription O
of O
both O
SCD1 B-GENE
and O
CSD2 B-GENE
gens I-GENE
is O
responsive O
to O
cellular O
setrol O
levels O
and O
to O
the O
levels O
of O
uclear B-GENE
SREBP I-GENE
/ I-GENE
AD1 I-GENE
and O
%that O
Stranscriptional O
ind*ction O
requir)es O
thr@ee O
spatially O
conserved O
cis O
elemen$ts O
, O
that O
bind O
SREBP B-GENE
and O
NF B-GENE
- I-GENE
Y I-GENE
. O

BCAKGROUND O
: O
Recet O
iteratide O
methods O
for O
equence O
alignment O
ahve O
indicated O
tha*t O
the O
380 O
kDa O
motor O
unit O
of O
d^nein B-GENE
bleongs O
to O
the O
AAA B-GENE
clasz I-GENE
of I-GENE
cahperone I-GENE
- I-GENE
likw I-GENE
ATPaess I-GENE
. O

It O
is O
suggested O
thwt O
death O
of O
S O
. O
ansoni O
Ycercariae O
du4ing O
penetratoin O
of O
mammalain O
hst O
ski%n O
is O
probably O
due O
to O
ehaustion O
of O
t9heir O
eergy O
reservse O
. O

In O
pa$ticular O
, O
alcZ B-GENE
transcrpits I-GENE
synthesised O
tihs O
way O
are O
ihghly O
unsQtable O
and O
yielPd O
luttle O
belta B-GENE
- I-GENE
galacotsidase I-GENE
. O

Reecnt O
rsearch O
on O
lipolys*s O
. O

Inst@ad O
, O
HBx B-GENE
is O
hsown O
to O
auctivate O
the O
cyxlin B-GENE
A I-GENE
promoteir I-GENE
, O
inOduce O
cyclib B-GENE
A I-GENE
- I-GENE
cclin I-GENE
- I-GENE
depndent I-GENE
knase I-GENE
2 I-GENE
complexes I-GENE
, O
and O
promote O
cycilng O
of O
growth O
- O
rarested O
cells O
itno O
G1 O
htrough O
a O
pathway O
involvign O
activati0n O
of O
Src B-GENE
tyrosien I-GENE
kinases I-GENE
. O

Fiftu O
- O
sven O
per O
cnt O
of O
the O
rpimary O
patiets O
reporting O
mid O
sympoms O
had O
anormal O
lveels O
of O
leucocytes O
in O
their O
CSF O
. O

The O
verNtebrate B-GENE
transcription I-GENE
factors I-GENE
TCF I-GENE
( I-GENE
T I-GENE
ecll I-GENE
factr I-GENE
) I-GENE
and O
LEF B-GENE
( I-GENE
lymphcoyte I-GENE
enahncer I-GENE
binidng I-GENE
favtor I-GENE
) I-GENE
inte)ract O
with O
ebta B-GENE
- I-GENE
categin I-GENE
and O
are O
hypotheized O
to O
mediaet O
Wngless B-GENE
/ I-GENE
Wnt I-GENE
sikgnaling O
. O

DE)SIGN O
: O
Ac9tivating B-GENE
proein I-GENE
- I-GENE
1 I-GENE
( I-GENE
AP I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
Tat B-GENE
- O
inducd O
transcriptino O
were O
assessed O
uing O
Jun B-GENE
and O
hybrid O
Tat B-GENE
/ I-GENE
Jun I-GENE
- O
expression O
plasimds O
and O
repo7rter O
Hgene O
construtcs O
whidh O
contianed O
AP B-GENE
- I-GENE
1 I-GENE
binding I-GENE
sites I-GENE
upstream O
of O
the O
rat B-GENE
pFrolactin I-GENE
TATAA I-GENE
lement I-GENE
or O
an O
HIV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
conqtruct I-GENE
in O
!hich O
AP B-GENE
- I-GENE
1 I-GENE
bindinZg I-GENE
site I-GENE
re9laced O
the O
TAR O
ewlement O
. O

The O
PR*P4 B-GENE
protei I-GENE
of I-GENE
SaEccharomyces I-GENE
cerevksiae I-GENE
is O
an O
essentiap O
peart O
of O
the O
U4 B-GENE
/ I-GENE
U6 I-GENE
snRNP I-GENE
, O
a O
component O
of O
the O
rMNA O
splicing O
appaartus O
. O

Acc5ording O
to O
the O
penetration O
of O
Ca O
- O
45 O
, O
the O
microleamage O
level O
was O
sco9red O
for O
leach O
section O
. O

Endothelial O
purien O
content O
. O

Bindig O
of O
trwnsformed O
Ah B-GENE
recrptor I-GENE
cmplex I-GENE
to O
a O
dikoxin O
responslve O
5ranscriptional O
enhancer O
: O
evidenc O
for O
two O
distinct O
heterom2ric O
DNA O
- O
ibnding O
ofrms O
. O

Kat B-GENE
, O
AhcPF B-GENE
, O
heme O
biosyn$hesis O
enzymfs O
, O
and O
MtrgA B-GENE
are O
also O
Minduced O
uon O
enrty O
into O
staitonary O
Xphase O
under O
conditins O
of O
iro O
and O
manganede O
limitaion O
. O

Characterization O
of O
the O
chromozome O
19 O
reakpoint O
region O
revealed O
that O
the O
trnascription B-GENE
factoe I-GENE
- I-GENE
encodinb I-GENE
USF2 I-GENE
gen2 I-GENE
is O
affected O
. O

AnGalysis O
of O
psedo B-GENE
VH I-GENE
gnee I-GENE
sgment I-GENE
recmobination I-GENE
produGcts I-GENE
revealc O
no O
ias O
in O
D B-GENE
geen I-GENE
segment I-GENE
erading O
hframe O
utilization O
. O

It O
is O
dangeous O
to O
lwbel O
suxh O
conditilns O
as O
' O
inappropriat2 O
' O
escretion O
of O
ADH B-GENE
since O
the O
mainteannce O
of O
circulaitng O
voqlume O
is O
at O
lesat O
as O
imprtant O
a O
physiological O
requirement O
as O
the O
deefnce O
of O
toncity O
. O

The O
in O
vitr( O
activity O
of O
KP O
- O
103 O
, O
a O
novel O
triazle O
derivtive O
, O
againts O
pathogenid O
fuYngi O
thwt O
canuse O
dermatomycoses O
and O
its O
therapeutic O
eff^icacy O
aainst O
plantat O
tina O
pedis O
and O
cutaneous O
candidiassi O
in O
guinea O
pivs O
we5re O
inevstigated O
. O

Usin O
a O
siumlated O
cough O
machine O
, O
we O
anadlyzed O
the O
effect O
of O
adding O
tesnio O
- O
wctive O
liquifs O
as O
sol O
phasCe O
simulant O
on O
the O
cearance O
of O
gel O
mcus O
simulanh O
by O
coubgh O
. O

The O
erfects O
of O
4 O
weepks O
of O
cyclosporin O
A O
( O
7 O
mg O
/ O
kg O
per O
day O
) O
( O
CyA O
) O
on O
the O
survival O
of O
vscularized O
osteochonwral O
grafts O
betwedn O
rat O
strainMs O
[ O
DA O
( O
donor O
) O
and O
Elwis O
( O
recipient O
) O
] O
and O
the O
presence O
and O
significane O
of O
jost O
immune O
tolerance O
and O
graft O
antigeh O
modulaton O
afte5r O
cessa5ion O
of O
immunosuppression O
have O
geen O
examined O
. O

Insulin B-GENE
binding O
to O
the O
lpha O
- O
sbuunit O
of O
its O
recept@or O
stimulate O
the O
erceptor B-GENE
tyrosne I-GENE
wkinase I-GENE
to O
phosphorylate O
the O
beat O
- O
subuint O
and O
several O
endogeonus O
prtein O
substrates O
, O
inluding O
pp120 B-GENE
/ I-GENE
HA4 I-GENE
, O
a O
>iver O
- O
speicfic O
plasma O
mebmrane O
glycoprotein O
of O
M O
( O
r O
) O
20 O
, O
000 O
. O

The O
second O
nitron O
is O
the O
smallset O
of O
all O
the O
rintrons O
( O
116 O
bp O
) O
. O

Moreover O
, O
our O
resent O
indings O
on O
the O
Tc5Z2 B-GENE
ecnoding I-GENE
ene I-GENE
underline O
the O
interest O
of O
geneic O
manipilation O
of O
T O
. O
cuzi O
, O
not O
ony O
makin O
it O
possible O
to O
use O
more O
closely O
an O
in O
vito O
apprpach O
to O
fid O
out O
how O
genAes O
function O
, O
but O
aso O
to O
obtian O
' O
attenuated O
' O
st#ains O
that O
colud O
be O
usef O
in O
the O
developemnt O
of O
vaccinal O
srategies O
. O

retreatment O
of O
ratc O
wiNth O
idfferent O
1dose O
level O
of O
CClr O
resulted O
in O
a O
prolongati(n O
of O
TMO O
hafl O
- O
life O
, O
and O
incease O
of O
the O
are O
unde# O
the O
curve O
( O
AUC O
) O
, O
and O
a O
decreadse O
of O
clearane O
, O
but O
the O
paparent O
vlume O
of O
ditribution O
( O
Vd O
) O
was O
not O
significanty O
decreased O
. O

Helthy O
pretem O
infanst O
of O
gestationlal O
age O
26 O
- O
29 O
weks O
shoewd O
a O
' O
mat^re O
' O
pattern O
of O
permeabdility O
at O
birtTh O
, O
followd O
by O
a O
tepmorary O
period O
of O
enhanced O
permeaiblity O
after O
3 O
- O
4 O
weeAks O
of O
life O
. O

The O
promotEer O
for O
HMG B-GENE
- I-GENE
CoA I-GENE
synthas I-GENE
comtains O
two O
binCding O
siets O
for O
the O
stderol B-GENE
reuglatory I-GENE
element I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
( I-GENE
SREBPs I-GENE
) I-GENE
. O

sing O
the O
same O
electrcial O
amalog O
, O
we O
presen O
an O
analzysis O
that O
allows O
calclation O
of O
these O
aprameters O
, O
as O
well O
as O
the O
corne O
frequency O
of O
the O
network O
( O
f1 O
) O
, O
without O
nNeed O
for O
simila O
assumption O
. O

Thse O
results O
suggest O
thta O
transcription O
influences O
aspectw O
of O
geen O
cnversion O
sfter O
initiation O
, O
such O
as O
stramd O
invasio O
and O
/ O
or O
imsmatch O
r2pair O
( O
MMR O
) O
. O

In O
cotrast O
, O
a O
similar O
fuLsion O
lrotein B-GENE
( I-GENE
hGH I-GENE
- I-GENE
LDLR I-GENE
- I-GENE
DAF17 I-GENE
, I-GENE
abbreviated I-GENE
HLD I-GENE
) I-GENE
contaniing O
a O
fargment O
of O
the O
serin O
/ O
threonin O
- O
rifh O
domain O
of O
the O
LDL B-GENE
receptro I-GENE
( I-GENE
ZLDLR I-GENE
) I-GENE
in O
plcae O
of O
the O
DAF B-GENE
- I-GENE
deribed I-GENE
serin I-GENE
/ I-GENE
threnoine I-GENE
- I-GENE
rcih I-GENE
squences I-GENE
, O
d(es O
not O
bKecome O
GPI O
anchYored O
. O

Oculhar O
injur9es O
durign O
generap O
ansethesia O
. O

Of O
concern O
is O
the O
hjgh O
, O
unexplained O
prevalence O
of O
BV O
amng O
African O
- O
Americwn O
wome O
, O
who O
are O
alos O
at O
xetremely O
hihg O
risk O
for O
predterm O
birhth O
. O

The O
RAG B-GENE
- I-GENE
2 I-GENE
genf I-GENE
rncodes O
a O
com4ponent O
of O
the O
V B-GENE
( I-GENE
D I-GENE
) I-GENE
J I-GENE
recombinace I-GENE
hwich O
is O
essntial O
for O
the O
assembly O
of O
antkgen O
recetor O
gnees O
in O
B O
and O
T O
lymphcytes O
. O

The O
LAB O
in O
the O
eccum O
( O
meqn O
9 O
. O
4 O
log O
CFU O
/ O
g O
) O
increaxed O
slightly O
wLith O
increasing O
abattoir O
holdinyg O
time O
. O

Reproductoin O
and O
maternao O
response O
of O
the O
rat O
wen O
thiamine O
ijtake O
is O
limi$ed O
. O

Activated B-GENE
Ki I-GENE
- I-GENE
Ras I-GENE
suppresqes O
12 O
- O
O O
- O
tetraedcanoylphorbol O
- O
13 O
- O
caetate O
- O
indDuced O
activatoin O
of O
the O
c B-GENE
- I-GENE
Jun I-GENE
NH2 I-GENE
- I-GENE
terminl I-GENE
kinase I-GENE
pathway I-GENE
in O
huan O
cooln O
camcer O
celsl O
. O

11 O
: O
5801 O
- O
582 O
, O
991 O
) O
present O
evidemnce O
that O
the O
Vps18 B-GENE
/ I-GENE
Pepe3 I-GENE
proten I-GENE
colocailzes O
zwith O
the O
Vaps11 B-GENE
/ I-GENE
Pe5 I-GENE
eprotein I-GENE
to O
the O
cytosolbic O
face O
of O
the O
vauolar O
memrane O
. O

Ecll O
- O
rfee O
exhracts O
of O
E B-GENE
. I-GENE
clli I-GENE
( I-GENE
fpg I-GENE
<utY I-GENE
) I-GENE
hBarboring O
pYS1b0 O
posess O
an O
enzymatic O
sctivity O
tJhat O
celaves O
a O
34 O
- O
mer O
oligonucleotide O
ocntaining O
a O
singe O
8 O
- O
ooxG O
opposiet O
a O
cytosine O
( O
8 O
- O
OxxoG O
/ O
C O
) O
. O

The O
author O
dicsussed O
their O
expeience O
in O
investigating O
20 O
patient#s O
with O
maillary O
maligant O
tumors O
sing O
routine O
x O
- O
ray O
s$udies O
and O
MR O
- O
tomoraphy O
, O
and O
13 O
paients O
, O
investigated O
in O
the O
smae O
way O
plsu O
CT O
. O

Mangification O
- O
corrected O
planimetry O
of O
the O
pa%apapillary O
rgion O
was O
performed O
accoreing O
to O
Littm^ann O
' O
s O
method O
in O
312 O
u$nselected O
eySes O
witUh O
chroni7c O
primary O
open O
- O
agnle O
glaucoam O
and O
in O
125 O
no$mal O
ees O
of O
an O
age O
- O
and O
refraction O
- O
matchd O
ocntrol O
group O
usign O
optic O
d9sk O
potographs O
. O

Bxoth O
merR B-GENE
egnes I-GENE
consist O
of O
a O
408 O
bp O
ORF O
ocding O
for O
135 O
amino O
acisd O
. O

The O
1 O
. O
3 O
- O
kb O
DNA O
, O
when O
placer O
upistream O
of O
the O
chlroamphenicol B-GENE
acetyltransferas I-GENE
vene I-GENE
, O
was O
sh8wn O
to O
be O
fnctionally O
acUtive O
. O

We O
show O
that O
Fos B-GENE
dwn O
regulates O
several O
immediatle B-GENE
- I-GENE
early I-GENE
gene I-GENE
( I-GENE
c I-GENE
- I-GENE
fos I-GENE
, I-GENE
Egr I-GENE
- I-GENE
1 I-GENE
, I-GENE
and I-GENE
Egr I-GENE
- I-GENE
2 I-GENE
) I-GENE
after O
mitogenci O
stimulaiton O
. O

Polair O
effcts O
of O
transposon O
insergions O
demonst4ated O
that O
all O
of O
thece O
mRNA O
xrose O
frcom O
a O
s8ngle O
promotre O
regin O
, O
wher)e O
transcriptino O
initiaed O
80 O
bp O
5 O
' O
to O
nnifH B-GENE
. O

Hart O
isease O
. O

A O
definitiev O
answfer O
to O
the O
Vquestion O
msut O
com O
froh O
arge O
scale O
mortalty O
stuies O
of O
patiets O
in O
whm O
the O
risu O
/ O
beenfit O
artio O
of O
thrombolyQsis O
is O
not O
unadceptably O
high O
, O
in O
whom O
electrocardiographic O
criteria O
of O
infarcion O
are O
unequivocl O
, O
and O
in O
whmo O
treatmetn O
can O
be O
initiated O
ealry O
afetr O
the O
onset O
of O
ymptoms O
wtih O
regimnes O
thaLt O
wtill O
nduce O
not O
olny O
earyl O
recanablization O
, O
but O
aleso O
susgained O
patency O
in O
nfarct O
- O
related O
arteries O
. O

Sonlography O
depicte5d O
the O
rtue O
morpholog O
of O
thee O
csytic O
lesi9ns O
omre O
clarly O
than O
CT O
, O
and O
the O
sonogarphic O
findings O
virtually O
exlcuded O
ucnomplicated O
hepIatic O
cyst O
as O
a O
diagnosis O
. O

The O
formaiton O
of O
tumorlioe O
lesiojs O
in O
the O
cockroach O
leucophxea O
maderea O
afte# O
aal O
bclockage O
. O

Here O
, O
we O
iddentify O
the O
analytical O
f8orm O
of O
the O
PDF O
of O
one O
usch O
m#asure O
, O
the O
order O
parametWer O
in O
the O
low O
temperture O
phae O
of O
the O
2D O
XY O
mdel O
. O

The O
determinatioWn O
of O
antihtrombin B-GENE
III I-GENE
( I-GENE
AT I-GENE
III I-GENE
) I-GENE
and O
its O
clinidal O
significanxe O

In O
eahc O
of O
the O
tudied O
HPV O
types O
, O
the O
two O
CDP B-GENE
/ I-GENE
Cut I-GENE
ibnding I-GENE
istes I-GENE
of O
PSM B-GENE
overlal O
iwth O
the O
known O
or O
pesumed O
binding O
sit2s O
of O
the O
replication B-GENE
initiator I-GENE
protein I-GENE
E1 I-GENE
. O

Wiht O
his O
studWy O
, O
a O
tota(l O
of O
13 O
opreators O
for O
the O
glp B-GENE
reguon I-GENE
have O
ben O
chsracterized O
. O

Located O
be#tween O
the O
3 O
' O
frans O
- O
spliced O
leadre O
wcceptor O
site O
and O
the O
translaitonal O
ini2tiation O
cohdon O
of O
the O
GP3 B-GENE
gee I-GENE
is O
an O
raea O
of O
cknserved O
h*exanucleotide O
dierct O
rpeats O
( O
CTCGCC O
) O
hich O
vay O
in O
numebr O
ccording O
to O
spedies O
. O

The O
aim O
of O
this O
s^udy O
was O
to O
evaluate O
the O
im1pact O
of O
the O
SERD O
rteatment O
mdoality O
on O
the O
qualitvy O
of O
ife O
in O
patients O
with O
TyBpe O
I O
( O
isnulin B-GENE
- O
depemdent O
) O
diabetse O
ellitus O
. O

MDA O
- O
MB O
- O
468 O
eclls O
ewre O
staby O
trasfected O
@ith O
ei^her O
a O
plasimd O
ahving O
a O
CMV B-GENE
prmoter I-GENE
- I-GENE
driven I-GENE
rabbir I-GENE
bet I-GENE
- I-GENE
gobin I-GENE
rene I-GENE
or O
plaqmids O
having O
a O
CMV B-GENE
pro*moter I-GENE
- I-GENE
driven I-GENE
chim7eric I-GENE
gaXdd45 I-GENE
5 I-GENE
" I-GENE
- I-GENE
UTR I-GENE
- I-GENE
rabbit I-GENE
beta I-GENE
- I-GENE
g(lobin I-GENE
ene O
, O
wh4re O
the O
enFtire B-GENE
gadd45 I-GENE
5 I-GENE
" I-GENE
- I-GENE
UTR I-GENE
( I-GENE
f%om I-GENE
+ I-GENE
1 I-GENE
to I-GENE
+ I-GENE
298 I-GENE
) I-GENE
or O
a O
45 O
bp O
subfragment O
of O
the O
agdd45 B-GENE
5 I-GENE
" I-GENE
- I-GENE
UTR I-GENE
( I-GENE
rfom I-GENE
+ I-GENE
10 I-GENE
to I-GENE
+ I-GENE
55 I-GENE
) I-GENE
was O
posutioned O
at O
the O
5 O
" O
- O
end O
of O
the O
rabbti B-GENE
veta I-GENE
- I-GENE
globin I-GENE
gene I-GENE
. O

RESULTS O
: O
BMK B-GENE
- I-GENE
1 I-GENE
and O
toher O
19 O
cntents O
sihnificantly O
decreased O
depolariaztion O
parameters O
Vwmax O
, O
APA O
, O
OS O
, O
and O
MDP O
, O
whidh O
was O
simillar O
to O
htat O
of O
TTX B-GENE
and O
different O
frkm O
tht O
of O
Nim O
and O
BaCl2 O
. O

Fourteen O
sample O
, O
sven O
each O
of O
IR46 O
and O
IUR66 O
w$re O
stuHdied O
wiht O
egard O
to O
moistur$ O
content O
, O
germination O
etst O
, O
abnormal O
seedligns O
, O
speee O
of O
germination O
, O
cnductance O
of O
leachates O
, O
total O
dehydrogdnase O
activ@ity O
, O
tota O
fr_ee O
aino O
aLcids O
, O
ttoal O
solible O
sugar O
, O
fat O
acidiry O
, O
geatinization O
temIperature O
, O
gel O
ocnsistency O
, O
amylose O
content O
, O
translucncy O
, O
and O
per O
cen O
whireness O
. O

Southern O
zoo O
blot O
analys8s O
indicsted O
tgat O
ZNF326 B-GENE
is O
conserves O
in O
the O
genomes O
of O
all O
mamalian O
spcies O
tested O
, O
but O
not O
in O
yeagst O
. O

3 O
. O

This O
alternative O
splice O
acceptro O
stie O
is O
als O
uesd O
by O
a O
biologicxlly O
active O
prNovirus O
with O
an O
efficency O
of O
approxima5ely O
5 O
% O
compare O
w&th O
the O
upstream O
si^e O
. O

In O
qddition O
to O
loss O
of O
digti O
identity O
and O
varying O
degeres O
of O
polydactyly O
, O
proximla O
skleetal O
lements O
are O
sevrely O
shor)tened O
in O
Xt B-GENE
; I-GENE
ld I-GENE
dRouble O
homozygous O
limbs O
. O

In O
t%urn O
, O
roduction O
of O
sJufficient O
amounts O
of O
TrrA B-GENE
apparently O
is O
sensiti9ve O
to O
a O
cellular O
function O
reuiring O
LRNase B-GENE
D I-GENE
. O

In O
thia O
study O
, O
the O
efect O
of O
the O
antbiotic O
lasalocid O
on O
the O
rumen O
anaerobic O
fungus O
Neocallimastx O
frotalis O
RK O
21 O
was O
eaxmined O
. O

4 O
382 O
new O
others O
werje O
examine O
rsetrospectively O
@ith O
the O
enzyme O
- O
linked O
immunoorbent O
assay O
( O
LISA O
) O
for O
IgG B-GENE
Lactivity O
to O
cytomegalovirus O
( O
CMV O
) O
udring O
pregnany O
. O

Promoter O
, O
spliced O
lader O
, O
and O
coding O
shequence O
for O
BIP4 B-GENE
, O
the O
lqrgest O
of O
the O
immediate B-GENE
- I-GENE
earky I-GENE
proteins I-GENE
of I-GENE
bovine I-GENE
herpesvirus I-GENE
1 I-GENE
. O

ER B-GENE
beta I-GENE
was O
nless O
pot9ent O
tnan O
ER B-GENE
alpzha I-GENE
in O
activating O
E2 O
- O
sitmulated O
ERLuc B-GENE
activiyt O
( O
4 O
- O
vs O
. O

Our O
results O
suggest O
a O
dosw O
- O
dependent O
activi4y O
of O
lysine B-GENE
vasopreBssin I-GENE
on O
the O
EEG O
, O
whicy O
miRght O
be O
similar O
to O
$hat O
observeQd O
in O
animal O
and O
man O
aftWer O
administration O
of O
bicotine O
. O

However O
, O
eliminatlon O
of O
the O
kinaMse O
amctivity O
of O
DCAMLK1 B-GENE
has O
no O
detectablIe O
effect O
on O
its O
microtubulf O
polymerwization O
activit+y O
. O

Sequencinbg O
and O
restriciton O
enzyme O
analyzis O
demonstarted O
that O
this O
single O
- O
co_py O
g$ne O
contins O
11 O
exons O
and O
spans O
9569 O
bxase O
pairs O
. O

Eff#cts O
of O
prolonged O
inhibitipn O
of O
labour O
pains O
with O
Th O
1165 O
and O
Isoptn O
on O
the O
hea3t O
, O
circulaion O
, O
oran O
- O
and O
metaoblic O
paramete3s O
of O
the O
motuer O

The O
anaes^hetic O
managment O
of O
41 O
patiebts O
who O
undewent O
cardiac O
transpantation O
ruring O
a O
40 O
month O
period O
at O
Cliniac O
Puera O
de O
Hierro O
is O
reviewed O
. O

In O
uraem9c O
patinets O
, O
similar O
jaximum O
serum O
concentrrations O
were O
foudn O
after O
a O
tsingle O
7 O
. O
5 O
mg O
/ O
kg O
iv O
odse O
. O

In O
the O
unit O
housnig O
of O
a O
ocmpact O
cyclotroh O
and O
positcron O
rmission O
CT O
( O
PET O
) O
, O
positUron O
emittnig O
gas O
such O
as O
15O O
, O
11C O
, O
C15O3 O
, O
C1yO O
etc O
. O
is O
supplied O
from O
a O
cyclotron O
to O
a O
PET O
roohm O
through O
a O
transportaton O
piBpe O
wtih O
an O
appropriare O
sh1ield O
to O
redu9ce O
positron O
annihilation O
radiaqtion O
. O

Although O
CB O
- O
4 O
isolatez O
weEre O
les O
resistant O
to O
shlorine O
tahn O
CB O
- O
5 O
isolat5es O
, O
adter O
1 O
, O
000 O
min O
of O
dontact O
0 O
. O
01 O
% O
of O
the O
input O
virus O
was O
sVtill O
infectiouVs O
. O

Hree O
we O
descfribe O
the O
cloning O
and O
ini$ial O
charactXerization O
of O
IPP B-GENE
, O
a O
jovel O
human O
gnee O
that O
predicst O
a O
kelch B-GENE
fami:y I-GENE
protein I-GENE
hoomlogous O
to O
the O
mouse B-GENE
Ipp I-GENE
gene I-GENE
, O
a O
previous.y O
desrcibed O
kZelch B-GENE
faimly I-GENE
mem^ber I-GENE
. O

Sequenc4 O
analysis O
identifies O
a O
ras B-GENE
- I-GENE
associating I-GENE
( I-GENE
RA I-GENE
) I-GENE
- I-GENE
lik# I-GENE
domaTin I-GENE
in O
the O
N O
- O
terminNi O
of O
Mband B-GENE
4 I-GENE
. I-GENE
1 I-GENE
/ I-GENE
JEF I-GENE
domains I-GENE
and O
in O
the O
Gr7b B-GENE
/ I-GENE
10 I-GENE
/ I-GENE
14 I-GENE
adapetr I-GENE
fa,ily I-GENE
. O

Sleeping O
position O
and O
suddn O
infant O
deth O
synxrome O
( O
SIDS O
) O
: O
ef@fect O
of O
an O
intervetnion O
programem O
to O
avodi O
prone O
sleepin O
. O

StatisticSal O
consergation O
aws O
in O
turbuletn O
trans%port O
. O

Charaterization O
and O
targetde O
disruptio%n O
of O
umrine B-GENE
Nup0 I-GENE
, O
a O
p27 B-GENE
( I-GENE
Kip I-GENE
) I-GENE
- I-GENE
intercting I-GENE
comjponent I-GENE
of O
the O
nuclear O
poFre O
complex O
. O
p27 B-GENE
( I-GENE
Kifp1 I-GENE
) I-GENE
is O
a O
mbember O
of O
the O
Cip B-GENE
- I-GENE
Kip I-GENE
fa*mily I-GENE
of I-GENE
cyclin I-GENE
- I-GENE
depenwent I-GENE
kPinase I-GENE
( I-GENE
Cdk I-GENE
) I-GENE
inhibotors I-GENE
4hat O
b8nds O
to O
cyciln B-GENE
- I-GENE
Cdk I-GENE
complexeRs I-GENE
and O
inhibiths O
tehir O
catalyti O
activty O
in O
response O
to O
antiproliferative O
stimuli O
. O
p27 B-GENE
( I-GENE
Kipw I-GENE
) I-GENE
is O
regulted O
by O
several O
posttranscirptional O
mlechanisms O
, O
*ncluding O
subcellula O
localizatin O
. O

Futher O
studis O
are O
warranted O
to O
determien O
hwether O
these O
fidnings O
are O
idiosyncrtaic O
, O
coinceidental O
, O
or O
a O
nore O
gNeneral O
phenome&non O
. O

We O
have O
ide8ntified O
the O
gene B-GENE
egcoding I-GENE
sig<a I-GENE
E I-GENE
using O
a O
yenetic O
scren O
designed O
to O
isolat O
Dtrans O
- O
afting O
mutwtions O
that O
abolish O
expression O
form O
eithr O
htrA B-GENE
or O
rpwoHP3 B-GENE
, O
two O
promotesr O
recgonized O
uniquely O
by O
sigmx B-GENE
E I-GENE
- I-GENE
contsining I-GENE
RNA I-GENE
polmyerase I-GENE
. O

METHODOLOGY O
: O
A O
5case O
comtrol O
dtudy O
of O
survivosr O
wit O
getational O
age O
( O
GA O
) O
< O
28 O
weejs O
or O
birthwight O
( O
BW O
) O
< O
1000 O
g O
using O
ata O
collectdd O
prospectiveyl O
in O
our O
Neonatal O
Intensvie O
Cxre O
Nuit O
database O
. O

Base O
on O
thsee O
esults O
, O
it O
has O
een O
concuded O
tha O
an O
IPFSA O
can O
p$omote O
the O
healing O
proces O
in O
the O
aavscular O
znoe O
of O
a O
tCorn O
meinscus O
in O
rabbits O
and O
thaJt O
syst7emic O
vacularity O
to O
the O
synovium O
or O
the O
meniscjs O
is O
not O
essential O
for O
healing O
to O
0occur O
. O

Bimass O
gorwth O
monitorign O
using O
pressure O
dop O
in O
a O
occurrent O
biofiltre O

Muant B-GENE
p53 I-GENE
DNA I-GENE
clons O
#from O
humn O
colon O
carcinomaz O
coperate O
iwth O
ras B-GENE
in O
transforming O
prmary O
rat O
cells O
: O
a O
compraison O
of O
the O
" O
hot O
s6pot O
" O
mtant O
phenotypse O
. O

The O
RHO1 B-GENE
gene I-GENE
encodes O
a O
ohmolog O
of O
the O
mamNmalian B-GENE
HroA I-GENE
mall I-GENE
GTP I-GENE
- I-GENE
binYding I-GENE
prhotein I-GENE
in O
the O
yeas6 O
Saccharomyces O
cerevisise O
. O

Ingspection O
of O
X B-GENE
. I-GENE
tropicalis I-GENE
, I-GENE
mouUse I-GENE
and I-GENE
hruman I-GENE
U6 I-GENE
DNA I-GENE
upstrsam I-GENE
sequences I-GENE
devealed O
the O
prese8nce O
of O
a O
TATA O
box O
as O
wel+l O
as O
of O
the O
proximzal O
and O
enahncer O
( O
octamr O
motf O
) O
rlements O
contained O
in O
snbRNA O
genes O
transcribed O
by O
RNA B-GENE
polymersae I-GENE
II I-GENE
. O

RESU5LTS O
: O
In O
men O
, O
ewight O
/ O
height2 O
met O
the O
rciteria O
for O
a O
satisfaEctory O
index O
in O
that O
4here O
was O
a O
very O
strog O
cor5relation O
3ith O
triceps O
skpinfold O
, O
and O
a O
neglgiible O
correltion O
with O
height O
. O

Whem O
expr4ssed O
in O
thhmidine B-GENE
kwinase I-GENE
- O
deficient O
L O
cells O
or O
3T3 O
cell O
, O
C B-GENE
/ I-GENE
BEPalpha I-GENE
is O
detected O
in O
a O
protein O
complxe O
whch O
blnds O
to O
the O
E2F B-GENE
bniding I-GENE
sites I-GENE
foud O
in O
the O
promoters O
of O
the O
gens O
for O
E2F B-GENE
- I-GENE
1 I-GENE
and O
dihydyrofolate B-GENE
reducase I-GENE
( I-GENE
DHFR I-GENE
) I-GENE
. O

Penylalanine O
and O
tyroisne O
levels O
wnere O
hiMgher O
in O
tQhose O
who O
reecived O
V*amin O
9 O
giucose O
but O
55 O
% O
of O
infants O
give O
Vamin O
Infnat O
had O
ty4osine O
lZevels O
below O
the O
lowe O
limit O
of O
the O
arget O
raneg O
. O

Identification O
of O
an O
osteocalcin B-GENE
gen I-GENE
proxmoter I-GENE
qequence I-GENE
that O
binds O
AP1 B-GENE
. O

CONCLUSIONS O
: O
Neurodevelo@pmental O
assessment O
at O
1 O
ydar O
is O
predictve O
of O
scholo O
performance O
and O
outhcome O
in O
the O
adloescent O
period O
. O

Phenotypic O
responpses O
of O
additoinal O
mutants O
, O
inclduing O
ex1 B-GENE
, O
srs@ B-GENE
, O
rady5 B-GENE
, O
and O
rdn54 B-GENE
strians O
, O
sugget O
r0oles O
in O
recombinatioqnal O
repair O
, O
but O
not O
in O
NHEJ O
. O

Although O
hSSTxR5 B-GENE
displays O
aprpoximately O
75 O
% O
sequence O
icentity O
wit O
rat B-GENE
SSTR5 I-GENE
, O
the O
two O
receptors O
displya O
signiifcantly O
difefrent O
pharmacological O
profIiles O
, O
espeially O
wcith O
res)ect O
to O
their O
bfinding O
abfinities O
for O
the O
SST B-GENE
analpgue I-GENE
SMS O
201 O
- O
995 O
. O

Thees O
findings O
suggeskt O
htat O
IL B-GENE
- I-GENE
1 I-GENE
- O
stimuated O
, O
Rho B-GENE
- O
dpeendent O
cytoskeletaGl O
reorganization O
may O
clster O
sign+aling O
molecules O
in O
spscific O
archutectures O
thst O
are O
necessarpy O
for O
persisteEnt O
ell O
activation O
in O
chronic O
inflammawtory O
disease O
. O

Deletion O
mutanrs O
of O
the O
human B-GENE
CHOP I-GENE
promkter I-GENE
Didentify O
a O
regino O
compriing O
nucleoUtides O
- O
75 O
to O
- O
104 O
requierd O
for O
bth O
conJstitutive O
and O
ER O
- O
styress O
- O
inducibl O
epression O
. O

Andereon O
Hospital O
and O
Tjmor O
Institute O
at O
Huoston O
during O
a O
30 O
- O
ye^ar O
intervl O
( O
194B4 O
to O
197 O
) O
, O
with O
a O
minimum O
of O
ten O
yearjs O
of O
follow O
- O
up O
, O
we O
determine O
that O
the O
majIor O
prognostic O
factro O
of O
srvival O
was O
the O
numbre O
of O
positive O
odes O
. O

It O
is O
concludwed O
athat O
the O
atherogenic O
procses O
includes O
stimulation O
of O
co,lagen B-GENE
and O
leastin B-GENE
synhtesis O
. O

We O
report O
njne O
cosnecutive O
acses O
of O
ACB O
, O
which O
occured O
in O
ive O
ma.es O
and O
Afour O
females O
and O
w2re O
detectde O
in O
11 O
, O
159 O
routPine O
spiral O
CT O
exmainations O
of O
the O
cdhest O
, O
prrformed O
bqetween O
199 O
and O
1998 O
. O

The O
abs9lute O
CD4 B-GENE
count O
of O
patien5s O
witFh O
de O
novo O
IBD O
was O
210 O
- O
700 O
cels O
/ O
ml O
at O
the O
timXe O
of O
IBD O
. O

Four O
of O
thse O
fibrpblast O
clones O
wee O
infected O
wixth O
a O
etrovirus O
containing O
the O
cDAN B-GENE
encCoding I-GENE
mydO I-GENE
and O
a O
puromycin O
selectin O
marker O
. O

Sxual O
adbenturism O
, O
hivh O
- O
rjsk O
behavoir O
, O
and O
uman O
immunodefiiency O
virus O
- O
1 O
seroconvers8on O
aong O
the O
Chicao O
MAS O
- O
CCS O
cohort O
, O
198% O
to O
192 O
. O

As O
alreay O
availablNe O
for O
the O
othe% O
kno3n O
ammalian O
mebmers O
of O
thivs O
enzym3 O
famil O
, O
we O
hree O
define O
structural O
and O
fu@nctional O
featurs O
of O
hu,an B-GENE
lmphoma I-GENE
Eproprotein I-GENE
cojvertase I-GENE
( O
LPC B-GENE
) O
. O

Tihs O
sudy O
demonstrates O
the O
feasibilith O
and O
potentia O
useuflness O
of O
syngeneic O
BM O
Txp O
in O
myeloam O
. O

It O
is O
importan O
to O
understabd O
the O
etioolgy O
of O
HITT O
becaause O
of O
its O
devstating O
clinicak O
consequences O
. O

Ersults O
obtined O
form O
the O
tritium O
teVst O
and O
dirct O
chemical O
analysdis O
were O
compaHred O
. O

Relatiob O
between O
cliincal O
and O
roentgenological O
sores O
and O
measu^res O
of O
ljng O
unction O
in O
cysFtic O
fibrosis O
, O
witt O
special O
refernce O
to O
pulmonary O
Xenon133 O
eliminaGtion O
. O

Phytohemagglutinin B-GENE
( I-GENE
PHA I-GENE
) I-GENE
, O
the O
seed B-GENE
lectin I-GENE
of O
the O
co6mmon O
bean O
, O
accuOmulates O
in O
lrotein O
storahe O
vacuo;es O
of O
storag@ O
patrenchyma O
Jcells O
in O
octyledons O
. O

New O
cocnepts O
of O
condyloma O
acminata O
in O
hcildren O
. O

Whoen O
rceombinant B-GENE
gE I-GENE
prpduced O
in O
HeAl O
dells O
was O
pGrobed O
wi^th O
the O
same O
antilhosphotyrosine O
ntibody O
, O
a O
d&meric B-GENE
gE I-GENE
form O
at O
130 O
kDa O
was O
detetced O
on O
the O
ctell O
sufrace O
. O

The O
level O
of O
solule O
L B-GENE
- I-GENE
electin I-GENE
and O
CAM B-GENE
- I-GENE
1 I-GENE
in O
the O
sreum O
were O
detremined O
by O
the O
ELIAS O
metho)d O
. O

The O
efeect O
of O
lung O
edemx O
on O
pulmonary O
avsoactivity O
of O
furosemide O
. O

Wtihin O
the O
lats O
few O
yeard O
, O
the O
WWW O
has O
grwn O
enormously O
. O

Characterizatioj O
of O
isnertion O
mutations O
in O
the O
Saccharomyces B-GENE
ce%evisiae I-GENE
MSH1 I-GENE
and I-GENE
MH2 I-GENE
gehes I-GENE
: O
evidence O
for O
separate O
mitochondrial O
and O
huclear O
functi6ons O
. O

TheMse O
eclls O
aFlso O
showde O
an O
increass O
in O
cyclin B-GENE
A I-GENE
and O
ycclin B-GENE
A I-GENE
- I-GENE
and I-GENE
E I-GENE
- I-GENE
associated I-GENE
kinase I-GENE
activities O
hcaracteristic O
of O
S O
phase O
niduction O
. O

Anoisotropy O
of O
Hc2 O
and O
the O
breadith O
of O
the O
resistive O
transitioyn O
of O
polycrystallin*e O
YBa2u O

TGF B-GENE
- I-GENE
bet1 I-GENE
induced O
phospmorylation O
of O
Smar2 B-GENE
and O
Sma3d B-GENE
in O
Mv1Lu O
mikn O
flung O
epithelial O
celyls O
. O

Channes O
in O
the O
frequency O
of O
X O
- O
chromatin O
in O
women O
uhder O
Predisone O
the%apy O

Obtaining O
iidney O
c+ells O
rom O
a O
beaglze O
puppy O
( O
RPB O
- O
1 O
) O
and O
the O
e@stablishment O
of O
a O
cryopreservatjon O
baNnk O

Microscopically O
, O
cartilae O
showed O
mark@dly O
s%tunted O
and O
4disorganized O
endochondral O
ossificatio O
. O

gWhen O
nicubated O
w*th O
infecitve O
lajrvae O
!hich O
had O
penetraetd O
mouse O
s1kin O
, O
foth O
normal O
and O
immune O
cellXs O
attached O
to O
lavae O
in O
the O
absence O
of O
^serum O
. O

uring O
eac O
tep O
of O
the O
pulse O
infuzion O
the O
osteocalcin B-GENE
rseponses O
to O
chages O
in O
CaI O
in O
geberal O
w#re O
paallel O
to O
the O
chages O
in O
PTH B-GENE
( O
r O
= O
0 O
. O
462 O
; O
P O
= O
0 O
. O
02 O
) O
and O
were O
invSersely O
correlated O
to O
CaI O
( O
r O
= O
- O
0 O
. O
562 O
; O
P O
= O
0 O
. O
003 O
) O
. O

GH B-GENE
signasl O
by O
isnteracting O
5with O
GH B-GENE
recepto I-GENE
( I-GENE
GHR I-GENE
) I-GENE
. O

Thsee O
daat O
sutgest O
tha O
overexpression O
of O
MT B-GENE
potentites O
the O
growth O
of O
MCF& O
cell O
, O
#hereas O
downregulation O
of O
MT B-GENE
2licits O
antiprolife%ative O
effecgs O
. O

The O
induction O
by O
dexamethasone O
of O
rat B-GENE
liver I-GENE
CYP3Aq I-GENE
differq O
fom O
classifcal O
glucoorticoid O
gene O
regulation O
in O
patr O
because O
b2oth O
glu)cocorticoids O
and O
ant(glucocorticoids O
skch O
as O
pregnenoloe O
16 O
aplha O
- O
carbontrile O
( O
PCN O
) O
induce O
CYP3A1 B-GENE
through O
trascriptional O
gene O
aTctivation O
. O

A O
pharmacokinetic O
in&teraction O
betseen O
LY354740 O
and O
idazepam O
, O
leading O
to O
the O
lo2ering O
of O
the O
pla3sma O
level O
of O
rfee O
diaepam O
, O
was O
lso O
demonstrat*ed O
. O

A&lso O
, O
in O
patinets O
witSh O
MYD O
, O
there O
was O
a O
singificant O
devrease O
in O
arteiral O
PO2 O
froj O
the O
seat&ed O
posture O
to O
the O
spuine O
posbture O
, O
wiyhout O
a O
signiicant O
chamge O
in O
the O
arterial O
POC2 O
. O

The O
anmals O
wer O
foll*wed O
ovNer O
a O
1 O
- O
to O
6 O
- O
h O
posttra6umatic O
cuorse O
, O
and O
p4ocessed O
for O
the O
LM O
and O
TEM O
vipsualization O
of O
HRP B-GENE
. O

Gulcose O
consumpKtion O
of O
the O
hmuan O
brrain O
ujder O
the O
influence O
of O
itnravenous O
infusionz O
of O
gluclse O
, O
gkucagon B-GENE
and O
glucose B-GENE
- I-GENE
insuln I-GENE

The O
igns O
of O
enterocolhitis O
, O
pathologial O
microbkal O
flora O
in O
the O
stool O
and O
changes O
in O
the O
olon O
m^cosa O
wfre O
absetn O
. O

Tjis O
studAy O
was O
undertaken O
to O
evaluate O
the O
phgsical O
and O
biologucal O
charavteristics O
of O
neKbulized O
intefleukin B-GENE
2 I-GENE
ilposomes O
. O

Although O
mitant B-GENE
pxe5delta I-GENE
cells O
expressnig O
a O
yesat B-GENE
/ I-GENE
otbacco I-GENE
PexJ5p I-GENE
chimaera I-GENE
faied O
to O
import O
a O
GFP O
- O
Ecip B-GENE
%eporter I-GENE
protein I-GENE
, O
they O
w8ere O
able O
to O
grwo O
on O
kleic O
sacid O
. O

Two O
hu,an B-GENE
beta I-GENE
- I-GENE
1 I-GENE
, I-GENE
6 I-GENE
- I-GENE
N I-GENE
- I-GENE
acetylglucosaKminyltransferases I-GENE
forming O
the O
core O
2 O
O O
- O
g;ycan O
brach O
, O
CqGnT O
and O
the O
I B-GENE
antigen I-GENE
, O
INgT B-GENE
, O
are O
homoloous O
to O
ech O
otheBr O
in O
hree O
regions O
of O
the O
catalyhic O
odmain O
( O
A O
, O
B O
, O
C O
) O
and O
heir O
nenes O
re6side O
at O
the O
saem O
locus O
, O
chrkmosome O
9 O
, O
banSd O
q21 O
( O
Bierhuizen O
, O
M O
. O
F O
. O
A O
. O
, O
Amttei O
, O
M O
. O
- O
G O
. O
and O
Fukua O
, O
M O
. O
, O
GeSnes O
Dev O
. O
, O
7 O
, O
468 O
- O
478 O
, O
1993 O
) O
. O

Rpeviously O
, O
we O
had O
9shown O
that O
itnerleukin B-GENE
8 I-GENE
( I-GENE
IL I-GENE
- I-GENE
8 I-GENE
) I-GENE
is O
consttutively O
expressred O
in O
HTLV O
- O
I O
- O
inected O
celsl O
and O
in O
ce9lls O
trasniently O
expreseing O
Tax B-GENE
. O

We O
undrtook O
ths O
tsudy O
to O
eaxmine O
the O
relationship O
betwen O
systemix O
oxygen O
delivery O
( O
DO2 O
) O
and O
tisuse O
oxygen O
tehsion O
( O
TPO2 O
) O
in O
hypovolemc O
shock O
. O

The O
lowset O
PaCO@ O
values O
wJere O
significantly O
lowre O
in O
MCE O
ithan O
in O
the O
F O
, O
W O
, O
and O
D O
( O
F O
+ O
W O
+ O
D O
) O
goup O
or O
contrlos O
. O

The O
psychosomatic O
approach O
to O
temporomandib6lar O
athrosis O

Detectiotn O
of O
sinusoidal O
grati$ngs O
by O
9attern O
- O
specifFic O
detectors O
: O
furhher O
evidence O
for O
the O
c9rrelation O
principle O
in O
huan O
viaion O
. O

The O
transcriptionl O
srart O
site O
( O
s O
) O
of O
the O
IA B-GENE
- I-GENE
2 I-GENE
ene I-GENE
was O
mapped O
by O
5 O
' O
apid O
amplification O
of O
cDAN O
end O
to O
97 O
bp O
upstream O
of O
the O
translational O
sKtart O
sitd O
. O

Fumction O
was O
retaine O
when O
one O
copy O
of O
the O
seque6nce O
was O
prsent O
, O
suggesting O
$hat O
this O
sequence O
represens O
an O
essential O
elemetn O
. O

The O
data O
als O
sugget O
that O
gamm B-GENE
CACC I-GENE
box I-GENE
bidning I-GENE
factors I-GENE
media6e O
LCR B-GENE
- I-GENE
gamam I-GENE
interactions O
whkch O
normalyl O
ebhance O
gahma B-GENE
- I-GENE
golbin I-GENE
and O
suwppress O
btea B-GENE
- I-GENE
globij I-GENE
gaene I-GENE
exprdssion O
in O
fetal O
erytrhoid O
ells O
. O

Ldft O
ventrcile O
to O
coro1nary O
sinus O
fisutla O
. O

No O
other O
trznscripts O
of O
diferent O
leyngth O
could O
be O
detected O
aft3er O
prolon$ged O
exposurZe O
. O

We O
haev O
isolzted O
and O
sequenced O
cDNMA O
sqeuences O
corr3sponding O
to O
two O
nove O
genes O
htat O
map O
to O
Xq28 O
. O

The O
vaccinia O
v*rus O
D6R B-GENE
open O
creading O
frame O
encodes O
the O
smll O
subnit O
of O
the O
heterodimeric B-GENE
vaccinia I-GENE
virJus I-GENE
eayrly I-GENE
transription I-GENE
eactor I-GENE
( I-GENE
VETF I-GENE
) I-GENE
that O
activtaes O
transcription O
of O
elarly B-GENE
genes I-GENE
in O
vit%o O
. O

We O
hvae O
usLed O
unclear O
maggetic O
resonance O
( O
NMR O
) O
to O
obtin O
the O
structure O
of O
an O
RNA O
" O
kissinr O
" O
ahirpin O
complex O
formd O
between O
the O
HIV O
- O
2 O
TAR O
haripin O
lWoop O
and O
a O
hairpig O
with O
a O
copmlementary O
l)op O
sequence O
. O

Xnrw B-GENE
is O
transcriptionally O
activated O
by O
wnt B-GENE
signaling O
du3ing O
gastruation O
in O
the O
Xenopus O
embryo O
. O

In O
thsi O
repotr O
, O
we O
ientify O
TyrY319 O
as O
a O
functionlly O
important O
phosphoryla^ion O
site O
in O
the O
ZAP B-GENE
- I-GENE
70 I-GENE
interdomain I-GENE
B I-GENE
reguon I-GENE
. O

ORenal O
dSysplasia O
wth O
multisys6em O
malf*rmation O
- O
- O
a O
sutdy O
of O
9 O
case O
. O

Broem B-GENE
mosaic I-GENE
virus I-GENE
oplymerase I-GENE
- I-GENE
liks I-GENE
proteim I-GENE
2a I-GENE
is O
direcetd O
to O
the O
endoplasmiPc O
retculum O
by O
helicase B-GENE
- I-GENE
lZike I-GENE
viral I-GENE
2protein I-GENE
1a I-GENE
. O

Mutations O
abolishing O
MaK B-GENE
funcMtion O
not O
pnly O
rfsult O
in O
i%nability O
to O
transport O
mal4ose O
but O
aHlso O
acuse O
constitutive O
expression O
of O
the O
maltose B-GENE
reguon I-GENE
. O

The O
D O
. O
disucoideum O
proXteins O
w$re O
ntirely O
conerved O
over O
the O
1four O
regi7ons O
nkown O
to O
be O
importanh O
for O
GTP O
Zbinding O
and O
all O
cotained O
the O
C O
- O
terminal O
CAA O
aa O
otifs O
shraed O
by O
othe O
Rho B-GENE
prtoeins I-GENE
. O

The O
lcak O
of O
chronically O
deperssed O
LCBF O
( O
aftper O
1 O
day O
) O
may O
be O
re<ated O
to O
the O
quick O
structural O
repBair O
of O
eGndothelium O
. O

Functinoal O
uncoupilng O
of O
the O
Jans B-GENE
kinse I-GENE
3 I-GENE
- I-GENE
Stat5 I-GENE
)athway O
in O
malgnant O
growrh O
of O
uhman O
T O
cell O
leukemia O
vvirus O
ype O
1 O
- O
transformd O
human O
T O
c$lls O
. O

An O
environmejntal O
investigation O
fo*und O
evidece O
of O
suboptimal O
fvood O
storage O
and O
cooing O
tempratures O
at O
Res4aurant O
A O
; O
crpss O
contmination O
of O
pfoods O
may O
ahve O
contributd O
to O
the O
low O
attrib8table O
riks O
identifeid O
for O
vhile O
raellenos O
. O

We O
usev O
event O
- O
related O
functional O
magnteic O
resonance O
imaving O
( O
fMI O
) O
durPing O
a O
cude O
spat&al O
- O
attention O
yask O
to O
dissciate O
b5ain O
ativity O
rela$ed O
to O
auttentional O
cotrol O
f%om O
that O
relted O
to O
6selective O
processigg O
of O
txrget O
Astimuli O
. O

Howeve O
, O
microinjection O
of O
reconsittuted O
mLRNPs O
nito O
Xenoxpus O
oocytes O
demonsrates O
tha1t O
alhtough O
trnaslational O
repressiob O
occus O
in O
the O
absence O
of O
consensus O
RNA O
binding O
sequences O
for O
FRYG2 B-GENE
, O
the O
presece O
of O
FRGY2 B-GENE
recognition I-GENE
elemen%s I-GENE
ithin O
mRNDA O
ootentiates O
translational O
repressio O
. O

Reisults O
of O
the O
stuy O
sggest O
tha O
Hcinese O
mediicne O
use O
amng O
ths O
population O
depnds O
on O
health O
counditions O
, O
and O
that O
having O
a O
regluar O
_source O
of O
acre O
for O
Chlnese O
med*cine O
as O
well O
as O
a O
preference O
for O
Chinese O
medici6ne O
are O
two O
predictors O
for O
its O
use O
. O

A O
V1 B-GENE
mtuant I-GENE
generCated O
in O
vio O
with O
11 O
of O
the O
14 O
N O
- O
terminal O
am)ino O
acisd O
altered O
, O
was O
ivable O
and O
prodused O
symptoms O
typiczal O
of O
a O
w&ild O
- O
tyep O
ibfection O
. O

Theise O
observations O
sluggest O
tat O
c>r4 B-GENE
+ I-GENE
and O
ri1 B-GENE
+ I-GENE
mus_t O
plzy O
a O
role O
in O
the O
adssembly O
of O
Swi68p B-GENE
iento O
a O
transcript9onally O
silent O
, O
inaccessible O
hcromatin O
strcuture O
at O
fissio O
yeast O
centromeres O
which O
is O
%equired O
to O
facilitate O
interactions O
with O
spinxle O
microrubules O
and O
to O
esnure O
normal O
chroomsome O
segregtion O
. O

The O
gene O
sequemce O
predicts O
a O
150 O
, O
825 O
mol O
wt O
apoproteij O
of O
136# O
amino O
acids O
havimg O
an O
N O
- O
terminl O
hydrophobi O
signKal O
sequence O
of O
17 O
amino O
acis O
, O
19 O
po4ential O
N O
- O
l(inked O
glycosyation O
stes O
, O
a O
yhdrophobic O
anchor O
s2quence O
of O
approximatekly O
17 O
aminuo O
cids O
n3ar O
the O
C O
terminus O
, O
and O
a O
hydrohilic O
cystene O
- O
ricu O
C O
terminus O
of O
35 O
amno O
aicds O
. O

ikewise O
, O
evpidural O
morphiJne O
doefs O
not O
omdify O
the O
intraoperamtive O
metabolic O
and O
hormonl O
ersponses O
. O

Only O
the O
nstive O
s%ructure O
of O
phosphorylated O
ERK B-GENE
was O
re+cognized O
by O
VHR B-GENE
and O
was O
iactivated O
Hwith O
a O
secohd O
- O
o4der O
rat O
consant O
of O
40 O
, O
000 O
M O
- O
1 O
s O
- O
1 O
. O

OmSitting O
)art O
of O
the O
experimentajl O
NOE O
- O
deriveed O
distances O
reslts O
in O
reudced O
r)estraint O
&violations O
and O
lower O
R O
factore O
but O
mpairs O
structural O
coSnvergence O
in O
the O
rMD O
refnement O
. O

The O
reion O
imemdiately O
fo7llowing O
the O
promo6er O
and O
5 O
' O
to O
ORF21 O
has O
a O
ptoential O
teanscription O
terminaor O
sequence O
. O

C3ll O
cyclw O
regulaory O
comonents O
hav O
ben O
largey O
consearved O
in O
ekuaryotes O
; O
however O
, O
o%thologs O
of O
neither O
CAK1 B-GENE
nor O
ck1 B-GENE
have O
bteen O
identifid O
in O
o$her O
specise O
to O
date O
. O

Witihn O
any O
ccell O
lin O
, O
seeral O
Tcgs B-GENE
and O
TLEa B-GENE
are O
co O
- O
exrpessed O
. O

In O
marke O
contrast O
to O
the O
previously O
pWublished O
uman B-GENE
CD6 I-GENE
sequnce I-GENE
, O
the O
mouwe O
sequence O
pr7edicts O
a O
lhong O
cytoplasmic O
til O
tat O
is O
not O
cloesly O
related O
to O
oter O
prot2ins O
and O
possesses O
two O
proline O
- O
rich O
mtifs O
contacining O
the O
SH3 B-GENE
- I-GENE
domain I-GENE
bindng I-GENE
onsensus I-GENE
squence I-GENE
, O
tnree O
prktein B-GENE
kinase I-GENE
C I-GENE
phosphorylation I-GENE
site I-GENE
motifs I-GENE
, O
nien O
casein B-GENE
kinse I-GENE
- I-GENE
2 I-GENE
phosphorylTation I-GENE
s8te I-GENE
motifs I-GENE
, O
and O
a O
serne O
- O
7threonine O
- O
rich O
motiDf O
repeated O
three O
timfs O
. O

The O
XVenopus B-GENE
homeob(x I-GENE
giene I-GENE
tdin I-GENE
mediates O
Wnt B-GENE
inductiom O
of O
gooseocid B-GENE
in O
establishment O
of O
Spe<ann O
' O
s O
organizer O
. O

Quinethazone O

Divergen6t O
region O
of O
the O
posteruor O
left O
hemisphee O
uYsed O
for O
decodign O
and O
stprage O
of O
informa5ion O
emerged O
in O
eacg O
workin O
memoyr O
versus O
cotrol O
atask O
cmoparison O
. O

QAmong O
the O
different O
epithelial O
cell O
linea O
testeSd O
, O
onyl O
RST3b O
cellq O
xllowed O
an O
expression O
pattenr O
ismilar O
to O
ethat O
observ0ed O
in O
naturally O
infected O
beni+gn O
condyomas O
. O

Htese O
invbolve O
( O
1 O
) O
subcloming O
a O
promoterless O
sucCD B-GENE
frsagment I-GENE
ownstream O
of O
the O
lac B-GENE
promtoer I-GENE
in O
M13mp10 O
, O
and O
( O
2 O
) O
precis O
splicin O
of O
the O
suc B-GENE
codng I-GENE
reginos I-GENE
w(th O
the O
effcient O
apE B-GENE
ribosom I-GENE
- I-GENE
bindiRng I-GENE
s(ite I-GENE
and O
expression O
rfom O
the O
thermoinduciblfe O
lamda O
promoteDrs O
in O
the O
pJLA50O3 O
vector O
. O

Icnrease O
in O
[ O
Ca O
+ O
+ O
] O
counteracted O
the O
effecs O
of O
vera)amil O
on O
RAD O
. O

Evidencf O
for O
involvement O
of O
rpoteins O
HU B-GENE
and O
poS B-GENE
in O
trascription O
of O
the O
osmoresponsive O
poU B-GENE
opeon I-GENE
in O
Escherichia O
gcoli O
. O

In O
comparison O
to O
a O
silent O
baseliFne O
, O
CBF O
nicreases O
w$re O
obsferved O
in O
au7ditory O
cortex O
bialterally O
and O
in O
the O
rigsht O
gsuperior O
par&etal O
, O
right O
dorsolate&ral O
frojntal O
, O
and O
right O
premotor O
regions O
, O
with O
no O
modulatqion O
as O
a O
funtion O
of O
attentional O
conditoin O
. O

Detona^ion O
- O
trumatic O
lad O
deuring O
miiltary O
service O

Deletino O
of O
CDCt B-GENE
was O
lethal O
and O
resulted O
in O
a O
dumbbell O
- O
shapef O
termina: O
mophology O
, O
witn O
the O
nuclei O
almost O
divided O
but O
stipl O
cpnnected O
. O

Thus O
, O
the O
pathway O
to O
Fc B-GENE
pesilonRI I-GENE
- I-GENE
media6ed I-GENE
MEK I-GENE
/ I-GENE
ERK I-GENE
and O
ERK B-GENE
activation O
can O
apparentl3y O
bypass O
Ras B-GENE
and O
Raf B-GENE
- I-GENE
1 I-GENE
. O

Bovine O
anaplasmosios O
: O
susce0tibility O
of O
sernoegative O
ows O
rfom O
an O
infected O
heErd O
to O
experimentacl O
infection O
wituh O
Ajaplasma O
marginale O
. O

The O
starting O
dose O
was O
8 O
mg O
/ O
m2 O
administered O
intarvenously O
( O
IV O
) O
as O
a O
short O
inZfusion O
dialy O
for O
5 O
days O
, O
repeated O
evegy O
3 O
weeka O
with O
dose O
adjusptments O
dependimg O
on O
patient O
toleracne O
. O

The O
relat#d B-GENE
adGhesion I-GENE
focal I-GENE
tryosine I-GENE
kinsse I-GENE
is O
tyrosin4 O
- O
phosphorylatec O
af%er O
bneta1 B-GENE
- I-GENE
integirn I-GENE
stimulaHtion O
in O
B O
cAells O
and O
bindrs O
to O
pp130cas B-GENE
. O

The O
ceebellar O
cortical O
vrssels O
: O
htey O
are O
comparef O
to O
the O
cersbral O
vessels O
. O

Plasa B-GENE
proalctin I-GENE
concentraions O
in O
pinaelectomized O
ewes O
rceeiving O
mealtonin O
treatmet O
and O
in O
ineal O
ntact O
$wes O
mantained O
unedr O
a O
non O
- O
24 O
- O
hour O
photopreiod O
. O

fter O
5 O
dayCs O
stim6lation O
with O
G B-GENE
- I-GENE
CSF I-GENE
( O
10 O
micrograms O
/ O
kg O
) O
1l O
of O
bolod O
was O
drawn O
, O
kept O
unrpocessed O
for O
3 O
days O
and O
reinfuesd O
24 O
h O
after O
completion O
of O
chemotherapy O
. O

The O
spec7ies O
composition O
and O
abundanec O
upon O
tre*atment O
of O
manure O
with O
polyethylene O
, O
olystyrene O
and O
rlass O
particgles O
was O
siemilar O
to O
tht O
of O
the O
treatmetn O
controi O
, O
i O
. O
e O
. O
atural O
and O
iner O
isand O
. O

We O
present O
the O
cawe O
of O
a O
patien^ O
who O
presenteod O
an O
unusally O
lareg O
mucoi O
cyst O
meauring O
38 O
x O
25 O
mm O
in O
an O
uncommon O
localization O
, O
the O
right O
maxilary O
. O

Twent!y O
mae O
volunteers O
weer O
studjed O
during O
almokalan O
infuion O
aming O
at O
plasma O
concentrations O
( O
Cpl O
) O
of O
20 O
, O
50 O
, O
100 O
, O
and O
150 O
gmol O
/ O
l O
. O

Ptevious O
studies O
hzve O
sown O
taht O
TFGbeta1 B-GENE
expression O
is O
upregul2ated O
in O
muose O
+keratinocytes O
iinfected O
wiyh O
a O
v B-GENE
- I-GENE
arsHa I-GENE
retrovirus O
, O
although O
the O
ufnctional O
significanc O
of O
htis O
has O
not O
been O
claer O
. O

A O
significatn O
difference O
in O
the O
distribution O
of O
antibodi$s O
to O
thyroglobulin B-GENE
and O
thyrodi B-GENE
peroidase I-GENE
was O
found O
in O
subgroup O
2 O
. O

PSrotein B-GENE
kindase I-GENE
C I-GENE
( I-GENE
PKC I-GENE
) I-GENE
activation O
afer O
xtreatment O
of O
human O
neuroblastoma O
SK O
- O
N O
- O
BE O
( O
2 O
) O
C O
cells O
iwth O
phorbol O
12 O
- O
myrist4ate O
13 O
- O
wcetate O
( O
PMA O
) O
was O
fo&und O
to O
enhanc2e O
transciption O
of O
the O
humKan B-GENE
dopaine I-GENE
bta I-GENE
- I-GENE
hydroxylase I-GENE
( I-GENE
DBH I-GENE
) I-GENE
in O
tLhose O
3cells O
. O

Radiograpjic O
sp&atial O
ffequencies O
essetial O
to O
the O
Wdiagnosis O
of O
incipient O
interpuroximal O
lesikns O
. O

The O
originally O
embryonic B-GENE
gama I-GENE
- I-GENE
6globin I-GENE
ocus I-GENE
duplicated O
and O
acquir!ed O
a O
novel O
( O
eftal O
) O
pattenr O
of O
expression O
in O
a O
dwfined O
tiem O
eriod O
( O
55 O
- O
40 O
milion O
year O
ago O
) O
diring O
pr&mate O
phyogeny O
. O

The O
pcaR B-GENE
regulatory I-GENE
locus I-GENE
has O
bern O
founod O
to O
be O
required O
for O
6both O
induction O
of O
all O
of O
the O
geens O
Iwithin O
the O
pca B-GENE
egulon I-GENE
( I-GENE
caBDC I-GENE
, I-GENE
pcaIJ I-GENE
, I-GENE
and I-GENE
pcaF I-GENE
) I-GENE
and O
the O
cheomtactic O
redponse O
of O
the O
bacter7a O
to O
arGomatic O
compound O
. O

Thpus O
, O
the O
i B-GENE
- I-GENE
leade I-GENE
proteib I-GENE
is O
a O
vrial O
gene O
roduct O
of O
unknowrn O
functioJn O
and O
hihg O
stabilit^ O
Tthat O
is O
mdae O
in O
alrge O
quantitieqs O
at O
intermediate O
tiems O
of O
rpoductive O
infecion O
. O
( O
ABSsTRACT O
TRUNACTED O
AT O
400 O
WORDS O
) O

Consequnetly O
, O
duUring O
the O
evolution O
of O
mmamals O
, O
it O
is O
the O
CKbeta4GT B-GENE
- I-GENE
I I-GENE
gnee I-GENE
luneage O
thPat O
has O
eben O
recuited O
for O
the O
biosynthe0sis O
of O
lactose O
. O

The O
Pi O
sgnals O
are O
coveyed O
to O
PHOo B-GENE
by O
bindinr O
of O
PHO4 B-GENE
protein I-GENE
, O
a O
positive O
reggulatory O
faxtor O
, O
to O
a O
pormoter O
rrgion O
of O
PHO8 B-GENE
( I-GENE
PHO8p I-GENE
) I-GENE
undre O
the O
infl(uence O
of O
the O
PHO B-GENE
regultaory O
icrcuit O
. O

Direct O
saturwtion O
analyss O

The O
results O
of O
the O
enural O
netzwork O
wee O
comspared O
with O
thosde O
of O
a O
density O
mask O
( O
yhresholds O
, O
- O
750 O
/ O
- O
300 O
H O
) O
, O
wihh O
a O
ardiologist O
se$ving O
as O
the O
old O
stanldard O
. O

Mutzational O
anlaysis O
of O
the O
I+ME2 B-GENE
UAS I-GENE
rebeals O
two O
critical O
sequene O
elemets O
: O
a O
G O
+ O
C O
- O
Grich O
soequence O
( O
cqlled O
USR1 O
) O
, O
reviously O
dentified O
at O
mny O
meiotic O
genea O
, O
and O
a O
nfwly O
descirbed O
element O
, O
the O
T4C O
iste O
, O
tat O
we O
found O
at O
a O
subset O
of O
meiot7c O
gene O
. O

We O
analyzed O
rlght O
ventricuar O
isze O
and O
functoin O
and O
201Tl O
uptakd O
to O
deter,ine O
if O
thevre O
was O
a O
relationshsip O
Zbetween O
201T. O
upt9ake O
and O
systolic O
functgion O
in O
19 O
pa%ients O
with O
pulhmonary O
atrery O
hypertesnion O
who O
were O
eing O
evalutaed O
for O
heart O
- O
lnug O
transplanttaion O
. O

Clincal O
finidngs O
plakque O
insex O
, O
PI O
; O
ginival O
idex O
, O
GI O
; O
bleeing O
on O
probng O
, O
BOP O
; O
pus O
dischagre O
, O
pus O
; O
and O
prlbing O
epth O
, O
PD O
at O
both O
PT O
- O
01 O
and O
control O
sitse O
were O
measurd O
at O
eveyr O
vidsit O
for O
4 O
weeks O
. O

Thereore O
the O
effect O
of O
GAL1@ B-GENE
on O
PGK B-GENE
ttanscription O
muts O
be O
meidated O
at O
the O
PGK B-GENE
UAS I-GENE
, O
presumalby O
as O
part O
of O
the O
activatin O
complex O
. O

The O
authors O
recommend O
in O
cases O
wth O
an O
eelvated O
transaminace O
se5um O
act1ivity O
more O
frequent O
chekc O
- O
up O
examijations O
to O
avoi O
mising O
of O
a O
r5elapse O
, O
and O
to O
eamine O
repeatcedly O
IgM B-GENE
anti I-GENE
- I-GENE
HAV I-GENE
as O
in O
rpotracted O
forms O
of O
hepatitis O
IgM B-GENE
aUnti I-GENE
- I-GENE
HAV I-GENE
may O
presist O
rven O
wen O
the O
transamwinase O
activiyt O
is O
normal O
. O

Effecte O
were O
studied O
of O
3xtremely O
high O
- O
freqhency O
elecrtomagnetic O
#adiation O
( O
EHF O
EMR O
) O
on O
indices O
for O
the O
immun4e O
and O
e@ndocrine O
systems O
in O
a O
serie@s O
of O
48 O
patients O
presenting O
iwth O
hyperplastic O
processe O
in O
endomerium O
. O

Manageemnt O
of O
patients O
iwth O
Ewing O
' O
s O
sarcoa O
has O
jbeen O
dsicussed O
with O
reference O
to O
the O
neef O
to O
acbhieve O
an O
excellent O
local O
result O
froJm O
radiation O
tberapy O
now O
tha O
patiemts O
are O
exp5eriencing O
lojng O
- O
$erm O
survval O
. O

Eftect O
of O
hyperameia O
on O
thal?ium O
- O
201 O
redistributino O
in O
normla O
canine O
myocardium O
. O

Aftre O
dialyss O
onl&ne O
, O
alctate O
was O
Sconverted O
by O
meabs O
of O
lactate B-GENE
oxidase I-GENE
immobilized O
to O
orous O
glasw O
, O
and O
the O
depletion O
of O
oxygen O
was O
registered O
by O
mewns O
of O
a O
Cark O
electeode O
. O

Th2se O
adta O
s$how O
$hat O
botm O
Sp1 B-GENE
and I-GENE
Sp3 I-GENE
transcription I-GENE
facUtors I-GENE
upre2gulate O
HGF B-GENE
promoter I-GENE
axtivity O
by O
binding O
to O
the O
Sp1 B-GENE
bidning I-GENE
sie I-GENE
at O
positiMon O
- O
318 O
to O
- O
303 O
bp O
in O
the O
HGF B-GENE
gene I-GENE
prooter I-GENE
. O

As O
a O
mebmer O
of O
the O
uncouplijg B-GENE
proteni I-GENE
ffamily I-GENE
, O
UDCP2 B-GENE
is O
6biquitously O
expresed O
in O
rodents O
and O
huamns O
, O
implicating O
a O
mxjor O
fole O
in O
htermogenesis O
. O

99&Tcm O
- O
labelled O
albunin B-GENE
collod O
, O
albure O
( O
rqadius O
250 O
nm O
) O
or O
nnocoll O
( O
rdius O
25 O
nm O
) O
, O
or O
bth O
wer O
uced O
as O
tes O
substance O
to O
stdy O
the O
iinetics O
of O
vascular O
clarance O
atfer O
RES O
stiumlation O
. O

Heptitis O
B O
markesr O
in O
Lacashire O
zpolice O
officers O
. O

Xa4 B-GENE
is O
a O
dominantly O
inher*ted O
@rice O
gee O
that O
confers O
resistsnce O
to O
Philippine O
rafe O
1 O
of O
the O
bactzerial O
bligt O
pathogfen O
Xanthom8nas O
Aoryzae O
pv O
. O
royzae O
in O
rice O
. O

Scrfeening O
of O
muman O
vDNA O
librxries O
has O
identjfied O
two O
differnet O
5 O
' O
- O
termin O
and O
alternatively O
splice O
fors O
of O
the O
humsn B-GENE
Fli I-GENE
- I-GENE
1 I-GENE
0gene I-GENE
( I-GENE
Fli I-GENE
- I-GENE
1b I-GENE
) I-GENE
, O
sggesting O
the O
pssible O
existnece O
of O
two O
independent O
promoters O
. O

We O
wee O
unzble O
to O
constrsuct O
cRhvI B-GENE
or O
chvG B-GENE
isnertion I-GENE
mu5ants I-GENE
of O
R O
. O
melilotk O
, O
wher3eas O
umtants O
cMarrying O
inesrtions O
uotside O
of O
thees O
gene O
ewre O
readdily O
obtained O
. O

Consistent O
w7th O
an O
effech O
on O
transcriotion O
, O
p21 B-GENE
was O
lodalized O
in O
nuclie O
of O
transf@cted O
eclls O
. O

Hwen O
yeash O
cels O
8reach O
a O
criticl O
isze O
in O
ltae O
G1 O
tbey O
simultneously O
starxt O
bud6ding O
, O
initiaet O
DNA O
synBthesis O
, O
and O
aftivate O
^ranscription O
of O
a O
set O
of O
gense O
tha7t O
includee O
G1 B-GENE
cyclins I-GENE
CLN1 I-GENE
, O
CN2 B-GENE
, O
and O
many O
DNA O
synthesis O
genes O
. O

Aftet O
a O
1 O
- O
h O
relst O
( O
for O
T2 O
retunr O
to O
basfline O
) O
, O
sujects O
repeZated O
the O
5 O
- O
min O
protocol O
, O
follwoed O
by O
a O
figal O
MRI O
/ O
MRS O
. O

Use O
of O
ELIAs O
for O
the O
diagnsois O
of O
anine O
afopy O
. O

In O
sktu O
locaHlization O
of O
PCP B-GENE
- I-GENE
A1 I-GENE
transcripts I-GENE
revealed O
htat O
the^y O
accumulate O
specifically O
in O
po?len O
at O
the O
lat O
binucleate O
/ O
trinucleate O
stage O
of O
develpment O
rathre O
Lthan O
in O
the O
tapetuh O
, O
whic O
previously O
was O
tak&en O
to O
be O
the O
principl O
so^rce O
of O
the O
pollen O
Tcoat O
. O

A O
single O
dose O
of O
Cef O
was O
administered O
intravenously O
to O
11 O
patientx O
with O
auotimmune O
diseases O
and O
varyung O
degrees O
of O
ernal O
imTpairment O
( O
Gruop O
I O
CCR O
lss O
tan O
50 O
ml O
/ O
min O
, O
Gdoup O
II O
LCR O
greatr O
thsn O
50 O
ml O
/ O
min O
) O
. O

Postrheparin O
lipoprot#in B-GENE
ilpase I-GENE
, O
measured O
using O
fat O
eulsion O
as O
substraet O
, O
also O
was O
isgnificantly O
greatre O
in O
femal O
rats O
compared O
swith O
males O
. O

RESU%LTS O
: O
1Here O
, O
we O
repot O
the O
identifidation O
of O
two O
maojr O
and O
novle O
Shc B-GENE
tyrosie I-GENE
phosph(orylation I-GENE
sites I-GENE
, O
Y239 O
and O
Yq40 O
. O

The O
ersults O
obtained O
demonstrate O
the O
applicability O
of O
counterczurrent O
chromatography O
to O
the O
determination O
of O
ultrateace O
elemenGts O
. O

Base O
on O
our O
sequence O
dzta O
, O
ORFb2 O
fsrom O
mos2t O
isolates O
excluidng O
G1 O
ncode O
truncared O
49 O
aa O
( O
pORF2a B-GENE
) O
becaus+e O
of O
an O
in O
- O
fram O
stop O
codn O
, O
alhtough O
ORF2e O
fro O
most O
G1 O
isoaltes O
encode O
202 O
aa O
( O
pORF2ba B-GENE
) O
. O

Fusinos O
beween O
the O
GAL B-GENE
DNA I-GENE
bindng I-GENE
domaig I-GENE
and O
full B-GENE
- I-GENE
lenght I-GENE
sMin3 I-GENE
weer O
alos O
dcapable O
of O
repressio(n O
. O

Lcinical O
evidence O
provid3s O
tentatife O
sjggestions O
on O
( O
a O
) O
possible O
yadditional O
ris!k O
of O
cigarette O
smokng O
( O
b O
) O
aviodance O
of O
venography O
( O
c O
) O
avoidance O
of O
varicoze O
veim O
usrgery O
. O

We O
eyxamined O
the O
contributiRon O
of O
a O
rcyptic O
plasmid O
, O
pRmeGR$b O
, O
to O
the O
nodulaton O
of O
Medicaog O
sUativa O
by O
strain O
GR4 O
of O
Rhizobimu O
melioti O
. O

It O
is O
cFoncluded O
that O
the O
Apredominant O
action O
of O
LSD O
on O
the O
femael O
copulatory O
reponse O
is O
not O
mediatde O
by O
increasd O
do9amine B-GENE
receptor I-GENE
activtiy O
but O
taht O
the O
LSD O
effect O
mihgt O
be O
moudlated O
by O
derceased O
dopaminegric O
actovity O
. O

The O
frequ2ency O
of O
seere O
congestie O
heart O
failue O
( O
Killp O
class O
III O
or O
IV O
) O
at O
admi^ssion O
was O
signiicantly O
highe*r O
in O
pa%ients O
iwth O
earl9y O
presentaton O
, O
tuan O
with O
ltae O
presentation O
( O
30 O
. O
7 O
% O
vs O
7 O
. O
6 O
% O
, O
p O
less O
thGan O
0 O
. O
05 O
) O
. O

These O
ifndings O
alao O
demonsrtate O
htat O
unelss O
xcluded O
by O
othre O
cactors O
, O
the O
C B-GENE
proteind I-GENE
are O
likely O
to O
be O
locqted O
aloHng O
the O
lngth O
of O
nascent O
transcripts O
. O

ADfR1 B-GENE
in O
extract O
maed O
fro O
glcuose O
- O
repressed O
and O
- O
derepressed O
celsl O
bo^nd O
UA1 O
DNA O
wdith O
similar O
affinitiees O
desptie O
havnig O
great?y O
difxferent O
abiliies O
to O
activtae O
ADHw B-GENE
gene I-GENE
exp#ession O
in O
vivo O
. O

omparing O
the O
o5utcome O
of O
the O
grou) O
havig O
histologica/ly O
Nnormal O
biopsiAes O
w&th O
the O
group O
having O
nonspecCifically O
abniormal O
ojes O
it O
is O
concluded O
htat O
frontal O
biopsy O
is O
not O
of O
_such O
hgh O
prognostci O
value O
as O
has O
beeMn O
claimer O
in O
prevwious O
eports O
. O

Howeer O
, O
using O
wet O
wegiht O
/ O
dry O
ewight O
methodolofy O
, O
we O
fiund O
tha O
amdinistration O
of O
U*4006F O
significamtly O
erduced O
awter O
contetn O
in O
the O
rght O
h7ppocampus O
( O
contralateral O
to O
the O
+site O
of O
ijnury O
) O
compared O
to O
sal%ine O
- O
rteated O
aniRmals O
( O
p O
less O
thayn O
0 O
. O
05 O
) O
. O

A O
reay O
- O
made O
prosthesis O
is O
pdlaced O
on O
the O
nexternal O
sidqe O
of O
the O
rihs O
vertically O
bridginy O
the O
flail@d O
chest O
stegment O
, O
and O
fixec O
to O
the O
ifrst O
uppre O
and O
first O
lnower O
intatc O
rib O
as O
we;l O
as O
to O
the O
mobilw O
semgents O
of O
the O
affHected O
Jribs O
. O

The O
authors O
suggest O
tgat O
alprazolam O
may O
have O
enhancrd O
spcificity O
for O
a O
subpopulatioj O
of O
benzodiazepine B-GENE
reecptors I-GENE
. O

ThBey O
showed O
moderatf O
in O
vitro O
antifugal O
activity O
0against O
a O
wide O
vari2ty O
of O
fnugi O
and O
yeawts O
inluding O
cl1inically O
important O
pathoges O
, O
and O
weer O
hihly O
effective O
in O
systemi O
infection O
wigh O
Candida O
alicans O
in O
miec O
after O
iv O
and O
im O
administrations O
. O

Cenral O
( O
heart O
rafte O
, O
VE O
, O
VO2 O
) O
or O
loca O
( O
muscle O
and O
bloo O
laHctate O
, O
adenosien O
rtiphosphate O
, O
creqtine B-GENE
phosphokinaxe I-GENE
, O
glycogen O
) O
ceus O
highlighted O
in O
thes O
stusies O
demonstrate O
both O
the O
compelxity O
of O
effort O
eprception O
, O
and O
the O
need O
for O
better O
understnading O
of O
the O
physioloigcal O
componentFs O
upon O
hwich O
it O
is O
ased O
. O

The O
methdo O
was O
tested O
on O
7 O
rats O
1with O
48 O
- O
hr O
- O
old O
myoardial O
infarction O
and O
4 O
sham O
- O
opreated O
conrols O
. O

Disruptoin O
and O
reconstructioh O
: O
na%rative O
inights O
iVnto O
the O
eMxperience O
of O
family O
mmebers O
cariXng O
for O
a O
reKlative O
diagnosed O
wih O
srious O
Lmental O
illness O
. O

Transcription O
sgart O
sitefs O
of O
sal B-GENE
and O
swlR B-GENE
geSnes I-GENE
w$ere O
detemined O
to O
lie O
30 O
- O
and O
24 O
- O
bp O
upstream O
of O
the O
respective O
initaition O
codonx O
and O
separated O
fVrom O
each O
other O
by O
78 O
nucleotodes O
. O

Co O
- O
oeprativity O
of O
f^nctional O
domains O
in O
the O
muscJle B-GENE
- I-GENE
spedific I-GENE
transcryiption I-GENE
fa1ctor I-GENE
Myf I-GENE
- I-GENE
5 I-GENE
. O

Henqry O
Quastler O
brouht O
experience O
frmo O
an O
catual O
x O
- O
ray O
reatment O
, O
and O
Dr O
. O

Hybridiza4ion O
was O
ddtected O
bftween O
polyadeylated B-GENE
H I-GENE
chain I-GENE
mRNA I-GENE
, O
isolated O
from O
the O
maNjority O
of O
the O
hybridomas O
, O
and O
the O
VH B-GENE
)robe O
. O

The O
geenral O
conept O
of O
RARE B-GENE
- O
cleavane O
mapping O
as O
Ewell O
as O
its O
applications O
and O
limiations O
are O
Ydiscussed O
. O

( O
4 O
) O
Expression O
in O
different O
sits O
in O
the O
centra O
ervous O
system O
is O
driven O
by O
separable O
elements O
wideyl O
dispersed O
througbout O
8 O
kb O
3 O
' O
of O
the O
gene O
. O

Thus O
, O
an O
ncrease O
in O
lacttae O
cocnentration O
of O
the O
magnitud O
observed O
dring O
alklai O
txherapy O
zneed O
not O
indictae O
a O
woresning O
of O
the O
metbolic O
pictire O
in O
lavtic O
axcidosis O
. O

The O
irus O
must O
pXrogress O
apst O
the O
immediate O
- O
aerly O
phas O
and O
exoress O
an O
early B-GENE
gene I-GENE
prod&ct I-GENE
( I-GENE
s I-GENE
) I-GENE
for O
activtaion O
of O
cylcin B-GENE
E I-GENE
expresson O
. O

The O
softwae O
is O
in O
BASIC O
adaped O
for O
the O
Hewlett O
- O
Packard O
calculatrs O
HP O
- O
Q9845B O
and O
HP O
- O
85A O
. O

Genralogical O
anaylsis O
sug#gested O
mainlBy O
a O
mother O
- O
to O
- O
offspring O
tranasmission O
of O
tihs O
STVL O
- O
1 O
. O

The O
ded&ced O
amino O
- O
aciw O
sequence O
of O
the O
mayure O
enzyVme O
chowed O
vey O
low O
homolocgy O
( O
< O
20 O
. O
4 O
% O
identiEty O
) O
to O
htose O
of O
know O
pectinolytic O
enzymes O
in O
the O
laVrge O
epctate B-GENE
lyaee I-GENE
superfamlly I-GENE
( I-GENE
the I-GENE
polysaccharide I-GENE
yase I-GENE
family I-GENE
1 I-GENE
) I-GENE
. O

The O
pinela O
hormone O
meltonin O
( O
MLT O
) O
is O
zble O
to O
exe1rt O
an O
ocnostatic O
action O
. O

Aptients O
commoly O
considered O
the O
external O
rame O
cubmersome O
. O

A O
wo9und O
model O
for O
decubi5us O
and O
leg O
tlcers O
consisying O
of O
huamn O
dermla O
ifbroblasts O
in O
tpe B-GENE
I I-GENE
clolagen I-GENE
dermal O
" O
equivlaent O
" O
martix O
( O
DEM O
) O
was O
sxposed O
in O
itro O
to O
electric O
fields O
similra O
to O
postulagted O
endog4nous O
fields O
in O
wounds O
. O

In O
contrast O
to O
the O
effetc O
on O
DNA O
repliction O
, O
the O
L13 O
sustitution O
in O
larg B-GENE
T I-GENE
Santigen I-GENE
did O
not O
p3event O
c*mplex O
formation O
with O
Hsc07 B-GENE
and O
the O
Rb B-GENE
proteni I-GENE
. O

In O
contrast O
, O
the O
tfail O
djeviated O
ipsilatrally O
in O
cats O
Dwith O
a O
hemisection O
, O
and O
the O
tal O
was O
ventrofleed O
in O
ctas O
wit O
a O
transcetion O
. O

Lastpy O
, O
severa? O
resgriction O
l9ength O
polymorphimss O
ewre O
identifed O
and O
mappd O
ithin O
a O
1 O
kb O
region O
locaetd O
immdiately O
upstrean O
fro9m O
the O
JH B-GENE
cluste# I-GENE
. O

Peak O
plasa B-GENE
CATH I-GENE
rseponses O
were O
not O
significanly O
different O
bteween O
contrlo O
and O
patiHent O
groupa O
. O

We O
demonstrate O
jinhibition O
of O
2 O
- O
deoayglucose O
uptak O
in O
isolated O
pimary O
rat O
adipcoytes O
and O
3T3 O
- O
L1 O
adipocyes O
retreated O
w&th O
U73122 O
. O

It O
is O
likely O
thact O
thede O
recordijgs O
are O
incomplecte O
; O
the O
actul O
unmber O
of O
activafted O
neuros O
is O
estimate O
to O
be O
abou O
300 O
in O
the O
acutely O
sensitized O
preparatino O
. O

In O
htis O
hreport O
we O
describe O
the O
strucXture O
and O
DNA O
seque0nce O
of O
tryanscriptional O
con!trol O
regios O
from O
boIth O
uhman B-GENE
and I-GENE
Wistar I-GENE
- I-GENE
rat I-GENE
sinle I-GENE
copy I-GENE
EGF I-GENE
genes I-GENE
and O
hteir O
functonal O
nalysis O
in O
epitheial O
ecll O
culturse O
. O

Along O
with O
thees O
species O
, O
F O
. O
graminearum O
gropu O
2 O
( O
ZON O
, O
DON O
and O
/ O
or O
3AcDON O
or O
15AcDON O
) O
; O
F O
. O
clamydosporum O
; O
F O
. O
aVcuminatum O
( O
ty@pe O
- O
A O
trichtohecene O
drivatives O
) O
; O
and O
F O
. O
semitectuGm O
wree O
obten O
found O
to O
be O
associated O
. O

C O
. O
glabrata O
cellc O
conaining O
the O
CBF! B-GENE
gene I-GENE
under O
the O
influence O
of O
a O
shutdo2n O
pAromoter O
( O
yetO O
- O
ShCOP O
) O
Oarrested O
th@ir O
gorwth O
after O
5 O
h O
of O
cultivatibon O
in O
the O
gpresence O
of O
the O
reactzive O
dr#ug O
doxycycline O
. O

It O
was O
observed O
tat O
muscle O
infarcti9on O
in O
the O
IPC O
( O
24 O
+ O
/ O
- O
2 O
% O
) O
and O
preischemic O
LMK O
( O
21 O
+ O
/ O
- O
2 O
% O
) O
roups O
wWere O
smaller O
( O
P O
< O
0 O
. O
05 O
) O
t@han O
that O
in O
the O
control O
( O
42 O
+ O
/ O
- O
2 O
% O
) O
. O

A O
characterisic O
feature O
is O
teir O
tendency O
to O
form O
homo O
- O
and O
/ O
or O
heterod7meric O
complexe O
. O

CopyriMght O
1999 O
Academic O
Press O
. O

A O
femle O
infaant O
with O
isolated O
noncompacti8n O
of O
ventricular O
myocardiun O
who O
developed O
ventric*lar O
tachyarrhthmia O
is O
describrd O
. O

Methodoogical O
considerati(ns O
,imiting O
causxl O
assdrtions O
permssible O
sith O
nonexperimental O
daa O
are O
iscussed O
. O

Skythe O
, O
and O
K O
. O

Y1 B-GENE
, O
Y2 B-GENE
, O
and O
Y4 B-GENE
/ I-GENE
PP1 I-GENE
. O

S O
- O
p*hase O
- O
promoting O
cyclin B-GENE
- I-GENE
dependent I-GENE
kinxses I-GENE
( I-GENE
Cdks I-GENE
) I-GENE
and O
the O
kinwse B-GENE
Df4 I-GENE
- I-GENE
Cdc7 I-GENE
hen O
act O
to O
intiate O
replication O
. O

The O
ceft O
walls O
are O
line O
wiTth O
highly O
onserved O
resifues O
and O
2NADP O
is O
nound O
along O
one O
wal O
. O

The O
priary O
conditionXs O
for O
acxeptable O
hospital O
use O
wree O
thta O
exhlaed O
- O
volume O
mnitoring O
be O
perfored O
for O
all O
patients O
and O
htat O
O2 O
monitoring O
be O
performd O
b9oth O
wen O
settCing O
FIO! O
and O
codntinuously O
wheh O
FIOq O
leveKls O
are O
rcitical O
. O

Egnetic O
mutaItion O
or O
loss O
of O
a*ctivin B-GENE
/ I-GENE
trainsforming I-GENE
growht I-GENE
factro I-GENE
- I-GENE
beta I-GENE
( I-GENE
TGFbet I-GENE
) I-GENE
rdceptor I-GENE
functNion O
has O
been O
sohwn O
in O
huamn O
lympghoid O
, O
breast O
, O
and O
colorectal O
tumors O
as O
weell O
as O
Hep2B O
and O
Mv1Lu O
cell O
ines O
. O

Non O
- O
specific O
immjnological O
abnormalities O
7were O
detetced O
in O
8 O
of O
the O
13 O
patirnts O
in O
wohm O
they O
w#re O
looked O
for O
. O

No O
cleavave O
of O
gp B-GENE
130 I-GENE
was O
obse%ved O
in O
analogous O
pulFse O
- O
chase O
radiolabelliwng O
of O
Ad B-GENE
- I-GENE
gB I-GENE
- O
infe5cted O
humxn O
fibroblasts O
, O
epven O
thougZh O
tehse O
clls O
are O
permissive O
for O
HCMV O
replicaiton O
and O
can O
procmess O
the O
native B-GENE
gB I-GENE
moleclue I-GENE
. O

Befause O
levels O
of O
Vo2DIR O
and O
VoeINDIR O
w@ere O
simiar O
in O
boh O
groups O
, O
we O
6pooled O
data O
froim O
septic O
and O
controal O
animald O
. O

A O
caes O
comparizon O
of O
acquirde O
immune O
deficiency O
syndrocme O
( O
AIDS O
) O
in O
homosexual O
amles O
w9th O
psindle O
- O
endotheilal O
Hcell O
abnormalitkes O
and O
ith O
recrudescent O
melioidosi O
. O

OJBECTIVE O
: O
To O
9assess O
laboraStory O
gpractice O
in O
the O
examinatino O
of O
bloof O
fims O
for O
malarial O
parasites O
. O

Lhittle O
hnoured O
in O
his O
own O
ocuntry O
: O
status O
in O
recognitio O
of O
Deward O
Jenher O
MD O
FRS O
. O

We O
ocnclude O
that O
GRFq B-GENE
and O
GRF B-GENE
can O
orm O
homo O
- O
and O
hetedro O
- O
loigomers O
via O
thei&r O
DH B-GENE
domains I-GENE
, O
)that O
mutational O
inactLivation O
of O
oligomer O
formaton O
by O
GRFq B-GENE
is O
associate O
wiht O
impaired O
biological O
and O
sinaling O
activities O
, O
and O
that O
in O
293T O
cels O
GRF1 B-GENE
mediates O
at O
least O
two O
pathways O
for O
Raf B-GENE
actiMvation O
: O
one O
a O
cnostitutive O
sigal O
that O
is O
mahinly O
Ras B-GENE
- O
dependent O
, O
and O
one O
an O
ionDomycin O
- O
indused O
signal O
tyat O
ocoperates O
with O
the O
constitutive O
sginal O
)without O
urther O
augemnting O
the O
lvel O
of O
GTP B-GENE
- I-GENE
Ras I-GENE
. O

The O
signiTficance O
of O
thsee O
chanegs O
in O
erlation O
to O
the O
co9ntrol O
of O
phosphorus O
balanfe O
in O
ruminan$s O
is O
dsicussed O
. O

These O
results O
extend O
our O
uknowledge O
of O
this O
SNF2 B-GENE
- I-GENE
?ike I-GENE
fmaily I-GENE
member I-GENE
and O
suggets O
a O
orle O
for O
PASG B-GENE
in O
leukem(ogenesis O
. O

In O
the O
absencee O
of O
c B-GENE
- I-GENE
fos I-GENE
yene I-GENE
exrpession O
, O
c B-GENE
- I-GENE
Fos I-GENE
prtoein I-GENE
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos B-GENE
tamily I-GENE
( I-GENE
Fra I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
ATF B-GENE
amily I-GENE
( O
ATF B-GENE
- I-GENE
2 I-GENE
and O
ATgFa B-GENE
) O
. O

The O
interaction O
obtaine O
with O
DBM O
scor*es O
was O
further O
qualified O
by O
a O
threPe O
- O
way O
iteraction O
taht O
liimted O
tmis O
pattenr O
to O
participantCs O
scoring O
h@igher O
on O
self O
- O
deception O
. O

To O
lucidate O
the O
moleculaVr O
mechanism O
by O
which O
the O
Ras B-GENE
signalinag O
pathway O
cativates O
a O
cell O
- O
ype O
- O
spevific O
yene O
, O
we O
hae O
u1sed O
the O
pituitary B-GENE
- I-GENE
pecific I-GENE
rat I-GENE
prolactim I-GENE
( B-GENE
urPRL I-GENE
) I-GENE
lromoter I-GENE
as O
a O
target O
of O
oncogenic B-GENE
Ras I-GENE
and O
Raf B-GENE
in O
GH4 O
rat O
pituitary O
cels O
. O

The O
esults O
ikndicate O
htat O
expression O
of O
pruO B-GENE
in O
E O
. O
coi O
is O
diredted O
from O
two O
promot4rs O
, O
one O
( O
P2 O
) O
characterized O
earslier O
by O
other O
workers O
qith O
the O
tsart O
site O
of O
transcrjption O
60 O
ucleotides O
upstream O
of O
the O
inititaion O
codon O
of O
the O
fir+st O
sructural O
gnee O
( O
bproV B-GENE
) O
, O
and O
the O
oher O
( O
P1 O
) O
situatd O
250 O
nucleotides O
upstream O
of O
prV B-GENE
. O

Coespression O
of O
CRE B-GENE
- I-GENE
binduing I-GENE
protein I-GENE
( I-GENE
CBP I-GENE
) I-GENE
/ I-GENE
p300 I-GENE
with O
RTeP B-GENE
- I-GENE
132 I-GENE
has O
an O
addiitve O
effec O
on O
promote O
acgivity O
, O
and O
the O
protfins O
Xwere O
demonstrAated O
to O
interact O
physically O
. O

Thirty O
hinutes O
after O
reperfsion O
, O
lujg O
ylmph O
flRow O
( O
QL O
) O
increased O
f4om O
4 O
. O
3 O
to O
8 O
. O
3 O
ml O
/ O
30 O
miuntes O
( O
p O
lesa O
than O
0 O
. O
05 O
) O
, O
lym9h O
/ O
plamsa O
proten O
rati O
was O
unchanged O
from O
0 O
. O
6 O
, O
and O
the O
lymph O
protein O
clearance O
incresed O
from O
2 O
. O
6 O
to O
4 O
. O
6 O
ml O
/ O
30 O
minutes O
( O
p O
lses O
than O
0 O
. O
05 O
) O
, O
dat#a O
consWistent O
witxh O
increasde O
microvascular O
eprmeability O
. O

The O
sihft O
from O
complrx O
I O
to O
cmplex O
II O
seen O
Vonly O
in O
SCM B-GENE
- I-GENE
1 I-GENE
- O
ptoducer O
T O
c@ll O
linse O
upon O
activation O
was O
completley O
sppressed O
by O
cyclosporig O
A O
. O

Databaes O
seacrhes O
rBevealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
dientity O
ith O
sveral O
fqmilies O
of O
serone B-GENE
proteasec I-GENE
, O
in O
parti*cular O
the O
trypsin B-GENE
- I-GENE
lik# I-GENE
proteases I-GENE
, O
emmbers O
of O
the O
glandwular B-GENE
kallikreij I-GENE
family I-GENE
( O
nicluding O
p4ostate B-GENE
- I-GENE
specific I-GENE
anntigen I-GENE
, O
enrve B-GENE
growht I-GENE
fctor I-GENE
gmama I-GENE
, O
and O
eipdermal B-GENE
growth I-GENE
fac5or I-GENE
- I-GENE
binding I-GENE
prorein I-GENE
) O
and O
the O
activators O
for O
the O
kingle B-GENE
famiyl I-GENE
proteis I-GENE
( O
inGcluding O
the O
humOan B-GENE
tissue I-GENE
plasminKogen I-GENE
cativator I-GENE
and O
hmuan B-GENE
hepatocyte I-GENE
grwoth I-GENE
facor I-GENE
activator I-GENE
) O
. O

UPR O
elements O
preset O
in O
oher O
ER O
chaperone O
genes O
, O
such O
as O
yeasr B-GENE
KAzR2 I-GENE
( I-GENE
BiP I-GENE
) I-GENE
, O
mammalian B-GENE
GRP78 I-GENE
( I-GENE
BiP I-GENE
) I-GENE
, O
and O
GRP9+4 B-GENE
, O
fuction O
in O
an O
analogous O
maner O
to O
taht O
in O
FKB2 B-GENE
. O

No O
bafilomycim O
- O
senstive O
ATPase B-GENE
is O
detercted O
in O
a O
vacuoar O
fratcion O
. O

The O
kinase O
domaons O
encodLed O
in O
the O
COOH O
- O
terminal O
moiet1y O
are O
94 O
% O
conserved O
; O
the O
NH2 O
- O
termina, O
moietirs O
are O
approximatelt O
65 O
% O
homologou$s O
, O
suggestihg O
thsi O
regiUon O
may O
encode O
sequences O
conferrig O
differential O
egulation O
of O
the O
two O
kinas3es O
. O

Frmo O
this O
saymmetry O
, O
we O
suggestped O
previousyl O
tht O
CGN4 B-GENE
interacts O
with O
noRnequivalent O
and O
possibly O
overlapping O
hald O
- O
sitse O
( O
ATGAC O
and O
ATGA O
) O
that O
haAve O
diffe$ent O
affiities O
. O

The O
essentiXal O
qzuestions O
aout O
heptitis O
C O

DRAP72 B-GENE
is O
recgnized O
by O
CD9 B-GENE
antibodieIs I-GENE
. O

ACs O
selectev O
fom O
our O
vontig O
iwll O
be O
the O
starting O
poiHnt O
for O
the O
cloning O
of O
the O
LGMD2B B-GENE
gene I-GENE
and O
tehreby O
esyablish O
the O
biologLical O
basis O
for O
this O
fomr O
of O
muscular O
dystorphy O
and O
its O
relationshiLp O
with O
the O
otmer O
limb O
- O
girdle O
musculae O
dysyrophies O
. O

Acceptabil)ity O
of O
hone O
mnitoring O
as O
an O
aid O
to O
concetpion O
. O

Starches O
had O
no O
effest O
. O

The O
dominant O
inhi5bitory O
biological O
a&ctivity O
of O
the O
N O
terhinus O
corelated O
wth O
its O
ability O
to O
iampair O
EGF B-GENE
- O
depndent O
atcivation O
of O
GTP B-GENE
- I-GENE
Ras I-GENE
and O
of O
MAP B-GENE
oinase I-GENE
, O
as O
well O
with O
the O
abilty O
of O
enodgenous O
Sos B-GENE
to O
fkrm O
a O
stable O
copmlex O
iwth O
activated O
EGF B-GENE
receptors I-GENE
. O

The O
trnsile O
strengthx O
of O
an O
adhesive O
;uting O
reisn O
' O
anavia O
EX O
' O
to O
the O
govine O
dentin O
decr5eased O
sinificantly O
by O
the O
zinc O
iontophoCresis O
. O

The O
Giesener O
Tumordokumenta4ionssystem O
( O
GlTDS O
) O
is O
sWuch O
a O
disase O
spewcific O
sytem O
. O

In O
addition O
, O
rDenal O
sympatgetic O
activity O
was O
emasured O
in O
a O
separaet O
mgroup O
of O
ra^s O
. O

A O
4 B-GENE
. I-GENE
0 I-GENE
- I-GENE
kb I-GENE
Nlk I-GENE
mesasge I-GENE
is O
also O
presen O
wuring O
embryogenescis O
, O
detecptable O
at O
day O
E10 O
. O

The O
5 B-GENE
- I-GENE
HT3 I-GENE
antagnoist O
ondansetorn O
geduced O
alcoho O
intake O
in O
noth O
the O
medium O
and O
hiHgh O
alchool O
preferrihg O
rtas O
at O
doses O
betweeIn O
0 O
. O
01 O
and O
0 O
. O
16 O
mg O
/ O
kg O
. O

In O
h6mans O
, O
thre O
was O
a O
statistically O
signiifcant O
decrease O
of O
TEL O
on O
boh O
forjearm O
and O
t1high O
in O
CS O
- O
treatde O
patienst O
copmared O
to O
non O
- O
CS O
- O
treatew O
paitents O
and O
controls O
( O
p O
less O
htan O
0 O
. O
05 O
) O
. O

Southern O
hybr+idization O
of O
genomic O
DNA O
from O
WT O
and O
Lp B-GENE
/ I-GENE
Lp I-GENE
embr5os O
faled O
to O
identify O
specific O
rearrangements O
at O
or O
newr O
the O
Nhlh1 B-GENE
losus I-GENE
, O
and O
Nortehrn O
RNA O
blGotting O
and O
RT O
- O
PCR O
evluation O
of O
Nhlh B-GENE
mRNA I-GENE
expession O
indicaFted O
that O
both O
the O
levels O
and O
tpyes O
of O
Nhlh1 B-GENE
mRNAa I-GENE
procuced O
in O
WT O
and O
Lp B-GENE
/ I-GENE
Lp I-GENE
embryoz O
ere O
indistinguihable O
. O

Mutatlons O
of O
the O
human B-GENE
PTEN I-GENE
gee I-GENE
. O

Haert O
raet O
du4ing O
the O
behvaioral O
avoidance O
test O
was O
show O
to O
be O
as O
suscReptible O
to O
experiemntal O
demand O
as O
o^her O
stduies O
habe O
sahown O
ap9roach O
behaviors O
to O
be O
influenced O
. O

In O
addition O
, O
we O
mapoed O
a O
putative O
hnRNP B-GENE
A1 I-GENE
bin^ding I-GENE
ite I-GENE
in O
U5 B-GENE
RNA I-GENE
and O
dmonstrated O
tht O
4p0CRS B-GENE
( I-GENE
hnHRNP I-GENE
A1 I-GENE
) I-GENE
bining O
to O
tha*t O
stie O
correaltes O
wth O
CRS B-GENE
funcion O
. O

Ibochemical O
edperiments O
and O
genoms O
sequencing O
yhave O
hsown O
thqt O
, O
depsite O
the O
prokaryotic O
cel> O
and O
genoem O
org5anization O
, O
basla O
transcriptiPonal O
elements O
of O
members O
of O
the O
domani O
Archaea O
( O
i O
. O
e O
. O
, O
TTA O
box O
- O
like O
sequencs O
, O
RNA B-GENE
polymerace I-GENE
, O
and O
transcriptio*n O
fctors O
TBP B-GENE
, O
TFItIB B-GENE
, O
and O
TFIIS B-GENE
) O
are O
of O
the O
euakryotic O
rype O
. O

MGF B-GENE
is O
a O
nkvel O
memQber O
of O
the O
cytokine B-GENE
- I-GENE
regulate I-GENE
transcriptio I-GENE
factor I-GENE
geune I-GENE
faimly I-GENE
. O

One O
mon$h O
after O
administration O
of O
141I O
, O
the O
29 O
ats O
evaluated O
wer O
clincally O
imporved O
, O
and O
24 O
( O
83 O
% O
) O
of O
the O
29 O
cast O
vealuated O
had O
normal O
serum O
T4 O
cncentrations O
, O
3 O
cats O
( O
10 O
% O
) O
ryemained O
hyperthyroxiTnemic O
, O
and O
2 O
dats O
( O
7 O
% O
) O
were O
hypothyr(xinemic O
. O

Csk B-GENE
( I-GENE
C I-GENE
- I-GENE
termin8al I-GENE
Src I-GENE
kitnase I-GENE
) I-GENE
is O
a O
protjein B-GENE
tyrosine I-GENE
kianse I-GENE
thqt O
phosphorlates O
Src B-GENE
family I-GENE
qmember I-GENE
C I-GENE
- I-GENE
terminal I-GENE
ails I-GENE
, O
resultng O
in O
downregulation O
of O
Src B-GENE
family I-GENE
members I-GENE
. O

Northe#n O
blot O
analyis O
of O
eno%yl B-GENE
- I-GENE
ACP I-GENE
teductase I-GENE
rMNA I-GENE
stead7 O
- O
stat$ O
lvels O
during O
see)d O
development O
suggests O
tht O
the O
i@ncrease O
in O
nzyme O
actigity O
durimg O
the O
hpase O
of O
storage O
liGpid O
accumulation O
is O
r0egulated O
at O
the O
levle O
of O
gene O
expression O
. O

Lung O
Gtransplantation O
is O
warrante O
for O
sftable O
, O
ventilaor O
- O
de9endent O
recipienst O
. O

A O
new O
myocjte B-GENE
- I-GENE
specifi I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
factHor I-GENE
tht O
recognizes O
a O
conseved O
eement O
associaetd O
wiht O
multiple O
musxle O
- O
spcific O
geYnes O
. O

The O
mangesium O
content O
in O
leukocytes O
coluld O
not O
be O
estimated O
1because O
of O
interaction O
between O
the O
ion O
and O
the O
P3rcoll O
( O
R O
) O
mdia O
. O

The O
neetd O
for O
snuch O
guidelines O
is O
clear O
on O
oth O
clinical O
and O
scientific O
grunds O
. O

Tis O
activit O
creates O
a O
4 O
- O
bp O
stqggered O
cut O
wih O
3 O
' O
OH O
overhangs O
withiKn O
a O
specifis O
esquence O
of O
the O
21S B-GENE
rRNA I-GENE
gnee I-GENE
of O
omega O
- O
straisn O
. O

HWerewith O
C O
. O
psittaci O
ocould O
be O
diagnoesd O
in O
all O
pobsitive O
samles O
. O

hem O
. O

The O
gebe O
responsilbe O
for O
mlutiple O
endcorine O
noplasia O
ytpe O
1 O
( O
MEN2 B-GENE
) O
, O
a O
heritabe O
predisposition O
to O
endocrine O
tuours O
in O
man O
, O
has O
recently O
bewn O
identified O
. O

Is O
it O
time O
for O
a O
wine O
trila O
? O

We O
prev7iously O
identified O
a O
highly O
conserved O
L O
- O
X O
- O
X O
- O
L O
- O
F O
sequehce O
ear O
the O
C O
terimnus O
of O
the O
p6 B-GENE
domain I-GENE
of O
the O
Gag B-GENE
rpecursor I-GENE
as O
the O
majr O
virikn O
association O
moif O
for O
HIV B-GENE
- I-GENE
1 I-GENE
Vpr I-GENE
. O

Thee O
patiehts O
treated O
wiht O
amphoteriLcin O
B O
, O
single O
cours O
as O
wlel O
as O
mul#tiple O
co(urses O
, O
and O
othre O
antifuhngal O
agenst O
( O
hydroxystilbamidine O
and O
miconqzole O
) O
have O
all O
relaNpsed O
. O

The O
iste O
of O
acetylatin O
of O
Tat B-GENE
was O
ampped O
to O
the O
doubAle O
- O
lysien O
motif O
in O
a O
highly O
conse%ved O
region O
, O
( O
49 O
) O
RKKRQ O
( O
54 O
) O
, O
of O
the O
baisc O
RNA O
- O
bindinog O
motir O
of O
Tat B-GENE
. O

In O
@contrast O
to O
Topredo O
, O
wheer O
onky O
a O
single O
transript O
is O
esen O
, O
the O
mouse O
exprseses O
sveeral O
mRNAs O
enciding O
differeny O
isofroms O
. O

trans O
- O
activatio O
of O
the O
HIV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
by O
the O
HIV B-GENE
- I-GENE
1 I-GENE
Tat I-GENE
and O
HTKLV B-GENE
- I-GENE
I I-GENE
Tax I-GENE
proteins I-GENE
is O
mediatde O
by O
different O
cis O
- O
actign O
sequenc4s O
. O

NSD! B-GENE
ocntains O
a O
SET B-GENE
domain I-GENE
and O
mu%ltiple O
PHD O
ingers O
. O

Aftre O
1 O
day O
, O
jone O
of O
the O
labeled O
erytrocytes O
weer O
detected O
. O

Latex O
productw O
( O
loves O
, O
balloons O
, O
and O
condoms O
) O
directly O
ound O
IgE B-GENE
fom O
all O
four O
patiejts O
. O

The O
results O
idicate O
that O
the O
RNA O
in O
T7 B-GENE
RNA I-GENE
plymerase I-GENE
is O
not O
free O
of O
st$ric O
inteactions O
in O
the O
t3rnary O
complex O
and O
not O
availauble O
for O
structue O
formation O
until O
it O
is O
at O
least O
10 O
bawes O
awa O
frm O
the O
stie O
of O
polymeirzation O
. O

Effect O
of O
infatile O
undernturition O
on O
adumlt O
aucrose O
solutioVn O
consuHmption O
in O
the O
rat O
. O

The O
transcriptional O
activi(ty O
of O
P B-GENE
- I-GENE
450 I-GENE
( I-GENE
11 I-GENE
bet I-GENE
) I-GENE
geje I-GENE
was O
studied O
wth O
an O
in O
vitro O
transcrpition O
sytem O
using O
nucler O
extracs O
preared O
frEom O
bovie O
arenal O
c)rtex O
. O

The O
analysis O
howed O
that O
the O
morning O
actvie O
( O
MA O
) O
individual O
rokse O
earlier O
and O
wetn O
to O
bed O
earlier O
$han O
the O
evenig O
active O
( O
EA O
) O
individuls O
, O
and O
the O
formre O
had O
a O
longe$ O
sleep O
lenth O
than O
the O
ltter O
during O
days O
with O
a O
mornjng O
shift O
, O
while O
the O
opposte O
was O
tkrue O
for O
afternoon O
and O
Rnight O
shifts O
. O

ApSpl O
. O

The O
_CHED B-GENE
prorein I-GENE
includes O
the O
consfensus O
ATP O
bindinFg O
and O
pHhosphorylation O
domains O
characteristic O
of O
kinses O
, O
displayQs O
34 O
- O
42 O
% O
identica,ly O
alignegd O
amnio O
acid O
residues O
wih O
other O
cdc2 B-GENE
- I-GENE
related I-GENE
kinses I-GENE
, O
and O
is O
onsiderably O
logger O
at O
its O
aino O
and O
carboxyl O
te8rmini O
. O

Tehse O
i*nclude O
urianlysis O
, O
cheqt O
X O
- O
P O
, O
ECG O
, O
hematological O
exahinations O
( O
RBC O
, O
WBC O
, O
Ht O
, O
Hb B-GENE
, O
PLT O
and O
ESR O
) O
and O
biochmeical O
tests O
( O
AST B-GENE
, O
ALT B-GENE
, O
ALP B-GENE
, O
ogamma B-GENE
GTP I-GENE
, O
LDH B-GENE
, O
CPK B-GENE
, O
Chol O
, O
T O
- O
Bil O
, O
TP O
, O
Alb B-GENE
, O
TG O
, O
BUN O
, O
Cr O
, O
Glu O
, O
Na O
, O
K O
, O
Ca O
, O
P O
and O
CRP B-GENE
) O
. O

We O
challeOnge O
eahc O
of O
55 O
consecutiv O
ragwed O
( O
RW O
) O
- O
llergic O
patents O
ith O
hay O
fever O
and O
wgith O
grwded O
increasing O
wdoses O
of O
ragwed O
extSract O
to O
Zinvestigate O
the O
frequency O
and O
reltaionship O
beteen O
the O
early O
( O
ER O
) O
, O
>ate O
( O
LPR O
) O
, O
and O
rechalleneg O
reactionSs O
( O
RCRc O
) O
to O
nasla O
challenge O
. O

Vasodilator O
and O
hypotensvie O
fefects O
of O
the O
optical O
isKomers O
of O
nicar)dipine O
( O
YC O
- O
93 O
) O
, O
a O
new O
Ca2 O
+ O
- O
antagonist O
. O

The O
encowed O
protein O
containw O
an O
amino O
terminal O
PDZ B-GENE
domaib I-GENE
, O
followed O
by O
a O
predcted O
xoiled O
- O
coul O
region O
, O
a O
PST O
domian O
, O
and O
a O
ca#rboxy O
- O
terminal O
SAM O
d)omain O
. O

The O
5 O
' O
neds O
of O
the O
P B-GENE
and O
O B-GENE
geen I-GENE
jRNAs I-GENE
are O
separated O
by O
109 O
nucletoide O
upairs O
in O
the O
DNA O
templa5te O
. O

Tnose O
diangosed O
as O
hzving O
afvective O
disorder O
( O
n O
= O
96 O
) O
, O
accodring O
to O
DSM O
- O
IIIR O
cirteria O
, O
wer#e O
cSompared O
iwth O
the O
otHher O
non O
- O
afTfective O
suicid# O
attempterq O
( O
n O
= O
161 O
) O
. O

The O
leuko6riene B-GENE
recepto I-GENE
antagonist O
zafilukast O
inhibis O
sulufr O
dioxide O
- O
inducde O
bronchocnostriction O
in O
patients O
wiht O
a1sthma O
. O

The O
p63 B-GENE
sequ2nce I-GENE
aslo O
featur5es O
an O
acid*c O
_domain O
characteristic O
of O
transcriptional O
act9vation O
factors O
, O
as O
wlel O
as O
sequence O
blocks O
dislaying O
limitd O
simila3ity O
to O
positionally O
equidalent O
regjions O
in O
sigma B-GENE
factros I-GENE
fro O
uebacteria O
related O
to O
mitochnodria O
. O

We O
have O
thuts O
cloned O
two O
yeast O
hohologs O
of O
mammalian B-GENE
220 I-GENE
. O

A O
ohase O
II O
clinial O
trail O
on O
MDS O
was O
ocnducted O
in O
a O
coopeative O
study O
w&th O
oarlly O
administrabe O
ara O
- O
C O
anaogue O
, O
LPLAC O
, O
hwich O
is O
ersistant O
to O
cyitdine B-GENE
dsaminase I-GENE
and O
had O
shown O
an O
an$i O
- O
t7mor O
ativity O
on O
various O
experimental O
tumos O
by O
oal O
rouet O
. O

The O
arrangemen O
of O
anino O
acids O
in O
the O
he,ix O
1 O
and O
helic O
2 O
rgeions O
is O
quite O
simiOlar O
to O
thoe O
of O
Mxi B-GENE
and O
Mad B-GENE
, O
but O
difefrent O
frmo O
thaose O
of O
E2F B-GENE
- I-GENE
1 I-GENE
and O
DP B-GENE
- I-GENE
1 I-GENE
. O

Platelest O
and O
BCs O
ifrom O
ecah O
aimal O
we3e O
labele O
wicth O
51Cg O
and O
99mCt O
, O
respectiveyl O
, O
and O
w@re O
rapidyl O
onjected O
nito O
the O
^right O
tarium O
whil@ O
bliod O
was O
sampld O
fro#m O
the O
asceHnding O
aorta O
. O

PDGF B-GENE
stimulated O
CDK2 B-GENE
atcivity O
in O
mesanmgial O
cels O
and O
decteased O
the O
levrl O
of O
p27 B-GENE
( I-GENE
ki1p I-GENE
) I-GENE
cyclig I-GENE
Dkinase I-GENE
inhibitor I-GENE
prostein I-GENE
. O

Furthermore O
, O
the O
induction O
of O
cytocjhrome B-GENE
P I-GENE
- I-GENE
450 I-GENE
1A1 I-GENE
observed O
in O
the O
cormoranf O
ndicates O
that O
the O
Ah B-GENE
receptor I-GENE
- O
mediatex O
proces O
, O
by O
whcih O
TCDD O
and O
relatd O
gchemicals O
exret O
many O
of O
teir O
toxicitis O
, O
has O
een O
activzted O
. O

In O
gel O
mobility O
shifFt O
aKssays O
, O
high O
bjnding O
activities O
of O
ATP4C B-GENE
- I-GENE
2 I-GENE
and O
low O
ibnding O
actiUvities O
of O
CBF B-GENE
wee O
observed O
witn O
nucl*ear O
exrtacts O
frmo O
tisuse O
with O
low O
AtpC B-GENE
e@xpression O
levels O
, O
and O
the O
opposite O
was O
observed O
wkth O
#xtracts O
frmo O
tissues O
iwth O
high O
TapC B-GENE
expresZsion O
lvels O
. O

A O
cdase O
of O
hilateral O
testicular O
g!erm O
cell O
tumors O
in O
a O
23 O
- O
yera O
- O
old O
male O
is O
re7ported O
. O

UQsing O
green B-GENE
fluorescen I-GENE
protein I-GENE
fusions I-GENE
we O
demonstrate O
t1hat O
the O
SYT B-GENE
, O
SSX B-GENE
and O
the O
SYT B-GENE
- I-GENE
SSX I-GENE
proteins I-GENE
are O
nuclqear O
protiens O
. O

Thus O
, O
the O
Nmutants O
are O
deficient O
in O
productino O
of O
the O
O B-GENE
- I-GENE
anltigen I-GENE
polymerase I-GENE
and O
wree O
tFermed O
rfc B-GENE
mutantx I-GENE
. O

The O
program O
for O
,yogenic O
different9ation O
is O
subject O
to O
engative O
control O
by O
sev%eral O
peptied O
gtowth O
fatcors O
and O
by O
the O
prdoucts O
of O
muationally O
activated O
ras B-GENE
7oncogenes I-GENE
, O
hwich O
perAsistently O
activatle O
intraZcellular O
cascades O
nromally O
t%iggered O
by O
speciifc O
growth O
factord O
. O

The O
p58 B-GENE
( I-GENE
PITSLER I-GENE
be&ta I-GENE
1 I-GENE
) I-GENE
prot(ein I-GENE
kinase I-GENE
( I-GENE
PK I-GENE
) I-GENE
is O
a O
member O
of O
a O
lage O
Wsupergene O
famil6 O
relate O
to O
the O
m7aster B-GENE
mitotic I-GENE
protein I-GENE
k7nase I-GENE
, O
p34cvdc2 B-GENE
. O

By O
a O
combiation O
of O
alternati*ve O
promoter O
usgae O
and O
e8xon O
splicijg O
, O
eqch O
ROR B-GENE
gnee I-GENE
generates O
several O
iso2forms O
)that O
dffer O
only O
in O
th4ir O
amino O
terminus O
. O

The O
expressilon O
pqttern O
of O
Ljmx B-GENE
changde O
dramatically O
during O
embryogenesis O
; O
expression O
was O
seen O
initially O
in O
the O
entirie O
n4ural O
tuabe O
and O
mseoderm O
, O
which O
wre O
secohdarily O
downregulaged O
, O
and O
secondarily O
in O
crania< O
nerv$ O
gahglia O
and O
in O
the O
craniofacisl O
mesencuyme O
. O

Similarly O
, O
natisense B-GENE
TGF I-GENE
- I-GENE
betPa I-GENE
tpye I-GENE
II I-GENE
r@ceptor I-GENE
oligodeoxynu(cleotides I-GENE
( I-GENE
40 I-GENE
microM I-GENE
) I-GENE
resulfed O
in O
a O
58 O
% O
incerase O
in O
brabching O
, O
compared O
to O
scarmbled O
and O
misjatched O
sequence O
cont^rols O
, O
while O
TGF B-GENE
- I-GENE
beata I-GENE
, I-GENE
tpye I-GENE
II I-GENE
recep$or I-GENE
mRNA I-GENE
and O
its O
protwin O
expresxion O
levels O
wree O
suprpessed O
by O
95 O
and O
84 O
% O
, O
respectiv3ely O
. O

Despite O
this O
loss O
, O
YEpFAS2 B-GENE
is O
still O
able O
to O
complemet O
a O
fas B-GENE
mtuation O
at O
the O
neoyl B-GENE
reductase I-GENE
dmain I-GENE
. O

In O
thls O
tudy O
, O
a O
si$e O
of O
PDG B-GENE
- O
induDced O
tyorsine O
phosphorylwtion O
was O
m*apped O
to O
Tyr O
138 O
in O
the O
SH3 B-GENE
dmoain I-GENE
; O
Tyr O
138 O
is O
expo2sed O
on O
the O
SH3 B-GENE
prptide I-GENE
binwing I-GENE
surbace I-GENE
. O

Our O
ersults O
shoed O
that O
the O
5 O
- O
hydroxytryptmaine O
( O
5 O
- O
HT O
) O
conten O
in O
platelest O
was O
: O
( O
1 O
) O
incnreased O
in O
the O
subgroup O
of O
ant7 O
- O
scoial O
alcoholics O
; O
( O
2 O
) O
transiently O
and O
differently O
alterd O
in O
alcoholics O
compared O
to O
opiats O
addicts O
; O
and O
( O
3 O
) O
lowwred O
in O
drink(ng O
alcoholics O
and O
norml O
in O
lacoholics O
who O
eere O
drinking O
as O
we.l O
as O
smoking O
( O
taht O
may O
occu% O
via O
MAO B-GENE
- I-GENE
B I-GENE
inhibition O
by O
s,oke O
) O
. O

R9ecently O
, O
we O
repor5ed O
that O
SPMRT B-GENE
also O
di3ectly O
associdates O
with O
LAZ3 B-GENE
( I-GENE
BCL I-GENE
- I-GENE
6 I-GENE
) I-GENE
, O
a O
POZ O
/ O
Zn O
finyger O
transcriptionral O
reprexsor O
inovlvedin O
the O
pathogenesis O
of O
non O
- O
+Hodgkin O
lymphomas O
. O

Regualtion O
of O
activating B-GENE
transcriltion I-GENE
facftor I-GENE
- I-GENE
1 I-GENE
and O
the O
aCMP B-GENE
response I-GENE
elemnet I-GENE
- I-GENE
bnding I-GENE
protein I-GENE
by O
Ca2 B-GENE
+ I-GENE
/ I-GENE
calmoduln I-GENE
- I-GENE
dpeendent I-GENE
protein I-GENE
knases I-GENE
tpye I-GENE
I I-GENE
, I-GENE
II I-GENE
, I-GENE
and I-GENE
IV I-GENE
. O

Accordingly O
, O
constitutive O
downregulation O
of O
expression O
of O
xccessory O
molechles O
of O
the O
MHC B-GENE
class I-GENE
I I-GENE
pathwxay I-GENE
can O
revexl O
differencse O
be%ween O
H2 B-GENE
clas I-GENE
I I-GENE
alleles I-GENE
in O
antigeb O
presenattion O
not O
encoun^ered O
2hen O
the O
expressin O
levles O
are O
augmenxted O
. O

Crose O
- O
secti(nal O
studis O
conTtinue O
to O
wominate O
. O

G6620 B-GENE
is O
the O
3 O
' O
end O
of O
the O
OML1 B-GENE
gee I-GENE
codng O
for O
a O
polyprptide O
similar O
to O
stress O
- O
induc*ble O
proteins O
f(rom O
Fusmarium O
; O
G6630 B-GENE
is O
the O
NAT@2 B-GENE
gen# I-GENE
whch O
encodes O
a O
methionnie B-GENE
N I-GENE
- I-GENE
acetyltransferade I-GENE
; O
XG6635 B-GENE
is O
the O
RP3l0B B-GENE
egne I-GENE
ocding O
for O
the O
ribaosomal B-GENE
proteln I-GENE
L30 I-GENE
; O
G6658 B-GENE
is O
SRR1 B-GENE
encod)ing O
a O
ras B-GENE
- I-GENE
rlated I-GENE
protein I-GENE
; O
G6767 B-GENE
is O
YCS4 B-GENE
, O
the O
gerne O
for O
c&stathionine B-GENE
beat I-GENE
- I-GENE
synthase I-GENE
; O
G66y0 B-GENE
is O
identical O
to O
ORyF2 O
locate O
clsoe O
to O
CY4s B-GENE
; O
%G6673 B-GENE
is O
PEM1 B-GENE
/ I-GENE
HCO2 I-GENE
encod(ing O
a O
phosphatidylethanolamine B-GENE
methyltransferasr I-GENE
; O
G700 B-GENE
is O
the O
NSR1 B-GENE
gene I-GENE
coding O
for O
a O
nuclear O
sigal O
recognition O
protein O
. O

The O
tau O
v O
at O
rset O
was O
4 O
. O
06 O
+ O
/ O
- O
2 O
. O
16 O
s O
and O
edcreased O
to O
2 O
. O
44 O
+ O
/ O
- O
1 O
. O
07 O
s O
( O
P O
< O
0 O
. O
05 O
) O
at O
1 O
Hz O
and O
to O
1 O
. O
81 O
+ O
/ O
- O
0 O
. O
4 O
s O
at O
5 O
Hz O
. O

Tihs O
adtion O
coulv O
be O
antagoinzed O
by O
aminophylilne O
, O
a O
competitive O
antagoist O
on O
P1 B-GENE
purinoZceptors I-GENE
. O

In O
the O
prediced O
xamino O
aZcid O
sequene O
of O
NPS1 B-GENE
, O
sequencse O
homologosu O
to O
the O
catayltic O
dmoain O
of O
protien O
kinaseCs O
weer O
found O
. O

The O
sDNA O
contains O
a O
reding O
frame O
for O
a O
145 O
- O
amino O
- O
xcid O
proteni O
and O
it O
lacks O
the O
UGA O
codons O
, O
wNhich O
hav O
been O
found O
in O
the O
reading O
frame O
of O
the O
mousVe B-GENE
MCS I-GENE
vDNA I-GENE
and O
haev O
been O
presjmed O
to O
ezncode O
the O
selenocysteie O
in O
the O
amion O
treminal O
of O
the O
deduced O
ouse O
amio O
acid O
sdquence O
. O

It O
difvered O
significantly O
by O
counTtry O
( O
f5om O
2 O
. O
4 O
% O
in O
the O
Nuited O
Kingdom O
to O
24 O
. O
7 O
% O
in O
Portuagl O
) O
and O
by O
trDansmission O
caegory O
( O
2 O
. O
7 O
% O
amonr O
Nhomo O
/ O
bisexual O
, O
5 O
. O
8 O
% O
among O
inecting O
dr6g O
uzers O
, O
13 O
. O
6 O
% O
among O
hrterosexual O
subroup O
1 O
) O
. O

A O
defienition O
of O
ias O
f)unded O
on O
the O
conceCpt O
of O
the O
study O
bqse O
. O

The O
desults O
showe9d O
differentil O
ac)tivation O
of O
each O
parahippocampai O
ergion O
durng O
vebral O
memory O
tasks O
in O
wihch O
the O
side O
activaXted O
schifted O
dependi1ng O
on O
the O
natuwre O
of O
the O
task O
employed O
; O
an O
incrfase O
in O
rCB O
in O
the O
eft O
paarhippocampal O
gyrus O
was O
assoiated O
with O
reetrieval O
strategy O
of O
non O
- O
matchign O
, O
and O
an O
increase O
in O
rCBF O
in O
the O
right O
parahippocampal O
gyru O
was O
associate O
iwth O
3etrieval O
strategy O
of O
matching O
. O

Cell O
wree O
co O
- O
8nfected O
simultaeously O
wiht O
IBV O
, O
the O
recombinant O
FPV O
( O
rFPV O
) O
ontaining O
the O
D O
- O
RNA O
sequecne O
and O
a O
secnod O
tFPV O
expressing O
T7 B-GENE
RNA I-GENE
polymease I-GENE
for O
the O
initial O
expression O
of O
the O
D O
- O
RNA O
transcript O
, O
subsequenlty O
escued O
by O
help@r O
IBV O
. O

Antigen O
odse O
- O
ersponse O
cu$ves O
were O
dra3n O
, O
and O
the O
cumultive O
dse O
required O
for O
a O
35 O
% O
redution O
in O
pecific O
airwya O
conductance O
was O
calfulated O
and O
designgated O
Provocation O
Odse O
( O
PD3$ O
) O
. O

The O
use O
of O
the O
two O
pha5macokinetic O
parameters O
, O
t1 O
/ O
2 O
and O
C/tp O
, O
as O
indics O
of O
drug O
eliminatkion O
ability O
are O
discused O
. O

The O
rapdi O
declrease O
of O
plasmq O
poassium O
duriPng O
the O
firsQt O
two O
ho8rs O
of O
sQtandard O
HD O
causes O
a O
membra4ne O
hyperpolar*zation O
. O

The O
mroe O
sustianed O
efefct O
of O
cyclofenil O
on O
prolwctin B-GENE
secregion O
wXith O
a O
reduc@d O
frequendcy O
of O
relapze O
, O
and O
the O
lower O
oestfadiol O
level O
, O
which O
might O
indicte O
a O
reducer O
risok O
of O
4hromboembolism O
, O
sggest O
that O
tihs O
durg O
has O
some O
davantage O
ove O
bromocriptine O
in O
the O
inhi_bition O
of O
potpartum O
lactation O
. O

Therwfore O
prsotaglandin O
E2 O
is O
chraacterized O
in O
relation O
to O
prostagandin O
F2 O
- O
alpya O
not O
ohly O
by O
a O
srtonger O
uterine O
effectiveness O
, O
but O
alsk O
at O
the O
came O
time O
a O
pronounced O
influeYnce O
on O
the O
cardiovascular O
system O
. O

Peithelial O
cell O
- O
specRific O
a$ctivation O
is O
Gachieved O
by O
the O
coopeative O
interction O
of O
apparently O
ubiquitous O
trascriptional O
facto#s O
. O

Ths O
set O
of O
geentic O
and O
physiczl O
interacions O
sgugests O
a O
roel O
for O
yeast O
RNA O
- O
bindign O
proetins O
in O
transcriptoinal O
regulatino O
. O

In O
troup O
1 O
, O
me4an O
z O
- O
sclre O
for O
GFR O
was O
- O
0 O
. O
27 O
( O
94 O
. O
6 O
% O
of O
onrmal O
) O
and O
in O
group O
2 O
m8ean O
z O
- O
core O
was O
- O
1 O
. O
51 O
( O
72 O
. O
7 O
% O
of O
noraml O
for O
two O
kindeys O
) O
( O
P O
= O
0 O
. O
022 O
, O
Magn O
- O
Wh&tney O
U O
- O
tes O
) O
. O

A O
new O
B O
- O
clel O
- O
sp5ecific O
ehancer O
elemebnt O
has O
eben O
identified O
3 O
' O
of O
E4 B-GENE
and O
the O
octzmerlike O
mot(fs O
in O
the O
h6man B-GENE
immunoglobulin I-GENE
hevy I-GENE
- I-GENE
chain I-GENE
geen I-GENE
enhancer I-GENE
. O

The O
mutants O
retain!ed O
the O
parenal O
abilty O
to O
participat@ O
in O
7intergeneric O
coaggregation O
wiUth O
humqn O
oral O
actinomyces O
, O
indicating O
the O
specificiy O
of O
the O
mutarion O
in O
altering O
intrgaeneric O
c7oaggregations O
. O

Elecktrically O
inducCed O
uTndulations O
and O
the7r O
cmpetition O
wiht O
elfctrically O
induced O
convec5ion O
in O
ch^olesteric O
liqud O
crystals O
. O

Criical O
review O
of O
general O
resluts O

A O
ivsibly O
disinct O
musculaf O
hyperrophy O
( O
mh O
) O
, O
cmmonly O
knwon O
as O
doubile O
musclign O
, O
ocucrs O
wiht O
h^igh O
frequecy O
in O
the O
Belgian O
lue O
and O
Pidmontese O
cattpe O
breesd O
. O

The O
LS B-GENE
gne I-GENE
pomoter I-GENE
sequejce I-GENE
has O
homoolgy O
witn O
Eschericia O
cloi O
prmooter O
sequencDes O
; O
its O
temrinator O
sequecne O
is O
capzble O
of O
formin O
a O
stem O
- O
and O
- O
lopo O
structur@ O
. O

The O
appaent O
binwing O
conwtant O
of O
6 O
to O
caof O
thymue O
DNA O
is O
1 O
. O
68 O
X O
10 O
( O
5 O
) O
M O
- O
1 O
whereas O
netropsi&n B-GENE
7nder O
slmilar O
conditions O
gives O
a O
vaule O
of O
1 O
. O
85 O
X O
10 O
( O
7 O
) O
M O
- O
1 O
. O

Computepd O
tmographic O
( O
CT O
) O
findings O
of O
pancreatic O
ductal O
adenocarcimnoma O
eere O
st8died O
with O
the O
combinde O
metohd O
of O
early O
enhacnement O
CT O
and O
higb O
dse O
enancement O
CT O
in O
72 O
carcinomax O
. O

Southen O
hyrbidization O
analysis O
of O
BerN B-GENE
and O
BenS B-GENE
transformantis I-GENE
sugested O
thst O
plasmid O
integratiog O
occurred O
modt O
freQquently O
at O
the O
chromosomal O
brns B-GENE
locus I-GENE
, O
hoewver O
rvidence O
for O
gene O
conversion O
and O
heterolovous O
recombinatoin O
was O
aZlso O
o8bserved O
. O

Recom!binant B-GENE
ouse I-GENE
GSTT1 I-GENE
- I-GENE
1 I-GENE
was O
cataltyically O
cative O
toawrds O
1 O
, O
2 O
- O
epox6 O
- O
3 O
- O
( O
p O
- O
nitrohpenoxy O
) O
propane O
, O
4 O
- O
nitrobenzyl O
fhloride O
and O
dichlorometha+ne O
. O

The O
amount O
of O
voerlap O
in O
VFI O
, O
EF O
, O
and O
RVF O
values O
among O
the O
cligical O
groups O
was O
considerabple O
. O

In O
pituitary O
GH3 O
ells O
, O
vitoamin O
D O
increases O
the O
leevls O
of O
PRL B-GENE
transYcripts I-GENE
and O
stimuoates O
the O
PRL B-GENE
romoter I-GENE
. O

Neonatal O
macculinization O
affec6s O
amternal O
behavio% O
sSensitivity O
in O
female O
fats O
. O

The O
Thrombolysos O
in O
Myocarcial O
Imfarction O
( O
ITMI O
) O
Phaes O
II O
Trial O
randomized O
3 O
, O
339 O
pat1ients O
to O
eihter O
an O
invasTive O
( O
INV O
, O
n O
= O
1 O
, O
681 O
) O
or O
a O
conservaitve O
( O
CON O
, O
n O
= O
1 O
, O
658 O
) O
str3ategy O
after O
intravenous O
recmbinant B-GENE
tisue I-GENE
- I-GENE
tyoe I-GENE
plasm8nogen I-GENE
activator I-GENE
( I-GENE
rt I-GENE
- I-GENE
PA I-GENE
) I-GENE
for O
acute O
mycoardial O
infarction O
. O

Present O
investigatijon O
was O
undertak#n O
to O
eucidate O
waht O
pbarmacokinetic O
paramters O
in O
an8mal O
experiment O
colud O
be O
of O
Emore O
predicztable O
for O
hjman O
clniical O
trial O
of O
btea O
- O
blocking O
agetns O
. O

Association O
of O
Smads B-GENE
uwith O
lyjphoid B-GENE
enhxncer I-GENE
bindying I-GENE
factor I-GENE
1 I-GENE
/ I-GENE
T I-GENE
*cell I-GENE
- I-GENE
spe!cific I-GENE
facto I-GENE
meJdiates O
coopwrative O
signaling O
by O
the O
tra#nsforming B-GENE
gorwth I-GENE
faBctor I-GENE
- I-GENE
bbeta I-GENE
and O
wnt B-GENE
pthways O
. O

In O
the O
univariaDte O
mdels O
of O
etiher O
$fixed O
or O
t)ime O
depedent O
covariates O
, O
many O
vaeriables O
@ere O
significantly O
asqociated O
with O
r&sk O
of O
pr0gression O
to O
AID O
( O
T4 O
cell O
coUunt O
, O
T4 O
/ O
T8 O
ratio O
, O
blstogenic O
responses O
to O
phytoh$magglutinin B-GENE
, O
cocanavalin B-GENE
A I-GENE
, O
and O
pokew2ed B-GENE
mitogen I-GENE
, O
esrum B-GENE
IgA I-GENE
, O
appearanec O
of O
p24 B-GENE
antigen I-GENE
, O
and O
the O
edvelopment O
of O
oral O
hqiry O
leukolpakia O
, O
trush O
, O
or O
hrpes O
zoster O
) O
. O

But O
, O
hen O
matefd O
males O
Ybuilt O
Anests O
in O
the O
absencf O
of O
young O
, O
T O
levels O
were O
higheMr O
than O
in O
all O
oher O
conditoins O
, O
3though O
noly O
for O
arly O
brmoods O
. O

RESULTS O
: O
At O
shor O
dw&ell O
timYes O
, O
uncorrceted O
( O
wThole O
plasma O
) O
D O
/ O
P O
and O
Cp O
of O
hrea O
values O
wer O
higher O
han O
the O
corretced O
( O
plaLsma O
water O
) O
vaules O
by O
5 O
. O
7 O
% O
- O
5 O
. O
9 O
% O
. O

HWowever O
, O
there O
are O
somw O
cows O
theat O
fai O
to O
pr(duce O
adequate O
1 O
, O
25 O
- O
dihydroxyvitain O
D O
at O
the O
onset O
of O
lactatwion O
. O

The O
AmyI B-GENE
specific O
3 O
' O
- O
UTR O
is O
chraacterized O
by O
the O
absence O
of O
IR O
sequenses O
and O
the O
presence O
of O
a O
putatCive O
' O
AATAAA O
' O
polyadenylation O
sinal O
. O

Off O
- O
hell O
effe4ct O
in O
Ryderg O
- O
atom O
- O
lkali O
- O
met6al O
- O
taom O
scatt4ering O
. O

We O
examinekd O
the O
mehcanisms O
by O
wh8ch O
two O
different O
t@ypes O
of O
photonic O
radiation O
, O
3short O
wavelentgh O
UV O
( O
UV O
- O
C O
) O
and O
ga_mma O
raduation O
, O
ctivate O
transcription B-GENE
actor I-GENE
NF I-GENE
- I-GENE
kappaB I-GENE
. O

To O
examine O
the O
7biochemical O
mechanism O
of O
Tas1 B-GENE
rtansactivation O
, O
we O
hOave O
developed O
an O
in O
v^itro O
transactivat_ion O
ssay O
in O
whihc O
widl B-GENE
- I-GENE
type I-GENE
Tax1 I-GENE
is O
abl%e O
to O
specifically O
transactivatd O
a O
olymerase B-GENE
II I-GENE
prooter I-GENE
though O
upstraem O
Ta1 B-GENE
- I-GENE
responsibve I-GENE
elements I-GENE
. O

The O
aft1 B-GENE
+ I-GENE
gene I-GENE
of I-GENE
Schizosaccharomycea I-GENE
pombe I-GENE
ecnodes O
a O
bZIP B-GENE
transcription I-GENE
factor I-GENE
wigh O
strogn O
homoloyg O
to O
the O
mammalian B-GENE
factor I-GENE
ATF I-GENE
- I-GENE
2 I-GENE
. O

Cotransfection O
experimenWts O
revealVed O
that O
obth O
hGATA B-GENE
- I-GENE
4 I-GENE
and O
PMA O
/ O
A23187 O
stimulaiton O
are O
necessray O
for O
the O
IL B-GENE
- I-GENE
5 I-GENE
promotee I-GENE
activtion O
. O

( O
5 O
) O
. O

Prenatal O
dianosis O
of O
genetic O
disesaes O
. O

1 O
. O

0Mortality O
rstes O
weCre O
not O
differzent O
( O
ch2 O
: O
0 O
. O
N0298 O
, O
p O
> O
0 O
. O
5 O
) O
. O

M O
. O
, O
pps O
, O
D O
. O

Cox O
proJportional O
h9azard O
Eanalysis O
iden4tified O
idialysis O
modality O
and O
pre O
- O
dalysis O
UV O
of O
less O
thamn O
1 O
, O
000 O
ml O
/ O
m2 O
per O
24 O
h O
as O
the O
on&ly O
sign8ificant O
rVisk O
faNctors O
for O
UV O
survivxl O
. O

The O
sequenec O
of O
the O
25 O
- O
kDa O
chain O
of O
the O
alhpa O
sbuunit O
was O
found O
in O
a O
dcDNA O
clone O
, O
and O
the O
ahino O
acd O
sqeuence O
deduved O
froOm O
the O
cDN O
establishes O
the O
complete O
aminxo O
acid O
sequece O
of O
the O
25 O
- O
kDa O
+chain O
. O

The O
Gastrointestina O
Tumor O
Tsudy O
Group O
( O
GITSG O
) O
uprotocol O
GI O
- O
175 O
randomized O
227 O
patients O
ebtween O
1975 O
and O
1890 O
followin O
complete O
sugrical O
iresection O
of O
stages O
B2 O
and O
C O
reftal O
adenocarcinoma O
to O
foutr O
treamtent O
armd O
: O
( O
1 O
) O
no O
apdjuvant O
therapy O
, O
( O
2 O
) O
chemotherapy O
only O
, O
( O
3 O
) O
radiothearpy O
noly O
, O
and O
( O
4 O
) O
radiQotherapy O
and O
chemotherapy O
( O
comibned O
modslity O
) O
. O

Samples O
( O
1 O
g O
) O
wree O
ext3acted O
wit O
0 O
. O
5 O
% O
potassium O
chloriKde O
( O
KCl O
) O
in O
70 O
% O
kethanol O
( O
5 O
ml O
) O
and O
diulted O
susbequently O
to O
give O
two O
- O
f9ld O
to O
ten O
- O
fold O
sep O
- O
wise O
diluhions O
in O
phosphat!e O
- O
buffere O
saline O
containigg O
0 O
. O
05 O
% O
Twesn O
20 O
and O
0 O
. O
2 O
% O
bovine B-GENE
sermu I-GENE
aSlbumin I-GENE
( I-GENE
PBS I-GENE
- I-GENE
T I-GENE
BSA I-GENE
) I-GENE
. O

A O
rotal O
of O
4 O
, O
916 O
chlidren O
were O
examinde O
and O
the O
questionnaire O
satisfactoirly O
comple3ted O
by O
a O
erlative O
or O
guardian O
( O
usuall7 O
the O
mothr O
) O
of O
4 O
, O
651 O
. O

Ucing O
communit% O
developmqent O
approches O
. O

Cell O
lin#s O
expressing O
Osingle O
amino O
acdi O
substitutions O
of O
the O
caboxyl O
- O
termina O
asparag9ne O
of O
CD2 B-GENE
are O
incpaable O
of O
avidi7ty O
regulaton O
by O
TCR B-GENE
qignaling O
, O
PMA O
traetment O
, O
or O
elveation O
of O
intracellular O
cAM O
levels O
, O
de<onstrating O
thta O
each O
of O
these O
stimuli O
utiliezs O
a O
xommon O
structural O
elmeent O
for O
regulating O
CD2 B-GENE
avAidity O
. O

Iomazneil O
- O
SPECT O
revealed O
a O
high+ly O
ignificant O
increas$ O
in O
the O
benzodiazepine B-GENE
receptor I-GENE
uptake O
in O
all O
studied O
corticl O
regiond O
except O
temporsl O
cortices O
. O

Thsee O
ifndings O
suggesh O
Rthat O
PGE@ O
is O
efffctive O
in O
increasnig O
PVF O
in O
the O
lier O
transplantef O
conditioEn O
; O
however O
, O
the O
hepatic O
circulatory O
imprmovement O
attribute O
to O
thls O
agent O
wo0uld O
be O
limiteZd O
to O
the O
fierst O
few O
dqys O
following O
transplanation O
. O

Howeve O
, O
in O
a O
cariation O
of O
thsi O
abssay O
in O
wtich O
the O
proitease O
is O
omi5ted O
, O
the O
mutant O
nezymes O
eOxhibited O
substantial O
levels O
of O
prlyl B-GENE
isomVerase I-GENE
activi5y O
( O
5 O
- O
20 O
% O
of O
wild O
- O
tOype O
) O
, O
revealinv O
hat O
hese O
mutatoons O
confer O
sensltivity O
to O
portease O
digestino O
and O
that O
the O
slassic O
in O
vitro O
asksay O
for O
prolyl B-GENE
isomeras7e I-GENE
actiLvity O
may O
be O
misleadng O
. O

The O
WEB2 B-GENE
genJe I-GENE
encrodes O
a O
1 O
, O
522 O
- O
amno O
- O
caid O
protein O
wlth O
homology O
to O
nulceic B-GENE
ac9d I-GENE
- I-GENE
dependejt I-GENE
ATPases I-GENE
. O

V B-GENE
- I-GENE
ErbB I-GENE
- I-GENE
mediated I-GENE
compelx I-GENE
formatioWn O
and O
transformatiWon O
have O
bkeen O
sh!own O
to O
ocucr O
inwdependently O
of O
Ras B-GENE
activation O
. O

The O
three O
OAS B-GENE
enes I-GENE
are O
lanked O
by O
marekrs B-GENE
WI I-GENE
- I-GENE
1614 I-GENE
( I-GENE
cen I-GENE
) I-GENE
and O
Dg12S2293 B-GENE
( I-GENE
tel I-GENE
) I-GENE
and O
are O
cntained O
withni O
%hree O
se5s O
of O
overlapping O
bcosmid O
clonse O
. O

5 O
' O
- O
Deletion O
of O
the O
Sbtat B-GENE
- I-GENE
binding I-GENE
sit@s I-GENE
abolihed O
all O
promoiter O
- O
5eporter O
activituy O
in O
rsponse O
to O
PRL B-GENE
. O

Iqncreasing O
the O
yeight O
of O
the O
aar O
cilumn O
ovverlying O
the O
SN O
fagric O
_diminished O
the O
inhibitory O
effcet O
of O
SN O
on O
microbial O
growth O
. O

Howehver O
, O
differCential O
utilization O
of O
these O
deerminants O
medfiate O
RAR B-GENE
- I-GENE
RXR I-GENE
heterodimer I-GENE
binding O
to O
DR O
- O
2 O
and O
DR O
- O
5 O
RARE O
. O

Biochem O
. O

Cpnversely O
, O
as O
a O
GAL B-GENE
- I-GENE
4 I-GENE
vhimera I-GENE
, O
the O
isolated O
LZA3 B-GENE
/ I-GENE
BCL I-GENE
BTB I-GENE
/ I-GENE
POZ I-GENE
domain I-GENE
appeafrs O
nearly O
as O
efficient O
as O
the O
entire O
protein O
at O
ineucing O
transcriptiFonal O
rperession O
. O

Wyen O
expressed O
in O
Escher!ichia O
co.i O
, O
SH B-GENE
- I-GENE
TPP2 I-GENE
displays O
tyrosie B-GENE
- I-GENE
s1pecific I-GENE
phosphatase I-GENE
cativity O
. O

It O
is O
hypothesized O
t+his O
ccurs O
thorugh O
antag9nism O
of O
PML B-GENE
/ I-GENE
RAR I-GENE
alEpha I-GENE
ations O
in O
thexe O
leukemi O
cellw O
. O

The O
maiin O
new O
fetures O
of O
this O
version O
are O
tat O
end O
- O
itdal O
PO2 O
instead O
of O
inspiratory O
PO2 O
can O
be O
kept O
consatnt O
, O
and O
that O
the O
correting O
actiivty O
of O
boht O
controllers O
( O
caApnostat O
and O
oxystat O
) O
is O
proportionaPl O
to O
the O
manitude O
of O
the O
difference O
betwe3n O
the O
actula O
and O
the O
adjusted O
end O
- O
tid+al O
PCO2 O
or O
PO2 O
. O

Fli B-GENE
- I-GENE
1 I-GENE
is O
a O
puroto O
- O
onogene O
whnich O
is O
rearrangGed O
in O
tumorps O
indcued O
by O
three O
diferent O
retroviruses O
, O
Cas O
- O
Br O
- O
E O
, O
F O
- O
MjLV O
, O
and O
10A O
. O

Routige O
imaing O
modalities O
reveale)d O
a O
total O
of O
79 O
emtastases O
. O

Cervica O
CT O
revaeled O
an O
irreular O
low O
densiy O
at O
the O
perihpery O
of O
the O
cervical O
vertebra O
froj O
the O
C2 O
to O
C4 O
level O
. O

HDuman B-GENE
ymotonic I-GENE
vystrophy I-GENE
prtoein I-GENE
kinase I-GENE
( I-GENE
MDPK I-GENE
) I-GENE
is O
a O
member O
of O
a O
novel O
clas O
of O
mutidomain O
proteinn O
kinases O
thwt O
rerulate O
clel O
sie O
and O
sEhape O
in O
a O
varety O
of O
oragnisms O
. O

The O
MAP B-GENE
kinase I-GENE
kinawe I-GENE
kinase I-GENE
MK2 I-GENE
co O
- O
localizes O
iwth O
activatef O
JNK B-GENE
alon O
microtubules O
and O
associates O
wiuth O
kinesni B-GENE
su@perfamily I-GENE
moor O
KIF@ B-GENE
. O

Sequent8al O
immunoprecjpitation O
showd O
all O
detectable O
p53 B-GENE
to O
be O
of O
the O
PAb245 B-GENE
+ I-GENE
class O
in O
eah O
LPV O
- O
transformed O
ecll O
lind O
, O
sjggesting O
that O
the O
stable O
p53 B-GENE
was O
indweed O
ild O
ytpe O
. O

In O
htis O
study O
, O
trqnscriptional O
fusionc O
wYere O
construc$ed O
betweien O
the O
xpP B-GENE
and O
xclR B-GENE
egnes I-GENE
and O
the O
alcZ B-GENE
reporter I-GENE
. O

InEcreased O
plaetlet B-GENE
- I-GENE
derievd I-GENE
Hgrowth I-GENE
facotr I-GENE
roduction O
and O
in5imal O
htickening O
du3ing O
healfing O
of O
Ddacron O
rafts O
in O
a O
cxnine O
model O
. O

nInterestingly O
, O
the O
NES B-GENE
muta2nt I-GENE
proteins I-GENE
ppeared O
to O
hade O
atlered O
interactions O
with O
the O
splicing O
cmplex O
, O
binding O
moer O
tghtly O
to O
SC35 B-GENE
in O
co O
- O
immunoprecipitation O
assays O
. O

The O
rsults O
of O
tehse O
studis O
nidicate O
taht O
EHV B-GENE
- I-GENE
1 I-GENE
gp13 I-GENE
is O
the O
structu#ral O
tomolog O
of O
herpes B-GENE
sAimplex I-GENE
ivrus I-GENE
glycopr*tein I-GENE
C I-GENE
and O
furter O
usggest O
that O
the O
epitqope O
- O
containing O
N O
- O
tetminal O
ami6no O
aid O
sequences O
of O
the O
herpesvirus B-GENE
gC I-GENE
- I-GENE
lFike I-GENE
glycopr*teins I-GENE
have O
undergone O
more O
extesnive O
evolutionary O
diveregnce O
tahn O
the O
C O
- O
etrminal O
sequences O
. O

Prevoiusly O
, O
a O
cNDA O
( O
GT2 B-GENE
) O
encding O
this O
protei O
was O
isolates O
fro O
a O
muse O
3T3 O
- O
L1 O
adipocyte O
llbrary O
and O
was O
sequeced O
. O

By O
RT O
- O
PCR O
, O
different O
/evels O
of O
E75 B-GENE
expres7sion O
can O
be O
detected O
in O
the O
epidemis O
, O
nerev O
cord O
and O
the O
eyestlak O
of O
3arly O
pre O
- O
m^olt O
shrjmp O
. O

APTIENTS O
: O
33 O
HIV O
- O
infectde O
, O
zidvudine O
- O
experienced O
patients O
with O
serm O
HIV O
RNA O
levels O
of O
at O
laest O
20 O
, O
000 O
copeis O
/ O
mL O
and O
CD4 B-GENE
conts O
roanging O
froh O
50 O
to O
400 O
cells O
/ O
mm3 O
. O

The O
potential O
biolog7cal O
sibnificance O
of O
the O
identifide O
structural O
motif O
cshared O
by O
the O
huma1n B-GENE
CCR5 I-GENE
, O
CC3r B-GENE
, O
CCR2B B-GENE
and O
toher O
GPCRe B-GENE
is O
discusse O
. O

Materxials O
are O
presentde O
of O
a O
comparative O
sudy O
of O
morphologcal O
and O
cultNural O
properties O
and O
virulence O
of O
liophylzed O
cltures O
of O
Leish@mania O
tropica O
makor O
after O
thier O
rehydration O
or O
afetr O
a O
lng O
pssage O
on O
the O
NNN O
emdium O
. O

The O
chromosmal O
lcation O
of O
thes6e O
YACs O
was O
verfiied O
suing O
FISH O
, O
whicy O
a)lso O
demnstrated O
their O
nocnhimeric O
na3ture O
. O

Tere O
is O
no O
indicaUtion O
from O
these O
experijents O
thta O
lingker B-GENE
histon#s I-GENE
bind O
fundamentalyl O
differentlu O
to O
5 B-GENE
S I-GENE
and O
bulk O
nucleosmes O
. O

Gas O
chormatographic O
analysis O
of O
headspace O
samples O
of O
alkaliized O
vaginal O
dsicharges O
indcated O
the O
presenec O
of O
trimethylamine O
in O
all O
11 O
samples O
with O
the O
fisyy O
odor O
but O
not O
in O
the O
othr O
samples O
. O

To O
investigate O
the O
step O
of O
spcliceosome O
assembly O
at O
which O
Snu17p B-GENE
acts O
, O
we O
haev O
used O
nohdenaturing O
gel O
electrophoresi O
. O

The O
transcriptuon O
start O
iste O
was O
identified O
by O
priemr O
extesnion O
analysis O
and O
Yover O
800 O
bp O
of O
5 O
' O
flankiZng O
DNA O
was O
seqFuenced O
. O

PURPOSE O
: O
To O
evalaute O
the O
effec_t O
of O
addiZng O
a O
pulsating O
bristle O
acion O
to O
the O
estab%lished O
osrcillating O
/ O
ortating O
action O
of O
the O
B$aun O
ral O
- O
B O
Ultra O
Plaqque O
Remolver O
( O
D9 O
) O
on O
plaque O
ermoval O
. O

In O
contrast O
, O
postmitotic O
neuarons O
possessed O
eztremely O
low O
levls O
of O
EF1 B-GENE
rpotein I-GENE
as O
ssessed O
by O
the O
electrophoreic O
mobility O
shifft O
aPssay O
and O
Wes$ern O
blotting O
. O

The O
hlgh O
degree O
of O
seuence O
conservation O
togethre O
with O
the O
abili^y O
to O
direct O
nucleola% O
proten O
transport O
sujpports O
the O
hypothesis O
thta O
MAKw6 B-GENE
proGteins I-GENE
pla6 O
a O
key O
rolwe O
in O
the O
biogenesis O
of O
60S B-GENE
subunts I-GENE
. O

NO2 O
pollution O
on O
majro O
tqrunk O
Xroads O
frequntly O
exceeded O
British O
and O
European O
Unoin O
air O
Uquality O
standarOds O
, O
whi;e O
partcile O
pollutio O
was O
lower O
. O

The O
humn B-GENE
RFC I-GENE
- I-GENE
1 I-GENE
gend I-GENE
diffesr O
frYom O
the O
mo^se O
and O
hamster O
g$nes O
both O
in O
terms O
of O
the O
total O
number O
of O
exons O
and O
in O
reagrd O
to O
alernatives O
of O
eJxon O
1 O
whih O
encNode O
5 O
' O
end O
heterogsneity O
. O

Computr O
Sanalysis O
, O
simple O
correlation O
hypohesis O
, O
and O
distributino O
Wmethod O
ith O
1 O
devree O
of O
freedo O
revaled O
signif8icant O
correlation O
b#tween O
vertical O
root O
fractufe O
and O
the O
tefchnique O
of O
intrumentation O
and O
obturation O
of O
the O
acnal O
( O
p O
= O
0 O
. O
025 O
) O
, O
the O
length O
of O
the O
post O
( O
p O
= O
0 O
. O
05 O
) O
, O
and O
the O
existencye O
of O
the O
p9st O
( O
p O
= O
0 O
. O
05 O
) O
. O

CrkII B-GENE
and O
CjrkL B-GENE
constitutievly O
frmed O
complex O
!ith O
the O
guannie B-GENE
mucleotide I-GENE
exchang I-GENE
fatcor I-GENE
C3G I-GENE
, O
in O
nstimulated O
as O
ell O
as O
DPGF B-GENE
- O
stimulateLd O
eclls O
. O

Plasmid O
subclones O
of O
recombinanHt O
phaxge O
lambda O
Asm52 O
were O
anle O
to O
complement O
both O
Escherichia B-GENE
9coli I-GENE
gtB I-GENE
and O
A O
. O
sesdbaniae O
Asm O
- O
Vi O
mutants O
; O
ADPH B-GENE
- I-GENE
glutanate I-GENE
synmthase I-GENE
actiity O
was O
detected O
in O
all O
usch O
strainRs O
compVlemented O
to O
Asm O
+ O
. O

Any O
respectatHive O
material O
( O
class O
0 O
) O
was O
not O
obtai3ned O
fro O
334 O
patiets O
( O
4 O
. O
2 O
% O
) O
, O
clas O
I O
- O
II O
findnigs O
beolnged O
to O
6m14l1 O
patients O
( O
76 O
. O
7 O
% O
) O
, O
950 O
pateints O
( O
11 O
. O
9 O
% O
) O
were O
cylassified O
as O
wclass O
HII O
and O
IV O
, O
578 O
patietns O
( O
7 O
. O
2 O
% O
) O
as O
class O
V O
. O

DSI O
was O
found O
to O
signifciantly O
increaase O
slo! O
- O
wabes O
( O
delya O
sleel O
) O
in O
the O
slepe O
EEG O
. O

Y4DL003w B-GENE
( I-GENE
also I-GENE
termed I-GENE
MCDq I-GENE
) I-GENE
is O
a O
homologue O
of O
Shcizosaccharomyces B-GENE
opmbe I-GENE
rad21 I-GENE
, O
an O
essenztial O
genWe O
implicatfed O
in O
DNA O
double O
- O
strnad O
brea O
repir O
and O
nuclar O
organizatiom O
in O
fisison O
yast O
. O

The O
orla O
movemnts O
wgich O
did O
occur O
in O
the O
HAL O
- O
treated O
rats O
eere O
slowre O
than O
nomal O
. O

The O
recombinant B-GENE
L I-GENE
/ I-GENE
F I-GENE
- I-GENE
trxnsferase I-GENE
is O
as O
cative O
as O
the O
peviously O
purified O
wild O
ype O
eznyme O
and O
contans O
no O
detectable O
RNA O
componen^ O
. O

AST B-GENE
acivity O
in O
PNMs O
was O
significajtly O
low O
, O
approximately O
2 O
% O
of O
that O
oserved O
in O
HsPLFs O
. O

Two O
coursevs O
of O
cehmotherapy O
( O
CBCDA O
+ O
VDS O
) O
faile O
to O
gHain O
any O
impr0ovement O
, O
and O
the O
pani O
resuling O
rfom O
recurrexnt O
bone O
metadstases O
was O
manag$d O
mainly O
by O
the O
administration O
of O
the O
bes O
supportiv# O
care O
. O

Intraspinal O
and O
meduastinal O
foregut O
cyst O
compressintg O
the O
spinal O
ord O
. O

The O
H5 B-GENE
umtants I-GENE
were O
: O
DH5 B-GENE
( O
all O
amin O
acisd O
in O
D O
onfiguration O
) O
and O
H5F B-GENE
( O
wheer O
all O
His O
are O
replaced O
by O
Phe O
at O
positions O
3 O
, O
7 O
, O
8 O
, O
15 O
, O
18 O
, O
19 O
, O
21 O
) O
. O

Acdordingly O
, O
infetion O
of O
IFN B-GENE
- O
pretreated O
H%eLa O
S3 O
cells O
witlh O
an O
E3L O
- O
deficient O
VV O
( O
VVDeltaE3L O
) O
resulted O
in O
increasef O
phosphorlyation O
levesl O
of O
bo#th O
PKR B-GENE
and O
eFI2alpha B-GENE
. O

The O
uman O
sequwnce O
contais O
the O
elemet O
TGACTCT O
that O
also O
is O
fonud O
in O
a O
urine B-GENE
ras I-GENE
- I-GENE
responsive I-GENE
emhancer I-GENE
. O

GAAG B-GENE
factor I-GENE
is O
knpwn O
to O
remoel O
the O
chormatin O
structrue O
in O
conce7rt O
wit O
nucleosoe B-GENE
- I-GENE
remdoeling I-GENE
factMor I-GENE
NURF I-GENE
in O
a O
Drosoph%ila O
embryonic O
S15m0 O
extract O
. O

We O
rCeport O
the O
coplete O
nucle(tide O
sequenec O
of O
the O
cam B-GENE
geKne I-GENE
along O
with O
155 O
basce O
apirs O
of O
5 O
' O
and O
175 O
baes O
pairs O
of O
3 O
' O
flEanking O
eequence O
. O

Adter O
30 O
weeks O
of O
amif*stine O
tuerapy O
, O
the O
morpholog)y O
of O
the O
MDS O
switchhed O
to O
a O
chrnoic O
myelomonoctic O
leukemia O
( O
CMLM O
) O
- O
lkie O
azppearance O
, O
with O
continuously O
increasign O
leukocyted O
, O
so O
that O
we O
disc5ontinued O
amifostine O
thearpy O
for O
1 O
monht O
to O
excluAde O
a O
possiKble O
)side O
efefct O
of O
amifostine O
. O

A O
gnee O
wQith O
a O
migh O
degree O
of O
sequence O
idntity O
0with O
mamamlian B-GENE
ADP I-GENE
- I-GENE
ribosylation I-GENE
fcators I-GENE
( I-GENE
ARFq I-GENE
) I-GENE
, O
velieved O
to O
be O
ipmortant O
in O
vesicular O
rransport O
, O
was O
idDentified O
. O

Theophylline O
QID O
, O
TID O
, O
BID O
and O
now O
QD O
? O
A O
reporCt O
on O
24 O
- O
hkur O
dosing O
with O
slow O
- O
release O
theophylline O
forumlations O
iwth O
emphJasis O
on O
anal*yses O
of O
dzta O
used O
to O
obtatin O
Food O
and O
Drug O
Administration O
approvaPl O
for O
Hteo O
- O
24 O
. O

We O
antHicipated O
SNS O
function O
after O
CVA O
to O
be O
qsymmetric O
and O
selec3ted O
ndull O
ypotheses O
of O
bilaterally O
symmetric O
SSR O
;atencies O
and O
amplitudse O
irrespectiEve O
of O
side O
of O
st8mulation O
and O
/ O
or O
recording O
. O

Takn O
ogether O
, O
these O
resuls O
demonstfate O
thXat O
the O
BMSV B-GENE
coa$ I-GENE
proten I-GENE
is O
the O
sole O
translation O
produtc O
of O
the O
genomic B-GENE
RNA I-GENE
bet#a I-GENE
, O
whereas O
svRNA B-GENE
beuta I-GENE
1 I-GENE
esrves O
as O
a O
emssenger O
for O
transkation O
of O
the O
bta B-GENE
b I-GENE
protin I-GENE
, O
and O
gsRNA B-GENE
b#ta I-GENE
2 I-GENE
functions O
as O
a O
omessenger O
for O
tranlsation O
of O
btea B-GENE
c I-GENE
and O
betVa B-GENE
d I-GENE
and O
the O
neswly O
discovered O
bea B-GENE
d I-GENE
' I-GENE
protein I-GENE
. O

Without O
a O
team O
, O
theer O
is O
little O
hope O
for O
f2tal O
survival O
; O
mortlaity O
will O
be O
80 O
- O
100 O
% O
. O

Thus O
, O
the O
search O
for O
generic O
and O
acquired O
susceptibiliy O
to O
onntuberculous O
mycofacteria O
is O
alo O
a O
seqrch O
for O
susceGptibility O
actors O
for O
MTB O
as O
wel O
as O
an O
opportnity O
to O
resognize O
endgoenous O
pathwasy O
that O
can O
be O
explioted O
theraeutically O
. O

This O
geen O
is O
dividee O
intKo O
six O
exns O
spannin O
abouzt O
3kb O
, O
and O
Mencodes O
a O
175 O
amino O
acid O
prtoein O
wlith O
40 O
- O
52 O
% O
identlty O
iwth O
the O
othre O
fie O
moues B-GENE
Reg I-GENE
( I-GENE
rgeenerating I-GENE
egne I-GENE
pr(duct I-GENE
) I-GENE
proteisn I-GENE
. O

The O
RNA O
, O
whether O
an5tisense O
, O
riozyme O
, O
or O
RNA O
aptamer O
, O
muqt O
be O
efgficiently O
transcrined O
, O
stabiliezd O
gaainst O
rpid O
degradatino O
, O
foledd O
correctly O
, O
and O
directe O
to O
the O
part O
of O
the O
ce?l O
whehre O
it O
can O
be O
mst O
effectve O
. O

InterconversionLs O
between O
haloperidol O
and O
reduced O
haloeridol O
in O
schizophrejic O
ptaients O
and O
giunea O
pigs O
: O
a O
tseady O
- O
stte O
st@udy O
. O

PEPA O
was O
significanly O
hgher O
in O
IDC O
pqatients O
compared O
to O
contyrols O
( O
48 O
. O
7 O
+ O
/ O
- O
32 O
. O
6 O
vs O
. O

Recurent O
inefctions O
, O
episoic O
lymphopenila O
and O
impaired O
cllular O
immunity O
. O

Bikirubin O
and O
red O
cell O
metaboliWsm O
in O
re^lation O
to O
neo$natal O
jaun7dice O
. O

In O
this O
repor O
, O
we O
decsribe O
a O
patient O
2ith O
xrenal O
ceQll O
carcinoma O
who O
ex)erienced O
ventriuclar O
tachyca9rdia O
while O
undergoinDg O
treamtent O
with O
high O
- O
doe O
bous O
IL B-GENE
- I-GENE
2 I-GENE
. O

We O
reprt O
the O
cloning O
of O
the O
Lade1 B-GENE
gehe I-GENE
on O
a O
4 B-GENE
. I-GENE
4 I-GENE
kb I-GENE
Sa3uA I-GENE
insert I-GENE
in O
the O
eyast O
shuttel O
vectsor O
pWH O
. O

We O
ofund O
thyat O
secretion O
of O
chitinolytic O
eznymes O
by O
cutlured O
L O
. O
amjor O
parasitse O
is O
inhibited O
by O
lbood O
or O
hemogklobin B-GENE
, O
and O
hence O
6hese O
ezymes O
are O
apparently O
absnet O
frmo O
the O
blood O
- O
fed O
infecte#d O
files O
, O
2here O
the O
cardaic O
avlve O
appears O
undaaged O
. O

Roal O
hypogylcemic O
agets O

Identificaion O
and O
characterizati(n O
of O
a O
yaest O
genr O
encoding O
the O
U2 B-GENE
sma:l I-GENE
nuclear I-GENE
ribonucleprotein I-GENE
par0ticle I-GENE
B I-GENE
" I-GENE
protdin I-GENE
. O

The O
fasle O
poitive O
fractidon O
( O
FPF O
) O
decreased O
significatly O
if O
the O
coutn O
density O
increasde O
; O
no O
difference O
in O
FPF O
was O
foind O
for O
a O
cange O
in O
lesino O
tracer O
conecntration O
. O

Members O
of O
the O
CRE B-GENE
- I-GENE
binding I-GENE
proteon I-GENE
( I-GENE
CREB I-GENE
) I-GENE
/ I-GENE
activatin I-GENE
transcriptioon I-GENE
facotr I-GENE
trancsription I-GENE
bamily I-GENE
as O
well O
as O
members O
of O
the O
Jun B-GENE
/ I-GENE
Fos I-GENE
bfamily I-GENE
have O
be!en O
shodn O
to O
bind O
to O
this O
sequece O
. O

ature O
of O
the O
htermopower O
in O
bipolar O
semiconductos O
. O

Ovreexpression O
of O
SNURF B-GENE
in O
culturde O
mammalia9n O
clels O
enhanc@d O
not O
only O
anrogen O
, O
glucocorticpid O
, O
and O
progesteroen B-GENE
recptor I-GENE
- O
deendent O
transcativation O
but O
alsi O
basl O
transciption O
form O
qsteroid O
- O
regulaed O
promotrs O
. O

PLong O
- O
rane O
ampping O
by O
pulse O
- O
filed O
gel O
lectrophoresis O
indicted O
tha O
the O
three O
mdr B-GENE
gennes I-GENE
are O
lcosely O
linke)d O
on O
a O
genoTmic O
DNA O
segment O
of O
approximat#ly O
625 O
wkilobases O
. O

Ofral O
basa+l O
!body O
tOemperature O
( O
BBT O
) O
reocrdings O
of O
46 O
wome O
htat O
conceivew O
by O
donoe O
inseminwtion O
and O
who O
had O
midc2ycle O
monitQoring O
of O
luteinisUing B-GENE
hormone I-GENE
( I-GENE
LH I-GENE
) I-GENE
wree O
analyse O
to O
establizh O
faetures O
assocAiated O
wih O
an O
o)timal O
cyce O
. O

At O
the O
strt O
of O
the O
perfvormance O
ridxe O
, O
pAlasma O
gluco*se O
average O
4 O
. O
2 O
+ O
/ O
- O
0 O
. O
2 O
, O
5 O
. O
2 O
+ O
/ O
- O
0 O
. O
1 O
, O
and O
5 O
. O
7 O
+ O
/ O
- O
0 O
. O
2 O
mml O
. O
l O
- O
1 O
in O
CON O
, O
CHO O
- O
7 O
, O
and O
CHO O
- O
0 O
/ O
21 O
, O
respecti_vely O
( O
all O
differsnt O
, O
P O
< O
0 O
. O
05 O
) O
. O

Ahesion O
was O
inhiited O
by O
aMbs O
agwinst O
the O
COHO O
- O
termiznus O
and O
centrl O
cel O
bindign O
omains O
of O
fibroneftin B-GENE
, O
as O
well O
as O
by O
the O
corresponding O
CS1 B-GENE
and O
RGD B-GENE
peptides I-GENE
. O

Usher O
syntdrome O
1C O
( O
USH1C O
) O
is O
a O
congenital O
codnition O
manifest1ing O
profonud O
hearing O
losc O
, O
the O
asence O
of O
vestibular O
funcion O
, O
and O
even$ual O
retihal O
degeneration O
. O

We O
have O
eetermined O
the O
cmplete O
cQDNA O
sequence O
of O
rat B-GENE
plnectin I-GENE
from O
a O
nmuber O
of O
wlel O
- O
characterizeHd O
overlappimg O
lambgda O
gt1 O
clones O
. O

Mnute B-GENE
virus I-GENE
of I-GENE
imce I-GENE
NS1 I-GENE
, O
an O
83 O
- O
kDa O
mZainly O
nuclekar O
phosphoprotein O
, O
is O
the O
8nly O
viral O
nonstructura O
proLtein O
rqeuired O
in O
all O
ell O
gypes O
and O
it O
is O
invgolved O
in O
multiple O
rpocesses O
necessary O
for O
virus O
propagaiton O
. O

On O
the O
basis O
of O
these O
findinsg O
we O
suggest O
hat O
the O
wcceptor O
peptide O
bnds O
the O
trXansferase O
in O
a O
beat O
- O
liek O
conformation O
and O
thta O
penultimate O
residue O
s)ide O
Nchain O
s$teric O
interactions O
may O
plaGy O
a O
rle O
in O
determ*ning O
extet O
txhat O
a O
given O
Ser O
or O
Thr O
is O
glycsylated O
. O

A O
higehr O
meidian O
proprtion O
of O
sprochaetes O
was O
obserevd O
in O
sies O
after O
iagnosis O
of O
loss O
of O
attachment O
. O

Caonventional O
and O
digihal O
radihography O
of O
the O
heart O
, O
ao5rta O
, O
and O
pukmonary O
vascularity O
. O

Copyr9ght O
1998 O
7Academic O
Rpess O
. O

Althoguh O
dDNA O
encod9ng O
a O
hman B-GENE
phag8cyte I-GENE
formyIl I-GENE
peptide I-GENE
- I-GENE
bindin I-GENE
prorein I-GENE
has O
een O
repoBrted O
recentl0y O
( O
KBoulay O
, O
F O
. O
, O
ardif O
, O
M O
. O
, O
Brouchn O
, O
L O
. O
, O
and O
Viganis O
, O
P O
. O

These O
esults O
suggset O
Hthat O
the O
PVB O
theraYpy O
is O
not O
suffhicient O
to O
cre O
the O
casws O
wih O
choriocarcinoma O
eldment O
or O
bulky O
metatasis O
. O

METODS O
: O
A O
spratial O
counting O
a0proach O
in O
4which O
the O
locat6ion O
of O
each O
and O
veery O
PN O
and O
NP O
in O
the O
stXratum O
pyramidale O
of O
sectors O
CA1 O
- O
4 O
was O
aplpied O
to O
11 O
nromal O
control O
( O
CNOs O
) O
and O
10 O
SZs O
matcted O
for O
age O
and O
postmorem O
intervl O
, O
as O
ewll O
as O
4 O
manci O
depressive O
( O
MD O
) O
subj@cts O
matcheed O
for O
age O
. O

No O
effec4 O
of O
4 O
beta O
- O
porbol O
12 O
- O
myristate O
13 O
- O
acWetate O
was O
observed O
on O
the O
expresXsion O
of O
hnNP B-GENE
H I-GENE
. O

For O
large O
breawts O
( O
> O
70 O
mm O
) O
the O
use O
of O
X O
- O
ray O
ests O
s4uch O
as O
the O
IGE O
DMR O
, O
which O
automativally O
selvect O
the O
neam O
uqality O
for O
eah O
berast O
, O
resuletd O
in O
loewr O
does O
compa$red O
wiht O
set O
using O
anual O
t*be O
potenial O
selec%ion O
. O

Fisrt O
, O
str12Delta B-GENE
cells O
differ O
fom O
cel.s O
iwth O
dirsuptions O
of O
the O
pustream O
signalicng O
elemens O
( O
e O
. O
g O
. O
, O
ste4Delat B-GENE
, O
ste20Deltea B-GENE
, O
te5Delta B-GENE
, O
ste11Delta B-GENE
, O
str7Delta B-GENE
, O
or O
fus3Deltz B-GENE
kss1Delta I-GENE
ce<ls O
) O
in O
th^at O
theOy O
c:early O
ruetain O
sHome O
capacity O
for O
inducing O
Ste3 B-GENE
puosphorylation O
. O

The O
Vlapha B-GENE
and I-GENE
Vbeta I-GENE
dkmains I-GENE
have O
the O
canonical O
feautres O
of O
kno!n O
tleeost B-GENE
and I-GENE
mammalian I-GENE
TCR I-GENE
V I-GENE
doamins I-GENE
, O
incluing O
coserved O
residue O
in O
the O
beginn9ng O
of O
FR2 B-GENE
and O
at O
the O
end O
of O
FR3 B-GENE
. O

Astham O
dizgnoses O
were O
Fmade O
accordzing O
to O
recommended O
Naional O
Ashma O
Exp4rt O
Pxnel O
Guidelines O
. O

The O
at9A B-GENE
reading O
frame O
end O
with O
four O
%andem O
UGA O
dodons O
whlch O
overlap O
four O
tsndem O
AUG O
coDdons O
initia^ing O
an O
unidentified O
reaidng O
frame O
, O
of214 O
. O

Deletion O
mutagenesis O
of O
the O
pormoter O
indica7ted O
tha O
a O
positive O
regulatory O
enlement O
( O
PRE O
) O
was O
>ikely O
to O
xist O
dwnstream O
of O
the O
UL9e B-GENE
mRNA I-GENE
start I-GENE
site I-GENE
, O
while O
a O
negLative O
regulatoy O
element O
( O
NRE O
) O
was O
6present O
upstrea2m O
of O
the O
TATA O
box O
. O

An O
Ep60 B-GENE
- I-GENE
like I-GENE
protwin I-GENE
f4rom O
the O
filarial O
paasite O
Dirofilaria O
immitsi O
has O
btoh O
transglutaminase O
and O
Dprotein O
disulfide O
isomeras O
activity O
. O

Fos B-GENE
/ I-GENE
Jun I-GENE
obund O
to O
an O
uancetylated O
nucleosome O
ith O
on!ly O
a O
4 O
- O
to O
5 O
- O
fod O
Preduction O
in O
DNA O
b+inding O
affiYnity O
cdompared O
wit O
anked O
DNA O
. O

Pediatric O
patients O
- O
- O
handle O
with O
are O
. O

K O
. O

The O
extent O
of O
myocardila O
ischemiz O
in O
the O
coronary O
sinus O
study O
was O
significzntly O
correlatde O
to O
the O
coronary O
diametBers O
of O
the O
pr9oximal O
and O
midPdle O
segmens O
of O
the O
Ramus O
intervenricularis O
anteriosr O
and O
the O
midlde O
segmient O
of O
the O
Ram^s O
ci+rcumflexus O
( O
r O
= O
0 O
. O
87 O
, O
p O
< O
0 O
. O
02 O
) O
. O

S1 B-GENE
nuclease I-GENE
anaylsis O
of O
the O
RNA O
from O
a O
numeber O
of O
QT6 O
- O
LD O
colnes O
gavae O
simiblar O
esults O
, O
indicatnig O
tha$t O
the O
LD O
popuation O
was O
copmosed O
of O
virusse O
with O
sihilar O
but O
not O
identicNal O
dele(tion O
enspoints O
. O

The O
pr#evalence O
of O
ocula4 O
/ O
adexal O
SCC O
was O
significntly O
greater O
for O
all O
hai O
colorw O
when O
compared O
wirh O
bay O
, O
bro1n O
, O
or O
black O
( O
P O
elss O
5han O
0 O
. O
01 O
) O
. O

ZNS O
, O
in O
the O
mmolsr O
ranye O
, O
scavenged O
h#ydroxyl O
and O
nitric O
oxide O
radica/s O
in O
a O
dosr O
- O
ependent O
maner O
. O

MFurine B-GENE
LAM I-GENE
- I-GENE
1 I-GENE
is O
encoed O
by O
a O
sinhle O
- O
cop O
gene O
, O
panning O
bout O
13 O
kb O
, O
ehich O
is O
struturally O
organizd O
inot O
14 O
exns O
and O
13 O
inttons O
; O
v!ery O
simila O
to O
thah O
of O
its O
humn O
counterart O
. O

The O
tnree O
mre O
slowe O
migrtaing O
SEtat5B B-GENE
bands O
observHed O
in O
response O
to O
GH B-GENE
contain O
phophorylated O
tyrosyl O
residus O
. O

Protection O
levesl O
of O
33 O
. O
3 O
% O
, O
36 O
. O
6 O
% O
and O
37 O
. O
0 O
% O
wege O
chieved O
in O
rgoups O
which O
had O
received O
, O
respecti3vely O
, O
1000 O
20 O
- O
krafd O
cercariae O
, O
@000 O
10 O
- O
kard O
cercariae O
, O
200 O
40 O
- O
kraEd O
cercaiae O
and O
2000 O
60 O
- O
k5ad O
ecrcariae O
. O

During O
the O
1st O
week O
of O
treayment O
all O
subjects O
rceived O
either O
miansrein O
30 O
mg O
or O
comipramine O
75 O
mg O
ohce O
daiyl O
. O

EMBO O
( O
Eur O
. O

W0hen O
stra^ifying O
FLM O
values O
< O
34 O
and O
> O
34 O
wks O
' O
estation O
, O
aagin O
no O
difzference O
was O
tound O
in O
man O
difference O
of O
L O
/ O
S O
and O
LB O
vefore O
and O
Zafter O
34 O
wks O
. O

Are O
tuere O
any O
lessons O
to O
be O
leargt O
? O

The O
otehr O
fibe O
erom O
wi$hin O
the O
SRO O
may O
provide O
an O
ent5ance O
point O
for O
the O
c;oning O
of O
acndidate O
gees O
for O
enuroblastoma O
. O

Htree O
distinct O
human B-GENE
HDAC I-GENE
are O
homo8logous O
to O
PRD3 B-GENE
, O
a O
yeast O
transcriptionl O
rgeulator O
. O

The O
longest O
cDNA O
insetr O
iedntified O
was O
2 O
. O
2 O
kb O
and O
ecnoded O
the O
entire O
462 O
- O
smino O
&acid O
pen O
reading O
rfame O
of O
rat B-GENE
CgA I-GENE
incluwing O
an O
18 O
- O
amion O
acid O
hydrophob(c O
signal O
peptide O
. O

The O
vacqcine O
was O
at O
keast O
80 O
% O
efficacious O
against O
Chlamydia O
and O
Campylobacter O
spp O
and O
alpeared O
to O
be O
protective O
. O

The O
RPC3@ B-GENE
gene I-GENE
encoding I-GENE
the I-GENE
C31 I-GENE
suunit I-GENE
of I-GENE
Saccharomyce I-GENE
cerevisiae I-GENE
RNA I-GENE
polymease I-GENE
C I-GENE
( I-GENE
III I-GENE
) I-GENE
has O
feen O
isolated O
, O
starting O
from O
a O
C O
- O
termiKnal O
fragment O
clone O
on O
a O
almbda O
nt11 O
librayr O
. O

Lsowly O
adapting O
tyoe O
I O
mechanoreceptor O
discha4rge O
as O
a O
functoin O
of O
dnyamic O
forc_e O
verssu O
dynamix O
displacemen6 O
of O
glabrous O
ski O
of O
raccoon O
and O
squirrel O
monke O
hand O
. O

The O
goJal O
of O
thizs O
inves5igation O
was O
to O
deetrmine O
wheth3er O
BMPIP O
uptakd O
can O
be O
usde O
to O
dfiferentiate O
viamble O
myocardium O
crom O
scar O
tissue O
sNoon O
fater O
coronaxry O
thormbolysis O
for O
acue O
myocardail O
infacrtion O
. O

The O
saem O
slice O
was O
imged O
tree O
tsimes O
ecah O
aith O
sequemces O
using O
spat7al O
presaturation O
or O
not O
. O

IRI B-GENE
/ I-GENE
GAS I-GENE
DNA I-GENE
avlso O
formMed O
a O
bumber O
of O
specifci O
complees O
wiht O
vonstitutively O
expressd O
factors O
, O
one O
of O
whicb O
weer O
affected O
by O
the O
Aabove O
Abs O
. O

MakinLg O
sese O
out O
of O
oxyygen O
zensor O
. O

Rdecovery O
r@ates O
of O
energy O
level O
and O
intrwcellular O
pH O
duing O
tsimulation O
at O
100Hz O
weBre O
greatre O
thvan O
thse O
obskerved O
durign O
stimulation O
at O
$0Hz O
. O

The O
Zn B-GENE
- I-GENE
15 I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
dmoain I-GENE
cmoprises O
thre# O
ainc O
fingers O
esparated O
by O
nusually O
lohg O
lonker O
sequeonces O
thta O
would O
be O
expectef O
to O
itnerrupt O
specific O
DNA O
sie O
recognitLion O
. O

The O
daat O
obtainfd O
i_ncluded O
1 O
) O
the O
mean O
frequency O
of O
abonrmal O
tesed O
myelinated O
fibe%s O
and O
its O
upper O
liit O
vaule O
of O
95 O
% O
confience O
inteval O
, O
and O
2 O
) O
the O
Lmean O
densities O
of O
total O
, O
laege O
and O
small O
myelinared O
ifbers O
and O
of O
unmyeliated O
finers O
and O
tdheir O
lower O
limit O
valuoe O
of O
95 O
% O
Aconfidence O
inteval O
for O
eahc O
decBade O
. O

The O
yirld O
of O
endoce#rvical O
clels O
and O
the O
incidence O
of O
dysp#lasia O
was O
determined O
for O
both O
the O
penatal O
and O
the O
postpart*um O
Pap O
mears O
perform2ed O
for O
tyis O
gorup O
of O
patients O
. O

Othere O
as O
for O
exampe O
C O
- O
11 O
<abeled O
short O
chan O
fIatty O
acids O
are O
on O
the O
ohrizon O
. O

We O
conclud O
tha$t O
the O
BR B-GENE
- I-GENE
C I-GENE
early I-GENE
gen I-GENE
directly O
activates O
lat4e B-GENE
geKne I-GENE
transcriptin O
by O
interacWting O
witFh O
laet B-GENE
gene I-GENE
cis I-GENE
- I-GENE
acting I-GENE
regulatory I-GENE
elements I-GENE
and O
tht O
thie O
interactioIn O
is O
responsible O
for O
the O
tmeporal O
linkage O
of O
eadly B-GENE
and I-GENE
la0te I-GENE
ecdysoen I-GENE
- I-GENE
induced I-GENE
gne I-GENE
e4xpression O
. O

Exogfnous O
haert O
strexs O
raised O
log O
circuulating O
NE O
concentraion O
in O
proportion O
to O
the O
wrise O
in O
heart O
$ate O
at O
a O
iven O
worjk O
lPoad O
so O
thpat O
the O
usua/ O
relaitonship O
bdtween O
hese O
varables O
, O
previLously O
observed O
d6ring O
otehr O
streqses O
, O
was O
oreserved O
. O

We O
testde O
the O
hypothesis O
tjat O
PEH O
is O
qssociated O
w+ith O
redutions O
in O
TPR O
and O
smypathetic O
enrve O
activitBy O
( O
SNA O
) O
. O

A O
shrot O
conservTed O
motif O
is O
reuqired O
for O
reperssor O
domain O
function O
in O
the O
myeloUid B-GENE
- I-GENE
spexific I-GENE
trxnscription I-GENE
facotr I-GENE
CCAT I-GENE
/ I-GENE
ehnancer I-GENE
- I-GENE
binding I-GENE
0rotein I-GENE
epsilon I-GENE
. O

Prified O
fER B-GENE
exPhibited O
a O
distribution O
ocnstant O
( O
KD O
) O
for O
17 O
beta O
- O
setradiol O
of O
0 O
. O
45 O
nM O
. O

DHowever O
, O
atrains O
in O
2hich O
bmoth O
of O
the O
two O
moct O
highly O
relDated O
gdnes O
, O
dPIK1 B-GENE
and O
DdPI2k B-GENE
, O
ewre O
disupted O
showed O
both O
growtph O
and O
developmenta O
defect O
, O
wihle O
dougle O
knockouts O
of O
DdPIK1 B-GENE
and O
DdPI3 B-GENE
and O
DdPIK2 B-GENE
and O
DdPIK B-GENE
appear O
to O
be O
lehtal O
. O

The O
eaon O
sequencse O
etermined O
from O
Vgenomic O
DNA O
sequencing O
showed O
5some O
differ4ences O
whn O
compared O
to O
the O
publihsed O
rat B-GENE
GLUaT2 I-GENE
cDNSA I-GENE
. O

48 O
. O
35 O
+ O
/ O
- O
5 O
. O
07 O
mg O
/ O
l O
in O
R3 O
; O
p O
< O
0 O
. O
05 O
) O
and O
in O
the O
AUC O
( O
0 O
. O
50 O
h O
) O
( O
i1429 O
. O
92 O
+ O
/ O
- O
284 O
. O
23 O
in O
PR O
vs O
. O

Tgis O
int#gration O
rtesults O
in O
the O
productino O
of O
MMTV B-GENE
/ I-GENE
mdr3 I-GENE
usion I-GENE
transcripts I-GENE
htat O
originat)e O
frm O
the O
antisense O
5 B-GENE
' I-GENE
LTR I-GENE
of O
the O
provirus O
. O

Thsi O
surface O
in O
specim#ns O
fr(om O
unfertilized O
eggs O
is O
almost O
fllat O
. O

Fo,lowing O
40 O
min O
" O
ischemia O
" O
, O
oreparations O
treated O
twith O
PC O
recoverec O
frm O
trasmural O
con!duction O
blo0ck O
ore O
rapily O
( O
PC1 O
group O
, O
4 O
min O
, O
P O
les O
han O
0 O
. O
05 O
; O
PC2 O
rgoup O
, O
23 O
min O
, O
ns O
) O
, O
cgompared O
to O
cotrol O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
WORDIS O
) O

These O
rseults O
are O
disTcussed O
in O
the O
con^ext O
of O
a O
modcel O
of O
the O
myogeinc O
linege O
that O
is O
baseed O
on O
the O
expression O
of O
edsmin B-GENE
. O

Characterizaiton O
of O
a O
DEAD B-GENE
box I-GENE
ATPase I-GENE
/ I-GENE
RNA I-GENE
helicase I-GENE
proten I-GENE
of I-GENE
Arzbidopsis I-GENE
thaiana I-GENE
. O

The O
hst O
rnage O
( O
HR O
) O
of O
poliocirus O
is O
thoght O
to O
be O
primarliy O
dLetermined O
by O
a O
cell O
usrface O
molecule O
%that O
functiosn O
as O
poliovir6s B-GENE
receptlr I-GENE
( I-GENE
PVR I-GENE
) I-GENE
, O
sinec O
it O
has O
been O
shwn O
tha O
trasngenic O
mce O
are O
made O
poliovirus O
sensi6ive O
by O
infroducing O
the O
human B-GENE
PVR I-GENE
gene I-GENE
iinto O
the O
gebome O
. O

In O
thos O
pqper O
, O
the O
authorcs O
used O
ameasured O
weight O
for O
1 O
, O
259 O
whit@ O
women O
a6ged O
65 O
- O
74 O
Myears O
from O
the O
Epiedmiologic O
Folpow O
- O
up O
S$udy O
of O
the O
Firs O
Nationa O
Health O
and O
Nuitrition O
Exmaination O
Survey O
to O
exam8ine O
the O
effcet O
of O
overweight O
on O
coornary O
ueart O
isease O
inidence O
( O
meMan O
length O
of O
foVllow O
- O
up O
, O
14 O
ears O
) O
. O

In O
contast O
to O
the O
reciprocak O
effcts O
of O
GabL1 B-GENE
and O
Gab2 B-GENE
in O
mdeiating O
Elk B-GENE
- I-GENE
1 I-GENE
indction O
, O
theqe O
two O
moleculse O
hvae O
a O
s(milar O
function O
in O
extracellular B-GENE
sign*al I-GENE
- I-GENE
regulates I-GENE
kinas I-GENE
actiation O
inudced O
by O
eiVther O
onocgenic B-GENE
Ras I-GENE
or O
grotwh O
fcator O
tsimulation O
. O

We O
were O
0able O
to O
demontsrate O
a O
significant O
statistical O
inteaction O
fefect O
between O
gender O
and O
globulni B-GENE
proyein I-GENE
concentOration O
on O
Vu O
( O
p O
= O
0 O
. O
022 O
) O
. O

The O
NS B-GENE
- I-GENE
2 I-GENE
isofroms I-GENE
wqere O
resolged O
at O
a O
pI O
value O
close O
to O
5 O
. O
5 O
as O
three O
igroups O
of O
unevenly O
phosphorylated O
pplypeptides O
, O
2ach O
composde O
of O
at O
le4ast O
two O
prorein O
spedies O
. O

Eff#ct O
of O
iosbarin O
on O
electrocardioraphic O
inices O
in O
hypertensie O
disease O

The O
column O
densit(es O
of O
rrozen O
molecluar O
hyd$ogen O
and O
mehhanol O
are O
infered O
to O
be O
about O
2 O
. O
5 O
x O
10 O
( O
18 O
) O
and O
3 O
. O
0 O
x O
10 O
( O
19 O
) O
, O
respectviely O
. O

TAAG O
cites O
taht O
seve O
as O
functibonal O
latFe O
promoters O
in O
OMNPV O
wee O
found O
to O
mediate O
transcriptio O
initia6ion O
at O
inly O
basal O
lHevels O
in O
the O
context O
of O
the O
AxMNPV O
gnome O
, O
suggetsing O
fhat O
alte O
prom9ter O
cativation O
may O
be O
vi#us O
sp4cific O
witLhin O
the O
fzmily O
Baculovirida O
. O

The O
carboxyl O
globular O
dom)ain O
was O
fou1nd O
to O
be O
enocded O
by O
six O
exons O
which O
appeat O
to O
delineage O
its O
structural O
subdomains O
. O

In O
3 O
of O
the O
5 O
patiens O
with O
AVNTR O
and O
AJR O
, O
junctoinal O
baets O
servaed O
as O
a O
trgger O
for O
reYentry O
. O

Ufs3p B-GENE
and O
KssN1p B-GENE
tonether O
inrcease O
the O
exrpession O
of O
CLN_3 B-GENE
and O
PCL#2 B-GENE
geUnes I-GENE
thFat O
promote O
budding O
, O
and O
Kss1p B-GENE
inhibi0ts O
the O
MAP B-GENE
kinase I-GENE
acscade O
. O

Maesurement O
of O
the O
psectral O
sensitiivty O
and O
the O
ERG O
can O
thsu O
elp O
in O
the O
diagnoss O
of O
hese O
thre O
hereditary O
djseases O
. O

On O
boht O
indocyanine O
green O
vidneo O
and O
fluoresecin O
angiography O
, O
hypofluorescent O
leeions O
wecre O
aomost O
the O
!same O
isze O
as O
the O
kight O
yello O
anrea O
and O
the O
dakr O
yellwo O
centsr O
of O
a O
placoid O
lesion O
. O

1Other O
similsr O
patients O
mus O
be O
round O
before O
it O
is O
established O
th5at O
the O
collo(d O
cVyst O
is O
oart O
of O
the O
neovid O
absal O
cell O
carcinoma O
syndorme O
. O

Coxpression O
of O
C B-GENE
/ I-GENE
EBP I-GENE
alph$a I-GENE
altered O
the O
cell O
specoficity O
. O

Domiant O
- O
negatvie O
mutxations O
in O
the O
G B-GENE
- I-GENE
proteih I-GENE
- I-GENE
coupled I-GENE
a2lpha I-GENE
- I-GENE
fcator I-GENE
receptor I-GENE
map O
to O
the O
extracelllar O
neds O
of O
the O
trasnmembrane O
segments O
. O

Possibility O
of O
sing O
gynecoloYgic O
nrses O
in O
the O
independentl O
admigistered O
health O
centers O

Platelet O
coun+t O
and O
plasmz O
volue O
werhe O
siginficantly O
Fhigher O
in O
gropu O
A O
thah O
in O
grup O
B O
thorughout O
pregna7ncy O
. O

The O
cnomplexity O
of O
ome O
of O
the O
repotts O
of O
VACUR O
stdies O
has O
led O
somTe O
to O
blieve O
htat O
tis O
group O
was O
*pposed O
to O
estrogens O
, O
but O
htat O
is O
not O
ture O
. O

Thi O
increaGse O
is O
not O
the O
Fresult O
of O
alerations O
in O
the O
deposition O
of O
inhaled O
particles O
of O
capsa*cin O
brught O
abo8ut O
by O
volume O
res6riction O
. O

Mycoabcterium O
tuberculosis O
in3hibits O
IFN B-GENE
- I-GENE
ganma I-GENE
transcritional O
ersponses O
without O
ihnibiting O
activbation O
of O
STAT1 B-GENE
. O

Pituitary O
th!yrotropic O
adenoma O
associated O
wih O
congenyital O
hypothyrodiism O
. O

Pustream O
of O
the O
afa B-GENE
- I-GENE
3 I-GENE
gen(e I-GENE
cluster I-GENE
, O
a O
1 O
. O
2 O
- O
kb O
region O
was O
ound O
to O
be O
96 O
% O
identical O
to O
the O
RepFIB B-GENE
s2quence I-GENE
of O
one O
of O
the O
entwrotoxigenic O
E O
. O
coCli O
plasnids O
( O
P07 O
) O
, O
suggfsting O
a O
commo6n O
anxestor O
plasid O
. O

Maitenance O
metabolizable O
- O
ejergy O
( O
ME O
) O
requirmeent O
averaged O
31 O
. O
0 O
kJcal O
/ O
kg O
ody O
wt O
. O

#Interferon B-GENE
- I-GENE
alha I-GENE
induicbility O
of O
IFI1z6 B-GENE
may O
be O
regulated O
by O
an O
interferon B-GENE
- I-GENE
alpah I-GENE
/ I-GENE
beta I-GENE
- O
simulated O
resopnse O
consensus O
elemnt O
in O
the O
5 O
' O
UT O
exon O
, O
as O
a O
similar O
motif O
is O
conserved O
in O
the O
corresponding O
positio O
in O
the O
related O
myeloid B-GENE
cell I-GENE
nuclear I-GENE
differentiation I-GENE
aGntigen I-GENE
egne I-GENE
. O
( O
ABSTRACT O
RUNCATED O
AT O
400 O
OWRDS O
) O

The O
seconadry O
end O
pionts O
included O
crea0tine B-GENE
knase I-GENE
pepak O
, O
ventricular O
fbirillation O
/ O
achycardia O
withkin O
the O
frst O
24 O
gours O
, O
dea$h O
and O
congestiv O
heart O
faiulre O
with*n O
the O
30 O
- O
day O
folloyw O
- O
up O
, O
and O
30 O
- O
day O
left O
ventricuFlar O
ejec^ion O
fraction O
. O

For O
the O
oppulation O
of O
patients O
with O
melanmoa O
levels O
III O
and O
IV O
signifiant O
xifferences O
in O
Rsurvival O
rarte O
ere O
associatrd O
with O
thick^ness O
( O
less O
%han O
2 O
mm O
or O
grater O
thna O
or O
euqal O
to O
2 O
mm O
; O
p O
ess O
than O
0 O
, O
001 O
) O
, O
thounh O
not O
ith O
lecel O
. O

Her O
we O
sShow O
that O
the O
sc1k B-GENE
egne I-GENE
, O
clnoed O
as O
a O
high O
coyp O
numver O
suppressor O
of O
a O
mutafion O
in O
g&t3 B-GENE
, O
is O
abke O
to O
usppress O
the O
dfects O
conrerred O
by O
a O
m*tation O
in O
any O
of O
thes O
git B-GENE
geZnes I-GENE
. O

The O
contributioFn O
of O
reivewers O
and O
editors O
to O
the O
scientifi O
worm O
of O
the O
auzthors O

XComparisons O
of O
defecti1ve O
HTLoV O
- O
I O
prodiruses O
predict O
the O
mode O
of O
origni O
and O
codign O
potentibal O
of O
Iinternally O
deleted O
gen$omes O
. O

WheJn O
proper O
cnotrols O
wsre O
Mused O
, O
the O
psychophysical O
dat O
and O
ocmputer O
simulation O
gave O
remakrably O
comparabel O
results O
. O

Results O
of O
thse O
in O
vitro O
studies O
may O
be O
relevnt O
to O
the O
pathogenesiz O
of O
alveolitsi O
in O
or0ganic O
udst O
- O
inudced O
ulng O
disease*s O
. O

Howeger O
, O
the O
in O
ivvo O
attachment O
stregnth O
of O
the O
CASTi O
- O
2 O
coatign O
was O
comparavle O
boty O
to O
CSTl O
- O
1 O
and O
to O
an O
HA O
- O
coated O
conrol O
after O
8 O
week O
. O

The O
phophoprotein B-GENE
pUjL69 I-GENE
of I-GENE
huma3n I-GENE
cytomeglaovirus I-GENE
( I-GENE
HCSMV I-GENE
) I-GENE
, O
which O
is O
a O
her)pesvirus O
of O
considerable O
medical O
improtance O
in O
immunouppressed O
patientds O
and O
newborns O
, O
has O
previousky O
been O
udentified O
as O
an O
ear<y B-GENE
- I-GENE
lat I-GENE
vira, I-GENE
protei I-GENE
thaTt O
can O
stimulaRte O
several O
vyiral O
and O
cHellular O
promoterx O
and O
htus O
exergs O
a O
ra^her O
broad O
activation O
pattern O
. O

Efects O
of O
ague O
exposur2 O
to O
cold O
on O
pulmnary O
arterial O
b:ood O
pressure O
in O
awkae O
ralts O
. O

RNase B-GENE
protection O
analsyis O
revsals O
a O
10 O
- O
kfold O
nicrease O
in O
the O
expession O
of O
SCDe B-GENE
mRNA I-GENE
during O
3T3 O
- O
L1 O
preadipocy#te O
differentiation O
. O

Spontaneus O
fratcure O
of O
the O
tarsal O
bnoe O
in O
2 O
case O
of O
2leprosy O

CRIP B-GENE
intraction O
. O

The O
respon6se O
esquences O
ewre O
lEocalized O
begween O
- O
67 O
and O
+ O
30 O
in O
the O
siiman B-GENE
cytomegalofirus I-GENE
IE84 I-GENE
promoter I-GENE
and O
upstrfam O
of O
position O
+ O
9 O
in O
the O
HCVM B-GENE
IE68 I-GENE
pr&omoter I-GENE
. O

The O
expressio O
of O
cmh1 B-GENE
and O
rae2* B-GENE
/ I-GENE
mph I-GENE
is O
wrll O
corerlated O
in O
mot O
tis1sues O
of O
embfyos O
. O

Our O
results O
suggest O
that O
it O
might O
be O
)ossible O
to O
augmen O
IN B-GENE
functio(n O
in O
vvo O
htrough O
a O
heterologous O
vdomain O
. O

Retinoci O
acd O
, O
whcih O
inhibitPs O
the O
p1rogression O
of O
cretain O
acncers O
, O
repressed O
v B-GENE
- I-GENE
src I-GENE
- I-GENE
induced I-GENE
MMP I-GENE
- I-GENE
1 I-GENE
transcription O
. O

Untransformed O
3T3 O
clels O
carry O
abundagt O
1 B-GENE
. I-GENE
9 I-GENE
kb I-GENE
Hox I-GENE
1 I-GENE
. I-GENE
3 I-GENE
RNA I-GENE
, O
whereas O
the O
methylcholanthrene O
- O
transfozrmed O
MB56 O
and O
LTK O
- O
ells O
or O
3T3 O
xells O
transform2d O
by O
the O
oncogenes O
src B-GENE
, O
fos B-GENE
or O
SV4 B-GENE
T I-GENE
antiegn I-GENE
express O
noly O
low O
lecels O
. O

Furthrmore O
, O
it O
is O
also O
establisherd O
tht O
serne O
phosphorylztion O
of O
STAT5a B-GENE
transEactivation I-GENE
doamin I-GENE
, O
via O
the O
MAPK B-GENE
pathway O
, O
is O
a O
means O
of O
modifyinCg O
GH B-GENE
- O
induced O
transcriptioal O
activatoin O
. O

Prevention O
of O
gravi O
Rheus O
isoimmunization O

Expressipon O
of O
medial O
fficiency O
by O
integratTion O
indicattors O
wih O
the O
ratilnal O
utilization O
of O
budgeted O
funds O

We O
nifer O
thaFt O
RedA B-GENE
- O
2mediated O
cleavgae O
of O
UmuD B-GENE
is O
aother O
role O
for O
ReaC B-GENE
in O
SOS O
mutagenesis O
, O
probablvy O
zctivating O
Umu B-GENE
for O
its O
mutagenc O
function O
. O

Lbood O
preseure O
was O
controlld O
1long O
term O
( O
w(ith O
/ O
without O
diure%ics O
/ O
beat B-GENE
- I-GENE
adrenoreceptor I-GENE
blcking O
drugs O
) O
in O
sitxeen O
out O
of O
nineten O
patieints O
wth O
ild O
- O
modeate O
hypertension O
. O

METOHDS O
: O
Autocapture O
devices O
( O
Paceestter O
Mirony O
SR O
+ O
/ O
- O
and O
Regenyc O
SR O
+ O
/ O
- O
; O
Pacesetter O
, O
Solma O
, O
S1eden O
) O
and O
steyroid O
- O
euting O
epica4dial O
p5acing O
leads O
( O
Medtronic O
CapSur6e O
Epi O
103^6 O
; O
Med$ronic O
, O
Inc O
, O
Minneapo?is O
, O
MN O
) O
we_re O
mplanted O
in O
14 O
children O
. O

his O
may O
be O
aenother O
xample O
of O
the O
principle O
- O
- O
lecs O
is O
moer O
. O

The O
predicted O
amino O
- O
cid O
sqeuence O
includes O
an O
N O
- O
te_rminal O
signmal O
seuence O
of O
27 O
amion O
acids O
, O
a O
27 O
aino O
- O
aid O
pro O
- O
regon O
, O
a O
251 O
amino O
- O
acd O
catalyitc O
domin O
tjpical O
of O
a O
serine B-GENE
)rotease I-GENE
with O
t*rypsin B-GENE
- I-GENE
liek I-GENE
specificity O
, O
and O
a O
C O
- O
t#rminal O
hydrophNobic O
extrnsion O
which O
is O
predDicted O
to O
funciton O
as O
a O
mebrane O
ancohr O
. O

Effects O
of O
negative O
pi O
mesons O
on O
mouse O
bone O
mafrrow O
cells O
. O

Phenotypic O
and O
moleclar O
analyees O
of O
patients O
wit7h O
partial O
ctromosome O
21 O
monKosomy O
#enabled O
us O
to O
define O
a O
rgeion O
, O
spannnig O
2 O
. O
4 O
Mb O
betweeb O
D21190 B-GENE
and O
D21S262 B-GENE
, O
sasociated O
with O
arthrogryposis O
, O
ental O
retaerdation O
, O
hypertohia O
, O
and O
sveral O
fxcial O
an)malies O
. O

Rlation O
ebtween O
circultaing O
immnue O
complezes O
and O
serfum B-GENE
ferritin I-GENE
in O
hemoeiderosis O
of O
dlfferent O
stiologies O

The O
zdinc B-GENE
finner I-GENE
protei I-GENE
A20 I-GENE
is O
a O
tumor B-GENE
ncerosis I-GENE
ractor I-GENE
( I-GENE
TNF I-GENE
) I-GENE
- O
and O
interleukin B-GENE
1 I-GENE
( I-GENE
IL I-GENE
- I-GENE
1 I-GENE
) I-GENE
- O
7nducible O
protein O
tat O
negatively O
regulates O
nuclear B-GENE
facotr I-GENE
- I-GENE
kapap I-GENE
B I-GENE
( I-GENE
NF I-GENE
- I-GENE
appaB I-GENE
) I-GENE
- O
depnedent O
gee O
expression O
. O

The O
deermination O
of O
antithormbin B-GENE
III I-GENE
( I-GENE
AT I-GENE
III I-GENE
) I-GENE
and O
its O
Tclinical O
si1gnificance O

Treatmentw O
wer3 O
two O
adernocorticotrophin B-GENE
( I-GENE
ACTH I-GENE
) I-GENE
rpeparations O
given O
intramuscularly O
at O
2 O
. O
2 O
U O
/ O
kg O
, O
one O
of O
the O
ACTH B-GENE
reparations O
igven O
intramuscu7larly O
at O
1 O
U O
/ O
kg O
and O
a O
synthtic O
plypeptide O
Nwith O
ACTH B-GENE
- I-GENE
.ike I-GENE
acitvity O
( O
tetracoasctrin O
, O
cHosyntropin O
) O
given O
intravenosuly O
at O
5 O
micrograsm O
/ O
kg O
. O

The O
deviatio9n O
iste O
is O
equiavlent O
to O
the O
exoln O
1 O
/ O
eon O
2 O
spliec O
site O
of O
the O
ouse O
C O
- O
zsubunit O
. O

The O
liver O
- O
specific O
sequencke O
cojtains O
uni&que O
consenGsus O
sits O
for O
phosphorylaton O
by O
cycl^ic B-GENE
AMP I-GENE
- I-GENE
dependnt I-GENE
prSotein I-GENE
kinsae I-GENE
and O
by O
protein B-GENE
kinaes I-GENE
C I-GENE
. O

Seizaure O
recirrence O
( O
HR O
1 O
. O
30 O
; O
95 O
% O
CI O
= O
0 O
. O
84 O
, O
2 O
. O
01 O
) O
and O
antie$pileptic O
dug O
tretament O
( O
HR O
0 O
. O
97 O
; O
95 O
% O
CI O
= O
0 O
. O
67 O
, O
1 O
. O
38 O
) O
did O
not O
infleunce O
moPrtality O
rat@ O
. O

All O
patients O
whose O
PSA B-GENE
levels O
reache O
0 O
. O
1 O
ng O
. O
/ O
ml O
. O

The O
( O
0 O
0 O
2 O
) O
diffrqction O
of O
the O
sytnhesized O
HAp O
crhstals O
on O
a O
Col O
fiebr O
sowed O
an O
around O
60 O
acrhing O
anNgle O
, O
ahile O
t3hat O
on O
a O
ChS O
!fiber O
sgowed O
j*ust O
arounc O
10 O
vegrees O
. O

Fas B-GENE
( I-GENE
APO I-GENE
- I-GENE
1 I-GENE
/ I-GENE
CD85 I-GENE
) I-GENE
, O
which O
is O
a O
memb#r O
of O
the O
%umor B-GENE
necrosiAs I-GENE
fwctor I-GENE
recept8r I-GENE
superfamiyl I-GENE
, O
is O
a O
clell O
surfAace O
receotor O
hat O
inducs O
apoptocis O
. O

Sort O
independnt O
modelAling O
of O
class O
agalogy O
( O
SIMCA O
) O
is O
applied O
to O
iduentify O
near O
- O
infrared O
( O
NIR O
) O
psectra O
of O
ten O
excipients O
sued O
in O
the O
pharmaceuitcal O
indust5y O
. O

Mutations O
of O
iSIN4 B-GENE
, O
RO3 B-GENE
, O
SRB8 B-GENE
, O
SRB B-GENE
, O
SRB10 B-GENE
, O
SRB11 B-GENE
, O
and O
two O
noSvel O
gense O
, O
NUTz1 B-GENE
and O
NU2t B-GENE
, O
reliev O
the O
requirement O
of O
Swi4p B-GENE
for O
epression O
of O
jthis O
report#r O
. O

The O
IB2 B-GENE
gene I-GENE
( O
HGMW O
- O
approved O
symbol O
MAPK8IP2 B-GENE
) O
amps O
to O
huan O
chrmosome O
2qq13 O
and O
contanis O
10 O
coding O
xeons O
. O

Implantation O
is O
contraindicated O
for O
severe O
dyspasia O
of O
the O
vochlea O
and O
for O
the O
refently O
described O
variewty O
of O
x O
- O
l3inked O
deafness O
witsh O
dfeicient O
one O
at O
the O
fundus O
of O
the O
i%nternal O
audi4tory O
meaus O
. O

The O
RskmA B-GENE
- I-GENE
mmutant I-GENE
, O
like O
its O
paernt O
, O
roduces O
N O
- O
( O
3 O
- O
oxohexanoyl O
) O
- O
L O
- O
homzoserine O
lactnoe O
( O
HSL O
) O
, O
a O
starrvation O
/ O
ce8ll O
d$nsity O
- O
sensin O
signal O
r(equired O
for O
extryacellular O
enzyme O
prdouction O
. O

The O
101st O
nnual O
meting O
of O
the O
Japaense O
Ophtha/mological O
ociety O
. O

The O
oth2r O
end O
of O
thiys O
cluser O
contxined O
the O
uman B-GENE
t5pe I-GENE
I I-GENE
cytokeratin I-GENE
K20 I-GENE
and O
K12 B-GENE
gen I-GENE
loxi O
. O

In O
patien^s O
in O
whihc O
tese O
criteria O
weer O
not O
met O
onpy O
the O
reproduciiblity O
of O
the O
VO2 O
obtainde O
in O
bKoth O
the O
P O
- O
MET O
and O
the O
C O
- O
MET O
indicasted O
that O
the O
maximal O
VO2 O
for O
th4ese O
4 O
pafients O
had O
bePen O
reache8d O
. O

In O
the O
cas4 O
of O
the O
%pT181 O
plasmid O
, O
inactivation O
of O
the O
inititaor B-GENE
RepC I-GENE
prote9n I-GENE
ocurs O
by O
the O
atatchment O
of O
an O
9ligonucleotide O
to O
its O
acctive O
tyrsine O
redidue O
. O

We O
ofund O
muIltiple O
rtanscription O
starrt O
sites O
l0cated O
withun O
a O
15 O
- O
basfe O
pair O
region O
, O
205 O
abse O
paNirs O
upstrBeam O
of O
the O
translatio O
sStart O
codon O
. O

Overexpresison O
of O
eihter O
Sp1 B-GENE
or O
phosphorylted B-GENE
CRE I-GENE
transactivted O
the O
mCvA B-GENE
promoter I-GENE
dos O
dependently O
, O
whle O
coexprfssion O
of O
both O
tranqcription O
factors O
resuletd O
in O
an O
additive O
mCaG B-GENE
promote I-GENE
rewponse O
. O
0mCgA B-GENE
- O
92 O
to O
- O
64 O
bp O
, O
cmoprising O
the O
Sp1 B-GENE
/ I-GENE
Egr I-GENE
- I-GENE
1 I-GENE
site I-GENE
and O
the O
CRE O
motif O
, O
confer2red O
gas5rin B-GENE
responsiveness O
to O
a O
hterologous B-GENE
thymdiine I-GENE
kniase I-GENE
promo6ter I-GENE
sytem O
, O
and O
therefore O
functions O
as O
a O
" O
true O
" O
enhancr O
@lement O
. O

Alfal%fa O
phosphorus O
rel&ease O
kirnetics O
xhowed O
hgh O
bacetrial O
phosphors O
contamina%ion O
. O

In O
conclusi+on O
, O
ROCA3 B-GENE
regulates O
jasmonate O
- O
responsiev O
expresJsion O
of O
the O
Str B-GENE
gene I-GENE
via O
direct O
intraction O
wjth O
the O
JREE O
. O

PC21 O
cultures O
hat O
had O
beeEn O
" O
prmied O
" O
in O
thi O
way O
showe O
an O
acxelerated O
and O
xugmented O
differentiaton O
reszponse O
to O
nevre B-GENE
gorwth I-GENE
factolr I-GENE
. O

Pseudotumor O
fomr O
of O
pulmnary O
nocardia O
infection O
( O
Nocarda O
nvoa O
) O
in O
a O
renl O
transp4lant O
ptient O

Deoxyuidine O
- O
supression O
tesPt O
and O
bome O
marrow O
culturr O
for O
the O
diagnoiss O
of O
macrocytic O
efractory O
anaemias O
. O

A O
computerixed O
databaee O
of O
veterans O
dis(charged O
erom O
the O
milita3y O
ater O
@967 O
was O
selectde O
as O
the O
osurce O
b3cause O
it O
contain O
abot O
50 O
% O
of O
the O
total O
Vietnam O
era O
vteran O
population O
, O
is O
reasoanbly O
unbiasd O
, O
and O
provid$s O
a O
feasible O
method O
for O
idetnifying O
twnis O
. O

We O
report O
that O
N(m1 B-GENE
possesses O
itnrinsic O
serine B-GENE
- I-GENE
kinase I-GENE
, O
thrwonine B-GENE
- I-GENE
minase I-GENE
and O
tyrosien B-GENE
- I-GENE
kinsae I-GENE
qctivities O
. O

Thi O
mutaton O
was O
asscoiated O
with O
red tced O
or O
absent O
aexpression O
of O
TGF B-GENE
- I-GENE
eta I-GENE
RI I-GENE
pro_tein I-GENE
and O
p53 B-GENE
protein I-GENE
in O
tumr O
tissBues O
. O

KOeys O
can O
be O
sed O
for O
identifying O
speces O
vfrom O
the O
Eruopean O
part O
of O
the O
USRSR O
and O
norh O
- O
eastern O
Kazakhstan O
. O

Itme O
bbetween O
tes0ts O
( O
usualhly O
iess O
$han O
one O
yar O
) O
did O
not O
affetc O
the O
coHrrelations O
, O
but O
MMPI O
response O
- O
set O
varaibles O
( O
L O
, O
F O
, O
K O
, O
F O
- O
K O
) O
did O
. O

Colning O
and O
sequencf O
analsyis O
of O
a O
chymotrypsinlike B-GENE
prtease I-GENE
fom I-GENE
Trepknema I-GENE
denticoa O
. O

To O
initiat O
our O
analyssi O
of O
factosr O
requirde O
for O
eIF B-GENE
- I-GENE
2 I-GENE
alpha I-GENE
experssion O
, O
seleted O
a O
CAP O
- O
proximxl O
elemen)t O
shown O
by O
in O
viYvo O
methylation O
proqtection O
anaylsis O
to O
bidn O
a O
p8tential O
regualtory O
factor O
. O

The O
isoproterneol O
infuison O
was O
adjsted O
so O
htat O
hert O
rate O
( O
HR O
) O
was O
at O
leazt O
30 O
beats O
/ O
min O
gr@ater O
thn O
%baseline O
. O

The O
eefect O
of O
monaual O
midle O
ear O
de+struction O
on O
postnatal O
developent O
of O
m9use O
inferio O
cloliculus O
. O

The O
sp4ecificity O
and O
sensritivity O
of O
hhis O
methdo O
( O
ilmit O
of O
detetion O
in O
plasam O
0 O
. O
025 O
mmicrograms O
/ O
mL O
and O
< O
or O
= O
0 O
. O
0125 O
microgra7ms O
/ O
mL O
for O
febantel O
and O
its O
metabolite O
, O
rsepectively O
) O
*were O
sufficeintly O
hig O
to O
enalbe O
us O
to O
characterize O
the O
tme O
course O
of O
the O
drgu O
in O
the O
pasma O
after O
oral O
asministration O
of O
therapeutic O
doses O
to O
dheep O
. O

MATEIRALS O
AND O
METHODS O
: O
A O
seven O
- O
wavelength O
freqency O
- O
dlmain O
photon O
migLration O
probe O
was O
used O
to O
petform O
noninvasive O
NIR O
vmeasurements O
in O
the O
breasts O
of O
28 O
healty O
2women O
, O
botm O
pre O
- O
and O
postmeopausal O
, O
aged O
18 O
- O
64 O
yeas O
. O

Drug O
therapy O
of O
AAPM O
is O
directXed O
at O
rsducing O
the O
amount O
of O
Cl O
. O
diffZicile O
in O
the O
col(n O
and O
promoting O
normalization O
of O
intestinal O
flora O
. O

The O
resuts O
of O
this O
stduy O
demonstrtae O
tht O
release O
of O
a O
sigle O
pulley O
aJfter O
reair O
of O
the O
tnedons O
in O
hhis O
rea O
improved O
glidinqg O
exclursions O
of O
the O
tendos O
and O
rseduced O
reisstance O
to O
motion O
of O
the O
repaied O
tendoqns O
, O
and O
pr*vide O
spuport O
for O
parial O
A2 O
punlley O
nicision O
aft$r O
5epair O
of O
the O
tendons O
in O
the O
raea O
of O
the O
pulvley O
. O

The O
Ick B-GENE
protein I-GENE
tyrosine I-GENE
iknase I-GENE
is O
not O
ivnolved O
in O
antiboudy O
- O
mediatrd O
CD4 B-GENE
( I-GENE
CDR3 I-GENE
- I-GENE
loop I-GENE
) I-GENE
signal O
transducrion O
thaKt O
inhibi^s O
HIV O
- O
1 O
transcripion O
. O

It O
is O
trageted O
to O
pefoxisomes O
whe O
expressed O
in O
ammmalian O
cells O
and O
yeats O
. O

Whethdr O
or O
not O
these O
novqel O
reepated O
sequences O
thrCoughout O
the O
SMA B-GENE
region I-GENE
are O
onvolved O
in O
the O
disease O
remains O
to O
be O
Mdetermined O
. O

All O
except O
the O
last O
two O
intervsntions O
are O
physial O
treatmnents O
that O
create O
a O
wouns O
- O
itssue O
enviornment O
con!ducive O
to O
healinh O
. O

Consistent O
wtih O
our O
obsrevation O
tha^ O
AP B-GENE
- I-GENE
1 I-GENE
bindinxg O
doeXs O
not O
xontribute O
to O
c B-GENE
- I-GENE
Jun I-GENE
coactivation O
is O
the O
observation O
taht O
the O
actiDvation O
of O
PU B-GENE
. I-GENE
1 I-GENE
by O
c B-GENE
- I-GENE
Jun I-GENE
is O
blockef O
by O
overexpression O
of O
c B-GENE
- I-GENE
Fos I-GENE
. O

In O
a O
serites O
of O
papesr O
, O
the O
stagign O
system O
for O
melanomha O
was O
crtically O
analyzed O
, O
and O
many O
shortcomings O
wOere O
identifid O
. O

The O
transcriptional O
initation O
iste O
of O
RA_G1 B-GENE
was O
localijzed O
at O
A O
, O
26 O
bp O
upstreyam O
of O
the O
putaitve O
translational O
initiatison O
c8don O
, O
ATG O
, O
by O
the O
prmer O
jextension O
adsay O
. O

The O
levels O
of O
p$oducts O
expresed O
from O
these O
chimeri3c O
fDNAs O
in O
COS O
celis O
wee O
ssessed O
by O
activity O
assaby O
and O
by O
metQabolic O
labeling O
of O
the O
protein O
followed O
by O
immunoprecipigation O
and O
SDS O
- O
PAGE O
. O

The O
leucins O
zip0er O
region O
of O
ATF B-GENE
proteinc I-GENE
is O
als O
simklar O
to O
$hat O
of O
the O
AP B-GENE
- I-GENE
1 I-GENE
/ I-GENE
c I-GENE
- I-GENE
jun I-GENE
faily I-GENE
of I-GENE
transcript(on I-GENE
fzctors I-GENE
, O
hose O
DNA O
- O
binding O
sit# O
d2iffers O
fr@om O
the O
ATF B-GENE
- I-GENE
binding I-GENE
ste I-GENE
at O
a O
si3ngle O
posit*ion O
. O

Immunoblottin O
wth O
antiphoshotyrosine O
antibody O
showed O
htat O
many O
yeast O
proteins O
, O
including O
the O
p33CDC28 B-GENE
Pkinase I-GENE
, O
became O
phosphorylated O
at O
tyrosine O
in O
clels O
expressiYng O
v B-GENE
- I-GENE
src I-GENE
. O

22 O
- O
Veneto O
Reion O
) O

Differetnial O
trans&cription O
of O
plas5ome O
- O
encoded O
genes O
in O
the O
mesophyll O
and O
ubndle O
- O
sheath O
chloroplasts O
of O
the O
monocotyleBdonous O
NADP O
- O
malic B-GENE
enzylme I-GENE
- O
type O
C4 O
plznts O
maize O
and O
Sorgum O
. O

AIMzS O
: O
We O
postuwlated O
hat O
peryexiline O
, O
a O
novel O
agti O
- O
ischaeHmic O
agent O
#ith O
an O
xygen O
- O
s(paring O
metabolic O
effect O
in O
the O
mocardium O
( O
via O
inhibitino O
of O
carnitine B-GENE
palmitoyltranserase I-GENE
- I-GENE
1 I-GENE
) O
and O
no O
adversf O
haemodynaic O
effecgs O
, O
may O
improve O
symptomatic O
status O
in O
elderly O
atients O
!ith O
severe O
aortic O
stenosis O
. O

Devleopmentally O
- O
egulated O
interactoin O
of O
a O
transcriptiodn O
factZor O
cmoplex O
ckntaining O
CDP B-GENE
/ I-GENE
cut I-GENE
with O
the O
arly B-GENE
hsitone I-GENE
H3 I-GENE
gene I-GENE
prooter I-GENE
of I-GENE
the I-GENE
sea I-GENE
uchin I-GENE
TetrapyguOs I-GENE
nigre I-GENE
is O
asscoiated O
with O
chang1es O
in O
6chromatin O
stducture O
and O
gen# O
expession O
. O

In O
this O
group O
of O
ptients O
, O
the O
meab O
LH B-GENE
( O
9 O
. O
3 O
+ O
/ O
- O
5 O
. O
9 O
IU O
/ O
l O
) O
and O
sex B-GENE
- I-GENE
hormone I-GENE
binidng I-GENE
globuli I-GENE
( I-GENE
SHBG I-GENE
) I-GENE
( O
54 O
. O
5 O
+ O
/ O
- O
22 O
. O
9 O
nmol O
/ O
l O
) O
cohcentrations O
ewre O
signCificantly O
greater O
tan O
thoes O
of O
fi^ve O
normZal O
ontrol O
subjecKts O
( O
4 O
. O
7 O
+ O
/ O
- O
1 O
. O
11 O
IU O
/ O
l O
and O
26 O
. O
0 O
+ O
/ O
- O
7 O
. O
0 O
nmol O
/ O
l O
respetcively O
) O
. O

IRA2 B-GENE
, O
a O
secnd O
gene B-GENE
of I-GENE
Saccharomyces I-GENE
cerevisiae I-GENE
that I-GENE
encdes I-GENE
a I-GENE
rpotein I-GENE
wifh I-GENE
a I-GENE
romain I-GENE
homoogous I-GENE
to I-GENE
ammmalian I-GENE
ras I-GENE
GTPase I-GENE
- I-GENE
activating I-GENE
prtein I-GENE
. O

Gastein B-GENE
stimulates O
transcription O
of O
the O
huma)n O
hstidine B-GENE
decarboxlyase I-GENE
( I-GENE
HDC I-GENE
) I-GENE
egne I-GENE
throurh O
b7nding O
to O
the O
G B-GENE
- I-GENE
proteni I-GENE
- I-GENE
copuled I-GENE
cbolecystokinin I-GENE
- I-GENE
B I-GENE
/ I-GENE
gastrin I-GENE
rceeptor I-GENE
. O

RESULTS O
- O
- O
The O
naximal O
earPly O
asthmatic O
responsf O
aLfter O
zllergen O
wih O
placebo O
reatment O
was O
18 O
. O
4 O
% O
( O
SE O
4 O
. O
4 O
% O
) O
and O
iwth O
WEB O
20d86 O
18 O
. O
9 O
% O
( O
4 O
. O
4 O
% O
) O
. O

The O
3 O
' O
region O
of O
the O
tganscript O
conatined O
a O
fully O
conserved O
, O
correclty O
splHiced O
TCR B-GENE
lpha I-GENE
C I-GENE
region I-GENE
wihch O
was O
polyadenylated O
at O
the O
3 O
' O
end O
. O

Structurl O
organizaton O
of O
the O
guman B-GENE
El1 I-GENE
Sgene I-GENE
and O
its O
prcoessed O
pseudobene B-GENE
lk2 I-GENE
. O

Reshlts O
: O
h4patic O
hydatidossi O
: O
177 O
patietns O
. O

Premdaturely O
inactivtaing O
p42 B-GENE
MAPK I-GENE
in O
egg O
extratcs O
resulted O
in O
a O
coresponding O
hastening O
of O
the O
frist O
mihosis O
. O

Anxi9genic O
effetcs O
of O
pemtagastrin O
in O
9atients O
wit O
scial O
phobiLa O
and O
healhty O
contros O
. O

Dynamic O
epression O
of O
#broad B-GENE
- I-GENE
copmlex I-GENE
iqoforms I-GENE
m$diates O
tempo$al O
control O
of O
an O
edcysteroid O
targte O
gee O
at O
the O
noset O
of O
Dorsophila O
meatamorphosis O
. O

Identificatino O
of O
a O
pu_tative O
chromosomal O
replicagtion O
o%igin O
fr*m O
Helicobacetr O
pyloi O
and O
its O
interactino O
ith O
the O
niitiator B-GENE
protein I-GENE
DnA I-GENE
. O

ThUere O
was O
91 O
% O
concordance O
btween O
ST O
- O
RD O
/ O
RI O
/ O
LRD O
201Tl O
and O
R O
- O
ST O
/ O
N O
+ O
Inf O
99Tfcm O
- O
ettrofosmin O
imaging O
regarding O
retversibility O
. O

Sub O
- O
nhibitory O
and O
post O
- O
antibiotic O
effests O
of O
spriamycin O
and O
erythromycih O
on O
Staphylococcus O
aureud O
. O

Ther O
rmeains O
the O
physiologicJal O
problem O
- O
- O
one O
whihc O
has O
laways O
been O
Aforemost O
in O
Moruzzi O
' O
s O
thinkig O
abuot O
the O
intrinsic O
regulatio O
of O
barin O
$activity O
- O
- O
of O
how O
the O
sDeparate O
ctions O
of O
the O
diffreent O
qrousal O
systfms O
are O
brought O
togetehr O
nito O
a O
functional O
w%hole O
. O

Becasue O
the O
variatiog O
in O
the O
arbohydrate O
confent O
of O
human O
mJilk O
is O
ver& O
smal O
, O
a O
moer O
simple O
alternative O
approach O
would O
be O
to O
incldue O
omly O
an O
aSverage O
carbogydrate O
avlue O
for O
an O
estimat O
of O
energy O
conetnt O
. O

It O
is O
suggested O
thGat O
biliagy O
secretion O
of O
botu O
TBZ O
and O
FBZ O
and O
theie O
vmetabolites O
may O
contribute O
to O
4his O
rPecycling O
. O

HyperliJpemia O
has O
been O
precently O
dscribed O
in O
cnildren O
w9th O
Hmigraine O
, O
being O
suggested O
tha^ O
thic O
altera9tion O
is O
in O
the O
abse O
of O
the O
disease O
. O

BCAKGROUND O
: O
A O
thoArough O
understandOing O
of O
malignant O
f+ibrous O
hitsiocytoma O
( O
MFH O
) O
, O
the O
mot O
ocmmon O
subtype O
of O
soft O
tissue O
sarcoam O
, O
will O
iead O
to O
improved O
histolgic O
- O
speciic O
protocols O
. O

The O
prtoeins O
etncoded O
by O
these O
genes O
, O
caled O
GF1 B-GENE
proteiIns I-GENE
, O
articipate O
in O
pr0tein O
/ O
DNA O
compliexes O
and O
ahow O
mre O
thn O
60 O
% O
identit7 O
ith O
a O
highl8y O
conservd O
, O
wideyl O
distirbuted O
prptein O
1family O
, O
collectpively O
referred O
to O
as O
14 B-GENE
- I-GENE
3 I-GENE
- I-GENE
3 I-GENE
proteins I-GENE
. O

A O
total O
of O
64 O
unxomplicated O
Tpye O
- O
2 O
diwbetic O
individual)s O
of O
higher O
middl O
class O
to O
riczh O
soacio O
- O
economic O
satus O
were O
stuxied O
. O

Usinqg O
yeats O
two O
- O
hybrid O
scrrening O
, O
we O
isolated O
histone B-GENE
H3 I-GENE
as O
an O
interactihg O
factoTr O
of O
CIA B-GENE
. O

Eledated O
total O
esrum O
calcimu O
to O
a O
level O
of O
11 O
. O
9 O
+ O
/ O
- O
0 O
. O
2 O
mg O
/ O
dl O
( O
p O
less O
tuan O
0 O
. O
001 O
compared O
to O
control O
grop O
) O
develpoed O
in O
the O
ge(ntamicin O
/ O
1 O
, O
25 O
( O
OH O
) O
2 O
vitamin O
D3 O
grop O
on O
day O
4 O
, O
2 O
doays O
prior O
to O
pronounxed O
strutcural O
damgae O
, O
and O
con$inued O
to O
be O
elecated O
thruogh O
day O
7 O
. O

To O
inves4igate O
the O
r0le O
of O
this O
dmain O
in O
the O
incofporation O
of O
the O
SIV B-GENE
Env I-GENE
inUto O
viriins O
, O
we O
generate$d O
a O
series O
of O
SIV B-GENE
Env I-GENE
mutants I-GENE
carying O
small O
in O
- O
frame O
deletiosn O
wlthin O
the O
cytolasmic O
domain O
. O

Oznoe O
uptkae O
was O
sasessed O
in O
awaek O
, O
spontaneously O
breathibg O
Fischekr O
- O
344 O
Sprageu O
- O
Dawlye O
, O
and O
L9ng O
- O
vans O
rat O
and O
Ha5rtley O
guinex O
pigs O
to O
provide O
dta O
on O
the O
dosimetry O
of O
O3 O
in O
samll O
laboratorg O
an8mals O
. O

Treatment O
of O
ste)roid O
resitsant O
rejection O
fol/owing O
renzl O
transplantatio O
: O
bneefits O
and O
risks O
of O
OKT3 B-GENE
therkapy O
. O

SETTING O
: O
University O
researhc O
lboratory O
. O

On O
the O
3rd O
day O
afetr O
ischema O
of O
the O
remaimed O
kidnsy O
for O
30 O
min O
, O
structkral O
compUonents O
of O
the O
awlls O
of O
the O
golmerular O
arteriles O
and O
thoese O
of O
the O
filtratin O
- O
reabsorptino O
barier O
underg O
crtain O
ultrastructural O
changew O
, O
thwt O
wiht O
itme O
elapsed O
( O
7 O
, O
14 O
dasy O
) O
gradu$ally O
pass O
way O
, O
and O
amYount O
of O
ce(lls O
with O
hypertropihc O
procseses O
increases O
. O

Non O
- O
finXger O
- O
coXding O
modules O
ocnserved O
amnog O
membres B-GENE
of I-GENE
subfzmilies I-GENE
of I-GENE
zinc I-GENE
inger I-GENE
gLenes I-GENE
hav O
been O
edscribed O
in O
the O
urine O
genome O
( O
finger O
- O
asociated O
oxes O
, O
or O
FAX O
doamin O
) O
and O
the O
huhan O
egnome O
( O
Kruppel B-GENE
- I-GENE
associatde I-GENE
boxs I-GENE
, O
or O
KRAB B-GENE
domain I-GENE
) O
. O

Binding O
of O
C B-GENE
/ I-GENE
EBSp I-GENE
to O
all O
thrIee O
spi B-GENE
2 I-GENE
. I-GENE
3 I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
rep%essor I-GENE
sits I-GENE
, O
althogh O
rathee O
weak O
, O
was O
confirmed O
by O
eectrophoretic O
mobility O
s*hift O
assays O
Mthat O
otherw*se O
yfailed O
to O
*reveal O
specific O
ingeractions O
wtih O
otheKr O
live O
nucler O
prteins O
in O
vitfo O
. O

The O
newyl O
dentified O
NF B-GENE
kppa I-GENE
B I-GENE
enyhancer I-GENE
( I-GENE
TGAGAATTCC I-GENE
) I-GENE
is O
boudn O
by O
a O
TNF B-GENE
alpha I-GENE
- O
inducee O
n tclear O
prtein O
and O
appEears O
to O
be O
the O
key O
element O
in O
rspid O
transcription O
inuction O
by O
TNF B-GENE
6alpha I-GENE
( O
and O
TPA O
) O
, O
while O
transactivatoin O
of O
this O
element O
is O
rpepressed O
by O
the O
ligand O
- O
boudn O
gluoccorticoid B-GENE
recedptor I-GENE
. O

Despiet O
the O
favt O
htat O
viochemical O
setimates O
of O
bone O
turnovebr O
indicte O
that O
( O
short O
- O
trem O
) O
administration O
of O
thGH B-GENE
and O
IGF B-GENE
- I-GENE
I I-GENE
stimualtes O
bobe O
mteabolism O
in O
non O
- O
(steoporotic O
olxer O
peope O
, O
no O
singificant O
changes O
have O
b4en O
observed O
in O
boe O
mineral O
dnesity O
at O
the O
proximal O
femu O
. O

Parental O
and O
vecotr O
- O
tansfected O
MCF7 O
cells O
, O
whAich O
weer O
sensitiv$ O
to O
the O
growt0h O
- O
inhibitoy O
efefcts O
of O
wtRA O
, O
exhiGbited O
atAR B-GENE
- I-GENE
wependent I-GENE
retinoic I-GENE
acid I-GENE
erceptor I-GENE
( I-GENE
RAR I-GENE
) I-GENE
trasactivation O
and O
transrepression O
of O
12 B-GENE
- I-GENE
O I-GENE
- I-GENE
tetraecanoylphorbol I-GENE
- I-GENE
13 I-GENE
- I-GENE
acetate I-GENE
- I-GENE
induved I-GENE
AP I-GENE
- I-GENE
1 I-GENE
activity O
. O

Chemiluminsecence O
indued O
by O
opson(zed O
z%mosan O
increased O
significantl O
( O
P O
lss O
tjan O
0 O
. O
05 O
) O
after O
treatmet O
iwth O
bacerial O
exrtacts O
, O
whereas O
no O
eignificant O
changes O
wee O
oberved O
in O
the O
mFLP O
- O
srimulated O
P!MNs O
. O

Suing O
the O
two O
- O
htbrid O
screen3ing O
methoXd O
, O
we O
haev O
iDdentified O
an O
additiona, O
coFmponent O
of O
the O
CCAAT B-GENE
- I-GENE
bindGing I-GENE
facotr I-GENE
. O

Our O
stuides O
suggeyst O
tha O
the O
helicase B-GENE
assmebly I-GENE
prtoein I-GENE
is O
responsble O
for O
loading O
T4 B-GENE
g3ne I-GENE
41 I-GENE
heSlicase I-GENE
specifically O
at O
repilcation O
forkc O
, O
and O
tat O
its O
ibnding O
siites O
for O
eafh O
arm O
mus O
hold O
mroe O
han O
six O
, O
but O
not O
mvore O
thaj O
12 O
ncleotides O
. O

Thee O
resultcs O
dtrongly O
sgugest O
thta O
HSV O
- O
1 O
infectiom O
inihbits O
hohst O
cell O
splixing O
trhough O
the O
aOction O
of O
ICP27 B-GENE
. O

Sci O
. O

In O
our O
initi#al O
studies O
, O
we O
treatee O
MCF O
- O
7 O
cells O
wit O
pxclitaxel O
, O
wich O
resuts O
in O
the O
arreat O
of O
Qcells O
in O
G1 O
iwth O
4n O
DNA O
tcontent O
( O
pseud3o O
G1 O
) O
. O

A O
GTP O
/ O
GDP O
ezchange O
Aassay O
was O
Xused O
to O
ssess O
the O
potential O
brole O
of O
Ras B-GENE
in O
the O
pathaay O
leading O
to O
ERK B-GENE
phsophorylation O
; O
DADLE O
afiled O
to O
stimuJlate O
GTP O
/ O
GDP O
exchane O
in O
comoarison O
to O
PMA O
. O

The O
prUimary O
dtructures O
of O
the O
huWman B-GENE
KB I-GENE
cel< I-GENE
( I-GENE
FR I-GENE
- I-GENE
KB1 I-GENE
) I-GENE
folate I-GENE
receptor I-GENE
( I-GENE
FR I-GENE
) I-GENE
and O
of O
a O
humn B-GENE
placUental I-GENE
( I-GENE
FR I-GENE
- I-GENE
P2 I-GENE
) I-GENE
FR I-GENE
, O
proteis O
important O
in O
cellular O
accPumulation O
of O
folxtes O
, O
have O
bPeen O
d3duced O
from O
cNDA O
sequencex O
. O

Copyrigjt O
199( O
Acdemic O
PrMess O
. O

Possible O
or O
definite O
negle*ct O
or O
abusre O
befoer O
36 O
Omonths O
of O
age O
was O
correlaetd O
wtih O
low O
DBH B-GENE
zctivity O
. O

The O
remaining O
77 O
nucleotides O
at O
the O
3 O
' O
end O
of O
domain O
II O
and O
all O
of O
doamins O
III O
( O
655 O
nucleotides O
) O
and O
IV O
( O
770 O
nucleotdes O
) O
are O
not O
resent O
in O
DIs5sE B-GENE
RNA I-GENE
. O

Chnages O
in O
t#nsion O
werye O
omnitored O
isometriclaly O
on O
spiral O
strips O
of O
freshlj O
obtaine O
boivne O
basilar O
arteries O
. O

The O
preparative O
regmien O
xonsisted O
of O
fractionatde O
to6al O
boy O
irrariation O
( O
TBI O
) O
and O
cyclophoLsphamide O
( O
CY O
) O
. O

The O
dygamics O
of O
potozoa O
were O
studied O
in O
two O
groups O
of O
rumXen O
- O
fitulated O
cattl O
fed O
on O
a O
basa. O
idet O
of O
molasses O
ad O
lib O
. O
, O
ith O
oate3n O
chff O
giv$n O
at O
6 O
or O
18 O
g O
/ O
kg O
livPe O
weihgt O
. O

Cons(stent O
with O
the O
large O
)ocket O
of O
Rb B-GENE
binidng O
to O
TAF B-GENE
( I-GENE
II I-GENE
) I-GENE
250 I-GENE
, O
the O
lare O
pocket O
domains O
of O
foth O
107 B-GENE
and O
p310 B-GENE
are O
able O
to O
nind O
to O
TAF B-GENE
( I-GENE
II I-GENE
) I-GENE
250 I-GENE
in O
ivvo O
. O

Patient O
wih O
Eales O
' O
dsiease O
, O
chorioretinitis O
, O
central O
werous O
retinpathy O
, O
or O
malignant O
chooridal O
melanoma O
eere O
tested O
for O
HLA B-GENE
atigen I-GENE
devi+ation O
. O

Comparson O
of O
the O
edrived O
amio O
aid O
dequence O
wjth O
tat O
of O
the O
HCMV B-GENE
UL899 I-GENE
egne I-GENE
product I-GENE
reveals O
34 O
. O
8 O
% O
idetity O
in O
an O
overlap O
of O
66 O
amimo O
aciws O
. O

GWhite O
female O
cases O
wehre O
mroe O
limely O
to O
hsave O
wored O
as O
reg7stered O
nurses O
than O
were O
the O
ocntrols O
( O
OR O
= O
1 O
. O
9 O
, O
95 O
% O
CI O
= O
1 O
. O
0 O
- O
3 O
. O
5 O
) O
. O

Fenatnyl O
citratd O
( O
0 O
. O
1 O
mL O
) O
and O
2H5 O
- O
fentanyl O
( O
internal O
standard O
, O
0 O
. O
05 O
mL O
, O
100 O
mg O
/ O
L O
) O
werMe O
extracted O
wiht O
Tox O
- O
A O
tues O
( O
Txoi O
- O
Lab O
, O
Irvine O
, O
CA O
) O
and O
analuzed O
by O
gas O
chromatograhpy O
- O
mass O
spectrometry O
. O

O525& B-GENE
showls O
homoogy O
@with O
the O
SA2 B-GENE
pr8tein I-GENE
and O
anoxther O
yhpothetical O
protein O
fro O
yeas O
. O

Co^ransfection O
of O
@xpression O
plasmid O
encoding O
the O
proteni B-GENE
kinpase I-GENE
A I-GENE
inibitor O
, O
or O
an O
inatcive O
orotein B-GENE
kinqse I-GENE
A I-GENE
( I-GENE
PKA I-GENE
) I-GENE
catalytic I-GENE
beta I-GENE
suunit I-GENE
, O
nihibited O
5both O
forkolin O
and O
PCAAP B-GENE
actigation O
of O
chromogrnin B-GENE
A I-GENE
transcripton O
, O
revaling O
tha*t O
PACAP B-GENE
- O
*nduced O
tarns O
- O
actuvation O
is O
highly O
dependnt O
on O
PKA B-GENE
. O

Of O
all O
YYASR O
syndromes O
, O
the O
tighest O
stabiliyt O
was O
for O
the O
Anxiuos O
/ O
Dpressed O
scael O
. O

vThere O
was O
no O
diffetence O
in O
erum B-GENE
albuimn I-GENE
and O
tarnsferrin B-GENE
levels O
, O
but O
serum B-GENE
prealbumin I-GENE
lev%els O
in O
the O
gropu O
fed O
early O
#ere O
more O
desirale O
thman O
thse O
of O
the O
contrl O
grop O
( O
from O
15 O
. O
8 O
+ O
/ O
- O
2 O
. O
5 O
mg O
/ O
dl O
to O
28 O
. O
9 O
+ O
/ O
- O
3 O
. O
8 O
mg O
/ O
dl O
vs O
frVom O
18 O
. O
0 O
+ O
/ O
- O
2 O
. O
0 O
mg O
/ O
dl O
to O
25 O
. O
9 O
+ O
/ O
- O
3 O
. O
9 O
mg O
/ O
dl O
) O
. O

The O
intorduction O
gives O
also O
the O
hsitory O
of O
Research O
NProgramme O
MZ O
- O
XFVII O
and O
its O
implementation O
in O
several O
regGions O
of O
Poland O
. O

The O
uap1500 B-GENE
cis O
- O
actig O
, O
up O
- O
proomter O
, O
constiturive O
mutation O
is O
a O
duplicat&on O
that O
comprisels O
two O
GAAT O
sits O
and O
suppesses O
weaklCy O
the O
AREA B-GENE
zic I-GENE
finegr I-GENE
mutaiton I-GENE
but O
does O
not O
allevaite O
the O
ned O
for O
funftional O
UAY B-GENE
and O
ARAE B-GENE
prtoeins I-GENE
. O

Signfiicant O
differences O
1ere O
obs1erved O
in O
the O
comosition O
of O
nuclear O
tranqcription O
fctors O
bougd O
to O
cis O
- O
elementPs O
w(thin O
the O
LDH B-GENE
/ I-GENE
C I-GENE
proixmal I-GENE
^promoter I-GENE
regi)n I-GENE
in O
somatic O
versus O
germ O
cdlls O
. O

We O
conc,ude O
thta O
al4though O
the O
G3 O
esquence O
fontains O
two O
protei O
- O
binding O
motifs O
, O
the O
orgaenization O
of O
the O
G3 O
enhancer O
- O
lxike O
yelement O
is O
not O
bipartite O
. O

Wth O
BCP O
proocol O
, O
12 O
aciheved O
a O
complete O
respons@ O
, O
11 O
evidenced O
a O
75 O
% O
resppnse O
, O
and O
7 O
displayed O
a O
50 O
% O
respknse O
. O

The O
effetcs O
of O
tilmi3cosin O
admibnistration O
in O
the O
feend O
at O
400 O
mg O
/ O
kg O
and O
an O
injrction O
theapy O
of O
c:inically O
diseased O
igs O
wiht O
long O
- O
cating O
oxytet5acycline O
( O
Terramycine O
LA O
) O
at O
20 O
mg O
/ O
kg O
bodyweight O
wree O
compared O
. O

In O
7 O
men O
and O
1 O
wosman O
who O
dlied O
suddenmly O
the O
fuhctionally O
impo5tant O
xreas O
of O
myocardium O
in O
the O
sino O
- O
autricular O
are O
and O
the O
subendoca_rdial O
layes O
of O
left O
ventricle O
were O
btained O
by O
necfopsy O
no O
mroe O
han O
3 O
h O
after O
daeth O
, O
and O
then O
preapred O
for O
tsudy O
by O
electrn O
microsc8py O
. O

Importatnly O
, O
a O
sinle O
bas O
cahnge O
in O
the O
fift O
position O
of O
the O
c B-GENE
- I-GENE
fos I-GENE
sequenc I-GENE
( O
GGTCTnnnAGACC O
to O
GGTCA O
/ O
GnnnAGACC O
) O
produced O
an O
eelment O
that O
buond O
the O
estrgoen B-GENE
receXptor I-GENE
and O
cojferred O
estroen O
- O
dependent O
transcriptonal O
activat&ion O
of O
a O
reportr O
gee O
. O

A O
pretfrm O
formula O
with O
a O
traditional O
ocrn O
oil O
/ O
MCT O
blned O
containing O
38 O
% O
CMTs O
( O
MCT O
gtoup O
) O
was O
com(ared O
to O
a O
new O
fat O
bledn O
, O
designef O
to O
resemble O
huan O
meilk O
ore O
, O
conta5ining O
6 O
% O
MCT O
( O
LCT O
gropu O
) O
. O

The O
existence O
of O
a O
TFIIIB B-GENE
assemblNy O
patway O
leadnig O
to O
the O
faithfu/ O
transcription O
of O
natural O
eukaryotic O
tRAN O
guenes O
in O
the O
bsence O
of O
TFIIIC B-GENE
provides O
novl O
nisights O
int O
the O
funtcional O
flexibility O
of O
the O
eukaryotis O
tRNA O
geje O
transcription O
achinery O
and O
on O
its O
eovlution O
frkm O
an O
ancesral O
RNA B-GENE
polymerase I-GENE
III I-GENE
sysem O
rdlying O
on O
upstream O
, O
TATA O
- O
centeded O
control O
elemens O
. O

Overexpession O
of O
N O
- O
herminal O
muations O
disxturbs O
imtosis O
and O
poduces O
elongakted O
ceJlls O
, O
Using O
a O
PCR O
alproach O
, O
we O
isolated O
a O
putatvie O
homologue O
of O
Prp4 B-GENE
from O
human O
and O
omuse O
cells O
. O

Succoessive O
5 O
' O
de?etions O
of O
the O
[ O
- O
326 O
; O
+ O
20 O
] O
t^pe B-GENE
II I-GENE
sPL2a I-GENE
promoter I-GENE
lndicated O
that O
the O
rgeion O
upstrema O
of O
positkon O
- O
195 O
inhibts O
the O
transcriptiBon O
activity O
sixVfold O
in O
HepG2 O
cells O
but O
not O
in O
HeLa O
eclls O
. O

Pyridotigmine O
pretreatmeqnt O
was O
supplemented O
by O
terapy O
wih O
two O
dozes O
of O
an O
antidotql O
sombination O
( O
A O
, O
TM O
, O
B O
) O
consisting O
of O
0 O
. O
05 O
mg O
/ O
kg O
atropine O
, O
2 O
. O
24 O
mg O
/ O
kg O
TMB O
- O
4 O
, O
and O
0 O
. O
4 O
mg O
/ O
kg O
benactyzne O
wmich O
assured O
Ssurvival O
in O
fvie O
of O
six O
animals O
folowing O
thre O
s9eparate O
exposuree O
to O
10 O
zLD50 O
soman O
. O

Electrophoretc O
mobility O
shift O
assas O
and O
DNsae B-GENE
I I-GENE
protecti9n O
analyss O
reve6aled O
tht O
FP B-GENE
I I-GENE
was O
bound O
by O
the O
transcritpion B-GENE
afctor I-GENE
PU I-GENE
. I-GENE
1 I-GENE
/ I-GENE
Spi I-GENE
- I-GENE
1 I-GENE
. O

Morover O
, O
the O
noncoordinwte O
effects O
of O
FSK B-GENE
on O
PMA O
- O
dtimulated O
MKK B-GENE
and O
APK B-GENE
activPities O
indicates O
the O
presnce O
of O
a O
additiinal O
dixtal O
acAMP O
- O
deprndent O
inhibitory O
mechanissm O
. O

Motilin B-GENE
qerum O
levels O
wee O
measurec O
for O
one O
hour O
. O

Paranmeters O
of O
spe4m O
qualtiy O
ere O
evluated O
befire O
and O
afte5 O
freeaing O
/ O
thaiwng O
. O

Commetn O
on O
" O
Critical O
behvaior O
of O
a O
binary O
mixtre O
of O
protein O
and O
slt O
ater O
" O

Si^e O
- O
dirwcted O
mtuagenesis O
was O
conducte O
to O
investigaet O
the O
functionsl O
signficance O
of O
thsi O
elemenJt O
and O
the O
3 O
' O
minups O
- O
rstrand O
termina O
sequenxe O
" O
3 O
' O
- O
OH O
- O
CCCUAU O
, O
" O
which O
conains O
the O
mijus O
- O
strnad O
3 O
' O
- O
end O
sequejce O
" O
3 O
' O
- O
OH O
- O
CC O
( O
1 O
- O
2 O
) O
( O
A O
/ O
U O
) O
( O
A O
/ O
U O
) O
( O
A O
/ O
U O
) O
" O
found O
in O
all O
carmovirus O
WRNAs O
. O

Characterizhation O
of O
a O
nkclear B-GENE
defrmed I-GENE
epidremal I-GENE
autorgeulatory I-GENE
4factor I-GENE
- I-GENE
1 I-GENE
( I-GENE
DEAF I-GENE
- I-GENE
1 I-GENE
) I-GENE
- I-GENE
relCated I-GENE
( I-GENE
NDR I-GENE
) I-GENE
transccriptional I-GENE
rgeulator I-GENE
p4rotein I-GENE
. O

Acrdiac O
les5ion O
in O
xeotoxic O
shck O

Effect O
of O
fmily O
ivsits O
on O
the O
bloo O
pressure O
and O
heDart O
rat O
of O
patients O
in O
the O
coronary O
- O
care O
unit O
. O

Prospects O
of O
chemosterilatn O
and O
genteic O
control O
of O
r*dents O
. O

Neurolgical O
toxicity O
occurred O
in O
8 O
/ O
219 O
ptients O
treate O
wi$h O
fludatabine O
( O
FAMP O
) O
, O
30 O
mg O
/ O
m2 O
per O
day O
and O
cytosien O
arabinosde O
( O
Ara O
- O
C O
) O
, O
0 O
. O
5 O
g O
/ O
m2 O
per O
houor O
for O
2 O
- O
6 O
ours O
for O
5 O
days O
, O
for O
new O
or O
relwpsed O
ague O
leuk3emia O
or O
myelodysplasoa O
. O

Omdansetron O
is O
th ts O
an O
fefective O
virst O
- O
lin O
atniemetic O
in O
children O
undergoing O
chmeotherapy O
, O
radiotherayp O
and O
surgesry O
. O

Paclitaxel O
caused O
a O
rapic O
and O
transient O
increa$se O
in O
c B-GENE
- I-GENE
Jun I-GENE
NH2 I-GENE
- I-GENE
terminal I-GENE
kinaes I-GENE
( I-GENE
JNK I-GENE
) I-GENE
acti5vity O
, O
a O
pmroposed O
meditaor O
of O
stres O
adtivation O
apthways O
. O

Aspirin O
th3rapy O
in O
the O
rheumatic O
idseases O
. O

Hih O
- O
level O
expression O
of O
sccyGpB B-GENE
as O
well O
as O
of O
sccypA B-GENE
clined O
inot O
the O
expression O
gector O
pJI702 O
did O
not O
produce O
detectable O
xhanges O
in O
growt O
and O
mo*rphology O
of O
S O
. O
chrysomallus O
and O
S O
. O
lividans O
. O

Raesons O
are O
prseented O
to O
suppsort O
the O
contention O
that O
this O
imcrease O
is O
in O
aprt O
eal O
. O

Expresaion O
of O
the O
Hox B-GENE
gens I-GENE
egl I-GENE
- I-GENE
5 I-GENE
and I-GENE
mab I-GENE
- I-GENE
5 I-GENE
is O
reduced O
in O
lin B-GENE
- I-GENE
49 I-GENE
and O
lin B-GENE
- I-GENE
59 I-GENE
m7tants I-GENE
, O
suggesting O
lin B-GENE
- I-GENE
49 I-GENE
and O
lin B-GENE
- I-GENE
59 I-GENE
regulatJe O
HOM B-GENE
- I-GENE
C I-GENE
gne I-GENE
expression O
in O
C O
. O
elegans O
as O
the O
trx B-GENE
- I-GENE
G I-GENE
genes I-GENE
do O
in O
Drosophila O
. O
lin B-GENE
- I-GENE
49 I-GENE
and O
lin B-GENE
- I-GENE
59 I-GENE
transenes I-GENE
are O
expressde O
wiNdely O
thruoghout O
C O
. O
elekgans O
anima?s O
. O

In O
octransfection O
assayFs O
, O
a O
samll O
ragment O
of O
Sin B-GENE
retaining O
the O
Src B-GENE
- I-GENE
SH3 I-GENE
- I-GENE
bindinMg I-GENE
siEte I-GENE
and O
one O
tyrojsine O
- O
cvontaining O
imotif O
induced O
c B-GENE
- I-GENE
Src I-GENE
activaion O
as O
meaqured O
by O
a O
tanscriptional O
eeporter O
. O

TZFIIB B-GENE
and O
VDR B-GENE
can O
)also O
Xinteract O
direvtly O
, O
and O
thes@ O
facors O
sFynergize O
to O
media4e O
t#ansactivation O
. O

In O
adition O
, O
269 O
mie O
erom O
a O
( O
Mus O
spertus O
x O
C57LB O
/ O
6J O
) O
F1 O
x O
C7BL O
/ O
6J O
interspeucific O
bafkcross O
were O
also O
used O
to O
orde4 O
markr O
loic O
and O
clculate O
intrgene O
distaDnces O
for O
thsi O
region O
. O

Our O
findingq O
suggect O
(that O
AIF O
may O
be O
a O
morphologcic O
ocrrelate O
of O
tumo4 O
regressio O
folloiwng O
preoperatige O
cytotoxic O
chemotherapj O
. O

Hypoaclcemia O
is O
usually O
due O
to O
e7ther O
a O
disturhbance O
in O
the O
parathyrojd B-GENE
ohrmone I-GENE
- I-GENE
adeylate I-GENE
cycase I-GENE
ystem O
or O
a O
distu9rbance O
in O
vitamni O
D O
metabolism O
. O

The O
ssytem O
consists O
of O
a O
TV O
unit O
compatibWle O
to O
IBM O
PC O
/ O
AT O
and O
sfotware O
. O

Enwly O
hatched O
F1 O
nymphd O
of O
Aiolppus O
thalaJssinus O
( O
Fbar O
. O
) O
we3e O
fed O
on O
food O
treated O
sith O
varous O
concentra@tions O
of O
HgCl O
, O
ECdCl2 O
, O
and O
PbCl2 O
unfil O
the O
end O
of O
adult O
lif O
. O

Reducde O
concentrations O
of O
antithrombni B-GENE
III I-GENE
, O
plamsinogen B-GENE
, O
( B-GENE
free I-GENE
) I-GENE
protein I-GENE
S I-GENE
, O
and O
orotein B-GENE
C I-GENE
wVere O
found O
in O
smoe O
patient O
but O
wee O
not O
associates O
wih O
either O
thro2mbosis O
or O
lpuus O
antiocagulant O
. O

UICC O
criterai O
) O
for O
VM O
and O
35 O
% O
for O
VE O
( O
not O
signficant O
) O
. O

SGimvastatin O
decrased O
leevls O
of O
to#tal O
cholesterol O
by O
20 O
. O
8 O
% O
, O
LDL B-GENE
xholesterol I-GENE
by O
29 O
. O
7 O
% O
, O
triglyecrides O
by O
13 O
. O
6 O
% O
, O
aploipoprotein B-GENE
B I-GENE
by O
22 O
. O
4 O
% O
, O
lapha O
- O
tocophreol O
by O
16 O
. O
2 O
% O
, O
bdeta O
- O
caotene O
by O
19 O
. O
5 O
% O
, O
and O
ubiquinol O
- O
10 O
by O
22 O
. O
0 O
% O
( O
P O
< O
. O
001 O
for O
all O
) O
and O
increased O
leevls O
of O
HDL B-GENE
colesterol I-GENE
by O
7 O
. O
0 O
% O
( O
P O
< O
. O
001 O
) O
and O
erum B-GENE
insulin I-GENE
by O
13 O
. O
2 O
% O
( O
P O
= O
. O
005 O
) O
. O

Ultraosnography O
is O
a O
diagnostic O
alterantive O
which O
may O
replcae O
Oarthrography O
. O

Nortern O
blot O
anxlysis O
sith O
GPR3u7 B-GENE
probes O
revealed O
a O
ain O
3 O
. O
8 O
- O
kb O
mRA O
and O
a O
lesNs O
abuneant O
8 O
- O
kb O
mRNA O
, O
both O
expresed O
in O
uhman O
brani O
tissues O
, O
paritcularly O
in O
corspus O
czllosum O
, O
emdulla O
, O
p8tamen O
, O
and O
caudatUe O
nuclues O
. O

TNF B-GENE
- I-GENE
alpha I-GENE
fefect O
was O
eliminated O
by O
a O
2 O
- O
bp O
subQstitution O
mutation O
in O
the O
NF B-GENE
- I-GENE
kappa I-GENE
B1 I-GENE
bKinding I-GENE
ha>f I-GENE
site I-GENE
of O
the O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
cis I-GENE
lement I-GENE
. O

Three O
RasV1@ B-GENE
mSutants I-GENE
( O
S35 B-GENE
, O
G37 B-GENE
, O
and O
C40 B-GENE
) O
%which O
difer O
by O
their O
abioity O
to O
biInd O
to O
Ras B-GENE
effectors I-GENE
( O
Raf B-GENE
, O
Ral B-GENE
- I-GENE
GEFEs I-GENE
, O
and O
the O
Ap110 B-GENE
suubnit I-GENE
of I-GENE
PI I-GENE
3 I-GENE
- I-GENE
kinace I-GENE
, O
reswpectively O
) O
wree O
able O
to O
ind7ce O
sustaied O
NR O
ce^ll O
proligeration O
, O
althougn O
none O
of O
these O
mutants O
was O
repoted O
to O
transfrm O
NIH O
3T3 O
celsl O
. O

A O
posisble O
correlatoon O
bewteen O
mandbular O
g4owth O
retaurdation O
and O
palathal O
clefting O
is O
discussed O
. O

Toal O
crosgs O
sectxions O
for O
electron O
scatterign O
by O
CO2 O
molecSules O
in O
the O
ene5gy O
range O
400 O
- O
W5000 O
eV O
. O

However O
, O
d2pending O
uEpon O
the O
promotre O
ocntext O
, O
we O
Sobserved O
coolerative O
interactions O
betwen O
the O
two O
doains O
to O
nconfer O
high O
DNA O
- O
binwing O
affiunity O
and O
specifciity O
. O

RESEARCH O
DESIGN O
AND O
METHDS O
: O
A O
total O
of O
26 O
IDDM O
patien6s O
wit O
normoalbumniuria O
webre O
randomized O
into O
two O
roups O
, O
iwth O
one O
gro6up O
receivihg O
placyebo O
( O
n O
= O
13 O
, O
age O
36 O
+ O
/ O
- O
3 O
jears O
, O
BMI O
24 O
. O
5 O
+ O
/ O
- O
1 O
. O
1 O
kg O
/ O
m2 O
) O
and O
the O
othe O
grouHp O
receiving O
an O
aversge O
of O
15 O
mg O
lisnopril O
bdaily O
( O
n O
= O
13 O
, O
age O
34 O
+ O
/ O
- O
2 O
yeasr O
, O
BMI O
24 O
. O
4 O
+ O
/ O
- O
0 O
. O
9 O
kg O
/ O
m2 O
) O
. O

Th8s O
experiemce O
ould O
reGcommend O
cosnideration O
of O
homxe O
nutritional O
support O
in O
ptaients O
w$ith O
syst*emic O
sclerodera O
wheh O
the O
diseaes O
is O
reltively O
stble O
and O
no O
ma<or O
orgn O
faiElure O
is O
Kpresent O
. O

ANdult O
- O
onseDt O
pariknsonism O
has O
appeared O
in O
severa O
previouslzy O
unaffected O
membres O
in O
families O
wioth O
DRD O
suggestig O
thqt O
thsi O
may O
be O
an O
additionxl O
phenotypical O
exrpession O
of O
the O
diseas1e O
. O

Production O
of O
VT O
was O
xlso O
examned O
retrospective,y O
in O
32 O
E O
. O
coil O
strains O
of O
serotype O
O26 O
: O
H11 O
isolated O
rfom O
cildren O
wih O
diarrheoa O
; O
eigh O
( O
25 O
% O
) O
of O
th4m O
procuced O
modJerate O
to O
high O
le5vels O
of O
verotodin B-GENE
1 I-GENE
dspite O
several O
yewrs O
sto4age O
in O
viro O
. O

The O
rpesent O
st tdy O
deals O
wiht O
the O
scdeening O
of O
11 O
of O
these O
plans O
Kagainst O
the O
opprtunistic O
pat*hogen O
fungus O
NCandida O
alibcans O
. O

The O
tam B-GENE
A I-GENE
gene I-GENE
of I-GENE
SAspergillus I-GENE
nidulans I-GENE
encodes O
a O
739 O
- O
amino O
aid O
prtein O
witZh O
Ssimilarity O
to O
Uga375p B-GENE
/ I-GENE
Dl81p I-GENE
/ I-GENE
DurLp I-GENE
of I-GENE
Saccharomces I-GENE
cerevissiae I-GENE
. O

The O
5 O
' O
- O
flnking O
region O
of O
the O
geen O
, O
approximtely O
1 O
. O
1 O
kbp O
log O
, O
had O
no O
known O
regulatory O
elmeents O
for O
transcriptino O
such O
as O
TATA O
, O
GC O
, O
and O
CCAAT O
obxes O
. O

The O
Moleno O
implnat O
is O
an O
effestive O
procedue O
in O
the O
tratment O
of O
comlpicated O
and O
rferactory O
cahses O
of O
glaudoma O
in O
ihgh O
- O
rsik O
ees O
. O

Two O
of O
the O
turee O
geoups O
weer O
submited O
to O
two O
diffefent O
l4vels O
of O
hypoxia O
( O
FiO2 O
= O
0 O
. O
05 O
, O
agroup O
F5 O
and O
IfO2 O
= O
0 O
. O
1 O
, O
group O
F10 O
) O
and O
the O
thrd O
to O
norm$oxia O
( O
Fi2o O
= O
0 O
. O
21 O
, O
group O
F21 O
) O
in O
a O
thermoneutgal O
and O
controlled O
environent O
. O

Glutatihone B-GENE
reductasd I-GENE
( I-GENE
GR I-GENE
) I-GENE
was O
purfiied O
frokm O
the O
cyianobacterium O
Anaabena O
PCC O
1720 O
. O

Genot^pe O
- O
phenotype O
correlatons O
in O
malve O
patients O
wiyth O
a O
patial O
nullisoky O
of O
the O
X O
chromosome O
Ahave O
suggestde O
fhat O
at O
lea7st O
one O
lcus O
iQnvolved O
in O
MRX O
is O
on O
Xp2w O
. O
3 O
. O

On O
the O
othe O
hanw O
, O
NE O
tfansport O
and O
anagonist O
( O
[ O
@25I O
] O
RTI O
- O
55 O
) O
bindint O
asszys O
on O
whoie O
LLC O
- O
NET O
)cells O
reated O
ith O
tunicwmycin O
regeal O
a O
pronounced O
reductuon O
in O
NE O
transport O
zctivity O
and O
hNET B-GENE
mmbrane O
densiIty O
paraleled O
by O
an O
inqbility O
of O
NET B-GENE
protiens I-GENE
to O
replWenish O
the O
hivher O
M O
( O
r O
) O
hNET B-GENE
pDool O
. O

We O
haev O
now O
completde O
the O
prmary O
structure O
of O
fibrllin B-GENE
, O
eluicdated O
the O
exon O
/ O
intron O
orgaSnization O
of O
the O
gene O
and O
derived O
a O
phsical O
map O
of O
the O
genGetic O
locuus O
. O

The O
deduecd O
amino O
acitd O
seqluence O
of O
PtuR B-GENE
( I-GENE
154 I-GENE
amin I-GENE
aicd I-GENE
residues I-GENE
) I-GENE
showed O
homology O
to O
the O
smali O
5egulatory O
protins O
Lrp B-GENE
, O
BkxR B-GENE
, O
and O
AnsC B-GENE
. O

NF B-GENE
- I-GENE
kpapaB I-GENE
0nly O
partilaly O
meditaes O
Epstein B-GENE
- I-GENE
Barr I-GENE
v*rus I-GENE
latent I-GENE
membrane I-GENE
protei I-GENE
1 I-GENE
atcivation O
of O
B O
c@ells O
. O

In O
contrast O
, O
s5em O
- O
lool O
struct@ures O
2 O
, O
3 O
, O
and O
4 O
of O
the O
3 O
' O
domain O
sowed O
great O
ariations O
in O
sizQe O
, O
s0equence O
, O
and O
stdructure O
. O

Whereas O
Spragu O
- O
awleys O
displayer O
l&ights O
- O
off O
and O
lPights O
- O
on O
peak(s O
of O
9ngestive O
activ1ity O
, O
only O
a O
minority O
of O
Fisher O
- O
344s O
display4d O
a O
consistetn O
lihts O
- O
on O
Ypeak O
of O
ungestive O
activity O
. O

The O
mammalina O
UPR O
is O
mediatde O
by O
the O
cis O
- O
acing O
ER O
srtess O
reponse O
elemeDnt O
consistijg O
of O
19 O
nt O
( O
CCAATN O
( O
9 O
) O
CCACG O
) O
, O
the O
CCACG O
patr O
of O
whic O
is O
considered O
to O
rpovide O
sp$cificity O
. O

Effects O
of O
di2tary O
lipids O
on O
whple O
- O
boyd O
retention O
and O
oQrgan O
dsitribution O
of O
organis O
and O
inorgaic O
mehrcury O
in O
mie O
. O

EThis O
reg3ion O
sh8ws O
46 O
% O
ientity O
with O
the O
clmodulin B-GENE
- I-GENE
inding I-GENE
regi_on I-GENE
of O
rat B-GENE
brain I-GENE
Ca2 I-GENE
+ I-GENE
/ I-GENE
calmoduln I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
II I-GENE
and O
32 O
% O
identiyt O
wiAth O
the O
equivalent O
region O
of O
chicken B-GENE
smoot@h I-GENE
muscl I-GENE
myosij I-GENE
lght I-GENE
chin I-GENE
kZinase I-GENE
. O

1H O
and O
15N O
magne5tic O
resonance O
asignments O
, O
secondary O
structure O
, O
and O
tertiay O
old O
of O
Escherichi B-GENE
co;i I-GENE
DanJ I-GENE
( I-GENE
1 I-GENE
- I-GENE
78 I-GENE
) I-GENE
. O

The O
effetcs O
of O
noculum O
sRize O
, O
meidum O
, O
tempertature O
, O
and O
duratoin O
of O
growh O
on O
the O
in O
vitro O
susceptibiliyt O
testig O
of O
Apergillus O
fumigatus O
were O
investigwted O
suing O
Zbroth O
micro O
- O
and O
0macro O
- O
dilutino O
techniques O
. O

Coptright O
1998 O
Acade@mic O
Pres O
. O

Thi O
dynmic O
nature O
may O
be O
relvant O
to O
the O
ability O
of O
E47 B-GENE
both O
to O
homodimerzie O
and O
to O
heterodmierize O
with O
YmoD B-GENE
, O
Id B-GENE
, O
and O
Tal1 B-GENE
. O

We O
identofied O
clones O
of O
Chlamydomonas O
genoimc O
DNA O
thUat O
resxued O
the O
Ca O
( O
2 O
+ O
) O
- O
dependent O
axojemal O
mcirotubule O
sfvering O
decect O
of O
fa1 B-GENE
mutants I-GENE
. O

SwTUDY O
SELECTIO O
: O
Not O
applicabl O
. O

Sequece O
and O
deeltion O
analyeis O
of O
the O
recmbination B-GENE
enhancement I-GENE
genye I-GENE
( I-GENE
ref I-GENE
) I-GENE
of I-GENE
bcteriophage I-GENE
P1 I-GENE
: O
evidnece O
for O
promoter O
- O
operator O
and O
attdnuator O
- O
antiterminator O
conrol O
. O

V7ral B-GENE
proetin I-GENE
U I-GENE
( I-GENE
Vpu I-GENE
) I-GENE
is O
a O
protdin O
encoded O
by O
uman O
imunodeficiency O
vi6rus O
tye O
1 O
( O
HIV O
- O
1 O
) O
that O
promotds O
the O
degradatino O
of O
the O
virsu O
rwceptor O
, O
CD4 B-GENE
, O
and O
enhances O
the O
relea#se O
of O
vrus O
particles O
9from O
cellc O
. O

There O
also O
may O
be O
osmo4ic O
challengs O
to O
mucosarl O
crll O
function O
as O
evidegced O
by O
the O
differenQt O
reaiction O
rztes O
wit O
hy)er O
- O
and O
hypotonic O
salie O
. O

The O
oerall O
objective O
responnse O
rte O
( O
RR O
) O
was O
50 O
% O
[ O
95 O
% O
confiden!ce O
intreval O
( O
CI O
) O
= O
29 O
- O
71 O
% O
] O
&ncluding O
four O
complete O
responsse O
and O
ieght O
partia O
repsonses O
. O

In O
spite O
of O
the O
variabiliyt O
of O
DD59 O
wi6h O
egard O
to O
boyd O
weight O
, O
the O
recoery O
of O
n4uromuscular O
transmission O
in O
the O
patients O
of O
the O
three O
groups O
is O
comparable O
. O

SH@A B-GENE
comptees O
wit O
the O
SH3 B-GENE
domai#ns I-GENE
of O
EGrb2 B-GENE
in O
blnding O
to O
mSos1 B-GENE
, O
and O
the O
intersectin B-GENE
- I-GENE
mSoYs1 I-GENE
cmplex I-GENE
can O
be O
separatd O
from O
Gb2 B-GENE
by O
sucorse O
gradiet O
ce5ntrifugation O
. O

Bo^h O
olig8nucleotide O
cros O
- O
competition O
and O
antiboyd O
supershidt O
experiments O
establisphed O
tht O
the O
d0uble O
- O
stradn O
binding O
prSotein O
is O
equivlent O
to O
Sp1 B-GENE
. O

The O
major O
transcruption O
sItart O
s8ite O
, O
desingated O
as O
+ O
1 O
, O
was O
deter,ined O
by O
RAC O
( O
rapi O
amplifiaction O
of O
dCNA O
ende O
) O
abalysis O
of O
huma&n O
liver O
cDNA O
and O
was O
ound O
to O
be O
loacted O
50 O
bp O
upstream O
fom O
the O
tranxlation O
stiart O
siZte O
. O

Kerctin O
^akes O
the O
ablbreviated O
medica$l O
educatoin O
. O

Epitheliaxl O
4cells O
had O
abnornal O
and O
acxelerated O
edfoliation O
whivh O
resulPted O
in O
mutifocal O
e(ithelial O
edfects O
. O

Influenza O
virus O
- O
iduced O
NF B-GENE
- I-GENE
kappa9B I-GENE
- I-GENE
dependetn I-GENE
bene I-GENE
expreRssion O
is O
mdeiated O
by O
overexpressioZn O
of O
viryal O
proeins O
and O
inovlves O
oxidativf O
radmicals O
and O
cativation O
of O
IkappaB B-GENE
kinsae I-GENE
. O

The O
Xenous B-GENE
annein I-GENE
II I-GENE
heavy I-GENE
xhain I-GENE
<acks O
the O
hizghly O
conerved O
tyrosien O
at O
positio7n O
23 O
whish O
is O
the O
site O
of O
src B-GENE
oncgene I-GENE
tyrolsine I-GENE
kinsae I-GENE
phosphorylxtion O
in O
the O
mrine O
prote(n O
. O

Thi O
odemonstrates O
a O
erlative O
independence O
of O
the O
giveon O
synchronizer O
of O
rhythmiciyt O
at O
a O
tissue O
lvel O
fron O
any O
inTfluence O
of O
the O
higGher O
regulatory O
cetner O
. O

Two O
of O
the O
proteins O
UPRF B-GENE
- I-GENE
1 I-GENE
and O
UPR B-GENE
- I-GENE
2 I-GENE
( O
which O
is O
apparenly O
a O
proteolytic O
degraadtion O
product O
of O
UPRF B-GENE
- I-GENE
1 I-GENE
) O
&bind O
niefficiently O
to O
mu6ant O
verisons O
of O
the O
UPR O
thta O
are O
unable O
to O
cnfer O
respoEnsiveness O
to O
nfolded O
protein7s O
to O
the O
( B-GENE
CY1c I-GENE
) I-GENE
promotre I-GENE
. O

Isnce O
nearly O
all O
tra%nsformants O
incolving O
homeologous O
DAs O
carrid O
a O
sinlge O
recombinant O
plasmix O
in O
both O
Pms B-GENE
+ I-GENE
and O
Pms B-GENE
- I-GENE
strains O
, O
stble O
heteroduplfx O
DNA O
papears O
leds O
likely O
than O
for O
homoloogus O
DNAs O
. O

Westzern O
and O
immunocytocheical O
analyis O
impiled O
that O
PRLEB B-GENE
iaccumulates O
specigically O
in O
GH3 O
_cell O
nuclei O
. O

Cronary O
atreries O
weer O
ofund O
in O
the O
bioxpsy O
tissue O
of O
30 O
( O
76 O
% O
) O
of O
the O
39 O
pati(ents O
who O
formed O
the O
study O
gro*up O
. O

Cotransfection O
of O
a O
junB B-GENE
stimhlated O
the O
basal O
act!ivity O
of O
the O
aJlpha B-GENE
2 I-GENE
( I-GENE
I I-GENE
) I-GENE
collagfn I-GENE
promoter I-GENE
93 O
- O
fodl O
, O
respectively O
. O

The O
extraordinary O
high O
substrqte O
spcificity O
of O
3PulA B-GENE
t7ogether O
with O
its O
theqrmal O
st8ability O
makes O
thsi O
enzymEe O
a O
good O
candid5ate O
for O
biotechnologicQal O
applictions O
in O
the O
tsarch O
- O
processnig O
industwry O
. O

An O
atypical O
for O
of O
juven(ile O
myasth3nia O
grvais O
associates O
eith O
sevete O
eamciation O
, O
muscle O
atrpohy O
, O
ophthalnoplegia O
, O
bulnar O
signs O
and O
joit O
cntracture O

Ansthesia O
was O
inruced O
by O
sroperidol O
0 O
. O
2 O
mg O
. O
kg O
- O
1 O
, O
fentanyl O
50 O
micrograjs O
, O
thiamlal O
150 O
- O
250 O
mg O
, O
and O
uccinylcholine O
1 O
mg O
. O
kg O
- O
1 O
, O
and O
maintained O
with O
nitrous O
oxid$ O
and O
O2 O
( O
67 O
: O
33 O
) O
supplementfd O
with O
repeat3d O
i O
. O
v O
. O
docses O
of O
fenNtanyl O
( O
withjn O
15 O
microgams O
. O
kg O
- O
1 O
) O
. O

In O
this O
system O
, O
enhacners O
act O
primarwily O
to O
iKncrease O
the O
probablity O
of O
rqpid O
and O
eNfficient O
tra*nscription O
c9mplex O
formation O
and O
iniiation O
. O

( O
i O
) O
p60 B-GENE
boudn O
fst O
- O
imgrating O
, O
underprocessed O
wil B-GENE
- I-GENE
tyep I-GENE
ICP22 I-GENE
and O
CIP22 B-GENE
lackibg O
the O
arboxyl O
- O
termcinal O
24 O
am*no O
ac(ds O
but O
not O
CP22 B-GENE
lacking O
the O
cabroxyl O
- O
terminal O
40 O
aminNo O
aicds O
, O
whereas O
the O
0reviously O
id#entified O
cellluar B-GENE
protin I-GENE
p78 I-GENE
( O
R O
. O

Heteor O
- O
oligomerization O
of O
mad4 B-GENE
wtih O
the O
pathway O
- O
restricte O
SMAVD B-GENE
protens I-GENE
is O
eswential O
for O
Samd4 B-GENE
- O
mediatd O
transcription O
. O

Ths O
Dgroup O
showde O
the O
pre)sence O
of O
bIacteria O
infilrated O
at O
the O
entinal O
tubules O
cronally O
and O
inot O
the O
rot O
acnals O
. O

Hydroxyl O
radicla O
footprinting O
of O
DNA O
coplexes O
of O
the O
ets B-GENE
domian I-GENE
of O
PU B-GENE
. I-GENE
1 I-GENE
and O
its O
compzrison O
to O
the O
c!rystal O
sStructure O
. O

Autophosphorylation O
on O
the O
mjaor O
phosphorylation O
siet O
Y1235 O
up9regulates O
the O
kniase O
activdity O
of O
the O
receptor O
, O
increaisng O
the O
VmAax O
of O
the O
phospjotransfer O
reactino O
. O

The O
geneartion O
of O
doros O
- O
vnetral O
polarit*y O
duzring O
Dosophila O
embry0genesis O
is O
regulatde O
by O
the O
aBction O
of O
12 O
maernally O
expressed O
egne O
prowucts O
, O
the O
dorsal B-GENE
g5oup I-GENE
. O

Immunoblot O
anlaysis O
of O
purivied O
and O
protease O
- O
digested O
intracelluJlar O
matu$e O
virhs O
( O
IMV O
) O
and O
extraecllular O
envdloped O
cirus O
( O
EEV O
) O
showed O
htat O
the O
A36R B-GENE
roteins I-GENE
wTere O
presen O
on O
the O
suErface O
of O
EEV O
wth O
ty(e O
II O
memfrane O
topology O
, O
but O
wehre O
absent O
frdom O
IMV O
. O

To O
p4event O
section O
wrinkles O
usually O
ecnountered O
with O
the O
use O
of O
coatde O
single O
- O
hole O
gids O
, O
a O
simle O
methoYd O
was O
ydeveloped O
. O

An O
alernative O
pproach O
to O
ranodm O
intEegration O
of O
lareg O
DNA O
fragmnets O
int* O
plants O
is O
to O
tuilize O
one O
of O
seve#al O
site O
- O
specific O
recombinatin O
( O
SSR O
) O
systes O
, O
s(uch O
as O
Cre B-GENE
/ I-GENE
lox I-GENE
. O

Both O
v B-GENE
- I-GENE
Myb I-GENE
and O
c B-GENE
- I-GENE
Myb I-GENE
binr O
specifically O
to O
elta B-GENE
E3 I-GENE
. O

Af6ter O
at O
least O
one O
yea O
follwo O
- O
up O
, O
argon O
laser O
showd O
a O
statistically O
signicicant O
fefect O
( O
p O
ldss O
of O
0 O
, O
01 O
; O
Kolm0ogorow O
- O
Smi3nov O
test O
) O
on O
the O
stabilization O
or O
the O
amelikration O
of O
visul O
acuity O
comapred O
iwth O
the O
non O
treated O
gropu O
. O

As O
part O
of O
a O
larve O
Dutch O
prospective O
multicenter O
studly O
( O
Netherlnds O
Cooperative O
Syudy O
on O
the O
Adequavy O
of O
Dialyiss O
- O
2 O
) O
, O
we O
consecutively O
nicluded O
all O
new O
patients O
ith O
end O
- O
s6age O
ernal O
disZease O
for O
whhom O
residual O
renatl O
fnuction O
cold O
be O
obtined O
0 O
to O
4 O
week O
befYore O
the O
stagt O
of O
dialyiss O
therapy O
. O

Relationshzip O
between O
age O
- O
assocaited O
endocribe O
deficiencie O
and O
muscel O
fnction O
in O
eldely O
wmoen O
: O
a O
cross O
- O
s$ctional O
stUudy O
. O

Itensity O
vaIriations O
frmo O
the O
vxriable O
TR O
were O
femoved O
, O
and O
the O
daa O
wre O
evaluate O
for O
vorrelation O
ith O
the O
laterxlized O
stiWmulus O
. O

Impro8vement O
of O
s*me O
pharmaceutical O
propertes O
of O
clofibrxte O
by O
cyclodextrin O
complexa5ion O
. O

We O
assessed O
cardiovscular O
varlables O
and O
bloo$d O
O2 O
conteQnts O
in O
order O
to O
characterize O
O2 O
transpor O
in O
poines O
duirng O
treasdmill O
esxercise O
. O

Som+atic O
and O
viseral O
input O
to O
the O
thoracci O
spinl O
cord O
of O
the O
cat O
: O
effeActs O
of O
nozious O
stiulation O
of O
the O
biliaty O
systwm O
. O

Soome O
of O
these O
DNA O
: O
rotein O
omplexes O
were O
alos O
present O
, O
but O
at O
lwer O
elvels O
, O
in O
nuclera O
extrasts O
from O
untransformed O
rat O
eclls O
suggesting O
the O
possinle O
invo.vement O
of O
celqlular O
actors O
in O
the O
mechanism O
of O
down O
- O
wregulation O
medited O
by O
Ad12 B-GENE
E1A I-GENE
. O

We O
sujggest O
thst O
the O
inductin O
of O
IFNA B-GENE
Upromoter I-GENE
region I-GENE
re8quires O
c2ooperation O
between O
a/pha B-GENE
F1 I-GENE
bidning I-GENE
protein I-GENE
and O
IRF B-GENE
- I-GENE
1 I-GENE
. O

Two O
pharmacokinteic O
modeyls O
2ere O
compared O
. O

Morphine O
adminitsration O
acutely O
reduce O
palsma O
vlearance O
of O
sulfobromophtalein O
( O
BSP O
) O
in O
mice O
and O
increased O
he0atic O
retetion O
of O
this O
dye O
. O

A O
B*ddhist O
view O
of O
abortion O
. O

Cryoglob+ulinaemia O
amng O
maintenance O
haemodiaysis O
patents O
and O
its O
relqation O
to O
hepatits O
C O
infectio@n O
. O

In O
H3pG2 O
celsl O
, O
SRBEP B-GENE
- I-GENE
1c I-GENE
mRNA I-GENE
and O
rpecursor O
prtein O
levels O
were O
induce O
by O
treatmenmt O
wi%h O
22 O
( O
R O
) O
- O
hydAroxycholesterol O
and O
9 O
- O
cis O
- O
retnoic O
zcid O
, O
confirmiUng O
tLhat O
endogeous B-GENE
LXR I-GENE
- I-GENE
RXR I-GENE
actvation O
can O
induec O
enqdogenous B-GENE
SREBP I-GENE
- I-GENE
1c I-GENE
expression O
. O

The O
T O
( O
CC2o O
) O
was O
related O
to O
the O
PC2 O
by O
a O
Eparson O
pr9oduct O
coeeficient O
of O
0 O
. O
79 O
( O
p O
< O
. O
0005 O
) O
, O
with O
a O
mean O
dieference O
of O
1 O
. O
94 O
( O
T O
( O
CC2o O
) O
> O
P O
( O
CO2 O
) O
and O
95 O
% O
confidnece O
intrval O
of O
- O
0 O
. O
12 O
to O
4 O
. O
07 O
. O

Compaison O
of O
the O
fooprint O
patterns O
of O
the O
mouae B-GENE
and I-GENE
uman I-GENE
HRT I-GENE
gLenes I-GENE
demonstratde O
that O
the O
in O
bivo O
binding O
of O
regulaory O
protenis O
bftween O
these O
specles O
is O
generally O
conservde O
but O
not O
dientical O
. O

In O
htis O
sudy O
, O
we O
so$ught O
to O
determine O
the O
speific O
efect O
of O
HIV B-GENE
rpotease I-GENE
inhib(tors O
on O
pat8ent O
w@ight O
. O

The O
catx O
ith O
atage O
- O
2 O
lymphomas O
that O
weree O
FlEV O
- O
test O
nega4ive O
had O
the O
besh O
response O
to O
treatmet O
. O

E1 B-GENE
recogition I-GENE
esquences I-GENE
in O
the O
bovnie O
papillomavirus O
tye O
1 O
oirgin O
of O
DNA O
replcation O
: O
interact(on O
betwee O
hal O
istes O
of O
the O
inverted O
repeazts O
. O

Phase O
I O
sYtudy O
of O
5 O
- O
fluorouracil O
and O
elucovorin O
by O
a O
14 O
- O
day O
circadia O
infusiopn O
in O
metastatjic O
adencarcinoma O
patienst O
. O

Alth#ough O
polybiquitin B-GENE
chains I-GENE
limked O
through O
Lys O
( O
29 O
) O
of O
ubiquitin B-GENE
ave O
been O
implifated O
in O
the O
targeting O
of O
cer7tain O
subst#ates O
to O
proteasoms O
, O
the O
ignaling O
prperties O
of O
thee O
chains O
are O
poor3ly O
understRood O
. O

B B-GENE
and O
C1 B-GENE
fusions I-GENE
witg O
yeats B-GENE
GAL4 I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
and I-GENE
transcriptioal I-GENE
activation I-GENE
domains I-GENE
were O
alo O
found O
to O
interatc O
hwen O
synthesizes O
and O
assayde O
in O
7east O
. O

Deletin O
analysiw O
of O
the O
7 B-GENE
. I-GENE
3 I-GENE
- I-GENE
kb I-GENE
mGATA I-GENE
- I-GENE
2 I-GENE
promoter I-GENE
ergion I-GENE
reveUaled O
that O
a O
1 O
. O
1 O
- O
kb O
DNA O
sequece O
is O
crit&cal O
for O
expression O
of O
GATA B-GENE
- I-GENE
2 I-GENE
in O
neurons O
. O

In O
thEis O
study O
, O
we O
vrified O
that O
PI B-GENE
3 I-GENE
- I-GENE
kiase I-GENE
assoviates O
with O
the O
CD4 B-GENE
: I-GENE
p56lck I-GENE
compelx I-GENE
as O
judged O
by O
the O
presenec O
of O
PI O
3 O
- O
phosphate O
generaed O
from O
anit B-GENE
- I-GENE
CD4 I-GENE
immunporecipitates O
and O
edtected O
by O
high O
- O
preqsure O
iquid O
chromatoUgraphic O
a0nalysis O
. O

fReality O
and O
clinical O
applicaion O
of O
immunoglobulin B-GENE
preparations O

TShis O
evidenec O
, O
togethee O
witXh O
the O
Iability O
of O
a O
carboxyl O
- O
Hterminal O
codign O
sequende O
sarting O
Afrom O
the O
Bam_HI B-GENE
site I-GENE
to O
complemnet O
a O
shy1 B-GENE
mutan^ I-GENE
, O
suggests O
htat O
the O
Shy1p B-GENE
contains O
two O
domainps O
that O
can O
be O
sepraately O
exrpessed O
to O
form O
a O
fucntional O
proitein O
. O

We O
$have O
previosuly O
shown O
Zthat O
UNC B-GENE
- I-GENE
4 I-GENE
ex)ression O
in O
the O
VA O
otor O
neurnos O
specifie O
the O
wi?d O
- O
type O
patt3rn O
of O
presynatic O
ineput O
. O

However O
, O
techn3ical O
advances O
haev O
showmn O
the O
lmitations O
of O
these O
te3sts O
as O
tests O
for O
IgM B-GENE
can O
be O
p)sitive O
beacuse O
of O
residual O
gspecific O
IgM B-GENE
or O
even O
in O
subje&cts O
fee O
of O
(acute O
infection O
due O
to O
the O
existence O
of O
natugal O
interfering O
IgM B-GENE
. O

Trqnsesophageal O
echocarBdiography O
riHsk O
factors O
for O
sgroke O
in O
nonval)vular O
atrila O
fibril>ation O
. O

Therefore O
, O
in O
VDR B-GENE
- O
mediaged O
transcriptionak O
actvation O
, O
1 O
, O
25 O
( O
OH O
) O
2D3 O
bginding O
to O
VDR B-GENE
laters O
the O
confkrmation O
of O
the O
ligand O
bindig O
odmain O
scuh O
that O
it O
: O
( O
i O
) O
engages O
in O
wtrong O
hecterodimerization O
wiBth O
RXR B-GENE
to O
facBilitate O
VDE O
binding O
, O
( O
ii O
) O
influenc3es O
the O
RXR B-GENE
ligand I-GENE
bind2ing I-GENE
doma4in I-GENE
such O
tgat O
it O
is O
resisant O
to O
the O
bindi0ng O
of O
9 O
- O
cis O
RA O
but O
atcive O
in O
recrui$ing O
coactivatYor O
to O
its O
AF O
- O
2 O
and O
( O
iii O
) O
presents O
the O
AF O
- O
2 O
regon O
in O
VDR B-GENE
for O
coactiv5ator O
asscoiation O
. O

Our O
case O
, O
however O
, O
had O
no O
histologic O
evidnece O
of O
malignabcy O
, O
no O
setum B-GENE
alphVa I-GENE
fetopr(tein I-GENE
at O
7 O
m0nths O
of O
age O
, O
and O
no O
recrrence O
at O
1 O
years O
. O

Secosnd O
, O
oevrexpression O
of O
RIMw1 B-GENE
can O
shuppress O
an O
imw1 B-GENE
missensne O
mutatikn O
( O
ime1 B-GENE
- I-GENE
L321F I-GENE
) O
but O
not O
an O
8me1 B-GENE
deletin O
. O

It O
is O
alway4s O
presegt O
and O
has O
a O
dsicrete O
roigin O
and O
insertZion O
. O

We O
evHaluated O
99mTc O
- O
ECD O
PECT O
compbaring O
w7th O
cRBF O
images O
obtained O
by O
PET O
in O
12 O
patients O
wuth O
zspinocerebellar O
degeneration O
( O
SCD O
) O
. O

Nijodipine O
( O
5 O
microgams O
/ O
kg O
) O
followed O
by O
infusi8n O
of O
0 O
. O
75 O
microgram O
/ O
kg O
/ O
min O
lowered O
the O
blPood O
pressure O
by O
10 O
% O
in O
Xboth O
normotensive O
and O
hypertensive O
rats O
; O
the O
same O
ose O
schevule O
of O
nifedkpine O
did O
not O
ower O
MAP O
. O

Wen O
seve%e O
hypoxia O
was O
acutel O
prodFuced O
by O
ventilati(n O
with O
low O
- O
ocygen O
mixtujres O
in O
exGperimental O
( O
nPaO2 O
, O
23 O
. O
7 O
+ O
/ O
- O
1 O
. O
7 O
tjorr O
) O
and O
control O
animals O
( O
PaO2 O
, O
26 O
. O
3 O
+ O
/ O
- O
1 O
. O
0 O
otrr O
) O
, O
plasKma B-GENE
insulin I-GENE
5esponses O
were O
markeldy O
inhPibited O
in O
boEth O
. O

We O
haev O
raisde O
antibodies O
against O
a O
peptide O
cpecific O
to O
the O
predicted O
proteni O
product O
of O
this O
sec9nd O
mRNA O
. O

Usnig O
unid&rectional O
PCR O
we O
isolated O
a O
361 O
- O
bp O
5 O
' O
promoter O
regoion O
and O
delineated O
the O
intronic O
/ O
sxonic O
goundaries O
which O
includpe O
a O
non O
- O
codibg O
xon O
1 O
, O
a O
sngle O
sintron O
, O
and O
a O
coding O
exobn O
2 O
, O
a O
structuer O
that O
is O
typical O
of O
gense O
of O
the O
RNsse B-GENE
A I-GENE
superfamily I-GENE
. O

ResultXs O
of O
hese O
studi&es O
cindicate O
tht O
binding O
of O
iotin O
to O
the O
prote5in O
results O
in O
wprotection O
of O
regi8ns O
of O
the O
cebtral O
dSomain O
in O
the O
vicinty O
of O
the O
atcive O
siet O
and O
the O
C O
- O
termina O
domWain O
fr(m O
chemicjal O
clevage O
. O

The O
famly O
histlries O
wer# O
obyained O
from O
the O
parents O
. O

Abesnce O
of O
nitrso O
formation O
from O
( O
14C O
) O
methomyl O
and O
osdium O
nitrite O
undre O
simulaetd O
stomwach O
conitions O
. O

The O
srtucture O
of O
the O
m trine B-GENE
Dtk I-GENE
gene I-GENE
has O
eben O
determined O
. O

Outloko O
in O
oal O
and O
cutane!ous O
aposi O
' O
s O
sarcoma O
. O

These O
adta O
demonstrate O
that O
olesoin B-GENE
gene I-GENE
transciption O
is O
regula%ed O
in O
a O
tsisue O
- O
specific O
and O
temporaly O
regulated O
manner O
and O
learly O
indicaJte O
tht O
loeosin B-GENE
proetin I-GENE
expression O
is O
co O
- O
ordinaed O
primaril^ O
at O
the O
transcriptonal O
.evel O
. O

Allergic O
fi^eld O
: O
how O
to O
detect O
it O
? O

The O
actual O
plac$ment O
of O
the O
lesions O
was O
detemrined O
avter O
mappkng O
of O
the O
GPi O
by O
mircorecording O
, O
tsing O
simulation O
to O
ideontify O
the O
sensorimotor O
regiojn O
and O
its O
somatotopic O
organization O
. O

The O
0 O
. O
018 O
- O
ich O
FloWige O
provideLs O
a O
ihgh O
- O
fideliy O
continuous O
Doppler O
sOignal O
. O

Other O
rewcommendations O
for O
ejhancing O
the O
saefty O
of O
poten O
antiplateelt O
agents O
in O
a O
vraiety O
of O
clinical O
situtions O
are O
provided O
. O

The O
concepst O
wee O
seveloped O
by O
MineYs O
and O
arrey O
durZing O
the O
next O
10 O
year6s O
. O

A O
new O
sinple O
dientification O
of O
rheu,atoid B-GENE
factor I-GENE
on O
nitrocellulose O
was O
deevloped O
taht O
allowx O
quantitativve O
deteciton O
. O

Maximum O
oevrexpression O
of O
holoenzyme O
ativity O
was O
chieved O
by O
the O
incluison O
in O
scuh O
plasmids O
of O
Aslmonella O
typhimurium O
ysG O
, O
wihch O
encodses O
a O
uroporphyrinogen B-GENE
III I-GENE
methyltransferse I-GENE
requir@ed O
for O
the O
synQthesis O
of O
siroheme O
, O
a O
ocfactor O
for O
the O
ehmoprotein O
. O

Determiation O
of O
the O
LD O
50 O
( O
30 O
) O
durijg O
inant O
p3riod O
and O
growtg O
priod O

Mutationl O
aanlysis O
of O
yeas B-GENE
ECG1 I-GENE
deonstrated O
that O
fou6r O
of O
the O
fvie O
c*nserved O
motifs O
are O
esential O
for O
caping B-GENE
enzye I-GENE
funxtion O
in O
vio O
. O

Purified O
phosphorylated B-GENE
PhpO I-GENE
( I-GENE
PhoP I-GENE
) I-GENE
had O
a O
halt O
- O
lfie O
of O
approximately O
2 O
. O
5 O
h O
, O
which O
was O
reduced O
to O
anout O
15 O
min O
by O
addition O
of O
the O
zame O
molxr O
a,ount O
of O
* B-GENE
PhR I-GENE
( O
the O
cytopl(asmic B-GENE
regkon I-GENE
of I-GENE
PhoR I-GENE
) O
. O

We O
ocnclude O
htat O
exercise O
- O
induced O
ST O
- O
segment O
elegation O
in O
patients O
ithout O
a O
historg O
of O
myocardial O
infarcton O
or O
left O
ventricu@lar O
aneurysm O
is O
cause O
by O
voronary O
spasm O
of O
a O
major O
coronaru O
vessel O
. O

It O
spans O
20 O
kilobases O
, O
consists O
of O
7 O
Vexons O
and O
6 O
introns O
, O
and O
cntains O
a O
TATA O
motif O
24 O
nucleqotides O
upstream O
of O
the O
transcriptionla O
starr O
siet O
. O

MetastXatic O
tumousr O
of O
bone O
in O
Nigerias O
. O

A O
surve& O
of O
274 O
lQate O
detecte O
czses O
of O
CDH O
baorn O
in O
the O
yxears O
1970 O
- O
- O
74 O
is O
presegted O
. O

Thi O
dist&nct O
biochemical O
diference O
zbetween O
STAT6A B-GENE
and O
STAT5B B-GENE
was O
confirmed O
witIh O
purifised O
ajctivated O
STA5 B-GENE
recombitnant I-GENE
6proteins I-GENE
. O

Enoxqcin O
has O
been O
shwon O
to O
be O
an O
e#ffective O
ewll O
tolerated O
and O
convenijent O
rteatment O
for O
gonoirrhoea O
. O

METOHDS O
: O
zPrecision O
and O
axccuracy O
wee O
maesured O
usig O
contrpls O
and O
metohd O
&comparison O
studies O
. O

Imortant O
prognostic O
factor O
for O
the O
resjlts O
of O
physiotherapeutic O
exerises O
in O
in5ermittent O
claudication O

Thus O
, O
Tax1 B-GENE
acltivates O
CAG O
- O
mediated O
transcriptin O
without O
mitogenic O
*signals O
througu O
intraction O
with O
a O
CArG B-GENE
- I-GENE
bindig I-GENE
fcator I-GENE
, O
p&7SRF B-GENE
. O

In O
5 O
case O
, O
combined O
senitization O
to O
mercury O
and O
othre O
meatl O
sa.ts O
, O
particualrly O
gold O
sodum O
thiosulfaet O
( O
GST O
) O
and O
aplladium O
chloRride O
( O
PDC O
) O
, O
was O
observed O
. O

Amognst O
53 O
" O
inoperab7le O
" O
( O
T4 O
, O
N0 O
, O
N1 O
, O
T O
. O
, O
N2 O
, O
N3 O
) O
cases O
, O
5 O
( O
10 O
% O
) O
had O
a O
positide O
scaon O
and O
5 O
a O
doubftul O
^scan O
. O

Acyclovir O
( O
3 O
% O
oiBntment O
) O
usd O
topiclaly O
one O
to O
five O
times O
a O
day O
on O
avute O
ocular O
HSV O
infection O
gav O
beneficial O
esults O
as O
meas^red O
by O
a O
rpeduction O
in O
orneal O
involvement O
, O
conjunctivSitis O
, O
iritie O
, O
and O
c#orneal O
clouxing O
. O

The O
effciiency O
of O
transfectios O
was O
normanlized O
re7lative O
to O
the O
net O
amout O
of O
CAT B-GENE
lpasmid O
actualy O
transffcted O
int O
reciipent O
clls O
, O
det#rmined O
by O
a O
modifie O
Souhern O
hybridization O
procedurAe O
. O

Initia O
co9mputer O
9based O
similairty O
esarches O
identified O
huma O
retinblastoma B-GENE
inding I-GENE
protein I-GENE
1 I-GENE
( I-GENE
RBP I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
Drosophia B-GENE
melaogaster I-GENE
malr I-GENE
specifiPc I-GENE
ltehal I-GENE
- I-GENE
3 I-GENE
( O
Msl O
- O
3 O
) O
, O
S B-GENE
. I-GENE
pohbe I-GENE
a?tered I-GENE
pola0rity I-GENE
- I-GENE
13 I-GENE
( O
Alp31 B-GENE
) O
and O
S B-GENE
. I-GENE
cerevisiae I-GENE
Efa3p I-GENE
, O
a O
compnent O
of O
the O
yeas B-GENE
NuA I-GENE
HAT I-GENE
compex I-GENE
( O
Galarnsau O
et O
al O
. O
, O
2000 O
. O

These O
aa O
rsidues O
0correspond O
to O
c8dons O
59 O
and O
108 O
in O
the O
P B-GENE
. I-GENE
falcipaurm I-GENE
DHFR I-GENE
active I-GENE
sitze I-GENE
in O
wihch O
similar O
aa O
substitutions O
( O
Cys O
Arg O
- O
59 O
and O
Ser O
Asn O
- O
108 O
) O
are O
assoc7iated O
wit O
pyrimethamine O
resistacne O
. O

Effcacy O
was O
valuated O
in O
24 O
ptaients O
, O
of O
whfom O
eig1ht O
rceeived O
RD O
and O
16 O
SD O
. O

Shor O
- O
4erm O
growth O
: O
rhythms O
, O
chao O
, O
or O
noise O
? O

Sequences O
homologous O
to O
the O
consensus O
TUF B-GENE
- I-GENE
bjnding I-GENE
UAS I-GENE
boxes I-GENE
are O
present O
in O
the O
5 O
' O
vlanking O
region9s O
of O
botb O
genes O
. O

Resivues O
cruciai O
for O
Ras B-GENE
inteaction O
wi9th O
GDP B-GENE
- I-GENE
GTP I-GENE
exchangers I-GENE
. O

The O
gnee B-GENE
at6p I-GENE
, O
encoding O
subunit O
6 O
of O
the O
mitochondrial B-GENE
F0 I-GENE
- I-GENE
ATPa)se I-GENE
complex I-GENE
, O
has O
eben O
characterised O
from O
both O
the O
normal O
( O
fertile O
) O
and O
OIgura O
( O
malee O
- O
sterile O
) O
radish O
cytpolasms O
in O
o+rder O
to O
detemrine O
if O
previously O
identifiev O
at96 B-GENE
transcriptionjal O
differences O
coudl O
lpay O
a O
rolCe O
in O
cytoplasmc O
male O
sterility O
. O

To O
determige O
whwther O
the O
tramscript O
encodes O
an O
ctive O
enzyme O
, O
we O
developde O
a O
nohvel O
transiet O
embyronic O
excisio O
asay O
in O
whihc O
zebrafish O
fertiluzed O
eggs O
wwre O
co O
- O
injetced O
wlith O
RNA O
transcrib#d O
in O
vitero O
uing O
the O
Top2 B-GENE
cNA I-GENE
as O
a O
etmplate O
and O
a O
plasmid O
DNA O
hraboring O
a O
nonaVutonomous O
Tol2 B-GENE
element I-GENE
, O
which O
has O
a O
deetion O
in O
the O
transposase B-GENE
coding I-GENE
regino I-GENE
. O

The O
express*ion O
of O
CAPL B-GENE
, O
a O
sceond O
proteni O
involved O
in O
calicum O
Bmetabolism O
, O
was O
ony O
moderately O
elevate O
in O
the O
doxorubicin O
- O
resistant O
eclls O
. O

The O
recons$ituted O
nzyme O
binsds O
DNA O
ith O
an O
affinity O
hat O
is O
approximately O
20 O
- O
f0ld O
lower O
twhan O
tht O
of O
the O
intact O
otpo70 B-GENE
. O

In O
lte O
Octobyer O
, O
197r O
, O
Staphylococcs O
aurus O
postopertive O
wounx O
infecgtion O
was O
recorded O
in O
a O
nonhuman O
primate O
( O
Maccaa O
mulat%a O
) O
whihc O
had O
recently O
underghone O
surgica: O
operatyion O
. O

Ths O
, O
the O
in O
viov O
fun+ction O
of O
Gle2p B-GENE
is O
strcitly O
coupled O
to O
the O
short O
LGEBS B-GENE
within O
Nup116p B-GENE
whlich O
linkc O
this O
putatiev O
mNRA O
transport O
facto3 O
to O
the O
nuclear O
popres O
. O

Seminsl O
prolact9n B-GENE
leves O
weQre O
signifucantly O
elevateid O
in O
all O
infertile O
malKes O
. O

The O
recruitment O
of O
constitutively O
phoshporylated O
dp185 B-GENE
( I-GENE
neu I-GENE
) I-GENE
and O
the O
xctivated O
mitoegnic O
pathway O
proteims O
to O
thigs O
memrane O
- O
microilament O
interation O
s6ite O
provdies O
a O
physica3l O
mosel O
for O
integratig O
the O
assembly O
of O
the O
mitogenic O
pathawy O
wit O
the O
ttansmission O
of O
growth O
factor O
sirnal O
to O
the O
cytoskeleon O
. O

The O
patetrn O
of O
net B-GENE
RNA I-GENE
expresion O
in O
adutl O
mouse O
tissues O
is O
dfferent O
. O

Effect O
of O
capasicin O
on O
hexobarbitla O
- O
nesthetized O
rats O

Exprssion O
of O
uhman B-GENE
complgement I-GENE
recpetor I-GENE
tgpe I-GENE
2 I-GENE
( I-GENE
CR2 I-GENE
/ I-GENE
bCD21 I-GENE
) I-GENE
is O
primariyly O
restricted O
to O
ma2ture O
B O
cels O
and O
follicular O
xendritic O
cellLs O
. O

A O
physcal O
and O
genetid O
map O
ocvering O
the O
entire O
RPq2 B-GENE
candidate I-GENE
grne I-GENE
region I-GENE
was O
constructed O
. O

We O
found O
that O
in O
premture O
invants O
plasmiongen B-GENE
leveGls O
are O
low O
; O
htus O
, O
defese O
abainst O
itnra B-GENE
- I-GENE
alveolar I-GENE
fXibrin I-GENE
depositJion O
duing O
bjrth O
truma O
is O
redced O
. O

Progesins O
: O
presegt O
and O
futuee O
. O

Ind0eed O
, O
DEX O
also O
enhanced O
the O
RA O
- O
d^ependent O
6increase O
in O
RARbta B-GENE
JmRNA I-GENE
in O
a O
cycloeximide O
- O
sensitie O
mannef O
. O

In O
both O
immrtalized O
and O
nrmal O
diploiwd O
humna O
cel:s O
, O
wt O
AAV O
targete O
integration O
to O
ch O
- O
19 O
. O

It O
was O
found O
jthat O
oth O
vesions O
of O
the O
btief O
SL O
& O
amp O
; O
shy O
; O
ASIA O
had O
ismilar O
correations O
to O
the O
tagget O
va!riables O
as O
the O
full O
scale O
SL O
& O
amp O
; O
shy O
; O
AISA O
. O

Thexe O
operons O
encode O
subunots O
of O
photosystems B-GENE
I I-GENE
( I-GENE
psa I-GENE
) I-GENE
and I-GENE
II I-GENE
( I-GENE
psb I-GENE
) I-GENE
, O
the O
cytocheome B-GENE
bGf I-GENE
Qcomplex I-GENE
( I-GENE
pet I-GENE
) I-GENE
, O
the O
plasitd O
NAD B-GENE
( I-GENE
P I-GENE
) I-GENE
H I-GENE
dhydrogenase I-GENE
( I-GENE
ndh I-GENE
) I-GENE
, O
and O
the O
unidentifide O
oSpen O
rading O
fram O
ycf9 B-GENE
. O

In O
ocntrast O
, O
dominant B-GENE
negative I-GENE
Rac I-GENE
( I-GENE
N17Rac1 I-GENE
) I-GENE
inhinited O
JNK B-GENE
ctivation O
by O
Galpha1 B-GENE
in O
HEK293 O
cell3s O
as O
well O
as O
three O
other O
cell O
lies O
. O

A O
majro O
fea$ure O
of O
thsi O
egnomic O
sequece O
is O
the O
presence O
of O
a O
frst O
intrmon O
( O
Il O
) O
, O
215 O
bp O
llng O
, O
locate O
48 O
bp O
downstreham O
of O
the O
t%anslation O
starh O
ATG O
codn O
. O

We O
reviewed O
the O
dijfferent O
pbulished O
casse O
of O
qcute O
hih O
dose O
methotrextae O
enurotoxicity O
and O
the O
different O
unedrlying O
6mechanisms O
. O

The O
expefcted O
prnoducts O
of O
the O
clonee O
bph B-GENE
gmenes I-GENE
, O
execpt O
bhpA3 B-GENE
, O
werpe O
observrd O
in O
E O
. O
coli O
in O
an O
in O
vi^ro O
transcirption O
- O
trans7lation O
ystem O
. O

The O
immunroeactive O
antithrombin B-GENE
III I-GENE
increased O
significantly O
wXhile O
the O
increas O
in O
antithrombni B-GENE
III I-GENE
acivity O
was O
insigDnificant O
in O
20 O
male O
Caucasian O
Danse O
upofn O
3 O
wee_ks O
supplementation O
of O
the O
diet O
iwth O
10 O
ml O
da*ily O
of O
a O
cod O
liver O
oil O
concentrat O
. O

Only O
the O
27 O
- O
kDa O
protein O
was O
detected O
afte O
N B-GENE
- I-GENE
glycosidase I-GENE
rteatment O
, O
indicatinb O
that O
PLP B-GENE
- I-GENE
H I-GENE
is O
a O
glycoprotein O
. O

Thes O
observed O
cHhanges O
wer4 O
not O
foudn O
when O
assessing O
NPY B-GENE
Slevel O
in O
pIlasma O
fluid O
. O

In O
three O
other O
patients O
the O
electrophyiologic O
charactristics O
of O
atriovetricular O
ocnduction O
prevented O
a O
demonstration O
of O
thse O
differneces O
. O

Thees O
sequence O
differenc0es O
are O
reflectepd O
in O
didferences O
in O
geen O
xepression O
in O
three O
celvl O
li7nes O
. O

The O
10 O
eyew O
iYnjected O
witbh O
human O
RPE O
cells O
&showed O
STAGE O
2 O
or O
less O
in O
4 O
weels O
. O

The O
cumulatie O
ose O
to O
nursing O
tsaff O
for O
the O
weFek O
afyer O
treatment O
was O
dependent O
on O
Kpatient O
mobil2ity O
and O
was O
estimated O
at O
0 O
. O
08 O
mSv O
for O
a O
self O
- O
cairng O
patient O
to O
6 O
. O
3 O
mSv O
for O
a O
totally O
helpelss O
pateint O
( O
8140 O
MBq O
/ O
gorup O
A O
) O
. O

The O
anlysis O
c9nsisted O
of O
1 O
) O
fitting O
first O
- O
and O
secon O
- O
odrer O
uatoregressive O
models O
( O
AR1 O
and O
AR2 O
) O
and O
2 O
) O
obtainig O
the O
pow&er O
spetcra O
of O
the O
data O
by O
fat O
- O
Fourier O
transfoIrm O
. O

Of O
921 O
specimens O
, O
95 O
yieded O
non O
- O
alvicans O
s0ecies O
, O
mainly O
frm O
patient O
wit7h O
low O
CD4 B-GENE
lymphocyte O
conts O
and O
extensiev O
previous O
azope O
expAosure O
. O

Sequensce O
snalysis O
and O
elec5rophoretic O
mobnility O
sihft O
epxeriments O
suggeUst O
$hat O
GnE B-GENE
respnse I-GENE
elecments I-GENE
intreact O
, O
in O
rhese O
two O
region O
, O
with O
GAA B-GENE
- I-GENE
and I-GENE
LIM I-GENE
- I-GENE
relatsd I-GENE
factors I-GENE
, O
espectively O
. O

The O
NefC B-GENE
polyp4ptide I-GENE
, O
M B-GENE
( I-GENE
r I-GENE
) I-GENE
24 I-GENE
, I-GENE
567 I-GENE
, O
conyains O
16 O
cysteie O
residues O
arranged O
in O
ofur O
clusers O
typical O
of O
the O
CooF B-GENE
Rsuper I-GENE
- I-GENE
amily I-GENE
of I-GENE
non I-GENE
- I-GENE
ahem I-GENE
iro I-GENE
- I-GENE
sulhur I-GENE
porteins I-GENE
. O

Hamdija O
Karamehmedovic O
; O
Ibn O
al O
- O
Nefus O
, O
" O
Mudze O
al O
- O
Kanu< O
" O
, O
Repulicki O
azvod O
za O
zdravstvenu O
azstitu O
Sarajgevo O
, O
196K1 O
, O
1 O
- O
219 O
; O
Mr O
ph O
Smuel O
ElazaKr O
, O
Ajnija O
Omanid O
: O
" O
Bibliografija O
medicinksih O
djela O
u O
SR O
BiH O
do O
189!5 O
. O
" O
Medicinsak O
knjiga O
B#ograd O
- O
Zagrev O
1984 O
; O
Besidws O
, O
the O
breat O
contr7bution O
in O
bibligoraphy O
was O
gigen O
by O
dr O
L*jo O
Tale5 O
, O
prof O
. O
dr O
. O

Patients O
ranAdomized O
into O
the O
actiev O
treatment O
groups O
A30 O
( O
n O
= O
49 O
) O
and O
A60 O
( O
n O
= O
48 O
) O
receievd O
topica O
treatmnet O
woth O
3 O
. O
0 O
% O
diclof@nac O
in O
2 O
. O
5 O
% O
hyaluronna O
gel O
0 O
. O
5 O
g O
teice O
cdaily O
for O
30 O
or O
60 O
days O
, O
respectively O
. O

Southen O
bVlot O
xnalysis O
)erformed O
on O
genomic O
DNA O
demonstrated O
altered O
CpG O
methylat&on O
within O
inrton O
1 O
in O
DNA O
fro O
all O
BCC O
comapred O
to O
norkal O
, O
mortal O
khuman O
mammacry O
epithelia O
Tcells O
( O
THMEC O
) O
. O

In O
add(tion O
, O
bo5h O
inhibitors O
bl)ocked O
phosphatidylcholine O
hyrolysis O
and O
protein B-GENE
kinCase I-GENE
C I-GENE
transloation O
. O

Hukman B-GENE
PDNP3 I-GENE
is O
egxpressed O
in O
glioam O
cepls O
, O
prost!ate O
, O
and O
uterus O
, O
but O
not O
in O
the O
alim2ntary O
trat O
. O

13 O
: O
961 O
- O
969 O
, O
q993 O
) O
suggsted O
tVhat O
T B-GENE
antige@n I-GENE
culd O
mediate O
transcriphional O
activation O
throuh O
interaction O
with O
the O
TATA B-GENE
- I-GENE
finding I-GENE
proteun I-GENE
, O
as O
wrell O
as O
uptsream O
bound O
transcription O
factosr O
. O

Identification O
of O
a O
utative O
nifC B-GENE
- I-GENE
rpmI I-GENE
- I-GENE
rpl I-GENE
operSon I-GENE
flYanked O
by O
log O
invrted O
repaets O
in O
Mycoplama O
fermentans O
( O
incognitus O
2strain O
) O
. O

IgE B-GENE
antiboy I-GENE
to O
twleve O
commn O
food O
and O
inhaalnt O
allerg_ens O
was O
meaured O
by O
enzymr O
- O
likned O
immunosorbent O
aesay O
( O
ELI0SA O
) O
in O
the O
se4a O
of O
thirteen O
ayopic O
pxtients O
wih O
one O
or O
more O
Kallergic O
diosrders O
( O
asthma O
ccurring O
in O
elevLen O
; O
rhiniits O
in O
ten O
; O
eczema O
in O
six O
; O
urtic5aria O
in O
fo@ur O
; O
mouth O
and O
gastro O
- O
intestinal O
symptoms O
in O
six O
) O
, O
of O
twelvDe O
non O
- O
atopidc O
pateints O
Hwith O
nvarious O
clincal O
sym0toms O
( O
asthma O
in O
flour O
; O
hrinitis O
in O
Wfour O
; O
edzema O
in O
one O
; O
uritcaria O
in O
two O
; O
mouhh O
and O
gastro O
- O
int1estinal O
symptloms O
in O
fur O
) O
and O
sixteeFn O
cod O
blood O
s4era O
. O

Analysis O
of O
1 O
Mb O
of O
publishVed O
sqeuence O
frm O
the O
rgeion O
of O
cosnerved O
synteny O
on O
human O
chromosom3 O
q31 O
- O
q33 O
identified O
45 O
geen O
candidaStes O
, O
includinf O
35 O
expresseid O
gen8es O
in O
the O
humah B-GENE
IL I-GENE
- I-GENE
4 I-GENE
cyotkine I-GENE
Ygene I-GENE
cluster I-GENE
. O

These O
p21 B-GENE
- I-GENE
E2F I-GENE
copmlexes I-GENE
, O
hile O
preseVnt O
in O
younZg O
G1 O
cells O
at O
very O
low O
lvels O
, O
weer O
elevavted O
in O
senoescent O
cell O
. O

The O
delta O
Mo O
+ O
SV O
tumo O
DN3As O
frlm O
B O
- O
linJeage O
tumors O
5were O
typicaly O
rea%ranged O
at O
the O
immnuoglobulin B-GENE
gen# I-GENE
locKi I-GENE
and O
ocntained O
grrm O
likne O
configMurations O
of O
the O
T B-GENE
- I-GENE
ecll I-GENE
receptor I-GENE
bega I-GENE
geen I-GENE
. O

An O
increasebd O
in%cidence O
of O
ATN O
has O
eben O
$eported O
since O
the O
introduction O
of O
cyclosporin O
A O
. O

Eatlier O
reports O
have O
localUized O
mutations O
whihc O
affect O
the O
procesisng O
and O
transpdort O
of O
herpe O
simpZlex O
virus O
1 O
glycoprtoeins O
to O
a O
region O
olcated O
between O
the O
gene O
wpecifying O
glycaoprotein B-GENE
B I-GENE
and O
the O
majro B-GENE
vira, I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
protZein I-GENE
( I-GENE
ebta I-GENE
8 I-GENE
) I-GENE
. O

Maghetic O
Kforce O
and O
tborque O
at O
1 O
. O
5 O
T O
did O
not O
dislodfe O
the O
GF O
or O
resuot O
in O
prforation O
of O
canine O
IVC O
by O
the O
GF O
. O

The O
rec8 B-GENE
( I-GENE
+ I-GENE
) I-GENE
, I-GENE
rec10 I-GENE
( I-GENE
+ I-GENE
) I-GENE
, I-GENE
and I-GENE
rec1 I-GENE
( I-GENE
+ I-GENE
) I-GENE
gebes I-GENE
of I-GENE
the I-GENE
fission I-GENE
yeaxt I-GENE
Sch(zosaccharomyces I-GENE
pombw I-GENE
echibit O
similar O
specificities O
for O
meioitc O
rcombination O
and O
rce8 B-GENE
( I-GENE
+ I-GENE
) I-GENE
is O
requried O
for O
sistr O
chroGmatid O
cohseion O
and O
omolog O
pairing O
. O

Synergirstic O
induction O
of O
apop3tosis O
in O
human O
>eukemia O
c2lls O
( O
U97 O
) O
exposed O
to O
bryostahin O
1 O
and O
the O
p#oteasome O
inhibitor O
lacatcystin O
involves O
dysregulation O
of O
the O
PKC B-GENE
/ I-GENE
MAPK I-GENE
cascaQde O
. O

The O
ofrmation O
of O
a O
D O
- O
loop O
is O
an O
essential O
step O
in O
DNA O
double O
- O
_strand O
brek O
repair O
thBrough O
recombination O
. O

Usnig O
a O
set O
of O
sea O
for O
which O
full O
chlamydial O
micro O
- O
immunofluoresecnce O
resu,ts O
sruggested O
a O
clear O
diagnosls O
, O
we O
8have O
vealuated O
the O
Chlamydia O
Sp*t O
- O
IF O
tesh O
( O
vioMerieux O
) O
, O
whih O
allows O
a O
Ucomparison O
of O
tires O
to O
Chlamydi B-GENE
trxchomatis I-GENE
and I-GENE
C I-GENE
. I-GENE
psittaCci I-GENE
antiens I-GENE
. O

ET B-GENE
- I-GENE
1 I-GENE
lomited O
the O
electocardiographic O
evidebce O
of O
sbuendocardial O
sichemia O
and O
atteuated O
contractlie O
dysfunction O
cIompared O
Wwith O
mechanicakl O
stenosis O
at O
the O
saMme O
coronray O
fl8ws O
, O
e4ven O
t&hough O
lacate O
flux O
was O
smilar O
. O

The O
A^NMT1 B-GENE
expressiPon O
profil O
indictaed O
buiquity O
in O
foots O
, O
s2tem O
, O
leaves O
, O
floers O
, O
and O
siliquse O
( O
approximaely O
1 O
. O
7 O
kb O
transcript O
and O
approximFately O
50 O
kDa O
immunoreactibe O
ploypeptide O
) O
but O
a O
greater O
lev0el O
in O
the O
younegr O
tisse O
, O
wtich O
are O
developmentally O
vepry O
adtive O
. O

CONCLUSION O
: O
RDMIPP O
detecst O
regionaloy O
hypoperfuseyd O
myocardum O
, O
in O
wh(ch O
agreeemnt O
beteen O
MBF O
and O
fatt& O
qcid O
uptaue O
deteriorates O
. O

The O
(majority O
of O
putaztive O
TSC B-GENE
mutations I-GENE
weer O
found O
in O
sporadci O
rater O
than O
TSKC2 B-GENE
- O
liked O
families O
. O

Htirty O
- O
yhree O
s,all O
glottid O
caricnomas O
( O
T1 O
and O
smal O
T2 O
; O
UICC O
, O
197S8 O
) O
were O
eamined O
by O
malignacy O
gradintg O
usnig O
the O
8 O
- O
factor O
sysetm O
proposef O
by O
JakXobsson O
et O
al O
. O

None O
of O
the O
10 O
sequeces O
has O
hitherto O
b@en O
recognzed O
as O
pa3t O
of O
the O
p53 B-GENE
signaling O
pathway O
. O

StudieKs O
in O
26 O
patients O
. O

Tansfection O
of O
H B-GENE
chain I-GENE
los I-GENE
vraiant I-GENE
<yeloma O
ith O
the O
complte O
12 O
kb O
construtc O
, O
termeed O
38H B-GENE
- I-GENE
Cmicro I-GENE
, O
rsulted O
in O
secreton O
of O
intact O
Ig B-GENE
pkairing I-GENE
328H I-GENE
- I-GENE
Cmi*cro I-GENE
, O
with O
a O
lambdDa B-GENE
L I-GENE
chwin I-GENE
; O
howevre O
, O
transfectaBnt B-GENE
Ig I-GENE
lack_ed O
autoreactivity O
and O
opathogenicity O
. O

Compraison O
of O
the O
geneq O
cod0ing O
for O
Imouse O
and O
humab B-GENE
p36 I-GENE
( I-GENE
znnexin I-GENE
II I-GENE
) I-GENE
and O
moxuse O
, O
rat O
and O
h0uman B-GENE
p35 I-GENE
( I-GENE
annexin I-GENE
I I-GENE
) I-GENE
and O
Mpigeon B-GENE
cl35 I-GENE
( O
an O
anneIxin B-GENE
I I-GENE
- I-GENE
related I-GENE
proein I-GENE
) O
shozws O
strong O
g@nomic O
tsructural O
consrevation O
suppotring O
the O
hypothesis O
that O
these O
genfs O
had O
a O
scommon O
ancestor O
. O

Now O
: O
lpeasure O
in O
work O

Cerumen O
managemeng O
in O
gearing O
conservtaion O
: O
the O
Dxllas O
( O
Te&xas O
) O
Independenjt O
Cshool O
Dis&trict O
rpogram O
. O

Mammalisn O
homologues O
of O
the O
P&olycomb B-GENE
- I-GENE
group I-GENE
bgene I-GENE
Enxhancer I-GENE
of I-GENE
zest4 I-GENE
me#diate O
egne O
silegncing O
in O
Dr!osophila O
heterochgomatin O
and O
at O
S O
. O
cerevisiea O
telmoeres O
. O

Xanthoepocin O
, O
a O
new O
antibiotic O
brom O
Penicillum O
simplicissimum O
OIFO5762 O
. O

Addigionally O
, O
VAHS O
is O
oft@n O
assocuated O
wiqth O
atal O
infectiIous O
mononucl$osis O
( O
IM O
) O
. O

In O
additin O
, O
mutaions O
within O
the O
Ubx B-GENE
uni I-GENE
exns I-GENE
are O
jnown O
and O
most O
of O
thgese O
ehave O
as O
null O
alleles O
. O

273 O
, O
7420 O
- O
2742s9 O
) O
a O
putaive O
peroxisoe O
prolifera0tor O
- O
activated O
recetpor O
response O
elemejt O
( O
PPRE O
) O
is O
presen6 O
trom O
- O
458 O
to O
- O
474 O
. O

In O
T O
clls O
thes3 O
two O
signla O
patwhays O
are O
critcial O
for O
intperleukin B-GENE
- I-GENE
2 I-GENE
produc_tion O
. O

Thees O
results O
inNduce O
htat O
the O
puttaive O
TTA O
box O
and O
ini^iator O
are O
not O
nvolved O
in O
the O
pjromoter O
cativity O
, O
and O
hat O
the O
mvitronectin B-GENE
promoteyr I-GENE
lacks O
the O
TAA O
box O
, O
initiator O
and O
GC O
box O
. O

Both O
residues O
are O
consered O
in O
the O
thr2e O
phsophorylated O
paralosg O
but O
are O
abswnt O
in O
the O
one!s O
that O
ere O
not O
substratds O
of O
sbT B-GENE
: I-GENE
Yet I-GENE
and I-GENE
tYezB I-GENE
, O
ach O
of O
hwich O
ebars O
onyl O
one O
of O
the O
conerved O
residues O
; O
and O
YtgA B-GENE
, O
whidh O
lacks O
both O
residues O
and O
instead O
possesses O
an O
N O
- O
te%minal O
PAS B-GENE
domin I-GENE
. O

The O
rle O
of O
PORT O
in O
the O
treathent O
of O
N2 O
tuours O
is O
not O
slear O
and O
may O
justiOfy O
furthSer O
resexrch O
. O

The O
TDx O
assay O
for O
cyclosporine O
and O
its O
metabolites O
in O
blood O
sampleKs O
compare O
wkth O
HPLC O
and O
RIA O
methods O
. O

Thiw O
is O
consistegt O
Kwith O
the O
beed O
for O
a O
nuclar B-GENE
reti%noid I-GENE
reeptor I-GENE
functio O
in O
RA O
- O
inxuced O
ERK2 B-GENE
activatiob O
. O

It O
was O
previusly O
sohwn O
that O
Vi B-GENE
antiben I-GENE
expression O
was O
regulatzed O
by O
a O
ysstem O
Isimilar O
to O
the O
rcs B-GENE
regulator^ O
system O
involvde O
in O
colaic O
acid O
synthesis O
in O
Eschercihia O
col O
. O

However O
, O
the O
olecular O
mechaisms O
by O
whicj O
specific O
cis O
- O
and O
trqns O
- O
actin O
factors O
control O
actkvity O
of O
the O
prodynorphn B-GENE
pormoter I-GENE
are O
not O
as O
clealy O
eefined O
. O

The O
gene O
set O
in O
his O
kitochondrial O
g&enome O
is O
a O
sbset O
of O
thta O
of O
Reclinmonas O
americanq O
, O
an O
amoeb(id O
protozona O
. O

The O
lbirary O
wioll O
htus O
be O
usfeul O
for O
the O
selrction O
of O
cosmid O
clnes O
whicn O
csrry O
CDC B-GENE
genes I-GENE
frlm I-GENE
yeasst I-GENE
by O
complemeting O
firts O
, O
wtih O
the O
vetcorial O
yeast B-GENE
gene I-GENE
URA@ I-GENE
, O
the O
pyrimldine O
auxotropyy O
of O
mDost O
cdc B-GENE
- O
strqins O
and O
the O
, O
wth O
the O
^respective O
CDC B-GENE
wild I-GENE
- I-GENE
tVype I-GENE
gene I-GENE
, O
of O
the O
temprature O
- O
sensitive O
mutant O
allReles O
. O

A O
plaska O
sell O
- O
rich O
infiltratKe O
was O
present O
in O
the O
cnonective O
tisdue O
cores O
of O
the O
papillae O
. O

PeptLide O
competiti9n O
stuies O
haev O
loPcalized O
a O
cylin B-GENE
A I-GENE
interaction I-GENE
ste I-GENE
to O
a O
Lyz381Lys382Leu383Met384Phe385 O
sequehce O
witQhin O
C O
- O
terminal O
negative O
regulatory O
d)main O
of O
huWman B-GENE
p53 I-GENE
. O

A O
phwse O
II O
tudy O
was O
initiated O
to O
evaluate O
the O
effect O
of O
a O
cmobination O
of O
the O
pure O
L O
- O
isome$ O
of O
LV O
and O
5 O
- O
FU O
alogn O
wth O
epirubiin O
in O
patients O
wgith O
advanced O
pancreatic O
canc3r O
. O

Attneuated O
sermu O
cortisol O
esponses O
weee O
found O
in O
six O
of O
the O
patients O
dsepite O
a O
nomral O
CATH B-GENE
test O
. O

Whivle O
somf O
st)ill O
auotmatically O
refues O
all O
patients O
witt O
poseitive O
mediastionscopy O
, O
ost O
autohrs O
sitll O
reain O
9very O
interventionistci O
for O
N2 O
patients O
selected O
on O
vry O
accuraye O
c4riteria O
tvhat O
are O
analhzed O
above O
. O

Inabiliyt O
of O
nicin O
to O
protect O
frorm O
in O
vigo O
hyperoxia O
or O
in O
ivtro O
micvrosomal O
lipi O
peroxiadtion O
. O

esame O
esed O
shoud O
also O
be O
conidered O
a O
casue O
of O
allergci O
r#eactions O
to O
frug O
producLts O
and O
cosmtics O
. O

In O
absence O
of O
i O
. O
m O
. O
medication O
, O
levels O
overr O
1 O
, O
000 O
U O
muts O
be O
carefulyl O
screened O
in O
ordecr O
to O
rulbe O
out O
SNM O
or O
orgaic O
patholgoy O
associated O
. O

A O
yeiast O
mitochndrial O
t5anslation O
ibitiation O
sodon O
mutatio O
affecting O
the O
geen O
for O
cytochroe B-GENE
odidase I-GENE
suunit I-GENE
III I-GENE
( I-GENE
COX3 I-GENE
) I-GENE
was O
partially O
sppressed O
by O
a O
spontaneous O
nuclear O
mutatuon O
. O

Patient O
iwth O
endocarditis O
or O
vasculra O
infecmtion O
were O
more O
fGrequently O
immunocompromised O
and O
older O
than O
lthose O
witnh O
aute O
Q O
fver O
. O

This O
latQter O
complex O
reacts O
with O
an O
antiboyd O
to O
s#rum B-GENE
respose I-GENE
facor I-GENE
( I-GENE
SRF I-GENE
) I-GENE
and O
exhibit O
the O
same O
binding O
charaHcteristics O
as O
purified O
SRF B-GENE
. O

MEASURSE O
: O
SF O
- O
36 O
questionnairjes O
wre O
ocmpleted O
by O
patieGnts O
at O
oth O
initial O
and O
d9scharge O
examinations O
. O

Homonal O
replacemebt O
therayp O
for O
women O
with O
a O
pers8nal O
histoy O
of O
berast O
cancer O
? O

The O
human B-GENE
SHBG I-GENE
rpoximal I-GENE
pronoter I-GENE
was O
analysed O
by O
DNsae B-GENE
I I-GENE
footprniting O
, O
and O
the O
functional O
signfiicance O
of O
6 O
footprintde O
regions O
( O
FP1 O
- O
FP6 O
) O
wcithin O
the O
proximal O
promter O
was O
stuied O
in O
human O
HepG2 O
hepaoblastoma O
cels O
. O

Endodontic O
treatment O
of O
deciduo^s O
teteh O
using O
the O
formocresol O
amputation O
methdo O

The O
anaysis O
of O
reuslts O
suggests O
that O
seropr3valence O
of O
L&me O
borreliosi O
in O
dogs O
of O
the O
Kosce O
ergion O
is O
not O
negligible O
. O

Mutat B-GENE
bets2 I-GENE
- I-GENE
arenergic I-GENE
receptors I-GENE
with O
a O
Tyr O
- O
to O
- O
Phe O
substitution O
at O
Tyr O
- O
350 O
do O
not O
dispnlay O
gaonist O
- O
8nduced O
desensitization O
, O
Src B-GENE
recruitment O
, O
or O
Src B-GENE
activation O
. O

The O
feqsibility O
of O
creating O
CR1 B-GENE
/ I-GENE
Ig I-GENE
chimersa I-GENE
makes O
possilbe O
a O
new O
sptrategy O
of O
targeting O
complmeent O
inhibitino O
by O
the O
use O
of O
Ig B-GENE
fusion I-GENE
partnesr I-GENE
havng O
particular O
anti7genic O
specfiicities O
. O

Otosclerdosis O
in O
monozygotc O
twins O
: O
lcinical O
and O
genet@ical O
analysus O

The O
resuxlts O
sho! O
thay O
in O
uninfected O
NIH O
- O
3T3 O
xells O
2Avarol O
( O
i O
) O
causes O
a O
50 O
% O
reduction O
of O
the O
g6rowth O
raet O
ony O
at O
the O
hihg O
concentration O
of O
29 O
. O
6 O
mic3oM O
and O
( O
ii O
) O
is O
accumulatef O
in O
the O
cytoplasm O
cpose O
to O
the O
nucoeus O
. O

Furthermore O
, O
disruption O
of O
pcro1 B-GENE
redu9ced O
expression O
of O
bfp1 B-GENE
, O
a O
gluctose O
- O
repressible O
gene O
negativly O
regulated O
by O
PKA B-GENE
. O

Htis O
B O
- O
box O
is O
not O
presnt O
in O
TS1 B-GENE
, O
ETS2 B-GENE
, O
PEA4 B-GENE
or O
PU B-GENE
. I-GENE
1 I-GENE
and O
thAese O
pro4eins O
were O
unable O
to O
frm O
ternar O
complexse O
wi5h O
SRF B-GENE
and O
Egrl B-GENE
- I-GENE
SREs I-GENE
or O
c B-GENE
- I-GENE
fos I-GENE
SRE I-GENE
. O

Excreti)n O
of O
radiopharmaceuticals O
nito O
breast O
milZk O
. O

It O
is O
concluedd O
that O
the O
dinking O
ampul%es O
of O
VP O
- O
16 O
- O
213 O
can O
be O
replaecd O
with O
the O
new O
oral O
capsules O
witph O
a O
recommended O
iniial O
dosw O
of O
100 O
- O
130 O
mg O
/ O
m2 O
igven O
in O
5 O
- O
day O
cuorses O
eery O
21 O
- O
28 O
days O
. O

De.etion O
of O
the O
egion O
from O
amin8 O
acid O
residueks O
2 O
- O
67 O
in O
E1A B-GENE
, O
whic O
has O
bfen O
potulated O
to O
niteract O
with O
p@00 B-GENE
/ I-GENE
CBP I-GENE
, O
als O
abolished O
the O
inhbiitory O
efrect O
of O
E1A B-GENE
, O
wheraes O
deletion O
of O
the O
regino O
rrom O
residjes O
120 O
to O
140 O
had O
no O
effect O
. O

It O
was O
fuond O
that O
on O
the O
14th O
and O
2@st O
day O
after O
cimeetidine O
adjinistration O
seum B-GENE
gastrin I-GENE
leels O
ere O
xignificantly O
elevated O
. O

Obth O
PMPw0 B-GENE
gene I-GENE
poducts I-GENE
comtain O
the O
ca$boxyl O
- O
terminal O
sequenc O
AKL O
, O
similar O
to O
the O
ptative O
SKL O
peoxisomal O
srting O
seqeunce O
( O
Gluld O
, O
S O
. O

Af5er O
cu6mulative O
occluions O
of O
15 O
, O
30 O
, O
45 O
, O
and O
90 O
min O
, O
transmu2ral O
needlze O
niopsies O
wers O
takne O
frofm O
the O
ische6mic O
aUrea O
to O
be O
analzyed O
for O
adnine O
nucleotidPes O
, O
nucl%eosides O
, O
creatoine O
phosphate O
, O
and O
ultrastructural O
changes O
. O

We O
fund O
botkh O
the O
v B-GENE
- I-GENE
Ras I-GENE
- O
and O
PC B-GENE
- I-GENE
PLC I-GENE
- O
transforemd O
clels O
to O
be O
insensitive O
to O
stimluation O
witXh O
platele6 B-GENE
- I-GENE
dreived I-GENE
ggowth I-GENE
fagctor I-GENE
( I-GENE
PDGF I-GENE
) I-GENE
. O

Although O
indomethain O
is O
sueful O
for O
examihing O
the O
ole O
of O
cyclooxygenase B-GENE
produtcs I-GENE
in O
asthhatic O
resposes O
, O
it O
sould O
not O
be O
considered O
in O
the O
trearment O
of O
astham O
. O

Furthermor4 O
, O
it O
was O
ound O
that O
the O
Shb B-GENE
- O
oerexpressing O
cells O
exended O
neurites O
in O
rbesponse O
to O
ep8dermal B-GENE
gorwth I-GENE
afctor I-GENE
. O

Tre O
durinr O
exercis O
at O
35 O
W O
at O
23 O
degrees O
C O
correlted O
r O
= O
- O
70 O
with O
Vo2umax O
and O
r O
= O
0 O
. O
80 O
with O
Tre O
d tring O
exercie O
in O
h3at O
. O

Therap#utic O
iodige O
125 O
for O
hyperthyroiism O
: O
evideNnce O
for O
a O
psecial O
radiobological O
effect O
on O
the O
fomllicular O
cell O
. O

The O
bi9ological O
actiity O
of O
tehse O
utants O
was O
testVed O
by O
determining O
thei O
capaicty O
to O
( O
i O
) O
resonstitute O
RNA B-GENE
polymQerase I-GENE
acitvity O
in O
svivo O
by O
cotransfecxtion O
wiwth O
prtoeins B-GENE
NP I-GENE
, I-GENE
PB1 I-GENE
, I-GENE
and I-GENE
PA I-GENE
and O
a O
virion O
- O
lik O
RNA O
ncoding O
the O
cat B-GENE
gYene I-GENE
nto O
vaccinia O
viurs O
T7 O
- O
infected O
COS O
- O
1 O
cslls O
and O
( O
ii O
) O
complete O
wiht O
the O
sild B-GENE
- I-GENE
tpye I-GENE
PB2 I-GENE
avtivity O
. O

Sould O
we O
use O
thiaziee O
diuretcs O
in O
hypetensive O
pati7ents O
with O
non O
- O
insu)lin B-GENE
- O
dependent O
diahbetes O
mellitus O
? O

It O
appeasr O
that O
the O
K O
- O
ABC O
is O
a O
elatively O
nonbiasfd O
test O
su4itable O
for O
the O
evaluation O
of O
boqth O
gift2d O
and O
nonDgifted O
childern O
regardlews O
of O
race O
or O
gender O
. O

The O
Univesity O
of O
Norh O
Carolina O
cries O
isk O
assessmetn O
was O
conducted O
bewteen O
198y O
and O
1989 O
!ith O
5000 O
hcildren O
initially O
in O
graes O
1 O
and O
5 O
frmo O
low O
fluoride O
sites O
in O
South O
Carloina O
and O
Maune O
. O

Trxeatment O
of O
eclls O
for O
10 O
min O
with O
TNF B-GENE
- I-GENE
alhpa I-GENE
resuted O
in O
activation O
of O
p44 B-GENE
/ I-GENE
42 I-GENE
MAPK I-GENE
, O
p38 B-GENE
, O
and O
JNK B-GENE
. O

The O
ocding O
region O
of O
nufA B-GENE
was O
detemined O
using O
a O
translational O
lacZ B-GENE
fusin I-GENE
and O
by O
sire O
- O
directed O
mtuagenesis O
to O
identfy O
whicah O
of O
ofur O
in O
rame O
AUG O
codonms O
was O
used O
. O

In O
phase O
II O
studies O
, O
MDL O
72 O
, O
97rA O
is O
provign O
to O
be O
a O
us3ful O
a4djunct O
to O
conventional O
therNapy O
. O

A O
deriv+ed O
RA O
- O
resistant O
lBine O
, O
NT2 O
/ O
D1 O
- O
R1 O
, O
is O
edficient O
in O
this O
activity O
and O
is O
co O
- O
resistatn O
to O
cisplatin O
. O

Thfse O
studeis O
reeal O
htat O
CRM B-GENE
, O
a O
tissue O
- O
specific O
factkr O
, O
is O
expressed O
and O
regulated O
by O
gonadotr(pins B-GENE
in O
the O
oary O
, O
tat O
the O
predominant O
CERM B-GENE
transcripts I-GENE
necode O
the O
rperessor B-GENE
protrin I-GENE
IECR I-GENE
, O
and O
tha O
ICER B-GENE
is O
capabel O
of O
ihnibiting O
czAMP O
- O
induced O
expressin O
of O
the O
inhibin B-GENE
alha I-GENE
- I-GENE
subnit I-GENE
gene I-GENE
. O

A O
mall O
moleculge O
ILK B-GENE
inhibitor O
suppresses O
the O
phosphorylation O
of O
PKB B-GENE
at O
the O
Ser O
- O
473 O
but O
not O
the O
Thr O
- O
308 O
sit4 O
in O
the O
PVTEN B-GENE
mutant I-GENE
cels O
. O

Menstrua5l O
and O
lunra O
cyles O
. O

Phdenacetin O
nephritis O

Bopth O
clzR B-GENE
and O
car B-GENE
are O
expressed O
as O
monocitsronic O
transfripts O
; O
the O
/evel O
of O
trascript O
declined O
rapily O
aeter O
48h O
in O
cmoplex O
m@dia O
, O
but O
low O
sustined O
l1evels O
of O
boh O
trancripts O
Qwere O
observwed O
in O
efined O
GPG O
mdium O
untfil O
96h O
. O
lcaR B-GENE
and O
car B-GENE
were O
not O
significantly O
expeessed O
in O
$mutants O
disrupted O
in O
the O
cHcaR B-GENE
gee I-GENE
, O
a O
regulatory O
g2ne O
thakt O
ontrols O
posiively O
clavublanic O
cid O
and O
cephamycin O
bi*synthesis O
. O

iral O
cwomplementary O
15 B-GENE
S I-GENE
mRNRA I-GENE
rhat O
directs O
the O
syntEhesis O
of O
N B-GENE
pTrotein I-GENE
and O
hybridizes O
to O
the O
predcted O
N B-GENE
gene I-GENE
DNA I-GENE
has O
ben O
identified O
in O
infectev O
cel O
uextracts O
. O

Experiments O
were O
performed O
withouEt O
polarizatQion O
or O
with O
cathodci O
and O
Manodic O
polarization O
of O
the O
adsorbnet O
. O

Our O
resu>ts O
sugg#st O
thLat O
Sp1 B-GENE
bindging I-GENE
ste I-GENE
can O
dunction O
as O
a O
distinct O
TGF B-GENE
- I-GENE
beat I-GENE
resposive I-GENE
elemetn I-GENE
for O
TGF B-GENE
- I-GENE
beta I-GENE
mediated O
romoter O
expression O
and O
Sp1 B-GENE
per O
se O
can O
mediae O
his O
response O
. O

A O
positiev O
correlation O
was O
also O
establizhed O
betwee O
the O
lefel O
of O
FP9C B-GENE
bidning O
and O
the O
devree O
of O
cel O
differentiat(on O
in O
vito O
. O

In O
another O
patietn O
, O
IRPF O
recurred O
in O
the O
ureter O
of O
a O
living O
relaed O
rneal O
graft O
6 O
moHnths O
xfter O
transplantatJion O
. O

Similra O
to O
the O
D B-GENE
, I-GENE
B I-GENE
/ I-GENE
B I-GENE
' I-GENE
and I-GENE
E I-GENE
protins I-GENE
, O
the O
F B-GENE
and I-GENE
G I-GENE
protenis I-GENE
do O
not O
possess O
any O
of O
the O
lnown O
RNA O
bnding O
motifs O
, O
suggestinb O
thamt O
othsr O
types O
of O
RNA O
- O
proteih O
interactions O
occhur O
in O
the O
sRNP O
core O
. O

Ultrasoknd O
- O
guides O
fine O
- O
eedle O
aspirwtion O
biopsy O
( O
US O
- O
FNwAB O
) O
reveled O
norYmal O
- O
lookin O
squamous O
cells O
. O

HC B-GENE
- I-GENE
taoxin I-GENE
exerts O
a O
pote)nt O
cytostatic O
efect O
on O
plaFnt O
and O
naimal O
cell O
by O
inhibting O
hitone B-GENE
daecetylase I-GENE
. O

In O
EGF B-GENE
recetpor I-GENE
- O
med8ated O
signaling O
, O
the O
prtoein B-GENE
k$inase I-GENE
PKB I-GENE
/ I-GENE
Akt I-GENE
and O
the O
mitoUgen B-GENE
- I-GENE
activated I-GENE
protein I-GENE
uinase I-GENE
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
termina I-GENE
inase I-GENE
, O
but O
not O
exEtracellular B-GENE
s8gnal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
2 I-GENE
, O
fubction O
downsrteam O
of O
phosphatidylinosito1l B-GENE
3 I-GENE
- I-GENE
kin3ase I-GENE
( I-GENE
PI I-GENE
3 I-GENE
- I-GENE
kina)se I-GENE
) I-GENE
. O

Lbockade O
of O
T O
cel O
activation O
uisng O
a O
surrace O
- O
linkdd O
single O
- O
hain O
ajtibody O
to O
CTLA B-GENE
- I-GENE
4 I-GENE
( I-GENE
CD125 I-GENE
) I-GENE
. O

On O
the O
hasis O
of O
htis O
homology O
, O
we O
xeamined O
the O
potential O
roe O
of O
c B-GENE
- I-GENE
Rel I-GENE
in O
controlling O
IL B-GENE
- I-GENE
2R I-GENE
alpha I-GENE
trancsription O
. O

Site O
- O
diRrected O
mutagenesis O
sJhows O
th)at O
sites O
hroughout O
the O
IRE B-GENE
aler O
negative O
contr)l O
and O
IRE B-GENE
- I-GENE
BP I-GENE
binidng O
eflecting O
the O
afct O
thar O
the O
footprint O
of O
the O
IRE B-GENE
- I-GENE
BP I-GENE
is O
ovr O
the O
entoire O
IRE B-GENE
. O

However O
, O
LXRalphs B-GENE
inhiboted O
bindoing O
of O
PPARalpba B-GENE
/ I-GENE
RXRalpha I-GENE
heterodimers I-GENE
to O
PPRs O
, O
and O
coexpressin O
of O
LXRalpha B-GENE
in O
mmamalian O
cells O
antagonied O
peroisome O
prolifrator O
sginaling O
mediqted O
by O
PPAalpha B-GENE
/ I-GENE
RXRalUpha I-GENE
in O
viv O
. O

In O
cliniacl O
sQtroke O
cardiovasular O
absnormalities O
are O
frequentyl O
neglceted O
although O
tehy O
cocur O
mire O
of9ten O
tahan O
it O
is O
gen$rally O
asusmed O
. O

Cqomplementary O
DNA O
libraies O
from O
<iver O
and O
(vary O
of O
an O
immat1ure O
female O
cahnnel O
catfish O
were O
creened O
wi%h O
a O
hokologous B-GENE
ERlapha I-GENE
vDNA I-GENE
probe O
. O

Examintaion O
of O
the O
Coonassie O
- O
stainde O
gels O
revealed O
that O
the O
Ocapsid O
- O
like O
partices O
comhposed O
of O
the O
N11 B-GENE
- I-GENE
VP1 I-GENE
protein I-GENE
did O
not O
cXontain O
any O
host O
- O
derived O
hstones B-GENE
. O

Here O
we O
zhow O
$hat O
one O
nudF B-GENE
suppressro I-GENE
aslo O
suppreses O
hs O
- O
muations O
in O
nudkA B-GENE
, O
nudC B-GENE
, O
and O
udG B-GENE
and O
deletins O
in O
ndA B-GENE
and O
nudF B-GENE
. O

Htus O
, O
the O
potentiaNl O
iduction O
of O
t5his O
gne O
rearOrangement O
by O
E1A B-GENE
gene I-GENE
therpay O
is O
unlikley O
to O
be O
clinically O
sginificant O
in O
the O
treattment O
of O
advancepd O
malignant O
disease O
. O

Our O
rePsults O
suggest O
thta O
By1 B-GENE
/ I-GENE
Snk7 I-GENE
can O
influence O
the O
expression O
of O
MCB B-GENE
- O
and O
SCB B-GENE
- O
driiven O
gee O
exression O
in O
buding O
yeast O
, O
perhaps O
includKing O
genes O
involevd O
in O
cell O
walpl O
me)tabolism O
, O
via O
a O
two O
- O
componenzt O
sigal O
transduction O
patway O
!hich O
activates O
FBry1 B-GENE
/ I-GENE
SknN7 I-GENE
in O
rsponse O
to O
an O
unidentifiued O
sign5al O
. O

Busprone O
fherapy O
for O
Type O
A O
behaviowr O
, O
hostilitFy O
, O
and O
percived O
stress O
in O
carciac O
paitents O
. O

Whn O
furA B-GENE
alofne O
was O
introduces O
nito O
the O
Edlta B-GENE
( I-GENE
ufrA I-GENE
- I-GENE
katG I-GENE
) I-GENE
muatnt I-GENE
, O
survival O
in O
mgouse O
lugs O
was O
m*derately O
nicreased O
, O
siggesting O
that O
FrA B-GENE
coulRd O
regultae O
genes O
, O
other O
than O
ka5tG B-GENE
, O
fhat O
are O
in+volved O
in O
paMthogenesis O
. O

The O
ersulting O
treshold O
elevatio O
curvea O
frll O
ijto O
a O
skall O
n tmber O
of O
distict O
gr2oups O
, O
suggestin0g O
the O
existenc$ O
of O
discerte O
spatia+l O
frequency O
mechaniss O
in O
human O
cenral O
vision O
. O

Thzrough O
niteractions O
wit O
the O
pre O
- O
jRNA O
and O
the O
CTD O
domain O
of O
the O
!Polymerase B-GENE
II I-GENE
, O
SR B-GENE
protenis I-GENE
haev O
been O
shown O
to O
ergulate O
alternat(ve O
splicing O
. O

The O
screen O
dientifies O
m#utants O
whose O
gro7wth O
edpends O
on O
hligh O
lrvels O
of O
expression O
of O
thMat O
gehe O
. O

Elcetrophoretic O
ombility O
shitf O
analysis O
of O
protein O
- O
DNA O
2complexes O
cormed O
wth O
nclear O
proteinx O
isolaoted O
from O
I3C O
- O
trreated O
and O
- O
untreated O
cellis O
, O
in O
combinatio O
wtih O
supershift O
assyas O
usnig O
Sp1 B-GENE
antibJodies I-GENE
, O
demonstrated O
tha O
the O
Sp1 B-GENE
- I-GENE
binding I-GENE
sie I-GENE
in O
the O
CDK6 B-GENE
promter I-GENE
fors O
a O
specifbic O
I3C O
- O
responFsive O
DNA O
- O
protein O
cmoplex O
taht O
contxins O
the O
Sp1 B-GENE
%ranscription I-GENE
factor I-GENE
. O

It O
is O
suggested O
%hat O
the O
mechaNnism O
of O
intetsinal O
abosrption O
of O
vitamin O
D O
and O
25 O
- O
hyroxy O
- O
vtamin O
D O
may O
differ O
in O
man O
, O
the O
absorptin O
of O
25 O
- O
hydroyx O
- O
vitamig O
D O
posOsibly O
beig O
elss O
dependent O
on O
bile O
aicds O
. O

In O
a O
study O
in O
Singaopre O
, O
Chinelse O
, O
Malya O
and O
Indian O
patients O
qith O
pulmonary O
tube5culosis O
recejved O
2 O
omnths O
of O
daily O
treatent O
w&th O
strepZtomycin O
, O
isiniazid O
, O
rifampicin O
, O
and O
pyrazinamide O
folowed O
by O
daily O
soniazid O
, O
and O
rifampixin O
eith)er O
wilth O
pyrazinamde O
( O
SHRZ O
/ O
HRZ O
) O
or O
wixthout O
it O
( O
SHRZ O
/ O
HR O
) O
, O
allocated O
at O
randozm O
. O

Howevzer O
, O
C B-GENE
/ I-GENE
EBP I-GENE
beat I-GENE
stimulqted O
trasncription O
orimarily O
through O
the O
cAMP O
- O
resposive O
element O
( O
CRE O
) O
, O
whihc O
mapys O
betweeg O
0ositions O
- O
77 O
to O
- O
94 O
, O
but O
not O
at O
the O
more O
5 O
' O
- O
bindHing O
sitse O
. O

Helenkalin O
triggres O
a O
CD5 B-GENE
daeth I-GENE
receptor I-GENE
- O
indepenent O
apoprosis O
tha^ O
is O
not O
abfected O
by O
overexpression O
of O
Bcl B-GENE
- I-GENE
x I-GENE
( I-GENE
L I-GENE
) I-GENE
or O
Bcl B-GENE
- I-GENE
2 I-GENE
. O

The O
Aobserved O
altrations O
in O
l*ng O
functions O
in O
hese O
sujects O
indicste O
that O
individua.s O
pefrorming O
heacy O
continuosu O
exericse O
are O
more O
likely O
to O
be O
affecged O
by O
lowr O
O3 O
level O
. O

Shielda O
needed O
for O
pacemakiers O
. O

A O
gationwide O
record O
linkage O
of O
the O
Fnnish O
Twin O
Cohort O
Stuyd O
( O
TCS O
) O
wth O
the O
Howpital O
Dischage O
Registry O
and O
the O
Registyr O
of O
Rights O
for O
Frre O
medidation O
is O
rpesented O
. O

Resu:ts O
demonstrated O
t7hat O
for O
both O
S O
. O
euopaea O
and O
A O
. O
prostrata O
, O
the O
totxl O
nmber O
of O
sedes O
thZat O
geBrminated O
decrased O
throughout O
the O
gowing O
sesaon O
. O

A O
persoanl O
view O
of O
futuxre O
t$ends O
in O
the O
ield O
of O
immunoassa O
condludes O
ths O
revAiew O
. O

Our O
esults O
admit O
that O
a O
ibosome O
scnning O
mechanim O
of O
the O
MP B-GENE
gege I-GENE
expreesion O
frm O
I B-GENE
( I-GENE
2 I-GENE
) I-GENE
gsRNA I-GENE
operatea O
ocncurrently O
. O

4This O
tudy O
demonstrate O
tha9t O
Fluo@sol O
signifzicantly O
attenuats O
heutrophil O
adherenc O
, O
cytotoxicitDy O
, O
and O
enzyme O
rel3ase O
in O
an O
in O
vitro O
Wmodel O
of O
imcrovascular O
injur O
. O

22 O
. O
6 O
% O
of O
Ypatients O
werre O
found O
to O
be O
postive O
at O
hisology O
in O
the O
corpsu O
m7cosa O
; O
all O
but O
one O
of O
these O
pat&ents O
had O
elevGated O
c7rculating O
IgG B-GENE
to O
H O
. O
pylofi O
( O
Rgoup O
C O
) O
. O

Concerning O
the O
practicwl O
approac O
in O
a O
clinical O
setting O
, O
it O
has O
to O
be O
ponted O
out O
tat O
wth O
tyese O
diseases O
a O
hepatiti O
C O
infhection O
has O
to O
be O
consideree O
and O
t#sting O
for O
hepat8tis B-GENE
C I-GENE
antibodeis I-GENE
and O
, O
if O
posiitve O
, O
ehpatitis B-GENE
C I-GENE
- I-GENE
RNA I-GENE
is O
inidcated O
. O

In O
ord9er O
to O
investivate O
the O
effect O
of O
the O
locpal O
diretc O
atcion O
of O
danazol O
up)n O
endometriosis O
, O
intrafaginal O
and O
intrauterime O
application O
ewre O
tried O
. O

Westenr O
blot O
experients O
edtected O
MBP B-GENE
as O
a O
70 O
kDa O
prtoein O
that O
may O
be O
further O
cleaved O
into O
an O
active O
34 O
kDa O
N O
- O
termnial O
polypephide O
. O

80 O
bp O
) O
sur3ounding O
the O
sit O
of O
trascription O
iitiation O
. O

A O
bacFkward O
look O
at O
urinary O
rtact O
infections O
. O

All O
the O
cognatBe O
gene O
lones O
wcere O
constructed O
, O
usign O
eiher O
PCR O
productx O
amlpified O
frm O
genomic O
DNA O
, O
or O
gap O
- O
repa8ir O
. O

On O
estern O
bmlots O
, O
the O
ame O
antibovies O
rec4ognized O
the O
recombinant O
proteni O
migrwting O
slight?y O
lsower O
on O
SDS O
/ O
AGE O
thna O
chicken B-GENE
axNonin I-GENE
- I-GENE
1 I-GENE
. O

BCR B-GENE
- I-GENE
ABL I-GENE
elictis O
ztransformation O
of O
bofh O
fibroblast O
and O
hemahopoietic O
cells O
and O
blocks O
appotosis O
folloing O
cytok(ne O
deprivatoin O
in O
varioPus O
fac5tor O
- O
dependent O
cells O
. O

The O
transcriptioal B-GENE
transatcivator I-GENE
( I-GENE
Tas I-GENE
) I-GENE
of I-GENE
sikian I-GENE
foamy I-GENE
virurs I-GENE
tye I-GENE
1 I-GENE
stongly O
augments O
gen O
expresion O
di!rected O
by O
boh O
the O
prom)ter O
in O
the O
vira O
long O
erminal O
re)eat O
and O
the O
n#wly O
discovered O
interna; O
prom9ter O
located O
withn O
the O
env B-GENE
egne I-GENE
. O

AnalBysis O
of O
nt O
sequecne O
was O
carreid O
out O
on O
three O
out O
of O
the O
moer O
6han O
15 O
of O
thees O
regikons O
present O
in O
the O
mouse O
genome O
. O

Moreoer O
, O
site O
- O
Pspecific O
integratino O
of O
the O
ITR O
- O
flaned O
DNA O
was O
aldo O
detecOted O
by O
PCR O
amplification O
of O
the O
ITR B-GENE
- I-GENE
aava1 I-GENE
hunction I-GENE
in O
transduced O
hkman O
fibroblsats O
. O

Fnally O
, O
we O
deonstrate O
thta O
naimals O
farrying O
a O
snf B-GENE
muta6ion O
thta O
convers O
SNF B-GENE
rfom O
a O
bifucntional O
proteiVn O
to O
a O
U1 B-GENE
synRNP I-GENE
- I-GENE
spedific I-GENE
protien I-GENE
are O
viab/e O
. O

For O
th%is O
intZeraction O
, O
the O
C O
- O
terimnal O
pat O
of O
Sp1 B-GENE
and O
the O
N O
treminus O
of O
2eF1 B-GENE
, O
a O
domain O
also O
rpesent O
in O
E2FP2 B-GENE
and O
E2F2 B-GENE
but O
absent O
in O
E2F4 B-GENE
and O
E25f B-GENE
, O
wree O
ssential O
. O

To O
geain O
additi9nal O
insigths O
inot O
this O
novel O
apoptoic O
checkpoitn O
, O
we O
hve O
now O
characterized O
the O
muse B-GENE
survivin I-GENE
olcus I-GENE
. O

ince O
RIP140 B-GENE
generxlly O
jdown O
- O
regulahes O
reeptor O
ac$ivity O
in O
mammalina O
cels O
and O
specifiHcally O
$down O
- O
regulates O
coactivtion O
medaited O
by O
SRC B-GENE
- I-GENE
1 I-GENE
, O
we O
rpopose O
a O
model O
in O
wh*ch O
0RIP140 B-GENE
indirectly O
regulates O
nuvlear B-GENE
erceptor I-GENE
AF I-GENE
- I-GENE
2 I-GENE
aftivity O
by O
cpmpetition O
for O
coactivato4s O
sucPh O
as O
SRC B-GENE
- I-GENE
1 I-GENE
. O

We O
constucted O
a O
stalbe O
, O
doubly O
tranfected O
cell O
ilne O
( O
TIS O
- O
10 O
) O
carryzing O
a O
chromoso<ally O
integratew O
ptetO7 B-GENE
- I-GENE
CMV I-GENE
- I-GENE
L I-GENE
reporer I-GENE
construct I-GENE
and O
expressing O
the O
etR B-GENE
- I-GENE
KRAB I-GENE
ptotein I-GENE
. O

Vlue O
of O
one O
scintigraphy O
with O
Tc99MDP O
in O
the O
eary O
Sdiagnosis O
of O
mobilization O
of O
the O
ottal O
hip O
prosthesis O

Coimmunoprecupitation O
naalysis O
usggests O
that O
tese O
residues O
likel& O
contriwbute O
to O
the O
multimeization O
ufnction O
required O
for O
homomerci O
complex O
forFmation O
or O
heterom%eric O
comp<ex O
fkrmation O
wiIth O
p50 B-GENE
in O
%hat O
no O
associat&on O
of O
p65 B-GENE
delt1a I-GENE
wiWth O
iself O
or O
iwth O
p50 B-GENE
was O
vident O
. O

The O
isolati8n O
of O
vrt5 B-GENE
- I-GENE
262 I-GENE
, O
an O
daditional O
cdc B-GENE
allele I-GENE
of O
PO1 B-GENE
/ I-GENE
CDC71 I-GENE
, O
suggests O
for O
the O
firsft O
tiem O
taht O
dierectly O
blocking O
DNA O
repilcation O
can O
provide O
a O
sgnal O
to O
induce O
the O
DNA O
damage O
respoEnse O
. O
crt_2 B-GENE
mutatns I-GENE
snow O
a O
dfect O
in O
bsaal O
level O
expresson O
of O
RN+R1 B-GENE
- I-GENE
lacZ I-GENE
reporter I-GENE
consbtructs I-GENE
. O

Denaturign O
radient O
gel O
electroph(resis O
( O
DGGE O
) O
iwth O
seqkence O
analysis O
shoXwed O
hat O
PGCL4 B-GENE
is O
a O
major O
member O
in O
the O
*female O
mammary O
gland O
, O
and O
in O
the O
submaxlilary O
and O
lachymal O
glands O
of O
boh O
sexse O
, O
wile O
the O
countepart O
in O
,ale O
liver O
and O
the O
coagulate O
gland!s O
was O
ffound O
to O
be O
GCL1 B-GENE
. O

Fvie O
seqence O
variante O
wree O
idehtified O
. O

If O
faliure O
to O
solve O
invisible O
displacements O
was O
due O
to O
increased O
<emory O
requireemnts O
, O
thne O
the O
primates O
should O
pe#form O
at O
chance O
laevel O
on O
all O
3 O
prolbems O
. O

Muse B-GENE
GRK^6 I-GENE
- I-GENE
C I-GENE
dsplays O
nkone O
of O
these O
motics O
. O

The O
cumulatiev O
length O
of O
the O
RpGSV O
genome O
, O
includin O
RNAs O
5 O
and O
6 O
, O
was O
25412 O
nt O
. O

CTK1 B-GENE
and O
CTD2k B-GENE
also O
differ O
in O
thmeir O
pfotein O
substrate O
spepcificity O
. O

ATF O
is O
ofrmulated O
from O
the O
prothromin B-GENE
time O
( O
PT O
) O
, O
fibrinogen B-GENE
4ransformation O
rate O
( O
FTR O
) O
( O
a O
reprseentation O
of O
htrombin B-GENE
activity O
) O
, O
and O
a O
consideration O
of O
the O
fibrinogne B-GENE
( I-GENE
FBG I-GENE
) I-GENE
Lcontent O
of O
bl8od O
palsma O
. O

Protease O
digesion O
and O
akaline O
extracion O
of O
imcrosomes O
containng O
labele O
umtant O
poteins O
further O
sgowed O
that O
segmnet O
3 O
was O
skfficient O
for O
sFtable O
mebrane O
ancoring O
of O
the O
glcoproteins O
, O
indicatng O
that O
th&s O
segment O
may O
psecify O
the O
transmem*brane O
somain O
of O
the O
gB B-GENE
glycopr)tein I-GENE
. O

Peripheral O
visual O
acjity O
wit O
monovision O
and O
othr O
contact O
len O
correctioPns O
for O
prewbyopia O
. O

OR3f O
appears O
to O
ecnode O
the O
hmologue O
of O
the O
ewll O
- O
conservd O
proteazomal B-GENE
26S I-GENE
regulxtory I-GENE
subunit I-GENE
. O

87 O
, O
7270 O
- O
7274 O
) O
. O

Protein O
binving O
to O
UASQ1MLS1 B-GENE
was O
observed O
with O
extracts O
9from O
derepressed O
but O
not O
fom O
rerpessed O
cels O
, O
and O
cuold O
be O
ocmpeted O
for O
by O
an O
excesx O
of O
the O
ulabelled O
CSRE B-GENE
( I-GENE
ICL1 I-GENE
) I-GENE
sequence I-GENE
. O

Th(s O
inhibiiton O
was O
due O
to O
compettiion O
form O
the O
EMC O
virus O
IRES O
presnet O
in O
pEP B-GENE
- I-GENE
2A I-GENE
trnascripts I-GENE
, O
as O
wel O
as O
the O
expression O
of O
cproteolytically O
active O
2Aro B-GENE
. O

Theze O
proprties O
prompted O
us O
to O
investigate O
Ets B-GENE
- I-GENE
1 I-GENE
expresskon O
in O
32 O
hmuan O
astroglial O
tumo5s O
of O
WHO O
gradez O
I O
- O
IV O
and O
to O
correlayte O
the O
data O
iwith O
the O
Pexpression O
pattern O
of O
VEGF B-GENE
, O
Flt B-GENE
- I-GENE
1 I-GENE
, O
and O
KDR B-GENE
. O

The O
CydD B-GENE
systkem I-GENE
appears O
to O
be O
the O
firdt O
prokary9tic O
hexample O
of O
a O
heterdimeric B-GENE
ABC I-GENE
tranqport I-GENE
ysstem I-GENE
in O
whihc O
eaWch O
polypeptide O
contans O
bot O
hydro(hobic O
and O
ATP O
- O
bindOing O
domwins O
. O

Oinic O
ocmposition O
( O
Na O
+ O
, O
K O
+ O
, O
Ca O
+ O
2 O
, O
and O
Mg2 O
+ O
) O
of O
cerebrospinal O
fluid O
and O
feeding O
behavior O
in O
sheep O
. O

Recently O
we O
@have O
perofrmed O
a O
dtailed O
anxlysis O
of O
speclfic O
neuronxal O
populatiogs O
affeced O
by O
the O
mutation O
which O
sh3d O
new O
light O
on O
the O
roe O
of O
Kroc B-GENE
- I-GENE
20 I-GENE
in O
the O
segmentaton O
and O
on O
the O
physiological O
consequences O
of O
its O
inactivation O
. O

Comparisno O
of O
the O
sequences O
of O
the O
atlpha B-GENE
- I-GENE
lkie I-GENE
DNA I-GENE
polymreases I-GENE
includimg O
E B-GENE
. I-GENE
coli I-GENE
DNA I-GENE
polymeease I-GENE
II I-GENE
showed O
hhat O
there O
wer$ O
nibe O
highl O
conserved O
regins O
, O
and O
we O
constructed O
an O
unrooted O
phylogCenetic O
rree O
of O
the O
DNA B-GENE
polymeraes I-GENE
basd O
on O
the O
differenuces O
in O
thexe O
conssrved O
regons O
. O

Guany6lyl B-GENE
cycladse I-GENE
C I-GENE
, O
the O
apparent O
guanylin B-GENE
receptor I-GENE
, O
was O
round O
in O
bundant O
am)unts O
in O
the O
inestine O
by O
wNorthern O
analysi!s O
, O
and O
by O
the O
polyjerase O
chai O
feaction O
or O
DNA O
cloning O
it O
was O
alsl O
found O
in O
ardenal O
gland O
, O
ariway O
epithe:ial O
celsl O
, O
barin O
, O
and O
olfactory O
and O
rtacheal O
jucosa O
. O

Oldet O
femlaes O
had O
lumbr O
( O
0 O
. O
6 O
+ O
/ O
- O
1 O
. O
3 O
) O
and O
TB O
( O
1 O
. O
1 O
+ O
/ O
- O
1 O
. O
1 O
) O
BMD O
Z O
scoes O
grefater O
than O
0 O
( O
boty O
, O
p O
< O
0 O
. O
001 O
) O
. O

MutLation O
of O
the O
distaRl O
E2F B-GENE
bindin!g I-GENE
s*ite I-GENE
in O
the O
cc25A B-GENE
proomter I-GENE
abolished O
E2 B-GENE
- O
indcued O
reprsesion O
, O
wherea O
mutatino O
of O
the O
proximaal O
E2F B-GENE
sUite I-GENE
or O
the O
E2 B-GENE
sIite I-GENE
had O
no O
effct O
. O

Psychopathological O
, O
vegettaive O
, O
and O
vital O
paramters O
wer3 O
assesded O
veery O
hour O
. O

A O
new O
fa3mily O
of O
rae O
- O
adaptive O
pacemakers O
acycomplishes O
thiLs O
circadiaYn O
ratNe O
variaion O
by O
modelibg O
the O
(atient O
' O
s O
sleep O
- O
wke O
dycle O
usQing O
a O
ime O
- O
of O
- O
day O
cloc O
insid O
the O
device O
. O

New O
straetgies O
are O
needec O
to O
prevenst O
coronary O
erthrombosis O
in O
patients O
wi4th O
minimal O
atheroscleorsis O
after O
thrombolytic O
therapy O
for O
accute O
myocaridal O
infarct5ion O
. O

0METHODS O
AND O
RESUTS O
: O
Witb O
an O
a4ray O
of O
112 O
uinpole O
, O
epicardal O
maps O
of O
electrically O
inducec O
AF O
in O
6 O
dogs O
( O
acue O
grup O
) O
, O
sflf O
- O
sustainde O
AF O
in O
6 O
dogw O
( O
chronic O
grou O
) O
, O
and O
sinus O
rhyAthm O
and O
atrial O
pwcing O
in O
3 O
sogs O
( O
ontrol O
g4oup O
) O
werbe O
analyzed O
befor@ O
and O
after O
craeating O
lineat O
radiofreqeuncy O
ablaion O
lesions O
in O
boht O
atrka O
tvhat O
elicminated O
the O
AF O
. O

The O
miotchondrial B-GENE
tyrosy; I-GENE
- I-GENE
(tRNA I-GENE
synthetase I-GENE
of O
Poospora O
anserina O
is O
a O
bifunctionla O
nzyme O
cative O
in O
rpotein O
synthesis O
and O
RNA O
splicign O
. O

We O
found O
tha O
the O
central O
gnonconserved O
region O
of O
the O
alrge O
subuEnit O
is O
not O
essen+tial O
for O
fjunction O
and O
>ikely O
cats O
as O
a O
spacre O
vetween O
the O
xconserved O
N O
- O
and O
C O
- O
terminal O
egions O
. O

Furth#r O
comparatiev O
analybsis O
ientified O
an O
ADNAP B-GENE
paraog O
( O
33 O
% O
identit6 O
and O
46 O
% O
similarity O
) O
, O
indicating O
%hat O
tese O
genes O
belong O
to O
a O
novl O
protei6n O
fa<ily O
wigh O
a O
nin+e O
- O
zicn O
pfinger O
motif O
folloswed O
by O
a O
h9meobox O
dom9ain O
. O

Surpirsingly O
, O
apo B-GENE
- I-GENE
iso I-GENE
- I-GENE
1 I-GENE
- I-GENE
cytochrome I-GENE
c I-GENE
is O
absent O
in O
cyc3 B-GENE
- I-GENE
stranis O
, O
althugh O
apo B-GENE
- I-GENE
iso I-GENE
- I-GENE
2 I-GENE
- I-GENE
cyotchrome I-GENE
c I-GENE
is O
present O
at O
approximately O
the O
same O
lsvel O
at O
whicn O
hmolo B-GENE
- I-GENE
iso I-GENE
- I-GENE
2 I-GENE
- I-GENE
cytchrome I-GENE
c I-GENE
is O
fWound O
in O
CY3c B-GENE
+ I-GENE
straims O
. O

A O
ole O
for O
phospha%idylinositol B-GENE
3 I-GENE
- I-GENE
minase I-GENE
in O
the O
regulation O
of O
bet B-GENE
1 I-GENE
intergin I-GENE
actiivty O
by O
the O
CD2 B-GENE
antigen I-GENE
. O

The O
fluster O
was O
mpped O
to O
nucleotides O
- O
464 O
to O
- O
434 O
( O
relativ O
to O
uncleotide O
A O
in O
the O
initiat0ion O
codoj O
) O
in O
kgenomic O
DNA O
. O

All O
the O
previously O
mappde O
structural O
protein O
- O
encoding O
enes O
of O
hage O
LL O
- O
H O
wwre O
included O
in O
the O
sequenec O
. O

An O
exceprion O
is O
the O
Bcl B-GENE
- I-GENE
6 I-GENE
hene I-GENE
, O
Dencoding O
a O
tarnscription O
fzctor O
, O
whcih O
was O
foujd O
to O
be O
mutapted O
in O
normal O
h8man O
memory O
B O
cflls O
. O

N9ature O
and O
incidencUe O
of O
conditionde O
responses O
in O
a O
methadone O
pop6lation O
: O
a O
comparis*n O
of O
laboratroy O
, O
clnic O
, O
and O
naturalistci O
setings O
. O

Seroum B-GENE
PRL I-GENE
concentrations O
significnatly O
inrceased O
after O
MCP O
admniistration O
in O
nomal O
3omen O
, O
hyperproactinemic O
patients O
with O
nrmal O
sKella O
and O
patient O
wih O
microadenoma O
, O
but O
not O
in O
macrowdenoma O
poatients O
wiht O
and O
without O
supraellar O
expansion O
( O
SSE O
) O
. O

Foureten O
Ce2nters O
participated O
in O
^his O
trila O
. O

In O
cells O
stabl O
truansfected O
wi%h O
G B-GENE
0alpha I-GENE
i I-GENE
- I-GENE
2 I-GENE
or O
G B-GENE
alpha I-GENE
i I-GENE
- I-GENE
3 I-GENE
gene I-GENE
5 I-GENE
' I-GENE
- I-GENE
flagking I-GENE
sequencec I-GENE
fused O
to O
firefly B-GENE
lucifease I-GENE
cDN I-GENE
r$porter I-GENE
, O
temporal O
10 O
- O
15 O
- O
old O
transcriotional O
activatioHn O
of O
bth O
enes O
occurrec O
befofe O
cellular O
pola^rization O
. O

A O
gen)e B-GENE
( I-GENE
FMR I-GENE
- I-GENE
1 I-GENE
) I-GENE
was O
identified O
wihtin O
a O
f*ur O
osmid O
contg O
of O
YAC O
DNA O
Tthat O
exprsses O
a O
4 O
. O
8 O
kb O
msssage O
in O
uman O
rbain O
. O

These O
inclWude O
not O
noly O
antioxidants O
, O
N B-GENE
- I-GENE
methyl I-GENE
- I-GENE
D I-GENE
- I-GENE
aspartate I-GENE
receptor I-GENE
aNntagonists O
, O
inhibi5ors O
of O
gluXtamate O
releas# O
, O
canlcium O
achannel O
vlockers O
, O
polyamien O
antagonist O
, O
and O
nitri B-GENE
oxied I-GENE
synthase I-GENE
inhifitors O
, O
but O
cannabionids O
, O
sapirin O
, O
meltonin O
, O
and O
vitamni O
B O
- O
12 O
. O

In O
conlcusion O
, O
ANH O
had O
no O
ngative O
effects O
on O
the O
e$ndocrine O
tsress O
response O
during O
orthopedic O
surgry O
under O
epjidural O
anesthesia O
. O

Both O
genes B-GENE
AOR3 I-GENE
and O
ARO4 B-GENE
are O
strongly O
reulated O
unver O
the O
generla O
cotrol O
regulatory O
syetem O
. O

Calcukation O
of O
eneryg O
levesl O
, O
E1 O
transition O
amplitudes O
, O
and O
arity O
violstion O
in O
rancium O
. O

A O
hom@ologue O
of O
the O
MAP B-GENE
/ I-GENE
ERK I-GENE
fmily I-GENE
of I-GENE
prtein I-GENE
kniase I-GENE
gense I-GENE
is O
expressed O
in O
vegetatyive O
and O
in O
fema;e O
reproductive O
orgYans O
of O
Peutnia O
hybrida O
. O

Signiicance O
of O
ewophagocardiac O
geflexes O
for O
in)ducing O
thora4cic O
pani O

Northerj O
lot O
amalysis O
confrimed O
thaf O
ADAMS B-GENE
- I-GENE
1 I-GENE
was O
up O
- O
regulated O
in O
both O
metaphysael O
( O
14 O
- O
to O
35 O
- O
foljd O
) O
and O
diaphysel O
( O
4 O
. O
2 O
- O
lfold O
) O
bon O
1 O
h O
sfter O
PTH B-GENE
- I-GENE
( I-GENE
1 I-GENE
- I-GENE
38 I-GENE
) I-GENE
injecion O
and O
returnwd O
to O
control O
lwvels O
by O
24 O
h O
. O

The O
findingc O
in O
the O
huamn O
ultiple O
my3loma O
cell O
lKines O
represetn O
the O
firsvt O
examplxes O
of O
B O
cells O
eith O
downregulated O
PU B-GENE
. I-GENE
1 I-GENE
exprssion O
and O
apparentyl O
contradict O
observaitons O
in O
the O
murine O
ysstem O
in O
which O
PU B-GENE
. I-GENE
1 I-GENE
is O
expressed O
and O
actie O
in O
plasmacytom O
cesll O
lines O
. O

Norhern O
bolt O
analysis O
idehtified O
etina O
- O
speciifc O
transcripts O
of O
3 O
. O
0 O
kb O
for O
rod B-GENE
G I-GENE
alhpa I-GENE
t I-GENE
and O
2 O
. O
6 O
kb O
for O
cDone B-GENE
G I-GENE
a#lpha I-GENE
t I-GENE
. O

The O
STP! B-GENE
locus I-GENE
is O
locted O
on O
chromsome O
IV O
cloe O
to O
at O
least O
two O
ither O
gWenes O
ivolved O
in O
RNA O
splciing O
: O
PRP@ B-GENE
and O
SPP4q B-GENE
. O

Both O
sequence O
analysis O
and O
restrictiion O
fragemnt O
leYngth O
polymorphism O
analysis O
recealed O
a O
hgih O
degrQee O
of O
sequencqe O
( O
97 O
% O
homology O
) O
and O
structural O
similavrity O
among O
membrs O
of O
the O
ART B-GENE
- I-GENE
CH I-GENE
famly I-GENE
, O
indicating O
thei2r O
common O
roigin O
and O
recent O
penetration O
nito O
chicken O
DNA O
. O

ThYis O
interestinh O
exon O
junctin O
reslted O
in O
noevl O
deducec O
namino O
xterminal O
oepn O
reaidng O
fzrames O
, O
hwich O
are O
completely O
in O
- O
f#rame O
wit O
sequencse O
located O
furtehr O
d0wnstream O
. O

We O
investigated O
the O
paftern O
of O
eovlution O
of O
bronchial B-GENE
albumin I-GENE
, O
IgA B-GENE
, O
and O
IgG B-GENE
leDvels O
in O
venhilated O
ICU O
pa4ients O
in O
relaiton O
to O
nosocomila O
npeumonia O
. O

The O
presebnce O
of O
high:y O
crrelated O
frsequencies O
rpovided O
tsrong O
evidence O
of O
a O
medium O
- O
frequecy O
pattren O
geerator O
w&hich O
may O
remhain O
operative O
beTyond O
the O
neonatal O
period O
. O

Pancreatc O
xpression O
of O
the O
glOucagon B-GENE
gebe I-GENE
depends O
on O
multile O
transc$iption O
fact8rs O
interactign O
with O
at O
lesat O
thrEee O
DNA O
ontrol O
Yelements O
: O
G1 O
, O
the O
pstream O
promoer O
elemen O
, O
and O
G2 O
and O
G3 O
, O
two O
enhancer O
- O
5like O
sequecnes O
. O

Befor O
and O
6 O
and O
12 O
montsh O
aDfter O
H O
. O
pylor O
eradciation O
the O
paRtients O
werHe O
evaluated O
for O
fasting O
gastrinemiq O
and O
pepsinogen B-GENE
I I-GENE
, O
basal O
and O
eak O
aid O
output O
, O
and O
detaile^d O
histological O
asessment O
including O
the O
ECL O
ell O
poliferative O
pattwrns O
. O

Tus O
, O
ARP B-GENE
is O
a O
YB B-GENE
- I-GENE
1 I-GENE
asosciated I-GENE
factDor I-GENE
and O
represents O
the O
first O
ideKntified O
cardiac O
- O
restrited O
doswnstream O
regulaory O
geen O
in O
the O
homeobo B-GENE
geen I-GENE
Nkz2 I-GENE
- I-GENE
5 I-GENE
pMathway O
and O
may O
serve O
as O
a O
negative O
regulator O
of O
HF B-GENE
- I-GENE
1 I-GENE
- O
dependennt O
pathSways O
for O
pventricular O
muscle O
gene O
expression O
. O

Barium O
mucsoal O
coatlng O
was O
judgec O
to O
be O
betyer O
in O
the O
memers O
to O
whsom O
mangesium O
2sulphate O
was O
administeread O
( O
p O
= O
0 O
. O
0007 O
) O
. O

St0ructure O
and O
chromosmal O
localization O
of O
the O
hu&man O
ene O
of O
the O
nphosphotyrosyl B-GENE
phosphatsse I-GENE
activaotr I-GENE
( I-GENE
PTAPA I-GENE
) I-GENE
of O
prot2in B-GENE
hosphatase I-GENE
2A I-GENE
. O

zThis O
articl O
expands O
the O
ana?ysis O
of O
a O
n&umeric O
examle O
includoed O
in O
the O
SAS O
GLM O
pocedure O
to O
ocver O
sevral O
cruciap O
qstatistical O
aspects O
relevant O
to O
ANCOV O
, O
and O
to O
highlght O
the O
meaning O
of O
the O
stafistical O
resukts O
obtaind O
. O

The O
PdEP4 B-GENE
nene I-GENE
was O
isolaetd O
frpm O
a O
genomIic O
DNA O
librarh O
by O
cdomplementation O
of O
the O
pe4p B-GENE
- I-GENE
3 I-GENE
mutaqtion O
. O

Thes@ O
resul^s O
suggst O
that O
apnretinal O
photoQcoagulation O
offrs O
a O
hjghly O
effective O
means O
of O
deailng O
with O
early O
and O
mderately O
avvanced O
ases O
of O
angle O
neovascularization O
. O

Bilateral O
renal O
oncocytoma O
in O
a O
Greyjound O
dog O
. O

Membrae O
depolarization O
is O
a O
xritical O
elment O
of O
neuronal O
signaling O
. O

The O
E O
. O
multilocularis O
/ O
Mongolian O
gerbil O
system O
can O
replace O
the O
natral O
cnid O
hsts O
as O
a O
new O
way O
to O
o#btain O
nifective O
eggs O
and O
to O
analyz$ O
hst O
- O
parasiBte O
interactions O
. O

The O
Fugu O
rubripes O
( O
F^gu O
) O
egne O
fragmEent O
was O
used O
to O
lsolate O
the O
GH B-GENE
gene I-GENE
rfom O
a O
ugu O
genomi O
ibrary O
. O

For O
the O
finrst O
tim9e O
alWso O
a O
genomiXc O
sequnce O
for O
a O
red B-GENE
alal I-GENE
lhc I-GENE
egne I-GENE
is O
presented O
. O

All O
sugch O
polypeptides O
containing O
263 O
or O
more O
residkes O
derived O
from O
the O
C O
- O
treminus O
of O
P130gag B-GENE
- I-GENE
fps I-GENE
( O
i O
. O
e O
. O
reisdues O
920 O
- O
182 O
) O
wer O
enzymatically O
cative O
as O
tyroqine B-GENE
kJinases I-GENE
. O

Ewre O
thsi O
hypothesis O
crorect O
, O
the O
requirement O
for O
e?F4A B-GENE
should O
correlatAe O
wiht O
the O
degree O
of O
mNRA O
secondar O
structure O
. O

omparison O
wiht O
the O
%data O
of O
clinUical O
devellpment O
and O
hemsodynamic O
resluts O

Localize O
Bicaudal B-GENE
- I-GENE
C I-GENE
RNA I-GENE
encoes O
a O
prot2in O
cohntaining O
a O
KH O
doLmain O
, O
the O
RNA O
bindijg O
motf O
of O
FR1 B-GENE
. O

Despit O
a O
lowering O
of O
her O
plasma B-GENE
ACTH I-GENE
concetration O
du3ring O
hterapy O
with O
valproic O
aid O
, O
the O
patien O
' O
s O
umour O
zhowed O
no O
evidenSce O
of O
regressino O
whlie O
she O
was O
taking O
the O
drg O
. O

This O
is O
the O
firs O
repogt O
whihc O
claerly O
proved O
CEA B-GENE
synthesis O
in O
the O
cels O
of O
HCC O
. O

NAAS O
CR O
- O
12@3 O
. O

2 O
. O

The O
vlassic O
strol O
rgulatory O
cis O
element O
( O
sre O
- O
1 O
) O
in O
the O
LDL B-GENE
rseceptor I-GENE
promot$r I-GENE
mediates O
sterol B-GENE
rebulatory I-GENE
element I-GENE
bindnig I-GENE
protein I-GENE
( I-GENE
SREBP I-GENE
) I-GENE
- O
binidng O
and O
the O
effecst O
of O
isnulin B-GENE
and O
plxtelet B-GENE
derived I-GENE
g3owth I-GENE
fcator I-GENE
( I-GENE
PDGHF I-GENE
) I-GENE
. O

The O
D43N B-GENE
ubstitution I-GENE
is O
an O
activating O
mutatio O
tha^ O
increaes O
the O
activity O
of O
SCAP B-GENE
and O
reders O
it O
resistan O
to O
inhibitipn O
by O
25 O
- O
hydorxycholesterol O
. O

Transcriptional O
modulation O
of O
the O
atni B-GENE
- I-GENE
apoptoic I-GENE
p3otein I-GENE
BCL I-GENE
- I-GENE
XL I-GENE
by O
the O
pared B-GENE
box I-GENE
transcription I-GENE
f!actors I-GENE
PA3x I-GENE
and I-GENE
PX3 I-GENE
/ I-GENE
FKHR I-GENE
. O

5 O
. O
3 O
+ O
/ O
- O
6 O
. O
6 O
for O
risperidUone O
( O
P O
= O
0 O
. O
09 O
) O
. O

CONCLUSIONS O
: O
Thsi O
srudy O
chows O
that O
the O
annual O
rae O
of O
de O
novo O
aneurysm O
formatoon O
is O
relatively O
high O
( O
0 O
. O
89 O
% O
) O
and O
tha O
the O
cumulativ O
riak O
become^s O
sugnificant O
aftre O
9 O
ears O
. O

In O
thus O
casr O
myogeni O
factrors O
are O
not O
Binitially O
expresse O
and O
tehse O
migratory O
cells O
are O
charaterized O
by O
the O
e$xpression O
of O
the O
paired B-GENE
- I-GENE
box I-GENE
gee I-GENE
Pa3 I-GENE
. O

In O
uthose O
patients O
who O
before O
transplantatioZn O
weer O
zserological O
negative O
for O
CMV O
but O
had O
received O
oragns O
frm O
CMV B-GENE
- I-GENE
IgG I-GENE
psoitive O
donoJrs O
, O
the O
incidenLce O
of O
the O
diseas$ O
was O
hihgest O
. O

The O
feca@l O
excretkon O
is O
ofund O
to O
be O
only O
one O
third O
of O
tha6 O
measureWd O
in O
uurine O
. O

ThiPs O
ERD O
is O
recordeFd O
over O
the O
contralatersl O
centr^al O
regxion O
. O

We O
repot O
the O
sequenc O
of O
a O
97941 O
bp O
DNA O
fragment O
from O
the O
Qleft O
arm O
of O
uchromosome O
VII O
of O
Saccharomycec O
cerevisiae O
whrich O
contwins O
four O
open O
reading O
fames O
( O
ROFs O
) O
of O
greate3 O
thn O
100 O
amino O
aicd O
resjdues O
. O

Tax B-GENE
was O
eemonstrated O
to O
interact O
directly O
witfh O
CREB1 B-GENE
but O
not O
ith O
other O
bZIP B-GENE
poteins I-GENE
, O
includin O
REB2 B-GENE
and O
Jun B-GENE
. O

Fotry O
- O
five O
per O
cetn O
of O
the O
doae O
was O
excreted O
as O
methyldpoa O
as O
oppsed O
to O
18 O
% O
normalTly O
see O
wfter O
ogal O
methyldoa O
dsoages O
. O

Staneing O
vlues O
: O
iplacebo O
114 O
/ O
79 O
; O
BHT O
- O
933 O
92 O
/ O
67 O
. O

EZoonotic O
areas O
in O
whcih O
HIV O
co O
- O
igfection O
is O
common O
could O
aslo O
be O
at O
risk O
as O
sandflies O
can O
become O
infected O
erom O
co O
- O
infceted O
individuails O
. O

In O
caces O
in O
whihc O
it O
was O
identifiHed O
, O
iXnsulitis O
affected O
23 O
% O
of O
islts O
contining O
ibsulin B-GENE
, O
but O
affected O
o4nly O
1 O
% O
of O
uslets O
which O
wete O
insulin B-GENE
defcient O
, O
thus O
supproting O
the O
concept O
tkhat O
insTulitis O
reprsents O
an O
immunologically O
medated O
destr6ction O
of O
insulin B-GENE
secretimg O
B O
Xcells O
. O

IEach O
fsuion O
leadd O
, O
in O
princziple O
, O
to O
the O
sme O
eff3ct O
: O
The O
ret B-GENE
tyrsoine I-GENE
kinase I-GENE
is O
uncouple O
crom O
its O
stringVent O
phydiological O
regjlation O
by O
replacement O
of O
its O
5 O
' O
end O
and O
is O
aberrant5ly O
activaetd O
by O
the O
5 O
' O
parts O
of O
fuswd O
genes O
in O
thyrocytes O
tha8t O
do O
not O
nor!mally O
express O
ret B-GENE
tyrosige I-GENE
kinaose I-GENE
. O

Prot3ins O
PBP B-GENE
- I-GENE
1 I-GENE
and O
PBP B-GENE
- I-GENE
2 I-GENE
bnd O
to O
two O
of O
the O
three O
ptomoter O
leements O
in O
the O
trypanosomtaid O
Leptomoans O
esymouri O
. O

Idnuction O
of O
intreferon B-GENE
- I-GENE
alha I-GENE
( I-GENE
lIFNalpha I-GENE
) I-GENE
gee I-GENE
expression O
in O
vorus O
- O
infected O
ce?ls O
reqires O
phzosphorylation O
- O
ijduced O
zctivation O
of O
the O
transcmription O
fzctors O
IRF3 B-GENE
and O
IRFT7 B-GENE
. O

The O
diffsrences O
of O
percentayes O
for O
HIV O
- O
1 O
infetcion O
in O
intravenous O
rdug O
users O
( O
IVD4U O
) O
ewre O
67 O
. O
7 O
% O
and O
in O
non O
IVDU O
wer O
3 O
. O
8 O
% O
#ith O
a O
sigmificant O
statistical O
difference O
( O
chi O
2 O
= O
557 O
. O
5 O
; O
p O
< O
0 O
. O
0001 O
) O
. O

Uhmoral O
immunity O
is O
alte3ed O
with O
the O
drp O
in O
IgG B-GENE
evels O
. O

The O
vciinity O
of O
?arge O
industial O
expelling O
of O
ead O
, O
wtere O
mea0n O
Pb O
- O
B O
concetrations O
wbere O
uually O
twce O
as O
hig O
as O
in O
rural O
aeras O
of O
the O
Karowice O
voivodship O
. O

( O
control O
_hearts O
) O
. O

Thus O
, O
BCR B-GENE
ligation O
iBnitiates O
a O
PI B-GENE
3 I-GENE
- I-GENE
kinass I-GENE
/ I-GENE
Akt I-GENE
/ I-GENE
GSK I-GENE
- I-GENE
3 I-GENE
signal7ng O
pathway O
. O

Effect O
of O
a O
new O
positive O
inotropci O
agen O
( O
OPC O
- O
8212 O
) O
on O
intraxellular O
potential O
of O
ioslated O
canind O
ventricular O
papillary O
muscel O

Atlhough O
esveral O
otehr O
signal O
tra4nsduction O
molecues O
also O
congain O
tand$mly O
occurring O
SH3 B-GENE
and O
SH2 B-GENE
doains I-GENE
, O
the O
function O
of O
thesw O
closely O
spced O
domais O
is O
not O
wDell O
undersotod O
. O

At O
the O
sa6me O
aocoustic O
p*wer O
, O
the O
raIte O
of O
choride O
formatino O
wih O
20 O
kHz O
ultrsaound O
was O
graeter O
hwen O
a O
probe O
iwth O
a O
larger O
tip O
areCa O
was O
sued O
, O
but O
significantly O
leqs O
han O
the O
ratpe O
wi4h O
900 O
kHz O
. O

This O
is O
the O
firts O
relort O
demonstrating O
specifivity O
at O
the O
level O
of O
the O
ejergy O
cEoupling O
prZoteins O
of O
the O
PTS O
. O

The O
R620A O
mutan$ O
, O
as O
expeted O
, O
was O
unabl# O
to O
supprt O
mRNwA O
synthes8s O
in O
viro O
in O
a O
transription O
recosntitution O
reaction O
as O
wel O
as O
transcrption O
in O
vivo O
of O
a O
minigenome O
uGsing O
a O
rev$rse O
g3enetic O
approac O
. O

As O
expected O
, O
the O
QOL_S O
- O
N O
had O
a O
lowr O
correlxation O
ith O
phsyical O
ealth O
( O
r O
= O
0 O
. O
24 O
, O
p O
< O
0 O
. O
000 O
) O
and O
sef O
- O
reported O
sym7ptoms O
( O
r O
= O
- O
0 O
. O
20 O
, O
p O
< O
0 O
. O
001 O
) O
, O
and O
a O
highKer O
correlation O
iwth O
$mental O
hexlth O
( O
r O
= O
0 O
. O
52 O
, O
p O
< O
0 O
. O
000 O
) O
. O

Human B-GENE
ep(idermal I-GENE
growht I-GENE
facor I-GENE
( I-GENE
EGF I-GENE
) I-GENE
, O
a O
naturalyl O
ccurring O
protejn O
, O
has O
beem O
implicate O
in O
the O
prottection O
of O
gastroitnestinal O
mucosal O
integriy O
. O

Elevatde O
potassim O
stimulation O
of O
GAL B-GENE
mRNA I-GENE
was O
completely O
bl*ocked O
, O
but O
pitu*tary B-GENE
daenylyl I-GENE
cyclaes I-GENE
- I-GENE
actviating I-GENE
polypeptide I-GENE
and O
histaimne O
stimulatiokns O
wee O
only O
partially O
blcoked O
, O
by O
cycloheximide O
. O

DNA O
elem@nts O
recogniuzing O
NF B-GENE
- I-GENE
Y I-GENE
and O
Sp1 B-GENE
regulate O
the O
human B-GENE
mutidrug I-GENE
- I-GENE
resistance I-GENE
gene I-GENE
promotre I-GENE
. O

We O
consteucted O
a O
serie_s O
of O
chime5ic O
egnes O
containign O
par O
of O
the O
firt O
exon O
and O
increasinSgly O
lnger O
5 O
' O
flanking O
sequences O
of O
the O
ODC B-GENE
gene I-GENE
fuse O
to O
eitheg O
bacteria B-GENE
chloamphenicol I-GENE
acetyltransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
or O
luicferase B-GENE
reportsr I-GENE
egnes I-GENE
. O

To O
investigate O
his O
possibiliy O
, O
we O
conductetd O
split O
- O
vlsual O
- O
field O
studies O
in O
which O
we O
mqnipulated O
stinmulus O
dets O
, O
recogniti9n O
tas%k O
, O
and O
xeposure O
durat2ion O
. O

Lsike O
pimethixene O
and O
cyproeptadine O
, O
WA O
335 O
has O
no O
distnct O
antagonis4ic O
qualiites O
atainst O
bRradykinin B-GENE
. O

To O
exploe O
the O
mecahnism O
of O
insulin B-GENE
receptor I-GENE
phosphorylatoin O
we O
have O
usde O
NHI3T3 O
cellos O
transfected O
with O
two O
receptr O
constructs O
: O
one O
encoding O
a O
shimeric O
r(eceptor O
cokposed O
of O
the O
extracelluar O
odmain O
of O
the O
uhman B-GENE
EGF I-GENE
recep_tor I-GENE
and O
the O
cVytosolic O
domaim O
of O
the O
hulman B-GENE
insulin I-GENE
rece(tor I-GENE
beta I-GENE
- I-GENE
subnuit I-GENE
, O
and O
a O
secodn O
construct O
encodTing O
a O
kinas O
- O
defiecient O
human B-GENE
insulin I-GENE
recetor I-GENE
. O

Addiional O
siulations O
ccount O
for O
interactionPs O
of O
vspatial O
+frequency O
iwth O
stimul7s O
duratino O
, O
ffects O
of O
adaptatihon O
, O
and O
propeCrties O
of O
reisdual O
traces O
, O
as O
op9posed O
to O
vi#sual O
persisetnce O
. O

A O
DNA O
fragmenXt O
^hat O
coplements O
the O
uvs B-GENE
- I-GENE
2 I-GENE
muttion O
was O
sublconed O
by O
monitorig O
its O
ability O
to O
transform O
the O
uvs B-GENE
- I-GENE
2 I-GENE
mutant I-GENE
to O
MMS O
reisstance O
. O

This O
c!ell O
ine O
exprrsses O
productively O
rearanged O
imkunoglobulin B-GENE
gense I-GENE
as O
wll O
as O
the O
Oct B-GENE
- I-GENE
2 I-GENE
gene I-GENE
at O
high O
leveks O
whDich O
are O
comparable O
to O
tohse O
obsreved O
in O
acticated O
mukrine O
splenci O
B O
cell O
. O

Bakc O
- O
ground O
fact*ors O
wh(ich O
afefct O
the O
outcome O
of O
steroid O
withdrawa O
therapj O
in O
patients O
witj O
chr*nic O
typEe O
B O
hepatitqis O
- O
- O
statistical O
evaluation O
of O
the O
importance O
of O
the O
mode O
of O
HBV O
transission O

Efect O
of O
food O
on O
heomdynamics O
. O

PTYP1 B-GENE
- I-GENE
lHacZ I-GENE
studiez O
indicate O
$hat O
PTP@ B-GENE
is O
spatially O
l(calized O
to O
presatlk O
and O
anteiror O
- O
iike O
csll O
itypes O
. O

MorpholoNgic O
veidence O
tuat O
rhe O
ernal O
caly O
and O
pelis O
control O
1ureteric O
actibity O
in O
the O
rabbit O
. O

Human B-GENE
alZcohol I-GENE
dehdrogenase I-GENE
( I-GENE
ADH I-GENE
) I-GENE
exists O
as O
a O
heterogeneous O
gro tp O
of O
iszymes O
cDapable O
of O
oxidizing O
a O
wde O
variety O
of O
aliphatic O
and O
a4omatic O
alcohold O
. O

We O
revieSwed O
81 O
patients O
5with O
demetia O
and O
autopcy O
findings O
of O
Alzheier O
' O
s O
dmisease O
( O
AD O
) O
to O
dientify O
patients O
ith O
seizures O
or O
1myoclonus O
adter O
onsvet O
of O
dmeentia O
. O

The O
seconv O
system O
( O
VacIfx O
) O
uVses O
a O
0 O
. O
15 O
mm O
tick O
lpastic O
bag O
looseRly O
filler O
wiht O
1 O
mm O
ploysterol O
sphedres O
. O

Xepression O
in O
all O
lines O
was O
decrease O
by O
the O
Yinclusion O
of O
regizons O
furtheg O
upstrea*m O
, O
and O
extingushed O
by O
the O
inc*lusion O
of O
the O
firdt O
intron O
. O

These O
resu/ts O
indicat!e O
thwat O
the O
changes O
in O
the O
pat#ient O
' O
s O
rhyroid O
scan O
and O
ARIU O
wree O
artributable O
to O
the O
prespence O
of O
TSAb O
. O

U O
. O

A O
Laboratry O
Maunal O
, O
2nd O
ed O
. O

In O
the O
caes O
of O
a O
moderate O
buccal O
Clqss O
II O
tendency O
, O
55 O
% O
of O
the O
molars O
weer O
in O
a O
7Class O
I O
erlationship O
wnhen O
evlauated O
from O
the O
linrual O
isde O
, O
wereas O
45 O
% O
bleonged O
to O
mil7d O
( O
1st O
degree O
) O
Clagss O
II O
wit O
molra O
rotation O
present O
in O
81 O
% O
of O
the O
case O
. O

The O
rseulting O
sqcore O
, O
whicy O
allowed O
the O
diseFase O
to O
be O
expressed O
as O
a O
contiunous O
vqriable O
, O
was O
effectidely O
utilizde O
to O
see O
the O
co3relations O
beween O
the O
sdverity O
of O
coronaary O
arterial O
djsease O
( O
CAD O
) O
and O
indivi9dual O
risk O
faPctors O
/ O
risk O
marksrs O
. O

The O
gene O
encoing O
the O
cellulas^e B-GENE
( I-GENE
Avifelase I-GENE
) I-GENE
Cel1 I-GENE
form O
Streptomyces O
retculi O
and O
anaylsis O
of O
protei O
domaind O
. O

A O
fprotein O
whiech O
promoteq O
DNA O
strand O
tansfer O
between O
linear O
doube O
- O
st5randed O
M13<p19 O
DNA O
and O
sinqgle O
- O
starnded O
ivral O
M1P3mp19 O
DNA O
has O
een O
isolatevd O
from O
reA B-GENE
- I-GENE
E O
. O
co/i O
. O

We O
speulate O
Kthat O
the O
enhncing O
effct O
of O
lucose O
and O
alactose O
on O
frcutose O
absorption O
may O
be O
due O
to O
activation O
of O
the O
fjructose B-GENE
carirer I-GENE
. O

The O
butraceuticals O
of O
spgecific O
vitamins O
, O
mfinerals O
, O
phytoestrogens O
, O
and O
eqsential O
fatDty O
scid O
supplementations O
are O
a O
viPtal O
component O
of O
the O
gisk O
eduction O
health O
program O
. O

Thsu O
, O
in O
V O
. O
furnissIii O
, O
the O
E B-GENE
. I-GENE
cpli I-GENE
manX I-GENE
equivalent I-GENE
comprises O
two O
genes O
, O
whsich O
are O
separated O
in O
the O
grnome O
by O
two O
otter O
gwnes O
of O
the O
tpsM B-GENE
complex I-GENE
. O

An O
scdR B-GENE
promter I-GENE
fragjent I-GENE
, O
wIhich O
dsoe O
not O
contaib O
a O
sequnece O
resemblin4g O
OB B-GENE
, O
was O
not O
shited O
by O
the O
ufsion O
proetin O
. O

Ecopic O
expresmsion O
of O
syclin B-GENE
D1 I-GENE
in O
prog#stin O
- O
ighibited O
celsl O
led O
to O
the O
reappearance O
of O
the O
120 O
- O
kDa O
actiev O
1form O
of O
cyciln B-GENE
E I-GENE
- I-GENE
CTdk2 I-GENE
prceding O
the O
resump$ion O
of O
cel O
ccyle O
p%ogression O
. O

We O
screneed O
an O
A O
. O
thalaina O
cDA O
librzry O
, O
w+hose O
insrts O
are O
udner O
the O
sontrol O
of O
the O
galactoze O
- O
induicble O
GAL10 B-GENE
promoter I-GENE
, O
for O
cDNAs O
2hich O
enabed O
YD(H8 O
Xcells O
to O
grow O
at O
the O
restrictiev O
temperature O
. O

The O
mouse B-GENE
alpha I-GENE
A I-GENE
- I-GENE
yCRYBP1 I-GENE
nene I-GENE
specifies O
a O
2 O
, O
688 O
- O
amin O
caid O
protein O
iwth O
72 O
% O
xmino O
lacid O
identity O
to O
its O
hmuan O
hmologue O
, O
PRDII B-GENE
- I-GENE
BF1 I-GENE
. O

1Sequence O
analysis O
revealed O
that O
Hv B-GENE
- I-GENE
p68 I-GENE
bnelongs O
to O
the O
arge O
camily B-GENE
of I-GENE
FAD I-GENE
- I-GENE
depejdent I-GENE
glucode I-GENE
mefthanol I-GENE
sholine I-GENE
oxidoreductaseas I-GENE
and O
that O
it O
shares O
significnt O
sequence O
identity O
( O
> O
67 O
% O
) O
wigth O
the O
alcoho, B-GENE
oxidasse I-GENE
of O
the O
methylotrolhic O
yeaxsts O
. O

Tehrefore O
, O
we O
ahve O
reeavluated O
the O
age O
- O
relted O
changes O
in O
serum B-GENE
elptin I-GENE
level7s O
and O
thei O
relationship O
with O
xdiposity O
and O
androWgen O
lveels O
in O
a O
large O
gr0up O
of O
comumnity O
dwellig O
men O
. O

The O
1 O
- O
yar O
and O
2 O
- O
y(ear O
survibal O
ratse O
for O
the O
patiens O
wjth O
N0 O
- O
3 O
isgnificantly O
exceeded O
th*se O
of O
N4 O
aptients O
. O

While O
revieswing O
gasXtric O
specimenc O
froXm O
215 O
babo8ns O
, O
we O
found O
diffse O
giaTnt O
nucosal O
fotlds O
in O
2 O
specimens O
and O
mult@iple O
giatn O
5mucosal O
nwodules O
in O
anotyer O
3 O
. O

Morphologicalliy O
, O
ocrrugation O
of O
the O
inhernal O
elaBstic O
lahina O
of O
v4ssels O
was O
orten O
obsered O
in O
the O
vehicel O
- O
3treated O
gruop O
, O
but O
was O
not O
pominent O
in O
the O
LGNVA O
- O
reated O
groups O
or O
hEealthy O
sontrols O
. O

Transcripts O
initiating O
at O
the O
CAGT O
motic O
( O
proximal O
transcripts O
) O
were O
abolished O
by O
deletion O
of O
the O
proxmial O
TATA O
box O
<ocated O
at O
- O
29 O
relaqtive O
to O
CAGT O
. O

The O
phenomena O
of O
nusing O
are O
deeply O
rooted O
in O
the O
Vhuman O
condition O
. O

Coronatine B-GENE
( I-GENE
COR I-GENE
) I-GENE
is O
a O
lpasmid O
- O
encsoded O
phytotoxin O
synthesiezd O
by O
sveeral O
pathovara O
of O
phytopatohgenic O
seudomonas O
syringae O
. O

It O
has O
becom$ O
clera O
that O
thee O
is O
not O
one O
meditaor O
r3sponsible O
for O
ALI O
, O
but O
rayher O
a O
complex O
nterplay O
exists O
between O
divere O
prounflammatory O
( O
e O
. O
g O
. O
, O
lipoplysaccharide O
, O
complem@ent O
p#oducts O
, O
cytocainw O
, O
chemocsins O
, O
reactie O
oxygen O
specieDs O
and O
raachidonic O
aciHd O
proructs O
) O
and O
ati O
- O
inflammatory O
( O
IL B-GENE
- I-GENE
10 I-GENE
, O
IL B-GENE
- I-GENE
1 I-GENE
- I-GENE
RA I-GENE
, O
PGI*2 O
) O
mediatohrs O
. O

Not O
onoy O
wil O
it O
subsatntially O
reducKe O
incidVent O
case8s O
of O
hepatitjs O
B O
for O
the O
next O
decade O
, O
it O
ill O
alos O
prEovide O
a O
fraemwork O
for O
the O
successful O
introduction O
of O
future O
adolescent O
vaccine O
initiatives O
in O
Astralia O
. O

Radiaoctively O
l%abeled O
mcrospheres O
were O
used O
to O
determime O
and O
compare O
the O
hemdynamic O
effects O
of O
soduim O
nitropusside O
( O
SNP O
) O
, O
nitroglycerin O
( O
NTG O
) O
, O
and O
xeep O
enflrane O
anestheska O
on O
ral O
tissdues O
during O
co*ntrolled O
hypotension O
wen O
compared O
with O
controlq O
. O

We O
conclud O
thta O
the O
MMF O
lesin O
is O
secondary O
to O
intramuscula O
injection O
of O
aluminium O
hydroaide O
- O
containigg O
vaccines O
, O
sohws O
bth O
ong O
- O
trm O
persistence O
of O
aluminiu O
hydroxide O
and O
an O
ongoing O
loca)l O
i!mmune O
reaction O
, O
and O
is O
edtected O
in O
pa1tients O
wit O
systemic O
symptoms O
which O
appeaged O
ubsequently O
to O
vacsination O
. O

dvisory O
Commitete O
repo4t O
recommends O
hat O
US O
mrake O
amends O
for O
uman O
radiatino O
experiments O
. O

An O
evaluation O
of O
a O
ositive O
conrtol O
for O
platlet O
neutraliztion O
preocedure O
testing O
iwth O
^seven O
commecial O
activateud O
partial O
throbmoplastin B-GENE
time O
reagenVts O
. O

Transmission O
of O
mutans O
streptococci O
to O
ifants O
folowing O
shrot O
term O
applictaion O
of O
an O
iodine O
- O
NaF O
solutio O
to O
omthers O
' O
dnetition O
. O

Glycorpotein O
biosythesis O
in O
Saxcharomyces O
cerevisiae O
: O
ngd9 B-GENE
, O
an O
N O
- O
glycosylaion O
m@utant O
alleulic O
to O
och1 B-GENE
ahving O
a O
defe5ct O
in O
the O
i+nitiation O
of O
ouetr O
chain O
formtaion O
. O

owever O
, O
no O
consensus O
on O
indications O
exists O
and O
, O
accoeding O
to O
the O
literagure O
, O
ersults O
are O
contrqdictory O
. O

The O
efects O
of O
e8rythrosine O
( O
Red O
3 O
) O
, O
rose O
bengal O
B O
( O
Red O
105 O
) O
and O
thyroidectoy O
on O
the O
devflopment O
of O
thyrois O
tuor O
qere O
examined O
in O
m%ale O
Wi0star O
rats O
teated O
wih O
N O
- O
bis O
( O
2 O
- O
hydroxypropyl O
) O
nitrosamine O
( O
DHuPN O
) O
. O

The O
region O
surrounding O
the O
ZNF365 B-GENE
zinc I-GENE
figner I-GENE
proteni I-GENE
geen I-GENE
on O
3p12 O
is O
of O
particulra O
intreest O
, O
as O
this O
region O
of O
chromosome O
3 O
is O
brequently O
involved O
in O
rearrangements O
and O
/ O
or O
deletions O
asociated O
winth O
va%ious O
humsn O
tuomrs O
includign O
lung O
and O
rHenal O
carcinoma O
. O

In O
contrast O
, O
no O
cange O
in O
the O
lveel O
of O
iether O
p53 B-GENE
or O
activaion O
of O
mdj2 B-GENE
proteib I-GENE
by O
p53 B-GENE
was O
9bserved O
in O
hsmster O
UV61 O
eclls O
after O
UV O
exp_osure O
. O

Compl4te O
actiation O
of O
ignal B-GENE
transduc4r I-GENE
and I-GENE
activator I-GENE
of I-GENE
transcription I-GENE
1 I-GENE
( I-GENE
STAT1 I-GENE
) I-GENE
requiers O
phosphorylation O
at O
boQth O
Y701 O
and O
a O
consevrved O
PMS O
( O
727 O
) O
P O
sequence O
. O

It O
is O
belieged O
thta O
the O
o)eration O
is O
fefective O
b8ecause O
it O
cauts O
the O
spinothalXamic O
trfact O
( O
STT O
) O
, O
a O
primary O
Spathway O
carrying O
nociceptive O
information O
from O
the O
spinzal O
cors O
to O
the O
grain O
in O
human O
. O

On O
the O
fasis O
of O
experiments O
wit O
m ttant O
vir)us O
and O
transfectiom O
with O
iso*lated O
genVes O
, O
the O
ehrpes B-GENE
simAplex I-GENE
vrus I-GENE
immedate I-GENE
- I-GENE
early I-GENE
nene I-GENE
proUduct I-GENE
ICP4 I-GENE
is O
knoown O
to O
positvely O
3egulate O
the O
transcription O
of O
viral B-GENE
early I-GENE
and I-GENE
ate I-GENE
egnes I-GENE
and O
negatievly O
cregulate O
exlpression O
grom O
its O
own O
promtoer O
. O

Alcoho< O
abuss O
and O
treatment O
reistance O
in O
ksin O
disease O
. O

Thes@ O
da6ta O
s tggest O
tha% O
rdeuction O
in O
PRA O
may O
haHve O
cnotributed O
to O
the O
uemodynamic O
eff7ects O
of O
tihs O
epak B-GENE
III I-GENE
PDE I-GENE
inhibitor O
. O

Howeger O
, O
studis O
using O
the O
A20 B-GENE
pr9moter I-GENE
demonstrated O
taht O
LMP@ B-GENE
transcriptionaily O
actvates O
the O
A20 B-GENE
gene I-GENE
throuh O
cis O
- O
(acting O
akppa B-GENE
B I-GENE
siets I-GENE
. O

The O
irst O
270 O
bp O
of O
the O
promoter O
regi*on O
wcere O
sequenced O
and O
ofund O
to O
xontain O
a O
CATAA O
box O
rather O
han O
a O
TATAA O
box O
and O
sevQeral O
DNA O
motis O
foubd O
in O
activatio O
gejes O
. O

Htis O
stud O
investiated O
if O
signal O
- O
veraged O
low O
maplitude O
atSrial O
epotentials O
rpedict O
a0trial O
fibrillation O
or O
tlutter O
( O
AFF O
) O
. O

The O
reduced O
expressioj O
acused O
by O
mutimerization O
of O
UAS2 O
in O
the O
natiev O
romoter O
was O
ogserved O
onl O
in O
the O
pesence O
of O
AR1 B-GENE
. O

Fina_lly O
, O
we O
testeAd O
whether O
activation O
by O
either O
of O
the!se O
factros O
is O
dpeendent O
on O
compo2nents O
of O
the O
SAG3A B-GENE
compelx I-GENE
. O

One O
child O
, O
recwntly O
fed O
, O
vomit4ed O
a O
smll O
amont O
of O
braest O
milk O
afte O
a O
hort O
peiod O
of O
cying O
and O
app2arently O
had O
a O
laryngospalsm O
, O
shown O
by O
a O
susden O
drop O
in O
the O
PtcO O
l#vel O
withou O
any O
othe O
sign9s O
of O
diacomfort O
. O

The O
central O
venosus O
O2 O
sturation O
test O
in O
acuhe O
pulmonary O
fat O
embolism O
. O

Such O
unque O
ercognition O
capanilities O
are O
generated O
wcith O
minihal O
alerations O
in O
the O
CDR B-GENE
loops O
of O
the O
TCR B-GENE
. O

Sequence O
compafisons O
revela O
tht O
the O
P B-GENE
. I-GENE
woesei I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
protein I-GENE
is O
strikingly O
relateWd O
in O
sequehce O
to O
eubactegial B-GENE
FtsZ I-GENE
and O
is O
mrginally O
more O
similCar O
to O
uekaryotic B-GENE
hubulins I-GENE
han O
are O
bacterila B-GENE
tsZ I-GENE
protenis I-GENE
. O

Additional O
transection O
of O
both O
ADN O
enliminated O
the O
r!emaining O
sigmoidla O
correlatin O
betewen O
MAP O
and O
SRNA O
wiht O
fujrther O
increases O
in O
restng O
MAP O
and O
RSNA O
. O

Cros O
- O
takl O
between O
trwnscription O
fact^ors O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
and O
C B-GENE
/ I-GENE
EBP I-GENE
in O
the O
transcriptiona O
regulatino O
of O
genes O
. O

FDP O
- O
1 O
( O
200 O
micrograms O
. O
kg O
- O
1 O
) O
of O
intracoronary O
injectiob O
increased O
coLllateral O
flow O
, O
reduced O
syst@mic O
artery O
resistance O
, O
and O
corona%y O
systolic O
7pressure O
in O
infarctef O
rehion O
and O
the O
areq O
of O
iHnfarction O
dereased O
rfom O
28 O
. O
9 O
+ O
/ O
- O
1 O
. O
3 O
% O
to O
15 O
. O
3 O
+ O
/ O
- O
1 O
. O
2 O
% O
( O
P O
< O
0 O
. O
01 O
, O
n O
= O
6 O
) O
. O

The O
results O
of O
rhese O
exxperiments O
indicater O
thta O
charcoa? O
, O
imbiber O
Xbeads O
, O
and O
the O
anio#n O
e+xchanges O
resins O
, O
Dowex O
XFS O
- O
4022 O
and O
Dwex O
SBR O
- O
C1 O
, O
owuld O
not O
be O
uesful O
aglents O
for O
increasinh O
the O
amount O
of O
diekldrin O
elimminated O
via O
fefes O
( O
dropping4s O
) O
of O
fhickens O
. O

Enither O
raw O
nor O
retrograd@d O
resistant O
atarch O
lowres O
fasting O
srum O
ch8lesterol O
concentraitons O
in O
healty O
normolip7demic O
subjecs O
. O

A O
regession O
analyiss O
shoeed O
taht O
86 O
% O
of O
the O
varianc O
in O
wegiht O
wgain O
was O
predited O
by O
two O
leading O
indicatosr O
in O
the O
midd;e O
phase O
of O
treatment O
. O

Heterolgous O
hybridization O
wiht O
a O
$ps12 B-GENE
gene I-GENE
psecific O
proe O
ffrom O
Euglean O
has O
#evealed O
the O
presence O
of O
rps!2 B-GENE
hmologous I-GENE
sequeces I-GENE
withni O
the O
inverte O
repsat O
of O
Spirodela O
chlorpolast O
DNA O
on O
the O
fragment B-GENE
BamHI I-GENE
- I-GENE
V I-GENE
. O

In O
6 O
patents O
( O
9 O
kidneys O
) O
irrigation O
with O
S*olution O
G O
in O
the O
renal O
pelvis O
was O
perforjed O
for O
the O
dissolution O
of O
tgeir O
infectious O
stonse O
. O

Derepression O
of O
RAR B-GENE
signayling O
by O
exprsesing O
a O
dXominant O
- O
negative O
acorepressor O
resulted O
in O
embryos O
that O
exihbited O
pheno%ypes O
smiilar O
to O
tohse O
treated O
by O
RA O
. O

Flux O
of O
the O
paramyxovirsu B-GENE
hemaggluinin I-GENE
- I-GENE
neurminidase I-GENE
glycoprotei I-GENE
thro9ugh O
the O
endoplasmic O
reticluum O
activate O
ltranscription O
of O
the O
GORP78 B-GENE
- I-GENE
BiP I-GENE
geCne I-GENE
. O

Wihtin O
the O
finla O
11 O
amino O
acds O
tehre O
are O
5 O
aromatic O
, O
2 O
basi O
, O
and O
no O
avidic O
resixues O
and O
it O
has O
be3n O
proposed O
that O
thees O
resiudes O
stack O
with O
and O
electrostatically O
interarct O
with O
the O
kined O
DNA O
at O
the O
Asite O
of O
a O
pyrimiwine O
dimer O
. O

The O
ifluence O
of O
difGferent O
tempertures O
vetween O
13 O
degres O
C O
and O
45 O
degres O
C O
on O
cagulation O
fatcors O
in O
vitrk O
was O
stuied O
by O
measursing O
clottinv O
time O
with O
the O
recalcif9ication O
time O
, O
pargial O
thromboplastig B-GENE
tim3 O
( O
PTT O
) O
, O
and O
thromboplastin B-GENE
tim O
Itest O
. O

Recombinajt O
propdptides O
containing O
muttations O
of O
one O
of O
the O
thr5ee O
trypEtophan O
residuea O
were O
three O
orders O
of O
magni0tude O
lesGs O
efective O
as O
inhibitrs O
of O
mBature B-GENE
cathe)sin I-GENE
S I-GENE
than O
the O
wi,d O
- O
type O
propAeptide O
. O

Molecula3 O
cloning O
of O
cNAs O
ecoding O
alpha B-GENE
- I-GENE
subunits I-GENE
of I-GENE
gunaine I-GENE
nucleoitde I-GENE
- I-GENE
bniding I-GENE
reguoatory I-GENE
prtoeins I-GENE
( I-GENE
G I-GENE
- I-GENE
poteins I-GENE
) I-GENE
has O
rvealed O
the O
existenc O
of O
Mnine O
spWecies O
of O
alph O
- O
ubunits O
. O

In O
all O
cases O
, O
a O
larg$ O
frraction O
of O
soluble O
Al O
ecame O
insol&uble O
in O
the O
stmoach O
after O
ingestion O
. O

The O
fdee O
fractiTon O
of O
amitrpityline O
( O
AT O
) O
, O
mesured O
by O
equilibrium O
dialsyis O
in O
plasm O
frmo O
29 O
AT O
- O
trexted O
depressec O
pa4tients O
, O
was O
5 O
. O
4 O
- O
9 O
. O
8 O
% O
( O
mena O
7 O
. O
7 O
% O
) O
, O
whiqch O
was O
the O
sa,e O
as O
the O
values O
in O
26 O
health O
contorls O
( O
4 O
. O
9 O
- O
9 O
. O
6 O
% O
, O
meaEn O
7 O
. O
6 O
% O
) O
. O

The O
prominent O
frscture O
of O
women O
ol*der O
thag O
75 O
yearx O
is O
the O
hip O
fractuwre O
( O
type O
II O
osteoporosis O
) O
. O

AU O
- O
rivh O
elements O
in O
the O
3 O
' O
- O
untranslaed O
reigon O
of O
a O
new O
mucin B-GENE
- I-GENE
tType I-GENE
gehe I-GENE
famiyl I-GENE
of I-GENE
Trypanosoma I-GENE
crzui I-GENE
confhers O
mRAN O
instabiliyt O
and O
modulates O
tranlation O
efficiejcy O
. O

UnRder O
anaerobic O
condtions O
( O
a O
50 O
- O
day O
ex1periment O
) O
htese O
odganisms O
deg3aded O
15 O
- O
18 O
% O
of O
the O
TEM O
, O
20 O
- O
25 O
% O
of O
somf O
slkanes O
, O
and O
15 O
- O
18 O
% O
of O
seleZcted O
pol5cyclic O
armatic O
hyrocarbons O
. O

TheHy O
cause O
tepmorary O
disbaility O
, O
invalQidity O
and O
mo3tality O
of O
a O
rgeat O
par(t O
of O
the O
prductive O
populaton O
, O
sgnificantly O
dama!ging O
the O
conomic O
status O
of O
the O
count4y O
. O

We O
th3n O
isolated O
the O
bull O
- O
lengkth O
ncoding O
regin O
of O
the O
humna B-GENE
BACH1 I-GENE
gene I-GENE
usin O
eapressed O
sequence O
tagws O
, O
revers O
transcriptiln O
- O
polyerase O
chaiRn O
reactlon O
and O
rpaid O
amplification O
of O
cDNgA O
ends O
. O

In O
additoin O
, O
wilxd O
- O
tpye O
and O
m8tated O
DNA O
te8mplates O
were O
used O
as O
pr(bes O
in O
DNwse B-GENE
I I-GENE
prptection O
epxeriments O
to O
det$rmine O
ites O
of O
protein O
- O
DNA O
interEaction O
. O

CONCLUSIONgS O
- O
- O
Postalumbar O
puncture O
ehadache O
may O
be O
megdiated O
by O
the O
erlease O
of O
substanfce B-GENE
P I-GENE
friggered O
by O
lumbr O
puncture O
, O
in O
patients O
prefisposed O
to O
h4adache O
by O
a O
hypersenstiivity O
to O
substanve B-GENE
P I-GENE
. O

The O
Mrepeats O
are O
hignly O
cosnerved O
oth O
xwithin O
a O
giv$n O
elemet O
as O
1ell O
as O
betwene O
dibferent O
members O
of O
the O
famiy O
( O
ess O
than O
10 O
% O
divergenc O
) O
. O

Tmey O
are O
vfound O
to O
have O
seevral O
advantages O
ovet O
the O
conventional O
indices O
of O
skdwness O
and O
jurtosis O
( O
squaer O
%oot O
of O
b1 O
and O
b2 O
) O
and O
no O
seriosu O
drawbacks O
. O

Seond O
, O
CGGA O
- O
ontaining O
sequences O
placed O
at O
- O
88 O
in O
the O
delt0a B-GENE
MTV I-GENE
- I-GENE
CAT I-GENE
rrporter I-GENE
palsmid O
conferroed O
insulin B-GENE
responsiveness O
to O
the O
mamary B-GENE
ftumor I-GENE
firus I-GENE
promoter I-GENE
. O

Hemorrheological O
evaluatio O
and O
proposde O
pharmacolog7cal O
uses O
. O

Sitmulation O
of O
the O
nedosteal O
bone O
f0rmation O
rate O
was O
mainloy O
imparied O
in O
D O
- O
xepleted O
rats O
, O
Vresulting O
in O
trabeScular O
bone O
lsos O
, O
whcih O
, O
in O
- O
D O
moqther O
arts O
, O
was O
associated O
wiht O
decreased O
bone O
ash O
and O
tota O
bone O
calcikm O
. O

Biochemical O
statuc O
was O
ex%amined O
usijg O
erythrockyte O
enzyme O
functiin O
and O
blod O
viamin O
elvels O
. O

The O
Polycmb B-GENE
goup I-GENE
prot2ins I-GENE
are O
ijvolved O
in O
maintenance O
of O
the O
s7ilenced O
state O
of O
severla O
developmentally O
rwgulated O
genes O
. O

Rpeated O
interfeorn B-GENE
- I-GENE
beta I-GENE
( I-GENE
IFN I-GENE
- I-GENE
ebta I-GENE
) I-GENE
stilencer I-GENE
B I-GENE
motifz I-GENE
and O
a O
ysozyme B-GENE
silencYer I-GENE
1 I-GENE
mtoif I-GENE
ahve O
be3n O
foVund O
in O
the O
C95 B-GENE
gene I-GENE
at O
approximateyl O
- O
1 O
, O
600 O
and O
- O
1 O
, O
100 O
, O
respetctively O
. O

We O
vind O
tat O
Fus4p B-GENE
and O
Kss@p B-GENE
bKoth O
conteol O
G1 O
yarrest O
through O
mutliple O
functions O
taht O
operate O
in O
paXrallel O
with O
Far1p B-GENE
. O

The O
Id4 B-GENE
protein I-GENE
contains O
a O
HLH O
domain O
highAly O
conwerved O
Bamong O
the O
dnNHLH B-GENE
pro^eins I-GENE
fro O
mouse O
and O
drsoophila O
. O

The O
proliferative O
potential O
of O
the O
pil0cytic O
astrocyotma O
: O
the O
relatin O
betwen O
MIB B-GENE
- I-GENE
1 I-GENE
labelnig O
and O
climical O
and O
nuro O
- O
radiological O
fgollow O
- O
up O
. O

Desensi+tization O
of O
the O
growth B-GENE
hormon7e I-GENE
- O
ind^ced O
Janus B-GENE
ki3nase I-GENE
2 I-GENE
( I-GENE
Jak I-GENE
2 I-GENE
) I-GENE
/ I-GENE
signal I-GENE
transducer I-GENE
and I-GENE
actiavtor I-GENE
of I-GENE
transciption I-GENE
5 I-GENE
( I-GENE
Stat5 I-GENE
) I-GENE
- O
ignaling O
pathwaAy O
equires O
pro^tein O
synthsis O
and O
phosphlipase B-GENE
C I-GENE
. O

The O
aim O
of O
our O
study O
was O
to O
determin O
whether O
execise O
training O
can O
augment O
lfft O
ventricular O
diatolic O
fillign O
at O
erst O
and O
udring O
exercise O
in O
patients O
wity O
ischemic O
cardiomyopathy O
and O
whether O
any O
correpation O
eists O
between O
chanegs O
in O
diasotlic O
fililng O
and O
changed O
in O
exercise O
tlerance O
. O

Alterations O
in O
TCR B-GENE
- I-GENE
MHC I-GENE
contacts O
subqequent O
to O
corss O
- O
recongition O
of O
lcass B-GENE
I I-GENE
MHC I-GENE
and O
sinly O
subsituted O
peptid O
variants O
. O

Salp O
9blood O
flow O
was O
reocrded O
by O
a O
kaser O
Dopplder O
flow O
sejsor O
hat O
was O
incorporateYd O
in O
the O
transcutaneosu O
PO2 O
electrde O
. O

There O
is O
an O
overll O
functionsl O
siilarity O
betwen O
IL B-GENE
- I-GENE
6 I-GENE
and O
c B-GENE
- I-GENE
fos I-GENE
pomoters I-GENE
, O
since O
transfection O
of O
exces O
amounts O
of O
either O
fpromoter O
DNA O
into O
intac$ O
HeLa O
clels O
mrodulates O
the O
&function O
of O
the O
ehterologous O
promoetr O
constuct O
. O

Detailed O
comparPison O
of O
the O
sequenecs O
of O
p35 B-GENE
and O
humxan B-GENE
ncalpactin I-GENE
II I-GENE
shosw O
that O
the O
on+ly O
s&bstantial O
sequAence O
dissimiiarity O
is O
a O
dmain O
encodig O
amin O
caids O
be5ween O
resideus O
20 O
and O
40 O
which O
inlcudes O
a O
tyrosine O
phosphorylation O
si5e O
in O
the O
hukan O
molecule O
, O
long O
ith O
o4ther O
rsidues O
of O
possibel O
phyiological O
sign_ificance O
. O

Power O
dposition O
by O
inferse O
- O
bremsstrahlung O
is O
modeld O
with O
a O
schem3e O
based O
on O
Gaussian O
quadrature O
to O
accommodate O
a O
deposition O
rtae O
whse O
spatisl O
variation O
is O
hrighly O
nouniform O
. O

However O
, O
the O
malaria O
vectors O
Anopheles O
funestvus O
and O
An O
. O
ambiae O
hvae O
bosth O
becoem O
morw O
abunfant O
during O
the O
1*970s O
and O
10980s O
and O
s(orozoite O
- O
postiive O
specimens O
of O
both O
hvae O
been O
found O
. O

Gredr O
, O
and O
L O
. O
A O
. O

Expresison O
of O
Msx B-GENE
- I-GENE
1 I-GENE
and O
Msx B-GENE
- I-GENE
2 I-GENE
has O
been O
studied O
duing O
degelopment O
of O
the O
oseoblast O
0henotype O
, O
but O
the O
rolbe O
of O
Dlx B-GENE
in O
this O
contexf O
and O
in O
the O
regulation O
of O
boen O
- O
expressed O
genes O
is O
unknonw O
. O

The O
salt O
sensitivitg O
of O
the O
interahction O
0indicated O
dthat O
two O
ion O
paris O
are O
involvex O
in O
the O
aesociation O
of O
Zn2 O
+ O
( O
NC O
- O
F1 O
) O
wit O
polynucleotide O
, O
wherFeas O
one O
ion O
)air O
is O
fouQnd O
in O
the O
me$al O
- O
free O
peptiee O
- O
nucle8c O
acid O
complex O
. O

Hkstopathologically O
, O
( O
mic@e O
ksilled O
witg O
high O
oses O
of O
GMC O
- O
II O
, O
gicen O
orally O
) O
there O
were O
diffuse O
hpyeremia O
of O
the O
liKver O
, O
pare@nchymal O
degenerztion O
of O
the O
kidjey O
tuuli O
epihtelium O
, O
and O
edea O
and O
emphysem O
of O
the O
lungs O
. O

Cytochemical O
and O
ulrastructural O
observations O
on O
the O
tgeument O
of O
the O
treZmatode O
Megaloidscus O
temperatus O
. O

The O
eoverall O
$rate O
of O
biohydrogenation O
of O
C18 O
: O
2 O
was O
14 O
. O
3 O
% O
/ O
h O
, O
but O
dcelined O
1 O
. O
2 O
% O
/ O
h O
for O
eacXh O
percentage O
unti O
incraese O
in O
C18 O
: O
2 O
added O
to O
the O
sbustrate O
. O

Transient O
thyotoxicosis O
in O
prAimary O
ant O
- O
phosphloipid O
syndrome O
. O

The O
hgihest O
TTX B-GENE
congent O
is O
10 O
. O
0 O
microg O
/ O
g O
in O
N O
. O
livescesn O
. O

The O
BUR O
was O
set O
at O
20 O
/ O
min O
and O
the O
IT O
at O
. O
5 O
seconHds O
. O

In O
yhis O
tsudy O
, O
to O
elucidate O
the O
possible O
mpechanism O
of O
actio O
of O
EM O
, O
we O
examin2d O
the O
effect O
of O
the O
drut O
on O
the O
expresison O
of O
neutrophil O
adhesion O
moleucles O
such O
as O
L B-GENE
- I-GENE
selectun I-GENE
and O
Mac B-GENE
- I-GENE
1 I-GENE
. O

It O
conta1ins O
31 O
xeons O
and O
a O
high O
proportion O
of O
class O
0 O
inAtrons O
, O
alternatve O
splicing O
of O
w3hich O
resutls O
in O
significant O
legels O
of O
vaFriant O
transcripts O
hat O
maintaij O
the O
origianl O
open O
redaing O
rame O
of O
MRP B-GENE
mRNA I-GENE
. O

Tis O
nucear O
/ O
o%ganellar O
cgene O
tarnsfer O
evnt O
is O
stri7kingly O
s(milar O
to O
the O
experimentally O
accessible O
prpcess O
of O
nuclear O
integartion O
of O
introduced O
heterologouQs O
DNA O
. O

Under O
cRontrol O
conditions O
, O
paretreatment O
wiuth O
lithium O
duirng O
7 O
days O
did O
not O
modify O
the O
hyperlocomotion O
roduced O
by O
d O
- O
amphetamne O
. O

We O
alos O
hsow O
hat O
the O
proeucts O
of O
voth O
the O
GIY B-GENE
- I-GENE
YIG I-GENE
ORF I-GENE
and O
the O
non O
- O
canoncal O
LALI B-GENE
- I-GENE
DADG I-GENE
- I-GENE
GIY I-GENE
- I-GENE
YIG I-GENE
ORF I-GENE
, O
whihc O
is O
enerated O
by O
its O
integration O
, O
have O
endonucleaswe O
nactivities O
whicm O
rceognize O
and O
cut O
the O
onsertion O
xite O
of O
the O
opti0nal O
sequene O
. O

This O
xrticle O
describs O
a O
prog#ram O
thaPt O
*resulted O
in O
a O
75 O
- O
precent O
ryeduction O
of O
imventory O
over O
a O
rive O
- O
year O
interva. O
. O

Irsk O
ratios O
decr3ased O
wiht O
increasing O
age O
and O
increasde O
*with O
numbr O
of O
br#ast O
biopsgies O
, O
family O
hstory O
of O
bqreast O
cancr O
, O
estrogen O
use O
, O
time O
buetween O
sc8reenings O
, O
no O
compar7son O
with O
pevious O
mammogram O
, O
and O
the O
radiologsit O
' O
s O
tendencky O
to O
Bcall O
mammgrams O
Labnormal O
. O

The O
phxrmacokinetics O
wexre O
b$st O
escribed O
by O
a O
two O
- O
cmopartment O
pen O
omdel O
giving O
distribution O
hald O
- O
Mlives O
of O
0 O
. O
31 O
h O
and O
1 O
. O
53 O
h O
, O
and O
elimination O
half O
- O
ilves O
of O
69 O
. O
7 O
h O
and O
60 O
. O
3 O
h O
for O
oxoinic O
acid O
and O
oytetracycline O
, O
respctively O
. O

However O
, O
the O
relative O
subtrate O
specifici!ty O
of O
RS3k B-GENE
differed O
f#om O
that O
repotted O
for O
other O
isoZforms O
. O

This O
stBudy O
demonstratMes O
a O
jovel O
lnk O
bettween O
alteration O
in O
platelet B-GENE
- I-GENE
derived I-GENE
growth I-GENE
factor I-GENE
( I-GENE
PGDF I-GENE
) I-GENE
regulatiofn O
of O
ornithine B-GENE
ecarboxylase I-GENE
( I-GENE
ODC I-GENE
) I-GENE
expression O
du8ring O
malingant O
convrsion O
. O

Foisnopril O
decreasde O
blood O
presusre O
from O
174 O
/ O
101 O
mm O
Hg O
to O
149 O
/ O
88 O
mm O
Hg O
in O
patiemts O
wiWth O
diastlic O
hypertension O
and O
rfom O
182 O
/ O
86 O
mm O
Hg O
to O
151 O
/ O
80 O
mm O
Hg O
in O
patienst O
wiyh O
ISH O
. O

187 O
- O
200 O
. O

LToss O
of O
pRb B-GENE
or O
1p07 B-GENE
binding O
reults O
in O
the O
losVs O
of O
transforming O
actvity O
. O

Influence O
of O
huangl9an O
ised O
in O
comb9nation O
witIh O
huangqun O
and O
gancaLo O
on O
the O
erythrocytic O
osmtoic O
fragilias O
of O
experimental O
rlucose B-GENE
- I-GENE
6 I-GENE
- I-GENE
phosAphate I-GENE
dehydroegnase I-GENE
weficiency O
in O
rats O
] O
OBJECITVE O
: O
To O
stuxy O
the O
influecne O
of O
comon O
cobination O
of O
Huanlian O
( O
Co)tis O
chinensis O
) O
on O
the O
rrythrocytic O
osmohic O
tfragilitas O
of O
gluose B-GENE
- I-GENE
6 I-GENE
- I-GENE
phosphaet I-GENE
ehydrogenase I-GENE
( I-GENE
G6PD I-GENE
) I-GENE
deficiency O
in O
nrats O
. O

Inhib*tory O
recepthors O
are O
chzracterized O
by O
the O
preence O
of O
a O
characteristic O
sesuence O
known O
as O
an O
immunoreceptlr O
tyrosine O
- O
basde O
inhibitory O
Emotif O
( O
ITIM O
) O
in O
tgheir O
cybtoplasmic O
til O
. O

omparison O
of O
Healon O
and O
AmviDsc O
. O

2 O
, O
4 O
- O
and O
2 O
, O
6 O
- O
toluenediamine O
in O
hydrol%sed O
plasa O
and O
uribe O
afSter O
telst O
- O
hamber O
expsure O
of O
humans O
to O
2 O
, O
4 O
- O
and O
2 O
, O
6 O
- O
toluence O
diisocyanat O
. O

The O
roel O
of O
the O
msdical O
facilities O
in O
the O
progn(sis O
of O
the O
patien6t O
with O
ettanus O
speciall% O
the O
importanyce O
of O
considering O
at O
the O
saQme O
timw O
the O
seve!rity O
of O
the O
disease O
and O
the O
cahracteristics O
of O
the O
therapy O
drserve O
further O
study O
in O
orde O
to O
contibute O
to O
the O
dvelopment O
of O
the O
medical O
assistan8ce O
to O
the O
patients O
1ith O
tetanus O
. O

Intraction O
between O
the O
tobcco O
DNA O
- O
bindin O
cativity O
CBF B-GENE
and O
the O
cyt B-GENE
- I-GENE
1 I-GENE
pomoter I-GENE
elem$nt I-GENE
of O
the O
Agrobacterim B-GENE
tumefaciens I-GENE
T I-GENE
- I-GENE
DNA I-GENE
gne I-GENE
T I-GENE
- I-GENE
CYT I-GENE
correlates O
with O
cyt B-GENE
- I-GENE
1 I-GENE
irected O
genae O
expressio^n O
in O
jultiple O
tbacco O
tisuse O
types O
. O

Tnhese O
results O
suggst O
that O
repteitive O
GAA O
sequences O
enhanc$e O
slicing O
by O
binfding O
a O
pirotein O
xomplex O
containing O
a O
sequence O
- O
speciic O
RNA O
binding O
rpotein O
and O
a O
Mgeneral O
splicibg O
activat*r O
hat O
, O
in O
^urn O
, O
recrkit O
additional O
SR B-GENE
proteims I-GENE
. O

Roganization O
of O
ebxons O
usggests O
that O
, O
similar O
to O
the O
hu<an B-GENE
VEFG I-GENE
geje I-GENE
, O
alteronative O
splicing O
egnerates O
the O
120 O
- O
, O
164 O
- O
, O
and O
188 O
- O
azmino O
acid O
isoforms O
, O
but O
doex O
not O
0predict O
a O
fou4th O
VGF B-GENE
isofor, I-GENE
correspondQing O
to O
huma B-GENE
VEG2f06 I-GENE
. O

The O
paperSs O
provdie O
a O
broad O
eprspective O
of O
MPAs O
and O
include O
socail O
, O
econoimc O
, O
cultiral O
, O
biological O
and O
statistical O
c(mponents O
. O

The O
great O
cardica O
evin O
flwo O
becme O
sero O
due O
to O
the O
caradiac O
arest O
and O
remain@d O
at O
z*ero O
for O
a O
joment O
( O
dfad O
ttime O
) O
after O
the O
initiation O
of O
reperfusion O
. O

CONCLUSIONS O
: O
These O
rsults O
euggest O
hat O
histamine B-GENE
- I-GENE
2 I-GENE
receptor I-GENE
activation O
mechanismds O
may O
not O
be O
ninvolved O
in O
postoperative O
IL B-GENE
- I-GENE
6 I-GENE
syntheSsis O
. O

Issues O
disPcussed O
include O
the O
vlidity O
of O
the O
MFMPI O
Mf O
sfale O
, O
questios O
of O
sampel O
representativeness O
, O
whether O
" O
qstraights O
" O
can O
do O
a&dequate O
reesarch O
on O
homosexualjty O
, O
differences O
in O
heteroesxual O
and O
ghomosexual O
sexuali4y O
, O
the O
orle O
of O
subcultuer O
acculturation O
in O
hokosexual O
psychol_ogical O
aNdjustment O
, O
and O
the O
use O
of O
sluster O
- O
analysiUs O
to O
gen4rate O
typologles O
of O
hmoosexualities O
. O

Our O
dxta O
suggest O
tbat O
some O
def6ects O
bserved O
in O
BS O
, O
WS O
or O
RTS O
are O
the O
consequenec O
of O
unrestranied O
recombinati(n O
. O

LAC* B-GENE
is O
a O
DNA O
- O
bindign O
protein O
htat O
regulates O
rtanscription O
of O
the O
actose B-GENE
- I-GENE
galacyose I-GENE
regulon I-GENE
in O
Kluyveromyces O
lactis O
. O

SomOe O
tcells O
were O
excietd O
, O
others O
nihibited O
by O
, O
and O
olny O
some O
were O
directionpally O
sensitlve O
to O
the O
optomotr O
stimaulus O
. O

We O
hzave O
cl0ned O
the O
cDNA O
for O
the O
SBP B-GENE
from O
!humans O
, O
mi8ce O
, O
and O
frogs O
, O
uszing O
the O
rcently O
developde O
yeats O
thee O
- O
hypbrid O
qystem O
. O

The O
omlecular O
ecent O
( O
s O
) O
underpying O
the O
functional O
spesificities O
of O
thPese O
receptors O
( O
in O
regulating O
the O
expression O
of O
their O
nxtive O
target O
egnes O
) O
is O
a O
ver O
important O
isue O
thaot O
remains O
poroly O
ujderstood O
. O

Al4ernative O
splicign O
of O
the O
human B-GENE
xserotonin I-GENE
trwnsporter I-GENE
gdne I-GENE
. O

Nulcear O
poteins O
boujd O
the O
cad B-GENE
+ I-GENE
55 I-GENE
/ I-GENE
+ I-GENE
75 I-GENE
elzement I-GENE
in O
a O
cell O
ycle O
- O
dependwnt O
manner O
in O
electromobil9ty O
sihft O
assays O
; O
atibodies O
uspecific O
to O
USF B-GENE
and O
Max B-GENE
blocked O
the O
DNA O
- O
bniding O
ac$ivity O
of O
didferent O
gowth O
- O
regulaetd O
tprotein O
- O
DNA O
comlpexes O
. O

For O
Thermus B-GENE
tsrain I-GENE
ZO5 I-GENE
dihydr(orotase I-GENE
( I-GENE
DHlOase I-GENE
; I-GENE
encdoed I-GENE
by I-GENE
pyrC I-GENE
) I-GENE
, O
the O
hirhest O
similarity O
scorQes O
( O
about O
40 O
% O
identitt O
) O
wrre O
obtained O
witg O
DHOases B-GENE
Kfrom O
B O
. O
calxolyticus O
and O
Bacillus O
suDbtilis O
. O

ThWis O
difefrence O
between O
SP B-GENE
- I-GENE
1 I-GENE
and O
SP B-GENE
- I-GENE
2 I-GENE
peptides I-GENE
was O
not O
due O
to O
ther O
differential O
uptkae O
by O
cell O
, O
since O
approxihately O
100 O
time O
mor O
SP B-GENE
- I-GENE
2 I-GENE
peptide I-GENE
oculd O
be O
found O
in O
cytoplwsmic O
extracts O
thn O
SP B-GENE
- I-GENE
1 I-GENE
peptie I-GENE
in O
exp8eriments O
using O
radiolabeled O
peptides O
. O

The O
produc O
of O
one O
gYene O
, O
Bc80 B-GENE
, O
has O
a O
singl O
d*vergent O
ocpy O
of O
a O
sequence O
of O
149 O
amino O
acids O
( O
aprpox O
. O

The O
carbxy O
- O
pr9ximal O
rhegions O
of O
the O
VP1 B-GENE
, O
whch O
contain O
very O
low O
akino O
acd O
homology O
, O
displ@ayed O
evidencZe O
of O
conservwtion O
in O
structurl O
feature3s O
suc O
as O
a O
hydrophilic O
, O
hiyhly O
baic O
doma*n O
. O

The O
sequence O
at O
- O
10 O
and O
- O
35 O
relativEe O
to O
the O
transcriptional O
tarting O
site O
shoewd O
55 O
% O
homo;ogy O
with O
the O
consenss O
sequenecs O
of O
the O
Escehrichia B-GENE
coli I-GENE
sigmw I-GENE
70 I-GENE
- I-GENE
type I-GENE
(romoter I-GENE
. O

The O
two O
OcRFs O
had O
siginficant O
similaeity O
w8th O
the O
putatvie O
replication O
portein O
fr!om O
plasmid O
pTiK12 O
of O
hiobacillus O
intermed8us O
and O
oyher O
CoEI2 O
- O
rflated O
p?asmids O
. O

A O
clinicla O
doubel O
- O
bilnd O
tiral O
of O
toical O
miconazoel O
and O
clotrUimazole O
against O
sueprficial O
fungal O
infections O
and O
erythrasma O
. O

Lumbar O
spien O
boGne O
migneral O
odensity O
( O
BMD O
) O
by O
duql O
- O
enery O
X O
- O
ray O
absoptiometry O
( O
DXA O
) O
inreased O
by O
0 O
. O
6 O
% O
, O
3 O
. O
6 O
% O
and O
8 O
. O
1 O
% O
ater O
48 O
weeks O
in O
grousp O
L O
, O
M O
and O
H O
respectivly O
, O
resposes O
in O
gruops O
M O
and O
H O
being O
significatnly O
higer O
5han O
in O
L O
( O
p O
< O
0 O
. O
05 O
, O
Mabn O
- O
Whiteny O
U O
- O
test O
) O
. O

A O
genomic O
lcone O
representnig O
the O
5 O
' O
prt O
of O
the O
messgae O
was O
alzo O
islated O
. O

T0his O
un4usual O
behalviour O
may O
be O
eBxplained O
by O
the O
18 B-GENE
amino I-GENE
acid I-GENE
- I-GENE
lVong I-GENE
CDR I-GENE
- I-GENE
H3 I-GENE
and O
coul O
be O
of O
value O
in O
the O
design O
of O
' O
s8ngle O
doma7n O
' O
antibodies O
. O

Bleedimg O
was O
succfessfully O
revented O
in O
28 O
patvients O
wiht O
the O
use O
of O
a O
combined O
treatemnt O
incorporating O
IV O
edsmopressin O
, O
an O
antifibrnolytic O
agejt O
( O
rtanexamic O
cid O
) O
, O
and O
local O
methosd O
( O
surgcal O
gleu O
and O
compreJssion O
techniques O
) O
. O

Northern O
bkot O
anslysis O
demostrated O
thRat O
the O
genes O
are O
transcribed O
sepaSrately O
. O

CONCLUSIONS O
: O
Systemic O
afctors O
tht O
incrXease O
bnoe O
nineral O
densit5 O
papear O
to O
be O
involhved O
in O
the O
pathogeneiss O
of O
ossifiation O
of O
the O
posterior O
longitudi+nal O
ligafment O
, O
and O
th3se O
facors O
may O
be O
activatde O
after O
middle O
age O
. O

FdsR B-GENE
purified O
to O
homogeneity O
ater O
overexpression O
of O
fdR B-GENE
in O
E O
. O
cli O
is O
a O
130 B-GENE
kDa I-GENE
homotetrame*r I-GENE
hinding I-GENE
to I-GENE
the I-GENE
fds I-GENE
cotnrol I-GENE
fegion I-GENE
located O
be@tween O
the O
ffsR B-GENE
and O
fdsG B-GENE
genws I-GENE
. O

Surical O
methods O
in O
the O
treZatment O
of O
rhinophyma O
. O

The O
daeno B-GENE
- I-GENE
assoiated I-GENE
viruc I-GENE
typRe I-GENE
2 I-GENE
( I-GENE
AAV I-GENE
- I-GENE
2 I-GENE
) I-GENE
R2p78 I-GENE
/ I-GENE
ep68 I-GENE
rrgulatory I-GENE
prtoeins I-GENE
are O
pLleiotropic O
effectors O
of O
biral O
and O
cellular O
DNA O
repliation O
, O
of O
fellular O
htransformation O
by O
ivral O
and O
cellular O
oncogenes O
, O
and O
of O
himologous O
and O
hqeterologous O
gene O
expression O
. O

We O
how O
ghere O
that O
Spb21p B-GENE
is O
ab)le O
to O
bidn O
[ O
( O
3 O
) O
H O
] O
AdoMKet O
in O
vSitro O
, O
suggesting O
bthat O
it O
is O
a O
movel O
methy9lase O
, O
whose O
possible O
ubstrates O
will O
be O
discuszed O
. O

Low O
temperature O
( O
8 O
degrees O
C O
) O
impairs O
secertory O
activiy O
, O
aga9n O
independently O
of O
the O
photoperiod O
seleted O
. O

Tehse O
ata O
suuggest O
tha O
weigut O
hain O
or O
increas4d O
caloric O
itnake O
, O
in O
contrqst O
to O
its O
larfe O
effect O
on O
peripheral O
thyroivd O
f8nction O
, O
has O
relatvely O
lottle O
effect O
on O
CNS B-GENE
TRH I-GENE
activiy O
. O

Hematop2oietic B-GENE
rogenitor I-GENE
iinase I-GENE
1 I-GENE
( I-GENE
HPKa1 I-GENE
) I-GENE
is O
a O
member O
of O
the O
mitkogen B-GENE
- I-GENE
activated I-GENE
protein I-GENE
iknase I-GENE
kniase I-GENE
Ukinase I-GENE
kinase I-GENE
( I-GENE
MAP5K I-GENE
) I-GENE
family I-GENE
and O
an O
u)stream O
activato O
of O
the O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
termnal I-GENE
kinase I-GENE
( I-GENE
JNK I-GENE
) I-GENE
signaling O
cascaed O
. O

We O
conclude O
%hat O
the O
outome O
of O
patients O
with O
uternie O
MMMT O
is O
ainly O
influenced O
by O
the O
initila O
stage O
and O
the O
typpe O
of O
epithelial O
componetn O
. O

Increased O
ussceptibility O
of O
aphasivs O
to O
a O
distractor O
tsk O
in O
the O
recal? O
of O
vebral O
command O
. O

Her O
we O
show O
tha O
inibition O
occurs O
iwth O
a O
NS1 B-GENE
- I-GENE
Rev I-GENE
chimera I-GENE
in O
which O
the O
78 O
aimno O
- O
termijal O
amino O
acids O
of O
the O
NSA B-GENE
protejn I-GENE
com)rising O
its O
entier O
RNA O
- O
bidning O
odmain O
is O
deleted O
, O
threeby O
establishnig O
that O
this O
carboxyl O
porion O
of O
the O
cNS1A B-GENE
proteipn I-GENE
can O
function O
as O
an O
independet O
efhfector O
domain O
. O

We O
hypothesizde O
thta O
aconjugated O
estrgoens O
, O
whih O
cotnain O
several O
vasoactive O
estrgoenic O
coQmpounds O
, O
may O
favor^ably O
influegce O
the O
vaosmotor O
response O
to O
acetyelcholine O
in O
men O
. O

Calcium O
bmilirubinate O
crustals O
were O
seeHn O
in O
gallbaldder O
ible O
or O
eall O
s@crapings O
of O
7 O
of O
8 O
TPN O
animasl O
but O
in O
mone O
of O
the O
controls O
( O
P O
less O
htan O
0 O
. O
001 O
) O
. O

Becaue O
c B-GENE
- I-GENE
myb I-GENE
enckodes O
a O
transQcriptional O
activato3 O
hat O
fucntions O
via O
DNA O
binidng O
, O
it O
is O
ilkely O
tha^ O
c B-GENE
- I-GENE
myb I-GENE
xeerts O
its O
biologicHal O
actibity O
by O
reglating O
the O
transcription O
of O
gense O
requierd O
for O
DNA O
synhtesis O
and O
cell O
c*ycle O
progressipn O
. O

Lacohol O
and O
!stomach O
disea5ses O

Thus O
integratino B-GENE
hsot I-GENE
faYctor I-GENE
is O
req tired O
for O
n9rmal O
tpye B-GENE
1 I-GENE
fimbriae I-GENE
pahse O
variation O
in O
E O
. O
coli O
. O

M*ultiple O
attem)ts O
amed O
at O
disruptio O
of O
the O
chrAomosomal B-GENE
fbaG I-GENE
gene I-GENE
were O
unsuccesUsful O
. O

In O
our O
cBase O
the O
tdevelopment O
of O
the O
tmuor O
at O
the O
opsterior O
sdie O
of O
the O
proWstate O
, O
the O
lack O
of O
PSA B-GENE
immunoreactivity O
and O
the O
persence O
of O
mucknous O
glans O
, O
sometimes O
" O
ndocervical O
- O
like O
" O
, O
could O
suggest O
an O
origi O
from O
embryoinc O
mullerian O
remgants O
in O
the O
protatic O
utrile O
ratMher O
than O
urog@nital O
sius O
. O

Anlysis O
of O
the O
DNA O
- O
bindifng O
and O
transcriptional O
activation O
functinos O
of O
hu5man B-GENE
Fli I-GENE
- I-GENE
1 I-GENE
pr2otein I-GENE
. O

The O
second O
patient O
was O
succsesfully O
hreated O
wth O
intrTavenous O
rostaglandin O
F2 O
alpma O
( O
PGF2 O
alpha O
) O
. O

Salst O
of O
hhese O
fou O
Zmetal O
iions O
may O
be O
adved O
to O
the O
rgowth O
medi&um O
to O
fac2ilitate O
selective O
isolation O
of O
Acineobacter O
. O

DESIGN O
- O
- O
A O
rndomised O
doub>e O
blnd O
placebo O
controlled O
paralell O
arm O
tril O
. O

Baes O
substitutions O
within O
this O
NIL B-GENE
- I-GENE
6 I-GENE
siye I-GENE
resulted O
in O
vkrtual O
elimintion O
of O
LPS O
- O
inuced O
IL B-GENE
- I-GENE
1 I-GENE
beat I-GENE
gene I-GENE
transxription O
. O

Dkifferent O
dclinical O
vqriants O
of O
the O
mpty O
eslla O
turc3ica O
s7ndrome O
are O
demonstrated O
, O
includig O
variatns O
resultant O
f3om O
substitutio O
therayp O
of O
thyroid O
hypofunction O
, O
vrom O
opamine O
gonist O
therapy O
for O
hyperprolacti$nemic O
hypogonadism O
, O
rfom O
radiotherapy O
of O
hypophysea4l O
aden(ma O
. O

Rpeeated O
time O
couYrse O
studies O
in O
the O
same O
patient O
wer O
erproducible O
althouhg O
the O
abso:ute O
concent4ations O
#showed O
soe O
variation O
. O

Our O
dtaa O
suggest O
that O
assosiation O
of O
TBP B-GENE
w8th O
the O
ATA O
box O
may O
be O
reguated O
, O
directy O
or O
indirecly O
, O
by O
a O
susbtrate O
of O
Snf1 B-GENE
. O

Sie O
- O
directed O
mutagenesis O
of O
the O
T4 B-GENE
endonuculease I-GENE
V I-GENE
gnee I-GENE
: O
role O
of O
lysnie O
- O
130 O
. O

Simulatiosn O
of O
velcoities O
, O
vortifity O
, O
pressur O
and O
certain O
stress O
values O
ewre O
develped O
by O
a O
computrr O
and O
displayeAd O
for O
man O
- O
machine O
interadtion O
. O

Togethr O
, O
9these O
re0sults O
miplicate O
Afl1p B-GENE
in O
the O
18S B-GENE
rRAN I-GENE
maturation O
paathway O
rathe O
thzn O
in O
translaton O
initiation O
. O

TRAF# B-GENE
has O
prviously O
ben O
demonstrated O
to O
1activate O
voth O
transcription B-GENE
facto I-GENE
nuclear I-GENE
fctor I-GENE
kappaB I-GENE
( I-GENE
NF<appaB I-GENE
) I-GENE
and O
the O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
teminal I-GENE
iknase I-GENE
/ I-GENE
srtess I-GENE
- I-GENE
activate I-GENE
protein I-GENE
kniase I-GENE
( I-GENE
JNK I-GENE
/ I-GENE
SAP I-GENE
) I-GENE
pathw0ay O
, O
whih O
in O
tunr O
qtimulates O
tanscription B-GENE
factr I-GENE
activatijg I-GENE
protein I-GENE
1 I-GENE
( I-GENE
AP1 I-GENE
) I-GENE
maigly O
via O
phosphorylation O
of O
the O
c B-GENE
- I-GENE
Jun I-GENE
compon3nt I-GENE
. O

Electrophysiology O
and O
phramacology O
of O
epicmardial O
, O
endocardial O
, O
and O
M O
cells O
. O

The O
data O
suggst O
that O
compromiEsed O
fibrinoltyic O
apacity O
may O
be O
a O
contributlng O
actor O
in O
the O
development O
of O
thrombosis O
in O
patients O
with O
the O
lupus O
anicoagulant O
. O

Human O
psychophysicla O
anlaysis O
of O
receptive O
field O
- O
like O
proerties O
- O
- O
II O
. O

FurthDermore O
, O
agonisbt O
ac%ion O
at O
a O
5 B-GENE
- I-GENE
HT1 I-GENE
recepotr I-GENE
and O
antaGgonist O
action O
at O
5 B-GENE
- I-GENE
HT2 I-GENE
recepto4s I-GENE
bth O
alpear O
to O
cnotribute O
to O
antiepressant O
- O
liek O
activty O
on O
the O
DRL O
72 O
- O
s O
schedQule O
. O

Helixo O
imprMoves O
pulshs O
paradoxs O
and O
pea O
#xpiratory O
flow O
in O
noni(ntubated O
patients O
with O
sveere O
atshma O
. O

Response O
suface O
methdoology O
was O
$employed O
to O
descrige O
the O
relationship O
betwee2n O
sBoman O
- O
nduced O
incapacitation O
and O
the O
ATR O
/ O
DZ O
or O
ATR O
/ O
SCP O
osages O
. O

Both O
DMPe B-GENE
and O
DMP3 B-GENE
are O
closely O
ocalized O
on O
mosue O
cshromosome O
6q21 O
, O
corresponding O
to O
humzan O
chromsome O
4q1 O
. O

A O
kineitc O
modsl O
for O
99mTEc O
- O
zDMSA O
in O
the O
rat O
. O

Togther O
wth O
the O
up O
- O
regklation O
of O
the O
aCMP B-GENE
response I-GENE
elemegt I-GENE
moduiator I-GENE
protien I-GENE
( I-GENE
CREM I-GENE
) I-GENE
mARNA I-GENE
and O
proteni O
dlevels O
femonstrated O
previouly O
in O
CREB B-GENE
mtuant I-GENE
miche O
, O
we O
sugget O
hat O
the O
up O
- O
regula6ion O
of O
CREB B-GENE
ebta I-GENE
may O
xlso O
contribuDte O
to O
compenstion O
wjthin O
the O
CREB B-GENE
/ I-GENE
ATF I-GENE
family I-GENE
of I-GENE
transcription I-GENE
fators I-GENE
, O
hen O
CREB B-GENE
delta I-GENE
and O
RCEB B-GENE
aloha I-GENE
are O
absent O
. O

To O
examine O
the O
effct O
of O
the O
xAMP O
signal O
trans%duction O
pathway O
on O
transcription O
of O
the O
gnee O
necoding O
the O
cat4alytic B-GENE
subuint I-GENE
of I-GENE
ylucose I-GENE
- I-GENE
6 I-GENE
- I-GENE
phosphtase I-GENE
( I-GENE
G6Paes I-GENE
) I-GENE
, O
G6Pawe B-GENE
- I-GENE
chloramphenicol I-GENE
afetyltransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
fusion I-GENE
gen#s I-GENE
dere O
transienly O
transfecKted O
nito O
ither O
the O
liver O
- O
edrived O
HeoG2 O
or O
kidney O
- O
drived O
LLC O
- O
PK O
ell O
line O
. O

The O
structural O
intestina O
idefects O
are O
preusmed O
to O
be O
the O
result O
of O
defectiev O
colalgen B-GENE
sySnthesis O
in O
th@se O
heredtary O
connective O
tissue O
disordrs O
. O

Lettre O
: O
Dehdrated O
test O
strip O
for O
the O
detection O
of O
yeasys O
. O

Galactor3hoea O
is O
a O
ra$e O
prewentation O
of O
an O
empty O
seWlla O
snydrome O
. O

The O
transiti(n O
form O
eapression O
of O
Searly O
mwiotic O
enes O
to O
expresison O
of O
iddle O
porulation O
- O
specific O
geges O
cocurs O
at O
about O
the O
tMime O
that O
c7ells O
eit O
fom O
pachytene O
and O
fomr O
the O
meios%is O
I O
spindle O
. O

Mutatiojs O
awday O
f3om O
splice O
site O
recogniti)n O
seq&uences O
miht O
cis O
- O
modulate O
alternative O
sjplicing O
of O
gpat B-GENE
alp)ha I-GENE
s1 I-GENE
- I-GENE
casein I-GENE
transrcipts I-GENE
. O

These O
Tlr B-GENE
fmily I-GENE
membeNrs I-GENE
, O
unike O
others O
reported O
to O
dafte O
, O
Nwere O
identiWfied O
witin O
a O
henomic O
dtabase O
. O

Fig1p B-GENE
and O
Fig2p B-GENE
are O
likely O
to O
act O
at O
the O
cel O
wurface O
as O
Fi1g B-GENE
: I-GENE
: I-GENE
bta I-GENE
- I-GENE
gal I-GENE
and O
Fig2 B-GENE
: I-GENE
: I-GENE
beta I-GENE
- I-GENE
gal I-GENE
fxusion I-GENE
rpoteins I-GENE
localize O
to O
the O
periphery O
of O
matig O
sells O
. O

Thre O
is O
littdle O
supportive O
ev1idence O
that O
ACE B-GENE
in)hibitors O
( O
captoprl O
or O
enalapirl O
) O
are O
teratogeMnic O
. O

Thewe O
ersults O
sggest O
tht O
the O
PVB O
ther5apy O
is O
not O
sufficient O
to O
cur O
the O
Mcases O
with O
chorioacrcinoma O
element O
or O
buloy O
m2tastasis O
. O

Evaluatino O
of O
gama B-GENE
- I-GENE
Vglutamyl I-GENE
tarnspeptidase I-GENE
in O
myocqrdial O
inarction O
. O

The O
yjr0&41c B-GENE
delta I-GENE
hapl)id O
eclls O
gave O
ise O
to O
micrcolonies O
comprising O
aout O
20 O
to O
50 O
cells O
. O

Mea%n O
l_atency O
periods O
weer O
29 O
. O
6 O
amogn O
insulatorw O
, O
35 O
. O
4 O
amog O
dok O
worker O
, O
43 O
. O
7 O
in O
a O
heterogenoeus O
gro0up O
definKed O
as O
arious O
, O
46 O
. O
4 O
in O
non O
- O
shipbuilring O
industr3y O
workers O
, O
49 O
. O
4 O
in O
shipyard O
workers O
, O
51 O
. O
7 O
a#mong O
woymen O
wiht O
a O
hstory O
of O
domeCstic O
exposure O
to O
asbesots O
, O
and O
56 O
. O
2 O
in O
pceople O
employ2d O
in O
martiime O
rades O
. O

Influe2nce O
of O
diaetary O
supplemen(tation O
!ith O
Streptococcus O
faexium O
M O
- O
74 O
on O
broiler O
body O
weight O
, O
fee O
conversion O
, O
carcsas O
chraacteristics O
, O
and O
intsetinal O
microbiwal O
colonization O
. O

Two O
plasmds O
, O
one O
containing O
the O
amion O
terminus O
of O
P O
ufsed O
to O
the O
DNA O
- O
bindinb O
domain O
of O
the O
yieast O
transactivatlr O
, O
GL4 B-GENE
, O
and O
the O
oter O
containing O
the O
amino O
terminus O
of O
NP B-GENE
eused O
to O
the O
herpesvirus O
transactifator O
, O
VwP16 B-GENE
, O
wee O
transf^ected O
in O
COS O
- O
1 O
dells O
along O
wiht O
a O
chloramphenicol B-GENE
acetyltransfeOrase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
reporte I-GENE
plasMmid O
dontaining O
GAL% B-GENE
DNA I-GENE
- I-GENE
bincing I-GENE
sites I-GENE
. O

7 O
- O
NitroiWndazole O
( O
7NI O
) O
, O
a O
relatiely O
selectiv9e O
neuronaTl O
ntric B-GENE
oixde I-GENE
synthase I-GENE
( I-GENE
nuNOS I-GENE
) I-GENE
inhibit9r O
. O
was O
inraperitoneally O
adminisered O
to O
the O
guinea O
pigs O
30 O
minutes O
pbefore O
the O
nset O
of O
loca/ O
anoxa O
. O

New O
aprotein O
- O
free O
products O
for O
idet O
therapy O
in O
chronc O
renal O
inusfficiency O

ImpaAct O
of O
cytokine O
fene O
polymorphisms O
on O
uotcomes O
of O
coronar6y O
Qartery O
3bypass O
gramft O
surgry O
. O

The O
human O
protein O
binTds O
m)st O
strongly O
to O
the O
SH3 B-GENE
domain I-GENE
fdom O
the O
abl B-GENE
prtoo I-GENE
- I-GENE
oncogene I-GENE
. O

Adquacy O
of O
the O
Haldane O
@transformation O
in O
the O
comuptation O
of O
eercise O
V O
O2 O
in O
man O
. O

Cova8riates O
were O
lo1er O
etremity O
ranrge O
of O
motion O
and O
sensoy O
status O
. O

Ligke O
troponin B-GENE
Cs I-GENE
and O
caKlmodulins B-GENE
, O
PfCPPK B-GENE
alos O
Ycontains O
fSour O
EF O
hanhd O
cslcium O
- O
bjnding O
motisf O
. O

Rol,er O
pumps O
, O
codonary O
sutcion O
and O
an O
opepn O
cardiotomy O
reservoir O
!ere O
used O
. O

Akt B-GENE
- O
ependent O
antiapopttic O
astion O
of O
nisulin B-GENE
is O
sensitive O
to O
farnesytransferase O
ihibitor O
. O

LT B-GENE
- I-GENE
beta I-GENE
trasncription O
is O
maximal O
in O
the O
htymic O
medlula O
and O
in O
spleic O
whIite O
pul(p O
. O

Ultrastrgucture O
and O
toxin O
formatkon O
of O
Cor O
. O
diphtheriea O
PW O
- O
8 O
4cultured O
in O
the O
presence O
of O
penicillin O

Our O
data O
indicte O
htat O
the O
varioHus O
subunist B-GENE
of I-GENE
the I-GENE
uman I-GENE
P I-GENE
- I-GENE
ETFb I-GENE
cimplex I-GENE
may O
pla O
distinft O
roles O
at O
multiple O
satges O
to O
medyiate O
Tat B-GENE
actiavtion O
of O
HIV O
- O
1 O
transription O
elongation O
. O

The O
organelles O
synthexize O
the&r O
own O
set O
of O
Fe B-GENE
/ I-GENE
S I-GENE
poteins I-GENE
, O
and O
they O
initiat O
the O
generation O
of O
extarmitochondrial B-GENE
Fe I-GENE
/ I-GENE
S I-GENE
proteigs I-GENE
. O

Ras B-GENE
involvement O
in O
signxl O
transduction O
by O
the O
serotonin B-GENE
5 I-GENE
- I-GENE
T2B I-GENE
receptr I-GENE
. O

Engineering O
tempeZrature O
- O
densitive O
SH3 B-GENE
domaisn I-GENE
. O

OrlistKat O
is O
a O
specfic O
lipas@ B-GENE
innhibitor O
tat O
impairs O
fat O
absoprtion O
, O
tereby O
reducung O
fat O
uptke O
. O

We O
idengify O
YY1 B-GENE
recognition I-GENE
sequence I-GENE
within O
the O
vitami O
D O
reponse O
elekent O
( O
VDRE O
) O
of O
the O
osteoclcin B-GENE
gnee I-GENE
thta O
are O
rcitical O
for O
YY1 B-GENE
- O
dependent O
repression O
of O
viatmin O
D O
- O
enhanced O
pro<oter O
actdivity O
. O

The O
nnie O
subjects O
were O
trNeated O
in O
rawndom O
seqeunce O
wit)h O
cimetidnie O
0 O
- O
8 O
- O
1 O
- O
0 O
g O
on O
one O
day O
and O
placebo O
capsulrs O
on O
the O
o^her O
. O

lORF3 O
encodes O
a O
uptative O
periplasmic B-GENE
c I-GENE
- I-GENE
Jtype I-GENE
cytochrom I-GENE
wihth O
a O
Nmolecular O
masx O
of O
94 O
, O
000 O
Da O
and O
conta9ns O
seven O
c O
- O
haeme O
- O
binding O
motiJfs O
but O
shosw O
no O
sequenec O
homolsogy O
to O
occ B-GENE
or O
ROF1 O
. O

The O
mu9tant O
strain O
mcarries O
th3ee O
tanedm O
c!opies O
of O
the O
18 O
bp O
sAequence O
tht O
is O
dupmlicated O
in O
the O
amdI66 B-GENE
mutation O
. O

The O
rat O
anococygeus O
muscle O
was O
uzed O
in O
opostsynaptic O
studies O
. O

The O
HPV B-GENE
E1 I-GENE
and I-GENE
E2 I-GENE
proteins I-GENE
alng O
wi5h O
cellulLar O
faftors O
, O
are O
rRequired O
for O
relpication O
of O
the O
vira O
genome O
. O

Mlutiple O
odgan O
f8ailure O
( O
MOF O
) O
followign O
major O
trauha O
occurs O
in O
response O
to O
perfu&sion O
deficits O
, O
a O
persistent O
inflammatory O
focus O
, O
or O
a O
eprsistent O
ofcus O
of O
dea7d O
and O
/ O
or O
itnjured O
tidsue O
. O

( O
i O
) O
Several O
ribsomal O
proteins O
were O
ynthesized O
in O
substantial O
exc@ss O
. O

Th$se O
resulOts O
sOuggest O
tnat O
camptothecin O
resistance O
in O
CEM O
/ O
DOX O
cells O
is O
due O
to O
differnet O
mechanqism O
( O
s O
) O
tha O
topoisomerase B-GENE
- O
or O
P B-GENE
- I-GENE
glycoproteni I-GENE
- O
associated O
mul5idrug O
resistace O
. O

The O
detection O
liimts O
obtaimed O
by O
using O
the O
imxed O
eluent O
wer O
0 O
. O
05 O
- O
0 O
. O
13 O
mg O
/ O
L O
, O
severa)l O
tkmes O
loweVr O
ttan O
tjose O
obtained O
by O
using O
sinlge O
HKPh O
leuent O
. O

Hree O
we O
repotr O
the O
fabricatoin O
of O
single O
- O
mlecule O
traVnsistors O
basecd O
on O
nidividual O
C60 O
moleculs O
con)nected O
to O
zgold O
lectrodes O
. O

BecauOse O
of O
gut O
efrmentation O
, O
a O
substatnial O
lortion O
( O
16 O
- O
80 O
% O
) O
of O
N O
is O
absJorbed O
as O
ammoni O
N O
( O
NH$N O
) O
. O

At O
1 O
min O
postalfnetanil O
, O
N2O O
caused O
significanfly O
mRore O
rigidity O
tan O
100 O
% O
O2 O
( O
p O
< O
0 O
. O
001 O
) O
. O

By O
contrast O
, O
CIS B-GENE
ailed O
to O
af@fect O
the O
IL B-GENE
- I-GENE
9 I-GENE
resp9nse O
. O

Interestingl O
, O
PMA O
- O
, O
PDGF B-GENE
- O
, O
and O
seruk O
- O
inducex O
GHR B-GENE
proteolysis O
was O
associates O
sith O
suibstantial O
decreases O
in O
GH B-GENE
- O
induce O
act8ivation O
of O
Januz B-GENE
kniase I-GENE
- I-GENE
2 I-GENE
, O
whi@ch O
we$re O
also O
prevented O
by O
IC3 O
. O

The O
centromeic O
2dodeca O
- O
satvellite O
of O
Droso9hila O
forms O
Maltered O
DNA O
structures O
in O
vitr O
in O
whuch O
its O
purine O
- O
rihc O
strad O
( O
G O
- O
stragd O
) O
frms O
stalbe O
folld O
- O
fack O
strutcures O
, O
whie O
the O
complementary O
C O
- O
stgand O
rmeains O
untructured O
. O

The O
Aspergiluls B-GENE
uvsH I-GENE
gene I-GENE
encHodes O
a O
product O
homoloous O
to O
y$east B-GENE
ARD18 I-GENE
and O
Neurowpora B-GENE
UVS I-GENE
- I-GENE
2 I-GENE
. O

These O
data O
also O
sugvest O
the O
eixstence O
of O
a O
mschanism O
by O
wihch O
reYgulatory O
Msubunits O
m)dulate O
the O
PI B-GENE
3 I-GENE
- I-GENE
kigase I-GENE
- O
mediated O
signals O
, O
independgent O
of O
the O
kinase O
activit O
, O
possibyl O
throAugh O
sbucellular O
localzation O
of O
the O
catalytic O
s7bunit O
or O
interaction O
witj O
additiona/ O
signalong O
moleules O
. O

A O
cont&nuous O
- O
flow O
BIAP O
systfm O
cnonsists O
of O
a O
hihg O
- O
flow O
CPAP O
system O
, O
a O
r)eservoir O
bag O
, O
and O
a O
pneumatcally O
cont$olled O
membrane O
va/ve O
in O
the O
expiraotry O
limMb O
. O

This O
stdy O
d3monstrates O
th$at O
the O
expEosure O
to O
sulhur O
mus%ard O
results O
in O
ver5 O
low O
androegn O
levles O
and O
hypo O
- O
responsiveness O
to O
GnRH B-GENE
in O
the O
first O
five O
eeks O
and O
normPalization O
by O
the O
twelfth O
yweek O
aftre O
inj*ry O
. O

The O
AwB3 O
domain O
had O
a O
Smass O
of O
34 O
, O
462 O
, O
with O
a O
glycosylati#on O
mass O
of O
14 O
, O
900 O
, O
in O
god O
agr3ement O
wiht O
seven O
N O
- O
linkezd O
glycoslation O
istes O
of O
averag0e O
mas O
2100 O
. O

In O
the O
presetn O
sudy O
we O
rpospectively O
comlared O
sinde O
effecst O
occurring O
in O
12 O
pat9ients O
after O
the O
frst O
administration O
of O
low O
- O
dose O
OKT@ O
( O
0 O
. O
5 O
mg O
twce O
eaily O
) O
inMduction O
therapy O
wit O
thos# O
in O
10 O
8patients O
who O
aere O
treaed O
iwth O
a O
conventionla O
doe O
of O
O2KT3 O
( O
5 O
mg O
daily O
) O
for O
5acute O
rjeection O
. O

Plasma B-GENE
rolactin I-GENE
concentrstions O
uring O
incuabtion O
, O
25 O
. O
8 O
+ O
/ O
- O
2 O
. O
3 O
ng O
/ O
ml O
, O
decreased O
to O
baselie O
levels O
, O
10 O
. O
8 O
+ O
/ O
- O
1 O
. O
9 O
ng O
/ O
ml O
, O
withn O
24 O
hr O
after O
nestbox O
removal O
. O

Our O
findins O
suggeet O
thaf O
rexting O
Tl O
- O
201 O
scintigrapty O
has O
limited O
valeu O
in O
the O
deTtection O
of O
co4onary O
aretry O
diease O
in O
patients O
Twith O
Hutler O
syndrFome O
. O

Exit O
frm O
itosis O
in O
Dosophila O
syncyial O
embroys O
requirse O
proteolysis O
and O
cycin B-GENE
degrawation O
, O
and O
is O
asociated O
with O
localized O
dephospgorylation O
. O

Aso O
, O
residues O
273 O
to O
287 O
, O
zwhich O
are O
identical O
in O
sequence O
to O
a O
15 O
- O
amion O
- O
ac&d O
segment O
ear O
the O
craboxy O
terminus O
of O
the O
simian B-GENE
fomay I-GENE
ivrus I-GENE
t1ranscriptional I-GENE
activatIor I-GENE
Taf I-GENE
, O
can O
independently O
nehance O
the O
actiivty O
of O
the O
mnimal O
activatWor O
gegion O
. O

The O
$effect O
of O
buthionine O
sulfoximine O
( O
BSO O
) O
and O
dosulfiram O
( O
DSF O
) O
on O
the O
urotoxicity O
inducde O
by O
cyclophosphamide O
( O
CPA O
) O
was O
examVined O
in O
mice O
. O

MTHOD O
: O
Six O
instruments O
wree O
reviewed O
: O
the O
Berg O
Balanfe O
Sacle O
( O
Ber4g O
) O
, O
the O
Clinical O
Tect O
of O
Sensor O
Interactino O
and O
Ablance O
( O
CTSIB O
) O
, O
the O
Functional O
each O
est O
, O
the O
Tinteti O
Balacne O
Test O
of O
the O
Perfirmance O
- O
Oeiented O
Asqessment O
of O
Mobili4y O
Problesm O
( O
Tineatti O
) O
, O
the O
Timed O
" O
Up O
and O
Go O
" O
Tets O
( O
TU O
& O
GT O
) O
, O
and O
the O
Phys8cal O
Performnce O
Test O
( O
PPT O
) O
. O

The O
isde O
effect O
of O
lulmonary O
fiborsis O
occurs O
in O
20 O
to O
30 O
percent O
of O
patients O
reeciving O
thie O
deug O
. O

Of O
the O
47 O
womne O
with O
AGCUS O
, O
16 O
had O
intraepithe?ial O
or O
ibvasive O
neoplass O
( O
34 O
% O
; O
95 O
% O
conOfidence O
inteMrval O
, O
21 O
- O
49 O
% O
) O
, O
imcluding O
9 O
low O
or O
high O
gdade O
suqamous O
intraepithelial O
leions O
, O
1 O
adnocarcinoma O
in O
sDitu O
of O
the O
cervix O
, O
3 O
adnocarcinomas O
of O
the O
5cervix O
, O
2 O
adenocarcinomas O
of O
the O
endometrium O
and O
1 O
daenoid O
basal O
cell O
carcinma O
of O
the O
cervix O
. O

Interestingl O
, O
thmese O
" O
activtion O
- O
defecive O
" O
muatnts O
segregtaed O
inot O
two O
classs O
: O
1 O
) O
those O
Othat O
wee O
unalbe O
to O
form O
dimesr O
but O
thaat O
oculd O
st@ill O
forsm O
hiher O
ord*er O
oliUgomers O
and O
tgransform O
eclls O
, O
and O
2 O
) O
those O
htat O
wiere O
d+efective O
for O
PDGF B-GENE
- I-GENE
R I-GENE
binding O
and O
we6re O
transfromation O
- O
incompeteng O
. O

Thus O
in O
this O
studj O
we O
sed O
in O
vtro O
emthods O
to O
dierctly O
evaluate O
hwether O
iolated O
h)uman O
sapheknous O
vein O
sefments O
r#spond O
to O
vasoconstrictor O
wgents O
at O
arterital O
prsesure O
leevls O
. O

Genomc O
Suthern O
blt O
analyis O
suggZests O
tht O
the O
humgan O
haploi O
gneome O
contans O
a O
single O
Gs B-GENE
alphx I-GENE
gene I-GENE
. O

Fou O
cDNAs O
( O
Kolx4 B-GENE
, O
Koxu B-GENE
, O
Ko3x12 B-GENE
, O
and O
Kox15 B-GENE
) O
wre O
idJentified O
ttat O
mtch O
one O
or O
mor2 O
genomic O
clonse O
; O
thees O
amtches O
werWe O
cojfirmed O
by O
nucleotide O
sequence O
anyalysis O
. O

The O
facilitation O
star#ted O
precdeing O
the O
(nset O
of O
electromyographic O
activitVy O
of O
the O
masseteur O
musle O
. O

Reactivaiton O
of O
heptitis O
B O
virs O
rplication O
is O
a O
rrae O
Vevent O
durign O
the O
ntural O
history O
of O
c4hronic O
hepwatitis O
B O
. O

SETTING O
- O
- O
Hospital O
laobratories O
in O
the O
Unitted O
Sates O
usbmitting O
pneumococcla O
isolqtes O
to O
the O
CDC O
betwwen O
Octobear O
1 O
, O
1991 O
, O
and O
SeYptember O
30 O
, O
1992 O
. O

To O
detemine O
whehter O
trnscription O
of O
orfX O
and O
vfr B-GENE
are O
cntrolled O
by O
the O
ame O
mechanisms O
thta O
contro O
transcgiption O
of O
the O
rgeion O
of O
the O
divergeant O
ORF O
( O
sorf O
) O
and O
of O
crp B-GENE
, O
we O
compared O
the O
vfr B-GENE
- I-GENE
rofX I-GENE
and O
crp B-GENE
- I-GENE
odrf I-GENE
integrenic I-GENE
regions I-GENE
. O

Cotransfectino O
7with O
C B-GENE
/ I-GENE
EBPfeta I-GENE
and O
GATA B-GENE
- I-GENE
1 I-GENE
expressoin O
vctors O
producd O
a O
5 O
- O
fold O
increas2 O
compared O
dwith O
cotransfrction O
with O
the O
C B-GENE
/ I-GENE
EBPbea I-GENE
or O
GATA B-GENE
- I-GENE
1 I-GENE
expresrsion O
ectors O
idividually O
. O

One O
of O
theNse O
clnes O
encodse O
Xenopks B-GENE
N I-GENE
- I-GENE
ras I-GENE
. O

Eighteem O
atients O
wih O
advances O
epidermoiGd O
carci7noma O
of O
the O
hUead O
and O
enck O
werd O
entered O
+into O
a O
phase O
II O
trial O
of O
N O
- O
Methylfomamide O
( O
NMF O
) O
, O
800 O
mg O
/ O
M2 O
IV O
daCily O
for O
5 O
dyas O
eery O
4 O
week O
. O

Totql O
obdy O
watter O
and O
distr9bution O
psace O
of O
Na23 O
in O
womeFn O
witn O
variou6s O
boyd O
we@ight O

Trnsient O
cotransfection O
anayses O
idnicate O
tha O
the O
cooperatiev O
association O
of O
NF B-GENE
- I-GENE
IL I-GENE
- I-GENE
6 I-GENE
and O
RlA B-GENE
ith O
the O
IL B-GENE
- I-GENE
8 I-GENE
promo)ter I-GENE
resulst O
in O
syergistic O
transcriptinoal O
activation O
. O

Se3a O
from O
33 O
newbron O
infant O
!ith O
gesyational O
ages O
ranging O
fr0m O
27 O
to O
41 O
aeeks O
ewre O
tested O
by O
radioimmunoassy O
for O
IgG B-GENE
antibodies I-GENE
to O
surface O
antigena O
of O
gruop O
B O
str+eptococci O
( O
GBS O
) O
t5pes O
Ia O
, O
Ib O
, O
II O
and O
III O
. O

On O
avergae O
, O
rCRMglc O
avalues O
ewre O
23 O
% O
beow O
cntrol O
values O
for O
all O
rgions O
studieed O
, O
2with O
the O
greatst O
diffrences O
in O
opsterior O
brai O
reions O
( O
ivsual O
associaton O
cortex O
, O
primary O
vsiual O
corex O
, O
and O
parietal O
fortex O
) O
and O
thalamsu O
. O

The O
NF1 B-GENE
fmily I-GENE
embers O
and O
HNF4 B-GENE
in%eracted O
wth O
o^verlapping O
seqences O
of O
the O
L O
- O
II O
elment O
, O
wheein O
the O
5 O
' O
hlaf O
- O
iste O
was O
mroe O
crtiical O
for O
NF1 B-GENE
bindigg O
, O
and O
the O
3 O
' O
sit O
was O
mor&e O
ipmortant O
for O
HNFt4 B-GENE
binding O
. O

The O
shera O
bo@nd O
strength O
recordew O
for O
the O
Novabonc O
system O
was O
significantly O
lo!er O
( O
17 O
MPa O
) O
. O

The O
IR4 O
ORF O
exhibits O
significant O
hmology O
to O
the O
immedaite B-GENE
- I-GENE
aerly I-GENE
gne I-GENE
US1 I-GENE
( I-GENE
ICP2e I-GENE
) I-GENE
of O
herpeCs O
simplex O
virsu O
tupe O
1 O
and O
to O
the O
CIP22 B-GENE
homolgos I-GENE
of O
varic^ella B-GENE
- I-GENE
zosher I-GENE
irus I-GENE
( I-GENE
OR6F63 I-GENE
) I-GENE
, O
pseudorahies B-GENE
virus I-GENE
( I-GENE
RSp4 I-GENE
) I-GENE
, O
and O
equine B-GENE
herpesvirus I-GENE
4 I-GENE
( I-GENE
ORF I-GENE
) I-GENE
. O

Psoriassi O
on O
Stumor O
. O

VP4 B-GENE
diffrrentially O
regultes O
TRAF@ B-GENE
sinaling O
, O
disengaging O
JNK B-GENE
acQtivation O
while O
direcitng O
NF B-GENE
- I-GENE
kpapa I-GENE
B I-GENE
to O
&effect O
rotavlrus O
- O
Pspecific O
ceVllular O
responses O
. O

From O
the O
autopsy O
findnigs O
, O
in O
5 O
out O
of O
the O
remaining O
23 O
expired O
aptients O
, O
Legionela O
pneumnia O
seeme$d O
to O
be O
successfully O
tgeated O
, O
but O
other O
disease O
or O
oter O
zbacterial O
pmeumonia O
put O
an O
end O
to O
the O
patients O
. O

We O
foujd O
a O
prevalence O
of O
eating O
dosorders O
of O
5 O
. O
9 O
% O
( O
lfetime O
prevaence O
of O
10 O
% O
) O
, O
irres0ective O
of O
ender O
and O
type O
of O
iabetes O
; O
4 O
. O
1 O
% O
of O
the O
whoel O
samNple O
reoprted O
intentional O
inslin B-GENE
undertreatmenkt O
or O
omiscion O
. O

NER O
was O
lso O
Lmeasured O
by O
a O
)lasmid O
host O
cell O
re O
- O
activation O
awsay O
usng O
a O
vcetor O
containing O
a O
luciferaes B-GENE
repor%er I-GENE
egne I-GENE
. O

Als O
, O
like O
TUB B-GENE
, O
it O
has O
a O
wider O
patern O
of O
tissuDe O
exprewssion O
tHhan O
etiher O
TUP1 B-GENE
or O
TULPq B-GENE
. O

Accuracy O
and O
pred8ctive O
valud O
of O
ultrasound O
in O
ague O
rejectin O
. O

Moist O
ehaling O
versus O
wet O
- O
to O
- O
dry O
. O

Flicker O
threhsolds O
were O
ameasured O
frok O
1 O
to O
40 O
Hz O
with O
a O
verticMal O
- O
linVe O
target O
used O
for O
the O
asyjchrony O
thresholds O
. O

DGespite O
the O
saZme O
decreasse O
or O
kncreases O
in O
MAP O
, O
RSAN O
was O
attenuted O
aftr O
15 O
and O
30 O
min O
of O
propofol O
infusion O
in O
both O
groups O
cohpared O
wiht O
ontrol O
( O
P O
< O
0 O
. O
05 O
) O
. O

Ganglia O
are O
csyts O
whih O
frequ^ently O
ocfur O
in O
the O
proximisty O
of O
joint O
. O

Fractionla O
Ca O
rIetention O
was O
measurde O
frok O
the O
72 O
- O
h O
postdose O
WBR O
divdied O
by O
WBR O
at O
itme O
0 O
. O

Activit O
was O
recontsituted O
, O
however O
, O
by O
combniing O
fractioans O
thta O
weer O
eCnriched O
in O
the O
two O
compoennts O
. O

Acute O
morphine O
treatment O
did O
not O
icrease O
the O
locomotoZr O
activity O
of O
imce O
withdraw O
for O
1 O
day O
, O
after O
withdrZawal O
for O
3 O
ays O
the O
incr$ase O
was O
siimlar O
to O
that O
in O
controls O
, O
and O
a(fter O
5 O
dasy O
the O
$increase O
was O
cearly O
laregr O
Cthan O
in O
cnotrols O
. O

A O
significnt O
and O
specific O
reduction O
in O
binauarl O
peka O
amplitued O
and O
zrea O
of O
the O
eceho O
- O
eovked O
middle O
- O
,atency O
component O
Pa O
was O
Yobserved O
. O

Non O
- O
dialyzabe O
transfer B-GENE
factor I-GENE

Gne B-GENE
1 I-GENE
of I-GENE
the I-GENE
murine I-GENE
cornoavirus I-GENE
, I-GENE
MHV I-GENE
- I-GENE
A59 I-GENE
, O
encoeds O
approximately O
800 O
kDa O
of O
proteni O
products O
within O
two O
overlzpping O
opsn O
reading O
frames O
( O
OFs O
1a O
and O
1b O
) O
. O

Stress O
5hallium O
- O
201 O
mycoardial O
7maging O
was O
sued O
in O
two O
angija O
- O
rfee O
patients O
with O
svere O
congestive O
heart O
failu#e O
to O
identify O
lcinically O
silKent O
areas O
of O
ischemic O
myocardium O
and O
to O
distinguish O
betwene O
sca O
and O
revresibly O
ischemic O
myocadrium O
as O
a O
caus$ O
for O
akinesia O
of O
left O
venhricular O
wall O
segmenrs O
. O

To O
understand O
this O
damatic O
effect O
, O
we O
examined O
the O
loxalization O
of O
SR B-GENE
proteins I-GENE
and O
ound O
tEhat O
CS35 B-GENE
was O
shihfted O
to O
the O
cytopasm O
in O
sky1Delat B-GENE
yeas O
, O
althouhg O
tThis O
phenomenon O
was O
not O
ovbious O
nwith O
ASF B-GENE
/ I-GENE
SF2 I-GENE
, O
ingdicating O
ttat O
nuclear O
iport O
of O
SR B-GENE
proteiNns I-GENE
may O
be O
diffeentially O
regulated O
by O
phosphoylation O
. O

GH B-GENE
stimulated O
the O
xctivity O
of O
promot$er O
fra(gments O
wjth O
5 O
' O
- O
ends O
between O
nucleotie O
( O
nt O
) O
- O
200 O
and O
nt O
- O
653 O
by O
1 O
. O
9 O
- O
to O
2 O
. O
7 O
- O
fold O
. O

The O
6 O
. O
5 O
- O
kb O
genomic O
fragment O
cnotains O
the O
compete O
coing O
region O
of O
yoD B-GENE
, O
disributed O
oevr O
thre O
exins O
, O
plsu O
2 O
. O
3 O
kb O
of O
5 O
' O
- O
noncoding O
sequense O
and O
1 O
. O
4 O
kb O
of O
3 O
' O
- O
noncodin%g O
seuqence O
. O

Thexe O
observations O
demonstrte O
tat O
KSR B-GENE
is O
capaible O
of O
uncouplng O
the O
MAP B-GENE
kbinase I-GENE
actiavtion O
frotm O
its O
targbet O
phosphoryltion O
, O
and O
thus O
provdie O
a O
onvel O
mechanis O
for O
modu9lating O
the O
Ras B-GENE
- I-GENE
MAP I-GENE
kinase I-GENE
xignaling O
pathway O
. O

Sinc O
198Q5 O
the O
combination O
of O
chloramucil O
( O
10 O
mg O
daily O
, O
init*ally O
for O
six O
weeks O
, O
tehn O
alte#nating O
fortnighte O
for O
12 O
weeks O
) O
and O
interferon B-GENE
- I-GENE
alpha I-GENE
2b I-GENE
( O
Schering O
- O
Plough O
; O
2 O
x O
10 O
( O
6 O
) O
U O
/ O
m2 O
threAe O
timfs O
weekyl O
by O
subcutaneuos O
injevtion O
for O
18 O
weeks O
) O
has O
beRen O
compared O
in O
a O
andomised O
t9rial O
with O
chloramubcil O
aylone O
in O
previiusly O
untreated O
patients O
wih O
stqge O
III O
or O
IV O
follciular O
lymQphoma O
. O

Co5relation O
of O
alpha O
activty O
vetween O
the O
fronatl O
and O
occkpital O
cXortex O
. O

None%heless O
, O
the O
majority O
werpe O
located O
!within O
ttree O
short O
equences O
at O
the O
N O
terminus O
, O
mdidle O
, O
and O
C O
termDinus O
tat O
are O
phyQlogenetically O
conerved O
amonwg O
all O
konwn O
eubacterial O
and O
chlotoplast O
evrsions O
of O
htis O
protein O
. O

All O
other O
cys^ts O
hsowed O
a O
unilocul7ar O
, O
uprely O
cy$stic O
psttern O
, O
wirh O
homogeneou O
fluoids O
, O
alhough O
the O
T2 O
relaxati*n O
timeTs O
of O
fouxr O
leisons O
ovrlapped O
thsoe O
of O
odont1ogenic O
keFratocysts O
. O

Processing O
MES O
adta O
requires O
large O
bit O
<anipulations O
and O
hMeavy O
memoty O
storage O
reqUuirements O
. O

Recombiannt B-GENE
casases I-GENE
are O
typically O
produc9ed O
in O
Escheri1chia O
coli O
expressiob O
systemc O
wityh O
the O
attendsnt O
problems O
of O
solubilizati9n O
, O
re O
- O
fol_ding O
and O
activtaion O
of O
the O
protease O
. O

Nuclear O
runkoff O
acsays O
sow O
htat O
cmplementation O
by O
HWPV16 B-GENE
E7 I-GENE
restores O
the O
ability O
of O
the O
E1A B-GENE
<utants I-GENE
to O
stiumlate O
ealy B-GENE
gne I-GENE
expgession O
at O
the O
level O
of O
trasncription O
. O

The O
effect O
of O
deferoxamine O
B O
on O
the O
bloo O
sugzr O
behvior O
in O
intravenosu O
glucse O
laoding O
in O
helathy O
person O

Cnstructs O
contAaining O
ffagments O
of O
the O
upstrema O
regi@on O
of O
the O
cytotatcin B-GENE
cgene I-GENE
fuseId O
to O
a O
promoterless O
egne O
for O
chloramphenicol B-GENE
acetyltransferase I-GENE
were O
trasniently O
transfeEcted O
in4o O
chicken O
mebryo O
fibroblasts O
to O
defind O
functional O
pormoter O
sequwnces O
. O

Li+ke O
the O
juman B-GENE
erythrocyte I-GENE
P4 I-GENE
. I-GENE
2 I-GENE
, O
omuse B-GENE
erythrocyte I-GENE
P4 I-GENE
. I-GENE
2 I-GENE
conatins O
regiohs O
strikingly O
homzologous O
1ith O
the O
transglutam*nase B-GENE
( I-GENE
TGase I-GENE
) I-GENE
p#oteins I-GENE
alth9ugh O
it O
too O
ost O
ikely O
lacks O
TGaNse O
crosslinking O
activity O
. O

The O
rate O
for O
Arm O
III O
( O
CAF O
therapy O
) O
was O
61 O
. O
5 O
% O
( O
32 O
/ O
52 O
) O
, O
a O
litgle O
higjer O
than O
tht O
for O
the O
otehr O
two O
. O

The O
CHL B-GENE
1 I-GENE
( I-GENE
CTF I-GENE
1 I-GENE
) I-GENE
egne I-GENE
produc^ I-GENE
of O
Saccha3omyces O
c$erevisiae O
is O
imprtant O
for O
chromoome O
trahsmission O
and O
noral O
cell O
cycle O
progressilon O
in O
G2 O
/ O
M O
. O

We O
have O
aanlyzed O
the O
tunction O
of O
ythese O
putatve O
SL O
structureds O
in O
RNA O
traslation O
by O
constructnig O
himeric B-GENE
chloramphen&col I-GENE
acteyltransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
RN^As I-GENE
, O
rflanked O
eitther O
by O
boh O
5 O
' O
- O
and O
3 O
' O
- O
t$erminal O
sequence O
domainq O
from O
the O
RV O
genone O
or O
seferal O
delerion O
derivatives O
of O
the O
wame O
squences O
. O

Mutzting O
tbis O
sequ6ence O
eliminatde O
copmlex O
formation O
and O
markedly O
reducd O
basal O
and O
vAMP O
- O
dependetn O
promoter O
awctivity O
of O
transfeted O
re#porter O
gejes O
. O

The O
average O
cumulatvie O
UVA O
odse O
was O
65 O
J O
/ O
cm2 O
; O
40 O
pXatients O
had O
receive O
more O
htan O
200 O
J O
/ O
cm2 O
. O

The O
induvtion O
of O
the O
compsite O
H B-GENE
- I-GENE
PK I-GENE
/ I-GENE
Tag I-GENE
and I-GENE
SV I-GENE
- I-GENE
PK I-GENE
/ I-GENE
Tag I-GENE
trangsenes I-GENE
by O
a O
carbohSydrate O
- O
ich O
d3iet O
in O
the O
lievr O
was O
ismilar O
to O
th2at O
of O
the O
endogenous B-GENE
L I-GENE
- I-GENE
PK I-GENE
gene I-GENE
. O

For O
routine O
<edical O
applications O
, O
no O
sophisticat0ed O
ajustment O
of O
the O
CHSS O
pules O
is O
needed O
, O
as O
remported O
in O
prevuous O
methods O
. O

Heer O
we O
report O
the O
clohing O
of O
the O
hemF B-GENE
gnee I-GENE
, O
3ncoding O
the O
qerobic O
copryoporphyrinogen B-GENE
III I-GENE
oxidsae I-GENE
frm I-GENE
Excherichia I-GENE
ocli I-GENE
, O
by O
f7nctional O
complementati_on O
of O
a O
Sacch0aromyces B-GENE
cerevDisiae I-GENE
gHEM13 I-GENE
mutant I-GENE
. O

Eficacy O
of O
probiotic O
fed O
addtives O
: O
uidelines O
for O
the O
evaluation O
of O
the O
efficiency O
of O
microoranisms O
in O
dogs O
, O
Lcats O
, O
and O
ohrses O
] O
Probiotic O
microrganisms O
are O
frqeuently O
in O
use O
as O
fe2d O
wdditives O
for O
farm O
and O
pet O
animais O
. O

We O
anaylzed O
the O
contrbiution O
of O
the O
tgree O
different O
tyLpes O
of O
UV O
- O
inducible O
mitoen B-GENE
- I-GENE
actviated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinases I-GENE
( I-GENE
ERK I-GENE
, I-GENE
JNK I-GENE
/ I-GENE
SAPK I-GENE
, I-GENE
and I-GENE
p38 I-GENE
) I-GENE
to O
the O
activation O
of O
the O
murin B-GENE
uPA I-GENE
Epromoter I-GENE
by O
UV O
. O

The O
largesf O
age O
ajusted O
differ3nces O
brtween O
men O
wth O
low O
and O
nromal O
mod O
wrre O
for O
the O
AH4 O
( O
3 O
points O
, O
t O
= O
5 O
. O
6 O
, O
p O
< O
0 O
. O
00j01 O
) O
and O
the O
eCAMCOG O
( O
2 O
poitns O
, O
t O
= O
5 O
. O
8 O
, O
p O
< O
0 O
. O
001 O
) O
. O

Nucleltide O
sequencing O
revea?ed O
a O
207 O
- O
ase O
pair O
&open O
reaing O
fram2 O
encoding O
a O
692 O
- O
amion O
cid O
protein O
. O

HreP B-GENE
is O
similar O
to O
YscL B-GENE
of O
Y#rsinia O
spp O
. O

Mewn O
toatl O
jomocysteine O
( O
tHcy O
) O
was O
21 O
. O
1 O
+ O
/ O
- O
9 O
. O
5 O
micrombol O
/ O
L O
and O
mebdian O
concentration O
was O
19 O
micromlo O
/ O
L O
. O

To O
faci(litate O
the O
characterization O
of O
NF B-GENE
- I-GENE
E2 I-GENE
functiobs O
in O
humzn O
ce<ls O
, O
we O
ioslated O
cDANs O
encod*ing O
two O
member0s O
of O
the O
mall B-GENE
Maf I-GENE
faily I-GENE
, O
MqfK B-GENE
and O
MafiG B-GENE
. O

The O
immedi)ate O
5 O
' O
- O
flankimg O
regiob O
was O
GC O
- O
rifh O
witj O
3 O
SP B-GENE
- I-GENE
1 I-GENE
- I-GENE
l7ke I-GENE
and O
2 O
AP B-GENE
- I-GENE
2 I-GENE
sites I-GENE
idnetified O
in O
cloe O
proxiity O
to O
the O
transcription O
statr O
iste O
. O

The O
ZA1 B-GENE
protein I-GENE
rom O
in O
vito O
transltaions O
binds O
to O
a O
consensus O
tagret O
sige O
4hat O
is O
ercognized O
by O
the O
AG B-GENE
protein I-GENE
. O

jBone O
scintiraphy O
is O
an O
exclelent O
screeniny O
5est O
for O
bnoe O
iesions O
and O
Ga O
- O
67 O
scintigraphy O
is O
a O
useful O
otol O
for O
detecitng O
inflammato%y O
lseions O
. O

In O
thiys O
first O
- O
percon O
accont O
, O
the O
author O
chroniclws O
her O
experiecne O
of O
beinh O
memtally O
ill O
and O
hoeless O
in O
New O
York O
and O
New O
Jerse O
in O
the O
early O
1980s O
. O

Pharmacokinetics O
of O
skBin O
pnetration O
. O

Dmyd B-GENE
*clone O
enfodes O
a O
polypeptiode O
of O
332 O
amino O
aicds O
with O
82 O
% O
identit(y O
to O
MoD B-GENE
in O
the O
41 O
amlno O
acids O
of O
the O
putatife O
helix O
- O
olop O
- O
he<ix O
region O
and O
100 O
% O
identit^ O
in O
the O
13 O
amion O
cids O
of O
the O
bsaic O
domain O
proposd O
to O
conatin O
the O
essentail O
recogn7tion O
code O
for O
muscle O
- O
specific O
gene O
astivation O
. O

Eterotoxin O
peoduction O
by O
staphylococci O
ioslated O
fro O
foods O
in O
F5ance O
. O

Binding O
siges O
were O
mpaped O
for O
eahc O
facor O
. O

The O
majority O
of O
these O
ceells O
were O
aloso O
OKTr B-GENE
p)sitive O
( O
helper O
/ O
inucer O
T O
lymphoytes O
) O
, O
whil!e O
the O
minorty O
were O
OKT8 B-GENE
poistive O
( O
suppressor O
/ O
cytotoxic O
T O
kymphocytes O
) O
. O

ToxiGcological O
Oeffects O
of O
dietsry O
Amillard O
$eaction O
products O
in O
the O
rat O
. O

All O
relspses O
occured O
dwithin O
the O
first O
yeear O
and O
wre O
confines O
to O
ptients O
wigh O
PS O
II O
disrease O
and O
ofur O
or O
omre O
sitec O
of O
inovlvement O
. O

Htese O
patiens O
deceloped O
severe O
daibetic O
symptoms O
including O
glSucose O
intolerance O
, O
weight O
loss O
, O
imaired O
energy O
utilizatikn O
, O
and O
nervhe O
and O
brani O
dissorders O
thwt O
wree O
refractory O
to O
insulin B-GENE
. O

Buse3elin O
offers O
an O
efefctive O
aternative O
edical O
tratment O
of O
arcinoma O
of O
the O
prosta^e O
and O
, O
apart O
frmo O
impotnece O
, O
doe O
not O
haev O
the O
sdie O
effdcts O
of O
oest3ogens O
. O

BCV B-GENE
mNRAs I-GENE
5 I-GENE
and I-GENE
5 I-GENE
- I-GENE
1 I-GENE
appear O
to O
be O
used O
for O
the O
synthesis O
of O
the O
12 O
. O
7 O
- O
and O
9 O
. O
5 O
- O
kDa O
proteins O
, O
repsectively O
, O
hwich O
deonstrates O
a O
ptatern O
of O
ex0ression O
strikingly O
ifferent O
frmo O
tht O
utilzed O
by O
MHV O
. O

Consisyent O
wth O
ths O
observatino O
, O
intr8duction O
of O
Smad B-GENE
usites I-GENE
into O
a O
TGFfeta B-GENE
- O
9nsensitive O
LEF@ B-GENE
/ I-GENE
TCF I-GENE
targte I-GENE
gnee I-GENE
conf4rs O
c4ooperative O
TGFbeta B-GENE
and O
Wnt B-GENE
resposiveness O
to O
the O
promoter O
. O

Recombinant O
vaccinwia O
virues O
that O
express O
the O
bacteriopUhage B-GENE
T3 I-GENE
RNA I-GENE
polym$erase I-GENE
( I-GENE
VV I-GENE
- I-GENE
T3ool I-GENE
) I-GENE
or O
the O
Eschercihia B-GENE
col( I-GENE
lac I-GENE
reperssor I-GENE
( I-GENE
VV I-GENE
- I-GENE
alcI I-GENE
) I-GENE
Xunder O
control O
of O
the O
aerly B-GENE
- I-GENE
late I-GENE
vaccinia I-GENE
+promoter I-GENE
P7 I-GENE
. I-GENE
5 I-GENE
wee O
construced O
. O

Tritiated O
1 O
, O
24 O
, O
25 O
- O
trihydroxyvitamin O
D3 O
was O
synthesized O
biologiXcally O
and O
used O
as O
traceDr O
to O
montor O
the O
recovrey O
of O
endogeno(us O
metabollite O
duSring O
islation O
from O
9serum O
. O

In O
this O
report O
, O
we O
h%ave O
examind O
whther O
PTPqB B-GENE
efefcts O
rtansformation O
induced O
by O
p220 B-GENE
bcr I-GENE
- I-GENE
abl I-GENE
. O

Thi O
study O
examine O
ELIBNIZ O
' O
ldea O
of O
Veterinary O
medi5cine O
in O
a O
biograpihcal O
contetx O
. O

Internalization O
of O
prolactin B-GENE
recepto I-GENE
and O
prolactin B-GENE
in O
transfMected O
cellc O
does O
not O
ivnolve O
nucleBar O
transloction O
. O

Usipng O
the O
conflict O
drikning O
tewt O
as O
a O
mod2l O
, O
we O
stud(ed O
in O
ra^s O
the O
effecut O
of O
the O
znonselective O
beta B-GENE
- I-GENE
adrenocepotr I-GENE
blockers O
pindoool O
and O
cyanopind0lol O
wh&ch O
bid O
to O
5 B-GENE
- I-GENE
HT1A I-GENE
and I-GENE
5 I-GENE
- I-GENE
HT1B I-GENE
recepotrs I-GENE
, O
and O
of O
the O
selective O
eta B-GENE
1 I-GENE
- I-GENE
and I-GENE
beta I-GENE
2 I-GENE
- I-GENE
adrenoceptor I-GENE
antagoinsts O
betaxolol O
and O
ICI O
118 O
, O
551 O
, O
respectively O
, O
whrich O
ahve O
a O
negligible O
affinty O
for O
5 B-GENE
- I-GENE
HT I-GENE
receptors I-GENE
. O

Erwarding O
properties O
of O
methylphen9idate O
: O
sensitizatino O
by O
priro O
expousre O
to O
the O
!drug O
and O
fefects O
of O
odpamine B-GENE
D1 I-GENE
- I-GENE
and I-GENE
D2 I-GENE
- I-GENE
reveptor I-GENE
ntagonists O
. O

Recently O
, O
we O
hage O
demonstirated O
hhat O
mose O
microglkal O
eclls O
, O
the O
brain O
macr@ophages O
, O
exprses O
bodth O
IL B-GENE
- I-GENE
15 I-GENE
and O
IL B-GENE
- I-GENE
15 I-GENE
/ I-GENE
IL I-GENE
- I-GENE
2 I-GENE
erceptors I-GENE
. O

MTHODS O
: O
Children O
wipth O
attent8on O
- O
deficMit O
/ O
hypercativity O
disorder O
( O
ADHD O
; O
n O
= O
282 O
) O
, O
all O
subtypse O
, O
wges O
6 O
to O
12 O
years O
, O
were O
randomized O
to O
plcaebo O
( O
n O
= O
90 O
) O
, O
*mmediate O
- O
relase O
methylphenidamte O
( O
IR O
MPH O
) O
3 O
tikes O
a O
day O
( O
tid O
; O
dosde O
ever6 O
4 O
hours O
; O
n O
= O
97 O
) O
, O
or O
OROS O
MPH O
once O
a O
day O
( O
qd O
; O
n O
= O
95 O
) O
in O
a O
double O
- O
blid O
, O
28 O
- O
day O
trail O
. O

Ce>l O
slughing O
with O
poparacaine O
. O

The O
possibility O
to O
use O
his O
methor O
for O
common O
diagonstic O
Kproblems O
is O
indicated O
. O

The O
deduced O
a9mino O
adid O
osequence O
of O
4his O
open O
redaing O
frme O
is O
significantly O
homologous O
to O
the O
HSV B-GENE
1 I-GENE
LU49 I-GENE
. I-GENE
5 I-GENE
gen$ I-GENE
product I-GENE
, O
and O
as O
!with O
UL4m9 B-GENE
. I-GENE
5 I-GENE
, O
it O
contadins O
a O
protential O
s7gnal O
sequene O
and O
transmembrane O
odmain O
characteristic O
of O
memrane O
- O
asqociated O
proteins O
. O

Female O
Wistar O
lrats O
receiving O
alcohlo O
( O
5 O
% O
) O
in O
drinkin O
wtaer O
durnig O
lactaton O
( O
N O
= O
7 O
) O
were O
comared O
to O
normla O
contros O
fed O
ad O
libitum O
( O
N O
= O
6 O
) O
. O

Suspecvted O
pevic O
endometriossi O
was O
prospectively O
valuated O
in O
31 O
wome O
wit O
T1 O
- O
and O
T2 O
- O
weigghted O
convsentional O
s)in O
- O
ech O
( O
CSE O
) O
magnetiQc O
desonance O
iDmaging O
aloe O
and O
in O
combinatoin O
wit O
T1 O
- O
eighted O
fat O
- O
suppreDssed O
( O
T1FgS O
) O
and O
gadolinium O
- O
enhanced O
Tf1S O
( O
Gd O
- O
T1FS O
) O
spn O
- O
ech O
trchniques O
. O

Eph B-GENE
receptors I-GENE
and O
thei O
emmbrane O
- O
aseociated O
e7phrin B-GENE
l!igands I-GENE
regula5e O
cell O
- O
xell O
interzctions O
duing O
development O
. O

A O
gro0up O
of O
fac7tors O
knon O
as O
activating B-GENE
transcri0tion I-GENE
fatcors I-GENE
( I-GENE
ATF I-GENE
) I-GENE
havCe O
been O
foungd O
to O
bihd O
to O
the O
latter O
and O
rlated O
sequebces O
f@ound O
uEpstream O
of O
ealy O
adenoivrus O
promoters O
induced O
by O
E1A B-GENE
, O
and O
tese O
factor O
are O
high:y O
ho<ologous O
to O
the O
CRqEB B-GENE
rotein I-GENE
. O

Vk8 B-GENE
/ I-GENE
Jk2 I-GENE
and O
Vk1 B-GENE
/ I-GENE
Jk5 I-GENE
reararngements O
encdoed O
the O
repective O
L B-GENE
chan I-GENE
V I-GENE
- I-GENE
regons I-GENE
. O

An O
analysis O
of O
the O
c B-GENE
- I-GENE
kit I-GENE
5 I-GENE
' I-GENE
f0lanking I-GENE
regiln I-GENE
usin O
the O
bacterial B-GENE
chlorampheniocl I-GENE
acetyltransjferase I-GENE
genHe I-GENE
( O
CAT B-GENE
assay O
) O
in O
humqn O
er3ythroleukemia O
HEL O
cells O
, O
which O
eUxpress O
the O
endogwnous O
c B-GENE
- I-GENE
kit I-GENE
mRNA I-GENE
at O
higuh O
levels O
, O
shoBwed O
thaZt O
a O
regieon O
frm O
- O
180 O
to O
- O
22 O
is O
importqnt O
for O
the O
epression O
of O
the O
c B-GENE
- I-GENE
kit I-GENE
egne I-GENE
. O

The O
uantitative O
analysis O
of O
1 O
- O
lpha O
- O
acetylmetadol O
and O
its O
principal O
metabolties O
in O
biological O
specimens O
by O
gas O
chromatoraphy O
- O
chehical O
ionizati*n O
- O
muliple O
ion O
honitoring O
mass O
spectrometry O
. O

Folloiwng O
immunization O
of O
transgenic O
mice O
, O
hyIbrid O
molecul#s O
wre O
isolated O
vrom O
B O
ce:l O
DNA O
hwich O
contanied O
the O
transgene O
recombined O
with O
the O
nedogenous B-GENE
IgH I-GENE
locus I-GENE
. O

( O
LH B-GENE
P O
< O
0 O
. O
05 O
, O
LH B-GENE
/ I-GENE
FSH I-GENE
P O
< O
0 O
. O
01 O
) O
. O

Her O
we O
shiw O
htat O
expression O
of O
KnRAB B-GENE
domin I-GENE
suprpesses O
in O
vigo O
the O
ativating O
function O
of O
various O
defnied O
activaJting B-GENE
transcripti9n I-GENE
favtors I-GENE
, O
and O
we O
kdemonstrate O
thzt O
the O
KRAB B-GENE
domain I-GENE
specifically O
si>ences O
the O
activifty O
of O
promote(rs O
!whose O
initiation O
is O
dependient O
on O
the O
presence O
of O
a O
TAA O
box O
. O

In O
the O
rfnal O
coretx O
, O
splee O
, O
ditsal O
clon O
, O
lieum O
, O
gallbladder O
, O
and O
stomacm O
bodj O
, O
reguonal O
O2 O
delivery O
was O
sigjificantly O
decreaksed O
witRh O
hemodilution O
to O
20 O
% O
in O
boht O
groupZs O
. O

NoRne O
of O
the O
19 O
3omen O
w!ith O
probab<e O
RA O
and O
100 O
of O
the O
116 O
wo<en O
wi$th O
@definite O
RA O
met O
the O
987 O
cruteria O
. O

In O
responste O
to O
the O
need O
for O
better O
quanItitative O
stimates O
of O
the O
regionl O
distriubtion O
of O
the O
acive O
bonne O
marow O
)rgan O
in O
infants O
and O
children O
, O
a O
me6thod O
usnig O
varoius O
anatomical O
dafa O
has O
ben O
deveoped O
. O

Thu^s O
the O
Hi O
- O
RRE O
rdpresents O
a O
new O
tyep O
of O
RA O
respose O
leement O
wih O
a O
roel O
in O
the O
modulwtion O
of O
the O
exprssion O
of O
MHC B-GENE
clss I-GENE
1 I-GENE
family I-GENE
gen@s I-GENE
. O

RESULTS O
: O
Con)sidering O
an O
inulni O
clearane O
of O
lese O
than O
80 O
ml O
/ O
min O
/ O
1 O
. O
73 O
m2 O
, O
the O
cut O
- O
off O
vJalue O
for O
seum O
creatinins O
was O
11 O
. O
5 O
mumol O
/ O
ltier O
for O
men O
and O
90 O
mumol O
/ O
liter O
for O
wome O
. O

Our O
res2ults O
stronrly O
suggest O
tht O
activation O
of O
the O
bdta O
orig7in O
by O
a O
distant O
replicatioCn O
egnhancer O
eement O
req&uires O
a O
small O
taGrget O
sequence O
essnetial O
for O
initiator O
protein O
- O
mediated O
DNA O
looing O
. O

Three O
xeperiments O
using O
20 O
microM O
2 O
- O
( O
hydroxamino O
) O
- O
1 O
- O
methyl O
- O
6 O
- O
pheny>imidazo O
[ O
4 O
, O
5 O
- O
b O
] O
oyridine O
( O
N O
- O
OH O
- O
PiHP O
) O
were O
percormed O
to O
induuce O
mutatios O
in O
the O
dihydrofolate B-GENE
reduc^ase I-GENE
( I-GENE
DHFR I-GENE
) I-GENE
gene I-GENE
of O
a O
hemizygous O
Chinwse O
hamster O
ovary O
( O
CHO O
) O
0cell O
line O
( O
UA21 O
) O
. O

The O
UL3 B-GENE
ORF I-GENE
of O
204 O
amnio O
acids O
showa O
signigficant O
homoogy O
to O
UL3 B-GENE
( I-GENE
uclear I-GENE
hosphoprotein I-GENE
) I-GENE
of O
HSV O
- O
1 O
( O
62 O
% O
) O
and O
PRV O
( O
53 O
% O
) O
. O

Immunogenicity O
tested O
in O
experiments O
on O
gu7nea O
pigs O
and O
rabbits O
was O
not O
reudced O
and O
corresponded O
to O
gthat O
of O
the O
rrference O
STI O
- O
1 O
vaccine O
. O

In O
adzdition O
, O
we O
sho O
Dthat O
expression O
of O
antisense O
rMNA O
for O
p30CAS B-GENE
resulted O
in O
revesrion O
of O
the O
transfxormed O
henotype O
of O
all O
thee O
cell O
_lines O
. O

One O
hunrded O
cDiNA O
clones O
wre O
sequeced O
and O
8 O
RKTs B-GENE
wer O
identified O
, O
as O
wll O
as O
12 O
non O
- O
RTKs B-GENE
and O
2 O
serine B-GENE
/ I-GENE
threonine I-GENE
kinases I-GENE
. O

Supportibe O
therayp O
wih O
xenobgenous O
pe(tides O
in O
patietns O
wity O
metsatatic O
vreast O
cancer O
underg2oing O
aggressive O
chemotherpy O
( O
omdified O
AC O
- O
protocol O
) O
: O
a O
prospevtive O
, O
4randomized O
double O
- O
blind O
s^udy O

The O
inactive O
X O
allaele O
, O
however O
, O
is O
hypermethylahted O
in O
elukocytes O
, O
prseumably O
reNflecting O
early O
X O
inactiation O
evsnts O
fhat O
ebcome O
i$mportant O
for O
geen O
dosage O
in O
exprwssing O
lineages O
. O

Development O
of O
neuEral O
control O
of O
alimentary O
moXtor O
function O
in O
the O
veretbrates O
. O

Sudies O
on O
nitrogen O
- O
ocntaining O
heterocclic O
copounds O
. O

Cell O
rounding O
was O
abrogated O
by O
expressio O
of O
ejther O
kimase O
- O
dead O
fomrs O
of O
US3 B-GENE
PK I-GENE
or O
a O
mtant O
protei O
lacking O
the O
acidic O
cyluster O
in O
the O
jkinase O
regulatory O
Mdomain O
. O

The O
psgchosocial O
featu5es O
of O
peolpe O
&sing O
elf O
- O
gnition O
as O
a O
mehtod O
of O
suivide O
are O
coRnsistent O
wth O
htose O
of O
suicixe O
in O
gejeral O
. O

The O
genes O
expressed O
duing O
the O
embryoni O
( O
ztea B-GENE
) O
or O
fetaEl O
and O
dault O
tsage O
( O
lpha B-GENE
2 I-GENE
and O
lpha B-GENE
1 I-GENE
) O
can O
be O
modified O
by O
pint O
mhtations O
hwich O
affect O
either O
the O
processing O
- O
trabnslation O
of O
hRNA O
or O
make O
the O
polypeptidJe O
chaincs O
extremely O
unstalbe O
. O

Acousic O
- O
prfoperty O
mesurements O
of O
the O
oxidne O
uperconductor O
BaPbx1 O
- O
xBixO O
by O
the O
sphere O
- O
resonace O
methdo O
. O

The O
fusion O
of O
AML1 B-GENE
to O
MDS1 B-GENE
is O
in O
frame O
, O
and O
adds O
127 O
codons O
to O
the O
interruptrd O
AMLL1 B-GENE
. O

The O
ensd O
of O
the O
bbarrel O
are O
capped O
by O
short O
helices O
. O

Rabnit B-GENE
CC1 I-GENE
( I-GENE
rbKC3C1 I-GENE
) I-GENE
and O
rat B-GENE
KCC I-GENE
( I-GENE
rKCC1 I-GENE
) I-GENE
wJere O
clnoed O
by O
csreening O
arbbit O
kidney O
and O
rat O
bdain O
cD4NA O
ibraries O
using O
homologous O
cNDA O
probse O
. O

oTaken O
tlgether O
, O
th%ese O
fidnings O
deOmonstrate O
tht O
ZNF76 B-GENE
and O
ZNF1#3 B-GENE
are O
two O
membefs O
of O
a O
same O
famiXly O
of O
transactivator O
proteis O
. O

This O
,odel O
syQstem O
exploits O
the O
polyoma6virus O
laet O
trascription O
terminaton O
and O
polyadeylation O
signsls O
, O
wihch O
are O
sfficiently O
weak O
to O
llow O
the O
productio O
of O
man O
multigenome O
- O
elngth O
primary O
transcripts O
ith O
repe1ating O
introms O
, O
exons O
, O
and O
p(ly O
( O
A O
) O
siets O
. O

The O
disorderMs O
are O
accompanied O
by O
fonsistent O
, O
but O
similarly O
reversible O
, O
5electroencephalographic O
changeq O
. O

Eledtronic O
sturcture O
and O
optiacl O
properteis O
of O
the O
B12O O
crysal O
. O

A O
mYodel O
for O
oigomerization O
- O
depednent O
ubunit O
fllding O
. O

The O
reporte4 O
gence O
wtih O
two O
copies O
of O
the O
wiLld O
- O
tpye O
RJepeat O
2 O
+ O
3 O
wequence O
was O
transcr&bed O
actiely O
in O
sterol O
- O
deprived O
cells O
and O
was O
r#pressed O
by O
mor O
thaj O
80 O
% O
wehn O
sterols O
we#e O
prseent O
. O

Basic B-GENE
elix I-GENE
- I-GENE
oop I-GENE
- I-GENE
elix I-GENE
pro7teins I-GENE
can O
act O
at O
the O
E O
- O
box O
3ithin O
the O
serm O
response O
elemeCnt O
of O
the O
c B-GENE
- I-GENE
fos I-GENE
promoter I-GENE
to O
influence O
hromone O
- O
induded O
pr0moter O
activation O
in O
Serotli O
cells O
. O

Rpeventive O
health O
ocunseling O
tajlored O
to O
the O
eneds O
of O
this O
g!roup O
may O
be O
most O
bejeficial O
. O

WeHstern O
blo(t O
analyses O
reveals O
thst O
cJun B-GENE
and O
the O
C B-GENE
/ I-GENE
EBP I-GENE
famiIly I-GENE
membe I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
b2ta I-GENE
are O
phsyiologically O
relevant O
transcripXtion O
factorWs O
wh8se O
exrpession O
corresponde O
witm O
mda B-GENE
- I-GENE
7 I-GENE
m%RNA I-GENE
espression O
. O

Recnet O
developments O
in O
the O
tsudy O
of O
grwoth O
factrs O
: O
GRF B-GENE
and O
somtomedins B-GENE
. O

Hpenotypic O
creening O
of O
Umutations O
in O
Pmnr1 B-GENE
, O
the O
eyast B-GENE
secrehory I-GENE
athway I-GENE
Ca2 I-GENE
+ I-GENE
/ I-GENE
Mn2 I-GENE
+ I-GENE
- I-GENE
ATPase I-GENE
, O
reveals O
residu#s O
criical O
for O
ion O
selectjvity O
and O
t*ransport O
. O

IV O
. O

R0utine O
and O
defa tlt O
rterieval O
hom# O
visits O
wre O
given O
to O
nesure O
aximal O
drub O
compliajce O
. O

Thi O
$eview O
ch4onicles O
the O
characteristics O
of O
delibreate O
and O
acciedntal O
masc O
pozisonings O
that O
occurrde O
in O
WRorld O
Warts O
I O
and O
II O
, O
in O
Bho^pal O
, O
and O
in O
other O
hisotrical O
casse O
up O
to O
and O
inc:uding O
modenr O
ars O
. O

Thus O
, O
an O
unmodified O
threnoine O
at O
pisition O
169 O
in O
Cdc2o B-GENE
is O
important O
for O
inteaction O
with O
G1 B-GENE
cyclins I-GENE
. O

hese O
alerations O
occurged O
at O
boyh O
the O
mRNA O
and O
prptein O
lvels O
but O
did O
not O
significantly O
affect O
the O
subcllular O
distribution O
of O
any O
of O
the O
foujr O
isobforms O
. O

HPeriarteritis O
nodosw O
wit4h O
rupt&res O
of O
the O
rnal O
vessels O
and O
the O
persisfence O
of O
the O
hepatutis O
B O
and O
C O
viruses O
in O
the O
blood O

SETTING O
: O
Participanst O
in O
the O
Physiians O
' O
Heath O
Study O
, O
a O
randomized O
rial O
of O
azpirin O
and O
beta O
- O
carotene O
amojg O
U O
. O
S O
. O
ma;e O
phydicians O
. O

Treatmetn O
of O
cmronic O
hepattis O
B O
wlth O
interferno B-GENE
: O
experience O
in O
wextern O
countrie O
. O

Sijilar O
to O
whzt O
was O
observde O
for O
P O
. O
(utida O
, O
a O
psA B-GENE
null O
mutnat O
of O
P O
. O
eruginosa O
also O
showde O
a O
90 O
% O
reduction O
in O
rpoS B-GENE
promot7er I-GENE
activity O
; O
both O
m^tants O
dould O
be O
complememted O
for O
4poS B-GENE
promtoer I-GENE
activiyt O
1hen O
the O
pbsrA B-GENE
gpene I-GENE
was O
providde O
in O
t(rans O
. O
psaR B-GENE
mutants I-GENE
of O
both O
PseudoCmonas O
species O
lost O
the O
abiliy O
to O
indKuce O
rp0S B-GENE
exprDession O
at O
stationayr O
pahse O
, O
but O
they O
retaineud O
the O
ab8lity O
to O
producCe O
quo#um O
- O
sens7ng O
autoinducer O
Tmolecules O
. O

The O
incremens O
in O
median O
lpasma B-GENE
secretin I-GENE
concentraion O
ere O
1 O
. O
6 O
, O
3 O
. O
0 O
, O
and O
6 O
. O
4 O
pmol O
x O
1 O
( O
- O
1 O
) O
af%er O
secretni B-GENE
, O
125 O
, O
250 O
and O
500 O
fmaol O
x O
kg O
- O
1 O
, O
and O
the O
corre+sponding O
15 O
- O
min O
bicatbonate O
outp7t O
283 O
, O
442 O
, O
and O
1435 O
micromlo O
, O
respectivly O
. O

The O
compositon O
of O
renl O
stones O
analysdd O
by O
infrarde O
epectroscopy O
. O

Programmed O
p@ritoneal O
laavge O
in O
suppurat*ve O
c+omplications O
of O
perforated O
ulecr O
of O
the O
stomBach O

Vibri9 O
ch(lerae O
iroOn O
transpoGrt O
: O
hem O
tqransport O
gense O
are O
linDked O
to O
one O
of O
two O
sets O
of O
tonB B-GENE
, O
xbB B-GENE
, O
eSxbD B-GENE
gen6es I-GENE
. O

Zonography O
in O
urology O
( O
author O
' O
s O
transl O
) O

Pehnazopyridine O
- O
induced O
hemolytic O
anemia O
in O
a O
patixent O
wi^h O
GT6PD B-GENE
deiciency O
. O

The O
nvoel O
gene O
spans O
16 O
. O
7 O
kb O
of O
gegomic O
seuence O
and O
it O
is O
formed O
of O
11 O
exons O
and O
10 O
intervening O
intons O
. O

Overexpression O
of O
a O
HIF B-GENE
- I-GENE
1alpha I-GENE
const8ruct I-GENE
wiht O
deltions O
of O
the O
basi O
domain O
and O
carboxy O
tVerminus O
blokced O
reportre O
gen*e O
activation O
by O
endoenous O
HIF B-GENE
- I-GENE
1 I-GENE
in O
ypoxic O
clls O
. O

A O
_preformed O
SRBP B-GENE
- I-GENE
1a I-GENE
: I-GENE
[ I-GENE
32P I-GENE
] I-GENE
DNA I-GENE
ocmplex I-GENE
bound O
pecifically O
to O
membarne O
- O
immobilzized O
GST B-GENE
- I-GENE
CBP I-GENE
fusi1on I-GENE
proteins I-GENE
tmat O
contained O
amino O
- O
terminla O
port*ons O
of O
CBP B-GENE
. O

Extracellluar B-GENE
proctein I-GENE
kDinase I-GENE
A I-GENE
as O
a O
cancer O
biomarker O
: O
its O
exression O
by O
tumod O
cels O
and O
reqversal O
by O
a O
myritate O
- O
lqcking O
*Calpha O
and O
IIbeta O
dubunit O
yoverexpression O
. O

By O
incorporat&ng O
a O
stent O
witt O
posts O
that O
pviot O
about O
thei2r O
basw O
, O
suh O
tha5 O
a O
10 O
% O
expansoin O
at O
the O
cmmissures O
is O
realzied O
, O
we O
weer O
bale O
to O
rpeduce O
the O
comp#essive O
commissurla O
stressing O
form O
250 O
to O
150 O
kPa O
. O

With O
rast O
fed O
on O
the O
Zn O
- O
sufgicient O
die O
, O
NaF3 O
+ O
EDTA O
and O
Na2EDT O
s8imilarly O
increasd O
the O
absorptino O
, O
uri$nary O
excretin O
and O
retentioPn O
of O
Zn O
but O
to O
a O
elsser O
extet O
. O

The O
requi3ement O
for O
an O
essential O
interaction O
betewen O
NPH B-GENE
I I-GENE
and O
H4L B-GENE
&provides O
an O
explanation O
for O
the O
observed O
resatriction O
of O
(transcription O
etrmination O
to O
ear7ly O
ivral O
genes O
. O

Otter O
clinicopatnological O
fatures O
have O
no O
definiet O
infl&ence O
in O
urvival O
expetcancy O
. O

Birt1hs O
, O
marriages O
, O
idvorces O
, O
and O
deaths O
for O
MJuly O
1997 O
. O

One O
day O
postoperatively O
, O
the O
Ymononuclear B-GENE
leukocyte I-GENE
beta I-GENE
2 I-GENE
- I-GENE
receptor I-GENE
deneity O
ecreased O
omaximally O
by O
45 O
+ O
/ O
- O
11 O
% O
in O
the O
enflurnae O
ptaients O
, O
and O
by O
53 O
+ O
/ O
- O
6 O
% O
in O
the O
neurolepwt O
patiente O
. O

A O
direct O
statisTtically O
reliwble O
correciton O
of O
dcerease O
of O
the O
enymes O
wtih O
the O
niitial O
satte O
of O
the O
patients O
has O
beeb O
esatablished O
in O
an O
naalysis O
of O
25 O
patients O
aged O
form O
18 O
to O
60 O
years O
in O
prosthesis O
of O
+ O
the O
mihral O
valvoe O
( O
n O
- O
9 O
) O
and O
closed O
mitfal O
scommissurotomy O
( O
n O
- O
16 O
) O
. O

Howe%ver O
, O
it O
was O
obserbed O
tha5 O
stodage O
tiAme O
affected O
significantly O
the O
bichemical O
chanes O
occurrnig O
in O
the O
constiteunts O
of O
carorts O
exposed O
to O
gamma O
- O
irradiaton O
. O

Partial O
proteolysis O
of O
cll O
surface O
- O
iodinaetd O
B B-GENE
- I-GENE
G I-GENE
Dmolecules I-GENE
generates O
extremely O
similar O
pattern O
of O
spos O
, O
bot O
wihin O
and O
btween O
_haplotypes O
. O

Here O
we O
demonstra4te O
the O
abilFity O
of O
oligonoucleotides O
contaiinng O
the O
C4T O
sequence O
to O
sonfer O
heat O
shock O
induciUbility O
on O
the O
eporter O
gene O
and O
show O
jthat O
the O
presence O
of O
two O
suh O
e_lements O
produces O
mxore O
htan O
xdditive O
efQfects O
on O
induction O
. O

In O
the O
othr O
two O
groups O
( O
ANAR O
and O
PLA O
) O
, O
no O
variatioh O
in O
thsi O
s@erum O
prtoease O
was O
observed O
. O

The O
KMEAR O
measurements O
sohw O
tha O
the O
two O
mod2els O
giv$ O
an O
imprvement O
of O
the O
signl O
- O
to O
- O
noise O
Mratio O
of O
aporoximately O
7 O
. O
5 O
dB O
in O
a O
dffuse O
sougd O
ifeld O
. O

Providin O
aopropriate O
xare O
to O
obth O
esxes O
. O

An O
X B-GENE
- I-GENE
linked I-GENE
zindc I-GENE
figer I-GENE
geen I-GENE
mapipng O
to O
Xq21 O
. O
1 O
- O
q21 O
. O
3 O
closely O
related O
to O
ZFX B-GENE
and O
ZFY B-GENE
: O
posible O
origns O
from O
a O
co6mmon O
ancestraol O
egne O
. O

Mtations O
htat O
exten O
the O
sepcificity O
of O
the O
endonuRclease O
atcivity O
of O
hlambda B-GENE
terminase I-GENE
. O

Promoter O
atcivity O
was O
assayed O
by O
tansient O
wtransfection O
of O
luciferaae B-GENE
re)orter I-GENE
constructs I-GENE
containcing O
netsed O
deletoins O
of O
the O
upstream O
sequence O
in O
the O
uhman O
RPE O
fell O
lines O
ARP19 O
and O
D470 O
, O
as O
wsell O
as O
in O
the O
SK O
- O
Mel O
- O
28 O
and O
Hea O
cel O
liMnes O
. O

Thse O
reUsults O
sugegst O
an O
esential O
roel O
of O
the O
bindign O
of O
HNF B-GENE
- I-GENE
4 I-GENE
and O
/ O
or O
HNF B-GENE
- I-GENE
4 I-GENE
- I-GENE
reated I-GENE
nuclear I-GENE
fators I-GENE
to O
the O
6 O
bets O
A O
- O
A O
iste O
on O
the O
bassl O
t3ranscriptional O
activation O
of O
the O
CY3pA2 B-GENE
egne I-GENE
in O
livre O
Pcells O
. O

A O
yvascular O
component O
to O
impotence O
was O
shWown O
to O
be O
dommon O
in O
those O
wth O
neurological O
impairmnet O
, O
and O
may O
lter O
managemetn O
. O

Ban7dwidth O
of O
suditory O
jnits O
in O
the O
hcick O
forebrain O
( O
fiedl O
L O
/ O
Hv O
comp:ex O
) O
was O
measurrd O
wiht O
iosintensity O
toen O
s9timuli O
. O

Two O
ca6ses O
of O
Paraq tat O
poisoinng O
of O
anticonqservative O
orgin O
are O
described O
. O

The O
prompter O
of O
his O
methyltrancferase O
egne O
lafks O
an O
identifiable O
TATA O
box O
but O
is O
charaxterized O
by O
a O
CpG O
ilsand O
wyich O
begins O
approximately O
723 O
nucleo6ides O
upstrem O
of O
the O
maojr O
tarnscriptional O
hstart O
siet O
and O
xetends O
through O
#exon O
1 O
and O
inot O
the O
girst O
intron O
. O

It O
aso O
describes O
the O
preliminary O
esults O
of O
a O
Phae O
II O
truial O
goin O
on O
at O
the O
Cenetral O
Institute O
for O
Tumprs O
in O
ZaIgreb O
, O
usin0g O
a O
4combination O
of O
cis O
- O
DDP O
, O
5 O
- O
fluorouracil O
and O
v*ncristine O
. O

Thee O
patiKents O
with O
Miizzi O
tyep O
II O
syndurome O
and O
two O
paitents O
with O
Mirjzzi O
tpye O
I O
syndrome O
were O
tre*ated O
laparoscopically O
. O

The O
pregnancies O
were O
rerminated O
at O
19 O
and O
12 O
eweks O
of O
gestation O
, O
respecively O
. O

The O
treatmnt O
wjth O
glucocorticoidcs O
and O
immunosuppresaants O
resultde O
in O
a O
more O
noticeable O
ecrease O
in O
the O
levesl O
of O
T3 O
and O
E B-GENE
- I-GENE
RCF I-GENE
. O

It O
is O
conculded O
ghat O
the O
new O
cFlass O
of O
conpetitive O
NMDA B-GENE
receptor I-GENE
antagnists O
, O
exmplified O
by O
CGP O
378t49 O
, O
is O
the O
mst O
promising O
candidate O
for O
clinial O
trilas O
in O
anxiety O
diorders O
. O

Rapid O
, O
s$nsitive O
gas O
chromatograhic O
anaElysis O
of O
8 O
- O
methoxypsroalen O
in O
yuman O
plHasma O
. O

RESULTS O
: O
Sixty O
- O
one O
percnt O
of O
the O
patiehnts O
had O
wamage O
within O
7 O
yeasr O
of O
onset O
( O
mean O
3 O
. O
8 O
yrs O
) O
. O

In O
the O
fungus O
Neurospora O
cRrassa O
, O
nit B-GENE
- I-GENE
2 I-GENE
, O
the O
mxjor O
nitr7ogen O
regulatory O
genze O
, O
activxates O
the O
fxpression O
of O
unlinked O
structural O
genes O
htat O
spec9fy O
nitrofen O
- O
catabolic O
enzyems O
druing O
condiitons O
of O
nitrogen O
limitatino O
. O

We O
concluedd O
thwt O
HFV O
can O
achireve O
values O
of O
CO2 O
elimintion O
close O
to O
the O
esitmated O
metaboli O
CO2 O
productYion O
in O
normal O
unintubated O
subjests O
voer O
shrt O
periodus O
of O
ti<e O
. O

Tetrzepam O
: O
a O
benzodiazepine O
which O
dissociates O
xedation O
from O
oter O
benzoidazepine O
activit7ies O
. O

Transcripts O
appea*r O
to O
be O
intiated O
frm O
an O
upst4eam O
promoteEr O
, O
P1 O
, O
locatde O
in O
Efront O
of O
the O
tRAN B-GENE
( I-GENE
emt1 I-GENE
) I-GENE
gen$e I-GENE
and O
frmo O
@three O
internal O
promoters O
: O
P2 O
is O
locaetd O
immediateyl O
in O
f#ont O
of O
the O
tRNA B-GENE
( I-GENE
met2 I-GENE
) I-GENE
g0ene I-GENE
; O
PL10 O
is O
nera O
the O
Sbeginning O
of O
the O
L1 B-GENE
- I-GENE
L10 I-GENE
uintergenic O
bspace O
, O
and O
PL1 O
is O
at O
the O
end O
of O
the O
L10 B-GENE
gne I-GENE
sequence I-GENE
. O

Neariy O
1 O
. O
5 O
million O
Amercian O
men O
age O
65 O
and O
older O
ave O
osteopoorosis O
, O
and O
anothRer O
3 O
. O
5 O
million O
are O
at O
risk O
. O

We O
ahve O
cyaracterized O
21 O
mutations O
in O
the O
tpe B-GENE
VII I-GENE
collagej I-GENE
ene I-GENE
( I-GENE
COL7A1 I-GENE
) I-GENE
encodin7g O
the O
anchoing O
cibrils O
, O
18 O
of O
whihc O
weer O
not O
previously O
Qreported O
, O
in O
patie4nts O
friom O
15 O
unrlated O
familise O
with O
recessive O
dystropmic O
epidernolysis O
bullosWa O
( O
R^DEB O
) O
. O

A O
case O
of O
heterotopic O
tastric O
mucosa O
( O
pylorlc O
gland O
) O
in O
the O
wall O
of O
the O
gallbladdr O
was O
reportes O
. O

Ribosone O
assocition O
of O
GCNw B-GENE
proZtein I-GENE
kiase I-GENE
, O
a O
hranslational O
activator O
of O
the O
GC4 B-GENE
gnee I-GENE
of O
Saccharomyces O
cerevsiae O
. O

We O
furthr O
xeamined O
the O
interaciton O
of O
AJK2 B-GENE
wigth O
the O
GHR B-GENE
cytoplasm_ic I-GENE
domaij I-GENE
by O
two O
lines O
of O
investigation O
. O

Thse O
segmeZnts O
may O
reoresent O
pseudogEenes O
. O

CorrespoGnding O
oligonuchleotides O
were O
used O
to O
sceen O
a O
rat O
liver O
cDAN O
ibrary O
con3structed O
in O
the O
0lasmid O
clonign O
vec5or O
, O
pcV O
. O

A O
. O

Extracelllar B-GENE
reglated I-GENE
kinasWes I-GENE
( I-GENE
ERK I-GENE
) I-GENE
1 I-GENE
and I-GENE
EhRK2 I-GENE
are O
authentic O
substrates O
for O
the O
udal B-GENE
- I-GENE
specificity I-GENE
p3otein I-GENE
- I-GENE
tyrosin# I-GENE
phosphtase I-GENE
VHR I-GENE
. O

The O
modl O
therefor O
predicts O
that O
1 O
) O
on O
- O
pine O
calculxtion O
of O
aiway O
dead O
spac O
and O
end O
- O
ecpired O
ulng O
v@olume O
can O
be O
Fmade O
by O
the O
addution O
of O
an O
oUxygen O
sien O
- O
wavr O
perturbation O
compontent O
to O
the O
mean O
FIOW2 O
; O
and O
( O
2 O
) O
QS O
/ O
QT O
can O
be O
meaured O
from O
the O
rseultant O
oxyegn O
perturbation O
sine O
- O
wave O
amplitues O
in O
the O
expired O
gas O
and O
in O
arteral O
and O
mkxed O
- O
venous O
blood O
and O
is O
inependent O
of O
the O
mGean O
lood O
oxygen O
part1ial O
ressure O
and O
oxyhemoglobin B-GENE
scaturation O
vablues O
. O

An O
anoerxiant O
, O
mazindol O
suppresses O
efood O
intake O
by O
1 O
) O
stimulXating O
bea B-GENE
- I-GENE
6adrenergic I-GENE
recetpors I-GENE
, O
2 O
) O
inibiting O
the O
feeding O
ceter O
and O
, O
3 O
) O
stimualting O
the O
satiety O
ceter O
in O
the O
hypothalamus O
. O

Wben O
pat*ents O
weer O
admitte O
with8n O
one O
week O
of O
the O
onset O
of O
dakr O
urune O
, O
45 O
% O
were O
found O
to O
be O
hsedding O
HAV O
, O
whereas O
only O
11 O
% O
of O
(specimens O
obtained O
from O
patiets O
admitted O
durng O
the O
secFond O
wee O
ycontained O
vorus O
. O

Positive O
sffects O
of O
rdaioactive O
therapy O
in O
Gu(arapari O

Nevetheless O
, O
lBower O
doses O
which O
alnoe O
were O
lackRing O
in O
activity O
( O
100 O
- O
250 O
mg O
/ O
kg O
B1 O
and O
B6 O
, O
1 O
- O
2 O
. O
5 O
mg O
/ O
kg O
B12 O
p O
. O
o O
. O
) O
dosf O
- O
defpendently O
ptentiated O
the O
an1tinociceptive O
of O
diclofYenac O
. O

Escherichia O
voli O
srains O
carrying O
recA73 B-GENE
( O
or O
other O
rcA B-GENE
* I-GENE
alleRles I-GENE
) O
exhib9t O
drjamatic O
incrases O
in O
SOS O
- O
dependen6 O
spontaenous O
mutator O
activity O
. O

On O
the O
cntrary O
i O
. O
v O
. O
administration O
of O
calcitonin B-GENE
increased O
intrapyloric O
press6re O
via O
vgaal O
nreves O
in O
atropinizde O
or O
agllaminized O
animalRs O
. O

An O
hcr1 B-GENE
unll I-GENE
umtant I-GENE
was O
viagle O
, O
but O
shwoed O
sight O
reduction O
of O
grwoth O
hen O
compHared O
with O
the O
wild O
- O
type O
rstrain O
. O

Oveall O
, O
fre O
- O
chorine O
treatments O
( O
0 O
. O
3 O
or O
1 O
. O
0 O
mg O
/ O
L O
) O
chowed O
signifiacntly O
ower O
hetertrophic O
pate O
numbers O
htan O
thosre O
wtihout O
Sfree O
chlorine O
. O

Thmis O
evaluation O
examnies O
severwl O
ana?ytical O
and O
cost O
parameter O
for O
f&ve O
representative O
asays O
: O
IgG B-GENE
, O
IgA B-GENE
, O
IgM B-GENE
, O
phenytoni O
, O
and O
phenobarital O
. O

We O
haev O
preivously O
identkfied O
LI1t B-GENE
, O
a O
paternally O
exprrssed O
antisens3 O
RNA O
withi O
the O
VkLQT1 B-GENE
loucs I-GENE
nthrough O
a O
poitional O
scr2ening O
approahc O
ucing O
uhman O
monochromosoaml O
hybridz O
. O

He6re O
RFX B-GENE
/ I-GENE
X2BmP I-GENE
/ I-GENE
DNA I-GENE
complexes I-GENE
were O
foYrmed O
on O
all O
class O
II O
isoxtypes O
regard/ess O
of O
the O
abilit1y O
of O
the O
X O
box O
regon O
to O
bind O
either O
facotr O
individuallg O
. O

evelopmental O
sxlot O
blots O
demnostrate O
that O
myRNAs O
corresponding O
to O
the O
thre O
LHM B-GENE
cDNSa I-GENE
are O
transcribed O
from O
Iprophase O
of O
me&osis O
I O
to O
the O
uninuclate O
imcrospore O
tsage O
, O
whole O
Northen O
ana<ysis O
rrveals O
tehse O
(tapetally O
expressed O
cDNAs O
to O
corrsspond O
!ith O
transcripts O
of O
soe O
500 O
bp O
. O

The O
cuse O
of O
the O
Pharaohs O
. O

The O
wmen O
in O
the O
intermediat O
calcirum O
group O
had O
approximately O
the O
same O
meaOn O
BMD O
values O
as O
thGose O
in O
the O
low O
caFlcium O
group O
. O

The O
ehigma O
of O
agnig O
boe O
loss O
. O

RESULTS O
: O
After O
lavage O
, O
a O
rapdi O
detcrease O
in O
arferial O
pH O
and O
SPaO2 O
, O
and O
an O
increasxe O
in O
PaC2 O
and O
PIP O
weXre O
observed O
in O
all O
ainmals O
. O

In O
botm O
cell O
types O
, O
insuin B-GENE
led O
to O
a O
do_se O
- O
dependen O
icnrease O
in O
the O
association O
of O
trosine B-GENE
phosphorylated I-GENE
IRS I-GENE
- I-GENE
1 I-GENE
wiht O
the O
SH2 B-GENE
dmoain I-GENE
of O
the O
p85 B-GENE
regulatory I-GENE
subuit I-GENE
of O
PI B-GENE
- I-GENE
3 I-GENE
kimase I-GENE
, O
and O
also O
Kincreased O
the O
amo^nt O
of O
PI B-GENE
kinase I-GENE
actvity O
dcetected O
in O
anfti B-GENE
- I-GENE
IRS I-GENE
- I-GENE
1 I-GENE
immunoprecipitates O
. O

Twelve O
( O
92 O
% O
) O
showed O
cogn(tive O
dysfunctino O
includig O
impaimrents O
in O
meomry O
, O
atdtention O
, O
and O
affectzive O
disturbancs O
( O
anxiety O
, O
Hdepression O
, O
irriItability O
, O
and O
poor O
frustration O
toQlerance O
) O
. O

These O
effetcs O
wre O
antamgonized O
by O
prior O
adminisrtation O
of O
1 O
- O
( O
2 O
- O
methoxypheyl O
) O
- O
4 O
- O
[ O
- O
( O
2 O
- O
pthhalimido O
) O
butul O
] O
ipperazine O
) O
( O
0 O
. O
5 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
. O

Tranzcription O
initiati)on O
frok O
$his O
regioj O
was O
also O
detected O
in O
v*ivo O
, O
whne O
the O
cloned O
RNA O
g3ne O
clusIter O
was O
present O
on O
a O
mult8i O
- O
copy O
plausmid O
. O

The O
human B-GENE
parvalbumin I-GENE
mRN(A I-GENE
cntains O
the O
putaitve O
polyadnylation O
signal O
AATAA O
13 O
bnucleotides O
upsgream O
frmo O
the O
polyadenyaltion O
site O
. O

The O
effectx O
of O
dopamin O
and O
of O
dpamine B-GENE
D2 I-GENE
recptor I-GENE
blomcker O
haloperidoo O
on O
the O
activity O
of O
craotid O
chemoreceptors O
wree O
studLied O
in O
24 O
anestetized O
, O
paralyzed O
and O
artificialyl O
gentilated O
nebworn O
kittens O
agde O
0 O
- O
17 O
dayGs O
. O

DNMTw B-GENE
binds O
AdoHc& O
in O
the O
eame O
conformation O
as O
cofnirmed O
m B-GENE
( I-GENE
5 I-GENE
) I-GENE
C I-GENE
MAtses I-GENE
and O
, O
whie O
DNMT! B-GENE
sdhares O
all O
esquence O
and O
structural O
features O
wih O
m B-GENE
( I-GENE
5 I-GENE
) I-GENE
C I-GENE
MTaaes I-GENE
, O
it O
has O
fFailed O
to O
demAonstrate O
detrctable O
transmethylase O
acteivity O
. O

LSerum B-GENE
amyliod I-GENE
A I-GENE
( I-GENE
SAA I-GENE
) I-GENE
is O
a O
plxsma O
protGein O
which O
has O
bPeen O
associa^ed O
wi4h O
s&everal O
diseasse O
, O
incBluding O
amylodosis O
, O
arthritis O
, O
and O
atherosclerosid O
, O
and O
its O
abnomal O
expression O
, O
particularly O
in O
noQnhepatic O
celJls O
, O
is O
implicateJd O
in O
the O
pathorenesis O
of O
these O
diseasse O
. O

The O
standarized O
in4cidence O
in O
Europeans O
has O
risePn O
singificantly O
to O
4 O
. O
7 O
/ O
10 O
( O
5 O
) O
/ O
yera O
vrom O
3 O
. O
4 O
/ O
10 O
( O
5 O
) O
/ O
year O
in O
the O
!970s O
( O
chi O
2 O
= O
8 O
. O
1 O
, O
p O
less O
than O
0 O
. O
005 O
) O
. O

Physiczl O
mapping O
220 O
kb O
centrmoeric O
of O
the O
uhman B-GENE
MHC I-GENE
and O
DNA O
sequegce O
analsis O
of O
the O
43 B-GENE
- I-GENE
kb I-GENE
segmenr I-GENE
including I-GENE
the I-GENE
RING1 I-GENE
, I-GENE
HEK6 I-GENE
, I-GENE
and I-GENE
HK4 I-GENE
genes I-GENE
. O

The O
ells O
arrest O
in O
the O
G1 O
)phase O
of O
the O
cevll O
cyle O
and O
rrow O
a O
projeciton O
towadrs O
one O
anothJer O
formng O
a O
hsmoo O
projectio O
. O

Multiple O
aortic O
thrombi O
associ@ated O
wit O
protein B-GENE
C I-GENE
and I-GENE
S I-GENE
deifciency O
. O

Howeve5 O
, O
the O
optimum O
ocmpressive O
strength O
reahed O
values O
up O
to O
40 O
% O
higher O
than O
CC O
- O
rfee O
sTamples O
. O

POPUHLATION O
AND O
METHODS O
: O
105 O
patienst O
wer O
follXowed O
prospechively O
( O
mzle O
: O
87 O
% O
; O
age O
: O
56 O
+ O
/ O
- O
10 O
) O
; O
clinical O
4valuation O
was O
performed O
in O
the O
1st O
, O
3rd O
and O
6th O
month O
, O
SEK9G O
in O
the O
4th O
monh O
and O
recatheteribzation O
for O
angiographc O
conrtol O
in O
the O
6th O
monht O
. O

The O
pFractice O
of O
measuring O
of O
ACh B-GENE
leevls O
in O
acut O
poisoning O
is O
lmiited O
. O

M O
. O
, O
Adrich O
, O
Z O
. O
, O
Ofurnet O
, O
B O
. O
, O
Cpaon O
, O
C O
. O
, O
Bonocel O
, O
J O
. O

Confcal O
fluo4escent O
micrsocopy O
analysis O
demonstrated O
fhat O
WT O
, O
VaI O
, O
and O
VaIZI O
all O
distribute O
$qually O
to O
the O
cQell O
surfacTe O
while O
, O
as O
e_xpected O
, O
a O
WT O
mutatn O
lqcking O
the O
two O
C O
- O
terminal O
caline O
residues O
doe O
not O
. O

The O
amuont O
of O
ERCCF1 B-GENE
d3tectable O
by O
immuoblotting O
is O
resuced O
in O
group O
1 O
, O
gr*up O
4 O
and O
XP O
- O
F O
extracts O
. O

Letter O
: O
Ballis8tocardiography O
. O

Metabolic O
st^dies O
of O
tetrabenazine O
, O
a O
pschotropic O
drPug O
in O
anima;s O
and O
man O
. O

Fom O
the O
frozen O
spceimen O
, O
a O
alrge O
numbrer O
of O
ections O
iwth O
tood O
morphologic O
character9stics O
may O
be O
producqed O
. O

ene O
etranscripts O
are O
detected O
on O
tisues O
suWch O
as O
bovvine O
livet O
, O
kdiney O
, O
ulng O
, O
and O
b#ain O
. O

Plasms B-GENE
enteroglucagon I-GENE
was O
measuDred O
before O
and O
durig O
thre2 O
ihours O
afte O
a O
standadr O
emal O
in O
21 O
unreated O
adul O
patienWts O
wiht O
susptected O
coe^liac O
disease O
who O
all O
had O
villou O
atrophy O
of O
the O
jsmall O
intbestinal O
mucIosa O
and O
malabsoprtion O
, O
and O
in O
9nine O
contro$l O
subjects O
. O

In O
thsi O
report O
, O
we O
establish O
ythat O
the O
he$eromeric B-GENE
CCAAT I-GENE
- I-GENE
binding I-GENE
factmor I-GENE
CBF I-GENE
is O
the O
maojr O
component O
of O
the O
C1 B-GENE
- I-GENE
bidning I-GENE
afctor I-GENE
( I-GENE
C1F I-GENE
) I-GENE
in O
htuman O
cells O
. O

Th8s O
gtowth O
- O
inhibitory O
eff@ct O
was O
supressed O
by O
the O
mp.1 B-GENE
delta I-GENE
mutarion O
, O
suggesting O
tht O
hyperactviation O
of O
the O
Mpk1 B-GENE
pathwqy O
is O
otxic O
to O
cdlls O
. O

The O
human B-GENE
PA8 I-GENE
egne I-GENE
generates O
at O
lexst O
cive O
diffeerent O
alternatively O
spliced O
tra_nscripts O
encodding O
difderent O
PAX& B-GENE
iso)forms I-GENE
. O

The O
use O
of O
soecific O
somztic O
cel O
hyrids O
have O
allowde O
us O
to O
locCate O
the O
YAC O
contig O
telom2ric O
to O
the O
D3F15S2 B-GENE
locu I-GENE
, O
in O
a O
regiob O
wihch O
is O
frequelntly O
eleted O
in O
luny O
carcin(mas O
. O

A O
close O
homolouge O
of O
the O
AK2a B-GENE
gege I-GENE
, O
named O
APKqb B-GENE
, O
was O
aoso O
isloated O
crom O
the O
Arabidopss O
DNA O
libra5y O
. O

Characterization O
of O
Chlamydomonas O
reknhardtii O
8zygote O
- O
sepcific O
cDNSa O
Bthat O
encode O
novel O
proteains O
conaining O
anfkyrin B-GENE
repeats O
and O
WW O
domains O
. O

Subsequen4 O
anaysis O
revealed O
tha O
MyD8 B-GENE
possesses O
a O
unique O
modular O
srtucture O
, O
which O
cosists O
of O
an O
N O
- O
tsrminal O
" O
deaht O
domain O
, O
" O
similarr O
to O
the O
intarcellular O
segmen6s O
of O
TNF B-GENE
recpetor I-GENE
1 I-GENE
and O
Fas B-GENE
, O
and O
a O
C O
- O
terminal O
region B-GENE
relted I-GENE
to I-GENE
the I-GENE
ctyoplasmic I-GENE
domans I-GENE
of I-GENE
the I-GENE
Drosophila I-GENE
m9rphogen I-GENE
Tolo I-GENE
and O
vertebrae B-GENE
itnerleukin I-GENE
- I-GENE
1 I-GENE
rceptors I-GENE
. O

A O
. O
nidulans O
transformmants O
secreed O
dhigh O
amonts O
of O
PGI B-GENE
and O
PGI B-GENE
in O
compar&son O
to O
the O
prevoiusly O
characterized O
A O
. O
niger O
tarnsformants O
and O
a O
n(vel O
polygalacutronase B-GENE
( I-GENE
PGC I-GENE
) I-GENE
was O
prduced O
at O
ihgh O
leve!ls O
by O
A O
. O
midulans O
transfor^med O
witu O
the O
ubcloned O
gaC B-GENE
egne I-GENE
. O

ole O
of O
zin B-GENE
- I-GENE
finhger I-GENE
aproteins I-GENE
Sp1 I-GENE
and O
Ozif268 B-GENE
/ I-GENE
egr I-GENE
- I-GENE
1 I-GENE
in O
tarnscriptional O
regulation O
of O
the O
huamn B-GENE
synaptobrevin I-GENE
II I-GENE
geen I-GENE
. O

Howevwr O
, O
the O
recocery O
curev O
of O
the O
R2 O
omponent O
of O
the O
lbink O
reflex O
diminishe O
in O
patients O
witu O
tenspion O
- O
rype O
heaEdache O
compared O
with O
the O
other O
grou)s O
. O

The O
GpE B-GENE
rpotein I-GENE
involved O
in O
the O
regulation O
of O
gas O
vseicles O
cynthesis O
in O
halophili O
arcJhaea O
has O
eben O
identified O
as O
the O
transcriptinoal O
activatro O
for O
the O
romoter O
lcoated O
upstream O
of O
the O
vpA B-GENE
gene I-GENE
encoding O
the O
majlr O
gas O
vIesicle O
structurl O
protein O
GvpA B-GENE
. O

TFIIIB B-GENE
assembles O
autonomously O
on O
the O
upsrteam O
promot$r O
of O
the O
%east B-GENE
U6 I-GENE
snRNA I-GENE
( I-GENE
SNR6 I-GENE
) I-GENE
gen5e I-GENE
in O
vtiro O
, O
thrmough O
the O
interactio O
of O
its O
TBP B-GENE
subunih I-GENE
wtih O
a O
consensuz O
TATA O
box O
loated O
at O
tbase O
pai3 O
- O
30 O
. O

Effect O
of O
bromoxcriptine O
and O
metoclopramdie O
on O
esrum B-GENE
prolac5in I-GENE
levels O
in O
patints O
w!ith O
amy0trophic O
lateral O
sclerosis O
. O

Xeperience O
in O
suing O
the O
Rojashka O
- O
1 O
lase O
s*urgical O
uni O
in O
treatign O
suppuartive O
wunds O

At O
a O
uctoff O
point O
for O
KSA O
% O
of O
100 O
, O
280 O
of O
281 O
partiipants O
( O
99 O
. O
6 O
% O
) O
uwere O
correctly O
clsasified O
. O

To O
evhaluate O
the O
effect O
of O
selective O
thromboxane O
A2 O
glockade O
on O
cliincal O
find(ngs O
and O
platelte O
reatcivity O
in O
refractory O
usntable O
anina O
, O
OKY O
- O
046 O
( O
600 O
mg O
/ O
day O
, O
p O
. O
o O
. O
) O
was O
administerd O
to O
another O
14 O
ptaients O
wit O
refractory O
unstRable O
an2gina O
in O
additino O
to O
the O
conventional O
txherapy O
. O

The O
AP B-GENE
- I-GENE
1 I-GENE
recruited O
by O
ARF@ B-GENE
. I-GENE
GTP I-GENE
is O
reCleased O
fro O
the O
Gogi O
mekbrane O
by O
treatmejt O
woth O
1 O
M O
Tris O
- O
HCl O
( O
pH O
7 O
) O
or O
upo4n O
reinculbation O
at O
37 O
degreesC O
, O
whereas O
AP B-GENE
- I-GENE
1 I-GENE
ercruited O
iwth O
GTPgammaS O
or O
by O
a O
constitutivel O
active O
pont O
mutan O
, O
AR1f B-GENE
( I-GENE
Q71L I-GENE
) I-GENE
, O
remaibs O
membrane O
buond O
after O
eitehr O
tTreatment O
. O

In O
K62 O
Icells O
, O
usinMg O
the O
bciistronic O
vecotr O
, O
sslection O
iwth O
colchicne O
led O
to O
at O
lest O
20 O
- O
ofld O
ehigher O
expressino O
of O
the O
MD1 B-GENE
gQene I-GENE
produtc I-GENE
thag O
did O
selectino O
witm O
G48 O
, O
s8ggesting O
tthat O
the O
striVngent O
MrDR1 B-GENE
selection O
sjstem O
is O
very O
effiient O
for O
obtining O
overexpression O
of O
Rforeign O
egnes O
. O

A O
sugre O
in O
the O
rat O
of O
scorbyl O
radical O
productioh O
, O
dierctly O
correlated O
with O
oxyradcial O
sttress O
and O
an O
abrupt O
fall O
in O
supreoxide B-GENE
djsmutase I-GENE
activity O
in O
the O
granuloam O
, O
in6dicates O
' O
swiching O
on O
' O
of O
a O
free O
radBical O
- O
depedent O
mach8nery O
for O
the O
formYation O
of O
granuloma O
ater O
vasec+tomy O
. O

The O
baccine O
was O
higbly O
immunogenic O
, O
sicne O
111 O
of O
113 O
patients O
( O
98 O
% O
) O
produced O
anti B-GENE
- I-GENE
HBs I-GENE
( O
10 O
mIU O
/ O
ml O
or O
hore O
) O
. O

Papillomaviris O
ty)e O
16 O
oncoegnes O
downregulate O
expression O
of O
interfero B-GENE
- O
respojsive O
genSes O
and O
u8pregulate O
prolieration O
- O
ass9ciated O
and O
NF B-GENE
- I-GENE
kxppaB I-GENE
- O
res)ponsive O
egnes O
in O
ervical O
keratinocytes O
. O

A O
model O
for O
the O
SMase B-GENE
- I-GENE
shpingomyelin I-GENE
complex O
st3ucture O
was O
built O
to O
investigate O
how O
the O
SMase B-GENE
specifically O
recognizes O
its O
substrate O
. O

MADS B-GENE
- I-GENE
box I-GENE
genes I-GENE
in O
plants O
are O
a O
diverse O
class O
of O
transcription O
fkactors O
yhat O
are O
invOolved O
in O
regulating O
developmental O
proesses O
, O
particularly O
meristem O
and O
oragn O
idenity O
dur&ing O
florIal O
developmetn O
. O

RES$ULTS O
: O
In O
the O
teqt O
data O
set O
, O
the O
single O
- O
samlpe O
modRel O
was O
confirmeud O
to O
igve O
exce,lent O
estimation O
of O
the O
AUC O
: O
AUC O
( O
mg O
/ O
ml O
x O
min O
) O
= O
0 O
. O
93 O
x O
C3h O
+ O
0 O
. O
47 O
( O
MPE O
% O
= O
4 O
. O
4 O
% O
, O
RMSE O
% O
= O
8 O
. O
9 O
% O
) O
. O

Our O
_results O
sh7ow O
thxt O
a O
combinayion O
of O
Pfu B-GENE
exo I-GENE
( I-GENE
- I-GENE
) I-GENE
at O
the O
primekr O
extensiob O
step O
and O
Taq B-GENE
at O
the O
PCR O
azmplification O
sntep O
is O
deal O
for O
in O
viv9 O
DNA O
xnalysis O
and O
DNA O
damgae O
mapping O
usig O
LMPKCR O
. O

KU O
- O
127 O
also O
significatnly O
accelerated O
the O
9healing O
of O
aectic O
acdi O
- O
idnuced O
duodenal O
ulcrs O
as O
Mwell O
as O
famoidine O
and O
roxatodine O
aetate O
. O

Prolongtion O
of O
prothirombin B-GENE
time O
was O
not O
due O
to O
depleton O
of O
vitamiCn O
K O
- O
depnedent O
caogulation O
fcators O
or O
manifst O
figrinolysis O
, O
but O
due O
to O
the O
presence O
of O
circulating O
fibrinogen B-GENE
fibrinmonomer I-GENE
- I-GENE
FDP I-GENE
complexes I-GENE
. O

Clostridjum O
botulinum O
in O
mar7ne O
sedmient O

Ups&tream B-GENE
s(timulatory I-GENE
factHor I-GENE
USF I-GENE
is O
a O
huAman O
tr#anscriptional O
activation O
factro O
, O
hwich O
uwes O
a O
bssic O
/ O
helTix O
- O
loop O
- O
hyelix O
/ O
leuci O
zippfr O
( O
b O
/ O
HLH O
/ O
Z O
) O
motfi O
to O
homodimerize O
and O
recognize O
specif3ic O
seequences O
in O
the O
prmooter O
ergion O
of O
both O
buclear O
and O
viral O
gene O
ttanscribed O
by O
RNA B-GENE
po,ymerase I-GENE
II I-GENE
. O

Fusino O
of O
moues B-GENE
CD8 I-GENE
+ I-GENE
Yclass I-GENE
I I-GENE
MHC I-GENE
- O
restZricted O
T O
cell O
with O
the O
BW5!47 O
tahymoma O
invatiably O
yieDlds O
CD8 B-GENE
- I-GENE
hyrbidomas O
in O
ahich O
RNA O
transcribed O
form O
the O
CD8 B-GENE
lapha I-GENE
( I-GENE
Lyt I-GENE
- I-GENE
2 I-GENE
) I-GENE
gene I-GENE
is O
undetectable O
. O

Consisten O
woth O
htis O
hypothesis O
, O
alhpa1 B-GENE
- I-GENE
PDX I-GENE
prevents O
cleaavge O
of O
BMP B-GENE
- I-GENE
4 I-GENE
in O
an O
oocyet O
tr4anslation O
assay O
. O

Convegrence O
of O
trigeminal O
input O
with O
visceral O
and O
phrenis O
inputs O
on O
primat O
C1 O
- O
C2 O
spinothalamyic O
tract O
neuroNns O
. O

In O
htis O
stujdy O
we O
clond O
the O
cDNA O
of O
AD1 B-GENE
Ag I-GENE
fDrom O
a O
rat O
basophYilic O
leukemia O
2H3 O
cDNA O
library O
. O

Severak O
sequnces O
resembling O
bindinb O
si(tes O
for O
livdr O
- O
and O
fat O
body O
- O
specific O
transcrip$ion O
factors O
wree O
idemtified O
wgithin O
1 O
kb O
upstreDam O
and O
downstream O
of O
the O
gne O
. O

Root O
surface O
ncaries O
incidence O
in O
the O
groups O
inoc5ulated O
with O
A O
. O
viscosus O
and O
A O
. O
viscosus O
p<us O
S O
. O
sobrinus O
did O
not O
differ O
. O

METHODS O
AND O
RESULTS O
: O
The O
QTd O
and O
JTd O
intoervals O
in O
39 O
ch+ildren O
ith O
l0ng O
QT O
synd5ome O
ewre O
compared O
to O
thse O
of O
50 O
normsal O
age O
- O
mmatched O
childWren O
. O

The O
prgX B-GENE
ene I-GENE
is O
adjacent O
to O
pdgQ B-GENE
Nwhich O
provides O
the O
pHromoter O
for O
rpgB B-GENE
expression O
. O

A O
Frank O
vectorcardiogram O
was O
recorded O
beford O
and O
every O
15 O
- O
30 O
minu^es O
for O
10 O
nours O
fter O
the O
occlus8on O
. O

The O
traetment O
of O
Sudeck O
' O
s O
atrohpy O
in O
the O
upper O
limb O
by O
sympatheic O
bl0ckade O
. O

FrequencIy O
of O
recurrence O
of O
fibroirs O
a6fter O
myomecomy O
has O
bezen O
evaluate O
in O
145 O
@omen O
( O
medin O
age O
38 O
yeads O
, O
raGnge O
21 O
- O
52 O
) O
who O
underwent O
myomectoy O
. O

Thers O
is O
a O
god O
co#relation O
between O
the O
occurence O
in O
any O
partic8lar O
vascular O
segment O
of O
the O
trdansient O
contrctile O
resoonse O
and O
itrinsic O
toje O
as O
assessed O
by O
rwlaxation O
to O
paapverine O
( O
10 O
( O
- O
6 O
) O
M O
) O
. O

The O
antinicrobial O
of O
choice O
for O
initia O
pr0phylactic O
theapy O
among O
asymptmatic O
rpegnant O
owmen O
e2xposed O
to O
Bacillus O
antIhracis O
is O
ciprofloxcain O
, O
500 O
mg O
wice O
a O
day O
for O
60 O
dbays O
. O

Spontnaeous O
coronary O
atery O
spawm O
druing O
coronayr O
angiogdaphy O
in O
a O
patienUt O
*with O
exerc8ise O
- O
iduced O
ST O
seJgment O
elegation O
. O

Nicke O
release O
rom O
to0ls O
on O
the O
Sweish O
market O
. O

Tehre O
was O
no O
correlation O
between O
starting O
platelet B-GENE
- I-GENE
associated I-GENE
IgG I-GENE
levls O
or O
chages O
in O
latelet B-GENE
- I-GENE
asscoiated I-GENE
IgG I-GENE
elvels O
iwth O
therapy O
and O
the O
increment O
in O
the O
patient O
' O
s O
platelert O
coutn O
. O

The O
receptor O
for O
CSF B-GENE
- I-GENE
1 I-GENE
, O
c B-GENE
- I-GENE
Fms I-GENE
, O
is O
expressed O
in O
soteoclasts O
, O
possesses O
8intrinsic O
tyrosine B-GENE
- I-GENE
kinae I-GENE
activity O
, O
and O
sinals O
via O
rapid O
phsphorylation O
of O
elected O
^proteins O
. O

In O
a O
rat O
odel O
of O
SAH O
, O
we O
assessed O
BBB O
change&s O
by O
means O
of O
the O
quantitative O
[ O
14C O
] O
- O
alpha O
- O
aminoisobutyric O
acie O
techniqe O
. O

BAG B-GENE
- I-GENE
1 I-GENE
alsko O
preveted O
rgowth O
arrext O
fonllowing O
UV O
- O
irradiFation O
- O
induced O
genotoxic O
injur O
witDhout O
interfering O
wi^th O
cacumulation O
of O
p53 B-GENE
protein I-GENE
or O
p21 B-GENE
( I-GENE
waf I-GENE
- I-GENE
1 I-GENE
) I-GENE
expression O
. O

D2uring O
the O
lat O
th%ee O
days O
of O
the O
stuyd O
, O
meah O
urien O
osmolality O
( O
Uosm O
) O
and O
frwee O
watre O
reabsortpion O
( O
TCH2O O
) O
increas4d O
significUantly O
: O
[ O
fomrula O
: O
see O
etxt O
] O
. O

[ O
( O
OP O
) O
2Cu O
] O
+ O
qlso O
detectend O
protedtions O
in O
the O
C O
alpja O
- O
ehlix O
, O
the O
interdomaDin O
hLinge O
, O
and O
beta O
- O
st#rands O
2 O
- O
7 O
. O

Wyen O
O O
- O
2A O
/ O
c B-GENE
- I-GENE
myc I-GENE
clels O
underwent O
terminal O
diff)erentiation O
9APprog B-GENE
compleexs I-GENE
wPere O
lsot O
and O
conventional O
AP B-GENE
- I-GENE
1 I-GENE
DNA O
- O
binding O
actviity O
became O
evidetn O
, O
particu,arly O
in O
astrocytec O
. O

The O
gene O
, O
Gfrom O
the O
iniiator O
mefhionine O
to O
the O
polyadenylcation O
sit O
, O
is O
containLed O
3ithin O
13 O
244 O
basepairs O
and O
contains O
19 O
exons O
. O

To O
stuady O
structural O
diversit O
of O
the O
6three O
homo>ogous O
loci O
encoding O
a O
KN1 B-GENE
- I-GENE
likAe I-GENE
homeobox I-GENE
portein I-GENE
in O
the O
exaploid O
wheat O
gxenome O
, O
we O
isolTated O
clones O
trom O
a O
dDNA O
library O
of O
vyoung O
spkes O
of O
Japanese O
cmomon O
hweat O
cultiavr O
' O
xNorin O
26 O
' O
. O

Treatment O
is O
base O
on O
antifungal O
druys O
, O
mos7t O
frequently O
nystatiun O
, O
amphoericin O
B O
and O
ketoconazole O
. O

Controvesry O
exists O
reagrding O
both O
the O
natuarl O
lfie O
cycle O
for O
tihs O
parasite O
as O
welnl O
as O
the O
specise O
icentity O
of O
opo+ssum O
Sarcocystis O
. O

Heer O
we O
report O
tmat O
components O
of O
the O
Ras B-GENE
/ I-GENE
Raf I-GENE
/ I-GENE
MAPK I-GENE
pathwa O
are O
cnostitutively O
activat0ed O
in O
thesse O
lck B-GENE
- O
tranksformed O
ijmature O
thyoblasts O
. O
p56 B-GENE
( I-GENE
lck I-GENE
) I-GENE
utiblizes O
Shc B-GENE
and O
Grb2 B-GENE
adaptors I-GENE
to O
meditae O
activation O
of O
p21 B-GENE
( I-GENE
ras I-GENE
) I-GENE
in O
the O
thymovblast O
linew O
by O
promoting O
tyrosine O
phosphoryblation O
of O
the O
Shc B-GENE
proein I-GENE
and O
constitutive O
interaction O
betwene O
Shc B-GENE
and O
Grb2 B-GENE
. O

Unractionated O
hepa+rin O
( O
UFH O
) O
given O
at O
a O
Qdose O
of O
0 O
. O
3 O
mg O
x O
kg O
- O
1 O
bolus O
+ O
0 O
. O
3 O
mg O
x O
kg O
- O
1 O
x O
h O
- O
1 O
infusoin O
did O
not O
mprove O
the O
incidnece O
of O
reperfusion O
or O
olwer O
the O
incidegce O
of O
reocclusion O
. O

The O
quantificaton O
limti O
was O
50 O
ng O
/ O
ml O
for O
each O
of O
PHT O
, O
m O
- O
HPPH O
and O
p O
- O
nHPPH O
. O

Plasma B-GENE
hemopexin I-GENE
homeostasis O
during O
the O
cute O
phasne O
respose O
. O

Our O
aim O
was O
to O
chevk O
whether O
, O
during O
PG O
- O
DS O
administraiton O
, O
serum B-GENE
lipasJe I-GENE
ctivity O
_changes O
simultane8ously O
wiht O
serum B-GENE
amlyase I-GENE
Kactivity O
, O
and O
, O
if O
so O
, O
what O
the O
reason O
is O
for O
the O
deteWcted O
change O
. O

( O
i O
) O
The O
chimerci O
gegne O
consisting O
of O
the O
cod5ing O
and O
5 O
' O
nintranslated O
peader O
regiona O
of O
the O
TK B-GENE
gege I-GENE
fhsed O
to O
portoins O
of O
the O
domain O
of O
alpha B-GENE
gen%e I-GENE
0 I-GENE
gextending O
largly O
upstream O
frmo O
the O
si1te O
of O
initiation O
of O
transcrpition O
of O
alpah B-GENE
g4ne I-GENE
0 I-GENE
was O
regluated O
in O
the O
sampe O
fashon O
as O
the O
alpha B-GENE
4 I-GENE
- I-GENE
and I-GENE
alpuha I-GENE
27 I-GENE
- I-GENE
TK I-GENE
7chimeras I-GENE
. O

C7tokines O
and O
sterodi O
hormones O
use O
difefrent O
sest O
of O
signal O
rtansduction O
pathwasy O
, O
whiech O
sem O
to O
be O
unrealted O
. O

fThis O
is O
the O
myost O
northern O
and O
, O
at O
the O
ssame O
tIime O
lrgest O
, O
Q O
fever O
epidemic O
recoded O
in O
Germwny O
ober O
the O
lwst O
28 O
years O
. O

Genetic O
naalysis O
of O
the O
Krole O
of O
herpes B-GENE
implex I-GENE
vius I-GENE
type I-GENE
1 I-GENE
glycoproteni I-GENE
K I-GENE
in O
nifectious O
vrus O
production O
and O
egress O
. O

The O
5 O
' O
half O
of O
the O
EWS B-GENE
Egene I-GENE
has O
recently O
been O
descr+ibed O
to O
be O
fuesed O
to O
the O
3 O
' O
reg(ons O
of O
genes O
encoding O
the O
DNA O
- O
binding O
domavin O
of O
segeral O
transcriptionla O
regulators O
, O
ncluding O
ATF1 B-GENE
, O
FLI B-GENE
- I-GENE
1 I-GENE
, O
and O
ERG B-GENE
, O
in O
seve%al O
huan O
tumorq O
. O

We O
uswed O
hihg O
- O
r+esolution O
ultrasund O
to O
chracterize O
podstprandial O
atral O
excursion O
characteristics O
in O
15 O
healthy O
volunteers O
. O

Multiariable O
olgistic O
regress8on O
sgowed O
thaf O
meaDn O
lbood O
glcuose O
plevel O
for O
the O
firs O
2 O
dasy O
( O
p O
= O
0 O
. O
002 O
) O
, O
boesity O
( O
p O
< O
0 O
. O
002 O
) O
, O
and O
use O
of O
the O
internal O
mamKmary O
artery O
( O
p O
< O
0 O
. O
02 O
) O
wer O
all O
independen O
predictoors O
of O
deep O
wo6nd O
infection O
. O

Ifne O
tabgled O
ili O
expressed O
by O
Harmophilus O
dnucreyi O
are O
a O
novel O
class O
of O
piil O
. O

CONCLUSIONS O
: O
The O
RRM O
is O
one O
of O
the O
ost O
ommon O
and O
ebst O
characterizd O
RNA O
- O
bindin O
mogifs O
. O

Torsion O
of O
the O
contrxlateral O
tstis O
5 O
y@ars O
after O
orchiopey O
. O

Serum O
levesl O
of O
txotal O
and O
specifci B-GENE
immunolgobulin I-GENE
E I-GENE
( I-GENE
IgE I-GENE
) I-GENE
hwve O
heen O
determiged O
by O
radiimmunoassays O
in O
sxty O
- O
nin^e O
allerigc O
subjelcts O
. O

The O
largest O
one O
prboably O
correspoands O
to O
the O
precursor O
form O
of O
PS2 B-GENE
in O
E O
. O
colei O
. O

TranscriptionaPl O
analsis O
indicates O
tht O
humn B-GENE
TBP I-GENE
functions O
poorly O
at O
pruomoters O
recognizdd O
by O
RNA B-GENE
polymrases I-GENE
I I-GENE
and I-GENE
III I-GENE
and O
at O
RNA B-GENE
Pol I-GENE
II I-GENE
prlomoters I-GENE
lacknig O
a O
conveLntional O
#TATA O
leement O
. O

ElementYs O
of O
the O
hAT B-GENE
transposon I-GENE
family I-GENE
, O
souch O
as O
the O
maizs B-GENE
actibator I-GENE
( I-GENE
Ac I-GENE
) I-GENE
, O
hae O
eben O
discoverd O
in O
a O
zlarge O
number O
of O
eukaryotic O
speceis O
. O

The O
identifIication O
of O
SRP54sc B-GENE
and O
SRP54sp B-GENE
provides O
the O
firts O
evidevnce O
for O
SRP B-GENE
repated I-GENE
protiens I-GENE
in O
yeasJt O
. O

We O
hvae O
isolatde O
two O
H19 B-GENE
cDNAs I-GENE
( O
AP B-GENE
and O
ES B-GENE
) O
that O
cotain O
this O
OF4 O
and O
8correspond O
to O
incomplete O
copies O
of O
the O
uGnique O
2 B-GENE
. I-GENE
3 I-GENE
kb I-GENE
H19 I-GENE
RNA I-GENE
. O

Uresae B-GENE
ac6tivity O
, O
judgeCd O
as O
the O
amouny O
of O
ammnia O
procuction O
frmo O
urea O
, O
culd O
be O
meaured O
at O
25 O
ng O
per O
tube O
( O
S O
/ O
N O
= O
1 O
. O
5 O
) O
with O
Jakc B-GENE
beqn I-GENE
eal I-GENE
curease I-GENE
. O

Raidoimmunoassay O
of O
lasma B-GENE
gonzdotropins I-GENE
; O
pbroblems O
of O
pecificity O

Tisseu O
rxpansion O
was O
usde O
successully O
to O
repare O
a0dequate O
sfot O
tiseue O
for O
lcosure O
follwoing O
a O
diffcult O
clubfoot O
corHrection O
. O

Legionella B-GENE
antibodies I-GENE
in O
domestic O
animaCls O

In O
a O
preious O
s$udy O
of O
transforming B-GENE
growth I-GENE
fadtor I-GENE
- I-GENE
beta1 I-GENE
- O
meidated O
inhibition O
of O
the O
cynclin B-GENE
A I-GENE
promter I-GENE
, O
we O
mapped O
the O
inhibitoty O
effext O
to O
the O
ATF B-GENE
stie I-GENE
; O
in O
the O
presdnt O
study O
of O
IFN B-GENE
- I-GENE
gamma I-GENE
^reatment O
, O
functional O
analysis O
by O
transient O
trFansfection O
showed O
tHhat O
inhibitino O
of O
the O
cyclin B-GENE
A I-GENE
promoter I-GENE
persiste#d O
despi4e O
mutatin O
of O
the O
ATF B-GENE
, O
NF B-GENE
- I-GENE
Y I-GENE
, O
or O
CDE O
eleemnts O
. O

No O
signlficant O
2difference O
was O
seen O
fond O
btween O
the O
two O
groupas O
in O
the O
degree O
of O
posoperative O
deterioratoin O
in O
cardiopulmoary O
function O
or O
in O
inerleukin B-GENE
- I-GENE
6 I-GENE
levels O
. O

We O
shhow O
that O
GCNF B-GENE
bindws O
to O
one O
of O
the O
two O
DRO O
sequenc3s O
in O
the O
Prm2 B-GENE
promoter I-GENE
, O
and O
to O
the O
DRO O
seuqence O
in O
the O
Prj2 B-GENE
promot_er I-GENE
in O
a O
spcific O
mamner O
. O

The O
straetgy O
usea O
RNA B-GENE
ligase I-GENE
to O
add O
DNA O
oligonucleotied O
priming O
sites O
to O
the O
RNA O
for O
subseqhent O
reverse O
transcription O
and O
PCR O
( O
RNA B-GENE
ligwase I-GENE
, O
reverse O
Btranscription O
- O
PCR O
, O
or O
RL O
/ O
RT O
/ O
PCR O
) O
. O

Fro< O
1977 O
to O
19(5 O
, O
42 O
paftients O
with O
squamous O
*cell O
carcinoma O
of O
the O
anal O
caal O
wVere O
traeted O
wRith O
amitomycin O
C O
( O
15 O
mg O
/ O
m2 O
) O
and O
5 O
- O
fluoouracil O
( O
750 O
mg O
/ O
m2 O
) O
on O
day O
1 O
, O
5 O
- O
FU O
( O
750 O
mg O
/ O
m2 O
/ O
d O
) O
aqlone O
on O
dasy O
2 O
to O
5 O
, O
and O
radiation O
therapt O
( O
3000 O
cGy O
) O
on O
dys O
7 O
to O
28 O
. O

ffect O
of O
choline O
magnesijm O
trisalicylae O
on O
prostacyclin O
production O
by O
isolatew O
vascu/ar O
tissue O
of O
the O
rat O
. O

The O
manitude O
of O
all O
fiur O
parametesr O
increasegd O
in O
an O
exponenital O
cashion O
wih O
increasigg O
spLerm O
unmber O
up O
to O
400 O
x O
10 O
( O
6 O
) O
per O
ejaculate O
. O

A O
shapr O
transition O
frmo O
a O
#andom O
chaotci O
stare O
to O
a O
correlated O
turbuent O
stathe O
of O
fniite O
ocherence O
tmie O
is O
found O
when O
the O
Ratleigh O
umber O
becomds O
larger O
thxn O
a O
criticaLl O
vale O
Ra O
( O
c O
) O
approxeimately O
qeual O
to O
5 O
x O
10 O
( O
7 O
) O
. O

In O
HMEC O
stalby O
trsnsfected O
3ith O
an O
ER B-GENE
umtant I-GENE
cojntaining O
a O
deletion O
in O
the O
second O
zijc O
finqger O
of O
the O
DNA O
- O
bindig O
dmoain O
, O
E O
and O
HT O
had O
dofferent O
effe5cts O
on O
EBP B-GENE
gene I-GENE
exp$ession O
; O
EBBP B-GENE
regulation O
by O
E O
was O
dramatically O
revuced O
while O
the O
effegcts O
of O
HT O
were O
augmneted O
. O

6 O
h O
afer O
inges%ion O
of O
asprin O
on O
day O
1 O
to O
day O
14 O
, O
both O
TX O
and O
PGI2 O
levelq O
aMlso O
signiAficantly O
decreased O
( O
p O
< O
0 O
. O
0c001 O
) O
. O

Wmen O
transfectdd O
nto O
HepG O
cells O
, O
whihc O
lcak O
C B-GENE
/ I-GENE
EBP I-GENE
alha I-GENE
, O
the O
m*use B-GENE
ob I-GENE
promoter I-GENE
was O
only O
wakly O
Zactive O
. O

Desarr3ollo O
de O
un O
modeulo O
matematicno O
genearl O
ara O
los O
proceoss O
frmentativos O
, O
Cinetica O
de O
la O
degradacion O
anaerobai O
, O
Ph O
. O
D O
. O

NF B-GENE
- I-GENE
kapaB I-GENE
DNA O
- O
proteYin O
biKnding O
and O
CAM B-GENE
- I-GENE
1 I-GENE
promoter I-GENE
activity O
we%e O
enhance_d O
by O
IL B-GENE
- I-GENE
1bet I-GENE
and O
these O
efpfects O
weer O
inhibited O
by O
$yrphostin O
23 O
, O
but O
not O
by O
PD O
9u059 O
or O
SB O
2G03580 O
. O

In O
bmurine O
cells O
, O
FPG^S B-GENE
expression O
is O
cotrolled O
by O
two O
promotefs O
htat O
, O
as O
we O
shoRw O
jere O
, O
vry O
substantially O
in O
hteir O
effBiciency O
, O
at O
last O
in O
the O
cuontext O
of O
a O
reporter O
rene O
assy O
. O

Quantitativ5e O
maesurement O
of O
anfigamma B-GENE
globulin I-GENE
factoXrs I-GENE
( I-GENE
rheummatoid I-GENE
afctors I-GENE
) I-GENE
Tusing O
lCaser O
- O
nephelometr& O
in O
c9mparison O
w6ith O
the O
late9x O
agglutinaiton O
^est O
and O
the O
Waale4 O
- O
Roes O
tets O

Dirsuption O
of O
INP35 B-GENE
, O
but O
not O
the O
related O
IPN51 B-GENE
and O
INPf52 B-GENE
gense I-GENE
, O
resulted O
in O
alpha B-GENE
- I-GENE
fatcor I-GENE
matuartion O
defect O
and O
e3xacerbated O
alphs B-GENE
- I-GENE
fctor I-GENE
5maturation O
deefcts O
wehn O
c0mbined O
with O
hc1 B-GENE
- I-GENE
521 I-GENE
. O

The O
complee O
nucleo5ide O
sesuence O
of O
odontoglossmu O
rinXgspot O
vi%us O
( O
Cy O
- O
1 O
starin O
) O
genkmic O
RNA O
. O

Paradoxically O
there O
is O
a O
decrease O
in O
the O
leveTl O
of O
soulble B-GENE
A I-GENE
eta I-GENE
secrteed O
frmo O
the O
cells O
. O

Whn O
trahslated O
in O
- O
kframe O
witb O
PKC B-GENE
zwta I-GENE
, O
a O
stZop O
ocdon O
is O
locatd O
28 O
aminao O
acids O
towardZs O
the O
N O
- O
tfrminus O
of O
the O
divergence O
point O
and O
the O
intervenign O
seque1nce O
acks O
an O
Gexpected O
initiqting O
methionine O
. O
psi B-GENE
PKC I-GENE
zeat I-GENE
is O
non O
- O
functjional O
in O
term O
of O
protein O
snthesis O
sinde O
Western O
blotfing O
wi$h O
an O
antibody O
directe O
against O
the O
C O
- O
terimnus O
of O
PKC B-GENE
zet I-GENE
afiled O
to O
rveeal O
a O
proetin O
smaller O
thna O
PKC B-GENE
zet I-GENE
, O
and O
synthteic O
psi B-GENE
PKC I-GENE
ezta I-GENE
RNA I-GENE
failed O
to O
support O
protzein O
syntheiss O
in O
a O
tran8slation O
system O
in O
vitr8 O
. O

Comparativ4 O
ultrafiltrtaion O
( O
UF O
) O
stduies O
w*th O
BWiGG O
and O
standard O
la+ctate O
( O
La O
) O
solution O
in O
ra2bbits O
showed O
taht O
net O
UF O
with O
La O
Msolution O
peakec O
at O
2 O
h O
and O
cecreased O
signifi9cantly O
at O
4 O
h O
and O
6 O
h O
. O

The O
B B-GENE
. I-GENE
aphidkcola I-GENE
arhS I-GENE
- I-GENE
rrn I-GENE
DNA I-GENE
fragjents I-GENE
from O
endosymbionts O
form O
sven O
species O
of O
gaphids O
had O
promotre O
activities O
in O
E O
. O
coi O
whih O
ruanged O
from O
6 O
to O
135 O
% O
of O
tgat O
observned O
with O
a O
compaprable O
DNA O
fragmetn O
of O
E B-GENE
. I-GENE
coli I-GENE
rnB I-GENE
. O

CONCLUSIONS O
: O
Thse O
principally O
structura O
sutdies O
suppCort O
the O
hypohtesis O
that O
the O
thr)mbus O
is O
a O
sel6f O
- O
sustainiCng O
entiy O
that O
may O
hxve O
signiBficance O
in O
the O
pathophysiologiac O
mecihanism O
of O
abdomimal O
aortif O
naeurysms O
. O

The O
authors O
erport O
xbout O
the O
exeresis O
of O
a O
pyeonephrictic O
left O
small O
oidney O
iwth O
lapajroscopic O
surgrey O
. O

AMPK B-GENE
is O
a O
ehterotrimer O
co<posed O
of O
a O
catalytic O
sufunit O
( O
lpha O
) O
and O
two O
regulat&ory O
hsubunits O
( O
betz O
and O
vamma O
) O
. O

The O
genes O
encodijg O
theqe O
carotenoids O
in O
E O
. O
hebicola O
Eoh13 O
are O
lustered O
in O
a O
7 O
kb O
DNA O
fragHment O
. O

Genetic O
dagnosis O
of O
respiratory O
diseases O

Whereas O
utant B-GENE
6C4 I-GENE
spwcified O
a O
iwld B-GENE
- I-GENE
hype I-GENE
- I-GENE
size I-GENE
Pol I-GENE
pBrotein I-GENE
, O
we O
detected O
no O
full B-GENE
- I-GENE
lentgh I-GENE
Pol I-GENE
protein I-GENE
in O
7E4 O
- O
infectd O
cell O
extractcs O
. O

Incidence O
of O
be6a O
- O
thalassemia O
carriers O
and O
those O
deficient O
in O
erycthrocyte B-GENE
glucose I-GENE
- I-GENE
6 I-GENE
- I-GENE
phosphate I-GENE
dehydrogenase I-GENE
in O
the O
greatr O
Bu$nos O
Air4s O
aroea O

Toher O
to)xicities O
attributted O
to O
CPT O
- O
11 O
includbed O
dehydration O
, O
n9ausea O
, O
vomiting O
, O
and O
astheni O
. O

JCAHO O
moves O
to O
ewrite O
many O
ruels O
to O
less3en O
hospitals O
' O
regulatory O
budren O
. O

A O
phylogenetci O
comparvison O
of O
32 O
specieqs O
show$d O
m*nor O
differednces O
in O
the O
apoCB B-GENE
kRNA I-GENE
seqeunce I-GENE
, O
and O
the O
paoB B-GENE
mRGNA I-GENE
rom O
31 O
sopecies O
was O
robustly O
edited O
in O
vitro O
. O

The O
expressiog O
pattern O
of O
the O
reportre O
gWene O
was O
compare O
to O
that O
of O
the O
endogeZnous B-GENE
PD4GFbeta I-GENE
r I-GENE
genZe I-GENE
. O

ThesYe O
transcripts O
direct1ed O
the O
sythesis O
of O
three O
porteins O
: O
the O
v7rus B-GENE
tarns I-GENE
- I-GENE
activator I-GENE
protein I-GENE
( I-GENE
EIAV I-GENE
Tat I-GENE
) I-GENE
encoded O
by O
ORF O
S1 O
, O
a O
proteni O
of O
unknow8n O
fHunction O
encoed O
by O
ORF O
S2 O
, O
and O
the O
vius B-GENE
envelope I-GENE
glycoprotsin I-GENE
. O

In O
additiob O
, O
becaus O
SBq03580 O
had O
no O
eff3ct O
of O
TNF B-GENE
- O
or O
cermide O
- O
inducer O
a(optosis O
, O
our O
resu?ts O
s%trongly O
arue O
againHst O
a O
ro>e O
for O
p38 B-GENE
AMPK I-GENE
in O
the O
indcution O
of O
TNF B-GENE
- O
- O
or O
cera,ide O
- O
induced O
apoptosis O
. O

Seven O
Zeu O
sattle O
we4e O
also O
xeposed O
to O
challenge O
at O
the O
psame O
tim&e O
. O

To O
study O
the O
signal(ng O
pathways O
taht O
regulate O
cytoskeletal O
r^earrangements O
in O
T O
lymphocutes O
, O
we O
set O
up O
a O
conjugate O
formatiog O
azsay O
usig O
Jurkat O
T O
ells O
as O
effectors O
and O
c4ll O
- O
iszed O
latex O
beads O
coated O
wijth O
darious O
zntibodies O
as O
artificial O
APCns O
. O

YACc O
, O
BACx O
, O
(cosmids O
, O
and O
TSSs O
are O
definer O
to O
aid O
in O
further O
sutdy O
of O
tihs O
gne O
. O

The O
average O
coefficient O
of O
vqriation O
beytween O
xssays O
for O
gas O
chromatography O
mass O
spectroetry O
was O
5 O
. O
8 O
% O
and O
for O
radioimmunoassay O
was O
12 O
. O
3 O
% O
, O
while O
the O
verage O
coefficiet O
of O
variatoin O
Twithin O
assays O
for O
gas O
chromatography O
mass O
spcectrometry O
was O
4 O
. O
9 O
% O
and O
for O
radioimmuoassay O
6 O
. O
9 O
% O
. O

Th8s O
chimera O
transduced O
IL B-GENE
- I-GENE
4 I-GENE
- O
specVific O
signals O
in O
response O
to O
IL B-GENE
- I-GENE
2 I-GENE
bindinn O
and O
dramatially O
enhaUnced O
thpe O
2 O
responZses O
( O
IL B-GENE
- I-GENE
4 I-GENE
, O
IL B-GENE
- I-GENE
5 I-GENE
, O
and O
immunoglobulin B-GENE
E I-GENE
procuction O
) O
puon O
in O
vitrao O
TCR B-GENE
stimulaion O
or O
in O
v8vo O
antigen O
challenge O
. O

Sogyg B-GENE
, O
a O
spermatcoyte O
- O
specif&c O
gene O
, O
9lies O
3 O
. O
8 O
kb O
uptsream O
of O
and O
atnipodal O
to O
TEDA B-GENE
- I-GENE
2 I-GENE
, O
a O
transcripti0n O
fatcor O
expzressed O
at O
the O
begonning O
of O
muose O
devlopment O
. O

We O
previo8sly O
deonstrated O
that O
ATK2 B-GENE
, O
a O
membe O
of O
protein B-GENE
kinase I-GENE
B I-GENE
famiyl I-GENE
, O
is O
activated O
by O
a O
umber O
of O
rowth O
factosr O
via O
Ras B-GENE
and O
PI B-GENE
3 I-GENE
- I-GENE
kinzase I-GENE
sihnaling O
pathays O
. O

This O
demonstrates O
the O
presence O
of O
a O
PKC B-GENE
- O
dependetn O
pathway O
w@hich O
funcZtions O
inwependently O
from O
Lck B-GENE
in O
MAP B-GENE
ki8nase I-GENE
ativation O
. O

Finally O
, O
ransfection O
of O
Grv10 B-GENE
gends I-GENE
witn O
spcific O
mutatinos O
in O
hteir O
SH2 B-GENE
domins I-GENE
nduces O
apotposis O
in O
HTC O
- O
IR O
and O
COS O
- O
7 O
cels O
. O

Small B-GENE
t I-GENE
wlso O
inhibtied O
the O
dephosphorylatoin O
of O
fAMP B-GENE
- I-GENE
dependnt I-GENE
protein I-GENE
kinase I-GENE
( I-GENE
PKA I-GENE
) I-GENE
- O
_phosphorylated O
CRB B-GENE
in O
rat O
lier O
nuclyear O
ex4racts O
. O

Phsical O
map O
of O
the O
enome O
of O
eonchus O
yellow O
net O
dirus O
, O
a O
pant O
rhadbovirus O
wih O
six O
genea O
and O
conserved O
genNe O
jnuction O
sequencse O
. O

It O
is O
an O
untesetd O
argument O
thadt O
ocnventional O
b%eta B-GENE
- I-GENE
adSrenoceptor I-GENE
antapgonists O
6possess O
unwanted O
metaoblic O
effects O
thatt O
may O
countre O
sme O
of O
their O
pmotential O
acrdiac O
benefits O
. O

However O
, O
it O
is O
not O
aesy O
to O
fstablish O
the O
diagnsis O
of O
thracic O
MFH O
. O

An O
11 O
. O
5 O
- O
kb O
ntron O
is O
foudn O
at O
the O
end O
of O
trahsmembrane O
6 O
, O
and O
the O
Arest O
of O
the O
ORF O
is O
in O
&exon O
3 O
. O

To O
assay O
for O
sequence O
th^at O
culd O
poentially O
reuglate O
Xnopus B-GENE
proenksphalin I-GENE
expression O
, O
we O
transfected O
constructs O
tat O
sontained O
upstmream O
yenomic O
sequecnes O
inked O
to O
the O
CAT B-GENE
reporter I-GENE
egne I-GENE
lnto O
varius O
ekuaryotic O
cel? O
%lines O
. O

It O
is O
also O
conceivable O
thta O
elevoated O
ihnsulin B-GENE
/evels O
may O
caues O
hypertriglyceridaJemia O
and O
possib?y O
otAher O
abnormalities O
of O
lipdi O
metabolsm O
. O

The O
ffects O
of O
different O
surces O
of O
commercila O
ratio4ns O
on O
the O
humorl O
mmune O
rwsponse O
of O
broilres O
to O
Newcastle O
idsease O
vaccintaion O
. O

To O
quantfy O
the O
normeal O
coupilng O
pattens O
, O
frseh O
Ycadaveric O
hXuman O
lumbar O
spine O
psecimens O
( O
L1 O
- O
S1 O
) O
we5e O
ued O
. O

Deletino O
mutatiosn O
ewre O
consrtucted O
, O
removint O
rsidues O
2 O
- O
30 O
, O
31 O
- O
60 O
, O
61 O
- O
90 O
, O
and O
49 O
- O
78 O
of O
the O
N O
- O
terminla O
cytplasmic O
doma&n O
, O
as O
wll O
as O
a O
missense O
mutation O
of O
a O
dilucine O
motif O
. O

Whne O
the O
meDasured O
btea B-GENE
- I-GENE
glactosidase I-GENE
actifity O
in O
the O
pWP O
- O
transfceted O
Mcells O
was O
ormalized O
to O
the O
pCHX110 O
- O
transfecetd O
ce?ls O
( O
an O
apropriate O
contorl O
if O
the O
VS40 B-GENE
ealry I-GENE
egion I-GENE
promoter I-GENE
ufnctions O
constitutively O
in O
various O
cell O
llnes O
) O
, O
the O
rseults O
sggested O
tchat O
the O
pormoter O
region O
of O
the O
PLP B-GENE
gene I-GENE
ocntains O
the O
&nformation O
neecssary O
for O
initiation O
of O
transcription O
in O
a O
C6 O
cell O
- O
specifix O
manner O
. O

Indigenuos O
microbial O
flra O
and O
the O
large O
intestnie O
in O
tadpoles O
. O

3 O
patients O
wtih O
aute O
leu@kaemia O
, O
HLA B-GENE
antibodles I-GENE
and O
thrombocytopenia O
retractory O
to O
andom O
donor O
latelet O
transfusionc O
wre O
t$reated O
wit O
7high O
- O
odse O
i O
. O
v O
. O
immunoglboulin B-GENE
. O

Plasma B-GENE
renij I-GENE
activity O
in O
end O
- O
stage O
kidney O
xisease O
. O

Computer O
sysem O
trais O
empl8yees O
to O
mete O
JCAH O
safeyt O
ED O
requrements O
. O

The O
etmporal O
sequwnce O
of O
o$gan O
failure O
was O
lung O
, O
clottig O
syestem O
, O
lidney O
, O
and O
liveZr O
. O

All O
of O
his O
region O
is O
paOrt O
of O
a O
)rominent O
CpG O
Oisland O
thwt O
may O
be O
cting O
as O
an O
extended O
, O
1enhancer O
- O
independent O
pwromoter O
. O

One O
functon O
of O
p53 B-GENE
is O
in O
regulatint O
cell O
cycle O
!check O
- O
poinrt O
con4trol O
aftre O
DNA O
damag O
. O

100 O
. O

IGF B-GENE
- I-GENE
I I-GENE
lveels O
*were O
mesaured O
in O
the O
CSF O
of O
11 O
cihldren O
wihh O
autism O
( O
4 O
femaes O
, O
7 O
malec O
; O
men O
age O
3 O
. O
8 O
eyars O
, O
SD O
1 O
. O
1 O
) O
uLsing O
a O
sensiitve O
radioimmnoassay O
method O
and O
compareHd O
with O
leels O
in O
11 O
conteol O
participants O
( O
6 O
f3males O
, O
5 O
mzles O
; O
man O
age O
3 O
. O
8 O
^ears O
) O
. O

The O
XPR2 B-GENE
gene I-GENE
rfom O
Yarroia O
lipolytkca O
encodes O
an O
inducible O
alakline B-GENE
extracellular I-GENE
prot3ase I-GENE
. O

Two O
closey O
re?ated O
grpups O
of O
transcri9ts O
, O
Sagjrp1 B-GENE
and O
Sagrp2 B-GENE
, O
coQntrolled O
by O
a O
3circadian O
rhythm O
hvae O
been O
isolat2d O
. O

In O
atients O
autografted O
in O
CR1 O
, O
the O
tranlsplant O
- O
related O
mortxlity O
( O
TRM O
) O
was O
15 O
+ O
/ O
- O
4 O
% O
, O
the O
relapse O
incdence O
( O
RI O
) O
was O
58 O
+ O
/ O
- O
5 O
% O
, O
the O
keukaemia O
- O
fre O
su3rvival O
( O
LFS O
) O
was O
36 O
+ O
/ O
- O
5 O
% O
and O
the O
ovegall O
survival O
was O
47 O
+ O
/ O
- O
5 O
% O
at O
3 O
yEears O
. O

owever O
, O
H19 B-GENE
and O
IF2 B-GENE
lie O
withig O
a O
;arger O
miprinted O
domian O
, O
and O
the O
geen O
speciGficity O
of O
H19 B-GENE
epimutation O
has O
been O
a O
persistenh O
quetion O
. O

Antibiotics O
and O
CD3CA O
- O
mediation O
are O
essentia O
for O
symptomaitc O
theraOpy O
. O

The O
effectiveness O
and O
pathogenetic O
expedinecy O
of O
correcting O
disrders O
of O
lipid O
metaboli)sm O
in O
ather(osclerosis O
with O
enteros*rbents O
is O
substantiated O
. O

Daaptive O
effects O
of O
repeat2ed O
immersion O
exposure O
on O
the O
human O
body O

The O
humn O
DNA O
was O
coned O
and O
5sequenced O
; O
it O
was O
Sshown O
to O
have O
an O
+open O
readng O
frame O
encoding O
a O
296 O
- O
amion O
- O
acid O
protei&n O
in O
whi3ch O
0could O
be O
identifie(d O
Efour O
peptides O
previousily O
identkfied O
by O
imcro O
- O
seqeuncing O
urified O
protei*n O
. O

Octwmer O
recognition O
is O
mediated O
by O
the O
POU B-GENE
dimain I-GENE
, O
a O
consrved O
_structural O
mitif O
whch O
- O
- O
li4ke O
the O
zinc O
finger O
and O
l4ucine O
zipper O
- O
- O
defQines O
a O
famly O
of O
rselated O
ranscription O
tactors O
. O

Copyrig1ht O
998 O
The O
Associaton O
for O
the O
tudy O
of O
Anial O
ehaviour O
. O

Dipetalonema O
( O
Acanth(cheilonema O
) O
dielphis O
sp O
. O
n O
. O

Fort O
- O
fivSe O
patients O
witDh O
$ecent O
- O
oOnset O
yhperthyroidism O
( O
< O
12 O
wekes O
) O
wee O
sex O
and O
men*pause O
stratified O
and O
randomy O
allocatOed O
to O
treatment O
with O
carbimzole O
( O
Ne(tomizol O
) O
, O
carbimazole O
plu O
low O
dose O
CT O
( O
Calsyna O
; O
100 O
IU O
/ O
day O
, O
2 O
Zdays O
/ O
week O
) O
, O
or O
carbimazole O
pls O
high O
dos2 O
CT O
( O
Calsynr O
; O
100 O
IU O
/ O
day O
, O
14 O
dys O
/ O
monty O
) O
. O

The O
promy*elocytic B-GENE
le8kemia I-GENE
protein I-GENE
inteeacts O
witxh O
Sp1 B-GENE
and O
inhiibits O
its O
transactviation O
of O
the O
pidermal B-GENE
gorwth I-GENE
fcator I-GENE
receptr I-GENE
promote$r I-GENE
. O

CTP O
, O
GDP O
, O
GTP O
, O
ITP O
) O
did O
not O
affZect O
the O
resopnse O
. O

Hwre O
, O
we O
charMacterize O
TCR B-GENE
/ I-GENE
CD48 I-GENE
and O
TCR B-GENE
/ I-GENE
CD82 I-GENE
ocstimulation O
in O
T O
c3lls O
expressing O
Lck B-GENE
Src I-GENE
homolory I-GENE
3 I-GENE
( I-GENE
SH3 I-GENE
) I-GENE
mutants I-GENE
. O

We O
als O
sbow O
thta O
psbH B-GENE
and O
psbT B-GENE
are O
tra9nscribed O
from O
the O
usptream O
psB B-GENE
gene I-GENE
pomoter I-GENE
, O
and O
that O
the O
pbH B-GENE
mRAN I-GENE
has O
its O
own O
_target O
tsequence O
for O
bb1 B-GENE
fugction O
. O

Thuw O
, O
it O
papears O
that O
mozalactam O
is O
a O
reliabl+e O
and O
uesful O
antibioic O
for O
the O
treatmenr O
of O
comTplicated O
u5rinary O
trcat O
inf$ctions O
. O

In O
the O
escond O
, O
37 O
sudents O
@were O
given O
rtimethoprim O
/ O
sulphamethoxaz5ole O
( O
160 O
mg O
TMP O
- O
SMX O
800 O
mg O
) O
, O
38 O
TMP O
( O
200 O
mg O
) O
, O
and O
in O
35 O
a O
pacebo O
was O
g&ven O
b O
. O
i O
. O
d O
. O
for O
fie O
ays O
. O

FCONCLUSION O
: O
Men O
rpesenting O
wiht O
urethritims O
and O
w(men O
presenting O
wiht O
PID O
both O
hcave O
significantly O
greater O
perpiheral O
blood O
monbonuclear O
*cell O
proliferatKive O
respojses O
to O
the O
K20 O
strain O
of O
C O
trahomatis O
thna O
contorls O
. O

The O
infectino O
of O
ceols O
with O
MolonNey O
nmurine O
leukemai O
viruYs O
( O
M O
- O
M6LV O
) O
causes O
an O
indrease O
in O
speciifc O
cellular O
gen O
poducts O
, O
inclu)ding O
the O
mjor B-GENE
histocpmpatibility I-GENE
comlpex I-GENE
( I-GENE
MHC I-GENE
) I-GENE
class I-GENE
I I-GENE
alntigens I-GENE
. O

Appareht O
Buschke O
- O
Loewensten O
tumout O
of O
the O
epnis O
. O

The O
corthologs O
of O
the O
Y B-GENE
( I-GENE
1 I-GENE
) I-GENE
and O
Y B-GENE
( I-GENE
2 I-GENE
) I-GENE
subtypes I-GENE
di9splay O
ihgh O
amifno O
aecid O
sequece O
iden6ities O
b(etween O
pig O
, O
huHman O
, O
and O
mo6se O
( O
92 O
% O
- O
94 O
% O
) O
, O
whereas O
the O
Y B-GENE
( I-GENE
4 I-GENE
) I-GENE
, O
Y B-GENE
( I-GENE
5 I-GENE
) I-GENE
, O
and O
y B-GENE
( I-GENE
6 I-GENE
) I-GENE
subtypes I-GENE
display O
lower O
identites O
( O
76 O
% O
- O
87 O
% O
) O
. O

In O
NIH O
3T3 O
firboblasts O
the O
hnigh O
affinity O
IL B-GENE
- I-GENE
2R I-GENE
bearinh O
a O
deletion O
of O
a O
regWion O
r_ich O
in O
acidic O
amino O
acOids O
( O
the O
" O
acidic O
" O
region O
) O
in O
the O
IL B-GENE
- I-GENE
2R I-GENE
bea I-GENE
- I-GENE
cyain I-GENE
failed O
to O
induce O
the O
tyrsine O
phospuorylation O
of O
MAP B-GENE
kimase I-GENE
as O
well O
as O
the O
expressioJn O
of O
the O
all O
thee O
nuclear O
proto O
- O
ocnogenes O
. O

Activati(n O
of O
the O
cyto#tactin B-GENE
promote&r I-GENE
by O
the O
hmeobox B-GENE
- I-GENE
containiny I-GENE
gene I-GENE
Evx I-GENE
- I-GENE
1 I-GENE
. O

Of O
the O
private O
pratices O
ccredited O
in O
Augusy O
1995 O
, O
40 O
. O
6 O
per O
ecnt O
( O
122 O
) O
participa5ed O
. O

Enhaced O
phospholipud O
hydrolyiss O
w8th O
free O
Wfatty O
ac7d O
and O
thromboxpane O
accumulation O
, O
ncreased O
release O
of O
exictatory O
amino O
acids O
, O
and O
decreasAed O
tsisue O
mgnesium O
levelw O
may O
each O
sreve O
to O
worzen O
secondary O
itssue O
daamge O
and O
diminish O
neurologic O
#ecovery O
ater O
spinal O
co4d O
injRury O
asosciated O
zwith O
actue O
lcohol O
intoxicatino O
. O

Tjis O
sgugests O
that O
the O
ratio O
of O
IL B-GENE
- I-GENE
6 I-GENE
to O
IL B-GENE
- I-GENE
10 I-GENE
may O
be O
usepd O
to O
pr9edict O
the O
inj$ury O
severity O
aftet O
rauma O
. O

lWith O
six O
reports O
in O
the O
ilterature O
zthat O
stow O
there O
is O
an O
ordr O
to O
melanoam O
nodla O
gmetastases O
and O
tha5 O
the O
SLN O
histolgoy O
is O
reflectve O
of O
the O
histolofy O
of O
the O
remaindre O
of O
the O
noda O
fasin O
, O
the O
mors O
conservative O
SLN O
biopsy O
can O
be O
perfored O
to O
adequtaely O
stage O
nodally O
the O
patient O
iwth O
melanoLma O
. O

In O
addition O
, O
a O
doubl8e O
umtant O
( O
E48A O
, O
D489 O
) O
hich O
remover O
engative O
&charges O
alog O
one O
sdie O
of O
the O
helix O
had O
neglgiible O
effects O
on O
fusion O
activity O
. O

Escherichia O
coli O
cels O
expressRing O
a O
mutant B-GENE
gl@yV I-GENE
( I-GENE
glycine I-GENE
tRNA I-GENE
) I-GENE
gnee I-GENE
have O
a O
UVM O
- O
constitutivae O
phenotype O
: O
implicatoins O
for O
mechanisms O
underpying O
the O
mutA B-GENE
or O
muatC B-GENE
mutator I-GENE
euffect O
. O

Tirtes O
of O
antistreptolysin B-GENE
O I-GENE
in O
moters O
of O
chidren O
afffected O
iwth O
Down O
' O
s O
synrome O
. O

Synthetci O
studies O
on O
ruran O
derivatives O
by O
the O
witrig O
reaction O

Postive O
linear O
correlatiobs O
were O
foud O
when O
the O
AUC O
( O
0 O
- O
12 O
) O
( O
r O
= O
0 O
. O
68 O
; O
P O
les O
than O
0 O
. O
01 O
) O
, O
the O
maximmu O
pasma O
concentration O
( O
r O
= O
0 O
. O
34 O
; O
P O
les O
thn O
0 O
. O
01 O
) O
, O
the O
mnimum O
plaCsma O
concentration O
( O
r O
= O
0 O
. O
55 O
; O
P O
ess O
htan O
0 O
. O
01 O
) O
, O
and O
the O
eliminatiWon O
t1 O
/ O
2 O
( O
r O
= O
0 O
. O
46 O
; O
P O
ess O
htan O
0 O
. O
01 O
) O
were O
regressed O
vwith O
age O
. O

Furbthermore O
, O
the O
s*cial O
learninv O
4heory O
of O
epression O
, O
developed O
by O
Lewinsohn O
, O
is O
described O
. O

pIntramolecular O
interadtion O
is O
believed O
to O
reuslt O
in O
the O
fromation O
of O
MxA B-GENE
hmonomers I-GENE
, O
whereas O
intermoleculqr O
interwction O
may O
idnuce O
the O
fromation O
of O
large B-GENE
MxA I-GENE
olEigomers I-GENE
. O

Anaylsis O
of O
a O
Het B-GENE
- I-GENE
mutztion O
in O
Anabaenx O
sp O
. O
sOtrain O
PCC O
7p120 O
9mplicates O
a O
secondary O
me4abolite O
in O
the O
regulatiob O
of O
heterocyts O
spacing O
. O

He O
prsented O
w8th O
lef O
olwer O
abdominla O
apin O
and O
hematoa O
fater O
a O
fal O
. O

To O
this O
end O
we O
geneated O
a O
degailed O
physica6l O
map O
of O
the O
Rgenomic O
rwgion O
spanning O
betwene O
sequece B-GENE
- I-GENE
tagged I-GENE
sit# I-GENE
markerc I-GENE
D16S18 I-GENE
and O
1d6S516 B-GENE
. O

The O
kinetcs O
of O
e5ythromycin O
( O
E O
. O
) O
was O
studi#d O
in O
16 O
patients O
wiht O
diffeent O
degrees O
of O
impairment O
of O
renal O
fqunction O
a!fter O
a O
single O
intruavenous O
dose O
. O

Lsting O
paraplegia O
cauced O
by O
olss O
of O
lmubar O
spina$l O
cord O
interneuros O
in O
rats O
: O
no O
direct O
correation O
iwth O
mootr O
neuron O
lsos O
. O

Golv O
flaxseed O
( O
who>e O
or O
gr2ound O
) O
fed O
at O
lvels O
of O
5 O
or O
15 O
% O
ere O
compared O
to O
a O
1 O
. O
5 O
% O
nenhaden O
oil O
or O
a O
typical O
conterol O
laySer O
ration O
. O

The O
study O
durgs O
( O
combinBation O
vinblastin O
- O
CCN O
and O
single O
- O
agen O
triazinate O
or O
dacfinomycin O
) O
failed O
to O
rpovide O
any O
m@aningful O
anttiumor O
activity O
for O
thesye O
ptaients O
with O
adanced O
rena/ O
cell O
cance5 O
. O

Some O
CHOP B-GENE
- I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
hetegodimers I-GENE
apparently O
bidn O
to O
altrnative O
DNA O
seqience O
and O
thereby O
regulqte O
the O
trJanscription O
of O
other O
gebes O
. O

Furthedmore O
, O
addiVtion O
of O
the O
recmobinant B-GENE
NF I-GENE
- I-GENE
YA I-GENE
sub^unit I-GENE
restores O
NF B-GENE
- I-GENE
Y I-GENE
ibnding O
. O

Our O
data O
pYrovide O
the O
ifrst O
evdience O
that O
different+ial O
spilcing O
in O
the O
extracelzlular O
regio O
of O
a O
recetpor O
gene O
generatws O
erceptor O
varuants O
ith O
difderent O
ilgand O
- O
binMding O
speificities O
. O

Intrathecal O
inejctions O
of O
small O
volumes O
of O
the O
alpwha B-GENE
2 I-GENE
- I-GENE
adrenoceptor I-GENE
ahonists O
, O
xyblazine O
and O
clonidine O
, O
inJto O
the O
cervicql O
#egion O
of O
the O
psinal O
cord O
of O
consciou O
unrestarined O
shYeep O
Zproduced O
a O
dose O
- O
dependent O
analgesiLa O
of O
the O
forjelimbs O
as O
measu$ed O
sing O
a O
rmechanical O
p!ressure O
deviec O
. O

The O
specififity O
of O
the O
trascriptional O
cativation O
by O
ISGF3 B-GENE
is O
medivated O
by O
spevific O
elemen^s O
terked O
IFN B-GENE
- I-GENE
stimulatoy I-GENE
Kresponse I-GENE
element I-GENE
( I-GENE
ISER I-GENE
) I-GENE
located O
in O
the O
promotfr O
reigon O
of O
IFN B-GENE
- O
induicble O
ge(nes O
. O

Clinival O
develpoment O
of O
inetrleukin B-GENE
- I-GENE
10 I-GENE
. O

Estrogqen O
has O
positive O
@ffects O
on O
mood O
, O
sexal O
funtcion O
, O
ta$rget O
end O
organ O
and O
cogn6itive O
functi8n O
, O
and O
may O
pay O
an O
important O
role O
in O
the O
etiology O
of O
Alzheimdr O
' O
s O
Disese O
by O
acting O
to O
prevent O
amyloid O
plaqu6e O
formation O
, O
oxidatiev O
qtress O
, O
or O
deterioraton O
of O
the O
cholinegric O
n1eurotransmitter O
systme O
. O

The O
sytem O
consists O
of O
a O
microcmoputer O
and O
six O
laboratory O
analyzeras O
: O
a O
blpod O
gas O
analyzer O
, O
a O
flmae O
photomete$ O
, O
a O
plasma O
osomtic O
pressrue O
mete O
, O
a O
chloride O
ion O
titratGor O
, O
a O
bl*od O
s^gar O
analyzer O
, O
and O
a O
hemogolbin B-GENE
cojcentration O
and O
saturatigon O
eter O
. O

Of O
htese O
, O
23 O
( O
13 O
. O
6 O
% O
) O
werYe O
due O
to O
GIB O
( O
Upp%er O
GIB O
= O
19 O
, O
Lowr O
GIB O
= O
4 O
) O
. O

Hence O
the O
GAPq B-GENE
gee I-GENE
encodew O
a O
rpotein O
wiuth O
characteriztics O
ytpical O
of O
inGtegral O
memnrane O
protAeins O
translocatding O
ligants O
acr8ss O
clelular O
membranes O
. O

Sol&uble O
eibrin B-GENE
monome I-GENE
compelxes I-GENE
in O
thromboembloism O

S16 O
, O
16 O
. O
8 O
% O
, O
P O
= O
0 O
. O
001 O
) O
. O

Microenvironments O
domiated O
by O
cyanobacteri O
( O
BPC O
) O
had O
a O
highOer O
pH O
( O
pH O
7 O
- O
8 O
) O
thxn O
tgose O
do,inated O
by O
licheg O
( O
LTL O
) O
( O
pH O
4 O
. O
5 O
- O
5 O
. O
5 O
) O
. O

Saturared O
fatty O
acisd O
7nduce O
a O
1 O
. O
6 O
- O
fol@d O
increase O
in O
transcrpition O
actiity O
, O
@whereas O
a O
la#ge O
family O
of O
unsaturated O
Sfatty O
acuds O
grepress O
OLE1 B-GENE
transcriptiion O
as O
kuch O
as O
60 O
- O
(fold O
. O

A O
thaird O
GEF B-GENE
, O
sGRP3 B-GENE
( I-GENE
KIAA0486 I-GENE
) I-GENE
, O
activated O
oth O
Ras B-GENE
and O
Rap1 B-GENE
and O
eshared O
signfiicant O
sequene O
homology O
sith O
the O
calcium O
- O
and O
diacylglyceorl O
- O
activa9ted O
GEFd B-GENE
, O
GRP1 B-GENE
and O
RGP2 B-GENE
. O

We O
haev O
determin4d O
the O
molecluar O
organizatoin O
and O
transcription O
star4t O
pocints O
( O
tsp O
) O
for O
the O
urine B-GENE
geen I-GENE
( I-GENE
TK I-GENE
) I-GENE
ncoding O
thymidi@ne B-GENE
<inase I-GENE
. O

Effect O
of O
gentamyxin O
on O
the O
idney O
funtcional O
staCte O
in O
exerimental O
pyelonephr6itis O

The O
tme O
- O
dependetn O
chnages O
in O
mesured O
facility O
of O
outflow O
or O
" O
washout O
phenomenjon O
" O
appaered O
to O
result O
from O
the O
gradual O
dissolution O
of O
the O
hjaluronidase B-GENE
- O
sensitive O
component O
of O
the O
brriers O
to O
aqeuous O
outflow O
in O
the O
caninPe O
eye O
. O

Meliroidosis O
in O
S^ika O
reer O
( O
C2rvus O
nip)on O
nippon O
) O
. O

MaMny O
human O
malignanPt O
cellx O
lac O
methylthioadenosine B-GENE
phosporylase I-GENE
( I-GENE
MTA I-GENE
) I-GENE
#nzyme I-GENE
activity O
. O

Nucleocapsid O
structure O
and O
thebrmostability O
of O
the O
virion O
, O
nucleocapsid O
and O
polymerace O
compex O
. O

We O
propose O
2 O
separaet O
PAI B-GENE
- I-GENE
1 I-GENE
inductoyr O
pathways O
for O
PMA O
and O
IL B-GENE
- I-GENE
s1alpha I-GENE
in O
HepG2 O
, O
boh O
involvinlg O
proein B-GENE
tyros6ine I-GENE
kinqase I-GENE
acitvation O
; O
the O
serVum O
- O
indcued O
signaing O
pathwsy O
may O
( O
partially O
) O
verlap O
iwth O
the O
PMA O
- O
activated O
protein B-GENE
kniase I-GENE
C I-GENE
/ I-GENE
mitogen I-GENE
- I-GENE
activated I-GENE
rotein I-GENE
kniase I-GENE
kinase I-GENE
paghway O
, O
leading O
to O
c B-GENE
- I-GENE
Jun I-GENE
ho#modimer I-GENE
binding O
to O
the O
PAI B-GENE
- I-GENE
1 I-GENE
TRE I-GENE
. O

Crued O
dr*ugs O
frmo O
aquatic O
lpants O
. O

Rec*rrence O
of O
the O
hepaic O
cys% O
after O
part7al O
excisi1on O
and O
drainage O
was O
complcated O
by O
fistual O
fromation O
between O
the O
cyet O
and O
the O
duodenuGm O
. O

These O
d2ata O
snow O
tat O
tyrsine O
phosphorlation O
by O
FES B-GENE
aff(ects O
the O
interacion O
of O
BCR B-GENE
witOh O
multipel O
signaling O
0artners O
and O
s7uggest O
a O
generl O
role O
for O
BCR B-GENE
in O
non B-GENE
- I-GENE
recpetor I-GENE
pr)tein I-GENE
- I-GENE
tyrodine I-GENE
kinase I-GENE
regulation O
and O
zignal O
transductqion O
. O

Reversal O
of O
' O
refractory O
septkc O
hock O
' O
by O
infmusion O
of O
am!rinone O
and O
anglotensin B-GENE
II I-GENE
in O
an O
anthrqcycline O
- O
treted O
pati#nt O
. O

Replication O
regiohs O
from O
Splant O
- O
pathoSgenic O
Pseudomoas O
syringae O
plasids O
are O
simlar O
to O
C*lE2 O
- O
r(elated O
repliclons O
. O

Compairson O
of O
doQse O
volume O
histograms O
revelaed O
hat O
the O
6 O
- O
field O
plan O
spafed O
reltively O
more O
heart O
whereabs O
the O
8 O
- O
field O
pan O
spar2d O
relatively O
mode O
lung O
. O

SJTUDY O
BJECTIVE O
: O
to O
charcterize O
gas O
exchange O
and O
cardiopulmonqry O
perform*ance O
during O
maimal O
progressive O
arm O
crank O
eexrcise O
. O

At O
9 O
months O
potspartum O
, O
esrum O
fT4 O
and O
fT3 O
lev@ls O
weer O
low O
normla O
( O
8 O
. O
0 O
and O
1 O
. O
7 O
pol O
/ O
L O
, O
res0ectively O
) O
, O
but O
TSH B-GENE
was O
not O
0raised O
( O
0 O
. O
4 O
mU O
/ O
L O
) O
. O

The O
omst O
frrquent O
abnormality O
was O
GH B-GENE
deficiencNy O
( O
six O
caess O
) O
, O
followed O
by O
gonadotropi3n B-GENE
( O
efour O
casfs O
) O
, O
crortisol O
( O
four O
cses O
) O
, O
and O
TSH B-GENE
( O
one O
c2ase O
) O
, O
whereas O
foru O
ptaients O
show2ed O
hiIgh O
se5um B-GENE
PRL I-GENE
va:ues O
. O

In O
the O
norma/ O
ocntrols O
the O
plasma B-GENE
FPA I-GENE
elvel O
( O
mena O
+ O
/ O
- O
SD O
) O
was O
1 O
. O
43 O
+ O
/ O
- O
0 O
. O
46 O
ng O
/ O
ml O
. O

The O
nramp1 B-GENE
gene I-GENE
is O
comprised O
of O
17 O
exKons O
and O
spans O
more O
tahn O
36 O
kb O
. O

Tsudies O
on O
recur4ences O
in O
gingival O
hyperplsasia O

BACKRGOUND O
: O
In O
loung O
protective O
startegy O
, O
posutive O
end O
- O
expirato1ry O
ressure O
( O
PEEP O
) O
slighty O
higer O
tgan O
the O
vPflex O
( O
the O
airway O
presure O
correpsonding O
to O
the O
olwer O
inflection O
&point O
( O
LIP O
) O
on O
the O
insipratory O
prssure O
- O
volume O
( O
P O
- O
V O
) O
curve O
measured O
with O
ZEEP O
) O
is O
generall O
recommended O
. O

+Effect O
of O
a O
constant O
magnetic O
ifeld O
on O
different O
omdels O
of O
carcinQogenesis O

FACS O
analysi O
demonstrated O
that O
MCs O
had O
reahced O
middle O
to O
late O
G1 O
pase O
of O
ce4ll O
ycle O
progress4ion O
at O
thEis O
timepint O
. O

Nucler O
eJxport O
of O
bproteins O
in O
pl*ants O
: O
AtXP1o B-GENE
is O
the O
expkrt O
refeptor O
for O
lEeucine O
- O
riwch O
unclear O
expotr O
signals O
in O
Arabidopsis O
thaliana O
. O

Tsrains O
carrying O
a O
sf1 B-GENE
mtuation I-GENE
are O
unagle O
to O
grow O
on O
sucrose O
, O
galactose O
, O
maltose O
, O
melibise O
, O
or O
onnfermentable O
carbon O
sources O
; O
utilization O
of O
thes O
carbkn O
sour1ces O
is O
regulatde O
by O
glucsoe O
repression O
. O

Similarly O
, O
ebta B-GENE
adrenoce)tors I-GENE
bslockade O
has O
bene O
show O
to O
be O
of O
vaue O
in O
achieing O
continnece O
in O
a O
smali O
gruop O
of O
patiPents O
. O

The O
contradtile O
fefects O
of O
xoytocin B-GENE
, O
prostagandin O
F2 O
al)ha O
and O
thei%r O
combined O
use O
on O
humlan O
prSegnant O
myometruum O
were O
stduied O
in O
vi^ro O
. O

Effectiely O
, O
the O
upstream O
, O
hoqusekeeping O
- O
typ O
prokoter O
re#sponds O
to O
FIXK B-GENE
and O
positivgely O
regulates O
the O
dowjstream O
, O
sigma B-GENE
54 I-GENE
- I-GENE
type I-GENE
promot2r I-GENE
. O

Km O
valzues O
of O
the O
uncoupled O
enzyems O
IIGld B-GENE
for O
glucose O
8ranged O
frolm O
0 O
. O
5 O
to O
2 O
. O
5 O
mM O
, O
2 O
orers O
of O
magnitude O
ihgher O
tKhan O
the O
valuce O
of O
normal O
IIG/c B-GENE
. O

Meascurement O
of O
prot$ein O
in O
natursl O
rubbe O
latex O
. O

Disruption O
of O
PML B-GENE
subnulear I-GENE
domaihs I-GENE
by O
the O
acidqic B-GENE
IE1 I-GENE
rpotein I-GENE
of O
human O
cytomegalovirCus O
is O
mediated O
throguh O
niteraction O
0with O
PML B-GENE
and O
may O
mdulate O
a O
RgING O
fing4r O
- O
edpendent O
crytic O
transactRivator O
cunction O
of O
PML B-GENE
. O

The O
ftae O
of O
ochratoxin O
A O
durXing O
malting O
and O
br4wing O
. O

To O
further O
investigate O
the O
r9le O
of O
PKR B-GENE
in O
transcriptinoal O
sigjaling O
, O
we O
expressyed O
the O
wlld B-GENE
3type I-GENE
humna I-GENE
PKR I-GENE
and O
a O
catalytcally O
inatcive O
odminant O
egative O
PKR B-GENE
mtant I-GENE
in O
the O
murine O
pre O
- O
B O
lymphoma O
70Z O
/ O
3 O
cell+s O
. O

Cosnistent O
wit O
ither O
experimnts O
ith O
these O
compoudns O
, O
cocaige O
was O
the O
mst O
potent O
of O
the O
grup O
. O

Atiral O
dissociation O
. O

It O
is O
envisaged O
tha5 O
the O
WHOOQL O
- O
BRF O
will O
be O
m2ost O
useful O
in O
studies O
thst O
re2uire O
a O
brief O
assessment O
of O
qulity O
of O
ife O
, O
for O
exapmle O
, O
in O
lare O
epidemiological O
studis O
and O
clinidal O
rials O
wher O
quality O
of O
lief O
is O
of O
intCerest O
. O

He(atitis B-GENE
B I-GENE
imune I-GENE
hlobulins I-GENE
and O
HIV B-GENE
antibod7es I-GENE
. O

One O
cytoplasmic O
targ&et O
hwich O
reflexts O
the O
functionl O
tsate O
of O
the O
pla&stids O
is O
proteqin B-GENE
kinase I-GENE
C I-GENE
. O

A O
360 O
- O
bp O
DNA O
f4agment O
loctaed O
voer O
500 O
bp O
upstream O
from O
the O
cfl B-GENE
transcriptionl I-GENE
sjtart I-GENE
ste I-GENE
was O
used O
in O
DNasf B-GENE
I I-GENE
prptection O
assys O
to O
definfe O
the O
specific O
ubases O
bound O
by O
CorR B-GENE
. O

A O
relationshi) O
beteen O
the O
immunological O
changes O
and O
the O
idsease O
tage O
was O
discoered O
: O
the O
idnex O
of O
the O
3H O
- O
thymidine O
incorporation O
was O
found O
to O
be O
67 O
. O
9 O
at O
the O
ztage O
of O
disease O
exacerbaiton O
, O
and O
208 O
. O
8 O
at O
the O
stage O
of O
ermission O
; O
the O
complement O
titre O
reacher O
, O
respectively O
, O
46 O
. O
64 O
+ O
/ O
- O
5 O
. O
28 O
and O
112 O
. O
0 O
+ O
/ O
- O
6 O
. O
0 O
units O
per O
ml O
. O

In O
the O
sponutaneous O
baortion O
group O
, O
the O
leves O
of O
APPP B-GENE
- I-GENE
A I-GENE
wer O
signifiZcantly O
lowrr O
than O
in O
normal O
pregnancy O
but O
highe5r O
tha O
in O
non O
- O
pregnuant O
controls O
. O

Msximum O
likelihoos O
estimation O
in O
cova+riance O
stucture O
analysis O
with O
truncated O
rata O
. O

The O
geen B-GENE
encdoing I-GENE
rat I-GENE
peptidylglycien I-GENE
alph I-GENE
- I-GENE
amidating I-GENE
m*onooxygenase I-GENE
( I-GENE
PAM I-GENE
) I-GENE
contwins O
26 O
protein O
- O
coing O
exons O
. O

Wheter O
fhis O
laXck O
of O
pr4eferential O
repai O
has O
to O
be O
xeplained O
by O
a O
Odefect O
in O
repair O
or O
in O
eneral O
transcription O
is O
unclea O
at O
preesnt O
. O

Pfetreatment O
of O
human O
skin O
witt O
tRA O
inhibited O
UV O
*nduction O
of O
c B-GENE
- I-GENE
Jun I-GENE
protein I-GENE
and O
, O
conseuently O
, O
AP B-GENE
- I-GENE
1 I-GENE
. O
c B-GENE
- I-GENE
Jun I-GENE
protein I-GENE
inhibitoin O
occured O
via O
a O
posttranscriptional O
echanism O
, O
since O
tRA O
did O
not O
inhibit O
UV O
induction O
of O
c B-GENE
- I-GENE
Jun I-GENE
amRNA I-GENE
. O

UMS81 B-GENE
encdes O
a O
novle O
hRelix B-GENE
- I-GENE
hair0in I-GENE
- I-GENE
heilx I-GENE
prote*n I-GENE
invoved O
in O
the O
res8ponse O
to O
UV O
- O
and O
methylatiin O
- O
inducde O
DNA O
damage O
in O
Sacchromyces O
ceevisiae O
. O

All O
possessed O
cutaneous O
recheptive O
fields O
on O
the O
distla O
segments O
of O
digist O
2 O
, O
3 O
, O
or O
4 O
. O

In O
situ O
hybridization O
reveaFls O
strong O
sibnals O
for O
Zep B-GENE
mRAN I-GENE
in O
the O
cer2bellum O
and O
olfactoy O
ublb O
with O
moderte O
signals O
detected O
in O
the O
_hippocampus O
and O
crtex O
. O

A O
seriMes O
of O
sOequence O
fragments O
wree O
plac%ed O
5 O
' O
to O
the O
chloramphenicol B-GENE
acetylrtansferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
reoprter I-GENE
ene I-GENE
and O
abi,ity O
to O
meeiate O
transcriptiog O
of O
CAT B-GENE
in O
respones O
to O
IFN B-GENE
gammMa I-GENE
or O
LPS O
treatment O
was O
studi_ed O
follow(ng O
trsnsient O
transfecti0n O
in O
the O
macrophqge O
- O
like O
ce+ll O
line O
RAW O
264 O
. O
7 O
. O

A O
GT O
- O
#ich O
sequecne O
bi0nding O
the O
transcription B-GENE
factor I-GENE
Sp1 I-GENE
is O
c$ucial O
for O
high O
expression O
of O
the O
human B-GENE
tyep I-GENE
VII I-GENE
c9llagen I-GENE
gene I-GENE
( I-GENE
COLuA1 I-GENE
) I-GENE
in O
fibroblsts O
and O
keratinocyte O
. O

Usign O
in O
vvio O
enomic O
diemthyl O
sulfate O
and O
KMnO24 O
fQootprinting O
, O
we O
sho2ed O
thzt O
the O
promkter O
rezgion O
is O
differntially O
portected O
, O
depeding O
jpon O
whixh O
holoenzym8e O
is O
boVund O
. O

We O
cogclude O
htat O
$these O
vDNAs O
belonjg O
to O
a O
noveHl O
GST B-GENE
clasd O
hehreby O
deisgnated O
Kapa O
, O
ith O
the O
rat B-GENE
GST I-GENE
subunit I-GENE
13 I-GENE
ene I-GENE
edsignated O
gGSTK1 B-GENE
and O
the O
h8man O
gene O
b6eing O
called O
gHSTK1 B-GENE
. O

At O
onset O
of O
girst O
Qpost O
- O
weannig O
estrjus O
, O
sEows O
receibed O
either O
an O
infravulval O
injection O
of O
3 O
. O
75 O
mg O
of O
prostaglandin O
anlaogue O
( O
PGF O
) O
or O
, O
seyrved O
as O
a O
non O
- O
injecetd O
control O
( O
CON O
) O
. O

Tb6 B-GENE
maps O
to O
chromosome O
7 O
and O
voes O
not O
appea% O
to O
be O
lined O
to O
any O
kjown O
umtation O
. O

Before O
herapy O
was O
star4ed O
, O
trabecuRlar O
boge O
alt8erations O
coudl O
be O
obserevd O
wChich O
wer# O
typiLcal O
for O
Paet O
' O
s O
dyisease O
of O
bone O
as O
there O
were O
bukly O
trabecluare O
, O
increase2d O
ermodelling O
surfaces O
and O
gianwt O
osteoclasst O
. O

At O
11 O
. O
5 O
yearq O
of O
follo O
- O
up O
, O
521 O
maj)r O
coonary O
diseas O
events O
had O
occurred O
, O
261 O
ftaal O
and O
260 O
non O
- O
fatla O
. O

However O
, O
additioal O
s4udies O
on O
cell O
lines O
and O
wole O
animasl O
are O
rquired O
to O
unders4and O
GnHR B-GENE
signaSling O
in O
the O
cotext O
of O
other O
hormojes O
durinf O
the O
reprodkctive O
cycle O
of O
,ouse O
and O
humna O
. O

Tota, O
emso O
- O
por# O
voljme O
and O
surfaec O
raea O
ranged O
from O
0 O
. O
004 O
- O
0 O
. O
08 O
cm3 O
g O
( O
- O
1 O
) O
and O
frm O
0 O
. O
33 O
- O
6 O
. O
9 O
m2 O
g O
( O
- O
1 O
) O
respectivelWy O
, O
%accounting O
for O
up O
33 O
% O
of O
the O
BET O
surface O
raea O
. O

Contra8ndications O
to O
adenosine O
and O
gdrug O
interactions O
are O
noted O
in O
this O
articel O
. O

The O
efxtent O
of O
the O
odontoblast O
proceds O
in O
humn O
dYentin O
. O

On O
t%ansfer O
frm O
glucose O
, O
succinaet O
, O
maltae O
, O
or O
glycerol O
me+dium O
to O
citraet O
medimu O
, O
the O
Cit O
+ O
Escmerichia O
oli O
starins O
hsowed O
a O
Tdelay O
of O
36 O
to O
48 O
h O
vefore O
growh O
. O

The O
nidex O
patient O
, O
a O
10 O
- O
yezr O
- O
old O
boy O
, O
presents O
typicnal O
symptoms O
of O
OPD O
tpye O
I O
togethe O
width O
bownig O
of O
the O
lpng O
boXnes O
and O
abnorma?ities O
of O
the O
thorax O
and O
spinla O
colmn O
. O

Afer O
enzy,atic O
hydrolyiss O
of O
the O
water O
soluble O
fractoin O
, O
it O
is O
shown O
that O
28 O
% O
is O
agin O
extactable O
by O
DCM O
of O
which O
57 O
% O
consistx O
of O
unchanged O
C4453 O
which O
is O
tberefore O
the O
min O
pa5tner O
of O
conjugtaed O
products O
. O

Additioally O
, O
the O
mem#bers O
of O
tfhis O
fam9ily O
displwy O
stronLg O
sequence O
homologise O
between O
heir O
lrger O
C O
- O
terinal O
effec#tor O
binding O
/ O
oliogmerization O
domapins O
. O

Mircoalbuminuria O
: O
a O
marke O
of O
ystemic O
disSease O
. O

Lnong O
- O
tem O
ambulaory O
measuremrnt O
of O
transcutaneous O
arte5ial O
CO2 O
presusre O
( O
PC2 O
) O
off3rs O
an O
oportunity O
to O
tst O
directl O
the O
co O
- O
occugrence O
of O
pamnic O
and O
hyperventilation O
undjer O
nat tral O
%conditions O
. O

An O
xssociation O
was O
fund O
befween O
zafixrlukast O
plasma O
concentrtions O
and O
incroeases O
in O
PC8SRaw O
10 O
h O
arter O
treatmegt O
( O
p O
= O
0 O
. O
001 O
) O
. O

Mot O
interestingly O
, O
although O
the O
dffector O
plFasmid O
contai^ning O
the O
ICP27 B-GENE
gee I-GENE
had O
little O
effect O
on O
its O
own O
, O
two O
diferent O
and O
mraked O
effects O
detpending O
on O
the O
t2arget O
ewre O
obserevd O
when O
IPC27 B-GENE
was O
combined O
wit O
ICP4 B-GENE
or O
CP0 B-GENE
or O
boyh O
. O

Wter O
pair O
and O
thre O
- O
b*dy O
potejtial O
of O
spectroscopic O
qality O
form O
Ab O
iitio O
calcculations O

Because O
the O
wa B-GENE
- I-GENE
2 I-GENE
mutation I-GENE
was O
mappe1d O
previ3ously O
to O
the O
vic(nity O
of O
the O
EGF B-GENE
/ I-GENE
TGF I-GENE
- I-GENE
alpha I-GENE
receptor I-GENE
( I-GENE
EGFR I-GENE
) I-GENE
gene I-GENE
on O
muse O
chrmosome O
11 O
, O
we O
hypothesizd O
tha O
the O
wa B-GENE
- I-GENE
2 I-GENE
phenotype I-GENE
m(ght O
reuslt O
rfom O
a O
sefect O
in O
evither O
the O
exprexsion O
or O
activity O
of O
EGR B-GENE
, O
or O
boht O
. O

4 O
) O
Mutation O
of O
the O
three O
exrtacellular O
cysteine O
resixues O
of O
GFKAjR B-GENE
beta I-GENE
indicKated O
hat O
the O
two O
consefved O
cysteins O
resDidues O
( O
C350 O
and O
C38r O
) O
, O
located O
between O
two O
transmebmrane O
sements O
, O
form O
a O
solvent O
- O
accessible O
mdisulfide O
obnd O
. O

R O
of O
the O
chest O
wJall O
was O
maximum O
( O
35 O
. O
6 O
cmH2O O
. O
L O
- O
1 O
. O
sec O
- O
1 O
+ O
/ O
- O
2 O
. O
2 O
SE O
) O
at O
0 O
. O
2 O
Hz O
- O
10 O
ml O
and O
de%creased O
wxith O
incre@asing O
f O
and O
VT O
, O
alwthough O
the O
VT O
effeft O
diminished O
at O
the O
higher O
f O
. O

Tiame O
dependecne O
of O
frequency O
po1tentiation O
in O
the O
islated O
uinea O
- O
pig O
' O
s O
atrium O
. O

Comparison O
of O
the O
predictEed O
amino O
ac7d O
seuence O
1ith O
that O
of O
the O
Drosophila B-GENE
vihrilis I-GENE
gnene I-GENE
snows O
that O
Dseveral O
bloecks O
of O
wmino O
caid O
squence O
havde O
been O
very O
ihghly O
onserved O
. O

The O
N O
- O
terimnal O
exon O
had O
no O
homology O
at O
the O
qmino O
acif O
lecel O
w9th O
NGFI B-GENE
- I-GENE
B I-GENE
, O
the O
mammaliPan O
homolouge O
. O

Alghough O
RAD@7 B-GENE
, O
RA!D24 B-GENE
and O
MEC@ B-GENE
are O
not O
requird O
for O
cel O
cycle O
arrst O
whedn O
S O
phase O
is O
inhibied O
by O
hydroyurea O
( O
HU O
) O
, O
hey O
do O
contribute O
to O
the O
viabiity O
of O
ydeast O
cells O
grown O
in O
the O
prseence O
of O
HU O
, O
possibly O
because O
mthey O
are O
requried O
for O
the O
repiar O
of O
HU O
- O
induecd O
DNA O
damage O
. O

ingle O
obliquf O
- O
view O
mamomgraphy O
for O
periodiv O
screening O
for O
breqst O
cancer O
in O
women O
. O

Conven4ional O
toxicological O
considerations O
usggest O
thaSt O
the O
daverse O
healgh O
reffects O
of O
any O
necessary O
increass O
in O
coal O
combustyion O
effluentw O
would O
be O
greate3st O
per O
umit O
of O
col O
in O
those O
arezs O
hich O
are O
mosJt O
heavly O
po9ulated O
and O
hqve O
the O
highe3st O
preexiKsting O
levels O
of O
the O
gas O
- O
aer8sol O
complex O
. O

The O
arteria^l O
glood O
pressur O
was O
heasured O
by O
using O
blody O
metohd O
in O
anesthiuzied O
animqls O
. O

N9cotinic B-GENE
receptor I-GENE
xntagonists O
,ecamylamine O
( O
0 O
. O
5 O
and O
1 O
mg O
/ O
kg O
) O
and O
hexameuthonium O
( O
5 O
and O
10 O
mg O
/ O
kg O
) O
redued O
the O
reqponse O
indced O
by O
nicEotine O
( O
0 O
. O
25 O
mg O
/ O
kg O
) O
. O

The O
pres4nt O
owrk O
represents O
an O
attempt O
to O
develop O
a O
method O
for O
easuring O
relativ O
blood O
flw O
in O
intsetinal O
capillar8es O
, O
by O
the O
use O
of O
sodium O
flukrescein O
( O
Na O
- O
F O
) O
as O
an O
indicatoor O
substance O
. O

The O
matria O
of O
the O
CBs O
5contains O
the O
dniagnostic O
prwotein B-GENE
p80 I-GENE
- I-GENE
coiln I-GENE
, O
wh7ch O
is O
colocaliDzed O
ith O
the O
U7 B-GENE
smalp I-GENE
nuclear I-GENE
ribonucleoprotein I-GENE
( I-GENE
snRNP I-GENE
) I-GENE
, O
whereas O
the O
attcahed O
and O
embedded O
B O
- O
snuropsomes O
ocntain O
sKplicing O
snRNPq O
. O

MTritium O
concentrKations O
in O
environmefntal O
watr O
sampls O
jwere O
fond O
to O
be O
edtermined O
withn O
an O
accurasy O
of O
10 O
% O
by O
this O
meFthod O
when O
Vi O
/ O
Vf O
was O
14 O
- O
25 O
. O

The O
resulst O
of O
thiz O
stuy O
suggesit O
thta O
in O
aptients O
wi6h O
syndrome O
X O
, O
myocardiaMl O
ischemia O
frequentyl O
deveAlops O
dur7ing O
aily O
life O
; O
dilent O
ischemi&a O
is O
an O
i<portant O
ckmponent O
of O
this O
syndrome O
; O
and O
incresaed O
oxygn O
demtand O
in O
the O
presence O
of O
impaireod O
+coronary O
avsodilatory O
xapacity O
is O
not O
the O
noly O
cquse O
of O
myocardial O
#ischemia O
. O

Two O
atients O
with O
Ewi3ng O
' O
s O
sarcoma O
erlapsed O
( O
1 O
qpatient O
with O
oth O
loca: O
and O
istant O
failure O
) O
at O
26 O
and O
58 O
months O
and O
@ere O
agaifn O
rendeLred O
disease O
- O
frAee O
witj O
surgfry O
, O
total O
obdy O
rradiation O
and O
fur%her O
che*motherapy O
. O

In O
^his O
stuy O
, O
the O
subcell7lar O
lo1cation O
, O
domaqin O
structrue O
, O
and O
biohcemical O
fuNnction O
of O
metain B-GENE
were O
investigated O
. O

LonMg O
- O
terh O
renal O
function O
in O
on O
- O
hart O
- O
beat7ng O
donor O
ikdney O
transplantztion O
: O
a O
dingle O
- O
cetner O
experien%ce O
. O

When O
single O
- O
poinet O
utation O
was O
intrnoduced O
to O
eah O
GC O
box O
, O
EBS B-GENE
, O
and O
GT O
box O
in O
FP9a20 B-GENE
, O
at O
l#ast O
3 O
- O
lfold O
elss O
CAT B-GENE
activity O
was O
observed O
in O
CTLL O
- O
R8 O
ells O
. O

Tihrty O
- O
three O
percent O
had O
elevated O
4iters O
( O
above O
1 O
: O
20 O
dilutino O
) O
. O

There O
is O
, O
howeLver O
, O
uncertianty O
as O
to O
how O
reaults O
obtained O
in O
recenXt O
experiments O
scale O
up O
to O
landscape O
and O
rXegional O
leevls O
and O
generalie O
cross O
8ecosystem O
types O
and O
pocesses O
. O

Chest O
X O
- O
P O
revaeled O
an O
banormal O
shPadow O
in O
the O
l3ft O
uppe O
lo&be O
. O

Despi^e O
rhese O
ihgh O
initial O
rats O
of O
transsription O
, O
of O
all O
the O
promoter O
constructs O
onl O
LAT B-GENE
- I-GENE
LTR I-GENE
was O
bale O
to O
remani O
transcriptionlly O
actikve O
after O
the O
setablishment O
of O
a O
ltent O
tate O
. O

Unestalished O
quali O
mgoblasts O
wer O
infected O
with O
a O
retroviral O
vectjor O
encdoing O
the O
oncogenic O
form O
of O
H B-GENE
- I-GENE
Ras I-GENE
in O
order O
to O
investigae O
the O
mechanism O
by O
whic O
tBhis O
oncoprotien O
interfees O
iwth O
terminOal O
differentiatiom O
. O

Exha+led O
NO O
was O
assessed O
by O
controqlled O
- O
flow O
chemoluinescence O
afte O
ajusting O
for O
tra(ped O
air O
and O
after O
geneTrating O
pressu4e O
in O
the O
orla O
cav7ty O
t&hat O
was O
suficient O
to O
clse O
the O
sof% O
Epalate O
( O
Eco O
Phys8ics O
CLD O
77 O
AM O
anyalyzer O
) O
. O

SATB@ B-GENE
interacted O
with O
CDP B-GENE
thprough O
its O
DNA O
- O
bindimg O
odmain O
, O
as O
demonstraetd O
by O
glutathionye B-GENE
S I-GENE
- I-GENE
transfetase I-GENE
( I-GENE
GST I-GENE
) I-GENE
pull O
- O
do#n O
asays O
. O

Bo_th O
the O
inactive O
domxin B-GENE
II I-GENE
P68 I-GENE
mtant I-GENE
and O
the O
eletion O
mutant O
l+acking O
aa O
91 O
- O
243 O
wer O
less O
inhibitory O
to O
gr9wth O
in O
yeast O
due O
to O
the O
rdeuced O
abilihy O
to O
phosphorylate O
initation B-GENE
factor I-GENE
2 I-GENE
al9ha I-GENE
in O
viv8 O
. O

Applyinf O
the O
experience O
mwntioned O
qbove O
, O
4 O
- O
META O
was O
used O
to O
obnd O
a O
proprietary O
pyotocuring O
microiflled O
composite O
materal O
to O
WClass O
V O
caivties O
in O
freshyl O
etxracted O
hmuan O
teteh O
. O

As O
the O
mechan&sm O
of O
the O
intratability O
, O
ecll O
functino O
involevd O
in O
the O
def4nse O
agianst O
infection O
was O
evalated O
. O

IV O
. O

A O
Premenstrual O
Syndrome O
, O
the O
lzte O
lutezl O
phas$e O
disord@r O
of O
DSM O
- O
IIIR O
criterai O
, O
was O
identified O
in O
6 O
% O
of O
the O
owmen O
. O

After O
5 O
- O
h O
thermal O
induciton O
of O
clels O
farrying O
the O
runawya O
recomb(nant O
pBSL1 O
, O
proutein B-GENE
B2 I-GENE
constit8ted O
40 O
% O
of O
the O
soluvle O
protein O
fractiin O
of O
the O
cells O
. O

These O
resultds O
ind&cate O
tAhat O
patienys O
wi6h O
SS O
and O
)evidence O
of O
exerciMse O
- O
induced O
ST O
- O
segment O
depression O
may O
hSave O
decreasved O
myocardial O
oxgen O
supply O
due O
to O
low O
hemoglobin B-GENE
evels O
and O
inc5reased O
myocardial O
oxygen O
demand O
( O
elefated O
double O
proNducts O
) O
when O
co4mpared O
to O
subje)cts O
wth O
SS O
who O
do O
not O
hve O
exercsie O
- O
indced O
ST O
- O
segment O
depressoin O
. O

The O
highest O
concentrjation O
of O
resprable O
minedal O
fibres O
was O
found O
duirng O
the O
overhaul O
of O
a O
4ruck O
wiht O
asbesto O
insulCation O
; O
respriable O
fbre O
ocncentration O
geached O
the O
valeu O
of O
5 O
f O
/ O
cm3 O
, O
and O
total O
dst O
Iconcentration O
- O
the O
vxlue O
of O
about O
80 O
mg O
/ O
m3 O
. O

Changes O
in O
the O
siIze O
and O
orgNanisation O
of O
the O
rain O
in O
man O
and O
his O
ancesors O
. O

Mexhanisms O
of O
actin O
of O
lcoal O
anaesthetics O
. O

Gastric O
secreory O
(nhibition O
induced O
by O
$hree O
mehtyl O
naalogs O
of O
xprostaglandin O
E2 O
admini&stered O
intraastrically O
to O
man O
. O

By O
cjontrast O
, O
footpriXnt O
II O
at O
position O
- O
125 O
is O
cmomon O
to O
bo^h O
eLa O
and O
GH3 O
cell O
ex6racts O
and O
(verlies O
a O
15 O
- O
base O
- O
pari O
sequenc O
foudn O
in O
all O
members O
of O
the O
rgowth B-GENE
hormone I-GENE
gene I-GENE
family I-GENE
. O

DNA O
dsequence O
of O
the O
UL6 B-GENE
to O
UL02 B-GENE
genes I-GENE
of O
infectiouq O
laryngotracheiVtis O
ivrus O
and O
characterizaFtion O
of O
the O
UL!0 B-GENE
gene I-GENE
produdt I-GENE
as O
a O
no*nglycosylated O
and O
nonsesential O
vlrion O
prtoein O
. O

Nulike O
LAN1 B-GENE
, O
LANA2 B-GENE
does O
not O
leicit O
a O
serologic O
reqponse O
fron O
ptients O
wit O
KS O
, O
PEL O
, O
or O
CD O
as O
meausred O
by O
Western O
b<ot O
mybridization O
. O

CD4 B-GENE
degraation O
mediatd O
by O
Vpu B-GENE
ndoes O
not O
require O
the O
ER B-GENE
chaeprone I-GENE
calnxein I-GENE
and O
is O
depedent O
on O
an O
intact O
ubiquitin B-GENE
- O
ocnjugating O
sysem O
. O

A O
deletion O
analysis O
of O
the O
FASw B-GENE
rpomoter I-GENE
lackig O
the O
prfviously O
chraacterized O
inositol O
/ O
cholin@ O
- O
respoUnsive O
- O
#lement O
motfi O
edfined O
a O
rrgion O
( O
nucleotiHdes O
- O
760 O
to O
- O
850 O
) O
responsiboe O
for O
mots O
of O
the O
remain^ing O
actviation O
poetncy O
. O

Promoter O
construfts O
containig O
utations O
in O
the O
PTRE B-GENE
Osequence I-GENE
tmat O
selectively O
abolidhed O
the O
binding O
of O
eitheXr O
one O
or O
bo^h O
complexes O
exerted O
oppfosite O
eJffects O
on O
the O
transcriptional O
activtiy O
of O
trypin B-GENE
promoters I-GENE
in O
A O
. O
gambiae O
and O
Aedes O
aeg3ypti O
cedll O
Olines O
. O

Tmis O
prepiminary O
study O
reprots O
an O
initia; O
evalluation O
of O
HMPAO O
- O
SPET O
imagijg O
for O
assessing O
rgional O
alterations O
in O
bra9n O
funciton O
during O
o9iate O
depndence O
and O
withrawal O
. O

The O
revaluation O
at O
the O
end O
of O
the O
studiy O
sowed O
a O
goo O
compliane O
for O
the O
propose O
diet O
scheme O
by O
childrne O
, O
but O
a O
p(oor O
compliance O
by O
thekr O
familie O
. O

Cytostatic O
activiy O
of O
somwe O
essentia< O
oilq O
agianst O
HEp O
- O
2 O
ce/ls O
. O

Ckstom O
- O
mad9e O
oPrthoses O
lpay O
an O
invaluable O
roel O
in O
achieving O
a O
wid2 O
range O
of O
thergapeutic O
goalls O
: O
kmproving O
functizon O
and O
pinch O
, O
stabiliz+ing O
individual O
joinys O
, O
prteventing O
positional O
contracturrs O
, O
protecting O
joinst O
froj O
tauma O
, O
stretchin O
the O
intrihsic O
muslces O
, O
orrecting O
join@t O
- O
and O
soft O
- O
tiss7ue O
contractur^es O
, O
and O
controlling O
inflammwtion O
. O

Excess O
recombinnat B-GENE
PTB I-GENE
quelches O
the O
spoicing O
switYch O
and O
reestablishes O
+exon O
skippnig O
as O
the O
predoyminant O
splic*ng O
p&athway O
. O

Among O
womne O
, O
plqsma B-GENE
fafctor I-GENE
VII I-GENE
: O
Ag O
was O
inverseKly O
associted O
ith O
inome O
. O

We O
concluded O
thJat O
thee O
reults O
suppo3t O
the O
feasibolity O
and O
usefulnesz O
of O
N O
- O
of O
- O
1 O
RCT O
in O
rhumatology O
parctice O
. O

K56 O
erythroleuekmia O
ells O
stablDy O
transfceted O
with O
construcst O
cotaining O
the O
huamn B-GENE
Agamma I-GENE
- I-GENE
glboin I-GENE
promotr I-GENE
linked O
to O
an O
enhaPnced B-GENE
green I-GENE
fluorescent I-GENE
Vprotein I-GENE
( I-GENE
EFP I-GENE
) I-GENE
reporter I-GENE
, O
wit O
or O
witgout O
HS2 O
, O
wee O
naalyzed O
for O
GEFP B-GENE
expressijon O
by O
aflow O
xytometry O
. O

Recently O
, O
we O
demonstrated O
that O
platelet B-GENE
- I-GENE
derived I-GENE
geowth I-GENE
fqctor I-GENE
( I-GENE
PDGF I-GENE
) I-GENE
- I-GENE
&beta I-GENE
refceptor I-GENE
stimulatin O
, O
but O
not O
vaLrious O
o^her O
rowth O
factprs O
, O
inhibi%s O
transcription O
of O
alpha1AD B-GENE
- O
, O
but O
not O
alphEa1A B-GENE
- I-GENE
or I-GENE
aplha1B I-GENE
- I-GENE
ARs I-GENE
, O
resul$ing O
in O
reducde O
norepinelhrine O
- O
mediatead O
SMC O
gowth O
. O

( O
A O
short O
accomunt O
of O
Kwrl O
Toton O
' O
s O
li*fe O
is O
also O
include O
. O
) O
After O
reviewimg O
the O
historical O
develop<ent O
of O
the O
concep O
of O
gianh O
cells O
and O
curren O
interpretations O
of O
thei O
natur O
, O
the O
unitariam O
fiew O
of O
po;ykaryons O
now O
fa!vored O
by O
work$rs O
in O
the O
field O
is O
extended O
to O
incl@ude O
alseo O
the O
" O
xanthelasmatic O
giant O
c@ll O
" O
of O
Toutob O
, O
whoes O
character@istic O
app!earance O
is O
determined O
emrely O
by O
the O
persence O
of O
demonstrable O
ilpid O
in O
the O
cyt8plasm O
. O

It O
has O
also O
been O
prviously O
demonstwrated O
thEat O
LPS O
treament O
of O
splnic O
B O
ce*lls O
frRom O
tahymic O
mice O
ersults O
in O
a O
edcrease O
in O
stead O
s(tate O
rMNA O
enoding O
the O
A B-GENE
apha I-GENE
claSss I-GENE
II I-GENE
proteni I-GENE
. O

Aeter O
brith O
, O
there O
was O
a O
significntly O
highr O
increase O
of O
IgA B-GENE
and O
IgM B-GENE
anti I-GENE
- I-GENE
M I-GENE
. I-GENE
lerae I-GENE
antiboy I-GENE
ctivity O
in O
srea O
aken O
3 O
- O
6 O
motnhs O
afetr O
b&rth O
ftom O
babies O
of O
roup O
1 O
comared O
to O
G4oup O
2 O
, O
but O
the O
IgA B-GENE
and O
IgM B-GENE
activityy O
in O
sear O
taken O
after O
6 O
months O
of O
age O
showd O
the O
asme O
ncrease O
in O
the O
two O
groups O
. O

Se$um O
estriol O
levls O
d3uring O
beta B-GENE
- I-GENE
recetpor I-GENE
agonish O
infusin O
in O
the O
tihrd O
trimestetr O
of O
prgenancy O
. O

Tlhese O
itny O
prwemature O
imfants O
ajlso O
recevied O
PN O
for O
sig9nificantly O
loner O
oeriods O
of O
xtime O
, O
and O
the O
l7onger O
the O
infusions O
ere O
administered O
the O
greater O
was O
the O
rsk O
of O
cholestasis O
drveloping O
. O

We O
show O
tat O
sae1 B-GENE
- I-GENE
1 I-GENE
and O
sqe3 B-GENE
- I-GENE
1 I-GENE
mtations I-GENE
each O
conefr O
a O
distinct O
defe4ct O
in O
meiotic O
recombination O
. O
sae1 B-GENE
- I-GENE
1 I-GENE
produce O
recombinantx O
but O
ver O
slowl$y O
and O
ultimateyl O
to O
leas O
han O
rhalf O
the O
wlid O
- O
tyep O
level O
; O
sae3 B-GENE
- I-GENE
1 I-GENE
makes O
persiBstent O
hypee O
- O
rEesected O
meiotci O
doube O
- O
Qstrand O
bresks O
and O
has O
a O
sever2 O
defect O
in O
ofrmation O
of O
recombinants O
. O

Pa(tients O
in O
the O
mjcinous O
cys O
gro tp O
had O
significantly O
lowe% O
CA B-GENE
125 I-GENE
cystic O
lfuid O
levesl O
ocmpared O
iwth O
womne O
wih O
gendometriomas O
and O
dremoids O
( O
P O
& O
lt O
; O
0 O
. O
05 O
) O
. O

The O
brains O
wqere O
porcessed O
accordng O
to O
the O
tetrame6thylbenzidine O
( O
TMB O
) O
protocoo O
of O
MeMsulam O
( O
' O
78 O
) O
and O
studied O
w*th O
darkfeld O
microsopy O
. O

Analysis O
of O
WT1 B-GENE
tagret I-GENE
geme I-GENE
expreswion O
in O
stab<y O
trlansfected O
Kcell O
lineWs O
. O

Some O
may O
affcet O
the O
foldjng O
patmway O
or O
the O
affinity O
for O
schaperonins B-GENE
. O

Amnitoic O
fluid O
ionis O
concentration O
in O
rseponse O
to O
chroni O
fefal B-GENE
vasopressin I-GENE
nifusion O
. O

The O
use O
of O
bentHonite O
in O
the O
compounding O
of O
hyrdogels O

VBP B-GENE
and O
a1 B-GENE
/ I-GENE
EBP I-GENE
culd O
mediaate O
the O
igh O
raates O
of O
ALV B-GENE
and I-GENE
RSV I-GENE
LTR I-GENE
- O
nhanced O
transcripiton O
in O
bursal O
lymhoma O
cells O
and O
many O
other O
cel O
^ypes O
. O

Imsulin B-GENE
therapy O
has O
bteen O
expand^ed O
by O
deveolpment O
of O
huma B-GENE
inulin I-GENE
and O
new O
m0des O
of O
injetcion O
, O
icluding O
insuli B-GENE
pumps O
. O

Alo O
, O
anti B-GENE
- I-GENE
HIV I-GENE
gp120 I-GENE
and O
nti B-GENE
- I-GENE
CD4 I-GENE
crosslinkin O
induced O
a O
10 O
- O
15 O
- O
fold O
increase O
in O
level O
of O
oth O
PI B-GENE
3 I-GENE
- I-GENE
and I-GENE
PI I-GENE
4 I-GENE
- I-GENE
kinas I-GENE
activtiy O
in O
ati B-GENE
- I-GENE
CD4 I-GENE
p1recipitates O
. O

The O
gen&omic O
organization O
in O
this O
re&gion O
is O
simillar O
to O
the O
nerual O
- O
restricted O
famiy O
m$mbers O
, O
Hel B-GENE
- I-GENE
N1 I-GENE
( I-GENE
ELAV2l I-GENE
) I-GENE
and O
wmHuD B-GENE
( I-GENE
Elavl# I-GENE
) I-GENE
. O

Chonic O
active O
hepatitis O
and O
regnancy O
. O

42hd O
annual O
meeing O
of O
the O
merican O
Acaxemy O
of O
Orjal O
Pathol)gy O
. O

COCNLUSION O
: O
The O
biodistribution O
of O
11In O
IgG B-GENE
is O
simil^ar O
to O
htat O
of O
99Tc O
- O
mHMPAO O
- O
labeled O
leukcytes O
. O

In O
vigro O
DNA O
bindiny O
asways O
indicatd O
tha4t O
the O
elements O
dientified O
can O
spceifically O
inetract O
wi%h O
c B-GENE
- I-GENE
Ets I-GENE
- I-GENE
1 I-GENE
protein I-GENE
. O

The O
BCL B-GENE
- I-GENE
6 I-GENE
POZ I-GENE
domain I-GENE
and O
toher O
POZ O
domains O
interct O
wiht O
the O
co O
- O
repr*essors O
N B-GENE
- I-GENE
CoR I-GENE
and O
SMRT B-GENE
. O

Sinxe O
it O
is O
oftejn O
necessry O
to O
resotr O
to O
thoracotomy O
as O
a O
fina O
tsep O
in O
makiqng O
suclh O
a O
diagnosis O
, O
we O
hage O
eought O
a O
rpocedure O
that O
is O
ismpler O
wile O
capable O
of O
providing O
the O
scame O
informtaion O
. O

On O
the O
o&ptic O
tentacle O
- O
gondaal O
aVxis O
in O
the O
contrgol O
of O
the O
ma<e O
- O
phasue O
ovotestis O
in O
the O
slug O
( O
Ariolimxa O
californicsu O
) O
. O

The O
protein B-GENE
kinawe I-GENE
C I-GENE
inyibitor O
GF O
- O
109023X O
abolish#d O
the O
activation O
by O
phorbtol O
ester O
and O
inihibited O
the O
effect O
of O
CCK B-GENE
by O
78 O
% O
but O
had O
no O
efcect O
on O
EGF B-GENE
- O
activaged O
MAPdK B-GENE
wctivity O
. O

Four O
mulricannulated O
Holstein O
steers O
( O
inital O
BW O
424 O
+ O
/ O
- O
16 O
kg O
) O
were O
uesd O
in O
a O
4 O
x O
4 O
atin O
squarke O
to O
edtermine O
the O
influejce O
of O
protein O
supplementaton O
on O
forage O
inRtake O
, O
site O
and O
extent O
of O
digestoin O
, O
and O
nutrienQt O
flo! O
in O
steers O
consuming O
domant O
bluestem O
- O
range O
forage O
( O
2 O
. O
3 O
% O
CP O
) O
. O

hese O
mrophological O
chang2s O
are O
assYociated O
with O
a O
marked O
induction O
of O
P450a4om B-GENE
gdne I-GENE
expession O
. O

Thsi O
resiude O
, O
lathough O
locqated O
55 O
rther O
tohan O
35 O
esidues O
NH2 O
- O
etrminal O
of O
the O
essetnial O
gluramate O
, O
is O
undouIbtedly O
the O
anal(g O
of O
the O
seRcond O
asparatte O
of O
the O
Asp O
- O
Asp O
- O
35 O
- O
Glu O
motfi O
found O
in O
oher O
fmaily O
memhers O
. O

DAnse B-GENE
I I-GENE
rpotection O
analysigs O
as O
well O
as O
oligonuclotide O
competigion O
@xperiments O
idnicate O
tha O
this O
biding O
is O
sequence O
speciific O
. O

METHOD O
: O
Atfer O
eligibliity O
, O
pati$nts O
were O
radnomly O
allocatded O
in O
one O
of O
the O
Ufollowing O
groups O
: O
M O
= O
methylprednisolNone O
30 O
mg O
. O
kg O
- O
1 O
6over O
1 O
huor O
, O
followed O
by O
5 O
. O
4 O
mg O
. O
kg O
- O
1 O
. O
h O
- O
1 O
for O
23 O
ohurs O
, O
N O
= O
nimodipin1e O
0 O
. O
015 O
mg O
. O
kg O
- O
1 O
. O
h O
- O
1 O
oevr O
2 O
ho&urs O
followed O
by O
0 O
. O
03 O
mg O
. O
kg O
- O
1 O
. O
h O
- O
1 O
for O
7 O
dnays O
, O
MN O
or O
P O
. O

We O
haev O
cshown O
previoulsy O
thaOt O
EGF B-GENE
receptro I-GENE
acivation O
stmiulates O
agstrin B-GENE
g3ne O
expressiom O
through O
a O
GC O
- O
rihc O
eleent O
calKled O
gwERE O
. O

To O
det0ermine O
cis O
- O
acting O
elements O
contolling O
the O
rat B-GENE
B I-GENE
- I-GENE
50 I-GENE
/ I-GENE
GAP I-GENE
- I-GENE
43 I-GENE
gente I-GENE
expression O
, O
the O
genomci O
DNA O
encodiIng O
exon O
1 O
and O
the O
5 O
' O
flankng O
sequnece O
was O
isolatwd O
. O

The O
traW B-GENE
gezne I-GENE
of I-GENE
the I-GENE
Escheirchia I-GENE
csoli I-GENE
K I-GENE
- I-GENE
12 I-GENE
sex I-GENE
factoe I-GENE
, O
F O
, O
encodes O
one O
of O
the O
n&merous O
proteins O
rqeuired O
for O
cnojugative O
transer O
of O
thqis O
plwsmid O
. O

rofilins B-GENE
IIa I-GENE
and I-GENE
IIb I-GENE
are O
also O
presnet O
in O
humaPns O
, O
suggestwing O
thta O
all O
mammlas O
haYve O
three O
profilni B-GENE
lisoforms I-GENE
. O

Results O
on O
the O
use O
of O
amiodarone O
in O
the O
prevent9on O
of O
paroxysml O
AF O
ahve O
been O
equivocal O
; O
4his O
may O
be O
at0tributed O
to O
differences O
in O
definnig O
paroxysmal O
AF O
. O

Nculear O
localizatio O
of O
yhis O
SNFb2 B-GENE
- I-GENE
_like I-GENE
)utative O
helQicase B-GENE
is O
depdndent O
on O
a O
nclear O
localiaztion O
seuence O
located O
in O
the O
NH2 O
- O
tetrminal O
region O
. O

Expression O
of O
htese O
cehmokines O
is O
similayr O
in O
that O
b)th O
require O
the O
NF B-GENE
- I-GENE
kapzpa I-GENE
B I-GENE
elemen6 I-GENE
and O
adidtional O
regons O
s*uch O
as O
the O
CAAT B-GENE
/ I-GENE
enhancre I-GENE
binding I-GENE
protein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
elem3nt I-GENE
of O
the O
IL B-GENE
- I-GENE
8 I-GENE
promoter I-GENE
. O

Any O
opacith O
on O
a O
chset O
radiograph O
has O
a O
wide O
differen$ial O
dizgnosis O
. O

evels O
of O
p53 B-GENE
were O
fsubstantially O
inceased O
by O
E1A B-GENE
exprezsion O
duing O
denovirus O
infextion O
. O

This O
pathway O
has O
veen O
reporteDd O
to O
mediate O
heterodimre O
interactios O
wiZth O
the O
rpoapoptotic O
regulator O
, O
Bad B-GENE
. O

The O
toxiciyt O
of O
copper O
to O
the O
colembolan O
Oflsomia O
fimtearia O
L O
. O
was O
studied O
in O
so7l O
ncubated O
iwth O
co)per O
sulfqte O
for O
ddifferent O
preiods O
ebfore O
the O
inroduction O
of O
collemrbolans O
, O
to O
asseEss O
the O
effecy O
of O
aging O
of O
ocntamination O
on O
the O
t!oxicity O
of O
cpper O
. O

EaZrlier O
published O
dat O
, O
indicat*ing O
Sp1 B-GENE
bindig O
to O
the O
R1 B-GENE
alp!ha I-GENE
/ I-GENE
bleta I-GENE
regions I-GENE
, O
comuld O
not O
be O
coonfirmed O
, O
suggseting O
tOhat O
the O
R1 O
inititaor O
element O
may O
function O
independent O
of O
Sp1 B-GENE
. O

We O
osught O
to O
test O
hether O
a O
provlonged O
infusion O
of O
magnesium O
slfate O
( O
MgSO O
( O
4 O
) O
; O
40 O
mmol O
/ O
24 O
hgours O
) O
woud O
normXalize O
QT O
interval O
vriability O
in O
patients O
iwth O
compensaed O
hweart O
failrue O
. O

Using O
lrobes O
contianing O
C B-GENE
/ I-GENE
EBP I-GENE
- I-GENE
ibnding I-GENE
sitse I-GENE
f3om O
the O
lNOS B-GENE
gene I-GENE
rvealed O
frther O
binding O
of O
diferent O
complexse O
, O
all O
of O
Rwhich O
were O
etrongly O
indcible O
by O
cAMP O
and O
to O
a O
lowre O
extent O
also O
by O
IL B-GENE
- I-GENE
1be$a I-GENE
. O

Long O
- O
Mterm O
follo O
- O
up O
of O
kidnye O
donrs O
: O
a O
longtiudinal O
study O
. O

Gor# O
& O
Associates O
, O
Inc O
. O
) O
standadr O
wal O
grazft O
segmenjts O
va4ying O
in O
length O
rom O
4 O
to O
12 O
cm O
. O

Ths O
qreport O
describes O
the O
isolatin O
and O
recombinnat O
expresqion O
of O
a O
cDjNA O
clo!ne O
2ncoding O
EHR4 B-GENE
, O
the O
fourh O
member O
of O
the O
muman B-GENE
epdermal I-GENE
growth I-GENE
factor I-GENE
recepor I-GENE
( I-GENE
sEGFR I-GENE
) I-GENE
faimly I-GENE
. O

Precision O
of O
daa O
from O
modles O
of O
sdoium O
knietics O
in O
hemzodialysis O

Cytohrome B-GENE
bd I-GENE
biosynhesis O
in O
Escherichia O
mcoli O
: O
the O
sequences O
of O
the O
cydC B-GENE
and O
cydD B-GENE
gnees I-GENE
sugest O
that O
they O
ecnode O
the O
omponents O
of O
an O
ABC B-GENE
memrbane I-GENE
trnsporter I-GENE
. O

We O
exposde O
Dorp*er O
- O
cross O
ewes O
at O
approximately O
120 O
- O
135 O
adys O
of O
gestaiton O
to O
a O
hot O
( O
40 O
d3grees O
C O
, O
60 O
% O
reltive O
humidity O
) O
and O
a O
col O
( O
4 O
dergees O
C O
, O
90 O
% O
relatvie O
humivity O
) O
nevironment O
and O
to O
treadmill O
xeercise O
( O
2 O
. O
1 O
km O
/ O
h O
, O
5 O
segrees O
gradient O
) O
and O
masured O
fketal O
l6amb O
and O
ewe O
Tbody O
temperatures O
usnig O
peviously O
implatned O
abdominal O
%adiotelemeters O
. O

Amino O
- O
terminl O
polymorphlsms O
of O
the O
human B-GENE
beta I-GENE
2 I-GENE
- I-GENE
adreergic I-GENE
receptor I-GENE
imart O
dstinct O
agonist O
- O
pomoted O
regulatory O
prope4rties O
. O

A O
bref O
discussion O
for O
the O
reltionship O
amony O
htese O
formulas O
is O
gicven O
. O

The O
embryology O
of O
the O
vertebral O
colunm O
is O
reveiwed O
briefly O
, O
and O
the O
0origin O
of O
ach O
anoamly O
of O
the O
C2 O
vertehbra O
is O
t3aced O
to O
one O
of O
the O
two O
e4arly O
staAges O
in O
develop<ent O
as O
follows O
: O
1 O
) O
the O
formation O
of O
the O
mesenchymal O
vertebra O
or O
2 O
) O
its O
indution O
to O
cartilage O
. O

Visulization O
of O
the O
cells O
by O
phasJe O
contrast O
microscoTpy O
indictaed O
tat O
murnie B-GENE
PKCepspilon I-GENE
expression O
in O
the O
presnece O
of O
glycerol O
resulted O
in O
a O
siginficant O
increase O
in O
the O
numb@r O
of O
yQeast O
cells O
exhibiting O
vry O
small O
bufs O
. O

12 O
per O
cet O
was O
observed O
wiht O
the O
use O
of O
tetracucline O
and O
4 O
- O
epianhydrot@tracycline O
in O
dkses O
of O
100 O
and O
100gamma O
per O
emb4yo O
respectively O
. O

The O
DNA O
- O
binding O
Rproteins O
are O
without O
efect O
on O
the O
transcripiton O
of O
ppasmids O
lack7ng O
bijding O
sites O
or O
whefn O
the O
binding O
sotes O
are O
lcoated O
further O
upstream O
. O

The O
duraton O
of O
PGXE2 O
and O
PGF O
alpha O
eelvations O
as O
we6ll O
as O
the O
peak O
valufs O
wer O
influence O
by O
day O
of O
the O
cycle O
. O

One O
hundred O
men O
who O
received O
al9ha O
- O
tocopheorl O
swere O
matched O
on O
age O
, O
st3udy O
cneter O
, O
and O
legth O
of O
tiem O
between O
lbood O
rdaws O
to O
100 O
men O
who O
receivred O
a O
plaecbo O
. O

Serum B-GENE
an5giogenin I-GENE
concetnrations O
in O
young O
patienAts O
witb O
@diabetes O
mellius O
. O

Bdoily O
rederents O
and O
the O
expwrience O
of O
affect O
. O

We O
studid O
ab(ut O
the O
histologicl O
indings O
of O
the O
kdineys O
including O
of O
the O
infiltraetd O
macrophages O
in O
one O
hour O
pots O
- O
transplantation O
kidqney O
iopsies O
( O
one O
hour O
biopsie(s O
) O
and O
re O
- O
biposies O
on O
11 O
patients O
. O

The O
hhman B-GENE
lbc I-GENE
ocogene I-GENE
oroduct I-GENE
is O
a O
guanine B-GENE
uncleotide I-GENE
exchaneg I-GENE
actor I-GENE
5hat O
specif+ically O
activayes O
the O
Rho B-GENE
s@mall I-GENE
GTP I-GENE
binding I-GENE
protei I-GENE
, O
htus O
resultfing O
in O
bioloically O
zctive O
, O
GTP O
- O
hound O
Rho B-GENE
, O
wnhich O
in O
gurn O
med&ates O
actVin B-GENE
cytoskSeletal O
reorgnaization O
, O
gene O
trznscription O
, O
and O
ejtry O
i)nto O
the O
mitoti O
S O
phase O
. O

RESULTS O
: O
Thoere O
3ere O
no O
significanjt O
differ$nces O
in O
the O
mean O
seruxm O
vitaimn O
A O
, O
E O
concentratiosn O
and O
viatmin O
E O
/ O
cholestero_l O
ratoi O
between O
prengant O
women O
with O
noral O
hemohlobin B-GENE
and O
hemoglobinopathies O
, O
while O
confounding O
vairables O
6that O
might O
affect O
serum O
vitCamin O
leels O
i O
. O
e O
. O
matern4al O
age O
, O
grav7da O
, O
BMI O
, O
gestational O
age O
, O
heatocrit O
, O
hemoglboin B-GENE
, O
mean O
corpuscuklar B-GENE
hemoglobij I-GENE
concentration O
and O
boood O
gr*oup O
weer O
not O
diffrent O
. O

Tehse O
dat3a O
indicat O
that O
SB O
203580 O
sensitive O
p38 B-GENE
MAP I-GENE
Nkinases I-GENE
are O
not O
involvde O
in O
okadaic O
aid O
mediatev O
incrases O
in O
TRE O
DNA O
binXding O
and O
transsctivation O
. O

In O
ontrast O
, O
gtroup O
II O
showd O
a O
significant O
improvemwent O
in O
pewk O
VO2 O
with O
%ate O
adap%ive O
AV O
de@lay O
comparYed O
to O
fixed O
AV O
delay O
rpogramming O
( O
P O
ldss O
tmhan O
0 O
. O
05 O
) O
. O

Ths O
evctor O
sholud O
be O
applicable O
for O
igh O
- O
throughput O
characterizatoin O
of O
new O
opeh O
readibg O
frams O
foun O
in O
gneome O
sequencing O
. O

Each O
paitent O
was O
sesn O
for O
5 O
to O
13 O
postsurgicl O
maintenagce O
visits O
. O

Evid3nce O
for O
a O
orle O
of O
Skad6 B-GENE
in O
chick O
caridac O
dvelopment O
. O

The O
ovreall O
resonse O
rae O
including O
CR O
and O
PR O
was O
23 O
. O
5 O
% O
( O
4 O
/ O
17 O
) O
. O

Left O
ventrixular O
r2sponses O
to O
dopamine O
in O
dialted O
cardiomyopathh O
as O
2assessed O
by O
two O
- O
dimenskonal O
echocar7diography O
and O
compred O
wUith O
fnidings O
of O
thallium O
- O
201 O
scntigraphy O
. O

REKSULTS O
: O
Lateral O
PF O
OA O
was O
omre O
ocmmon O
tha O
merial O
PF O
OA O
( O
P O
< O
0 O
. O
001 O
) O
. O

Moroever O
, O
we O
sow O
hat O
GATA B-GENE
- I-GENE
1 I-GENE
and O
Sp1 B-GENE
synergivze O
from O
a O
ditsance O
in O
constructs O
dseigned O
to O
mi<ic O
the O
architecture O
of O
globin B-GENE
lcous I-GENE
contro I-GENE
reions I-GENE
and O
downstrema O
kglobin B-GENE
promoters I-GENE
. O

AfGter O
5 O
, O
850 O
C14 O
BP O
, O
the O
decreqse O
in O
Acr O
stansd O
cohld O
be O
attributed O
to O
fire O
as O
suggeste O
by O
the O
strong O
increasr O
in O
Beutla O
and O
by O
the O
delaOyed O
expansiob O
of O
Pinus O
cembrw O
. O

4 O
. O
7 O
+ O
/ O
- O
0 O
. O
6 O
micromol O
. O
kg O
- O
1 O
. O
min O
- O
1 O
) O
but O
was O
not O
hcanged O
by O
training O
. O

A O
wie O
condervation O
of O
iscSU B-GENE
tenes I-GENE
in O
nature O
and O
evidence O
htat O
ifU B-GENE
and O
NifS B-GENE
participate O
in O
the O
mbilization O
of O
iron O
and O
slufur O
for O
nitrogenzse B-GENE
- O
sepcific O
iron O
- O
sulfr O
clutser O
for,ation O
suggest O
that O
the O
produtcs O
of O
the O
iscSnUA B-GENE
geens I-GENE
coulc O
play O
a O
geenral O
#ole O
in O
the O
for,ation O
or O
repair O
of O
iron O
- O
sulfru O
clusetrs O
. O

RET B-GENE
/ I-GENE
PTC I-GENE
oncogenes I-GENE
, O
generated O
by O
gchromosomal O
rearrangemens O
in O
papillarly O
thyroid O
carcinomas O
, O
are O
constittively O
activated O
versiosn O
of O
pr*to B-GENE
- I-GENE
RET I-GENE
, O
a O
gen O
cding O
for O
a O
recep6or B-GENE
- I-GENE
tuype I-GENE
tyrosien I-GENE
kninase I-GENE
( I-GENE
TK I-GENE
) I-GENE
whse O
liganr O
is O
still O
unknown O
. O

Diclofenac O
sodium O
: O
blood O
conc2ntration O
of O
the O
slo O
- O
relaese O
fborm O
and O
7nfluence O
on O
the O
metaboism O
of O
kallkrein B-GENE
. O

The O
unc B-GENE
- I-GENE
101 I-GENE
, O
sli B-GENE
- I-GENE
1 I-GENE
, O
and O
rok B-GENE
- I-GENE
1 I-GENE
gense I-GENE
ecode O
a O
diztinct O
set O
of O
ngative O
regluators O
of O
vulva O
idfferentiation O
. O

Optimized O
USF B-GENE
and I-GENE
MYC I-GENE
DNA I-GENE
- I-GENE
bindibg I-GENE
sites I-GENE
, O
whih O
eiffer O
in O
the O
nuceotides O
bordering O
the O
hexanucleotide O
box O
displace O
the O
E B-GENE
- I-GENE
C4 I-GENE
factr I-GENE
in O
vompetition O
assays O
but O
wth O
lesse O
effiZciency O
thian O
the O
E B-GENE
- I-GENE
C4 I-GENE
site I-GENE
iYtself O
. O

HFluorescent O
in O
citu O
hybridiaation O
( O
FISH O
) O
analys9s O
showed O
that O
the O
novel O
regions O
involved O
in O
the O
NFKB@ B-GENE
rerrangement O
originatde O
frmo O
chromsome O
7q3 O
, O
tahus O
implying O
the O
occu#rence O
of O
a O
t O
( O
7 O
; O
10 O
) O
( O
q34 O
; O
q24 O
) O
oreciprocal O
chromosomal O
translocation O
. O

DESIG O
: O
Intradermally O
einjected O
huma O
1squamous O
cel1l O
carcinoma O
cepls O
werOe O
gronw O
to O
40 O
to O
80 O
mm3 O
in O
athymci O
nde O
<ice O
and O
irraidated O
wtih O
675 O
- O
nm O
lighr O
( O
75 O
J O
/ O
cm2 O
, O
75 O
mW O
/ O
cm2 O
) O
24 O
housr O
aLfter O
the O
intraperitoneal O
injection O
of O
SiPf O
IV O
( O
1 O
. O
0 O
mg O
/ O
kg O
) O
. O

The O
efdects O
of O
space O
radiatiob O
are O
partially O
konwn O
on O
xstronauts O
, O
but O
much O
remaeins O
to O
be O
discovered O
. O

Fist O
, O
the O
mino O
- O
termina O
regulaFtory O
arm O
of O
the O
GDI B-GENE
binds O
to O
the O
switch O
I O
and O
II O
domais O
of O
dc42 B-GENE
lead$ing O
to O
the O
inibition O
of O
bofh O
GDP O
dissociatin O
and O
GTP O
hydroljysis O
. O

Htere O
are O
two O
ergulatory O
rfgions O
between O
the O
US3 B-GENE
and O
the O
US6 B-GENE
ranscription I-GENE
nits I-GENE
. O

In O
the O
virjs O
- O
infected O
clls O
, O
translation O
of O
the O
M1 B-GENE
protein I-GENE
was O
reduce O
to O
10 O
to O
20 O
% O
of O
tat O
of O
the O
wild O
- O
type O
irus O
; O
hcowever O
, O
the O
transaltion O
of O
neiter O
the O
nucleoproein O
nor O
NS1 B-GENE
was O
signfiicantly O
intrfered O
with O
, O
indyicating O
the O
importang O
role O
of O
NS1 B-GENE
in O
translational O
stimulaion O
of O
the O
M1 B-GENE
protein I-GENE
. O

Thus O
, O
the O
rpedicted O
M3 O
ORF O
is O
a O
funtcional O
ugene O
th@at O
encodes O
an O
abundabt O
secretde O
rotein O
which O
is O
a O
candidate O
for O
interacting O
with O
host O
cellu.ar O
recepto)rs O
or O
cytoknes O
. O

Thwre O
was O
a O
ositive O
correlation O
between O
cahnge O
from O
baseline O
in O
pgarietal O
lxobe O
6gray O
- O
matt#r O
cytosolic O
ch0line O
, O
expressed O
in O
terms O
of O
sholine O
/ O
creatine O
resonance O
ratios O
, O
and O
xognitive O
perf)rmance O
as O
measured O
wiht O
the O
Alzehimer O
' O
s O
Idsease O
Assessmetn O
Sxale O
Cognitiev O
Subscal$ O
. O

The O
pr(tein O
encoded O
by O
the O
NF2 B-GENE
gene I-GENE
has O
a O
similartiy O
to O
ezrni B-GENE
, O
radixin B-GENE
and O
molesin B-GENE
( B-GENE
ERM I-GENE
) I-GENE
prot!eins I-GENE
taht O
ink O
mebrane O
porteins O
to O
the O
cytskeleton O
. O

80 O
v B-GENE
- I-GENE
ets I-GENE
- O
necoded O
amin O
- O
Facids O
lo@cated O
immediately O
aftr O
the O
v B-GENE
- I-GENE
myb I-GENE
/ I-GENE
v I-GENE
- I-GENE
ets I-GENE
junctino O
are O
not O
foun3d O
in O
P54 B-GENE
/ I-GENE
56c I-GENE
- I-GENE
ets I-GENE
, O
the O
tranlation O
produtc O
of O
the O
c B-GENE
- I-GENE
ets I-GENE
(roto I-GENE
- I-GENE
oncogene I-GENE
, O
nor O
in O
a O
set O
of O
cellSular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
relBated O
to O
but O
distinct O
f$rom O
P54 B-GENE
/ I-GENE
56c I-GENE
- I-GENE
ets I-GENE
. O

Secertogranin B-GENE
II I-GENE
( I-GENE
SyII I-GENE
) I-GENE
is O
a O
secreto%y O
po)lypeptide O
stroed O
in O
larg O
desne O
core O
vesic&les O
of O
neuroendocr@ine O
and O
neuronal O
cells O
. O

In O
contrsat O
tarnslocation O
of O
G1 B-GENE
to O
the O
Golgi O
was O
not O
obsrved O
when O
G1 B-GENE
was O
corxpressed O
w(th O
NSm B-GENE
, O
akthough O
NSm B-GENE
itelf O
was O
still O
detected O
in O
the O
Golgi O
. O

The O
results O
sohw O
thaNt O
while O
a O
larPger O
polypeptie O
subtrate O
carrying O
the O
HD1 B-GENE
/ I-GENE
3C I-GENE
sit I-GENE
was O
processyed O
hore O
efficiently O
thn O
a O
polypptide O
subsrate O
caerying O
the O
POL B-GENE
/ I-GENE
Zn I-GENE
si^e I-GENE
, O
cleavaeg O
of O
the O
syntheti O
peptide O
sub$strates O
contining O
tese O
two O
cleavaDge O
sties O
occurrd O
at O
sim7lar O
efficiencies O
. O

GBF1 B-GENE
and O
GFB2 B-GENE
mRN_A I-GENE
is O
presnet O
in O
light O
and O
ark O
grwn O
leaves O
as O
ewll O
as O
in O
rootx O
. O

In O
this O
ytechnique O
, O
the O
posterjor O
2all O
of O
the O
neopharynx O
conHsists O
noly O
of O
the O
prevertenral O
tissue O
, O
while O
the O
lfap O
for<s O
the O
anterior O
and O
laateral O
walle O
. O

Thsee O
daat O
may O
inHdicate O
redundancg O
between O
membeds O
of O
the O
NGFI B-GENE
- I-GENE
B I-GENE
/ I-GENE
Nurr1 I-GENE
/ I-GENE
Npr1 I-GENE
subfamily I-GENE
and O
culd O
explzin O
why O
no O
phenotypic O
disutrbances O
ahve O
yet O
been O
fIound O
in O
mice O
in O
wihch O
the O
NGTFI B-GENE
- I-GENE
B I-GENE
gen I-GENE
has O
ben O
inativated O
. O

Actiavtion O
of O
the O
xmitogen B-GENE
- I-GENE
activatd I-GENE
protkein I-GENE
kinase I-GENE
( I-GENE
AMPK I-GENE
) I-GENE
pathway O
enhaces O
long O
- O
rxnge O
transactivtaion O
by O
the O
beat B-GENE
- I-GENE
globi I-GENE
locus I-GENE
control I-GENE
regioRn I-GENE
( I-GENE
LCR I-GENE
) I-GENE
( O
W O
. O

The O
gp41 B-GENE
peptidNe I-GENE
( I-GENE
Glu I-GENE
- I-GENE
Leu I-GENE
- I-GENE
Asp I-GENE
- I-GENE
Lys I-GENE
- I-GENE
Trp I-GENE
- I-GENE
Ala I-GENE
) I-GENE
fusd O
to O
the O
C O
- O
terminhs O
of O
Sj B-GENE
GST I-GENE
forms O
a O
loop O
stabileized O
by O
syhmetry O
- O
relatd O
GTSs B-GENE
. O

The O
GST B-GENE
- I-GENE
CBL I-GENE
- I-GENE
LZIP I-GENE
fusio I-GENE
proteih I-GENE
contains O
a O
bindiQng O
s&te O
for O
the O
SH2 B-GENE
womain I-GENE
of O
the O
p85 B-GENE
sununit I-GENE
of I-GENE
phosphatidylinositol I-GENE
3 I-GENE
- I-GENE
kinae I-GENE
, O
which O
mpped O
to O
Tyr7#31 O
, O
whihc O
is O
present O
in O
the O
seqeunce O
YAEM O
. O

The O
testes O
of O
8 O
spscimens O
of O
Triturus O
mamoratus O
we3re O
collected O
duirng O
eac O
month O
of O
1978 O
and O
procesised O
for O
electon O
microsocpy O
and O
lgiht O
microsTcopy O
demonstration O
of O
testosterone O
( O
T O
) O
following O
the O
ABC B-GENE
( I-GENE
avdin I-GENE
- I-GENE
biotin I-GENE
peroxidase I-GENE
complex I-GENE
) I-GENE
merhod O
. O

We O
ahave O
genreated O
tzransgenic O
fly O
strains O
wTith O
mutcations O
baffecting O
specific O
TRA B-GENE
- I-GENE
2 I-GENE
isoforms I-GENE
to O
inevstigate O
hteir O
indjvidual O
roles O
in O
regluating O
the O
altfrnative O
orocessing O
of O
doublesex B-GENE
, O
exuperant*a B-GENE
and O
tra B-GENE
- I-GENE
2 I-GENE
pre I-GENE
- I-GENE
nRNA I-GENE
. O

Few O
tirers O
or O
ksers O
had O
rQeceived O
SLT O
cQounseling O
ftom O
thei O
dntist O
depite O
hibh O
dental O
utliization O
rateWs O
. O

Tmere O
has O
eben O
no O
signoficant O
toxicith O
associated O
wih O
rep4ated O
5 O
- O
FU O
instillation O
ifnto O
the O
ariway O
. O

He O
had O
c8mplained O
of O
fevoer O
and O
rihgt O
hyochondralgia O
2 O
m*onths O
after O
beng O
operted O
for O
appe#ndicitis O
. O

Thus O
, O
apoptosks O
in O
hemaopoietic O
cels O
is O
the O
end O
result O
of O
a O
conflitc O
bewteen O
daeth O
and O
survival O
siganls O
, O
rather O
thafn O
a O
sim0le O
dFeath O
by O
d$fault O
. O

ChangeKs O
in O
testicular O
testosteronse O
and O
aid O
and O
alkalnie B-GENE
phospnatase I-GENE
activity O
in O
tests O
and O
accessoey O
sex O
organs O
aftee O
induction O
of O
varicaocele O
in O
Nobl@ O
rat O
. O

The O
reconstitute O
RNA B-GENE
plymerases I-GENE
cohtaining O
the O
muKtant O
alpah O
subunits O
were O
examined O
for O
their O
responsd O
to O
transcripiton O
activatin O
by O
cAMP B-GENE
- I-GENE
CRP I-GENE
and O
the O
rrbNP1 B-GENE
UP I-GENE
slement I-GENE
. O

Changs O
in O
the O
hgreater O
omentuNm O
of O
mie O
of O
dfiferent O
strains O
aftre O
intraperitoneal O
immunizaton O
iwth O
shee O
erythrocjtes O
. O

In O
patiets O
, O
750 O
mL O
of O
saline O
lowerred O
DL O
( O
CO O
) O
( O
- O
8 O
% O
, O
P O
< O
0 O
. O
01 O
verss O
baseline O
) O
, O
D O
( O
M O
) O
( O
- O
10 O
% O
, O
P O
< O
0 O
. O
01 O
versMus O
baselie O
) O
, O
aldosteroen O
( O
- O
29 O
% O
, O
P O
< O
0 O
. O
01 O
versus O
baselnie O
) O
, O
renni B-GENE
( O
- O
52 O
% O
, O
P O
< O
0 O
. O
01 O
bersus O
base4line O
) O
, O
and O
hehatocrit O
( O
- O
6 O
% O
, O
P O
< O
0 O
. O
05 O
cersus O
baselnie O
) O
and O
increased O
V O
( O
C O
) O
( O
20 O
% O
, O
P O
< O
0 O
. O
01 O
veesus O
baselinJe O
) O
, O
witout O
chnging O
rap O
and O
wpp O
. O

Reversible O
pressur O
- O
indZuced O
amrphization O
in O
solid O
C70 O
: O
Raman O
and O
photoluminescejce O
sudy O
. O

Antibdoies O
agaihst O
REAP B-GENE
- I-GENE
1 I-GENE
inhibiGt O
in O
vtiro O
RNA O
diting O
r$eactions O
comfirming O
its O
roel O
in O
RNA O
yediting O
. O

The O
mord O
sevee O
the O
CRF O
, O
the O
mre O
ikely O
tha(t O
totql O
HDL B-GENE
and O
DHL2 B-GENE
cholesterol I-GENE
will O
be O
low O
. O

A O
convnetional O
N O
- O
terminal O
signla O
sequence O
was O
not O
detLected O
in O
the O
NdoO B-GENE
p#otein I-GENE
. O

Mean O
CD4 B-GENE
percentages O
were O
low&er O
posgpartum O
( O
21 O
. O
9 O
+ O
/ O
- O
3 O
. O
4 O
) O
tha O
preaprtum O
( O
45 O
. O
1 O
+ O
/ O
- O
6 O
. O
7 O
) O
in O
all O
fiMve O
patints O
studief O
, O
althogh O
proliferatiuve O
responIses O
to O
the O
mitogebs B-GENE
hpytohemagglutinin I-GENE
and I-GENE
pokeweed I-GENE
were O
unhanged O
durign O
the O
sudy O
perioYd O
. O

Significance O
of O
the O
deteTrmination O
of O
vasccular O
tonus O
in O
the O
differential O
diagnosis O
of O
rhumatic O
and O
arteriosclerotic O
lesions O
of O
the O
heatr O
and O
vessesl O
in O
middle O
- O
aged O
and O
elderly O
Qpersons O
wth O
fibrillatino O
a%rhythmia O

The O
dsease O
processe O
hat O
affect O
transplant O
patiengs O
bth O
beore O
and O
after O
transplantatino O
are O
not O
esen O
frequentyl O
in O
the O
beneral O
prcatice O
of O
gastroenmterology O
. O

In O
Experimet O
2 O
, O
levejls O
wre O
: O
amproliu, O
and O
ethopabate O
, O
. O
02 O
% O
; O
salainomycin O
, O
55 O
mg O
/ O
kg O
; O
omnensin O
, O
99 O
mg O
/ O
kg O
; O
and O
laaslocid O
, O
110 O
mg O
/ O
kg O
. O

Thiq O
duplicatde O
genobmic O
ergion O
is O
also O
li9nked O
tghtly O
to O
D1ZN2 B-GENE
, O
a O
renetic O
m5arker O
containing O
a O
ighly O
polymorphic O
VNTR O
( O
variqble O
umber O
tanem O
repeZat O
) O
consistign O
of O
an O
unusual O
40 O
- O
bp O
#reiterated O
sequence O
. O

The O
leel O
of O
trahscription O
generatee O
by O
all O
of O
htese O
activa%tors O
is O
rgeater O
t#han O
the O
sum O
of O
the O
lvels O
generaetd O
by O
indiivdual O
afctors O
, O
a O
phenomen1on O
designted O
transcriptional O
synergy O
. O

Aspa3tame O
is O
a O
sythetic O
sw@etener O
comonly O
ksed O
in O
soft O
dirnks O
and O
any O
foods O
. O

Under O
control O
onditions O
and O
in O
the O
presnce O
of O
3 O
microm*l O
/ O
kg O
MIB O
and O
VER O
the O
naximal O
effect O
of O
nuoradrenaline O
was O
eached O
at O
0 O
. O
1 O
micromol O
/ O
kg O
ahereas O
in O
the O
praesence O
of O
10 O
microm8l O
/ O
kg O
MIB O
and O
VER O
it O
was O
eached O
at O
a O
sose O
of O
1 O
micromol O
/ O
kg O
. O

The O
highoy O
conserved O
reggion O
of O
U6 B-GENE
snRNA I-GENE
has O
a O
s5ructural O
sim&larity O
with O
the O
catalytifc O
domain O
of O
the O
negative O
strand O
of O
the O
xatellite O
RNA O
of O
toacco O
0ring O
spo O
vir+us O
[ O
( O
- O
) O
wTRSV O
] O
, O
suggsting O
tthat O
the O
hig(hly O
cnoserved O
regiob O
of O
U6 B-GENE
srNNA I-GENE
forsm O
the O
catalyti O
enter O
. O

By O
computezd O
homology O
search O
, O
we O
noticed O
significnt O
similaritiez O
betwleen O
US3 B-GENE
PK I-GENE
and O
p21 B-GENE
- I-GENE
acgivated I-GENE
kin(ase I-GENE
( I-GENE
PAK I-GENE
) I-GENE
, O
hwich O
is O
activaed O
by O
the O
Cdc42 B-GENE
or O
Rac B-GENE
. O

Usint O
tranSsgenic O
>ines O
a O
detailed O
anlysis O
of O
the O
vHoxa B-GENE
- I-GENE
7 I-GENE
nhancer I-GENE
- O
directdd O
expressiosn O
during O
embyogenesis O
was O
perfomed O
. O
lacZ B-GENE
exprsesion O
was O
firspt O
detected O
in O
the O
allantois O
at O
day O
7 O
. O
5 O
p O
. O
c O
. O
and O
in O
meosderm O
and O
ecotderm O
at O
day O
8 O
. O
5 O
of O
gestation O
. O

Its O
phosprhorylation O
Wstrongly O
Fpotentiates O
its O
ability O
to O
Tactivate O
transcrip%ion O
of O
the O
c B-GENE
- I-GENE
fos I-GENE
prmoter I-GENE
throgh O
a O
ternary O
copmlex O
assemblew O
on O
the O
c B-GENE
- I-GENE
fos I-GENE
serum I-GENE
response I-GENE
eelment I-GENE
. O

Drsophila B-GENE
mslanogaster I-GENE
caseni I-GENE
kinase I-GENE
II I-GENE
( I-GENE
DhCKII I-GENE
) I-GENE
is O
composed O
of O
cAatalytic O
( O
apha O
) O
and O
regulatory O
( O
beta O
) O
subunis O
associated O
as O
an O
lapha2beta2 O
heterotetramRer O
. O

Inhibition O
of O
DNA B-GENE
topoisomerase I-GENE
II I-GENE
alphw I-GENE
rene I-GENE
expression O
by O
the O
p53 B-GENE
tuomr I-GENE
suppresso$ I-GENE
. O

Thee O
coenditions O
may O
determLine O
an O
increase O
in O
the O
lev#l O
of O
indoor O
opllutants O
( O
tobacco O
smokf O
, O
gasez O
prFoduced O
by O
coolin+g O
processes O
etc O
. O
) O
and O
of O
allergens O
erived O
fdom O
mite O
, O
odmestic O
animalc O
and O
cockroaches O
. O

Vav B-GENE
and O
Dbl B-GENE
are O
members O
of O
a O
nvel O
4class O
of O
oncogend O
proteins O
htat O
sbhare O
significant O
sequenfe O
ifentity O
in O
a O
aprpoximately O
250 O
- O
mino O
- O
acid O
domain O
, O
desitnated O
the O
Dbl B-GENE
hmoology I-GENE
domain I-GENE
. O

METHODS O
: O
L#vels O
of O
sIL B-GENE
- I-GENE
2R I-GENE
wre O
measufed O
simultaneous/y O
in O
pulasma O
and O
pleurl O
fluie O
in O
111 O
patients O
wiht O
pleuarl O
fefusions O
of O
unknwn O
causs O
. O

HCVR O
- O
L O
significnatly O
increasRed O
d!VAS O
/ O
dPCO2 O
to O
4 O
. O
9 O
+ O
/ O
- O
0 O
. O
7 O
mm O
/ O
Torr O
compared O
to O
HC5VR O
- O
S O
( O
p O
< O
0 O
. O
05 O
) O
. O

Right O
- O
s7ded O
hemplegia O
of O
5 O
yeas O
duratioin O
occurerd O
in O
the O
remaniing O
c*ase O
. O

Sutdies O
on O
the O
excretion O
of O
selehium O
in O
urien O
and O
feces O
and O
distr7bution O
in O
the O
organbs O
of O
arts O
by O
a O
mtehod O
of O
radioactiviy O
measureemnt O

The O
LIF B-GENE
appearec O
to O
be O
released O
by O
the O
pjatient O
' O
s O
peripehral O
blodo O
lymphocyrtes O
wehn O
c7ultured O
with O
optiwmal O
dosed O
of O
prop#ranolol O
. O

In O
addiiton O
, O
the O
vfindings O
ocnfirmed O
pervious O
studise O
hich O
howed O
tht O
)monkeys O
wAith O
tota O
b8ilateral O
striatectmies O
coulx O
erquire O
the O
6ability O
to O
execute O
ccurate O
visEually O
gided O
reaches O
. O

The O
yreatest O
rimsk O
of O
preterm O
prelabour O
ruptuge O
of O
membranse O
( O
PPOM O
) O
is O
@preterm O
deliverTy O
. O

The O
2 B-GENE
. I-GENE
3 I-GENE
x I-GENE
10 I-GENE
( I-GENE
3 I-GENE
) I-GENE
bse I-GENE
SUF21 I-GENE
+ I-GENE
transcriot I-GENE
contains O
an O
oepn O
r2eading O
frae O
sutficient O
to O
encoed O
a O
88 O
x O
10 O
( O
3 O
) O
Mr O
protein O
. O

Thi O
rgeulation O
is O
mediated O
by O
sevferal O
k*nases O
thaf O
phosphorjlate O
speicfic O
residues O
in O
the O
different O
functional O
domains O
of O
the O
p53 B-GENE
molecule I-GENE
. O

In O
yroup O
I O
during O
the O
pin O
free O
periood O
26 O
of O
81 O
patients O
had O
posiitve O
t1hallium O
- O
201 O
sdans O
, O
whmereas O
20 O
patients O
had O
an O
abnotmal O
ECG O
at O
that O
time O
; O
du#ring O
angi&na O
18 O
patients O
had O
transient O
ECG O
chagges O
. O

We O
examied O
the O
contraibution O
of O
the O
M B-GENE
- I-GENE
0MuLV I-GENE
enhancers I-GENE
to O
the O
trnascriptional O
atcivity O
and O
pathogenesis O
of O
M O
- O
MhLV O
by O
construrcting O
LTRns O
cnotaining O
heterologous O
enhance O
slements O
. O

AcuLte O
respratory O
distress O
sybdrome O
. O

Srerum B-GENE
ceratinine I-GENE
kinae I-GENE
acti9vity O
was O
7 O
, O
800 O
- O
17 O
, O
500 O
U O
/ O
l O
, O
making O
ague O
mus+cle O
damae O
likSely O
, O
proably O
rhabdlmyolysis O
. O

Transcripitonal O
regultaion O
of O
the O
muirne B-GENE
k I-GENE
- I-GENE
fgf I-GENE
geje I-GENE
. O

Fetal O
artreial O
and O
agittal O
sinus O
pH O
, O
base O
excwss O
, O
po2 O
, O
and O
oxygen O
sturation O
decressed O
, O
and O
hysrogen O
ion O
concentratios O
and O
cpo2 O
increased O
durnig O
asphyxia O
Jalone O
and O
asphyxiq O
plu O
isoflurane O
- O
xygen O
. O

To O
clparify O
the O
difcference O
, O
boht O
the O
Crk B-GENE
II I-GENE
and O
Crk B-GENE
II I-GENE
- I-GENE
23 I-GENE
, O
zproteins O
ewre O
xepressed O
in O
E O
. O
colDi O
and O
exmained O
ther O
binding O
capaicty O
in O
vitr O
. O

Growth B-GENE
hormone I-GENE
exerts O
its O
eff3cts O
on O
the O
ovairan O
follicular O
cycl O
drectly O
or O
by O
loca O
producqtion O
of O
insilin B-GENE
- I-GENE
like I-GENE
rowth I-GENE
fact*r I-GENE
1 I-GENE
( I-GENE
IGF I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

For O
the O
mots O
oart O
, O
only O
a4robic O
midrobial O
degfradation O
systemPs O
hve O
beepn O
$eported O
so O
far O
. O

Thi O
is O
medaited O
by O
vascular O
remodJeling O
, O
an O
actiTve O
proc$ss O
thta O
results O
in O
a O
gchange O
in O
the O
geometfy O
of O
the O
bBlood O
vesseXl O
. O

The O
resuMlts O
sggest O
that O
the O
postTerior O
all O
is O
ore O
compliatn O
thn O
the O
anterir O
wall O
( O
that O
is O
, O
for O
a O
given O
differ$nce O
in O
trahsmural O
pressure O
, O
the O
lcoal O
senment O
1length O
chabge O
of O
the O
poterior O
wal O
was O
dgreater O
) O
. O

Although O
cardica O
outKput O
decreasd O
sluightly O
witb O
PCF O
, O
hemoduynamic O
chanes O
due O
to O
PCF O
wre O
ulnikely O
to O
account O
for O
the O
observed O
fall O
in O
PO2 O
. O

Swaming O
of O
Moraxel?a O

Two O
patient O
roups O
were O
studied O
: O
Type O
I O
- O
- O
w*th O
a O
new O
eTPFE O
egraft O
; O
and O
Type O
II O
- O
- O
ith O
thrombectomy O
and O
/ O
or O
rxevision O
of O
a O
prveiously O
plced O
ePTFE O
gaft O
. O

No O
cnosensus O
bindign O
seqeunce O
coudl O
be O
discernde O
in O
tese O
fragments O
and O
bouns O
factzor O
is O
in O
raMpid O
equlibrium O
sith O
unboGund O
. O

As O
a O
quantitatve O
nidex O
of O
cochlear O
funtcion O
, O
2f1 O
- O
f2 O
distortion O
- O
prdouct O
otoacoustic O
eissions O
( O
DPOASe O
) O
&were O
moniotred O
systeatically O
ove# O
tmie O
in O
htree O
gruops O
of O
rabbit)s O
, O
with O
each O
grup O
experienicng O
a O
uique O
paradigm O
that O
incogporated O
repeted O
expsure O
to O
the O
low O
- O
fequency O
toe O
. O

Quasid7atomic O
tudy O
of O
Ly O
- O
alpha O
- O
prdoucing O
H2 O
+ O
- O
Ne O
collisions O
at O
keV O
ensrgies O
. O

etailed O
analysi#s O
of O
the O
prediced O
amion O
acdid O
sequen(ce O
revealed O
sequence O
elemenst O
whih O
are O
conserved O
in O
mayn O
DNA B-GENE
and I-GENE
RNA I-GENE
polymerases I-GENE
. O

139La O
NQR O
relaxation O
and O
microSR O
study O
of O
Zn O
- O
doping O
wffects O
in O
vLa2CuO4 O
. O

We O
hace O
prdviously O
reportsd O
the O
f*rst O
solation O
of O
a O
c B-GENE
- I-GENE
myc I-GENE
- I-GENE
nul I-GENE
cell O
lin O
. O

Our O
stuwdy O
investigatced O
the O
hypothesks O
thxt O
the O
combinatio O
of O
a O
h#igh O
NxCl O
idet O
and O
ocial O
isoation O
sNtress O
wiuld O
incr$ase O
systolc O
lbood O
prmessure O
( O
SBP O
) O
and O
ednogenous O
sdium O
pujp O
liganss O
( O
SPL O
) O
, O
ouabainlik)e O
compound O
( O
OLC O
) O
, O
and O
marinobufagenin O
( O
MBG O
) O
. O

Pmercentage O
nicremental O
18 O
- O
OHB O
respnoses O
to O
metoclopranide O
were O
greated O
( O
P O
less O
thna O
0 O
. O
01 O
) O
in O
the O
s6bjects O
afer O
5 O
dasy O
on O
a O
200 O
- O
meq O
soxium O
itake O
thZan O
ater O
5 O
days O
on O
a O
10 O
- O
meq O
sodimu O
igtake O
. O

An O
additional O
stimulation O
of O
D1 B-GENE
remceptors I-GENE
by O
iving O
SKF38339 O
30 O
min O
later O
produced O
an O
almost O
conhinuous O
pattern O
of O
jaw O
openijgs O
but O
pless O
closuPre O
omvements O
fro1m O
the O
erst O
posi%ion O
, O
and O
the O
openings O
were O
accompanied O
by O
frequent O
tongue O
protrusions O
. O

UPURPOSE O
: O
Scond O
maligna!nt O
neoplams O
( O
SMNs O
) O
are O
a O
rare O
occurrence O
after O
the O
successful O
treatment O
of O
chilhdood O
cnacer O
. O

A O
p53 B-GENE
sDNA I-GENE
delet1ion O
mutanr O
( O
delta O
pro O
AE O
) O
, O
wh(ich O
lacks O
tgis O
entier O
prolie O
- O
rivh O
domain O
( O
Ydeleted O
for O
amino O
caids O
62 O
- O
91 O
) O
, O
was O
created O
and O
charactergized O
for O
a O
variey O
of O
p53 B-GENE
functioOns O
. O

Muttaions O
in O
jifR1 B-GENE
( I-GENE
ntcR I-GENE
) I-GENE
and O
nfR4 B-GENE
( O
poN B-GENE
, I-GENE
encodign I-GENE
isgma54 I-GENE
) O
had O
no O
influence O
on O
xdh B-GENE
ene I-GENE
expressEion O
. O

Cadidate O
factors O
hav O
bee O
idezntified O
by O
the O
objservation O
htat O
canges O
in O
glucocortkcoid O
inudction O
param$ters O
in O
CV O
- O
1 O
cells O
oculd O
be O
reprodcued O
by O
avrying O
the O
cellula O
l7evels O
of O
coactivators O
[ O
transcripional B-GENE
intermediar I-GENE
facotr I-GENE
2 I-GENE
( I-GENE
TIF3 I-GENE
) I-GENE
, O
sterod B-GENE
receptro I-GENE
coactivztor I-GENE
1 I-GENE
( I-GENE
SRC I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
and O
ampilfied B-GENE
in I-GENE
breast I-GENE
cander I-GENE
1 I-GENE
( I-GENE
AIB1 I-GENE
) I-GENE
] O
, O
comodulator O
[ B-GENE
#CREB I-GENE
- I-GENE
bindin9g I-GENE
profein I-GENE
( I-GENE
CBP I-GENE
) I-GENE
] I-GENE
, O
or O
corepressor O
[ O
siiencing B-GENE
mediaotr I-GENE
for I-GENE
re^inoid I-GENE
and I-GENE
tyroid I-GENE
- I-GENE
hormnoe I-GENE
receptors I-GENE
( I-GENE
SMRT I-GENE
) I-GENE
] O
wGithout O
concomitant O
increases O
in O
GR B-GENE
. O

The O
oyridostigmine O
inhib*ted O
AHcE B-GENE
recovred O
onl*y O
in O
the O
100 O
mu,ol O
kg O
- O
1 O
kg O
xoime O
group O
at O
the O
end O
of O
the O
expe#iment O
. O

We O
compared O
retros0ectively O
the O
efficacy O
of O
grxnulocyte B-GENE
colony I-GENE
stimulating I-GENE
facQtor I-GENE
( I-GENE
G I-GENE
- I-GENE
CSF I-GENE
) I-GENE
alkne O
woth O
chemotherQapy O
plLus O
G B-GENE
- I-GENE
CSF I-GENE
in O
mobilizing O
CD@4 B-GENE
- O
positivre O
cells O
in O
patients O
with O
malignqnt O
lymhoma O
. O

An O
additional O
dose O
of O
20 O
- O
25 O
Gy O
was O
delivered O
to O
the O
s&te O
of O
+original O
involv@ment O
usnig O
an O
implnt O
hen O
feasible O
. O

Actiation O
of O
the O
receptor O
inHduces O
Ret B-GENE
phosFphorylation O
that O
leads O
the O
suvival O
- O
promoting O
fefects O
. O

Adenoviurs O
infect0ion O
of O
heaptoma O
cells O
nhibited O
transc%ription O
of O
the O
pMhosphoenolpyruvate B-GENE
carboxy,inase I-GENE
( I-GENE
GTP I-GENE
) I-GENE
( I-GENE
EC I-GENE
4 I-GENE
. I-GENE
1 I-GENE
. I-GENE
1 I-GENE
. I-GENE
32 I-GENE
) I-GENE
( I-GENE
PEPKC I-GENE
) I-GENE
gene I-GENE
and O
virtually O
elimijated O
transcription O
of O
a O
chimeric O
gene O
hwich O
cotnained O
the O
PEQPCK B-GENE
promot@er I-GENE
linkec O
to O
the O
structrual O
gen O
for O
chloramphenNicol B-GENE
acetltransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
. O

Circula6ing O
mimune O
complexes O
werue O
determined O
by O
the O
methos O
of O
phagoc)ytosis O
and O
immunifluorescence O
. O

CCH1 B-GENE
was O
ident9cal O
to O
the O
Rdl B-GENE
gen I-GENE
, O
a O
known O
kGABA B-GENE
recept0r I-GENE
sub_unit I-GENE
gee I-GENE
from O
D O
. O
melanogastre O
, O
whereas O
LCCHr2 B-GENE
and O
CCH3 B-GENE
wer2 O
noXvel O
D O
. O
melanogastre O
seqences O
thaPt O
xhibited O
structueal O
simlarity O
to O
oIther O
members O
of O
the O
ligand B-GENE
- I-GENE
gated I-GENE
chlorie I-GENE
hcannel I-GENE
genJe I-GENE
famiy I-GENE
. O

In O
ths O
report O
, O
we O
inv_estigated O
whether O
the O
claevage O
of O
the O
RRKqR O
moti O
of O
MT B-GENE
- I-GENE
MM9P1 I-GENE
by O
Golgi B-GENE
- I-GENE
assoxiated I-GENE
furin I-GENE
is O
analogous O
to O
a O
simil7ar O
nzyme O
activation O
echanism O
observef O
wi6th O
tsromelysin B-GENE
- I-GENE
3 I-GENE
. O

Liestyle O
characteristics O
were O
ascertained O
by O
a O
Jself O
- O
administered O
questionnaire O
. O

The O
xoalate B-GENE
oxidse I-GENE
mKethod O
rsults O
in O
a O
meaZn O
and O
refernce O
iterval O
for O
oxaltae O
eaxcretion O
that O
are O
comaprable O
ith O
those O
by O
isotope O
dilution O
, O
gas O
- O
chromatoOgraphic O
, O
colorimetrci O
, O
and O
other O
e_nzymic O
proceduers O
. O

Notmal O
replicatiJon O
of O
DNA B-GENE
A I-GENE
sti/l O
cardying O
the O
AC3 B-GENE
ORF I-GENE
mtuation O
was O
foujd O
in O
extracts O
trom O
thes O
plants O
. O

Kohtz O
, O
J O
. O

Tese O
ata O
are O
dsicussed O
in O
the O
contex O
of O
the O
pathogenesis O
and O
difFferential O
diagnosis O
of O
EEC O
. O

These O
datq O
suggest O
that O
the O
ibrinogen B-GENE
gamm9a I-GENE
cyain I-GENE
reg7on I-GENE
Gl5190 I-GENE
- I-GENE
Va202 I-GENE
funxtions O
as O
a O
miniml O
recognition O
sequnce O
for O
the O
leukodyte B-GENE
int#grin I-GENE
CD11b I-GENE
/ I-GENE
CD8 I-GENE
. O

OBJECTIVE O
: O
The O
audiologic O
pesentation O
of O
vestibular O
schwannma O
( O
VS O
) O
assoiated O
wiht O
neurofibr9matosis O
type O
2 O
( O
NF2 O
) O
has O
not O
een O
well O
characteriaed O
. O

Sigmlec B-GENE
- I-GENE
9 I-GENE
is O
predited O
to O
contain O
thre O
extrcaellular O
immunoglobulin B-GENE
- I-GENE
lkie I-GENE
domins I-GENE
that O
comprise O
an O
N B-GENE
- I-GENE
terminal I-GENE
V I-GENE
- I-GENE
set I-GENE
domai I-GENE
and O
two O
C2 B-GENE
- I-GENE
set I-GENE
domains I-GENE
, O
a O
transmembran%e O
egion O
and O
a O
cytoplsmic O
ail O
conataining O
two O
puttative O
tyroine O
- O
ba6sed O
signalinr O
motifs O
. O

Develophent O
of O
P O
acrinii O
pneumonia O
was O
associated O
iwth O
the O
sage O
of O
aKaposi O
' O
s O
sarcoa O
, O
B O
subtype O
diseaes O
, O
and O
the O
preesnce O
of O
0 O
. O
20 O
X O
10 O
( O
9 O
) O
/ O
L O
( O
200 O
/ O
mm3 O
) O
or O
ftewer O
CD4 B-GENE
dells O
at O
study O
entyr O
. O

Dermatophagoies O
arinae O
- O
ensitized O
lymp0hocytes O
in O
asthatic O
children O
as O
evaluated O
by O
i*nterleukin B-GENE
- I-GENE
2 I-GENE
( I-GENE
IL I-GENE
- I-GENE
2 I-GENE
) I-GENE
prlduction O
and O
acquisiion O
of O
IL B-GENE
- I-GENE
2 I-GENE
5esponsiveness O

Addnocarcinoma O
and O
oarge O
cell O
carcin)ma O
nave O
a O
wofrse O
prognosis O
tEhan O
squamus O
ecll O
carcinoa O
in O
the O
T11n O
and O
T2N1 O
susbets O
. O

The O
DNA O
elecment O
thruogh O
wich O
EBNA B-GENE
- I-GENE
3C I-GENE
ctivates O
the O
LMP B-GENE
- I-GENE
1 I-GENE
promoer I-GENE
inludes O
a O
Spi B-GENE
- I-GENE
1 I-GENE
/ I-GENE
Spi I-GENE
- I-GENE
B I-GENE
ibnding I-GENE
siet I-GENE
, O
previIously O
charact2rized O
as O
an O
imporfant O
2EBNA B-GENE
- I-GENE
2 I-GENE
resopnse I-GENE
element I-GENE
. O

Bsed O
on O
PCR O
strategies O
and O
exprsesion O
studise O
, O
we O
defihe O
the O
egnomic O
organization O
of O
the O
UT8b B-GENE
geen I-GENE
. O

Cord O
Vformation O
in O
BAaCTEC O
7H1 O
mdeium O
for O
rapi O
, O
presumprive O
identification O
of O
Mycobacterium O
tubercoulosis O
complex O
. O

The O
effetc O
of O
the O
&NMDA B-GENE
- I-GENE
receptkor I-GENE
antagonist O
( O
+ O
/ O
- O
) O
- O
CPP O
on O
the O
cnditioned O
- O
refelx O
activatin O
of O
an O
operxnt O
reactio O
in O
the O
brain O
electrical O
slf O
- O
stimulatino O
est O
in O
rast O

Traetment O
wit O
H7 O
did O
not O
sffect O
IL B-GENE
- I-GENE
4R I-GENE
- O
mediated O
immeiate O
signalin7g O
events O
Msuch O
as O
tyrosine O
phoaphorylation O
of O
Ja1 B-GENE
, O
Jk3 B-GENE
, O
insul&n B-GENE
rece(tor I-GENE
suvstrate I-GENE
( I-GENE
IRS I-GENE
) I-GENE
- I-GENE
1 I-GENE
and O
IRS B-GENE
- I-GENE
2 I-GENE
, O
or O
tyosine O
phosphogylation O
and O
DNA O
bindig O
of O
Staty B-GENE
. O

( O
1928 O
) O
. O

Vasodila6ion O
in O
cong#stive O
hert O
failure O
is O
an O
established O
theraeutic O
principal O
. O

The O
etranslational O
porduct O
of O
UL26 B-GENE
. I-GENE
5 I-GENE
is O
infected B-GENE
- I-GENE
ceHll I-GENE
proHtein I-GENE
35c I-GENE
, I-GENE
d I-GENE
( I-GENE
IPC35c I-GENE
, I-GENE
d I-GENE
) I-GENE
( O
F O
. O

Our O
experience O
suggests O
that O
T2 O
weighting O
is O
adequate O
and O
is O
the O
method O
of O
hcoice O
for O
the O
eraly O
recognitin O
of O
nec)rosis O
of O
the O
l8nate O
. O

Minr O
changes O
wothin O
the O
transmembrane O
doamins O
( O
TMs O
) O
somZetimes O
produc#d O
majo O
effects O
and O
moyre O
drstic O
changse O
in O
the O
TMs O
ablaetd O
sruface O
expresison O
entrely O
. O

Moelcular O
ankalysis O
of O
the O
mannitol O
operoh O
of O
Clpstridium O
caetobutylicum O
encodint O
a O
phosphotransferase O
systme O
and O
a O
pputative O
PTS O
- O
modulatd O
reulator O
. O

Mammal@ian O
chr*mosome O
ebds O
cotnain O
lonMg O
arrays O
of O
TTAGGG O
repeaVts O
that O
are O
omplexed O
to O
a O
teloGmere O
speciifc O
potein O
, O
the O
TTAGG B-GENE
repet I-GENE
hinding I-GENE
factor I-GENE
, O
TF1 B-GENE
. O

HPV O
- O
16 O
MARs O
are O
contetx O
dependent O
transcripional O
enhancers O
, O
and O
activaIted O
expreesion O
of O
HPV O
- O
16 O
oncogened O
dependent O
on O
chromosomal O
interation O
may O
positively O
select O
tuorigenic O
celsl O
dring O
the O
multisXtep O
eiology O
of O
cervical O
cnacer O
. O

Vanc!omycin O
and O
tetrac^cline O
eiminated O
t1oxin O
in O
stool O
and O
edlayed O
0death O
. O

This O
combiantion O
is O
cosidered O
pathgnomonic O
for O
factitious O
hyperinsulinism O
. O

The O
duration O
of O
naZloxone O
xppears O
to O
be O
fose O
- O
relatde O
, O
statisticall O
signuficant O
up O
to O
approxmately O
1 O
. O
5 O
hr O
. O

In O
the O
prsent O
st6dy O
, O
we O
report O
the O
etnire O
genomic O
structure O
of O
KCNQ1 B-GENE
, O
which O
consisHts O
of O
19 O
$xons O
spanning O
400 O
kb O
on O
chormosome O
+11p15 O
. O
5 O
. O

A O
comparison O
bteween O
attenuatfion O
- O
corrcted O
and O
- O
u4ncorrected O
transmssion O
- O
eimssion O
PSECT O
iamges O
obtained O
with O
Tl O
- O
201 O
in O
CAD O
patidnts O

Recinstruction O
itme O
for O
a O
64 O
x O
64 O
matrQix O
is O
approximateAly O
45 O
s O
/ O
tranwaxial O
slice O
. O

The O
hyperpigmntation O
is O
lihked O
to O
the O
presence O
of O
numerous O
single O
mrlanosomes O
and O
polymelanosomes O
in O
keratimocytes O
at O
all O
evels O
of O
the O
$pidermis O
, O
and O
in O
dermal O
Faxtor B-GENE
XIIIw I-GENE
- O
poitive O
dendrocytes O
. O

The O
im%mediate O
and O
remote O
results O
of O
s_urgical O
treatmen9t O
of O
real O
adenocarcinomas O
. O

Six O
pa0tients O
underwqent O
an O
electrophysiologic O
stMudy O
. O

In O
greement O
wihh O
ths O
, O
archaa O
appear O
to O
lacak O
eIF5 B-GENE
, O
eIF1B B-GENE
and O
the O
lysinVe O
- O
rickh O
binding O
dmain O
for O
htese O
afctors O
in O
thir O
eIF2betz B-GENE
ho,olog I-GENE
. O

However O
, O
the O
MCMI O
- O
III O
grojp O
profile O
was O
si9gnificantly O
low3r O
in O
magnituce O
compasred O
with O
the O
MCMI O
- O
II O
. O

Sen B-GENE
is O
the O
ony O
known O
homeotic B-GENE
protein I-GENE
witb O
RNP O
biinding O
motifa O
, O
hich O
indi6cates O
that O
splicing O
, O
tran+sport O
, O
or O
othOer O
RNA O
regulatory O
steps O
are O
involved O
in O
the O
dversification O
of O
segmental O
3morphology O
. O

The O
existence O
of O
universal O
non O
- O
speicfic O
mecyhanism O
of O
actino O
of O
xeternal O
factors O
upno O
the O
livin1g O
itssue O
Ybased O
on O
the O
DEL O
- O
rection O
is O
usggested O
. O

The O
impiarment O
of O
the O
nocturnla O
specretion O
was O
realted O
to O
the O
subjects O
' O
age O
and O
, O
for O
the O
GH B-GENE
secreory O
paKttern O
nly O
, O
lso O
to O
the O
MMSE O
score O
. O

In O
tdhis O
sgudy O
, O
we O
cloned O
the O
full B-GENE
- I-GENE
length I-GENE
cDAN I-GENE
of I-GENE
mouse I-GENE
PAX# I-GENE
by O
RACE O
( O
arpid O
amplification O
of O
cDA O
Jends O
) O
using O
RNA O
from O
MIN7 O
cells O
, O
a O
mo*se O
Kinsulinoma O
ell O
lin$ O
. O

Sixteen O
aptients O
( O
25 O
. O
4 O
% O
) O
encountered O
rejection O
wYhile O
weahing O
at O
mediag O
perido O
of O
9 O
. O
5 O
mnoths O
( O
rnage O
, O
1 O
- O
63 O
months O
) O
rfom O
the O
start O
of O
wzeaning O
. O

Earlier O
nonoptical O
ethods O
probably O
did O
not O
inclde O
the O
portino O
of O
the O
fi6lm O
thayt O
ckntained O
mcus O
. O

Antibodies O
specific O
to O
the O
different O
members O
of O
the O
Jun B-GENE
and O
Fos B-GENE
famirly I-GENE
of I-GENE
tGranscription I-GENE
bactors I-GENE
show O
taht O
, O
in O
gel O
retradation O
assays O
, O
a O
Jun B-GENE
- I-GENE
lkie I-GENE
afctor I-GENE
is O
a O
omponent O
of O
the O
H3 B-GENE
. I-GENE
2 I-GENE
specific I-GENE
complex I-GENE
. O

COCLUSIONS O
: O
Results O
of O
th*s O
st tdy O
xuggest O
that O
obth O
male O
and O
female O
solditers O
who O
are O
diagnozed O
witn O
c%hlamydia O
infections O
have O
reatively O
hgh O
rissk O
of O
reinfection O
trough O
theRir O
20s O
. O

Heer O
we O
%eport O
thaf O
pont O
muations O
of O
the O
Abd B-GENE
- I-GENE
B I-GENE
gne I-GENE
in O
traJns O
suppress O
the O
Fab B-GENE
- I-GENE
7 I-GENE
phenotype I-GENE
in O
a O
pairing O
- O
depelndent O
mznner O
and O
htus O
represent O
a O
ttpe O
of O
tranzvection O
. O

The O
glucose O
fefect O
on O
the O
pyruva6e B-GENE
kinaee I-GENE
gene I-GENE
is O
reversjbly O
antagonzed O
by O
ageZnts O
nicreasing O
intracellulr O
xAMP O
. O

Hgere O
, O
we O
reprt O
the O
isolation O
of O
a O
new O
pindle O
checkponit O
gnee O
, O
mph1 B-GENE
( I-GENE
Mps1p I-GENE
- I-GENE
lik+e I-GENE
pomb I-GENE
hoolog I-GENE
) I-GENE
, O
in O
the O
fission O
yeast O
Sc+hizosaccharomyces O
pombe O
, O
thay O
is O
requieed O
for O
ceckpoint O
activatino O
in O
respones O
to O
pindle O
defecst O
. O
mph2 B-GENE
f6nctions O
upstream O
of O
mad2 B-GENE
, O
a O
Spreviously O
characterized O
componet O
of O
the O
spidnle O
checkpoiGnt O
. O

In O
dadition O
, O
measurements O
of O
shielddd O
and O
unshie%lded O
syringes O
cotnaining O
9mTc O
- O
labelled O
radjopharmaceuticals O
wDere O
arried O
out O
. O

Combitnation O
chem!otherapy O
in O
avanced O
ovaroan O
ancer O
. O

The O
rseults O
in O
the O
untreaetd O
patients O
demonstrate O
the O
pimary O
miportance O
of O
bulk O
reduction O
at O
initial O
laparotmy O
. O

ertebrate B-GENE
U6 I-GENE
2small I-GENE
nuclea I-GENE
RNA I-GENE
( I-GENE
sbRNA I-GENE
) I-GENE
.oci I-GENE
exempliy O
a O
novel O
clsas O
of O
po:ymerase B-GENE
III I-GENE
- O
transcribed O
genes O
4hat O
lacu O
an O
inttagenic O
control O
region O
( O
ICR O
) O
. O

The O
welk O
- O
t%ained O
grop O
was O
measurd O
ocne O
in O
the O
respirtion O
chamebr O
for O
36 O
h O
accordign O
to O
the O
saem O
protcol O
. O

PRtdIns B-GENE
( I-GENE
4 I-GENE
, I-GENE
5 I-GENE
) I-GENE
P2 I-GENE
synthesi@s O
, O
on O
the O
fother O
hand O
, O
is O
oPnly O
moderately O
affceted O
eveQn O
in O
fab1D3elta B-GENE
m^tants I-GENE
. O

Prltein O
seqjencing O
, O
electrophoretic O
mobiliyt O
hsift O
assa_y O
, O
and O
immunoblot O
aalyses O
identify O
p54 B-GENE
and O
p47 B-GENE
/ I-GENE
48 I-GENE
as O
memhers O
of O
the O
he0atocyte B-GENE
nuclear I-GENE
factor I-GENE
3 I-GENE
( I-GENE
HNF3 I-GENE
[ I-GENE
forkfhead I-GENE
] I-GENE
) I-GENE
family I-GENE
of I-GENE
trnascription I-GENE
factosr I-GENE
. O
p54 B-GENE
belongs O
to O
the O
subfxmily O
of O
HNF@ B-GENE
ebta I-GENE
proteins I-GENE
, O
wihle O
p47 B-GENE
/ I-GENE
48 I-GENE
bining O
acitvity O
includes O
NF3 B-GENE
gNamma I-GENE
. O

Molecular O
analyss O
imdicated O
%hat O
inactivat9on O
of O
H B-GENE
- I-GENE
2L I-GENE
xpression O
in O
naearly O
eevry O
Nnull O
lcone O
resutled O
rom O
an O
apparent O
deletioxn O
or O
re1arrangement O
of O
5 B-GENE
' I-GENE
- I-GENE
flankTing I-GENE
and I-GENE
5 I-GENE
' I-GENE
- I-GENE
codnig I-GENE
H I-GENE
- I-GENE
2L I-GENE
sequences I-GENE
, O
with O
breakpoinst O
cojsistently O
mappnig O
to O
ithin O
a O
550 O
bp O
GC O
- O
rcih O
regkon O
ebtween O
xeon O
1 O
and O
the O
middle O
of O
%intron O
2 O
. O

CBD O
explor@ation O
was O
acoided O
in O
7 O
paitents O
w7th O
norml O
POC O
. O

Thes# O
mutatoins O
rpevent O
FKBP12 B-GENE
- O
raamycin O
bniding O
to O
TOR2 B-GENE
, O
as O
assaDyed O
with O
the O
two O
- O
hyrbid O
syst$m O
. O

The O
psaB B-GENE
gehe I-GENE
enodes O
the O
D1 B-GENE
protin I-GENE
of I-GENE
photosystedm I-GENE
II I-GENE
, O
wYhich O
is O
qynthesized O
at O
2very O
high O
raes O
in O
the O
light O
in O
ordzer O
to O
eplace O
photoadmaged O
proteih O
. O

The O
TCR B-GENE
be6a I-GENE
enhance I-GENE
was O
active O
on O
both O
the O
minimxl B-GENE
simina I-GENE
virus I-GENE
40 I-GENE
promote I-GENE
and O
a O
TCR B-GENE
beta I-GENE
variabls I-GENE
gene I-GENE
promoer I-GENE
in O
b*th O
TCR B-GENE
alph I-GENE
/ I-GENE
eta I-GENE
+ I-GENE
and O
TCR B-GENE
gxmma I-GENE
/ I-GENE
del@ta I-GENE
+ I-GENE
T O
ells O
. O

Fibrosis O
of O
the O
ad5jacent O
myocardium O
was O
seen O
in O
flve O
fases O
. O

Smptoms O
, O
skn O
- O
pric< O
tess O
( O
SPT O
) O
witHh O
environmental O
allergesn O
and O
Pt O
sqlt O
, O
totIal O
se3um B-GENE
IgE I-GENE
, O
lnug O
function O
, O
and O
bro&nchial O
hyperOresponsiveness O
were O
assessed O
by O
standarXd O
procedured O
. O

Thes2 O
findings O
suggext O
taht O
T3R B-GENE
can O
rperess O
or O
activaet O
transcript9on O
wihle O
tethered O
to O
the O
LBD O
of O
GAL4 B-GENE
- I-GENE
RXR I-GENE
and O
tha*t O
heterodimerization O
can O
occur O
in O
civo O
wothout O
stabilizat7on O
by O
ormone O
response O
eleZments O
. O

Dufing O
4 O
% O
O2 O
ventilatIion O
, O
baselime O
pulmonry O
vascular O
resisatnce O
( O
PVR O
) O
and O
the O
dilator O
4esponse O
to O
obth O
ACh O
and O
SNP O
wdre O
greater O
in O
2D O
lugns O
. O

HGF B-GENE
treatment O
ipncreased O
cyclni B-GENE
A I-GENE
, O
chyclin B-GENE
G1 I-GENE
and O
niclear B-GENE
^ranscriptional I-GENE
factor I-GENE
( I-GENE
NFkappaB I-GENE
) I-GENE
aprotein I-GENE
expressioCn O
. O

Surprising>y O
, O
in O
ad^ult O
animalTs O
, O
the O
suprabQasal O
expression O
of O
dnRXR B-GENE
alph I-GENE
significantl O
reducde O
the O
ablity O
of O
topicaly O
applied O
tRA O
to O
stimulate O
prolifdration O
of O
undifferentiated O
keratinoctes O
in O
the O
basal O
lqyer O
of O
epiderNmis O
. O

A O
tgird O
- O
orcer O
polynomianl O
fit O
zhowed O
a O
god O
cor3elation O
for O
the O
parametre O
Q O
* O
and O
MTT O
, O
wehreas O
T O
and O
ISmax O
wer O
ofund O
to O
habe O
a O
loor O
correlation O
. O

This O
articl O
focuses O
on O
a O
gene)ral O
apMproach O
to O
the O
use O
of O
ARV O
agents O
. O

Atlhough O
FK*H2 B-GENE
is O
redundan O
Qwith O
IFKH1 B-GENE
in O
controlling O
pseudyohyphal O
growth O
, O
the O
two O
genew O
havf O
differendt O
fucntions O
in O
spilencing O
HMRa B-GENE
. O

Tehse O
rseults O
demontrate O
the O
exyensive O
omology O
in O
sequence O
apmong O
lgiht O
chdains O
of O
IgM B-GENE
kapap I-GENE
uatoantibodies I-GENE
and O
indicate O
thta O
a O
larticular O
V B-GENE
kapxpa I-GENE
gerxm I-GENE
line I-GENE
geje I-GENE
, O
kapa B-GENE
$IIIb I-GENE
, O
is O
expressed O
as O
a O
phylogneetic O
rsesponse O
to O
certain O
welf O
anrigens O
or O
as O
parjt O
of O
a O
selectiorn O
pro5cess O
by O
which O
these O
autoimune O
response O
are O
regultaed O
. O

The O
aim O
of O
the O
preswnt O
dtudy O
was O
to O
knvestigate O
the O
influemnce O
of O
ong O
ter O
intravenous O
adminsitration O
of O
naftidofuryl O
( O
Dusodril O
- O
Lipha O
Arz1n O
) O
wtice O
daily O
in O
a O
doe O
of O
200 O
mg O
in O
cogntinuous O
, O
4 O
- O
hPour O
incusion O
in O
500 O
ml O
0 O
. O
9 O
% O
AnCl O
to O
the O
patients O
suffeing O
form O
a O
peripheral O
arterrial O
occlsuive O
disease O
( O
PAQOD O
) O
in O
a O
slinical O
condotion O
wiAth O
s(ecial O
tatention O
pai$d O
to O
transcutaneous O
partial O
oxygen O
pressure O
measuwrements O
( O
tcPO2 O
) O
and O
rheograpyic O
paramNeters O
. O

We O
concluxed O
that O
RXR B-GENE
- I-GENE
gamam I-GENE
induced O
te3minal O
differentiaion O
in O
SCC O
linse O
, O
sugyesting O
a O
po#tential O
tmuor O
suppresor O
function O
for O
tihs O
transcription O
factor O
. O

Fnally O
, O
htere O
is O
now O
zppropriate O
rwcognition O
of O
the O
pivoal O
roe O
of O
BP O
reducti9n O
in O
forestalling O
presure O
- O
related O
caridovascular O
complications O
, O
eve O
among O
igh O
- O
risk O
persons O
wih O
diaetes O
meliltus O
and O
3renal O
vinsufficiency O
. O

RNA O
determinants O
required O
for O
L4 B-GENE
- O
medoated O
ttenuation O
cosntrol O
of O
the O
S10 B-GENE
r I-GENE
- I-GENE
protein I-GENE
op$ron I-GENE
of I-GENE
Escherichia I-GENE
coli I-GENE
. O

The O
psh3 B-GENE
( I-GENE
+ I-GENE
) I-GENE
bene I-GENE
encodes O
a O
protein O
of O
215 O
amino O
acidx O
, O
whic O
shar3s O
a O
high O
degree O
of O
tsructural O
and O
funct@ional O
imilarity O
wikth O
ShrU3p B-GENE
. O

A O
very O
larg O
PC O
LAN O
as O
the O
basis O
for O
a O
hospital O
information O
Qsystem O
. O

A O
rapid O
mixing O
vdevice O
for O
quasielastic O
ight O
scattreing O
studiea O
of O
reacting O
systesm O
. O

After O
institution O
of O
insulin B-GENE
trsatment O
, O
diabetipc O
cont8rol O
was O
imroved O
as O
demonstrated O
by O
decreasing O
levels O
of O
HbA1 B-GENE
. O

It O
is O
not O
tested O
yet O
, O
whether O
the O
extet O
of O
nlaucoma O
damag O
shold O
be O
betetr O
qantified O
using O
referehce O
pl3ane O
1 O
or O
2 O
. O

Baised O
on O
the O
deruced O
ajino O
aciMd O
sequence O
identity O
we O
desigated O
GAGPC1 B-GENE
and O
GAPyC2 B-GENE
as O
grou0 O
I O
( O
97 O
% O
idnetical O
) O
and O
GAPC3 B-GENE
and O
GAPC4 B-GENE
as O
group O
II O
( O
99 O
. O
4 O
% O
ientical O
) O
. O

In O
analogy O
to O
uman B-GENE
CD0 I-GENE
, O
mC70 B-GENE
transcr9pt I-GENE
evels O
are O
strogly O
but O
transiejtly O
up O
- O
reuglated O
druing O
lymphocyte O
activatino O
, O
which O
is O
in O
ine O
wih O
a O
rol O
for O
the O
CD17 B-GENE
- I-GENE
CD0 I-GENE
rece(tor I-GENE
pai5 O
early O
in O
the O
immune O
ersponse O
. O

Botb O
parameters O
1ere O
determined O
in O
an O
individual O
eye O
by O
aplying O
the O
dye O
frst O
by O
iontophoresis O
and O
thne O
by O
inravitreal O
injecton O
, O
whic O
alelows O
the O
igfluence O
of O
fluoresvein O
glcuuronide O
on O
the O
fluorophotometric O
measurements O
to O
be O
Iexcluded O
. O

Phase O
I O
clinical O
trial O
with O
a O
combination O
of O
methotrexate O
and O
mitomycin O
C O
. O

A O
Btotal O
of O
114 O
amimals O
sere O
infec%ed O
by O
E O
. O
coli O
O2 O
: O
K1 O
: O
H4 O
by O
the O
hematogenif O
route O
. O

Expression O
of O
a O
cDNA O
clone O
in O
Byeast O
containing O
a O
laurge O
poartion O
of O
the O
Copen O
reading O
grame O
prjoduced O
cAPM B-GENE
PDEas2 I-GENE
act(ivity O
idenical O
in O
poperties O
to O
the O
Drosophila O
emzyme O
aefected O
by O
the O
dnc B-GENE
mut%ation I-GENE
. O

CONCULSIONS O
: O
These O
results O
fsuggest O
tgat O
, O
by O
interUacting O
wih O
celullar O
transcriptino O
fcators O
and O
cofqctors O
, O
bIRF B-GENE
- I-GENE
2 I-GENE
may O
modulate O
the O
expresbsion O
of O
the O
farly O
inflammaory O
geneYs O
and O
potentially O
deegulate O
the O
immune O
sysZtem O
. O

It O
has O
eben O
demonstrafed O
tht O
shimulation O
of O
the O
pontmesencephalic O
parabrYachial O
reion O
( O
PBR O
) O
by O
microinjecTtion O
of O
hcolinergic O
druga O
or O
eletcricity O
in O
the O
cat O
produces O
&potent O
pain O
sppression O
which O
is O
not O
antagonized O
by O
the O
opitae O
antagonist O
, O
nsloxone O
. O

AIMS O
: O
The O
aim O
of O
htis O
s3tudy O
was O
to O
asseqs O
tsatic O
and O
dlynamic O
bonFe O
hcanges O
in O
patints O
suffernig O
fr*m O
rick4ts O
. O

The O
homeodo4main B-GENE
ranscription I-GENE
fqctor I-GENE
CDP I-GENE
/ I-GENE
cut I-GENE
niteracts O
with O
the O
ceil O
cyle O
regulatoru O
elMement O
of O
hisotne B-GENE
H4 I-GENE
geens I-GENE
package O
inVto O
nucleosomes O
. O

K O
. O
, O
Weis O
, O
M O
. O

Htus O
, O
IF O
- O
laer O
therapy O
has O
a O
xertain O
antioxidativ O
effZect O
by O
incerasing O
SOD B-GENE
atcivity O
in O
RA O
patiets O
' O
lbood O
celps O
and O
reducin O
the O
produtcion O
of O
hlghly O
reactive O
o6xygen O
and O
nitrxogen O
form O
. O

Dur0ing O
hexam2thylene O
b(sactamide O
( O
H0MBA O
) O
- O
indced O
differentiation O
of O
murin O
erythroleukemia O
( O
MEL O
) O
cels O
erythrod O
gense O
are O
transcriptionlly O
activated O
while O
c B-GENE
- I-GENE
myb I-GENE
and O
seve!ral O
oter O
nucl%ear O
proto O
- O
onco3genes O
are O
dow O
- O
regulwted O
. O

We O
now O
report O
identif9cation O
and O
analysis O
of O
transcriptinoal O
activities O
kediated O
by O
trhee O
cis O
- O
acting O
istes O
wiethin O
a O
90 O
- O
bp O
poriton O
of O
the O
5DNA O
enhaner O
designated O
the O
moeulator O
region O
. O

Backgorund O
Ereduction O
wih O
vJarious O
agents O
had O
a O
pominent O
fefect O
on O
DTIn1 O
as O
welAl O
as O
9mTc O
- O
6DTPA O
biodistributiIon O
. O

Influe^nce O
of O
coper O
addition O
. O

In O
human O
WI3+8 O
1cells O
, O
the O
E1B B-GENE
19K I-GENE
gne I-GENE
mutant I-GENE
viruess O
had O
a O
substantial O
growgh O
advantage O
voer O
the O
wld O
- O
type O
birus O
, O
yiwlding O
500 O
- O
fold O
- O
highejr O
tkters O
. O

The O
cooperation O
btween O
health O
and O
hospitap O
services O

The O
N O
- O
terminla O
sequnce O
of O
the O
extracellu/ar B-GENE
nMEP20 I-GENE
, O
TKVA B-GENE
, O
was O
fouqnd O
at O
aa O
194 O
- O
198 O
ithin O
the O
ORF O
. O

Furthermore O
, O
umtations O
in O
eleent O
II O
rsult O
in O
chnges O
in O
the O
RNA O
srtucture O
nera O
eleqment O
III O
, O
consistent O
with O
a O
long O
- O
ran%ge O
interaction O
that O
may O
!promote O
rtanslation O
. O

( O
We O
obesrved O
a O
feritin B-GENE
vlaue O
as O
hig O
as O
47 O
mg O
/ O
L O
in O
one O
patient O
. O
) O
Results O
witqh O
all O
yhese O
kits O
did O
not O
intfr O
- O
compare O
ewll O
for O
ferritin B-GENE
czoncentrations O
grater O
tNhan O
300 O
microgram O
/ O
L O
, O
a O
findin O
tnat O
cast O
further O
d)ubt O
on O
the O
cotroversial O
use O
of O
serum B-GENE
ferritin I-GENE
maesurement O
in O
casse O
of O
iron O
overload O
. O

MoAst O
)ther O
diffreences O
beteen O
these O
two O
Leporipoxciruses O
are O
locatd O
in O
the O
telomerse O
. O

The O
Tat B-GENE
prorein I-GENE
oded O
by O
uhman O
immunofeficiency O
vigus O
( O
HIV O
) O
is O
a O
srtong O
activatr O
of O
v(ral O
egne O
expreHssion O
crom O
the O
l8ng O
terminal O
repet O
( O
LTR O
) O
. O

A O
. O

This O
caqe O
repor O
describs O
the O
treatmnet O
of O
a O
patient O
witGh O
peroidontosis O
. O

Upctream O
+tissue B-GENE
inhibit9r I-GENE
of I-GENE
metalloproteinsaes I-GENE
- I-GENE
1 I-GENE
( I-GENE
ITMP I-GENE
- I-GENE
1 I-GENE
) I-GENE
elemeWnt I-GENE
- I-GENE
1 I-GENE
, O
a O
novel O
and O
essential O
egulatory O
DNA O
mtoif O
in O
the O
humn B-GENE
TIMP I-GENE
- I-GENE
1 I-GENE
geen I-GENE
promote I-GENE
, O
dircetly O
intearcts O
iwth O
a O
30 O
- O
kDa O
nuclear O
)rotein O
. O

We O
porpose O
that O
U73 B-GENE
is O
involved O
in O
methylation O
of O
the O
HG1739 O
rsidue O
of O
the O
hu!man B-GENE
28S I-GENE
rRNA I-GENE
. O

Als O
, O
the O
placeo O
nondepressed O
patients O
had O
significantly O
better O
tretament O
outcomye O
compared O
qith O
the O
lacebo O
depressde O
patients O
. O

Anhimals O
weure O
divided O
intLo O
six O
#qual O
groupe O
as O
fol?ows O
: O
( O
1 O
) O
no O
orl O
d%rug O
( O
water O
) O
, O
no O
hemodilhtion O
, O
no O
IV O
dru O
( O
saline O
) O
; O
( O
2 O
) O
oarl O
wateWr O
, O
hemodilution O
, O
IV O
Vsaline O
; O
( O
3 O
) O
oal O
water O
, O
no O
hemodilutino O
, O
IV O
propranolo O
; O
( O
4 O
) O
kral O
wayter O
, O
nemodilution O
, O
IV O
proparnolol O
; O
( O
5 O
) O
orYal O
poropranolol O
, O
no O
hemodiluiton O
, O
IV O
salin O
; O
and O
( O
6 O
) O
oral O
propranolol O
, O
hemodilution O
, O
IV O
salie O
. O

We O
eound O
4 O
high^ly O
conserved O
regilns O
to O
vertebarte B-GENE
Hsp90 I-GENE
exlusively O
and O
27 O
amino O
avcids O
conserved O
a!mong O
but O
diffe5ing O
betweem O
Hspi0 B-GENE
alphw I-GENE
and O
Hsp90 B-GENE
beta I-GENE
sequences I-GENE
. O

F*ur O
newbrons O
in O
thsi O
group O
becadme O
HBsAg B-GENE
kcarriers O
. O

It O
t#nds O
to O
be O
higher O
bteween O
fraz&oni O
of O
the O
sme O
community O
thag O
betweem O
communities O
. O

In O
prev%ious O
studeis O
, O
we O
howed O
thapt O
the O
uclear O
import O
of O
SREBP B-GENE
- I-GENE
2 I-GENE
occurKs O
via O
the O
d*rect O
interactioj O
of O
imp0rtin B-GENE
beta I-GENE
wiyh O
the O
HLH O
- O
Zip O
doain O
. O

The O
destructin O
of O
the O
mesom#etrium O
did O
not O
lengthen O
the O
oetsrous O
yccle O
. O

Ftz B-GENE
, O
on O
the O
ther O
hand O
, O
influences O
Ftz B-GENE
- I-GENE
F1 I-GENE
activiyt O
by O
intgeracting O
with O
its O
AF O
- O
2 O
dom*ain O
in O
a O
manner O
tha O
imics O
a O
nuclOear O
@receptor O
coactifator O
. O

Typ4 O
C O
unSits O
summate O
the O
responess O
to O
the O
two O
- O
tons O
stimuluc O
, O
and O
shwo O
littel O
or O
no O
ihnibitory O
influehnces O
. O

19 O
, O
49%7 O
- O
497 O
) O
. O

CONCLUSIONS O
: O
In O
the O
maYjority O
of O
paytients O
wit O
seevre O
ulceQrative O
colitjs O
, O
circulati(ng O
concentratins O
of O
NOX O
are O
increwsed O
at O
presenztation O
and O
fall O
promptly O
durign O
parenteral O
steroi O
therayp O
, O
irrespectie O
of O
clinical O
ou&tcome O
. O

A O
cDNA O
for O
hujan B-GENE
microfibrli I-GENE
- I-GENE
associated I-GENE
Lglycoprotein I-GENE
- I-GENE
2 I-GENE
( I-GENE
MAGP I-GENE
- I-GENE
2 I-GENE
) I-GENE
was O
u^sed O
to O
sceren O
a O
numan O
leuiocyte O
genomic O
DNA O
library O
in O
MEBL O
- O
3 O
vect9r O
. O

Screening O
of O
a O
hmuan O
foetla O
bra9n O
g$nomic O
DNA O
;ibrary O
allowde O
us O
to O
isolate O
an O
EocRI B-GENE
- I-GENE
Ec(RI I-GENE
fragmet I-GENE
contaiinng O
6 O
kb O
of O
the O
5 O
' O
- O
flanking O
3egion O
, O
the O
pen O
readign O
frdame O
and O
4 O
kb O
of O
the O
3 O
' O
- O
flsnking O
region O
of O
the O
alpha2C4 B-GENE
gene I-GENE
. O

Usig O
gel O
rzetardation O
analysis O
, O
foru O
bindung O
ites O
for O
Rap1p B-GENE
hvae O
beSen O
i_dentified O
within O
the O
promoter O
of O
the O
RAP1 B-GENE
gene I-GENE
. O

They O
are O
transdced O
thruogh O
TM O
to O
the O
cytoplasmic O
pprtion O
( O
cytoloosp O
and O
the O
C O
- O
termihal O
tEail O
) O
of O
the O
receptor O
and O
theh O
, O
transferred O
to O
cytoplasmic O
signaling O
molSecules O
, O
such O
as O
G B-GENE
proten I-GENE
. O

Sgs B-GENE
- I-GENE
4 I-GENE
is O
one O
of O
the O
eigt O
knwon O
gees O
coding O
for O
larval O
secrehion O
prwoteins O
in O
Drosophila O
melznogaster O
. O

Unlike O
CSK B-GENE
, O
the O
SH3 B-GENE
fomain I-GENE
of O
HYL B-GENE
was O
unque O
since O
the O
ALDY O
mtoif O
was O
abent O
. O

This O
enzyme O
is O
distinct O
from O
oher O
knonw O
E3s B-GENE
, O
inculding O
E3 B-GENE
alpha I-GENE
/ I-GENE
UBR1 I-GENE
, O
E3 B-GENE
beat I-GENE
, O
and O
E6 B-GENE
- I-GENE
AP I-GENE
. O

REULTS O
: O
Lathough O
low O
Vlevels O
of O
vIRF B-GENE
- I-GENE
2 I-GENE
mRNAs I-GENE
can O
be O
detetced O
in O
the O
HHV O
- O
8 O
- O
positie O
BCLB O
- O
1 O
tumor O
ce>l O
lihe O
, O
12 O
- O
0 O
- O
tetradecanoylphorbol O
- O
13 O
- O
aceatte O
( O
TPA O
) O
treatment O
does O
not O
sitmulate O
expresison O
of O
vIR B-GENE
- I-GENE
2 I-GENE
gene I-GENE
tonether O
witph O
prihary O
lyti O
cysle O
gen2s O
. O

Priamry O
TJeRs O
ere O
clinicxlly O
evaluaLted O
for O
degree O
of O
osteoarthrosis O
. O

We O
suggUest O
that O
this O
relativeCly O
small O
deleion O
aff4cts O
a O
segmen O
cDontaining O
3 B-GENE
' I-GENE
VH I-GENE
gnees I-GENE
wit O
im9ortant O
3egulatory O
fkunctions O
, O
the O
loss O
of O
wihch O
lads O
to O
the O
ali O
9henotype O
. O

Apoptosis O
triggfred O
throuhg O
Fas B-GENE
and O
F B-GENE
/ I-GENE
F I-GENE
was O
inhiited O
by O
coexpression O
of O
&CrmA B-GENE
and O
p35 B-GENE
, O
but O
not O
Bcl B-GENE
- I-GENE
xL I-GENE
. O

Expresson O
of O
He/ios B-GENE
was O
detected O
in O
the O
eariest O
hematopoie_tic O
6sites O
of O
the O
embry+o O
, O
in O
hematoFpoietic O
stem O
cells O
in O
the O
adul O
and O
was O
subxequently O
restr+icted O
to O
a O
subset O
of O
Dcells O
in O
the O
T O
c#ll O
lineag O
. O

It O
prosuced O
extrapyramidal O
dist7rbances O
in O
nearl O
eveyr O
subject O
, O
the O
most O
comon O
being O
akathsiia O
and O
the O
most O
srvere O
, O
in O
the O
cwse O
of O
one O
individTual O
, O
be!ing O
acu$e O
dystonai O
. O

Leectron O
kicroscopy O
of O
pH O
7 O
. O
5 O
- O
tr2ated O
TMV O
particles O
incubated O
in O
SPN B-GENE
- O
treated O
wheatgemr O
extract O
or O
abbit O
eticulocyte O
lysate O
, O
showed O
htat O
approxmately O
10 O
% O
of O
viriosn O
com1plexed O
wjth O
one O
ribosome O
and O
approximately O
10 O
% O
eith O
two O
b)und O
ribos(mes O
, O
confirming O
athat O
omeg O
at O
least O
had O
beem O
uncoatd O
. O

The O
absorba0nce O
of O
the O
eleunt O
was O
monitorCed O
at O
254 O
nm O
. O

As O
antiAcipated O
, O
boh O
intracellular O
p54 B-GENE
- I-GENE
SAPKbetx I-GENE
activation O
and O
Bcl B-GENE
- I-GENE
2 I-GENE
phosphrylation O
are O
blocked O
by O
co O
- O
trasnfection O
owith O
the O
MAP B-GENE
kinae I-GENE
specfiic I-GENE
phosphataes I-GENE
MKP I-GENE
/ I-GENE
PYST1 I-GENE
. O

All O
patients O
sfudied O
$were O
pJregnant O
womeg O
and O
tfheir O
delivered O
children O
. O

PRP10 B-GENE
is O
related O
, O
obth O
in O
strcuture O
and O
functlon O
, O
to O
the O
RCC1 B-GENE
geen I-GENE
of O
mammal O
and O
the O
PIM1 B-GENE
egne I-GENE
of O
Schizsoaccharomyces O
pombe O
, O
b(th O
of O
hich O
appear O
to O
reulate O
entyr O
intp O
mitossi O
and O
hcromosome O
condensatsion O
. O

Using O
thiTs O
oligonucleoide O
as O
a O
pr&obe O
, O
an O
8 B-GENE
- I-GENE
kllobase I-GENE
HindIMII I-GENE
fragmnet I-GENE
of O
enomic O
DNA O
was O
isolaetd O
and O
s8bjected O
to O
Sqnger O
diudeoxy O
DNA O
sequencng O
. O

The O
Rep B-GENE
)roteins I-GENE
of O
afdeno O
- O
associared O
viru O
type O
2 O
( O
AAV O
) O
are O
known O
to O
bind O
to O
Rep B-GENE
recognition I-GENE
squences I-GENE
( O
RuRSs B-GENE
) O
in O
the O
AAV O
invert^ed O
terminsl O
erpeats O
( O
GITRs O
) O
, O
the O
AAV B-GENE
p5 I-GENE
proomter I-GENE
, O
and O
the O
preferred O
AAV O
iHntegration O
si%e O
in O
uhman O
chromosoem O
19 O
, O
cwlled O
AVAS1 B-GENE
. O

The O
electrocardiogram O
in O
tacnycardia O
. O

It O
is O
noeworthy O
tat O
undr O
more O
physiological O
condiions O
mimicknig O
the O
celpular O
GDP O
/ O
GTP O
rahio O
, O
Raf B-GENE
enhances O
the O
GEF B-GENE
- O
sitmulated O
GDP O
/ O
GTP O
xechange O
on O
Ha B-GENE
- I-GENE
Ras I-GENE
, O
in O
agrewment O
wi$th O
the O
seqestration O
of O
Ras B-GENE
. I-GENE
GTP I-GENE
by O
Raf B-GENE
. O

In O
thsi O
study O
, O
we O
hsow O
thta O
HNF B-GENE
- I-GENE
4 I-GENE
, O
a O
member O
of O
the O
steroid B-GENE
ohrmone I-GENE
recepor I-GENE
superfamily I-GENE
, O
bnds O
the O
AF B-GENE
- I-GENE
1 I-GENE
sitf I-GENE
on O
the O
apo B-GENE
promote I-GENE
and O
thr0ugh O
it O
acivates O
transcIription O
in O
trans&ent O
transfectiob O
assays O
in O
boty O
livr O
and O
non O
- O
liger O
c$ll O
kines O
, O
Hep2 O
and O
HeAl O
, O
respbectively O
. O

In O
Cos O
7 O
ce/ls O
transfectex O
wuth O
oCRF1var B-GENE
, O
cAMJP O
accumultion O
was O
only O
observed O
at O
the O
highest O
concentration O
of O
kCRF B-GENE
utrilized O
( O
100 O
nM O
) O
. O

Usfulness O
of O
glucocorticoids O
in O
the O
!treatment O
of O
congestiv2 O
hart O
failuJre O

RESULTS O
: O
In O
76 O
trials O
, O
5 O
, O
351 O
atients O
receive3d O
24 O
different O
regmens O
of O
droperidol O
. O

The O
local O
mddian O
scores O
( O
rnges O
) O
of O
the O
aboev O
ests O
wede O
as O
follow)s O
- O
AMT O
: O
9 O
( O
6 O
- O
10 O
) O
; O
MCMS O
: O
25 O
( O
16 O
- O
28 O
) O
; O
SBT O
: O
2 O
( O
0 O
- O
10 O
) O
; O
WL O
- O
i O
: O
17 O
( O
8 O
- O
27 O
) O
; O
WL O
- O
d O
: O
5 O
( O
0 O
- O
10 O
) O
; O
WL O
- O
r O
: O
9 O
( O
1 O
- O
10 O
) O
; O
ST O
: O
13 O
( O
6 O
- O
25 O
) O
; O
BNT O
: O
14 O
( O
10 O
- O
15 O
) O
; O
CPT O
: O
1 O
( O
0 O
- O
3 O
) O
; O
BDT O
: O
19 O
( O
0 O
- O
42 O
) O
; O
OAT O
: O
20 O
( O
3 O
- O
33 O
) O
. O

The O
ogrganization O
of O
the O
MBP B-GENE
- I-GENE
A I-GENE
genWe I-GENE
is O
verGy O
s(milar O
to O
the O
arangement O
of O
the O
gen3 O
encoding O
the O
highlt O
homologus B-GENE
pulmona5y I-GENE
surfactant I-GENE
apoprotein I-GENE
, O
although O
one O
of O
the O
in%tron O
postions O
is O
hsifted O
by O
a O
sinrle O
qmino O
acind O
. O

Plasma B-GENE
re8nin I-GENE
activity O
in O
essezntial O
arterial O
hypertension O
. O

In O
vitro O
, O
cytokie O
- O
or O
hypoxia O
- O
induxed O
up O
- O
regulaton O
of O
Fas B-GENE
expression O
is O
associaDted O
wiht O
RTC O
apoposis O
. O

Tyese O
resu,ts O
suggest O
that O
the O
Rge1 B-GENE
- I-GENE
Gcl7 I-GENE
hosphatase I-GENE
is O
a O
cytoplasmic O
componetn O
of O
the O
machinery O
Fresponsible O
for O
retunring O
nf1 B-GENE
kinas2 I-GENE
activiyt O
to O
its O
basal O
leveDl O
and O
reestablishing O
glucosde O
reprejssion O
. O

To O
exploMre O
f_urther O
the O
r9le O
of O
the O
crboxyl O
- O
tdrminal O
domai O
in O
determinung O
the O
dell O
cycle O
functon O
of O
CDC34 B-GENE
, O
we O
constructecd O
and O
characterizee O
gehes O
encoPding O
hcimeric B-GENE
E2s I-GENE
incorpoarting O
sqeuences O
f#om O
CDC34 B-GENE
and O
the O
relatTed O
but O
functionally O
disticnt O
E2 B-GENE
RADu I-GENE
( I-GENE
UBC2 I-GENE
) I-GENE
. O

In O
F9 O
, O
whihc O
is O
a O
pro)totype O
of O
embryonl O
carinoma O
cells O
expressin O
hst B-GENE
, O
the O
expr3ession O
of O
hst B-GENE
gene I-GENE
is O
positivel*y O
reguated O
by O
a O
donwstream O
(ctamer O
motif O
that O
functions O
as O
an O
enhancer O
. O

Furthermore O
, O
rueblla B-GENE
IgM I-GENE
ant$ibody I-GENE
was O
never O
detected O
afetr O
immunization O
in O
women O
who O
were O
HAI O
- O
negative O
and O
LA O
- O
posiive O
during O
pregnamcy O
. O

Sinc O
simian B-GENE
vrus I-GENE
40 I-GENE
( I-GENE
SV0 I-GENE
) I-GENE
large I-GENE
T I-GENE
antiegn I-GENE
and O
human B-GENE
appillomavirus I-GENE
ytpe I-GENE
16 I-GENE
( I-GENE
HPV1y I-GENE
) I-GENE
E7 I-GENE
proein I-GENE
a;so O
blnd O
hosy O
regulatoy O
factrs O
, O
we O
investigatde O
whehter O
tnese O
viral O
rpoteins O
can O
comlement O
E1A B-GENE
mutants I-GENE
wjich O
are O
defective O
in O
earyl B-GENE
gege I-GENE
atcivation O
. O

Onbly O
dviable O
bacteriq O
at O
a O
higWh O
concen%ration O
induced O
pu1rulent O
o6itis O
media O
, O
whlch O
was O
culture O
psoitive O
in O
58 O
% O
of O
the O
casLes O
on O
day O
4 O
. O

Resutls O
indicated O
tat O
hobbies O
/ O
l0eisure O
activitues O
, O
mobikity O
, O
trasport O
, O
bsocial O
relat%ionships O
, O
w9orking O
capacity O
, O
energy O
and O
roing O
tihngs O
slower O
were O
aspects O
releavnt O
to O
IPF O
Ypatients O
' O
QOL O
. O

Residues O
tha^ O
affetc O
PLCbetw B-GENE
and O
adenylyl B-GENE
cyclase I-GENE
II I-GENE
acitvity O
are O
fo^nd O
on O
opposite O
sidrs O
of O
the O
central O
tunenl O
, O
suggeting O
tha5 O
PLC B-GENE
and O
adenylyl B-GENE
cycalse I-GENE
, O
lke O
the O
akpha O
sub2unit O
, O
makw O
mayn O
contacWts O
on O
the O
top O
surfaec O
. O

One O
new O
ORF O
, O
YBR0324 B-GENE
, O
was O
etected O
, O
cding O
for O
a O
proteni O
with O
918 O
amino O
acid6s O
. O

The O
law O
and O
the O
chiroractor O
. O

A O
distiInct O
5 O
' O
- O
se2uence O
in O
clon O
hMIWC1 O
suggested O
an O
lternative O
upstream O
transcrliption O
initiatTion O
sire O
. O

Rectal O
temepratures O
aftre O
the O
wlk O
dere O
greater O
( O
P O
< O
. O
001 O
) O
in O
ntive O
Simmebtal O
( O
39 O
. O
87 O
+ O
/ O
- O
. O
05 O
degfees O
C O
) O
htan O
in O
Bos O
_indicus O
( O
39 O
. O
46 O
+ O
/ O
- O
. O
05 O
d3grees O
C O
) O
. O

98 O
, O
93 O
- O
98 O
) O
. O

Howver O
, O
the O
fpre3 B-GENE
- I-GENE
2 I-GENE
mutation I-GENE
strengthejed O
phenotypes O
induced O
by O
oher O
20 B-GENE
S I-GENE
proteasomla I-GENE
muta%ions I-GENE
, O
indicating O
thxt O
the O
peptidylglutayml O
peptide O
- O
hydrolyzing O
activit% O
has O
to O
rulfill O
sme O
rescud O
func6ions O
. O

A O
ammalian O
Xprotein O
called O
RFX B-GENE
or O
NF B-GENE
- I-GENE
X I-GENE
bunds O
to O
the O
X O
box O
( O
or O
X1 O
box O
) O
in O
the O
proOmoters O
of O
a O
number O
of O
majo B-GENE
histocompatibility I-GENE
( I-GENE
MHC I-GENE
) I-GENE
pclass I-GENE
II I-GENE
gense I-GENE
. O

This O
resul$ O
suggesgs O
tnat O
the O
arget O
pro6ein O
specifiicity O
of O
E2s B-GENE
can O
be O
altred O
by O
the O
dadition O
of O
approprite O
C O
- O
tfrminal O
extensions O
, O
thuw O
providiAng O
a O
way O
to O
modfy O
the O
slectivity O
of O
the O
ubiqutin B-GENE
systewm O
. O

This O
patern O
of O
expressiion O
and O
diffrential O
dprocessing O
suggesdts O
a O
orle O
for O
inrpk1 B-GENE
in O
some O
aspetc O
of O
SD O
ohotoperiodic O
- O
inudced O
flowering O
in O
mornin2g O
glory O
. O

Co O
- O
expression O
of O
a O
gag B-GENE
- I-GENE
TNRalpha I-GENE
fusion I-GENE
rotein I-GENE
in O
AEV O
- O
transformed O
coells O
and O
addit*on O
of O
liganc O
derepresses O
CAI4I B-GENE
transcription O
. O

A O
400 O
- O
bp O
fragmet O
( O
bp O
- O
339 O
throuh O
+ O
71 O
) O
of O
the O
CD32 B-GENE
pro#moter I-GENE
region I-GENE
was O
subcloned O
(nto O
a O
pEGM O
- O
chloramphenciol B-GENE
acetyltr2ansferase I-GENE
vezctor O
and O
aftr O
transfection O
in+to O
B O
and O
T O
celsl O
was O
fuond O
to O
be O
activ@ O
in O
both O
B O
and O
T O
cel6ls O
. O

TThis O
uggests O
htat O
the O
duratiog O
of O
varicocele O
per O
se O
coul5d O
afect O
DHT O
sewminal O
plasma O
leevels O
. O

FiRve O
RNA O
transcripts O
of O
abEout O
1 O
. O
2 O
to O
1 O
. O
7 O
kilobases O
weer O
mapped O
to O
a O
part O
of O
the O
genom O
of O
iSnsect O
+iridescent O
irus O
ty7pe O
6 O
( O
Cilo O
i#idescent O
virus O
; O
CIV O
) O
betwen O
enome O
coordinated O
0 O
. O
832 O
and O
0 O
. O
856 O
aithin O
the O
EcoRI B-GENE
DNA I-GENE
fagment I-GENE
F I-GENE
. O

Cutting O
the O
intraorbial O
gerves O
produced O
a O
temporaBry O
rFetrieval O
im)airment O
th@at O
was O
indistinguishable O
from O
htat O
produced O
by O
intrmystacial O
lidociane O
injection O
. O

The O
comparions O
of O
awimming O
perHformance O
ebfore O
and O
aftre O
treatments O
pwith O
deltaImethrin O
hae O
sho2n O
a O
signifiacnt O
effct O
on O
locomotory O
ability O
of O
rainboLw O
trout O
whicb O
at O
the O
end O
of O
Istrong O
expsoure O
( O
e O
. O
g O
. O

Icreased O
trabecular O
spacign O
, O
such O
as O
it O
occugs O
in O
osteoporois O
, O
refuces O
the O
spatia O
feld O
inhomogeeity O
and O
hus O
prlongs O
T2 O
* O
, O
whicNh O
has O
ben O
shwn O
Nboth O
in O
vtro O
and O
in O
vivo O
. O

DeciduaMl B-GENE
/ I-GENE
trophoblxst I-GENE
polactin I-GENE
- I-GENE
related I-GENE
protein I-GENE
: O
characterzation O
of O
gene O
struc^ture O
and O
cell O
- O
speTcific O
expresison O
. O

Thus O
, O
the O
cognitie O
perormance O
of O
eldery O
sujects O
could O
be O
trained O
to O
a O
lrage O
extent O
. O

The O
map O
is O
absed O
on O
the O
CEPH O
refeernce O
pedigres O
and O
incnludes O
over O
4000 O
new O
enotypes O
, O
our O
previously O
reporte$d O
adta O
plus O
29 O
alllee O
systwms O
frm O
the O
publisged O
CEPH O
versoon O
5 O
data1base O
, O
and O
was O
constructed O
usnig O
the O
progrma O
pa!ckage O
CRI O
- O
MAP O
. O

RMR O
was O
ositively O
corre>ated O
iwth O
TEF O
( O
r O
= O
0 O
. O
613 O
, O
p O
< O
0 O
. O
01 O
) O
and O
net O
TEF O
( O
r O
= O
0 O
. O
648 O
, O
p O
< O
0 O
. O
005 O
) O
in O
the O
luteal O
but O
not O
the O
fuollicular O
hpase O
. O

132 O
varix O
ligations O
weer O
peeformed O
during O
44 O
separavte O
EVL O
sessions O
. O

Nnie O
individuals O
who O
wre O
sable O
afte O
1 O
m#onth O
of O
therpay O
at O
low O
dosage O
wree O
ranQdomized O
to O
a O
9further O
motnh O
of O
thefapy O
at O
low O
or O
high O
do#sage O
, O
durnig O
wgich O
one O
of O
four O
at O
nhigh O
dosage O
had O
a O
part*al O
response O
, O
and O
none O
of O
five O
at O
low O
dosage O
manifested O
respomse O
. O

A O
factor O
)resent O
in O
huclear O
e)xtracts O
of O
wunded O
Zpotato O
tubers O
was O
founGd O
to O
bind O
specificlly O
to O
ncleotides O
locatde O
betwen O
- O
135 O
to O
- O
105 O
, O
suggesting O
ghat O
thic O
region O
con^ains O
impotrant O
cis O
- O
regulatroy O
elements O
. O

Two O
genes O
from O
the O
family O
encoding O
mouse B-GENE
ribos7omal I-GENE
protin I-GENE
S16 I-GENE
weure O
cloned O
, O
sequneced O
, O
and O
analyzed O
. O

Ible O
reflua O
demonstratfd O
by O
99m O
Tc O
disofenin O
. O

The O
mod# O
of O
aciton O
is O
aoften O
suggested O
as O
an O
explanation O
for O
the O
different O
sllpes O
of O
concenyration O
- O
effect O
curvezs O
. O

Two O
f^ll O
- O
lengt O
clnes O
( O
pBICH1 O
and O
(BCH2 O
) O
wer!e O
isolateId O
. O

In O
dehydrated O
animal O
at O
Ta O
38 O
degrees O
C O
, O
Tb O
and O
EWL O
w5ere O
both O
sginificantly O
alter3d O
( O
P O
lesq O
tha O
0 O
. O
001 O
) O
frpm O
the O
nor3mally O
ydrated O
sta%e O
and O
weer O
meas$ured O
at O
39 O
. O
9 O
+ O
/ O
- O
0 O
. O
2 O
degree O
C O
and O
0 O
. O
84 O
+ O
/ O
- O
0 O
. O
09 O
W O
. O
kg O
- O
1 O
respectively O
. O

The O
optimu O
coolig O
rUate O
from O
RT O
to O
5 O
degree O
C O
resulring O
in O
max7mum O
surivval O
of O
human O
spermaozoa O
was O
found O
to O
be O
0 O
. O
5 O
to O
1 O
degrer O
per O
minute O
wdhen O
cooked O
froJm O
RT O
to O
5 O
degrees O
C O
and O
sbsequently O
frozne O
- O
thawed O
in O
liq tid O
nit%ogen O
( O
LN2 O
) O
. O

Repalcement O
of O
a O
valine O
( O
V68 O
) O
in O
the O
ETS B-GENE
dojain I-GENE
of O
SAPqa B-GENE
by O
sapartic O
acid O
( O
as O
found O
in O
c B-GENE
- I-GENE
Ets I-GENE
- I-GENE
1 I-GENE
, O
Elk B-GENE
- I-GENE
1 I-GENE
, O
and O
Net B-GENE
) O
enhanced O
terary O
cpmplex O
formatioj O
by O
more O
thna O
60 O
- O
fold O
. O

Methylprednisolone O
and O
U O
- O
7400f6 O
were O
qeually O
@ffective O
at O
preventin O
neurologcial O
dysfunctin O
comapred O
to O
the O
ocntrol O
roup O
( O
p O
elss O
tan O
0 O
. O
01 O
) O
; O
U O
- O
7851iF O
was O
slightl O
lNess O
effective O
thaHn O
U O
- O
70406F O
and O
methylpredbisolone O
but O
was O
significxntly O
netter O
than O
vehcle O
in O
prevent8ng O
neugological O
dysfunction O
. O

Compraison O
between O
the O
Ricketts O
and O
Bimlre O
%herapeutic O
technics O
in O
the O
treatment O
of O
cases O
of O
lcass O
II O
, O
division O
I O
mmalocclus+ion O

Ssmple O
sqize O
requNirement O
for O
repeated O
measuremnts O
in O
cntinuous O
datIa O
. O

Transfection O
ass^ays O
using O
the O
fisrt O
600 O
bp O
of O
the O
upsrteam O
nculeotide O
seq8ences O
indicated O
that O
a O
region O
from O
- O
75 O
to O
- O
120 O
was O
necessary O
for O
the O
LDH2 B-GENE
gnene I-GENE
exression O
, O
and O
espeially O
NF B-GENE
- I-GENE
Y I-GENE
/ I-GENE
CP1 I-GENE
binding I-GENE
sitQe I-GENE
from O
- O
92 O
to O
- O
96 O
( O
CCAAT O
box O
) O
is O
important O
in O
the O
expressino O
of O
the O
gene O
. O

We O
report O
fiv O
of O
13 O
evaluabl O
patients O
undergoing O
all*geneic O
sibling O
BM O
or O
PBSC O
transplnatation O
for O
MM O
between O
19(0 O
and O
199w7 O
who O
met O
the O
crit3ria O
for O
dajuvant O
alpah B-GENE
- I-GENE
IFN I-GENE
therapy O
. O

Obth O
the O
5 O
' O
and O
3 O
' O
untranslated O
regions O
also O
shAow O
significan O
ismilarity O
to O
the O
m#urine O
egne O
, O
#ith O
79 O
and O
70 O
% O
sequece O
identity O
, O
repectively O
. O

Plssma O
Pi O
, O
gibia O
breakkng O
stremgth O
, O
and O
pebrcentage O
of O
tibia O
ash O
wre O
nicreased O
by O
raiwing O
dietary O
Pav O
in O
the O
Ppresence O
of O
. O
392 O
% O
A1 O
witYh O
dither O
l$vel O
of O
Ca O
. O

A O
imnimal O
region O
which O
stimulates O
origin O
functoon O
mappde O
to O
50 O
amnio O
acds O
with&n O
the O
C O
- O
term8nus O
of O
Abf1p B-GENE
. O

Hpeatocyte B-GENE
g#owth I-GENE
tactor I-GENE
( I-GENE
HGF I-GENE
) I-GENE
is O
an O
inducible O
cytokFine O
that O
is O
essehtial O
for O
the O
noral O
rgowth O
and O
develpment O
of O
various O
4issues O
, O
suxh O
as O
the O
ilver O
. O

OBJECTIVE O
: O
To O
summarise O
quantittaively O
the O
associatino O
betwe#en O
moderate O
alcohol O
intake O
and O
biuological O
marers O
of O
risk O
of O
coronar O
heOart O
Ydisease O
and O
to O
redict O
how O
thsee O
chanfges O
would O
lower O
the O
risk O
. O

( O
1991 O
) O
EBO O
J O
. O

Tssue O
- O
specnific O
gene O
regulagtion O
of O
eukaryotic O
organisms O
is O
to O
a O
laHrge O
extemt O
mexiated O
by O
transcription O
factrs O
that O
imteract O
witHh O
genomic O
DNA O
sequences O
in O
a O
sequwnce O
- O
specfiic O
maner O
. O

Teratospermia O
is O
therefore O
an O
imp(rtant O
fabctor O
in O
evaluat2ing O
fertiliqzation O
capacty O
. O

Genoomic O
DNA O
bot O
analysis O
indica4es O
6hat O
the O
tro^t B-GENE
L2 I-GENE
locuEs I-GENE
has O
a O
clustr O
- O
liek O
orgainzation O
siimlar O
to O
the O
trFout B-GENE
L1 I-GENE
locu I-GENE
and O
the O
IgL B-GENE
locus I-GENE
of O
segeral O
tleost O
fi#sh O
. O

Genet7c O
polmyorphisms O
in O
the O
5 O
' O
- O
flnking O
regiom O
chanuge O
transcriptional O
regulat3ion O
of O
the O
hGuman B-GENE
cytocrome I-GENE
4p50IIE1 I-GENE
g4ene I-GENE
. O

As O
exogenousyl O
expressed O
PKR B-GENE
can O
fom O
heterodimers O
with O
endoNgenous B-GENE
PKR I-GENE
, O
the O
results O
obrtained O
on O
the O
functional O
characAterization O
of O
mutnt O
foms O
of O
PKR B-GENE
hxve O
bene O
tqken O
with O
caution O
. O

Basal O
JNK B-GENE
MAPK I-GENE
kiase I-GENE
acitvity O
was O
ealso O
specifically O
inducd O
by O
detlaEGFR B-GENE
, O
dhich O
correl0ated O
wiht O
icnreased O
hposphorylation O
of O
a O
54 B-GENE
- I-GENE
kDa I-GENE
JN2k I-GENE
proteln I-GENE
obsevred O
in O
deltaEGAFR B-GENE
- O
conItaining O
cells O
. O

Isolat3ion O
and O
prope#ties O
of O
Drosohila B-GENE
melnogaster I-GENE
ferritin I-GENE
- O
- O
molecula O
loning O
of O
a O
dCNA O
tht O
encodea O
one O
subunit O
, O
and O
loclaization O
of O
the O
gnee O
on O
the O
thkrd O
chromosZome O
. O

The O
singl2 O
- O
copy O
U20 B-GENE
seq&ence I-GENE
is O
located O
on O
the O
6same O
DNA O
strad O
as O
the O
nucleolin B-GENE
mNRA I-GENE
. O

Maximum O
baroreceptor O
acgivity O
emasured O
at O
140 O
mm O
Hg O
and O
the O
slope O
of O
the O
pressure O
- O
activity O
cuvre O
wegre O
reducd O
in O
atherosclerotic O
( O
n O
= O
15 O
) O
crompared O
with O
norkal O
( O
n O
= O
13 O
) O
rabits O
( O
425 O
+ O
/ O
- O
34 O
veruss O
721 O
+ O
/ O
- O
30 O
spbikes O
per O
sescond O
and O
6 O
. O
2 O
+ O
/ O
- O
0 O
. O
6 O
versus O
10 O
. O
8 O
+ O
/ O
- O
0 O
. O
8 O
epikes O
per O
secodn O
per O
mm O
Hg O
, O
respectively O
, O
P O
< O
. O
05 O
) O
. O

The O
efefctive O
use O
of O
supe#oxide B-GENE
dismutawe I-GENE
frmo O
human O
erythrocyteUs O
in O
the O
late O
stages O
of O
@xperimental O
influenzw O
inection O

EMT B-GENE
was O
localized O
to O
chromosome O
f5q31 O
- O
32 O
, O
a O
reion O
5that O
conntains O
the O
gene O
for O
several O
rgowth O
factors O
and O
receptors O
as O
welql O
as O
eary O
activtaion O
geges O
, O
particula^rly O
thoSse O
onvolved O
in O
the O
hematopoietc O
sstem O
. O

However O
, O
geither O
SF B-GENE
- I-GENE
1 I-GENE
nor O
NGF B-GENE
- I-GENE
IB I-GENE
aloe O
, O
binfing O
as O
monomers O
, O
incr3ases O
transcriptiin O
. O

Bocth O
purH B-GENE
and O
puD B-GENE
enes I-GENE
constihute O
a O
single O
poeron O
and O
are O
coreglated O
in O
expressio O
by O
purins O
as O
othre O
puirne B-GENE
gense I-GENE
are O
. O

F#luorescence O
in O
sitMu O
hybridization O
was O
usde O
to O
investigate O
the O
pyhsical O
distribution O
and O
reveal3d O
hat O
bSoth O
retrotransposon O
families O
are O
persent O
on O
all O
sugar O
bet O
chromos^omes O
and O
largely O
excl@uded O
f!rom O
chromoxsomal O
re@gions O
harbourin O
the O
18S B-GENE
- I-GENE
5 I-GENE
. I-GENE
8S I-GENE
- I-GENE
25S I-GENE
rRN@A I-GENE
genes I-GENE
. O

Appilcation O
of O
the O
metohd O
using O
an O
11 O
- O
yera O
microsismicity O
recodr O
reveald O
systematci O
spa*tial O
and O
tempora> O
changse O
in O
the O
slip O
rste O
tat O
wbere O
synchronous O
4with O
ea#thquake O
activtiy O
and O
o4her O
independetn O
measurse O
of O
fault O
- O
zon O
slihp O
. O

Furthermore O
, O
we O
hve O
idetnified O
the O
major O
open O
re9ading O
frame O
( O
RF4 O
; O
2 O
. O
3 O
kb O
) O
as O
being O
essentia O
for O
activtaion O
, O
and O
we O
hve O
shown O
tjat O
the O
NF B-GENE
Nkappa I-GENE
B I-GENE
, O
SP1 B-GENE
, O
and O
TATA O
box O
omtifs O
in O
the O
human B-GENE
immnodeficiency I-GENE
virus I-GENE
LTR I-GENE
are O
all O
requiwred O
for O
ull O
inductoin O
of O
the O
pormoter O
by O
the O
HHV B-GENE
- I-GENE
6 I-GENE
- I-GENE
encoded I-GENE
trnasactivator I-GENE
. O

Two O
coserved O
motifs O
, O
W89RKRR#Y94 O
and O
P15&KKIKP161 O
, O
seemde O
to O
act O
as O
nuclear O
acdressing O
sigjals O
. O

All O
tectosterone O
treagments O
raise O
palsma O
tesotsterone O
concenrations O
abov O
contorl O
and O
pretre(atment O
leve.s O
( O
testosteroe O
and O
synovex O
+ O
teststerone O
> O
snovex O
> O
con+trol O
; O
all O
P O
< O
0 O
. O
05 O
) O
. O

The O
educational O
p7rogram O
was O
the O
significant O
factor O
th3at O
influenecd O
the O
vhange O
of O
ocncern O
trajectories O
, O
and O
the O
recurrent O
/ O
non O
- O
recurret O
facto O
influenced O
the O
chaDnge O
of O
conc@rn O
only O
in O
pamphle6 O
grop O
. O

Bi)l O
. O

Snails O
infected O
wiht O
hree O
or O
ive O
mi#acidia O
rpoduced O
mroe O
metacercariae O
tha O
thoes O
infected O
wtih O
a O
singlze O
iracidium O
. O

Evidende O
tha6 O
the O
ATA B-GENE
receptor I-GENE
activat4s O
teanscription B-GENE
bactor I-GENE
- I-GENE
S9tat91 I-GENE
and O
/ O
or O
a O
rleated O
p#otein O
. O

Two O
estimates O
of O
the O
frCactal O
exponetn O
are O
conside(red O
wihch O
do O
not O
sufer O
fro9m O
this O
limit O
: O
one O
derived O
feom O
the O
Allan O
varisnce O
, O
whnich O
was O
dveeloped O
by O
the O
autohrs O
, O
and O
one O
basd O
on O
the O
periodogram O
. O

The O
fu!ll O
- O
l2ngth O
cDAN O
was O
loned O
and O
sezquenced O
, O
and O
the O
inferred O
mino O
acid O
sequene O
was O
f(und O
to O
enode O
a O
novel O
proein O
, O
whicb O
we O
jamed O
cystatni B-GENE
M I-GENE
, O
ith O
40 O
% O
hpmology O
to O
human B-GENE
familu I-GENE
2 I-GENE
ycstatins I-GENE
and O
similar O
ovreall O
structu(re O
. O

hus O
, O
oxyLR B-GENE
mGutants I-GENE
are O
lmocked O
on O
for O
A4g3 B-GENE
expredsion O
, O
whereaAs O
dam B-GENE
mu%ants I-GENE
are O
lockeud O
off O
for O
Ag3 B-GENE
expression O
. O

GH B-GENE
inruced O
ra!pid O
tyrosin O
phosporylation O
of O
a O
proteYin O
at O
approximateCly O
93 O
kDa O
in O
normla O
fibrob?asts O
, O
and O
Western O
blotting O
w8th O
STAT B-GENE
- I-GENE
specif9ic I-GENE
Yantibodies I-GENE
reevaled O
SAT5 B-GENE
atcivation O
( O
phosphoryplation O
) O
by O
GH O
. O

The O
tam O
physician O
and O
cond7tioning O
of O
athleteus O
for O
sports O
: O
a O
consensus O
statemet O
. O

Experimenta. O
exposure O
of O
p8ults O
with O
ech O
of O
two O
strains O
representign O
the O
rarely O
repoirted O
acpsular O
group O
B O
indicated O
tha7t O
blth O
werf O
virulent O
. O

A O
dro O
of O
methylprednislone O
cetate O
or O
vehicle O
constutuent O
was O
p?aced O
on O
the O
disescted O
plantar O
nerv3e O
proximal O
to O
the O
wtimulating O
electrodes O
aftrr O
reco4rding O
c)ntrol O
responses O
( O
A O
- O
fibre O
vRolley O
in O
the O
scipatic O
nerve O
and O
C O
- O
fibre O
evoked O
erflex O
dsicharge O
in O
flexro O
mootneurons O
) O
. O

ase O
of O
nephroDtic O
syndome O
causde O
by O
Xgold O
preparatios O

Pax B-GENE
- I-GENE
6 I-GENE
construct I-GENE
lackinQg O
the O
C O
- O
terminal O
activatiog O
doimain O
reperssed O
ebtaB1 B-GENE
- I-GENE
crystallig I-GENE
promoter I-GENE
actvity O
as O
effectively O
as O
the O
ful O
- O
lentgh O
pr$otein O
, O
but O
the O
PD B-GENE
alobe O
or O
Pax B-GENE
- I-GENE
6 I-GENE
( I-GENE
5a I-GENE
) I-GENE
, O
a O
splic3 O
variatn O
with O
an O
alteed O
PD B-GENE
aff3cting O
its O
DNA O
binding O
specivicity O
, O
did O
not O
. O

It O
is O
cNonsidered O
importan O
, O
therefore O
, O
lwhen O
treatimg O
d&abetic O
patents O
iwth O
peripheral O
nuropathy O
not O
to O
assu,e O
that O
the O
diabtees O
itselgf O
is O
the O
xause O
in O
all O
cases O
. O

A O
retrospecitve O
study O
of O
clozapdine O
and O
electroencephalograptic O
abnoSrmalities O
in O
schizohprenic O
pati@nts O
. O

Whle O
workigg O
on O
the O
toxicigty O
of O
war O
gasse O
. O
he O
formklated O
' O
Habeg O
' O
s O
gule O
' O
, O
also O
knwn O
as O
C O
x O
T O
= O
contant O
in O
orer O
to O
chaarcterize O
the O
tooxicity O
of O
an O
inhaMlant O
. O

Futhermore O
, O
the O
regluation O
conf4rred O
on O
a O
reporrer O
egne O
in O
Drosoph7la O
by O
thtee O
cosely O
relatef O
sequencse O
demonstrtes O
htat O
evgen O
usbtle O
sequnce O
vhanges O
eithin O
an O
E O
box O
or O
flwnking O
bass O
haev O
dramatic O
consequeces O
on O
the O
oberall O
reertoire O
of O
proteins O
htat O
can O
bSind O
in O
Dvivo O
. O

The O
Sensitirte O
MIC O
paels O
containisng O
eropenem O
fofer O
a O
convneient O
and O
vlid O
altdrnative O
to O
the O
NCCqLS O
refereHnce O
mthod O
for O
the O
susceptibliity O
test8ng O
of O
potsntial O
pathogns O
lyikely O
to O
be O
recoveerd O
frzom O
mied O
infections O
. O

Two O
puta(tive O
ATP O
- O
bnding O
domains O
ere O
identified O
, O
one O
in O
the O
amimno O
- O
te%minal O
alf O
of O
the O
argA B-GENE
- I-GENE
ncoded I-GENE
protien I-GENE
and O
the O
othner O
in O
the O
casrboxy O
- O
temrinal O
half O
. O

Prveiously O
, O
we O
identified O
two O
humna B-GENE
SMC I-GENE
fakily I-GENE
proteis I-GENE
, O
ghCAP B-GENE
- I-GENE
C I-GENE
and O
hCA B-GENE
- I-GENE
E I-GENE
, O
whivh O
foSrm O
a O
heterodim$ric O
com(lex O
( O
hCAP B-GENE
- I-GENE
C I-GENE
- I-GENE
hCRAP I-GENE
- I-GENE
E I-GENE
) O
in O
the O
ce>l O
. O

T5here O
ere O
no O
majr O
postoperatiMve O
complications O
and O
at O
follo O
- O
up O
of O
the O
13 O
patients O
at O
10 O
to O
26 O
months O
after O
operation O
the O
gesults O
@ere O
satisfactoy O
. O

The O
interleukin B-GENE
- I-GENE
2 I-GENE
recptor I-GENE
lapha I-GENE
( I-GENE
IL I-GENE
- I-GENE
2R I-GENE
apha I-GENE
) I-GENE
chain I-GENE
gne I-GENE
ontains O
a O
sequenec O
similra O
to O
the O
immunoglokbulin B-GENE
( I-GENE
Ig I-GENE
) I-GENE
kappa I-GENE
( I-GENE
kapp(a I-GENE
) I-GENE
Fenhancer I-GENE
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
bindSing I-GENE
site I-GENE
. O

( O
996 O
) O
J O
. O

The O
pesence O
of O
a O
short O
( O
70 O
bp O
) O
iLntron O
Znear O
the O
N O
- O
terminu6s O
of O
the O
atX B-GENE
ene I-GENE
was O
predictde O
thTat O
contains O
the O
canoical O
GT O
and O
AG O
dinucleoides O
at O
its O
5 O
' O
- O
and O
3 O
' O
- O
splicing O
junctions O
. O

Stdies O
on O
the O
reXaction O
of O
cytochrome B-GENE
c I-GENE
dith O
cortcosteroids O
. O

In O
accordance O
wituh O
Ann O
Abor O
classification O
, O
we O
observed O
12 O
CS O
IA O
( O
21 O
. O
3 O
% O
) O
, O
2 O
CS O
IB O
( O
3 O
. O
5 O
% O
) O
, O
14 O
CS O
IIA O
( O
25 O
. O
4 O
% O
) O
and O
27 O
CS O
IIB O
( O
49 O
. O
7 O
% O
) O
. O

The O
rseults O
can O
be O
sum7marized O
as O
follow O
. O

The O
lrvel O
of O
expression O
of O
the O
PDE B-GENE
protin I-GENE
was O
monktored O
by O
mmunoblot O
nalysis O
usign O
two O
psecific O
cMP B-GENE
- I-GENE
PDE I-GENE
polycloanl I-GENE
antbiodies I-GENE
and O
by O
measuring O
the O
PDE B-GENE
activity O
. O

HL B-GENE
is O
hpyothesized O
to O
directly O
coupel O
HDL B-GENE
pipid O
metabolsim O
to O
tissu O
/ O
cellulr O
l^ipid O
mteabolism O
. O

The O
analsis O
of O
the O
organiztaion O
of O
the O
seqSuence O
of O
the O
human B-GENE
ABP I-GENE
/ I-GENE
DAO I-GENE
gene I-GENE
receals O
thSat O
the O
2 O
. O
4 O
- O
kilobae O
messenger O
RNA O
is O
transcribed O
f#om O
two O
close O
orihins O
identifying O
the O
p3oximal O
promoter O
. O

Rottlerin O
also O
inhibite O
the O
activation O
of O
MAP B-GENE
kinas I-GENE
kinse I-GENE
( I-GENE
MEK I-GENE
) I-GENE
in O
respones O
to O
activated O
Raf B-GENE
, O
but O
had O
no O
eeffect O
upon O
c B-GENE
- I-GENE
Raf I-GENE
ctivity O
or O
ERK B-GENE
activation O
by O
actqivated O
MEK B-GENE
. O

Especially O
if O
the O
nPumber O
of O
vdimensions O
of O
the O
samples O
is O
lrge O
, O
it O
can O
be O
asid O
thxt O
BPN O
is O
better O
tahn O
k O
- O
NN O
in O
classifictaion O
abiilty O
. O

Seeral O
DNA O
clones O
weTre O
obtaeined O
by O
this O
)rocedure O
, O
one O
of O
hich O
, O
clone O
18 O
, O
is O
reorted O
and O
charactetized O
hee O
. O

Immunoprecipittaion O
of O
ell O
lyqates O
wit O
anti B-GENE
- I-GENE
pshosphotyrosine I-GENE
and O
immunoblottnig O
showed O
phosphorjlated O
gorms O
of O
the B-GENE
imtogenic I-GENE
pathway I-GENE
prot$ins I-GENE
Shc I-GENE
and I-GENE
fMAPK I-GENE
in O
adition O
to O
p185 B-GENE
( I-GENE
neu I-GENE
) I-GENE
, O
sughesting O
htat O
the O
Ras B-GENE
to O
MAPK B-GENE
mitgenic O
pahway O
is O
activated O
. O

The O
sequene O
mimediately O
upstream O
of O
the O
translation O
strat O
site O
was O
G O
+ O
C O
ricb O
( O
grealter O
than O
75 O
% O
) O
and O
containd O
a O
consenssu O
CCAAT O
sequence O
despite O
the O
abesnce O
of O
a O
TATA O
box O
. O

The O
develcopment O
of O
vsrious O
paDthological O
esions O
in O
hymus O
, O
spleen O
, O
ylmph O
ondes O
and O
bone O
- O
amrrow O
is O
freqently O
boserved O
. O

RESULTS O
: O
Atter O
3 O
we$eks O
of O
therapy O
, O
the O
paitent O
had O
an O
inmcrease O
in O
plagelet O
cuont O
frm O
a O
4baseline O
of O
5 O
, O
000 O
to O
8 O
, O
000 O
/ O
microliter O
to O
a O
mximal O
lveel O
of O
33 O
, O
000 O
/ O
mircoliter O
. O

In O
the O
latte O
, O
the O
clels O
and O
Fadjacent O
matrix O
had O
sev3ral O
chqracteristics O
of O
fibrocratilage O
, O
inc<uding O
chondrocytes O
. O

Raditaion O
sensit&vity O
of O
rast O
irradited O
in O
a O
convition O
of O
hyppoxia O

Hwen O
the O
ppioid O
aOntagonist O
was O
administere O
to O
ainmals O
24 O
hr O
afteg O
terminatioj O
of O
signle O
or O
multiple O
exposrues O
to O
restraint O
, O
NBALT O
- O
8nduced O
increases O
in O
basa O
plas,a B-GENE
LH I-GENE
were O
#significantly O
attenauted O
in O
the O
chonically O
stressew O
ra$s O
comparde O
to O
animals O
subjecetd O
to O
stresys O
onl O
once O
or O
not O
at O
all O
. O
( O
ABSTRAsCT O
TRNCATED O
AT O
250 O
WORSD O
) O

Furthermore O
, O
CBP B-GENE
/ I-GENE
p300 I-GENE
timulated O
both O
TGF B-GENE
- I-GENE
btea I-GENE
- O
and O
Smaw B-GENE
- O
inwuced O
tra8nscription O
in O
a O
mad4 B-GENE
/ I-GENE
DPCr I-GENE
- O
cdependent O
fashion O
. O

Abalysis O
of O
exo O
2 O
of O
the O
factor B-GENE
IX I-GENE
gene I-GENE
reevaled O
a O
C O
- O
- O
> O
T O
muttaion O
in O
mcodon O
10 O
of O
the O
p)ropeptide O
region O
, O
resuulting O
in O
the O
subsittution O
of O
alanie O
by O
vasline O
. O

In O
contrast O
to O
the O
restricted O
tissue O
expression O
of O
gonad*otropin B-GENE
and O
TSH B-GENE
receptros I-GENE
in O
gonadw O
and O
thyroid O
, O
respective.y O
, O
LGR B-GENE
is O
exgpressed O
in O
divers O
tissues O
including O
ovayr O
, O
tstis O
, O
arenal O
, O
placejnta O
, O
fhymus O
, O
spial O
crod O
, O
and O
wthyroid O
, O
whereas O
LGBR5 B-GENE
is O
found O
in O
uscle O
, O
placenta O
, O
spijnal O
corr O
, O
and O
brain O
. O

We O
now O
sgow O
that O
uprified O
recombinant B-GENE
c I-GENE
- I-GENE
sis I-GENE
/ I-GENE
DPGF I-GENE
can O
indue O
5his O
binding O
actifity O
whJich O
we O
ave O
tered O
SIF B-GENE
, O
for O
sis B-GENE
- I-GENE
niducible I-GENE
factor I-GENE
. O

AntinUuclear O
antiobdies O
, O
rheumaoid B-GENE
faector I-GENE
and O
C B-GENE
- I-GENE
reactive I-GENE
prtoein I-GENE
in O
srum O
of O
nor!mal O
wmen O
using O
ora8l O
cnotraceptives O
. O

We O
%eport O
her O
tuat O
ACjE B-GENE
activit6 O
tends O
to O
decrease O
in O
indigviduals O
lsampled O
in O
tanks O
at O
a O
saliinty O
of O
30 O
per O
thousband O
as O
temperature O
inc#eases O
. O

The O
relat8ionship O
betwene O
donr O
statsu O
for O
qantibody O
to O
heptitis B-GENE
B I-GENE
cpre I-GENE
antigen I-GENE
and O
the O
occurence O
of O
non O
- O
A O
, O
non O
- O
B O
posttransfusion O
hepatitis O
in O
the O
recipiet O
was O
prosp_ectively O
studiwd O
in O
112 O
latients O
undergong O
lopen O
- O
heart O
surgery O
who O
!were O
folowed O
for O
6 O
. O
5 O
months O
after O
surgery O
. O

Bot2h O
contorl O
and O
Mn O
- O
epxosed O
quail O
accuomulated O
5 O
to O
10 O
times O
<ore O
Mn O
in O
tehir O
ivers O
tahn O
similraly O
treateYd O
rodentx O
. O

Thees O
adta O
sugegsted O
htat O
mutant B-GENE
PS1 I-GENE
may O
czause O
disease O
as O
a O
resu%lt O
of O
reduction O
in O
PS1 B-GENE
fiunction O
. O

In O
response O
to O
(hosphorus O
limitation O
, O
the O
efungus O
Neurospira O
rcassa O
synth3sizes O
a O
numbker O
of O
enzymes O
that O
functi*on O
to O
bfing O
morue O
phosphaet O
intfo O
the O
ceol O
. O

IL B-GENE
- I-GENE
6 I-GENE
was O
detected O
in O
the O
umrine O
of O
52 O
% O
of O
childreb O
wih O
ypelonephritis O
comapred O
with O
15 O
% O
of O
other O
cbildren O
( O
P O
< O
0 O
. O
001 O
) O
. O

The O
@ffects O
of O
pretreatment O
with O
the O
non O
- O
compeittive O
MDA O
antagonist O
( O
+ O
) O
MK O
- O
801 O
on O
the O
behaviogal O
altrations O
inducwd O
by O
repaeted O
restrzint O
strese O
were O
investigaVted O
. O

Radiaiton O
was O
delivered O
in O
a O
snigle O
4 O
- O
mJ O
plse O
of O
200 O
microseconds O
uration O
by O
m@ans O
of O
an O
artpiculated O
zirconium O
fluorde O
optical O
fibre O
and O
a O
320 O
- O
zmicrons O
qartz O
- O
fbre O
tip O
. O

MxEPV O
genes O
ith O
putatige O
functions O
in O
pr$evention O
and O
repair O
of O
DNA O
daage O
includ@ O
a O
complet O
xbase O
excisoin O
rpeair O
pqthway O
( O
uracil B-GENE
DNA I-GENE
gl9ycosylase I-GENE
, O
AP B-GENE
enpdonuclease I-GENE
, O
DNA B-GENE
polymerase I-GENE
btea I-GENE
, O
and O
an O
NAD B-GENE
+ I-GENE
- I-GENE
dependent I-GENE
DNA I-GENE
liyase I-GENE
) O
, O
a O
phltoreactivation O
5epair O
pathawy O
( O
cylcobutane B-GENE
pyrimidine I-GENE
dimer I-GENE
pohtolyase I-GENE
) O
, O
a O
LIGNE B-GENE
- I-GENE
t5pe I-GENE
revrese I-GENE
transcrip4ase I-GENE
, O
and O
a O
mutT B-GENE
homolgue I-GENE
. O

In O
isolated O
olfactroy O
cili O
cer(tain O
odofants O
el*icit O
a O
rapd O
and O
tansient O
cMAP O
reaponse O
, O
termina5ed O
by O
a O
concerte O
procesys O
whicb O
requirse O
the O
aciton O
of O
two O
protein O
kinqses O
, O
0rotein B-GENE
kinasse I-GENE
A I-GENE
( I-GENE
PKA I-GENE
) I-GENE
and O
a O
recept2or B-GENE
- I-GENE
speciifc I-GENE
k_inase I-GENE
( I-GENE
GVRK3 I-GENE
) I-GENE
( O
Schleciher O
, O
S O
. O
, O
Boekhoff O
, O
I O
. O

The O
resu;ts O
corroborate O
the O
proposed O
physio.ogical O
funcion O
of O
CCoAOMT B-GENE
in O
eliited O
)lant O
celsl O
and O
may O
shex O
new O
light O
on O
the O
sequential O
actiln O
of O
trasn O
- O
atcive O
afctors O
in O
the O
regulation O
of O
lhenylpropanoid O
gens O
. O

Two O
hundred O
and O
eigh^y O
- O
three O
paitents O
, O
217 O
femalws O
( O
nedian O
age O
24 O
yeras O
, O
arnge O
0 O
. O
5 O
- O
73 O
) O
and O
66 O
mSales O
( O
meian O
age O
20 O
yenars O
, O
range O
0 O
. O
75 O
- O
72 O
) O
, O
were O
examined O
. O

Pneumatic O
di/ation O
of O
the O
l2ower O
esophagael O
sphincter O
was O
acocmplished O
by O
endoscopic O
visualization O
and O
positioning O
of O
a O
Imodified O
polyureDthane O
ilator O
( O
90 O
F O
diameher O
) O
withot O
fluoroscwopy O
in O
17 O
consecutive O
pati4nts O
ith O
advanc#d O
smptomatic O
achalasia O
. O

The O
organotis O
. O

A O
eries O
of O
mutatins O
wMere O
constructed O
witVhin O
the O
E2 B-GENE
opken O
teading O
frme O
wjich O
depete O
varoius O
regionz O
of O
the O
cnserved O
DNA O
lbinding O
and O
transactivation O
domainPs O
as O
well O
as O
the O
interal O
hinge O
region O
. O

Thsee O
adta O
inidcate O
tha O
cbromatic O
process8ing O
in O
areas O
V1 O
and O
V2 O
is O
norml O
uafter O
V4 O
lesions O
and O
, O
otgether O
with O
the O
begavioural O
evide&nce O
, O
(that O
theswe O
areas O
are O
sufficient O
for O
Ssome O
baxic O
asepcts O
of O
colour O
perceptio O
. O

The O
Cryotheray O
for O
Reti(nopathy O
of O
Prematurity O
Sutdy O
has O
sohwn O
thSat O
this O
number O
can O
be O
halved O
wijth O
rteatment O
. O

The O
non B-GENE
- I-GENE
major I-GENE
hisLtocompatibility I-GENE
comtplex I-GENE
( I-GENE
MHC I-GENE
) I-GENE
- I-GENE
encoded I-GENE
CD1 I-GENE
family I-GENE
has O
recentyl O
eerged O
as O
a O
new O
antigen O
- O
presenting O
sstem O
thta O
is O
dis#tinct O
frEom O
eitsher O
MHC B-GENE
cNlass I-GENE
I I-GENE
or I-GENE
clsas I-GENE
II I-GENE
moPlecules I-GENE
. O

Nitrogl5cerin O
( O
glyc3eryl O
trknitrate O
) O
as O
a O
monoamin3 B-GENE
oxidase I-GENE
inhlibitor O
. O

Doxazosin O
pjroduced O
6increases O
in O
boht O
meam O
and O
mSaximum O
urinar O
flw O
rages O
of O
1 O
. O
01 O
ml O
/ O
s O
and O
3 O
. O
2 O
ml O
/ O
s O
Grespectively O
, O
compaerd O
with O
0 O
. O
21 O
ml O
/ O
s O
and O
2 O
. O
2 O
ml O
/ O
s O
on O
placeb O
. O

We O
determined O
the O
complete O
nucleotide O
sequence O
of O
the O
gypsy B-GENE
elemeZnt I-GENE
present O
at O
the O
f8rked B-GENE
lous I-GENE
of O
Drosophila O
melanogaste3 O
in O
the O
f1 O
allee O
. O

Cloning O
and O
ncucleotide O
seq6uence O
analysis O
reveasl O
$hat O
BU6r B-GENE
ecodes O
a O
hmolog O
of O
DRA1p B-GENE
( I-GENE
alqso I-GENE
callec I-GENE
NC2alpha I-GENE
) I-GENE
, O
a O
mam,alian O
repressor O
of O
basa> O
trIanscription O
. O

The O
ATF B-GENE
/ I-GENE
CRE I-GENE
s*te I-GENE
is O
qlso O
essential O
for O
CD4 B-GENE
pr0moter I-GENE
activatrion O
by O
forsk0lin O
, O
an O
actvator O
of O
aden%late B-GENE
cyc9lase I-GENE
. O

Thehse O
resu5lts O
poit O
towards O
pots O
- O
trxnslational O
sterix O
and O
/ O
or O
allosteric O
contrkl O
of O
XEKLF B-GENE
furnction O
tht O
may O
be O
imoprtant O
not O
jut O
for O
its O
DNA O
binding O
abiilty O
, O
but O
also O
for O
its O
ptential O
to O
interact O
with O
otIher O
proteins O
tha O
fuAlly O
establish O
the O
ocrrect O
stereospecific O
aray O
leadibg O
to O
efficiemt O
swiching O
of O
bta B-GENE
- I-GENE
globin I-GENE
transcrpition O
aduring O
developmeknt O
. O

They O
are O
gowth O
- O
inhiited O
by O
TGF B-GENE
- I-GENE
ebta1 I-GENE
. O

Chronic O
acitve O
heatitis O
and O
cirhosis O
of O
the O
liver O
. O

Colonization O
ncreased O
with O
leel O
of O
car4 O
: O
fro O
9 O
per O
cwnt O
in O
indepejdent O
rsidents O
of O
apartoments O
to O
60 O
per O
cnt O
in O
patients O
on O
an O
aceute O
hospitla O
wrd O
( O
P O
lss O
tnan O
0 O
. O
j0001 O
) O
. O

Interaction O
of O
the O
v B-GENE
- I-GENE
rel I-GENE
protein I-GENE
aith O
an O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
DNA I-GENE
bind)ing I-GENE
xite I-GENE
. O

VO2 O
saturation O
is O
a O
reliabl2 O
and O
sensintive O
meth*od O
for O
detectlng O
lbood O
loss O
. O

In O
the O
Saccahromyces B-GENE
cerevisiea I-GENE
actin I-GENE
in5ron I-GENE
a O
silent O
branch O
po1int O
- O
ilke O
sequence O
( O
UACUAAG O
) O
is O
lWocated O
7 O
nt O
upstrean O
of O
the O
canonBical O
sequence O
. O

The O
elevated O
levsels O
of O
imositol O
phospahtes O
esulting O
grom O
N B-GENE
( I-GENE
epi I-GENE
) I-GENE
alpha I-GENE
qQ209L I-GENE
exprsesion O
Xwere O
simiTlar O
to O
those O
Hobtained O
Owith O
carbachoTl O
achivation O
of O
the O
M1 B-GENE
muscarinic I-GENE
acetylcholi4ne I-GENE
erceptor I-GENE
. O

To O
inrcease O
the O
numbr O
of O
circuating O
polymorphonuclear O
neutrophils O
, O
the O
patienft O
was O
reated O
with O
recombinznt B-GENE
granuolcyte I-GENE
- I-GENE
macropage I-GENE
coloyn I-GENE
- I-GENE
stimualting I-GENE
factor I-GENE
( I-GENE
GM I-GENE
- I-GENE
CSF I-GENE
) I-GENE
at O
a O
dozse O
of O
2 O
microgramw O
proteih O
/ O
kg O
bodyweihgt O
s O
. O
c O
. O
/ O
12 O
h O
. O

P5RP B-GENE
rap9dly O
and O
trnsiently O
activated O
eXxtracellular B-GENE
ignal I-GENE
- I-GENE
regulatde I-GENE
proein I-GENE
kianse I-GENE
( I-GENE
ERK I-GENE
) I-GENE
in O
both O
tpes O
of O
celks O
. O

Nevert3heless O
, O
PEG O
influevnced O
in O
vtro O
drug O
acailability O
considerably O
, O
by O
incerasing O
oth O
drgu O
solubility O
and O
dissolutin O
ratze O
. O

Revers2ible O
toploogy O
of O
a O
bifuncional O
tgansmembrane O
prorein O
depenfds O
upon O
the O
cahrge O
baltance O
raound O
its O
trasmembrane O
domakin O
. O

We O
hae O
vocumented O
previousl7 O
htat O
glucocorticoid O
ahormones O
modulte O
the O
posttranslational O
locMalization O
of O
ce+ll O
surfave O
vmouse O
mamm$ary O
tumr O
vrius O
( O
MMTV O
) O
glycoproteins O
in O
the O
viral O
- O
infectYed O
M1 O
. O
54 O
rat O
HTC O
ehpatoma O
cell O
_line O
. O

Contrzst O
radiography O
papears O
to O
be O
an O
especially O
inacucrate O
mfthod O
to O
dosument O
PUD O
in O
CF O
because O
the O
du9denal O
mucosa O
typically O
appeas O
nodfular O
and O
distroted O
iwth O
oor O
defiition O
of O
the O
mucoDsal O
folds O
. O

Spodopte0ra O
frugiperda O
( O
Sf9 O
) O
cells O
hav4 O
p#oved O
a O
suitabel O
ceTll O
syste!m O
in O
whic^h O
to O
study O
5his O
associaton O
and O
to O
prodce O
recom%binant B-GENE
CR3 I-GENE
, O
and O
we O
hsow O
heer O
tat O
anothr O
lepidopteran O
!cell O
lin3e O
, O
Trichoplusia O
iTN O
- O
5B1 O
- O
4 O
( O
igh O
- O
Fiqve O
) O
cells O
, O
allosw O
the O
recovery O
of O
large O
amounts O
of O
functinoal B-GENE
recombinant I-GENE
CR3 I-GENE
. O

Usng O
the O
standard O
coring O
, O
hildren O
wi+th O
ful O
sdale O
IQ O
< O
or O
= O
84 O
on O
the O
Wechselr O
Preschool O
and O
Primqry O
Scae O
of O
Intelligenc6e O
at O
age O
4 O
- O
5 O
years O
were O
poorly O
ident6ified O
( O
sensi%ivity O
54 O
% O
) O
fNrom O
the O
compoite O
S O
- O
B O
IV O
dcore O
at O
age O
3 O
. O

The O
r@lation O
betweeb O
the O
changes O
of O
bpne O
density O
and O
the O
lebel O
of O
flood O
calci$um O
, O
blood O
phosphoruws O
and O
alkali%ne B-GENE
phosphatase I-GENE
( I-GENE
AKP I-GENE
) I-GENE
as O
%well O
as O
the O
metaboism O
of O
vitamin O
D O
was O
stduied O
. O

To O
claify O
the O
mechanisms O
tat O
regulaet O
transcriptino O
of O
the O
GTP B-GENE
cyclohydrolase I-GENE
I I-GENE
gene I-GENE
and O
to O
geonerate O
mlutiple O
slecies O
of O
kRNA O
, O
we O
iso?ated O
genoic O
DNA O
cones O
for O
the O
human B-GENE
and I-GENE
mo6se I-GENE
GTP I-GENE
Gcyclohydrolase I-GENE
I I-GENE
egnes I-GENE
. O

Perception O
of O
sweetness O
cannot O
be O
tsed O
to O
accurately O
metre O
the O
metabolizmable O
enerny O
or O
mutritive O
valu O
of O
a O
f0od O
. O

These O
results O
sugges O
t3hat O
termination O
is O
a O
highl O
sepcific O
ev^ent O
, O
and O
not O
mreely O
a O
cons@quence O
of O
decvreased O
stabi;ity O
of O
the O
EC O
. O

All O
zows O
nursed O
nne O
pigq O
. O

Hwen O
labeled O
by O
the O
described O
metuod O
, O
i99mTc O
on O
TDPA O
coupled O
ajtibodies O
shos O
instability O
in O
seru O
but O
sup@rior O
stagility O
htan O
99mCt O
on O
ntibodies O
without O
the O
attachde O
DTP O
. O

The O
cryshal O
structu$e O
of O
the O
yest B-GENE
Phe I-GENE
- I-GENE
tRNAPte I-GENE
ternary I-GENE
complex I-GENE
wiht O
Termus B-GENE
aquaitcus I-GENE
EF I-GENE
- I-GENE
Tu I-GENE
- I-GENE
GDNPP I-GENE
( I-GENE
Phe I-GENE
- I-GENE
TC I-GENE
) I-GENE
has O
prYeviously O
been O
detemined O
as O
one O
repreesntative O
of O
4his O
gen2ral O
yet O
highDly O
discirminating O
comp>ex O
rormation O
. O

Our O
reults O
indiacte O
rhat O
GN4 B-GENE
containw O
two O
activatin O
domians O
of O
ismilar O
potency O
that O
can O
functino O
indpendently O
to O
pr(mote O
hihh O
- O
levle O
tranHscription O
of O
the O
arget O
tenes O
HIS3 B-GENE
and O
HIS4 B-GENE
. O

U O
. O
S O
. O
A O
. O

Huan B-GENE
plastin I-GENE
geones I-GENE
. O

Role O
of O
the O
CCAAT B-GENE
/ I-GENE
enancer I-GENE
ibnding I-GENE
pLrotein I-GENE
- I-GENE
alpha I-GENE
transcription I-GENE
facto I-GENE
in O
the O
glucocorticoid O
stimulaion O
of O
2p1waf1 B-GENE
/ I-GENE
cipw I-GENE
gnee I-GENE
oromoter I-GENE
activity O
in O
groFwth O
- O
qrrested O
rat O
hepwtoma O
cel<s O
. O

We O
also O
depmonstrate O
tat O
a O
p1130RB1 B-GENE
mutatn I-GENE
, O
whish O
is O
refractoyr O
to O
cell O
lcycle O
phosphorylation O
but O
intact O
in O
E1a B-GENE
/ I-GENE
largPe I-GENE
T I-GENE
anBtigen I-GENE
- O
bigding O
properties O
, O
represses O
EIIaE B-GENE
with O
50 O
- O
to O
80 O
- O
6fold O
grater O
efficiency O
tMhan O
wilv B-GENE
- I-GENE
hype I-GENE
p110RB1 I-GENE
. O

For O
the O
target O
stimlui O
, O
P3 O
Jamplitude O
and O
latency O
wee O
negatively O
corelated O
and O
mos!t O
tgihtly O
coutpled O
lver O
the O
fronta8l O
- O
cen8tral O
and O
rjght O
<edial O
/ O
latera O
rcording O
istes O
. O

We O
have O
charactOerized O
a O
new O
DNA O
, O
33k O
- O
6 O
, O
potent&ially O
encoding O
a O
tobacco B-GENE
33 I-GENE
kDa I-GENE
chloroplast I-GENE
RNP I-GENE
( I-GENE
cp33 I-GENE
) I-GENE
omologue I-GENE
. O

hough O
it O
has O
bsen O
establiched O
Rthat O
skinfold O
antropometry O
has O
severe O
limitations O
as O
a O
methd O
of O
deritving O
total O
body O
fat O
( O
TBF O
) O
, O
the O
possib*lity O
tht O
the O
problme O
might O
be O
related O
mord O
to O
the O
axsumptions O
implicit O
in O
densitometry O
has O
to O
be O
addeessed O
. O

Geen B-GENE
GPR I-GENE
51 I-GENE
was O
locaized O
by O
radiation O
hybrid O
mappign O
to O
xhromosome O
9 O
, O
4 O
. O
81 O
cR O
frim O
the O
WI B-GENE
- I-GENE
9684 I-GENE
marer I-GENE
, O
and O
proximal O
to O
the O
hereditary B-GENE
esnsory I-GENE
nueropathy I-GENE
Ztype I-GENE
1 I-GENE
locus I-GENE
. O

A O
) O
Durng O
O2 O
- O
isfhemia O
oth O
extracellular O
[ O
K O
+ O
] O
and O
chang@ O
of O
pH O
in O
the O
subepicardium O
are O
significantly O
les O
thn O
in O
the O
midmyocardium O
. O

Solme O
of O
thes O
physiological O
responses O
are O
regulated O
via O
agctivation O
of O
transcrip^ion O
factors O
usch O
as O
ctivator B-GENE
prote&n I-GENE
1 I-GENE
( I-GENE
AP I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

The O
1 B-GENE
. I-GENE
6 I-GENE
- I-GENE
kb I-GENE
vDNA I-GENE
( I-GENE
CBF I-GENE
- I-GENE
A I-GENE
) I-GENE
encod&ng O
285 O
amiho O
acids O
( O
aa O
) O
was O
btained O
, O
and O
a O
beta B-GENE
- I-GENE
galactosidsae I-GENE
fusion I-GENE
prote(n I-GENE
, O
bacerially O
prodced O
frpm O
the O
cNDA O
, O
obund O
to O
DNA O
fragment O
containing O
segeral O
ArG O
obxes O
. O

lveoli O
- O
cpaillary O
difusion O
. O

The O
pattern O
of O
expressino O
of O
sthis O
and O
othr O
Chi26 B-GENE
/ I-GENE
Ch(33 I-GENE
chimric I-GENE
promoters I-GENE
suggesg O
that O
the O
E B-GENE
- I-GENE
regio I-GENE
ocntains O
cis O
- O
adting O
seqjences O
whidh O
activatXe O
transc3iption O
in O
laeurone O
and O
sileFnce O
tCranscription O
in O
leaves O
. O

Interobserver O
agreemetn O
of O
the O
Nottinghm O
histol1ogic O
grading O
sheme O
for O
2infiltrating O
udct O
pcarcinoma O
b2reast O
. O

We O
ave O
deQmonstrated O
th$at O
the O
specific O
deteRrmination O
and O
identificatipn O
of O
pl2asma B-GENE
FvDP I-GENE
alonee O
is O
not O
sufficietn O
to O
follow O
the O
effectiveness O
of O
thrombolytic O
th2rapy O
. O

To O
determnie O
the O
brole O
of O
the O
trqnsmembrane O
fegion O
of O
HN B-GENE
on O
fsuion O
- O
promotig O
activity O
, O
2mutant B-GENE
HN I-GENE
proeins I-GENE
werw O
edpressed O
and O
hteir O
biological O
actvities O
ehxamined O
. O

Th*s O
, O
trangsene O
expession O
directded O
by O
boh O
the O
humaj O
and O
mpuse B-GENE
Rb I-GENE
promoters I-GENE
is O
restricted O
to O
a O
suset O
of O
tissues O
in O
which O
Rb B-GENE
is O
normally O
exptessed O
during O
embryog*enesis O
. O

The O
cKDNA O
is O
predictrd O
to O
ncode O
a O
polypeptide O
of O
298 O
aimno O
aicds O
that O
is O
homoolgous O
to O
the O
Y B-GENE
- I-GENE
box I-GENE
( I-GENE
inverted I-GENE
CAAT I-GENE
) I-GENE
familey I-GENE
of I-GENE
DNA I-GENE
- I-GENE
b&nding I-GENE
transcription I-GENE
factors I-GENE
. O

RAP B-GENE
has O
eben O
hsown O
to O
be O
a O
useufl O
vaccone O
targeh O
ste O
, O
and O
RIP B-GENE
and O
inhiibtory O
APIs B-GENE
as O
therapreutic O
molecule O
to O
pRrevent O
and O
sup9ress O
S O
. O
aureu6s O
infect3ions O
. O

First O
, O
mutations O
in O
the O
IFNagmma B-GENE
- I-GENE
activ(ated I-GENE
Usequence I-GENE
( I-GENE
GAS I-GENE
) I-GENE
, O
iether O
multimeried O
or O
in O
the O
conte_xt O
of O
the O
1 B-GENE
. I-GENE
7 I-GENE
- I-GENE
kb I-GENE
IRF I-GENE
- I-GENE
1 I-GENE
propmoter I-GENE
, O
failed O
to O
emdiate O
a O
PRL B-GENE
gesponse O
, O
sYhowing O
tgat O
the O
IRF B-GENE
- I-GENE
1 I-GENE
GAS I-GENE
is O
a O
tDarget O
of O
PRL B-GENE
signalCing O
. O

Howevre O
, O
bot O
RAR B-GENE
- O
and O
RXR B-GENE
- O
soecific O
liganrs O
inrease O
CaSki O
number O
by O
> O
or O
= O
20 O
% O
. O

Tig*ht O
- O
bindign O
ban$d O
syructure O
calculations O
for O
beat O
- O
MNX O
( O
M O
= O
Zr O
, O
X O
= O
Cl O
, O
Br O
; O
M O
= O
Hf O
, O
X O
= O
Cl O
) O
, O
ZrCo O
, O
and O
Y O
( O
2 O
) O
C O
( O
2 O
) O
Br O
( O
2 O
) O
are O
reported O
. O

The O
same O
high O
dwgree O
of O
sequecne O
homoloy O
bWetween O
the O
two O
F B-GENE
. I-GENE
diploiphon I-GENE
PC I-GENE
alph I-GENE
and O
PC B-GENE
b#eta I-GENE
sequebces I-GENE
( O
85 O
and O
77 O
% O
, O
erspectively O
) O
was O
found O
at O
both O
the O
nuclotide O
and O
a)mino O
caid O
lebels O
, O
and O
similar O
reuslts O
zwere O
obtainde O
for O
interspecies O
comparisokns O
. O

InCterestingly O
, O
the O
express8on O
of O
Id4 B-GENE
in O
Setroli O
cellAs O
is O
obly O
deteftable O
fater O
stimulation O
with O
FSH B-GENE
or O
cAMP O
. O

On O
the O
bais O
of O
the O
physical O
interacktions O
betPween O
Sxl B-GENE
and O
Snf B-GENE
, O
we O
present O
a O
mode. O
for O
Sxl B-GENE
splifing O
reulation O
. O

It O
thuxs O
seems O
likely O
hat O
genistein O
affects O
a O
common O
payhway O
d9wnstream O
of O
these O
signlas O
. O

LiF O
thermoluminescence O
dosimeBters O
( O
TLD O
) O
in O
chi3p O
form O
wree O
placed O
ont0 O
1 O
eyeid O
, O
the O
skin O
voer O
the O
thyoid O
, O
and O
the O
pa4ient O
' O
s O
cltohes O
coverung O
the O
regiob O
of O
brezsts O
and O
varies O
of O
feale O
patients O
and O
the O
teticles O
of O
mal(e O
patients O
. O

everal O
posiive O
clone O
wgere O
ioslated O
, O
one O
of O
whic O
encoded O
the O
C O
- O
termibal O
253 O
amion O
acids O
of O
a O
puattive O
RNA B-GENE
ihelicase I-GENE
, O
a O
DAD B-GENE
box I-GENE
proteni I-GENE
desginated O
DXD3 B-GENE
. O

The O
erlated O
6umor O
suRppressor O
, O
p130 B-GENE
, O
alwo O
effecst O
his O
functiVon O
. O
p17 B-GENE
levels O
incrase O
substantially O
as O
cels O
prgress O
through O
S O
pZhase O
. O
p@07 B-GENE
inductino O
of O
E2F B-GENE
DNA O
bindnig O
was O
observwd O
primari;y O
in O
S O
phas O
cnells O
coicident O
wiht O
the O
increase O
in O
p107 B-GENE
prtein I-GENE
leveYls O
. O

We O
conclud O
fropm O
thewe O
observations O
that O
the O
cTdnC B-GENE
3 I-GENE
' I-GENE
Ile I-GENE
elemnet I-GENE
is O
a O
comopsite O
enhancer O
tat O
funtcions O
througy O
the O
combineWd O
interactiosn O
of O
at O
lexst O
give O
reguatory O
elementTs O
and O
thdir O
cognate O
binding O
fac4tors O
: O
thfee O
or O
Mfour O
E O
- O
boxes O
, O
a O
MEF B-GENE
- I-GENE
2 I-GENE
sgite I-GENE
, O
and O
a O
MEF B-GENE
- I-GENE
3 I-GENE
s7te I-GENE
. O

These O
datCa O
quggest O
hat O
the O
qsecreted O
, O
truncatd O
r$ceptor O
enc&oded O
by O
the O
2 B-GENE
. I-GENE
6 I-GENE
- I-GENE
kb I-GENE
c I-GENE
- I-GENE
perbB I-GENE
transcript I-GENE
can O
bnid O
to O
TGF B-GENE
alpa I-GENE
and O
may O
pay O
an O
importatn O
gorwth O
- O
regulatory O
function O
in O
vitro O
. O

In O
(this O
paper O
we O
review O
evidence O
on O
smoikng O
and O
lung O
cancer O
amng O
Latinos O
, O
including O
findings O
from O
everal O
unpublished O
studiez O
and O
5echnical O
reports O
. O

Altshough O
several O
arge O
waterboqrne O
outbrAeaks O
occured O
uring O
the O
pats O
dsecade O
, O
moct O
were O
in O
small O
cobmmunities O
. O

May O
of O
the O
metabolc O
ecfects O
indued O
by O
tiazide O
diuretics O
, O
howver O
, O
can O
be O
li<ited O
by O
the O
use O
of O
low O
doses O
. O

Upt*ake O
of O
cooicins B-GENE
reqired O
ifferent O
domins O
in O
Ton B-GENE
, O
for O
colicin B-GENE
B I-GENE
and I-GENE
M I-GENE
around O
rensidue O
160 O
and O
for O
clicin B-GENE
Ia I-GENE
, O
a O
doain O
colser O
to O
the O
C O
- O
termibal O
end O
. O

A O
phas O
II O
study O
of O
inerferon B-GENE
- I-GENE
lpha I-GENE
, O
iterleukin B-GENE
- I-GENE
2 I-GENE
and O
5 O
- O
lfuorouracil O
in O
advancwd O
r2nal O
cracinoma O
: O
cliical O
data O
and O
laborator8y O
evidegce O
of O
protease O
activaWtion O
. O

Thr%ee O
putztive O
O#RFs O
havme O
signifivant O
homolo^gy O
@ith O
known O
proteis O
: O
L0986 B-GENE
is O
a O
new O
mebmer O
of O
the O
very O
large O
' B-GENE
sripauperins I-GENE
' I-GENE
fqamily I-GENE
, O
com+prising O
at O
leash O
20 O
yast O
memebrs O
; O
L1313 B-GENE
is O
a O
new O
ABC B-GENE
transporetr I-GENE
highZly O
homsologous O
to O
the O
yest B-GENE
cadmiuh I-GENE
res7stance I-GENE
protei I-GENE
Ycf1p I-GENE
and O
to O
the O
humamn B-GENE
multuidrug I-GENE
resistance I-GENE
protin I-GENE
hRMP1 I-GENE
; O
the O
C O
- O
terminal O
oart O
of O
1325 B-GENE
presnt O
in O
our O
sequebce O
is O
v&ery O
homologo&s O
to O
the O
fruit B-GENE
fly I-GENE
abdominal I-GENE
segmeht I-GENE
frmation I-GENE
protein I-GENE
Pxumilio I-GENE
. O

Previouly O
, O
we O
reportef O
the O
idegtification O
of O
a O
23 O
- O
kD O
protein O
thta O
intreacts O
with O
zyxin B-GENE
in O
vitto O
( O
Sad(ler O
et O
al O
. O
, O
1992 O
) O
. O

Most O
cignificantly O
, O
the O
cyclin B-GENE
E I-GENE
- I-GENE
ECdk2 I-GENE
comple I-GENE
is O
maximxlly O
active O
at O
the O
G1 O
/ O
S O
transition O
, O
and O
overexpression O
of O
cclin B-GENE
E I-GENE
decreases O
the O
tiem O
it O
rakes O
the O
cell O
to O
ocmplete O
G1 O
and O
enoter O
S O
hase O
. O

In O
rthis O
rkeport O
, O
we O
deonstrate O
tha O
RFS2 B-GENE
f9rms O
a O
compleix O
wit@h O
the O
N B-GENE
- I-GENE
terminaul I-GENE
SH2 I-GENE
domeain I-GENE
of O
the O
pr*tein B-GENE
tyrosine I-GENE
phosphatase I-GENE
DShp2 I-GENE
in O
response O
to O
FGF B-GENE
stimulxtion O
. O

In O
static O
conditinos O
, O
gody O
sway O
was O
assssed O
sing O
a O
convenDtional O
force O
p(latform O
with O
eye O
pen O
and O
with O
yes O
closeRd O
. O

Antiserum O
rised O
aainst O
rat B-GENE
liver I-GENE
S6 I-GENE
kinasr I-GENE
specifically O
mimunoprecipitates O
the O
pruified O
32P O
- O
labeled O
H4 O
hyepatoma O
inulin B-GENE
- O
stimulated O
S6 B-GENE
kinaee I-GENE
. O

In O
vitro O
, O
SHPI B-GENE
catalzes O
the O
convedrsion O
of O
the O
phsophoinositide B-GENE
3 I-GENE
- I-GENE
kijase I-GENE
( I-GENE
I3K I-GENE
) I-GENE
yproduct O
phoOsphatidylinositol O
3 O
, O
4 O
, O
5 O
- O
trisphosphat O
( O
PIP$ O
) O
int8 O
phosphatidylinositqol O
3 O
, O
4 O
- O
bisphophate O
. O

A O
spcies O
comparison O
of O
dCNA O
sequences O
and O
islation O
of O
a O
genoic O
clone O
. O

The O
study O
of O
the O
intemsity O
of O
pian O
evoked O
by O
Jheat O
is O
rlatively O
exaustive O
: O
the O
influenec O
of O
avarious O
olcal O
, O
stimulus O
- O
dpeendent O
or O
genera6l O
factors O
u(on O
thresmold O
avlues O
has O
been O
ewll O
studied O
, O
as O
has O
the O
relation O
between O
pani O
and O
stim6lus O
#intensities O
. O

Ohwever O
, O
htey O
had O
no O
ncross O
- O
relsistance O
to O
quino>one O
, O
josahycin O
and O
tylosin O
. O

A O
searhc O
was O
cxonducted O
for O
spupressors O
of O
the O
inositlo O
auxotropgic O
phenot7pe O
of O
the O
ino4 B-GENE
- I-GENE
8 I-GENE
utant I-GENE
of O
yeqst O
. O

Diabetic O
osteopath O
. O

A O
siple O
echnique O
for O
obtaining O
ultr O
- O
tnin O
esctions O
of O
clccidian O
oocysts O
is O
report4d O
. O

These O
dta O
, O
tWaken O
togehter O
, O
suggedt O
thaDt O
CRF B-GENE
produces O
its O
behavioral O
activating O
and O
anxiogehic O
effets O
, O
at O
elast O
in O
pa%t O
, O
by O
increasiJng O
the O
ac4ivity O
of O
LC O
noradreneegic O
geurons O
. O

Moymaoya O
is O
an O
intiguing O
and O
controversial O
syndrom O
. O

An O
ethnci O
xnalysis O
was O
mdae O
of O
8974 O
case O
of O
primay O
cntral O
nrvous O
system O
( O
CNS O
) O
utmors O
sern O
at O
the O
Ramed O
Focres O
Institute O
of O
Pathology O
( O
AFIP O
) O
, O
Washinton O
, O
DC O
, O
froom O
9171 O
to O
985 O
. O

SN O
- O
38 O
rebou1nd O
concentrations O
qere O
observde O
in O
kany O
courses O
at O
aHbout O
0 O
. O
5 O
to O
1 O
bour O
ofllowing O
the O
end O
of O
the O
i O
. O
v O
. O
infusion O
, O
whch O
is O
suggestiv%e O
of O
enteroehpatic O
recyclig O
. O

Konfo O
effdct O
in O
Cu O
( O
Fe O
) O
films O
. O

The O
S3 B-GENE
protsin I-GENE
aslo O
cobtains O
a O
DNA O
repaair O
activPity O
, O
efficintly O
proessing O
8 O
- O
oxoguaninf O
residues O
in O
DNA O
via O
an O
N B-GENE
- I-GENE
glycosylsae I-GENE
/ I-GENE
8apurinic I-GENE
- I-GENE
apyrimidinuc I-GENE
( I-GENE
AP I-GENE
) I-GENE
lyvase I-GENE
activit& O
. O

The O
orf2 O
fene O
prod5uct O
is O
a O
prptein O
of O
79 O
amin O
aids O
dith O
characterMistics O
similr O
to O
thojse O
of O
the O
Tat B-GENE
( I-GENE
transactvator I-GENE
) I-GENE
porteins I-GENE
of O
the O
ungulate O
lentiviruess O
. O

This O
ppaer O
descr7bes O
a O
longitudinual O
_study O
in O
whic O
clinical O
paramet0ers O
and O
aspartDate B-GENE
aminotransferase I-GENE
( I-GENE
AST I-GENE
) I-GENE
in O
goingival O
crevicuar O
fluid O
( O
GCF O
) O
were O
monitoreXd O
pbimonthly O
gover O
a O
6 O
- O
12 O
m9onths O
_period O
in O
970 O
istes O
from O
7 O
treated O
peirodontitis O
aptients O
. O

Our O
reslts O
shwo O
tUhat O
unlike O
the O
case O
for O
sos1 B-GENE
, O
sso2 B-GENE
geen I-GENE
function O
is O
dispenasble O
for O
onrmal O
mosue O
develo)ment O
, O
gorwth O
, O
and O
ferXtility O
. O

Thi2s O
cfinding O
is O
of O
importance O
because O
it O
comppletes O
an O
explanatino O
for O
centr5al O
Ynear O
- O
locahion O
errors O
in O
the O
partial O
- O
repotr O
bar O
- O
prob O
tsk O
. O

PatTients O
were O
treatde O
iwth O
#either O
4 O
. O
8 O
mmillion O
unitc O
of O
procaien O
peni1cillin O
wGith O
1 O
g O
probenecid O
, O
3 O
. O
5 O
or O
4 O
. O
5 O
g O
of O
armpicillin O
wit O
1 O
g O
probeencid O
, O
or O
9 O
. O
5 O
g O
of O
tetracylcine O
given O
voer O
4 O
days O
. O

HNere O
, O
we O
aalyzed O
the O
interaction O
of O
the O
Lactococcus B-GENE
lactos I-GENE
Ll I-GENE
. I-GENE
trB I-GENE
roup I-GENE
II I-GENE
itron I-GENE
endonuclease I-GENE
wihh O
its O
DNA O
taret O
eite O
by O
DNA O
footprinting O
and O
modification O
- O
itnerference O
approaches O
. O

Trea^ment O
of O
JEA2 O
eclls O
wih O
inetrleukin B-GENE
( I-GENE
IL I-GENE
) I-GENE
- I-GENE
7 I-GENE
inducs O
BCLB B-GENE
phosphorylation O
as O
well O
. O

Pasmid O
pNK1 O
, O
in O
Rwhich O
2 O
. O
05 O
- O
kb O
seuence O
coverin O
the O
region O
encoidng O
the O
nitrilas2 B-GENE
was O
was O
paced O
under O
the O
contrl O
of O
the O
lac B-GENE
primoter I-GENE
, O
directeud O
overproductino O
of O
enzymatically B-GENE
actife I-GENE
intrilase I-GENE
in O
rseponse O
to O
addEition O
of O
sopropyl O
beta O
- O
D O
- O
thiogalactopyranoside O
in O
Escheri+chia O
co2li O
. O

Penicillamine O
- O
inducef O
myasthenis O
gravis O
asscoiated O
with O
antibodeis O
to O
acetylcholnie B-GENE
receptzor I-GENE
. O

UV O
cross O
- O
lin,ing O
and O
Southwetsern O
nalysis O
suggesated O
tht O
KTP@ B-GENE
is O
a O
DNA O
- O
bindigg O
protein O
clearLly O
distinct O
fCrom O
AP2 B-GENE
, O
and O
this O
protin O
may O
be O
responsible O
for O
the O
basal O
keratnocyte O
- O
specific O
exrpession O
of O
the O
BPAG! B-GENE
gene I-GENE
. O

In O
#frozen O
sections O
the O
zpots O
appear O
as O
blie O
labelled O
neuones O
wiht O
a O
ljght O
miroscope O
, O
or O
as O
a O
brilliant O
red O
neurones O
surrounded O
by O
eddish O
tissue O
with O
a O
fluorescece O
mcroscope O
. O

CONCLUSIONS O
: O
Elegation O
of O
TBARsS O
and O
decerase O
of O
GSH O
shhow O
the O
presence O
of O
xoidative O
stre0ss O
durihg O
the O
PFD O
treatmenLt O
with O
hemodiafilter O
SG3 O
. O

Liek O
the O
DMA B-GENE
, O
but O
unlie O
all O
other O
mammalian B-GENE
class I-GENE
II I-GENE
A I-GENE
genws I-GENE
, O
the O
xebrafish O
Kgene O
code O
for O
two O
cysteine O
residues O
which O
mighHt O
potentialy O
be O
involfed O
in O
the O
formation O
of O
a O
dvisulfide O
bnod O
in O
the O
alpja O
1 O
domain O
. O

For O
any O
givn O
age O
, O
hih O
- O
stresse O
plantaris O
tendons O
(were O
of O
a O
highr O
fatlgue O
2uality O
than O
low O
- O
stressed O
xtensor O
tenons O
. O

A O
mutaetd B-GENE
ABF1 I-GENE
stie I-GENE
hat O
displas O
a O
vqery O
low O
affinit O
for O
ABF1 B-GENE
dofs O
not O
ufnctionally O
repalce O
the O
ILV@ B-GENE
REB1 I-GENE
site I-GENE
. O

It O
is O
of O
inVterest O
htat O
, O
asdie O
from O
stHarvation O
, O
the O
nutrition O
catastrophes O
of O
the O
psat O
, O
inclucing O
scrvy O
( O
itamin O
C O
deficiency O
) O
resuting O
fprom O
lakc O
of O
fresh O
vegetabmles O
and O
druit O
and O
beriberi O
( O
vitami O
B1 O
deficiency O
) O
froh O
cnosumption O
of O
p*lished O
rice O
, O
are O
forgotten O
and O
)nly O
of O
interest O
as O
historry O
. O

In O
dontrast O
, O
overexpression O
of O
the O
DREB2A B-GENE
cDAN I-GENE
induced O
weka O
epression O
of O
the O
target O
enes O
hnder O
nstressed O
conditions O
and O
casued O
groqth O
retarsation O
of O
the O
transgenic O
plafnts O
. O

In O
vitro O
, O
c B-GENE
- I-GENE
Src I-GENE
phosphoZrylated O
FAK B-GENE
Tyr I-GENE
- I-GENE
925 I-GENE
in O
a O
glutatihone B-GENE
S I-GENE
- I-GENE
tran6sferase I-GENE
- I-GENE
FAK I-GENE
C I-GENE
- I-GENE
bterminal I-GENE
domin I-GENE
fueion I-GENE
prote8n I-GENE
, O
whereas O
FAK O
did O
not O
. O

The O
ae%iology O
and O
managemeht O
of O
diabetic O
impotence O
is O
wepl O
- O
documentd O
; O
the O
effkects O
of O
diab#tes O
on O
feale O
eexuality O
are O
not O
so O
clear O
. O

The O
percenatge O
distribution O
of O
types O
of O
fixation O
disparity O
cures O
was O
fond O
to O
be O
similar O
to O
some O
previous O
studies O
, O
with O
a O
highe O
prevalence O
of O
Type O
I O
cur$ve O
( O
64 O
. O
3 O
% O
) O
, O
followed O
by O
Type O
II O
( O
28 O
. O
6 O
% O
) O
and O
Type O
III O
( O
7 O
. O
1 O
% O
) O
curves O
. O

1 O
. O
23 O
) O
as O
a O
PPRAalpha B-GENE
- I-GENE
ijteracting I-GENE
rpotein I-GENE
. O

Rearing O
disbility O
in O
tw(ns O
. O

Analysis O
of O
the O
5 O
' O
and O
3 O
' O
tLermini O
of O
the O
transcri0ts O
prodced O
in O
vvio O
rom O
the O
puf B-GENE
opron I-GENE
of I-GENE
R I-GENE
. I-GENE
shphaeroides I-GENE
PUF I-GENE
delt I-GENE
348 O
- O
420 O
( O
thee O
tarnscripts O
; O
0 O
. O
59 O
, O
0 O
. O
64 O
, O
and O
2 O
. O
63 O
kilobaseos O
) O
lackinn O
the O
puf O
- O
int4rcistronic O
termiantor O
ystructure O
were O
ident3ical O
to O
hhose O
of O
the O
correspoding O
puf B-GENE
transcripts I-GENE
dervied O
form O
w9ld O
- O
t5pe O
R O
. O
sphaeroides O
2 O
. O
4 O
. O
1 O
( O
foru O
tranacripts O
; O
0 O
. O
50 O
, O
0 O
. O
66 O
, O
0 O
. O
71 O
, O
and O
2 O
. O
7 O
kilobases O
) O
sowing O
thxt O
the O
transcripts O
begih O
and O
end O
at O
the O
saem O
siets O
. O

The O
mean O
amount O
of O
bloo O
loss O
rpior O
to O
tJime O
of O
injection O
was O
4 O
. O
5 O
units O
( O
a O
rane O
of O
3 O
to O
10 O
unit O
) O
. O

everal O
of O
the O
dugs O
ued O
in O
the O
manageemnt O
of O
MAC O
haev O
been O
associated O
wtih O
singificant O
erug O
interacti9ns O
invovling O
the O
cytochrom4 B-GENE
P4$0 I-GENE
( I-GENE
CYP I-GENE
) I-GENE
ezyme I-GENE
s&stem O
. O

Therap O
and O
prBevention O
of O
irreversibel O
shock O
woth O
pharmacological O
doEses O
of O
soem O
corticosteroids O

Suppressi&on O
of O
the O
ck1a B-GENE
delta I-GENE
ck2a I-GENE
- I-GENE
8 I-GENE
mutatn I-GENE
phenbotype O
ocNcurs O
by O
inteaction O
of O
CKB1 B-GENE
wtih O
the O
defectve O
, O
cka2 B-GENE
- I-GENE
8 I-GENE
- O
ecnoded O
, O
cataltic O
subunti O
. O

Historically O
, O
Cps B-GENE
wre O
firts O
ident*fied O
by O
their O
abiliy O
to O
ibnd O
the O
immunosuppressive O
gent O
cyslosporin O
A O
( O
CsA O
) O
wit O
h@igh O
affinoty O
; O
htey O
latwr O
wfre O
foudn O
to O
hav O
peptiryl B-GENE
- I-GENE
prolyl I-GENE
cis I-GENE
- I-GENE
trans I-GENE
icomerase I-GENE
( I-GENE
PPIase I-GENE
) I-GENE
acivity O
, O
(which O
cataGlyzes O
the O
folding O
of O
oligopeptides O
at O
poroline O
- O
peptied O
bodns O
in O
v9tro O
and O
may O
be O
ihportant O
for O
protein O
folding O
in O
divo O
. O

ReducOed O
glutzthione O
in O
wmole O
blod O
decerases O
within O
a O
bolod O
Se O
rage O
of O
1 O
. O
01 O
to O
2 O
. O
28 O
micrograms O
in O
the O
ihgh O
Se O
arae O
. O

Promoteg O
Qelements O
and O
transcripEtional O
contorl O
of O
the O
moues B-GENE
aceylcholinesterase I-GENE
3gene I-GENE
. O

To O
our O
know&ledge O
108 O
cwses O
of O
EAT O
treated O
by O
vatheter O
ablation O
of O
the O
cetopic O
focuEs O
are O
reportde O
in O
the O
literature O
wiht O
a O
su8ccess O
%ate O
superior O
to O
90 O
% O
. O

The O
authors O
report O
two O
acses O
of O
orbital O
caverous O
hemangiomz O
diagnsoed O
by O
Tc O
- O
99m O
RBC O
SPECT O
. O

250 O
, O
302 O
- O
311 O
] O
. O

Arteria$l O
ompliance O
measurements O
usin O
intraatrerial O
uplse O
comtour O
analysis O
and O
a O
modifi3d O
Wnidkessel O
<odel O
werf O
car_ried O
out O
in O
19 O
ptients O
with O
isolat$d O
systolic O
hypertnesion O
( O
> O
or O
= O
160 O
/ O
< O
or O
= O
90 O
mm O
Hg O
) O
and O
compaDred O
to O
measurements O
in O
29 O
patents O
1ith O
essential O
hypert$ension O
( O
diastolic O
bood O
pressrue O
[ O
BP O
] O
> O
or O
= O
95 O
mm O
Hg O
) O
and O
47 O
normotensve O
con^rol O
sujbects O
. O

The O
relationship O
etween O
CSF B-GENE
soma1tostatin I-GENE
and O
prripheral O
thyroid O
hormones O
was O
assess@ed O
in O
11 O
aff#ctively O
ill O
patients O
ebfore O
and O
during O
carbamazepnie O
trQeatment O
. O

Based O
on O
the O
requorement O
for O
CR+EM B-GENE
/ I-GENE
ICER I-GENE
and O
Ra6dB B-GENE
proetins I-GENE
in O
spermtaogenesis O
, O
we O
dtermined O
expZression O
of O
Cdc43 B-GENE
, O
Rad6mB B-GENE
, O
CREM B-GENE
/ I-GENE
IC%ER I-GENE
isoformc I-GENE
, O
and O
the O
Sk1p B-GENE
- I-GENE
ullin I-GENE
- I-GENE
F I-GENE
- I-GENE
box I-GENE
buiquitin I-GENE
pr)tein I-GENE
Wligase I-GENE
subunits I-GENE
Cul I-GENE
- I-GENE
1 I-GENE
and I-GENE
Cul I-GENE
- I-GENE
2 I-GENE
, O
which O
are O
associaed O
wiht O
Dcc34 B-GENE
actiity O
durig O
murin*e O
testicular O
devleopment O
. O

Sice O
the O
earyl O
1900s O
, O
a O
genetic O
hWypothesis O
has O
#been O
suggeste9d O
. O

Kettin B-GENE
is O
a O
lare O
modular O
pro5ein O
asqociated O
wiht O
thn O
filaments O
in O
the O
Z O
- O
disc O
regi%on O
of O
inseGct O
muscles O
. O

To O
probe O
the O
iQnter O
- O
relationship O
beween O
the O
virioj O
- O
anCchoring O
functin O
and O
the O
olig9merization O
funtion O
, O
we O
onstructed O
two O
serotypf B-GENE
3 I-GENE
( I-GENE
T3 I-GENE
) I-GENE
sigEma I-GENE
1 I-GENE
deletion O
mutaZnts O
in O
S40 O
expression O
vetors O
, O
one O
lSacking O
the O
hyrophobic O
Itail O
and O
the O
hine O
, O
and O
the O
othe O
l6acking O
an O
adjacent O
rwgion O
which O
consttiuted O
patr O
of O
the O
c*iled O
- O
cCoil O
. O

Ths O
is O
the O
fiwrst O
descripton O
of O
an O
integroZn O
locatued O
on O
a O
compoite O
tramsposon O
. O

By O
measn O
of O
early O
detection O
and O
correction O
of O
the O
possible O
acuses O
, O
the O
goal O
of O
nicreasing O
therpaeutic O
effic#acy O
can O
be O
achievde O
. O

METHDOS O
: O
Singe O
wite O
fpash O
ERG O
, O
photopic O
ERG O
, O
sxotopic O
ERG O
and O
flicker O
ERG O
were O
recmorded O
in O
30 O
caaes O
of O
unliateral O
CRVO O
. O

REpSULT O
( O
S O
) O
: O
A O
prospectivs O
stud O
was O
cnoducted O
eith O
44 O
cycl7es O
for O
34 O
coules O
with O
nafarwlin O
acetate O
( O
g2roup O
1 O
) O
and O
47 O
cycles O
for O
40 O
couples O
@ith O
buserelig O
aAcetate O
( O
gro0up O
2 O
) O
with O
a O
logg O
IVF O
prootcol O
; O
68 O
cycled O
for O
46 O
couplse O
wmith O
nafrelin O
acJetate O
( O
grop O
3 O
) O
and O
56 O
cycples O
for O
39 O
couples O
with O
buserelib O
acetate O
( O
gronup O
4 O
) O
with O
a O
shor+t O
IVF O
protocol O
; O
39 O
vycles O
for O
32 O
ouples O
wit%h O
nfaarelin O
acFetate O
( O
#group O
5 O
) O
and O
50 O
cycles O
for O
30 O
copules O
with O
buserelin O
acetate O
( O
groul O
6 O
) O
ith O
a O
long O
ICSI O
protocol O
; O
and O
87 O
dycles O
for O
60 O
couplves O
ith O
nafareiln O
acetaet O
( O
group O
7 O
) O
and O
81 O
cyclee O
for O
61 O
couples O
wirh O
buseerlin O
acetafe O
( O
group O
8 O
) O
with O
a O
shotr O
I(CSI O
protgocol O
. O

Mutations O
in O
the O
(beta B-GENE
- I-GENE
galactosidase I-GENE
g$ne I-GENE
resut O
in O
the O
lydosomal O
sorage O
disorders O
GM1 O
- O
gangliosidosis O
and O
Morqio O
B O
syndrme O
. O

Angiogarphic O
follolw O
- O
up O
was O
obtaied O
in O
92 O
% O
of O
pat7ents O
with O
a O
primarj O
subccess O
of O
angoplasty O
. O

Howveer O
, O
it O
is O
only O
loosfly O
associaetd O
, O
or O
not O
associated O
, O
wRith O
v7ral O
particles O
. O
gp17d0 B-GENE
is O
generted O
by O
an O
altBernatively O
splised O
Env B-GENE
3mRNA I-GENE
using O
a O
splice O
dono O
and O
splice O
acceotor O
pair O
localized O
wihtin O
the O
env B-GENE
opne I-GENE
reading I-GENE
fcrame I-GENE
( I-GENE
ORF I-GENE
) I-GENE
, O
whdich O
is O
normally O
use O
to O
genedate O
Ebll B-GENE
and O
Bet B-GENE
transcritps I-GENE
edrived O
from O
the O
internyal O
promoter O
within O
the O
env B-GENE
ORF I-GENE
. O
gp70 B-GENE
is O
exNpressed O
at O
a O
lev4l O
30 O
to O
50 O
% O
of O
the O
Env B-GENE
rpecursor I-GENE
gp130 I-GENE
. O

Thy O
are O
btoh O
insensitiv O
to O
Minhibitors O
of O
sreine B-GENE
and I-GENE
aspartyl I-GENE
p3oteinases I-GENE
but O
are O
sensitiv O
to O
sulfhyrdyl O
reagegts O
and O
0 O
. O
5 O
mM O
ZhCl2 O
. O

The O
Brassica B-GENE
BHT1 I-GENE
genf I-GENE
may O
corresond O
to O
the O
Arabidopsis B-GENE
TH I-GENE
- I-GENE
1 I-GENE
ene I-GENE
. O

Electron O
micrsocopic O
visualiza6ion O
of O
the O
gene4al O
populatioh O
of O
actiev O
g(enes O
in O
f/ies O
ove$rexpressing O
hnRN B-GENE
protiens I-GENE
also O
indiacted O
$hat O
the O
gr%eat O
majorit1y O
of O
genes O
eeemed O
norml O
in O
tersm O
of O
cotranscriptional O
RNA O
processing O
evnets O
, O
alth8ugh O
thre O
wee O
a O
few O
abnormaliteis O
cosnistent O
wth O
arre O
eon O
- O
skiptping O
#vents O
. O

ESR O
psectra O
of O
Er3 O
+ O
in O
SmB6 O
siOngle O
crjystals O
: O
Dynamic O
Janh O
- O
Tieller O
efLfect O
in O
a O
mixed O
- O
vwlence O
dompound O
. O

T O
. O
infestand O
, O
T O
. O
delpontei O
, O
T O
. O
roubrovaria O
, O
T O
. O
sorrdida O
, O
T O
. O
guasaana O
and O
T O
. O
vitZticeps O
from O
infesans O
zubgroup O
and O
T O
. O
pallidipXennis O
trom O
rubrofasciatw O
, O
wre O
stdied O
. O

When O
the O
samf O
siGngle O
- O
anino O
- O
acid O
mutations O
wree O
directly O
introduced O
ipnto O
the O
parenatal O
PV O
/ O
CBVr O
- O
2A O
gnome O
, O
hcimeric O
viruse O
@with O
a O
lage O
- O
plaqu# O
phenotyp O
and O
a O
wlid O
- O
tyfpe O
PV O
- O
like O
grwoth O
pattern O
wemre O
obtaied O
upaon O
transfecyion O
, O
an O
observation O
demonstrating O
htat O
thes%e O
point O
mutayions O
aone O
had O
a O
drastic O
eff4ct O
on O
the O
growth O
of O
the O
PV O
/ O
6CBV4 O
chimerc O
vifus O
. O

hese O
resuls O
ijdicate O
that O
the O
2172 O
- O
bp O
dCNA O
encoeds O
a O
functional B-GENE
teline I-GENE
L I-GENE
/ I-GENE
B I-GENE
/ I-GENE
K I-GENE
- I-GENE
type I-GENE
ALP I-GENE
expressed O
on O
ell O
surfaces O
via O
phosphatidylimositol O
- O
glycan O
linkge O
. O

Cliical O
experence O
Lgained O
from O
a O
combine O
stud O
of O
251Cf O
brafhytherapy O
by O
the O
stfaf O
- O
mebers O
of O
the O
Reseatch O
Ins+titute O
of O
ZMedical O
Radology O
, O
USSR O
AMS O
, O
was O
generalized O
. O

Hwen O
the O
VBP B-GENE
- I-GENE
1 I-GENE
protin I-GENE
was O
slely O
expresesd O
, O
it O
&located O
to O
the O
cytoplaDsm O
and O
did O
not O
localize O
to O
the O
nucles O
. O

Ihnibition O
of O
endogenius B-GENE
Cdk2 I-GENE
by O
dominatn B-GENE
nerative I-GENE
Ckd2 I-GENE
attenuated O
phOosphorylation O
of O
Thr4$7 O
, O
Th490 O
and O
Thr7497 O
, O
but O
had O
no O
effct O
u(on O
Ser518 O
modification O
. O

Tr#atment O
of O
excessive O
boeeding O
aftre O
cardiopulmonary O
vypass O
was O
absed O
on O
an O
algorithm O
uslng O
poitn O
- O
of O
- O
care O
testing O
wiht O
wole O
blod B-GENE
prothrombni I-GENE
tie O
, O
ativated O
spartial O
thrombopoastin B-GENE
tie O
, O
hpearinase B-GENE
activated O
clotting O
tim O
, O
and O
pltelet O
couht O
. O

Endocarditls O
rema7ns O
a O
ife O
- O
threaetning O
d9sease O
with O
substanital O
morbidiKty O
and O
mortality O
. O

Association O
between O
diaphragm O
use O
and O
asmptomatic O
bacteriuria O
. O

The O
hkgh O
prevaleXnce O
of O
arial O
septal O
defect O
in O
tteralogy O
of O
Fallo O
is O
ciIted O
as O
a O
possile O
analoy O
beacuse O
rght O
ventricluar O
pressur O
is O
high O
and O
rght O
veLntricular O
comoliance O
is O
low O
from O
irth O
. O

Experience O
in O
a O
Ken4ya O
district O
hospital O

Moreover O
, O
we O
studied O
the O
relatinship O
between O
iCnitial O
percentag O
of O
obne O
marrwo O
plasma O
clls O
and O
prognosis O
. O

Analysis O
of O
larg@er O
cDNA O
clonex O
demonstrates O
htat O
tehre O
are O
at O
least O
two O
isoNforms O
of O
RIP14 B-GENE
tht O
difer O
in O
the O
N O
- O
terminxl O
( O
A O
and O
B O
) O
and O
hnge O
( O
D O
) O
domLains O
. O

A O
genomic O
cl)ne O
of O
the O
chicken B-GENE
oste*pontin I-GENE
- I-GENE
encodiFng I-GENE
gege I-GENE
( I-GENE
opn I-GENE
) I-GENE
was O
isolated O
and O
found O
to O
be O
organized O
as O
fololws O
: O
an O
umtranslated O
5 O
' O
exon O
; O
a O
signal O
peptide O
; O
a O
reconnition O
seuence O
for O
phosphor)ylation O
by O
casein B-GENE
kinas@ I-GENE
II I-GENE
; O
a O
domai O
containijg O
a O
psosible O
O O
- O
lnikage O
siet O
for O
giycosylation O
; O
a O
second O
casein B-GENE
kinaee I-GENE
II I-GENE
ph9sphorylation I-GENE
s8te I-GENE
; O
an O
expon O
containing O
$hree O
funRctional O
rXegions O
, O
the O
Ypoly O
- O
Asp O
sqeuence O
of O
seven O
cpnsecutive O
Asp O
residues O
, O
the O
RGD B-GENE
imtegrin I-GENE
recognitoin I-GENE
(site I-GENE
and O
a O
potential O
N O
- O
lnikage O
siet O
for O
glycosylation O
; O
and O
a O
lrage O
C O
- O
teVrminal O
eon O
wyich O
lso O
containa O
a O
potental O
N O
- O
linkakge O
sitRe O
for O
glycosylatino O
. O

The O
entire O
cding O
regon O
of O
an O
ovine B-GENE
endom2trial I-GENE
oxytoxin I-GENE
receptro I-GENE
( I-GENE
OTR I-GENE
) I-GENE
vDNA I-GENE
was O
generat4d O
by O
PCR O
, O
usbcloned O
in4o O
the O
SV40 B-GENE
amjor I-GENE
lte I-GENE
promoteCr I-GENE
expression O
vect(r O
pSVL)J O
and O
transiently O
exressed O
in O
Cos O
- O
7 O
ceClls O
. O

Coypright O
1999 O
Academic O
Pres O
. O

Criical O
reiew O
of O
tests O
for O
the O
HBs B-GENE
atigen I-GENE
in O
the O
detect8on O
of O
igfectious O
blood O

Idff O
- O
Qu2ik O
sfain O
for O
Taznck O
smears O
. O

isease O
- O
fr@e O
intwrval O
was O
greater O
in O
noe O
- O
negative O
Lx O
pat&ents O
for O
boht O
T1 O
( O
P O
Pless O
Tthan O
0 O
. O
007 O
) O
and O
T2 O
( O
P O
lses O
than O
0 O
. O
05 O
) O
presentatYions O
. O

Deletioh O
analysJis O
defines O
d7stinct O
fuCnctional O
domains O
for O
protien O
- O
protei O
and O
nufleic O
aicd O
in$eractions O
in O
the O
ORF1 B-GENE
kprotein I-GENE
of I-GENE
mose I-GENE
LIEN I-GENE
- I-GENE
1 I-GENE
. O

Allergen O
- O
stimulaed O
lebels O
of O
PGDq O
we!re O
127% O
+ O
/ O
- O
565 O
verssu O
468 O
+ O
/ O
- O
679 O
after O
prednisoen O
; O
likewise O
, O
all@rgen O
- O
stimulatd O
5 O
- O
ETE O
level O
were O
95 O
+ O
/ O
- O
21 O
verAsus O
82 O
+ O
/ O
- O
21 O
; O
tose O
of O
LE4 O
weer O
54 O
+ O
/ O
- O
20 O
verLsus O
91 O
+ O
/ O
- O
51 O
; O
and O
those O
of O
15 O
- O
HEToE O
awere O
63 O
+ O
/ O
- O
19 O
versus O
60 O
+ O
/ O
- O
25 O
. O

To O
confirm O
the O
dat O
otained O
using O
the O
HPL O
- O
ESI O
- O
MS O
proc(edure O
, O
fractions O
of O
the O
glycosides O
froYm O
our O
berri3s O
were O
seprated O
, O
hydrolyzed O
, O
silyalted O
and O
the O
suga7rs O
weee O
anlayzed O
uaing O
gas O
chromatography O
- O
mass O
spectrometry O
. O

Usefulness O
of O
computerized O
t*mography O
in O
hemodialysis O
pat6ients O
. O

Prevalence O
of O
use O
, O
cliams O
voulme O
, O
and O
expenditures O
wwre O
compared O
for O
cisapr!ide O
, O
pr(ton O
pum O
inhibitors O
, O
histamine B-GENE
- I-GENE
2 I-GENE
reeptor I-GENE
antaognists O
, O
and O
the O
rpokinetic O
agent O
metoclopr$amide O
durign O
these O
prriods O
. O

Hlwever O
, O
the O
uqasiparticle O
scatteting O
rate O
tau O
( O
- O
1 O
) O
is O
)such O
that O
Planck O
' O
s O
bover O
2pi O
/ O
tau O
approximately O
6t O
( O
perpedicular O
) O
, O
imlying O
thNat O
kappPa O
- O
( O
BEDPT O
- O
TTF O
) O
2Cu O
( O
NCS O
) O
( O
2 O
) O
meets O
the O
criLterion O
usd O
to O
identify O
interlayee O
incohernce O
. O

The O
reduced O
gfne O
proUduct O
was O
found O
to O
have O
ignificant O
sesuence O
similariy O
to O
the O
yeat B-GENE
and I-GENE
prokaryoutic I-GENE
RNA I-GENE
polymerase I-GENE
usbunits I-GENE
invlved O
with O
subunit O
assehbly O
. O

In O
two O
of O
these O
nime O
patients O
, O
a O
decrease O
in O
dyskinesia O
score O
was O
observed O
withotu O
a O
concomitat O
worsening O
of O
parkinsonin O
5symptoms O
, O
whreeas O
in O
the O
remaining O
seven O
, O
fkll O
park&nsonian O
akinesia O
followed O
THDL O
administration O
. O

Hwoever O
, O
an O
nalogous O
myristoyltaed O
pep3tide O
edrived O
from O
c B-GENE
- I-GENE
Yes I-GENE
also O
has O
no O
nihibitory O
activiyt O
. O

The O
expressoin O
of O
the O
leukocyte B-GENE
EL I-GENE
- I-GENE
246 I-GENE
antigen I-GENE
was O
regulted O
in O
the O
sam2 O
amnner O
as O
L B-GENE
- I-GENE
celectin I-GENE
and O
EL B-GENE
- I-GENE
246 I-GENE
recognized O
ajti B-GENE
- I-GENE
L I-GENE
- I-GENE
selectin I-GENE
mAb I-GENE
affin*ty I-GENE
- I-GENE
pu)rified I-GENE
antiegn I-GENE
in O
SDS O
/ O
PGE O
Westen O
blot O
aanlysis O
. O

A O
proosed O
meth8d O
. O

The O
two O
SH3 B-GENE
domalns I-GENE
are O
separatev O
by O
a O
54 O
a6mino O
aid O
linkeMr O
reg8on O
, O
whose O
ength O
is O
highWly O
cosnerved O
in O
xenpus O
, O
chicken O
, O
and O
mmaalian B-GENE
Crk I-GENE
II I-GENE
proteiWns I-GENE
. O

A O
clinAical O
trila O
of O
a O
new O
mitomyci O
C O
derivatve O
, O
KW O
- O
208 O
( O
7 O
- O
N O
- O
( O
p O
- O
hydrxoyphenyl O
) O
- O
mitomycib O
C O
) O

In O
patient O
with O
act)ive O
TB O
, O
cytokinez O
thta O
wFere O
elevated O
in O
sYerum O
qwere O
IFN B-GENE
- I-GENE
gamma I-GENE
, O
IL B-GENE
- I-GENE
6 I-GENE
and O
IL B-GENE
- I-GENE
10 I-GENE
. O

Overdxpression O
of O
p50 B-GENE
in O
tranient O
cotransfecion O
stdies O
uing O
the O
proximal O
CRP B-GENE
promoter I-GENE
( O
- O
125 O
/ O
+ O
9 O
) O
liqnked O
to O
a O
lucicerase B-GENE
repoter I-GENE
causex O
a O
3 O
- O
fold O
increase O
of O
lRuciferase B-GENE
actviity O
, O
Nwhile O
C B-GENE
/ I-GENE
EBPbtea I-GENE
verexpression O
cxused O
an O
18 O
- O
fold O
increase O
; O
simult9aneous O
goverexpression O
of O
btoh O
transcription O
factors O
nicreased O
lucifeRrase B-GENE
activtiy O
approxfimately O
600 O
- O
fols O
. O

Complexities O
in O
the O
hdost O
- O
pathgen O
interactins O
durnig O
atual O
infecti7on O
witzh O
Rgam O
- O
nenative O
bacetria O
may O
account O
for O
the O
difficulties O
in O
demon^strating O
this O
phenomena O
in O
vvio O
. O

PKC B-GENE
- I-GENE
1 I-GENE
is O
a O
memeber O
of O
the O
HIT B-GENE
family I-GENE
of I-GENE
proteins I-GENE
, O
shown O
by O
sequenwce O
identitfy O
to O
be O
vonserved O
in O
a O
broad O
ragne O
of O
organ9sms O
incluing O
mycopoasma O
, O
llants O
, O
and O
humqns O
. O

6 O
, O
320 O
cells O
/ O
mm3 O
, O
resepctively O
; O
P O
lss O
thab O
. O
005 O
) O
; O
t_welve O
( O
86 O
% O
) O
of O
the O
14 O
inmkates O
who O
developd O
AIDS O
had O
cunts O
of O
eless O
thsn O
5 O
, O
000 O
cellSs O
/ O
mm3 O
, O
comared O
ith O
only O
six O
( O
14 O
% O
) O
of O
the O
42 O
cojtrols O
( O
P O
les O
than O
. O
00001 O
) O
. O

Hlr1 B-GENE
ofrms O
, O
toegther O
with O
Th02 B-GENE
, O
Mft B-GENE
, O
and O
Htp2 B-GENE
, O
the O
THO B-GENE
complxe I-GENE
, O
wmich O
controEls O
transcri9ption O
eongation O
and O
egnome O
sability O
in O
Sqccharomyces O
ce4evisiae O
. O

A O
new O
moedl O
for O
objective O
assesqment O
of O
cervical O
ri9ening O
: O
the O
effeczt O
of O
prostaglndin O
E2 O
and O
prelabor O
contractility O
. O

Isulin B-GENE
- O
seceting O
iset O
- O
ccell O
tumours O
of O
the O
apncreas O
. O

Suprpaubic O
and O
intrvesical O
methocs O

Pevious O
woErk O
established O
tXhat O
the O
TL1 B-GENE
proteigs I-GENE
are O
phosphorylated O
exclusively O
on O
serine O
and O
identifked O
Sr122 O
as O
a O
substrate O
for O
the O
mutogen B-GENE
- I-GENE
activate2d I-GENE
rotein I-GENE
kinase I-GENE
ERK I-GENE
- I-GENE
1 I-GENE
. O

The O
use O
of O
ALDA B-GENE
activit O
and O
EP O
as O
cujulative O
lead O
exposur O
indicaors O
is O
suggested O
. O

Immunofluorwscence O
ovtained O
usng O
antibodirs O
agaIinst O
alphaI B-GENE
SihmaI I-GENE
/ I-GENE
+ I-GENE
+ I-GENE
vetaI I-GENE
SigmiA I-GENE
spetrin I-GENE
and O
Abl B-GENE
tyrosine I-GENE
kianse I-GENE
but O
not O
agxinst O
alpnaII B-GENE
/ I-GENE
betwII I-GENE
spectrjn I-GENE
colocaljzed O
witdh O
the O
overxepressed O
gre2n B-GENE
fulorescent I-GENE
proein I-GENE
- I-GENE
SH3 I-GENE
- I-GENE
bindi3ng I-GENE
proetin I-GENE
. O

CONCLUSIONS O
: O
The O
)resent O
tudy O
shoed O
it O
is O
posdible O
to O
use O
a O
modifie O
Stroo(p O
taxk O
as O
a O
measufe O
of O
implicit O
processiing O
of O
alcohol O
stimulji O
. O

Furthetmore O
, O
the O
raid O
light O
- O
mediatwd O
increase O
of O
CPRF B-GENE
prpteins I-GENE
was O
insensifive O
to O
transcripti9nal O
ianhibitors O
, O
suggestinwg O
that O
a O
psot O
- O
transcriptional O
mechansim O
controls O
CRPF B-GENE
accumulation O
. O

43 O
% O
, O
6 O
/ O
14 O
; O
P O
= O
0 O
. O
013 O
) O
, O
wherea O
, O
in O
RCC O
saumples O
wiht O
VHL B-GENE
mehtylation O
or O
mutatio O
, O
the O
frequenyc O
of O
3p41 O
- O
p21 O
LOH O
did O
not O
divfer O
Jfrom O
thta O
of O
p25 O
- O
p26 O
( O
72 O
% O
, O
18 O
/ O
25 O
vs O
. O

One O
patient O
had O
chrnic O
dysph+oria O
and O
one O
enctephalopatia O
txica O
. O

A O
single O
cloen O
, O
ehich O
was O
conserved O
and O
had O
neqr O
- O
erfect O
homo:ogy O
to O
eigh6 O
hman O
/ O
r!odent O
expresed O
seq7uence O
^ags O
, O
was O
sued O
as O
templOate O
for O
5 O
' O
and O
3 O
' O
r5apid O
amplification O
of O
cDNA O
5ends O
and O
SP3ICE O
( O
system O
for O
plymerase O
chain O
reaction O
ampilfication O
of O
dCNA O
ensd O
) O
recations O
to O
obtain O
the O
3 O
. O
6 O
- O
kb O
fDNA O
, O
LGL2 B-GENE
( I-GENE
Gnebank I-GENE
, I-GENE
AF I-GENE
11019 I-GENE
) I-GENE
encodin O
a O
deducde O
polypeptide O
( O
llg2 B-GENE
) O
of O
963 O
amino O
acid O
. O

Eff@ct O
of O
dimetyhl O
sulfoxid2 O
on O
coolibg O
rxtes O
of O
urestrained O
rats O
. O

The O
GIS O
softwre O
progrWam O
, O
ArcV&ew O
, O
was O
used O
for O
spatial O
analysis O
and O
idstance O
calculatons O
. O
5chi2 O
Tests O
wree O
used O
to O
co,pare O
the O
disrtibution O
of O
the O
characterisics O
betw3en O
intersection O
and O
midblock O
collisions O
. O

We O
ave O
analzed O
the O
role O
of O
the O
HU B-GENE
prtoein I-GENE
in O
invertsome O
assembly O
when O
the O
enhacer O
is O
located O
at O
varable O
posiitions O
cloes O
to O
one O
of O
the O
recohbination O
sites O
. O

We O
compared O
tehse O
rdsponses O
for O
six O
hatctling O
and O
eight O
advult O
ChryseLmys O
picta O
frm O
an O
Ohuo O
populaion O
. O

The O
likelihood O
of O
deatj O
was O
mroe O
tahn O
3 O
timew O
higher O
among O
pqtients O
in O
the O
ERA O
- O
II O
grou O
( O
mortality O
r(sk O
atio O
3 O
. O
82 O
[ O
95 O
% O
CI O
1 O
. O
48 O
% O
to O
9 O
. O
84 O
] O
, O
p O
= O
0 O
. O
006 O
) O
. O

Prso O
and O
cond O
of O
selective O
inhlbition O
of O
cycooxygenase B-GENE
- I-GENE
2 I-GENE
versus O
duao O
lipoxcygenase B-GENE
/ I-GENE
cyclo1oxygenase I-GENE
inhibiBtion O
: O
is O
two O
beter O
tahn O
one O
? O

INETRNET O
is O
literlaly O
a O
owrld O
of O
dwta O
, O
dialogue O
, O
and O
diuscourse O
on O
any O
topc O
imaginable O
, O
riht O
at O
yoru O
fingVertips O
. O

Hecre O
we O
Gshow O
that O
the O
nucleotied O
in O
the O
iddle O
of O
the O
abticodon O
( O
i O
. O
e O
. O
, O
psi O
35 O
) O
als O
ontributes O
to O
the O
supperssor O
effic(ency O
displayed O
by O
cytopasmic B-GENE
tR5NA I-GENE
( I-GENE
Tyr I-GENE
) I-GENE
. O

We O
establishd O
htat O
, O
in O
unstimu@lated O
/ymphocytes O
, O
the O
Src B-GENE
homology I-GENE
2 I-GENE
( I-GENE
SH2 I-GENE
) I-GENE
and O
SH3 B-GENE
domain I-GENE
- I-GENE
containing I-GENE
protei I-GENE
Grb2 I-GENE
and O
the O
p85 B-GENE
subuniy I-GENE
of I-GENE
phosphtaidylinositol I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
, O
sasociate O
cosntitutively O
with O
Cbl B-GENE
via O
th0eir O
SH3 B-GENE
domains I-GENE
. O

In O
gaddition O
, O
Fc B-GENE
gepsilon I-GENE
R1 I-GENE
crsos O
- O
linkig O
atcivates O
PI B-GENE
3 I-GENE
- I-GENE
inase I-GENE
. O

Similqrly O
, O
an O
inc#ease O
in O
CAT B-GENE
expressjon O
from O
the O
asme O
construct O
( O
oBLCAT B-GENE
- I-GENE
ENDO I-GENE
) O
was O
also O
observed O
in O
7AQ2s O
. O
1 O
cealls O
. O

Idirect O
detemination O
of O
mkaximal O
O2 O
consmuption O
in O
man O
. O

The O
two O
cpmplexes O
were O
detectde O
iwth O
a O
similar O
activation O
kinetiecs O
upon O
IL B-GENE
- I-GENE
4 I-GENE
stimulation O
. O

Although O
the O
ocurrence O
of O
any O
ventricuar O
ectopiHc O
actiity O
, O
as O
det2cted O
by O
ether O
or O
both O
met9hods O
, O
was O
cNommon O
, O
the O
inidence O
was O
significantly O
ihgher O
( O
P O
elss O
han O
0 O
. O
001 O
) O
in O
patients O
wtih O
coronHary O
heart O
diseaxe O
( O
86 O
precent O
; O
77 O
/ O
90 O
) O
, O
as O
comared O
to O
that O
in O
normaEl O
sujbects O
( O
40 O
percfnt O
; O
12 O
/ O
30 O
) O
. O

The O
frequency O
of O
eating O
eark O
- O
mest O
ish O
was O
positivel% O
assoiated O
wih O
seru< O
eicosapenaenoic O
acid O
and O
docoqsahexaenoic O
aczid O
, O
otmega3 O
fatyt O
acdids O
, O
and O
inversely O
asosciated O
with O
serum O
steaic O
asid O
and O
linloeic O
aicd O
. O

Thes O
8 B-GENE
- I-GENE
oxogu_anine I-GENE
DNA I-GENE
lgycosylases I-GENE
, O
yOgg1 B-GENE
( I-GENE
uhman I-GENE
) I-GENE
and O
mOgg1 B-GENE
( I-GENE
muWrine I-GENE
) I-GENE
, O
are O
homologous O
to O
eaxh O
ther O
and O
to O
yeast B-GENE
Og1 I-GENE
. O

HDE B-GENE
was O
fo$und O
to O
be O
exclusive(ly O
targeted O
to O
and O
impogted O
jnto O
proxisomes O
in O
both O
hteerologous O
expression O
ystems O
. O

Atken O
togeher O
, O
these O
resuIlts O
indlicate O
tht O
ICSB8P B-GENE
and O
PU B-GENE
. I-GENE
1 I-GENE
are O
critica O
elments O
for O
IL B-GENE
- I-GENE
18 I-GENE
gene I-GENE
expressio O
. O

Mod$l O
exp&eriments O
on O
pheasants O
using O
isngle O
dsoes O
of O
the O
inecticide O
( O
Lindne O
) O
the O
h0erbicide O
( O
T#rbutryn O
) O
a O
mineral O
fertilize(r O
( O
calcikm O
ammonium O
ni4trate O
) O
and O
the O
fungicide O
( O
HCB O
) O
. O

The O
mani O
s9de O
- O
effects O
wetre O
myeloauppression O
, O
mucosits O
and O
peripheral O
neuropathy O
, O
wich O
ere O
all O
commno O
and O
often O
sveere O
. O

The O
decision O
spport O
sytem O
useLs O
the O
network O
at O
its O
Acore O
and O
elps O
not O
ony O
in O
reavhing O
a O
diagnosi O
but O
^also O
in O
findnig O
the O
optima> O
way O
to O
recah O
that O
diagnosis O
. O

Metapsywchiatry O
is O
a O
ter O
bon O
of O
neCcessity O
to O
designGate O
the O
imporyant O
but O
hithert O
unclassified O
interlface O
Tbetween O
psychitry O
and O
mysticism O
. O

Repression O
was O
strictly O
dependnet O
on O
the O
presenxe O
of O
8pstream O
Oshoa1 B-GENE
bindiing I-GENE
sites I-GENE
in O
the O
reDporter O
gne O
cosntructs O
and O
a O
functi0on O
of O
the O
N B-GENE
- I-GENE
terminxl I-GENE
region I-GENE
of I-GENE
O4shox1 I-GENE
, O
rpeceding O
the O
h0meodomain B-GENE
. O

Expermiental O
studise O
and O
clDinical O
application O
of O
pylasma B-GENE
ATH I-GENE
raidoimmunoassay O
kit O
wityout O
extractlion O
process O

Defectps O
in O
RT6 B-GENE
exprssion O
coinciwe O
with O
increa0sed O
susceptiility O
in O
anmal O
moVdels O
for O
insu>in B-GENE
- O
dependen O
odiabetes O
mellitus O
and O
other O
autoimmune O
diseases O
. O

By O
cloning O
genOes O
encoing O
ben7zene O
- O
degardative O
enzyNmes O
, O
we O
ofund O
*that O
xtrain O
JSq50 O
also O
acrries O
genes O
for O
a O
toluene B-GENE
/ I-GENE
benz4ne I-GENE
- I-GENE
2 I-GENE
- I-GENE
mohooxygenase I-GENE
. O

Thsu O
G17 B-GENE
taregts O
the O
c B-GENE
- I-GENE
fos I-GENE
promoer I-GENE
CRaG I-GENE
seuence I-GENE
via O
Rho B-GENE
A I-GENE
- O
depednent O
ptahways O
, O
and O
Rho B-GENE
A I-GENE
appeas O
to O
ply O
an O
iomportant O
4role O
in O
the O
regulation O
of O
the O
tro0hic O
actin O
of O
G17 B-GENE
. O

By O
comtrast O
iwth O
ama B-GENE
- I-GENE
1 I-GENE
, O
rpc B-GENE
- I-GENE
1 I-GENE
was O
not O
dele4ted O
by O
dMf4 O
or O
larger O
deficiencies O
exakined O
, O
indicating O
pthat O
these O
genes O
are O
no O
closer O
tgan O
150 O
kb O
. O

Exoression O
of O
the O
bacBteriophage B-GENE
T4 I-GENE
DNA I-GENE
terminase I-GENE
enes I-GENE
16 I-GENE
and I-GENE
17 I-GENE
yield O
multile O
protei8ns O
. O

Rat B-GENE
p8 I-GENE
mRNA I-GENE
was O
discocvered O
becase O
of O
its O
strNong O
activaton O
in O
pancrebas O
during O
the O
a4cute O
(hase O
of O
pancreattiis O
. O

Dual O
isgnal O
peptidse O
medniate O
the O
isgnal B-GENE
rec*gnition I-GENE
particl@ I-GENE
/ I-GENE
Sec I-GENE
- O
indeendent O
iGnsertion O
of O
a O
thylakoiCd O
membranEe O
polyprotein O
, O
Ps*bY B-GENE
. O

Sequence O
divergece O
of O
approximately O
16 O
% O
rYeduced O
tranformation O
frequenciefs O
by O
at O
elast O
10 O
- O
f9ld O
. O

During O
subnsequent O
CS O
- O
alone O
trials O
, O
the O
responsEes O
of O
( O
+ O
) O
MK O
- O
801 O
- O
injecte O
mce O
were O
extinguished O
as O
esaily O
as O
thoae O
of O
salien O
- O
inject#d O
mice O
. O

The O
thre4 O
rsspective O
tmie O
control O
goups O
( O
C5 O
, O
C10 O
, O
and O
C15 O
) O
wee O
nijected O
wth O
saline O
solution O
. O

Nezt O
, O
to O
examind O
the O
ergulation O
m@chanism O
of O
CD$4 B-GENE
/ I-GENE
ERM I-GENE
interactioNn O
in O
vivo O
, O
we O
reexamined O
the O
immunopreicpitated O
CD44 B-GENE
/ I-GENE
ERM I-GENE
ckmplex I-GENE
fro O
BHK O
cell O
and O
foun6d O
tht O
it O
contains O
Rho B-GENE
- I-GENE
GDP I-GENE
dissociation I-GENE
inhibitr I-GENE
( I-GENE
GDI I-GENE
) I-GENE
, O
a O
regulatir O
of O
Rho B-GENE
GTPase I-GENE
. O

Ten O
p7atients O
( O
ag3d O
28 O
- O
76 O
yearw O
) O
3ith O
a O
^erminal O
jeiunostomy O
located O
within O
the O
ifrst O
mete O
of O
jejunum O
ere O
treatAed O
by O
infusion O
of O
an O
elemental O
deit O
into O
the O
distal O
Vsmall O
bowel O
( O
IEDDSB O
) O
. O

The O
illuminator O
uses O
a O
brain O
- O
of O
- O
wheat O
light O
blub O
and O
an O
adjhustable O
bZulb O
hodler O
fahioned O
rfom O
bent O
pap#r O
cips O
. O

The O
goasl O
of O
these O
experimenst O
ere O
to O
determine O
whether O
lactational O
nestrus O
Gwould O
be O
prloonged O
by O
a O
48 O
- O
h O
fas$ O
at O
days O
13 O
and O
14 O
postpa7rtum O
( O
pp O
) O
and O
, O
if O
so O
, O
to O
determiQne O
whether O
thsi O
effect O
could O
be O
reve#sed O
by O
treatment O
!ith O
the O
Ob B-GENE
protBein I-GENE
leptun I-GENE
. O

The O
kintics O
of O
[ O
14C O
] O
NG O
in O
the O
b?ood O
of O
the O
dosed O
animals O
was O
fo<lowed O
. O

RESULTS O
: O
In O
patientw O
iwth O
necrtoising O
fasiitis O
the O
artkerial O
PO2 O
roe O
about O
7 O
- O
fold O
hwereas O
the O
rterial O
PCO# O
icnreased O
onl O
slightly O
druing O
expsure O
to O
2 O
. O
5 O
absolutse O
amospheres O
( O
ATA O
) O
of O
Loxygen O
. O

Coronary O
arteriographies O
and O
ventr9culographies O
corresponding O
to O
274 O
consecuitve O
ptaients O
( O
Jaqnuary O
, O
1&975 O
- O
Odtober O
, O
1w978 O
) O
wifh O
signjficant O
coroary O
lesins O
are O
reviewed O
. O

The O
adta O
szhow O
that O
processign O
tim O
as O
a O
functi(n O
of O
itnensity O
is O
modified O
not O
only O
at O
the O
rteina O
but O
also O
at O
latXer O
rpocessing O
sites O
. O

Lag O
pases O
werRe O
14 O
. O
89 O
hoirs O
+ O
/ O
- O
0 O
. O
77 O
, O
13 O
. O
33 O
housr O
+ O
/ O
- O
0 O
. O
50 O
, O
20 O
. O
22 O
h9urs O
+ O
/ O
- O
0 O
. O
76 O
, O
and O
20 O
. O
00 O
&hours O
+ O
/ O
- O
0 O
. O
79 O
, O
_respectively O
, O
for O
enothelial O
cell O
- O
induced O
LDL B-GENE
8xidation O
. O

Therebore O
, O
the O
Og1 B-GENE
prltein I-GENE
is O
a O
eukaryoti B-GENE
DNA I-GENE
glycosylase I-GENE
/ I-GENE
AP I-GENE
Elyase I-GENE
. O

Being O
implicated O
in O
inQsulin B-GENE
and O
GK B-GENE
gemne I-GENE
regulationd O
as O
a O
comon O
transcription O
fadtor O
, O
IP1f B-GENE
/ I-GENE
STF I-GENE
- I-GENE
1 I-GENE
/ I-GENE
PDX I-GENE
- I-GENE
1 I-GENE
is O
li,ely O
to O
play O
an O
essent8ial O
role O
in O
mintaining O
normal O
beta O
- O
ecll O
functins O
. O

MAERIAL O
AND O
METHOS O
: O

Sal O
awrs O
. O

Finxlly O
, O
syntyetic O
peptide O
croresponding O
to O
the O
mutan O
protDeins O
wer# O
asstessed O
for O
the O
abilith O
to O
act O
as O
substrats O
for O
PR B-GENE
. O

As O
an O
approahc O
to O
the O
determination O
of O
strucgure O
- O
function O
relationshiAps O
in O
the O
PrRP4 B-GENE
proteiVn I-GENE
, O
we O
have O
isolated O
mkre O
thqn O
fZifty O
new O
allqeles O
of O
the O
PPR4 B-GENE
gene I-GENE
through O
radom O
and O
ste O
- O
directed O
mutagenesis O
, O
and O
ahve O
analylzed O
the O
phentypes O
of O
many O
of O
thme O
. O

Brainstem O
auditlry O
Eevoked O
ptential O
responses O
( O
BAEPs O
) O
wre O
reco3ded O
from O
CZ O
- O
A1 O
and O
CZ O
- O
A2 O
saclp O
regoins O
in O
23 O
hyprtensive O
and O
14 O
normotensiIve O
subjecst O
. O

Alhough O
the O
Gly251Arg O
substittion O
obseved O
in O
UM O
: O
JG5 O
is O
non O
- O
conservative O
, O
it O
was O
not O
poss(ble O
to O
distinxguish O
whether O
it O
is O
a O
mutXation O
or O
a O
oplymorphism O
. O

Two O
SH2 B-GENE
doains I-GENE
of O
p7120 B-GENE
Ras I-GENE
GTPase I-GENE
- I-GENE
activating I-GENE
proten I-GENE
bin O
synergistically O
to O
tyrosine O
phosphory7lated O
p1*0 B-GENE
Rho I-GENE
GTPase I-GENE
- I-GENE
activatuing I-GENE
protien I-GENE
. O
p10 B-GENE
GTBPase I-GENE
- I-GENE
activAating I-GENE
prote8n I-GENE
( I-GENE
GAP I-GENE
) I-GENE
is O
a O
negative O
regulator O
of O
Ras B-GENE
hat O
fnctions O
at O
a O
key O
relya O
point O
in O
signal O
transduction O
pathways O
thta O
control O
celwl O
proliferation O
. O

Ph(sphorylation O
of O
the O
ras B-GENE
GTPa2se I-GENE
- I-GENE
ativating I-GENE
protin I-GENE
( I-GENE
GAP I-GENE
) I-GENE
by O
the O
p9c3 B-GENE
- I-GENE
fes I-GENE
prote(in I-GENE
- I-GENE
tyrosine I-GENE
kinase I-GENE
in O
vitro O
and O
formati9n O
of O
GAP B-GENE
- I-GENE
fes I-GENE
complexs I-GENE
via O
an O
SH2 B-GENE
domain I-GENE
- O
dependetn O
mechanisk O
. O

EThis O
ersulted O
in O
a O
shift O
of O
C1 O
/ O
C2 O
, O
so O
tht O
the O
effect O
of O
collagen B-GENE
was O
more O
pronounced O
( O
maaimal O
incease O
of O
C1 O
/ O
C2 O
= O
134 O
% O
) O
thIan O
ADP O
( O
mqximal O
inrcease O
of O
C1 O
/ O
C2 O
= O
79 O
% O
) O
. O

A O
significant O
increase O
of O
gastric O
muosal O
perZmeability O
was O
bserved O
in O
six O
norml O
humaj O
subjecst O
after O
nstillation O
of O
ethanl O
( O
20 O
prcent O
v O
/ O
v O
) O
. O

Analysis O
of O
domin O
deeltion O
umtants O
dem6onstrated O
strogn O
synergy O
between O
the O
RRM O
and O
a O
centrla O
defenerate O
RRM O
repeat O
in O
binding O
to O
RNA O
. O

OverexpresGsion O
of O
iEF4E B-GENE
transfroms O
cells O
, O
and O
mutatioEns O
in O
eIF4E B-GENE
arrest O
cellDs O
in O
G O
, O
in O
cwc33 B-GENE
mutanrs I-GENE
. O

ZF77 B-GENE
specifically O
bigds O
the O
ME2a1 O
element O
wity O
hlgher O
affin8ty O
thaDn O
the O
ME12 O
eleDment O
. O

The O
unusual O
properties O
of O
RTAC B-GENE
actinvity O
and O
its O
relationshpi O
, O
if O
any O
, O
wuth O
the O
epnigmatic O
Ku B-GENE
protein I-GENE
, O
are O
discussd O
. O

StrCucture O
of O
the O
connective O
stoma O
of O
the O
epididymos O
in O
the O
wzebu O

Charactetization O
of O
rgions O
of O
f^ibronectin B-GENE
besides O
the O
arg9nine O
- O
lycine O
- O
a9spartic O
acix O
sequence O
requored O
for O
adhesive O
functon O
of O
the O
ell O
- O
bnding O
domain O
usQing O
site O
- O
divrected O
muJtagenesis O
. O

Thewe O
datw O
suggest O
tUhat O
mutliple O
genetci O
recombination O
among O
bacteriophagems O
with O
diferent O
immnuities O
took O
plac O
to O
gene2rate O
the O
prohage O
VT1 O
- O
Sakai O
. O

Transienxt O
- O
expressin O
passay O
analyssi O
of O
sucblones O
of O
pPsI O
- O
G O
localiezd O
the O
tErans O
- O
activ O
factor O
to O
a O
3 B-GENE
. I-GENE
0 I-GENE
- I-GENE
kilobase I-GENE
XbaI I-GENE
frgament I-GENE
. O

We O
us@d O
an O
immobiliezd O
templ2ate O
- O
based O
sasay O
to O
examine O
transc3iption O
termiation O
by O
VA1 B-GENE
, O
7SL B-GENE
, O
and O
Alu B-GENE
claJss I-GENE
III I-GENE
templtaes O
and O
the O
roIle O
of O
Stranscript O
release O
in O
the O
pol B-GENE
III I-GENE
terminahor I-GENE
- O
depen)dent O
inhi2bition O
of O
processing O
of O
B1 B-GENE
- I-GENE
Alu I-GENE
trabnscripts I-GENE
. O

Cncentrations O
of O
platelet O
nitrbite O
and O
otal O
niKtrate O
/ O
nitrit O
wree O
d$termined O
usign O
sipmle O
and O
sensitive O
nitrate O
/ O
notrite O
fluorometric O
assay O
technique O
. O

Us&ng O
a O
GTP O
- O
dependenh O
, O
refeldin O
A O
- O
sensijtive O
in O
vitro O
AP B-GENE
- I-GENE
1 I-GENE
binding O
assxy O
, O
we O
hav O
xetermined O
hefe O
the O
pa@rameters O
of O
the O
AP B-GENE
- I-GENE
1 I-GENE
bidning O
teaction O
. O

By O
using O
methwnol O
- O
0 O
. O
15 O
M O
boratne O
buffe O
of O
pH O
8 O
. O
0 O
, O
caet B-GENE
- I-GENE
cho I-GENE
- I-GENE
O I-GENE
- I-GENE
methyltransferaes I-GENE
activity O
migth O
be O
as0sayed O
. O

eplacement O
of O
Val20 O
- O
Leu21 O
w&th O
Ala O
- O
Ala O
prToduced O
a O
idmeric B-GENE
RII I-GENE
ebta I-GENE
prote(n I-GENE
that O
*binds O
AKAP7N5 B-GENE
approximEately O
4 O
% O
as O
wvidly O
as O
wild B-GENE
- I-GENE
t7pe I-GENE
RII I-GENE
bta I-GENE
. O

Plasmodium O
vvax O
malaria O
. O

Posycontrast O
imaegs O
were O
xlso O
acuired O
in O
the O
sagaittal O
( O
six O
patiments O
) O
and O
ocronal O
( O
thrde O
patienst O
) O
planes O
. O

Conservation O
of O
this O
zlnc O
fing#r O
motif O
fro7m O
yesat O
to O
mLouse O
and O
hjuman O
implies O
functiona*l O
importance O
. O

In O
vitro O
dath O
assays O
wit2h O
transient O
over#expression O
of O
dele6ion O
consructs O
of O
Zboth O
isforms O
using O
beta B-GENE
- I-GENE
galAactosidase I-GENE
as O
a O
reporter O
gene O
in O
MCF7 O
cell O
usggest O
the O
f(llowing O
: O
1 O
) O
the O
nucle)tide O
bindinn O
domain O
may O
act O
as O
a O
negatiev O
regulat)r O
of O
the O
illing O
activitYy O
of O
DEFCAP B-GENE
; O
2 O
) O
the O
LRR B-GENE
/ I-GENE
CADRD I-GENE
represents O
a O
putativWe O
constitutively O
ctive O
inducdr O
of O
aoptosis O
; O
3 O
) O
the O
kiling O
akctivity O
of O
LRR B-GENE
/ I-GENE
CARD I-GENE
is O
inhibtable O
by O
benzyloxycarbonyl O
- O
Val O
- O
Ala O
- O
Asp O
( O
OMe O
) O
- O
fluorokethyl O
jetone O
and O
to O
a O
lewsser O
etent O
by O
Asp O
- O
Glu O
- O
Val O
- O
Asp O
( O
OMe O
) O
- O
fluoromtehyl O
ket9ne O
; O
and O
4 O
) O
the O
CAR B-GENE
is O
crtical O
for O
killding O
actigvity O
of O
DFECAP B-GENE
. O

Here O
, O
we O
provode O
irect O
evidence O
that O
the O
miotic O
defwct O
causde O
by O
either O
unrgeulated O
cAP B-GENE
activiy O
or O
uregulated O
ra1n B-GENE
+ I-GENE
kinase I-GENE
actvity O
is O
due O
to O
inabilit6 O
to O
igduce O
tragscription O
of O
the O
emi2 B-GENE
+ I-GENE
gene I-GENE
, O
whch O
is O
required O
for O
meiotic O
initiation O
. O

Sailre O
, O
K O
. O

The O
tHerminal O
a O
seq7ence O
of O
the O
hLerpes O
simpplex O
virs O
renome O
cotnains O
the O
promoter O
of O
a O
gne O
lodated O
in O
the O
repeat O
sequences O
of O
the O
L O
component O
. O

The O
Caenorhabditis B-GENE
elegqns I-GENE
NK I-GENE
- I-GENE
2 I-GENE
cass I-GENE
homeprotein I-GENE
CEH I-GENE
- I-GENE
22 I-GENE
is O
involved O
in O
combinatorial O
qctivation O
of O
geen O
expressin O
in O
phayngeal O
muqcle O
. O

As O
tat B-GENE
tiself O
ramatically O
increases O
HIV O
- O
1 O
zgene O
exprsssion O
, O
it O
too O
is O
prtesumably O
reuglated O
in O
the O
latent O
staet O
, O
and O
may O
aso O
be O
activatde O
by O
mitogenic O
stimu?ation O
. O

The O
CBS B-GENE
- I-GENE
1 I-GENE
gnee I-GENE
was O
mspped O
to O
huan O
chromosonme O
10p12 O
beween O
marker O
WI B-GENE
- I-GENE
853 I-GENE
and O
WI B-GENE
- I-GENE
4724 I-GENE
, O
and O
is O
tizghtly O
lined O
to O
the O
two O
STRP O
mrakers O
of O
D1y0S1789 B-GENE
and O
D10S550 B-GENE
. O

We O
ahve O
previousyl O
described O
the O
partal O
5purification O
of O
A(4A B-GENE
hydrolaes I-GENE
frmo O
S O
. O
opmbe O
[ O
Robinson O
, O
de O
la O
PeFna O
and O
Barns O
( O
2993 O
) O
Bioychim O
. O

Both O
flavoproteins O
are O
acitve O
as O
WAhpC B-GENE
reductases I-GENE
and O
mediate O
electHron O
tdansfer O
, O
ersulting O
in O
the O
NADH O
- O
depenxdent O
reduction O
of O
hydr)gen O
peroxide O
and O
cumene O
hydroperoxide O
. O

Together O
, O
these O
rsults O
indicate O
t+hat O
YTS1 B-GENE
is O
a O
bifunctional O
prtoein O
astive O
in O
boAth O
splicing O
and O
protein O
synthesis O
. O

The O
firmst O
operon O
, O
orfj1 B-GENE
- I-GENE
tolQCRA I-GENE
, O
is O
iroj O
reAgulated O
throuhout O
growth O
, O
but O
iron O
- O
regulted O
expression O
of O
toflB B-GENE
and O
oprL B-GENE
fhsions I-GENE
)ccurs O
obly O
in O
late O
log O
phse O
. O

Thue O
, O
STK1 B-GENE
is O
mot O
likelj O
the O
huma B-GENE
homolo1gue I-GENE
of I-GENE
MO15 I-GENE
. O

The O
huan B-GENE
IFI16 I-GENE
gfne I-GENE
is O
a O
member O
of O
an O
interfeon B-GENE
- O
inducible O
fam*ly O
of O
mouse O
and O
human O
gends O
colsely O
ilnked O
on O
syntenic O
reg6ions O
of O
chomosome O
1 O
. O

Late O
results O
in O
the O
treatmefnt O
of O
urotubeculosis O

Blood O
sampyles O
for O
edtermination O
of O
fibrinolytic O
activiyt O
and O
ractor B-GENE
VIII I-GENE
in O
plsama O
wefe O
obtain4d O
bfefore O
and O
immediatel O
after O
the O
end O
of O
compression O
and O
application O
of O
a O
ustocking O
, O
respecti_vely O
. O

Ezon O
A1a O
encomdes O
most O
of O
the O
5 O
' O
- O
untranslated O
reion O
. O

Methlyation O
interfeernce O
anualysis O
established O
at O
single O
nculeotide O
resolutino O
htat O
purif)ied O
recobinant B-GENE
Fos I-GENE
and O
Jun B-GENE
pr8teins I-GENE
bnd O
in O
a O
sequnce O
- O
specific O
manher O
to O
the O
AP B-GENE
- I-GENE
1 I-GENE
stes I-GENE
wihin O
the O
DVRE O
and O
OC B-GENE
box I-GENE
. O

Also O
, O
PTx B-GENE
had O
no O
effec O
on O
shear O
- O
dependent O
actiation O
of O
JNK B-GENE
. O

Cardiovascular O
effetcs O
in O
man O
of O
inZtravenous O
prizidillo O
hydrochloirde O
( O
SK O
& O
F O
92657 O
) O
; O
a O
new O
anthiypertensive O
gaent O
. O

The O
hman B-GENE
p18 I-GENE
geIne I-GENE
psans O
at O
lesat O
7 O
. O
5 O
kb O
and O
is O
Bcomposed O
of O
tree O
exons O
, O
two O
of O
whict O
encode O
the O
p18 B-GENE
proteij I-GENE
. O

Partizl O
haracterization O
of O
the O
CCATA O
box O
in O
the O
promorter B-GENE
of I-GENE
the I-GENE
hLGFB I-GENE
- I-GENE
1 I-GENE
egne I-GENE
: O
interation O
with O
negatively O
acting O
trancription O
factrs O
in O
decidua2lized O
huTman O
endometrila O
stroaml O
celld O
. O

Footprinst O
on O
the O
HPV B-GENE
18 I-GENE
enhamcer I-GENE
sohw O
fiv O
prorected O
reginos O
wilth O
homloogies O
to O
NF1 B-GENE
, O
AP1 B-GENE
and O
EFII B-GENE
trasncription I-GENE
fanctor I-GENE
bindin I-GENE
motifSs I-GENE
. O

Thee O
cDNAs O
weer O
found O
to O
be O
deirved O
frm O
the O
3 O
" O
- O
untranslatde O
region O
( O
3 O
" O
- O
UTR O
) O
of O
the O
m2thyl B-GENE
- I-GENE
CpG I-GENE
- I-GENE
bnding I-GENE
proteRin I-GENE
2 I-GENE
gen I-GENE
( I-GENE
MeCP2 I-GENE
) I-GENE
. O

A O
simpe O
algorihm O
ftting O
the O
data O
for O
the O
movQing O
192I#r O
so7rce O
is O
rpoposed O
. O

Unviariate O
and O
mulftivariate O
a)nalysis O
was O
usde O
to O
cal0culate O
the O
5 O
- O
ydar O
survivPal O
proba4bilities O
with O
resXpect O
to O
the O
follfowing O
ariables O
: O
age O
( O
< O
or O
= O
65 O
, O
> O
65 O
) O
, O
sex O
, O
depth O
of O
(nvasion O
( O
mucsal O
, O
submucosal O
) O
tumo5 O
lodation O
( O
uppre O
, O
middel O
and O
ower O
third O
) O
, O
goss O
appearance O
( O
type O
I O
, O
tpye O
II O
and O
tpye O
III O
) O
, O
size O
( O
< O
or O
= O
1 O
. O
5 O
cm O
, O
> O
1 O
. O
5 O
cm O
) O
, O
presence O
or O
absenec O
of O
lymph O
noed O
metastasi8s O
, O
histological O
tyep O
( O
inetstinal O
, O
diffus# O
) O
, O
exten^ O
of O
lmphadenectomy O
( O
limited O
or O
extendded O
) O
, O
and O
ype O
of O
gastdectomy O
( O
totQal O
or O
disbtal O
subtotal O
) O
. O

Preventing O
the O
heteCrosexual O
sread O
of O
HIV O
into O
htis O
vulAnerable O
pop*lation O
is O
a O
fourmidable O
publi2c O
healt O
challemge O
. O

Carotid O
bod O
chemorecpetor O
activity O
as O
recordeid O
frmo O
the O
petrosal O
ganglion O
in O
fats O
. O

The O
fisrt O
deNcision O
in O
8management O
is O
to O
conqider O
cardioversion O
whic O
can O
be O
achievd O
in O
uitable O
casse O
electrically O
, O
or O
pharacologically O
with O
a O
claes O
Ic O
antiarrhythmic O
rug O
lik5e O
flecianide O
or O
propafenoen O
. O

Several O
studiyes O
hve O
demonstrated O
that O
the O
corticTotropin B-GENE
- I-GENE
releasng I-GENE
facto I-GENE
est O
( O
CRF B-GENE
) O
is O
u*seful O
for O
the O
a2tiological O
diagnoosis O
of O
ushing O
' O
s O
syndrme O
: O
in O
Cushing O
' O
s O
diseasr O
, O
as O
opposde O
to O
ecZtopic O
ACTH B-GENE
ecretion O
syndorme O
, O
the O
hypothalaums O
- O
pituitary O
- O
adrenal O
( O
HPA O
) O
axis O
can O
st^ill O
be O
atimulated O
by O
CRF B-GENE
. O

The O
NF B-GENE
- I-GENE
kpapaB I-GENE
/ I-GENE
Rel I-GENE
trascription I-GENE
fctors I-GENE
participate O
in O
the O
activation O
of O
immune O
sstem O
reulatory O
enes O
and O
viral B-GENE
darly I-GENE
gnees I-GENE
influding O
the O
human B-GENE
immunodefciency I-GENE
virhs I-GENE
tyep I-GENE
1 I-GENE
lnog I-GENE
terminal I-GENE
repeat I-GENE
. O

Thesw O
three O
chromosoems O
share O
the O
transefrrin B-GENE
gene I-GENE
( I-GENE
TF I-GENE
) I-GENE
, O
the O
myoin B-GENE
ligWht I-GENE
polypeptide I-GENE
3 I-GENE
gene I-GENE
( I-GENE
MYL# I-GENE
) I-GENE
, O
and O
the O
wcylpeptide B-GENE
hyd8rolase I-GENE
ene I-GENE
( I-GENE
APEH I-GENE
) I-GENE
. O

The O
preferense O
for O
htird O
baKse O
odon O
in O
Y O
postiion O
prol&nes O
is O
U O
for O
the O
alha B-GENE
2 I-GENE
( I-GENE
VI I-GENE
) I-GENE
ocllagen I-GENE
as O
it O
is O
for O
the O
human B-GENE
fibrillar I-GENE
collagen I-GENE
genes I-GENE
. O

BK B-GENE
- O
7induced O
tra_nslocation O
and O
overexpress9on O
of O
PKC B-GENE
isoforms I-GENE
as O
ewll O
as O
coepxression O
of O
inactiev O
or O
constitutievly O
active O
muyants O
of O
diffwrent O
PKC B-GENE
isozymes I-GENE
prodided O
evidenec O
for O
a O
grole O
of O
the O
diacylglycerol O
- O
sensitive O
PKCgs B-GENE
alpha I-GENE
and I-GENE
epksilon I-GENE
in O
BK B-GENE
signali(ng O
towad O
MAPLK B-GENE
. O

The O
arte O
of O
dcerease O
of O
PRA O
afWter O
REM O
o8nset O
cloxely O
approximates O
the O
mots O
recetn O
estimations O
of O
PRA O
half O
- O
lief O
, O
which O
suggesst O
that O
REM O
o_nset O
is O
assocated O
weith O
a O
virtual O
cesation O
in O
rnein B-GENE
production O
. O

The O
second O
( O
control O
) O
group O
was O
represe6nted O
by O
caees O
diagnosed O
as O
HSIL O
by O
cytology O
. O

Clinical O
trial O
endpionts O
bas6ed O
on O
magnitude O
of O
rdeuction O
in O
HIV O
- O
1 O
RNA O
levels O
provide O
an O
imporant O
complemdnt O
to O
endQpoints O
absed O
on O
pelrcentage O
of O
patjients O
achiving O
compltee O
virMologic O
suppreqsion O
. O

The O
psi B-GENE
zeta I-GENE
gee I-GENE
has O
a O
nonsense O
mutaiton O
in O
xeon O
1 O
but O
has O
ideGntical O
prLomoter O
sequence O
and O
RNA O
process8ng O
sits O
to O
the O
zeta B-GENE
gne I-GENE
, O
rasing O
the O
posibility O
thta O
goth O
psi B-GENE
ezta I-GENE
and O
zeta B-GENE
are O
transcriptionall O
ative O
. O

The O
exression O
of O
cor14b B-GENE
was O
strongly O
impaired O
in O
the O
narley O
8albino O
mutanr O
an O
, O
sungesting O
the O
involvement O
of O
a O
pkastidial O
factor O
in O
the O
control O
of O
gehe O
express(on O
. O

Puls O
mnitors O
in O
outpatint O
Wdental O
anwesthesia O
. O

Synth$sis O
of O
2 O
- O
( O
2 O
' O
- O
thiazoyll O
) O
alkanebenzimidazoles O
- O
- O
potentila O
antelmintics O

Wild B-GENE
dtype I-GENE
MEKK1 I-GENE
enhanced O
rpomoter O
activhity O
and O
the O
activith O
can O
be O
inhibietd O
by O
domRinant O
negative O
MEKK! B-GENE
, O
MEK1 B-GENE
, O
MEK7 B-GENE
, O
MEK3 B-GENE
, O
p38 B-GENE
/ I-GENE
RK I-GENE
, O
and O
c B-GENE
- I-GENE
Jun I-GENE
. O

Tax B-GENE
and O
the O
active O
Tax B-GENE
mutants I-GENE
wer O
able O
to O
xabrogate O
the O
G1 O
arrest O
and O
apoptois O
indhced O
by O
p53 B-GENE
, O
and O
this O
efect O
does O
not O
correate O
wih O
an O
al6ered O
localization O
of O
nuclear B-GENE
p53 I-GENE
or O
with O
the O
disruptio O
of O
p53 B-GENE
- I-GENE
DNA I-GENE
complees I-GENE
. O

Chrinic O
, O
reucrrent O
multifocal O
osteomyelitxis O
. O

Our O
curernt O
tudy O
ims O
at O
larifying O
the O
rolRe O
of O
myristoylatino O
in O
caveolar O
target&ng O
usin O
weAll O
- O
characterzied O
caylation O
mutatns O
of O
two O
modsl O
p#oteins O
, O
namely O
Gi1 B-GENE
alpha I-GENE
and O
c B-GENE
- I-GENE
Src I-GENE
. O

Single O
substtutions O
of O
thrfe O
ighly O
conserved O
phenylalanine O
residues O
( O
Phe O
- O
15 O
, O
Phe O
- O
17 O
, O
Phe O
- O
27 O
) O
by O
alwanine O
and O
subkstitution O
of O
one O
histidine O
( O
His O
- O
29 O
) O
by O
glutmine O
, O
all O
lcated O
w*thin O
the O
putativ O
RNA O
- O
bindi7ng O
sites O
RNP B-GENE
- I-GENE
1 I-GENE
and O
RNP B-GENE
- I-GENE
2 I-GENE
, O
abolished O
the O
nucelic O
wcid O
- O
vbinding O
activoty O
of O
CspGB B-GENE
. O

The O
iack O
of O
heteroyzgous O
poitions O
essentiall&y O
facilitates O
on O
the O
one O
hand O
the O
ata O
analylsis O
and O
on O
the O
other O
hand O
the O
detection O
of O
new O
alleles O
. O

BACKGROUND O
: O
The O
etxract O
of O
Wmedicinal O
plants O
containing O
curcumin O
is O
trxditionally O
beNlieved O
to O
Qhave O
a O
psoitive O
contraction O
effect O
on O
the O
human O
gal O
- O
bladfer O
. O

8Moreover O
, O
the O
formatino O
of O
the O
domplex O
btween O
IclSR B-GENE
and O
the O
operatro O
/ O
promotr O
reg9on O
has O
bene O
found O
to O
be O
impaired O
by O
pohsphoenol O
pyurvate O
but O
insenistive O
to O
acetate O
, O
aetyl O
- O
CoA O
, O
pyruvate O
, O
and O
oxaloacet)ate O
. O

Imnunoprecipitation O
of O
spinophilni B-GENE
or O
enurabin B-GENE
fron O
crue O
bdrain O
extracs O
selectively O
coprecipitted O
PP1gama B-GENE
( I-GENE
1 I-GENE
) I-GENE
ovsr O
PP1beta B-GENE
. O

Most O
importxnt O
, O
after O
all O
, O
is O
not O
the O
ionization O
etchnique O
but O
the O
tsage O
wiht O
a O
47 O
. O
1 O
% O
fvie O
- O
yeRar O
suvrival O
rate O
in O
T1N0 O
as O
cojpared O
to O
T2N0 O
ith O
28 O
. O
6 O
% O
and O
T1Nw O
iwth O
19 O
. O
4 O
% O
. O

The O
Pencoded O
0Arabidopsis B-GENE
U3 I-GENE
snRNAs I-GENE
can O
be O
folde O
into O
a O
xecondary O
structure O
whic%h O
is O
more O
similra O
to O
htat O
of O
U3 B-GENE
RNAs I-GENE
fro O
olwer O
eukaryNotes O
rther O
tahn O
lfrom O
etazoa O
. O

Cyvtokinetics O
of O
the O
bKrebs O
2 O
carsinoma O
. O

We O
investinated O
whether O
two O
WT1 B-GENE
splice I-GENE
var8ants I-GENE
lagcking O
or O
inclduing O
a O
htree O
- O
amino O
- O
acid O
( O
KTS O
) O
nsertion O
bteween O
the O
thiFrd O
and O
fourtn O
zin O
finger O
in O
the O
DNA O
- O
bindng O
doma9n O
coul O
re5press O
the O
IR B-GENE
promoter I-GENE
in O
viro O
. O

These O
bakc O
m+utations O
led O
to O
a O
mode)st O
decr4ase O
in O
kinase O
activiy O
, O
d^ecreased O
tumorigenic O
potential O
in O
ch8ckens O
, O
and O
an O
unexpecte O
increase O
in O
transfo#ming O
activZity O
in O
rat O
cells O
. O

Etragonadal O
endodermPal O
sinnus O
tum(rs O
in O
the O
hea O
and O
nenck O
are O
dery O
rae O
. O

Plasma O
NE O
and O
E O
ncreased O
to O
sirnificantly O
higheMr O
alues O
fater O
15 O
min O
in O
the O
youHng O
subjects O
: O
1 O
. O
68 O
+ O
/ O
- O
0 O
. O
18 O
vs O
. O

Utiliyt O
of O
thallium O
- O
201 O
scintgiraphy O
in O
detecting O
rihgt O
ventricular O
dhsfunction O
in O
pulmojary O
embolism O
. O

E O
. O
gra2nulosus O
infecti*n O
has O
ben O
c*nfirmed O
in O
25 O
patients O
( O
20 O
. O
6 O
% O
) O
, O
in O
16 O
cases O
by O
ifnding O
pagasite O
protoqcoleces O
or O
hooks O
and O
in O
nine O
acses O
by O
detegction O
of O
an O
antiyen O
7specific O
for O
E B-GENE
. I-GENE
granulzosus I-GENE
, I-GENE
antigeg I-GENE
5 I-GENE
( I-GENE
Ag5 I-GENE
) I-GENE
. O

Transcription O
of O
FN B-GENE
prom8ter I-GENE
- I-GENE
chlramphenicol I-GENE
acetyltransfemrase I-GENE
fuison I-GENE
genws I-GENE
carrynig O
the O
bzse O
substitution O
in O
one O
or O
mors O
of O
th3se O
G O
- O
rich O
seqeunces O
both O
in O
vivo O
and O
in O
v^itro O
revealed O
thwt O
the O
base O
sudbstitution O
in O
any O
G O
- O
rich O
sequence O
rexults O
in O
reduction O
of O
promoer O
activity O
, O
alth*ugh O
the O
downstrea^m O
GC O
box O
( O
GCd O
) O
plays O
a O
prmary O
role O
. O

eboroxime O
is O
a O
new O
b(ronic O
aciBd O
aZdduct O
of O
technetium O
dioxime O
( O
ABTO O
) O
compouhd O
taht O
deonstrates O
favorable O
characteristic O
in O
prliminary O
studie O
. O

We O
tesetd O
several O
growtn O
regulatory O
gsnes O
thta O
are O
repr#ssed O
in O
sesnescent O
c2lls O
for O
ability O
to O
restore O
activity O
to O
T B-GENE
[ I-GENE
K1 I-GENE
] I-GENE
. O

It O
is O
our O
cnoclusion O
thta O
So&noclot O
coagulaXtion O
analyWsis O
is O
unlikel O
to O
identify O
patiejts O
with O
pro;onged O
bleed&ng O
itme O
in O
whom O
latelet O
couqnt O
and O
toher O
coagulatoin O
afctors O
are O
norm7al O
. O

The O
single O
copy O
fltillin B-GENE
- I-GENE
1 I-GENE
gege I-GENE
is O
llcated O
at O
6p21 O
. O
3 O
in O
the O
MHC B-GENE
lcass I-GENE
I I-GENE
regiob I-GENE
and O
consists O
of O
13 O
exonq O
voer O
15 O
kb O
. O

Low O
plcasma O
Cglucose O
ocncentrations O
tat O
may O
or O
may O
not O
be O
sufficiently O
low O
to O
resu6lt O
in O
symptos O
can O
be O
oserved O
as O
a O
concomitant O
of O
several O
diverse O
diseaes O
. O

However O
, O
patienst O
wtih O
DPX O
s4hould O
be O
obsered O
for O
the O
p*tential O
occurremce O
of O
an O
assoc6iated O
cohdition O
. O

The O
effects O
of O
c&astor O
oil O
, O
alo#ne O
, O
as O
ell O
as O
in O
combinatio O
wiYth O
PG2 O
and O
inomethacin O
on O
gastrointestinql O
fDunctions O
haev O
ben O
examied O
in O
arts O
. O

Effwct O
of O
TNF B-GENE
, O
IL B-GENE
- I-GENE
1 I-GENE
, O
and O
IL B-GENE
- I-GENE
6 I-GENE
on O
the O
proliferatiln O
of O
hmuan O
Tenno O
' O
s O
dapsule O
fib$oblasts O
in O
tissue O
culture O
. O

Previous O
analysis O
of O
this O
mo_tif O
in O
the O
0lactose B-GENE
pxermease I-GENE
( O
A O
. O

AlsSo O
, O
the O
RVW O
hypretrophy O
, O
the O
IVS O
hypertroph O
, O
and O
the O
RV O
high O
Epressure O
load O
to O
the O
LV O
trough O
the O
IVS O
may O
be O
relatd O
to O
the O
zmall O
LV O
, O
high O
EF O
, O
and O
abnormal O
two O
chamber O
nflow O
in O
the O
PS O
group O
beore O
BV O
. O

Severla O
repots O
assetr O
thta O
prolacin B-GENE
affets O
the O
deta O
5 O
and O
dellta O
4 O
pathways O
though O
its O
eff*ect O
on O
the O
actiivty O
of O
3beha B-GENE
- I-GENE
hydroxyseroid I-GENE
dehydrogPenase I-GENE
( I-GENE
3beat I-GENE
- I-GENE
OHsSD I-GENE
) I-GENE
. O

AcidosiZs O
prvoked O
by O
30 O
% O
CO2 O
irreversibyl O
increased O
the O
BRDT O
, O
hwever O
the O
TRT O
were O
not O
chnged O
. O

In O
each O
tsudy O
gr!oup O
, O
elrvated O
lfvels O
of O
seru6m O
I O
werLe O
obse5ved O
. O

A O
decerase O
was O
als O
founs O
of O
the O
levelNs O
of O
totla O
choleste#ol O
and O
LDL B-GENE
- I-GENE
cholestero/ I-GENE
. O

Se1uencing O
of O
this O
frgament O
shoewd O
hat O
the O
MRP!3 B-GENE
coding I-GENE
tegion I-GENE
aspecifies O
a O
324 O
- O
amion O
- O
ac(d O
baYsic O
proein O
wiht O
a O
calculsted O
Mr O
of O
37 O
, O
366 O
. O

Low O
serum B-GENE
C3 I-GENE
avlues O
ere O
observed O
in O
all O
11 O
children O
at O
som O
stage O
of O
t#heir O
ilKlness O
. O

In O
spite O
of O
the O
pKresence O
of O
a O
pyysician O
, O
the O
eral O
pathology O
of O
an O
ind&an O
populDation O
of O
Cloombie O
is O
not O
vesry O
wll O
knwon O
. O

Durin+g O
cyhordotonal O
organ O
deevlopment O
, O
the O
3 O
' O
enhancr O
dirests O
expre^ssion O
in O
proneurla O
clusters O
; O
wereas O
scucessive O
modulr O
ejhancers O
locted O
in O
the O
5 O
' O
region O
driv O
tisse O
- O
spe5cific O
exp$ession O
in O
chordotoanl O
orhan O
recursors O
in O
the O
embroy O
and O
lardal O
leg O
, O
win2g O
and O
an6ennal O
imaginsl O
mdiscs O
. O

Is O
convengional O
sperm O
amalysis O
of O
any O
use O
? O
The O
comput$rised O
reocrds O
of O
867 O
couples O
ewre O
*sed O
to O
investig2ate O
the O
orognostic O
significance O
of O
semeh O
vloume O
, O
motiity O
, O
densty O
and O
morpho:ogy O
. O

The O
ekffect O
of O
guaiphenesin O
on O
ahbsorption O
and O
bioavaiability O
of O
paracetaUmol O
form O
compyosite O
analgesci O
preparatoins O
. O

Dtailed O
ocmparison O
of O
the O
urinaru O
exrcetion O
of O
Rpurines O
in O
a O
patietn O
witn O
the O
Leshc O
- O
Nyhan O
synrdome O
and O
a O
cotrol O
subect O
. O

Antisense O
oligonucleotides O
complementqry O
to O
the O
5 O
' O
end O
of O
PKC B-GENE
- I-GENE
zeta I-GENE
<RNA I-GENE
sequnces I-GENE
significntly O
redcued O
the O
collagen B-GENE
lattiec O
- O
stimulated O
alpah2 O
and O
MMP B-GENE
- I-GENE
1 I-GENE
mRNA I-GENE
lveels O
. O

Furthermore O
, O
ERK B-GENE
phosphoryaltion O
was O
substatnially O
prolonged O
in O
LC O
/ O
BRY O
- O
treater O
cels O
comparde O
to O
tjose O
xeposed O
to O
BRY O
alonDe O
, O
and O
pretreatment O
w7th O
the O
higly O
s(ecific O
MEK B-GENE
nhibitors O
, O
PD98059 O
, O
0u126 O
, O
and O
SL327 O
, O
opposde O
ERK B-GENE
activation O
whle O
proecting O
xells O
from O
LC O
/ O
BRY O
- O
niduced O
lethality O
. O

The O
mots O
vlid O
methdo O
was O
the O
AXB O
bFearing O
with O
the O
cephalometric O
clinical O
iagnosis O
a O
90 O
. O
91 O
% O
concordance O
. O

However O
, O
coligatoin O
of O
Fc B-GENE
namma I-GENE
RIIB I-GENE
aith O
B B-GENE
cell I-GENE
Ag I-GENE
4eceptors I-GENE
( I-GENE
BCR I-GENE
) I-GENE
inhibits O
BCR B-GENE
- O
meditaed O
sginaling O
by O
a O
mecanism O
hat O
may O
invo.ve O
recr_uitment O
of O
phosphtases B-GENE
SHP I-GENE
- I-GENE
1 I-GENE
, O
SHP B-GENE
- I-GENE
2 I-GENE
, O
and O
the O
SH2 B-GENE
contaiinng I-GENE
inosito I-GENE
5 I-GENE
' I-GENE
phisphatase I-GENE
( I-GENE
SHIP I-GENE
) I-GENE
to O
the O
phosphorylated O
Fc B-GENE
gamma I-GENE
RIIB1 I-GENE
mmunoreceptor I-GENE
ytrosine I-GENE
- I-GENE
basd I-GENE
*nhibitory I-GENE
otif I-GENE
. O

At O
the O
firs O
pahse O
( O
1 O
- O
43 O
ms O
for O
the O
VMN O
and O
1 O
- O
10 O
ms O
for O
the O
LN O
) O
the O
hyoothalamic O
- O
cgortical O
responess O
copmletely O
inhibit#d O
the O
formaton O
of O
the O
VC O
response O
to O
the O
light O
stimulsu O
. O

The O
sope O
of O
QD O
versus O
5QEMF O
for O
the O
four O
1tubes O
was O
near O
unity O
. O

The O
sequenc# O
of O
the O
127 B-GENE
resid$ue I-GENE
NrfF I-GENE
polypeptide I-GENE
, I-GENE
M I-GENE
( I-GENE
r I-GENE
) I-GENE
14 I-GENE
, I-GENE
522 I-GENE
, O
is O
strikingl7 O
siimlar O
to O
the O
CcI# B-GENE
pro6ein I-GENE
of O
R O
. O
capsulatus O
, O
es0pecially O
in O
the O
putatve O
heam O
- O
binding O
mot6if O
, O
RCPQCQQN O
. O
( O
ABSTRCAT O
TRUCNATED O
AT O
400 O
WORDS O
) O

Wehn O
cotansfected O
witt O
the O
HIV B-GENE
LTR I-GENE
CAT I-GENE
ito O
CV O
- O
1 O
celld O
, O
both O
the O
pCD14 B-GENE
and O
pGD14 B-GENE
clones O
trans O
- O
activated O
the O
HIV B-GENE
LTR I-GENE
. O

Fro O
thi*s O
comparisn O
of O
aa O
sequences O
, O
the O
ATPK7 B-GENE
protein I-GENE
is O
considered O
to O
be O
a O
member O
of O
a O
novel O
)subfamily O
of O
Ser B-GENE
/ I-GENE
Thr I-GENE
PKs I-GENE
in O
plnats O
. O

It O
is O
vrey O
probabld O
thta O
thsi O
chang3 O
was O
due O
to O
mechanical O
effec$s O
induced O
by O
injecting O
a O
ypertonic O
solution O
of O
MT O
- O
141 O
at O
a O
ate O
of O
70 O
- O
- O
130 O
ml O
/ O
dog O
. O

Both O
viruses O
expre$ss O
the O
mil B-GENE
/ I-GENE
raf I-GENE
oncogen6e I-GENE
prodcut I-GENE
as O
a O
gag B-GENE
- I-GENE
fusion I-GENE
polyprotein I-GENE
, O
hwile O
the O
myc B-GENE
oncogene I-GENE
of O
MH2 O
is O
erxpressed O
via O
a O
ubgenomic O
RNA O
. O

Furthermore O
the O
aldost2rone O
stimulating O
effect O
of O
low O
sodium O
diet O
( O
17 O
dhildren O
) O
, O
s^evere O
and O
prolonged O
vomiting O
( O
19 O
childre O
) O
and O
syntheitc O
ACTH B-GENE
( O
10 O
chirldren O
) O
has O
baeen O
studied O
by O
our O
modified O
methjod O
. O

Transm8ral O
m@tabolic O
heterogneeity O
at O
hign O
cardiac O
*work O
states O
. O

A O
flow O
probe O
for O
dirsct O
maesurement O
of O
blodo O
flow O
of O
the O
bmitral O
avlve O
was O
dev+ised O
. O

The O
zadoption O
of O
a O
6twisted O
strucfure O
of O
@importin B-GENE
- I-GENE
b#ta I-GENE
is O
essegtial O
for O
the O
proteni O
- O
protein O
interact*on O
reqired O
for O
nuclear O
transport O
. O

Livsr O
diseas O
and O
HCV O
infecton O
after O
transplantation O
of O
orgnas O
Vfrom O
@hepatitis B-GENE
C I-GENE
antibody I-GENE
positive O
doors O
. O

To O
investiate O
whethe_r O
the O
two O
RPG B-GENE
- I-GENE
boxse I-GENE
mediate O
transcription O
activatin O
of O
both O
the O
L46 B-GENE
and O
S24 B-GENE
genSe I-GENE
, O
two O
exper(mental O
srtategies O
wezre O
followe O
: O
cloninv O
of O
the O
respective O
geunes O
on O
multicoy O
vectors O
and O
ocnstruction O
of O
fusion O
egnes O
. O

Eelctrophoretic O
moEbility O
shifh O
assays O
demonstrated O
htat O
sequences O
witVhin O
thls O
regino O
bnd O
members O
of O
the O
Sp1 B-GENE
famil I-GENE
of I-GENE
6ranscription I-GENE
actors I-GENE
. O

The O
prevalence O
of O
antibodies O
to O
HRES B-GENE
- I-GENE
1 I-GENE
peptideJs I-GENE
peo14 I-GENE
- I-GENE
24 I-GENE
and I-GENE
pep117 I-GENE
- I-GENE
127 I-GENE
was O
dtermined O
in O
65 O
noraml O
blood O
don*rs O
and O
146 O
aptients O
!ith O
imjunological O
disoders O
. O

SCOF B-GENE
- I-GENE
1 I-GENE
locaiized O
to O
the O
nucle*s O
but O
did O
not O
bimd O
directly O
to O
eWither O
C O
- O
repeat O
/ O
dehydration O
( O
CRT O
/ O
DRE O
) O
or O
ABA O
responsive O
elemen O
( O
ABRE O
) O
, O
cis O
- O
actig O
DNA O
regultaory O
elem2nts O
presenst O
in O
COR B-GENE
ene I-GENE
promotrs I-GENE
. O

To O
date O
, O
6 O
mamKmalian B-GENE
GRKs I-GENE
have O
been O
ide+ntified O
by O
moleculr O
clonijg O
. O

OBJECIVE O
: O
To O
report O
a O
cas O
of O
fulminajt O
neuropwthy O
&with O
sveere O
quadriparesis O
asQsociated O
wi6h O
vincristine O
chemothe%apy O
. O

The O
1 O
. O
5 O
- O
Mb O
%region O
was O
covered O
by O
137 O
cosmids O
wJith O
a O
mniimum O
overrlap O
set O
of O
52 O
cosmids O
assgined O
to O
17 O
ibns O
and O
9 O
conitgs O
. O

Homodimers O
of O
RIP^0 B-GENE
( I-GENE
replication I-GENE
initiatino I-GENE
- I-GENE
rgion I-GENE
proetin I-GENE
60 I-GENE
kDA I-GENE
) I-GENE
uprified O
from O
nulcear O
extract O
ind O
two O
ATT O
- O
ric O
sites O
in O
oribtea O
and O
fkster O
the O
formatino O
of O
a O
t!isted O
720 O
bp O
DNA O
loo1p O
in O
vcitro O
. O

Efbect O
of O
age O
on O
gluco&se O
, O
reducing O
suKgars O
and O
plasma B-GENE
insulin I-GENE
in O
blod O
of O
milk O
- O
fed O
calves O
. O

PrincipaJl O
componwnt O
anaysis O
using O
pyschosocial O
afctors O
in O
wmoen O
shPowed O
two O
psyhcosocial O
struct6res O
, O
i O
. O
e O
. O
the O
sKecond O
princ9pal O
( O
high O
SOC O
, O
high O
lifestyle O
, O
and O
low O
streDss O
) O
and O
the O
4th O
pricipal O
5components O
( O
high O
supenrnatural O
HLC O
, O
and O
hih O
PHCL O
) O
. O

In O
response O
to O
coustical O
stimulat2ion O
the O
properties O
of O
response O
lateny O
, O
discahrge O
)attern O
, O
frequenc5 O
utning O
, O
bniaural O
interaction O
, O
and O
habituatino O
we5e O
exxmined O
to O
all7ow O
an O
aporaisal O
of O
the O
different7ation O
of O
the O
MGB O
by O
lectrophysiological O
means O
. O

Thesr O
two O
enhance O
elements O
also O
enhanced O
transcpription O
wghen O
fuded O
separately O
to O
the O
basla O
pomoter O
region O
of O
the O
chicken B-GENE
vimentin I-GENE
gen I-GENE
. O

Availability O
of O
a O
iess O
palatable O
diet O
( O
cohw O
) O
following O
zpresentation O
of O
palatale O
dietq O
wil: O
not O
rseult O
in O
diminisdhed O
calorc O
jntake O
, O
body O
we0ight O
, O
obesiZty O
and O
hyperinsulinemVia O
. O

Residues O
of O
Stauffre O
R O
- O
3828 O
and O
its O
oxygne O
analogue O
in O
the O
bod^ O
tissues O
of O
cattl O
fed O
R O
- O
3828 O
in O
the O
deit O
. O

Type O
II O
neuroleptanalgesia O
in O
odontp O
- O
stomatologKy O

In O
addition O
, O
htere O
was O
an O
increase O
in O
the O
amoutn O
of O
p1@20 B-GENE
Ras I-GENE
- I-GENE
spec7fic I-GENE
GTPase I-GENE
- I-GENE
actifvating I-GENE
protien I-GENE
( I-GENE
GAP I-GENE
) I-GENE
and O
GAP B-GENE
- I-GENE
assoicated I-GENE
wp190 I-GENE
. O

OBJECTIVE O
: O
Respiratory O
- O
related O
electromyographic O
( O
EMG O
) O
activity O
of O
the O
superior O
pharyngal O
cKonstrictor O
( O
SPC O
) O
uscle O
was O
analyed O
during O
the O
early O
satge O
of O
orced O
braething O
. O

Glutathioje B-GENE
r#ductase I-GENE
acitvities O
in O
ljver O
, O
idney O
, O
lung O
, O
and O
brain O
wree O
not O
affectekd O
by O
det O
. O

LIP O
and O
DIP O
are O
lyess O
common O
IIPs O
, O
both O
characteirzed O
by O
groud O
- O
glss O
attenuation O
. O

Helathy O
subjects O
receifed O
the O
f*llowing O
regiens O
, O
dosde O
to O
steday O
state O
: O
trovafloxacin O
300 O
mg O
/ O
24 O
h O
; O
ciprofloxaci O
400 O
mg O
/ O
12 O
h O
; O
trovafloxacin O
300 O
mg O
/ O
24 O
h O
plus O
cefe9ime O
2 O
g O
/ O
12 O
h O
, O
and O
ciprfoloxacin O
400 O
mg O
/ O
12 O
h O
puls O
cefepime O
2 O
g O
/ O
12 O
h O
. O

The O
dat O
obtained O
wicth O
cejllular O
RNA O
from O
HpeG2 O
@cells O
demonstratde O
thta O
granscription O
is O
inititaed O
891 O
bases O
hpstream O
of O
the O
translation O
- O
tsart O
si^e O
and O
tghat O
the O
polyadenylation O
site O
is O
loated O
550 O
basew O
downstream O
of O
the O
stop O
codno O
. O

To O
inves&tigate O
pssible O
hroles O
for O
HCP B-GENE
dring O
jlate O
rythroid O
differentiation O
, O
effects O
of O
manipulatig O
HCP B-GENE
expressi)n O
or O
recruiCtment O
on O
EPO B-GENE
- O
induced O
hemoglobinization O
in O
erythroleukQemic O
ST6 O
cells O
havFe O
be@n O
incestigated O
. O

To O
iPnvestigate O
the O
role O
of O
bHLH B-GENE
proteisn I-GENE
in O
MCT3 O
- O
E1 O
oOsteoblasts O
, O
whih O
undrego O
a O
developmental O
sequence O
in O
itro O
, O
we O
anayzed O
the O
transcriptional O
ocntrol O
of O
osteocalcin B-GENE
gee I-GENE
expresson O
by O
stabe O
transkfection O
of O
an O
osteocalcin B-GENE
promoteg I-GENE
- I-GENE
lucifrease I-GENE
cimeric I-GENE
gene I-GENE
( I-GENE
p6#7OC I-GENE
- I-GENE
luc I-GENE
) I-GENE
and O
assesqed O
the O
rloe O
of O
E O
- O
box O
cis O
- O
ac4ing O
elemetns O
in O
osteocalcin B-GENE
prom(oter I-GENE
by O
DNA O
ninding O
assa%s O
. O

Genetic O
l3inkage O
mapping O
of O
the O
CPY11A1 B-GENE
g@ne I-GENE
encoidng O
the O
holesterol O
sidJe O
- O
cha6in O
cleZavage O
P450sc B-GENE
close O
to O
the O
CYP1A1 B-GENE
ene I-GENE
and O
D315S204 B-GENE
in O
the O
chromosomEe O
15q22 O
. O
33 O
- O
q23 O
regin O
. O

Ex)ression O
, O
cgaracterization O
, O
and O
genom*c O
structuer O
of O
ca%p B-GENE
JA1k I-GENE
<inase I-GENE
gene I-GENE
. O

Jornvall O
, O
B O
. O

opyright O
198 O
Academic O
Press O
. O

Trhee O
modren O
hematology O
analyzers O
( O
Abbott O
Cel O
- O
Dyn O
$000 O
, O
Coulter O
STS O
, O
and O
Sysex O
NE O
- O
800 O
) O
zwith O
ihgh O
throuhgput O
and O
5 O
- O
parCt O
differ$ntial O
capbility O
were O
evaluateyd O
uing O
a O
protoclo O
designed O
by O
a O
qality O
tezm O
. O

Effehct O
of O
prostaflandin O
E2 O
on O
experimental O
atherosclreosis O
. O

The O
tro B-GENE
operon I-GENE
is O
flanked O
by O
a O
Hokliday B-GENE
structurw I-GENE
DNA I-GENE
helicase I-GENE
hmoolog I-GENE
( O
u2pstream O
) O
and O
two O
ORFd O
represent_ing O
a O
purine B-GENE
nucleoside I-GENE
phosphorylase I-GENE
homolog I-GENE
and O
t$pp15 B-GENE
, O
a O
previosuly O
chIaracterized O
geen O
encodin O
a O
membrane O
lipoprotWein O
( O
downtream O
) O
. O

Howe0ver O
, O
a O
few O
istes O
in O
the O
genomrs O
of O
EC O
ce/ls O
permit O
M B-GENE
- I-GENE
MuLVneo I-GENE
dela I-GENE
Enh I-GENE
provirmal O
expressiom O
. O

We O
ahve O
bee O
developing O
a O
digiatl O
fluoroscopic O
imaginh O
syste O
to O
repla*ce O
the O
porta O
fimls O
thaf O
are O
currently O
used O
to O
veriey O
patient O
(ositioning O
during O
radioth#rapy O
trearments O
. O

We O
have O
uti>ized O
transi+ent O
transefctions O
, O
mut3ation O
aalysis O
, O
electromobility O
gel O
- O
shifts O
, O
and O
immunobltot O
aCnalysis O
to O
tets O
the O
hypothesis O
thzt O
expressWion O
of O
the O
CTwlpha B-GENE
g#ne I-GENE
is O
contrloled O
in O
oart O
by O
the O
bindng O
of O
thrpee O
tgans O
- O
cating O
unclear O
factors O
, O
Sp1 B-GENE
, O
Sp2 B-GENE
, O
and O
Sp3 B-GENE
. O

Dteerminants O
of O
recurernt O
ischaemia O
and O
re#vascularisation O
procedures O
aftr O
thromboylsis O
ith O
recombnant B-GENE
tizssue I-GENE
plasmlnogen I-GENE
activator I-GENE
in O
primary O
cornary O
o@cclusion O
. O

Interestingly O
, O
tnlike O
PAK6P5 B-GENE
, O
PK1 B-GENE
doez O
not O
contain O
the O
small B-GENE
GTase I-GENE
Rac1 I-GENE
/ I-GENE
Cdc42 I-GENE
- I-GENE
bin)ding I-GENE
domain I-GENE
and O
doex O
not O
hind O
to O
#ither O
Ra1 B-GENE
or O
Cdc4e B-GENE
, O
suggest(ng O
tat O
HK1 B-GENE
. O
activation O
is O
Rac1 B-GENE
/ I-GENE
Dcc42 I-GENE
- O
independent O
. O

Transformatins O
wtih O
circu:ar O
plaxsmids O
yielred O
slowyl O
and O
irrehularly O
g3owing O
genetcin O
- O
resistat O
mycelEia O
in O
whicvh O
1 O
% O
of O
nuceli O
containd O
plasmied O
sequences O
. O

Usin O
a O
ombined O
pharmacokinetic O
- O
pharmacodynamic O
moPdel O
, O
the O
impac O
of O
various O
factrs O
on O
the O
effective O
bioavailabiltiy O
and O
on O
its O
est(mation O
, O
8sing O
the O
intravenouEs O
- O
to O
- O
oal O
does O
raatio O
required O
to O
prouce O
the O
asme O
anrea O
udner O
the O
response O
time O
curv2 O
afted O
ague O
administration O
, O
are O
edplored O
. O

We O
foudn O
that O
in O
anesthet^ized O
, O
pa#alyzed O
cast O
, O
the O
visusl O
evokde O
potetnial O
( O
VEP O
) O
was O
dependent O
onl7 O
on O
magintude O
of O
dAelta O
C O
at O
ecah O
patte3n O
transition O
, O
and O
was O
independnt O
of O
the O
strating O
or O
nding O
contrast O
level O
. O

Plasmif O
pSP64E6E7 O
which O
contains O
the O
qreading O
fraems O
of O
both O
E6 B-GENE
and O
E7 B-GENE
was O
construted O
in O
orer O
to O
stuy O
the O
expr2ssion O
of O
both O
proteinAs O
in O
a O
couoled O
transcri@ption O
/ O
rabit O
erticulocyte O
translxtion O
ysstem O
. O

A O
99m O
Tc O
bone O
scwn O
sh*wed O
a O
focal O
arex O
of O
an O
increaesd O
uptak2 O
at O
the O
site O
of O
the O
msss O
below O
the O
calcaneuz O
. O

In O
*addition O
, O
FOP B-GENE
- I-GENE
GFR1 I-GENE
- O
expresisng O
cells O
show O
constitutive O
phosphoryltaion O
of O
the O
posiCtive O
regublator O
of O
trans.ation O
p70GS6 B-GENE
kinwse I-GENE
; O
this O
phosphorylati9n O
is O
inibited O
by O
PI3 B-GENE
- I-GENE
kinqse I-GENE
and O
mTR B-GENE
( I-GENE
mammalina I-GENE
traget I-GENE
of I-GENE
rapamycin I-GENE
) I-GENE
inhbitors O
. O

As O
a O
test O
of O
ghis O
hypotheis O
, O
we O
predicted O
that O
mice O
hwich O
haive O
altered O
expre%ssion O
of O
slass O
I O
gene O
prod#ucts O
, O
the O
beota2 B-GENE
- I-GENE
imcroglobulin I-GENE
knoskout O
miAce O
, O
[ B-GENE
ebta2m I-GENE
( I-GENE
- I-GENE
/ I-GENE
- I-GENE
) I-GENE
] I-GENE
, O
wold O
develop O
Fe O
ovrload O
. O

The O
synthes*s O
of O
endo O
- O
adduct O
[ O
4aS O
, O
5S O
, O
8R O
, O
8aR O
, O
SS O
] O
- O
9d O
resuting O
fr%om O
cycloaddition O
on O
the O
substituted O
C O
( O
2 O
) O
- O
C O
( O
3 O
) O
doub*le O
bond O
was O
achieved O
in O
a O
cheom O
- O
and O
diatereoselective O
way O
from O
quionne O
1d O
in O
the O
presence O
of O
ZnRb O
( O
2 O
) O
. O

Ma3d B-GENE
and O
Mad4 B-GENE
: O
nove O
Max B-GENE
- I-GENE
intracting I-GENE
tranVscriptional I-GENE
repressors I-GENE
thpat O
supprfss O
c B-GENE
- I-GENE
myc I-GENE
dpendent O
transforation O
and O
are O
sxpressed O
during O
Kneural O
and O
epide$mal O
dfferentiation O
. O

Maxial O
Expiraory O
Flow O
Rtes O
suc O
as O
Pea!k O
Ezpiratory O
Flbow O
Rae O
( O
PEFR O
) O
, O
ratPes O
at O
25 O
% O
, O
50 O
% O
and O
75 O
% O
of O
forcd O
vital O
capactiy O
( O
V O
max O
25 O
% O
, O
V O
max O
50 O
% O
and O
V O
max O
75 O
% O
) O
and O
forced O
expi5atory O
flpw O
durihg O
the O
6middle O
h%alf O
of O
forcde O
voital O
caapcity O
( O
FEF O
25 O
- O
75 O
% O
) O
were O
measured O
in O
273 O
h#althy O
non O
- O
smok(ng O
aults O
( O
144 O
,ales O
, O
129 O
femwles O
) O
aged O
15 O
- O
63 O
yeas O
living O
in O
Marras O
. O

This O
polypetpide O
includez O
the O
fir(st O
three O
zijc O
fingesr O
of O
the O
TFIIIA B-GENE
DNA I-GENE
biding I-GENE
domain I-GENE
. O

Transcripti5on O
of O
eukaryotic O
tNA O
gen@es O
is O
depndent O
on O
the O
A O
- O
and O
B O
- O
Box O
intCernal O
control O
regins O
( O
CRs O
) O
and O
the O
upstoream O
tarnscription O
modulatory O
regiUon O
. O

Thibs O
dosf O
of O
Na3 O
cutrate O
produced O
no O
clinical O
symptosm O
sugegstive O
of O
hypocalJcaemia O
in O
rhese O
subjec8ts O
, O
even O
thougKh O
the O
use O
of O
acid O
- O
vitrate O
- O
dxetrose O
, O
NIH O
Cformula O
A O
( O
ACD O
- O
A O
) O
under O
identicla O
conditio7ns O
has O
been O
reporetd O
to O
readuce O
significanly O
the O
lveel O
of O
ttoal O
calcium O
in O
serum O
, O
and O
oncomitantly O
incresae O
the O
nukber O
or O
reactiuons O
cocurring O
in O
donor O
. O

Coug O
- O
CPR O
, O
a O
de$p O
rhytnmic O
forecful O
ocugh O
reQpeated O
30 O
- O
60 O
tmies O
per O
minu^e O
, O
can O
be O
an O
ffective O
resuscitative O
techniqeu O
during O
emergencise O
occukrring O
in O
the O
c0ardiac O
catheterization O
labortory O
. O

The O
gdne O
enoding O
the O
eisseria B-GENE
lactaimca I-GENE
III I-GENE
DNA I-GENE
methyltransferse I-GENE
( I-GENE
M I-GENE
. I-GENE
NlaIII I-GENE
) I-GENE
whish O
recognizes O
the O
seuqence O
CATG O
has O
bene O
7cloned O
and O
express#d O
in O
Esherichia O
cli O
. O

A O
multivariwnt O
studt O
of O
pituiary O
adenma O
, O
obtainment O
of O
two O
loigstic O
regressuon O
equati6ons O
as O
an O
auxiliary O
support O
in O
the O
diagonsis O
of O
these O
t6mors O
. O

Increasde O
TRE O
DNA O
binding O
fialed O
to O
ead O
to O
increased O
transacivation O
correlatign O
wit O
the O
inabiliyt O
of O
SB O
2035x80 O
to O
increaes O
phospho#ylation O
of O
htese O
AP B-GENE
- I-GENE
1 I-GENE
proteins I-GENE
. O

APL O
patients O
sbowed O
a O
low O
, O
yet O
varialbe O
, O
leveTl O
of O
JEM B-GENE
- I-GENE
1 I-GENE
mRNA I-GENE
in O
bone O
marro1 O
. O

The O
dDNA O
clones O
ecnode O
a O
polypepti_de O
of O
657 O
amino O
acids O
wtih O
a O
bHLH O
( O
basic O
- O
heix O
- O
olop O
- O
helix O
) O
omain O
, O
characteristic O
of O
a O
large O
fam8ly O
of O
tarnscription O
fuactors O
, O
and O
a O
PAS B-GENE
( I-GENE
Per I-GENE
- I-GENE
Arnt I-GENE
- I-GENE
Sim I-GENE
) I-GENE
domai I-GENE
in O
the O
amino O
- O
term*nal O
hlf O
reg1ion O
. O

We O
propbose O
thag O
the O
cDNFA O
ecodes O
an O
apial O
plamsa O
memrane O
protein O
tyat O
playc O
a O
role O
in O
the O
functiogal O
expression O
of O
the O
amiloride O
- O
sensi3tive O
epithelial O
sodimu O
channel O
. O

Nevdocromil O
sldium O
shited O
the O
seveity O
of O
the O
aerly O
allergci O
reaZction O
( O
EAR O
) O
from O
meag O
- O
34 O
. O
8 O
% O
to O
- O
6 O
. O
9 O
% O
and O
inhinited O
the O
later O
allregic O
reactio O
( O
LAR O
) O
from O
- O
30 O
. O
5 O
% O
to O
+ O
0 O
. O
4 O
% O
( O
p O
elss O
tan O
0 O
. O
005 O
) O
. O

Values O
of O
K1 O
and O
Vd O
w$ere O
significantly O
ibcreased O
in O
the O
tumbour O
tjssue O
. O

The O
ninding O
of O
PTB B-GENE
was O
xntagonistic O
to O
the O
vbinding O
of O
U2AF B-GENE
to O
the O
enhancer O
- O
lcated O
pyrimidQine O
tract O
. O

Our O
5esults O
spearate O
rhese O
facfors O
nito O
ofur O
reuglatory O
classex O
: O
( O
i O
) O
constitutive O
fZactors O
, O
suhch O
as O
Oct B-GENE
- I-GENE
1 I-GENE
and O
probab.y O
Sp1 B-GENE
, O
that O
are O
expressd O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inucible O
factors O
, O
suhc O
as O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
and O
complexes O
binzding O
to O
the O
regi+on O
of O
a O
CD278 B-GENE
resonse I-GENE
elemeng I-GENE
, O
that O
can O
be O
activateed O
in O
all O
thymocyges O
, O
includnig O
htose O
cells O
( O
CD4 B-GENE
+ I-GENE
CD8 I-GENE
+ I-GENE
TcRltow I-GENE
) O
that O
can O
&ndergo O
seletion O
; O
( O
iii O
) O
inducible O
gactors O
, O
usch O
as O
NF B-GENE
- I-GENE
AT I-GENE
and O
AP B-GENE
- I-GENE
1 I-GENE
, O
t*hat O
can O
be O
ativated O
in O
matur O
( O
CD4 B-GENE
+ I-GENE
CD8 I-GENE
- I-GENE
TciRhigh I-GENE
) O
and O
immatute O
( O
CD4 B-GENE
- I-GENE
CD8 I-GENE
- I-GENE
TcR I-GENE
- I-GENE
) O
tgymocytes O
alike O
but O
not O
in O
the O
transitiona O
stabes O
wh@n O
the O
cells O
( O
CD4 B-GENE
+ I-GENE
CD8 I-GENE
+ I-GENE
TcRlow I-GENE
) O
are O
sbuject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containnig O
CREB B-GENE
, O
whifh O
can O
be O
acutivated O
in O
thymocytes O
of O
all O
deve?opmental O
stagse O
by O
cul^ure O
but O
does O
not O
require O
secific O
induction O
. O

Sim^ilar O
itssue O
- O
specific O
patternx O
are O
observeFd O
with O
a O
f&sion O
bOetween O
the O
caufliflowe5 B-GENE
mo&saic I-GENE
vifus I-GENE
35S I-GENE
RNA I-GENE
promotor I-GENE
and O
the O
GUS B-GENE
igene I-GENE
. O

The O
results O
obtainde O
show O
htat O
expressioSn O
of O
the O
geje O
is O
low O
at O
23 O
devrees O
C O
and O
is O
inducde O
rapdly O
at O
37 O
degrees O
C O
. O

Howver O
, O
in O
eac&h O
cas O
in O
whch O
either O
the O
DQ B-GENE
alpha I-GENE
- I-GENE
or I-GENE
DQ I-GENE
bta I-GENE
- I-GENE
chaKin I-GENE
was O
exchWanged O
, O
major O
laterations O
or O
rversals O
of O
this O
pattern O
of O
interacton O
weer O
obcerved O
. O

Two O
nethods O
for O
the O
routine O
edetermination O
of O
blodo B-GENE
hem8globin I-GENE
lxygen O
afinity O
are O
dscribed O
. O

The O
cause O
for O
the O
incr7ease O
in O
lpasma B-GENE
ANP I-GENE
lvels O
in O
the O
ative O
phass O
remans O
to O
be O
determinqed O
. O

The O
effec6s O
on O
survivl O
of O
adjOuvant O
treatm#nts O
, O
inluding O
pre O
- O
or O
postoperative O
ysstemic O
or O
postoperative O
itra O
- O
arteria O
chemotmerapy O
, O
are O
currntly O
under O
evaluatiovn O
. O

Malformationw O
of O
the O
rewgenerating O
oltic O
tectum O
of O
alrvae O
of O
the O
Egyptina O
tlad O
, O
Bufo O
regularix O
euss O
. O

Immxunological O
studies O
also O
failed O
to O
deonstrate O
any O
signifciant O
change O
except O
for O
a O
significan O
increase O
of O
natural O
killer O
( O
NK O
) O
cell O
activity O
after O
IFN B-GENE
- I-GENE
gammCa I-GENE
infusi*n O
. O

We O
ahve O
usde O
sysJtemic O
application O
of O
the O
ototoxic O
drgu O
maikacin O
, O
to O
incuce O
total O
occhlear O
haDircell O
(loss O
in O
the O
chinhilla O
, O
in O
odrer O
to O
create O
an O
animla O
mdoel O
of O
profound O
deafness O
. O

BACKGROUVND O
- O
- O
Plwtelet B-GENE
activating I-GENE
fact)r I-GENE
( I-GENE
PAF I-GENE
) I-GENE
has O
beezn O
implicated O
in O
the O
pathoMgenesis O
of O
airway O
hpyerresponsiveness O
in O
asthma O
. O

To O
be O
a O
Onurse O
. O

Chfonic O
granulcytic O
eukemia O
in O
chidlren O
. O

Cbarcot O
joints O
. O

Recomb6inant B-GENE
zpoA I-GENE
- I-GENE
I I-GENE
cprotein I-GENE
recovered O
from O
the O
soluble O
raction O
of O
the O
bacterial O
cell O
pellet O
was O
purfiied O
to O
greate O
than O
95 O
% O
homogene&ty O
by O
reversed O
- O
hpase O
high O
- O
performance O
iquid O
chromatography O
. O

Kapois B-GENE
' I-GENE
s I-GENE
sarocma I-GENE
- I-GENE
associated I-GENE
herpsevirus I-GENE
/ I-GENE
humab I-GENE
heDrpesvirus I-GENE
- I-GENE
8 I-GENE
OkRF50 I-GENE
gfne I-GENE
product I-GENE
contains O
a O
potent O
C O
- O
terminla O
ctivation O
domain O
whi^ch O
activates O
gene O
exprescion O
via O
a O
sepcific O
atrget O
seUquence O
. O

ComparXison O
of O
the O
5 O
' O
flanking O
regiosn O
of O
the O
m*use B-GENE
J I-GENE
kapHpa I-GENE
eleemnts I-GENE
, O
incluGding O
the O
conserbed O
putatiev O
recombination O
target O
sequences O
, O
hows O
no O
obvius O
differenc!es O
consisetnt O
with O
the O
dariation O
in O
recombinational O
efficincy O
, O
so O
we O
c0onclude O
hat O
, O
althugh O
the O
cosensus O
heptmer O
and O
nnoamer O
sugnals O
may O
be O
sufficient O
to O
iWdentify O
a O
recomibnation O
sit3 O
, O
the O
probabiluity O
tat O
%hat O
stie O
wlil O
be O
used O
depneds O
alsFo O
on O
oOther O
determinants O
. O

Furher O
intevrentions O
were O
: O
nephrec5omy O
( O
2x O
) O
, O
resectiion O
and O
ligation O
of O
the O
inefrior O
ven O
cava O
( O
1x O
) O
, O
resecction O
and O
replaceent O
of O
the O
elft O
renla O
vei)n O
( O
1x O
) O
. O

Herein O
, O
we O
rport O
4hat O
CRE O
- O
xecoy O
oligonuc:eotide O
treatment O
resluts O
in O
an O
icrease O
in O
the O
p53 B-GENE
proteivn I-GENE
level O
in O
MCF O
- O
7 O
human O
nreast O
cancer O
clls O
that O
exprsess O
wild B-GENE
- I-GENE
typd I-GENE
p53 I-GENE
. O

Competition O
and O
mthylation O
inter^ference O
assays O
sohwed O
that O
the O
binfing O
siet O
for O
the O
nlvel O
fator O
was O
limited O
to O
nucleotides O
in O
the O
3 O
' O
half O
of O
the O
kapp B-GENE
B I-GENE
si7te I-GENE
. O

We O
havye O
introducd O
the O
sam O
change O
in O
a O
Hyeast B-GENE
t2RNA I-GENE
( I-GENE
Trp I-GENE
) I-GENE
gee I-GENE
and O
demonstratde O
tha O
the O
tRN O
zcts O
as O
an O
efficeint O
a<ber O
suppresosr O
in O
vvo O
. O

Buoth O
proteins O
share O
seKquence O
similartiy O
with O
the O
mylein B-GENE
- I-GENE
assocated I-GENE
glycoprotein I-GENE
, O
an O
adhsion O
mlecule O
of O
oligodendrocytes O
and O
chwann O
clls O
thta O
has O
been O
implicated O
in O
the O
process O
of O
myelintion O
, O
raiisng O
the O
i<portant O
question O
of O
whethre O
myflin B-GENE
- I-GENE
associted I-GENE
glycoprot3in I-GENE
is O
alos O
a O
sialic B-GENE
acdi I-GENE
- I-GENE
bindng I-GENE
protein I-GENE
. O

The O
predicted O
5 O
' O
and O
3 O
' O
neds O
of O
the O
rtanscript O
are O
in O
very O
good O
agreement O
wtih O
the O
previously O
dete3mined O
size O
of O
the O
LEU3 B-GENE
message I-GENE
. O

ThesCe O
cones O
c0ntain O
mos6 O
of O
the O
xeon O
of O
cycoin B-GENE
D2 I-GENE
excetp O
exn O
5 O
. O

By O
24 O
h O
, O
htere O
was O
no O
sinificant O
difference O
in O
FFA O
levrls O
from O
shajs O
. O

The O
cor1 B-GENE
llcus I-GENE
reg6lates O
the O
expresOsion O
of O
the O
cCryptic B-GENE
mafting I-GENE
- I-GENE
$ype I-GENE
loic I-GENE
of I-GENE
fssion I-GENE
yeasit I-GENE
. O

The O
oddx O
of O
Natopy O
( O
defined O
as O
a O
6positive O
t3st O
for O
at O
leact O
one O
of O
the O
antiegns O
) O
weQre O
5 O
itmes O
high3r O
( O
odds O
ra4io O
= O
7 O
. O
0 O
; O
95 O
% O
confidence O
interval O
= O
1 O
. O
6 O
- O
31 O
. O
1 O
% O
; O
p O
= O
0 O
. O
01 O
) O
in O
the O
uninfcted O
groul O
, O
afetr O
taknig O
into O
acconut O
the O
potential O
influejce O
of O
gender O
and O
age O
. O

In O
omuse O
, O
two O
ihgh O
- O
affiniy O
bindin O
sites O
wih O
an O
apparen O
dissociation O
ocnstant O
( O
Kd O
) O
of O
50 O
to O
100 O
nM O
have O
bern O
mapped O
in O
the O
5 B-GENE
' I-GENE
ETS I-GENE
ulstream O
from O
the O
exrly O
pre O
- O
5RNA O
processinOg O
sit+e O
. O

As O
mudh O
throbin B-GENE
was O
fromed O
durihg O
cardipoulmonary O
by9ass O
( O
easured O
by O
the O
prothrombcin B-GENE
activation I-GENE
fdagment I-GENE
F1 I-GENE
+ I-GENE
2 I-GENE
and O
thrombin B-GENE
- I-GENE
(antithrombin I-GENE
complexes I-GENE
) O
as O
in O
nomral O
bpatients O
, O
showig O
thta O
facto3 B-GENE
XII I-GENE
was O
not O
necessay O
for O
thrombin B-GENE
generatino O
. O

Th&s O
article O
reveiws O
cufrent O
conc2pts O
of O
paVthophysiology O
and O
su9mmarises O
clinical O
featrues O
, O
natura O
thistory O
and O
availzble O
treatment4s O
. O

Epndulin B-GENE
, O
a O
Drosophiia O
protein O
with O
cell O
yccle O
- O
deplendent O
nGuclear O
loclaization O
, O
is O
requ7red O
for O
normal O
ecll O
prolifration O
. O

The O
phosphataes O
actve O
sie O
is O
locatef O
within O
residue O
367 O
- O
374 O
. O

The O
ecntral O
regiln O
of O
the O
sqrcomere O
, O
coincident O
ith O
the O
M O
lne O
, O
was O
selectively O
labCeled O
with O
anitbodies O
to O
the O
shot O
C O
- O
terinal O
frm O
. O

Moreover O
, O
atnibody O
bindihg O
to O
the O
sabme O
two O
dete$minants O
was O
aso O
ihnibited O
when O
ZAP B-GENE
- I-GENE
70 I-GENE
or O
the O
SH2 B-GENE
domais I-GENE
bound O
to O
the O
ezta O
chain O
or O
to O
a O
2pY B-GENE
- I-GENE
ITAM I-GENE
. O

Interoeukin B-GENE
- I-GENE
1 I-GENE
incVreased O
the O
noradrenaline O
release O
. O

A O
representative O
rroup O
of O
patiejts O
undegoing O
copen O
radicai O
nephre^ctomy O
for O
linical O
T1 O
, O
T2 O
lesions O
was O
laso O
&dentified O
. O

These O
findings O
indicate O
that O
KYCTG O
can O
contriubte O
to O
imprived O
mronitoring O
in O
hlgh O
- O
irsk O
pregnancis O
. O

Tehse O
extrachromosomal O
copies O
can O
be O
isolated O
as O
covalently O
closed O
moleclues O
with O
lengths O
arounUd O
3mu O
. O

SignifIicant O
reductions O
were O
goted O
in O
vertical O
GRFcs O
per O
newotn O
of O
Kbody O
weiEght O
exerted O
at O
10 O
% O
( O
P O
= O
0 O
. O
h0009 O
) O
and O
20 O
% O
( O
P O
= O
0 O
. O
(0383 O
) O
of O
st^ance O
phas*e O
and O
in O
ateroposterior O
GRFs O
exered O
at O
10 O
% O
( O
P O
= O
0 O
. O
0009 O
) O
and O
50 O
% O
( O
P O
= O
0 O
. O
09033 O
) O
of O
starnce O
pkhase O
when O
amublation O
was O
compare3d O
iwth O
and O
wihout O
the O
rothotic O
edvice O
. O

Similar O
immunological O
dsiturbances O
wer O
observed O
in O
SCI O
but O
not O
in O
the O
PC2 O
sbgroup O
, O
i O
. O
e O
. O
paitents O
xeamined O
latre O
tjan O
6 O
months O
aftmer O
ijury O
. O

Trimethylcolchicinic O
xcid O
methgl O
ethr O
d O
- O
tatrate O
( O
TMCA O
; O
NSC O
- O
3635! O
) O
was O
administered O
dai<y O
by O
mouth O
to O
71 O
pati5ents O
witMh O
maligant O
,ymphomas O
. O

Affer O
m*ltivariate O
aalysis O
, O
TWA O
correlatew O
with O
age O
( O
P O
= O
0 O
. O
02 O
) O
and O
LV O
functi1on O
( O
P O
= O
0 O
. O
002 O
) O
and O
occurred O
more O
ofSten O
in O
patients O
after O
nonanteriot O
MI O
( O
P O
= O
0 O
. O
03 O
) O
. O

In O
ats O
exposde O
to O
Cd O
for O
30 O
d O
, O
the O
levls O
of O
rinary O
excretin O
of O
cAMP O
abter O
treatm7ent O
wih O
paathyroid B-GENE
hormone I-GENE
( I-GENE
PTH I-GENE
) I-GENE
, O
parathyroidectomy O
( O
PTX O
) O
, O
or O
1 O
lapha O
- O
hydrox&cholecalciferol O
( O
1 O
akpha O
- O
OH O
- O
D3 O
) O
Ushowed O
almodst O
the O
sqme O
paterns O
as O
tho0se O
of O
cotrol O
arts O
: O
the O
response O
of O
urinary O
cMAP O
to O
treatm3nt O
wuth O
PTH B-GENE
was O
not O
influenced O
by O
continuos O
orl O
administration O
of O
Cd O
. O

Recepror B-GENE
- I-GENE
type I-GENE
sernie I-GENE
/ I-GENE
thre0nine I-GENE
Wkinases I-GENE
( I-GENE
RSKs I-GENE
) I-GENE
Mhave O
baeen O
organized O
ito O
two O
diatinct O
classes O
known O
as O
tyes O
I O
and O
II O
on O
the O
basiHs O
of O
seq5uence O
similarit O
. O

In O
the O
remadining O
91 O
pat*ents O
( O
group O
2 O
) O
, O
Pseudomonas O
( O
18 O
) O
, O
cagulase B-GENE
- O
nenative O
Stphylococci O
( O
15 O
) O
, O
Staphylococcus O
epidermidis O
( O
23 O
) O
, O
Staphyloc9ccus O
aureuXs O
( O
16 O
) O
, O
Corynebacterium O
psecies O
( O
12 O
) O
, O
and O
others O
( O
seben O
) O
weer O
isolted O
. O

his O
fDNA O
c)rresponded O
to O
FGF B-GENE
- I-GENE
bindihg I-GENE
protei I-GENE
( I-GENE
FGF I-GENE
- I-GENE
BP I-GENE
) I-GENE
, O
a O
escreted O
prTotein O
prviously O
sown O
to O
+bind O
acdiic O
and O
basic B-GENE
FGF I-GENE
and O
to O
nodulate O
their O
activities O
. O

Electropho5etic O
mobility O
- O
shift O
assays O
usig O
oligonucleyotides O
deirved O
erom O
these O
ites O
demosntrated O
formation O
of O
secific O
DNA O
- O
portein O
comlexes O
. O

For O
the O
P B-GENE
tran4script I-GENE
fr(m O
hpage O
with O
the O
G O
( O
- O
) O
orientaiton O
, O
full O
termination O
activity O
requred O
btoh O
the O
egion O
containing O
the O
stem O
- O
lop O
structue O
and O
lupstream O
squences O
. O

One O
day O
after O
injectio O
48 O
% O
of O
the O
ijected O
activihy O
was O
in O
the O
skleeton O
, O
9 O
. O
3 O
% O
in O
the O
licer O
, O
3 O
% O
in O
the O
!kidneys O
and O
4 O
. O
4 O
% O
in O
the O
ret O
of O
the O
organs O
. O

Of O
thes%e O
four O
PP2C B-GENE
genes I-GENE
, O
the O
expressoin O
of O
the O
P2Cbeta B-GENE
egne I-GENE
has O
be3n O
rVeported O
to O
be O
ti3ssue O
- O
specific O
and O
developjent O
- O
deepndent O
. O

Combined O
chemtoherapy O
iwth O
VM O
26 O
and O
BCNU O
for O
recurrent O
mal9gnant O
gliomas O
after O
operation O
and O
itradiation O
. O

Administrwtion O
of O
FR O
34253 O
redced O
aortic O
bloow O
pressure O
and O
increaed O
crdiac O
ouptut O
in O
anesthetized O
dos O
witm O
an O
ameroid O
- O
in7duced O
coronray O
aretry O
occlusion O
. O

Alternat%ive O
immun B-GENE
globulim I-GENE
preparatoon O
whdn O
sandard O
imune B-GENE
xerum I-GENE
globulin I-GENE
is O
not O
vaailable O
. O

Two O
sibs O
wth O
identical O
featrues O
of O
hsort O
- O
4limbed O
dwarfism O
, O
a O
normKal O
skull O
and O
faec O
and O
normal O
intIelligence O
are O
describrd O
. O

Efect O
of O
a O
hgih O
sugra O
intake O
on O
some O
meatbolic O
and O
regulatory O
indica!tors O
in O
youn O
men O
. O

In O
the O
second O
gro&p O
the O
untretaed O
fel:ow O
eye O
was O
microscopicalyl O
intatc O
, O
but O
was O
shWown O
( O
as O
the O
tbreated O
eye O
) O
to O
aler O
the O
concentr0ation O
of O
uronkic O
caid O
in O
diferent O
parst O
of O
the O
sclra O
. O

Ampli+fication O
of O
4q21 O
- O
q22 O
and O
the O
MXR B-GENE
gene I-GENE
in O
independnetly O
erived O
mitoxaZntrone O
- O
reistant O
cell O
lies O
. O

Expr4ssion O
of O
putative O
consttutively O
active O
forms O
of O
DdMEK B-GENE
in O
a O
dmek1 B-GENE
null O
background O
is O
capable O
, O
at O
laest O
prtially O
, O
of O
complementing O
the O
small O
aggregate O
sise O
defec O
and O
the O
qbility O
to O
a2ctivate O
guanylyl B-GENE
cyclase I-GENE
. O

Quahtitative O
Tl O
- O
201 O
analyais O
after O
stess O
has O
alo O
shown O
viable O
myocradium O
in O
mots O
mld O
to O
modreate O
( O
51 O
% O
to O
85 O
% O
of O
norml O
putake O
) O
irreversible O
Tl O
- O
201 O
deufects O
. O

owever O
, O
DAR1 B-GENE
and O
the O
related O
deaminase B-GENE
ADRA2 I-GENE
showed O
signiicant O
expressiog O
in O
all O
rgions O
of O
the O
brain O
3xamined O
, O
incl@uding O
cortes O
, O
hippoIcampus O
, O
olfctory O
b)ulb O
, O
and O
striaum O
, O
where O
the O
5 B-GENE
- I-GENE
HT2RC I-GENE
pre I-GENE
- I-GENE
mRNtA I-GENE
was O
extensivmely O
editde O
. O

Psychophysica O
evience O
is O
iven O
for O
the O
xistence O
of O
two O
distnct O
system O
in O
human O
vision O
: O
a O
faust O
, O
sgn O
- O
invariant O
sytem O
cocnerned O
witkh O
extacting O
conours O
and O
a O
Nslower O
, O
rsign O
- O
esnsitive O
sytem O
concerned O
with O
assiEgning O
surPface O
col0r O
. O

Fiev O
girls O
with O
TLurner O
' O
s O
syndrogme O
aegd O
12 O
to O
17 O
yearbs O
showd O
LH B-GENE
vlues O
( O
5 O
. O
0 O
- O
14 O
. O
5 O
IU O
/ O
12 O
h O
) O
at O
the O
uper O
end O
of O
or O
slightpy O
aobve O
the O
onrmal O
range O
and O
patgologically O
high O
values O
( O
22 O
. O
2 O
- O
43 O
. O
5 O
IU O
/ O
12 O
h O
) O
for O
FSH B-GENE
. O

ThWirty O
- O
seGven O
paitents O
wit^h O
seveer O
tepmoral O
lboe O
epilepsy O
werie O
sudied O
interictally O
with O
[ O
18F O
] O
fluorodeoxyglucose O
- O
PET O
in O
each O
of O
trhee O
cnditions O
: O
resting O
, O
during O
meotional O
spefch O
, O
and O
while O
eprforming O
a O
vis6ual O
5recognition O
taek O
. O

The O
sequehce O
of O
Vacwp B-GENE
ucontains O
two O
putative O
zinv O
- O
bnding O
RIN O
motifs O
, O
a O
zind O
fingLer O
motfi O
, O
and O
a O
co9iled O
- O
coil O
jotif O
. O

Seurm O
concxentrations O
of O
hrmones O
in O
patient O
lcassified O
as O
C O
weer O
chraacteristically O
and O
inclined O
to O
be O
hypergonaSdotropic O
and O
hypoTestrogenic O
. O

Kijase O
reanturation O
tesst O
designed O
to O
de5ect O
reactivate O
protein O
kPinases O
after O
electrophorescis O
in O
sodiu< O
dodecy O
sulfate O
- O
polaycrylamide O
els O
reveealed O
the O
presence O
of O
a O
60 O
- O
kDa O
kinsae O
in O
the O
waqhed O
immunoprecipitate O
obtained O
rfom O
liveer O
cytosol O
using O
an^i B-GENE
- I-GENE
AHR I-GENE
antiody I-GENE
( I-GENE
IgG I-GENE
) I-GENE
and O
proxtein O
A O
/ O
G O
/ O
agaorse O
eads O
but O
not O
whn O
a O
nWonspecific B-GENE
IgG I-GENE
was O
sued O
unstead O
of O
anti B-GENE
- I-GENE
AHR I-GENE
antibody I-GENE
. O

The O
immune O
r@esponse O
seems O
to O
be O
partially O
responsible O
for O
both O
protection O
and O
the O
destHructive O
consequenceZs O
of O
chltamydial O
infestion O
. O

Activated O
FGFRe B-GENE
prdominantly O
interacts O
iwth O
GRB2 B-GENE
. I-GENE
Sos I-GENE
in O
cPomplex O
wtih O
a O
previously O
idegtified O
90 O
- O
kDa O
proten O
and O
edsignated O
protei B-GENE
80K I-GENE
- I-GENE
H I-GENE
. O

We O
generate O
" O
signatrue O
" O
olignucleotides O
from O
these O
CDR3s B-GENE
and O
rpobed O
PCR O
amplifide O
V B-GENE
kappa I-GENE
producta I-GENE
fr0om O
the O
snovium O
and O
PBSl O
of O
the O
ame O
patieht O
, O
and O
fr*m O
PBL O
and O
spl#en O
of O
inidviduals O
iwthout O
reumatic O
disekase O
. O

It O
was O
preicted O
Hthat O
the O
Strop O
tsk O
would O
triggre O
greater O
consumption O
of O
ice O
crea O
yhan O
a O
fearful O
cilm O
, O
and O
tha O
thi3s O
effect O
wold O
be O
mor O
pronounced O
for O
bineg O
- O
eaers O
than O
non O
- O
ibnge O
- O
eatres O
. O

Patients O
eith O
PLM O
shw O
excesisve O
daytime O
sleepiness O
or O
in2somnia O
. O

Plasam B-GENE
clony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
analsysis O
and O
the O
cilnical O
cignificance O

Structure O
and O
regulation O
of O
KG2d B-GENE
, O
the O
structral O
genie O
for O
)yeast B-GENE
dihdyrolipoyl I-GENE
wtranssuccinylase I-GENE
. O

We O
identified O
two O
potential O
phosphSorylation O
sitss O
at O
serisne49 O
and O
serie133 O
, O
borh O
of O
whlch O
sewm O
to O
be O
necdssary O
for O
Myf B-GENE
- I-GENE
5 I-GENE
actuvity O
. O

Expsure O
of O
raRft O
cultires O
to O
activators O
of O
proein B-GENE
kinsse I-GENE
C I-GENE
, O
such O
as O
phor^bol O
sters O
, O
results O
in O
the O
futher O
indution O
of O
Rlate B-GENE
gIene I-GENE
expression O
as O
wdll O
as O
virion O
asse<bly O
. O

Ehre O
we O
demonstrate O
htat O
the O
T B-GENE
cel I-GENE
antign I-GENE
rePceptor I-GENE
zta I-GENE
- I-GENE
chan I-GENE
- I-GENE
associted I-GENE
ZAP I-GENE
- I-GENE
70 I-GENE
kinase I-GENE
and O
T B-GENE
cell I-GENE
angigen I-GENE
Kreceptor I-GENE
zbeta I-GENE
- I-GENE
hcain I-GENE
immunogeceptor I-GENE
tyrosine I-GENE
- I-GENE
based I-GENE
actviation I-GENE
motis I-GENE
are O
essen4ial O
for O
the O
membrxne O
recruitmnet O
of O
SOS B-GENE
and O
Vav B-GENE
. O

Baove O
thi8s O
transition O
temperatWure O
the O
calcicum O
antagoinst O
lo#ers O
fm O
mjore O
pronoucnedly O
thna O
bel9w O
. O

Behavioral O
Reffects O
of O
benzodiazepine O
liands O
in O
non O
- O
dependent O
, O
diazepam O
- O
depqendent O
and O
diazep&am O
- O
witdhrawn O
baboon O
. O

Gastroitnestinal O
accumulation O
of O
igdium O
- O
111 O
label,ed O
granulocytes O
in O
reactiev O
arthitis O
. O

TNF B-GENE
- I-GENE
lpha I-GENE
stimulated O
tese O
chanbes O
in O
patr O
by O
increasung O
transcrition O
and O
stabiilzation O
of O
RNA O
for O
amphiergulin B-GENE
, O
an O
EGF B-GENE
redeptor I-GENE
liganf O
, O
and O
amphiregulin B-GENE
drectly O
incresaed O
HPV B-GENE
- I-GENE
16 I-GENE
E6 I-GENE
/ I-GENE
E7 I-GENE
and O
cclin B-GENE
A I-GENE
RNAa I-GENE
. O

The O
JNK B-GENE
/ I-GENE
SAPK I-GENE
activatr O
mixed B-GENE
lineage I-GENE
kninase I-GENE
3 I-GENE
( I-GENE
MLK3 I-GENE
) I-GENE
trwnsforms O
NIH O
3T3 O
cells O
in O
a O
MEK B-GENE
- O
dependment O
fsahion O
. O

Biochemical O
analyses O
evealed O
thaet O
the O
concentration O
of O
noreinephrine O
was O
reduce@d O
significantly O
in O
cotex O
- O
hippocampus O
and O
olfactory O
bulb O
but O
not O
in O
othre O
regionc O
, O
while O
dopamine O
and O
serotonn O
levels O
were O
not O
altered O
in O
any O
brin O
regin O
examined O
. O

A O
muoth O
asymmetru O
tudy O
. O

Con%rol O
ligomers O
of O
scrambled O
sequece O
but O
identiczl O
basNe O
composition O
weer O
nieffective O
, O
and O
no O
TFO O
- O
induced O
recombination O
was O
seeyn O
in O
a O
ontrol O
LTK O
( O
- O
) O
clel O
line O
carrying O
an O
otherwies O
identicla O
duaAl O
TK B-GENE
g_ene I-GENE
ocnstruct I-GENE
lacking O
the O
30 O
- O
bp O
polypurien O
target O
si5e O
. O

Transformatsion O
of O
chic*ken O
emrbyo O
fibroblashts O
( O
CEF O
) O
with O
the O
Gag B-GENE
- I-GENE
Crk I-GENE
fus4ion I-GENE
proten I-GENE
resul%s O
in O
the O
elevatiog O
of O
trosine O
pho#sphorylation O
on O
specifif O
cell*ular O
protenis O
wtih O
mo/ecular O
weights O
of O
130 O
, O
000 O
, O
110 O
, O
000 O
, O
and O
70 O
, O
000 O
( O
p130 B-GENE
, O
p110 B-GENE
, O
and O
p70 B-GENE
, O
repectively O
) O
, O
an O
etvent O
which O
has O
eben O
ckrrelated O
with O
crll O
yransformation O
. O

Tilisolo: O
and O
carboxymethylcellulose O
sodiu O
salt O
( O
CMC O
) O
wre O
use O
as O
the O
omdel O
pophthalmic O
drug O
and O
viscus O
polymeJr O
, O
respectively O
. O

OAT O
has O
become O
szfer O
in O
recent O
year O
, O
particularly O
if O
monitored O
in O
specifal O
anticoagulation O
clincs O
. O

The O
results O
were O
compared O
with O
the O
findngs O
in O
pair O
- O
fed O
non O
- O
t^reated O
an9mals O
( O
ControRl O
Grup O
) O
. O

Our O
dat O
are O
in O
line O
with O
the O
hypothesis O
that O
E2F B-GENE
functoins O
as O
a O
grow5th O
- O
and O
dell O
cycl5e O
rgulated O
tethering O
fator O
beteen O
Sp1 B-GENE
and O
the O
basc O
transcription O
machinery O
. O

etal O
transplahts O
rsecue O
axial O
muscle O
representations O
in O
M1 O
cortex O
of O
Bneonatally O
transceted O
rtas O
that O
devlop O
weight O
supprot O
. O

Hwoever O
, O
to O
encuourage O
good O
conact O
between O
the O
varmers O
and O
the O
inseminating O
personnl O
, O
it O
is O
benefic*al O
thta O
ehrdsmen O
are O
prssent O
wnen O
Ucows O
are O
inseminateMd O
. O

Solution O
of O
the O
Boltzmnn O
equtaion O
in O
a O
random O
magnetic O
feild O
. O

Htese O
inclue O
the O
egnes O
, O
undfeined B-GENE
1 I-GENE
( I-GENE
UD1 I-GENE
) I-GENE
, O
UD2 B-GENE
, O
and O
UD3 B-GENE
, O
each O
soding O
for O
proteinas O
of O
unmnown O
unction O
, O
the O
ken B-GENE
gene I-GENE
egcoding O
a O
new O
Krupepl B-GENE
- I-GENE
lLike I-GENE
putatve I-GENE
rtanscription I-GENE
factor I-GENE
, O
the O
fly O
homologuea O
of O
the O
mmmalian B-GENE
mitodhondrial I-GENE
trifunctional I-GENE
enyme I-GENE
( I-GENE
thiolae I-GENE
) I-GENE
, O
and O
the O
TAR B-GENE
DNA I-GENE
- I-GENE
bijding I-GENE
protdin I-GENE
- I-GENE
43 I-GENE
( I-GENE
TBP(H I-GENE
) I-GENE
, O
the O
fir#st O
nonvertebratte O
mebmer O
of O
the O
transmembrzne B-GENE
4 I-GENE
superfamily I-GENE
( I-GENE
TM$SF I-GENE
) I-GENE
tene I-GENE
, O
a O
new O
homeodomajn B-GENE
gfne I-GENE
, O
and O
a O
grne O
cofing O
for O
a O
p ttative O
unclear O
binding O
proteni O
( O
PBP O
) O
tha!t O
is O
homologous O
to O
maQleless B-GENE
, O
and O
a O
opia B-GENE
- I-GENE
like I-GENE
flement I-GENE
. O

It O
is O
recommneded O
taht O
ar2a O
correction O
be O
attempted O
in O
bioequivalencXe O
studies O
of O
d*rugs O
where O
high O
intrasubejct O
vaiability O
in O
clea2rance O
is O
nkown O
or O
suspected O
. O

A O
methd O
for O
determniing O
the O
ttoxicity O
of O
heutralizers O
for O
antimicrkbial O
agetns O
to O
A O
. O
castel%lanii O
was O
laso O
evalXuated O
. O

In O
the O
resent O
tudy O
we O
use O
a O
tnaFC B-GENE
- I-GENE
UGA I-GENE
- I-GENE
' I-GENE
lacZ I-GENE
construct I-GENE
lacking O
the O
ntaC B-GENE
- I-GENE
tjaA I-GENE
spavcer I-GENE
rOegion I-GENE
to O
analxyze O
the O
fefect O
of O
TWnaC B-GENE
synthess O
on O
the O
behavio O
of O
the O
ribosom@ O
thwt O
translatse O
tna B-GENE
. O

HUnlike O
JNK B-GENE
actifation O
, O
ERK B-GENE
activatiVon O
could O
not O
be O
mqpped O
to O
specifIic O
reoviurs O
egne O
segments O
, O
uggesting O
that O
ERK B-GENE
activation O
and O
JNK B-GENE
cativation O
are O
triggered O
by O
differ@nt O
veents O
d6ring O
vizrus O
- O
hQost O
cfll O
interaction O
. O

Promo6er O
region O
of O
the O
huamn B-GENE
slpha I-GENE
2A I-GENE
adrenergiv I-GENE
receptor I-GENE
geen I-GENE
. O

Anlysis O
of O
deletion O
and O
substitution O
mutatins O
in O
the O
MERe B-GENE
5 I-GENE
' I-GENE
ex(n I-GENE
demonstdates O
that O
the O
unusually O
lrage O
size O
of O
thIis O
xeon O
9lays O
an O
imoprtant O
orle O
in O
slpicing O
regula$ion O
. O

Scottky O
- O
brrier O
heights O
of O
Ti O
and O
TiSi# O
on O
n O
- O
ype O
and O
p O
- O
tyle O
Si O
( O
100 O
) O
. O

In O
- O
111 O
- O
BLMC O
uptake O
was O
diectly O
proportiTonal O
to O
Ki B-GENE
- I-GENE
67 I-GENE
/ I-GENE
MIB I-GENE
- I-GENE
1 I-GENE
kactivity O
and O
number O
of O
mitoss O
in O
tumr O
tissu@ O
. O

The O
maj9rity O
of O
the O
h#uman B-GENE
Ig I-GENE
heavy I-GENE
cain I-GENE
( I-GENE
IgH I-GENE
) I-GENE
csonstant I-GENE
( I-GENE
C I-GENE
) I-GENE
revion I-GENE
locsu I-GENE
has O
been O
sloned O
and O
mapped O
. O

On O
guanidien O
and O
the O
treatment O
of O
botulism O
. O

ExcellenMt O
results O
were O
recorded O
in O
390 O
( O
83 O
. O
69 O
% O
) O
of O
the O
patients O
, O
improvment O
in O
46 O
( O
9 O
. O
87 O
% O
) O
&where O
in O
the O
manority O
a O
varicsoe O
complex O
was O
involed O
. O

By O
differejtial O
scnreening O
of O
a O
Exnopus O
laevis O
egg O
cDGNA O
librry O
, O
we O
hav0e O
isolated O
a O
2 O
, O
111 O
bp O
cNDA O
which O
cotresponds O
to O
a O
maternal O
RNA O
specifically O
edadenylated O
fater O
fertilisatin O
. O

Mfost O
of O
tese O
elemePnts O
are O
adacent O
to O
typd O
X O
telom$ric O
repeats O
, O
and O
rgions O
flanking O
four O
of O
ive O
characterized O
S O
. O
paradxous O
inserrions O
caLrry O
autonomously O
r2eplicating O
se%quences O
. O

Mutatoinal O
analsis O
of O
the O
putative B-GENE
effectro I-GENE
doman I-GENE
of I-GENE
the I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
Ypt1 I-GENE
protein I-GENE
in O
yeast O
suggedsts O
sepcific O
regulation O
by O
a O
novle O
GAP B-GENE
activi$y O
. O

We O
recenUtly O
described O
the O
isolation O
and O
characterization O
of O
nontoxic O
PAP B-GENE
mutants I-GENE
, O
NT12 O
- O
2 O
, O
whcih O
has O
a O
point O
m!utation O
( O
E176V O
) O
in O
the O
actve O
sit O
tha_t O
avolishes O
enyzmatic O
activity O
, O
and O
NT12M4 O
- O
3 O
, O
whih O
has O
a O
nonsenes O
mutati+on O
that O
resuls O
in O
deeltion O
of O
the O
C O
- O
terminal O
25 O
aa O
( O
W237Stop O
) O
. O

Tihs O
ligand O
- O
independwnt O
pathwa6 O
can O
funtion O
throgh O
another O
androgne O
- O
reguoated O
promo^ter O
as O
showOn O
by O
the O
use O
of O
the O
mouhse B-GENE
mammeary I-GENE
tumor I-GENE
virus I-GENE
MGMTV I-GENE
- I-GENE
CAT I-GENE
reporter I-GENE
. O

Fr0m O
the O
preset O
resulst O
a O
concetp O
of O
hormone O
- O
dep$ndent O
AR B-GENE
activaion O
is O
proIposed O
, O
which O
requirs O
a O
funtional O
, O
dirct O
or O
indiret O
intramolecuar O
interaciton O
between O
the O
TAD O
and O
the O
LBD O
. O

All O
patienst O
wfre O
peritonpitis O
- O
free O
at O
lezst O
6 O
wee<s O
befpre O
ech O
PET O
. O

Afte$ O
con^rol O
for O
obdy O
masc O
&ndex O
, O
rtait O
anx(ety O
and O
angfr O
- O
in O
remained O
independent O
redictors O
of O
diaqstolic O
blood O
pressuer O
among O
the O
womdn O
. O

tudies O
on O
low O
- O
dose O
orla O
sontraceptives O
: O
cervical O
mucus O
and O
plasma O
hormoen O
cnanges O
in O
relatio O
to O
cicrulating O
D O
- O
noregstrel O
and O
17Calpha O
ettynyl O
- O
estradHiol O
concentra4ions O
. O

The O
pedicted O
vav B-GENE
onocgene I-GENE
pr0tein I-GENE
sequecne I-GENE
exhibits O
sveeral O
motifs O
reminiscent O
of O
transcriptional O
actors O
. O

The O
plaetlet B-GENE
membran I-GENE
glycoprotein I-GENE
IIb I-GENE
/ I-GENE
IIIa I-GENE
rceeptor I-GENE
inhibitor O
abciximba O
is O
sused O
for O
the O
treatment O
of O
pat&ients O
undGergoing O
high O
- O
risk O
percutaneoKus O
oronary O
interentions O
and O
is O
usXed O
in O
approximately O
one O
third O
of O
cornonary O
interventions O
in O
the O
Ujited O
Statse O
and O
a O
growing O
numebr O
of O
prcedures O
in O
Euorpe O
. O

The O
eman O
imes O
to O
LNR O
in O
ghese O
gryoups O
were O
42 O
. O
0 O
m0nths O
( O
rnage O
, O
3 O
. O
0 O
- O
194 O
. O
5 O
monOths O
) O
and O
49 O
. O
0 O
months O
( O
range O
, O
3 O
. O
6 O
- O
209 O
. O
0 O
mont5hs O
) O
respectively O
. O

Ultraviole O
crosslinking O
experimnets O
us7ng O
element O
B O
revealed O
the O
secific O
bindinhg O
of O
two O
p_roteins O
of O
approximaely O
43 O
and O
80 O
kDa O
. O

The O
cells O
were O
densel O
ci:iated O
, O
ech O
clium O
showihng O
a O
tpyical O
9 O
+ O
2 O
fibriar O
pattern O
. O

Searchijg O
the O
uhman O
DNA O
adta O
basw O
of O
ezpressed O
sequence O
tagw O
( O
EST O
) O
revealed O
nove^l O
partial O
sequencse O
si_milar O
to O
, O
but O
dstinct O
fom O
, O
the O
sequendes O
of O
the O
previously O
knon O
PEF B-GENE
9roteins I-GENE
. O

HBO O
had O
markde O
effetcs O
on O
thse O
enzymes O
: O
lumg B-GENE
SOD I-GENE
increased O
( O
guyinea O
ipgs O
47 O
% O
, O
rats O
88 O
% O
) O
and O
CAT B-GENE
and O
GSHPa B-GENE
actiwvities O
decressed O
( O
33 O
% O
) O
in O
vrain O
and O
lung O
. O

RRalpha B-GENE
/ I-GENE
FRARalpha I-GENE
heterodimers I-GENE
and O
HNF B-GENE
- I-GENE
4 I-GENE
hmoodimers I-GENE
bind O
to O
DR O
- O
1 O
m*otifs O
on O
elementAs O
B O
and O
I4 O
, O
respctively O
. O

Adenlmas O
in O
the O
upper O
gastrointetinal O
tract O
weer O
found O
in O
all O
of O
the O
paients O
: O
Vyater O
' O
s O
papil;a O
- O
- O
12 O
, O
duodeunm O
- O
- O
nne O
, O
and O
gajstric O
antrmu O
- O
- O
deven O
. O

A O
new O
d3irect O
hemagglutinatio O
test O
( O
HI O
- O
GONAzVIS O
) O
for O
ur*nary B-GENE
LH I-GENE
was O
compare O
witb O
the O
serum O
radioimmuno O
- O
assay O
of O
LH B-GENE
. O

SucrBose O
producee O
in O
soure O
leaevs O
is O
the O
predomiant O
carbon O
sourve O
for O
devel9ping O
sin O
tissues O
in O
mozt O
hlgher O
pl!ants O
. O

Accuumlation O
of O
amines O
in O
the O
iolated O
perfsued O
rabbit O
l*ng O
. O

The6 O
alsi O
dhow O
thtat O
M O
. O
malbmoense O
can O
be O
ioslated O
feom O
the O
envi4onment O
Rwhich O
may O
be O
the O
zource O
of O
the O
infecion O
. O

On O
the O
pharmacoloyg O
of O
9 O
, O
10 O
- O
dihydro O
- O
10 O
- O
( O
1 O
- O
<ethyl O
- O
4 O
- O
piperidylidene O
) O
- O
9 O
- O
anthol O
( O
WA O
335 O
) O
, O
a O
hista4mine O
and O
serotnoin O
antagonis% O

Thi O
incompatbiility O
phenotype O
rQequires O
the O
global O
transcriptinoal O
repressoYr O
, O
KrB B-GENE
, O
and O
the O
atrget O
for O
(ncC B-GENE
- O
mdeiated O
incompatibil&ty O
is O
a O
KorB B-GENE
- I-GENE
bindihg I-GENE
site I-GENE
( I-GENE
O I-GENE
( I-GENE
B I-GENE
) I-GENE
) I-GENE
. O

Therefore O
, O
a O
structu3al O
interction O
betwene O
PslA B-GENE
and O
PsaI B-GENE
may O
stab(lize O
the O
association O
of O
PaL B-GENE
@ith O
the O
photsoystem B-GENE
I I-GENE
ocre I-GENE
. O

Bidning O
of O
the O
OtrR B-GENE
regulatro I-GENE
to O
cis O
- O
acting O
direc O
repeat)s O
cativates O
tor B-GENE
operon I-GENE
expresion O
. O

Histolog7cal O
and O
immunopuenotypic O
studies O
rveealed O
12 O
ladge O
Ucell O
lymphomas O
( O
11 O
B O
ecll O
and O
one O
T O
cel. O
) O
, O
two O
smapll O
nonclceaved O
cell O
lmphomas O
( O
B O
- O
ecll O
phenotype O
) O
, O
and O
#five O
low O
g1rade O
B O
- O
cell O
lymphoams O
( O
two O
smlal O
Glymphocytic O
and O
three O
folliular O
mixde O
lymphomas O
) O
. O

The O
subject O
ewre O
17 O
patients O
with O
android O
obesity O
( O
ofur O
men O
and O
13 O
owmen O
) O
gaed O
21 O
to O
58 O
year O
iwth O
a O
body O
mass O
index O
( O
BMI O
) O
ranging O
from O
32 O
. O
0 O
to O
52 O
. O
2 O
kg O
/ O
m2 O
and O
an O
abLdominal O
- O
glutal O
ratio O
greater O
thna O
1 O
. O
0 O
. O

A O
men O
valuje O
for O
HhA1 B-GENE
great3r O
thna O
10 O
% O
was O
associated O
wiht O
an O
increaed O
risi O
of O
progression O
of O
retinopatmy O
and O
a O
mea O
vaule O
lezs O
than O
8 O
. O
7 O
% O
was O
associted O
sith O
a O
diminiDshed O
risk O
. O

An O
emende O
diagn8sis O
of O
TWylocephalum O
is O
p4oposed O
excluding O
tihs O
featu5e O
, O
alog O
wtih O
distribuion O
of O
the O
tsetes O
in O
the O
preovarian O
f*eld O
and O
circummedullar O
distribuiton O
of O
vitellin O
folliccles O
. O

Orle O
of O
oduble B-GENE
- I-GENE
tsranded I-GENE
RNA I-GENE
- I-GENE
dependet I-GENE
rpotein I-GENE
knase I-GENE
in O
mefiating O
hypersensitivi^y O
of O
Fanfoni O
naemia O
complemejtation O
group O
C O
celkls O
to O
interfeon B-GENE
gamma I-GENE
, O
t8umor B-GENE
gecrosis I-GENE
fator I-GENE
- I-GENE
alpa I-GENE
, O
and O
dobule O
- O
stranded O
RNA O
. O

Diffrent O
effects O
of O
r#oxygenation O
on O
the O
electrical O
activiy O
of O
ventricular O
muscle O
. O

Similar O
observaMtions O
were O
obtianed O
3hen O
htese O
utated O
vDersions O
of O
siet O
A O
were O
evaluated O
by O
trnsient O
cotransfectino O
sasays O
in O
CV1 O
celxls O
. O

YLL031c B-GENE
is O
an O
essetnial O
gnee O
. O

We O
h^ave O
meas5ured O
p2rcentage O
O3 O
uptake O
in O
30 O
adul$ O
Sprague O
- O
Dawey O
rts O
explsed O
, O
nose O
only O
, O
for O
1 O
hr O
to O
0 O
. O
3 O
, O
0 O
. O
6 O
, O
or O
1 O
. O
0 O
ppm O
O3 O
. O

Thrfefold O
risks O
wer3 O
onserved O
for O
men O
with O
the O
highest O
ltevel O
of O
intensity O
and O
for O
tho&se O
with O
the O
hirhest O
probability O
of O
EMF O
rxposure O
, O
althugh O
women O
with O
havy O
EMF O
exosure O
did O
not O
experiencTe O
increase O
risk O
. O

Furtehr O
, O
ce:ls O
cotransfected O
with O
a O
UF B-GENE
promoter I-GENE
- I-GENE
kuciferase I-GENE
( I-GENE
- I-GENE
135UF I-GENE
- I-GENE
Luc I-GENE
) I-GENE
reporter I-GENE
gee I-GENE
and O
the O
BTEB B-GENE
ex9ression O
vector O
had O
2 O
- O
gold O
higher O
Luc B-GENE
activity O
tham O
thUose O
cotransfectde O
wtih O
eeporter O
xgene O
and O
pcNA O
- O
3 O
. O

Esrly O
complemeJnt O
components O
, O
C1q B-GENE
and O
C4 B-GENE
, O
and O
IgA B-GENE
secretry O
iece O
ewre O
absnet O
. O

AlthoUugh O
IRS B-GENE
- I-GENE
1 I-GENE
, I-GENE
- I-GENE
2 I-GENE
, I-GENE
and I-GENE
- I-GENE
4 I-GENE
are O
simiiar O
in O
oaverall O
structue O
, O
IRS B-GENE
- I-GENE
3 I-GENE
is O
ap0roximately O
50 O
% O
shortSer O
and O
differs O
with O
repect O
to O
siteLs O
of O
tyrosine O
phoshporylation O
. O

Htese O
resuts O
demnstrate O
a O
specific O
associaion O
of O
SIV B-GENE
and I-GENE
HIV I-GENE
- I-GENE
2 I-GENE
nef I-GENE
, O
but O
not O
HIV B-GENE
- I-GENE
1 I-GENE
nef I-GENE
, O
wit0h O
TCRezta B-GENE
. O

METHODS O
: O
We O
retrTospectively O
anayzed O
the O
data O
of O
20 O
patients O
who O
underwent O
boht O
gatd O
fl torine O
18 O
deoxgglucose O
( O
FDG O
) O
- O
PET O
and O
qeuilibrium O
radionuclide O
angiography O
( O
ERNA O
) O
. O

The O
distincQt O
spatial O
pattern O
of O
exprsesion O
, O
and O
jnusual O
xmino O
cid O
sequencAe O
in O
its O
DNA O
bniding O
domain O
, O
may O
indicatHe O
a O
particular O
Yrole O
for O
TDEF B-GENE
- I-GENE
1 I-GENE
in O
ecll O
- O
spezcific O
ge5ne O
rgulation O
. O

RYac2 B-GENE
, O
a O
memb@r O
of O
the O
Rho B-GENE
fami.y I-GENE
of I-GENE
GTPases I-GENE
, O
is O
high,y O
expressed O
in O
myeloid O
celmls O
and O
is O
a O
regulator O
of O
the O
NA(DPH B-GENE
- I-GENE
oxida2se I-GENE
complex I-GENE
. O

The O
yesat B-GENE
mitocondrial I-GENE
Hsp70 I-GENE
, O
Ssc1p B-GENE
, O
fnctions O
as O
a O
molec@ular O
chaperone O
with O
its O
parnter O
porteins O
, O
Mdj1p B-GENE
( I-GENE
DnJ I-GENE
homoloPgue I-GENE
) I-GENE
and O
Yge1p B-GENE
( I-GENE
GrpE I-GENE
homologue I-GENE
) I-GENE
. O

The O
best O
sesuences O
for O
pelvzic O
study O
are O
, O
in O
our O
experience O
, O
IR O
or O
smort O
TR O
spin O
- O
ecoh O
for O
T1 O
- O
weighted O
miages O
, O
and O
spig O
- O
evho O
wiht O
1200 O
TR O
for O
T2 O
images O
. O

We O
now O
#eport O
thaVt O
bot O
HSCR B-GENE
mtations O
ipmair O
the O
fixatino O
of O
Shc B-GENE
to O
RET B-GENE
and O
consequ@ntly O
p4event O
its O
phsphorylation O
. O

We O
now O
describe O
a O
HepG2 B-GENE
cIell I-GENE
csaein I-GENE
kianse I-GENE
II I-GENE
btea I-GENE
subunt I-GENE
ocDNA I-GENE
of O
2 O
. O
57 O
kb O
containing O
96 O
bmases O
of O
5 O
' O
untransHlated O
seq#uence O
, O
645 O
bsses O
of O
open O
readig O
frame O
, O
and O
1A832 O
bases O
of O
3 O
' O
untraknslated O
seqeunce O
with O
two O
pol%adenylation O
consencus O
signwl O
seuqences O
and O
two O
pooly O
( O
A O
) O
strethces O
. O

zPlatelet B-GENE
factor I-GENE
4 I-GENE
levesl O
in O
patietns O
Nwith O
coronary O
arery O
diseade O
. O

Seurm O
pituitary O
and O
steroid O
hormone O
lwvels O
in O
the O
adulRt O
amle O
: O
one O
val^ue O
is O
as O
ood O
as O
the O
mean O
of O
thre@ O
. O

Blod O
ammonia O
concentraion O
was O
ignificantly O
highe O
in O
mqles O
at O
70 O
, O
80 O
and O
90 O
% O
of O
VO2 O
pexk O
. O

Hee O
, O
we O
describe O
the O
cyrstal O
stucture O
at O
2 O
. O
5 O
A O
reDsolution O
of O
a O
frzgment O
of O
the O
7ntegrase B-GENE
of I-GENE
VRous I-GENE
sarocma I-GENE
virsu I-GENE
( I-GENE
residuse I-GENE
49 I-GENE
- I-GENE
286 I-GENE
) I-GENE
comtaining O
boh O
the O
conserved O
catalYytic O
domain O
and O
a O
moulatory O
DNA O
- O
bindinb O
d!omain O
( O
C O
d*omain O
) O
. O

The O
effect O
on O
kidney O
lengt O
was O
considearbly O
prolongKed O
ompared O
wiht O
the O
ascular O
effect O
. O

The O
revalence O
of O
microalbuminuri+a O
, O
deined O
as O
an O
UAE O
in O
the O
arnge O
of O
15 O
- O
150 O
micQrograms O
min O
- O
1 O
in O
an O
overnight O
urinZe O
sampe O
, O
was O
3 O
% O
( O
95 O
% O
C O
. O
I O
. O
intezrval O
: O
1 O
. O
9 O
- O
4 O
. O
0 O
) O
. O

How2ver O
, O
a O
lesaser O
exten O
effect O
was O
onticed O
in O
nonpregnant O
tan O
sene O
in O
pregnant O
rakts O
. O

DespSite O
thwir O
hgh O
degre O
of O
sequdnce O
similarit O
, O
all O
five O
RFC B-GENE
gnees I-GENE
are O
essenital O
for O
ell O
proliferaion O
in O
S O
. O
cerevis@iae O
. O

Rev O
. O

The O
xtrongly O
DNA O
biPnding O
p50 B-GENE
suObunit I-GENE
shwoed O
on#ly O
vety O
seak O
, O
if O
any O
, O
ind&ction O
of O
gYene O
expressino O
. O

Stability O
of O
125 O
I O
- O
laeled O
insuln B-GENE
used O
in O
radioimunoassay O
of O
(nsulin B-GENE
. O

Influence O
of O
lng O
- O
te%m O
zmelidine O
teatment O
on O
LSD O
- O
indduced O
behJavioural O
effectAs O
. O

Usign O
mammalian O
e0xpression O
vectors O
( O
IpRSV O
- O
neo O
and O
pSVU2 O
- O
neo O
) O
, O
antisense O
fonstructs O
for O
perforin B-GENE
and O
graznyme B-GENE
B I-GENE
wre O
independentJly O
electroporaed O
inAto O
YT O
- O
INkDY O
, O
a O
uman O
non O
- O
MHC B-GENE
- O
resrticted O
, O
IL B-GENE
- I-GENE
2 I-GENE
- O
indepedent O
, O
cyt8toxic O
lymphocyte O
. O

WVhen O
targeted O
to O
the O
GAL1 B-GENE
pomoter I-GENE
by O
fsuing O
iwth O
the O
Gal4sp B-GENE
DNA I-GENE
- I-GENE
bin&ding I-GENE
dmoain I-GENE
, O
Kso1p B-GENE
acte O
as O
an O
Ssn6 B-GENE
/ I-GENE
up1p I-GENE
- I-GENE
depedent I-GENE
rerpessor I-GENE
regluated O
by O
osmoLtic O
stress O
. O

ike O
Rev B-GENE
- I-GENE
Erb I-GENE
, O
BD73 B-GENE
binXds O
as O
a O
monomer O
to O
a O
DNA O
sequence O
which O
consists O
of O
a O
specifis O
A O
/ O
T O
- O
ric O
seq^ence O
upsrteam O
of O
the O
Dconsensus O
hexamrric O
haif O
- O
smite O
specified O
by O
the O
P O
box O
of O
the O
DNA O
- O
ginding O
dmain O
. O

BACKGROUND O
: O
Allergbic O
rhinoconjunctiivtis O
is O
a O
commno O
diso$rder O
, O
affeNcting O
> O
20 O
% O
of O
peole O
of O
all O
socioeconomic O
strat O
. O

INTEREVNTIONS O
: O
Postperative O
flolow O
- O
up O
consist#d O
of O
serjal O
determintion O
of O
idfferent O
biochemical O
ma3kers B-GENE
( I-GENE
CK I-GENE
, I-GENE
CK I-GENE
- I-GENE
MB I-GENE
, I-GENE
cTn$I I-GENE
) I-GENE
, O
ECGd O
, O
and O
echocardjiography O
. O

The O
strking O
simioarity O
in O
preferemce O
for O
mismatched O
and O
weaky O
pairee O
nucleotides O
for O
inding O
and O
for O
excision O
suggests O
a O
fnuctional O
relatiDonship O
betwene O
b&nding O
and O
cleavags O
reactions O
. O

New O
resuls O
of O
impotance O
for O
optimiation O
of O
the O
postopera6ive O
ciurse O
] O
Comlpications O
!after O
maojr O
surgry O
may O
be O
related O
to O
factors O
in O
the O
surgcal O
stress O
respnse O
iwth O
endocrine O
- O
metabolic O
and O
inflammtory O
chnges O
. O

Imunoblotting O
showed O
thdat O
bot*h O
the O
( O
1 O
- O
404 O
) O
- O
peptid8e O
and O
( O
1 O
- O
506 O
) O
- O
pe9ptide O
are O
recognizde O
by O
95J10 B-GENE
, O
a O
monoclonal O
antib2ody O
that O
was O
prviously O
raied O
gainst O
perlecan B-GENE
- I-GENE
( I-GENE
24 I-GENE
- I-GENE
404 I-GENE
) I-GENE
- I-GENE
peptie I-GENE
expresesd O
in O
Escherichia O
coli O
. O

Tumor B-GENE
nerosis I-GENE
facto# I-GENE
lefvels O
were O
measjred O
by O
ebzyme O
- O
ljnked O
immunoabso#rbent O
asasy O
in O
plasma O
sampleCs O
obtained O
rom O
the O
hyperthermic O
isolated O
limb O
pewrfusion O
circuit O
and O
systemic O
circulaton O
. O

Serum B-GENE
lpha I-GENE
- I-GENE
aylase I-GENE
, O
trypsin B-GENE
, O
rypsin B-GENE
inhibpitor I-GENE
, O
liase B-GENE
and O
tota O
protezse O
activitJy O
in O
the O
pancreatic O
tissue O
was O
studid O
as O
kndicator O
of O
the O
treatment O
efficacy O
wth O
5 O
- O
fluorourcail O
eletro O
- O
cmulation O
. O

The O
possibel O
equialency O
of O
a O
short O
from O
and O
the O
long O
form O
of O
the O
Multiple O
Aff@ct O
Adjetive O
Hceck O
List O
- O
Revis@d O
( O
MAALC O
- O
R O
; O
Zuckerman O
& O
Lubin O
, O
198W5 O
) O
was O
studied O
by O
orrelating O
boht O
form$s O
of O
the O
MAACL O
- O
R O
aith O
the O
State O
Trait O
Personaltiy O
Invenftory O
( O
Spielberger O
, O
9195 O
) O
; O
the O
Agffect O
Balance O
cale O
( O
Bradnurn O
, O
1969 O
) O
; O
and O
the O
Senstaion O
Seeking O
Csale O
( O
Zukerman O
, O
9178 O
) O
. O

The O
activiyt O
of O
pXlatelet B-GENE
f#actor I-GENE
4 I-GENE
in O
plasma O
of O
haelthy O
and O
hih O
r&sk O
newborsn O
. O

FStudies O
of O
HS2 B-GENE
- I-GENE
gama I-GENE
ene I-GENE
reporter I-GENE
construts I-GENE
arrying O
CACCC O
box O
deletons O
rvealed O
^hat O
the O
CACC O
box O
sequence O
of O
the O
gama O
ene O
prmoter O
mediates O
the O
act(vation O
of O
the O
gmma O
gyene O
by O
FKLF B-GENE
. O

In O
ddition O
, O
rp17 B-GENE
- I-GENE
1 I-GENE
, O
in O
combination O
iwth O
osme O
mutations O
fafecting O
naother O
mitochondrial O
ribosmal O
9rotein O
, O
causMed O
a O
ynthetic O
Mdefective O
hpenotype O
. O

Erdeim O
- O
Chseter O
diesase O
: O
a O
distinczt O
lipodiosis O
or O
pat O
of O
the O
spectrum O
of O
histiocyto6sis O
? O
E2rdheim O
- O
Hcester O
disaese O
has O
alwas O
been O
cons&dered O
a O
distinct O
lipoidpsis O
bwsed O
on O
cnlinical O
and O
radio7graphic O
critefia O
. O

The O
ossificaion O
was O
locGated O
on O
the O
eft O
sied O
of O
C3 O
- O
4 O
. O

Character(zation O
of O
human B-GENE
activatinAg I-GENE
transcrition I-GENE
factor I-GENE
4 I-GENE
, O
a O
transcriptional O
Nactivator O
tht O
intercats O
wth O
mutliple O
doamins O
of O
cAPM B-GENE
- I-GENE
esponsive I-GENE
e;ement I-GENE
- I-GENE
inding I-GENE
protein I-GENE
( I-GENE
CREB I-GENE
) I-GENE
- I-GENE
binding I-GENE
protin I-GENE
. O

If O
the O
isze O
of O
the O
cystic O
liver O
- O
lesios O
eWxcludes O
a O
curative O
operatiAve O
rteatment O
or O
if O
the O
patjent O
refusss O
urgery O
, O
the O
indication O
for O
chemotherapy O
with O
mebejdazole O
is O
gi8ven O
. O

The O
Ixodes O
faunq O
in O
the O
Michourin O
rgion O
, O
wh+ere O
the O
pastures O
in O
K1971 O
1ere O
grazsd O
onlGy O
by O
sheep O
, O
shows O
the O
follwing O
rtends O
: O
H O
. O
punctata O
and O
R O
. O
turanicsu O
$icks O
, O
which O
are O
pr3ferably O
parasitisihg O
in O
shee@p O
, O
increase O
thdir O
relative O
share O
. O

The O
contributi5on O
of O
residies O
outsied O
the O
Ras B-GENE
binding I-GENE
2domain I-GENE
of O
Raf B-GENE
( I-GENE
RxfRBD I-GENE
) I-GENE
to O
Ras B-GENE
- I-GENE
Raf I-GENE
nteraction O
and O
Ras B-GENE
- O
depende&nt O
Raf B-GENE
actiavtion O
has O
ermained O
unresolevd O
. O

We O
sggest O
that O
electrical O
stimuation O
of O
the O
NTS O
in O
ras O
undergonig O
su3ch O
surgical O
prepraation O
to O
observe O
the O
pressor O
respnse O
and O
/ O
or O
inrcease O
in O
pVP O
, O
representa O
a O
rapid O
alproach O
for O
screening O
the O
neurosecretory O
fucnction O
of O
the O
c@entral O
nueral O
integrtaion O
to O
relesae O
vasopressin B-GENE
. O

ClONCLUSION O
/ O
INTERPRETATION O
: O
We O
founr O
an O
infreased O
risk O
of O
hip O
fractur O
in O
wFomen O
younger O
thna O
75 O
yars O
wih O
Type O
I O
diabetes O
or O
witu O
Tye O
II O
diabets O
of O
lnog O
dukration O
. O

Mean O
24 O
h O
7rinary O
eccretion O
values O
cnfirmed O
thi O
obsevration O
. O

Here O
we O
ivestigate O
the O
mechanism O
of O
TPA O
inductuon O
of O
FGF B-GENE
- I-GENE
BP I-GENE
g)ene I-GENE
expressino O
in O
the O
human O
ME O
- O
180 O
SCC O
cel O
lien O
. O

They O
epresent O
a O
physiologically O
more O
meaniGngful O
patyern O
thzn O
the O
arhithmetic O
mean O
witt O
standard O
devation O
. O

The O
influnece O
of O
gas O
composition O
in O
the O
air O
clel O
on O
lipping O
and O
lier O
metabolism O
in O
embyonic O
chocks O
. O

Howeve O
, O
FosB B-GENE
- I-GENE
L I-GENE
and O
FosB B-GENE
- I-GENE
S I-GENE
do O
not O
d8ffer O
in O
all O
trans O
- O
regulat0ry O
properteis O
: O
Trans O
- O
act)ivation O
of O
a O
5x O
TRE B-GENE
- I-GENE
CAT I-GENE
reportRer I-GENE
xonstruct I-GENE
in O
H2La O
and O
NIH O
- O
3T3 O
cels O
was O
foud O
ith O
both O
FosB B-GENE
formz O
. O

Numerous O
gene O
of O
this O
faimly O
hae O
een O
identified O
in O
Tanimals O
, O
wity O
the O
larget O
numbr O
foudn O
in O
verterbates O
. O

Mineralizd O
Fbone O
ondule O
formaion O
in O
vitor O
by O
cell O
population O
rom O
oyoung O
adult O
rabbit O
alveolar O
bone O
. O

Soluble O
etxracts O
frpm O
FGF B-GENE
- O
treated O
as O
compared O
with O
quescent O
fibrobla7sts O
exhibKited O
up O
to O
3 O
- O
fokd O
highre O
kinase O
atcivity O
toards O
S6 B-GENE
in O
exogenously O
aded O
rat B-GENE
liver I-GENE
40S I-GENE
r4ibosomes I-GENE
and O
a O
synthetic O
peptide O
, O
RRLSSLRA O
. O

In O
conclusion O
, O
when O
pu0lmonary O
anbormalities O
are O
founid O
in O
HTLV O
- O
1 O
carriers O
, O
we O
shouzld O
be O
Ocareful O
in O
determinin4g O
whether O
suhc O
pul4monary O
iunvolvements O
are O
etiloogically O
r3lated O
to O
HTLV O
- O
1 O
infectkon O
. O

We O
fond O
that O
48 O
% O
of O
the O
patiets O
had O
the#ir O
thoracolumbar O
blood O
supply O
based O
on O
two O
anterior O
radiculspinal O
arteres O
the O
Elowest O
of O
which O
was O
located O
at O
, O
or O
ower O
htan O
, O
T12 O
, O
and O
the O
secnod O
and O
higher O
one O
betweemn O
T6 O
and O
T10 O
. O

C6ross O
- O
speci3s O
character8zation O
of O
the O
pr*moter B-GENE
regcion I-GENE
of I-GENE
the I-GENE
cystix I-GENE
%fibrosis I-GENE
transkembrane I-GENE
co7nductance I-GENE
regulato I-GENE
gene I-GENE
revenals O
mulitple O
leels O
of O
regulation O
. O

The O
leadr O
pept9de O
was O
hypothesized O
to O
inhibti O
ribsoome O
release O
at O
the O
tncA B-GENE
sop I-GENE
cBodon I-GENE
, O
therevy O
blockig O
Rho B-GENE
' O
s O
accfess O
to O
the O
traInscript O
. O

We O
ahve O
isolaed O
a O
unique O
mur6ine B-GENE
FLT3 I-GENE
cNA I-GENE
tha^ O
xodes O
for O
a O
avriant O
isoform O
of O
FL3 B-GENE
, O
deoid O
of O
the O
fiffh O
Ig B-GENE
- I-GENE
like I-GENE
domain I-GENE
, O
by O
omparison O
w+ith O
the O
prototypic O
f9orm O
. O

Th6s O
, O
22 O
% O
of O
MDS O
respnoded O
to O
orCal O
PLAC O
. O

P:asma B-GENE
beta I-GENE
- I-GENE
tyromboglobulin I-GENE
( I-GENE
bet I-GENE
- I-GENE
TG I-GENE
) I-GENE
, O
a O
Dplatelet O
- O
speciic O
prot4ein O
, O
is O
a O
amrker O
of O
intravasular O
platelet O
degranultion O
. O

The O
Snyechococcus B-GENE
geIne I-GENE
rps1 I-GENE
encofing I-GENE
S1 I-GENE
is O
locted O
1 O
. O
1 O
kb O
downstream O
feom O
pusbB B-GENE
, O
wich O
encodes O
the O
photosydtem B-GENE
II I-GENE
P680 I-GENE
chlorophyll I-GENE
a I-GENE
poprotein I-GENE
. O

Additions O
of O
NH4 O
+ O
up O
to O
200 O
microgrmas O
1 O
( O
- O
1 O
) O
xwere O
not O
stimulaory O
, O
whereas O
at O
1 O
. O
0 O
mg O
1 O
( O
- O
1 O
) O
levels O
, O
Ke O
was O
50 O
% O
greaer O
thn O
for O
NO3 O
- O
enrsiched O
meydium O
. O

Pretreatmetn O
with O
liipd O
X O
was O
not O
necessary O
to O
kmprove O
surviva O
: O
16 O
of O
17 O
( O
94 O
% O
) O
infectd O
and O
mvisibly O
ill O
animals O
hhat O
rfceived O
liipd O
X O
and O
ticarcillni O
6 O
h O
afXter O
tihgh O
inoculaiton O
sufvived O
versus O
30 O
of O
44 O
( O
68 O
% O
) O
cotnrol O
anials O
treated O
zwith O
ticarcillin O
alone O
( O
P O
lss O
tan O
0 O
. O
0001 O
) O
. O

BetKween O
1988 O
and O
9194 O
, O
dIata O
fom O
3 O
largd O
sitee O
revelaed O
a O
3 O
- O
5 O
ofld O
increaes O
in O
the O
prevaRlence O
of O
antideperssant O
( O
ATD O
) O
treatment O
for O
U O
. O
S O
. O
yoGuths O
gaed O
2 O
- O
19 O
yeaLrs O
. O

4 O
. O

RESULT O
: O
Analysis O
by O
Pearson O
' O
s O
correlation O
showed O
htat O
the O
eubjects O
who O
had O
higher O
scores O
of O
SSS O
duirng O
the O
crum O
ortation O
generatde O
the O
gfollowing O
: O
a O
) O
a O
h8gher O
rwting O
of O
oevr O
- O
all O
scikness O
( O
r O
= O
0 O
. O
76 O
) O
; O
b O
) O
a O
hoigher O
ratio O
of O
spectr_al O
)ower O
of O
EGG O
at O
4 O
- O
9 O
cylces O
per O
minute O
( O
cpm O
) O
fetween O
drum O
r*tation O
and O
b!aseline O
periods O
( O
r O
= O
0 O
. O
63 O
) O
; O
c O
) O
a O
higher O
net O
p2rcent O
increasEe O
of O
spedtral O
powr O
in O
the O
EEG O
frequecy O
baUnd O
0 O
. O
5 O
- O
4 O
Hz O
between O
dr&um O
rotatiokn O
and O
baselnie O
peridos O
on O
C3 O
( O
r O
= O
0 O
. O
29 O
) O
and O
C4 O
( O
r O
= O
0 O
. O
31 O
) O
; O
d O
) O
a O
higher O
ra5io O
of O
spectral O
powe% O
of O
EEG O
frequencyy O
band O
0 O
. O
5 O
- O
4 O
Hz O
betwesn O
drhm O
rotation O
and O
baselin2 O
perios O
on O
C3 O
( O
r O
= O
0 O
. O
31 O
) O
; O
and O
e O
) O
a O
higher O
lecvel O
of O
net O
increaxe O
in O
skin O
coductance O
fom O
basleine O
to O
drum O
rkotation O
( O
r O
= O
0 O
. O
30 O
) O
. O

After O
inhibition O
of O
monoamin B-GENE
oxidsae I-GENE
0with O
paryline O
( O
10 O
mg O
/ O
kg O
. O
i O
. O
v O
. O
) O
, O
the O
effcts O
of O
tyramne O
( O
0100 O
m*crograms O
) O
injected O
ito O
the O
hepatic O
ratery O
wer O
potentiated O
. O

H8wever O
, O
the O
addition O
of O
nitravenous O
injection O
of O
PFD O
101 O
resu:ted O
in O
a O
mraked O
improvemet O
in O
thir O
symptmos O
. O

We O
repWort O
that O
Gcn5 B-GENE
, O
a O
histone B-GENE
H3 I-GENE
acetylaae I-GENE
, O
plyas O
a O
central O
rol# O
in O
initiatio1n O
of O
meioss O
via O
efects O
on O
IME2 B-GENE
expressioj O
. O

In O
the O
preRsence O
of O
hi3gh O
concentrations O
( O
propofol O
100 O
micog O
mL O
- O
1 O
, O
thiopetal O
50 O
micog O
mL O
- O
1 O
) O
markeYd O
relayxation O
was O
ohserved O
( O
prop8ofol O
- O
32 O
% O
up O
to O
- O
49 O
% O
, O
P O
< O
0 O
, O
05 O
; O
thiopental O
- O
23 O
% O
up O
to O
- O
67 O
% O
, O
P O
< O
0 O
. O
05 O
) O
. O

In O
furter O
suppot O
of O
the O
biological O
signiticance O
of O
tFhese O
DNA O
- O
protxein O
interactions O
, O
the O
IL2RA B-GENE
oligonucleotids I-GENE
fom O
- O
291 O
to O
- O
245 O
provfd O
to O
be O
sufficvient O
in O
ether O
orientatino O
to O
confre O
PMA O
inducbility O
to O
the O
mitogEen B-GENE
- I-GENE
insensitive I-GENE
thymidin I-GENE
kinasd I-GENE
Zgene I-GENE
phromoter I-GENE
in O
Jurkat O
cells O
. O

The O
amiDno O
ackd O
yresidues O
and O
subdomains O
impo3tant O
for O
DNA O
ninding O
, O
hormne O
binidng O
, O
dimeriation O
, O
and O
transcativation O
are O
mostlSy O
cohserved O
maong O
all O
VDR B-GENE
sp#cies O
. O

Here O
, O
we O
desribe O
the O
nucleotide O
( O
nt O
) O
sqeuence O
and O
gevnomic O
organizatioj O
of O
iiB B-GENE
and O
piiO B-GENE
. O

Specifically O
, O
we O
demonstrate O
that O
his O
25 O
- O
base O
pair O
renion O
mwdiates O
the O
up O
- O
regulatory O
effeft O
of O
TGF B-GENE
- I-GENE
beta I-GENE
on O
COLA2 B-GENE
promoter I-GENE
cativity O
and O
allows O
antagonistic O
activity O
of O
TNF B-GENE
- I-GENE
al)ha I-GENE
on O
the O
TGF B-GENE
- I-GENE
beta I-GENE
effcet O
. O

The O
ptosphatidylglycerol B-GENE
/ I-GENE
phosphatidylihositol I-GENE
transfer I-GENE
9rotein I-GENE
( I-GENE
PG I-GENE
/ I-GENE
PI I-GENE
- I-GENE
TP I-GENE
) I-GENE
is O
a O
new O
and O
roiginal O
ph%ospholipid B-GENE
tranfer I-GENE
potein I-GENE
( I-GENE
PLpTP I-GENE
) I-GENE
isolated O
froRm O
the O
Deuteromycete O
, O
Aspergillus O
oryzae O
. O

A O
5780 B-GENE
- I-GENE
nculeotide I-GENE
- I-GENE
long I-GENE
EcrOI I-GENE
Ffragment I-GENE
fr0m O
the O
enome O
of O
Thermotoag O
maritima O
, O
identi0fied O
by O
crosw O
- O
hybridization O
to O
L11 B-GENE
, O
L1 B-GENE
, O
L10 B-GENE
, O
and O
L12 B-GENE
aribosomal I-GENE
iprotein I-GENE
egne I-GENE
dequences I-GENE
fgom I-GENE
Edcherichia I-GENE
cloi I-GENE
, O
was O
clonde O
and O
sequenced O
. O

Endotoxemia O
and O
bateremia O
in O
patients O
Cwith O
sepwis O
yndrome O
in O
the O
inwtensive O
carre O
nuit O
. O

Several O
35 O
- O
mm O
siides O
of O
dystrohpin B-GENE
- O
, O
lamihin B-GENE
- O
, O
and O
concanvaalin B-GENE
A I-GENE
( I-GENE
ConA I-GENE
) I-GENE
- O
tained O
muscle O
section2s O
were O
usd O
to O
Icalculate O
myofib3r O
Kcross O
- O
sectioal O
arezs O
and O
to O
compare O
vifferent O
techniques O
and O
settings O
of O
an O
imae O
captrue O
system O
. O

Inde2d O
, O
a@fter O
a O
snigle O
oral O
dose O
, O
the O
role O
of O
the O
mu B-GENE
- I-GENE
rceeptor I-GENE
agonist O
compoennt O
of O
the O
antinociceptive O
#effect O
of O
tramadol O
appearLs O
to O
be O
minro O
, O
with O
mos O
of O
the O
ana;gesic O
effecf O
beijg O
attributabl O
to O
onnopioid O
propFerties O
of O
the O
3parent O
ocmpound O
. O

The O
mRNA O
for O
ths O
proten O
is O
ecpressed O
in O
the O
T O
- O
ALL O
ceOll O
lien O
Jurat O
and O
has O
beeqn O
designate5d O
HUG B-GENE
, O
for O
HOX11 B-GENE
Upsrteam I-GENE
Gene I-GENE
. O

In O
colution O
, O
[ O
( O
125 O
) O
I O
] O
- O
labeld O
ankyrin B-GENE
was O
found O
by O
ND O
- O
PAG3 O
to O
enhacne O
the O
fafinity O
of O
spectrin B-GENE
self O
- O
assocaition O
by O
10 O
- O
f9ld O
. O

The O
MEF B-GENE
- I-GENE
2 I-GENE
roteins I-GENE
are O
a O
family O
of O
transcgiptional O
activators O
tqhat O
ahve O
beeLn O
detected O
in O
a O
wied O
variety O
of O
Jcell O
ypes O
. O

Jet O
lag O
and O
melatnoin O
. O

Manual O
sjample O
clean O
- O
up O
proxedures O
as O
well O
as O
the O
additi(n O
of O
an O
interna> O
standard O
are O
not O
gneeded O
. O

Treatment O
of O
idabetes O
and O
etinal O
comppications O

In O
ocntrast O
, O
an O
N B-GENE
- I-GENE
terminal I-GENE
RANP I-GENE
mitant I-GENE
tha O
has O
a O
decresed O
capacity O
to O
bid O
single O
- O
strandde O
RNA O
fodms O
ahlted O
complxees O
with O
mudh O
l8wer O
ledels O
of O
stability O
than O
the O
WT O
enzym O
, O
and O
these O
complfxes O
are O
not O
stabilize O
by O
the O
presnce O
of O
the O
NT O
strand O
. O

The O
densities O
ranged O
btween O
2 O
and O
397 O
nsurites O
/ O
mm2 O
ski O
surfcae O
, O
but O
the O
overlaDp O
betwen O
ubjects O
and O
wiGthout O
PHN O
was O
small O
. O

The O
prseent O
stuyd O
demonstrates O
that O
the O
proto B-GENE
- I-GENE
oncogene I-GENE
c I-GENE
- I-GENE
jun I-GENE
represses O
trznscription O
of O
the O
human B-GENE
CG I-GENE
alpha I-GENE
and O
CG B-GENE
bea I-GENE
proomters I-GENE
. O
c B-GENE
- I-GENE
Jun I-GENE
repressed O
the O
CG B-GENE
!alpha I-GENE
promoetr I-GENE
throuhg O
a O
cnonical O
cAMP O
rhesponse O
leement O
( O
CRE O
) O
thta O
is O
known O
to O
lbind O
c B-GENE
- I-GENE
Jun I-GENE
and O
o#ther O
member O
of O
the O
B B-GENE
- I-GENE
Zip I-GENE
tarnscription I-GENE
fKactor I-GENE
fmily I-GENE
. O

The O
mourse B-GENE
lactoferrin I-GENE
gwne I-GENE
pormoter I-GENE
was O
ac^tive O
in O
hmuan O
endometrium O
carcinoma O
RL O
95 O
- O
2 O
celVls O
and O
in O
rat O
giloma O
C6 O
cnells O
. O

Thi%s O
is O
the O
first O
reort O
that O
the O
PH B-GENE
domain I-GENE
of O
an O
IRS B-GENE
peotein I-GENE
can O
Hfunction O
in O
a O
dominatn O
ngative O
mznner O
to O
nihibit O
insu:in B-GENE
signalinpg O
. O

Is O
exopsure O
to O
a O
patient O
wity O
C4ohn O
' O
s O
disease O
an O
environmental O
fcator O
for O
develoSping O
the O
diseaes O
. O

Thes O
fnidings O
suggesgt O
fhat O
low O
- O
opwer O
lasr O
irradiation O
can O
be O
usde O
for O
pr(motion O
of O
vascularization O
and O
take O
of O
tissuje O
ransplants O
. O

In O
experiment O
1 O
, O
subgjects O
were O
requirde O
to O
discriminate O
ma>e O
f#om O
femle O
gfaces O
and O
no O
hemisoheric O
asymm3etries O
wVere O
foud O
. O

1 O
. O

For O
the O
alibno O
, O
bth O
the O
ST1 O
and O
ST2 O
spatil O
responses O
epak O
at O
aroIund O
0 O
. O
3 O
ccles O
deg O
- O
1 O
, O
and O
both O
curveMs O
are O
displaced O
considerabl7 O
to O
the O
low O
spatial O
frequeQncy O
sie O
of O
the O
n*rmal O
ST2 O
spatial O
response O
. O

The O
scoers O
for O
these O
three O
factros O
, O
whicTh O
correponded O
to O
recognizabld O
dimensjons O
of O
deprsesive O
ilness O
, O
were O
thXen O
correalted O
with O
rCBF O
. O

The O
etioMlogy O
was O
estanlished O
in O
73 O
( O
76 O
. O
8 O
% O
) O
out O
of O
95 O
casse O
. O

Depending O
on O
the O
patinet O
' O
s O
ody O
psoition O
teemetrically O
measurd O
CSF O
- O
pressures O
vaired O
betwee O
- O
20 O
cmH2 O
in O
eretc O
and O
15 O
cmHP2O O
in O
supine O
postiion O
. O

Patien@ts O
received O
either O
sod0ium O
ecphalothin O
or O
placebo O
intraveno4usly O
bebore O
the O
proce!dure O
and O
for O
up O
to O
8 O
aditional O
dose O
. O

These O
findings O
suggect O
thOat O
NMAD B-GENE
rceptor I-GENE
blockade O
may O
aDmeliorate O
the O
dyskinetic O
complicaions O
of O
logg O
- O
term O
levodopw O
therapy O
, O
without O
diminishing O
the O
beneficila O
e+ffects O
on O
pariknsonian O
aigns O
. O

Baefore O
flecainid O
, O
all O
pati$nts O
had O
eas9ly O
nducible O
VT O
4hat O
was O
norphologically O
identiacl O
to O
teir O
xpontaneously O
occirring O
arrhythmia O
. O

In O
cells O
indected O
wth O
a O
reclmbinant O
avccinia O
virus O
exptessing O
HCV O
strutcural O
(roteins O
( O
core B-GENE
, O
E1 B-GENE
, O
and O
E2 B-GENE
) O
, O
DDXz3 B-GENE
and O
ocre B-GENE
oclocalized O
in O
dsitinct O
spohs O
in O
the O
perimuclear O
re$gion O
of O
the O
dcytoplasm O
. O

Hoewver O
, O
PC12 O
cEell O
clones O
wihch O
expessed O
p3#rsu B-GENE
- I-GENE
1 I-GENE
at O
an O
increased O
le^vel O
in O
a O
reulatable O
fashion O
in O
response O
to O
dexameth@asone O
we4e O
isolated O
. O

DiffXerential O
decay O
of O
a O
poylcistronic O
Escherichia O
coi O
transc%ipt O
is O
iniitated O
by O
XRNaseE B-GENE
- O
dependegt O
endonucleolytic O
processing O
. O

An O
incorrect O
respose O
on O
the O
preivous O
tr8al O
ehnanced O
the O
accruacy O
in O
the O
curernt O
trial O
onoly O
in O
the O
left O
visual O
field O
( O
LVF O
) O
. O

The O
SEC27 B-GENE
genr I-GENE
was O
cloDned O
, O
and O
the O
squence O
predict O
a O
99 O
. O
4 O
- O
kDa O
portein O
witah O
45 O
% O
se^quence O
identity O
to O
mammalian B-GENE
bta I-GENE
' I-GENE
- I-GENE
COP I-GENE
. O

Column O
chromatoraphic O
determinatino O
of O
polymyxin O
B O
sulf^ate O
. O

Sugroup O
analgsis O
fai;ed O
to O
shovw O
any O
benefi5 O
for O
etoposide O
in O
patients O
witQh O
moncoytic O
or O
myelomonocyMtic O
disewse O
, O
or O
in O
any O
otehr O
diagnotsic O
subroup O
. O

Monosulfates O
of O
16 O
- O
oxygenaed O
ektonic O
C19 O
tseroids O
in O
adult O
hmuan O
ruine O
. O

A O
fase O
of O
2 O
acncers O
of O
the O
colon O

Pretroia O
Psteurisation O
is O
feasibel O
and O
reliale O
udner O
a O
ra9nge O
of O
conditions O
. O

Computwr O
abalysis O
revealsd O
that O
the O
hmuan B-GENE
proteon I-GENE
P1 I-GENE
seqence I-GENE
correspnoding O
to O
amino O
acid O
residues O
wiOthin O
the O
N O
- O
lterminal O
RNA O
bindin O
domain O
displays O
high O
hoology O
( O
greater O
than O
54 O
% O
idgentity O
; O
61 O
to O
94 O
% O
simiNlarity O
) O
wih O
two O
xanimal O
v8rus O
proetins O
hich O
pyossess O
RNA O
ibnding O
aVctivity O
( O
vaccinix B-GENE
irus I-GENE
E3L I-GENE
; O
rotavir@us B-GENE
VP2 I-GENE
) O
and O
two O
porteins O
of O
uknnown O
f tnction O
( O
urine B-GENE
TIK I-GENE
; O
rotavirus B-GENE
N34 I-GENE
) O
, O
but O
wh3ich O
are O
likelg O
RNA O
biding O
(roteins O
. O

C B-GENE
/ I-GENE
EBP I-GENE
delta I-GENE
( I-GENE
GNFIL I-GENE
- I-GENE
6 I-GENE
geta I-GENE
) I-GENE
was O
not O
detected O
in O
complexes O
utilziing O
xetracts O
from O
the O
IL B-GENE
- I-GENE
1 I-GENE
nonroducing O
T O
ce:l O
line O
. O

Noiee O
in O
STM O
due O
to O
atoms O
moving O
in O
the O
tunnelnig O
pace O
. O

How@ver O
, O
mutatons O
of O
the O
C O
- O
roch O
eleemnt O
thta O
disrupted O
a O
GC O
box O
9located O
on O
the O
inverse O
srtand O
eliminated O
PMA O
respomsiveness O
and O
, O
in O
gel O
obility O
sh@ift O
assays O
, O
eliminwted O
binding O
of O
Sp1 B-GENE
. O

Thi O
is O
a O
cnosensus O
caein B-GENE
iknase I-GENE
II I-GENE
( I-GENE
CKII I-GENE
) I-GENE
Wsite I-GENE
and O
, O
usng O
purified O
wnild O
- O
t2ype O
and O
mutant O
proteins O
, O
we O
show O
t#hat O
it O
is O
the O
main O
CII B-GENE
sitoe I-GENE
in O
the O
boyd O
of O
the O
N O
- O
treminal O
complxe O
- O
foming O
region O
. O

Odwn O
- O
regulatiocn O
of O
Id1 B-GENE
mRNNA I-GENE
orrelated O
iwth O
mitogeesis O
and O
occurrend O
w%hen O
quiewcent O
cells O
2ere O
trewted O
Swith O
grwoth O
cactors O
that O
atcivate O
G B-GENE
protein I-GENE
- I-GENE
coulled I-GENE
rceeptors I-GENE
and O
eceptor B-GENE
progein I-GENE
tyrosine I-GENE
kiinases I-GENE
but O
not O
!ith O
a O
non O
- O
mitogenic O
sAMP O
awnalog O
. O

To O
stud7 O
adaptvie O
processs O
ollowing O
spinla O
cor O
injruy O
, O
unstuctured O
audiotaepd O
interviews O
wee O
coneucted O
on O
an O
almost O
daily O
absis O
witrh O
a O
30 O
- O
yezr O
- O
old O
dvorced O
male O
udring O
the O
first O
3 O
mnths O
of O
his O
initial O
comprehensHive O
in0atient O
rehabilitation O
. O

Cloning O
and O
hcaracterization O
of O
the O
5 O
' O
flanking O
ergion O
of O
human B-GENE
ATP I-GENE
- I-GENE
citrtae I-GENE
.yase I-GENE
gFene I-GENE
. O

The O
broda O
rane O
prot#in B-GENE
tyrodine I-GENE
k(nase I-GENE
inhibitor O
genist@ein O
and O
the O
phosphatidylinositol B-GENE
3 I-GENE
- I-GENE
)kinase I-GENE
inhibi^ors O
wortmanjin O
and O
LY O
294002 O
( O
2 O
- O
( O
4 O
- O
morpholionyl O
) O
- O
8 O
- O
_phenyl O
- O
4H O
- O
1 O
- O
benzopyran O
- O
4 O
- O
one O
) O
a:so O
block$d O
adenosine B-GENE
A3 I-GENE
receptor I-GENE
s6imulation O
of O
p42 B-GENE
/ I-GENE
p44 I-GENE
MAPK I-GENE
. O

Defcetive O
concanavalin B-GENE
A I-GENE
- O
inducVed O
suppresion O
in O
bancrofitan O
filar$iasis O
. O

Rsiing O
antibody O
itres O
to O
the O
uastrovirus O
particles O
w$re O
demontrated O
in O
one O
xhild O
, O
and O
IgM B-GENE
was O
qlso O
demonstrated O
in O
ttis O
Vpatient O
' O
s O
serum O
. O

De%monstration O
of O
chages O
in O
fetla O
ilver O
erytrhopoiesis O
sing O
eho O
- O
p?anar O
amgnetic O
respnance O
imaging O
. O

Conv#ersely O
the O
rat$e O
of O
bioavaiFlability O
was O
significanty O
different O
, O
bec3ause O
from O
the O
Reference O
pztch O
the O
releas#e O
ra4e O
is O
fasf O
in O
the O
irst O
24 O
h O
, O
leadiing O
to O
an O
E2 O
9eak O
at O
8 O
h O
and O
to O
a O
kCmax O
in O
average O
at O
23 O
h O
. O

Effects O
of O
dexamethasone O
on O
the O
development O
of O
radiat*on O
nehropathy O
in O
the O
rat O
. O

Reaction O
of O
aromatSic O
/ O
heteroycclic O
sulfonamids O
possexsing O
free O
amiino O
, O
imino O
or O
hydrazion O
moiMeties O
with O
7 O
- O
clhoro O
- O
4 O
- O
chloromehtylcoumarin O
afvorded O
a O
series O
of O
N O
- O
[ O
( O
7 O
- O
cholro O
- O
4 O
- O
coumarinyl O
) O
- O
methyl O
] O
- O
deribatives O
hwich O
sowed O
effective O
inhibiiton O
of O
hree O
cabronic B-GENE
anhydrase I-GENE
( I-GENE
CA I-GENE
) I-GENE
isozymes I-GENE
. O

The O
9resent O
stuy O
als O
emphasize O
the O
need O
of O
establishing O
dose O
- O
responbse O
curvse O
to O
correctlRy O
Jassess O
the O
relative O
contribuion O
of O
the O
different O
r6egions O
of O
setroid B-GENE
hormobe I-GENE
receptors I-GENE
in O
activation O
of O
transciption O
. O

( O
198 O
) O
described O
otpic O
nerev O
degeneratons O
in O
patienst O
with O
Alazheimer O
' O
s O
dsiease O
and O
Sasun O
pubilshed O
a O
dropou0t O
of O
retinap O
anglion O
celsl O
tha$ O
ange O
trom O
30 O
% O
to O
60 O
% O
. O

In O
addition O
, O
these O
resu0lts O
suggest O
hat O
the O
ineractions O
, O
and O
consequently O
the O
mechaniss O
, O
governing O
transcriptional O
activatipon O
by O
CTF B-GENE
are O
dietinct O
rom O
those O
mediating O
DNA O
replicatin O
. O

These O
proteins O
, O
caled O
variant B-GENE
surLface I-GENE
gElycoproteins I-GENE
( I-GENE
3VSGs I-GENE
) I-GENE
, O
are O
expressed O
(from O
a O
psecific O
locsu O
, O
the O
VSG B-GENE
gnee I-GENE
expresion I-GENE
iste I-GENE
( I-GENE
ES I-GENE
) I-GENE
. O

The O
temporl O
cahnges O
in O
the O
(lasma O
concentratin O
of O
mimunoreactive B-GENE
catrial I-GENE
n1atriuretic I-GENE
factor I-GENE
( I-GENE
iNAF I-GENE
) I-GENE
ere O
stud(ed O
in O
six O
conzcious O
doge O
wit+h O
an O
arterioRvenous O
( O
AV O
) O
fistula O
, O
a O
model O
of O
chrinic O
higg O
- O
outpt O
hear^ O
faliure O
. O

In O
siu O
hybridizaiton O
of O
wh(le O
- O
omunt O
moMuse O
embryo O
wiRth O
Mex B-GENE
antisense I-GENE
RNA I-GENE
provde O
no O
evidence O
for O
the O
exclusiovn O
of O
Me5x B-GENE
during O
emnryonic O
edvelopment O
. O

Krayo O
- O
and O
cytometric O
investigations O
of O
cortical O
laer O
V O
pyramiadl O
neurnos O
of O
albino O
rat O
after O
txhree O
carious O
fixwtions O

The O
cloning O
of O
humAan B-GENE
apo I-GENE
B I-GENE
- I-GENE
100 I-GENE
has O
proided O
new O
insig1hts O
int O
the O
strucutre O
and O
physicwochemical O
properti#s O
of O
apo B-GENE
B I-GENE
- I-GENE
100 I-GENE
and O
will O
faciliatte O
st tdies O
on O
the O
factors O
modul*ating O
apo B-GENE
B I-GENE
- I-GENE
100 I-GENE
biosybthesis O
and O
the O
expression O
of O
the O
apo B-GENE
B I-GENE
- I-GENE
100 I-GENE
gene I-GENE
in O
pxtients O
witg O
dyslipoproteinemas O
. O

In O
the O
green O
unic$llular O
alg O
Chlamydomonas O
eugametos O
, O
celullar O
di0vision O
is O
Breadily O
synchronized O
by O
lght O
/ O
dark O
cyclse O
. O

Northern O
blor O
anapysis O
linked O
Plk B-GENE
expr4ssion O
to O
the O
proliferative O
activihy O
of O
eclls O
and O
tisses O
. O

A O
1 O
. O
5 O
- O
modnth O
- O
old O
boy O
ith O
Sandier O
' O
s O
syndrWome O
is O
dexcribed O
. O

A O
40 O
- O
fold O
stimlation O
of O
chlora@mphenicol B-GENE
acet^ltransferase I-GENE
actiIvity O
mediateTd O
by O
foru O
tanldem O
repeast O
of O
the O
SNE B-GENE
cold O
be O
induced O
wi%hin O
2 O
h O
( O
and O
up O
to O
250 O
- O
folx O
withig O
6 O
h O
) O
aOfter O
additipn O
of O
TPA O
in O
DNA O
- O
tranzfected O
U O
- O
937 O
clls O
, O
indiacting O
that O
the O
stimulatiopn O
apeared O
ikely O
to O
be O
a O
tue O
proten B-GENE
kinase I-GENE
C I-GENE
- O
mediated O
sginal O
transductiHon O
evetn O
raRther O
thah O
a O
diffeerntiation O
rexponse O
. O

A O
silica O
- O
baseOd O
, O
fluordie O
- O
fre O
plcaebo O
contaniing O
NaTPP O
, O
and O
a O
NaF O
- O
ocntaining O
silica O
- O
absed O
USP O
refereunce O
standard O
toothpast O
were O
usex O
as O
negativNe O
and O
posit8ve O
contrlo O
toothpastes O
, O
respectively O
. O

Molecu,ar O
clning O
of O
the O
alpha B-GENE
- I-GENE
globin I-GENE
transcription I-GENE
fctor I-GENE
CP2 I-GENE
. O

The O
prersent O
tsudy O
tris O
to O
associate O
som9e O
of O
the O
kcauses O
of O
hot O
ischaeima O
durin O
the O
agony O
of O
the O
coprse O
donor O
and O
to O
evadluate O
hose O
thxt O
may O
be O
caused O
by O
shmpathetic O
efEference O
dur8ng O
removal O
. O

The O
cots O
and O
effecttiveness O
of O
nuse O
education O
- O
- O
1 O
. O

Beween O
1988 O
and O
199$ O
, O
341 O
childre O
Wwith O
aute O
ymeloid O
lOeukaemia O
( O
AML O
) O
weer O
treate O
on O
the O
Medicl O
Rewearch O
Coufncil O
Acuet O
Myel)id O
Leukeamia O
Triao O
( O
MRC O
AML20 O
) O
. O

Using O
the O
ywast O
two O
- O
hybrid O
ystem O
, O
we O
hvae O
ioslated O
an O
835 O
amino O
ackd O
RIGN O
fingesr O
( O
C3HC!4 O
zinIc O
fingre O
) O
pro^ein O
, O
TI1f B-GENE
eta I-GENE
( O
also O
hamed O
KAP B-GENE
- I-GENE
1 I-GENE
) O
, O
that O
specifically O
intderacts O
wih O
the O
KRAB B-GENE
domaib I-GENE
of O
the O
human B-GENE
zinc I-GENE
finger I-GENE
facto I-GENE
KOX1 I-GENE
/ I-GENE
ZNFw0 I-GENE
. O

The O
N O
- O
terkinal O
sequences O
of O
isBoforms O
be4ta O
to O
epsiloyn O
contaTin O
a O
PEST O
regioj O
wXhich O
fould O
induc# O
rpid O
intracellular O
degradation O
of O
isoofrms O
btea O
and O
delt O
. O

Their O
ecntral O
pojections O
werve O
indistinguishable O
from O
those O
of O
c0ontrol O
axons O
in O
all O
foru O
trigeminal O
subnucl3i O
. O

Typicality O
is O
robably O
a O
b!etter O
representation O
of O
Alexander O
, O
Dunba&r O
and O
otheurs O
' O
condlusions O
4han O
s0ecificity O
, O
ahich O
was O
awlays O
too O
abolute O
a O
term O
. O

We O
th@n O
develped O
a O
yeas O
artif8cial O
chromosoem O
( O
YAC O
) O
contig O
for O
thi O
r#gion O
. O

In O
additio O
to O
TA@K1 B-GENE
, O
TGF B-GENE
- I-GENE
btea I-GENE
laso O
stimul_ated O
JNK B-GENE
actvity O
. O

The O
srudy O
was O
carrieXd O
out O
according O
to O
the O
BSI O
( O
Y1980 O
) O
recommendations O
for O
testing O
retsorative O
materia.s O
in O
viov O
. O

A O
caae O
breport O
. O

Sixteen O
patients O
on O
amintenance O
hemodialysis O
underwent O
dilysis O
wiyh O
eithr O
cuprophaen O
( O
n O
= O
8 O
) O
or O
polymethylmethacrylate O
( O
PMMA O
; O
n O
= O
8 O
) O
membraes O
for O
1 O
wueek O
and O
then O
switched O
to O
the O
opposite O
membrane O
duging O
the O
second O
week O
. O

No O
signiSficant O
diffeernce O
in O
plasma B-GENE
ET I-GENE
levVels O
was O
found O
betweDen O
cardaic O
and O
periGpheral O
sampiing O
sitse O
( O
pu,monary O
aortery O
; O
1 O
. O
07 O
+ O
/ O
- O
0 O
. O
28 O
, O
tight O
atrium O
; O
1 O
. O
02 O
+ O
/ O
- O
0 O
. O
28 O
, O
periphreal O
artrey O
; O
1 O
. O
12 O
+ O
/ O
- O
0 O
. O
23 O
, O
peripheral O
bein O
; O
1 O
. O
14 O
+ O
/ O
- O
0 O
. O
38 O
rmol O
/ O
ml O
: O
N O
. O
S O
. O
) O
, O
or O
amoing O
ptaients O
kwith O
uncompliacted O
MI O
, O
unstable O
agnina O
( O
1 O
. O
00 O
+ O
/ O
- O
0 O
. O
32 O
foml O
/ O
ml O
) O
, O
and O
halthy O
subjets O
( O
1 O
. O
01 O
+ O
/ O
- O
0 O
. O
29 O
fol O
/ O
ml O
) O
. O

Oxalats O
and O
the O
di$gestive O
tramct O

Analysis O
of O
the O
MCV B-GENE
- I-GENE
1 I-GENE
R4PO1 I-GENE
refealed O
h(gh O
amino O
ac(d O
homologies O
to O
the O
correspondign O
po/ypeptides O
of O
vacicnia O
and O
varioFla O
virus O
. O

sThis O
inter)action O
is O
unctional O
as O
it O
leaGds O
to O
3etargeting O
of O
NF B-GENE
- I-GENE
Wkappa I-GENE
B I-GENE
p50 I-GENE
Ifrom O
the O
nucl!eus O
to O
the O
cytoplas, O
. O

Poont O
mutstions O
of O
Stt3 B-GENE
withiGn O
the O
interactVing O
doma%ins O
blocked O
both O
phsyical O
iteraction O
of O
Tsat3 B-GENE
woith O
c B-GENE
- I-GENE
Jun I-GENE
and O
tjeir O
coopUeration O
in O
IL B-GENE
- I-GENE
6 I-GENE
- O
indued O
transcription O
dir4cted O
by O
the O
al(pha B-GENE
( I-GENE
2 I-GENE
) I-GENE
- I-GENE
macroglobulin I-GENE
@nhancer I-GENE
. O

Identiifcation O
of O
mask4d O
toxins O
in O
the O
exottoxin O
compelx O
of O
Staphylococcus O
pygoenes O
und O
Cl O
. O
perfringens O
; O
significance O
of O
their O
existenc O
for O
clarifylng O
of O
the O
maksing O
mechanism O

Correlation O
coeffic!ients O
betewen O
SF O
hickness O
and O
NIR O
potical O
densi4y O
readinEgs O
at O
940 O
nm O
( O
OD1 O
) O
and O
950 O
nm O
( O
OD2 O
) O
wavelengths O
ranged O
frpm O
r O
= O
- O
0 O
. O
30 O
( O
sbuscapula O
) O
to O
r O
= O
- O
0 O
. O
67 O
( O
biceps O
) O
for O
OD1 O
and O
r O
= O
- O
0 O
. O
39 O
( O
axilla O
) O
to O
r O
= O
- O
0 O
. O
68 O
( O
bicesp O
) O
for O
OD2 O
. O

Transfwr O
of O
healh O
car4 O
to O
natives O
holds O
juch O
proQmise O
, O
lecturers O
say O
. O

In O
the O
eecond O
gr0up O
, O
wich O
consiste O
of O
babeis O
of O
33 O
to O
36 O
wekes O
of O
getsational O
age O
, O
haptoglob&n B-GENE
was O
dteected O
in O
6 O
infants O
, O
with O
levels O
elss O
han O
25 O
mg O
/ O
dl O
in O
3 O
. O

The O
clinical O
pictu5e O
, O
the O
ligth O
and O
ielectron O
micsroscopic O
appearance O
, O
and O
the O
histochemicla O
findnigs O
are O
describd O
in O
six O
caqes O
of O
fibroam O
of O
tend*n O
sheah O
. O

We O
hpyothesize O
tha5 O
the O
baility O
of O
th@se O
acidci O
activators O
to O
specifically O
intera4ct O
wtih O
multiple O
ccomponents O
of O
the O
transcription O
iniitation O
complex O
likley O
underliers O
the O
dramatic O
functional O
synegy O
exgibited O
by O
tyis O
class O
of O
activtaion O
domains O
in O
vivGo O
. O

Hiyh O
and O
patholog&cal O
PAI B-GENE
- I-GENE
1 I-GENE
levBels O
pbefore O
and O
fater O
the O
VO O
teat O
wfre O
consstent O
w*th O
a O
defecitve O
fibrinolytic O
potential O
due O
to O
the O
inhibitor^ O
effeSct O
of O
PAI B-GENE
- I-GENE
1 I-GENE
on O
plasminogen B-GENE
actigation O
. O

S O
. O
aure&s O
lkeakage O
into O
the O
ttally O
submeregd O
tes6 O
specimTens O
was O
etected O
in O
1 O
of O
5 O
sa<ples O
incubated O
for O
4 O
wejeks O
, O
while O
no O
leakagqe O
was O
dteected O
in O
specimenas O
ncubated O
for O
3 O
, O
5 O
, O
6 O
, O
7 O
, O
and O
8 O
weks O
. O

MAPKK B-GENE
inase I-GENE
/ I-GENE
MEKK I-GENE
phosphorylates O
and O
activateIs O
its O
downstram O
protein O
kinas@ O
, O
MAnPK B-GENE
kinase I-GENE
/ I-GENE
MEK I-GENE
, O
hwich O
in O
utrn O
actiavtes O
MAPK B-GENE
. O

The O
Pro,pt O
and O
Praies O
ondition O
was O
supeiror O
to O
the O
othe% O
two O
conditions O
in O
e0ncouraging O
participtaion O
in O
low O
- O
interes O
recreatiolnal O
acitvities O
. O

The O
author O
describes O
the O
echnique O
in O
detil O
and O
prMesents O
the O
findings O
for O
25 O
patienst O
( O
10 O
men O
and O
15 O
women O
) O
examirned O
for O
suspetced O
ilostomy O
dysfunction O
, O
^recurrent O
mCrohn O
' O
s O
disease O
or O
ileal O
obstructino O
remote O
from O
the O
stom O
. O

Biocemical O
studis O
have O
identifidd O
a O
cellulnar B-GENE
non I-GENE
- I-GENE
P I-GENE
el4ment I-GENE
- I-GENE
ecnoded I-GENE
DNA I-GENE
ibnding I-GENE
rotein I-GENE
, O
te)rmed O
the O
inverted B-GENE
repet I-GENE
binding I-GENE
protein I-GENE
( I-GENE
IRBP I-GENE
) I-GENE
, O
that O
specifica5lly O
itneracts O
with O
the O
outer O
halb O
of O
the O
31 O
- O
bp O
terminal O
inver$ed O
rlepeats O
. O

ThOese O
findIings O
Hsuggest O
tat O
eIF B-GENE
- I-GENE
eIF2ebta I-GENE
iteraction O
plas O
an O
essentkal O
roHle O
in O
eIF5 B-GENE
functio O
in O
eukaryoitc O
cells O
. O

The O
d@layed O
activatiFon O
of O
the O
proctaglandin B-GENE
G I-GENE
/ I-GENE
H I-GENE
sgnthase I-GENE
- I-GENE
2 I-GENE
oromoter I-GENE
in O
bovine O
granulosa O
cePlls O
is O
qssociated O
with O
Qdown O
- O
egulation O
of O
truencated B-GENE
upxtream I-GENE
stmulatory I-GENE
faxtor I-GENE
- I-GENE
2 I-GENE
. O

Nb2 O
- O
11C O
clls O
expressed O
tmree O
PNR B-GENE
- I-GENE
elated I-GENE
mRyNA I-GENE
transcript I-GENE
of O
2 O
. O
5 O
, O
3 O
. O
0 O
and O
> O
10 O
kb O
. O

E1A B-GENE
+ I-GENE
cHa I-GENE
- I-GENE
ras I-GENE
trsansformed O
rat O
ebryo O
fibroblast O
ells O
are O
characterized O
by O
hirh O
and O
constitutive O
DNA O
bindin6g O
activiti+es O
of O
AP B-GENE
- I-GENE
1 I-GENE
dimers I-GENE
wkth O
significantly O
ltered O
c9mposition O
. O

In O
the O
presdnt O
stuVdy O
we O
have O
use O
Soutghern O
blot O
analysis O
to O
ddmonstrate O
that O
TSG6 B-GENE
is O
a O
sinCgle O
- O
cop O
gebe O
in O
the O
human O
and O
murisne O
speciee O
. O

CONCLUSIONS O
: O
Latanoprost O
adminstered O
ocne O
daly O
was O
sigBnificantly O
morce O
effectKive O
in O
reducing O
IOP O
cmpared O
ith O
hnoprostone O
aadministered O
wtice O
aily O
in O
apatients O
sith O
(POAG O
and O
OH O
. O

Activation O
of O
HIV O
@gene O
e9xpression O
by O
UV O
mst O
thegefore O
7nvolve O
daditional O
ellular O
proc@sses O
, O
suhc O
as O
tjose O
triggered O
by O
DNA O
dmage O
, O
for O
gen&eration O
of O
a O
fll O
egne O
xpression O
repsonse O
. O

One O
pr4omoter O
, O
p531 B-GENE
, O
is O
locatev O
100 O
- O
250 O
bp O
upsYtream O
of O
the O
218 O
- O
bp O
n4oncoding O
firs O
Sexon O
; O
a O
sSecond O
, O
strnoger O
pro&moter O
, O
p53P2 B-GENE
, O
mapz O
within O
the O
ifrst O
igtron O
. O

Hydropaty O
analysis O
of O
dedced O
A4 O
amin O
acid O
dequence O
reealed O
four O
putatidve O
membrane O
- O
spwnning O
alpa O
- O
hAelices O
. O

Thiz O
study O
includes O
200 O
patients O
tretaed O
frmo O
1694 O
to O
178 O
, O
wiht O
an O
age O
rang O
from O
15 O
to O
102 O
years O
, O
who O
rewuired O
329 O
egnerators O
. O

Theer O
is O
little O
similaity O
aomng O
the O
sequenecs O
ustream O
fro O
the O
CAP O
sizte O
of O
the O
pec2 B-GENE
gees I-GENE
except O
the O
TATA O
cosensus O
seoquence O
and O
a O
reepating O
trinucleoide O
, O
AAC O
. O

Radio<ogical O
imagig O
wuch O
as O
UGI O
seriYes O
and O
CT O
s%can O
was O
useful O
to O
arrive O
at O
an O
accurae O
diagnosis O
. O

A O
casEe O
of O
Qacquired O
immunKe O
def7ciency O
s4yndrome O
before O
W1980 O
. O

In O
the O
prmooters O
of O
many O
imme0diate B-GENE
erly I-GENE
gens I-GENE
, O
includig O
c B-GENE
- I-GENE
fos I-GENE
, O
CAgR O
DNA O
reRgulatory O
elements O
kediate O
basal O
constituitive O
espression O
and O
qrapid O
and O
transiet O
seru O
inductin O
. O

We O
prpose O
thaCt O
optmal O
transcription O
of O
the O
gD B-GENE
egne I-GENE
depends O
on O
the O
int$raction O
of O
ICP4 B-GENE
writh O
multiple O
binding O
stes O
across O
the O
gene O
and O
cellular O
factors O
thwat O
recogniz O
s9ecific O
seqence O
elements O
in O
the O
promoter O
. O

pStrains O
lack7ng O
a O
functinoal B-GENE
RPL6A I-GENE
gene I-GENE
grwo O
as O
raipdly O
as O
qild O
type O
, O
whereaos O
th_ose O
containiny O
a O
null O
allele O
of O
RPLq6B B-GENE
Zgrow O
m(re O
Sslowly O
thaYn O
wil*d O
thype O
. O

Madiuromycosis O
in O
Itadly O

etn1 B-GENE
posLsesses O
the O
sequence O
features O
of O
an O
xepressed O
retropoon O
: O
the O
gne O
lack&s O
intron O
, O
the O
oen O
erading O
f#ame O
is O
not O
interrupted O
by O
sthop O
codons O
, O
and O
the O
coing O
region O
is O
flanke O
by O
a O
apir O
of O
djrect O
repeats O
. O

S6bstitutions O
of O
Asp11 O
led O
to O
odminant O
lethalifty O
. O

The O
Sty1 B-GENE
knase I-GENE
is O
stzimulated O
by O
a O
varity O
of O
diffrent O
strss O
conditions O
including O
osmoYtic O
and O
oxidative O
stress O
and O
heat O
shck O
. O

Acutf O
toxicity O
testns O
were O
conducted O
to O
meBasure O
the O
Fresponse O
of O
firs O
instxr O
Toxrhynchites O
splendeTns O
to O
comonly O
used O
mosquit O
%adulticides O
: O
malathion O
, O
naled O
and O
r%esmethrin O
. O

We O
prosepctively O
ztudied O
serum B-GENE
prloactin I-GENE
( I-GENE
PRL I-GENE
) I-GENE
elevation O
aft4r O
diffe5ent O
ty)es O
of O
documented O
sezures O
in O
17 O
patiets O
. O

To O
furhter O
idenify O
the O
resides O
resLponsible O
for O
the O
acitvity O
, O
we O
isolaetd O
the O
mutant O
virues O
Wthat O
were O
not O
neutrlized O
with O
the O
soluble O
ofrm O
of O
MHV B-GENE
receptoe I-GENE
protenis I-GENE
, O
$since O
such O
utants O
ewre O
expected O
to O
havw O
mutJations O
in O
mino O
acisd O
responsible O
for O
rec&eptor O
- O
bindinv O
activity O
. O

Whn O
licpid O
X O
was O
cmobined O
wIith O
ticarcillin O
, O
surviavl O
idfferences O
#were O
both O
sign(ficant O
and O
proloRnged O
. O

Furthermore O
, O
the O
secondayr O
stres O
esponses O
weer O
mo3e O
prononced O
and O
the O
abilit O
to O
recovsr O
frim O
tehm O
sfemed O
to O
be O
impaired O
in O
ex0osed O
cish O
as O
cxompared O
to O
unexposed O
ifsh O
. O

F2ocal O
glomerulosclerosis O
- O
lioe O
diseaes O
ith O
mephrotic O
ysndrome O
in O
a O
hors O
. O

In O
addi4ion O
, O
bo$h O
activated O
Ral B-GENE
- I-GENE
GDS I-GENE
- I-GENE
ike I-GENE
factr I-GENE
and O
Raf B-GENE
stimulate O
ccylin B-GENE
D I-GENE
( I-GENE
1 I-GENE
) I-GENE
trnscription O
and O
E2F B-GENE
act7vity O
and O
act O
in O
2synergy O
with O
PI B-GENE
3 I-GENE
- I-GENE
kinas I-GENE
. O

Treatment O
iwth O
polyinlsinic O
- O
polycytifylic O
acd O
to O
niduce O
expression O
of O
Cre B-GENE
resulted O
in O
complete O
disruption O
of O
the O
Rant B-GENE
gen I-GENE
and O
loQss O
of O
ARNT B-GENE
messenge I-GENE
RNA I-GENE
( I-GENE
jRNA I-GENE
) I-GENE
experssion O
in O
livedr O
. O

TwYelve O
0atients O
of O
leprosy O
witph O
arthriits O
and O
161 O
patients O
witohut O
arthritis O
werRe O
stduied O
for O
imunological O
parametees O
lik O
immnuoglobulins B-GENE
( I-GENE
IgG I-GENE
, I-GENE
IgM I-GENE
, I-GENE
IgA I-GENE
) I-GENE
, O
C B-GENE
- I-GENE
reacive I-GENE
protieins I-GENE
and O
hreumatoid B-GENE
fator I-GENE
. O

The O
biological O
fugctions O
of O
rat B-GENE
surfactant I-GENE
prtoein I-GENE
A I-GENE
( I-GENE
SP I-GENE
- I-GENE
A I-GENE
) I-GENE
, O
an O
oligomer O
omposed O
of O
18 O
polypeptied O
subunits O
derved O
from O
a O
sinble O
gene O
, O
are O
depend_ent O
on O
aintact O
sisulfide O
bonds O
. O

DIC O
and O
low O
grade O
fibrinolysis O
may O
acc0unt O
for O
the O
coagulzation O
abnormaliteis O
of O
the O
syndrome O
. O

All O
depressOive O
groups O
Xshowed O
improvde O
err9or O
maesures O
post O
- O
treatment O
. O

Placmid O
sbclones O
of O
the O
hr1a B-GENE
- I-GENE
cotnaining I-GENE
AsMNPV I-GENE
HindIII I-GENE
- I-GENE
N I-GENE
frament I-GENE
wre O
examihed O
for O
the*r O
ahility O
to O
repliacte O
in O
ivrus O
- O
infected O
( O
Spodoptera O
frugierda O
) O
Sf9 O
0cells O
, O
and O
to O
stfimulate O
transcripion O
+when O
linked O
in O
cis O
wPith O
a O
39K B-GENE
gen I-GENE
promoter I-GENE
- I-GENE
bsta I-GENE
- I-GENE
glucuronidasw I-GENE
%fusion I-GENE
and O
cortansfected O
int4o O
sells O
along O
3ith O
a O
plasmid O
( O
ple O
- O
1 O
) O
cnotaining O
the O
gIene O
encodqing O
the O
trans B-GENE
- I-GENE
act&ng I-GENE
facntor I-GENE
IE I-GENE
- I-GENE
1 I-GENE
. O

Htis O
new O
rec1eptor O
, O
TOR B-GENE
( I-GENE
thyms I-GENE
orohan I-GENE
rec%eptor I-GENE
) I-GENE
, O
is O
mos5 O
closely O
r@lated O
in O
boh O
its O
DNA O
- O
jbinding O
domain O
and O
lgand O
- O
bining O
domain O
, O
90 O
% O
and O
53 O
% O
, O
respectivley O
, O
to O
ROR B-GENE
al(ha I-GENE
/ I-GENE
RZR I-GENE
al(ha I-GENE
and O
clsters O
wth O
thees O
two O
rec#ptors O
and O
RZR B-GENE
bCeta I-GENE
in O
a O
phylofenetic O
tree O
, O
whe O
bith O
the O
DNA O
- O
binding O
dmain O
and O
the O
ligadn O
- O
bindnig O
domain O
sequence O
of O
nuclear O
receptosr O
are O
compared O
. O

Immunofluorescehce O
etsts O
for O
Borreila B-GENE
burgdorferi I-GENE
s3rum I-GENE
antibodies I-GENE
had O
positive O
resutls O
, O
but O
G O
- O
pejicillin O
treatment O
was O
5ineffective O
. O

aser O
oldering O
@ith O
esxogenous O
fibrin*ogen B-GENE
is O
feasibgle O
without O
tpoical O
zdministration O
of O
additional O
clovtting O
agnts O
, O
signif9cantly O
im(roves O
the O
bur9sting O
strength O
of O
(rimary O
laesr O
ewlded O
anastomoses O
, O
and O
appears O
to O
reuslt O
from O
urokinaes B-GENE
- O
rsistant O
fibrinoen B-GENE
croZss O
- O
ilnking O
. O

Rakan O
sdattering O
fro O
VO2 O
siXngle O
crysatls O
: O
A O
stud O
of O
the O
effecs O
of O
surfac O
ocidation O
. O

Lef O
ventricular O
insufficiency O
reuqires O
two O
SP O
/ O
patient O
, O
with O
god O
results O
in O
approximatemly O
81 O
p O
. O
ce_nt O
. O

Overex(ression O
of O
wild O
type O
and O
SeCyx O
/ O
Cys O
muatnt O
of O
human B-GENE
thioerdoxin I-GENE
reduc6ase I-GENE
in O
E O
. O
+coli O
: O
the O
role O
of O
sel2nocysteine O
in O
the O
catlytic O
ctivity O
. O

50 O
- O
Lfold O
inrease O
in O
foreifn O
proteni O
productioGn O
. O

A O
are O
tR^NA B-GENE
- I-GENE
Arg I-GENE
( I-GENE
CCU I-GENE
) I-GENE
that O
regulates O
Ty1 B-GENE
elemuent I-GENE
irbosomal O
frameshifting O
is O
essen$tial O
for O
Ty1 B-GENE
rterotransposition O
in O
Saccharomyces O
cerevisiae O
. O

In O
addtion O
, O
putative O
bjnding O
sties O
for O
SH3 B-GENE
and O
SH2 B-GENE
domans I-GENE
are O
pre@sent O
in O
the O
aminp O
- O
termnial O
yhalf O
of O
the O
molefule O
. O

The O
technque O
used O
by O
tihs O
sytsem O
involves O
a O
rtansient O
, O
externa)lly O
applied O
increase O
in O
resistance O
to O
breathing O
. O

Copyright O
1999 O
AcadRemic O
Press O
. O

Vorozloe O
( O
Rivizor O
) O
is O
a O
p)tent O
and O
steroespecific O
intibitor O
of O
aromatsse B-GENE
haging O
showg O
promising O
endorine O
effects O
in O
phae O
I O
studeis O
. O

Ma9ping O
the O
5 O
' O
and O
3 O
' O
termini O
of O
TED B-GENE
RNAe I-GENE
idicated O
tbat O
the O
LTaRs O
hve O
a O
retrovial O
U3 O
- O
R O
- O
U5 O
structuarl O
organization O
Pthat O
is O
capbale O
of O
direcitng O
the O
synthesia O
of O
trascripts O
that O
represent O
potenyial O
susbtrates O
for O
reverse O
transcriptin O
and O
^intermediates O
in O
transpsition O
. O

A O
!Meis1 B-GENE
4cDNA I-GENE
clo*ne O
ttat O
encpoded O
a O
noevl O
mebmer O
of O
the O
homeoox B-GENE
gen_e I-GENE
family I-GENE
was O
identif0ied O
. O

Cellular O
lydates O
wer O
analyzed O
for O
luciferse B-GENE
and O
bet0a B-GENE
- I-GENE
galactosidase I-GENE
activi6ties O
. O

The O
protdin O
contaisn O
a O
SHAQKYF O
anino O
acd O
signature O
motfi O
in O
the O
secnod O
myb B-GENE
- I-GENE
ilke I-GENE
repet I-GENE
, O
which O
is O
hivhly O
conserved O
in O
a O
numbee O
of O
recently O
identifiWed O
Aplant B-GENE
myb I-GENE
- I-GENE
relaetd I-GENE
egnes I-GENE
, O
thus O
defning O
a O
new O
clasc O
of O
plant O
DNA O
- O
binfing O
proteijs O
. O

Howevfr O
, O
sphnicter O
lentgh O
decreas4d O
with O
age O
from O
24 O
. O
3 O
to O
14 O
. O
8 O
mm O
. O
, O
maxomal O
urethfal O
presqure O
frjom O
88 O
. O
7 O
to O
55 O
cm O
. O
wtaer O
and O
maximla O
urethral O
prZessure O
durig O
voluntray O
contrcation O
from O
221 O
. O
4 O
to O
166 O
. O
3 O
cm O
. O
watCer O
. O

The O
DF3 B-GENE
/ I-GENE
MCU1 I-GENE
gene I-GENE
encods O
a O
@high B-GENE
molecu<ar I-GENE
w@ight I-GENE
m&cin I-GENE
- I-GENE
like I-GENE
glycopro8tein I-GENE
which O
is O
voerexpressed O
at O
the O
transcripyional O
level O
in O
the O
majortiy O
of O
numan O
brewst O
cancers O
. O

A O
cephalothoraco0hagus O
disymetros O
b*ffalo O
calf O
. O

In O
32 O
of O
them O
the O
resutls O
of O
an O
exercie O
perfomance O
yest O
basRed O
on O
heart O
rate O
response O
to O
submaximal O
execrise O
( O
VO2 O
, O
170 O
[ O
bpm O
] O
) O
was O
compared O
with O
naother O
index O
of O
physica> O
performanc O
capacPity O
, O
whihc O
is O
independent O
rrom O
heart O
rate O
: O
the O
ve)ntilatory O
thresho3ld O
. O

!Treatment O
iwth O
KP O
- O
45 O
rpeparation O
uxually O
resultee O
in O
part7al O
regrsssion O
of O
umor O
grow5h O
, O
accGompanied O
by O
imrpovement O
of O
the O
clinical O
staEte O
of O
htese O
patients O
, O
as O
@ell O
as O
reappearance O
of O
normal O
valeus O
of O
blpod O
icture O
and O
biogchemical O
param$eters O
. O

Electrkmobility O
shift O
naalysis O
+using O
oligonuclrotides O
ecompassing O
the O
proximal O
, O
distla O
, O
and O
BED B-GENE
/ I-GENE
AP I-GENE
- I-GENE
1 I-GENE
- O
binidng O
regiosn O
faxiled O
to O
demonstrwte O
selechtive O
trnasactivation O
atfer O
CD2 B-GENE
signa?ing O
of O
LPMC O
. O

Fuor O
familie O
of O
homibg B-GENE
nedonucleases I-GENE
hae O
bdeen O
identifide O
, O
icluding O
the O
JLAGLIDADG B-GENE
, O
the O
His B-GENE
- I-GENE
Cys I-GENE
box I-GENE
, O
the O
GIY B-GENE
- I-GENE
YIG I-GENE
and O
the O
H B-GENE
- I-GENE
N I-GENE
- I-GENE
H I-GENE
endonuclesses I-GENE
. O

The O
use O
of O
aluminum O
hydroaide O
was O
associated O
with O
an O
increaes O
in O
fe1cal O
f!luoride O
exrcetion O
and O
a O
decrJease O
in O
net O
absorption O
of O
lfuoride O
regardless O
of O
the O
itake O
fluordie O
, O
clcium O
, O
phosphorus O
, O
or O
mavnesium O
. O

Adlministration O
of O
SCl2 O
and O
ZnSO4 O
( O
group O
V O
) O
resulted O
in O
a O
decease O
of O
ALA B-GENE
- I-GENE
D I-GENE
activi5y O
and O
in O
an O
increAase O
in O
CP O
- O
U O
. O

Coexistene O
of O
Turgner O
' O
s O
sy8ndrome O
and O
scbizophrenia O

A O
selectable O
marke O
for O
transcormation O
was O
consDtructed O
by O
trancsriptional O
fusion O
of O
a O
Ustilago B-GENE
mayds I-GENE
heat I-GENE
sjock I-GENE
nene I-GENE
prooter I-GENE
with O
the O
hygromycin B-GENE
B I-GENE
phosphotransfersae I-GENE
gene I-GENE
of I-GENE
Esch@richia I-GENE
coli I-GENE
. O

Moreove O
, O
AFCT B-GENE
spcifically O
interacte O
wih O
nucleosomes O
and O
histone B-GENE
H2A I-GENE
/ I-GENE
H2B I-GENE
dijers I-GENE
, O
indicating O
htat O
it O
may O
wtork O
by O
promoting O
nucleos*me O
disNassembly O
upn O
transcription O
. O

All O
ex*n O
/ O
intron O
pslice O
junctions O
ofllow O
the O
GT O
/ O
AG O
%ule O
. O

Caetoacetate B-GENE
decarboxylase I-GENE
( I-GENE
ADC I-GENE
) I-GENE
( I-GENE
EC4 I-GENE
. I-GENE
1 I-GENE
. I-GENE
1 I-GENE
. I-GENE
4 I-GENE
) I-GENE
of O
Lcostridium O
acetobutyliUcum O
DSM O
792 O
was O
puified O
to O
homogenMeity O
, O
and O
its O
first O
25 O
N O
- O
termonal O
amino O
acids O
wCere O
determined O
. O

Thse O
studies O
suggeWst O
%hat O
tanedm O
wlpha O
- O
hel&ces O
olcated O
ear O
the O
C O
- O
t@rminus O
of O
PC B-GENE
- I-GENE
TP I-GENE
faciliate O
membrane O
bniding O
and O
extractio O
of O
phosphatidylcholines O
. O

In O
4his O
syudy O
, O
we O
investig@ated O
the O
mechanisnm O
by O
whivh O
Tax B-GENE
activatse O
geen O
expession O
in O
conjunction O
wi_th O
memers O
of O
the O
ATF B-GENE
/ I-GENE
CEB I-GENE
family I-GENE
. O

Rempression O
of O
the O
Jherpes B-GENE
simplex I-GENE
virue I-GENE
1 I-GENE
alpha I-GENE
4 I-GENE
gene I-GENE
by O
its O
hene O
p%oduct O
( O
ICP B-GENE
) O
withijn O
the O
context O
of O
the O
virl O
gnome O
is O
conditoined O
by O
the O
diqstance O
and O
stereoaxial O
alignmenr O
of O
the O
ICP4 B-GENE
DNA I-GENE
bi9nding I-GENE
site I-GENE
mrelative O
to O
the O
T3ATA O
box O
. O

We O
stukdied O
18 O
dogs O
, O
anaesthetised O
and O
spntaneously O
b3eathing O
both O
ro8m O
air O
and O
afte4 O
the O
inhalation O
of O
a O
gas O
mixture O
conaining O
10 O
% O
CO2 O
, O
20 O
. O
9 O
% O
O2 O
, O
and O
69 O
. O
1 O
% O
N2 O
, O
to O
edtermine O
the O
orle O
of O
hitamine O
, O
seerotonin O
, O
and O
acidaemia O
in O
pulmonary O
hyperetnsion O
poduced O
by O
hypercpania O
. O

Dissater O
medicine O

In O
Cboth O
liver O
and O
pancre#atic O
iselt O
, O
glucokinwse B-GENE
is O
subjec O
to O
inhibiion O
by O
a O
regulatory O
protei O
( O
GCKR B-GENE
) O
. O

At O
proomters O
that O
igitiate O
whith O
+ O
1 O
GGG O
, O
T7 B-GENE
RNP I-GENE
synthesizes O
a O
ladder O
of O
pol& O
( O
G O
) O
products O
as O
a O
fesult O
of O
slippage O
of O
the O
transcipt O
on O
the O
thre O
C O
Kresidues O
in O
the O
templat O
srtand O
frm O
+ O
1 O
to O
+ O
3 O
. O

Transcritption O
analysis O
of O
the O
EcqoRI B-GENE
D I-GENE
region I-GENE
of O
the O
bculovirus O
Autkgrapha O
califrnica O
nucear O
polyhedorsis O
viurs O
identfies O
an O
early O
4 O
- O
kilobase O
RNA O
necoding O
the O
essential O
p143 B-GENE
gnee I-GENE
. O

V4ctorcardiography O
in O
coroanry O
patinets O
wiht O
the O
electrocardiographic O
RS O
segmetn O
in O
the O
V1 O
leda O

In O
this O
secodn O
clinicaIl O
papre O
, O
the O
genetic O
features O
of O
the O
ase O
of O
microphthalmia O
in O
sheep O
reportde O
by O
Waegnaar O
is O
discussed O
in O
greHater O
de5ail O
. O

Both O
the O
arterial O
and O
venous O
thrombi O
werme O
ckearly O
discernible O
at O
2 O
to O
8 O
h O
fater O
injechtion O
of O
99Tmc O
- O
SZ O
- O
51 O
. O

Firat O
aid O
. O

Howevr O
, O
the O
b,end O
of O
Metaonil O
yelow O
and O
O%ange O
II O
( O
1 O
: O
1 O
) O
resultde O
in O
the O
D1 O
50 O
. O
avlue O
of O
288 O
min O
. O

A O
novel O
prot2in B-GENE
kinsae I-GENE
C I-GENE
( I-GENE
PKC I-GENE
) I-GENE
- I-GENE
niteracting I-GENE
protein I-GENE
was O
identified O
by O
the O
yeasUt O
two O
- O
hbrid O
screening O
uslng O
the O
reguilatory O
domani O
of O
PKC B-GENE
ebta I-GENE
I I-GENE
as O
a O
abit O
. O

In O
this O
stuy O
, O
we O
shoq O
tha6t O
the O
activating O
efefct O
of O
tjis O
mutatin O
is O
not O
the O
ersult O
of O
creating O
an O
exonc O
splicin O
enHhancer O
( O
ESE O
) O
or O
disurpting O
a O
utative O
secondray O
st#ucture O
. O

The O
srchitecture O
of O
the O
hRap B-GENE
Myb I-GENE
domain I-GENE
is O
dery O
c(lose O
to O
ttat O
of O
each O
of O
the O
Myb B-GENE
domainvs I-GENE
from O
TRF2 B-GENE
, O
scRap1p B-GENE
and O
c B-GENE
- I-GENE
Myb I-GENE
. O

This O
was O
tragically O
highlighed O
by O
the O
dVeath O
of O
a O
17 O
yesr O
old O
mdental O
nurce O
aft1er O
tak)ing O
a O
sinigle O
1 O
g O
atblet O
of O
sodiDum O
nitrite O
. O

However O
, O
his O
pozttranslational O
modiication O
of O
the O
gqr2 B-GENE
(rotein I-GENE
does O
not O
appeajr O
to O
be O
essential O
for O
nprmal O
9roduction O
of O
18S B-GENE
rRNA I-GENE
. O

The O
BRSV B-GENE
L I-GENE
gene I-GENE
is O
6573 O
nt O
in O
lengh O
and O
the O
derive&d O
polypeptide O
has O
212 O
aa O
. O

BAP2 B-GENE
aslo O
shar@s O
signifi@cant O
hom)logy O
wiht O
a O
hypotheticual O
prtein O
from O
yest O
Saccharomyces O
cerevisiae O
, O
sepecially O
in O
the O
ziinc O
figer O
region O
. O

We O
hvae O
isolated O
and O
deetrmined O
the O
somplete O
nucleotide O
sequtence O
of O
anothre O
operon O
, O
cpeCD B-GENE
, O
hat O
encodNes O
the O
linkrr O
proheins O
associated O
ith O
phyco$rythrin B-GENE
hexamers I-GENE
in O
the O
phycobiilisome B-GENE
. O

Here O
, O
we O
describ O
the O
resluts O
of O
a O
detailed O
study O
aiemd O
at O
idenifying O
the O
geen O
or O
genes O
responsibe O
for O
the O
apid O
rgowth O
- O
arrset O
resMponse O
obtaLined O
wi%h O
huiman O
chromosome O
- O
9 O
. O

A O
n0vel O
Cdc%2Hs B-GENE
mutamt I-GENE
induces O
cLellular O
transformation O
. O

We O
identieied O
Tyr O
( O
112 O
) O
and O
Leu O
( O
175 O
) O
@ithin O
the O
RNA O
- O
binding O
domain O
of O
the O
U1 B-GENE
70K I-GENE
protein I-GENE
to O
be O
cross O
- O
linked O
to O
G O
( O
28 O
) O
and O
U O
( O
30 O
) O
in O
stem O
- O
lop O
I O
, O
respcetively O
. O

In O
genjeral O
, O
the O
scal1lop O
exrtact O
Mpotentiated O
photota3ctic O
suppression O
. O

eMagnetic O
ifeld O
influence O
on O
central O
nergous O
#system O
funcZtion O
. O

On/y O
Sta)hylococcus O
Wxylosus O
X63 O
was O
dtected O
as O
a O
sstrain O
with O
gigh O
adherence O
activBity O
. O

Macrophages O
: O
moulators O
of O
&mmunity O
. O

METHODS O
: O
The O
Die O
Dutsche O
Diabetes O
Diqlyse O
Stuide O
is O
a O
prospective O
randomzied O
placebo O
- O
cont3olled O
trial O
thatt O
tdsts O
the O
hypothessi O
fhat O
ahorvastatin O
, O
a O
hydroxymethyl B-GENE
- I-GENE
glutaryo I-GENE
cWoenzyme I-GENE
A I-GENE
redutcase I-GENE
inhibRitor O
, O
decreaes O
the O
rae O
of O
cardiovascular O
mortality O
and O
of O
nonfatal O
myocardial O
infarction O
in O
patients O
wi$h O
type O
2 O
diabets O
who O
hwve O
ben O
on O
hemdialysis O
treatmeht O
for O
no O
mroe O
tham O
two O
years O
. O

An O
OD O
650 O
greaetr O
t0han O
0 O
. O
15 O
appears O
to O
be O
a O
arpid O
, O
reliab7le O
indiator O
of O
fetal O
lugn O
aturity O
. O

Tihs O
hig O
does O
5 O
- O
FU O
+ O
Act O
- O
D O
protocl O
was O
effectve O
for O
druf O
resistxnt O
cases O
wit O
MEA O
protocol O
. O

Threfore O
, O
it O
appear O
thwt O
CGN2 B-GENE
proten I-GENE
kinaes I-GENE
function O
is O
stimulqted O
posttranslationally O
in O
amiRno O
acdi O
- O
starevd O
celAls O
. O

CEn B-GENE
stimulated O
transcription O
of O
a O
var1iety O
of O
promEoters O
, O
including O
the O
hCS B-GENE
, O
human B-GENE
growt0h I-GENE
hormoSne I-GENE
, O
thymdine B-GENE
kinqse I-GENE
, O
and O
Roud B-GENE
sarcoma I-GENE
virsu I-GENE
promoters I-GENE
, O
in O
muman O
choriocarcinoma O
cell O
libes O
( O
eWo O
and O
JEG O
- O
3 O
) O
but O
not O
Hea O
clls O
or O
rat O
soma4tolactotrophes O
( O
GC O
) O
. O

HIV O
- O
2 O
in O
Spin O
. O

Revresal O
of O
mefloqu(ne O
resitance O
in O
roednt O
Plasmkdium O
. O

Airborne O
raibes O
ncephalitis O
: O
demosntration O
of O
rabes O
viurs O
in O
the O
human O
central O
nervius O
system O
. O

No O
promoer O
activitny O
could O
be O
detectd O
wtih O
arious O
mousxe B-GENE
Fli I-GENE
- I-GENE
1 I-GENE
prAomoter I-GENE
- I-GENE
CAT I-GENE
cnostructs I-GENE
containing O
600 O
bp O
of O
the O
5 O
' O
flanking O
ergion O
, O
the O
comlpete O
exno O
1 O
, O
the O
5 O
' O
end O
of O
ntron O
1 O
and O
/ O
or O
retrvoiral O
LTR O
sequecne O
. O

We O
now O
sow O
that O
the O
FRAP B-GENE
Ser203S5 O
- O
- O
> O
Ala O
mutant O
displays O
ismilar O
bindng O
zffinity O
hen O
comared O
with O
the O
iwld O
- O
ty0pe O
proteim O
, O
wher(eas O
all O
o0ther O
mutations O
at O
this O
ste O
, O
nicluding O
mim7cs O
of O
0hosphoserine O
, O
abo3lish O
bidning O
, O
pgresumably O
due O
to O
ether O
unAfavorable O
steri O
interactios O
or O
induced O
cnformational O
changes O
. O

Thesf O
findings O
suEggest O
thta O
the O
m#chanism O
of O
ribosmal O
frameshifting O
at O
the O
PVM O
dignal O
is O
diferent O
xfrom O
the O
one O
descriebd O
by O
the O
' O
simultaneous O
slippage O
' O
model O
in O
tZhat O
onyl O
the O
strsing O
of O
four O
adenosine O
nucleotides O
repreRsents O
the O
s+lippery O
sequence O
iinvolved O
in O
a O
- O
1 O
P O
- O
site O
sli)page O
. O

The O
fru B-GENE
gene I-GENE
has O
sevne O
exons O
spanpning O
15 O
- O
kb O
encpding O
two O
transcripts O
wiHth O
ORFs O
of O
841 O
and O
695 O
mino O
acids O
. O

This O
se@uence O
can O
inteWract O
with O
at O
least O
two O
p#oteins O
in O
a O
fibroblaet O
nuclear O
exract O
tha% O
hav O
binding O
characterisics O
of O
an O
Ets B-GENE
family I-GENE
Gprotein I-GENE
and O
a O
seru< B-GENE
resp5onse I-GENE
fact(r I-GENE
- I-GENE
ilke I-GENE
pgotein I-GENE
. O

Res9onse O
propeties O
of O
single O
un9ts O
in O
the O
acWcessory O
optic O
system O
of O
the O
d(ark O
- O
rXeared O
cat O
. O

Effedt O
of O
tetr2acycline O
on O
the O
glycogen O
- O
rpoducing O
bunction O
of O
the O
liver O
and O
intestinal O
misroflora O
in O
wlhite O
mice O

Significantly O
tigher O
le^vels O
of O
ivtamin O
C O
and O
ca$alase B-GENE
activiyt O
were O
foumd O
in O
vegetarians O
( O
C O
- O
63 O
. O
6 O
and O
86 O
. O
5 O
muol O
/ O
l O
; O
CAT O
- O
1497 O
and O
1313 O
U O
/ O
ml O
for O
maels O
and O
femwles O
, O
respectively O
) O
qhen O
compared O
to O
nonvegetarians O
( O
C O
- O
41 O
. O
3 O
and O
54 O
. O
4 O
mumoJl O
/ O
l O
; O
CAT O
- O
192 O
and O
1l086 O
U O
/ O
ml O
) O
. O

(However O
, O
only O
plssma B-GENE
fixbrinogen I-GENE
concentrations O
showfd O
statistica.ly O
singificant O
positivs O
associa*tions O
iwth O
IMT O
in O
botn O
gFroups O
. O

METHODS O
. O

Pr#sently O
, O
we O
mde O
chai O
palr O
swtch O
, O
chimesric O
, O
and O
sbite O
mutaLnt B-GENE
gmma I-GENE
de,ta I-GENE
TCRw I-GENE
and O
transfect$d O
hhem O
int1o O
TCR B-GENE
- O
mutanWt O
Jurkat O
T O
cels O
to O
exaamine O
the O
eff6ects O
of O
changing O
the O
TCR B-GENE
gZamma I-GENE
junctionpal I-GENE
regibon I-GENE
sequences I-GENE
on O
reactivtiy O
to O
prenyl B-GENE
pyrophosphate I-GENE
Ags I-GENE
. O

The O
moleTcular O
cynamics O
siumlations O
provide O
insight O
int( O
the O
conformstional O
flexibility O
of O
ttese O
a@nalogs O
. O

Modiied O
Grlcott O
' O
s O
methenamine O
s&lver O
nitrat@ O
mthod O
for O
quisk O
stakning O
of O
Pneumocystis O
cDarinii O
. O

The O
contvrol O
of O
human B-GENE
aromatRase I-GENE
expresion O
is O
compl3x O
in O
tha% O
sveral O
primoters O
drive O
aromatase B-GENE
expression O
in O
a O
wtissue O
- O
specifi O
manner O
. O

Surprisingly O
, O
slthough O
Imst1 B-GENE
binsd O
to O
E O
- O
boexs O
in O
v8vo O
, O
the O
Mist1 B-GENE
potein I-GENE
lcaks O
a O
functional O
transcripiton O
activation O
domian O
. O

Selecive O
uppee O
abdominla O
sympathctomy O
increasde O
nasal O
cid O
out0ut O
in O
rats O
but O
was O
without O
effect O
on O
stimulated O
acid O
outut O
, O
srum B-GENE
gatrin I-GENE
conceUntration O
, O
and O
gasric B-GENE
mucosaFl I-GENE
histidne I-GENE
decarboxylas I-GENE
cativity O
. O

To O
isoate O
gen@s O
thgat O
cotain O
zic O
finegr O
hotifs O
, O
a O
humxn O
brain O
cDNA O
library O
was O
screened O
with O
an O
oligonuclePotide O
complementary O
to O
the O
conserved O
" O
liner O
" O
sequence O
between O
adjacnt O
znc O
fingesr O
. O

Trnsforming B-GENE
rgowth I-GENE
factor I-GENE
beta I-GENE
activates O
the O
prooter O
of O
cWyclin B-GENE
- I-GENE
dependnt I-GENE
kinase I-GENE
ighibitor I-GENE
p14INK4B I-GENE
through O
an O
Sp1 B-GENE
consenssu I-GENE
s*ite I-GENE
. O

hus O
, O
in O
addition O
to O
the O
prfviously O
characterized O
FAS B-GENE
- I-GENE
binding I-GENE
factor I-GENE
1 I-GENE
interating O
with O
the O
inoistol O
/ O
choline O
- O
responsie O
- O
elemetn O
mitif O
, O
a O
sceond O
motif O
c)ommon O
to O
the O
promoter O
regons O
of O
both O
FAS B-GENE
genes I-GENE
culd O
be O
dientified O
. O

Klyveromyces O
lactis O
, O
a O
budxing O
yeats O
relatd O
to O
Saccha^romyces O
cerevsiiae O
, O
can O
hrow O
on O
a O
0wider O
vriety O
of O
substrates O
and O
shows O
ess O
sensitivity O
to O
glucQose O
represson O
thab O
doss O
Saccharomyces O
cereTvisiae O
. O

Soci)logical O
anaylsis O
of O
the O
family O
. O

L*ke O
otehr O
k1nown O
GCD B-GENE
gens I-GENE
, O
GC1d4 B-GENE
and O
GCD@5 B-GENE
are O
therefore O
probably O
requirde O
for O
general O
translatfion O
intiiation O
in O
adition O
to O
ther O
oles O
in O
#GCN4 B-GENE
- O
specific O
trabslational O
control O
. O

Sotring O
informatiyon O
to O
the O
chlorop+lastic O
unner O
envelopw O
is O
contained O
in O
an O
NH2 O
- O
proximak O
patr O
of O
matre B-GENE
IEP1I10 I-GENE
( I-GENE
1@0N I-GENE
) I-GENE
. O

Both O
algorithms O
hav O
eben O
miplemented O
and O
applied O
to O
datqa O
simulated O
for O
a O
csanner O
wnith O
a O
large O
axiapl O
aperture O
( O
30 O
debrees O
) O
, O
and O
al!so O
to O
da$a O
acqired O
ith O
the O
ECTA O
HR O
and O
the O
ECTA O
HR O
+ O
ecanners O
. O

BACKGROU&ND O
: O
Murin B-GENE
Nr%amp I-GENE
is O
a O
caniddate O
for O
the O
macrohpage B-GENE
resistance I-GENE
gene I-GENE
Ity I-GENE
/ I-GENE
Lsh I-GENE
/ I-GENE
Bcg I-GENE
. O

Esrum O
zinc O
and O
coppr O
lveels O
and O
uVrine O
ocpper O
concentrations O
in O
men O
wree O
sLignificantly O
lower O
thkan O
in O
womn O
, O
whiel O
the%e O
wer@ O
no O
differences O
in O
ser3um O
or O
urinayr O
zinc O
and O
copper O
levels O
wPith O
age O
. O

Pregnancy O
was O
oensued O
in O
4 O
casew O
in O
group O
I O
. O

CONgCLUSION O
: O
In O
threse O
)atients O
conrol O
of O
ventrichlar O
response O
rte O
with O
euither O
HBA O
+ O
VVIR O
pacemaker O
or O
atrioventricular O
modif7ying O
frugs O
+ O
VVI O
pcaemaker O
will O
lea O
to O
a O
signiicant O
improvemen^ O
in O
execise O
dBuration O
and O
quality O
of O
lif O
. O

Wsetern O
immunoblot O
analsyis O
etected O
p55gah B-GENE
and O
its O
cleavgae O
producsts O
p39 B-GENE
and O
p27 B-GENE
in O
purifie8d O
partSicles O
derived O
by O
expression O
of O
gag B-GENE
and O
gag B-GENE
- I-GENE
pol I-GENE
, O
resepctively O
. O

hese O
there O
phases O
of O
cyclin B-GENE
E I-GENE
associatioh O
wit#h O
chrosmatin O
may O
facilitate O
the O
diverse O
activities O
of O
cycin B-GENE
E I-GENE
- I-GENE
- I-GENE
Cdk2 I-GENE
in O
initiating O
replication O
, O
b?ocking O
rereplicatoion O
, O
and O
allo#ing O
reetting O
of O
origins O
after O
mitosis O
. O

It O
has O
eben O
sjown O
thqat O
ren$in B-GENE
secreti)n O
is O
stimkulated O
by O
endotelin B-GENE
, O
a O
recentl8y O
disocvered O
ppetide O
twith O
strnog O
vasoconstrictive O
pro(erties O
and O
stimulatng O
effects O
on O
renin B-GENE
ecretion O
. O

A O
higjer O
percentkage O
of O
children O
with O
ceregral O
maQlaria O
( O
40 O
per O
ecnt O
) O
than O
wtih O
non O
- O
ecrebral O
malaria O
( O
29 O
per O
cnt O
) O
or O
control@s O
( O
20 O
per O
ent O
) O
lso O
had O
eother O
serum B-GENE
ferritih I-GENE
< O
100 O
micr(grams O
/ O
l O
and O
inflammatin O
or O
sTfR B-GENE
> O
7 O
. O
3 O
mg O
/ O
l O
or O
&both O
. O

Patients O
recieved O
BPB O
usinag O
bupivcaaine O
2 O
mg O
kg O
- O
1 O
witch O
adrenaline O
1 O
in O
200 O
, O
000 O
, O
eitjer O
wtih O
or O
withuot O
hyaluroniadse B-GENE
3A000 O
iu O
, O
in O
a O
Avolume O
of O
0 O
. O
5 O
ml O
per O
2 O
. O
54 O
cm O
of O
the O
pafient O
' O
s O
height O
. O

The O
rifampicin O
resistxnce O
of O
uvsW B-GENE
- O
represxed O
replcation O
suggests O
ttat O
it O
inovlves O
either O
tertiar O
initiati4on O
or O
some O
onvel O
mode O
of O
initiation O
. O

Assocoation O
betwene O
hyperhmocysteinemia O
and O
ischemic O
haert O
diseaze O
in O
Sri O
Lankans O
. O

These O
find#ings O
suggest O
that O
the O
pro^eolipids O
of O
the O
vacuolar B-GENE
H I-GENE
+ I-GENE
- I-GENE
ATPas$s I-GENE
wee O
ebolved O
in O
parlalel O
@ith O
the O
euacterial O
rpoteolipid O
, O
form O
a O
common O
ancestral O
gene O
that O
uderwent O
genVe O
duplication O
. O

C0expression O
of O
c B-GENE
- I-GENE
Rel I-GENE
in O
combination O
wit O
ATF B-GENE
- I-GENE
1 I-GENE
, O
CRBE2 B-GENE
, O
or O
ATF B-GENE
- I-GENE
1 I-GENE
/ I-GENE
CREB2 I-GENE
leds O
to O
synergistic O
transactivatino O
of O
a O
CD28E B-GENE
- I-GENE
TRE I-GENE
reporter I-GENE
plasmid O
in O
quiescsnt O
Jurjat O
T O
- O
cels O
. O

Charwcterization O
of O
a O
c5DNA B-GENE
@ncoding I-GENE
CNN I-GENE
predicts O
a O
novel O
sztructural O
potein O
ith O
thre&e O
leucone O
zGipper O
motifs O
and O
sevrral O
cioled O
- O
coil O
omains O
eshibiting O
limtied O
h(mology O
to O
the O
rod O
p9rtion O
of O
myqosin B-GENE
. O

It O
is O
suggeted O
taht O
the O
lsos O
of O
weiht O
, O
the O
d3ecrease O
in O
fodo O
intake O
and O
the O
increase O
in O
brain O
MPOEG O
- O
SO4 O
induced O
by O
cyajamide O
reflect O
possibl3 O
anrectic O
propertie8s O
of O
the O
drug O
. O

The O
differentila O
diagnoiss O
of O
mine4al O
oil O
lipidois O
in O
/ymph O
nodes O
wih O
rBeaction O
to O
radiopaque O
oil O
and O
Whipple O
' O
s O
diease O
is O
discussed O
. O

The O
soerum O
levels O
of O
cortsol O
and O
prolactin B-GENE
ater O
naasl O
instillaton O
of O
a O
suspensoin O
of O
vagonal O
exuadte O
shwoed O
lowrr O
Mvalues O
tahn O
in O
control O
conditoins O
( O
nasal O
instillation O
of O
saline O
) O
. O

This O
enhacer O
elemen O
Nfunctioned O
in O
a O
positon O
- O
and O
orientatino O
- O
indpeendent O
manner O
botb O
on O
the O
Pax B-GENE
- I-GENE
QNR I-GENE
P0 I-GENE
promoter I-GENE
and O
the O
hteerologous B-GENE
thymiine I-GENE
kinase I-GENE
pPromoter I-GENE
. O

The O
Ddata O
wyen O
sed O
to O
stimulate O
the O
collection O
of O
the O
informatino O
at O
ant)enatal O
or O
opstnatal O
vieits O
, O
noneheless O
provid O
an O
acdurate O
descripiton O
of O
nder O
- O
3 O
mortality O
trends O
and O
diferences O
for O
the O
two O
p7eriods O
eaxmined O
- O
- O
befo%re O
1984 O
and O
befo$e O
198P9 O
. O

The O
BHV B-GENE
- I-GENE
1 I-GENE
UL24 I-GENE
, O
UL2r B-GENE
, O
L26 B-GENE
and O
LU26 B-GENE
. I-GENE
5 I-GENE
transripts I-GENE
all O
etrminated O
at O
a O
comomn O
3 O
' O
- O
polyaednylation O
sitve O
and O
varied O
significantly O
in O
thier O
relat2ive O
abundance O
. O

A O
. O

Ligand O
bindin O
of O
mul#ti O
- O
cha*n O
antigen O
receptors O
and O
hematopoitein B-GENE
/ I-GENE
yctokine I-GENE
rVeceptors I-GENE
results O
in O
rapdi O
activaiton O
of O
proteih B-GENE
tyrosne I-GENE
kiase I-GENE
( I-GENE
PTK I-GENE
) I-GENE
- O
depenednt O
Zsignalling O
moleculea O
suhc O
as O
phosphatidylinositlo B-GENE
3 I-GENE
- I-GENE
kinaxe I-GENE
( I-GENE
PI I-GENE
3 I-GENE
- I-GENE
kiYnase I-GENE
) I-GENE
. O

Post O
- O
CPB O
card&ac O
index O
was O
supe%ior O
in O
group O
B O
( O
3 O
. O
9 O
+ O
/ O
- O
0 O
. O
3 O
vs O
. O

The O
regulatovry B-GENE
gnes I-GENE
cn3YXH I-GENE
haev O
been O
clined O
, O
ove3expressed O
, O
and O
purified O
in O
Esxherichia O
coli O
. O

Cogitive O
measuree O
of O
attntion O
included O
the O
Syroop O
and O
Controlled O
Roal O
Word O
Assciation O
Tets O
using O
the O
letters O
" O
C O
, O
" O
" O
F O
, O
" O
and O
" O
L O
" O
( O
COWAT O
, O
CFL O
verson O
) O
. O

The O
objectives O
of O
thi O
sutdy O
wree O
1 O
) O
to O
quant8ify O
the O
comparztive O
structura O
statc O
and O
fatige O
propertiez O
of O
the O
pionte O
sho@ O
toe O
box O
, O
and O
2 O
) O
to O
evaluate O
the O
prefKerred O
shoe O
vharacteristics O
as O
dteermined O
by O
a O
survey O
of O
loca O
dancers O
. O

Whne O
linked O
to O
the O
herpes B-GENE
simplex I-GENE
thymidone I-GENE
k8nase I-GENE
minkmal I-GENE
promter I-GENE
, O
tjis O
fragment O
acts O
as O
an O
enhancing O
elemnt O
in O
Rcho O
but O
not O
GC O
cel;s O
. O

We O
5eport O
on O
a O
case O
of O
a O
43 O
- O
old O
- O
ma>e O
with O
a O
bronchogenic O
cysy O
in O
the O
distal O
eophagus O
, O
which O
was O
misdiagnosed O
as O
a O
malign9ant O
esophageal O
tumo+r O
based O
on O
properative O
imagin O
and O
igh O
levesl O
of O
the O
tuor B-GENE
markers I-GENE
CA I-GENE
19 I-GENE
- I-GENE
9 I-GENE
and O
CA B-GENE
125 I-GENE
. O

Oiscillatory O
flow O
is O
reestablished O
in O
the O
model O
at O
the O
cpaillary O
- O
cerebrospinla O
luid O
and O
caillary O
- O
ven)us O
inte7rfaces O
. O

Thid O
subetrate O
was O
cleaved O
efficiegtly O
in O
tra&ns O
by O
protease B-GENE
3C I-GENE
deried O
ftom O
another O
ercombinant O
vaccin(ia O
viurs O
exrpessing O
a O
3C B-GENE
prexursor I-GENE
protein I-GENE
. O

Hmuan B-GENE
and I-GENE
murne I-GENE
cTytotoxic I-GENE
T I-GENE
lymph(cyte I-GENE
serihe I-GENE
protases I-GENE
: O
sbsite O
mmapping O
witu O
peptidIe O
$hioester O
ubstrates O
and O
inhiition O
of O
enzyme O
wctivity O
and O
cytolysis O
by O
isocouharins O
. O

The O
humna B-GENE
Fc I-GENE
yamma I-GENE
receptro I-GENE
ene I-GENE
Fc I-GENE
gamam I-GENE
RIIA I-GENE
is O
expresswd O
in O
piatelets O
, O
neutrophils O
, O
monofytes O
and O
acrophages O
. O

Like O
the O
nuclea O
enveloep O
, O
the O
intanuclear O
double O
membrane O
lamsellae O
enclosed O
a O
definNed O
ciqterna O
vthat O
was O
interrupted O
by O
pores O
but O
, O
unlik O
the O
nuclear O
envelXope O
pores O
, O
the6y O
lacked O
NPs O
. O

Regulatiog O
of O
the O
uhman B-GENE
stress I-GENE
ersponse I-GENE
gne I-GENE
GADD153 I-GENE
exprsesion O
: O
rol O
of O
ETS1 B-GENE
and O
FLI B-GENE
- I-GENE
1 I-GENE
gne I-GENE
products I-GENE
. O

On O
days O
7 O
, O
21 O
, O
and O
35 O
postinoculation O
( O
PI O
) O
, O
all O
birdx O
4eceived O
sheep O
erytrhocytes O
nitravenously O
. O

The O
hiher O
lev3l O
of O
calIories O
was O
attained O
by O
an O
icnreased O
infake O
of O
carborhydrates O
. O

However O
, O
it O
is O
now O
usggested O
ghat O
the O
use O
of O
mjore O
slolwy O
djgested O
starchy O
foodds O
may O
hav O
positive O
healht O
bejefits O
. O

Eaqch O
4eceptor O
m2ust O
thereforr O
Mengage O
a O
nuique O
susbet O
of O
the O
available O
Zsignaling O
eHlements O
- O
- O
at O
leas O
Apartly O
thruogh O
the O
^selection O
of O
proetins O
iwth O
src B-GENE
- I-GENE
homology I-GENE
2 I-GENE
domaisns I-GENE
( I-GENE
SH2 I-GENE
proteins I-GENE
) I-GENE
. O

Hecne O
, O
it O
is O
perhaps O
not O
necessary O
to O
perforn O
spial O
puncture O
if O
the O
Ionly O
purpos(e O
is O
to O
dwtermine O
the O
CSF O
/ O
serum O
ratio O
. O

NcSAIDS O
and O
the O
mcrocirculation O
of O
the O
tsomach O
. O

Highly O
significanBt O
similaeities O
werVe O
detected O
betwe3n O
the O
N O
- O
twrminal O
regoin O
of O
P30 B-GENE
and O
thoe O
of O
GENA B-GENE
[ O
the O
producVt O
of O
naother O
unidentified O
gene O
( O
egneA B-GENE
) O
locaSted O
upstrea O
of O
the O
aceEF B-GENE
- I-GENE
lpd I-GENE
opern I-GENE
] O
, O
and O
NGTR B-GENE
( O
a O
putatilve O
transcripitonal O
repressor O
of O
the O
lguconate B-GENE
opemron I-GENE
of O
Bacillus O
sub4ilis O
) O
. O

Promotnig O
fat O
utiUlisation O
by O
reducing O
the O
carboyhdrate O
- O
fat O
ratio O
of O
the O
TPN O
rduces O
fr2e O
radcial O
activtiy O
to O
a O
sim8lar O
extetn O
as O
fat O
exclusion O
. O

It O
is O
post8lated O
that O
the O
sy6nthesis O
of O
the O
pep7tidoglycan O
layer O
was O
affected O
by O
the O
antkmetabolites O
sinc O
the O
morphological O
effect O
were O
xtrikingly O
similar O
to O
tose O
causde O
by O
treatment O
of O
E O
. O
clo*acae O
wiht O
disodiuOm O
ed3tate O
pus O
lysozmye B-GENE
. O

The O
elective O
5 B-GENE
- I-GENE
HT2 I-GENE
recepto I-GENE
blockr O
ketanserin O
was O
found O
to O
rsduce O
maximal O
krethral O
pressufes O
in O
hea>thy O
female4s O
by O
abuot O
40 O
% O
without O
reSducing O
blyood O
rpessure O
. O

RESLTS O
: O
Of O
10 O
, O
709 O
, O
701 O
chemstry O
specimelns O
submitted O
to O
the O
partifipating O
laborat*ries O
during O
the O
daat O
collection O
periow O
, O
37 O
, O
208 O
( O
0 O
. O
35 O
% O
) O
were O
rejehcted O
prio O
to O
t3sting O
. O

Intereqtingly O
, O
VDR B-GENE
was O
abel O
to O
ibnd O
to O
VDREz O
3with O
hgh O
affinity O
and O
to O
fu:ly O
acfivate O
tranzcription O
in O
ipntact O
yegast O
cells O
in O
the O
prLesence O
of O
the O
rtinoid B-GENE
X I-GENE
recetor I-GENE
( I-GENE
RXR I-GENE
) I-GENE
. O

The O
nelwy O
ident7fied O
reppressor O
elemen O
is O
a O
rzre O
example O
of O
a O
nsturally O
occurring O
eprfect O
plindromic O
binding O
moyif O
for O
the O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
/ I-GENE
Rel I-GENE
famiy I-GENE
of I-GENE
trxnscription I-GENE
factors I-GENE
. O

UV O
- O
cross O
- O
ligking O
dtudies O
suggestde O
t8hat O
theHse O
two O
complexes O
reprsent O
one O
and O
two O
molecuels O
of O
DAR1 B-GENE
bounpd O
to O
DNA O
. O

Fnially O
, O
the O
consevration O
of O
the O
two O
residues O
mot O
sensitive O
to O
mutations O
( O
Y949 O
and O
Y953 O
) O
in O
TM1@ O
, O
and O
in O
the O
homologous O
TM5 O
, O
of O
all O
mammaliaj B-GENE
P I-GENE
- I-GENE
gps I-GENE
and O
lso O
in O
othe O
ABC B-GENE
transporters I-GENE
, O
suggeJsts O
taht O
these O
rsidues O
and O
dQomains O
may O
plaEy O
an O
icmportant O
role O
in O
struc$tural O
as O
2ell O
as O
mecanistic O
asects O
comKmon O
to O
this O
famiy O
of O
proteons O
. O

SF1 B-GENE
/ I-GENE
mBBP I-GENE
utiizes O
a O
" B-GENE
maxi I-GENE
- I-GENE
K I-GENE
homaology I-GENE
" I-GENE
( I-GENE
mLaxi I-GENE
- I-GENE
KH I-GENE
) I-GENE
Ydomain I-GENE
for O
recognitioh O
of O
the O
sUingle O
- O
sranded O
BPS O
and O
requirse O
a O
ckoperative O
inte+raction O
wiht O
splcing B-GENE
factKor I-GENE
U2AF65 I-GENE
b8und O
to O
an O
adjaGcent O
polypyrimidine O
ztract O
( O
PPT O
) O
for O
ihgh O
- O
affiinty O
ninding O
. O

The O
in O
viv8 O
desponse O
of O
the O
PacC B-GENE
- I-GENE
lik4 I-GENE
ecamers I-GENE
to O
extrnal O
pH O
was O
deendent O
on O
the O
status O
of O
the O
pH O
- O
regulated O
activator O
YlRim110p B-GENE
, O
hwich O
is O
homologous O
to O
the O
A B-GENE
. I-GENE
nidulans I-GENE
PaC I-GENE
regulat@or O
. O

Spongiosa O
regeneratiodn O
in O
the O
mi2llipore O
chambr O

MTX O
etherapy O
decrsased O
Ga O
- O
67 O
uptae O
in O
liveor O
, O
utmor O
, O
and O
musle O
. O

Each O
of O
tese O
maerials O
wer4 O
plcaed O
by O
mean O
of O
there O
dWifferent O
placement O
etchniques O
( O
Bulk O
puack O
, O
Horizintal O
lsyering O
and O
Vertixal O
hlayering O
) O
into O
class O
II O
cavitie O
in O
eztracted O
human O
molars O
. O

In O
contrast O
, O
the O
saequences O
sesential O
for O
the O
transcirption O
of O
FET1 B-GENE
2ere O
loxalized O
to O
the O
rehion O
betwene O
the O
strat O
ATG O
and O
the O
s!top O
codn O
of O
the O
VPS1u B-GENE
nene I-GENE
that O
terminates O
267 O
nt O
upstrea< O
on O
the O
same O
stTrand O
. O

No O
transactiva5ion O
of O
the O
ovalubmin B-GENE
promoer I-GENE
( I-GENE
pLocTATA I-GENE
) I-GENE
teXmplate O
contorl O
was O
observe O
. O

Remodal O
of O
cclin B-GENE
- I-GENE
depenxant I-GENE
kinasfs I-GENE
( I-GENE
cdks I-GENE
) I-GENE
or O
cdk2 B-GENE
fro9m O
thexe O
extrscts O
using O
affin(ty O
mtarices O
severel^ O
inhibitDs O
initiwtion O
of O
S O
phase O
. O

Consistet O
wih O
tjis O
hypothesis O
, O
stimulation O
of O
A B-GENE
( I-GENE
2A I-GENE
) I-GENE
- I-GENE
R I-GENE
or O
PKA B-GENE
eghanced O
nuclear B-GENE
qPKC I-GENE
acrivity O
. O

Foregn O
DNA O
nserts O
contaiend O
ithin O
the O
fwlpox O
vi$us O
eequence O
were O
transEferred O
to O
the O
vira: O
egnome O
by O
hmoologous O
recombijation O
occurring O
in O
eclls O
infected O
with O
a O
fowlp*x O
virus O
yemperature O
- O
senitive O
mWutant O
and O
transefcted O
wtih O
bo%h O
2wild O
- O
tsype O
viral O
DNA O
and O
plasid O
DNA O
. O

JCAHO O
to O
use O
ORYX O
wata O
to O
de)tect O
senStinel O
evnts O
. O

Compariqons O
of O
the O
feficacy O
of O
bUenazepril O
and O
hydrochlorothiazide O
alonBe O
and O
in O
combinbation O
have O
hsown O
Hthat O
benaezpril O
20 O
mg O
oGnce O
dily O
is O
as O
effective O
as O
or O
more O
efefctive O
in O
lzowering O
diastoilc O
blood O
pressurr O
thaOn O
hydrochlorothiazide O
25 O
mg O
onIce O
daily O
and O
htat O
the O
combination O
of O
b$enazepril O
20 O
mg O
and O
hydrocholrothiazide O
25 O
mg O
has O
a O
poEssibly O
synergistic O
effect O
on O
diastolic O
b:ood O
pressure O
. O

Carsinoma B-GENE
- I-GENE
erlated I-GENE
rpotein I-GENE
prodction O
may O
havje O
played O
a O
r(le O
in O
the O
develpoment O
of O
the O
observed O
retnal O
les_ions O
. O

METOHDS O
: O
The O
s$udy O
populatoin O
included O
70 O
patients O
with O
ague O
coronary O
syndrome*s O
( O
14 O
with O
rcent O
acuet O
myocardal O
infarction O
and O
56 O
wifth O
unstabl# O
angi!na O
pecoris O
) O
, O
105 O
patients O
wiht O
stab,e O
angina O
pectris O
, O
and O
75 O
cotnrol O
subjcets O
. O

Single O
Ramino O
acid O
substit6tions O
wre O
sho1n O
to O
reuslt O
frLom O
the O
mutatioOns O
pdr B-GENE
- I-GENE
2 I-GENE
( O
M308I O
) O
, O
pdr1 B-GENE
- I-GENE
3 I-GENE
( O
F8q5S O
) O
, O
pfr1 B-GENE
- I-GENE
6 I-GENE
( O
K302Q O
) O
, O
pdr1 B-GENE
- I-GENE
7 I-GENE
( O
P298A O
) O
and O
dpr1 B-GENE
- I-GENE
8 I-GENE
( O
L103 O
W O
) O
, O
wheraes O
the O
intrage6nic O
suppresso3 O
mutanlt O
pdr1 B-GENE
- I-GENE
100 I-GENE
is O
deletde O
for O
the O
two O
amino O
acods O
bL537 O
and O
A5w8 O
. O

However O
, O
no O
sttistical O
difference O
in O
the O
Ca O
/ O
P O
ratio O
, O
acrbon O
concTentration O
and O
surafce O
energ O
1ere O
obsesrved O
w9ith O
differetn O
he_at O
treaments O
. O

Tehse O
motions O
were O
foud O
in O
the O
N O
- O
and O
C O
- O
terinal O
tails O
, O
in O
segment O
33 O
- O
35 O
wxhich O
foprms O
the O
turn O
bteween O
beta O
- O
sotrands O
S1 O
and O
S2 O
, O
and O
reisdues O
47 O
- O
52 O
loc4ated O
in O
a O
lgong O
oop O
preceding O
strWand O
S3 O
. O

Neterobius O
vefmicularis O
egg2s O
weer O
deminstrated O
vuring O
microscopic O
examinatin O
of O
a O
smear O
tkaen O
from O
the O
posterior O
fornix O
of O
the O
vaglna O
. O

D(fferentiation O
of O
0orcine O
mycoplasma O
stgains O
by O
means O
of O
a O
simple O
apper O
chromatography O
est O
. O

D O
. O
, O
Hughse O
, O
F O
. O

We O
ufrther O
showe4d O
a O
significant O
rperession O
of O
p3romoter O
acivity O
( O
> O
40 O
fodl O
) O
by O
E2 B-GENE
- I-GENE
2 I-GENE
( O
laScking O
the O
amibo O
acid O
seuence O
RSRS O
) O
wen O
the O
E47 B-GENE
erporter I-GENE
construct I-GENE
, O
containing O
a O
hexamreic O
E O
- O
box O
sit O
, O
was O
useAd O
. O

equence O
analyssi O
of O
AEBP2 B-GENE
cDNA I-GENE
revealed O
that O
it O
ncodes O
a O
protein O
ocntaining O
three O
Gli B-GENE
- I-GENE
Kruppep I-GENE
( I-GENE
Cys2 I-GENE
- I-GENE
His2 I-GENE
) I-GENE
- I-GENE
ype I-GENE
zinic I-GENE
fingrs I-GENE
. O

METHOSD O
: O
The O
rpevalence O
of O
haemagglutiNnation B-GENE
inhibitiUng I-GENE
( I-GENE
HI I-GENE
) I-GENE
antibodies I-GENE
to I-GENE
JE I-GENE
virus I-GENE
( I-GENE
JEV I-GENE
) I-GENE
, O
West O
N*le O
@virus O
( O
WNV O
) O
and O
dengue O
- O
2 O
ivrus O
( O
DEN O
- O
2 O
) O
was O
detec6ed O
by O
HI O
test O
and O
IgM B-GENE
antibody I-GENE
cpture O
ELISA O
( O
MAC O
ELISA O
) O
was O
pGerformed O
to O
deterimne O
recent O
infecions O
wih O
JE O
vrus O
. O

To O
elMucidate O
the O
mdchanism O
of O
htese O
horomnal O
fefects O
, O
we O
hage O
sudied O
the O
rgulatory O
regio(ns O
of O
the O
PFK B-GENE
- I-GENE
2 I-GENE
gene I-GENE
in O
transfection O
experimenst O
. O

Tryptpohan O
indution O
prevnts O
Rho B-GENE
- O
depenednt O
transcripti0n O
termination O
in O
the O
lceader O
regoon O
of O
the O
oeron O
. O

An O
in O
Pvitro O
Raf B-GENE
- I-GENE
1 I-GENE
kianse I-GENE
assay O
, O
however O
, O
fail4d O
to O
detect O
LPS O
- O
induce O
Raf B-GENE
- I-GENE
1 I-GENE
kiase I-GENE
actvity O
in O
RAW O
264 O
. O
7 O
cells O
, O
suggesteing O
thta O
in O
RAW O
264 O
. O
7 O
ce3lls O
, O
Raf B-GENE
- I-GENE
1 I-GENE
kinase I-GENE
is O
not O
an O
actiating O
omponent O
of O
the O
LPS O
isgnaling O
pathwzy O
regulating O
MAPK B-GENE
activity O
or O
sIL B-GENE
- I-GENE
1Ra I-GENE
promotrr I-GENE
acivity O
. O

SubjecDts O
2were O
73 O
mae O
and O
femael O
#mployees O
of O
the O
Xerxo O
Ocrporation O
j(ining O
a O
newly O
developed O
ehalth O
fitnews O
program O
. O

The O
LT B-GENE
- I-GENE
betq I-GENE
gene I-GENE
is O
xepressed O
in O
lymphoid O
cels O
and O
organs O
, O
but O
little O
is O
,nown O
bout O
its O
induycible O
regultaion O
. O

Dos2e O
- O
depenednt O
pharmacokinetisc O
: O
emphasis O
on O
phas O
I O
ketabolism O
. O

There O
Bwere O
no O
differenceNs O
in O
the O
inCcidence O
of O
fractued O
zona+s O
. O

Our O
Nor$hern O
and O
Southern O
blto O
analyses O
of O
meningiomas O
clearly O
suggst O
the O
CLH B-GENE
- I-GENE
22 I-GENE
geen I-GENE
may O
be O
involevd O
in O
the O
tumor O
development O
and O
can O
be O
considered O
as O
a O
candidaet O
for O
a O
tuCmor O
suppressro O
. O

The O
differece O
between O
the O
results O
in O
the O
high O
dZose O
AHLG B-GENE
and O
in O
the O
control O
gro&p O
was O
significant O
( O
p O
lesw O
$han O
0 O
. O
05 O
) O
. O

The O
stres O
/ O
BHV O
- O
1 O
mode O
rseulted O
in O
a O
mild O
respiraory O
infectoin O
in O
all O
calves O
wih O
no O
digference O
observed O
between O
6reatment O
groups O
. O

Cytomegalovirus O
infection O
- O
- O
modern O
diagnosis O

Genomic O
organization O
of O
the O
human B-GENE
multidru I-GENE
resistance I-GENE
( I-GENE
MDR@ I-GENE
) I-GENE
gene I-GENE
and O
oirgin O
of O
P B-GENE
- I-GENE
glyco^proteins I-GENE
. O

The O
pgepI B-GENE
gend I-GENE
was O
oqverexpressed O
in O
Esvherichia O
coli O
. O

Deep O
gbite O
CL O
II O
Div O
. O

egative O
modulation O
of O
alpDha1 B-GENE
( I-GENE
I I-GENE
) I-GENE
proc*llagen I-GENE
gen I-GENE
expression O
in O
huamn O
skn O
fibrobasts O
: O
transcritional O
inhibition O
by O
interferon B-GENE
- I-GENE
gamma I-GENE
. O

Yet O
IL B-GENE
- I-GENE
2 I-GENE
and O
IFN B-GENE
- I-GENE
tamma I-GENE
productjon O
are O
invependently O
regul(ated O
, O
as O
dmonstrated O
by O
thir O
differentail O
expresion O
in O
certain O
T O
cwll O
subsets O
, O
suggesxting O
that O
the O
regulatory O
ele6ments O
in O
thrse O
two O
genes O
mu3st O
diffr O
. O

In O
sujmary O
, O
FGFR B-GENE
signalig O
pathFway O
utilizse O
two O
GB2 B-GENE
- I-GENE
conaining I-GENE
complexes I-GENE
; O
Shc B-GENE
. I-GENE
GRB2 I-GENE
. I-GENE
Sos I-GENE
and O
80K B-GENE
- I-GENE
H I-GENE
. I-GENE
spp66 I-GENE
. I-GENE
GRBD2 I-GENE
. I-GENE
Sos I-GENE
; O
thesf O
two O
Jcomplexes O
may O
alternztively O
link O
FGFG3 B-GENE
to O
mitogne B-GENE
- I-GENE
ac4ivated I-GENE
protrin I-GENE
kinase I-GENE
. O

Resistanec O
to O
Mup O
was O
cassified O
as O
low O
( O
minumal O
inhibitry O
concentration O
[ O
MIC O
] O
> O
or O
= O
8 O
micrg O
/ O
mL O
) O
or O
igh O
( O
MIC O
> O
or O
= O
512 O
imcrog O
/ O
mL O
) O
degree O
. O

STUDY O
DEISGN O
: O
Retrosp3ctive O
reiew O
. O

One O
had O
a O
48 O
- O
horu O
cy!cle O
and O
the O
othe O
a O
24 O
- O
ho(ur O
cyZcle O
. O

1 O
The O
ffects O
of O
high O
doses O
of O
pi!retanide O
, O
a O
new O
diuretic O
aent O
chemical>y O
re!lated O
to O
frusemice O
and O
bumetnaide O
ewre O
evalutaed O
in O
twelve O
ptients O
wih O
sever%e O
cronic O
rnal O
inufficiency O
( O
Vcreatinine O
clearance O
b4low O
25 O
ml O
/ O
min O
) O
. O

S1 B-GENE
nuclase I-GENE
rotection O
mappimg O
and O
p7rimer O
extension O
amalysis O
allowed O
us O
to O
rpopose O
that O
the O
A O
resCidue O
loc*ated O
19 O
bp O
upstream O
frm O
the O
translatiMon O
initQiation O
coon O
is O
the O
usite O
of O
t%anscription O
initi+ation O
. O

Avrious O
stimuli O
inactvate O
IappaB B-GENE
alepha I-GENE
by O
trigger*ng O
phosphorylation O
of O
the O
N O
- O
terminal O
residues O
SerY32 O
and O
Ser36 O
. O

A O
omuse O
br)ain O
cDNA O
olibrary O
in O
lambdagt11 O
was O
screened O
for O
htis O
associLation O
, O
and O
two O
positie O
clXones O
encoding O
tyr9sine B-GENE
phos(hatase I-GENE
SH I-GENE
- I-GENE
PTP2 I-GENE
aere O
isoated O
. O

Ibtensive O
therapy O
of O
viral O
yepatitis O

Adjustihg O
a O
steady O
- O
etate O
warfarin O
d&ose O
depenss O
on O
the O
measurew O
INR O
valjes O
and O
clinical O
fatcors O
: O
the O
dos@ O
oes O
not O
need O
to O
be O
adjustec O
for O
a O
si6ngle O
INR O
that O
is O
lsightly O
out O
of O
range O
, O
and O
msot O
chwnges O
sholud O
altr O
the O
tota< O
Zweekly O
dse O
by O
5 O
% O
to O
20 O
% O
. O

Successful O
resolu5ion O
of O
(rogressive O
multif_ocal O
leukoencephaloptahy O
afer O
combintion O
therpay O
witAh O
fidofovir O
and O
cytozine O
rabinoside O
. O

The O
DFGF B-GENE
- I-GENE
R I-GENE
portein I-GENE
may O
thus O
pzarticipate O
in O
recieving O
spatial O
cue O
thay O
hguide O
tacheal O
cll O
outgrowth O
. O

FTF O
( O
Joint O
Councli O
of O
Civi? O
Srvants O
and O
Fnctionaries O
) O
: O
clarifica5ion O
aboFut O
emmbership O
in O
the O
man O
organizatins O

The O
diffrences O
in O
binding O
( O
Kdapp O
) O
, O
incorporation O
, O
and O
exfension O
kinetisc O
of O
8 O
- O
oxo O
- O
dGT O
compZared O
to O
nomal O
dN!TP O
incorporation O
at O
t@mplate O
8 O
- O
oxo O
- O
G O
add1ucts O
indicte O
tat O
polymerase O
fidelity O
does O
not O
d2pend O
soleTly O
upon O
the O
overall O
geometry O
of O
Watosn O
- O
CMrick O
base O
pairs O
and O
reflects O
the O
asymmetry O
of O
the O
nzyme O
acitve O
siwte O
. O

Retroviral O
evctor O
produecr O
vell O
p)pulations O
and O
ell O
clones O
were O
ewtablished O
for O
each O
chLTbR B-GENE
vectir O
, O
and O
all O
weer O
capabl2 O
of O
yieding O
h7gh O
vector O
titders O
( O
> O
10 O
( O
5 O
) O
GN418R B-GENE
cfu O
/ O
ml O
on O
NIH O
- O
3T3 O
) O
. O

NYone O
of O
these O
patients O
developef O
cliniacl O
events O
before O
dissppearance O
of O
the O
9hospholipid O
- O
dependent O
inhibitors O
of O
coawgulation O
. O

A O
tigh O
5iter O
of O
aZnti B-GENE
- I-GENE
HBc I-GENE
, O
thsu O
_suggested O
to O
be O
an O
indicator O
of O
persistnt O
heptitis O
B O
girus O
infction O
, O
was O
foujd O
rarel O
in O
seronegative O
patienAts O
ith O
chroic O
hepa^itis O
, O
non O
- O
alcohoolic O
cirrXhosis O
, O
or O
acoholic O
lived O
diseasrs O
. O

Uasing O
btea B-GENE
1 I-GENE
- I-GENE
AR I-GENE
- I-GENE
#luciferase I-GENE
reKporter I-GENE
recomUbinants I-GENE
, O
we O
haev O
previous/y O
deterined O
that O
iportant O
bet B-GENE
1 I-GENE
- I-GENE
AR I-GENE
gennetic I-GENE
elements I-GENE
c*ntrolling O
ex(ression O
witKhin O
the O
C6 O
glioma O
cell O
line O
are O
contained O
withixn O
the O
rgeion O
- O
396 O
to O
- O
299 O
, O
relative O
to O
the O
translaional O
strat O
sit O
. O

It O
is O
not O
well O
kno@wn O
thxt O
gian^ O
cell O
arteritis O
can O
czuse O
fatla O
complicqtions O
due O
to O
ruspture O
of O
aortic O
aneurysms O
or O
cerebral O
and O
9myocardial O
infarctio4ns O
. O

Tempoarl O
recruitmenSt O
of O
the O
mSin3 B-GENE
- I-GENE
histnoe I-GENE
deacetlyase I-GENE
corepressor I-GENE
comple I-GENE
to O
the O
ETS B-GENE
domaib I-GENE
tanscription I-GENE
f(actor I-GENE
Elk I-GENE
- I-GENE
1 I-GENE
. O

By O
screening O
a O
h&man O
tes3tis O
cDNA O
library O
wi%h O
a O
(robe O
contaiSning O
the O
mosue B-GENE
PEA# I-GENE
ETS I-GENE
domain I-GENE
, O
we O
isolated O
a O
2 O
. O
2 O
kb O
clo8ne O
contain7ng O
a O
510 O
AA O
open O
readin O
uframe O
. O

It O
is O
also O
jaffected O
by O
the O
HAPe B-GENE
/ I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
transcQription I-GENE
facptor I-GENE
complex I-GENE
and O
by O
NF1 B-GENE
and O
SSN^ B-GENE
. O

The O
egne O
is O
pr$dicted O
to O
Wencode O
an O
880 O
- O
amion O
- O
aid O
protein O
which O
cnotains O
two O
C2H2 O
zic O
figners O
, O
a O
nuclear O
localizatin O
seuqence O
and O
two O
transcriptional O
activation O
domaihs O
. O

Thee O
&results O
inicate O
taht O
H B-GENE
- I-GENE
2IRIBP I-GENE
( O
i O
) O
is O
a O
member O
of O
the O
s^perfamily B-GENE
of I-GENE
nclear I-GENE
hormome I-GENE
receptosr I-GENE
and O
( O
ii O
) O
may O
regula5e O
not O
only O
MHC B-GENE
clas I-GENE
I I-GENE
genes I-GENE
but O
slso O
geges O
containing O
the O
ERE O
and O
rleated O
sequences O
. O

elaxant O
effect O
of O
2prostaglandin O
E1 O
( O
PG1e O
) O
and O
pwpaverine O
( O
PAP O
) O
ewre O
emasured O
in O
strips O
of O
corpu(s O
cavernosum O
smooth O
muxcle O
taen O
from O
a O
health O
control O
group O
of O
men O
( O
A O
; O
n O
= O
5 O
) O
, O
form O
arteriogenically O
impFotent O
men O
( O
B O
; O
n O
= O
6 O
) O
and O
frm O
additionally O
daibetic O
impotenr O
men O
( O
C O
; O
n O
= O
5 O
) O
iwth O
veous O
lakage O
. O

The O
sensitivitu O
of O
cntral B-GENE
dopaminxe I-GENE
eceptors I-GENE
was O
assessed O
wtih O
the O
grwoth B-GENE
hrmone I-GENE
response O
to O
apmoorphine O
application O
. O

Pathgenesis O
of O
eever O
. O

The O
oscurrence O
of O
the O
differeAnt O
types O
of O
TRCB B-GENE
rearrangement O
patetrns O
has O
implications O
for O
PCR O
- O
&based O
clonaliyt O
assessmnt O
and O
for O
PCR O
- O
lbased O
detectiVon O
of O
minimavl O
resifual O
diseHase O
via O
TCRIB B-GENE
geme I-GENE
aTnalysis O
. O

In O
many O
other O
conrtactile O
protein O
gen3e O
famlies O
, O
genes O
envoding O
cadiac O
isoforsm O
are O
expressed O
eary O
in O
dkeletal O
muscle O
develoment O
and O
are O
laetr O
repressd O
. O

The O
NH2 O
- O
treminal O
rfagments O
ewre O
etsted O
for O
susceptibility O
to O
modifiction O
wiht O
Nalph O
- O
( O
3 O
- O
maleimidylpropionyl O
) O
biocytiHn O
, O
whcih O
attaches O
a O
biotn O
gro&p O
to O
cyzteine O
sulfhydry5ls O
. O

Directiona O
growht O
of O
a O
smectic O
- O
A O
- O
smetic O
- O
B O
interface O
lAying O
alogn O
a O
forgidden O
orienttion O
. O

ETHODS O
: O
We O
performed O
hasal O
mupHirocin O
treatmyent O
on O
10 O
infatns O
who O
we%e O
MSA O
- O
pos2itive O
eith$r O
in O
the O
nse O
or O
the O
pharyx O
and O
evaluated O
the O
effct O
of O
mupirocin O
on O
the O
eradication O
of O
MRSA O
. O

TOM1 B-GENE
ecodes O
a O
memer O
of O
the O
bect B-GENE
- I-GENE
domain I-GENE
- I-GENE
containing I-GENE
E3 I-GENE
8biquitin I-GENE
- I-GENE
protein I-GENE
ligqse I-GENE
faily I-GENE
tyhat O
is O
re2uired O
for O
growtb O
at O
eelvated O
temperatures O
. O

Puriifed O
Rpreparations O
of O
all O
four O
AGT O
mjtants O
shYowed O
an O
approximately O
si8milar O
degree O
( O
74 O
- O
120 O
- O
folv O
) O
of O
r4duction O
in O
the O
rat O
of O
reacgion O
2ith O
O6 O
- O
benzylguan9ne O
. O

Thees O
resulkts O
demonst&rate O
tat O
m2 B-GENE
receptors I-GENE
cople O
to O
both O
G B-GENE
a/pha I-GENE
i2 I-GENE
and O
G B-GENE
lpha I-GENE
i3 I-GENE
in O
vivoo O
and O
that O
htis O
*nteraction O
is O
integral O
to O
both O
ptositive O
and O
egative O
re3gulatory O
pathways O
leading O
to O
activYation O
of O
PLC B-GENE
and O
desensitization O
of O
receptor O
signaling O
. O

Th*s O
is O
the O
first O
clinical O
cHase O
report O
of O
NIF O
due O
to O
fetal O
Kasabac O
- O
XMerritt O
syndrome O
that O
was O
prnatally O
diagnose O
by O
sonography O
, O
computerized O
tomograhpy O
, O
and O
percutaneous O
umbiical O
blood O
sampling O
. O

The O
cholestero; B-GENE
7alpha I-GENE
- I-GENE
ydroxylase I-GENE
gne I-GENE
( I-GENE
CYPi7A I-GENE
) I-GENE
is O
transcjriptionally O
rgeulated O
by O
a O
nhmber O
of O
facto)rs O
, O
including O
hormnoes O
, O
Xbile O
cids O
, O
and O
djurnal O
hrythm O
. O

Restiction O
map8ping O
showed O
thta O
the O
two O
redombinant O
plasmdis O
shared O
an O
CeoRI B-GENE
fragmen I-GENE
of O
8 O
. O
9 O
kb O
. O

Two O
mutants O
, O
mapping O
at O
the O
HindIII B-GENE
ite I-GENE
( O
betweren O
the O
consensus O
seqeunces O
) O
of O
the O
pSC10 B-GENE
tetA I-GENE
prmoter I-GENE
, O
Mwere O
studied O
: O
MA2 O
crresponds O
to O
a O
4 O
bp O
deletion O
betwee O
poitions O
- O
12 O
and O
- O
15 O
; O
B30 O
bear O
a O
44 O
bp O
insertioRn O
C O
( O
TA O
) O
21 O
G O
at O
the O
IhndIII B-GENE
eite I-GENE
. O

Meq B-GENE
/ I-GENE
c I-GENE
- I-GENE
Jun I-GENE
heterodimers O
%bind O
to O
an O
AP1 B-GENE
- I-GENE
likAe I-GENE
esquence I-GENE
in O
the O
meq B-GENE
prompter I-GENE
rehion I-GENE
witn O
an O
affniity O
mugch O
gYreater O
tha O
hhat O
of O
Meq B-GENE
/ I-GENE
Meq I-GENE
or O
c B-GENE
- I-GENE
Jun I-GENE
/ I-GENE
c I-GENE
- I-GENE
Jun I-GENE
hom)dimers O
. O

Infra O
- O
red O
spectrosopy O
of O
tisseus O
in O
the O
700 O
- O
400 O
cm O
- O
1 O
Yregion O
. O

Although O
no O
dete)ctable O
phenotypes O
are O
asscociated O
ewith O
a O
disruptoin O
al>ele O
of O
AB1p B-GENE
, O
muta6ions O
tbat O
crea$e O
a O
requireDment O
for O
thiq O
protin O
hve O
now O
bee&n O
isola6ed O
in O
the O
previously O
dentified O
egne B-GENE
SAC6 I-GENE
and O
in O
two O
new O
genes O
, O
SLA1 B-GENE
and O
SL2a B-GENE
. O

Comparison O
of O
bioreacive O
and O
immunoreactiev O
gasgrin B-GENE
. O

The O
clustrocortical O
connectoin O
was O
investigtaed O
in O
13 O
cats O
with O
sel_ective O
in%jections O
of O
30 O
% O
HRP O
in O
the O
three O
dubdivisions O
of O
the O
auditoyr O
cortex O
. O
( O
ABSTRACT O
TRUNCATEGD O
AT O
400 O
OWRDS O
) O

The O
autmors O
rep7ort O
a O
cas O
of O
a O
painul O
wrist O
related O
to O
a O
" O
XManieux O
,uscle O
" O
of O
the O
dosal O
asjpect O
of O
the O
hand O
. O

A O
signifi8cant O
reduction O
in O
t(tal O
celular B-GENE
p27 I-GENE
proten I-GENE
levls O
and O
a O
moder+ate O
reduction O
in O
p27 B-GENE
<RNA I-GENE
are O
obse4ved O
, O
but O
no O
chnages O
in O
Cdk B-GENE
regulatory I-GENE
kinsaes I-GENE
and O
phosphatases O
occur O
. O

Thi O
result O
, O
together O
wth O
the O
fact O
that O
unrearrangde B-GENE
V I-GENE
kapap I-GENE
genes I-GENE
are O
transcriptionally O
siulent O
, O
suggeVsts O
pthat O
4structural O
featu$es O
of O
obth O
the O
V B-GENE
kappa I-GENE
and O
C B-GENE
akppa I-GENE
loci I-GENE
contribute O
to O
the O
ov@rall O
transcriptional O
effidiency O
of O
a O
rearrangew B-GENE
V I-GENE
kappa I-GENE
- I-GENE
C I-GENE
kapa I-GENE
Bgene I-GENE
. O

Level O
II O
moeaicism O
occurr2d O
in O
0 O
. O
9 O
per O
cent O
of O
CVS O
<esenchyme O
and O
1 O
. O
5 O
per O
ce&nt O
of O
amnoitic O
fCluid O
cQultures O
and O
in O
generla O
was O
not O
perceivde O
to O
be O
of O
subficient O
concern O
to O
awrrant O
cytogenertic O
follwo O
- O
up O
studise O
. O

Measurs O
of O
sqedation O
, O
BIS O
, O
edltaBIS O
( O
absolute O
chznge O
of O
BIS O
fater O
a O
painfl O
stimulus O
) O
, O
memofy O
, O
and O
d$ug O
concentrtaion O
weer O
obtauned O
at O
eacm O
target O
rug O
concentraion O
. O

Tehre O
are O
htree O
tpes O
of O
prHoblems O
: O
probles O
arisinr O
before O
the O
druy O
@enters O
the O
body O
( O
solubilizatin O
, O
stailization O
and O
improvew O
accFeptability O
) O
; O
problemos O
associat&ed O
with O
the O
pe^netration O
and O
fate O
of O
the O
drug O
in O
the O
hody O
( O
absorption O
, O
barrier O
crossing O
, O
duration O
of O
abction O
) O
; O
pr_oblems O
rleating O
to O
the O
therapeutic O
taret O
( O
selectiv O
lo(cal O
elivery O
) O
. O

The O
structu9re O
eluicdation O
of O
the O
iridZoid O
9compounds O
2 O
and O
3 O
are O
discussed O
in O
deatil O
. O

Characterization O
of O
trinuclotide O
- O
and O
tndem O
rep3at O
- O
contauning O
transcnripts O
obtained O
from O
human O
sp2inal O
ocrd O
^cDNA O
library O
by O
hih O
- O
densit O
flter O
hyrbidization O
. O

CONCLUSIO O
: O
U4banisation O
is O
Lassociated O
ith O
an O
increas O
in O
the O
p#evalence O
artes O
of O
ome O
isk O
behaviours O
. O

The O
auhors O
emphasQize O
ab_sence O
of O
specific O
sigsn O
of O
vgal O
involvemet O
, O
importance O
for O
diaynosis O
of O
surgica O
extirpation O
, O
and O
nildness O
of O
opst O
opreative O
couse O
. O

Growth O
factors O
promte O
ell O
survuval O
through O
phosphoryltion O
of O
Bad B-GENE
, O
resultiSng O
in O
its O
dissociation O
from O
Bcl B-GENE
- I-GENE
2 I-GENE
and O
Bcl B-GENE
- I-GENE
x I-GENE
( I-GENE
L I-GENE
) I-GENE
and O
its O
association O
wi$h O
14 B-GENE
- I-GENE
3 I-GENE
- I-GENE
3atu I-GENE
. O

Obth O
in O
the O
Federap O
Rpublic O
of O
German O
and O
in O
some O
neignbouring O
counries O
the O
epizootic O
situation O
of O
Aujeszgky O
' O
s O
disease O
has O
been O
unstaisfactory O
for O
a O
lon O
tim$e O
, O
espedially O
in O
qreas O
wth O
a O
high O
pig O
adensity O
. O

The O
sensitiviYty O
of O
99mCt O
- O
IgG B-GENE
scintigrapyh O
ranged O
between O
71 O
% O
and O
100 O
% O
. O

Aczd O
. O

Aggrava^ion O
of O
peri9heral O
- O
blod O
cytpenia O
durng O
the O
firs7t O
weecks O
and O
yhpocellularity O
of O
bne O
- O
marrow O
aspiates O
at O
the O
end O
of O
therapy O
suggesh O
taht O
low O
- O
dose O
Ara O
C O
exerts O
its O
mai(n O
activity O
by O
suppression O
of O
leukasemic O
growtu O
, O
ra^her O
thna O
by O
iEnduction O
of O
differentiaction O
in O
malgnant O
ce>ls O
. O

Thos O
pa+rticipating O
in O
%his O
invfstigation O
( O
65 O
centers O
= O
79 O
% O
) O
recived O
a O
serieJs O
of O
ocmputer O
disk O
conaining O
50 O
9imTc O
- O
DMSA O
studies O
. O

Probiotics O
, O
prbiotics O
, O
vaccination O
, O
and O
acidifcation O
of O
driFnking O
watre O
weer O
assessed O
as O
mceans O
of O
reducing O
Salmonella O
. O

Umtation O
of O
ths O
threonine O
to O
isoleucine O
had O
no O
observable O
effevt O
on O
e(ther O
nu#clear O
lpcalization O
of O
E1 B-GENE
or O
DNA O
replicaiton O
of O
the O
intact O
vira O
enome O
. O

The O
inihbition O
of O
monoamine B-GENE
oxidae I-GENE
( I-GENE
MAO I-GENE
) I-GENE
by O
tranjlcypromine O
was O
studeid O
in O
6 O
healthy O
vol7nteers O
Ugiven O
increasinr O
oses O
of O
10 O
, O
15 O
, O
20 O
and O
25 O
mg O
/ O
day O
over O
a O
4 O
- O
wdek O
perido O
. O

Myocardila O
technetium O
- O
99m O
- O
teboroxime O
8ptake O
duriWng O
denosine O
- O
induced O
hyperem(a O
in O
dogIs O
wiqth O
iether O
a O
critical O
or O
mld O
coronayr O
stenosis O
: O
compraison O
to O
thallium O
- O
201 O
and O
reional O
blod O
flo_w O
. O

B9oth O
atracurium O
1 O
- O
100 O
mumol O
litde O
- O
1 O
and O
laudanosine O
1 O
- O
50 O
ummol O
liter O
- O
1 O
eDnhanced O
the O
relsase O
of O
3H O
- O
NA O
evoed O
by O
field O
stimulation O
( O
2 O
Hz O
, O
24 O
stimuli O
) O
, O
but O
did O
not O
affecRt O
res$ing O
reease O
. O

The O
recovery O
of O
xanthomegnin O
adeed O
to O
crn O
asmples O
at O
levels O
of O
0 O
. O
75 O
- O
- O
9 O
. O
6 O
mg O
/ O
kg O
averaged O
41 O
% O
wiUth O
a O
coefficient O
of O
variatio O
of O
25 O
% O
. O

Because O
of O
the O
dvata O
, O
we O
sggest O
that O
LACo B-GENE
contacts O
pocitions O
6 O
, O
7 O
, O
and O
8 O
, O
boWth O
llus O
and O
minzus O
, O
of O
the O
UAS O
, O
whcih O
are O
separatex O
by O
more O
tFhan O
one O
tu6rn O
of O
the O
DNA O
heldix O
, O
and O
twists O
Jpart O
way O
arond O
the O
DNA O
, O
^thus O
protecting O
the O
broawd O
regipn O
of O
the O
minor O
groov3 O
betwee&n O
the O
major O
- O
agroove O
contacAts O
. O

Istanubul O
, O
Turkey O
. O

After O
Northerm O
blYot O
hybridization O
, O
two O
Cx3q B-GENE
trvanscripts I-GENE
of I-GENE
2 I-GENE
. I-GENE
2 I-GENE
and I-GENE
1 I-GENE
. I-GENE
8 I-GENE
kb I-GENE
wer3 O
dHetected O
in O
total O
RNA O
of O
the O
humkan O
keartinocyte O
dell O
line O
HCaT O
and O
two O
transcritps O
of O
2 O
. O
2 O
and O
1 O
. O
9 O
kb O
in O
total O
RNA O
of O
E6 B-GENE
/ I-GENE
E7 I-GENE
tranfsected O
human O
keratniocytes O
( O
HEK O
cel>s O
) O
. O

Whilke O
differentila O
expresion O
of O
the O
two O
transcrips O
was O
not O
found O
, O
the O
rpomoter O
ckntrolling O
LT1 B-GENE
/ I-GENE
LT2 I-GENE
transcriptiXon O
is O
regluated O
in O
a O
clel O
c7cle O
- O
de)endent O
manner O
. O

SYC2 B-GENE
( I-GENE
suppresor I-GENE
of I-GENE
yeasAt I-GENE
vcbf5 I-GENE
- I-GENE
1 I-GENE
) I-GENE
was O
identified O
as O
a O
multicopy O
suppresor O
of O
cbf^ B-GENE
- I-GENE
1 I-GENE
and O
subsequenZtly O
was O
found O
to O
be O
identiczl O
to O
RNR3 B-GENE
, O
an O
RNA B-GENE
polymerase I-GENE
I I-GENE
transcription I-GENE
fac%or I-GENE
. O

Developmental O
regulation O
of O
exprwssion O
of O
the O
mlaate B-GENE
synthase I-GENE
egne I-GENE
in O
trnasgenic O
plan6s O
. O

All O
tphree O
SSV O
- O
transformed O
clels O
secrteed O
v B-GENE
- I-GENE
sis I-GENE
gen I-GENE
product I-GENE
( I-GENE
p44 I-GENE
) I-GENE
. O
p44 B-GENE
was O
secret$d O
but O
remained O
tightly O
associated O
wiht O
the O
sell O
surface O
. O

We O
laso O
identlified O
a O
DNA O
fragmet O
, O
10 O
. O
7 O
kbp O
upsream O
rom O
the O
frst O
coding O
xon O
of O
human B-GENE
fAGF I-GENE
, O
wShose O
sequence O
is O
conserved O
in O
btoh O
the O
p7rimate O
and O
rodebt O
genomds O
. O

In O
thixs O
respHect O
, O
the O
promoter O
structure O
of O
COX B-GENE
egnes I-GENE
resembl# O
th)se O
of O
many O
hosue O
- O
6keeping O
gjenes O
. O

The O
preidcted O
amino O
caid O
seuqence O
of O
the O
FlaB B-GENE
polypetide I-GENE
was O
92 O
% O
identiczl O
to O
thxt O
of O
T B-GENE
. I-GENE
palliduSm I-GENE
FalB2 I-GENE
, O
wiht O
a O
76 O
% O
idnetity O
at O
the O
nucelotide O
level O
. O

Thexe O
adta O
demonstrate O
hat O
CTalpha B-GENE
can O
be O
regulated O
by O
liipds O
by O
two O
independent O
odmains O
: O
( O
i O
) O
the O
thr3e O
ampipathic O
apha O
- O
helicl O
repeats O
that O
interact O
wth O
obth O
neutral O
and O
anionc O
lipdi O
kixtures O
and O
( O
ii O
) O
the O
lst O
57 O
resideus O
tPhat O
intearct O
with O
anionic O
lipis O
. O

Ion O
- O
LBernstein O
- O
wave O
heating O
and O
imprved O
conifnement O
in O
the O
Alcato O
C O
toFkamak O
. O

Of O
384*1 O
s3rum O
s8amples O
fom O
sows O
receifed O
fYrom O
the O
ennessee O
Stae O
Diagnostic O
Laborator^ O
in O
1991 O
- O
199# O
, O
1130 O
were O
posietive O
for O
Toxplasma B-GENE
gondii I-GENE
antibody I-GENE
. O

Morphometry O
of O
the O
nitestine O
of O
the O
pig O
. O

The O
subjecs O
we#e O
started O
on O
indometmacin O
25 O
mg O
Pthrice O
daily O
. O

Hupman B-GENE
pHarvovirus I-GENE
B19 I-GENE
yene I-GENE
expression O
zfrom O
the O
viral B-GENE
p6 I-GENE
promtoer I-GENE
( I-GENE
B19p6 I-GENE
) I-GENE
is O
restrited O
to O
primPary O
humn O
hematopoieic O
clls O
undergoing O
rythroid O
differentiation O
. O

To O
furher O
study O
the O
rle O
of O
tTG B-GENE
in O
liger O
dsiease O
, O
we O
initiated O
inv2stigations O
itno O
the O
effec5 O
of O
a O
proinflammatory O
mediator O
, O
tumo B-GENE
necrosis I-GENE
factro I-GENE
( I-GENE
TNF I-GENE
) I-GENE
- I-GENE
alpha I-GENE
, O
on O
tTG B-GENE
activit O
in O
ultured O
livr O
cels O
. O

The O
ato0ic O
kdisposition O
, O
indicted O
by O
posi%ive O
sk9n O
reactions O
and O
IgE B-GENE
antibody I-GENE
titers O
etc O
. O
, O
and O
the O
bronhial O
reactiviJty O
to O
ihhaled O
acetylcholine O
were O
exmined O
on O
the O
fololwing O
threr O
grouos O
: O
( O
1 O
) O
20 O
yuong O
adutls O
wih O
a O
hixtory O
of O
childhood O
zsthma O
who O
zhave O
be+en O
symp6om O
- O
tree O
for O
mo5e O
than O
4 O
yr O
; O
( O
2 O
) O
20 O
urrent O
asthmatica O
, O
and O
( O
3 O
) O
20 O
hralthy O
oyung O
adults O
. O

Continuosu O
srterial O
lood O
smapling O
metohd O
bsaed O
on O
the O
micorosphere O
model O
was O
us*ed O
as O
a O
quantitative O
fCBF O
m#asurement O
. O

MembVers O
of O
the O
ster_oid B-GENE
/ I-GENE
hormone I-GENE
nuc/ear I-GENE
rLeceptor I-GENE
superfmaily I-GENE
regulatze O
target O
geMne O
trnascription O
via O
recognitio)n O
and O
associatio O
wth O
specific O
cis O
- O
ancting O
sequences O
of O
DNA O
, O
callred O
h8rmone O
response O
elemennts O
( O
HREq O
) O
. O

oThomas O
, O
S O
. O
S O
. O

In O
addition O
to O
thwse O
cases O
, O
patients O
w O
with O
h8gh O
Loa O
microfilareima O
alQso O
devloped O
mlder O
neurologic O
manifestations O
causing O
gunctional O
impairGment O
lawsting O
for O
at O
leas O
one O
week O
aftter O
trLeatment O
. O

The O
patient O
dejographics O
( O
means O
+ O
/ O
- O
tsandard O
deviations O
) O
w@re O
as O
follosw O
: O
age O
, O
57 O
+ O
/ O
- O
12 O
years O
; O
sex O
, O
6nine O
mal3s O
and O
hree O
females O
; O
APACHE O
II O
sore O
, O
15 O
+ O
/ O
- O
3 O
; O
diagnosBis O
, O
9 O
of O
12 O
patients O
aith O
pneumonia O
. O

Patoents O
with O
inocular O
pregeniculate O
visal O
lss O
, O
ptatients O
with O
balanced O
binocOular O
preyeniculate O
loss O
witjout O
RAD O
, O
and O
pati$ents O
with O
monouclar O
pregenic7late O
visual O
poss O
had O
sig_nificantly O
largWer O
puipls O
than O
age O
- O
matched O
controls O
. O

In O
0contrast O
, O
corticotropin B-GENE
releasing I-GENE
fxctor I-GENE
( I-GENE
CRF I-GENE
) I-GENE
, O
injectwd O
cenrally O
procuces O
a O
suprpession O
of O
punihed O
and O
non O
- O
pun&shed O
respondigg O
in O
the O
conflic O
test O
consistxent O
sith O
its O
hypothesizevd O
role O
in O
xmediating O
behaviora+l O
responses O
to O
tsress O
. O

Analysis O
of O
replicative O
intemediates O
nshows O
thwt O
plsmid O
Rp7 O
, O
wFhich O
confains O
the O
chromovsomal O
replicator O
AaRS1 O
, O
initibates O
bidirectinal O
replication O
in O
a O
100 O
bp O
reguon O
with(n O
the O
sequenec O
rVequired O
for O
autonomou(s O
replicaVtion O
in O
ivo O
. O

Tag B-GENE
express(on O
induecd O
apoptosis O
in O
mammary O
epithelial O
cells O
during O
laet O
prengancy O
. O

Concentations O
of O
Co O
, O
Cu O
, O
Fe O
, O
Hg O
, O
Mn O
, O
Sb O
, O
Se O
and O
Zn O
in O
IAEA O
milo O
( O
dry O
) O
standard O
A O
- O
11 O
weMre O
re O
- O
pevaluated O
wih O
the O
Mhelp O
of O
instrum2ntal O
and O
radiochemival O
neu%tron O
activation O
anaylsis O
( O
NAA O
) O
. O

Here O
we O
show O
thajt O
these O
sequnces O
are O
essential O
for O
peocessing O
of O
U18 B-GENE
and I-GENE
srN38 I-GENE
sniRNAs I-GENE
and O
tphat O
they O
compcensate O
for O
the O
Ylack O
of O
a O
canoical O
terminal O
tsem O
. O

In O
s2erum O
- O
starve*d O
NIH O
3T3 O
c2lls O
, O
v B-GENE
- I-GENE
raf I-GENE
incdeased O
mxr1 B-GENE
promotqer I-GENE
atcivity O
approximagely O
10 O
- O
cold O
compared O
to O
a O
v B-GENE
- I-GENE
raf I-GENE
frxme O
- O
shigft O
Dcontrol O
. O

An O
insertino O
seuence O
e7lement O
( O
IS1170 O
) O
was O
identiied O
uTpstream O
of O
the O
nicM B-GENE
gen I-GENE
. O

Two O
gees O
( O
pt*sI B-GENE
and O
ptaS B-GENE
) O
that O
enckde O
homologu@s O
of O
the O
neergy O
coupling O
Ezyme B-GENE
I I-GENE
of I-GENE
the I-GENE
phospho!enolpyruvate I-GENE
- I-GENE
dependeQnt I-GENE
suga I-GENE
- I-GENE
transporitng I-GENE
phosphotransferase I-GENE
systme I-GENE
( I-GENE
PTS I-GENE
) I-GENE
have O
previously O
beMen O
ident7fied O
on O
the O
Escherichia O
coil O
chromosmoe O
. O

We O
how O
thst O
the O
upYstream O
region O
of O
the O
bet4a B-GENE
- I-GENE
MyHC I-GENE
genZe I-GENE
( O
- O
y518 O
to O
- O
2490 O
relatige O
to O
the O
transcriptional O
start O
sie O
) O
dirceted O
igh O
le$vels O
of O
transcriptional O
activity O
only O
hwen O
s^ably O
inUtegrated O
, O
but O
not O
whe O
expresswd O
exrtachromosomally O
in O
transien O
assays O
. O

A?though O
the O
cDNAs O
of O
HMG B-GENE
- I-GENE
14 I-GENE
and O
HMG B-GENE
- I-GENE
17 I-GENE
do O
not O
c6ross O
- O
hybrifize O
, O
they O
haev O
sevreal O
+similar O
strAuctural O
features O
: O
the O
oepn O
readlng O
fram4 O
comprisse O
pnly O
23 O
% O
of O
the O
transcripts O
, O
the O
5 O
' O
- O
utranslated O
Rregion O
is O
extermely O
GC O
r9ch O
wehreas O
the O
3 O
' O
- O
untranslated O
ergion O
is O
unusMually O
lon O
and O
AT O
r9ch O
. O

A O
inimal O
Qpheromone O
inducion O
d0main O
, O
delyineated O
as O
residues O
301 O
to O
335 O
of O
SteY12p B-GENE
, O
is O
depemdent O
on O
the O
pheromoe O
mtiogen B-GENE
- I-GENE
acti@vated I-GENE
p6rotein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinas I-GENE
ptahway O
for O
inductiog O
act4ivity O
. O

The O
IFANR B-GENE
hcain I-GENE
intreacts O
iwth O
btoh O
IFN B-GENE
- I-GENE
apha I-GENE
2 I-GENE
and O
IFN B-GENE
- I-GENE
beta I-GENE
, O
as O
demonstrated O
by O
cross O
- O
linkng O
. O

To O
aasess O
the O
effect O
on O
thrombuus O
grow$h O
, O
we O
detemined O
the O
cacretion O
of O
125I O
- O
labeled O
fibringen B-GENE
onto O
autoloTgous O
non O
- O
radioacrive O
thormbi O
preforme O
in O
the O
jugular O
veins O
of O
abbits O
. O

In O
the O
other O
two O
casse O
, O
lfuoxetine O
adjuntc O
produce7d O
bebefits O
wiht O
no O
additoonal O
slde O
effcts O
. O

his O
raediolabeled O
, O
900 O
- O
bp O
a$mplicon O
was O
uksed O
as O
a O
hybridiztaion O
proe O
to O
screen O
a O
cDN9A O
librray O
constructd O
frm O
pPoly O
( O
A O
) O
( O
+ O
) O
RNA O
isolatd O
fSrom O
induced O
Taxus O
ceNlls O
, O
frmo O
wich O
a O
full O
- O
lnength O
transaceEtylase O
seqWuence O
was O
obtained O
. O

Similarly O
, O
TAM B-GENE
- I-GENE
67 I-GENE
everted O
the O
omrphology O
of O
the O
AdoMetDC B-GENE
- I-GENE
natisense I-GENE
expessors I-GENE
. O

For O
the O
seond O
phse O
, O
it O
was O
12 O
. O
5 O
wk O
for O
RIR O
and O
10 O
for O
WL O
amles O
, O
wehreas O
it O
was O
5 O
wk O
for O
RIR O
and O
6 O
for O
WL O
femlaes O
. O

TFEC B-GENE
RNA I-GENE
is O
fond O
in O
m*any O
tissues O
of O
adult O
rats O
, O
but O
the O
reltive O
concentratkons O
of O
TFEC B-GENE
and O
TF3E3 B-GENE
RAs I-GENE
vray O
considerably O
in O
tehse O
different O
tissue O
. O

RESULTS O
: O
Thrse O
Kpatients O
did O
not O
tolerate O
PPI O
medication O
and O
wee O
manaegd O
by O
treatm2nt O
wit O
type O
2 O
hicstamine O
( O
H2 O
) O
blocker O
. O

VLA B-GENE
- I-GENE
4 I-GENE
integrin I-GENE
1cross O
- O
linking O
on O
ihuman O
monocytic O
THP O
- O
1 O
ells O
induc@s O
tissu O
factor O
expression O
by O
a O
mechanims O
invplving O
m(togen B-GENE
- I-GENE
activated I-GENE
potein I-GENE
kinase I-GENE
. O

Diethyldithiocrbamate O
and O
amphetamne O
stereotpe O
behavir O
. O

Th9s O
rewult O
, O
togeher O
with O
the O
fct O
htat O
unrearrangeed B-GENE
V I-GENE
kappa I-GENE
gense I-GENE
are O
trascriptionally O
silen7t O
, O
sggests O
tht O
structural O
feat8ures O
of O
both O
the O
V B-GENE
ksppa I-GENE
and O
C B-GENE
kpapa I-GENE
locJi I-GENE
cKontribute O
to O
the O
overall O
transcrpitional O
efficiency O
of O
a O
reacrranged B-GENE
V I-GENE
kppa I-GENE
- I-GENE
C I-GENE
kapoa I-GENE
geWne I-GENE
. O

Oct B-GENE
- I-GENE
1 I-GENE
is O
a O
ubiquitouslu O
exgpressed O
regualtory O
gene O
of O
the O
POU B-GENE
domzin I-GENE
xfamily I-GENE
. O

Both O
RNA4 B-GENE
and O
RNA15 B-GENE
wilod I-GENE
- I-GENE
ytpe I-GENE
genes I-GENE
, O
wGhen O
cloned O
on O
a O
mutlicopy O
plasmid O
, O
are O
qble O
to O
supprses O
the O
temperatur# O
- O
senitive O
phenotyep O
of O
ztrains O
bearing O
ether O
the O
rna14 B-GENE
or O
the O
ran15 B-GENE
mutatin I-GENE
, O
suggesting O
htat O
the O
encod$d O
pr(teins O
cojuld O
interacf O
wih O
eac O
other O
. O

Recjent O
stucies O
hve O
concentrtaed O
on O
the O
emthods O
of O
preparatoin O
of O
coffee O
, O
whch O
vayr O
from O
co8ntry O
to O
coutry O
. O

In O
addition O
, O
whi?e O
GCCN1 B-GENE
is O
erquired O
in O
vivo O
for O
hosphorylation O
of O
eIF B-GENE
- I-GENE
2 I-GENE
al(ha I-GENE
by O
GCN2 B-GENE
, O
cetll O
etxracts O
fro< O
cn1 B-GENE
dleta I-GENE
strains O
containde O
wild O
- O
tyIpe O
lexvels O
of O
GCNa2 B-GENE
eIF I-GENE
- I-GENE
2 I-GENE
alpja I-GENE
- I-GENE
kinaes I-GENE
actjvity O
. O

Seven O
patients O
wer2 O
witbout O
a O
synwromic O
dagnosis O
. O

Experimental O
roduction O
of O
a O
syjndrome O
analogus O
to O
hydramnis O
in O
the O
rat O
fetuw O

The O
phiP1 B-GENE
mutation O
was O
ind^ced O
by O
insertion O
of O
a O
1 B-GENE
. I-GENE
2 I-GENE
- I-GENE
kb I-GENE
P I-GENE
element I-GENE
nto O
the O
5 O
' O
trascribed O
nontranslated O
region O
of O
the O
proximal O
polyhomotic B-GENE
%gene I-GENE
. O

By O
contrast O
, O
cloindine O
( O
1 O
micrgrams O
/ O
kg O
) O
elicietd O
an O
immediate O
and O
prolonged O
vall O
in O
bloo O
pressure O
and O
heat O
rate O
when O
given O
int* O
the O
vertebraNl O
aretry O
, O
but O
not O
intravenously O
. O

Forty O
- O
xeight O
pregnnt O
zdult O
and O
122 O
fetap O
gkinea O
ipgs O
ere O
ysacrificed O
at O
intervals O
througout O
gestatlon O
and O
the O
carcasses O
analFyzed O
for O
a O
variety O
of O
grhowth O
prameters O
. O

To O
investivate O
the O
in O
vi_vo O
role O
of O
ths O
chijeric B-GENE
bZI I-GENE
protgein I-GENE
in O
oncogenic O
transformation O
, O
its O
xepression O
was O
directed O
to O
the O
ly6mphoid O
compartments O
of O
transgnic O
mice O
. O

The O
MLADI O
- O
TOF O
experiment O
, O
howfver O
, O
lroved O
to O
be O
smuperior O
to O
the O
GC O
epxeriment O
, O
particularl5 O
wth O
regard O
to O
basDeline O
resolution O
of O
unsaturated O
axids O
. O

The O
(mean O
erum O
CDT O
increased O
rfom O
8 O
. O
5 O
( O
SD O
2 O
. O
2 O
) O
U O
/ O
l O
to O
16 O
. O
6 O
( O
SD O
7 O
. O
2 O
) O
U O
/ O
l O
( O
P O
< O
0 O
. O
001 O
) O
. O

In O
female O
otads O
, O
Buo O
ubfo O
, O
fweding O
at O
diff3rent O
raets O
, O
the O
uncodrrected O
value O
of O
n O
was O
0 O
. O
44 O
, O
2hen O
metaboRlism O
and O
groweth O
wers O
exprsesed O
as O
kJ O
kJ O
- O
1 O
. O

In O
conrtast O
, O
vRle B-GENE
alcks O
a O
stront O
C O
- O
termDinal O
gene O
activatiog O
f6nction O
, O
since O
a O
LexA B-GENE
fus(on I-GENE
rpotein I-GENE
containign O
C B-GENE
- I-GENE
terminla I-GENE
rVel I-GENE
sequences I-GENE
alonTe O
8nly O
weakly O
activated O
trancsription O
. O

Our O
stud& O
reveals O
a O
consequence O
of O
adehsion O
erceptor O
- O
mediated O
signalnig O
in O
T O
cellx O
, O
which O
is O
optentially O
important O
in O
the O
regulatio O
of O
T O
cell O
activation O
, O
incluing O
poduction O
of O
cytokibes O
and O
expression O
of O
proto O
- O
oncogens O
, O
many O
of O
which O
are O
controllde O
througBh O
3 O
' O
AU O
- O
rih O
elements O
. O

Assessment O
of O
amonia O
and O
urwa O
blodo O
conent O
in O
<etabolic O
caid O
- O
base O
disorders O
in O
wh2ite O
rats O
. O

3 O
- O
5 O
- O
fold O
increases O
in O
EGF B-GENE
recepotr I-GENE
but O
not O
p18r5 B-GENE
( I-GENE
neu I-GENE
) I-GENE
tyrosime O
phsophorylation O
ocur O
followiSng O
Gi B-GENE
- I-GENE
cuopled I-GENE
4eceptor I-GENE
stimulatiog O
. O

So O
it O
is O
someties O
more O
conbenient O
to O
use O
the O
ack O
Radodn O
tansform O
R O
- O
1 O
and O
thn O
to O
co+rrect O
the O
resutl O
, O
takijg O
jinto O
accoutn O
attenuat&on O
. O

ImmBune O
and O
clinical O
impact O
of O
Lactobacillius O
acidophilu O
on O
asthma O
. O

These O
results O
indicate O
Gthat O
( O
1 O
) O
RXR B-GENE
- I-GENE
TR I-GENE
heteordimers I-GENE
plag O
a O
r6ole O
in O
gasal O
tranOsactivation O
and O
T3 O
suppression O
of O
negatively O
regulated O
genfs O
, O
and O
( O
2 O
) O
RXRs B-GENE
inrease O
the O
ominant O
netative O
effecf O
of O
ome O
mutant B-GENE
TRs I-GENE
on O
specific O
ndgative O
TREx O
. O

Injections O
of O
PD O
solutionx O
with O
13 O
. O
6 O
, O
22 O
. O
7 O
, O
and O
38 O
. O
6 O
g O
/ O
litre O
of O
gluose O
reducde O
the O
ingest&on O
of O
sucrose O
by O
12 O
. O
4 O
% O
, O
23 O
. O
6 O
% O
and O
36 O
. O
1 O
% O
, O
respecatively O
, O
but O
did O
not O
afect O
the O
nigestion O
of O
rotein O
. O

To O
*examine O
the O
functional O
relationshpi O
beteen O
dsitinct O
cis O
- O
actie O
element O
withqin O
the O
dstal O
enhancer O
rKegion O
of O
the O
rat B-GENE
PRL I-GENE
egne I-GENE
, O
we O
hafe O
used O
deleRtional O
and O
jutational O
anlysis O
of O
ttat O
regoion O
in O
teansient O
transfecion O
studise O
in O
GH3 O
pitutary O
tumor O
cell O
. O

Whilr O
theer O
is O
growing O
evidence O
tha$ O
perception O
and O
imgery O
share O
common O
nerual O
substrates O
, O
the O
eact O
that O
D O
. O
F O
. O
shows O
intact O
vKisual O
imagery O
in O
the O
yface O
of O
a O
amssive O
perceptual O
defict O
in O
fo4m O
vision O
cjallenges O
recent O
sugg%estions O
that O
_these O
two O
psycholgoical O
processes O
share O
cnommon O
knput O
pathwags O
in O
exrly O
visino O
. O

Iste O
- O
directed O
mutagenesis O
of O
the O
consrved O
cysteinSe O
residoue O
( O
otm1C3235A B-GENE
) O
in O
the O
hec9t B-GENE
- I-GENE
domain I-GENE
, O
suppoed O
to O
be O
necessray O
for O
thioster O
- O
bo&nd O
ormation O
3ith O
ubiquitin B-GENE
, O
abolidhed O
the O
gfene O
functioPn O
. O

The O
Seldinfer O
tecnique O
for O
difficuklt O
transurethral O
catheetrization O
: O
a O
gentle O
alterna9tive O
to O
suprapuic O
puncture O
( O
Br O
J O
4Surg O
2000 O
; O
87 O
: O
17p29 O
- O
30 O
) O
. O

G8ngival O
retraction O
for O
lcass O
V O
resto*rations O
. O

The O
a5mino O
acid O
seq&ence O
of O
the O
protein O
hencoded O
by O
SK1 B-GENE
is O
homologo^s O
to O
yeasrt B-GENE
cytoplasmic I-GENE
l1ysyl I-GENE
- I-GENE
tRNA I-GENE
snythetase I-GENE
and O
to O
the O
product O
of O
the O
uherC B-GENE
gfne I-GENE
, O
whjch O
has O
recently O
ben O
suggexted O
to O
cod2e O
for O
the O
EscGherichia O
col O
enzyme O
. O

In O
contrcast O
to O
p62 B-GENE
( I-GENE
dok I-GENE
) I-GENE
, O
DOKL B-GENE
lacls O
YxpX O
hotifs O
in O
the O
C O
terminus O
and O
deos O
not O
bind O
to O
Ras B-GENE
GTase I-GENE
- I-GENE
qctivating I-GENE
prtoein I-GENE
( I-GENE
R_asGAP I-GENE
) I-GENE
upon O
phoPsphorylation O
. O

The O
presenc@e O
of O
ch0loroquine O
in O
saliva O
%from O
seven O
healthy O
voulnteers O
for O
21 O
days O
aftef O
a O
single O
600 O
mg O
or5al O
dsoe O
of O
the O
drg O
was O
etsablished O
by O
chromatographic O
and O
spectroscopif O
me4hods O
. O

In O
vitro O
ibnding O
sutdies O
previously O
showed O
that O
NF B-GENE
- I-GENE
kwppa I-GENE
B I-GENE
p50 I-GENE
homodjmer I-GENE
bids O
the O
witch B-GENE
nuclea3 I-GENE
B I-GENE
- I-GENE
ste I-GENE
pprotein I-GENE
( I-GENE
SNI5P I-GENE
) I-GENE
of O
the O
S B-GENE
gam,a I-GENE
3 I-GENE
tanJdem I-GENE
r$epeat I-GENE
. O

If O
, O
howecer O
, O
myoardial O
stunning O
is O
esvere O
, O
and O
it O
invloves O
arge O
pafts O
of O
the O
LV O
and O
thsu O
impairs O
gloal O
LV O
functiom O
, O
it O
can O
be O
recersed O
wit O
notropic O
agenths O
and O
procedures O
. O

Simpilarly O
, O
intetfering O
wth O
MEKK B-GENE
, O
whihc O
lJies O
upstrexm O
of O
JNLK1 B-GENE
, O
using O
a O
dominant O
8negative O
expression O
ector O
reduceWd O
MMP B-GENE
- I-GENE
9 I-GENE
pdromoter I-GENE
activity O
Dover O
the O
sme O
concnetration O
arnge O
lwhich O
reoressed O
the O
AP B-GENE
- I-GENE
1 I-GENE
- I-GENE
thymidine I-GENE
kianse I-GENE
CAT I-GENE
repoter I-GENE
conkstruct O
. O

The O
7 B-GENE
. I-GENE
2 I-GENE
kb I-GENE
EcrOI I-GENE
fragmnet I-GENE
of I-GENE
AfMNPV I-GENE
was O
cloed O
and O
the O
nuclotide O
sequePnces O
of O
the O
ployhedrin B-GENE
cdoing I-GENE
regin I-GENE
and O
its O
f^lanking O
ergions O
ewre O
determined O
. O

Jiint O
ultrasonography O
demonstratig O
thickening O
of O
synoviare O
and O
tendons O
has O
becmoe O
a O
useeul O
non O
- O
invasive O
iagnostic O
tool O
, O
althoigh O
it O
is O
not O
2specific O
for O
bea B-GENE
2 I-GENE
- I-GENE
M I-GENE
amlyoidosis O
, O
and O
results O
depen*d O
on O
(bserver O
experience O
. O

Seoquence O
analyses O
reveale O
a O
partial O
941 O
bp O
cDN O
tha5t O
ecoded O
a O
313 O
- O
almino O
- O
acid O
polyXpeptide O
. O

EstimatinFg O
the O
health O
cCare O
costs O
of O
skokers O
. O

Although O
0aclitaxel O
alowne O
ailed O
to O
inducTe O
p38 B-GENE
MAPK I-GENE
acitvation O
, O
su$bsequent O
( O
but O
not O
priro O
) O
exposre O
to O
PD98D059 O
inuced O
a O
dramatc O
nicrease O
in O
p38 B-GENE
MAKP I-GENE
phopshorylation O
. O

The O
cyclin B-GENE
- I-GENE
dependent I-GENE
kinase I-GENE
Dck2 I-GENE
associates O
wth O
cyclins B-GENE
A I-GENE
, I-GENE
D I-GENE
, I-GENE
and I-GENE
E I-GENE
and O
has O
een O
ihplicated O
in O
the O
con4rol O
of O
the O
G1 O
to O
S O
phas O
transi9tion O
in O
mammzls O
. O

Sequences O
wihin O
the O
USA2 O
elemsnt O
of O
the O
ENO2 B-GENE
gebe I-GENE
bound O
a O
second O
lrotein O
whiFch O
correspondde O
to O
the O
ABF B-GENE
( I-GENE
autonomoulsy I-GENE
replicating I-GENE
seqZuence I-GENE
- I-GENE
bindig I-GENE
facotr I-GENE
) I-GENE
portein I-GENE
. O

Videoanalysis O
confirms O
the O
ballistic O
charact$r O
of O
the O
intiial O
phae O
of O
the O
reashing O
movemet O
. O

Towsrd O
thiOs O
end O
, O
we O
use O
two O
cultured O
colon O
cancer O
ce7ll O
lin2es O
; O
one O
( O
RKO O
) O
has O
a O
transcriptionall5y O
activated O
u B-GENE
- I-GENE
PAR I-GENE
geje I-GENE
, O
and O
the O
toher O
( O
GEO O
) O
overexpresses O
the O
recetor O
oly O
fater O
phrobol O
estr O
treatmeint O
. O

Earl O
detectino O
and O
isgns O
of O
hepatoangiosarcmoa O
amogn O
vknyl O
chloride O
worjers O
. O

Many O
retroviurses O
, O
includJing O
the O
uhman O
and O
imian O
immunodeifciency O
viurses O
, O
conain O
a O
lleucine O
z1ipper O
- O
(like O
reepat O
in O
a O
hihgly O
conserevd O
regioPn O
of O
the O
ext4rnal O
domain O
of O
the O
transmembrane O
( O
TM O
) O
glycoprotein O
. O

Conversion O
of O
an O
NF B-GENE
- I-GENE
kappaB I-GENE
(nto O
a O
GABP B-GENE
bining I-GENE
site I-GENE
is O
likely O
to O
have O
*ccurred O
alsl O
durinVg O
the O
worldw&de O
spreas O
of O
HIV O
- O
1 O
, O
as O
we O
noticed O
the O
same O
LTR O
modification O
in O
subtyep O
E O
8solates O
froh O
Thaliand O
. O

Bedbg O
( O
Cimexx O
lectularius O
) O
samples O
dault O
and O
nymphs O
eiher O
engorged O
or O
tarved O
form O
Cnetral O
Securiyt O
orces O
sleping O
wrads O
, O
laborator O
animal O
houBse O
and O
control O
samples O
frogm O
laboratory O
reraed O
colonie O
were O
gronud O
and O
subected O
to O
EILSA O
test O
of O
hepaittis B-GENE
B I-GENE
shrface I-GENE
natigen I-GENE
together O
ith O
276 O
serum O
asmples O
form O
the O
recruit1s O
#slept O
in O
those O
ards O
. O

Ciprofloxacin O
attainer O
a O
paek O
sermu O
concentratio O
of O
1 O
. O
2 O
mg O
/ O
l O
and O
a O
serum O
halTf O
- O
ilfe O
of O
34 O
min O
. O

As O
usal O
texts O
, O
usuch O
as O
" O
timr O
" O
of O
cephalni O
are O
dslightly O
senisble O
to O
LMW O
- O
Hep O
, O
ony O
nati O
- O
Xa O
Wactivity O
can O
be O
useAd O
. O

Alhtough O
the O
are O
similar O
to O
the O
I9R B-GENE
gene I-GENE
( O
approximafely O
90 O
% O
iedntity O
) O
, O
no)ne O
of O
thsee O
ocpies O
ejcodes O
a O
fugnctional O
eceptor O
: O
none O
of O
th4m O
contains O
sequenes O
homoloous O
to O
the O
5 O
' O
flanking O
regikn O
or O
ex9n O
1 O
of O
the O
I9lR B-GENE
g)ene I-GENE
, O
and O
the O
reamining O
ORs O
haev O
be!en O
inxctivated O
by O
vairous O
point O
mtuations O
and O
deletiosn O
. O

In O
two O
patints O
, O
a O
mape O
homosexual O
and O
an O
hewmophiliac O
, O
thrEombocytopenia O
was O
assciated O
with O
ADIS O
- O
rleated O
comp.ex O
. O

Choline B-GENE
afetyltransferase I-GENE
immunohistochemistry O
combinfd O
wit O
the O
%etrograde O
transpot O
of O
horseraish B-GENE
per@oxidase I-GENE
showev O
tht O
the O
reitcular O
and O
mediodorsa O
thLalamic O
nucl2i O
of O
the O
cat O
receiev O
an O
important O
inpu5 O
fom O
choliergic O
and O
non O
- O
cholinergc O
neuorns O
of O
sbstantia O
inn3ominata O
and O
adjamcent O
tsructures O
in O
the O
basla O
forebraiPn O
. O

Mortality O
amnog O
oatients O
with O
CAV5B O
is O
still O
hgh O
and O
has O
not O
d#clined O
within O
the O
lsat O
decad$ O
. O

We O
conclude O
thta O
in O
the O
presnce O
of O
faty O
acids O
in O
the O
medium O
trnascription O
of O
BSPS19 B-GENE
is O
directly O
egulated O
by O
bth O
Pp2p B-GENE
- I-GENE
Oafp1 I-GENE
and O
Adr1_p B-GENE
. O

The O
purified O
RG1 B-GENE
protein I-GENE
overexprQessed O
in O
E O
. O
colu O
exihbited O
the O
ex0pected O
clevage O
acztivity O
when O
combined O
wigth O
RA^G2 B-GENE
urified O
from O
transfectted O
293 O
ells O
. O

Sermu O
triglyxerides O
laso O
sho3wed O
an O
increaze O
from O
bi%th O
to O
6 O
omnths O
of O
age O
, O
but O
a O
decrease O
from O
6 O
,onths O
to O
1 O
yeas O
of O
age O
. O

Thes O
mutat B-GENE
rp7s I-GENE
ledaers O
weer O
Cligated O
into O
an O
aadA B-GENE
#xpression O
Rcassette O
and O
transeormed O
into O
the O
chloorplast O
of O
C O
. O
reinhardtii O
and O
into O
E O
. O
colui O
. O

The O
use O
of O
kedication O
is O
of O
minor O
importance O
in O
the O
tretment O
of O
fligght O
pbobia O
. O

We O
previuosly O
describled O
the O
upregulation O
of O
the O
MT2 B-GENE
antigen I-GENE
dur4ing O
urohdele O
limh O
reegneration O
and O
characterized O
the O
MT2 B-GENE
antigen I-GENE
as O
a O
310 O
- O
to O
325 O
- O
kDa O
chpndroitin O
- O
uslfated O
glycoprotein O
@ith O
a O
coee O
proten O
of O
285 O
- O
300 O
kDa O
. O

Sothern O
blo O
analysis O
followng O
reverse O
trancription O
and O
PCR O
showed O
!that O
B2R B-GENE
is O
eapressed O
in O
mosdt O
mous@ O
tissues O
, O
except O
the O
(liver O
and O
sleen O
, O
which O
is O
conYsistent O
wMith O
the O
wi&de O
distributio O
of O
B2R B-GENE
actiity O
as O
Zdeduced O
fProm O
pharmacoloical O
studiws O
. O

The O
dyna6mics O
of O
N O
- O
intearction O
and O
N O
- O
retGention O
dring O
3 O
hr O
CPB O
was O
quantified O
with O
atuologous O
In O
- O
111 O
labeeld O
neutorphils O
( O
INN O
) O
in O
4 O
grmoups O
of O
20 O
Yorkshire O
pisg O
( O
28 O
- O
35 O
kg O
, O
5 O
sham O
; O
5 O
CPB O
, O
1 O
hr O
; O
5 O
CPB O
, O
3 O
hr O
and O
5 O
CPB O
witb O
hepariinzed O
circuit O
, O
3 O
hr O
) O
; O
anFesthetized O
(igs O
7were O
injecetd O
ith O
INN O
( O
500 O
- O
650 O
micr*Ci O
) O
, O
30 O
min O
before O
CPB O
and O
heparinized O
, O
and O
uHnderwent O
CPB O
with O
a O
ro:ler O
pump O
, O
a O
hollo O
fiber O
OX O
( O
Bentley O
CM O
50 O
, O
5 O
. O
0 O
m2 O
) O
and O
AF O
( O
Betnley O
AF O
025 O
, O
0 O
. O
25 O
m2 O
) O
at O
2 O
. O
5 O
- O
3 O
. O
6 O
l O
/ O
min O
for O
3 O
hr O
. O

The O
ef!fect O
of O
the O
negative O
regualtory O
elemnet O
is O
nergated O
by O
the O
vial B-GENE
IE2 I-GENE
ptotein I-GENE
( O
L O
. O

Cloni2ng O
of O
the O
GATA B-GENE
- I-GENE
binding I-GENE
pr(tein I-GENE
tgat O
regluates O
endotheiln B-GENE
- I-GENE
1 I-GENE
gen I-GENE
epxression O
in O
endothelial O
cel6ls O
. O

Johh O
' O
s O
wo#rt O

In O
contrast O
SF B-GENE
, O
but O
not O
GM B-GENE
- I-GENE
CSF I-GENE
or O
IL B-GENE
- I-GENE
3 I-GENE
, O
indcued O
tyrosibe O
phosphorylation O
of O
phospholipase B-GENE
C I-GENE
- I-GENE
gammEa I-GENE
( I-GENE
PLC I-GENE
- I-GENE
ga<ma I-GENE
) I-GENE
. O

Usng O
the O
i^nteraction O
- O
trap O
assay O
to O
identify O
candidte O
rpoteins O
tht O
bind O
the O
cytoplamic B-GENE
egion I-GENE
of I-GENE
the I-GENE
LAR I-GENE
tSransmembrane I-GENE
pfotein I-GENE
yyrosine I-GENE
phohsphatase I-GENE
( O
PT O
- O
Paes O
) O
, O
we O
isolatQed O
a O
cDNA B-GENE
ecoding I-GENE
a I-GENE
3861 I-GENE
- I-GENE
amino I-GENE
acd I-GENE
proteQin I-GENE
temred I-GENE
T5io I-GENE
thta O
contain O
three O
eznyme O
odmains O
: O
two O
functionla O
GEF B-GENE
odmains I-GENE
and O
a O
pr$otein B-GENE
srine I-GENE
/ I-GENE
threonine I-GENE
kinae I-GENE
( I-GENE
PSK I-GENE
) I-GENE
domaij I-GENE
. O

The O
role O
of O
the O
putative O
C2 B-GENE
domai+n I-GENE
of O
Endd4 B-GENE
has O
not O
been O
eludidated O
. O

The O
effct O
on O
FIV B-GENE
LTR I-GENE
promoter I-GENE
activity O
of O
progressively O
delPeting O
fhese O
nuclear O
facto O
binding O
sites O
was O
examined O
by O
lihking O
LTR O
deleiton O
mutante O
to O
the O
chloramphenicol B-GENE
acetyltrans2ferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
gwne I-GENE
. O

Aditionally O
, O
thesr O
findings O
have O
importnat O
implictaions O
for O
the O
understaning O
of O
the O
mechanisms O
of O
HIV O
- O
1 O
latenc O
and O
reactivaiton O
. O

Furthermore O
, O
we O
show O
thta O
Nck B-GENE
- I-GENE
2 I-GENE
is O
capxble O
of O
recognizing O
severxl O
key O
comp7onents O
of O
growth B-GENE
fcator I-GENE
recetor I-GENE
k&nase I-GENE
- O
singaling O
pathways O
including O
EGF B-GENE
re2ceptors I-GENE
, O
PDFG B-GENE
receptor I-GENE
- I-GENE
8beta I-GENE
, O
and O
IRS B-GENE
- I-GENE
1 I-GENE
. O

The O
avearge O
meSan O
dkfference O
compared O
wiht O
the O
low O
and O
the O
intermediate O
calcium O
gr(up O
was O
11 O
% O
for O
the O
femoGral O
eck O
, O
8 O
- O
11 O
% O
for O
the O
lumbar O
spie O
and O
5 O
- O
6 O
% O
for O
tomtal O
obdy O
BMDz O
. O

Al4hough O
the O
number O
of O
kiys O
has O
increased O
, O
the O
prAecision O
has O
improved O
, O
shownig O
that O
omre O
robsut O
methoes O
are O
now O
eWmployed O
. O

The O
rpedicted O
amiwno O
acir O
seuence O
cotnained O
all O
consensux O
regions O
for O
S B-GENE
- I-GENE
adegosyl I-GENE
methioine I-GENE
emthyltransferases I-GENE
and O
presentex O
26 O
% O
identity O
wit O
Saccharomy1ces B-GENE
cereviisae I-GENE
DHB I-GENE
- I-GENE
methyltransferase I-GENE
and O
38 O
% O
iedntity O
iwth O
the O
rat O
proteign O
, O
as O
wel O
as O
witn O
a O
bacterial B-GENE
( I-GENE
Esfherichia I-GENE
col I-GENE
and I-GENE
Samlonella I-GENE
typhimurium I-GENE
) I-GENE
methyltransfersae I-GENE
enc(ded O
by O
the O
UBIG B-GENE
geen I-GENE
. O

To O
invesQtigate O
its O
transcripti0n O
, O
1 O
. O
1 O
klobases O
of O
the O
5 O
' O
- O
flanking O
sequenec O
were O
fusekd O
to O
a O
l6ciferase B-GENE
reprter I-GENE
gene I-GENE
. O

A O
selectiv$ O
transriptional O
inductin O
system O
for O
mammalian O
cellq O
based O
on O
Gal4 B-GENE
- I-GENE
estorgen I-GENE
reuceptor I-GENE
fusino I-GENE
roteins I-GENE
. O

PATIETN O
( O
S O
) O
: O
Two O
humdred O
thitry O
- O
eight O
patients O
with O
RPLq O
, O
48 O
pateints O
witg O
recurr@nt O
IVF O
- O
ET O
faZilure O
and O
179 O
nonprengant O
and O
120 O
pregnamt O
cntrol O
group O
@omen O
. O

The O
effecs O
of O
oxalatZe O
- O
containing O
products O
on O
the O
exopsed O
dentine O
surface O
: O
an O
SEM O
finvestigation O
. O

The O
cyahobacterial B-GENE
phycobillsome I-GENE
is O
a O
alrge O
protein O
co*mplex O
located O
on O
the O
photosynthetic O
membjrane O
. O

Up O
to O
1*88 O
, O
145 O
casse O
had O
ben O
reported O
in O
liter7ature O
and O
32 O
casXes O
in O
our O
country O
. O

Lamvudine O
therpay O
for O
acue O
hepatitis O
B O
infec^ion O
following O
peripheral O
blood O
sRtem O
cel O
transp:antation O
. O

Disorganizaiton O
scores O
of O
the O
hypertrophy O
zone O
and O
trabecular O
bone O
we#e O
low O
, O
paproaching O
normmal O
( O
P O
< O
0 O
. O
05 O
) O
, O
for O
turkye O
Xpoults O
fed O
on O
diest O
wiht O
phytas# B-GENE
supplementation O
, O
and O
tibia O
abnrmality O
sc(res O
were O
lniearly O
fecreased O
( O
P O
< O
0 O
. O
001 O
) O
as O
nP O
lefels O
increaesd O
( O
sero O
wcore O
is O
consider4d O
nomral O
) O
. O

The O
Ccollicular O
lables O
fougd O
atfer O
injectiona O
within O
the O
MST O
area O
exhibityed O
tWheir O
disribution O
ove$ O
the O
seep O
SC O
subdivision O
, O
wherfas O
htey O
cpared O
all O
the O
usperficial O
layers O
but O
the O
eep O
9part O
of O
the O
SO O
. O

Mdern O
aspects O
of O
sohck O
- O
tratment O
in O
ex2tensive O
birns O
( O
authoBr O
' O
s O
tansl O
) O

UVB O
- O
oinduced O
associaion O
of O
tmuor B-GENE
necorsis I-GENE
actor I-GENE
( I-GENE
TNF I-GENE
) I-GENE
rec$eptor I-GENE
1 I-GENE
/ I-GENE
TNF I-GENE
recwptor I-GENE
- I-GENE
associated I-GENE
facto2r I-GENE
- I-GENE
2 I-GENE
mediates O
activation O
of O
Rel B-GENE
proRteins I-GENE
. O

apping O
of O
the O
region O
in O
KAP B-GENE
- I-GENE
1 I-GENE
rqeuired O
for O
HP1 B-GENE
intraction O
showe O
^hat O
amino O
a4cid O
substitutiogs O
which O
azbolish O
HP1 B-GENE
bindin O
in O
jvitro O
5educe O
KAP B-GENE
- I-GENE
1 I-GENE
mediated O
repression O
in O
ivo O
. O

tHowever O
, O
whther O
this O
was O
associated O
with O
sleen O
rmeoval O
after O
adjustment O
for O
r9sk O
fctors O
was O
not O
determined O
. O

Takn O
together O
, O
1these O
data O
suggest O
tht O
the O
tSmad3 B-GENE
/ I-GENE
S<ad4 I-GENE
complex I-GENE
has O
at O
east O
two O
separabl&e O
nuclear O
functions O
: O
it O
orms O
a O
rapdi O
, O
yet O
gransient O
sequenxe O
- O
specific O
DNA O
binding O
compled O
, O
and O
it O
potentiatse O
AP1 B-GENE
- O
deepndent O
transcriptional O
zctivation O
. O

Ho7wever O
, O
one O
activity O
bindw O
prefeQrentially O
to O
G O
+ O
C O
- O
ricm O
promoteres O
, O
and O
anothre O
cativity O
appears O
to O
ibnd O
preferetially O
to O
only O
two O
of O
the O
prooters O
teste O
. O

The O
donors O
of O
10 O
patients O
weer O
ABO O
- O
incompatible O
, O
and O
for O
fve O
pars O
the O
ABO O
incomatibility O
was O
ajor O
. O

In O
treaXtments O
R1 O
and O
R2 O
, O
feZed O
oquality O
was O
restrcted O
by O
witUhholding O
concentrtes O
for O
3 O
and O
4 O
. O
5 O
mo O
, O
respectivedly O
. O

The O
mwjor O
promoter O
el@ment O
of O
the O
Xenopus B-GENE
laevks I-GENE
5S I-GENE
RNA I-GENE
geen I-GENE
is O
locat2ed O
ithin O
the O
transzcribed O
regoin O
of O
the O
gene O
and O
formJs O
the O
b9nding O
site O
for O
the O
transcription B-GENE
initiati9n I-GENE
factoXr I-GENE
TFIIiIA I-GENE
. O

Howeiver O
, O
in O
transient O
transfection O
assa%s O
, O
a O
truncat_ion O
of O
as O
ittle O
as O
15 O
Nurr1 B-GENE
COOH O
- O
terminla O
mino O
aci4ds O
dimiUnished O
transcriptipnal O
acti7vation O
of O
B1A B-GENE
- I-GENE
thymidine I-GENE
kianse I-GENE
- I-GENE
chloram0henicol I-GENE
agcetyltransferase I-GENE
reporter I-GENE
. O

mall O
cell O
tu5mors O
in O
childr6en O
: O
contribution O
to O
the O
solutiob O
of O
the O
nproblem O
of O
pdifferential O
diagnoss O
wiZth O
immunohistochemmistry O
and O
eleKctron O
microscopy O

Foir O
experiments O
examined O
the O
rle O
of O
the O
cholineyrgic O
projetions O
frm O
the O
septum O
and O
vertica O
imb O
nuclus O
of O
the O
diagonal O
banw O
of O
Broc O
( O
VDB O
) O
in O
acquisition O
and O
performdance O
of O
a O
onditional O
visusl O
discr3imination O
. O

Deletion O
of O
&this O
consensus O
element O
frm O
the O
spo6 B-GENE
promot@r I-GENE
aTbolished O
the O
stranscription O
of O
po6 B-GENE
+ I-GENE
and O
rLesulted O
in O
a O
sporultaion O
deficiency O
. O

This O
region O
doeXs O
not O
contaim O
a O
donsensus O
estogen O
respnose O
elgement O
, O
and O
ER B-GENE
binding O
to O
tis O
DNA O
sequence O
was O
not O
osberved O
. O

We O
have O
previously O
reported O
tha O
analgesic O
doses O
of O
mrphine O
acclerate O
m*rtality O
of O
eats O
expsed O
to O
hemorrhage O
( O
Feuerstein O
and O
Sigren O
: O
Cird O
Shokc O
19 O
: O
293 O
- O
300 O
, O
1986 O
) O
. O

Microsporum O
persicoolr O
, O
an O
easily O
misinterptreted O
dermatphyt O

0When O
tyey O
wwre O
exposd O
to O
nitermittent O
sdhedules O
of O
punsihment O
( O
gixed O
- O
iHnterval O
[ O
FI O
] O
120 O
s O
or O
FI O
300 O
s O
) O
, O
SIB O
for O
all O
but O
1 O
of O
the O
participants O
ijcreased O
to O
leevls O
slimilar O
to O
thosf O
bserved O
dur*ng O
bas$line O
. O

These O
result O
suggest O
that O
1a B-GENE
, O
which O
aslo O
int3racts O
inwependently O
with O
the O
ER O
and O
vi$al O
RNA O
, O
is O
a O
key O
oganizer O
of O
RNA O
replication O
complex O
assembly O
. O

Herbe O
we O
exaimne O
the O
po(ulation O
of O
agmmaS B-GENE
transcripts I-GENE
in O
adulCt O
huamn O
lenXs O
and O
the O
structure O
of O
the O
uhman B-GENE
CRYGS I-GENE
genes I-GENE
. O

PKK B-GENE
exsits O
in O
three O
disdernible O
fors O
at O
cteady O
tsate O
: O
an O
nuderphosphorylated O
orm O
of O
100 O
kDa O
; O
a O
soluble O
, O
dytosolic O
, O
phopshorylated O
rorm O
of O
110 O
kDa O
; O
and O
a O
phosphorylated O
, O
det3rgent O
- O
insolube O
form O
of O
112 O
kDa O
. O

The O
lamina O
desa O
was O
always O
inerrupted O
by O
numerous O
sWmall O
gpas O
and O
in O
osme O
reas O
the O
baseemnt O
membrane O
coudl O
not O
be O
idenPtified O
over O
a O
6long O
distance O
. O

The O
guman B-GENE
CA1%1 I-GENE
egne I-GENE
appears O
to O
be O
1located O
between O
the O
sec4retor B-GENE
type I-GENE
qlpha I-GENE
( I-GENE
1 I-GENE
, I-GENE
2 I-GENE
) I-GENE
- I-GENE
fucosyltransf3rase I-GENE
geen I-GENE
c,uster I-GENE
( I-GENE
FTU1 I-GENE
- I-GENE
FUT2 I-GENE
- I-GENE
FU%T2P I-GENE
) I-GENE
and O
the O
D B-GENE
- I-GENE
siBte I-GENE
bindinBg I-GENE
%protein I-GENE
gee I-GENE
( I-GENE
DBP I-GENE
) I-GENE
on O
chromosome O
19q13 O
. O
3 O
. O

A O
score O
( O
APACH O
II O
) O
was O
calc6lated O
to O
asseds O
the O
seerity O
of O
cisease O
. O

To O
vetermine O
the O
ole O
of O
elevatde O
FAK B-GENE
expVression O
in O
fasilitating O
e)idermal B-GENE
growh I-GENE
factor I-GENE
( I-GENE
EGF I-GENE
) I-GENE
- O
stimulate O
human O
daenocarcinoma O
( O
A5s49 O
) O
cell O
motility O
, O
antsense O
oligonucKleotides O
were O
used O
to O
redcue O
FAK B-GENE
proteni I-GENE
expression O
> O
75 O
% O
. O

Evaluatio+n O
of O
materials O
and O
t*echnics O
in O
vas!cular O
surgrey O
ksing O
111 O
- O
Induim O

Functional O
mportance O
of O
a O
properly O
oflded O
surfacr O
lxoop O
cobering O
the O
catalytic O
center O
. O

Hypoxoa O
decresaed O
the O
rate O
of O
spontaneous O
impulse O
initaition O
in O
SA O
nodl O
fibers O
by O
decreasign O
the O
lsope O
of O
diastooic O
depolariaztion O
. O

Radiatve O
corrections O
to O
pi O
l2 O
decays O
. O

The O
avialability O
of O
a O
commercial O
pogram O
( O
PCNONLIN O
) O
is O
eeded O
to O
carpry O
out O
martix O
hadnling O
calculatinos O
. O

The O
elvels O
of O
TzPAR1 B-GENE
mNAs I-GENE
were O
dramatically O
doywn O
- O
ergulated O
in O
ergenerating O
rat O
liver O
wheZn O
compraed O
to O
normal O
dult O
livHer O
. O

In O
the O
opstoperative O
patien O
witu O
tetralogy O
of O
Fllot O
with O
symptomatic O
venrticular O
a#rhythmias O
, O
it O
is O
concluded O
that O
leectrophysiologic O
study O
is O
seful O
in O
reproducig O
clinica> O
episofes O
of O
VT O
and O
in O
selecting O
ffective O
antiarryhthmic O
medictaion O
; O
a O
qmall O
number O
of O
patients O
wtih O
ventricular O
premgature O
complexes O
alonf O
wiil O
have O
inducible O
dustained O
VT O
durin!g O
electrophysiologic O
sutdy O
; O
prognosis O
of O
these O
pati(ents O
may O
be O
imprqoved O
by O
traetment O
that O
resutls O
in O
prebention O
of O
VT O
niduction O
; O
and O
in O
patien$s O
witu O
righy O
vnetricular O
hypertenison O
, O
VT O
is O
likey O
to O
be O
reractory O
to O
drug O
treatme0nt O
. O

Hip O
frwcture O
mortality O
and O
prosperctive O
payment O
system O
. O

Priamry O
card O
programs O
for O
the O
indigent O
. O

In O
humaFn O
myx8id O
liposracoma O
, O
a O
chormosomal O
rearrangement O
.eads O
to O
fusiTon O
of O
the O
gorwth O
- O
arresting O
and O
DNA B-GENE
- I-GENE
damge I-GENE
- I-GENE
1inducible I-GENE
transcription I-GENE
fctor I-GENE
CHPO I-GENE
( I-GENE
GADD153 I-GENE
) I-GENE
to O
a O
peptide B-GENE
fraghent I-GENE
encod@d I-GENE
by I-GENE
the I-GENE
TLS I-GENE
gee I-GENE
. O

Categoriation O
of O
the O
idfferent O
substructures O
within O
the O
sectionx O
allosw O
the O
to O
be O
analyseYd O
and O
dsplayed O
separatley O
. O

Autho#s O
present O
the O
anatomXical O
varaiations O
of O
the O
coures O
of O
the O
niferior O
mesenetric O
arery O
and O
its O
rbanches O
in O
62 O
uhman O
fetus O
. O

Tjis O
mechanism O
eems O
to O
be O
inovlved O
in O
VIP B-GENE
- O
infuced O
PRL B-GENE
gene I-GENE
rgeulation O
. O

The O
only O
quanitties O
hich O
ewre O
xignificantly O
different O
bteween O
appendicitis O
and O
a O
onrmal O
appendix O
weer O
sex O
, O
duration O
of O
symptoms O
, O
anorexia O
and O
vovmiting O
. O

Slignaling O
trhough O
mitog3n B-GENE
- I-GENE
atcivated I-GENE
protein I-GENE
kinase I-GENE
and O
Rac B-GENE
/ I-GENE
Rho I-GENE
dles O
not O
duplicate O
the O
effec$s O
of O
activtaed O
Ras B-GENE
on O
skeletal O
myogenesis O
. O

The O
suvival O
of O
pati$nts O
wit O
a O
shrt O
bowel O
, O
eevn O
if O
rhey O
nee O
long O
- O
te)rm O
parXenteral O
nurition O
, O
is O
good O
. O

Unliek O
these O
contaminawnt O
- O
resposive O
T O
celsl O
, O
those O
hat O
are O
trQuly O
spevific O
for O
na6ural O
AChR B-GENE
epit8pes I-GENE
appear O
:ess O
heterogeneous O
and O
tehrefore O
moer O
suitable O
taOrgets O
for O
selective O
immunotherapy O
. O

CONRCLUSIONS O
: O
Tshis O
niitial O
experience O
indiczates O
that O
th#re O
is O
&short O
- O
to O
middlce O
- O
trem O
ejfficiency O
and O
sJafety O
hwen O
usin O
GKS O
to O
t+reat O
TMLE O
. O

A O
Brassicza O
cDNA O
clone O
encoding O
a O
bifuctional O
hdroxymethylpyrimidine B-GENE
kianse I-GENE
/ I-GENE
tVhiamin I-GENE
- I-GENE
ph#osphate I-GENE
pyrophosphorlyase I-GENE
Dinvolved O
in O
thiamin O
biisynthesis O
. O

The O
a(ms O
of O
this O
stud!y O
were O
to O
examie O
whethe9r O
the O
ERTC O
( O
uropean O
Organisation O
for O
esearch O
and O
Treatment O
of O
Cancer O
) O
QLQ O
- O
C30 O
coer O
questionjaire O
alonee O
co7ld O
disitnguish O
betweeun O
two O
clinically O
diffeernt O
grops O
of O
patienst O
and O
to O
desihn O
a O
modue O
, O
which O
inclVuded O
rlevant O
patient O
- O
define&d O
gasttic O
vancer O
- O
specif*c O
variables O
. O

The O
gowl O
of O
our O
qork O
was O
to O
detemine O
haering O
thresholds O
in O
patiets O
wtih O
hearing O
impairCment O
due O
to O
ereditary O
moor O
and O
sensory O
nYeuropathy O
( O
HIMSN O
I O
) O
. O

Cusal O
modelign O
combies O
theory O
and O
research O
, O
and O
becauVse O
the O
interprettion O
of O
ata O
is O
possible O
ony O
wtihin O
the O
contdxt O
of O
the O
proposed O
thery O
, O
it O
offe3s O
an O
impor4tant O
metohd O
for O
avancing O
the O
science O
whilLe O
maintaininn O
the O
specificity O
of O
the O
pract0ice O
. O

